<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/sitemap-new?view=xsl&amp;format=xsl&amp;layout=standard&amp;id=2"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc><![CDATA[https://www.osservatoriomalattierare.it/]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv]]></loc><lastmod>2018-02-15T04:26:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/22136-infezioni-in-gravidanza-nasce-una-rete-nazionale-per-rafforzare-screening-e-prevenzione]]></loc><lastmod>2025-06-27T13:04:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/19271-citomegalovirus-via-libera-della-fda-a-un-nuovo-test-molecolare]]></loc><lastmod>2022-11-15T18:34:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/18237-citomegalovirus-il-possibile-ruolo-delle-immunoglobuline-nel-trattamento-delle-infezioni-materno-fetali]]></loc><lastmod>2022-02-02T14:23:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/17558-citomegalovirus-ecco-come-il-sistema-immunitario-puo-sconfiggere-l-infezione]]></loc><lastmod>2021-06-20T16:17:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/15586-citomegalovirus-congenito-e-utile-lo-screening-prenatale]]></loc><lastmod>2020-01-20T10:25:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/15561-citomegalovirus-solo-il-20-delle-donne-lo-conosce]]></loc><lastmod>2020-01-18T18:41:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/13206-citomegalovirus-autorizzata-dalla-ce-l-immissione-in-commercio-di-letermovir]]></loc><lastmod>2018-02-07T11:16:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/11907-citomegalovirus-nove-mozioni-approvate-alla-camera]]></loc><lastmod>2017-07-16T16:54:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/11903-citomegalovirus-la-camera-dovrebbe-discutere-oggi-una-mozione-sul-tema-prevenzione]]></loc><lastmod>2017-06-19T13:57:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/11855-citomegalovirus-congenito-quali-prospettive-per-un-vaccino]]></loc><lastmod>2017-06-16T07:57:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/10446-citomegalovirus-necessari-degli-screening-autorizzati-prima-e-durante-la-gravidanza]]></loc><lastmod>2017-06-19T13:57:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/9186-citomegalovirus-i-dati-sulla-sicurezza-e-l-efficacia-del-trattamento-con-globuline-iperimmuni]]></loc><lastmod>2017-06-19T13:58:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/8838-citomegalovirus-congenito-uno-studio-ha-indagato-i-benefici-della-terapia-antivirale-sull-udito]]></loc><lastmod>2015-08-28T08:44:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/8339-infezione-congenita-da-citomegalovirus-lo-screening-neonatale-mirato-e-preferibile-a-quello-universale]]></loc><lastmod>2015-05-28T14:54:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/8237-citomegalovirus-e-vaccini-una-storia-lunga-50-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/7338-citomegalovirus-il-vaccino-sara-presto-sperimentato]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/6745-infezioni-materne-primarie-da-citomegalovirus-confermata-lutilita-delle-immunoglobuline]]></loc><lastmod>2019-06-18T17:57:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/6477-citomegalovirus-studio-indaga-la-validita-di-un-nuovo-test-di-avidita]]></loc><lastmod>2019-06-18T18:04:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/6374-negli-usa-si-spendono-in-media-143-milioni-di-dollari-allanno-per-neonati-affetti-dal-virus]]></loc><lastmod>2019-06-18T18:07:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/6055-citomegalovirus-nessuna-correlazione-tra-il-virus-e-la-condizione-di-sottopeso-nei-neonati]]></loc><lastmod>2019-06-18T18:20:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5972-citomegalovirus-individuata-unanomalia-cerebrale-tipica]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5917-citomegalovirus-congenito-effettuato-uno-studio-sulla-globulina-iperimmune-per-prevenire-linfezione]]></loc><lastmod>2019-06-18T18:26:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5879-sordita-causata-dal-citomegalovirus-risonanza-magnetica-aiuta-la-scelta-su-impianto-cocleare]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5810-citomegalovirus-identificata-una-proteina-che-regola-il-sistema-immunitario]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5421-citomegalovirus-congenito-ecco-come-il-virus-si-diffonde-nel-cervello]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5384-citomegalovirus-congenito-senza-screening-troppi-casi-vengono-ignorati]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5301-citomegalovirus-la-malattia-congenita-che-le-mamme-non-conoscono]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5248-citomegalovirus-nel-bambino-la-terapia-antivirale-da-miglioramenti-in-caso-di-perdita-di-udito-a-insorgenza-tardiva]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5205-citomegalovirus-il-test-di-screening-in-gravidanza-e-fondamentale]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5077-citomegalovirus-in-futuro-ci-sara-un-vaccino-per-ora-la-prevenzione-e-fondamentale]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5058-citomegalovirus-i-rugbisti-della-nazionale-promuovono-la-prevenzione]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/5034-citomegalovirus-in-abruzzo-attivo-un-servizio-di-screening-per-le-gestanti]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/4923-citomegalovirus-in-gravidanza-il-contagio-del-feto-si-puo-prevenire-ma-la-terapia-e-poco-conosciuta-alle-gestanti-viene-consigliato-laborto]]></loc><lastmod>2015-11-03T09:27:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/4924-citomegalovirus-giada-briziarelli-benetton-qla-terapia-ha-salvato-mia-figlia-isabellaq]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/4817-citomegalovirus-nei-paesi-in-via-di-sviluppo-e-la-prima-causa-di-malformazioni-congenite]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/4494-citomegalovirus-in-israele-si-sperimenta-lo-screening-neonatale-su-sangue-cordonale]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/4375-citomegalovirus-dalla-sardegna-il-primo-studio-del-metaboloma-dellurina-di-bambini-affetti-da-citomegalovirus]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/4173-cytomegalovirus-tracy-lha-contratto-in-gravidanza-e-suo-figlio-e-molto-malato-lei-ha-deciso-di-aiutare-la-ricerca]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/4100-infezione-da-citomegalovirus-per-i-neonati-meglio-ecografia-cerebrale-o-risonanza-magnetica]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/3956-citomegalovirus-uno-studio-delluniversita-di-parma-ne-scopre-nuovi-meccanismi-patogenetici]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/3946-citomegalovirus-una-proteina-potrebbe-eliminare-il-virus-latente]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/3924-citomegalovirus-congenito-si-fa-strada-lipotesi-di-uno-screening-in-gravidanza]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/3923-citomegalovirus-congenito-le-donne-lo-conoscono]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/3922-citomegalovirus-congenito-la-prima-arma-di-prevenzione-e-ligiene]]></loc><lastmod>2015-05-25T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/3850-citomegalovirus-e-virus-di-epstein-barr-potrebbero-essere-associati-a-casi-di-paralisi-cerebrale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/3752-infezione-da-citomegalovirus-negli-usa-si-valuta-lo-screening-in-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/3196-sordita-il-citomegalovirus-e-la-seconda-causa-nei-bimbi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/citomegalovirus-congenito-cmv/2713-diabete-il-citomegalovirus-e-un-fattore-di-rischio-per-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf]]></loc><lastmod>2024-03-13T12:10:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/22908-fibrosi-polmonare-idiopatica-ancora-aperto-larruolamento-per-lo-studio-genesi]]></loc><lastmod>2026-04-02T16:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/22510-fibrosi-polmonare-idiopatica-avviato-il-primo-registro-nazionale-e-il-censimento-dei-centri-di-riferimento]]></loc><lastmod>2025-11-18T18:06:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/22511-fibrosi-polmonare-idiopatica-ottimi-risultati-per-nerandomilast]]></loc><lastmod>2025-11-13T19:10:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/22421-fibrosi-polmonare-idiopatica-una-nuova-classificazione-delle-interstiziopatie-polmonari]]></loc><lastmod>2025-10-20T22:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/22007-fibrosi-polmonare-l-alba-di-una-nuova-era-per-i-pazienti]]></loc><lastmod>2025-05-21T18:19:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/20745-fibrosi-polmonare-idiopatica-dai-trial-clinici-due-delusioni-ma-anche-sei-speranze]]></loc><lastmod>2024-03-12T15:09:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/20170-ipf-a-roma-si-e-svolto-il-i-convegno-nazionale-fimarp]]></loc><lastmod>2023-09-29T17:43:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/20009-fibrosi-polmonare-idiopatica-a-padova-avviato-trial-clinico-su-molecola-anti-fosfodiesterasi-4b]]></loc><lastmod>2023-07-17T15:00:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/19656-fibrosi-polmonare-idiopatica-al-tor-vergata-una-targa-in-ricordo-di-bruno-domenici]]></loc><lastmod>2023-03-22T19:22:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/19510-interstiziopatie-polmonari-numerose-eterogeneee-e-meno-rare-di-quanto-si-pensi]]></loc><lastmod>2024-02-13T17:47:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/19384-fibrosi-polmonare-l-iter-diagnostico-e-ancora-troppo-lungo]]></loc><lastmod>2022-12-12T15:34:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/19043-malattia-polmonare-interstiziale-fibrosante-dati-incoraggianti-per-nintedanib-ad-uso-pediatrico]]></loc><lastmod>2022-09-11T14:29:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/18826-ipf-l-associazione-un-respiro-di-speranza-presente-anche-al-policlinico-tor-vergata]]></loc><lastmod>2022-06-24T16:24:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/18676-ipf-risultati-promettenti-da-un-innovativo-inibitore-delle-fosfodiesterasi-4b]]></loc><lastmod>2022-05-22T18:14:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/18653-ipf-i-vaccini-anti-covid-potrebbero-causare-rari-eventi-di-riacutizzazione-della-malattia]]></loc><lastmod>2022-05-15T20:31:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/18639-ipf-e-patologie-polmonari-in-lombardia-sara-presto-possibile-ricaricare-l-ossigeno-in-farmacia]]></loc><lastmod>2022-05-12T11:26:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/17764-ipf-il-video-racconto-di-achille-abbondanza-che-pedala-in-attesa-del-trapianto]]></loc><lastmod>2021-09-11T21:44:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/17251-ipf-la-pedalata-di-achille-abbondanza-per-ottenere-al-piu-presto-il-vaccino-per-i-piu-fragili]]></loc><lastmod>2021-04-02T18:00:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/16834-fibrosi-polmonare-e-malattie-reumatiche-un-associazione-ad-alto-rischio]]></loc><lastmod>2020-12-21T22:14:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/16819-malattie-polmonari-i-pazienti-devono-poter-ricaricare-l-ossigeno-anche-in-ospedale-e-in-farmacia]]></loc><lastmod>2020-12-17T10:02:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/16810-vaccino-per-il-covid-19-ai-pazienti-con-fibrosi-polmonare-dovrebbe-essere-data-la-priorita]]></loc><lastmod>2020-12-15T11:33:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/16799-ipf-e-patologie-polmonari-pazienti-in-attesa-di-poter-ricaricare-l-ossigeno-in-farmacia]]></loc><lastmod>2020-12-14T13:42:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/16784-fibrosi-polmonare-idiopatica-nuovi-farmaci-in-via-di-studio-anche-in-italia]]></loc><lastmod>2020-12-08T20:46:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/16601-ipf-fino-a-pochi-anni-fa-l-unica-vera-opzione-era-il-trapianto]]></loc><lastmod>2020-10-23T16:19:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/16538-malattie-fibrosanti-del-polmone-pazienti-ad-alto-rischio-di-fronte-al-covid-19]]></loc><lastmod>2020-10-07T09:18:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/16428-fibrosi-polmonare-idiopatica-in-questi-giorni-la-ipf-world-week]]></loc><lastmod>2020-09-13T22:40:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/16325-malattie-polmonari-fibrosanti-approvazione-europea-per-nintedanib]]></loc><lastmod>2020-07-26T14:55:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/16141-malattie-polmonari-fibrosanti-parere-positivo-del-chmp-per-nintedanib]]></loc><lastmod>2020-06-08T19:57:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/15662-fibrosi-polmonare-idiopatica-disponibili-in-lingua-italiana-le-linee-guida-per-la-diagnosi]]></loc><lastmod>2020-02-17T19:12:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/15466-ipf-e-reflusso-gastroesofageo-due-condizioni-spesso-correlate-ma-i-dubbi-sono-tanti]]></loc><lastmod>2019-12-01T22:11:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/15420-ipf-il-pirfenidone-in-ambito-real-life-conferma-i-risultati-sperimentali]]></loc><lastmod>2019-11-18T15:31:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/15357-fibrosi-polmonare-idiopatica-a-napoli-pneumologi-a-confronto]]></loc><lastmod>2019-10-29T17:58:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/15288-malattie-polmonari-fibrosanti-nintedanib-raggiunge-endpoint-primario-in-studio-di-fase-iii]]></loc><lastmod>2019-10-09T18:13:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/15275-fibrosi-polmonare-idiopatica-individuato-un-anticorpo-che-ne-rallenta-la-progressione]]></loc><lastmod>2019-10-07T20:08:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/15150-fibrosi-polmonare-idiopatica-silvia-serve-piu-considerazione-per-le-forme-familiari]]></loc><lastmod>2019-09-03T09:27:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/15077-ipf-uno-studio-suggerisce-il-trattamento-tempestivo-con-antifibrotici-per-rallentare-la-progressione-della-malattia]]></loc><lastmod>2019-07-30T13:56:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/14895-fibrosi-polmonare-idiopatica-a-catania-giovani-pneumologi-a-confronto]]></loc><lastmod>2019-06-09T17:16:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/14694-ipf-saracatinib-riceve-la-designazione-di-farmaco-orfano-dalla-fda]]></loc><lastmod>2019-04-05T18:04:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/14389-fibrosi-polmonare-idiopatica-nuovi-dati-sui-benefici-del-pirfenidone]]></loc><lastmod>2019-01-25T11:50:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/14317-ipf-iniziato-il-programma-di-sviluppo-di-fase-iii-del-farmaco-glpg1690]]></loc><lastmod>2018-12-30T21:16:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13993-ipf-grande-successo-per-la-prima-giornata-italiana]]></loc><lastmod>2018-10-03T18:18:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13967-ipf-nuovi-dati-su-pirfenidone-ne-consolidano-efficacia-e-sicurezza]]></loc><lastmod>2018-09-25T18:04:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13959-ipf-il-viagra-associato-a-nintedanib-ne-potenzia-l-efficacia]]></loc><lastmod>2018-09-24T17:41:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13937-ipf-voci-sott-acqua-partecipa-alla-salomon-running-milano-2018]]></loc><lastmod>2018-09-18T17:30:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13867-ipf-partita-la-nuova-edizione-di-pedalando-l-italia-senza-perdere-un-respiro]]></loc><lastmod>2018-08-27T16:18:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13811-ipf-fimarp-entra-nella-federazione-europea-eu-ipff]]></loc><lastmod>2018-08-01T16:54:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13695-ipf-la-partecipazione-ai-gruppi-di-supporto-ha-effetti-benefici-sui-pazienti]]></loc><lastmod>2018-06-25T17:40:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13611-ipf-testato-con-buoni-risultati-il-nuovo-farmaco-pentraxina-2-ricombinante]]></loc><lastmod>2018-06-02T09:25:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13572-identificata-l-origine-molecolare-della-fibrosi-polmonare-idiopatica]]></loc><lastmod>2018-05-19T17:07:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13277-ipf-voci-sott-acqua-diventa-la-prima-community-italiana-per-i-pazienti]]></loc><lastmod>2018-02-25T17:11:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13213-ipf-lo-smog-potrebbe-essere-una-possibile-causa]]></loc><lastmod>2018-02-11T17:04:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/13128-ipf-arriva-perfect-un-progetto-per-facilitare-la-diagnosi-precoce]]></loc><lastmod>2018-01-21T18:54:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12895-ipf-aggiornata-la-guida-di-omar-ai-centri-di-riferimento-italiani]]></loc><lastmod>2021-03-22T16:37:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12693-ipf-peggiore-qualita-del-sonno-e-rischio-di-apnee-notturne-per-i-pazienti]]></loc><lastmod>2017-09-27T08:19:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12681-ipf-week-2017-reverb-presenta-il-cortometraggio-ipf]]></loc><lastmod>2017-09-23T16:28:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12657-ipf-week-2017-numerose-le-iniziative-organizzate-dall-associazione-ama-fuori-dal-buio]]></loc><lastmod>2017-09-22T11:48:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12644-ipf-dati-clinici-favorevoli-per-nintedanib-piu-pirfenidone]]></loc><lastmod>2017-09-12T16:17:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12480-fibrosi-polmonare-idiopatica-al-via-la-seconda-fase-di-voci-sott-acqua]]></loc><lastmod>2017-07-10T09:29:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12419-ciao-guerriero-il-nostro-saluto-ad-alessandro-giordani]]></loc><lastmod>2017-09-12T15:30:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12398-pneumologia-la-federazione-fimarp-compie-i-primi-passi]]></loc><lastmod>2017-06-19T14:13:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12367-ipf-il-guerriero-stanco-arriva-a-bologna-per-il-congresso-aipo]]></loc><lastmod>2017-06-11T14:00:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12315-fibrosi-polmonare-idiopatica-nintedanib-migliora-la-funzionalita-polmonare]]></loc><lastmod>2017-05-25T12:17:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12314-fibrosi-polmonare-idiopatica-minor-rischio-di-decesso-con-pirfenidone]]></loc><lastmod>2017-06-19T14:13:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12297-ipertensione-polmonare-associata-a-ipf-buoni-risultati-da-inalatore-di-ossido-nitrico]]></loc><lastmod>2017-06-19T14:14:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12288-ipf-al-san-raffaele-di-milano-si-studia-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2017-05-18T13:32:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12238-ipf-a-milano-arriva-l-installazione-de-il-guerriero-stanco]]></loc><lastmod>2017-05-02T14:44:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12191-fibrosi-polmonare-idiopatica-i-nuovi-farmaci-riducono-sensibilmente-la-progressione-di-malattia]]></loc><lastmod>2017-04-20T11:04:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/12056-fibrosi-polmonare-idiopatica-2-pazienti-su-3-sono-stati-coinvolti-nella-scelta-del-trattamento]]></loc><lastmod>2017-03-12T16:43:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11996-fibrosi-polmonare-idiopatica-quando-anche-respirare-diventa-difficile]]></loc><lastmod>2017-02-26T17:31:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11734-ipf-a-torino-il-primo-trapianto-italiano-tramite-ricondizionamento-di-polmone-ex-vivo]]></loc><lastmod>2016-12-17T11:05:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11673-in-un-corto-la-battaglia-di-alessandro-contro-l-ipf]]></loc><lastmod>2016-12-01T15:40:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11614-ipf-un-incontro-parlamentare-sul-futuro-dei-pazienti-dopo-la-dichiarazione-scritta-26]]></loc><lastmod>2018-09-12T18:04:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11461-ipf-nel-regno-unito-il-pirfenidone-solo-per-le-forme-da-moderate-a-gravi]]></loc><lastmod>2016-10-15T22:26:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11419-ipf-week-2016-le-attivita-e-le-problematiche-dell-ambulatorio-di-napoli]]></loc><lastmod>2016-10-12T10:34:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11420-ipf-week-2016-quale-approccio-per-gestire-la-patologia]]></loc><lastmod>2016-10-12T10:33:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11425-fibrosi-polmonare-idiopatica-come-si-comunica-la-diagnosi-al-paziente]]></loc><lastmod>2016-10-10T08:41:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11412-ipf-week-2016-nasce-l-associazione-respirare-campania-dedicata-alla-fibrosi-polmonare-idiopatica]]></loc><lastmod>2016-10-07T17:10:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11413-fibrosi-polmonare-idiopatica-la-situazione-dei-pazienti-napoletani]]></loc><lastmod>2016-10-10T08:49:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11389-ipf-week-2016-le-testimonianze-dei-pazienti-modenesi]]></loc><lastmod>2016-10-05T14:23:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11388-ipf-week-2016-il-centro-per-le-malattie-rare-del-polmone-di-modena-in-prima-linea]]></loc><lastmod>2016-10-05T14:20:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11387-ipf-week-2016-i-traguardi-internazionali-e-i-prossimi-obiettivi]]></loc><lastmod>2016-10-05T14:04:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11384-ipf-week-2016-l-importanza-degli-eventi-di-sensibilizzazione-sulla-fibrosi-polmonare-idiopatica]]></loc><lastmod>2016-10-05T07:50:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11335-ipf-week-2016-grande-successo-per-i-40-eventi-e-per-la-campagna-diamorespiro]]></loc><lastmod>2016-09-27T14:03:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11309-fibrosi-polmonare-idiopatica-l-ue-concede-status-orfano-ad-una-nuova-molecola]]></loc><lastmod>2021-11-02T15:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11276-pubblicata-la-dichiarazione-scritta-sulla-ipf-da-parte-del-parlamento-europeo]]></loc><lastmod>2016-09-19T13:17:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11259-l-italia-sempre-piu-protagonista-della-settimana-mondiale-per-la-fibrosi-polmonare-idiopatica-ipf]]></loc><lastmod>2016-09-23T07:25:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11247-ipf-world-week-2016-tutti-gli-eventi-italiani]]></loc><lastmod>2016-09-21T09:48:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11204-fibrosi-polmonare-idiopatica-quasi-3-anni-di-vita-in-piu-grazie-alla-terapia-con-pirfenidone]]></loc><lastmod>2016-09-07T15:49:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11200-respirare-onlus-apre-tre-nuove-sedi-in-campania-puglia-e-calabria-per-essere-sempre-piu-vicina-ai-pazienti-con-rare-malattie-polmonari]]></loc><lastmod>2016-09-06T13:32:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11057-fibrosi-polmonare-idiopatica-le-manifestazioni-cardiache-hanno-un-impatto-significativo-sulla-mortalita]]></loc><lastmod>2016-07-29T12:25:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/11003-fibrosi-polmonare-idiopatica-adottata-dal-parlamento-europeo-la-dichiarazione-26-2016]]></loc><lastmod>2016-07-20T09:46:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10995-fibrosi-polmonare-idiopatica-online-la-guida-ai-centri-dispensatori-dei-farmaci]]></loc><lastmod>2021-03-22T16:40:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10912-ipf-avviato-studio-per-valutare-l-effetto-di-nintedanib-sui-biomarcatori-coinvolti-nel-processo-fibrotico]]></loc><lastmod>2016-07-04T22:39:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10910-fibrosi-polmonare-idiopatica-l-efficacia-di-nintedanib-confermata-da-nuovo-studio]]></loc><lastmod>2016-07-04T22:24:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10867-alessandro-il-guerriero-e-la-battaglia-contro-l-ipf]]></loc><lastmod>2016-06-28T10:04:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10842-fibrosi-polmonare-idiopatica-al-via-la-campagna-di-sensibilizzazione-diamorespiro-a-chi-non-ce-l-ha]]></loc><lastmod>2016-07-15T06:51:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10749-ipf-accordo-tra-boehringer-ingelheim-e-inventiva-pharma-per-la-ricerca]]></loc><lastmod>2016-06-07T07:59:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10639-ipf-nasce-un-portale-dedicato-alla-patologia]]></loc><lastmod>2016-06-12T19:09:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10640-fibrosi-polmonare-idiopatica-nuove-conferme-per-il-trattamento-con-pirfenidone]]></loc><lastmod>2016-05-18T08:24:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10614-fibrosi-polmonare-idiopatica-il-farmaco-nintedanib-a-disposizione-dei-pazienti]]></loc><lastmod>2016-05-17T09:42:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10602-l-europarlamento-alla-commissione-europea-fare-di-piu-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2016-05-15T07:20:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10570-ipf-nuove-possibilita-terapeutiche-dai-micro-rna]]></loc><lastmod>2016-05-10T13:22:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10476-a-siena-i-pazienti-con-ipf-hanno-dalla-loro-parte-una-nuova-associazione]]></loc><lastmod>2016-04-29T10:27:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10357-fibrosi-polmonare-idiopatica-gli-ultimi-dati-sull-epidemiologia-nel-nord-italia]]></loc><lastmod>2016-04-12T10:21:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10352-fibrosi-polmonare-idiopatica-il-farmaco-nintedanib-ora-in-commercio-in-italia]]></loc><lastmod>2016-04-11T14:18:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10330-ipf-in-lombardia-c-e-il-pdta-ma-pazienti-ancora-senza-esenzione]]></loc><lastmod>2016-04-14T10:09:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10329-fibrosi-polmonare-idiopatica-in-lombardia-nasce-una-nuova-associazione-di-pazienti]]></loc><lastmod>2016-04-08T12:30:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10328-fibrosi-polmonare-idiopatica-i-pazienti-uniti-verso-obiettivi-comuni]]></loc><lastmod>2016-04-08T12:53:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10312-la-fibrosi-polmonare-idiopatica-sara-finalmente-riconosciuta-come-malattia-rara]]></loc><lastmod>2016-04-05T15:48:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10311-ipf-camera-impegnata-nella-discussione-su-riconoscimento-della-patologia]]></loc><lastmod>2016-04-05T13:47:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10192-fibrosi-polmonare-idiopatica-al-governo-si-chiede-il-riconoscimento-a-livello-nazionale]]></loc><lastmod>2016-04-05T10:19:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10167-ossigenoterapia-il-ministero-risponde-difficile-trovare-una-soluzione-alle-differenze-regionali-ma-cerchiamo-una-soluzione]]></loc><lastmod>2016-03-11T08:15:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10097-fibrosi-polmonare-idiopatica-malattia-rara-riconosciuta-solo-in-due-regioni-italiane]]></loc><lastmod>2016-03-14T08:54:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10068-fibrosi-polmonare-idiopatica-nintedanib-ridurrebbe-le-esacerbazioni-acute]]></loc><lastmod>2016-02-29T12:18:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/10047-ipf-lo-stato-d-animo-dei-pazienti-frustrati-ma-determinati]]></loc><lastmod>2016-02-26T11:28:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9998-fibrosi-polmonare-idiopatica-nasce-a-bruxelles-la-federazione-europea-eu-ipff]]></loc><lastmod>2016-02-22T10:03:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9990-malattie-polmonari-al-ministro-lorenzin-si-chiede-di-superare-le-differenze-nei-sistemi-utilizzati-per-l-ossigenoterapia]]></loc><lastmod>2016-02-19T09:59:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9899-e-online-il-nuovo-aggiornamento-della-guida-per-i-pazienti-di-fibrosi-polmonare-idiopatica-2]]></loc><lastmod>2021-03-22T16:32:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9872-ipf-la-carta-europea-del-paziente-pubblicata-su-european-respiratory-journal]]></loc><lastmod>2016-02-01T12:07:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9864-fibrosi-polmonare-idiopatica-il-nice-raccomanda-l-uso-del-farmaco-ofev-nintedanib]]></loc><lastmod>2016-02-01T09:24:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9792-malattie-rare-nella-asl-roma-e-il-farmaco-non-arriva-paziente-fa-esposto-ai-carabinieri]]></loc><lastmod>2016-01-22T09:52:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9721-ipf-i-pazienti-del-lazio-dicono-addio-ai-difficoltosi-viaggi-nella-capitale-per-avere-il-farmaco]]></loc><lastmod>2016-01-11T10:37:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9702-ipf-interrotto-lo-studio-clinico-di-fase-ii-su-simtuzumab]]></loc><lastmod>2016-01-07T10:47:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9633-fibrosi-polmonare-idiopatica-cade-un-limite-all-utilizzo-del-pirfenidone]]></loc><lastmod>2015-12-16T14:15:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9622-fibrosi-polmonare-idiopatica-al-via-primo-studio-su-combinazione-nintedanib-e-pirfenidone]]></loc><lastmod>2015-12-15T10:45:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9433-ipf-week-2015-gli-obiettivi-di-airpp-e-unione-trapiantati-di-polmone-di-padova]]></loc><lastmod>2015-11-25T10:08:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9432-ipf-week-2015-il-prof-vancheri-spiega-i-progressi-raggiunti-e-le-problematiche-aperte]]></loc><lastmod>2015-11-25T10:03:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9431-ipf-week-2015-il-concerto-della-sauro-s-band-per-le-vie-di-modena]]></loc><lastmod>2015-11-25T09:58:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9430-ipf-week-2015-l-ass-un-respiro-di-speranza-spiega-le-problematiche-del-lazio]]></loc><lastmod>2015-11-25T09:55:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9429-ipf-week-2015-l-allarme-del-prof-valente-sempre-meno-specializzati-in-pneumologia]]></loc><lastmod>2015-11-25T09:51:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9386-ipf-scoperti-nuovi-biomarcatori-modificabili-nel-corso-della-terapia]]></loc><lastmod>2015-11-19T08:34:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9354-fibrosi-polmonare-idiopatica-imparare-dagli-errori-del-passato-per-promuovere-lo-sviluppo-di-nuovi-farmaci]]></loc><lastmod>2015-11-13T12:06:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9244-fibrosi-polmonare-idiopatica-livelli-di-mmp-10-nuovo-potenziale-biomarcatore]]></loc><lastmod>2015-10-28T15:49:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9187-fibrosi-polmonare-idiopatica-il-ritardo-diagnostico-peggiora-la-vita-dei-pazienti]]></loc><lastmod>2015-10-21T07:51:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9179-fibrosi-polmonare-idiopatica-e-attivo-il-servizio-gratuito-di-esperto-risponde]]></loc><lastmod>2015-10-20T08:12:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9089-ipf-world-week-2015-sabato-open-day-al-policlinico-di-modena]]></loc><lastmod>2015-10-09T13:10:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9061-ipf-world-week-gli-eventi-a-ravenna]]></loc><lastmod>2015-10-09T12:46:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9066-fibrosi-polmonare-idiopatica-il-nintedanib-rallenta-del-50-la-progressione-della-malattia]]></loc><lastmod>2015-10-08T10:53:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9048-ipf-world-week-open-day-all-ospedale-monaldi-di-napoli]]></loc><lastmod>2015-10-09T12:46:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9047-ipf-world-week-a-roma-il-convegno-respiriamo-insieme-vivere-ogni-giorno-con-l-ipf]]></loc><lastmod>2015-10-09T12:47:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9051-fibrosi-polmonare-idiopatica-35-000-nuovi-pazienti-diagnosticati-ogni-anno-in-europa]]></loc><lastmod>2015-10-07T08:36:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9043-ipf-world-week-gli-eventi-della-sicilia]]></loc><lastmod>2015-10-10T07:56:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9042-ipf-world-week-le-iniziative-di-milano]]></loc><lastmod>2015-10-09T12:47:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9046-fibrosi-polmonare-idiopatica-il-trattamento-a-lungo-termine-con-pirfenidone-riduce-la-mortalita-del-38]]></loc><lastmod>2015-10-07T07:28:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9035-ipf-world-week-gli-eventi-di-foggia]]></loc><lastmod>2015-10-09T12:47:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9033-ipf-world-week-gli-eventi-di-padova]]></loc><lastmod>2015-10-09T12:47:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9032-ipf-world-week-gli-eventi-del-veneto]]></loc><lastmod>2015-10-09T12:47:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9031-ipf-world-week-le-iniziative-a-monza]]></loc><lastmod>2015-10-09T12:47:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9028-ipf-world-week-le-iniziative-di-cagliari]]></loc><lastmod>2015-10-09T12:47:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9029-fibrosi-polmonare-idiopatica-i-pazienti-al-parlamento-europeo-per-chiedere-cure-accessibili-e-sostegno]]></loc><lastmod>2015-10-02T12:32:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9027-ipf-world-week-le-iniziative-di-pistoia]]></loc><lastmod>2015-10-09T12:48:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9026-dal-5-all-11-ottobre-2015-quarta-edizione-ipf-world-week]]></loc><lastmod>2016-03-14T10:42:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/9005-fibrosi-polmonare-idiopatica-tutti-gli-eventi-italiani-per-la-ipf-iworld-week-2015]]></loc><lastmod>2015-10-01T15:29:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8986-fiato-alla-speranza-il-video-per-la-settimana-mondiale-della-fibrosi-polmonare-2015]]></loc><lastmod>2015-09-24T15:46:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8956-roche-presentera-i-nuovi-dati-sul-farmaco-esbriet-nella-fibrosi-polmonare-idiopatica-al-congresso-della-european-respiratory-society-di-amsterdam]]></loc><lastmod>2015-09-22T08:03:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8939-fibrosi-polmonare-idiopatica-l-ambulatorio-dedicato-di-cosenza-e-trasferito-a-s-barbara-di-rogliano]]></loc><lastmod>2015-09-18T07:33:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8907-la-fibrosi-polmonare-idiopatica-e-il-ruolo-del-reflusso-gastroesofageo]]></loc><lastmod>2015-09-11T10:46:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8869-fibrosi-polmonare-idiopatica-ad-arezzo-un-ambulatorio-dedicato-ai-pazienti]]></loc><lastmod>2015-09-04T13:11:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8785-fibrosi-polmonare-idiopatica-nuovi-dati-a-favore-della-terapia-con-pirfenidone]]></loc><lastmod>2015-08-19T14:16:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8709-fibrosi-polmonare-idiopatica-una-malattia-che-lascia-senzafiato]]></loc><lastmod>2015-07-27T14:19:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8721-ipf-trapianto-di-polmone-riuscito-con-sistema-portatile-di-preservazione-ocs-lung]]></loc><lastmod>2015-07-30T13:35:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8707-fibrosi-polmonare-idiopatica-dal-5-all-11-ottobre-2015-torna-la-ipf-world-week]]></loc><lastmod>2015-07-27T14:14:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8705-fibrosi-polmonare-idiopatica-nata-a-roma-una-nuova-associazione-di-pazienti]]></loc><lastmod>2015-07-27T14:06:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8704-fibrosi-polmonare-idiopatica-oggi-la-diagnosi-e-piu-semplice-e-meno-invasiva]]></loc><lastmod>2015-07-27T14:02:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8702-fibrosi-polmonare-idiopatica-l-importanza-delle-associazioni-di-malati-rari]]></loc><lastmod>2015-07-27T13:43:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8701-fibrosi-polmonare-idiopatica-l-importanza-del-rapporto-tra-medico-e-paziente]]></loc><lastmod>2015-07-27T13:38:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8699-fibrosi-polmonare-idiopatica-prof-vancheri-terapie-hanno-radicalmente-cambiato-le-prospettive]]></loc><lastmod>2015-07-27T13:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8646-fibrosi-polmonare-idiopatica-pubblicate-le-linee-guida-interazionali]]></loc><lastmod>2015-07-21T07:00:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8648-fibrosi-polmonare-idiopatica-possibili-benefici-con-trattamenti-che-riducono-livelli-di-autoanticorpi]]></loc><lastmod>2015-07-20T15:20:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8625-fibrosi-polmonare-idiopatica-aperto-il-concorso-fotografico-ipf-world-week-contest-2015]]></loc><lastmod>2015-07-16T07:48:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8499-e-online-il-nuovo-aggiornamento-della-guida-per-i-pazienti-di-fibrosi-polmonare-idiopatica]]></loc><lastmod>2017-11-13T14:07:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8490-ipf-esperti-a-confronto-su-cause-diagnosi-e-cura]]></loc><lastmod>2015-06-22T10:15:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8448-ipf-dal-congresso-internazionale-ats-l-anticipazione-delle-nuove-linee-guida]]></loc><lastmod>2015-06-15T10:39:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8423-fibrosi-polmonare-idiopatica-se-ne-parla-a-modena-oggi-e-domani-in-un-convegno]]></loc><lastmod>2015-06-12T08:59:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8395-ipf-studio-italiano-real-life-dimostra-che-il-pirfenidone-rallenta-il-declino-della-capacita-vitale-forzata]]></loc><lastmod>2015-06-05T13:55:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8394-ipf-il-dr-harari-il-nostro-studio-indipendente-e-un-osservatorio-sulla-vita-reale]]></loc><lastmod>2015-06-05T13:35:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8402-fibrosi-polmonare-idiopatica-le-linee-guida-italiane-proposte-da-aipo-e-simer]]></loc><lastmod>2016-02-17T15:15:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8220-disponibile-il-nuovo-aggiornamento-della-guida-per-i-pazienti-di-fibrosi-polmonare-idiopatica-92514038]]></loc><lastmod>2021-03-22T16:27:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8140-malattia-polmonare-interstiziale-la-criobiopsia-transbronchiale-ha-una-migliore-resa-diagnostica-rispetto-a-quella-convenzionale]]></loc><lastmod>2015-05-25T13:21:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8136-fibrosi-polmonare-idiopatica-l-ipotiroidismo-e-molto-comune-tra-i-pazienti]]></loc><lastmod>2015-06-08T11:28:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/8015-malattie-rare-in-lombardia-il-pdta-per-la-fibrosi-polmonare-idiopatica-nella-regione-ne-sono-affette-circa-2000-persone]]></loc><lastmod>2015-05-25T13:20:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7877-la-carta-europea-del-paziente-con-fibrosi-polmonare-idiopatica-spiegata-da-rosalba-mele-di-ama]]></loc><lastmod>2015-05-25T13:12:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7857-senza-fiato-aiutaci-anche-tu-a-far-conoscere-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2015-05-25T13:12:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7846-parte-senzafiato-campagna-nazionale-di-sensibilizzazione-sulla-ipf]]></loc><lastmod>2015-05-25T13:19:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7832-fibrosi-polmonare-idiopatica-presto-i-trattamenti-disponibili-saranno-molti]]></loc><lastmod>2015-05-28T12:31:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7817-fibrosi-polmonare-idiopatica-solo-il-36-dei-pneumologi-francesi-attua-la-discussione-multidisciplinare-prevista-dalle-linee-guida]]></loc><lastmod>2015-05-28T12:32:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7705-malattie-rare-polmonari-nuovi-farmaci-e-nuove-prospettive]]></loc><lastmod>2015-05-28T12:32:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7665-fibrosi-polmonare-idiopatica-promettente-la-combinazione-pirfenidone-n-acetilcisteina]]></loc><lastmod>2015-05-28T12:36:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7620-fibrosi-polmonare-idiopatica-arriva-il-primo-documento-su-diagnosi-e-gestione-della-malattia]]></loc><lastmod>2015-05-25T13:17:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7442-fibrosi-polmonare-idiopatica-ue-approva-il-trattamento-con-nintedanib]]></loc><lastmod>2019-06-18T17:49:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7341-fibrosi-polmonare-idiopatica-aggiornata-la-guida-dei-centri-prescrittori-del-pirfenidone]]></loc><lastmod>2021-03-22T16:29:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7289-fibrosi-polmonare-idiopatica-attivo-un-nuovo-ambulatorio-in-sardegna-a-iglesias]]></loc><lastmod>2015-05-28T12:37:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7309-fibrosi-polmonare-idiopatica-il-premio-galeno-canadese-va-a-intermune-per-il-farmaco-esbriet-pirfenidone]]></loc><lastmod>2015-05-28T12:37:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7284-fibrosi-polmonare-la-rimozione-dei-lipidi-in-eccesso-sembra-attenuare-i-sintomi-della-patologia]]></loc><lastmod>2015-05-28T12:37:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7215-fibrosi-polmonare-idiopatica-nuovo-ambulatorio-attivato-a-casoria-napoli]]></loc><lastmod>2015-05-28T12:38:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7152-fibrosi-polmonare-idiopatica-in-calabria-il-primo-ambulatorio-dedicato-ai-pazienti-ipf]]></loc><lastmod>2015-05-28T12:38:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7155-fibrosi-polmonare-idiopatica-parere-positivo-del-chmp-ema-per-nintedanib]]></loc><lastmod>2015-05-28T12:38:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7067-fibrosi-polmonare-idiopatica-clinici-e-pazienti-insieme-per-dare-voce-alla-speranza]]></loc><lastmod>2015-05-28T12:39:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7066-fibrosi-polmonare-idiopatica-sostenere-la-ricerca-per-offrire-nuova-speranza]]></loc><lastmod>2015-05-28T12:39:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7065-fibrosi-polmonare-idiopatica-i-pazienti-attendono-ancora-il-riconoscimento-delle-esenzioni-per-malattia-rara]]></loc><lastmod>2015-05-28T12:40:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/7064-fibrosi-polmonare-idiopatica-in-quanti-sappiamo-di-cosa-si-trattta]]></loc><lastmod>2015-05-28T12:40:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6959-ipf-il-chmp-dellema-raccomanda-laggiornamento-della-scheda-tecnica-e-del-foglietto-illustrativo-di-esbrietr-pirfenidone-sottolineandone-i-benefici-in-termini-di-mortalita-e-rafforzandone-il-profilo-di-sicurezza]]></loc><lastmod>2015-05-28T12:41:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6940-fibrosi-polmonare-idiopatica-un-nuovo-studio-confronta-i-profili-proteici-dei-malati-con-quelli-dei-fumatori]]></loc><lastmod>2015-05-25T12:21:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6952-fibrosi-polmonare-idiopatica-la-patologia-e-la-testimonianza-di-alessandro-al-tg2-medicina-33]]></loc><lastmod>2015-05-28T12:41:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6887-ipf-fda-approva-terapia-con-nintedanib-negli-usa]]></loc><lastmod>2015-05-28T12:41:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6881-fibrosi-polmonare-idiopatica-esbriet-pirfenidone-approvato-anche-negli-stati-uniti]]></loc><lastmod>2015-05-28T12:42:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6854-disponibile-il-nuovo-aggiornamento-della-guida-per-i-pazienti-di-fibrosi-polmonare-idiopatica]]></loc><lastmod>2021-03-22T16:24:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6835-ipf-2014-grandissimo-successo-per-gli-eventi-italiani]]></loc><lastmod>2015-05-28T12:49:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6817-fibrosi-polmonare-idiopatica-una-app-per-aiutare-i-medici-a-riconoscere-la-patologia]]></loc><lastmod>2015-05-28T12:49:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6775-ipf-paziente-di-lecce-ritrova-la-speranza-dopo-il-trapianto-di-polmone-effettuato-a-padova]]></loc><lastmod>2015-05-28T12:50:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6774-presentata-oggi-al-parlamento-europeo-la-carta-del-paziente-con-fbrosi-polmonare-idiopatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6763-ipf-week-2014-ama-fuori-dal-buio-e-il-centro-malattie-rare-del-polmone-di-modena-aprono-le-porte-il-4-ottobre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6709-fibrosi-polmonare-idiopatica-anche-gilead-studia-un-farmaco-contro-la-malattia]]></loc><lastmod>2015-05-28T12:50:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6697-ipf-week-2014-tutti-gli-eventi-italiani-nella-settimana-dedicata-alla-fibrosi-polmonare-idiopatica]]></loc><lastmod>2015-05-28T12:51:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6657-ipf-dallers-di-monaco-la-conferma-terapia-con-pirfenidone-efficace-e-sicura-anche-a-lungo-termine]]></loc><lastmod>2015-05-28T12:51:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6643-fibrosi-polmonare-idiopatica-allers-conferme-per-nintedanib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6642-fibrosi-polmomare-lesposizione-allamianto-potrebbe-essere-correlata-alla-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6599-fibrosi-polmonare-idiopatica-soddisfacenti-i-primi-test-sulluomo-con-cellule-stromali-mesenchimali-placenta-derivate]]></loc><lastmod>2015-05-28T12:52:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6582-fibrosi-polmonare-idiopatica-e-tempo-del-registro-globale]]></loc><lastmod>2019-06-18T18:03:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6579-fibrosi-polmonare-idiopatica-roche-acquisita-intermune-per-83-miliardi-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6544-fibrosi-polmonare-idiopatica-diagnosi-e-terapia-le-acquisizioni-e-le-prospettive-future]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6523-fibrosi-polmonare-idiopatica-fda-concede-designazione-di-farmaco-orfano-al-trattamento-orale-gp-101]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6485-fibrosi-polmonare-idiopatica-firma-anche-tu-la-carta-europea-dei-pazienti]]></loc><lastmod>2015-05-26T16:20:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6467-fibrosi-polmonare-idiopatica-malattia-rara-riconosciuta-solo-in-toscana-e-piemonte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6458-ipf-oggi-disponiamo-di-una-terapia-efficace-ma-la-diagnosi-continua-ad-fondamentale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6454-pubblicato-laggiornamento-della-guida-per-i-pazienti-di-fibrosi-polmonare-idiopatica]]></loc><lastmod>2021-03-22T16:23:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6447-fibrosi-polmonare-idiopatica-prof-albera-fondamentale-porre-sempre-il-paziente-al-centro]]></loc><lastmod>2015-05-28T12:54:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6446-fibrosi-polmonare-idiopatica-disponibili-le-raccomandazioni-italiane-su-diagnosi-e-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6448-fibrosi-polmonare-idiopatica-pirfenidone-di-intermune-riceve-la-designazione-di-breakthrough-therapy-dallfda]]></loc><lastmod>2015-05-28T12:54:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6444-fibrosi-polmonare-idiopatica-grazie-al-modello-hub-spoke-migliorano-diagnosi-e-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6433-fibrosi-polmonare-idiopatica-status-di-breakthrough-therapy-negl-usa-per-nintedanib]]></loc><lastmod>2015-05-28T12:55:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6431-fibrosi-polmonare-idiopatica-la-guida-per-i-pazienti-pubblicata-sul-sito-della-sifo]]></loc><lastmod>2021-03-22T16:20:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6266-online-la-guida-ai-centri-ipf-2014]]></loc><lastmod>2021-03-22T16:18:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6236-fibrosi-polmonare-idiopatica-lema-valutera-lapprovazione-del-farmaco-sperimentale-nintedanib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6201-fibrosi-polmonare-al-policlinico-di-bari-un-ambulatorio-dedicato-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6157-fibrosi-polmonare-idiopatica-nessun-beneficio-significativo-dal-trattamento-con-la-sola-n-acetilcisteina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6155-ipf-week-2014-partecipa-al-concorso-e-diventa-protagonista-della-campagna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6181-giornata-del-respiro-la-fibrosi-polmonare-non-e-piu-orfana-di-terapia]]></loc><lastmod>2015-05-28T12:56:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6088-fibrosi-polmonare-idiopatica-buoni-risultati-per-il-farmaco-sperimentale-nintedanib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6087-fibrosi-polmonare-idiopatica-ipf-nuovo-studio-internazionale-conferma-efficacia-del-pirfenidone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/6053-fibrosi-polmonare-idiopatica-il-gene-adam33-sembra-essere-associato-al-rischio-dinsorgenza-della-malattia]]></loc><lastmod>2019-06-18T18:20:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5845-fibrosi-polmonare-idiopatica-le-raccomandazioni-per-migliorare-laderenza-alla-terapia]]></loc><lastmod>2016-05-27T12:30:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5578-malattie-rare-arriva-la-carta-del-paziente-con-fibrosi-polmonare-idiopatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5568-fibrosi-polmonare-idiopatica-intermune-annuncia-i-risultati-dello-studio-di-fase-3-ascend]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5390-fibrosi-polmonare-idiopatica-necessaria-una-discussione-multidisciplinare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5364-farmaci-sottoposti-a-monitoraggio-la-campania-li-svincola-dallobbligo-dinserimento-in-ptor]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5338-fibrosi-polmonare-idiopatica-laccumulo-di-ferro-puo-essere-un-marcatore-di-danno-vascolare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5306-fibrosi-polmonare-idiopatica-risultati-incoraggianti-per-la-terapia-combinata-con-pirfenidone-e-n-acetilcisteina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5251-malattie-respiratorie-rare-al-monaldi-di-napoli-il-futuro-centro-di-riferimento-regionale]]></loc><lastmod>2015-08-07T10:38:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5249-fibrosi-polmonare-idiopatica-il-successo-della-ipf-week-2013]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5220-ipf-a-breve-disponibile-la-guida-dei-centri-prescrittori-del-pirfenidone-unico-farmaco-approvato-come-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5151-fibrosi-polmonare-idiopatica-individuati-8-geni-che-contribuiscono-alla-predisposizione-alla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5148-fibrosi-polmonare-idiopatica-una-delle-cause-potrebbe-essere-un-virus]]></loc><lastmod>2019-06-19T08:06:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5163-il-nostro-omaggio-a-giovanna-corder]]></loc><lastmod>2017-11-13T15:46:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5141-giovanna-corder-e-mancata-ieri-allaffetto-dei-suoi-cari-il-nostro-ricordo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5085-fibrosi-polmonare-idiopatica-la-cistatina-c-e-un-buon-marcatore-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5093-fibrosi-polomonare-dopo-le-battaglie-politiche-ferranti-attende-ora-il-trapianto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/5024-fibrosi-polmonare-il-dott-mincarini-spiega-quando-e-associata-allenfisema-non-sottovalutare-i-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4981-fibrosi-polmonare-la-regione-emilia-ha-aggiornato-il-prontuario-terapeutico-ora-ai-pazienti-sara-fornito-il-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4957-fibrosi-polmonare-idiopartica-dopo-la-denuncia-di-omar-la-senatrice-bianconi-interroga-il-ministro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4950-fibrosi-polmonare-idiopatica-linfezione-del-batterio-helicobacter-pylori-potrebbe-peggiorarne-la-progressione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4954-la-risposta-di-osservatorio-alla-regione-emilia-romagna-le-nostre-affermazioni-supportate-dai-dati-ufficiali-di-aifa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4946-malattie-rare-lemilia-romagna-priva-i-malati-di-fibrosi-polmonare-della-sola-terapia-esistente-e-regolarmente-approvata-e-lunica-regione-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4910-fibrosi-polmonare-idiopatica-a-pisa-lambulatorio-dedicato-che-serve-il-nord-ovest-della-toscana]]></loc><lastmod>2015-05-28T12:57:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4850-fibrosi-polmonare-idiopatica-in-umbria-garantito-laccesso-alle-cure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4829-ipf-award-allitaliano-marco-mura-che-oggi-lavora-in-canada-il-riconoscimento-dei-colleghi-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4827-fibrosi-polmonare-idiopatica-e-litaliano-marco-mura-il-vincitore-dellipf-research-award]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4786-fibrosi-polmonare-idiopatica-ipf-al-san-martino-di-genova-ce-un-ambulatorio-dedicato-abilitato-alla-prescrizione-di-esbriet-il-primo-farmaco-approvato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4743-ipf-week-2013-grande-successo-per-gli-eventi-italiani-dedicati-alla-fibrosi-polmonare-idiopatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4667-fibrosi-polmonare-idiopatica-realizzato-uno-stetoscopio-elettronico-per-la-registrazione-dei-suoni-polmonari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4665-fibrosi-polmonare-idiopatica-la-storia-di-monica-mio-padre-ha-vinto-la-malattia-col-trapianto-diventero-un-medico-e-mi-occupero-di-malattie-rare-polmonari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4661-fibrosi-polmonare-idiopatica-a-padova-la-ipf-week-tra-medici-pazienti-e-ricercatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4530-ipf-world-week-la-settimana-mondiale-della-fibrosi-polmonare-idiopatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4554-fibrosi-polmonare-idiopatica-i-pazienti-hanno-bisogno-di-supporto-emotivo]]></loc><lastmod>2015-05-28T12:19:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4553-fibrosi-polmonare-idiopatica-come-si-vive-dopo-la-diagnosi]]></loc><lastmod>2015-05-28T12:20:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4507-fibrosi-polmonare-idiopatica-il-prof-cesare-saltini-fa-il-punto-su-diagnosi-e-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4463-fibrosi-polmonare-idiopatica-patologia-ancora-senza-esenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4442-fibrosi-polmonare-idiopatica-nuovo-studio-supporta-possibile-connessione-tra-fibrogenesi-e-danni-causati-dal-fumo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4427-fibrosi-polmonare-idiopatica-sempre-piu-pazienti-raggiungono-il-trapianto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4385-fibrosi-polmonare-e-nato-un-gruppo-di-supporto-per-capirla-e-affrontarla-insieme]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4391-fibrosi-polmonare-idiopatica-la-lombardia-tra-le-prime-regioni-a-identificare-i-centri-erogatori-di-esbrietr]]></loc><lastmod>2015-05-28T12:25:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4351-malattie-rare-polmonari-molti-i-progressi-nel-trattamento-di-ipf-linfangioleiomiomatosi-e-ipertensione-arteriosa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4339-fibrosi-polmonare-idiopatica-cosa-succede-quando-subentra-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4337-fibrosi-polmonare-idiopatica-le-nuove-acquisizioni-terapeutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4328-fibrosi-polmonare-idiopatica-da-stamattina-tutte-le-farmacie-ospedaliere-hanno-a-disposizione-il-primo-farmaco-per-la-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4303-malattie-rare-presentata-agli-esami-di-maturita-una-tesi-sulle-aziende-farmaceutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4279-intervista-prof-carlo-albera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4281-fibrosi-polmonare-idiopatica-intervista-al-prof-luca-richeldi]]></loc><lastmod>2025-05-21T10:14:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4282-fibrosi-polmonare-idiopatica-intervista-prof-carlo-vancheri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4280-fibrosi-polmonare-idiopatica-intervista-prof-venerino-poletti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4278-fibrosi-polmonare-idopatica-una-speranza-ed-un-supporto-concreto-per-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4232-intermune-annuncia-la-pubblicazione-delle-condizioni-di-prezzo-e-rimborso-per-esbriet-pirfenidone-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4222-fibrosi-polmonare-idiopatica-e-ufficiale-dal-29-giugno-nelle-farmacie-ospedaliere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4186-fibrosi-polmonare-idiopatica-a-modena-un-gruppo-di-supporto-per-pazienti-e-familiari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4165-fibrosi-polmonare-idiopatica-finita-lattesa-dei-pazienti-il-pirfenidone-finalmente-in-commercio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4123-fibrosi-polmonare-idiopatica-il-perclorato-dammonio-potrebbe-essere-una-causa-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4070-fibrosi-polmonare-idiopatica-vuoi-essere-il-testimonial-della-ipf-world-week-2013]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4049-fibrosi-polmonare-idipatica-individuata-una-mutazione-genetica-che-potrebbe-caratterizzare-i-casi-piu-aggressivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/4031-fibrosi-polmonare-idiopatica-nuove-scoperte-sullorigine-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3979-fibrosi-polmonare-idiopatica-negli-usa-collaborano-aziende-e-network-di-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3987-fibrosi-polmonare-idiopatica-quando-la-biotecnologia-vince-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3961-interstiziopatie-polmonari-a-napoli-attivato-un-ambulatorio-dedicato]]></loc><lastmod>2015-08-25T06:52:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3858-fibrosi-polmonare-idiopatica-e-interstiziopatie-a-genova-un-ambulatorio-dedicato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3829-fibrosi-polmonare-idiopatica-un-metodo-efficace-per-valutare-il-sintomo-della-tosse-persistente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3823-fibrosi-polmonare-idiopatica-in-inghilterra-e-galles-il-pirfenidone-raccomandato-per-forme-da-lieve-a-moderata]]></loc><lastmod>2016-10-07T16:37:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3765-premio-omar-vince-valentina-polati-con-un-servizio-sulla-fibrosi-polmonare-idiopatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3741-pirfenidone-richeldi-finalmente-un-percorso-di-cura-adeguato-e-controllato]]></loc><lastmod>2018-06-02T09:19:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3740-pirfenidone-vancheri-q-ottima-notizia-da-settembre-ad-oggi-sono-molti-i-nuovi-i-pazienti-che-attendono-una-speranzaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3736-fibrosi-polmonare-idiopatica-agostini-malattia-letale-ma-il-pirfenidone-ha-ridato-una-speranza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3731-fibrosi-polmonare-idiopatica-harari-qla-commercializzazione-del-pirfenidone-e-un-passo-importanteq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3730-fibrosi-polmonare-idiopatica-lattesa-dei-pazienti-ha-i-giorni-contati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3682-fibrosi-polmonare-idiopatica-la-malattia-che-toglie-il-fiato-a-modena-si-stima-che-i-casi-siano-circa-200]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3629-fibrosi-polmonare-idiopatica-dr-harari-500-pazienti-in-attesa-che-aifa-fissi-prezzo-del-pirfenidone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3602-fibrosi-polmonare-idiopatica-a-padova-effettuato-con-successo-trapianto-polmonare-bilaterale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3590-malattie-rare-polmonari-a-disposizione-il-telefono-aiuto-malattie-rare-polmonari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3575-fibrosi-polmonare-idiopatica-sempre-piu-medici-specialisti-prescrivono-il-pirfenidone]]></loc><lastmod>2017-01-12T18:32:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/3399-fibrosi-polmonare-idiopatica-confermato-il-ruolo-del-pirfenidone-disponibile-a-breve]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2989-fibrosi-polmonare-idiopatica-anticipati-in-tempi-in-francia-il-pirfenidone-e-in-commercio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2883-fibrosi-polmonare-idiopatica-anche-il-canada-approva-luso-del-pirfenidone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2819-fibrosi-polmonare-idiopatica-contro-la-tosse-continua-si-studia-luso-di-talidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2789-fibrosi-polmonare-idiopatica-ambrisentan-vietato-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2847-fibrosi-polmonare-idiopatica-successo-per-lincontro-romano-pazienti-pneumologi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2846-fibrosi-polmonare-idiopatica-on-line-la-guida-per-pazienti-e-familiari]]></loc><lastmod>2015-05-28T13:25:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2813-fibrosi-polmonare-idiopatica-ora-anche-le-marche-hanno-un-centro-che-dispensa-il-pirfenidone]]></loc><lastmod>2015-05-28T12:26:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2796-settimana-della-fibrosi-polmonare-idiopatica-ecco-gli-eventi-di-tutta-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2756-settimana-mondiale-ipf-litalia-e-parte-attiva-del-network-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2757-ipf-week-condivisione-mondiale-di-esperienze-competenze-e-saperi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2773-fibrosi-polmonare-idiopatica-nuovi-dati-confermano-lefficacia-del-pirfenidone-e-la-sicurezza-nel-lungo-periodo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2753-fibrosi-polmonare-idiopatica-la-francia-batte-litalia-in-velocita-stabilito-il-prezzo-del-pirfenidone-per-natale-sara-disponibile]]></loc><lastmod>2015-05-28T14:16:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2689-fibrosi-polmonare-idiopatica-dal-23-al-30-settembre-anche-litalia-celebra-la-settimana-mondiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2688-fibrosi-polmonare-idiopatica-a-teramo-e-catania-due-nuovi-centri-mettono-a-disposizione-il-pirfenidone]]></loc><lastmod>2015-05-28T14:20:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2636-fibrosi-polmonare-idiopatica-negli-usa-status-orfano-per-una-nuova-molecola]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2608-fibrosi-polmonare-idiopatica-il-farmaco-ambriesentan-non-deve-essere-utilizzato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2591-fibrosi-polmonare-idiopatica-per-ora-nessuna-speranza-sul-triplice-regime-farmacologico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2510-fibrosi-polmonare-idiopatica-il-pirfenidone-raggiunge-da-oggi-31-centri-italiani]]></loc><lastmod>2015-05-28T14:51:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2413-fibrosi-polmonare-idiopatica-associazione-ama-allincontro-con-i-pazienti-europei-a-bruxelles]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2412-fibrosi-polmonare-idiopatica-a-modena-alta-formazione-internazionalefibrosi-polmonare-idiopatica-a-modena-alta-formazione-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2378-fibrosi-polmonare-idiopatica-anche-il-policlinico-gemelli-offre-il-pirfenidone]]></loc><lastmod>2015-05-29T08:29:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2365-fibrosi-polmonare-idiopatica-a-padova-leccellenza-si-fa-in-equipe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2366-fibrosi-idiopatica-polmonare-a-padova-sono-due-i-centri-a-somministrare-il-pirfenidone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2320-malattie-rare-polmonari-dalle-infezioni-alla-ipf-a-milano-si-fa-il-punto-della-situazione]]></loc><lastmod>2015-05-29T08:39:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2210-fibrosi-polmonare-idiopatica-3-nuovi-centri-ospedalieri-pronti-a-dare-il-pirfenidone]]></loc><lastmod>2015-05-29T08:42:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2180-fibrosi-polmonare-idiopatica-il-ministro-interrogato-sullaccesso-al-pirfenidone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/2046-fibrosi-polmonare-idiopatica-giovanna-lha-vinta-e-si-racconta-in-un-libro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1996-vivere-con-la-fibrosi-polmonare-idiopatica-studio-su-pazienti-europei-mostra-i-bisogni-insoddisfatti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1995-fibrosi-polmonare-idiopatica-pazienti-piu-soddisfatti-se-in-cura-presso-centri-di-eccellenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1993-fibrosi-polmonare-idiopatica-la-diagnosi-e-ancora-un-problema]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1992-fibrosi-polmonare-idipatica-ecco-cosa-incide-sulla-qualita-della-vita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1926-fibrosi-idiopatica-polmonare-a-tor-vergata-visite-entro-7-giorni-e-un-day-hospital-dedicato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1925-fibrosi-polmonare-idiopatica-nuovi-farmaci-e-potenzialita-delle-cellule-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1924-fibrosi-polmonare-idiopatica-un-nuovo-predittore-di-sopravvivenza-per-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1893-fibrosi-polmonare-idiopatica-anche-i-sardi-avranno-il-farmaco-basta-ai-viaggi-fuori-dallisola]]></loc><lastmod>2015-05-29T08:51:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1853-fibrosi-polmonare-idiopatica-lunione-trapiantati-polmonari-consegna-due-borse-di-studio-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1851-fibrosi-polmonare-idiopatica-anche-la-puglia-avvia-il-dispensazione-del-pirfenidone]]></loc><lastmod>2015-05-29T08:52:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1821-fibrosi-polmonare-idiopatica-la-germania-riclassifica-il-pirfenidone-riconoscendogli-effetti-benefici-maggiori]]></loc><lastmod>2015-06-03T14:55:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1774-fibrosi-polmonare-idiopatica-ne-parla-oggi-su-telenova-il-dr-sergio-harari]]></loc><lastmod>2015-06-03T14:55:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1750-malattie-rare-polmonari-premiati-a-modena-il-prof-luca-richeldi-e-la-dottsa-cerri]]></loc><lastmod>2018-06-02T09:20:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1718-fibrosi-polmonare-idiopatica-compie-un-anno-il-pirfenidone-primo-farmaco-contro-la-patologia-il-suo-compleanno-coincide-con-la-giornata-delle-malattie-rare]]></loc><lastmod>2015-06-03T14:56:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1714-fibrosi-polmonare-idiopatica-alla-dottoressa-stefania-cerri-di-modena-un-finanziamento-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1675-fibrosi-polmonare-idiopatica-a-modena-premiata-la-ricerca-per-i-biomarcatori-della-rara-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1699-fibrosi-polmonare-idiopatica-alle-scotte-di-siena-sono-gia-seguiti-con-pirfenidone-9-pazienti]]></loc><lastmod>2015-06-03T14:58:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1667-fibrosi-polmonare-idiopatica-crescono-i-centri-che-forniscono-pirfenidone-ora-sono-20]]></loc><lastmod>2015-06-03T14:58:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1627-fibrosi-polmonare-idiopatica-anche-al-morgagni-di-forli-arriva-il-pirfenidone-primo-farmaco-contro-la-malattia]]></loc><lastmod>2015-06-03T15:00:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1606-fibrosi-polmonare-idiopatica-anche-in-abruzzo-il-pirfenidone-primo-farmaco-in-grado-di-rallentare-la-progressione-della-malattia]]></loc><lastmod>2015-06-03T15:02:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1601-fibrosi-polmonare-idiopatica-il-prof-pesci-spiega-la-malattia-e-il-funzionamento-del-pirfenidone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1589-malattie-polmonari-dal-2008-a-padova-ce-lunione-trapiantati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1587-fibrosi-polmonare-idiopatica-lunione-trapiantati-polmone-di-padova-utp-padova-gioisce-per-la-distribuzione-del-pirfenidone-essenziale-per-arrivare-in-buona-forma-al-trapianto-ora-bisogna-migliorare-le-capacita-di-diagnosiq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1586-fibrosi-polmonare-idiopatica-ipf-il-pirfenidone-e-ora-disponibile-in-13-centri-italiani]]></loc><lastmod>2015-06-03T15:02:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1543-fibrosi-polmonare-idiopatica-attivato-il-servizio-on-line-chiedi-allesperto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1421-fibrosi-idiopatica-polmonare-la-tripa-terapia-non-e-piu-unopzione-terapeutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1422-fibrosi-polmonare-idiopatica-richeldi-finalmente-una-terapia-efficace-il-pirfenidone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1424-fibrosi-polmonare-idiopatica-ecco-come-riconoscerne-i-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1409-al-via-il-congresso-nazionale-uip-aipo-sotto-la-lente-le-malattie-polmonari-molte-le-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/1102-fibrosi-idiopatica-polmonare-anche-boehringer-ingelheim-studia-un-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/719-fibrosi-polmonare-idiopatica-sul-lancet-nuove-conferme-per-il-pirfenidone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/551-fibrosi-polmonare-idiopatica-ecco-le-nuove-linee-guida]]></loc><lastmod>2017-04-14T18:01:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/498-fibrosi-polmonare-idiopatica-per-il-pirfenidone-uno-studio-post-approvazione-con-1000-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/497-fibrosi-polmonare-idiopatica-autorizzato-al-commercio-in-ue-il-primo-farmaco-orfano]]></loc><lastmod>2015-06-08T10:20:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/457-ricerca-aimip-onlus-pronta-a-lanciare-nuova-borsa-di-studio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/400-fibrosi-polmonare-idiopatica-la-bestia-nera-di-giovanna-sconfitta-dal-trapianto-di-polmoni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/367-fibrosi-idiopatica-polmonare-interrotti-i-trial-con-ambrisentan]]></loc><lastmod>2021-11-02T16:59:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/95-ibrosi-idiomatica-polmonare-al-via-progetto-di-ricerca-multicentrico-sui-marcatori-di-progressione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-polmonare-idiopatica-ipf/42-fibrosi-polmonare-idiopatica-risultati-parzialmente-positivi-per-sildenafil-da-uno-studio-in-fase-iii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare]]></loc><lastmod>2024-03-13T12:11:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/22625-ipercolesterolemia-familiare-omozigote-cosi-mio-figlio-ha-potuto-abbandonare-laferesi-e-il-catetere-venoso-centrale]]></loc><lastmod>2025-12-23T11:36:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/22508-ipercolesterolemia-familiare-eterozigote-positivi-i-dati-dello-studio-di-fase-iii-su-enlicitide]]></loc><lastmod>2025-11-12T16:50:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/22424-ipercolesterolemia-familiare-omozigote-aifa-approva-lestensione-duso-di-evinacumab]]></loc><lastmod>2025-10-21T07:48:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/22336-ipercolesterolemia-familiare-omozigote-la-storia-di-maria-grazia]]></loc><lastmod>2025-09-23T19:42:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/22069-ipercolesterolemia-familiare-omozigote-a-cagliari-il-farmaco-evinacumab-non-e-prescrivibile]]></loc><lastmod>2025-06-12T15:58:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21971-hofh-2-days-a-palermo-due-giornate-di-approfondimento-sull-ipercolesterolemia-familiare-omozigote]]></loc><lastmod>2025-05-09T17:22:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21951-ipercolesterolemia-familiare-omozigote-la-dieta-e-il-primo-passo-terapeutico]]></loc><lastmod>2025-05-01T11:03:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21952-ipercolesterolemia-familiare-omozigote-nasce-un-app-per-aiutare-i-pazienti-a-gestire-la-propria-alimentazione]]></loc><lastmod>2025-05-01T11:03:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21685-ipercolesterolemia-familiare-le-gocce-di-sangue-essiccato-sono-un-valido-strumento-di-screening]]></loc><lastmod>2025-02-03T17:35:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21656-il-consiglio-ue-chiede-sforzi-piu-incisivi-per-prevenire-le-malattie-cardiovascolari]]></loc><lastmod>2025-01-22T17:42:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21585-ipercolesterolemia-familiare-omozigote-con-le-nuove-terapie-e-possibile-evitare-l-aferesi-lipoproteica]]></loc><lastmod>2024-12-16T14:58:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21498-ipercolesterolemia-familiare-omozigote-trattare-precocemente-i-bambini-e-una-priorita]]></loc><lastmod>2024-11-18T17:36:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21426-ipercolesterolemia-familiare-omozigote-i-nuovi-farmaci-sono-disponibili-anche-per-l-eta-pediatrica]]></loc><lastmod>2024-10-25T15:04:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21407-ipercolesterolemia-familiare-omozigote-esperienze-di-medico-e-paziente-e-confronto]]></loc><lastmod>2024-10-22T09:49:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21313-ipercolesterolemia-familiare-solo-il-10-dei-pazienti-viene-diagnosticato-e-curato]]></loc><lastmod>2024-09-23T14:21:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/21262-ipercolesterolemia-familiare-omozigote-le-nuove-terapie-sono-disponibili-anche-in-sardegna]]></loc><lastmod>2025-02-05T09:00:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20923-ipercolesterolemia-familiare-in-europa-la-diagnosi-arriva-a-44-anni-ed-e-troppo-tardi]]></loc><lastmod>2024-05-02T06:44:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20777-ipercolesterolemia-arriva-in-italia-alirocumab-mensile]]></loc><lastmod>2024-03-18T18:24:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20744-ipercolesterolemia-spegnere-il-gene-difettoso-potrebbe-essere-la-soluzione]]></loc><lastmod>2024-03-12T14:59:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20523-ipercolesterolemia-familiare-l-effetto-sinergico-dell-aferesi-e-dei-nuovi-farmaci-ipolipemizzanti]]></loc><lastmod>2024-01-16T15:20:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20456-ipercolesterolemia-familiare-omozigote-il-federico-ii-di-napoli-primo-centro-italiano-a-iniziare-la-somministrazione-di-evinacumab]]></loc><lastmod>2023-12-21T13:09:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20429-ipercolesterolemia-familiare-omozigote-la-storia-di-mario-a-cui-la-malattia-e-stata-scoperta-per-caso]]></loc><lastmod>2023-12-11T11:34:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20364-ipercolesterolemia-familiare-omozigote-le-nuove-linee-guida-europee]]></loc><lastmod>2023-11-28T09:33:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20296-ipercolesterolemia-familiare-evinacumab-efficace-nei-pazienti-omozigoti]]></loc><lastmod>2023-11-06T11:44:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20297-ipercolesterolemia-familiare-omozigote-evinacumab-disponibile-in-italia]]></loc><lastmod>2023-11-06T11:02:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20250-ipercolesterolemia-familiare-in-italia-e-fattibile-uno-screening-su-tutta-la-popolazione-pediatrica]]></loc><lastmod>2023-10-23T08:56:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20141-ipercolesterolemia-familiare-tutte-le-iniziative-per-la-giornata-mondiale-del-24-settembre]]></loc><lastmod>2023-09-21T17:04:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/20062-screening-pediatrico-per-l-ipercolesterolemia-familiare-l-esempio-virtuoso-della-germania]]></loc><lastmod>2023-08-14T17:57:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/19983-malattie-cardiovascolari-i-decessi-sono-aumentati-del-60-negli-ultimi-30-anni]]></loc><lastmod>2023-07-07T14:29:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/19887-ipercolesterolemia-familiare-omozigote-la-fda-approva-evinacumab-per-bambini-da-5-a-11-anni]]></loc><lastmod>2023-06-14T18:28:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/19701-ipercolesterolemia-familiare-omozigote-con-lomitapide-ed-evinacumab-ottenuta-una-riduzione-di-colesterolo-ldl-superiore-al-90]]></loc><lastmod>2023-04-07T10:18:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/19370-ipercolesterolemia-familiare-l-obiettivo-e-lo-screening-pediatrico-universale]]></loc><lastmod>2022-12-07T18:49:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/18410-ipercolesterolemia-familiare-omozigote-troppe-le-disparita-di-trattamento-a-livello-globale]]></loc><lastmod>2024-09-19T17:15:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/17396-ipercolesterolemia-familiare-il-lungo-percorso-per-ottenere-una-diagnosi]]></loc><lastmod>2021-05-06T09:56:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/17137-colesterolo-ldl-l-approccio-migliore-e-the-lower-the-better]]></loc><lastmod>2021-03-07T13:11:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/16714-aterosclerosi-al-via-il-34-congresso-nazionale-sisa]]></loc><lastmod>2020-11-21T10:12:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/16697-ipercolesterolemia-parere-positivo-del-chmp-per-il-farmaco-inclisiran]]></loc><lastmod>2020-11-16T13:57:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/16563-le-ultime-novita-in-cardiologia-dal-15-al-30-ottobre-l-ottavo-cardioupdate]]></loc><lastmod>2020-10-13T10:02:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/16450-ipercolesterolemia-familiare-omozigote-il-nemico-invisibile-di-andrei]]></loc><lastmod>2020-09-14T16:55:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/16375-ipercolesterolemia-familiare-e-covid-19-le-raccomandazioni-per-la-gestione-dei-pazienti]]></loc><lastmod>2020-08-16T19:42:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/16288-ipercolesterolemia-familiare-omozigote-le-iniziative-della-sisa-per-migliorare-la-diagnosi]]></loc><lastmod>2020-07-14T15:23:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/16227-ipercolesterolemia-familiare-in-sardegna-e-piu-frequente]]></loc><lastmod>2020-06-28T19:57:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/16131-ipercolesterolemia-familiare-e-coronavirus-possibilita-di-un-maggior-rischio-cardiovascolare]]></loc><lastmod>2020-05-31T22:37:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/16081-ipercolesterolemia-approvazione-europea-per-l-acido-bempedoico]]></loc><lastmod>2020-05-19T19:59:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/15556-ipercolesterolemia-familiare-migliorare-la-diagnosi-per-34-milioni-di-persone-affette-nel-mondo]]></loc><lastmod>2020-01-07T17:00:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/15439-ipercolesterolemia-familiare-omozigote-nasce-hofh-today-la-prima-rivista-sulla-malattia]]></loc><lastmod>2019-11-24T17:31:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/15435-ipercolesterolemia-familiare-in-italia-migliora-la-capacita-di-diagnosi]]></loc><lastmod>2019-11-22T10:57:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/15262-ipercolesterolemia-familiare-la-pratica-clinica-conferma-l-efficacia-della-lomitapide]]></loc><lastmod>2019-10-02T17:54:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/15145-ipercolesterolemia-inclisiran-raggiunge-gli-endpoint-di-efficacia-nello-studio-di-fase-iii]]></loc><lastmod>2019-09-01T20:47:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/15137-ipercolesterolemia-familiare-sono-un-centinaio-i-pazienti-italiani-omozigoti]]></loc><lastmod>2019-08-27T17:44:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/14798-ipercolesterolemia-familiare-omozigote-dalla-terapia-standard-ai-nuovi-approcci]]></loc><lastmod>2019-05-13T17:47:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/14711-ipercolesterolemia-familiare-lettera-aperta-dell-anif-all-umberto-i]]></loc><lastmod>2019-04-11T08:10:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/14310-ipercolesterolemia-familiare-le-otto-nuove-raccomandazioni-da-presentare-all-oms]]></loc><lastmod>2018-12-24T12:14:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/14159-ipercolesterolemia-familiare-una-call-to-action-globale-per-migliorare-la-diagnosi]]></loc><lastmod>2018-11-15T16:38:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/13596-ipercolesterolemia-familiare-pediatrica-le-nuove-linee-guida-giapponesi]]></loc><lastmod>2018-05-26T17:21:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/12901-ipercolesterolemia-familiare-la-lotta-di-fh-europe-contro-la-mancata-diagnosi]]></loc><lastmod>2017-11-15T20:38:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/12782-ipercolesterolemia-familiare-mai-piu-viaggi-fra-agrigento-e-roma-per-un-bimbo-malato]]></loc><lastmod>2017-10-17T16:07:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/12670-ipercolesterolemia-familiare-le-iniziative-per-la-giornata-di-sensibilizzazione]]></loc><lastmod>2017-09-20T22:26:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/12624-ipercolesterolemia-favorevoli-i-risultati-a-lungo-termine-con-terapia-rnai]]></loc><lastmod>2019-01-17T17:23:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/12117-ipercolesterolemia-risultati-positivi-da-evolocumab]]></loc><lastmod>2017-07-16T16:59:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/11947-ipercolesterolemia-familiare-i-pcsk9-inibitori-saranno-il-cavallo-di-troia-rispetto-all-uso-dell-aferesi-lipoproteica]]></loc><lastmod>2019-08-06T09:45:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/11948-ipercolesterolemia-familiare-eterozigote-alirocumab-permette-di-ridurre-la-frequenza-dell-aferesi]]></loc><lastmod>2017-06-19T14:21:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/11782-ipercolesterolemia-familiare-omozigote-possibile-ridurre-il-colesterolo-con-lomitapide-e-aferesi-delle-lipoproteine]]></loc><lastmod>2017-06-19T14:21:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/11650-fh-europe-24-nazioni-in-campo-contro-l-ipercolesterolemia-familare]]></loc><lastmod>2016-12-01T17:55:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/11651-ipercolesterolemia-familiare-l-esperienza-inglese-lo-screening-insieme-ai-vaccini]]></loc><lastmod>2017-06-19T14:22:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/11471-ipercolesterolemia-familiare-omozigote-evolocumab-diventera-un-trattamento-di-routine]]></loc><lastmod>2016-10-17T09:37:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/11484-ipercolesterolemia-uno-studio-confronta-terapie-con-statine-con-altri-interventi-ipolipemizzanti]]></loc><lastmod>2016-10-18T14:09:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/11024-l-ipercolesterolemia-in-italia-una-patologia-che-costa-al-ssn-piu-di-un-miliardo-di-euro-all-anno]]></loc><lastmod>2016-07-25T15:26:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/11025-ipercolesterolemia-familiare-il-34-dei-pazienti-con-diagnosi-certa-o-probabile-non-viene-trattato-con-farmaci-ipolipemizzanti]]></loc><lastmod>2016-07-25T15:25:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10894-ipercolesterolemia-familiare-i-pazienti-si-raccontano-geoff-noble-il-sopravvissuto]]></loc><lastmod>2016-07-01T09:22:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10854-ipercolesterolemia-familiare-i-pazienti-si-raccontano-le-storie-di-marta-e-francesco]]></loc><lastmod>2016-06-24T13:21:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10848-ipercolesterolomia-buoni-dati-su-uso-pediatrico-di-atorvastatina]]></loc><lastmod>2016-06-24T12:18:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10822-ipercolesterolemia-familiare-i-pazienti-si-raccontano-eddie-sarfaty-il-comico-fatalista]]></loc><lastmod>2016-06-17T12:45:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10817-ipercolesterolemia-familiare-i-pazienti-si-raccontano-cornelia-poletto-la-chef-premurosa]]></loc><lastmod>2016-06-17T12:22:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10497-ipercolesterolemia-familiare-omozigote-cio-che-conta-e-il-fenotipo]]></loc><lastmod>2016-04-29T12:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10495-l-ipercolesterolemia-familiare-omozigote-non-colpisce-solo-i-pazienti-molto-giovani-o-con-livelli-elevatissimi-di-colesterolo-ldl]]></loc><lastmod>2016-04-29T10:44:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10493-elevati-livelli-di-trigliceridi-aumentano-il-rischio-di-infarto]]></loc><lastmod>2016-04-29T09:50:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10332-ipercolesterolemia-familiare-omozigote-risultati-positivi-per-il-farmaco-sperimentale-mbx-8025]]></loc><lastmod>2016-04-08T13:05:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10327-ipercolesterolomia-buoni-risultati-da-studio-di-fase-iii-per-bococizumab]]></loc><lastmod>2016-04-08T10:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10234-ipercolesterolomia-l-anti-pcsk9-alirocumab-e-ora-disponibile-in-italia]]></loc><lastmod>2016-03-21T16:06:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10110-ipercolesterolomia-gli-anticorpi-pcsk-9-aprono-nuove-prospettive-terapeutiche]]></loc><lastmod>2016-03-04T10:49:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/10004-ipercolesterolemia-familiare-a-che-eta-iniziare-ad-assumere-gli-inibitori-pcsk9]]></loc><lastmod>2016-02-22T11:26:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9960-sanofi-un-nuovo-sito-e-un-documentario-per-combattere-il-colesterolo]]></loc><lastmod>2016-02-12T15:12:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9897-dislipidemie-familiari-entro-il-2018-un-programma-regionale-per-diagnosi-precoce]]></loc><lastmod>2016-02-04T14:26:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9807-ipercolesterolemia-il-ruolo-dell-aferesi-terapeutica-e-l-esperienza-tedesca]]></loc><lastmod>2016-01-28T15:20:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9805-ipercolesterolemia-familiare-dott-ssa-guardamagna-oggi-possiamo-intervenire-efficacemente-in-eta-pediatrica]]></loc><lastmod>2016-01-22T15:18:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9800-dislipidemie-e-prevenzione-aterosclerosi-e-nata-la-societa-scientifica-internazionale-mighty-medic]]></loc><lastmod>2016-01-26T07:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9799-ipercolesterolemia-grazie-a-lomitapide-ridotta-la-frequenza-dell-aferesi-negli-adulti]]></loc><lastmod>2016-01-22T15:20:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9753-ipercolesterolemia-autosomica-recessiva-arh-il-prof-sandro-muntoni-cagliari-una-forma-rara-in-tutto-il-mondo-tranne-che-in-sardegna]]></loc><lastmod>2016-01-21T12:12:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9698-screening-a-cascata-per-ipercolesterolemia-familiare-in-olanda-64mila-test-genetici-in-20-anni]]></loc><lastmod>2016-01-04T14:40:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9684-ipercolesterolemia-familiare-negli-usa-si-raccomanda-lo-screening-universale-dei-lipidi-per-bambini-e-adolescenti]]></loc><lastmod>2015-12-28T11:40:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9683-adolescenti-con-ipercolesterolemia-familiare-le-esperienze-passate-e-la-storia-cardiovascolare-della-famiglia-influenzano-il-processo-decisionale-per-il-trattamento]]></loc><lastmod>2015-12-28T11:36:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9599-ipercolesterolemia-familiare-una-chiamata-alle-armi-globale]]></loc><lastmod>2015-12-15T08:28:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9590-ipercolesterolemia-familiare-primo-meeting-ufficiale-della-rete-europea-dei-pazienti]]></loc><lastmod>2015-12-14T08:28:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9593-a-n-i-f-associazione-italiana-ipercolesterolemia-familiare-la-presentazione-al-meeting-di-goeteborg]]></loc><lastmod>2015-12-14T08:29:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9592-fhsc-54-paesi-coinvolti-nel-registro-internazionale-dell-eas]]></loc><lastmod>2015-12-14T08:26:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9591-la-rete-delle-associazioni-dara-voce-ai-pazienti-in-tutta-europa]]></loc><lastmod>2015-12-14T08:29:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9483-giovanni-burtone-pd-ipercolesterolemia-il-governo-si-attivi-per-la-diagnosi-precoce]]></loc><lastmod>2015-11-30T16:24:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9455-ipercolesterolemia-familiare-presentati-i-dati-di-sperimentazione-avanzata-del-farmaco-praluent-alirocumab]]></loc><lastmod>2024-03-15T08:49:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9466-ipercolesterolemia-familiare-presentata-l-indagine-civica-di-cittadinanzattiva]]></loc><lastmod>2015-11-27T09:35:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9257-dutch-score-registro-dei-sams-e-progetto-lipigen-le-tre-iniziative-di-screening-per-l-ipercolesterolemia-familiare-avviate-dalla-sisa]]></loc><lastmod>2015-11-03T08:22:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9209-ipercolesterolomia-familiare-autosomica-dominante-alirocumab-ben-tollerato]]></loc><lastmod>2015-10-23T08:51:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9176-ipercolesterolemia-in-europa-e-ora-disponibile-il-farmaco-praluent-alirocumab]]></loc><lastmod>2024-03-15T08:51:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9132-ipercolesterolemia-nuovi-dati-sugli-anti-pcsk9-dal-congresso-internazionale-esc]]></loc><lastmod>2015-10-19T08:10:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/9131-ipercolesterolemia-familiare-omozigote-terapia-standard-e-nuovi-farmaci]]></loc><lastmod>2015-10-13T16:45:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8991-ipercolesterolemia-familiare-autosomica-dominante-la-caratterizzazione-funzionale-dei-geni-mutanti]]></loc><lastmod>2015-09-25T12:33:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8990-ipercolesterolemia-familiare-il-valore-dei-test-genetici-e-le-prospettive-per-gli-inibitori-pcsk9]]></loc><lastmod>2015-09-25T12:23:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8989-ipercolesterolemia-familiare-i-pazienti-sono-meno-colpiti-dal-diabete-di-tipo-2]]></loc><lastmod>2015-09-28T07:50:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8968-ipercolesterolemia-familiare-l-aferesi-delle-lipoproteine-riduce-fortemente-l-incidenza-di-eventi-cardiovascolari-nei-pazienti-alla-massima-terapia-farmacologica-tollerata]]></loc><lastmod>2015-09-22T14:18:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8967-ipercolesterolemia-familiare-omozigote-in-gravidanza-l-efficacia-dell-ldl-aferesi]]></loc><lastmod>2015-09-22T14:12:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8944-ipercolesterolomia-familiare-da-giovedi-24-settembre-la-settimana-della-prevenzione]]></loc><lastmod>2015-09-17T17:15:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8909-ipercolesterolemia-familiare-in-olanda-la-prevalenza-e-altissima]]></loc><lastmod>2015-09-11T10:54:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8827-ipercolesterolemia-familiare-eterozigote-esiti-positivi-dallo-studio-di-fase-iii-per-sodio-mipomersen]]></loc><lastmod>2015-08-27T13:51:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8829-ipercolesterolemia-familiare-omozigote-quattro-esperienze-con-lomitapide-nel-mondo-reale]]></loc><lastmod>2015-08-27T14:32:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8749-ipercolesterolemia-familiare-i-benefici-del-trattamento-con-ezetimibe-e-atorvastatina-vanno-oltre-l-effetto-ipolipemizzante]]></loc><lastmod>2015-07-31T14:00:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8748-ipercolesterolemia-familiare-nei-pazienti-con-sindromi-coronariche-acute-due-algoritmi-a-confronto]]></loc><lastmod>2015-07-31T13:54:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8681-ipercolesterolemia-familiare-sanofi-e-heart-uk-lanciano-una-campagna-per-la-diagnosi-precoce]]></loc><lastmod>2015-07-24T08:35:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8696-ipercolesterolemia-ema-raccomanda-approvazione-di-alirocumab-anticorpo-anti-pcsk9]]></loc><lastmod>2015-07-27T10:48:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8662-ipercolesterolemia-ema-approva-il-primo-inibitore-del-pcsk9]]></loc><lastmod>2016-02-15T16:30:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8628-ipercolesterolemia-risultati-preliminari-positivi-da-uno-studio-giapponese-del-farmaco-praluent-alirocumab]]></loc><lastmod>2024-03-15T08:53:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8574-ipercolesterolemia-e-dislipidemie-genetiche-attivo-il-nuovo-servizio-o-ma-r-esperto-risponde]]></loc><lastmod>2015-07-06T08:14:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8559-ipercolesterolemia-familiare-omozigote-il-punto-su-diagnosi-e-terapia]]></loc><lastmod>2015-07-10T12:41:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8561-ipercolesterolemia-familiare-omozigote-arriva-in-italia-un-farmaco-con-indicazione-specifica]]></loc><lastmod>2015-07-09T16:25:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8560-ipercolesterolemia-familiare-omozigote-ecco-cosa-vuol-dire-conviverci]]></loc><lastmod>2015-09-07T09:15:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8483-ipercolesterolemia-familiare-catapano-presidente-eas-necessario-promuoverne-la-conoscenza-fra-i-pediatri]]></loc><lastmod>2015-06-19T13:22:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8482-ipercolesterolemia-familiare-in-eta-pediatrica-guadagnare-decenni-di-vita-ottimizzando-diagnosi-e-trattamento]]></loc><lastmod>2015-06-19T13:14:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8498-ipercolesterolemia-online-il-questionario-di-cittadinanzattiva-per-i-pazienti]]></loc><lastmod>2015-06-23T10:43:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8473-ipercolestorolomia-familiare-nuovo-studio-real-life-dimostra-efficacia-di-lomitapide]]></loc><lastmod>2015-06-19T10:35:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8425-ipercolesterolomia-via-libera-dell-fda-per-alirocumab-ed-evolocumab]]></loc><lastmod>2015-06-12T09:14:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8379-ipercolesterolomia-approvazione-dell-ema-imminente-per-evolocumab]]></loc><lastmod>2015-06-05T08:14:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8313-ipercolesterolomia-ema-approva-il-farmaco-evolocumab]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8258-ipercolesterolemia-familiare-omozigote-lomitapide-efficace-indipendentemente-dallaferesi]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8133-ipercolesterolemia-incongruenze-nelle-linee-guida-per-il-trattamento-di-pazienti-adolescenti]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8063-ipercolesterolemia-familiare-anche-in-europa-la-malattia-e-nettamente-sottodiagnosticata]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8006-medici-e-associazioni-dei-pazienti-faremo-nascere-la-giornata-mondiale-dellipercolesterolemia-familiare]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8005-ipercolesterolemia-familiare-i-buoni-esempi-del-regno-unito-e-dei-paesi-bassi]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8003-ipercolesterolemia-familiare-pediatrica-lultimo-documento-di-consenso-delleas]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/8018-ipercolesterolomia-familiare-anacetrapib-ben-tollerato-ed-efficace]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7960-ipercolesterolemia-familiare-la-european-atherosclerosis-society-lancia-il-registro-globale]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7956-ipercolesterolemia-familiare-nel-mondo-i-pazienti-che-ottengono-una-diagnosi-sono-meno-dell1]]></loc><lastmod>2015-05-25T14:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7955-ipercolesterolemia-familiare-le-advocacy-di-tutto-il-mondo-a-confronto-in-scozia]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7954-ipercolesterolemia-familiare-quali-sono-le-condizioni-dei-pazienti-a-livello-mondiale]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7944-ipercolesterolomia-confermata-sicurezza-ed-efficacia-di-evolocumab]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7875-alta-prevalenza-di-ipercolesterolemia-familiare-fumo-e-diabete-nei-pazienti-con-infarto-miocardico-sotto-i-50-anni]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7871-ipercolesterolemia-familiare-la-ldl-aferesi-riduce-del-72-il-tasso-di-eventi-coronarici]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7865-ipercolesterolemia-sanofi-e-regeneron-annunciano-la-pubblicazione-dei-risultati-dello-studio-odyssey-lon-term-su-alirocumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7773-ipercolesterolemia-familiare-sottodiagnosticata-subdola-e-pericolosa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7721-ipercolesterolemia-familiare-omozigote-il-mipomersen-e-efficace-nel-ridurre-i-livelli-di-lipoproteina-a]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7552-ipercolesterolemia-familiare-omozigote-pubblicate-le-linee-guida-diagnostiche-internazionali]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7414-ipercolesterolemia-accettata-la-richiesta-di-revisione-maa-per-il-farmaco-alirocumab-da-parte-dellema]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7398-ipercolesterolemia-il-farmaco-alirocumab-efficace-anche-con-una-sola-somministazione-mensile]]></loc><lastmod>2015-05-25T14:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7356-ipercolesterolemia-familiare-sottodiagnosticata-quale-metodo-per-rilevarla]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7149-ipercolesterolemia-familiare-fornire-un-servizio-a-livello-nazionale-costa-meno-della-meta-del-previsto]]></loc><lastmod>2015-05-25T14:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7094-ipercolesterolemia-alnylam-e-the-medicines-company-intendono-avviare-uno-studio-di-fase-1-per-il-farmaco-aln-pcssc]]></loc><lastmod>2016-05-06T16:12:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7069-ipercolesterolemia-il-si-dellfda-alla-domanda-di-registrazione-per-evolocumab]]></loc><lastmod>2015-07-20T08:47:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7031-ipercolesterolemia-familiare-la-ldl-aferesi-riduce-le-microparticelle-in-circolo-causa-di-malattie-cardiovascolari]]></loc><lastmod>2015-05-25T14:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/7015-ipercolesterolemia-familiare-diagnosi-precoce-e-corretta-terapia-su-tg2-medicina-33]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/6802-colesterolo-e-malattie-cardiovascolari-due-minacce-da-tenere-sotto-controllo]]></loc><lastmod>2015-05-25T14:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/6800-ipercolesterolemia-familiare-omozigote-le-nuove-raccomandazioni-per-della-european-atherosclerosis-society]]></loc><lastmod>2015-05-25T14:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/6801-ipercolesterolemia-familiare-una-malattia-ancora-fortemente-sottodiagnosticata]]></loc><lastmod>2015-05-25T14:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/6638-ipercolesterolemia-familiare-limportanza-della-ldl-aferesi]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/6609-ipercolesterolemia-familiare-dati-positivi-per-il-farmaco-sperimetale-alirocumab]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/6407-lipoproteina-a-in-germania-e-trattata-con-lipidoaferesi]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/6405-iperlipidemia-pediatrica-in-italia-solo-l1-di-possibilita-di-diagnosi]]></loc><lastmod>2015-05-25T14:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/6402-ipercolesterolemia-familiare-limportanza-dello-screening-e-della-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/6241-ipercolesterolemia-familiare-presentati-i-risultati-dello-studio-tesla-al-congresso-eas-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/6203-ipercolesterolemia-familiare-studio-riporta-i-punti-di-vista-dei-malati-sullo-screening-genetico-a-cascata-e-sulla-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5941-ipercolesterolemia-i-farmaci-biologici-sono-le-prossime-scommesse-terapeutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5875-ipercolesterolemia-familiare-alirocumab-mostra-maggiore-attivita-rispetto-a-ezetimibe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5798-ipercolesterolemia-familiare-omozigote-risultati-positivi-per-lanticorpo-monoclonale-evolocumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5734-ipercolesterolemia-familiare-una-patologia-ancora-sottodiagnosticata-e-poco-trattata]]></loc><lastmod>2015-05-28T12:03:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5735-ipercolesterolemia-familiare-necessita-di-screening-a-cascata-per-prevenire-le-cardiopatie-ischemiche]]></loc><lastmod>2023-09-12T15:41:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5729-ipercolesterolemia-familiare-in-eta-pediatrica-puo-portare-alla-morte-prima-dei-20-anni]]></loc><lastmod>2015-05-28T12:05:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5730-ipercolesterolemia-familiare-screening-e-terapie-corrette-permettono-un-grande-risparmio]]></loc><lastmod>2015-05-28T12:04:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5635-ipercolesterolemia-attenzione-agli-infarti-precoci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5542-ipercolesterolemia-la-scoperta-della-funzione-di-un-recettore-apre-nuove-possibilita-di-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5496-ipercolesterolemia-familiare-anche-i-giovani-a-rischio-infarto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5142-ipercolesterolemia-autosomica-dominante-risultati-positivi-per-alirocumab-19668579]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/5122-ipercolesterolemia-autosomica-dominante-risultati-positivi-per-alirocumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/4860-ipercolesterolemia-positivo-lo-studio-dellinnovativa-tecnica-rnai-per-la-diminuzione-dei-livelli-di-colesterolo-ldl]]></loc><lastmod>2019-06-19T08:17:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/4570-ipercolesterolemia-familiare-omozigote-lomitapide-ora-a-carico-del-servizio-sanitario-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/4441-ipercolesterolemia-familare-omozigote-approvato-il-trattamento-con-lomitapide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/4163-ipercolesterolemia-familiare-omozigote-dalle-autorita-europee-parere-positivo-per-lomitapide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/4002-ipercolesterolemia-familiare-pubblicate-le-raccomandazioni-internazionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/3588-ipercolesterolemia-familiare-omozigote-la-fda-approva-luso-del-mipomersen-sodium]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/3444-ipercolesterolemia-omozigote-approvato-negli-usa-il-farmaco-lomitapide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/3417-ipercolesterolemia-nuovo-brevetto-per-il-farmaco-lomitapide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/3126-ipercolesterolemia-familiare-omozigote-successo-per-il-farmaco-lomitapide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/3064-ipercolesterolemia-familiare-omozigote-nuovo-riconoscimento-per-il-farmaco-mipomersen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/2344-ipercolesterolemia-omozigote-confermata-lefficacia-di-lomitapide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/2291-ipercolesterolemia-familiare-omozigote-fda-accetta-il-nuovo-farmaco-kynamro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/2281-ipercolesterolemia-familiare-confermato-il-successo-dellinibitore-della-pcsk9]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/2172-ipercolesterolemia-al-gemelli-un-ambulatorio-per-la-prevenzione-e-il-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/2133-ipercolesterolemia-familare-lomitapide-potrebbe-essere-un-nuovo-trattamento-orale-giornaliero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/1958-rischio-cardiovascolare-metabolico-una-nuova-strategia-per-prevenirlo-e-combatterlo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/1890-ipercolesterolemia-successo-per-le-sperimentazioni-sul-regn727-di-sanofi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/1540-ipercolesterolemia-familiare-la-malattia-spiegata-in-tre-video-in-lingua-italiana]]></loc><lastmod>2015-09-07T15:53:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/ipercolesterolemia-familiare-che-cose]]></loc><lastmod>2017-11-15T22:18:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/967-ipercolesterolemia-familiare-genzyme-richiede-aic-in-europa-per-il-mipomersen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/888-ipercolestemia-familiare-da-due-studi-di-terza-fase-conferme-per-il-mipomersen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipercolesterolemia-familiare/889-ipercolestereolemia-familiare-genzyme-chiedera-la-commercializzazione-in-ue-del-mipomersen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe]]></loc><lastmod>2026-03-18T10:48:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/22826-malattia-di-pompe-a-esordio-tardivo-in-italia-diagnosticato-solo-il-10-dei-casi-pediatrici-attesi]]></loc><lastmod>2026-03-09T17:37:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/22482-quanto-e-realmente-diffusa-la-malattia-di-pompe]]></loc><lastmod>2025-11-06T16:50:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/22138-malattia-di-pompe-a-esordio-infantile-la-terapia-a-dose-intensiva-puo-rappresentare-un-valido-approccio]]></loc><lastmod>2025-06-27T13:02:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/21949-dalla-diagnosi-alla-terapia-come-e-cambiata-la-vita-dei-pazienti-con-malattia-di-pompe]]></loc><lastmod>2025-05-01T11:56:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/21900-malattia-di-pompe-oggi-la-giornata-internazionale-di-sensibilizzazione-2025]]></loc><lastmod>2025-05-12T18:03:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/21901-malattia-di-pompe-il-punto-su-diagnosi-e-terapie-oggi-disponibili]]></loc><lastmod>2025-05-12T18:00:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/21902-vivere-con-la-malattia-di-pompe-il-fondamentale-ruolo-di-aiglico]]></loc><lastmod>2025-05-12T18:05:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/21903-l-impegno-di-amicus-therapeutics-per-le-persone-con-malattia-di-pompe]]></loc><lastmod>2025-05-12T18:02:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/21854-malattia-di-pompe-a-esordio-tardivo-esperti-e-pazienti-a-confronto-sulla-nuova-terapia-combinata]]></loc><lastmod>2025-03-28T11:50:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/21616-malattia-di-pompe-a-esordio-tardivo-arriva-in-italia-la-terapia-a-due-componenti]]></loc><lastmod>2025-01-08T09:53:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/21408-malattia-di-pompe-studio-italiano-approfondisce-le-cause-genetiche-della-patologia]]></loc><lastmod>2024-10-21T10:15:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/20934-malattia-di-pompe-i-benefici-di-un-attivita-fisica-a-lungo-termine]]></loc><lastmod>2024-05-04T18:10:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/20577-malattia-di-pompe-arriva-in-italia-la-nuova-terapia-enzimatica-con-avalglucosidasi-alfa]]></loc><lastmod>2024-01-30T11:44:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/20471-malattia-di-pompe-l-intelligenza-artificiale-come-strumento-per-migliorare-la-diagnosi]]></loc><lastmod>2024-06-18T14:06:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/20318-malattia-di-pompe-a-esordio-infantile-una-prognosi-migliore-con-avalglucosidasi-alfa]]></loc><lastmod>2023-11-10T16:06:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/20224-malattia-di-pompe-ok-della-fda-alla-terapia-con-cipaglucosidasi-alfa-e-miglustat]]></loc><lastmod>2023-10-13T14:52:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/20086-malattia-di-pompe-approvata-una-nuova-terapia-nel-regno-unito]]></loc><lastmod>2023-09-04T08:12:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/20048-malattia-di-pompe-miglustat-approvato-in-europa]]></loc><lastmod>2023-10-12T17:37:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/19600-therareside-2023-il-mio-tempo-la-storia-di-samuele]]></loc><lastmod>2023-03-08T18:20:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/18867-malattia-di-pompe-approvazione-europea-per-avalglucosidasi-alfa]]></loc><lastmod>2022-07-03T18:25:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/18728-malattia-di-pompe-da-caregiver-a-ricercatrice-con-un-indagine-rivolta-alle-famiglie-dei-pazienti]]></loc><lastmod>2022-06-04T17:03:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/18426-malattia-di-pompe-un-interrogazione-chiede-di-estendere-la-terapia-domiciliare-oltre-lo-stato-di-emergenza]]></loc><lastmod>2022-03-16T16:29:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/18368-giornata-mondiale-delle-malattie-rare-esce-la-versione-rimasterizzata-della-canzone-io-faro-di-tutto]]></loc><lastmod>2022-03-03T10:36:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/18214-malattia-di-pompe-esce-il-libro-il-gusto-dolce-dell-amore]]></loc><lastmod>2022-01-23T22:27:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/17870-malattia-di-pompe-la-regione-emilia-romagna-non-concede-ancora-l-home-therapy]]></loc><lastmod>2021-10-09T18:47:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/17849-malattie-lisosomiali-a-esordio-tardivo-cresce-la-fiducia-nello-screening-neonatale]]></loc><lastmod>2021-10-03T17:58:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/17022-malattia-di-pompe-iniziata-la-somministrazione-della-terapia-genica-spk-3006-nello-studio-resolute]]></loc><lastmod>2021-02-14T21:06:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/16737-terapia-domiciliare-per-la-malattia-di-pompe-ancora-piu-fondamentale-in-epoca-covid]]></loc><lastmod>2020-11-25T17:02:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/16523-malattia-di-pompe-l-ema-valuta-l-approvazione-di-avalglucosidasi-alfa]]></loc><lastmod>2020-10-05T21:36:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/16363-malattie-lisosomiali-l-emergenza-covid-19-evidenzia-i-vantaggi-della-terapia-domiciliare]]></loc><lastmod>2020-08-10T16:20:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/16350-malattia-di-pompe-positivi-i-primi-risultati-di-fase-iii-con-avalglucosidasi-alfa]]></loc><lastmod>2020-08-02T14:15:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/15392-malattia-di-pompe-conferme-di-efficacia-per-la-terapia-at-gaa]]></loc><lastmod>2023-10-12T18:04:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/14941-malattia-di-pompe-il-nuovo-appello-del-piccolo-nicola-per-ricevere-la-terapia-domiciliare]]></loc><lastmod>2019-06-23T13:44:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/14800-malattia-di-pompe-dati-preclinici-positivi-per-la-terapia-genica]]></loc><lastmod>2019-05-14T08:47:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/14785-la-malattia-di-pompe-puo-essere-diagnosticata-anche-dagli-pneumologi]]></loc><lastmod>2019-05-08T09:03:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/14511-malattia-di-pompe-designazione-breakthrough-therapy-per-il-farmaco-at-gaa]]></loc><lastmod>2020-12-16T09:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/14324-malattia-di-pompe-al-via-studio-di-fase-iii-sul-farmaco-at-gaa]]></loc><lastmod>2019-01-02T19:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/14199-malattia-di-pompe-in-lombardia-la-terapia-domiciliare-e-realta]]></loc><lastmod>2018-11-26T11:08:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/14200-malattia-di-pompe-i-medici-al-fianco-dei-pazienti-si-alla-terapia-domiciliare]]></loc><lastmod>2018-11-24T17:35:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/14201-malattia-di-pompe-antonietta-chiedo-solo-di-poter-curare-mio-figlio-a-casa]]></loc><lastmod>2018-11-24T17:34:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/14021-malattia-di-pompe-dati-positivi-per-il-farmaco-sperimentale-at-gaa]]></loc><lastmod>2018-10-10T17:07:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/14008-malattia-di-pompe-la-proposta-uno-screening-selettivo-per-le-famiglie-a-rischio]]></loc><lastmod>2018-10-10T09:50:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/13968-malattie-neuromuscolari-rare-la-gestione-multidisciplinare-del-paziente-cronico]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/13217-malattia-di-pompe-nuovi-dati-positivi-per-la-combinazione-atb200-at2221]]></loc><lastmod>2018-10-01T07:01:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/13075-malattia-di-pompe-infusioni-a-domicilio-per-un-piccolo-paziente-di-brescia]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/12776-malattia-di-pompe-conferme-di-benefici-muscolari-per-la-terapia-atb200-at2221]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/12374-malattia-di-pompe-chaperone-farmacologico-migliora-la-funzione-motoria]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/12344-malattia-di-pompe-due-genitori-lottano-perche-il-figlio-sia-curato-a-casa]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/12251-malattia-di-pompe-il-futuro-e-nello-screening-neonatale]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/12212-malattia-di-pompe-una-nuova-app-per-mettere-in-contatto-medici-e-pazienti]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/12192-malattia-di-pompe-il-bilancio-dopo-10-anni-di-terapia-enzimatica-sostitutiva]]></loc><lastmod>2018-11-23T17:21:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/11601-malattia-di-pompe-testata-sull-uomo-nuova-terapia-genica-per-la-forma-infantile]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/11274-malattia-di-pompe-a-esordio-tardivo-con-la-terapia-enzimatica-sostitutiva-la-funzionalita-polmonare-resta-stabile]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/11080-malattia-di-pompe-test-preclinici-aprono-alla-possibilita-di-nuove-strategie-terapeutiche]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/10853-malattia-di-pompe-ad-esordio-infantile-nuovo-studio-indaga-la-varianti-atipiche-della-patologia]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/10852-malattia-di-pompe-ad-esordio-infantile-terapia-enzimatica-utile-ma-da-sola-non-basta-per-arrestare-il-danno-muscolare]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/10587-malattia-di-pompe-da-studio-europeo-giunge-un-importante-scoperta-scientifica]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/10379-malattia-di-pompe-oggi-e-la-terza-giornata-internazionale]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/10219-malattia-di-pompe-il-farmaco-neogaa-pronto-per-la-sperimentazione-di-fase-iii]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/10108-malattia-di-pompe-lo-spot-together-we-are-strong-in-onda-nei-palinsesti-rai]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/9916-sindrome-di-pompe-la-diagnosi-dopo-12-anni-l-impegno-affinche-non-succeda-piu]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/9625-malattia-di-pompe-alla-maratona-telethon-ospite-anche-l-associazione-italiana-glicogenosi]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/8971-malattia-di-pompe-oggi-e-domani-a-brescia-specialisti-a-confronto]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/8766-malattia-di-pompe-l-esercizio-fisico-e-sicuro-ed-efficace]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/8573-malattia-di-pompe-studio-italiano-conferma-l-efficacia-del-test-dried-blood-spot]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/7992-malattia-di-pompe-studio-italiano-dimostra-lefficacia-del-dbs-test-per-lo-screening-della-patologia]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/7981-malattia-di-pompe-un-video-per-la-giornata-internazionale-dedicata-alla-patologia]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/7863-studio-pneumoloped-arruolato-il-primo-paziente]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/7403-malattia-di-pompe-il-ruolo-dello-pneumologo-nella-diagnosi-della-patologia]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/7264-malattia-di-pompe-la-drssa-letizia-manneschi-lo-screening-dovrebbe-essere-di-routine]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/7133-malattia-di-pompe-a-torino-il-congresso-internazionale-il-21-e-22-novembre-2014]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/6941-malattia-di-pompe-la-gravita-e-determinata-dalle-diverse-mutazioni-genetiche-associate]]></loc><lastmod>2018-10-01T07:01:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/6753-malattia-di-pompe-il-registro-di-patologia-migliora-la-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/6754-malattia-di-pompe-in-finlandia-e-ancora-piu-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/6559-malattia-di-pompe-da-telethon-la-sperimentazione-di-una-nuova-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/6521-malattia-di-pompe-negli-usa-la-terapia-sostitutiva-con-alglucosidasi-alfa-ora-disponibile-per-tutti-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/6224-malattia-di-pompe-diagnosi-e-trattamento-precoce-fanno-la-differenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/5891-malattia-di-pompe-il-punto-su-diagnosi-e-terapia]]></loc><lastmod>2017-06-19T14:46:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/5890-malattia-di-pompe-oggi-la-prima-giornata-internazionale]]></loc><lastmod>2015-05-27T07:12:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/4772-malattia-di-pompe-si-riunisce-oggi-a-roma-lesperienza-italiana-nella-gestione-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/4522-malattia-di-pompe-gli-usa-valutano-lintroduzione-dello-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/4343-malattia-di-pompe-a-piedi-da-rimini-a-bari-per-far-conoscere-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/3800-malattia-di-pompe-nuovi-risultati-positivi-per-la-terapia-in-combinazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/3746-malattia-di-pompe-anna-si-racconta-ne-lultimo-giorno-di-inverno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/3325-malattia-di-pompe-nuove-possibilita-terapeutiche-grazie-alluso-dei-lieviti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/3054-malattia-di-pompe-lo-screening-neonatale-a-taiwan-e-realta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/2984-malattia-di-pompe-un-antitumorale-potrebbe-aiutare-alcuni-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/2956-malattia-di-pompe-lo-screening-neonatale-puo-cambiare-radicalmente-la-vita-dei-pazienti]]></loc><lastmod>2017-06-19T14:47:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/2917-malattia-di-pompe-la-conferma-la-terapia-enzimatica-sostitutiva-migliora-la-vita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/2555-malattia-di-pompe-l88-per-cento-degli-olandesi-dice-si-allallargamento-dello-screening-neonatale]]></loc><lastmod>2015-05-28T14:50:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/2256-malattia-di-pompe-la-medicina-preventiva-quale-strumento-strategico-per-arrestarne-la-progressione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/2212-malattia-di-pompe-terapia-enzimatica-sostitutiva-e-sviluppo-cognitivo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/1514-malattia-di-pompe-toscano-terapia-va-cominciata-ai-primi-sintomi-alcuni-pazienti-attendono]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/1447-malattia-di-pompe-mongini-diagnosi-precoce-fondamentale-anche-per-le-forme-tardive]]></loc><lastmod>2015-06-05T15:49:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/1436-malattia-di-pompe-studio-italiano-su-terapia-con-alglucosidasi-ne-dimostra-effetti-positivi]]></loc><lastmod>2018-11-24T14:13:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/1198-pompe-bembi-terapia-in-fase-asintomatica-solo-il-tempo-e-gli-studi-diranno-cosa-e-meglio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/1134-malattia-di-pompe-dalla-diagnosi-allesordio-sono-passati-20-anni-tutti-in-salute]]></loc><lastmod>2015-06-05T17:17:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/1150-malattia-di-pompe-seidita-aig-giusto-attendere-i-sintomi-per-cominciare-la-terapia]]></loc><lastmod>2015-06-05T17:04:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/777-malattia-di-pompe-in-campania-potrebbero-essere-una-novantina-i-casi-senza-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/704-malattia-di-pompe-possibile-individuarla-facilmente-con-il-dbs-test]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/649-malattia-di-pompe-lalglucosidasi-alfa-puo-dare-benefici-anche-per-le-forme-ad-insorgenza-tardiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/538-malattia-di-pompe-ripartono-i-trial-con-at2220-il-farmaco-sara-pero-associato-alla-terapia-enzimatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/402-malattia-di-pompe-nuovo-impiantodi-genzyme-in-belgio-per-produzione-di-alglucosidasi-alfa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-pompe/384-malattia-di-pompe-al-via-trial-di-fase-12-della-proteina-bmn-701]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher]]></loc><lastmod>2025-02-04T09:30:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/22722-malattia-di-gaucher-di-tipo-3-risultati-positivi-dallo-studio-di-fase-iii-su-venglustat]]></loc><lastmod>2026-02-06T12:09:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/21362-malattia-di-gaucher-o-deficit-di-sfingomielinasi-acida-l-importanza-della-diagnosi-differenziale]]></loc><lastmod>2024-10-09T12:50:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/21018-malattia-di-gaucher-un-opuscolo-informativo-per-aiutare-i-medici-a-non-lasciarsela-sfuggire]]></loc><lastmod>2024-05-29T15:35:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/20774-malattia-di-gaucher-dagli-imminozuccheri-una-speranza-per-la-forma-neuropatica-della-patologia]]></loc><lastmod>2024-03-18T16:46:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/20161-malattia-di-gaucher-pubblicate-le-prime-linee-guida-per-la-diagnosi-di-laboratorio]]></loc><lastmod>2023-10-02T09:53:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/19489-malattia-di-gaucher-indagine-internazionale-rileva-la-necessita-di-informazioni-sulla-terapia-genica]]></loc><lastmod>2023-02-01T11:01:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/18923-malattia-di-gaucher-ho-atteso-30-anni-per-ottenere-la-diagnosi]]></loc><lastmod>2022-07-16T20:17:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/18066-malattie-lisosomiali-e-terapie-domiciliari-al-via-la-campagna-lost-moments]]></loc><lastmod>2021-12-05T14:46:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/17836-malattie-da-accumulo-lisosomiale-si-conclude-la-campagna-raro-chi-trova]]></loc><lastmod>2021-09-30T11:15:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/17795-malattia-di-gaucher-le-tre-terapie-enzimatiche-a-confronto]]></loc><lastmod>2021-09-20T13:51:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/16751-malattia-di-gaucher-ancora-troppe-disparita-regionali-su-accesso-a-terapia-domiciliare]]></loc><lastmod>2020-11-29T22:26:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/16510-malattia-di-gaucher-oggi-ricorre-la-giornata-mondiale-dedicata-alla-patologia]]></loc><lastmod>2020-09-30T10:52:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/16204-malattia-di-gaucher-di-tipo-1-l-impatto-psicologico-e-piu-sentito-dai-bambini]]></loc><lastmod>2020-06-21T20:50:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/16143-malattia-di-gaucher-una-delle-maggiori-criticita-e-l-aderenza-al-trattamento-e-ai-controlli]]></loc><lastmod>2020-06-08T20:01:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/15868-covid-19-e-malattie-rare-le-raccomandazioni-sulla-terapia-enzimatica-sostitutiva]]></loc><lastmod>2020-03-31T15:39:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/15745-malattia-di-gaucher-la-gestione-a-lungo-termine-del-paziente]]></loc><lastmod>2020-03-17T19:51:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/15611-malattia-di-gaucher-il-rischio-di-mieloma-multiplo-e-2-4-volte-piu-alto]]></loc><lastmod>2020-01-27T21:39:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/15461-malattia-di-gaucher-si-possono-attendere-anche-4-anni-per-una-diagnosi]]></loc><lastmod>2019-12-01T22:04:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/15280-malattie-di-gaucher-e-di-niemann-pick-gli-esperti-propongono-uno-screening-combinato]]></loc><lastmod>2019-10-08T18:07:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/15151-malattia-di-gaucher-la-storia-di-manuela-imprenditrice-e-sportiva]]></loc><lastmod>2019-09-03T10:47:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/14410-malattia-di-gaucher-francesco-e-la-sua-testimonianza-per-gaucherlives]]></loc><lastmod>2019-02-02T19:12:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/14342-malattia-di-gaucher-la-terapia-orale-puo-migliorare-la-vita-dei-pazienti]]></loc><lastmod>2019-01-30T10:49:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/13985-malattia-di-gaucher-alla-scoperta-dei-talenti-rari-con-il-progetto-fatto-x-arte]]></loc><lastmod>2019-10-16T14:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/13766-malattia-di-gaucher-al-fianco-dei-pazienti-c-e-l-associazione-italiana-gaucher-onlus]]></loc><lastmod>2018-07-18T09:53:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/13755-le-opzioni-terapeutiche-per-la-malattia-di-gaucher]]></loc><lastmod>2018-07-13T16:28:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/13747-malattia-di-gaucher-la-ricerca-avanza-anche-sul-fronte-diagnostico]]></loc><lastmod>2018-07-09T08:32:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/13734-malattia-di-gaucher-la-terapia-e-fondamentale-per-contrastare-il-dolore-cronico-dovuto-ai-danni-ossei]]></loc><lastmod>2018-07-07T09:46:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/13725-malattia-di-gaucher-la-diagnosi-precoce-e-fondamentale]]></loc><lastmod>2018-07-04T10:12:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/13718-gaucherlive-il-punto-su-diagnosi-terapia-e-qualita-della-vita-nella-malattia-di-gaucher]]></loc><lastmod>2018-07-19T11:30:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/13711-malattia-di-gaucher-focus-sulla-terapia-orale]]></loc><lastmod>2018-07-03T08:10:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/13712-malattia-di-gaucher-celeste-grazie-alla-terapia-orale-ho-realizzato-il-sogno-di-trasferirmi-all-estero]]></loc><lastmod>2018-07-03T08:10:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/12911-malattia-di-gaucher-eliglustat-disponibile-in-italia-in-classe-a]]></loc><lastmod>2017-11-18T16:40:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/12785-malattia-di-gaucher-tipo-1-anche-in-italia-arriva-la-terapia-orale-con-eliglustat]]></loc><lastmod>2017-10-17T14:36:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/12755-gaucher-celebrata-la-giornata-mondiale-ma-in-italia-si-lotta-ancora-per-la-terapia-domiciliare]]></loc><lastmod>2017-10-09T14:23:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/12396-malattia-di-gaucher-algoritmo-italiano-per-la-diagnosi-precoce-e-non-invasiva]]></loc><lastmod>2017-06-19T14:39:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/11473-malattia-di-gaucher-esiste-una-relazione-con-il-lupus-erimatoso-sistemico]]></loc><lastmod>2017-06-19T14:40:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/11357-malattia-di-gaucher-le-raccomandazioni-per-l-uso-del-farmaco-eliglustat]]></loc><lastmod>2016-10-04T14:30:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/11358-malattia-di-gaucher-risultati-rassicuranti-per-la-terapia-a-lungo-termine-con-taliglucerasi]]></loc><lastmod>2016-10-04T14:29:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/11427-malattia-di-gaucher-un-appello-per-le-infusioni-a-domicilio]]></loc><lastmod>2017-06-19T14:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/11426-malattia-di-gaucher-domani-a-genova-il-congresso-annuale]]></loc><lastmod>2017-06-19T14:40:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/11363-malattia-di-gaucher-nuovi-dati-positivi-per-l-ert-con-taliglucerasi-alfa]]></loc><lastmod>2016-10-01T12:39:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/11352-malattia-di-gaucher-due-diverse-terapie-a-confronto]]></loc><lastmod>2016-10-01T10:42:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/11375-rari-ma-non-soli-l-iniziativa-globale-dedicata-alla-malattia-di-gaucher]]></loc><lastmod>2017-06-19T14:41:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/11263-al-via-spotlight-on-gaucher-per-dare-visibilita-a-una-malattia-rara-e-ancora-poco-conosciuta]]></loc><lastmod>2016-09-16T13:09:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/10592-malattia-di-gaucher-per-i-pazienti-la-stanchezza-e-il-parametro-piu-importante]]></loc><lastmod>2016-05-16T15:52:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/9681-malattia-di-gaucher-le-previsioni-epidemiologiche-sulla-patologia-fino-al-2024]]></loc><lastmod>2015-12-28T11:30:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/9206-malattia-di-gaucher-comunicati-i-vincitori-dell-iniziativa-spotlight-on-gaucher]]></loc><lastmod>2015-10-23T08:35:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/8688-malattia-di-gaucher-shire-lancia-il-concorso-cinematografico-spotlight-on-gaucher]]></loc><lastmod>2015-07-24T09:52:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/8634-malattia-di-gaucher-e-di-niemann-pick-il-probiotico-saccharomyces-boulardii-migliora-la-tollerabilita-gastrointestinale-del-farmaco-miglustat]]></loc><lastmod>2015-07-16T14:04:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/8618-malattia-di-gaucher-gli-effetti-della-limitazione-nella-fornitura-di-imiglucerasi-sulla-gestione-terapeutica-dei-pazienti-francesi]]></loc><lastmod>2015-07-14T10:39:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/8346-malattia-di-gaucher-di-tipo-1-come-valutare-il-carico-e-la-risposta-al-trattamento]]></loc><lastmod>2015-05-29T09:54:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/8290-farmaci-orfani-genzyme-riceve-linnovation-award-di-nord]]></loc><lastmod>2015-05-27T08:52:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/7994-malattia-di-gaucher-tipo-1-eliglustat-approvato-anche-in-giappone]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/7938-malattia-di-gaucher-il-farmaco-orale-eliglustat-efficace-nella-terapia-di-mantenimento]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/7937-malattia-di-gaucher-si-e-concluso-il-gaucher-leadership-forum-2015]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/7643-malattia-di-gaucher-tipo-1-nuovi-dati-positivi-per-la-terapia-con-eliglustat]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/7637-malattia-di-gaucher-tipo-1-il-trattamento-con-eliglustat-conferma-la-sua-efficacia]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/7480-malattia-di-gaucher-approvato-eliglustat-come-terapia-orale-di-prima-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/7162-malattia-di-gaucher-parere-positivo-dellema-per-la-terapia-orale-con-eliglustat]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/6987-malattia-di-gaucher-profssa-carubbi-occorre-un-protocollo-diagnostico-corretto-per-riconoscere-le-malattie-lisosomiali]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/6843-malattia-di-gaucher-dal-gaslini-di-genova-un-algoritmo-per-non-sbagliare-la-diagnosi]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/6664-malattia-di-gaucher-fda-approva-eliglustat-21218872]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/6629-malattia-di-gaucher-lfda-concede-lapprovazione-a-taliglucerase-alfa-per-uso-endovenoso-in-pazienti-pediatrici]]></loc><lastmod>2015-05-25T15:17:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/6597-malattia-di-gaucher-nei-pazienti-in-terapia-di-sostituzione-enzimatica-il-95-dei-biomarcatori-risponde-in-due-anni]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/6589-malattia-di-gaucher-fda-approva-eliglustat]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/6510-malattia-di-gaucher-lema-e-la-food-and-drug-administration-promuovono-una-ricerca-clinica-congiunta]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/6361-malattia-di-gaucher-di-tipo-1-pfizer-riceve-la-certificazione-kosher-per-taliglucerase-alfa]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/6253-malattia-di-gaucher-come-si-diventa-grandi-con-una-malattia-rara]]></loc><lastmod>2015-08-10T07:16:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/6206-malattia-di-gaucher-grazie-a-un-gruppo-di-lavoro-italiano-nasce-il-primo-algoritmo-pediatrico-per-facilitare-la-diagnosi-della-rara-patologia]]></loc><lastmod>2017-06-15T09:57:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/5343-malattia-di-gaucher-scoperta-una-nuova-potenziale-terapia]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/5128-malattia-di-gaucher-la-fda-statunitense-concede-priorita-di-valutazione-al-farmaco-eliglustat]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/5064-malattia-di-gaucher-concluso-a-madrid-il-forum-interdisciplinare]]></loc><lastmod>2019-06-19T08:09:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/4603-malattia-di-gaucher-e-rischio-di-parkinson-e-giusto-informare-le-famiglie]]></loc><lastmod>2015-08-10T07:17:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/4552-malattia-di-gaucher-al-via-il-gaucher-generation-program]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/4512-malattia-di-gaucher-quanto-e-difficile-ottenere-una-diagnosi]]></loc><lastmod>2015-08-10T07:17:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/4511-malattia-di-gaucher-drssa-elena-procopio-la-consulenza-genetica-si-basa-sul-proporre-e-non-imporre]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/4451-gaucher-di-rocco-occorre-allenare-i-medici-a-riconoscere-i-sintomi]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/4335-malattia-di-gaucher-fatta-la-diagnosi-bisognerebbe-sempre-offrire-il-counseling-genetico]]></loc><lastmod>2015-08-10T07:18:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/3696-malattia-di-gaucher-linari-i-risultati-di-eliglustat-tartrato-sono-una-tappa-fondamentale-per-le-prospettive-terapeutiche-di-questa-malattia-raraq]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/3663-malattia-di-gaucher-conferme-positive-per-la-terapia-con-eliglustat-tartrato]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/3558-malattia-di-gaucher-tipo-1-nuovi-approcci-nella-terapia-di-sostituzione-enzimatica-e-in-quella-di-supporto]]></loc><lastmod>2015-05-25T15:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/3534-malattia-di-gaucher-una-nuova-app-per-una-piu-semplice-gestione-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/3065-malattia-di-gaucher-un-modello-per-la-ricerca-dalle-staminali-adulte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/3022-malattia-di-gaucher-ecco-di-dati-del-registro-francese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/2970-malattia-di-gaucher-la-prima-consensus-italiana-per-identificare-la-minimal-disease-activity]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/2930-gaucher-la-terapia-orale-migliora-la-vita-dei-pazienti-e-giova-al-servizio-sanitario-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/2863-terapie-domiciliari-di-rocco-gaslini-positiva-lesperienza-con-la-terapia-enzimatica-sostitutiva]]></loc><lastmod>2015-08-10T07:18:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/2858-malattia-di-gaucher-presto-disponibile-una-nuova-terapia-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/2581-malattia-di-gaucher-in-gravidanza-non-e-necessario-sospendere-la-terapia-sostitutiva]]></loc><lastmod>2015-05-28T14:26:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/2364-malattia-di-gaucher-al-via-la-commercializzazione-del-taliglucerase]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/2111-malattia-di-gaucher-approvato-il-taliglucerase-derivato-dalla-carota]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/1850-malattia-di-gaucher-mappate-le-caratteristiche-genetiche-e-cliniche-nella-penisola-iberica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/1666-malattia-di-gaucher-grande-successo-per-il-trattamento-orale-con-eliglustat-tartrato-ora-avviato-lo-studio-di-fase-tre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/1588-malattia-di-gaucher-in-forte-relazione-con-parkinson-e-altre-sinuleinopatie]]></loc><lastmod>2015-12-15T12:29:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/1301-gaucher-lassociazione-pazienti-a-convegno-sotto-i-riflettori-la-terapia-a-domilicio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/690-malattie-lisosomiale-bembi-difetta-un-enzima-prima-si-comincia-la-terapia-e-meglio-e]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/691-gaucher-giona-i-pazienti-potranno-finalmente-scegliere-il-farmaco-con-cui-si-trovano-meglio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/692-gaucher-torquati-aig-onlus-con-le-terapie-la-vita-dei-malati-e-completamente-cambiata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/693-gaucher-e-arrivato-in-italia-il-velaglucerasi-alfa-vpriv-nuovo-enzima-sostitutivo-targato-shire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/695-gaucher-la-valutazione-del-paziente-si-fa-con-la-tgmap]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/589-malattia-di-gaucher-bembi-valuteremo-lefficacia-di-dosi-ridotte-di-terapia-enzimatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/570-malattia-di-gaucher-dal-ministero-finanziamenti-una-nuova-ricerca-ad-udine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/490-malattia-di-gaucher-la-fda-chiede-piu-dati-per-lautorizzazione-del-taliglucerase-alfa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/454-malattia-di-gaucher-leliglustat-migliora-anche-la-situazione-delle-ossa-nei-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/307-malattia-di-gaucher-dalle-cellule-della-carota-e-in-arrivo-un-nuovo-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/106-malattia-di-gaucher-di-tipo-1-approvato-il-velaglucerase-alfa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-gaucher/69-malattia-di-gaucher-di-tipo-1-buoni-i-risultati-degli-studi-di-efficacia-del-velaglucerasi-alfa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry]]></loc><lastmod>2026-03-18T09:34:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/22954-malattia-di-fabry-la-terapia-genica-mostra-benefici-sulla-funzionalita-renale]]></loc><lastmod>2026-04-20T16:48:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/22888-malattia-di-fabry-al-via-il-mese-della-consapevolezza-aiaf-presenta-ti-racconto-la-fabry]]></loc><lastmod>2026-04-04T10:09:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/22868-malattia-di-fabry-ai-nastri-di-partenza-gli-studi-clinici-registrativi-su-lucerastat]]></loc><lastmod>2026-03-24T18:46:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/22803-febbri-ricorrenti-nella-malattia-di-fabry-quando-un-sintomo-potenzialmente-fuorviante-diventa-chiave-diagnostica]]></loc><lastmod>2026-02-28T12:09:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/22776-my-fabry-tree-quando-un-bosco-diventa-consapevolezza-sulla-malattia-di-fabry]]></loc><lastmod>2026-02-23T14:29:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/22751-malattia-di-fabry-parere-positivo-del-chmp-su-nuovo-regime-di-somministrazione-di-pegunigalsidasi-alfa]]></loc><lastmod>2026-02-17T08:51:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/22721-malattia-di-fabry-gli-effetti-del-farmaco-migalastat-sul-tessuto-cerebrale]]></loc><lastmod>2026-02-06T12:07:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/22646-malattia-di-anderson-fabry-al-policlinico-gemelli-una-mattinata-di-formazione-per-futuri-medici-e-specialisti]]></loc><lastmod>2026-01-22T11:41:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/22547-malattia-di-fabry-il-danno-cerebrale-sembra-andare-di-pari-passo-con-quello-renale]]></loc><lastmod>2025-11-25T09:41:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/21904-malattia-di-fabry-dalla-consapevolezza-al-sostegno-con-la-campagna-le-radici-di-fabry]]></loc><lastmod>2025-04-14T13:52:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/21838-genitorialita-e-gravidanza-nella-malattia-di-fabry-nuove-prospettive-per-le-famiglie]]></loc><lastmod>2025-03-25T14:43:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/21710-malattia-di-fabry-da-soli-i-test-biochimici-per-la-diagnosi-non-sono-abbastanza-attendibili-nelle-donne]]></loc><lastmod>2025-02-10T16:51:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/21621-malattia-di-fabry-quando-iniziare-la-terapia-nei-casi-pediatrici]]></loc><lastmod>2025-01-23T14:03:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/21300-malattia-di-fabry-occorre-prestare-piu-attenzione-alle-terapie-di-supporto]]></loc><lastmod>2024-09-18T14:00:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/21195-malattia-di-fabry-approvata-da-aifa-la-commercializzazione-della-terapia-enzimatica-sostitutiva-a-lungo-termine]]></loc><lastmod>2026-02-11T11:38:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/21112-malattia-di-fabry-necessario-un-modello-di-presa-in-carico-integrata-del-paziente]]></loc><lastmod>2024-06-27T07:26:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/21050-sonia-peronaci-porta-in-tavola-le-ricette-per-persone-con-malattia-di-fabry]]></loc><lastmod>2024-06-04T14:11:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/20870-malattia-di-fabry-al-via-la-campagna-do-re-mi-fabry]]></loc><lastmod>2024-04-15T11:16:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/20740-malattia-di-fabry-una-dieta-corretta-contribuisce-ad-alleviare-i-sintomi-gastrointestinali]]></loc><lastmod>2024-03-11T12:48:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/20657-malattia-di-fabry-pubblicati-i-risultati-di-fase-iii-di-pegunigalsidasi-alfa]]></loc><lastmod>2024-02-20T15:51:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/20626-malattie-rare-e-nutrizione-al-via-il-progetto-fabry-s-kitchen]]></loc><lastmod>2024-02-14T19:37:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/20239-fabry-e-parkinson-possibile-un-associazione-fra-le-due-patologie]]></loc><lastmod>2023-10-17T16:35:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/20029-malattia-di-fabry-il-livello-di-periostina-potrebbe-essere-un-indicatore-di-danno-ai-reni]]></loc><lastmod>2023-07-27T10:11:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/19939-malattia-di-fabry-la-terapia-genica-potrebbe-presto-diventare-una-realta]]></loc><lastmod>2023-06-25T21:09:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/19937-malattia-di-fabry-nasce-una-rete-di-esperti-per-la-diagnosi]]></loc><lastmod>2023-06-23T11:04:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/19689-aprile-il-mese-della-consapevolezza-per-la-malattia-di-anderson-fabry]]></loc><lastmod>2023-04-05T07:11:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/19595-malattia-di-fabry-parere-positivo-del-chmp-per-pegunigalsidasi-alfa]]></loc><lastmod>2023-03-07T09:50:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/19415-malattia-di-fabry-autorizzata-l-autosomministrazione-di-agalsidasi-alfa]]></loc><lastmod>2022-12-23T11:29:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/19387-malattia-di-fabry-piu-di-4000-euro-di-costi-indiretti-per-i-pazienti]]></loc><lastmod>2022-12-13T06:56:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/19010-malattia-di-fabry-in-forma-classica-fondamentale-un-inizio-precoce-della-terapia-enzimatica]]></loc><lastmod>2022-09-01T14:33:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/18594-malattia-di-fabry-risultati-clinici-favorevoli-dallo-studio-di-fase-iii-su-prx-102]]></loc><lastmod>2022-05-01T16:07:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/18501-malattia-di-fabry-al-via-la-campagna-di-sensibilizzazione-di-aiaf]]></loc><lastmod>2022-04-01T16:41:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/18234-malattia-di-fabry-meglio-iniziare-la-terapia-enzimatica-alla-comparsa-dei-primi-sintomi]]></loc><lastmod>2022-01-30T18:04:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/17800-malattia-di-fabry-le-prospettive-terapeutiche-nell-ambito-della-genetica]]></loc><lastmod>2021-09-21T21:29:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/17326-un-amico-raro-un-cartoon-di-successo-diventa-testimonial-della-malattia-di-fabry]]></loc><lastmod>2021-04-22T10:10:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/17134-malattia-di-fabry-le-differenze-fra-i-due-tipi-di-terapia-enzimatica-sostitutiva]]></loc><lastmod>2021-11-23T22:13:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/17098-malattia-di-fabry-e-terapia-enzimatica-maggiori-benefici-con-un-dosaggio-piu-alto]]></loc><lastmod>2021-11-23T22:14:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/16753-malattia-di-fabry-incidenza-elevata-fra-chi-ha-ricevuto-un-trapianto-di-rene]]></loc><lastmod>2020-11-29T22:59:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/16739-malattia-di-fabry-terapia-domiciliare-e-realta-solo-in-alcune-regioni-tobaldini-in-tempo-di-covid-e-indispensabile]]></loc><lastmod>2020-11-25T18:40:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/16151-malattia-di-fabry-gli-effetti-della-terapia-enzimatica-su-cuore-e-reni]]></loc><lastmod>2020-06-09T16:38:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/16022-malattia-di-fabry-in-che-modo-colpisce-il-cuore-e-i-reni]]></loc><lastmod>2020-05-03T23:23:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15997-la-storia-di-maricia-roccaro-la-dottoressa-che-ha-scoperto-di-avere-la-malattia-di-fabry]]></loc><lastmod>2020-04-28T09:19:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15936-malattia-di-fabry-aprile-e-il-fabry-awareness-month]]></loc><lastmod>2020-04-12T22:07:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15733-malattia-di-fabry-le-sfide-piu-complicate-per-il-cardiologo]]></loc><lastmod>2020-03-08T14:07:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15544-malattia-di-fabry-nasce-il-registro-italiano-fabry-stroke]]></loc><lastmod>2019-12-30T18:38:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15545-malattia-di-fabry-una-condizione-estremamente-eterogenea-nelle-donne]]></loc><lastmod>2019-12-30T18:38:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15542-malattia-di-fabry-in-quali-circostanze-e-indicata-la-biopsia-renale]]></loc><lastmod>2019-12-30T18:35:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15543-malattia-di-fabry-l-epigenetica-influenza-gravita-e-decorso-della-patologia]]></loc><lastmod>2019-12-30T18:34:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15538-malattia-di-fabry-cruciale-il-ruolo-del-cardiologo-soprattutto-in-fase-diagnostica]]></loc><lastmod>2019-12-30T18:35:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15536-anderson-fabry-importanza-dell-infiammazione-nella-progressione-della-malattia]]></loc><lastmod>2019-12-30T18:36:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15532-malattia-di-fabry-segni-e-sintomi-renali-possono-suggerire-la-presenza-della-patologia]]></loc><lastmod>2019-12-22T16:51:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15513-malattia-di-fabry-mariella-sarebbe-tutto-piu-semplice-con-le-infusioni-a-domicilio]]></loc><lastmod>2019-12-14T20:06:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15354-malattia-di-fabry-a-firenze-si-svolto-l-incontro-regionale-medici-pazienti-della-toscana]]></loc><lastmod>2019-10-28T19:12:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/15265-malattia-di-fabry-con-una-diagnosi-precoce-la-vita-migliora]]></loc><lastmod>2019-10-03T10:58:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14956-malattia-di-fabry-medici-e-pazienti-del-lazio-riuniti-all-incontro-aiaf]]></loc><lastmod>2019-10-16T14:47:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14666-malattia-di-fabry-i-risultati-di-un-indagine-nazionale-sulla-qualita-della-vita-dei-pazienti]]></loc><lastmod>2019-10-31T16:10:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14659-amicus-therapeutics-il-futuro-e-la-terapia-genica-ma-il-presente-e-fatto-di-innovazione-concreta]]></loc><lastmod>2019-06-25T14:32:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14216-malattia-di-fabry-ed-eventi-neurologici-centrali-esiste-un-nesso]]></loc><lastmod>2019-05-30T08:52:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14212-malattia-di-fabry-l-importanza-dello-screening-sulle-popolazioni-a-rischio]]></loc><lastmod>2019-05-30T08:52:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14198-malattia-di-fabry-l-impegno-di-shire-intervista-a-francesco-scopesi]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14195-malattia-di-fabry-il-fondamentale-ruolo-della-genetica]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14189-malattia-di-fabry-risultati-a-lungo-termine-con-la-terapia-enzimatica]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14190-malattia-di-fabry-ecco-perche-parliamo-di-pedigree]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14171-malattia-di-fabry-concluso-il-corso-annuale-time2fabry]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14039-malattia-di-fabry-le-raccomandazioni-in-ambito-nefrologico-e-i-nuovi-marker-diagnostici]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14038-malattia-di-fabry-l-importanza-di-un-corretto-management-del-paziente]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/14012-malattia-di-fabry-da-aiaf-onlus-un-questionario-sulla-qualita-di-vita-dei-pazienti]]></loc><lastmod>2019-09-10T14:16:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13842-malattia-di-fabry-approvazione-usa-per-migalastat]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13732-malattia-di-fabry-aiaf-onlus-fa-il-punto-su-obiettivi-e-progetti]]></loc><lastmod>2019-09-10T14:15:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13699-come-si-vive-con-una-malattia-rara-genetica-il-progetto-viverelafabry-per-una-migliore-conoscenza-e-una-diagnosi-piu-tempestiva-della-malattia]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13623-malattia-di-fabry-le-possibilita-terapeutiche-attuali-e-future]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13571-malattia-di-fabry-la-storia-di-angela-la-paura-dopo-la-diagnosi-e-la-speranza-nel-futuro]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13557-malattia-di-fabry-pasquale-si-racconta-per-promuovere-la-conoscenza-della-malattia]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13402-malattia-di-fabry-migalastat-approvato-in-giappone]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13363-malattia-di-fabry-da-aiaf-onlus-35-000-per-lo-studio-di-un-marcatore-diagnostico]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13231-malattia-di-fabry-fda-avvia-la-revisione-prioritaria-di-migalastat]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13203-malattia-di-fabry-il-racconto-di-rita-la-diagnosi-di-mio-figlio-dopo-20-anni-e-grazie-anche-al-web]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13155-malattia-di-fabry-nel-sud-della-sardegna-una-prevalenza-elevatissima]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13130-malattia-di-fabry-la-terapia-chaperonica-orale-ora-disponibile-anche-in-spagna]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13136-malattia-di-fabry-quando-il-dolore-nei-bambini-non-viene-creduto]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13127-malattia-di-fabry-roberta-si-racconta]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13022-malattia-di-anderson-fabry-in-toscana-un-centro-di-eccellenza]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/13005-malattia-di-fabry-la-nuova-terapia-orale-ha-cambiato-la-vita-di-molti-pazienti]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12990-malattia-di-fabry-perche-lo-screening-neonatale]]></loc><lastmod>2019-05-30T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12914-malattia-di-fabry-l-aderenza-terapeutica-e-un-problema-per-molti-pazienti]]></loc><lastmod>2019-05-30T08:52:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12884-malattia-di-fabry-una-risposta-migliore-con-la-terapia-enzimatica-precoce]]></loc><lastmod>2017-11-13T10:02:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12840-la-valutazione-della-stabilita-clinica-del-paziente-con-malattia-di-fabry-con-l-indice-fastex]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12841-malattia-di-fabry-un-algoritmo-innovativo-e-una-web-app-per-monitorare-la-patologia]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12772-malattia-di-fabry-uno-screening-neonatale-sistematico-e-fattibile]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12765-malattia-di-fabry-attivo-il-servizio-esperto-risponde]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12492-malattia-di-fabry-prossima-la-richiesta-di-approvazione-usa-per-migalastat]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12493-malattia-di-fabry-nuovi-dati-sul-confronto-tra-agalsidasi-alfa-e-beta]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12444-malattia-di-fabry-sostanziale-equivalenza-tra-alfa-e-beta-galattosidasi]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12170-malatla-terapia-di-sostituzione-enzimatica-e-scarsamente-efficace-nel-ridurre-la-malattia-cerebrovascolaretia-di-fabry-la-terapia-di-sostituzione-enzimatica-e-scarsamente-efficace-nel-ridurre-la-malattia-cerebrovascolare]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12077-malattia-di-fabry-l-associazione-aiaf-presenta-il-nuovo-comitato-scientifico]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12064-malattia-di-fabry-amicus-therapeutics-lancia-il-farmaco-migalastat-nel-regno-unito]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12074-malattia-di-fabry-gli-obiettivi-dell-associazione-aiaf-a-un-anno-dalla-sua-nascita]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/12047-malattia-di-fabry-arriva-in-italia-migalastat-il-primo-chaperone-farmacologico-orale]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/11919-malattia-di-fabry-il-cuore-e-l-organo-piu-coinvolto]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/11784-malattia-di-fabry-l-impatto-della-febbre-sulla-diagnosi]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/11691-malattia-di-fabry-sviluppato-un-modello-per-la-disfunzione-neuronale]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/11640-malattia-di-fabry-pubblicati-i-risultati-dello-studio-attract-su-migalastat]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/11320-il-dolore-nella-malattia-di-fabry-le-raccomandazioni-pratiche-per-la-diagnosi-e-il-trattamento]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/11310-malattia-di-fabry-in-germania-un-terzo-delle-pazienti-senza-terapia-enzimatica]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/11243-malattia-di-fabry-nuovi-dati-positivi-migalastat-molecola-chaperonica-a-uso-orale]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/10773-malattia-di-fabry-la-prof-ssa-carubbi-spiega-i-sintomi-la-diagnosi-e-la-terapia]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/10760-malattia-di-fabry-le-raccomandazioni-degli-esperti-italiani-in-campo-nefrologico]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/10747-malattia-di-fabry-europa-approva-farmaco-migalastat-per-pazienti-con-specifiche-mutazioni-genetiche]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/10320-malattia-di-fabry-quali-obiettivi-terapeutici-futuri]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/10307-malattia-di-fabry-approvato-dal-chmp-il-farmaco-migalastat]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/9860-malattia-di-fabry-la-qualita-di-vita-migliora-con-la-terapia-enzimatica-sostitutiva]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/9794-malattie-lisosomiali-a-padova-si-studiano-nuovi-marcatori-per-migliorare-la-terapia-sostitutiva]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/9473-malattia-di-fabry-nasce-il-primo-questionario-auto-somministrato-per-la-valutazione-del-dolore-nei-pazienti-adulti]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/9213-malattia-di-fabry-la-sintomatologia-gastro-intestinale-spesso-e-sottovalutata]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/9016-malattia-di-fabry-studio-tutto-italiano-scopre-nuovi-pazienti-indagando-tra-quelli-colpiti-da-ischemia]]></loc><lastmod>2019-05-30T08:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/8639-la-qualita-di-vita-nei-pazienti-con-malattia-di-fabry-pochi-dati-sugli-effetti-della-terapia-enzimatica-sostitutiva]]></loc><lastmod>2015-07-17T10:53:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/8236-malattia-di-fabry-la-fda-concede-la-revisione-accelerata-per-il-nuovo-farmaco-di-sanofi]]></loc><lastmod>2016-05-06T16:40:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/8042-malattia-di-fabry-inizio-e-cessazione-terapia-enzimatica-pubblicate-le-linee-guida]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/7709-malattia-di-fabry-quando-puo-essere-confusa-con-la-sclerosi-multipla]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/7355-diagnosi-incerta-della-malattia-di-fabry-negli-adulti-le-raccomandazioni-degli-esperti]]></loc><lastmod>2015-05-25T15:14:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/7285-malattia-di-fabry-le-raccomandazioni-dei-maggiori-esperti-italiani]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/7248-malattia-di-fabry-lagalsidasi-alfa-e-ben-tollerato-nei-pazienti-pediatrici]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/7159-malattia-di-fabry-la-gestione-del-paziente-al-san-gerardo-di-monza]]></loc><lastmod>2016-05-06T16:20:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/6991-malattia-di-fabry-limportanza-del-supporto-multidisciplinare-e-psicologico]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/6985-malattia-di-fabry-nuovi-studi-sul-paracalcitolo-e-sulle-molecole-chaperoniche-al-federico-ii-di-napoli]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/6861-malattia-di-fabry-il-centro-del-san-gerardo-di-monza-modello-di-approccio-multidisciplinare]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/6708-malattia-di-fabry-lospedale-san-gerardo-di-monza-fa-scuola-sulla-patologia-con-una-master-school-di-due-giorni]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/6636-malattia-di-fabry-novita-incoraggianti-per-il-chaperone-migalastat]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/6598-malattia-di-fabry-primo-confronto-tra-agalsidasi-alfa-e-agalsidasi-beta-ne-conferma-lequivalenza]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/6377-malattia-di-fabry-ulteriori-conferme-dellefficacia-della-terapia-sostitutiva-con-alfa-galattosidasi-a]]></loc><lastmod>2019-06-18T18:07:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/6213-malattia-di-fabry-esiti-favorevoli-dalla-terapia-continuativa-con-agalsidasi-beta]]></loc><lastmod>2019-06-18T18:16:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/6227-malattia-di-fabry-prevenire-il-danno-renale-e-possibile]]></loc><lastmod>2017-10-11T20:09:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/6208-malattia-di-anderson-fabry-rettifica-su-disponibilita-terapeutiche-in-italia]]></loc><lastmod>2017-07-04T16:02:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/5849-malattia-di-fabry-un-nuovo-metodo-per-lo-screening-di-donne-ad-alto-rischio]]></loc><lastmod>2019-06-18T18:28:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/5721-malattia-di-anderson-fabry-al-via-domani-a-roma-il-3d-fabry-expert-lounge]]></loc><lastmod>2017-07-04T16:04:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/5631-malattia-di-fabry-quando-si-manifesta-laspetto-neurologico]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/5585-malattia-di-fabry-la-terapia-di-sostituzione-enzimatica-ha-pochi-effetti-sulle-complicazioni-ma-e-efficace-nel-ridurre-la-massa-ventricolare]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/5259-malattia-di-fabry-alcune-manifestazioni-cardiache-possono-esserne-un-sintomo]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/5208-malattia-di-fabry-come-riconoscerla-da-un-danno-renale]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/5181-malattia-di-anderson-fabry-nuova-partnership-scientifica-fra-ibim-cnr-e-la-biotech-genzyme]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/5123-malattia-di-fabry-diagnosi-precoce-e-giusta-terapia-per-una-vita-normale]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/5075-malattia-di-anderson-e-fabry-formazione-avanzata-per-i-medici-della-federico-ii-di-napoli]]></loc><lastmod>2019-06-19T08:08:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/4993-malattia-di-fabry-si-indaga-il-ruolo-della-carenza-di-vitamina-d-nello-sviluppo-di-complicazioni]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/4962-malattia-di-fabry-un-possibile-nuovo-metodo-per-la-diagnosi-di-questa-rara-patologia]]></loc><lastmod>2019-06-19T08:13:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/4961-malattia-di-fabry-scoperta-nuova-mutazione-al-cnr-di-palermo]]></loc><lastmod>2015-05-25T15:14:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/4948-malattia-di-fabry-telethon-studia-la-terapia-con-nchaperoni-farmacologici]]></loc><lastmod>2015-11-17T14:40:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/4374-malattia-di-fabry-alla-federico-ii-di-napoli-si-studiano-le-molecole-chaperoniche-per-terapie-piu-facili-ed-economiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/4318-malattia-di-fabry-potrebbe-essere-confusa-con-le-febbri-periodiche-al-via-uno-studio-per-migliorare-la-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/4147-malattia-di-fabry-necessario-lo-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/3392-cardiomiopatie-e-malattia-di-fabry-un-binomio-troppo-spesso-misconosciuto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/3132-malattia-di-fabry-la-scarsa-conoscenza-della-malattia-porta-a-un-ritardo-nella-diagnosi-anche-di-10-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/2963-malattia-di-fabry-piccolo-studio-tranquillizza-i-pazienti-che-hanno-dovuto-variare-la-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/2839-malattia-di-fabry-e-malattia-di-pompe-garantiti-in-olanda-i-rimborsi-per-i-farmaci-orfani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/2815-malattia-di-anderson-fabry-la-diagnosi-precoce-puo-migliorare-la-vita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/2516-malattia-di-fabry-le-funzioni-cardiache-migliorano-con-la-terapia-sostitutiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/2485-malattia-di-fabry-un-nuovo-metodo-istologico-per-la-valutazione-renale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/2290-malattia-di-fabry-lenzima-difettoso-non-e-la-diretta-causa-dei-danni-vascolari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/2235-malattia-di-fabry-a-bologna-finanziati-due-studi-di-ricerca-sulle-malattie-neuromuscolari-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/2224-malattia-di-fabry-elaborato-un-indice-prognostico-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/1817-malattia-di-fabry-ritirato-il-dossier-registrativo-per-il-farmaco-agalsidasi-alfa-replagal-in-usa]]></loc><lastmod>2016-08-06T10:02:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/1755-malattia-di-fabry-genzyme-avvia-le-spedizioni-di-fabrazyme-dallimpianto-produttivo-di-framingham]]></loc><lastmod>2016-08-06T09:56:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/1546-malattia-di-fabry-fabrazyme-verso-il-ripristino-delle-scorte]]></loc><lastmod>2017-07-04T16:09:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/1076-malattia-di-fabry-partito-il-nuovo-studio-di-fase-tre-con-il-migalastat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/931-malattia-di-fabry-malattia-meno-severa-per-le-pazienti-spagnole]]></loc><lastmod>2020-06-06T09:24:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/837-malattia-di-fabry-studio-italiano-apre-la-strada-verso-terapia-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/566-malattie-di-fabry-e-gaucher-sembra-sicuro-il-passaggio-di-farmaci-di-genzyme-a-quelli-di-shire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/476-malattia-di-fabry-arriva-dal-mondo-vegetale-il-nuovo-farmaco-orfano-di-ibio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/242-malattia-di-fabry-gsk-prende-in-licenza-nuovo-farmaco]]></loc><lastmod>2026-04-08T17:06:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-fabry/218-malattia-di-fabry-lema-raccomanda-di-tornare-alla-dose-intera-di-fabrazyme-in-alternativa-si-puo-usare-il-replagal]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche]]></loc><lastmod>2022-02-01T14:53:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/22749-malattie-metaboliche-prosegue-a-verona-il-progetto-infermiere-case-manager-di-aismme]]></loc><lastmod>2026-02-13T09:58:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/22710-cure-palliative-e-malattie-metaboliche-ereditarie]]></loc><lastmod>2026-02-03T08:55:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/22369-acidurie-organiche-in-italia-si-stimano-dai-500-ai-700-pazienti]]></loc><lastmod>2025-10-03T16:57:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/22149-malattie-metaboliche-ereditarie-solo-16-centri-italiani-su-35-hanno-un-programma-di-transizione-dal-pediatrico-all-adulto]]></loc><lastmod>2025-07-01T21:09:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/22098-deficit-di-arginasi-1-una-malattia-ultra-rara-oggi-trattabile-se-diagnosticata-in-tempo]]></loc><lastmod>2025-06-17T15:41:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/22070-menu-scolastici-e-malattie-rare-quando-la-dieta-e-una-terapia-da-garantire-ogni-giorno]]></loc><lastmod>2025-06-11T18:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/21917-una-nuova-speranza-per-i-neonati-con-deficit-del-cofattore-molibdeno-di-tipo-a]]></loc><lastmod>2025-04-29T18:22:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/21768-malattie-metaboliche-ereditarie-serve-un-impegno-congiunto-per-superare-le-disparita-territoriali]]></loc><lastmod>2025-02-28T16:41:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/21733-il-ruolo-chiave-del-dietista-nella-gestione-delle-malattie-metaboliche-ereditarie]]></loc><lastmod>2025-02-17T19:30:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/21664-malattie-metaboliche-aismme-lancia-il-progetto-oltre-la-diagnosi-supporto-e-solidarieta-mme]]></loc><lastmod>2025-01-27T16:44:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/21344-in-cammino-da-mantova-a-padova-per-sensibilizzare-il-pubblico-sulle-malattie-metaboliche]]></loc><lastmod>2024-10-01T17:32:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/21179-malattie-metaboliche-alimenti-speciali-e-regolari-a-confronto]]></loc><lastmod>2024-07-17T14:36:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/20968-omocistinurie-a-roma-il-meeting-del-consorzio-internazionale-che-rinnovera-le-linee-guida]]></loc><lastmod>2024-05-15T00:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/20757-malattie-metaboliche-al-via-la-partnership-tra-cometa-asmme-e-lineasalute]]></loc><lastmod>2024-03-15T12:55:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/20750-pubblicato-il-primo-numero-del-journal-of-innate-metabolism-la-nuova-rivista-curata-da-simmesn]]></loc><lastmod>2024-03-13T18:11:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/20561-malattie-metaboliche-disponibile-il-quarto-volume-della-collana-cosa-mangera-da-grande]]></loc><lastmod>2024-01-28T17:45:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/20465-omocistinuria-classica-avviato-lo-studio-clinico-di-fase-iii-sulla-terapia-di-enzimatica-pegtibatinase]]></loc><lastmod>2023-12-19T18:09:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/20401-abruzzo-in-difficolta-lo-sportello-malattie-rare-e-metaboliche-dell-ospedale-di-pescara]]></loc><lastmod>2023-11-30T18:43:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/20262-acidemia-metilmalonica-cblc-nasce-una-rete-tra-famiglie-specialisti-e-istituzioni]]></loc><lastmod>2023-10-27T08:40:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/20222-giornata-mondiale-alimentazione-per-le-malattie-metaboliche-il-cibo-e-terapia-salvavita]]></loc><lastmod>2023-10-13T17:08:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/19888-malattie-metaboliche-ereditarie-aismme-mette-in-campo-l-infermiere-case-manager]]></loc><lastmod>2023-06-12T10:20:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/19977-acidemia-propionica-primi-test-clinici-per-una-terapia-sperimentale-basata-su-mrna]]></loc><lastmod>2023-07-04T11:05:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/19545-malattie-metaboliche-al-via-il-progetto-dritti-alla-meta]]></loc><lastmod>2023-02-18T07:13:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/19509-malattie-metaboliche-rare-aismme-propone-dei-questionari-a-pazienti-e-famiglie]]></loc><lastmod>2023-02-06T22:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/19450-malattie-metaboliche-presto-disponibili-i-due-nuovi-volumi-di-ricette-speciali-di-aismme]]></loc><lastmod>2023-01-14T15:32:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/19397-deficit-di-adenilsuccinato-liasi-la-vita-di-carola-tra-tanto-amore-e-fiducia-nella-scienza]]></loc><lastmod>2022-12-16T21:36:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/19269-dieta-chetogenica-quando-e-l-unica-terapia-per-continuare-a-vivere]]></loc><lastmod>2022-11-15T18:33:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/19162-acidemia-metilmalonica-il-trapianto-di-fegato-e-rene-e-la-terapia-piu-efficace-per-l-insufficienza-renale]]></loc><lastmod>2022-10-12T20:35:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/19065-deficit-di-adenilsuccinato-liasi-la-battaglia-di-carola-per-imparare-a-comunicare-con-gli-altri]]></loc><lastmod>2022-09-20T20:55:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/18996-deficit-di-cpt2-grazie-a-una-rubrica-del-new-york-times-esperti-italiani-effettuano-la-diagnosi-in-una-giovane-americana]]></loc><lastmod>2022-08-12T14:00:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/18946-malattie-metaboliche-al-via-il-progetto-aismme-cosa-mangera-da-grande]]></loc><lastmod>2022-07-24T13:29:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/18870-malattie-mitocondriali-presentato-un-documento-sulle-tecniche-di-sostituzione-dell-mtdna]]></loc><lastmod>2022-07-03T19:04:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/18770-malattie-metaboliche-ereditarie-a-verona-nasce-la-casa-per-i-pazienti-metabolici]]></loc><lastmod>2022-08-12T14:02:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/18649-deficit-di-glut1-rinnovati-i-finanziamenti-a-due-progetti-di-ricerca-italiani]]></loc><lastmod>2026-04-08T16:57:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/18383-malattie-metaboliche-aismme-subito-aggiornamento-screening-e-cure-precoci-per-salvare-i-neonati]]></loc><lastmod>2022-03-06T20:29:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/18259-sindrome-melas-charles-darwin-era-affetto-da-questa-rara-sindrome-mitocondriale]]></loc><lastmod>2022-02-23T19:45:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17998-malattie-metaboliche-a-verona-prende-il-via-il-progetto-camminiamo-insieme]]></loc><lastmod>2021-11-13T20:28:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17763-glicogenosi-un-libro-per-far-conoscere-la-patologia]]></loc><lastmod>2021-09-11T21:43:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17759-deficit-di-glut1-online-l-ultimo-video-di-sensibilizzazione-sulle-diete-speciali]]></loc><lastmod>2021-09-10T16:32:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17662-deficit-di-vlcad-a-trieste-individuata-la-patologia-in-una-neonata-grazie-alla-piattaforma-evai]]></loc><lastmod>2021-07-18T21:30:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17630-deficit-di-glut1-oggi-e-la-prima-giornata-internazionale-dedicata-alla-patologia]]></loc><lastmod>2021-07-07T17:54:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17555-deficit-di-glut1-diffuso-il-terzo-video-della-campagna-dedicata-alle-diete-speciali]]></loc><lastmod>2021-06-20T13:48:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17444-deficit-di-fruttosio-1-6-difosfatasi-con-una-presa-in-carico-adeguata-la-prognosi-puo-essere-eccellente]]></loc><lastmod>2021-05-16T16:00:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17443-deficit-di-fruttosio-1-6-difosfatasi-una-malattia-metabolica-che-colpisce-quasi-una-persona-ogni-150mila]]></loc><lastmod>2021-05-16T16:02:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17268-deficit-di-glut1-online-il-secondo-video-della-campagna-insiemeperilglut1]]></loc><lastmod>2021-04-07T17:38:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17260-deficit-di-glut1-l-associazione-italiana-lancia-la-carta-dei-diritti-del-paziente]]></loc><lastmod>2021-04-03T15:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17045-neonata-con-rarissima-malattia-metabolica-curata-a-perugia-grazie-alla-diagnosi-precoce]]></loc><lastmod>2021-02-21T13:21:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/17040-deficit-di-glut1-al-via-la-campagna-per-favorire-l-inclusione-dei-piccoli-pazienti]]></loc><lastmod>2021-02-18T09:50:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/16838-malattie-metaboliche-nasce-il-diario-della-mia-terapia]]></loc><lastmod>2020-12-22T16:47:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/16607-malattie-metaboliche-a-verona-parte-il-progetto-fianco-a-fianco]]></loc><lastmod>2020-10-24T09:52:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/16075-malattie-metaboliche-identificata-la-causa-di-un-nuovo-difetto-della-glicosilazione]]></loc><lastmod>2020-05-17T21:20:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/16019-deficit-di-glut1-sviluppata-la-nuova-versione-dell-app-ketonet]]></loc><lastmod>2020-05-05T13:56:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/15922-covid-19-mitocon-onlus-lancia-un-questionario-online]]></loc><lastmod>2020-04-08T11:01:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/15620-deficit-di-glut1-studio-sulla-malattia-vince-il-primo-seed-grant-di-telethon]]></loc><lastmod>2020-02-02T22:02:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/15618-malattie-metaboliche-a-torino-sperimentato-con-successo-l-impiego-di-staminali-del-fegato]]></loc><lastmod>2020-02-02T17:44:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/15457-deficit-di-glut1-identificate-nuove-mutazioni-genetiche-associate-alla-malattia]]></loc><lastmod>2019-11-26T18:24:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/15422-malattie-metaboliche-alla-scoperta-della-dieta-chetogenica-con-il-bambino-gesu]]></loc><lastmod>2019-11-22T17:10:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/15313-deficit-di-ssadh-scoperte-due-nuove-mutazioni]]></loc><lastmod>2019-10-15T16:14:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/15108-gangliosidosi-gm1-infantile-premiato-progetto-di-ricerca-dell-universita-di-padova]]></loc><lastmod>2019-08-08T16:37:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/14835-deficit-di-glut1-quando-lo-zucchero-non-arriva-al-cervello]]></loc><lastmod>2019-05-21T10:15:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/14834-deficit-di-glut1-l-ingegno-di-una-mamma-che-ha-inventato-un-app-per-la-dieta-chetogenica]]></loc><lastmod>2019-05-21T10:16:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/14593-malattia-da-deposito-di-glicogeno-ia-risultati-positivi-dallo-studio-di-fase-i-ii-sulla-terapia-genica]]></loc><lastmod>2019-03-18T19:35:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/14564-a-padova-il-primo-ambulatorio-per-pazienti-adulti-con-malattie-metaboliche-ereditarie]]></loc><lastmod>2019-03-12T16:03:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/14344-omocistinurie-e-acidurie-organiche-grazie-a-diagnosi-e-terapia-oggi-si-diventa-adulti]]></loc><lastmod>2019-01-09T19:16:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/14341-disturbi-della-glicosilazione-un-sondaggio-sulle-disfunzioni-immunitarie-associate]]></loc><lastmod>2019-01-08T19:15:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/14331-aciduria-glutarica-di-tipo-2-consigliata-la-vitamina-b2-in-caso-di-mutazioni-nel-gene-flad1]]></loc><lastmod>2022-04-04T16:51:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/14245-omocistinuria-e-acidurie-organiche-le-possibilita-terapeutiche-attuali-e-future]]></loc><lastmod>2019-01-09T17:19:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/14237-omocistinuria-e-acidurie-organiche-cosa-sono]]></loc><lastmod>2018-12-11T13:13:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/14213-aciduria-glutarica-di-tipo-1-la-malattia-puo-evolvere-in-tumori-cerebrali]]></loc><lastmod>2018-11-27T18:55:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/13908-difetti-del-ciclo-dell-urea-in-italia-si-contano-circa-250-pazienti-per-lo-piu-bambini]]></loc><lastmod>2018-09-10T21:07:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/13828-malattie-mitocondriali-maria-beatrice-benvenuti-e-il-nuovo-testimonial-di-mitocon-onlus]]></loc><lastmod>2018-08-07T10:02:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/13692-malattie-mitocondriali-al-convegno-nazionale-mitocon-onlus-il-punto-sulla-ricerca]]></loc><lastmod>2019-09-10T14:22:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/12626-deficit-di-glut1-possibili-benifici-cognitivi-con-integratore-alimentare]]></loc><lastmod>2017-09-12T11:17:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/12508-malattie-metaboliche-cosa-aspettarsi-dalla-terapia-genica]]></loc><lastmod>2017-07-16T09:28:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/11693-glicogenosi-di-tipo-i-un-associazione-due-libri-e-una-mostra-fotografica-per-far-conoscere-la-patologia]]></loc><lastmod>2016-12-06T17:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/11658-le-malattie-mitocondriali-rare-numerose-ed-eterogenee]]></loc><lastmod>2016-11-26T17:36:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/8994-la-glicogenosi-di-tipo-ia-ma-non-quella-di-tipo-ib-e-associata-a-un-aumentato-rischio-di-sindrome-metabolica]]></loc><lastmod>2015-09-25T13:16:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/8864-malattie-metaboliche-attenzione-all-uso-di-alimenti-a-fini-medici-speciali]]></loc><lastmod>2015-10-15T10:34:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/4776-difetti-congeniti-del-metabolismo-limportanza-degli-interventi-nutrizionali]]></loc><lastmod>2015-10-15T10:46:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/4198-ovaio-policistico-si-studia-la-relazione-tra-dieta-e-metabolismo]]></loc><lastmod>2015-10-15T10:46:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/3143-malattie-rare-neurometaboliche-nasce-un-network-internazionale-che-parte-da-padova]]></loc><lastmod>2015-10-15T10:46:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/2009-malattie-rare-orphan-europe-academy-per-hyperammonemia-acidemia-organica-e-disturbi-del-ciclo-metabolico-dellurea]]></loc><lastmod>2015-10-15T10:50:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/1694-sindrome-metabolica-la-causa-potrebbe-essere-il-recettore-toll-like]]></loc><lastmod>2016-04-14T10:03:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/1079-sindrome-metabolica-a-rischio-anche-i-reni-studio-usa-mostra-la-connessione]]></loc><lastmod>2015-10-15T10:46:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-metaboliche/1149-malattie-metaboliche-un-nuovo-disturbo-si-aggiunge-allelenco-la-carenza-di-adenosina-chinasi]]></loc><lastmod>2015-10-15T10:46:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare]]></loc><lastmod>2024-03-13T12:11:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/22880-ipertensione-arteriosa-polmonare-al-via-la-campagna-aria-di-vita]]></loc><lastmod>2026-04-02T08:08:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/22704-ipertensione-arteriosa-polmonare-ok-di-aifa-alla-rimborsabilita-di-sotatercept]]></loc><lastmod>2026-02-02T20:54:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/22403-ipertensione-arteriosa-polmonare-novita-terapeutiche-dal-congresso-ers-2025]]></loc><lastmod>2025-10-13T17:00:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/21263-ipertensione-arteriosa-polmonare-via-libera-in-europa-al-farmaco-sotatercept]]></loc><lastmod>2024-09-06T14:29:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/20939-ipertensione-arteriosa-polmonare-intesa-tra-chiesi-e-gossamer-per-lo-sviluppo-di-seralutinib]]></loc><lastmod>2024-05-06T16:09:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/20751-col-fiato-sospeso-un-evento-di-sensibilizzazione-sull-ipertensione-arteriosa-polmonare]]></loc><lastmod>2024-03-13T15:24:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/20136-ipertensione-arteriosa-polmonare-nuovi-risultati-positivi-per-sotatercept]]></loc><lastmod>2023-09-18T14:51:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/19618-ipertensione-arteriosa-polmonare-in-italia-ne-soffrono-circa-3-500-persone]]></loc><lastmod>2023-03-13T18:36:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/19577-ipertensione-arteriosa-polmonare-online-la-campagna-viaggio-alla-scoperta-della-pah]]></loc><lastmod>2023-02-28T15:54:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/19201-ipertensione-arteriosa-polmonare-positivi-risultati-di-fase-iii-per-sotatercept]]></loc><lastmod>2022-10-25T14:04:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/18622-ipertensione-arteriosa-polmonare-chiesi-punta-sugli-anticorpi-monoclonali-anti-emap-ii]]></loc><lastmod>2022-05-07T20:43:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/18356-ipertensione-arteriosa-polmonare-riparte-dal-lazio-la-campagna-la-vita-in-un-respiro]]></loc><lastmod>2022-03-03T13:31:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/17767-ipertensione-arteriosa-polmonare-nuovi-dati-clinici-a-favore-dell-utilizzo-precoce-di-selexipag]]></loc><lastmod>2021-09-14T11:14:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/17640-ipertensione-arteriosa-polmonare-emppathy-vince-la-prima-edizione-dell-hackathon-hack-for-pah]]></loc><lastmod>2021-07-13T10:59:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/17531-ipertensione-arteriosa-polmonare-disponibile-la-consegna-a-domicilio-del-farmaco-iloprost]]></loc><lastmod>2021-06-13T17:51:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/17380-ipertensione-arteriosa-polmonare-una-malattia-che-richiede-grande-sinergia-tra-gli-specialisti]]></loc><lastmod>2021-05-02T21:09:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/16832-ipertensione-arteriosa-polmonare-al-via-la-campagna-la-vita-in-un-respiro]]></loc><lastmod>2020-12-21T21:52:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/16460-ipertensione-arteriosa-polmonare-janssen-apre-una-nuova-area-terapeutica-dedicata]]></loc><lastmod>2020-09-17T13:49:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/16024-ipertensione-polmonare-benefici-dall-impiego-di-iloprost-inalatorio]]></loc><lastmod>2020-05-05T11:28:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/16018-ipertensione-polmonare-bayer-consegna-il-proprio-farmaco-a-domicilio]]></loc><lastmod>2020-05-03T21:09:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/13910-ipertensione-polmonare-in-italia-un-dispositivo-per-facilitare-la-terapia-inalatoria]]></loc><lastmod>2018-09-11T18:02:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/12275-ipertensione-polmonare-parte-da-napoli-il-progetto-di-un-network-internazionale-dedicato]]></loc><lastmod>2017-05-15T10:08:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/11159-ipertensione-polmonare-messo-a-punto-test-genetico-per-due-rare-forme-della-patologia]]></loc><lastmod>2016-08-30T13:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/10887-ipertensione-polmonare-ema-contraria-all-impiego-di-riociguat-per-malattia-causata-da-polmonite-interstiziale]]></loc><lastmod>2016-06-30T14:13:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/10710-ipertensione-arteriosa-polmonare-approvato-in-europa-selexipag]]></loc><lastmod>2016-05-30T15:14:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/10688-pavia-una-donna-salvata-grazie-a-una-tecnica-chirurgica-inventata-al-san-matteo]]></loc><lastmod>2016-05-30T07:33:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/10665-ipertensione-polmonare-individuata-nei-cani-una-rara-forma-umana-della-malattia]]></loc><lastmod>2016-05-20T13:07:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/10410-ipertensione-polmonare-cronica-tromboembolica-ipcte-la-fondazione-i-r-c-c-s-policlinico-san-matteo-di-pavia-individuata-come-centro-di-riferimento]]></loc><lastmod>2016-04-19T12:56:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/10081-ipertensione-polmonare-il-team-di-bayer-e-dell-universita-justus-liebig-vince-il-premio-deutscher-zukunftspreis]]></loc><lastmod>2016-03-01T14:35:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/9685-ipertensione-polmonare-tromboembolica-cronica-gli-effetti-del-trattamento-medico-e-chirurgico-sulla-qualita-della-vita]]></loc><lastmod>2016-05-06T16:45:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/9511-ipertensione-polmonare-federica-pellegrini-per-aipi-nel-calendario-masks-2016]]></loc><lastmod>2015-12-02T16:39:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/9474-ipertensione-polmonare-nuove-possibilita-d-uso-per-ambrisentan]]></loc><lastmod>2015-11-27T15:58:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/9221-ipertensione-arteriosa-polmonare-parare-positivo-del-chmp-per-combinazione-ambrisentan-tadalafil]]></loc><lastmod>2015-10-26T08:57:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/9115-ipertensione-arteriosa-polmonare-pubblicate-le-nuove-linee-guida-internazionali]]></loc><lastmod>2015-10-13T10:00:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/9114-ipertensione-arteriosa-polmonare-le-associazioni-italiane-all-esc-di-londra]]></loc><lastmod>2015-10-13T10:01:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/8844-ipertensione-polmonare-effetti-positivi-da-terapia-iniziale-con-ambrisentan-e-tadalafil]]></loc><lastmod>2015-08-31T08:54:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/8801-ipertensione-arteriosa-polmonare-il-futuro-saranno-le-cellule-staminali]]></loc><lastmod>2015-08-21T10:21:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/8245-ipertensione-arteriosa-polmonare-lfda-conferisce-la-designazione-di-farmaco-orfano-al-metil-bardoxolone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/8108-ipertensione-arteriosa-polmonare-associata-a-displasia-broncopolmonare-buoni-i-risultati-per-sildenafil]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/7759-ipertensione-polmonare-tromboembolica-cronica-cteph-dal-15-marzo-riociguat-disponibile-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/7384-ipertensione-arteriosa-depositata-la-domanda-per-selexipag]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/7297-ipertensione-polmonare-arteriosa-gsk-richiede-allema-nuove-indicazioni-per-ambrisentan]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/7046-ipertensione-polmonare-secondaria-anche-in-italia-si-arruolano-pazienti-per-sperimentazione-con-riociguat]]></loc><lastmod>2016-05-18T16:14:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/6667-ipertensione-polmonare-risultati-positivi-per-la-terapia-di-prima-linea-combinata-ambrisentan-tadalafil]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/6644-ipertensione-polmonare-tromboembolica-cronica-ceteph-confermata-la-sicurezza-del-trattamento-con-riociguat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/6384-ipertensione-arteriosa-polmonare-risultati-positivi-per-il-profarmaco-selexipag]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/6093-ipertensione-polmonare-cronica-tromboembolica-ipcte-il-trattamento-con-riuciguat-mostra-i-primi-successi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5946-ipertensione-polmonare-associata-a-sarcoidosi-bosentan-migliora-lemodinamica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5853-ipertensione-arteriosa-polmonare-approvato-sildenafil-per-i-pazienti-pediatrici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5794-ipertensione-arteriosa-polmonare-il-farmaco-bosentan-non-raggiunge-lend-point-primario-nello-studio-compass-ii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5816-ipertensione-polmonare-approvato-in-europa-il-trattamento-con-riociguat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5777-ipertensione-polmonare-atleti-e-malati-insieme-per-la-maratona-di-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5699-ipertensione-polmonare-costituito-il-registro-italiano-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5692-ipertensione-polmonare-cronica-tromboembolica-ipcte-lintervento-chirurgico-garantisce-ai-pazienti-una-vita-normale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5658-ipertensione-polmonare-come-sono-cambiate-le-opzioni-diagnostiche-e-terapeutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5690-malattie-rare-polmonari-necessario-migliorare-lapproccio-diagnostico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5657-ipertensione-polmonare-grazie-ad-aimar-un-approccio-globale-alla-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5686-ipertensione-polmonare-gli-interventi-chirurgici-possono-salvare-la-vita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5602-ipertensione-polmonare-una-nuova-formulazione-di-epoprosterenolo-migliora-la-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5358-ipertensione-polmonare-del-neonato-attenzione-agli-antidepressivi-in-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5360-ipertensione-polmonare-lema-adotta-parere-positivo-per-riociguat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5229-ipertensione-polmonare-il-farmaco-macitentan-approvato-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5068-ipertensione-polmonare-il-lazio-si-fa-capofila-di-un-network-nazionale-per-lappropriatezza-terapeutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5070-ipertensione-polmonare-lintervista-al-dott-patrizio-vitulo-pneumologo-dellismett-di-palermo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5072-intervista-a-vittorio-vivenzio-presidente-amip-associazione-malati-di-ipertensione-polmonare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/5069-ipertensione-polmonare-lintervista-al-prof-carmine-dario-vizza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4988-ipertensione-arteriosa-polmonare-realizzato-il-primo-studio-sulluomo-della-tecnica-di-denervazione-dellarteria-polmonare]]></loc><lastmod>2019-06-19T08:12:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4859-ipertensione-arteriosa-polmonare-approvato-il-farmaco-macitentan-negli-stati-uniti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4884-ipertensione-polmonare-in-europa-parere-positivo-per-il-trattamento-con-macitentan]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4832-ipertensione-polmonare-cronica-tromboembolica-ipcte-in-italia-siamo-bravissimi-ma-si-potrebbe-fare-meglio-con-una-diversa-organizzazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4831-ipertensione-polmonare-cronica-tromboembolica-ipcte-la-fondazione-irccs-policlinico-san-matteo-di-pavia-eccellenza-nella-chirurgia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4759-ipertensione-polmonare-fda-approva-il-trattamento-con-riociguat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4684-ipertensione-arteriosa-polmonare-dalla-diagnosi-alla-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4683-ipertensione-arteriosa-polmonare-fda-riconosce-a-riociguat-lo-status-di-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4671-il-canada-approva-riociguat-per-lipertensione-polmonare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4577-ipertensione-arteriosa-polmonare-ulteriori-conferme-per-macitentan]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4564-ipertensione-polmonare-sperimentata-sul-modello-animale-una-nuova-terapia]]></loc><lastmod>2019-06-19T08:24:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4521-ipertensione-polmonare-studio-europeo-conferma-i-benefici-del-riociguat-di-bayer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4470-ipertensione-polmonare-verso-lapprovazione-del-farmaco-riociguat-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4436-ipertensione-arteriosa-polmonare-identificate-sei-mutazioni-genetiche-legate-alla-forma-familiare-della-malattia]]></loc><lastmod>2019-06-19T08:29:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/4032-ipertensione-polmonare-arteriosa-nuovi-risultati-positivi-per-treprostinil-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3988-ipertensione-arteriosa-polmonare-il-5-maggio-la-giornata-mondiale-rimani-senza-fiato-per-lip]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3886-ipertensione-polmonare-fda-concede-concede-la-priority-review-al-farmaco-riociguat-di-bayer-per-lindicazione-al-trattamento-di-due-forme-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3675-ipertensione-arteriosa-polmonare-e-gravidanza-migliora-la-percentuale-di-successo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3747-ipertensione-polmonare-cronica-tromboemolitica-dati-positivi-per-il-trattamento-con-riociguat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3710-malattie-rare-in-italia-dott-sergio-harari-molti-i-progressi-fatti-finora]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3609-ipertensione-polmonare-arteriosa-novartis-ritira-la-domanda-di-registrazione-di-imatinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3610-ipertensione-polmonare-arteriosa-depositato-il-dossier-registrativo-di-riociguat-per-europa-e-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3284-ipertensione-polmonare-richiesta-la-registrazione-del-farmaco-macitentan]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3077-ipertensione-polmonare-i-risultati-definitivi-sul-farmaco-macitentan]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3057-ipertensione-polmonare-cronica-tromboembolica-riociguat-di-bayer-e-il-primo-farmaco-di-efficacia-dimostrata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/3008-ipertensione-polmonare-arteriosa-ottimi-risultati-per-il-farmaco-riociguat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/2997-ipertensione-arteriosa-polmonare-si-lavora-per-rendere-auto-iniettabile-il-treprostinil]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/2961-ipertensione-polmonare-arteriosa-e-ipertiroidismo-alto-il-rischio-di-morte-nei-pazienti-pediatrici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/2696-ipertensione-polmonare-in-usa-non-approvato-il-sildenafil-per-uso-pediatrico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/2667-ipertensione-arteriosa-polmonare-interrotto-lo-sviluppo-del-farmaco-cicletanina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/2169-ipertensione-arteriosa-polmonare-il-trattamento-con-macitentan-supera-fase-iii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1763-ipertensione-polmonare-da-bayer-la-campagna-qmozzafiatoq-time-to-breath]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1752-ipertensione-arteriosa-polmonare-il-treprostinil-orale-torna-ad-essere-unipotesi-concreta-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1717-ipertensione-polmonare-arteriosa-galie-qin-30-anni-abbiamo-alleviato-le-sofferenze-dei-pazienti-ma-la-tempestivita-della-diagnosi-e-la-scelta-delle-terapie-adatte-e-fondamentaleq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1640-ipertensione-arteriosa-polmonare-il-ruolo-dei-prostanoidi-nella-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1639-fiduciacostanzapsicologiaagire-imparare-a-convivere-con-lipertensione-arteriosa-polmonare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1384-ipertensione-polmonare-scoprire-di-aver-convissuto-venti-anni-con-la-malattia-e-sentirsi-fortunati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1312-ipertensione-polmonare-puo-essere-complicanza-dellhiv-soprattutto-negli-uomini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1226-ipertensione-arteriosa-polmonare-il-macitentan-di-actelion-ottiene-status-orfano-in-ue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1225-ipertensione-arteriosa-polmonare-il-progetto-time-matters-permette-di-condividere-esperienze-con-pazienti-di-tutto-il-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1121-ipertensione-polmonare-studio-su-imatinib-mostra-benefici-per-soggetti-gravi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/1028-ipertensione-arteriosa-polmonare-fallito-il-trial-con-treprostinil]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/971-ipertensione-arteriosa-polmonare-comune-nei-malati-la-carenza-di-ferro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/841-ipertensione-polmonare-il-bacio-blu-simbolo-della-campagna-europea-nel-guinnes-dei-primati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/803-ipertensione-arteriosa-polmonare-sky-tg-24-racconta-le-storie-di-claudia-federico-e-maria-pia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/745-ipertensione-polmonare-ce-un-metodo-non-invasivo-per-il-monitoraggio-emodinamico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/677-ipertensione-polmonare-arteriosa-ok-al-sildenafili-citrato-anche-per-pazienti-pediatrici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/633-ipertensione-polmonare-rossella-per-colpa-della-malattia-ho-dovuto-rinunciare-ad-un-figlio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/563-ipertensione-polmonare-arteriosa-alla-tavola-rotonda-di-lisbona-occhi-puntati-sul-riociguat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/525-ipertensione-arteriosa-polmonare-puo-essere-collegata-a-malattie-epatiche-croniche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/502-ipertensione-arteriosa-polmonare-il-videodiario-su-you-tube]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/501-l-ipertensione-arteriosa-polmonare-in-breve]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/500-ipertensione-polmonare-al-via-breathtaking-la-campagna-europea-di-sensibilizzazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/494-ipertensione-polmonare-quando-la-causa-e-nelle-cardiopatie-congenite]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/458-ipertensione-arteriosa-polmonare-nuovi-dubbi-sul-sitaxentan]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/455-ipertensione-arteriosa-polmonare-puo-essere-una-complicanza-di-sclerosi-sistemica-o-lupus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/446-cteph-chirurgia-prima-scelta-per-gli-inoperabili-maggiori-aspettative-di-vita-con-i-nuovi-farmaci]]></loc><lastmod>2015-06-08T10:34:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/445-cteph-che-cose-e-in-che-modo-avviene-la-diagnosi]]></loc><lastmod>2015-06-08T10:38:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/383-pah-e-cteph-anche-in-italia-e-possibile-partecipare-agli-studi-patent-e-chest]]></loc><lastmod>2015-06-08T11:19:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/324-ipertensione-arteriosa-polmonare-ritirato-il-thelin-stop-ai-trial]]></loc><lastmod>2021-11-02T16:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/245-ipertensione-polmonare-potrebbe-venire-da-una-scoperta-canadese-la-svolta-per-diagnosi-e-la-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/193-ipertensione-polmonare-la-forma-idipatica-e-collegata-al-meccanismo-di-ossidazione-degli-acidi-grassi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/181-ipertensione-polmonare-approvata-una-nuova-terapia-a-base-di-tadafil-parente-stretto-del]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/121-ipertensione-polmonare-trovato-un-marcatore-in-grado-di-predire-la-gravita-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/130-ipertensione-polmonare-arteriosa-arriva-il-farmaco-per-i-bambini]]></loc><lastmod>2021-11-02T17:00:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/72-ipertensione-polmonare-arteriosa-sildenafil-rimborsabile-anche-ai-pazienti-d-classe-funzionale-due]]></loc><lastmod>2021-11-02T17:01:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/52-ipertensione-polmonare-i-massimi-esperti-di-22-nazioni-si-sono-riuniti-al-santorsola-di-bologna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/48-ipertensione-polmonare-bayer-presenta-i-risultati-dello-studio-di-fase-due-su-riociguat]]></loc><lastmod>2015-06-08T16:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/47-ipertensione-polmonare]]></loc><lastmod>2015-06-08T16:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/36-ipertensione-arteriosa-polmonare-sidenafil]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipertensione-polmonare/24-ipertensione-polmonare-hdl-elevato-migliora-prognosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie]]></loc><lastmod>2025-12-09T18:52:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22942-emofilia-con-inibitori-arriva-in-italia-un-nuovo-farmaco-sottocute]]></loc><lastmod>2026-04-16T16:36:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22941-emofilia-lallarme-delle-associazioni-necessario-superare-la-carenza-di-specialisti]]></loc><lastmod>2026-04-17T07:21:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22948-emofilia-a-la-terapia-genica-lascia-il-mercato]]></loc><lastmod>2026-04-20T15:15:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22909-emofilia-marstacimab-ottiene-la-rimborsabilita-da-aifa]]></loc><lastmod>2026-04-02T15:57:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22683-emofilia-aifa-approva-nuova-terapia-sostitutiva-del-fattore-viii]]></loc><lastmod>2026-01-23T14:50:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22582-emofilia-migliorano-i-trattamenti-ma-occorre-fornire-unadeguata-assistenza-ai-pazienti]]></loc><lastmod>2025-12-09T08:17:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22579-emofilia-b-la-terapia-genica-per-la-prima-volta-in-italia]]></loc><lastmod>2025-12-04T09:27:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22518-emofilia-a-al-gemelli-primo-paziente-nel-lazio-trattato-con-terapia-genica]]></loc><lastmod>2025-11-14T18:14:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22314-emofilia-a-e-b-con-inibitori-positivi-i-risultati-topline-dello-studio-di-fase-iii-su-marstacimab]]></loc><lastmod>2025-09-16T11:53:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22270-emofilia-a-nuovi-sviluppi-nella-comprensione-del-danno-scheletrico-associato]]></loc><lastmod>2025-09-02T21:36:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/22227-emofilia-b-aifa-approva-la-rimborsabilita-della-terapia-genica]]></loc><lastmod>2025-07-30T17:53:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21925-emofilia-sensibilmente-piu-alto-della-norma-il-rischio-di-fratture-ossee]]></loc><lastmod>2025-04-19T11:02:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21716-emofilia-a-presentati-nuovi-dati-clinici-sul-farmaco-mim8]]></loc><lastmod>2025-02-10T17:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21551-adolescenti-con-emofilia-bisogni-specifici-richiedono-una-presa-in-carico-mirata]]></loc><lastmod>2024-12-02T16:53:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21532-management-2-0-un-progetto-che-affianca-clinici-e-associazioni-per-fornire-ai-pazienti-con-emofilia-le-migliori-cure-possibili]]></loc><lastmod>2024-11-27T14:04:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21527-ridefiniamo-l-inclusione-la-testimonianza-di-marco-follino]]></loc><lastmod>2024-11-26T16:48:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21523-emofilia-la-commissione-europea-approva-marstacimab]]></loc><lastmod>2024-11-26T11:07:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21450-malattie-ematologiche-rare-all-omar-talk-dedicato-all-inclusione-l-associazione-amare]]></loc><lastmod>2024-11-07T10:00:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21436-malattie-ematologiche-rare-all-omar-talk-l-importanza-della-health-equity]]></loc><lastmod>2024-10-28T17:11:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21412-malattie-ematologiche-rare-all-omar-talk-la-presentazione-del-progetto-ridefiniamo-l-inclusione]]></loc><lastmod>2024-10-23T10:06:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21329-emofilia-il-chmp-europeo-dice-si-all-uso-di-marstacimab]]></loc><lastmod>2024-09-27T10:23:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21285-emofilia-a-emicizumab-rimborsabile-in-italia-anche-per-la-malattia-in-forma-moderata]]></loc><lastmod>2024-09-13T15:13:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21227-emofilia-b-in-europa-arriva-una-nuova-terapia-genica]]></loc><lastmod>2024-08-09T15:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21147-emofilia-b-la-terapia-genica-etranacogene-dezaparvovec-di-csl-behring-approvata-e-rimborsata-in-danimarca-e-regno-unito]]></loc><lastmod>2024-07-04T16:18:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/21103-emofilia-arriva-froggy-un-supporto-per-migliorare-l-autoinfusione]]></loc><lastmod>2024-06-21T11:28:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20993-emofilia-l-importanza-del-benessere-articolare-promossa-dal-progetto-articoliamo]]></loc><lastmod>2024-05-20T11:25:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20880-emofilia-in-occasione-della-giornata-mondiale-le-associazioni-palestinesi-lanciano-un-appello-per-il-diritto-alla-salute]]></loc><lastmod>2024-04-17T17:41:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20879-emofilia-oggi-ricorre-la-xx-giornata-mondiale]]></loc><lastmod>2024-04-16T12:40:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20788-emofilia-l-italia-al-fianco-dell-albania-con-una-donazione-di-fattore-viii]]></loc><lastmod>2024-03-21T12:14:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20663-management-2-0-un-supporto-per-i-centri-che-si-prendono-cura-delle-persone-con-emofilia]]></loc><lastmod>2024-02-26T11:27:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20631-emofilia-a-la-terapia-genica-e-realta-anche-in-italia]]></loc><lastmod>2024-02-14T15:49:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20594-emofilia-a-grave-ok-di-aifa-alla-rimborsabilita-della-terapia-genica]]></loc><lastmod>2024-02-06T18:04:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20534-emofilia-b-nuovi-dati-positivi-per-etranacogene-dezaparvovec]]></loc><lastmod>2024-01-19T18:01:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20517-emofilia-a-i-vantaggi-dei-farmaci-a-emivita-emergono-anche-dalla-pratica-clinica-di-routine]]></loc><lastmod>2024-01-15T20:16:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20457-ematologia-al-congresso-ash-2023-nuovi-dati-su-emicizumab-nell-emofilia-a]]></loc><lastmod>2023-12-19T10:22:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20452-emofilia-buoni-i-dati-di-fase-iii-su-marstacimab]]></loc><lastmod>2023-12-18T14:45:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20416-emofilia-a-dati-real-world-confermano-l-efficacia-di-emicizumab-in-pazienti-con-inibitori]]></loc><lastmod>2023-12-06T08:46:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20384-emofilia-a-un-paziente-avatar-per-spiegare-i-benefici-dei-farmaci-a-emivita-prolungata]]></loc><lastmod>2023-11-28T09:31:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/20037-emofilia-lo-sport-e-necessario-per-una-buona-qualita-di-vita]]></loc><lastmod>2023-07-24T15:33:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19910-emofilia-utilizzare-la-realta-virtuale-per-educare-i-pazienti-a-gestire-al-meglio-la-patologia]]></loc><lastmod>2023-06-19T10:44:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19886-disordini-emorragici-congeniti-a-pescara-nasce-il-pdta-per-la-gestione-di-pazienti-in-chirurgia-orale-e-maxillo-facciale]]></loc><lastmod>2023-06-16T08:21:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19732-emofilia-la-priorita-e-migliorare-l-assistenza-ai-pazienti]]></loc><lastmod>2023-04-18T08:44:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19614-emofilia-a-nasce-emo-un-piano-di-servizi-domiciliari-per-i-pazienti]]></loc><lastmod>2023-04-14T22:34:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19716-emofilia-fondamentale-la-figura-dell-ortopedico-per-il-monitoraggio-della-salute-articolare]]></loc><lastmod>2023-04-14T22:38:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19736-emofilia-l-impegno-di-csl-behring-verso-pazienti-e-caregiver]]></loc><lastmod>2023-04-19T15:20:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19597-al-via-la-nuova-edizione-di-dialoghi-sull-emofilia-a]]></loc><lastmod>2023-03-08T18:30:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19640-emofilia-b-approvazione-europea-per-la-terapia-genica]]></loc><lastmod>2023-03-17T19:50:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19564-emofilia-il-riscontro-di-sinovite-puo-smascherare-eventuali-sanguinamenti-asintomatici]]></loc><lastmod>2023-02-22T18:00:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19550-emofilia-b-disponibile-in-italia-nonacog-beta-pegol]]></loc><lastmod>2023-02-22T11:15:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19511-emofilia-a-emicizumab-approvato-in-europa-anche-per-la-malattia-in-forma-moderata]]></loc><lastmod>2023-02-04T11:52:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19031-emofilia-un-nuovo-progetto-per-migliorare-la-gestione-dei-pazienti-nei-centri-italiani]]></loc><lastmod>2022-09-15T08:35:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19217-emofilia-a-approvata-in-europa-la-prima-terapia-genica-per-la-patologia]]></loc><lastmod>2022-10-26T13:36:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/19000-emofilia-la-storia-di-luca-che-sfida-la-malattia-a-colpi-di-pedale]]></loc><lastmod>2022-08-25T17:00:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18922-emofilia-a-nuovi-dati-rafforzano-il-profilo-di-sicurezza-ed-efficacia-di-emicizumab]]></loc><lastmod>2022-07-16T20:03:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18765-meno-male-il-dolore-visto-dalla-scienza-e-dalla-filosofia]]></loc><lastmod>2022-12-14T15:54:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18679-istituita-in-abruzzo-la-rete-regionale-per-le-malattie-emorragiche-congenite]]></loc><lastmod>2022-05-22T19:05:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18537-emofilia-l-appello-di-fedemo-per-la-xviii-giornata-mondiale]]></loc><lastmod>2022-04-11T15:04:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18502-emofilia-al-via-la-campagna-memo]]></loc><lastmod>2022-04-02T13:37:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18452-emofilia-nico-e-cosi-da-voce-agli-adolescenti-affetti-dalla-patologia]]></loc><lastmod>2022-04-20T08:54:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18380-emofilia-al-via-il-progetto-di-narrativa-emozionale-amori-rari]]></loc><lastmod>2022-03-05T21:30:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18246-emofilia-al-via-un-progetto-di-telemedicina-per-il-monitoraggio-a-distanza-degli-emartri]]></loc><lastmod>2022-02-02T13:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18229-emofilia-al-via-la-voce-straordinaria-della-normalita]]></loc><lastmod>2022-01-31T12:44:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18188-emofilia-quando-la-telemedicina-diventa-fondamentale-per-la-presa-in-carico-del-paziente-il-progetto-remote]]></loc><lastmod>2022-01-18T17:00:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18132-emofilia-b-ema-concede-valutazione-accelerata-alla-terapia-genica-etranacogene-dezaparvovec]]></loc><lastmod>2021-12-24T14:09:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18046-emofilia-a-i-dati-relativi-al-contesto-real-world-confermano-l-efficacia-di-damoctocog-alfa-pegol]]></loc><lastmod>2021-11-27T22:55:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18025-malattie-emorragiche-congenite-siglato-un-accordo-tra-italia-e-albania]]></loc><lastmod>2021-11-23T22:15:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/18031-malattie-emorragiche-congenite-in-abruzzo-arriva-l-autoinfusione]]></loc><lastmod>2021-11-23T22:15:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/17951-emofilia-il-programma-remote-premiato-al-forum-salute-della-leopolda]]></loc><lastmod>2021-10-29T11:33:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/17816-emofilia-assegnato-all-italia-il-bayer-hemophilia-awards-grant]]></loc><lastmod>2021-09-26T19:52:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/17712-l-avventura-di-luca-ciclista-emofilico-350-km-con-una-protesi-al-ginocchio]]></loc><lastmod>2021-08-06T20:24:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/17636-emofilia-b-lo-studio-ideal-entra-nella-fase-b]]></loc><lastmod>2021-07-11T17:32:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/17563-emofilia-duratura-riduzione-dei-sanguinamenti-con-damoctocog-alfa-pegol]]></loc><lastmod>2021-06-20T17:45:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/17533-emofilia-nessuna-criticita-specifica-nella-gestione-del-paziente-adolescente-in-epoca-covid]]></loc><lastmod>2021-06-16T10:36:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/17438-malattie-emorragiche-congenite-nasce-il-progetto-remote]]></loc><lastmod>2021-05-16T11:51:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/17296-emofilia-la-malattia-e-un-dato-oggettivo-ma-non-esaurisce-mai-le-possibilita-della-persona]]></loc><lastmod>2021-04-15T14:05:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/17286-emofilia-l-ecografia-e-uno-strumento-fondamentale-per-il-monitoraggio-articolare-dei-pazienti]]></loc><lastmod>2021-06-07T14:32:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/17102-emofilia-il-covid-19-ha-ridotto-o-azzerato-l-attivita-fisica-dei-pazienti]]></loc><lastmod>2021-04-19T17:47:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16892-malattie-emorragiche-congenite-una-guida-alla-vaccinazione-anti-covid]]></loc><lastmod>2021-01-17T21:52:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16830-emofilia-gli-ultimi-dati-sulle-terapie-geniche-in-sperimentazione]]></loc><lastmod>2020-12-21T18:27:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16815-emofilia-positivi-in-nuovi-dati-di-follow-up-su-emicizumab]]></loc><lastmod>2020-12-16T12:10:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16722-emofilia-occorre-garantire-terapie-personalizzate]]></loc><lastmod>2020-11-22T23:11:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16726-emofilia-in-puglia-un-protocollo-per-la-gestione-dei-pazienti-in-emergenza-covid]]></loc><lastmod>2020-11-23T12:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16690-emofilia-no-al-fai-da-te-nell-autosomministrazione-della-profilassi]]></loc><lastmod>2020-11-15T16:57:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16604-emofilia-b-con-albutrepenonacog-alfa-la-profilassi-ora-possibile-anche-ogni-21-giorni]]></loc><lastmod>2020-10-23T15:50:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16574-emofilia-a-nuove-conferme-per-damoctocog-alfa-pegol]]></loc><lastmod>2020-10-18T20:15:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16550-emofilia-a-disponibile-in-italia-un-nuovo-trattamento-somministrabile-una-volta-alla-settimana]]></loc><lastmod>2020-10-11T20:45:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16528-emofilia-parte-l-iniziativa-articoliamo-farsi-del-bene-muovendosi]]></loc><lastmod>2020-10-04T18:10:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16509-emofilia-tre-italiani-vincono-il-bayer-hemophilia-awards-program-2019]]></loc><lastmod>2020-09-29T19:33:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16471-i-miei-supereroi-in-un-cortometraggio-l-incertezza-e-la-di-un-gruppo-di-ragazzi-emofilici]]></loc><lastmod>2020-09-21T18:32:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16467-emofilia-l-appello-di-fedemo-nella-giornata-mondiale-dedicata-alla-malattia]]></loc><lastmod>2020-09-21T17:11:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16465-emofilia-la-regione-lombardia-riduce-i-centri-prescrittori-da-13-a-4]]></loc><lastmod>2020-09-20T18:09:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16437-emofilia-il-coraggio-dei-giovani-pazienti-alla-mostra-del-cinema-di-venezia]]></loc><lastmod>2020-09-13T23:32:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16309-emofilia-a-bayer-dona-ulteriori-50-milioni-di-unita-di-fattore-viii-come-aiuto-umanitario]]></loc><lastmod>2020-07-20T10:04:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16306-emofilia-nuovi-dati-di-fase-iii-rafforzano-il-profilo-di-sicurezza-di-emicizumab]]></loc><lastmod>2020-07-20T09:00:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16299-emofilia-b-approvato-il-regime-di-profilassi-ogni-21-giorni-con-albutrepenonacog-alfa]]></loc><lastmod>2020-07-19T16:59:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16273-emofilia-l-importanza-di-un-nuovo-modello-di-sanita-fondata-sul-valore]]></loc><lastmod>2020-07-08T14:14:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16253-emofilia-b-csl-behring-punta-sulla-terapia-genica-2]]></loc><lastmod>2020-07-06T11:47:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16221-emofilia-presentati-nuovi-dati-clinici-a-lungo-termine-su-fitusiran]]></loc><lastmod>2020-06-24T18:23:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16187-emofilia-l-appello-dei-pazienti-affinche-il-centro-di-bari-non-venga-trasferito]]></loc><lastmod>2020-06-18T08:39:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16178-emofilia-omar-lancia-il-servizio-l-esperto-risponde]]></loc><lastmod>2020-06-14T23:03:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/16000-emofilia-bayer-lancia-una-serie-di-video-per-tenersi-in-forma-restando-a-casa]]></loc><lastmod>2020-04-29T14:29:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15960-emofilia-rurioctocog-alfa-pegol-rimborsabile-in-italia]]></loc><lastmod>2020-04-16T15:19:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15961-emofilia-oggi-si-celebra-la-sedicesima-giornata-mondiale]]></loc><lastmod>2020-04-16T15:24:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15940-emofilia-a-emicizumab-rimborsabile-in-italia-anche-per-pazienti-senza-inibitori]]></loc><lastmod>2020-04-12T23:16:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15923-emofilia-farmaci-a-domicilio-grazie-a-iniziativa-domedica-kedrion]]></loc><lastmod>2020-04-08T15:42:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15840-coronavirus-sobi-organizza-la-consegna-domiciliare-dei-suoi-farmaci-per-emofilia]]></loc><lastmod>2020-03-24T22:05:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15613-emofilia-a-in-italia-arriva-damoctocog-alfa-pegol]]></loc><lastmod>2020-01-28T16:49:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15554-emofilia-il-cammino-di-santiago-di-nicola-pezzotta]]></loc><lastmod>2020-01-07T15:24:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15485-emofilia-a-le-quattro-p-del-nuovo-farmaco-damoctocog-alfa-pegol]]></loc><lastmod>2019-12-08T19:01:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15486-emofilia-a-attesa-per-l-arrivo-in-italia-di-damoctocog-alfa-pegol]]></loc><lastmod>2019-12-08T19:58:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15332-emofilia-al-via-in-lazio-il-progetto-riabilitazione-di-ael-onlus]]></loc><lastmod>2019-10-21T20:08:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15316-emofilia-a-catania-esperti-riuniti-per-una-migliore-gestione-del-paziente]]></loc><lastmod>2019-10-15T21:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15302-emofilia-aice-rassicura-i-pazienti-sull-impiego-di-emicizumab]]></loc><lastmod>2019-10-14T08:16:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15281-emofilia-a-firenze-un-laboratorio-per-imparare-a-gestire-le-criticita]]></loc><lastmod>2019-10-20T18:39:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15272-emofilia-dalla-a-alla-z-disponibile-la-nuova-edizione-del-libro]]></loc><lastmod>2019-10-06T21:19:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15248-emofilia-bayer-lancia-il-nuovo-programma-bhap-2019-per-la-ricerca-clinica]]></loc><lastmod>2019-10-01T16:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15101-emofilia-il-futuro-tra-speranze-e-criticita]]></loc><lastmod>2019-08-03T16:45:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15057-emofilia-in-italia-parte-l-iniziativa-libera-la-vita]]></loc><lastmod>2019-09-10T14:20:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15058-emofilia-a-i-dati-aggiornati-sulla-terapia-genica-valoctocogene-roxaparvovec]]></loc><lastmod>2019-07-21T18:10:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15052-emofilia-a-nuovi-dati-positivi-per-la-terapia-genica-sb-525]]></loc><lastmod>2019-07-21T18:13:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15023-emofilia-a-al-congresso-isth-2019-i-dati-aggiornati-su-emicizumab]]></loc><lastmod>2019-07-12T16:52:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/15013-emofilia-a-nuovi-dati-su-damoctocog-alfa-pegol-al-congresso-isth-2019]]></loc><lastmod>2019-07-09T17:20:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14963-emofilia-la-missione-delle-associazioni-regionali-migliorare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2019-07-01T14:45:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14964-emofilia-le-associazioni-storiche-nate-dall-incubo-del-sangue-infetto]]></loc><lastmod>2019-06-30T21:02:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14965-emofilia-l-impegno-dell-associazione-emofilici-di-brescia]]></loc><lastmod>2019-06-30T21:03:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14961-emofilia-l-alleanza-medico-paziente-nella-gestione-delle-terapie]]></loc><lastmod>2019-06-27T14:50:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14938-emofilia-anche-chi-e-nato-per-non-correre-puo-fare-la-maratona-di-new-york]]></loc><lastmod>2019-07-01T14:01:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14924-emofilia-il-numero-dei-pazienti-italiani-continua-ad-aumentare]]></loc><lastmod>2019-07-02T11:14:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14885-emofilia-strategie-innovative-per-aumentare-l-efficacia-della-terapia-genica]]></loc><lastmod>2019-06-20T11:00:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14853-emofilia-in-abruzzo-indispensabile-una-rete-di-assistenza-per-le-malattie-emorragiche-congenite]]></loc><lastmod>2019-06-20T11:04:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14824-parte-la-nuova-edizione-della-campagna-ridisegniamo-l-emofilia]]></loc><lastmod>2019-05-19T16:41:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14779-emofilia-e-vaccinazioni-dal-progetto-heva-le-prime-raccomandazioni-mai-stilate-sul-tema]]></loc><lastmod>2019-05-06T18:22:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14737-emofilia-ieri-la-xv-giornata-mondiale-dedicata-alla-patologia]]></loc><lastmod>2019-04-16T15:30:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14724-emofilia-siot-sottolinea-l-importanza-dell-ortopedico-nella-gestione-della-patologia]]></loc><lastmod>2019-04-14T09:59:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14649-emofilia-e-sport-quali-i-problemi-ancora-aperti]]></loc><lastmod>2019-06-20T12:29:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14648-percorso-diagnostico-terapeutico-assistenziale-per-i-pazienti-con-emofilia-qual-e-il-ruolo-del-farmacista-ospedaliero]]></loc><lastmod>2019-06-20T10:56:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14647-emofilia-sempre-piu-attenzione-alla-personalizzazione-della-terapia]]></loc><lastmod>2019-06-20T10:57:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14581-emofilia-a-emicizumab-approvato-in-europa-anche-per-pazienti-senza-inibitori]]></loc><lastmod>2019-03-15T17:28:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14498-emofilia-inizia-la-seconda-fase-del-premio-letterario-afiancodelcoraggio]]></loc><lastmod>2019-02-22T17:16:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14482-risentimento-e-poche-attenzioni-da-parte-dei-genitori-le-esperienze-dei-sibling-nell-emofilia]]></loc><lastmod>2019-02-18T21:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14467-emofilia-fondazione-roche-premia-i-sei-vincitori-del-bando-a-sostegno-di-progetti-sociosanitari-e-socioassistenziali]]></loc><lastmod>2019-02-18T10:34:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14447-emofilia-a-al-congresso-eahad-nuovi-standard-di-cura]]></loc><lastmod>2019-05-16T08:32:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14449-emofilia-b-la-terapia-genica-di-uniqure-passa-alla-sperimentazione-di-fase-iii]]></loc><lastmod>2019-02-11T18:33:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14443-emofilia-una-fiaba-per-insegnare-ai-bambini-come-la-diversita-sia-una-ricchezza]]></loc><lastmod>2019-02-10T21:23:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14386-si-e-concluso-able-il-contest-bayer-dedicato-all-emofilia]]></loc><lastmod>2019-01-25T16:20:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14340-emofilia-javier-zanetti-scende-in-campo-per-a-fianco-del-coraggio]]></loc><lastmod>2019-01-08T19:16:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14327-emofilia-ficarra-e-picone-per-il-premio-a-fianco-del-coraggio]]></loc><lastmod>2019-01-03T19:00:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14319-emofilia-l-appello-di-leonardo-pieraccioni-per-a-fianco-del-coraggio]]></loc><lastmod>2018-12-30T21:17:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14313-emofilia-b-trattato-il-primo-paziente-con-l-editing-del-genoma-in-vivo]]></loc><lastmod>2018-12-26T21:10:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14309-emofilia-per-a-fianco-del-coraggio-parla-gabriele-corsi]]></loc><lastmod>2018-12-24T12:08:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14297-emofilia-antonio-albanese-per-a-fianco-del-coraggio]]></loc><lastmod>2018-12-18T16:27:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14279-emofilia-prosegue-la-terza-edizione-di-a-fianco-del-coraggio]]></loc><lastmod>2018-12-13T19:07:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14275-emofilia-a-emicizumab-approda-in-italia]]></loc><lastmod>2018-12-13T09:40:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14243-emofilia-a-dati-positivi-per-la-terapia-genica-spk-8011]]></loc><lastmod>2018-12-09T10:02:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14224-emofilia-si-all-attivita-fisica-una-risorsa-per-tutte-le-eta]]></loc><lastmod>2018-11-30T17:53:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14215-emofilia-a-approvazione-europea-per-damoctocog-alfa-pegol]]></loc><lastmod>2018-11-28T18:53:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14088-emofilia-partita-la-terza-edizione-del-premio-afiancodelcoraggio]]></loc><lastmod>2018-10-29T09:58:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/14006-emofilia-percezione-e-gestione-del-dolore-l-indagine-del-centro-regionale-aou-di-parma]]></loc><lastmod>2018-10-08T18:10:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13982-piu-valore-da-bayer-per-le-associazioni-pazienti-grazie-ad-a-b-l-e-contest-dedicato-all-emofilia]]></loc><lastmod>2018-10-02T07:49:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13774-emofilia-b-pfizer-avvia-uno-studio-di-fase-iii-con-la-terapia-genica]]></loc><lastmod>2018-07-20T14:48:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13750-emofilia-da-fondazione-roche-un-bando-da-120mila-euro-per-le-associazioni-dei-pazienti]]></loc><lastmod>2018-07-10T15:25:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13741-emofilia-tempo-fino-a-fine-luglio-per-proporre-i-progetti-delle-associazioni-di-pazienti-al-contest-able]]></loc><lastmod>2018-07-12T11:30:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13742-emofilia-la-prevalenza-in-italia-e-in-costante-aumento]]></loc><lastmod>2018-07-07T16:25:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13714-emofilia-al-via-in-piemonte-il-progetto-alziamo-il-sipario-i-protagonisti-siete-voi]]></loc><lastmod>2018-07-02T09:37:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13683-emofilia-l-impegno-della-siaarti-per-combattere-il-dolore]]></loc><lastmod>2018-06-19T15:00:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13684-emofilia-il-dolore-non-sara-prerogativa-delle-nuove-generazioni]]></loc><lastmod>2018-06-19T14:56:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13680-emofilia-il-dolore-e-il-campanello-d-allarme-del-benessere-articolare]]></loc><lastmod>2018-06-19T15:10:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13681-dolore-in-emofilia-il-progetto-haemodol-e-le-linee-guida-nazionali]]></loc><lastmod>2018-06-21T07:34:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13687-emofilia-piu-del-50-dei-pazienti-convive-col-dolore-cronico]]></loc><lastmod>2018-06-21T11:45:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13591-nasce-lo-sport-ad-hoc-per-le-malattie-rare-proposto-il-modello-per-l-emofilia]]></loc><lastmod>2018-05-29T10:52:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13603-emofilia-a-al-via-la-campagna-social-ridisegniamo-l-emofilia]]></loc><lastmod>2018-05-28T09:19:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13585-emofilia-bayer-assegna-a-italia-stati-uniti-e-colombia-i-premi-per-i-migliori-progetti]]></loc><lastmod>2018-05-25T09:48:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13582-emofilia-a-nuovi-dati-clinici-dimostrano-l-efficacia-di-emicizumab]]></loc><lastmod>2018-05-23T10:54:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13579-emofilia-migliora-il-dolore-articolare-e-la-qualita-di-vita-con-le-terapie-di-sobi]]></loc><lastmod>2018-05-24T07:20:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13559-emofilia-ecco-la-carta-dei-diritti-dei-pazienti]]></loc><lastmod>2018-05-18T09:58:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13536-emofilia-con-able-bayer-sostiene-i-progetti-delle-associazioni-regionali-provinciali-e-locali]]></loc><lastmod>2018-05-10T10:55:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13480-emofilia-le-nuove-prospettive-terapeutiche-made-in-italy]]></loc><lastmod>2018-06-19T16:02:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13452-emofilia-dalla-a-alla-z-dalla-gioco-terapia-allo-sport-agonistico-disponibile-dopo-l-estate-la-nuova-pubblicazione]]></loc><lastmod>2018-04-17T11:12:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13451-emofilia-per-la-giornata-mondiale-avviato-il-progetto-emofilia-in-a-day]]></loc><lastmod>2018-04-17T11:57:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13444-emofilia-emicizumab-ottiene-per-la-seconda-volta-la-designazione-di-terapia-innovativa]]></loc><lastmod>2018-04-17T11:13:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13440-emofilia-oggi-la-giornata-mondiale-all-insegna-dei-limitizero]]></loc><lastmod>2018-04-17T14:44:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13442-xiv-giornata-mondiale-dell-emofilia-l-appello-di-fedemo]]></loc><lastmod>2018-04-17T09:46:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13436-emofilia-con-i-prodotti-a-emivita-prolungata-un-minore-impatto-anche-sul-caregiver]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13364-sport-ed-emofilia-fondamentale-la-protezione-della-profilassi-prima-che-la-scelta-della-disciplina]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13350-l-entusiasmo-di-malachi-emofilico-finalmente-nella-squadra-di-basket-del-college]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13334-emofilia-nuovi-contenuti-per-il-portale-di-bayer-sulla-malattia]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13311-emofilia-depressione-ansia-e-dolore-sono-trascurati]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13252-mio-figlio-ha-l-emofilia-il-racconto-di-francesca]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13235-emofilia-pediatrica-dalla-puglia-un-sistema-di-diagnostica-a-domicilio-e-teleconsulto]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13214-vi-presentiamo-limitizero-l-emofilia-secondo-la-generazione-z]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13212-emofilia-a-canada-e-italia-a-confronto-nella-gestione-della-patologia]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13211-emofilia-dal-congresso-ehad-la-conferma-coi-farmaci-a-emivita-prolungata-migliora-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13188-emofilia-a-l-ema-raccomanda-emicizumab-per-pazienti-con-inibitori]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13140-emofilia-e-comorbilita-negli-anziani-un-quadro-fatto-di-luci-ed-ombre]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13122-emofilia-a-niente-paura-per-le-vaccinazioni]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13102-emofilia-a-nuovi-dati-confermano-efficacia-e-sicurezza-di-emicizumab]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13094-emofilia-pazienti-liberi-da-trattamento-fino-a-14-giorni-con-le-nuove-terapie-a-emivita-prolungata-sviluppate-con-la-tecnologia-di-fusione-fc]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13092-emofilia-a-con-elocta-protezione-dai-sanguinamenti-anche-con-un-infusione-ogni-sette-giorni]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13091-emofilia-b-con-alprolix-una-protezione-sicura-ed-efficace-fino-a-oltre-14-giorni]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13052-emofilia-a-napoli-la-nuova-udienza-sul-caso-plasma-derivati]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13042-francesco-emofilico-e-veterano-delle-maratone]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13040-emofilia-il-rilancio-del-centro-di-latina-al-servizio-del-basso-lazio]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13012-luca-il-podista-emofilico-che-ha-partecipato-a-due-maratone-di-new-york]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13004-emofilia-con-i-prodotti-a-emivita-prolungata-un-risparmio-di-900mila-euro-a-paziente-in-70-anni]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13003-emofilia-b-la-terapia-genica-riduce-del-97-i-sanguinamenti-e-del-99-il-consumo-di-fattore-ix]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/13013-emofillia-nasce-il-progetto-emoazione-2017-2020]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12977-nuoto-corsa-e-motocross-con-l-emofilia-grave-la-storia-di-roberto]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12976-emofilia-da-fondazione-paracelso-arriva-la-nuova-app-alisei]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12920-emofilia-a-importanza-della-farmacocinetica-per-una-maggiore-protezione-i-dati-su-bay-818973]]></loc><lastmod>2018-04-17T09:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12912-emofilia-a-con-inibitori-prima-autorizzazione-a-livello-mondiale-per-emicizumab]]></loc><lastmod>2017-11-20T08:23:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12913-emofilia-alta-aderenza-alla-terapia-significa-meno-dolore-e-migliore-qualita-di-vita]]></loc><lastmod>2017-11-22T16:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12910-emofilia-l-esperienza-italiana-conferma-i-farmaci-a-emivita-prolungata-sono-un-vantaggio-per-i-pazienti-e-per-il-ssn]]></loc><lastmod>2017-11-22T16:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12902-emofilia-quando-l-innovazione-diventa-sostenibilita]]></loc><lastmod>2017-11-22T16:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12903-emofilia-innovazione-e-sostenibilita-si-possono-coniugare-l-esempio-dei-farmaci-di-sobi]]></loc><lastmod>2017-11-22T16:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12936-emofilia-a-ok-dell-ema-al-farmaco-rurioctocog-alfa-pegol]]></loc><lastmod>2019-01-17T17:21:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12883-emofilia-come-si-somministra-la-terapia]]></loc><lastmod>2018-08-27T11:26:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12880-xvi-congresso-aice-per-l-emofilia-l-impegno-di-bayer-nel-presente-e-nel-futuro]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12878-xvi-convegno-aice-presentato-il-progetto-per-la-stesura-della-carta-dei-diritti-della-persona-con-emofilia]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12875-dolore-in-emofilia-se-ne-parla-poco-ma-per-i-pazienti-e-un-problema-grave]]></loc><lastmod>2017-11-22T16:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12860-emofilia-a-benefici-articolari-a-lungo-termine-con-efmoroctocog-alfa]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12863-emofilia-in-8-anni-la-salute-articolare-peggiora-in-piu-di-un-terzo-dei-pazienti]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12849-emofilia-a-arruolato-il-primo-paziente-nello-studio-reitirate]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12839-emofilia-al-via-la-nuova-edizione-di-miles-for-haemophilia]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12833-emofilia-il-futuro-dei-pazienti-si-costruisce-oggi]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12820-emofilia-gli-inibitori-e-la-tecnica-per-contrastarli]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12813-emofilia-e-sport-le-discipline-consentite-e-quelle-off-limits]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12801-emofilia-a-con-efmoroctocog-alfa-il-dolore-si-riduce-del-31]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12777-emofilia-per-i-pazienti-e-fondamentale-poter-ridurre-la-frequenza-delle-infusioni]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12780-emofilia-la-malattia-limita-la-tua-vita-quali-informazioni-mancano-la-parola-ai-pazienti]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12749-emofilia-perche-si-sviluppano-gli-inibitori]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12760-abrogazione-del-limite-di-rinnovo-e-rilascio-della-patente-per-i-pazienti-emofilici-la-soddisfazione-di-fedemo]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12754-emofilia-cresce-il-centro-malattie-rare-di-pescara-punto-di-riferimento-per-duemila-malati]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12743-emofilia-a-studio-giapponese-real-world-conferma-la-sicurezza-di-elocta]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12740-emofilia-a-disponibile-anche-in-italia-il-nuovo-fattore-viii-singlechain]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12734-emofilia-con-i-prodotti-a-emivita-prolungata-si-riduce-l-utilizzo-del-fattore-fino-al-50]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12739-patente-di-guida-eliminato-il-divieto-per-gli-emofilici]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12728-emofilia-piu-di-un-terzo-dei-pazienti-potrebbe-avere-una-vita-migliore-con-una-maggiore-aderenza-alla-profilassi-ma-l-ago-fa-ancora-paura]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12730-emofilia-i-nuovi-farmaci-a-emivita-prolungata-favoriscono-un-aumento-della-compliance]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12692-emofilia-le-modalita-di-cura-della-malattia]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12689-emofilia-un-disturbo-non-solo-emorragico-ma-anche-ortopedico]]></loc><lastmod>2017-11-20T08:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12645-emofilia-il-video-di-bayer-che-spiega-la-malattia]]></loc><lastmod>2017-10-10T17:46:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12635-emofilia-a-fda-accorda-a-emicizumab-la-priority-review]]></loc><lastmod>2017-10-10T17:46:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12623-emofilia-fitusiran-efficace-in-somministrazioni-sottocutanee-mensili]]></loc><lastmod>2017-09-05T17:21:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12612-il-dolore-nell-emofilia-come-evitarlo-con-una-profilassi-efficace]]></loc><lastmod>2017-09-02T09:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12590-emofilia-a-ridimensionato-il-rischio-inibitori-in-pazienti-gia-trattati]]></loc><lastmod>2017-08-21T18:38:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12507-emofilia-quattro-i-centri-italiani-nel-prossimo-trial-su-terapia-rnai]]></loc><lastmod>2017-07-15T14:28:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12515-emofilia-al-via-limitizero-ragazzi-e-creativi-verso-la-realizzazione-di-uno-spot-pubblicitario]]></loc><lastmod>2017-07-18T13:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12486-protesi-di-ginocchio-il-metodo-bresciano-esportato-negli-usa]]></loc><lastmod>2017-07-10T15:12:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12489-emofilia-avanza-con-successo-lo-sviluppo-clinico-della-terapia-rnai]]></loc><lastmod>2019-01-17T17:32:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12476-emofilia-profilassi-con-terapie-a-emivita-prolungata-migliora-la-salute-delle-articolazioni]]></loc><lastmod>2017-07-06T09:44:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12466-emofilia-a-esiti-positivi-da-studi-registrativi-su-emicizumab]]></loc><lastmod>2019-01-17T17:35:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12460-emofilia-b-l-ema-approva-la-possibilita-di-dosaggio-con-alprolix-ogni-14-giorni-o-piu]]></loc><lastmod>2017-07-03T08:56:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12443-emofilia-da-bayer-video-e-illustrazioni-per-conoscere-la-malattia]]></loc><lastmod>2017-06-26T17:40:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12391-al-servizio-sull-emofilia-di-lidia-scognamiglio-del-tg2-il-premio-giornalistico-bayer]]></loc><lastmod>2017-06-19T14:07:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12368-conosci-l-emofilia-solo-il-47-degli-italiani-ne-ha-sentito-parlare]]></loc><lastmod>2017-06-13T10:10:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12347-emofilia-a-octocog-alfa-disponibile-anche-nel-lazio]]></loc><lastmod>2017-06-04T20:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12356-emofilia-uno-spot-per-raccontare-la-vita-con-la-malattia-nel-2017]]></loc><lastmod>2017-06-13T10:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12343-emofilia-dance-and-move-vince-il-premio-pfizer-miles-for-haemophilia]]></loc><lastmod>2017-06-19T14:07:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12323-chris-il-primo-emofilico-al-mondo-a-scalare-l-everest]]></loc><lastmod>2017-05-28T16:36:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12310-emofilia-a-acquisita-rara-tra-le-malattie-rare]]></loc><lastmod>2017-06-13T10:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12231-emofilia-online-il-nuovo-sito-di-bayer-dedicato-alla-patologia]]></loc><lastmod>2017-09-12T15:28:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12209-emofilia-risultati-preliminari-positivi-da-studio-di-fase-iii-per-emicizumab]]></loc><lastmod>2017-06-13T10:08:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12177-in-aumento-il-numero-degli-emofilici-in-italia-sono-quasi-5-mila-i-casi-oltre-il-3-in-piu-rispetto-al-2014]]></loc><lastmod>2017-07-10T15:33:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12176-xiii-giornata-mondiale-emofilia-fedemo-chiede-un-protocollo-nazionale-per-l-emergenza-in-pronto-soccorso]]></loc><lastmod>2017-06-13T10:08:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12131-emofilia-che-cosa-non-puo-mancare-nel-bagaglio-di-un-paziente]]></loc><lastmod>2017-06-13T10:13:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12103-emofilia-b-pubblicati-i-risultati-dello-studio-di-estensione-su-eftrenonacog-alfa]]></loc><lastmod>2017-06-13T10:13:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/12039-emofilia-b-alprolix-ottiene-il-rimborso-in-italia]]></loc><lastmod>2017-06-13T10:13:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11990-emofilia-a-acquisita-arriva-in-italia-susoctocog-alfa]]></loc><lastmod>2017-06-13T10:14:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11958-emofilia-b-ottenuta-anche-in-italia-l-autorizzazione-per-la-commercializzazione-di-albutrepenonacog-alfa]]></loc><lastmod>2017-06-13T10:14:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11949-emofilia-a-bayer-ottiene-la-rimborsabilita-per-bay-81-8973]]></loc><lastmod>2017-06-13T10:14:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11897-emofilia-presentati-da-shire-nuovi-dati-globali]]></loc><lastmod>2017-06-13T10:14:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11893-emofilia-il-premio-giornalistico-bayer-prorogato-fino-al-prossimo-30-aprile]]></loc><lastmod>2017-06-13T10:14:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11861-emofilia-a-sangamo-biosciences-annuncia-prossimo-avvio-di-un-trial-di-terapia-genica-in-fase-i-ii]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11790-emofilia-di-tipo-a-la-commissione-europea-approva-rviii-singlechain-afstyla]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11767-emofilia-a-emicizumab-raggiunge-l-endpoint-primario-in-uno-studio-clinico-di-fase-iii]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11656-emofilia-a-il-valore-aggiunto-di-octocog-alfa-e-la-flessibilita]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11574-emofilia-a-da-bayer-un-fattore-viii-ancora-piu-sicuro]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11535-emofilia-dal-convegno-aice-novita-sulla-medicina-di-precisione]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11518-emofilia-da-bayer-un-premio-dedicato-ai-progetti-di-ricerca]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11432-emofilia-b-a-roma-un-convegno-sulla-rara-patologia]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11361-emofilia-a-brescia-scoperta-una-specifica-mutazione-genetica-risalente-al-ii-secolo-a-c]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11381-emofilia-grande-successo-per-la-campagna-miles-for-haemophilia]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11196-emofilia-da-ragazzi-protetti-da-ogni-urto-a-personaggi-della-formula-1]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11099-emofilia-qual-e-il-costo-annuo-della-malattia]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11088-emofilia-a-sangamo-lancia-programma-di-sviluppo-clinico-per-nuova-terapia-genica]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11087-emofilia-b-da-usa-designazione-di-breakthrough-therapy-per-il-composto-spk-9001]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11115-emofilia-2]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11081-emofilia-la-prevalenza-nella-popolazione-italiana-e-di-6-4-casi-su-100-000-abitanti]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11071-emofilia-a-presentati-i-dati-di-uno-studio-d-estensione-su-emicizumab]]></loc><lastmod>2017-05-12T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/11061-emofilia-a-disponibile-anche-in-italia-efmoroctocog-alfa-il-primo-fattore-viii-ricombinante-a-emivita-prolungata-con-tecnologia-fc]]></loc><lastmod>2017-07-12T09:51:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10928-emofilia-lanciata-la-seconda-edizione-della-campagna-miles-for-haemophilia]]></loc><lastmod>2016-07-06T22:09:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10844-emofilia-al-via-il-primo-appuntamento-del-progetto-barriera-zero]]></loc><lastmod>2016-06-24T12:04:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10769-emofilia-a-reggio-calabria-attivo-il-primo-ambulatorio-dentistico-dedicato]]></loc><lastmod>2016-06-09T14:50:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10742-emofilia-b-ottimistici-i-primi-dati-dalla-sperimentazione-clinica-della-terapia-genica-spk-9001]]></loc><lastmod>2016-06-03T10:20:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10712-emofilia-online-un-tutorial-sull-utilizzo-dell-hilterapia]]></loc><lastmod>2016-05-31T08:11:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10657-emofilia-a-nuovo-farmaco-inserito-da-aifa-nella-classe-c-non-negoziata]]></loc><lastmod>2016-05-24T09:14:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10670-emofilia-a-nessun-rischio-aumentato-per-chi-utilizza-i-farmaci-ricombinanti]]></loc><lastmod>2016-05-23T08:21:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10593-emofilia-biogen-conferira-i-farmaci-ad-hoc-ad-una-nuova-azienda]]></loc><lastmod>2016-05-13T10:51:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10601-emofilia-b-la-commissione-europea-approva-idelvion]]></loc><lastmod>2020-07-20T17:00:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10600-emofilia-b-rfixfc-approvato-nell-unione-europea]]></loc><lastmod>2016-05-13T13:38:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10525-emofilia-al-via-il-premio-giornalistico-bayer]]></loc><lastmod>2016-05-03T13:44:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10458-emofilia-da-novo-nordisk-un-bando-per-finanziare-nuovi-progetti-di-ricerca]]></loc><lastmod>2016-04-26T15:03:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10437-emofilia-b-il-comp-raccomanda-di-mantenere-la-designazione-a-farmaco-orfano-di-rfixfc]]></loc><lastmod>2016-04-22T15:38:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10411-emofilia-b-confermato-lo-status-di-farmaco-orfano-per-idelvion]]></loc><lastmod>2016-04-20T07:45:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10392-emofilia-b-in-via-di-conferma-la-designazione-europea-di-farmaco-orfano-per-alprolix]]></loc><lastmod>2016-04-15T16:02:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10404-barriera-zero-un-progetto-destinati-ai-giovani-affetti-da-emofilia]]></loc><lastmod>2016-04-18T14:14:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10354-emofilia-fedemo-celebra-oggi-a-roma-la-xii-giornata-mondiale]]></loc><lastmod>2016-04-11T15:33:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10305-emofilia-a-ema-concede-lo-status-di-farmaco-orfano-alla-terapia-genica-bmn-270]]></loc><lastmod>2016-04-04T15:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10274-emofilia-b-pubblicati-i-risultati-sull-uso-profilattico-del-farmaco-benefix]]></loc><lastmod>2016-03-29T14:12:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10228-emofilia-pazienti-soddisfatti-del-ssn-ma-da-migliorare-le-terapie-domiciliari]]></loc><lastmod>2016-03-21T11:23:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10227-emofilia-oggi-e-possibile-ripensare-il-futuro-della-malattia-e-dei-pazienti]]></loc><lastmod>2016-03-21T11:25:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10212-emofilia-vince-il-premio-pfizer-il-progetto-un-tuffo-nel-futuro]]></loc><lastmod>2016-03-18T10:25:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10184-emofilia-a-il-composto-sperimentale-bmn-270-e-farmaco-orfano-negli-usa]]></loc><lastmod>2016-03-11T14:23:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10170-emofilia-in-puglia-nasce-un-nuovo-progetto-di-telemedicina]]></loc><lastmod>2016-03-11T09:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10080-emofilia-b-ema-raccomanda-l-approvazione-del-farmaco-sperimentale-idelvion]]></loc><lastmod>2016-03-01T11:20:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10074-emofilia-b-via-libera-dell-ema-al-farmaco-sperimentale-alprolix-rfixfc]]></loc><lastmod>2016-04-14T10:39:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/10025-emofilia-a-bayer-riceve-l-approvazione-europea-per-bay-81-8973]]></loc><lastmod>2016-02-24T11:38:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9823-emofilia-a-un-progetto-triennale-da-5-6-milioni-di-euro-per-curarla]]></loc><lastmod>2016-01-26T11:57:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9738-emofilia-a-ema-valutera-l-approvazione-della-terapia-sperimentale-rviii-singlechain]]></loc><lastmod>2016-03-14T08:56:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9657-emofilia-a-ema-raccomanda-l-approvazione-europea-del-farmaco-bay-81-8973]]></loc><lastmod>2015-12-22T10:54:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9620-emofilia-a-scoperta-una-molecola-che-potrebbe-impedire-lo-sviluppo-di-inibitori]]></loc><lastmod>2015-12-15T11:25:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9456-emofilia-a-acquisita-il-farmaco-obizur-arriva-anche-in-europa]]></loc><lastmod>2015-11-26T13:52:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9457-emofilia-a-negli-stati-uniti-autorizzata-la-vendita-del-farmaco-adynovate]]></loc><lastmod>2015-11-26T14:06:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9442-emofilia-a-fda-approva-adynovate-sia-come-profilassi-che-come-terapia-on-demand]]></loc><lastmod>2015-11-25T16:11:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9370-la-maratona-di-luca-per-l-emofilia-non-e-una-malattia-contagiosa-e-nessuno-deve-essere-discriminato]]></loc><lastmod>2015-11-19T08:38:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9352-emofilia-oggi-e-possibile-una-vita-normale]]></loc><lastmod>2018-02-15T18:32:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9351-emofilia-a-grave-in-adolescenti-e-adulti-la-profilassi-riduce-sensibilmente-gli-episodi-di-sanguinamento-rispetto-al-trattamento-on-demand]]></loc><lastmod>2015-11-13T10:38:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9346-emofilia-francesco-ha-affrontato-la-maratona-di-new-york-e-ha-vinto-la-sfida]]></loc><lastmod>2018-02-15T18:34:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9340-emofilia-a-studio-internazionale-dimostra-maggior-immunogenicita-della-terapia-ricombinante]]></loc><lastmod>2015-11-12T13:33:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9316-emofilia-e-malattia-di-von-willebrand-l-innesto-adiposo-autologo-per-riparare-le-ferite]]></loc><lastmod>2015-11-06T14:01:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9312-emofilia-telethon-e-gruppo-grifo-agroalimentare-insieme-per-la-ricerca]]></loc><lastmod>2015-11-06T13:29:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9298-atleti-anche-con-l-emofilia-la-maratona-di-new-york-di-francesco-enrico-e-luca]]></loc><lastmod>2015-11-06T11:06:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9262-emofilia-genzyme-prende-parte-allo-sviluppo-del-farmaco-aln-at3-di-alnylam]]></loc><lastmod>2015-11-17T14:24:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9275-emofilia-alcuni-pazienti-italiani-tra-i-partecipanti-della-maratona-di-new-york]]></loc><lastmod>2015-11-02T10:12:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9211-emofilia-a-avviata-la-sperimentazione-di-fase-i-ii-del-farmaco-bmn-270]]></loc><lastmod>2015-10-23T10:47:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9107-emofilia-disponibile-una-nuova-app-per-aiutare-i-bambini-a-parlare-della-malattia]]></loc><lastmod>2015-10-12T13:21:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/9045-emofilia-meglio-la-profilassi-o-la-somministrazione-on-demand]]></loc><lastmod>2015-10-06T15:09:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8881-emofilia-farmaco-sperimentale-di-roche-ottiene-la-breakthrough-therapy-designation-dall-fda]]></loc><lastmod>2015-09-08T08:54:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8836-emofilia-a-pubblicati-i-positivi-risultati-di-uno-studio-a-lungo-termine-sul-farmaco-eloctate]]></loc><lastmod>2015-08-28T08:28:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8802-emofilia-attenzione-alle-emorragie-cefaliche-nei-primi-mesi-di-vita]]></loc><lastmod>2015-08-21T10:25:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8755-emofilia-anche-i-bambini-possono-partire-per-le-vacanze-in-completa-sicurezza]]></loc><lastmod>2015-08-05T10:32:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8754-emofilia-il-centro-di-padova-non-va-in-vacaza]]></loc><lastmod>2015-08-14T16:46:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8753-emofilia-10-suggerimenti-per-andare-in-vacanza-in-sicurezza]]></loc><lastmod>2015-08-05T10:35:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8613-emofilia-b-baxalta-riferisce-gli-sviluppi-dello-studio-di-fase-i-ii-del-farmaco-sperimentale-bax-335]]></loc><lastmod>2015-07-13T13:12:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8516-emofilia-buoni-risultati-per-studio-di-fase-i-su-nuovo-farmaco]]></loc><lastmod>2015-06-26T09:37:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8511-emofilia-da-toronto-nuovi-dati-su-rfixfc-e-rfviiifc]]></loc><lastmod>2015-06-24T14:26:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8465-emofilia-continua-la-campagna-miles-for-haemophilia]]></loc><lastmod>2015-06-17T15:12:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8417-emofilia-premiato-l-ospedale-di-parma-per-l-organizzazione-nella-cura]]></loc><lastmod>2015-06-11T08:17:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8319-emofilia-parte-la-campagna-miles-for-haemophilia-your-personal-best]]></loc><lastmod>2015-06-03T08:09:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8138-emofilia-ora-correre-e-possibile]]></loc><lastmod>2015-06-08T11:28:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8033-emofilia-per-le-persone-affette-da-questa-patologia-ora-lo-sport-non-e-piu-un-tabu]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8022-emofilia-limpegno-di-baxter-per-la-qualita-della-vita]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8021-giornata-mondiale-dellemofilia-intervista-alla-dottssa-biasoli-responsabile-del-centro-emofilia-di-cesena]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8020-giornata-mondiale-dellemofilia-intervista-alla-dottssa-santoro-direttore-del-centro-emofilia-di-catanzaro]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/8019-giornata-mondiale-dellemofilia-le-sfide-italiane-per-una-miglior-qualita-di-vita-dei-pazienti]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7973-13-aprile-roma-xi-giornata-mondiale-dellemofilia]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7972-emofilia-ema-avvia-revisione-su-autorizzazione-per-farmaco-long-acting-di-csl-behring]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7907-emofilia-a-e-b-baxter-annuncia-risultati-positivi-per-bax-817]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7872-emofilia-b-risultati-positivi-per-rfixfc]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7882-emofilia-il-fattore-viia-di-baxter-per-i-pazienti-con-inibitori-supera-la-fase-iii]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7796-emofilia-urgente-una-strategia-europea-sui-registri]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7758-emofilia-nuove-prospettive-di-trattamento-dalla-terapia-genica]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7747-emofilia-behring-dona-2-milioni-di-ui-di-proteine-terapeutiche-al-wfh]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7727-emofilia-a-disponibile-in-italia-turoctocog-alfa]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7616-emofilia-aifa-ritira-un-lotto-del-farmaco-per-profilassi]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7503-pazienti-anziani-con-emofilia-rilevata-unalta-prevalenza-di-malattie-connesse-allinvecchiamento]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7497-emofilia-collaborazione-globale-per-lo-sviluppo-di-una-nuova-terapia-genica]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7381-emofilia-ancora-impossibile-determinare-gli-effetti-della-terapia-genica]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7270-medicinali-plasmaderivati-qinfettiq-fedemo-chiede-al-governo-renzi-un-intervento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7115-emofilia-b-luso-di-nonacog-beta-pegol-si-mostra-sicuro-ed-efficace]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7042-emofilia-fedemo-e-ivan-capelli-hanno-acceso-i-motori-a-vallelunga]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7029-emofilia-il-danno-articolare-come-un-film-in-3d]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6989-malattie-ereditarie-della-coagulazione-a-che-punto-sono-i-registri-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/7014-emofilia-in-corso-a-firenze-il-congresso-dellaice]]></loc><lastmod>2015-05-25T11:05:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6995-emofilia-a-fda-approva-il-farmaco-obizur]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6936-bayer-hemophilia-award-entro-il-30-novembre-le-candidature-per-il-bando-2014-2015]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6797-emofilia-a-disfunzioni-cognitive-non-correlate-a-gravita-della-malattia-ma-a-presenza-di-microemorragie-cerebrali]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6739-emofilia-b-i-nuovi-farmaci-sono-cinque-volte-piu-efficaci-ma-i-requisiti-dellema-ne-ritardano-la-messa-in-commercio]]></loc><lastmod>2025-11-20T08:32:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6661-emofilia-risultati-positivi-per-bax-855]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6612-emofilia-lunione-europea-ha-concesso-la-designazione-di-farmaco-orfano-a-aln-at3-di-alnylam]]></loc><lastmod>2019-06-18T18:02:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6488-emofilia-la-federazione-regionale-dellemilia-romagna-prende-posizione-sulla-richiesta-di-revoca-della-delibera-che-regola-anche-le-pratiche-di-autoinfusione]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6411-emofilia-studio-indaga-la-validita-della-scala-veritas-pro-nella-popolazione-pediatrica]]></loc><lastmod>2019-06-18T18:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6425-emofilia-nasce-il-primo-sito-dedicato-ai-pazienti-con-inibitore]]></loc><lastmod>2015-05-25T11:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6355-emofilia-a-bayer-healthcare-e-dimension-therapeutics-svilupperanno-una-nuova-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6322-emofilia-congenita-e-acquisita-lanticorpo-monoclonale-rituximab-consigliato-come-terapia-secondaria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6336-emofilia-bayer-firma-accordo-con-dimension-therapeutics-per-una-nuova-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6240-emofilia-fda-approva-trattamento-con-eloctate]]></loc><lastmod>2015-08-25T10:36:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6237-emofilia-il-registro-pednet-utile-nella-gestione-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6161-emofilia-a-presentati-i-nuovi-risultati-su-turoctocog-alfa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/6140-emofilia-grande-successo-per-concorriamo-insieme-svoltasi-sabato-scorso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5964-emofilia-per-bambini-una-vita-normale-grazie-alla-profilassi]]></loc><lastmod>2015-08-10T08:01:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5870-emofilia-la-sicurezza-arriva-dalla-formula-1-con-il-braccialetto-tecnologico-salvavita]]></loc><lastmod>2018-02-15T17:59:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5869-emofilia-oggi-la-giornata-mondiale-fedemo-in-arrivo-nuovi-trattamenti-farmaci-long-acting-e-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5847-emofilia-b-fda-approva-il-primo-fattore-ix-long-acting]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5634-emofilia-grazie-alle-nuove-terapie-i-pazienti-vivono-una-vita-normale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5623-emofilia-a-luso-di-octocog-alfa-non-aumenta-il-rischio-di-sviluppare-inibitori-lo-conferma-la-commissione-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5564-emofilia-a-profilassi-efficace-con-infusioni-meno-frequenti-grazie-al-fattore-viii-ricombinante-ad-azione-prolungata-di-bayer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5475-emofilia-a-grave-con-la-profilassi-i-pazienti-stanno-meglio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5437-emofilia-la-situazione-attuale-italiana-e-le-aspettative-per-il-futuro-spiegate-dagli-esperti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5454-emofilia-il-futuro-e-prevenire-i-sanguinamenti-le-nuove-prospettive-da-hemocases-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5165-emofilia-a-confermanata-l-efficacia-e-tollerabilita-della-terapia-obi-1]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5109-emofilia-pubblicati-i-risultati-dello-studio-sul-farmaco-eloctate]]></loc><lastmod>2019-06-19T08:07:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/5021-emofilia-difetti-della-coagulazione-e-odontoiatria-focus-sul-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4991-emofilia-sara-presto-avviata-la-sperimentazione-per-un-farmaco-con-tencina-rnai]]></loc><lastmod>2019-06-19T08:11:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4921-emofilia-a-il-rischio-inibitori-non-cambia-se-si-usano-plasma-derivati-o-ricombinanti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4864-emofilia-a-via-libera-da-parte-dellfda-allimpiego-del-farmaco-turoctocog-alfa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4737-emofilia-al-via-il-bayer-hemophilia-awards-program-2013-2014-che-finanzia-progetti-di-ricerca-e-di-formazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4656-emofilia-a-in-arrivo-un-nuovo-fattore-ricombinante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4402-emofilia-dati-incoraggianti-per-il-programma-terapeutico-con-rnai-di-alnylam]]></loc><lastmod>2015-11-13T12:25:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4399-emofilia-il-fattore-viii-ricombinante-kogenate-compie-25-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4373-emofilia-a-iniziato-lo-studio-pediatrico-di-fase-iii-su-una-nuova-molecola-di-fattore-viii-ricombinante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4329-emofilia-b-buoni-i-risultati-della-sperimentazione-con-alprolix]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4330-emofilia-b-buoni-i-risultati-della-sperimentazione-con-alprolix-33465576]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4325-emofilia-ridurre-i-sanguinamenti-innalza-la-qualita-della-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4292-emofilia-due-italiane-premiate-dal-bayer-hemophilia-awards-program]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4177-emofilia-arriva-la-siringa-preriempita-fusengo-facilita-liniezione-e-tiene-alla-larga-il-rischio-di-batteri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/4117-emofilia-a-udine-trapianto-di-fegato-su-paziente-con-epatite-c-e-sieropositivo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3942-emofilia-ieri-la-gionata-mondiale-fedemo-chidede-un-confronto-con-le-istituzioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3880-emofilia-scoperto-un-potenziale-farmaco-per-favorire-la-coagulazione-riattivando-le-piastrine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3785-emofilia-a-si-sviluppano-nuovi-farmaci-di-ultima-generazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3751-emofilia-ulteriori-dati-a-favore-dei-fattori-ricombinanti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3774-emofilia-a-richiesta-alla-fda-lautorizzazione-per-la-proteina-di-fusione-ricombinante-fviiifc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3661-emofilia-avviato-il-network-europeo-euhanet]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3631-emofilia-aice-premia-i-giovani-ricercatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3613-emofilia-la-terapia-personalizzata-garantisce-una-salute-migliore-e-un-buon-risparmio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3599-emofilia-prospettive-future-della-terapia-genica-e-cellulare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3525-emofilia-a-mannucci-studio-rodin-non-cambia-nulla-nella-gestione-clinica-del-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3501-emofilia-b-una-nuova-molecola-permette-di-diminuire-le-infusioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3519-emofilia-a-turchetti-necessario-orientare-anche-le-valutazioni-economiche-tenendo-conto-di-tutte-le-implicazioni-associate-a-una-terapia-farmacologica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3517-emofilia-a-il-fattore-viii-ricombinante-non-aumenta-in-rischio-di-sviluppare-linibitore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3360-emofilia-b-disponibili-i-dati-di-un-nuovo-fattore-ix-ricombinante]]></loc><lastmod>2018-10-25T16:14:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3342-emofilia-avviato-il-primo-progetto-nazionale-di-terapia-del-movimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3270-emofilia-lattivita-sportiva-moderata-e-consigliata-ai-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3267-emofilia-a-e-b-nuovo-trattamento-sperimentale-per-pazienti-che-hanno-sviluppato-anticorpi-neutralizzanti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3264-emofilia-bayer-finanzia-progetti-di-ricerca-grazie-all-hemophilia-awards-program]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3127-emofilia-a-risultati-positivi-per-un-nuovo-fattore-ricombinante-rrviiifc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3030-emofilia-a-richiesta-la-registrazione-di-turoctocog-alfa-fattore-ricombinante-di-terza-generazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3011-emofilia-nuove-linee-guida-wfh-grazie-alla-profilassi-di-vita-piu-lunga-e-attiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/3017-primo-registro-per-emofilia-acquisita-dati-sullefficacia-degli-immunosoppressori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2953-emofilia-inaugurata-globulandia-mostra-didattica-itinerante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2916-emofilia-interrotto-lo-sviluppo-del-farmaco-biotech-vatreptacog-alfa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2891-emofilia-b-un-nuovo-fattore-ricombinante-sara-presto-disponibile]]></loc><lastmod>2016-03-25T11:31:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2776-emofilia-viste-gratuite-in-calabria-grazie-a-icore-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2750-emofilia-la-salute-di-un-adolescente-messa-a-rischio-al-policlinico-di-perugia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2739-emofilia-balduzzi-valuta-uno-schema-di-accordo-stato-regioni-per-ladeguata-assistenza-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2724-emofilia-nessun-risarcimento-per-i-600-pazienti-danneggiati-dai-plasmaderivati-infetti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2672-emofilia-a-pescara-duemila-pazienti-rischiano-di-non-essere-curati-adeguatamente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2514-emofilia-a-la-tecnologia-migliora-laderenza-alla-terapia-e-potra-aiutar-a-fare-stime-precise-del-consumo-di-emoderivati]]></loc><lastmod>2020-06-03T18:18:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2538-emofilia-a-sicurezza-ed-efficacia-della-proteina-di-fusione-ricombinante-rfviiifc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2513-emofilia-b-lespressione-del-fattore-xi-nel-muscolo-scheletrico-dieci-anni-dopo-il-trasferimento-genico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2525-emofilia-i-tagli-della-spending-review-mettono-a-rischio-i-servizi-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2518-emofilia-a-octocog-alfa-si-dimostra-efficace-nel-ridurre-la-frequenza-dei-sanguinamenti-in-profilassi-secondaria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2504-biogen-idec-e-sobi-danno-il-via-a-studi-clinici-globali-sui-prodotti-candidati-ad-azione-prolungata-per-lemofilia-di-tipo-a-e-b-nei-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2506-emofilia-grazie-a-baxter-i-servizi-domiciliari-sono-a-portata-di-mano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2498-emofilia-in-veneto-solo-farmaci-low-cost-presentata-interpellanza-urgente-alla-camera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2495-emofilia-al-congresso-internazionale-di-parigi-si-parla-di-profilassi-e-infusioni-continue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2489-emofilia-bayer-avvia-uno-studio-clinico-di-fase-tre-con-un-nuovo-fattore-viii-ricombinante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2472-emofilia-al-via-il-trentesimo-congresso-internazionale-della-world-federation-of-hemophilia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2465-emofilia-presto-saranno-annunciati-i-vincitori-del-decimo-bayer-hemophilia-awards-program-bhap]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2443-emofilia-in-piemonte-i-pazienti-si-rivolgono-fuori-regione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2429-emofilia-a-la-speranza-del-futuro-e-il-trapianto-di-midollo-osseo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2380-emofilia-al-centro-lauriga-un-saggio-per-dimostrare-i-benefici-dellippoterapia-nei-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2330-emofilia-b-accordo-tra-baxter-e-chatham-per-la-terapia-con-trattamento-genetico-per-il-fattore-ix]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2319-emofilia-presentata-una-mozione-per-esportare-gli-emoderivati-nelle-aree-svantaggiate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2226-emofilia-a-anche-la-cina-approva-advate-terapia-ricombinante-di-baxter]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2178-emofilia]]></loc><lastmod>2015-05-29T08:44:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2092-factortrack-il-diario-smart-per-chi-soffre-di-emofilia-a]]></loc><lastmod>2020-06-03T18:14:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2087-emofilia-la-terapia-e-piu-facile-da-gestire-con-unapplicazione-per-il-telefonino]]></loc><lastmod>2020-06-03T18:21:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2026-emofilia-b-un-nuovo-fattore-ricombinante-per-trattamento-e-prevenzione-delle-emorragie]]></loc><lastmod>2016-03-25T11:34:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2016-emofilia-e-la-salute-del-terzo-settore-poveri-di-mezzi-ricchi-di-risorse]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2019-emofilia-accordo-interministeriale-per-lesportazione-dei-plasmaderivati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2017-emofilia-verso-laccreditamento-istituzionale-dei-centri-mec-fedemo-si-batte-per-la-definizione-dei-requisiti-minimi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/2003-giornata-mondiale-dellemofilia-qbisogna-adattare-la-cura-al-paziente-non-il-paziente-alla-curaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1948-emofilia-il-17-aprile-la-giornata-mondiale-pari-opportunita-di-accesso-ai-trattamenti-per-tutti-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1863-emofilia-lurgenza-puo-essere-affrontata-al-meglo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1864-emofilia-i-farmaci-sono-fondamentali-ma-la-crisi-rischia-di-creare-disparita-tra-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1839-emofilia-sotto-la-lente-di-buongiorno-regione-i-problemi-dei-pazienti-del-lazio]]></loc><lastmod>2015-06-03T14:54:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1838-emofilia-quattro-premi-per-i-migliori-contributi-scientifici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1804-malattie-rare-calizzani-fedemo-denuncia-qal-policlinico-umberto-i-solo-un-medico-per-1000-pazienti-emofilici-molti-vanno-fuori-regioneq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1795-emofilia-noi-mille-dimenticati-dalla-regione-lazio-fedemo-in-diretta-su-radio-popolare-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1721-emofilia-fedemo-e-associazione-emofilici-lazio-contro-la-regione-qritardi-gravi-nellaiorganizzazione-dei-centriq]]></loc><lastmod>2015-06-03T14:56:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1704-emofilia-fedemo-lancia-lallarme-la-crisi-mette-a-rischio-la-qualita-delle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1624-emofilia-a-puo-essere-controllata-con-factortrack-un-diario-infusionale-elettronico]]></loc><lastmod>2020-06-03T18:16:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1561-il-trattamento-con-ipilimumab-puo-indurre-la-malattia-il-fattore-xiii-della-coagulazione-puo-coadiuvare-la-terapia-tradizionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1563-emofilia-a-oltre-al-fattore-ottavo-anche-il-tredicesimo-fxiii-puo-aiutare-la-coagulazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1560-emoderivati-ancora-una-volta-lotti-bloccati-per-precauzione]]></loc><lastmod>2015-06-03T15:03:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1482-emofilia-su-apple-store-lapplicazione-b-nect-piattaforma-per-la-gestione-della-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1407-emofilia-ancora-30-giorni-per-usufruire-del-corso-fad]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1307-emofilia-a-trattamento-preventivo-con-feiba-in-pazienti-con-inibitore-riduce-episodi-di-sanguinamento]]></loc><lastmod>2025-10-26T11:15:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/emofilie-cosa-sono]]></loc><lastmod>2018-12-18T16:39:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1261-emofilia-basta-stare-in-disparte-nel-lazio-i-piccoli-pazienti-vanno-a-cavallo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1111-emofilia-in-piemonte-i-centri-di-riferimento-senza-personale-e-senza-locali-dedicati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1227-emofilia-pazienti-in-allarme-scelta-del-veneto-sul-lotto-unico-mette-a-rischio-accesso-a-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1151-emofilia-garnero-fedemo-in-caso-di-urgenza-servono-procedure-specifiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1105-emofilia-bayer-apre-ledizione-2011-2012-dellhemophilia-award-program]]></loc><lastmod>2020-09-25T07:46:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1088-emofilia-bayer-assegna-il-special-projects-award-al-prof-vandendriessche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1089-emofilia-molinari-gaslini-la-sfida-oggi-e-prevenire-le-complicanze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1074-emofilia-grazie-a-er-safe-factor-il-personale-di-pronto-soccorso-impara-a-gestire-correttamente-lurgenza]]></loc><lastmod>2015-06-05T17:27:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1075-emofilia-lemilia-romagna-allavanguardia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1039-emofilia-gli-specialisti-imparano-a-parlare-con-il-paziente-arriva-il-primo-corso-fad]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/1000-emofilia-prof-pemberton-i-malati-hanno-pagato-il-prezzo-piu-alto-della-ricerca-della-normalita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/993-emoderivati-dopo-analisi-su-donatore-tedesco-via-libera-a-6-dei-24-lotti-sequestrati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/979-emoderivati-pocchiari-studio-dimostra-che-ce-un-rischio-legato-alle-trasfusioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/976-emoderivati-zanetti-e-un-rischio-piu-teorico-che-reale-la-decisione-dellaifa-dimostra-che-il-sistema-funziona]]></loc><lastmod>2015-06-05T17:42:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/977-emoderivati-maggio-la-kreutzfeldt-jakob-puo-avere-unincubazione-di-molti-anni-ritiro-e-giusta-precauzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/952-emofilia-baxter-ha-presentato-a-kyoto-i-due-nuovi-farmaci-in-studio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/925-isth-2011-si-apre-sabato-a-kyoto-il-summit-degli-esperti-di-coagulopatie-e-malattie-trombotiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/885-emofilia-bimbi-e-adolescenti-in-vacanza-al-dynamo-camp-di-san-marcello-pistoiese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/860-emofilia-b-passi-avanti-per-la-terapia-grazie-al-genome-editing]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/826-emofilia-laice-con-il-supporto-di-bayer-premia-le-due-migliori-pubblicazioni-uscite-nel-2008-2010]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/683-emofilia-bayer-al-fianco-della-federazione-mondiale-per-formazione-e-cure-nei-paesi-svantaggiati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/620-emofilia-in-italia-aziende-e-associazioni-insieme-per-tanti-progetti-a-favore-dei-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/619-emofilia-assistenza-a-macchia-di-leopardo-primi-passi-verso-la-riorganizzazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/605-emofilia-dal-17-aprile-parte-il-progetto-head-us-per-la-prevenzione-dei-danni-articolari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/542-emofilia-a-nuovo-fattore-ricombinante-promette-di-ridurre-la-frequenza-delle-iniezioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/453-coagulopatie-parte-er-safe-factor-il-programma-a-vocazione-nazionale-per-il-supporto-ai-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/297-emofilia-in-calabria-uno-dei-pochi-centri-accreditati-aice]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/289-emofilia-nel-futuro-potrebbe-esserci-anche-la-terapia-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/234-emofilia-a-al-via-in-usa-e-in-germania-trial-con-fattore-8-ricombinante-derivato-da-linea-di-cellule-umane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/233-emofilia-a-bayer-promuove-un-programma-di-fitness-per-migliorare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2020-06-03T18:22:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/203-emofilia-pubblicati-i-dati-del-registro-nazionale-relativi-al-2008]]></loc><lastmod>2015-06-08T16:48:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/153-emofilia-scoperto-dei-ratti-che-sviluppano-spontaneamente-la-malattia-saranno-usati-per-studiare-nuove-terapie-geniche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emofilie/96-emofilia-a-il-programma-kogenaid-aiuta-i-malati-con-linfermiere-a-domicilio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-tessuto-limbare-corneale]]></loc><lastmod>2019-05-16T15:27:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-tessuto-limbare-corneale/10113-ustioni-della-cornea-presentata-a-rimini-la-prima-terapia-a-base-di-cellule-staminali-autologhe]]></loc><lastmod>2016-03-04T11:01:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-tessuto-limbare-corneale/8724-farmaci-orfani-quando-funziona-la-partnership-tra-pubblico-e-privato]]></loc><lastmod>2016-12-27T16:50:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-tessuto-limbare-corneale/7736-il-primo-farmaco-a-base-di-staminali-e-il-risultato-di-20-anni-di-ricerca-tutta-italiana]]></loc><lastmod>2015-08-03T09:25:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia]]></loc><lastmod>2025-02-03T10:30:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/22606-lipodistrofia-una-malattia-complicata-da-gestire-in-particolare-nelladolescenza]]></loc><lastmod>2025-12-18T19:40:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/22526-lipodistrofia-il-ruolo-della-genetica-e-essenziale-sia-per-la-diagnosi-che-per-il-follow-up]]></loc><lastmod>2025-11-18T18:05:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/22204-la-maddalena-di-donatello-aveva-la-lipodistrofia]]></loc><lastmod>2025-07-21T15:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/21847-lipodistrofie-ecco-l-instant-book-dedicato-alla-giornata-mondiale-2025]]></loc><lastmod>2025-04-03T14:38:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/21848-lipodistrofie-quando-manca-il-tessuto-adiposo]]></loc><lastmod>2025-05-19T11:06:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/21849-lipodistrofie-l-attenzione-va-posta-sin-dalla-prima-infanzia]]></loc><lastmod>2025-04-28T14:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/21851-lipodistrofie-la-diagnosi-arriva-da-un-esame-clinico-accurato-e-dalla-conoscenza-della-malattia]]></loc><lastmod>2025-04-28T14:04:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/21852-lipodistrofie-quando-la-salute-passa-anche-dalla-cucina]]></loc><lastmod>2025-04-04T14:11:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/21853-ricerca-e-attenzione-ai-pazienti-l-impegno-di-chiesi-global-rare-diseases]]></loc><lastmod>2025-04-03T07:11:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/21680-lipodistrofia-90-esperti-italiani-si-riuniscono-per-il-primo-congresso-nazionale]]></loc><lastmod>2025-01-30T19:22:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/18332-lipodistrofia-le-storie-di-due-pazienti-a-confronto]]></loc><lastmod>2022-02-23T14:44:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/18331-lipodistrofia-le-iniziative-dell-associazione-ailip]]></loc><lastmod>2022-02-23T14:45:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/17246-lipodistrofia-ailip-occorre-tutelare-tutti-i-pazienti-a-prescindere-dalla-loro-forma-di-malattia]]></loc><lastmod>2021-03-31T09:25:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/17233-giornata-mondiale-delle-lipodistrofie-le-battaglie-dell-associazione-italiana-ailip]]></loc><lastmod>2021-03-28T21:04:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/17048-lipodistrofia-la-diagnosi-e-complessa-ma-oggi-esistono-terapie-efficaci]]></loc><lastmod>2021-02-21T15:19:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/16873-encefalopatia-associata-a-lipodistrofia-la-metreleptina-puo-dare-benefici-anche-in-ambito-neurologico]]></loc><lastmod>2021-01-09T20:14:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/16328-lipodistrofia-la-terapia-con-metreleptina-ha-importanti-effetti-sul-metabolismo]]></loc><lastmod>2020-07-26T16:07:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/16097-lipodistrofia-il-farmaco-metreleptina-arriva-in-italia]]></loc><lastmod>2020-05-24T16:43:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/15864-lipodistrofia-il-31-marzo-e-la-giornata-mondiale]]></loc><lastmod>2020-03-30T13:31:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/15429-lipodistrofia-il-costante-impegno-di-ailip-al-fianco-dei-malati]]></loc><lastmod>2019-11-20T11:05:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/15416-lipodistrofia-e-importante-che-i-medici-sappiano-riconoscere-anche-le-forme-meno-gravi]]></loc><lastmod>2019-11-18T22:28:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/15395-lipodistrofia-la-forma-parziale-puo-essere-confusa-con-l-obesita]]></loc><lastmod>2020-05-22T14:48:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/15109-lipodistrofia-sperimentazione-su-volanesorsen-raggiunge-l-endpoint-primario]]></loc><lastmod>2019-08-08T16:38:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14996-lipodistrofia-a-pisa-un-laboratorio-di-analisi-all-avanguardia]]></loc><lastmod>2019-07-06T17:32:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14993-lipodistrofia-il-centro-di-pisa-inaugura-un-pdta-dedicato]]></loc><lastmod>2019-07-06T16:42:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14984-lipodistrofia-gestire-la-malattia-per-controllare-le-comorbilita]]></loc><lastmod>2019-07-05T21:18:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14928-lipodistrofia-i-pazienti-aspettano-anche-15-anni-per-la-diagnosi]]></loc><lastmod>2019-06-25T13:58:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14923-lipodistrofia-una-check-list-che-permetta-al-paziente-di-veder-riconosciuti-i-propri-diritti]]></loc><lastmod>2025-09-16T16:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14906-rendere-visibili-gli-invisibili-l-impegno-di-ailip-sulla-lipodistrofia]]></loc><lastmod>2019-06-25T14:02:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14897-lipodistrofia-il-focus-sulla-patologia-al-40-congresso-sie]]></loc><lastmod>2019-06-25T14:03:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14739-lipodistrofia-l-associazione-di-pazienti-ailip-presenta-le-sue-iniziative]]></loc><lastmod>2019-06-25T14:03:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14725-lipodistrofia-al-centro-obesita-e-lipodistrofie-di-pisa-nasce-un-pdta]]></loc><lastmod>2019-06-25T14:05:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14720-lipodistrofia-un-manifesto-in-8-punti-che-unisce-pazienti-medici-e-aziende]]></loc><lastmod>2019-06-25T14:08:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14719-lipodistrofia-a-firenze-la-nuova-sede-di-aegerion]]></loc><lastmod>2019-06-25T14:07:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14652-lipodistrofia-il-31-marzo-si-celebra-la-giornata-mondiale]]></loc><lastmod>2019-10-16T14:51:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14643-lipodistrofia-aegerion-inaugura-la-propria-sede-italiana]]></loc><lastmod>2019-10-16T14:48:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14453-lipodistrofia-al-meeting-easd-gli-esperti-illustrano-gli-ultimi-sviluppi-terapeutici]]></loc><lastmod>2019-02-13T16:49:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14402-le-lipodistrofie-a-bimbi-dei-miracoli-le-malattie-rare-spiegate-al-grande-pubblico]]></loc><lastmod>2019-01-31T08:36:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14346-lipodistrofia-prof-ssa-gambineri-la-disponibilita-della-leptina-sara-una-rivoluzione]]></loc><lastmod>2019-01-10T09:57:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14322-lipodistrofia-la-speranza-di-annalisa-si-chiama-leptina]]></loc><lastmod>2019-01-09T19:05:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14178-lipodistrofia-fare-rete-per-aiutare-meglio-i-pazienti]]></loc><lastmod>2018-11-21T17:56:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14174-lipodistrofie-il-punto-di-vista-dell-endocrinologo]]></loc><lastmod>2018-11-20T21:20:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14170-cosa-chiedono-i-pazienti-con-lipodistrofia-prima-di-tutto-una-diagnosi-tempestiva]]></loc><lastmod>2018-11-19T22:37:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/14163-lipodistrofia-la-diagnosi-precoce-come-prevenzione-del-danno]]></loc><lastmod>2018-11-18T16:54:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13987-lipodistrofie-le-problematiche-aperte-dal-punto-di-vista-degli-esperti-e-dei-pazienti]]></loc><lastmod>2018-10-03T10:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13939-lipodistrofia-la-malattia-rara-che-provoca-la-perdita-di-grasso-corporeo]]></loc><lastmod>2019-10-16T14:48:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13815-lipodistrofia-approvata-la-terapia-a-base-di-leptina-il-prof-santini-ne-spiega-il-funzionamento]]></loc><lastmod>2018-08-02T10:27:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13814-lipodistrofia-prof-wabitsch-con-la-metreleptina-ottimi-risultati]]></loc><lastmod>2018-08-02T10:27:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13809-lipodistrofia-approvato-in-europa-il-farmaco-metreleptina]]></loc><lastmod>2018-08-02T10:25:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13733-lipodistrofia-alla-perdita-di-grasso-si-associano-gravi-complicanze-metaboliche]]></loc><lastmod>2018-07-06T11:41:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13717-condividere-per-non-sentirsi-rari-lo-scopo-dell-associazione-italiana-lipodistrofie-ailip]]></loc><lastmod>2018-07-02T10:43:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13624-lipodistrofia-l-eterogeneita-complica-la-diagnosi]]></loc><lastmod>2018-06-04T19:58:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13621-parere-favorevole-del-chmp-sull-impiego-della-metreleptina-per-pazienti-con-lipodistrofia-generalizzata-e-parziale]]></loc><lastmod>2019-01-17T15:41:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13563-lipodistrofie-e-laminopatie-nasce-l-associazione-ailip]]></loc><lastmod>2018-05-19T11:44:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13562-lipodistrofia-non-esiste-un-registro-italiano-ma-si-punta-su-quello-europeo]]></loc><lastmod>2018-05-19T11:47:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/13541-endocrinologia-al-congresso-di-bari-occhi-puntati-sulla-lipodistrofia]]></loc><lastmod>2019-10-16T14:49:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/12506-lipodistrofia-i-pazienti-italiani-attendono-l-approvazione-della-leptina]]></loc><lastmod>2017-07-15T14:13:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/12434-lipodistrofia-diagnosi-piu-rapide-con-sequenziamento-next-gen]]></loc><lastmod>2017-06-24T15:41:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/12430-lipodistrofia-o-ma-r-inaugura-il-servizio-l-esperto-risponde]]></loc><lastmod>2017-06-24T09:53:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/12348-lipodistrofia-e-diabete-una-condizione-difficile-da-gestire]]></loc><lastmod>2017-06-19T14:30:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/12321-lipodistrofia-dal-gruppo-italiano-a-un-network-europeo]]></loc><lastmod>2017-06-19T14:31:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/12305-lipodistrofia-e-obesita-ecco-cosa-le-accomuna]]></loc><lastmod>2017-06-19T14:31:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/12235-lipodistrofia-tutte-le-novita-dal-piu-importante-congresso-europeo]]></loc><lastmod>2017-06-19T14:32:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/11666-con-metreleptina-notevoli-miglioramenti-nelle-malattie-secondarie-alla-lipodistrofia]]></loc><lastmod>2017-06-19T14:32:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/11655-lipodistrofia-un-solo-farmaco-disponibile-ma-non-ancora-in-europa]]></loc><lastmod>2016-11-28T16:45:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/11598-lipodistrofia-i-primi-passi-del-network-italiano]]></loc><lastmod>2016-11-14T00:14:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/11510-sindromi-lipodistrofiche-le-linee-guida-per-la-diagnosi-e-la-gestione]]></loc><lastmod>2016-10-23T11:01:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/10944-lipodistrofia-fondato-il-primo-network-italiano]]></loc><lastmod>2016-07-08T20:01:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/10941-lipodistrofia-il-trattamento-con-leptina-normalizza-il-comportamento-alimentare]]></loc><lastmod>2016-07-08T17:56:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/10915-lipodistrofia-i-primi-difficili-anni-di-alani]]></loc><lastmod>2016-07-05T13:57:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/10911-diabete-legato-a-sindromi-lipodistrofiche-un-anno-di-terapia-con-metreleptin-migliora-la-secrezione-di-insulina]]></loc><lastmod>2016-07-04T22:22:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/10907-una-nuova-sindrome-lipodistrofia-generalizzata-associata-ad-astrocitoma-pilocitico]]></loc><lastmod>2016-07-04T08:11:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/10177-lipodistrofia-generalizzata-lucia-e-dovuta-andare-negli-usa-per-sapere-che-a-pisa-potevano-curarla]]></loc><lastmod>2016-03-16T13:03:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/10176-lipodistrofia-un-solo-nome-ma-tante-manifestazioni-diverse-accomunate-dalla-perdita-di-grasso]]></loc><lastmod>2016-03-16T13:05:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/10168-lipodistrofia-congenita-generalizzata-che-cos-e]]></loc><lastmod>2018-03-22T15:14:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/9399-lipodistrofia-parziale-familiare-in-avvio-la-sperimentazione-di-fase-iii-su-volanesorsen-isis-apociiirx]]></loc><lastmod>2015-11-20T11:20:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/9127-lipodistrofia-familiare-studio-italo-canadese-individua-una-nuova-mutazione]]></loc><lastmod>2015-10-16T13:28:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/5594-lipodistrofia-approvato-metreleptin-negli-usa]]></loc><lastmod>2017-02-03T12:34:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/5192-lipodistrofia-metreleptin-raccoglie-il-parere-positivo-degli-esperti-dellfda]]></loc><lastmod>2015-05-27T09:02:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/5172-lipodistrofia-generalizzata-il-comitato-emdac-dellfda-raccomanda-lapprovazione-di-metreleptin]]></loc><lastmod>2016-03-11T09:03:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/4196-lipodistrofia-fda-concede-priority-review-per-il-farmaco-orfano-metreleptin]]></loc><lastmod>2015-05-27T09:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/4059-lipodistrofia-nuovi-dati-positivi-sulla-sperimentazione-con-metreleptin]]></loc><lastmod>2016-03-11T09:03:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lipodistrofia/2434-lipodistrofia-un-farmaco-e-in-grado-di-ridurre-i-livelli-di-glucosio-e-trigliceridi-nel-sangue]]></loc><lastmod>2015-05-27T09:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale]]></loc><lastmod>2024-03-13T12:11:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/22087-lal-d-se-la-non-conosci-non-la-riconosci-la-nuova-campagna-di-sensibilizzazione-di-aismme]]></loc><lastmod>2025-06-13T11:29:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/18473-deficit-di-lipasi-acida-lisosomiale-l-importanza-della-comunicazione-nelle-malattie-metaboliche]]></loc><lastmod>2022-03-30T15:09:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/18442-deficit-di-lipasi-acida-lisosomiale-una-diagnosi-precoce-e-la-principale-priorita]]></loc><lastmod>2022-03-21T16:41:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/13523-deficit-di-lipasi-acida-lisosomiale-ezetimibe-e-sicuro-ed-efficace]]></loc><lastmod>2018-05-05T09:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/13256-deficit-di-lipasi-acida-lisosomiale-lo-scoglio-della-diagnosi]]></loc><lastmod>2018-02-21T16:32:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/12586-deficit-di-lipasi-acida-lisosomiale-gran-parte-dei-pazienti-ha-meno-di-10-anni]]></loc><lastmod>2017-08-20T20:54:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/12459-deficit-di-lipasi-acida-lisosomiale-possibile-segnale-un-basso-colesterolo-hdl]]></loc><lastmod>2017-07-16T16:55:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/11517-deficit-di-lipasi-acida-lisosomiale-ora-c-e-una-cura-anche-per-la-forma-letale-infantile]]></loc><lastmod>2017-06-19T13:59:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/11463-deficit-di-lipasi-acida-lisosomiale-benefici-epatici-sostenuti-grazie-a-sebelipase-alfa]]></loc><lastmod>2017-06-19T14:00:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/10727-deficit-di-lipasi-acida-lisosomiale-epgonline-org-avvia-nuova-risorsa-educativa-sulla-malattia]]></loc><lastmod>2017-06-19T14:00:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/10142-deficit-di-lipasi-acida-lisosomiale-nuovi-dati-da-terapia-pediatrica-con-sebelipase-alfa]]></loc><lastmod>2017-06-19T14:01:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/9963-deficit-di-lipasi-acida-lisosomiale-positiva-la-sperimentazione-della-terapia-enizimatica-sostitutiva]]></loc><lastmod>2016-03-14T11:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/9644-il-farmaco-sebelipase-alfa-una-nuova-promettente-terapia-per-il-deficit-di-lipasi-acida-lisosomiale]]></loc><lastmod>2017-06-19T14:00:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/9595-deficit-di-lipasi-acida-lisosomiale-il-farmaco-kanuma-sebelipase-alfa-approvato-negli-usa]]></loc><lastmod>2016-03-11T14:10:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/9015-deficit-di-lipasi-acida-lisosomiale-al-via-il-programma-di-screening-promosso-da-sisa]]></loc><lastmod>2016-03-11T14:35:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/8612-deficit-di-lipasi-acida-lisosomiale-parere-positivo-dell-ema-per-l-approvazione-del-farmaco-sebelipase-alfa]]></loc><lastmod>2016-03-11T14:10:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/7461-deficit-di-lipasi-acida-lisosomiale-synageva-avvia-un-trial-per-il-farmaco-kanuma-sebelipase-alfa]]></loc><lastmod>2016-03-11T14:10:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-lipasi-acida-lisosomiale/3182-deficit-di-lipasi-acida-lisosomiale-nuove-speranze-dal-farmaco-sebelipase]]></loc><lastmod>2016-03-11T14:10:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare]]></loc><lastmod>2026-02-02T18:03:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22832-colangite-biliare-primitiva-seladelpar-ottiene-la-rimborsabilita-in-italia]]></loc><lastmod>2026-03-10T19:19:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22767-colangite-biliare-primitiva-criteri-diagnostici-chiari-ma-troppo-spesso-la-malattia-e-individuata-in-ritardo]]></loc><lastmod>2026-02-18T18:32:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22729-colangite-biliare-primitiva-chi-e-davvero-a-rischio-di-tumore-al-fegato]]></loc><lastmod>2026-02-10T15:36:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22463-colangite-biliare-primitiva-la-fotografia-dei-pazienti-italiani]]></loc><lastmod>2025-10-31T09:35:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22385-colangite-sclerosante-primitiva-completato-larruolamento-nello-studio-clinico-vistas]]></loc><lastmod>2025-10-08T10:53:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22301-colangite-biliare-primitiva-il-14-settembre-e-la-giornata-internazionale-di-sensibilizzazione]]></loc><lastmod>2025-09-13T14:49:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22300-colangite-biliare-primitiva-una-malattia-semplice-da-diagnosticare-e-con-varie-opzioni-terapeutiche-ma-ancora-poco-conosciuta]]></loc><lastmod>2025-09-13T14:50:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22299-colangite-biliare-primitiva-dopo-quasi-dieci-anni-abbiamo-a-disposizione-nuove-armi-per-combattere-la-malattia]]></loc><lastmod>2025-09-13T14:50:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22298-colangite-biliare-primitiva-servono-azioni-concrete-per-garantire-ai-pazienti-cure-adeguate]]></loc><lastmod>2025-09-13T14:50:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22216-colangite-biliare-primitiva-nasce-pbcheck-un-progetto-pensato-per-ottimizzare-il-monitoraggio-dei-pazienti]]></loc><lastmod>2025-07-28T17:54:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22158-colangite-biliare-primitiva-in-italia-colpisce-quasi-28-persone-ogni-100mila-abitanti]]></loc><lastmod>2025-07-04T12:41:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22146-sindromi-da-sovrapposizione-fra-epatite-autoimmune-e-colangite-biliare-primitiva-una-sfida-per-la-diagnosi]]></loc><lastmod>2025-06-30T13:38:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/22002-colangite-biliare-primitiva-elafibranor-rimborsabile-in-italia]]></loc><lastmod>2025-05-20T10:22:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21909-colangite-biliare-primitiva-attesa-per-l-arrivo-della-terapia-di-seconda-linea-con-elafibranor]]></loc><lastmod>2025-04-15T12:09:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21858-colangite-biliare-primitiva-e-acido-obeticolico-la-risposta-delle-associazioni-dopo-il-confronto-con-aifa]]></loc><lastmod>2025-04-04T07:51:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21859-colangite-biliare-primitiva-ancora-nessuna-soluzione-per-i-pazienti-che-utilizzavano-l-acido-obeticolico-cade-anche-l-ipotesi-di-applicare-la-legge-648-1996]]></loc><lastmod>2025-04-04T07:50:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21825-colangite-biliare-primitiva-nuove-opzioni-terapeutiche-sono-in-arrivo]]></loc><lastmod>2025-03-20T18:29:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21744-colangite-biliare-primitiva-seladelpar-approvato-in-europa]]></loc><lastmod>2025-02-21T12:02:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21599-colangite-biliare-primitiva-parere-positivo-del-chmp-su-seladelpar]]></loc><lastmod>2024-12-20T09:56:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21537-colangite-biliare-primitiva-il-tribunale-europeo-ripristina-la-decisione-della-ce-sull-acido-obeticolico]]></loc><lastmod>2024-11-29T08:46:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21517-colangite-biliare-primitiva-presentati-nuovi-dati-su-elafibranor]]></loc><lastmod>2024-11-25T16:44:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21335-colangite-biliare-primitiva-elafibranor-autorizzato-in-europa]]></loc><lastmod>2024-11-25T11:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21271-colangite-biliare-primitiva-in-ue-l-acido-obeticolico-rischia-di-non-essere-piu-disponibile]]></loc><lastmod>2024-09-10T14:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21260-colangite-biliare-primitiva-temporaneamente-sospesa-la-decisione-della-ce-sull-acido-obeticolico]]></loc><lastmod>2024-11-28T19:06:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21253-acido-obeticolico-revocata-l-autorizzazione-all-immissione-in-commercio-condizionata]]></loc><lastmod>2024-09-04T10:09:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21238-acido-obeticolico-i-ricercatori-dello-studio-cobalt-non-e-stata-data-sufficiente-importanza-alle-evidenze-del-mondo-reale]]></loc><lastmod>2024-08-22T15:11:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21234-colangite-biliare-primitiva-il-farmaco-acido-obeticolico-e-tuttora-prescrivibile-in-italia]]></loc><lastmod>2024-08-21T10:28:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21226-colangite-biliare-primitiva-il-caso-acido-obeticolico-arriva-in-parlamento]]></loc><lastmod>2024-09-12T11:45:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21223-colangite-biliare-primitiva-e-acido-obeticolico-le-raccomandazioni-dell-aifa]]></loc><lastmod>2024-08-06T16:00:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21221-acido-obeticolico-l-appello-degli-esperti-la-commissione-europea-mantenga-in-commercio-il-farmaco]]></loc><lastmod>2024-08-06T12:00:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21212-colangite-biliare-primitiva-e-acido-obeticolico-cosa-sta-accadendo-in-europa]]></loc><lastmod>2024-09-19T07:55:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21210-colangite-biliare-primitiva-e-sindrome-di-alagille-in-arrivo-due-nuove-terapie]]></loc><lastmod>2024-08-08T15:42:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21206-colangite-biliare-primitiva-la-protesta-dei-pazienti-contro-lo-stop-dell-ema]]></loc><lastmod>2024-08-10T13:36:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21169-colangite-biliare-primitiva-gli-esperti-italiani-rassicurano-sulla-sicurezza-dell-acido-obeticolico-dopo-il-parere-negativo-dell-ema]]></loc><lastmod>2024-07-14T17:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21122-malattie-epatiche-autoimmuni-positivi-i-primi-dati-di-fase-ii-su-volixibat]]></loc><lastmod>2024-06-27T10:30:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/21088-colangite-biliare-primitiva-nuovi-dati-di-fase-iii-confermano-l-efficacia-di-elafibranor]]></loc><lastmod>2024-06-17T12:08:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/20453-terapia-cellulare-con-macrofagi-una-speranza-per-i-pazienti-affetti-da-cirrosi-epatica]]></loc><lastmod>2023-12-19T10:59:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/20365-colangite-biliare-primitiva-presentati-i-risultati-dello-studio-di-fase-iii-su-elafibranor]]></loc><lastmod>2023-11-23T18:11:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/20169-colangite-biliare-primitiva-realizzato-un-volume-sulle-best-practice-italiane]]></loc><lastmod>2023-09-28T10:29:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/20104-colangite-biliare-primitiva-il-10-settembre-la-giornata-mondiale-di-sensibilizzazione]]></loc><lastmod>2023-09-09T13:43:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/19206-colangite-sclerosante-primitiva-incerta-l-efficacia-di-vidofludimus-calcio]]></loc><lastmod>2022-10-25T13:51:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/18756-colangite-biliare-primitiva-l-importanza-del-network-assistenziale-per-superare-le-disuguaglianze-nelle-cure]]></loc><lastmod>2022-06-12T10:31:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/18600-colangite-biliare-primitiva-con-l-intelligenza-artificiale-si-puo-prevedere-la-prognosi]]></loc><lastmod>2024-06-18T14:04:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/17308-colangite-biliare-primitiva-dal-cromosoma-x-nuove-indicazioni-sulla-causa-della-patologia]]></loc><lastmod>2021-04-18T13:47:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/17023-colangite-biliare-primitiva-la-stanchezza-non-sembra-essere-correlata-alla-malattia]]></loc><lastmod>2021-02-17T08:48:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/16786-malattia-da-igg4-una-patologia-infiammatoria-cronica-che-puo-colpire-tutti-gli-organi]]></loc><lastmod>2020-12-08T22:41:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/16415-colangite-biliare-primitiva-l-aggiunta-di-bezafibrato-alla-terapia-standard-aumenta-la-sopravvivenza]]></loc><lastmod>2020-09-07T16:10:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/16366-colangite-sclerosante-primitiva-una-delle-grandi-incognite-dell-epatologia]]></loc><lastmod>2020-08-10T16:18:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/16261-epatite-autoimmune-e-covid-19-ridurre-acriticamente-la-terapia-immunosoppressiva-e-un-rischio]]></loc><lastmod>2020-07-05T18:17:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/16084-colangite-biliare-primitiva-disponibile-la-consegna-a-domicilio-dell-acido-obeticolico]]></loc><lastmod>2020-05-20T00:23:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/15826-malattie-epatiche-autoimmuni-e-coronavirus-mai-modificare-la-terapia-immunosoppressiva]]></loc><lastmod>2020-03-24T12:04:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/15646-colangite-biliare-primitiva-il-farmaco-denosumab-potrebbe-portare-benefici]]></loc><lastmod>2020-02-10T21:48:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/15539-colangite-biliare-primitiva-ecco-perche-non-si-chiama-piu-cirrosi]]></loc><lastmod>2019-12-27T18:54:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/15473-colangite-biliare-primitiva-nessun-farmaco-e-efficace-per-l-osteoporosi-associata]]></loc><lastmod>2019-12-02T13:37:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/15227-colangite-biliare-primitiva-nuovi-dati-italiani-su-prevalenza-e-incidenza]]></loc><lastmod>2019-09-22T00:42:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/15216-colangite-biliare-primitiva-terapie-piu-efficaci-con-la-medicina-di-precisione]]></loc><lastmod>2019-09-21T21:49:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/15154-colangite-biliare-primitiva-pubblicate-le-nuove-linee-guida-inglesi]]></loc><lastmod>2019-09-03T15:55:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/14778-colangite-biliare-primitiva-l-acido-obeticolico-e-sicuro-ed-efficace-anche-dopo-3-anni-di-trattamento]]></loc><lastmod>2019-05-06T17:41:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/14509-colangite-biliare-primitiva-in-sperimentazione-un-farmaco-contro-il-prurito]]></loc><lastmod>2019-02-25T19:11:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/14393-malattie-rare-del-fegato-un-accordo-di-ricerca-fra-alnylam-e-camp4-therapeutics]]></loc><lastmod>2020-06-03T13:42:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/14318-malattie-epatiche-autoimmuni-al-san-gerardo-di-monza-un-ambulatorio-multispecialistico-per-bambini]]></loc><lastmod>2018-12-30T21:17:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/14284-malattie-epatiche-autoimmuni-le-rassicurazioni-di-aifa-sull-emergenza-colestiramina]]></loc><lastmod>2018-12-16T18:13:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/14186-malattie-epatiche-autoimmuni-i-pazienti-da-agosto-il-farmaco-colestiramina-e-introvabile]]></loc><lastmod>2018-11-22T10:30:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/14079-malattie-autoimmuni-del-fegato-il-filo-diretto-tra-specialisti-e-pazienti]]></loc><lastmod>2018-10-24T23:03:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/14078-malattie-autoimmuni-del-fegato-un-appello-all-unita-del-mondo-associativo]]></loc><lastmod>2018-10-24T23:02:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/13847-colangite-biliare-primitiva-un-modello-per-gestire-meglio-le-terapie]]></loc><lastmod>2018-08-16T16:25:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/13833-colangite-biliare-primitiva-con-l-acido-obeticolico-si-riduce-il-rischio-di-decesso-o-trapianto-di-fegato]]></loc><lastmod>2018-08-09T11:38:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/13483-colangite-biliare-primitiva-l-acido-obeticolico-e-in-grado-di-stabilizzare-la-fibrosi-e-la-cirrosi-nei-pazienti]]></loc><lastmod>2018-04-24T21:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/13397-colangite-biliare-primitiva-due-anni-i-tempi-medi-per-una-diagnosi-certa]]></loc><lastmod>2020-06-03T13:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/13057-ananas-liver-le-nanoparticelle-smart-vincono-l-open-accelerator]]></loc><lastmod>2017-12-22T11:58:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12783-malattie-epatiche-autoimmuni-nuovi-indicatori-per-guidare-le-decisioni-dei-clinici]]></loc><lastmod>2017-10-16T18:33:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12791-colangite-biliare-primitiva-ocaliva-acido-obeticolico-da-oggi-in-commercio-in-italia]]></loc><lastmod>2017-10-19T08:08:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12597-colangite-biliare-primitiva-aifa-rimborsa-ocaliva-acido-obeticolico-in-italia]]></loc><lastmod>2017-10-17T18:06:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12545-colangite-biliare-primitiva-significative-differenze-nei-geni-dei-pazienti-sardi]]></loc><lastmod>2021-04-19T18:16:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12423-ocaliva-acido-obeticolico-di-intercept-vince-il-premio-galeno-italia-2017-nella-categoria-farmaco-di-sintesi-chimica]]></loc><lastmod>2017-08-23T18:25:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12364-scade-il-30-giugno-il-bando-di-intercept-per-la-colangite-biliare-primitiva]]></loc><lastmod>2020-06-03T14:16:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12295-colangite-biliare-primitiva-definiti-i-criteri-per-il-controllo-della-malattia]]></loc><lastmod>2017-06-19T14:49:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12210-malattie-autoimmuni-del-fegato-nasce-l-associazione-amaf-monza-onlus]]></loc><lastmod>2017-06-19T14:50:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12211-le-nuove-sfide-per-le-malattie-autoimmuni-del-fegato-l-associazione-amaf-monza-onlus-e-la-rete-di-riferimento-europea-ern-rare-liver]]></loc><lastmod>2017-06-19T14:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12040-salute-della-donna-approvato-un-nuovo-farmaco-per-una-rara-patologia-del-fegato]]></loc><lastmod>2017-06-19T14:50:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11997-barbara-marini-intercept-malattie-autoimmuni-del-fegato-la-nostra-ricerca-e-nata-in-italia]]></loc><lastmod>2017-08-23T18:25:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/12005-congresso-aisf-tutte-le-novita-su-colangite-biliare-primitiva-ed-epatite-cronica-c]]></loc><lastmod>2021-04-19T18:17:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11979-colangite-biliare-primitiva-disponibile-la-prima-fotografia-della-popolazione-italiana]]></loc><lastmod>2017-02-24T09:32:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11884-colangite-sclerosante-primitiva-concluso-con-un-importante-scoperta-il-piu-grande-studio-di-genetica]]></loc><lastmod>2017-04-22T09:56:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11862-malattie-epatiche-autoimmuni-l-importanza-di-una-diagnosi-precoce]]></loc><lastmod>2017-01-29T18:24:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11858-colangite-biliare-primitiva-dopo-quasi-20-anni-i-pazienti-hanno-un-farmaco-a-loro-disposizione]]></loc><lastmod>2017-01-29T17:20:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11854-colangite-biliare-primitiva-quali-sono-le-cause-e-le-cure-lo-spiega-la-professoressa-floreani]]></loc><lastmod>2017-01-29T16:26:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11850-malattie-epatiche-autoimmuni-le-problematiche-ancora-aperte-in-italia]]></loc><lastmod>2017-01-30T15:05:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11730-colangite-biliare-primitiva-una-malattia-rara-ma-non-inserita-nella-lista]]></loc><lastmod>2016-12-16T18:46:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11731-colangite-biliare-primitiva-non-chiamiamola-cirrosi-colpisce-soprattutto-le-donne-e-non-e-associata-ad-alcol-o-stili-di-vita]]></loc><lastmod>2016-12-16T18:45:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11726-malattie-epatiche-autoimmuni-strazzabosco-fire-a-differenza-di-altre-malattie-del-fegato-non-sono-prevenibili]]></loc><lastmod>2017-01-26T15:04:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11725-malattie-autoimmuni-del-fegato-sono-tutte-rare-ma-solo-una-ha-il-riconoscimento-ufficiale-di-malattia-rara]]></loc><lastmod>2021-07-21T14:28:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11727-colangite-biliare-primitiva-l-agenzia-europea-per-i-medicinali-approva-l-acido-obeticolico]]></loc><lastmod>2024-08-08T10:06:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11514-colangite-biliare-primitiva-cymabay-procede-con-lo-sviluppo-clinico-della-molecola-mbx-8025]]></loc><lastmod>2016-10-23T14:54:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11462-colangite-sclerosante-primitiva-senza-nuovi-farmaci-il-40-dei-pazienti-avra-bisogno-di-un-trapianto]]></loc><lastmod>2021-04-19T18:12:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11457-intercept-pharmaceuticals-receives-positive-chmp-opinion-for-ocaliva-obeticholic-acid-for-the-treatment-of-primary-biliary-cholangitis-in-the-european-union]]></loc><lastmod>2021-04-19T18:11:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11406-malattie-epatiche-autoimmuni-epac-apre-il-servizio-gratuito-l-esperto-risponde]]></loc><lastmod>2021-04-19T18:11:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11383-malattie-autoimmuni-del-fegato-cosa-sono]]></loc><lastmod>2021-04-19T18:10:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11286-colangite-biliare-primitiva-made-in-italy-la-nuova-terapia-che-agisce-sulle-cause-della-malattia]]></loc><lastmod>2021-04-19T18:08:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/10726-colangite-biliare-primaria-fda-concede-approvazione-accelerata-per-il-farmaco-ocaliva-acido-obeticolico]]></loc><lastmod>2021-04-19T18:07:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/11290-colangite-biliare-primitiva-l-efficacia-dell-acido-obeticolico]]></loc><lastmod>2021-04-19T18:09:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/10653-colangite-sclerosante-primitiva-dall-international-liver-congress-le-principali-novita]]></loc><lastmod>2021-04-19T18:05:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/10521-steatoepatite-non-alcolica-e-colangite-sclerosante-nuovi-farmaci-in-via-di-sviluppo]]></loc><lastmod>2021-04-19T18:04:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/10405-colangite-biliare-primitiva-risultati-positivi-da-acido-obeticolico]]></loc><lastmod>2021-04-19T18:03:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/10335-colangite-biliare-primitiva-pbc-il-comitato-consultivo-della-fda-raccomanda-all-unanimita-l-approvazione-accelerata-del-farmaco-ocaliva]]></loc><lastmod>2021-04-19T18:02:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-epatiche-autoimmuni-rare/4264-colangite-sclerosante-primaria-psc-il-consumo-di-caffe-potrebbe-essere-collegato-ad-un-minor-rischio-di-contrarre-il-raro-disturbo-epatico]]></loc><lastmod>2021-04-19T18:01:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc]]></loc><lastmod>2025-03-19T09:34:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/21887-deficit-di-aadc-in-sicilia-trattata-con-la-terapia-genica-la-piu-piccola-paziente-europea]]></loc><lastmod>2025-04-08T10:49:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/21864-fenotipi-lievi-e-moderati-nel-deficit-di-aadc-da-casi-eccezionali-a-realta-clinica]]></loc><lastmod>2025-04-01T07:44:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/21770-deficit-di-aadc-terapia-genica-restituisce-speranza-a-una-piccola-paziente-siciliana]]></loc><lastmod>2025-03-03T09:59:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/21490-deficit-di-aadc-fda-approva-la-terapia-genica]]></loc><lastmod>2024-11-14T10:48:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/20418-la-terapia-genica-per-il-deficit-di-aadc-ora-disponibile-in-italia]]></loc><lastmod>2024-01-12T15:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/19954-la-storia-a-lieto-fine-di-simone-un-esempio-di-collaborazione-tra-persone-scienza-e-istituzioni]]></loc><lastmod>2023-06-27T13:18:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/19717-deficit-di-aadc-presto-simone-potra-accedere-alla-terapia-genica]]></loc><lastmod>2023-04-14T12:03:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/19608-deficit-di-aadc-i-genitori-di-simone-scrivono-alla-meloni-la-burocrazia-sta-togliendo-il-futuro-a-nostro-figlio]]></loc><lastmod>2023-04-14T22:00:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/19526-deficit-di-aadc-la-piccola-rylae-ann-e-rinata-grazie-alla-terapia-genica]]></loc><lastmod>2023-03-09T17:17:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/19005-deficit-di-aadc-la-speranza-del-piccolo-simone-e-di-poter-ricevere-al-piu-presto-la-terapia-genica]]></loc><lastmod>2022-08-30T13:15:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/18942-deficit-di-aadc-approvazione-europea-per-la-terapia-genica]]></loc><lastmod>2022-07-25T09:55:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/18688-deficit-di-aadc-il-chmp-raccomanda-l-approvazione-della-terapia-genica]]></loc><lastmod>2022-05-25T10:53:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/18096-deficit-di-aadc-benefici-prolungati-dalla-terapia-genica-ptc-aadc]]></loc><lastmod>2021-12-16T23:07:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/18051-deficit-di-aadc-l-efficacia-della-terapia-dipende-dalla-tempestivita-della-diagnosi]]></loc><lastmod>2021-11-28T00:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/17905-deficit-di-aadc-un-audioguida-per-conoscere-la-malattia-e-le-nuove-prospettive-terapeutiche]]></loc><lastmod>2021-10-19T09:13:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/17708-deficit-di-aadc-al-via-uno-studio-internazionale-sulla-patologia]]></loc><lastmod>2021-08-06T19:36:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/17569-deficit-di-aadc-perche-e-necessario-prendersi-cura-dei-caregiver]]></loc><lastmod>2021-06-22T11:12:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/17337-deficit-di-aadc-identificato-un-test-utile-per-lo-screening-neonatale]]></loc><lastmod>2021-06-22T12:13:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/17257-luca-6-mesi-e-affetto-da-deficit-di-aadc-la-pediatra-di-famiglia-riesce-a-riconoscerne-i-segni]]></loc><lastmod>2021-06-22T12:14:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/16764-deficit-di-aadc-centogene-e-ptc-collaborano-per-migliorare-la-diagnosi]]></loc><lastmod>2021-06-22T12:15:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/15367-deficit-di-aadc-risultati-positivi-per-la-terapia-genica]]></loc><lastmod>2021-06-22T10:40:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/11519-deficit-di-aadc-approvato-nuovo-studio-di-fase-iib-su-terapia-genica-sperimentale]]></loc><lastmod>2021-06-22T12:16:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/10901-deficit-di-aadc-il-nih-supportera-agilis-nello-sviluppo-di-una-terapia-genica-sperimentale]]></loc><lastmod>2021-06-22T10:42:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-aadc/10787-deficit-di-aadc-sperimentato-con-successo-un-semplice-ed-innovativo-metodo-di-screening]]></loc><lastmod>2021-06-22T10:43:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet]]></loc><lastmod>2017-10-27T10:31:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/22929-sindrome-di-dravet-passi-avanti-per-un-farmaco-sperimentale-mirato-allrna]]></loc><lastmod>2026-04-13T17:32:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/22723-epilessie-genetiche-al-buzzi-di-milano-nasce-il-centro-girasole]]></loc><lastmod>2026-02-10T15:36:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/19935-sindrome-di-dravet-oggi-la-giornata-internazionale]]></loc><lastmod>2023-06-25T15:33:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/19202-sindrome-di-dravet-fenfluramina-rimborsabile-in-italia]]></loc><lastmod>2022-10-25T13:51:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/16611-epilessia-il-ministero-della-salute-chiarisce-lo-status-del-cannabidiolo-in-italia]]></loc><lastmod>2023-08-07T16:36:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/15957-sindrome-di-dravet-un-indagine-sull-impatto-delle-restrizioni-per-covid-19]]></loc><lastmod>2020-04-16T13:46:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/15100-dravet-e-lennox-gastaut-opinione-positiva-del-chmp-per-cannabidiolo]]></loc><lastmod>2019-08-03T16:42:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/13786-sindrome-di-dravet-non-colpisce-solo-i-bambini-la-denuncia-necessaria-la-presa-in-carico-dell-adulto]]></loc><lastmod>2018-07-30T14:38:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/13785-sindrome-di-dravet-la-corretta-gestione-delle-crisi-epilettiche-nei-bambini-e-negli-adulti]]></loc><lastmod>2018-07-26T07:17:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/13784-sindrome-di-dravet-solo-nel-50-dei-cassi-di-mutazione-del-gene-scn1a-si-manifesta-la-malattia]]></loc><lastmod>2018-07-26T07:17:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/13082-sindromi-di-dravet-e-di-lennox-gastaut-richiesta-autorizzazione-europea-per-epidiolex]]></loc><lastmod>2018-05-03T10:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/12773-sindrome-di-dravet-ora-c-e-l-esenzione-per-la-rara-malattia-epilettica-e-due-farmaci-in-arrivo]]></loc><lastmod>2018-02-14T23:57:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/12130-sindrome-di-dravet-il-31-marzo-al-via-il-bando-finanziamento-progetti-2017]]></loc><lastmod>2017-10-20T08:28:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/11950-sindrome-di-dravet-arriva-un-progetto-per-favorire-l-inclusione-degli-alunni-affetti-dalla-patologia]]></loc><lastmod>2018-02-14T23:58:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/10272-sindrome-di-dravet-positivo-lo-studio-avanzato-sul-farmaco-cannabidiolo]]></loc><lastmod>2017-10-20T08:28:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/10267-sindrome-di-dravet-l-associazione-delle-famiglie-lancia-un-bando-di-ricerca-internazionale]]></loc><lastmod>2017-10-20T08:26:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/6964-sindrome-di-dravet-il-farmaco-epidiolex-di-gw-pharmaceutical-riceve-la-designazione-di-farmaco-orfano]]></loc><lastmod>2018-02-15T00:00:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/5389-mia-figlia-ha-la-sindrome-di-dravet-paure-e-speranze-la-storia-di-una-malattia-rara]]></loc><lastmod>2018-02-14T23:59:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/5083-sindrome-di-dravet-epidiolex-riceve-la-designazione-di-farmaco-orfano]]></loc><lastmod>2018-02-15T00:00:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/5041-sindrome-di-dravet-on-line-il-nuovo-sito-che-fornisce-informazioni-riguardo-il-registro-nazionale-della-malattia]]></loc><lastmod>2018-02-15T00:01:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/4902-sindrome-di-dravet-il-si-definitivo-dellema-allo-stiripentolo]]></loc><lastmod>2018-02-15T00:02:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-dravet/760-sindrome-di-dravet-ce-un-nuovo-gruppo-di-famiglie-italiane-che-si-battono-per-ricerca-e-assistenza]]></loc><lastmod>2018-02-15T00:10:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali]]></loc><lastmod>2024-03-13T12:12:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/21973-ceroidolipofuscinosi-neuronali-all-irccs-stella-maris-nasce-un-registro-dedicato]]></loc><lastmod>2025-05-09T17:50:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/21432-ceroidolipofuscinosi-concluso-il-quarto-convegno-nazionale-di-a-ncl]]></loc><lastmod>2024-10-28T17:07:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/19877-malattia-di-batten-il-9-giugno-si-celebra-la-giornata-mondiale]]></loc><lastmod>2023-06-08T18:05:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/18532-malattia-di-batten-la-storia-di-ilenia-e-devis-alla-ricerca-di-una-terapia-per-i-propri-figli]]></loc><lastmod>2023-11-20T09:11:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/18351-malattia-di-batten-14-varianti-ma-solo-per-una-di-queste-esiste-un-trattamento]]></loc><lastmod>2023-11-20T09:11:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/17454-ceroidolipofuscinosi-neuronali-il-progetto-adotta-un-batten-dog]]></loc><lastmod>2023-11-20T09:11:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/16772-ceroidolipofuscinosi-la-pandemia-di-covid-19-sta-demolendo-la-continuita-assistenziale]]></loc><lastmod>2023-11-20T09:11:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/20362-ceroidolipofuscinosi-neuronale-cln2-malattia-di-batten-disponibile-in-italia-il-farmaco-ceriliponase-alfa]]></loc><lastmod>2023-11-20T09:13:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/15560-ceroidolipofuscinosi-neuronali-la-regione-lazio-stanzia-un-fondo-di-200mila-euro]]></loc><lastmod>2020-01-09T17:37:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/15231-ceroidolipofuscinosi-parte-dalla-toscana-studio-di-fase-i-con-il-trealosio]]></loc><lastmod>2020-01-16T18:02:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/14335-malattia-cln3-iniziato-studio-clinico-sulla-terapia-genica]]></loc><lastmod>2019-01-07T21:21:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/14101-malattia-cln2-l-intervista-alla-dr-ssa-rita-faccini]]></loc><lastmod>2018-10-30T13:01:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/13933-dubbi-sulla-malattia-di-batten-su-o-ma-r-puoi-chiedere-all-esperto]]></loc><lastmod>2018-09-17T20:05:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/13866-malattia-di-batten-le-famiglie-dell-associazione-a-ncl-si-vince-insieme]]></loc><lastmod>2019-10-16T14:48:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/13851-malattia-cln3-la-patologia-e-le-speranze-di-papa-antonio]]></loc><lastmod>2018-10-15T12:14:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/13838-malattia-cln2-oggi-i-pazienti-possono-contare-sulla-terapia-enzimatica]]></loc><lastmod>2018-10-15T12:10:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/13830-malattia-di-batten-una-nuova-speranza-arriva-da-una-terapia-sperimentale-americana]]></loc><lastmod>2018-08-08T09:20:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/13640-ceroidolipofuscinosi-il-9-giugno-la-giornata-mondiale-per-la-malattia-di-batten]]></loc><lastmod>2018-06-08T22:08:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/13525-malattia-cln2-allo-studio-clinico-su-cerliponase-alfa-ha-partecipato-anche-il-bambino-gesu]]></loc><lastmod>2018-05-05T13:59:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/13500-malattia-cln2-cerliponase-alfa-riduce-il-declino-della-funzione-motoria-e-del-linguaggio]]></loc><lastmod>2018-04-28T16:00:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/12993-neurologia-pediatrica-al-congresso-di-matera-occhi-puntati-sulla-malattia-cln2]]></loc><lastmod>2018-02-14T23:53:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/12943-ceroidolipofuscinosi-neuronale-da-fondazione-ncl-un-bando-per-la-ricerca]]></loc><lastmod>2017-11-24T19:11:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/12822-ceroidolipofuscinosi-migliorano-le-cure-e-la-qualita-di-vita-dei-bambini-colpiti]]></loc><lastmod>2017-11-19T20:34:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/12821-il-cocktail-per-le-ceroidolipofuscinosi-terapia-genica-e-terapia-enzimatica-sostitutiva]]></loc><lastmod>2017-11-19T20:31:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/12807-ceroidolipofuscinosi-in-italia-la-forma-piu-frequente-e-la-cln2-che-riguarda-22-pazienti-su-100]]></loc><lastmod>2018-08-08T12:37:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/12806-malattia-cln2-risultati-positivi-dal-primo-trial-al-mondo-sulla-patologia]]></loc><lastmod>2018-02-14T23:54:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/12358-malattia-cln2-la-commissione-europea-approva-cerliponasi-alfa]]></loc><lastmod>2017-11-19T20:32:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/12232-ceroidolipofuscinosi-approvazione-dell-fda-e-parere-positivo-del-chmp-per-cerliponasi-alfa]]></loc><lastmod>2017-11-19T20:33:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/12035-malattia-di-batten-al-vaglio-una-possibile-terapia-per-ridurre-i-sintomi-e-migliorare-la-sopravvivenza]]></loc><lastmod>2017-11-19T20:37:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/11523-malattia-cln3-un-premio-per-sostenere-borse-di-studio-post-dottorato]]></loc><lastmod>2017-11-19T20:20:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/11119-malattia-cln2-fda-avvia-revisione-normativa-per-terapia-sperimentale-cerliponase-alfa]]></loc><lastmod>2017-11-19T20:37:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/10545-malattia-cln2-ema-accorda-revisione-accelerata-per-la-terapia-sperimentale-cerliponase-alfa]]></loc><lastmod>2017-11-19T20:21:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/7472-malattia-di-batten-presentati-nuovi-dati-relativi-a-cerliponase-alfa]]></loc><lastmod>2017-11-19T20:22:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/6520-malattia-di-batten-avviata-la-sperimentazione-della-terapia-enzimatica-sperimentale-al-bambino-gesu-di-roma]]></loc><lastmod>2017-11-19T20:22:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/4781-malattia-di-batten-avviata-la-sperimentazione-della-prima-terapia-di-sostituzione-enzimatica]]></loc><lastmod>2017-11-19T20:22:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/4417-malattia-di-batten-negli-usa-si-sviluppa-un-registro-dei-pazienti]]></loc><lastmod>2017-11-19T20:23:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ceroidolipofuscinosi-neuronali/3614-lipofuscinosi-ceroidi-neuronali-5-nuovi-casi-allanno]]></loc><lastmod>2017-11-19T20:23:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva]]></loc><lastmod>2025-09-25T15:59:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/22959-iperossaluria-primitiva-bambino-di-6-anni-trattato-con-successo-allospedale-di-padova]]></loc><lastmod>2026-04-22T17:42:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/22478-iperossaluria-primitiva-nasce-la-prima-associazione-italiana]]></loc><lastmod>2025-11-04T16:12:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/21468-iperossaluria-primitiva-oggi-ci-sono-terapie-efficaci-ma-la-diagnosi-dev-essere-precoce]]></loc><lastmod>2024-11-07T10:39:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/20410-iperossaluria-primitiva-di-tipo-1-i-campanelli-d-allarme-dal-punto-di-vista-del-nefrologo-e-dell-urologo]]></loc><lastmod>2024-02-28T17:53:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/20349-iperossaluria-primitiva-oggi-la-storia-naturale-della-malattia-e-cambiata-le-vicende-di-alice-e-karim]]></loc><lastmod>2023-11-15T17:50:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/19769-iperossaluria-primitiva-di-tipo-1-cosi-abbiamo-evitato-il-trapianto-di-fegato-in-un-paziente]]></loc><lastmod>2023-05-03T08:20:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/19546-iperossaluria-di-tipo-1-il-trapianto-di-rene-isolato-in-terapia-con-lumasiran-puo-essere-una-strategia-sicura]]></loc><lastmod>2023-02-21T08:28:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/19475-iperossaluria-primitiva-pubblicate-le-nuove-linee-guida-europee]]></loc><lastmod>2023-01-21T21:12:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/19405-iperossaluria-dopo-un-anno-di-trattamento-elia-cresce-forte-e-sano]]></loc><lastmod>2022-12-20T15:51:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/19302-iperossaluria-primitiva-nell-arco-di-un-secolo-grandi-progressi-nella-gestione-della-patologia]]></loc><lastmod>2022-11-20T11:39:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/19244-iperossaluria-al-bambino-gesu-la-sperimentazione-della-nuova-molecola-nedosiran]]></loc><lastmod>2022-11-17T18:46:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/19149-iperossaluria-primitiva-cosi-le-nuove-terapie-stanno-rivoluzionando-la-gestione-della-malattia]]></loc><lastmod>2022-10-06T16:14:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/18947-iperossaluria-primitiva-nonostante-i-progressi-il-ritardo-nella-diagnosi-e-ancora-troppo-elevato]]></loc><lastmod>2022-08-08T09:30:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/18575-iperossaluria-dopo-un-trapianto-di-fegato-il-piccolo-francesco-ha-dovuto-ricevere-un-rene-dal-papa]]></loc><lastmod>2022-04-24T19:20:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/18517-iperossaluria-primitiva-di-tipo-1-lumasiran-e-disponibile-in-italia]]></loc><lastmod>2022-04-05T09:03:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/18254-iperossaluria-primitiva-di-tipo-1-la-malattia-puo-manifestarsi-anche-senza-nefrolitiasi-e-nefrocalcinosi]]></loc><lastmod>2022-02-06T11:34:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/18093-iperossaluria-primitiva-di-tipo-1-gli-ultimi-aggiornamenti-su-lumasiran-dal-programma-illuminate]]></loc><lastmod>2021-12-12T18:04:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/17999-iperossaluria-necessaria-una-piu-stretta-collaborazione-fra-urologo-e-nefrologo]]></loc><lastmod>2021-11-13T20:41:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/17868-iperossaluria-primitiva-il-caso-di-giulio-due-trapianti-di-rene-e-due-recidive-di-malattia]]></loc><lastmod>2021-10-09T18:00:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/17729-iperossaluria-la-storia-dei-fratellini-achille-ed-elia]]></loc><lastmod>2021-08-29T17:56:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/17715-iperossaluria-salvato-un-bimbo-di-4-anni-con-un-rene-trapiantato-sul-pancreas]]></loc><lastmod>2021-08-12T11:53:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/17463-iperossaluria-la-storia-di-caterina-un-esempio-virtuoso-di-diagnosi-e-trattamento]]></loc><lastmod>2021-05-23T17:11:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/17352-iperossaluria-primitiva-di-tipo-1-lumasiran-riduce-l-ossalato-del-53-5-rispetto-al-placebo]]></loc><lastmod>2021-04-29T10:40:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/16733-iperossaluria-primitiva-di-tipo-1-lumasiran-approvato-in-europa]]></loc><lastmod>2020-11-24T12:16:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/16646-iperossaluria-primitiva-essenziale-lo-screening-familiare]]></loc><lastmod>2020-11-04T18:45:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/16431-iperossaluria-marco-e-i-suoi-12-anni-di-battaglia-contro-la-malattia]]></loc><lastmod>2020-09-15T13:48:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/16393-iperossaluria-primitiva-il-legame-fra-genotipo-e-fenotipo]]></loc><lastmod>2020-08-30T18:47:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/16373-iperossaluria-la-storia-di-antonino-e-del-suo-doppio-trapianto]]></loc><lastmod>2020-08-16T19:18:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/16307-iperossaluria-primitiva-per-la-diagnosi-serve-collaborazione-fra-il-nefrologo-e-l-urologo]]></loc><lastmod>2020-07-20T09:33:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/15531-iperossaluria-di-tipo-1-raggiunti-tutti-gli-endpoint-nello-studio-di-fase-iii-su-lumasiran]]></loc><lastmod>2019-12-22T15:08:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/15251-iperossaluria-primitiva-di-tipo-1-grave-coinvolgimento-oculare-nella-forma-infantile]]></loc><lastmod>2019-10-01T17:31:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/15121-iperossaluria-secondaria-riduzione-dell-ossalato-con-il-farmaco-sperimentale-alln-177]]></loc><lastmod>2019-08-18T16:51:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/14990-iperossaluria-primitiva-di-tipo-1-quattro-trial-per-valutare-il-farmaco-lumasiran]]></loc><lastmod>2019-07-09T18:06:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/14946-iperossaluria-primitiva-di-tipo-1-al-via-lo-studio-di-fase-iii-su-lumasiran]]></loc><lastmod>2019-06-26T08:57:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/14740-iperossaluria-primitiva-e-paraplegia-un-caso-clinico-particolare]]></loc><lastmod>2019-04-17T15:11:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/14512-iperossaluria-primitiva-possibili-i-problemi-dentali-anche-se-rarissimi]]></loc><lastmod>2019-02-26T12:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/13382-iperossaluria-primaria-di-tipo-1-valutazione-accelerata-dell-ema-per-lumasiran]]></loc><lastmod>2019-01-14T16:16:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/10273-iperossaluria-primaria-di-tipo-1-in-avvio-lo-sviluppo-clinico-del-candidato-farmaco-aln-go1]]></loc><lastmod>2019-01-14T16:17:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperossaluria-primitiva/5310-iperossaluria-primaria-avviato-uno-studio-di-conferma-sul-farmaco-oxabact-r]]></loc><lastmod>2019-01-14T16:19:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia]]></loc><lastmod>2022-10-10T15:49:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/22772-vivere-con-ladrenoleucodistrofia-moltissimi-i-bisogni-non-risposti-di-pazienti-e-famiglie]]></loc><lastmod>2026-02-20T18:30:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/22771-adrenoleucodistrofia-la-storia-di-michele-e-della-sua-famiglia]]></loc><lastmod>2026-02-20T18:30:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/22570-la-lombardia-inserisce-il-pdta-per-ladrenoleucodistrofia-nellelenco-regionale]]></loc><lastmod>2025-12-04T08:57:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/20085-adrenoleucodistrofia-attivo-all-umberto-i-un-percorso-specifico-per-la-patologia]]></loc><lastmod>2023-09-08T13:37:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/19163-adrenoleucodistrofia-cerebrale-niente-terapia-genica-in-europa]]></loc><lastmod>2022-10-10T15:42:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/17675-adrenoleucodistrofia-cerebrale-approvazione-ce-per-elivaldogene-autotemcel]]></loc><lastmod>2021-07-22T18:14:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/17228-adrenoleucodistrofia-cerebrale-nuovi-dati-sulla-terapia-genica-mostrano-una-stabilizzazione-della-malattia]]></loc><lastmod>2021-03-28T19:15:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/16693-adrenoleucodistrofia-la-terapia-di-supporto-dietetico-e-un-ausilio-fondamentale]]></loc><lastmod>2020-11-15T19:32:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/16534-adrenoleucodistrofia-cerebrale-ema-accetta-la-domanda-di-approvazione-di-eli-cel]]></loc><lastmod>2020-10-06T11:10:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/16392-adrenoleucodistrofia-cerebrale-presentati-gli-ultimi-dati-clinici-della-terapia-genica-eli-cel]]></loc><lastmod>2020-08-30T16:22:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/16378-leucodistrofie-a-milano-nasce-il-nuovo-centro-pediatrico-coala]]></loc><lastmod>2020-08-23T16:58:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/15638-adrenoleucodistrofia-presto-un-progetto-pilota-di-screening-intervenire-e-possibile]]></loc><lastmod>2020-02-07T08:43:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/15607-adrenoleucodistrofia-il-momento-piu-delicato-e-la-comunicazione-della-diagnosi]]></loc><lastmod>2020-01-26T19:11:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/15341-adrenoleucodistrofia-il-punto-della-situazione-su-diagnosi-e-terapie]]></loc><lastmod>2019-10-23T20:43:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/15300-adrenoleucodistrofia-nuove-raccomandazioni-per-evitare-una-crisi-surrenalica]]></loc><lastmod>2019-10-13T17:19:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/15273-adrenoleucodistrofia-lo-screening-neonatale-si-conferma-uno-strumento-efficace]]></loc><lastmod>2019-10-06T21:19:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/15213-adrenoleucodistrofia-cerebrale-dati-di-follow-up-positivi-per-la-terapia-genica]]></loc><lastmod>2019-09-21T21:05:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/15091-adrenoleucodistrofia-un-interrogazione-per-avviarne-lo-screening-neonatale]]></loc><lastmod>2019-07-31T20:21:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/14399-adrenoleucodistrofia-legata-all-x-lo-screening-neonatale-si-puo-fare-e-conviene]]></loc><lastmod>2019-05-21T17:42:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/13909-adrenoleucodistrofia-cerebrale-al-simposio-ssiem-nuovi-dati-sulla-terapia-genica]]></loc><lastmod>2019-05-21T17:44:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/13586-adrenoleucodistrofia-cerebrale-designazione-di-breakthrough-therapy-per-lenti-d]]></loc><lastmod>2019-05-16T15:55:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/13435-adrenoleucodistrofia-funzionalita-neurologica-stabile-grazie-alla-terapia-genica-lenti-d]]></loc><lastmod>2019-05-21T17:46:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/11740-adrenoleucodistrofia-legata-all-x-la-molecola-vk0214-e-farmaco-orfano-negli-usa]]></loc><lastmod>2019-05-21T17:47:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/11490-adrenoleucodistrofia-per-un-bimbo-americano-la-speranza-arriva-da-napoli]]></loc><lastmod>2019-05-16T15:59:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/11083-adrenoleucodistrofia-legata-all-x-positivo-lo-studio-proof-of-concept-su-candidato-farmaco-vk0241]]></loc><lastmod>2019-05-16T16:10:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/11031-adrenoleucodistrofia-legata-all-x-il-composto-min-102-entra-in-sperimentazione-clinica]]></loc><lastmod>2019-05-16T16:15:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/9288-l-eredita-dell-olio-di-lorenzo-e-la-storia-del-comitato-italiano-progetto-mielina]]></loc><lastmod>2019-05-16T16:22:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/adrenoleucodistrofia/329-adrenoleucodistrofia-la-risonanza-magnetica-e-utile-per-individuare-i-casi-atipici]]></loc><lastmod>2019-05-21T17:49:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth]]></loc><lastmod>2020-01-16T14:48:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/22351-malattia-di-charcot-marie-tooth-acmt-rete-lancia-campagna-nazionale-per-la-ricerca]]></loc><lastmod>2025-09-26T17:57:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/21399-charcot-marie-tooth-l-associazione-acmt-rete-impegnata-nella-formazione-dei-medici]]></loc><lastmod>2024-10-23T09:25:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/20992-annarita-mariniello-io-ballo-con-la-charcot-marie-tooth]]></loc><lastmod>2024-05-20T11:16:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/20231-malattia-di-charcot-marie-tooth-a-milano-una-mostra-per-conoscerla]]></loc><lastmod>2023-10-14T12:17:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/19934-malattia-di-charcot-marie-tooth-approvato-in-toscana-il-primo-pdta-italiano]]></loc><lastmod>2023-06-23T11:07:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/19847-malattia-di-charcot-marie-tooth-al-via-nuovo-bando-di-ricerca-di-acmt-rete]]></loc><lastmod>2023-06-01T09:20:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/19182-charcot-marie-tooth-ottobre-e-il-mese-dedicato-alla-patologia]]></loc><lastmod>2022-10-18T18:17:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/18902-charcot-marie-tooth-asst-di-mantova-premiata-per-un-progetto-di-riabilitazione-dei-pazienti]]></loc><lastmod>2022-07-09T20:29:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/18531-malattia-di-charcot-marie-tooth-esce-il-romanzo-la-forma-e-la-sostanza]]></loc><lastmod>2022-04-10T12:14:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/17867-malattia-di-charcot-marie-tooth-ottobre-e-il-mese-dedicato-alla-patologia]]></loc><lastmod>2021-10-09T17:50:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/17658-malattia-di-charcot-marie-tooth-numerosi-gli-approcci-terapeutici-in-via-di-studio]]></loc><lastmod>2021-07-18T18:34:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/17462-malattia-di-charcot-marie-tooth-in-toscana-nasce-una-rete-di-esperti]]></loc><lastmod>2021-05-23T16:48:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/16970-malattia-di-charcot-marie-tooth-lanciato-il-concorso-fotografico-faccia-da-cmt]]></loc><lastmod>2021-02-04T14:19:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/16548-malattia-di-charcot-marie-tooth-ottobre-e-il-mese-di-sensibilizzazione]]></loc><lastmod>2020-10-12T09:26:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/16547-malattia-di-charcot-marie-tooth-il-punto-sulla-patologia]]></loc><lastmod>2020-10-11T20:11:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/16251-charcot-marie-tooth-iniziata-la-tappa-solidale-della-genova-v-running-challenge]]></loc><lastmod>2020-07-05T16:46:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/16027-charcot-marie-tooth-un-questionario-sull-impatto-del-nuovo-coronavirus]]></loc><lastmod>2020-05-05T14:42:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/15362-charcot-marie-tooth-si-avvicina-la-richiesta-di-approvazione-del-farmaco-pxt3003]]></loc><lastmod>2020-01-15T11:17:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/15290-charcot-marie-tooth-ottobre-e-il-mese-dedicato-alla-malattia]]></loc><lastmod>2020-01-15T11:20:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/14894-malattia-di-charcot-marie-tooth-4b-uno-studio-internazionale-ne-ha-caratterizzato-le-varianti]]></loc><lastmod>2020-01-15T11:22:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/11769-charcot-marie-tooth-prof-ssa-alessandra-bolino-la-niacina-potrebbe-bloccare-la-degenerazione-nervosa]]></loc><lastmod>2020-01-15T11:55:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/11615-neuropatie-di-charcot-marie-tooth-la-speranza-arriva-da-un-farmaco-anti-colesterolo]]></loc><lastmod>2020-01-15T12:02:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/11316-charcot-marie-tooth-impegno-congiunto-per-biopontis-e-vib]]></loc><lastmod>2020-01-15T12:05:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/10393-malattia-di-charcot-marie-tooth-la-terapia-pxt-3003-in-fase-di-sperimentazione-avanzata]]></loc><lastmod>2020-01-15T12:14:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/9755-malattia-di-charcot-marie-tooth-uno-studio-a-guida-italiana-scopre-la-mutazione-causale]]></loc><lastmod>2020-01-15T12:25:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/7419-malattia-di-charcot-marie-tooth-risultati-incoraggianti-per-il-regime-di-combinazione-pxt3003]]></loc><lastmod>2020-01-15T12:29:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/4677-charcot-marie-tooth-il-ruolo-fondamentale-di-chirurgia-e-riabilitazione]]></loc><lastmod>2020-01-16T09:50:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/4675-charcot-marie-tooth-dott-stefano-ferranti-oggi-le-deformita-si-trattano-con-pratiche-minimamente-invasive]]></loc><lastmod>2020-01-16T09:58:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/4674-charcot-marie-tooth-la-patologia-altera-la-vita-in-maniera-globale]]></loc><lastmod>2020-01-16T10:05:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/4673-charcot-marie-tooth-fondamentale-la-chirurgia-ortopedica-per-prevenire-la-disabilita]]></loc><lastmod>2020-01-16T10:22:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/3649-sindrome-di-charcot-marie-tooth-primi-risultati-dallo-studio-su-ad-x71441]]></loc><lastmod>2020-01-16T10:48:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/3514-malattia-di-charcot-marie-tooth-di-tipo-1a-al-via-la-sperimentazione-di-un-nuovo-farmaco]]></loc><lastmod>2020-01-16T10:57:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-charcot-marie-tooth/1929-malattia-di-charcot-marie-tooth-a-mantova-una-borsa-di-studio-per-il-trattamento-riabilitativo]]></loc><lastmod>2020-01-16T11:16:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia]]></loc><lastmod>2021-02-10T10:53:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/22879-epilessia-oggi-si-celebra-il-purple-day]]></loc><lastmod>2026-03-26T11:10:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/22737-epilessia-ieri-la-giornata-internazionale-arte-innovazione-e-diritti-contro-stigma-e-discriminazione]]></loc><lastmod>2026-02-10T15:34:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/22697-epilessia-negli-anziani-importante-riconoscerla-e-curarla-adeguatamente]]></loc><lastmod>2026-01-30T08:29:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/22640-deestrategy-un-nuovo-modello-di-presa-in-carico-per-le-encefalopatie-dello-sviluppo-ed-epilettiche]]></loc><lastmod>2026-01-02T18:37:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/22245-epilessie-rare-e-complesse-a-roma-un-evento-sul-tema-della-transizione-dall-eta-pediatrica-a-quella-adulta]]></loc><lastmod>2025-08-12T07:47:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/22022-guida-e-uso-di-farmaci-il-ministero-chiarisce-i-casi-particolari-lice-e-fish-intervengono]]></loc><lastmod>2025-05-23T11:02:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/21886-epilessia-e-donne-dall-eta-fertile-alla-menopausa-da-lice-le-10-cose-da-sapere]]></loc><lastmod>2025-04-08T14:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/21869-epilessie-rare-e-complesse-urgente-l-approvazione-di-un-quadro-normativo-integrato]]></loc><lastmod>2025-04-02T15:08:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/21839-epilessie-rare-arriva-il-progetto-promise]]></loc><lastmod>2025-03-25T11:28:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/21784-epilessia-gelastica-la-risata-che-nasconde-una-malattia-la-cura-che-cambia-la-vita]]></loc><lastmod>2025-03-09T11:17:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/21641-epilessia-le-associazioni-dei-pazienti-serve-maggior-chiarezza-sul-nuovo-codice-stradale]]></loc><lastmod>2025-01-18T09:38:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/21601-epilessia-l-ictus-cerebrale-puo-aumentarne-il-rischio]]></loc><lastmod>2024-12-20T11:45:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/21574-attivato-il-nuovo-portale-pubblico-per-le-sperimentazioni-cliniche-nell-unione-europea-ctis]]></loc><lastmod>2024-12-12T20:56:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/21462-epilessia-identificate-nuove-varianti-rare]]></loc><lastmod>2024-11-06T10:11:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/21017-epilessia-si-attiva-la-piattaforma-digitale-per-il-teleconsulto-tra-i-centri-lice]]></loc><lastmod>2024-05-24T18:04:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20964-epilessia-le-associazioni-dei-pazienti-in-audizione-al-senato]]></loc><lastmod>2024-05-11T19:02:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20937-sardegna-adottati-i-pdta-per-epilessia-e-sclerosi-multipla]]></loc><lastmod>2024-05-06T15:23:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20767-epilessia-oltre-100-000-i-pazienti-trattati-con-cenobamato-in-tutto-il-mondo]]></loc><lastmod>2024-04-23T18:08:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20722-epilessie-rare-nel-40-dei-casi-e-accertata-l-origine-genetica]]></loc><lastmod>2024-03-06T16:08:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20692-epilessie-rare-nel-triveneto-si-rafforza-la-rete-tra-clinici-istituzioni-e-associazioni]]></loc><lastmod>2024-02-28T17:44:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20625-giornata-dell-epilessia-lanciata-la-nuova-campagna-di-sensibilizzazione-di-lice-e-fondazione-lice]]></loc><lastmod>2024-02-12T18:49:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20617-epilessia-realizzata-indagine-nazionale-sui-bisogni-reali-di-pazienti-e-caregiver]]></loc><lastmod>2024-02-13T12:26:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20468-epilessia-in-oltre-il-30-dei-casi-la-malattia-e-farmacoresistente]]></loc><lastmod>2023-12-19T18:23:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20422-epilessia-farmaco-resistente-al-gaslini-realizzato-il-primo-impianto-di-elettrodi-intracerebrali-in-un-bambino]]></loc><lastmod>2023-12-06T16:29:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20417-epilessie-rare-e-complesse-online-una-survey-per-migliorare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2024-02-13T12:28:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20366-epilessia-presentato-il-podcast-a-volte-non-abito-qui]]></loc><lastmod>2023-11-20T14:29:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20201-epilessia-brivaracetam-disponibile-in-italia-anche-per-pazienti-pediatrici]]></loc><lastmod>2023-10-08T19:00:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20191-epilessia-nelle-persone-affette-e-piu-alto-il-rischio-di-psicopatologia]]></loc><lastmod>2023-10-03T17:05:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20146-scn2a-e-scn8a-le-novita-dal-convegno-internazionale-svoltosi-in-danimarca]]></loc><lastmod>2023-09-22T13:41:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20129-epilessia-positivi-i-dati-clinici-a-lungo-termine-sul-cenobamato]]></loc><lastmod>2023-09-18T10:56:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20082-epilessia-il-corto-fuori-dall-acqua-alla-mostra-del-cinema-di-venezia]]></loc><lastmod>2023-09-04T05:55:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/20051-epilessia-al-giffoni-film-festival-il-cortometraggio-fuori-dall-acqua]]></loc><lastmod>2023-08-07T09:03:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/19992-epilessia-il-vademecum-della-lice-per-vacanze-in-sicurezza]]></loc><lastmod>2023-07-10T10:50:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/19953-epilessie-rare-lo-stato-dell-arte-e-i-nuovi-orizzonti-di-cura-in-lazio-e-campania]]></loc><lastmod>2023-06-25T21:22:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/19797-epilessia-per-la-giornata-della-famiglia-lice-accende-i-riflettori-sui-caregiver]]></loc><lastmod>2023-05-12T09:53:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/19803-epilessia-siglato-accordo-di-collaborazione-tra-angelini-pharma-e-jcr-pharmaceuticals]]></loc><lastmod>2023-05-12T15:46:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/19709-epilessia-la-storia-di-andrea-vince-il-contest-della-lice]]></loc><lastmod>2023-04-13T17:17:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/19621-epilessia-maschile-e-femminile-le-differenze-risiedono-nel-cervello]]></loc><lastmod>2023-03-14T19:23:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/19602-epilessie-rare-in-toscana-si-chiede-il-riconoscimento-della-malattia-genetica-stxbp1]]></loc><lastmod>2023-03-07T10:42:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/19530-epilessia-in-occasione-della-giornata-internazionale-al-via-un-contest-letterario-e-tante-iniziative-territoriali]]></loc><lastmod>2023-02-13T17:04:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/19265-epilessia-intelligenza-artificiale-per-segnalare-le-crisi-e-monitorare-i-pazienti]]></loc><lastmod>2022-11-11T11:34:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/19110-epilessia-piu-di-un-insegnante-su-2-non-saprebbe-come-comportarsi-di-fronte-a-una-crisi]]></loc><lastmod>2022-09-24T20:02:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18985-epilessia-presentato-il-rapporto-headway-focus-epilepsy]]></loc><lastmod>2022-08-08T15:12:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18952-epilessia-presentato-in-senato-un-decalogo-con-le-richieste-della-lice]]></loc><lastmod>2022-07-24T15:54:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18842-epilessia-farmaco-resistente-disponibile-in-italia-il-farmaco-cenobamato-come-opzione-terapeutica-per-i-pazienti-adulti]]></loc><lastmod>2022-06-27T10:32:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18797-epilessia-nasce-il-primo-registro-nazionale-delle-crisi-neonatali]]></loc><lastmod>2022-06-18T14:17:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18752-epilessia-concluso-il-45esimo-congresso-lice]]></loc><lastmod>2022-06-11T10:53:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18706-epilessia-oms-approva-il-piano-d-azione-globale-decennale]]></loc><lastmod>2022-05-30T10:01:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18317-epilessia-al-via-la-campagna-bymyepilepside]]></loc><lastmod>2022-02-21T14:55:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18289-epilessie-rare-nasce-l-associazione-scn2a-famiglie-in-rete]]></loc><lastmod>2022-06-27T10:36:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18288-epilessia-oggi-la-giornata-internazionale]]></loc><lastmod>2022-02-13T12:12:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18290-scn2a-dalla-storia-di-davide-nasce-la-prima-associazione-italiana-dedicata-alla-rara-patologia]]></loc><lastmod>2022-02-13T14:03:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18291-scn2a-un-encefalopatia-epilettica-certamente-sottodiagnosticata]]></loc><lastmod>2022-02-14T08:32:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18305-epilessia-per-la-giornata-internazionale-la-sede-di-ucb-italia-si-e-tinta-di-viola]]></loc><lastmod>2022-02-15T12:47:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18230-epilessia-la-terapia-non-e-mai-controindicata-per-il-vaccino-anti-covid]]></loc><lastmod>2022-01-30T16:43:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18139-epilessia-le-storie-di-inserimento-lavorativo-di-chi-soffre-della-patologia]]></loc><lastmod>2021-12-27T15:03:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18083-epilessia-da-lice-un-aggiornamento-sulle-modalita-di-gestione-della-carenza-di-diazepam-rettale]]></loc><lastmod>2021-12-12T15:10:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18070-epilessia-l-importanza-di-una-dieta-varia-ed-equilibrata]]></loc><lastmod>2021-12-05T21:21:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/18000-epilessie-rare-e-complesse-nasce-un-alleanza-formata-da-14-associazioni]]></loc><lastmod>2022-06-03T13:41:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17933-epilessia-importante-affidarsi-allo-specialista-nella-gestione-della-terapia]]></loc><lastmod>2021-10-23T22:22:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17797-epilessia-un-insegnante-su-tre-non-sa-come-comportarsi-in-caso-di-crisi]]></loc><lastmod>2021-09-21T21:05:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17666-epilessia-le-raccomandazioni-della-lice-per-una-vacanza-sicura]]></loc><lastmod>2021-07-18T22:11:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17664-epilessia-farmacoresistente-la-disabilita-invisibile-di-valentina-per-la-quale-nessun-luogo-e-quello-giusto]]></loc><lastmod>2021-07-18T21:54:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17534-epilessia-un-adolescente-su-4-ha-episodi-depressivi]]></loc><lastmod>2021-06-13T18:32:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17527-epilessia-carenza-e-irreperibilita-di-farmaci-per-molti-pazienti]]></loc><lastmod>2021-06-13T14:15:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17406-epilessia-oggi-diventare-mamma-non-e-rischioso]]></loc><lastmod>2021-05-09T14:56:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17355-epilessia-un-paziente-su-due-escluso-dal-mondo-del-lavoro]]></loc><lastmod>2021-04-29T18:21:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17272-epilessia-e-vaccino-anti-covid-ad-oggi-nessuna-conseguenza-emersa-per-i-pazienti]]></loc><lastmod>2021-04-08T11:38:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17244-epilessia-il-farmaco-cenobamato-approvato-dalla-commissione-europea]]></loc><lastmod>2021-03-30T20:10:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17209-epilessia-prosegue-nelle-scuole-la-campagna-educativa-digitale-di-lice]]></loc><lastmod>2021-03-21T23:45:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17222-epilessia-parlarne-al-lavoro-e-un-tabu-l-indagine-condotta-da-angelini-pharma]]></loc><lastmod>2021-03-25T14:50:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17200-malattie-neurologiche-e-disturbi-psichici-al-via-il-podcast-nodi]]></loc><lastmod>2021-03-21T19:52:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17123-l-epilessia-parla-al-femminile]]></loc><lastmod>2021-03-06T19:13:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17091-epilessia-un-sondaggio-sui-rischi-legati-alla-gravidanza]]></loc><lastmod>2021-02-28T16:26:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/17057-epilessia-laura-tassi-nuovo-presidente-della-societa-scientifica-lice]]></loc><lastmod>2021-02-24T15:09:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/16980-mutazione-del-gene-scn8a-in-italia-e-nata-l-associazione-dei-pazienti]]></loc><lastmod>2021-02-08T08:43:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/16960-epilessia-farmacoresistente-parere-positivo-dell-ema-per-cenobamato]]></loc><lastmod>2021-02-06T14:34:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/16973-epilessia-oggi-la-giornata-mondiale-2021-omar-inaugura-una-sezione-dedicata]]></loc><lastmod>2021-02-15T08:08:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/16700-epilessia-approvato-dall-oms-un-piano-d-azione-decennale-internazionale]]></loc><lastmod>2022-05-30T10:03:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/16558-epilessia-durante-la-pandemia-l-83-degli-specialisti-ricorre-alla-telemedicina]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/16177-sindrome-cdkl5-la-terapia-si-avvicina-grazie-a-scienza-e-associazioni]]></loc><lastmod>2021-02-09T20:32:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/16133-epilessia-la-terapia-aggiuntiva-con-cenobamato-migliora-il-controllo-delle-crisi]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/16113-epilessia-gli-effetti-del-lockdown-aumento-delle-crisi-disturbi-del-sonno-e-sintomi-depressivi]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/16087-epilessia-l-indagine-della-lice-sull-impatto-del-lockdown-per-covid-19]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/15774-epilessia-per-i-pazienti-nessun-rischio-maggiore-di-contrarre-il-virus-sars-cov-2]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/15549-epilessia-fotosensibile-le-10-regole-per-prevenire-le-crisi-durante-le-feste]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/15517-epilessia-al-bambino-gesu-una-nuova-tecnologia-per-studiare-la-malattia]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/15475-epilessia-la-dieta-chetogenica-riduce-le-crisi-nell-85-dei-casi]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/15455-epilessia-nuovi-dati-confermano-la-sicurezza-e-l-efficacia-di-cenobamate]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/15152-epilessia-tumorale-stilate-raccomandazioni-su-trattamento-e-presa-in-carico-del-paziente]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/14913-epilessia-presentata-la-prima-ricerca-italiana-di-medicina-narrativa-multicentrica]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/14914-epilessia-la-mappa-italiana-sull-accesso-prescrizione-e-dispensazione-dei-farmaci-antiepilettici]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/14459-epilessia-presentato-epineeds-il-primo-studio-sui-bisogni-dei-pazienti]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/14442-epilessia-oggi-la-giornata-internazionale-dedicata-alla-malattia]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/14311-epilessia-i-consigli-della-lice-per-trascorrere-serene-festivita-natalizie]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/13948-epilessia-infantile-importanti-risultati-dal-progetto-europeo-desire]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/13353-epilessia-tumorale-presentato-il-video-animato-vivere-senza-confini]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/12793-epilessia-a-fano-una-donna-rimproverata-per-via-di-una-crisi]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/12360-epilessia-fie-e-sandoz-contro-i-pregiudizi-sociali]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/11935-epilessia-la-sin-richiama-l-attenzione-sulla-gestione-del-percorso-diagnostico-terapeutico]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/11909-epilessia-oggi-la-giornata-mondiale]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/11891-epilessia-online-la-piattaforma-fieinsieme]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/11818-epilessia-ring14-international-finanzia-un-progetto-dell-istituto-negri-di-milano]]></loc><lastmod>2021-02-05T12:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/11371-epilessia-una-mappa-genetica-per-trovare-le-cause]]></loc><lastmod>2021-02-05T12:59:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/11283-29-settembre-2016-milano-convegno-fie-l-epilessia-esiste-parliamone]]></loc><lastmod>2021-02-05T12:59:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/10943-epilessia-pregabalin-rischioso-in-gravidanza-una-preoccupazione-che-dovra-essere-chiarita]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/10951-amicus-ha-acquisito-miamed-spin-off-dell-universita-di-bologna-allo-studio-terapia-per-la-sindrome-cdkl5]]></loc><lastmod>2021-02-09T20:32:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/10931-sindrome-da-carenza-di-cdkl5-amicus-therapeutics-lancia-un-nuovo-programma-preclinico]]></loc><lastmod>2021-02-09T20:32:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/10793-epilessia-effettuato-al-meyer-il-primo-intervento-con-il-nuovo-robot-stereotassico]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/10162-epilessia-nuove-evidenze-sui-rischi-del-valproato-in-gravidanza]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/10094-22-marzo-2016-roma-epilessia-insieme-si-puo]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/10034-epilessia-lo-scandalo-sul-valproato-di-sodio-causa-malformazioni-in-gravidanza]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/9812-epilessia-brivaracetam-approvato-dall-ema]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/9313-sindrome-cdkl5-alleviarne-i-sintomi-ora-potrebbe-essere-possibile]]></loc><lastmod>2021-02-09T20:32:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/9248-epilessia-da-ferrara-le-novita-su-diagnosi-e-terapia]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/9201-27-29-ottobre-2015-ferrara-la-ricerca-sull-epilessia-nell-unione-europea]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/8914-epilessia-nuove-conferme-per-perampanel]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/8588-epilessia-farmacoresistente-l-america-sceglie-siena-per-uno-studio-innovativo]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/8521-epilessia-buoni-risultati-per-trattamento-con-eslicarbazepina-acetato]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/8377-epilessia-identificate-nuove-mutazioni-genetiche-responsabili-della-patologia]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/8263-epilessia-ora-in-italia-e-in-commercio-perampanel]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/6946-epilessia-lus-fda-ha-accettato-la-revisione-supplementare-della-nda-per-il-farmaco-fycompar]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/6547-epilessia-la-ultragenyx-annuncia-licenza-di-proprieta-intellettuale-per-il-trattamento-con-triheptanoin]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/6250-epilessia-attenzione-alle-forme-rare-in-eta-pediatrica]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/5970-epilessia-il-libro-scritto-dai-pazienti-a-volte-non-abito-qui]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/5253-epilessia-nuovo-studio-dimostra-la-minor-pericolosita-di-valnoctamide-rispetto-a-valproato]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/5125-epilessia-una-nuova-terapia-non-invasiva-per-bloccare-le-crisi]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/4648-epilessia-disponibile-il-trattamento-di-emergenza-per-mucosa-orale-che-facilita-la-gestione-delle-crisi]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/4295-epilessia-in-barca-a-vela-contro-i-pregiudizi]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/4256-epilessia-focus-sul-primo-e-diary-e-sulla-terapia-chirurgica]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/4146-istituto-besta-finanziati-tre-progetti-di-ricerca-su-genetica-del-dolore-epilessia-e-tumori-cerebrali]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/3983-epilessia-il-5-maggio-la-giornata-nazionale-lice-promuove-linformazione-nelle-scuole]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/2523-atrofia-muscolare-spinale-associata-ad-epilessia-mioclonica-progressiva-scoperta-la-causa-le-mutazioni-nel-gene-asah1]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/2484-megalencefalia-epilessia-e-autismo-almeno-tre-le-mutazioni-implicate]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/2415-epilessia-100-medici-recitano-nel-film-mi-prendo-cura-di-te]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/2246-epilessia-con-crisi-miocloniche-astatiche-primi-risultati-della-terapia-con-rufinamide]]></loc><lastmod>2021-02-05T13:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/2192-epilessia-sostenere-la-ricerca-con-il-5-per-mille]]></loc><lastmod>2021-02-05T12:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/1124-sindrome-ring14-epilessia-e-prospettive-terapeutiche]]></loc><lastmod>2021-02-05T12:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/1110-encefalopatie-epilettica-infantile-parte-dal-mayer-il-lavoro-per-le-nuove-linee-guida]]></loc><lastmod>2021-02-09T20:55:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/981-sindrome-cdkl5-fondi-telethon-per-una-ricerca-delluniversita-di-siena]]></loc><lastmod>2021-02-09T20:32:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/903-autismo-ed-epilessia-dalla-stella-maris-di-calabrone-parte-studio-telethon]]></loc><lastmod>2021-02-05T12:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/874-epilessia-toscana-allavanguardia-dopo-il-meyer-anche-alle-scotte-luso-dellimpianto-di-elettrodi-per-individuare-la-zona-da-rimuovere]]></loc><lastmod>2021-02-05T12:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/624-autismo-ed-epilessia-scoperto-il-ruolo-del-gene-sinapsina-1]]></loc><lastmod>2021-02-05T12:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epilessia/526-epilessia-bimba-con-forma-farmacoresistente-operata-con-successo-al-meyer-grazie-alla-tecnica-seeg]]></loc><lastmod>2021-02-05T12:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme]]></loc><lastmod>2024-03-13T12:12:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/22626-anemia-falciforme-un-cortometraggio-per-raccontare-la-patologia-attraverso-larte]]></loc><lastmod>2025-12-23T11:55:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/21380-anemia-falciforme-a-perugia-il-primo-trattamento-con-crispr-in-tutta-europa]]></loc><lastmod>2024-10-10T18:07:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/21367-anemia-falciforme-ema-impone-uno-stop-precauzionale-sul-farmaco-voxelotor]]></loc><lastmod>2024-10-08T12:29:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/21152-anemia-falciforme-avviato-in-campania-un-progetto-di-diagnosi-precoce]]></loc><lastmod>2024-07-08T09:43:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/21097-anemia-falciforme-presentato-il-romanzo-sangue-a-falce]]></loc><lastmod>2024-06-19T11:21:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/20724-la-storia-di-clementine-l-infanzia-in-burkina-faso-la-drepanocitosi-ora-e-ricercatrice-alla-federico-ii]]></loc><lastmod>2024-03-08T15:59:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/20463-drepanocitosi-ancora-poco-nota-aghathe-devo-spiegare-la-mia-malattia-anche-ai-medici-di-pronto-soccorso]]></loc><lastmod>2023-12-19T14:50:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/20440-anemia-falciforme-negli-usa-approvate-due-terapie-geniche]]></loc><lastmod>2023-12-18T09:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/20434-drepanocitosi-la-comunita-scientifica-chiede-screening-universale-terapie-per-tutti-i-pazienti-e-sostegno-alla-ricerca]]></loc><lastmod>2023-12-13T09:12:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/20325-anemia-falciforme-tra-terapie-convenzionali-e-terapie-curative]]></loc><lastmod>2023-11-12T17:27:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/18508-anemia-falciforme-blood-artists-arriva-in-veneto]]></loc><lastmod>2023-01-26T16:07:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/18191-anemia-falciforme-disponibile-in-italia-la-prima-terapia-per-la-prevenzione-delle-crisi-vaso-occlusive]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/17714-anemia-falciforme-ripartono-gli-studi-clinici-sulla-terapia-genica-bb1111]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/17232-anemia-falciforme-occlusione-dei-vasi-sanguigni-e-dolore-per-il-39-dei-malati]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/17063-anemia-falciforme-temporanea-sospensione-degli-studi-clinici-sulla-terapia-genica]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/17046-anemia-falciforme-al-via-il-progetto-scan]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/16636-anemia-falciforme-crizanlizumab-approvato-in-europa]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/16542-anemia-falciforme-una-malattia-rara-ma-in-costante-crescita]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/16322-anemia-falciforme-parere-positivo-del-chmp-per-crizanlizumab]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/16193-anemia-falciforme-sostanziale-riduzione-di-crisi-dolorose-con-la-terapia-genica]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/15509-anemia-falciforme-dati-clinici-positivi-per-la-terapia-genica]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/14926-anemia-falciforme-ha-senso-un-programma-di-screening-neonatale-nazionale]]></loc><lastmod>2023-01-26T16:07:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/14300-anemia-falciforme-fda-accorda-revisione-accelerata-a-voxelotor]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/14036-anemia-falciforme-negli-usa-riparte-lo-sviluppo-clinico-del-farmaco-ctx001]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/13620-anemia-falciforme-fda-sospende-lo-sviluppo-clinico-di-ctx001]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/12510-anemia-falciforme-approvato-negli-usa-l-glutammina-polvere]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/11485-anemia-falciforme-risultati-deludenti-per-vepoloxamer]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/11223-drepanocitosi-nuovi-studi-possibili-all-ospedale-di-padova-grazie-al-finanziamento-di-citta-della-speranza]]></loc><lastmod>2023-01-26T16:06:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/11186-anemia-falciforme-sei-mesi-di-trattamento-con-idrossiurea-riducono-l-albuminuria]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/10280-anemia-falciforme-migliori-risultati-con-la-dose-raccomandata-di-idrossiurea]]></loc><lastmod>2023-01-26T15:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/7221-anemia-falciforme-la-terapia-con-idrossiurea-sembra-essere-sicura-ed-efficace]]></loc><lastmod>2023-01-26T16:07:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/6418-anemia-falciforme-sara-baxter-a-portare-avanti-lo-sviluppo-del-farmaco-aes-103]]></loc><lastmod>2023-01-26T16:07:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/5348-anemia-falciforme-prossimi-ad-essere-presentati-i-nuovi-dati-ottenuti-dallo-studio-clinico-della-terapia-sperimentale-con-l-glutammina]]></loc><lastmod>2023-01-26T16:07:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/anemia-falciforme/5191-anemia-falciforme-sperimentato-un-farmaco-per-il-trattamento-delle-crisi-vaso-occlusive]]></loc><lastmod>2023-01-26T16:07:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman]]></loc><lastmod>2024-06-06T14:03:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/22028-malattia-di-castleman-scoperto-il-primo-nuovo-sottotipo-dopo-45-anni]]></loc><lastmod>2025-05-29T09:24:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/21737-malattia-di-castelman-un-paziente-in-gravi-condizioni-e-oggi-in-remissione-grazie-all-ia]]></loc><lastmod>2025-03-20T23:36:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/21189-malattia-di-castleman-l-associazione-amica-per-non-sentirsi-soli]]></loc><lastmod>2024-07-22T14:23:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/21188-malattia-di-castleman-oggi-la-giornata-mondiale-patologia-quasi-sconosciuta-e-molto-sottovalutata]]></loc><lastmod>2024-07-22T14:24:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/21086-malattia-di-castleman-grazie-all-intelligenza-artificiale-potrebbero-arrivare-nuove-opzioni-terapeutiche]]></loc><lastmod>2024-06-18T14:06:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/20459-la-malattia-di-castleman-poco-conosciuta-e-non-correttamente-diagnosticata]]></loc><lastmod>2024-06-06T13:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/6305-malattia-di-castelman-lema-approva-siltuximab]]></loc><lastmod>2024-06-06T13:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/6104-malattia-di-castleman-mary-sembrava-una-bronchite-poi-la-scoperta-di-una-patologia-rara]]></loc><lastmod>2024-06-06T13:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/6006-malattia-di-castelman-dopo-il-si-dellema-callimmisione-in-ommercio-di-siltuximab-arriva-il-parere-positivo-dellfda]]></loc><lastmod>2024-06-06T13:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/5986-malattia-di-castleman-leuropa-approva-limmissione-in-commercio-del-primo-farmaco-rivolto-al-trattamento-della-patologia]]></loc><lastmod>2024-06-06T13:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/5848-malattia-di-castleman-dallema-parere-positivo-per-il-farmaco-sperimentale-siltuximab]]></loc><lastmod>2024-06-06T13:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/5183-malattia-di-castelman-conferme-per-siltuximab]]></loc><lastmod>2024-06-06T13:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/4858-malattia-di-castleman-richiesta-lapprovazione-in-europa-del-farmaco-sperimentale-siltuximab]]></loc><lastmod>2024-06-06T13:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-castleman/4580-malattia-di-castleman-nuove-speranze-dal-farmaco-siltuximab]]></loc><lastmod>2024-06-06T13:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/22008-acidosi-tubulare-renale-distale-un-menu-speciale-dedicato-ai-bambini-affetti-dalla-patologia]]></loc><lastmod>2025-05-22T17:21:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/21396-acidosi-tubulare-renale-distale-e-rene-a-spugna-midollare-due-patologie-strettamene-connesse]]></loc><lastmod>2024-10-17T10:55:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/20990-acidosi-tubulare-renale-distale-l-esperienza-delle-famiglie-una-terapia-c-e-ma-seguirla-non-e-semplice]]></loc><lastmod>2024-05-21T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/20529-acidosi-tubulare-renale-distale-con-le-nuove-terapie-e-possibile-ridurre-le-dosi-giornaliere-di-bicarbonato]]></loc><lastmod>2024-01-17T17:20:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/20011-acidosi-tubulare-renale-distale-importante-non-trascurare-i-fratelli-e-le-sorelle-dei-piccoli-pazienti]]></loc><lastmod>2023-07-20T07:58:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/19991-acidosi-tubulare-renale-distale-il-ruolo-della-diagnosi-pre-impianto-nella-prevenzione-della-malattia]]></loc><lastmod>2023-07-10T10:50:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/19970-acidosi-tubulare-renale-distale-fondamentale-sottoporre-i-piccoli-pazienti-a-screening-uditivo]]></loc><lastmod>2023-07-04T17:37:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/19946-acidosi-tubulare-renale-distale-una-dieta-equilibrata-serve-a-controllare-la-malattia]]></loc><lastmod>2023-06-25T21:18:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/19921-acidosi-tubulare-renale-distale-uno-studio-per-rendere-meno-invasivo-il-monitoraggio-dei-bicarbonati]]></loc><lastmod>2023-06-23T08:04:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/19901-acidosi-tubulare-renale-distale-creare-incontri-tra-le-famiglie-e-il-primo-passo-per-fare-rete]]></loc><lastmod>2023-06-15T18:33:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/18440-acidosi-tubulare-renale-distale-a-montecatini-terme-il-secondo-incontro-nazionale-dedicato-alla-malattia]]></loc><lastmod>2022-03-21T16:16:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/16824-acidosi-tubulare-renale-distale-parere-positivo-del-chmp-su-adv7103]]></loc><lastmod>2020-12-20T21:52:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/16284-acidosi-tubulare-renale-distale-nasce-una-casa-virtuale-per-i-pazienti]]></loc><lastmod>2020-07-14T15:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15385-acidosi-tubulare-renale-distale-condividerne-i-dati-per-migliorare-la-gestione-dei-pazienti]]></loc><lastmod>2019-11-07T17:53:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15379-acidosi-tubulare-renale-distale-la-rete-erknet-e-un-importante-risorsa-per-i-pazienti]]></loc><lastmod>2019-11-05T17:11:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15350-acidosi-tubulare-renale-distale-prioritario-definire-linee-guida-per-la-gestione-dei-pazienti]]></loc><lastmod>2019-10-30T17:24:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15318-acidosi-tubulare-renale-distale-una-patologia-che-si-manifesta-fin-dalla-nascita]]></loc><lastmod>2019-10-16T15:45:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15312-acidosi-tubulare-renale-distale-importante-comprenderne-il-quadro-genetico]]></loc><lastmod>2019-10-15T16:14:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15303-acidosi-tubulare-renale-distale-l-impatto-della-patologia-e-le-nuove-prospettive-terapeutiche]]></loc><lastmod>2019-10-13T16:56:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15291-acidosi-tubulare-renale-distale-un-evento-nato-dalla-volonta-di-due-genitori]]></loc><lastmod>2019-10-09T18:12:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15279-acidosi-tubulare-renale-distale-la-diagnosi-non-puo-non-passare-dal-test-genetico]]></loc><lastmod>2019-10-07T20:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15210-acidosi-tubulare-renale-distale-all-incontro-nazionale-le-famiglie-chiedono-nuove-terapie-che-migliorino-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2019-09-21T19:58:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15209-acidosi-tubulare-renale-distale-il-primo-incontro-nazionale-tra-medici-e-famiglie]]></loc><lastmod>2019-09-21T19:56:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15200-acidosi-tubulare-renale-distale-conoscerla-significa-diminuire-il-rischio-di-danni-a-lungo-termine]]></loc><lastmod>2019-09-18T19:49:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15194-acidosi-tubulare-renale-distale-diagnosi-e-possibilita-terapeutiche]]></loc><lastmod>2019-09-16T17:17:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15159-acidosi-tubulare-renale-distale-attenzione-al-passaggio-dall-infanzia-all-eta-adulta]]></loc><lastmod>2019-09-05T12:43:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15104-acidosi-tubulare-renale-distale-e-cistinuria-i-dati-di-prevalenza-in-usa-e-regno-unito]]></loc><lastmod>2019-08-06T22:17:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15069-l-acidosi-tubulare-renale-distale-tommaso-e-giorgia-cercano-altre-famiglie]]></loc><lastmod>2019-09-18T16:57:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/15053-acidosi-tubulare-renale-distale-al-meyer-condotto-uno-studio-su-pazienti-italiani]]></loc><lastmod>2019-07-21T18:12:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acidosi-renale-tubulare-distale/14999-acidosi-tubulare-renale-distale-per-diagnosi-precoce-servono-pediatri-e-medici-preparati]]></loc><lastmod>2019-07-24T09:52:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/21059-diagnosticare-e-trattare-l-acromegalia-con-l-intelligenza-artificiale-e-oggi-possibile]]></loc><lastmod>2024-06-18T14:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/20885-acromegalia-riconoscere-i-sintomi-non-e-complicato-fateci-caso]]></loc><lastmod>2024-04-18T17:15:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/20497-acromegalia-alto-l-impatto-sulla-salute-mentale]]></loc><lastmod>2024-01-09T11:17:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/20492-acromegalia-un-algoritmo-made-in-italy-guidera-gli-endocrinologi-alla-migliore-terapia]]></loc><lastmod>2024-01-08T12:44:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/20280-acromegalia-oggi-la-giornata-mondiale-anipi-ancora-molto-da-fare-per-una-diagnosi-precoce]]></loc><lastmod>2023-10-31T18:22:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/17659-acromegalia-al-primo-posto-tra-gli-esperti-mondiali-il-prof-andrea-giustina]]></loc><lastmod>2021-07-18T20:21:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/16976-acromegalia-fondamentale-per-i-pazienti-il-rapporto-con-il-medico-di-riferimento]]></loc><lastmod>2021-03-08T12:34:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/16956-acromegalia-l-aspetto-della-qualita-di-vita-e-centrale-nella-valutazione-del-paziente]]></loc><lastmod>2021-01-31T13:59:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/16948-acromegalia-una-patologia-rara-lenta-e-insidiosa]]></loc><lastmod>2021-01-30T23:03:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/16767-acromegalia-la-diagnosi-puo-arrivare-anche-dopo-8-anni]]></loc><lastmod>2020-12-04T14:28:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/16627-acromegalia-il-1-novembre-2020-la-giornata-mondiale]]></loc><lastmod>2020-10-29T17:56:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/15031-acromegalia-dal-congresso-cuem-buone-notizie-in-ambito-terapeutico]]></loc><lastmod>2019-07-12T19:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/12453-acromegalia-nuove-terapie-accelerano-il-ritorno-a-una-vita-normale]]></loc><lastmod>2017-07-02T17:18:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/12445-lorenzo-il-magnifico-soffriva-di-acromegalia]]></loc><lastmod>2017-06-27T13:25:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/11925-acromegalia-fino-a-domenica-uno-spot-per-farla-conoscere]]></loc><lastmod>2017-02-14T10:31:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/11823-acromegalia-un-terzo-dei-pazienti-va-incontro-a-fratture-vertebrali-si-indaga-sul-ruolo-della-vitamina-d]]></loc><lastmod>2017-01-23T10:44:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/11022-acromegalia-10-anni-di-vita-in-meno-per-i-pazienti-non-trattati]]></loc><lastmod>2016-07-26T08:18:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/10788-acromegalia-ora-si-cura-con-il-pasireotide]]></loc><lastmod>2016-06-14T08:34:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/10538-acromegalia-a-napoli-il-summit-internazionale-degli-esperti]]></loc><lastmod>2016-05-09T07:30:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/10293-acromegalia-negli-ultimi-15-anni-la-mortalita-si-e-dimezzata]]></loc><lastmod>2016-04-01T08:41:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/9966-acromegalia-le-terapie-combinate-a-base-di-analoghi-della-somatostatina-e-agonisti-della-dopamina]]></loc><lastmod>2016-02-12T15:41:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/9688-pulcinella-era-affetto-da-acromegalia-segni-e-sintomi-per-una-diagnosi-precoce]]></loc><lastmod>2015-12-28T13:08:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/9034-gigantismo-e-acromegalia-chiarito-il-ruolo-delle-microduplicazioni-in-xq26]]></loc><lastmod>2015-10-02T14:10:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/8792-acromegalia-pazienti-piu-a-rischio-di-fratture-vertebrali]]></loc><lastmod>2015-08-20T14:26:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/8597-acromegalia-il-prof-andrea-giustina-brescia-elevata-prevalenza-di-fratture-vertebrali-da-osteoporosi]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/8596-acromegalia-se-l-adenoma-supera-il-centimetro-di-diametro-l-intervento-chirurgico-ha-possibilita-di-successo-inferiori-al-50]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/8341-acromegalia-cortendo-ab-acquista-da-antisense-therapeutics-i-diritti-di-sviluppo-della-terapia-sperimentale-atl1103]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/7420-acromegalia-formulate-dalendocrine-society-linee-guida-di-pratica-clinica]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/7276-acromegalia-nuove-linee-guida-dellendocrine-society]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/6825-acromegalia-il-chmp-raccomanda-luso-di-signifor-lar]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/6202-acromegalia-presentati-i-risultati-dello-studio-paola]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/2158-acromegalia-il-trattamento-con-pasireotide-preferibile-a-quello-con-octreotide]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/811-acromegalia-la-diagnosi-anche-dopo-8-anni-e-lo-stesso-paziente-a-sottovalutare-i-sintomi]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/812-acromegalia-giustina-oggi-non-possiamo-piu-escludere-i-fattori-genetici]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/acromegalia/758-acromegalia-da-studio-francese-una-riabilitazione-per-la-cabergolina]]></loc><lastmod>2015-07-20T08:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/17679-albinismo-la-sfida-di-susana-rodriguez-alle-olimpiadi-di-tokyo]]></loc><lastmod>2021-07-25T16:26:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/8570-albinismo-oculocutaneo-di-tipo-iv-team-italiano-effettua-la-prima-caratterizzazione-molecolare]]></loc><lastmod>2015-07-09T09:06:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/7030-calendario-albinit-2015-la-vendita-supporta-la-ricerca-genetica-per-lalbinismo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/5586-albinismo-in-lombardia-esenzione-per-le-creme-solari-grazie-ad-albinit]]></loc><lastmod>2016-11-07T09:42:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/4958-albinismo-prosegue-anche-questanno-liniziativa-di-sensibilizzazione-tutti-i-colori-del-bianco]]></loc><lastmod>2019-06-19T08:13:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/2888-albinismo-vincere-i-pregiudizi-con-tutti-i-colori-del-bianco]]></loc><lastmod>2015-05-28T13:23:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/1445-albinismo-finalmente-un-film-dove-gli-albini-non-sono-i-cattivi-di-turno-white-man]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/772-albinismo-al-niguarda-di-milano-un-percorso-diagnostico-e-terapeutico-dedicato]]></loc><lastmod>2016-11-07T09:52:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/1108-albinismo-il-nitisinone-colora-peli-ed-occhi-delle-cavie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/820-albinismo-i-problemi-legati-alla-vista-sono-sottovalutati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/albinismo/710-albinismo-ce-molta-ignoranza-su-questa-condizione-lassociazioni-albinit-lavora-per-combatterla]]></loc><lastmod>2016-11-07T10:00:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/22623-alfa-mannosidosi-lipoacusia-puo-essere-un-campanello-dallarme]]></loc><lastmod>2025-12-29T10:14:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/22325-alfa-mannosidosi-servono-risposte-concrete-ai-bisogni-di-pazienti-e-famiglie]]></loc><lastmod>2025-09-21T09:23:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/21087-alfa-mannosidosi-quali-soluzioni-possono-migliorare-il-processo-diagnostico]]></loc><lastmod>2024-06-15T15:57:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/20721-la-storia-di-gabriella-la-vita-ad-ostacoli-di-una-caregiver]]></loc><lastmod>2024-03-06T16:00:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/19950-alfa-mannosidosi-il-film-rare-land-proiettato-all-epns-di-praga]]></loc><lastmod>2023-06-25T21:20:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/19568-alfa-mannosidosi-fda-approva-la-prima-terapia-enzimatica-sostitutiva]]></loc><lastmod>2023-02-24T12:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/19424-alfa-mannosidosi-la-storia-del-piccolo-alexandros-raccontata-in-un-film]]></loc><lastmod>2022-12-30T17:49:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/18945-alfa-mannosidosi-a-milano-un-convegno-di-approfondimento-sulla-patologia]]></loc><lastmod>2022-07-24T11:06:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/18215-alfa-mannosidosi-occorre-puntare-allo-screening-neonatale]]></loc><lastmod>2022-01-23T22:40:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/18174-alfa-mannosidosi-nei-pazienti-pediatrici-la-sintomatologia-e-assai-variabile]]></loc><lastmod>2022-01-15T16:13:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/18152-alfa-mannosidosi-cruciale-la-transizione-dall-eta-pediatrica-a-quella-adulta]]></loc><lastmod>2022-01-03T15:22:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/17953-alfa-mannosidosi-fondamentali-diagnosi-precoce-e-accesso-tempestivo-alle-terapie]]></loc><lastmod>2021-10-29T14:46:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/17871-alfa-mannosidosi-una-terapia-esiste-e-deve-essere-iniziata-precocemente]]></loc><lastmod>2021-10-09T18:57:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/17654-alfa-mannosidosi-grazie-alla-prontezza-del-pediatra-il-piccolo-thomas-ha-potuto-avere-una-diagnosi-precoce]]></loc><lastmod>2021-07-18T17:38:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/17641-alfa-mannosidosi-per-troppo-tempo-la-malattia-di-mio-figlio-non-e-stata-riconosciuta]]></loc><lastmod>2021-07-13T15:19:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/17556-alfa-mannosidosi-prioritario-incrementare-la-conoscenza-della-patologia-in-ambito-medico]]></loc><lastmod>2021-06-20T15:19:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/17208-alfa-mannosidosi-i-segnali-della-malattia-in-eta-pediatrica]]></loc><lastmod>2021-05-12T17:35:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/16926-alfa-mannosidosi-una-malattia-metabolica-ultra-rara-e-poco-conosciuta]]></loc><lastmod>2021-01-28T10:57:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/16698-alfa-mannosidosi-con-diagnosi-precoce-e-terapia-migliora-la-qualita-di-vita]]></loc><lastmod>2021-03-10T16:48:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/16491-alfa-mannosidosi-la-terapia-enzimatica-e-ora-rimborsabile-anche-in-italia]]></loc><lastmod>2020-10-12T17:22:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/13154-alfa-mannosidosi-ok-dell-ema-alla-terapia-enzimatica]]></loc><lastmod>2020-10-12T17:15:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/8904-alfa-mannosidosi-il-ruolo-della-mutazione-sul-gene-man2b1]]></loc><lastmod>2020-10-12T17:18:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/alfa-mannosidosi/4516-chiesi-farmaceutici-investe-sulle-malattie-rare]]></loc><lastmod>2020-10-12T17:18:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/14696-algodistrofia-lo-stato-dell-arte-su-diagnosi-e-terapia]]></loc><lastmod>2019-04-07T10:25:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/14409-algodistrofia-in-puglia-l-ossigenazione-iperbarica-e-una-prestazione-extra-lea]]></loc><lastmod>2019-02-06T18:17:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/10952-algodistrofia-e-dolore-cronico-per-migliorare-l-assistenza-necessari-pdta-e-linee-guida]]></loc><lastmod>2016-07-12T10:27:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/10813-sindrome-dolorosa-regionale-complessa-il-tipo-i-e-piu-comune-tra-le-adolescenti]]></loc><lastmod>2016-06-17T11:38:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/6958-sindrome-da-dolore-regionale-complesso-di-tipo-1-lenalidomide-non-raggiunge-lendpoint-primario-nello-studio-di-fase-ii]]></loc><lastmod>2019-06-18T17:54:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/5637-algodistrofia-la-diagnosi-e-difficile-ma-esiste-una-terapia-efficace]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/4960-algodistrofia-risultati-incoraggianti-per-la-terapia-con-neridronato-da-un-nuovo-studio-italiano]]></loc><lastmod>2016-12-01T22:04:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/3816-algodistrofia-colpisce-di-piu-gli-uomini-e-solo-la-meta-riesce-tra-riabilitazioni-e-farmaci-a-tornare-al-lavoro-allorigine-del-dolore-continuo-ce-spesso-un-trauma]]></loc><lastmod>2016-12-01T22:04:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/1595-algodistofia-confermato-il-ruolo-terapeutico-della-ketamina]]></loc><lastmod>2016-12-01T22:04:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/1278-algodistrofia-questa-sconosciuta-facciamo-il-punto-con-il-dott-massimo-varenna]]></loc><lastmod>2020-09-22T10:43:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/algodistrofia/1279-algodistrofia-varenna-inutile-fare-il-blocco-del-simpatico-e-accertato-che-non-funziona]]></loc><lastmod>2020-09-22T10:41:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/22930-amiloidosi-ereditaria-da-transtiretina-nel-libro-amyci-il-racconto-di-chi-vive-la-patologia]]></loc><lastmod>2026-04-13T17:32:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/22829-amiloidosi-attr-una-biopsia-cutanea-per-studiare-la-struttura-delle-fibrille-tossiche]]></loc><lastmod>2026-03-18T17:02:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/22796-da-una-comune-infiammazione-dellocchio-alla-diagnosi-di-amiloidosi-da-transtiretina]]></loc><lastmod>2026-02-26T13:40:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/22645-prevenire-e-combattere-lageismo-sanitario-passa-dalla-formazione-e-dallinformazione]]></loc><lastmod>2026-01-07T16:14:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/22524-amiloidosi-ereditaria-da-transtiretina-attesa-la-rimborsabilita-di-eplontersen-entro-il-2026]]></loc><lastmod>2025-11-18T18:05:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/21919-amiloidosi-da-transtiretina-sempre-piu-solide-le-evidenze-sull-efficacia-di-vutrisiran]]></loc><lastmod>2025-04-19T11:02:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/21547-amiloidosi-attr-ereditaria-cosi-il-farmaco-vutrisiran-ha-migliorato-la-compliance]]></loc><lastmod>2024-12-02T16:33:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/21424-amiloidosi-abbiamo-sempre-piu-strategie-terapeutiche-ma-l-obiettivo-e-migliorare-la-diagnosi]]></loc><lastmod>2024-10-25T15:01:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/21327-amiloidosi-da-transtiretina-con-vutrisiran-il-cardiologo-potrebbe-avere-un-arma-in-piu]]></loc><lastmod>2024-09-26T18:12:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/21273-amiloidosi-attrv-patisiran-e-efficace-nei-pazienti-con-la-mutazione-piu-frequente-in-italia]]></loc><lastmod>2024-09-10T13:47:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/21204-amiloidosi-dal-congresso-isa-tutte-le-novita-sulla-ricerca]]></loc><lastmod>2024-07-29T14:17:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/21161-amiloidosi-attr-vutrisiran-riduce-la-mortalita-e-gli-eventi-cardiovascolari]]></loc><lastmod>2024-07-09T12:00:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/21079-amiloidosi-hattr-pubblicate-le-nuove-linee-guida-internazionali-per-un-approccio-olistico]]></loc><lastmod>2024-06-13T15:41:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/20954-amiloidosi-ereditaria-da-transtiretina-il-farmaco-patisiran-stabilizza-la-malattia]]></loc><lastmod>2024-05-09T13:54:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/20839-amiloidosi-aa-studio-italiano-fornisce-indicazioni-per-individuare-i-pazienti-a-maggior-rischio]]></loc><lastmod>2024-04-06T15:43:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/20710-amiloidosi-hattr-con-cardiomiopatia-positivi-i-dati-di-fase-iii-su-patisiran]]></loc><lastmod>2024-03-04T19:24:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/20633-amiloidosi-al-vi-racconto-le-mie-cure-fra-sardegna-e-lombardia]]></loc><lastmod>2024-02-15T17:22:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/20513-amiloidosi-hattr-e-manifestazioni-gastrointestinali-le-raccomandazioni-degli-esperti-italiani]]></loc><lastmod>2024-01-12T17:30:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/20228-amiloidosi-ereditaria-da-transtiretina-eplontersen-mostra-benefici-nel-trattamento-della-polineuropatia]]></loc><lastmod>2023-10-14T11:43:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/20210-amiloidosi-ereditaria-da-transtiretina-da-ricercatori-italiani-due-approcci-per-migliorare-la-diagnosi]]></loc><lastmod>2023-10-12T14:12:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/20120-amiloidosi-hattr-via-libera-in-italia-per-il-farmaco-vutrisiran]]></loc><lastmod>2023-09-15T10:48:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/20083-amiloidosi-da-transtiretina-in-piu-del-20-dei-pazienti-anziani-con-cardiomiopatia-la-malattia-e-ereditaria]]></loc><lastmod>2023-09-04T06:09:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/19551-amiloidosi-al-tutte-le-sperimentazioni-in-corso]]></loc><lastmod>2023-02-28T17:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/19536-amiloidosi-al-daratumumab-rimborsabile-in-italia]]></loc><lastmod>2023-02-17T10:59:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/19523-amiloidosi-al-le-stime-parlano-di-circa-600-nuovi-pazienti-ogni-anno]]></loc><lastmod>2023-02-10T12:11:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/19491-screen-care-concluso-il-progetto-per-la-diagnosi-precoce-dell-amiloidosi-hattr]]></loc><lastmod>2023-02-01T11:05:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/19360-amiloidosi-al-precisione-e-rapidita-nella-diagnosi-sono-determinanti-per-l-esito-del-trattamento]]></loc><lastmod>2023-01-02T17:59:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/19228-amiloidosi-attr-con-cardiomiopatia-patisiran-puo-diventare-una-nuova-opzione-terapeutica]]></loc><lastmod>2022-10-30T11:44:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/19137-amiloidosi-in-piemonte-procede-lo-screening-per-le-persone-a-rischio]]></loc><lastmod>2022-10-03T19:53:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/19015-amiloidosi-hattr-a-fenotipo-misto-le-raccomandazioni-degli-esperti-italiani]]></loc><lastmod>2022-09-02T12:19:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/18903-amiloidosi-amytour-giunge-alla-sesta-edizione-e-fa-tappa-ad-alessandria]]></loc><lastmod>2022-07-09T20:53:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/18705-amiloidosi-hattr-positivi-i-dati-a-18-mesi-del-farmaco-sottocute-vutrisiran]]></loc><lastmod>2022-05-29T23:09:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/18556-amiloidosi-hattr-il-trattamento-con-patisiran-e-efficace-anche-dopo-il-trapianto-di-fegato]]></loc><lastmod>2022-04-15T22:02:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/18080-amiloidosi-pubblicato-il-quaderno-amytour]]></loc><lastmod>2021-12-10T10:56:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/18071-amiloidosi-hattr-la-manifestazione-gastrointestinale-piu-frequente-e-la-perdita-di-peso]]></loc><lastmod>2023-01-09T09:24:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/17972-amiloidosi-enormi-i-progressi-compiuti-grazie-alla-proteomica]]></loc><lastmod>2021-11-06T23:30:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/17939-amiloidosi-si-celebra-oggi-la-prima-giornata-mondiale-dedicata-alla-malattia]]></loc><lastmod>2021-10-25T15:28:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/17820-amiloidosi-al-una-nuova-combinazione-di-farmaci-e-efficace-in-piu-del-90-dei-casi]]></loc><lastmod>2021-09-28T13:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/17606-amiloidosi-al-prima-combinazione-di-farmaci-indicata-per-la-malattia]]></loc><lastmod>2021-07-02T13:59:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/17492-amiloidosi-parere-positivo-del-chmp-per-le-nuove-indicazioni-d-uso-di-daratumumab]]></loc><lastmod>2021-05-30T17:52:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/17468-amiloidosi-hattr-vutrisiran-raggiunge-tutti-gli-endpoint-nello-studio-helios-a]]></loc><lastmod>2021-05-24T16:38:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/17377-amiloidosi-hattr-patisiran-e-sicuro-ed-efficace-anche-dopo-6-anni-di-trattamento]]></loc><lastmod>2021-05-02T20:32:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/17188-amiloidosi-hattr-cos-e-cambiato-a-un-anno-dall-arrivo-in-italia-del-farmaco-patisiran]]></loc><lastmod>2021-03-17T15:34:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16957-amiloidosi-hattr-avviato-screening-genetico-in-due-paesi-della-sicilia]]></loc><lastmod>2025-02-07T10:08:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16904-amiloidosi-ereditaria-da-transtiretina-individuato-un-nuovo-biomarcatore]]></loc><lastmod>2021-01-19T23:58:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/17602-amiloidosi-hattr-conferme-di-efficacia-e-sicurezza-da-patisiran]]></loc><lastmod>2021-06-30T09:28:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16856-amiloidosi-attr-cardiomiopatia-e-tunnel-carpale-si-associano-in-un-paziente-su-cinque]]></loc><lastmod>2020-12-30T18:28:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16800-amiloidosi-ereditaria-da-transtiretina-il-trattamento-con-patisiran-migliora-la-qualita-di-vita]]></loc><lastmod>2021-03-12T18:22:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16626-amiloidosi-diagnosi-trattamento-e-telemedicina-nel-contesto-covid]]></loc><lastmod>2020-10-29T17:06:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16469-amiloidosi-consegnato-al-prof-merlini-il-primo-gianpaolo-merlini-award]]></loc><lastmod>2020-09-21T18:25:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16468-amiloidosi-hattr-le-nuove-opzioni-terapeutiche-e-gli-aspetti-da-chiarire]]></loc><lastmod>2020-09-25T19:41:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16347-amiloidosi-hattr-l-esperienza-siciliana-del-progetto-innovazione-inclusiva]]></loc><lastmod>2020-08-02T12:59:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16159-amiloidosi-ereditaria-da-transtiretina-nuovi-risultati-a-lungo-termine-su-patisiran]]></loc><lastmod>2020-06-10T09:16:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16144-amiloidosi-hattr-il-farmaco-inotersen-disponibile-in-italia]]></loc><lastmod>2020-06-08T09:21:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16123-amiloidosi-hattr-pubblicati-i-risultati-clinici-a-lungo-termine-di-inotersen]]></loc><lastmod>2020-06-04T08:51:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16111-amiloidosi-e-covid-19-alnylam-lancia-il-programma-amycare]]></loc><lastmod>2020-05-26T22:01:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/16057-amiloidosi-akcea-therapeutics-lancia-l-iniziativa-io-resto-a-casa]]></loc><lastmod>2020-05-11T17:45:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/15722-amiloidosi-da-transtiretina-il-presente-e-il-futuro-del-trattamento-con-patisiran]]></loc><lastmod>2020-03-04T19:17:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/15641-amiloidosi-hattr-via-libera-di-aifa-al-nuovo-farmaco-patisiran]]></loc><lastmod>2020-02-09T22:29:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/15426-amiloidosi-e-altre-malattie-rare-i-progetti-di-ricerca-e-sviluppo-di-akcea]]></loc><lastmod>2019-11-18T21:10:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/15419-amiloidosi-hattr-l-efficacia-della-terapia-con-oligonucleotidi-antisenso]]></loc><lastmod>2019-11-18T15:14:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/15413-amiloidosi-hattr-i-parametri-che-influenzano-la-risposta-alla-terapia]]></loc><lastmod>2019-11-16T23:33:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/15403-amiloidosi-hattr-la-diagnosi-differenziale-e-utile-per-distinguerla-dalla-cidp]]></loc><lastmod>2019-11-12T14:42:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/15402-amiloidosi-hattr-come-diagnosticarla-precocemente]]></loc><lastmod>2019-11-12T14:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/15324-amiloidosi-httr-come-distinguerla-dalle-altre-malattie-neurologiche]]></loc><lastmod>2022-11-21T17:43:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/15287-amiloidosi-alnylam-vince-il-prix-galien-italia-2019-per-il-farmaco-patisiran]]></loc><lastmod>2019-10-08T18:06:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/15112-amiloidosi-cardiaca-da-transtiretina-una-sperimentazione-in-corso-a-pavia]]></loc><lastmod>2019-11-18T15:51:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/14864-amiloidosi-necessario-migliorare-la-capacita-di-diagnosi-nei-centri-periferici]]></loc><lastmod>2019-05-29T20:52:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/14827-amiloidosi-al-l-impatto-dei-problemi-renali-sugli-esiti-del-trapianto-di-staminali]]></loc><lastmod>2019-05-19T18:07:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/14794-polineuropatia-amiloide-da-transtiretina-l-italia-quarta-al-mondo-per-la-frequenza]]></loc><lastmod>2019-05-12T20:11:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/14206-amiloidosi-attr-da-intellia-studi-preclinici-sull-uso-di-crispr-cas9]]></loc><lastmod>2018-11-26T21:32:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13872-amiloidosi-hattr-anche-per-i-pazienti-europei-arriva-la-terapia-rnai]]></loc><lastmod>2018-08-30T18:14:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13841-amiloidosi-hattr-patisiran-e-la-prima-terapia-rnai-approvata-al-mondo]]></loc><lastmod>2019-01-17T15:33:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13799-amiloidosi-hattr-alnylam-presenta-nuove-analisi-sul-farmaco-patisiran]]></loc><lastmod>2018-07-30T16:17:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13800-amiloidosi-hattr-parere-positivo-dal-chmp-europeo-per-patisiran]]></loc><lastmod>2018-07-30T17:01:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13765-amiloidosi-hattr-la-commissione-europea-approva-il-farmaco-inotersen]]></loc><lastmod>2019-01-17T15:40:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13751-amiloidosi-hattr-nuovi-dati-positivi-per-la-terapia-rnai-patisiran]]></loc><lastmod>2018-07-12T15:08:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13627-amiloidosi-attr-ereditaria-inotersen-riceve-il-via-libera-dell-ema]]></loc><lastmod>2018-06-06T12:31:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13503-amiloidosi-nuovi-dati-positivi-sul-farmaco-patisiran]]></loc><lastmod>2018-05-02T10:40:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13193-amiloidosi-hattr-fda-avvia-la-revisione-normativa-di-patisiran]]></loc><lastmod>2018-02-06T00:14:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13151-amiloidosi-hattr-patisiran-in-revisone-per-l-approvazione-europea]]></loc><lastmod>2018-01-27T13:59:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13063-amiloidosi-i-farmaci-attualmente-in-sperimentazione]]></loc><lastmod>2017-12-23T12:51:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/13049-amiloidosi-hattr-presentata-la-maa-per-il-farmaco-patisiran]]></loc><lastmod>2017-12-19T10:06:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12917-amiloidosi-hattr-le-ultime-tappe-del-farmaco-patisiran-verso-la-commercializzazione]]></loc><lastmod>2017-11-19T14:33:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12918-amiloidosi-attr-primo-appuntamento-europeo-per-medici-e-pazienti]]></loc><lastmod>2017-11-19T20:15:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12858-amiloidosi-hattr-soddisfatti-tutti-gli-endpoint-nello-studio-di-fase-iii-su-patisiran]]></loc><lastmod>2017-11-05T21:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12719-polineuropatia-amiloide-familiare-catepsina-e-ctse-possibile-marcatore-di-malattia]]></loc><lastmod>2017-10-01T18:54:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12686-amiloidosi-hattr-la-terapia-rnai-rallenta-la-progressione-di-malattia]]></loc><lastmod>2017-09-24T17:37:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12520-amiloidosi-e-ipoacusia-le-orecchie-rivelano-cio-che-si-nasconde-nel-cuore]]></loc><lastmod>2017-07-20T15:08:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12261-amiloidosi-i-pazienti-hanno-necessita-di-un-supporto-psicologico-e-di-consigli-sulla-procreazione]]></loc><lastmod>2017-07-16T16:53:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12249-amiloidosi-hattr-presentati-i-risultati-a-24-mesi-da-studio-di-fase-ii-su-patisiran]]></loc><lastmod>2019-01-17T17:38:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12230-amiloidosi-il-tempo-e-vita-ma-la-diagnosi-e-difficile]]></loc><lastmod>2017-06-19T13:48:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12189-amiloidosi-genetica-in-arrivo-i-risultati-dei-trial-clinici-su-due-nuovi-farmaci]]></loc><lastmod>2017-06-19T18:03:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/12151-amiloidosi-attr-un-paziente-su-tre-ha-una-prima-diagnosi-errata]]></loc><lastmod>2017-04-04T13:33:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/11883-amiloidosi-individuato-il-punto-debole-delle-plasmacellule-killer-che-causano-la-patologia]]></loc><lastmod>2017-04-03T18:25:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/11116-amiloidosi-da-transtiretina-pubblicati-nuovi-dati-clinici-a-lungo-termine-su-vyndaqel-tafamidis]]></loc><lastmod>2017-09-30T12:48:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/11020-amiloidosi-aggiornamenti-dal-programma-di-sviluppo-clinico-del-farmaco-ionis-ttrrx]]></loc><lastmod>2017-04-03T17:42:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/10381-amiloidosi-sperimentato-un-nuovo-metodo-per-la-diagnosi-precoce]]></loc><lastmod>2017-10-01T20:13:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/9912-amiloidosi-aa-conclusa-la-sperimentazione-avanzata-sul-farmaco-kiacta-eprodisate]]></loc><lastmod>2017-04-03T17:46:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/9405-amiloidosi-ttr-mediata-risultati-positivi-dalla-sperimentazione-di-fase-ii-di-patisiran-e-revusiran]]></loc><lastmod>2017-10-01T20:02:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/8771-polineuropatia-familiare-amiloidotica-iniziato-lo-studio-di-estensione-di-fase-iii-del-farmaco-sperimentale-patisiran]]></loc><lastmod>2017-10-01T20:14:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/8387-amiloidosi-sistemiche-primi-risultati-per-il-farmaco-sperimentale-neod001]]></loc><lastmod>2017-04-03T17:50:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/7443-amiloidosi-aa-associata-a-febbre-mediterranea-familiare-risultati-positivi-per-tocilizumab]]></loc><lastmod>2017-04-03T17:53:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/7022-polineuropatia-familiare-amiloidotica-alnylam-ha-presentato-gli-ultimi-risultati-ottenuti-sul-farmaco-patisiran]]></loc><lastmod>2017-10-01T20:15:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/5450-amiloidosi-ereditaria-scoperto-un-nuovo-farmaco-per-bloccarne-la-progressione]]></loc><lastmod>2017-04-03T18:09:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/4724-amiloidosi-attr-risultati-positivi-per-uno-studio-della-alnylam-pharmaceuticals]]></loc><lastmod>2017-04-03T18:10:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/4575-amiloidosi-attr-dati-promettenti-per-nuovo-farmaco-sperimentale]]></loc><lastmod>2017-04-03T18:12:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/3909-amiloidosi-transtiretina-disponibili-le-linee-guida-per-diagnosi]]></loc><lastmod>2017-04-03T18:15:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/1502-amiloidosi-ttr-tipo-fap-buoni-i-risultati-di-fase-1-del-farmaco-antisenso-isis-ttrx]]></loc><lastmod>2018-12-13T17:21:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/1367-amiloidosi-da-transtiretina-ema-approva-il-vyndaqel-il-primo-farmaco-disponibile]]></loc><lastmod>2017-04-03T18:19:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi/938-amiloidosi-da-trastiretina-ormai-vicino-lingresso-sul-mercato-di-vyndaqel]]></loc><lastmod>2017-04-03T18:24:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22911-ageismo-sanitario-la-battaglia-in-senato-leta-non-puo-essere-un-criterio-di-cura]]></loc><lastmod>2026-04-04T09:53:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22738-addio-ad-andrea-vaccari-una-voce-fondamentale-per-le-persone-con-amiloidosi]]></loc><lastmod>2026-02-10T15:33:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22594-amiloidosi-cardiaca-presto-il-primo-registro-nazionale]]></loc><lastmod>2025-12-12T12:21:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22554-amiloidosi-attr-con-cardiomiopatia-acoramidis-rimborsabile-in-italia]]></loc><lastmod>2025-11-26T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22543-quando-leta-diventa-un-ostacolo-alla-cura-il-position-paper-per-superare-lageismo-sanitario-e-garantire-diagnosi-appropriate-anche-nelle-malattie-rare-dellanziano]]></loc><lastmod>2025-11-27T10:52:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22441-malattie-rare-cardiache-merlo-sic-fondamentale-la-formazione-dei-cardiologi-e-il-lavoro-in-rete]]></loc><lastmod>2025-10-24T10:49:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22379-amiloidosi-e-malattie-rare-nellanziano-simg-impegnata-nella-formazione-dei-medici-di-medicina-generale]]></loc><lastmod>2025-10-08T10:54:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22361-amiloidosi-cardiaca-grande-successo-in-campania-per-il-progetto-di-formazione-dei-medici-di-base]]></loc><lastmod>2025-10-02T07:08:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22335-salute-cardiaca-formazione-e-informazione-sono-fondamentali]]></loc><lastmod>2025-09-23T19:45:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22269-amiloidosi-cardiaca-da-transtiretina-nuovi-dati-evidenziano-i-benefici-di-acoramidis-sulla-funzionalita-del-cuore]]></loc><lastmod>2025-09-02T21:36:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22212-amiloidosi-attr-a-baveno-un-meeting-dedicato-a-pazienti-e-medici]]></loc><lastmod>2025-07-28T10:47:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22192-amiloidosi-cardiaca-i-temi-dell-informazione-e-della-formazione-del-personale-sanitario-sono-cruciale]]></loc><lastmod>2025-07-23T17:50:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22171-amiloidosi-da-transtiretina-arriva-il-position-paper-per-pdta-personalizzati]]></loc><lastmod>2025-07-11T11:38:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22131-amiloidosi-cardiaca-da-transtiretina-approvazione-europea-per-vutrisiran]]></loc><lastmod>2025-06-25T14:46:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/22086-amiloidosi-cardiaca-quando-il-cuore-nasconde-una-malattia-rara]]></loc><lastmod>2025-06-13T08:38:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21836-amiloidosi-cardiaca-da-transtiretina-studio-guidato-dall-universita-di-trieste-apre-nuove-prospettive-di-trattamento]]></loc><lastmod>2025-03-25T14:41:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21759-amiloidosi-attr-con-cardiomiopatia-acoramidis-approvato-in-europa]]></loc><lastmod>2025-02-27T17:20:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21646-amiloidosi-cardiaca-due-importanti-scoperte-dal-san-matteo-di-pavia]]></loc><lastmod>2025-01-21T09:44:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21623-morto-a-82-anni-oliviero-toscani-era-affetto-da-amiloidosi-patologia-che-oggi-e-curabile]]></loc><lastmod>2025-01-13T11:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21608-amiloidosi-attr-con-cardiomiopatia-il-chmp-raccomanda-l-approvazione-di-acoramidis]]></loc><lastmod>2024-12-20T18:25:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21513-amiloidosi-cardiaca-pubblicato-sul-giornale-italiano-di-cardiologia-il-primo-pdta-nazionale]]></loc><lastmod>2024-11-22T08:53:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21466-amiloidosi-cardiaca-pazienti-clinici-e-istituzioni-presentano-insieme-il-position-paper-dei-bisogni-non-risposti]]></loc><lastmod>2024-11-07T08:14:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21363-amiloidosi-cardiaca-l-importanza-dell-awareness-per-una-patologia-rara-emergente]]></loc><lastmod>2024-11-13T12:25:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21316-amiloidosi-cardiaca-ecco-com-e-cambiata-la-mia-vita-con-la-malattia]]></loc><lastmod>2024-09-26T12:19:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21270-amiloidosi-cardiaca-la-testimonianza-di-anna-da-un-giorno-all-altro-sono-diventata-la-caregiver-di-mio-marito]]></loc><lastmod>2024-09-09T13:48:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21254-amiloidosi-cardiaca-da-transtiretina-nuovi-dati-positivi-sul-trattamento-con-tafamidis]]></loc><lastmod>2024-12-20T18:50:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21217-amiloidosi-cardiaca-la-storia-di-carlo-che-oggi-e-tornato-a-vivere-dopo-un-trapianto]]></loc><lastmod>2024-08-02T12:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/21193-amiloidosi-cardiaca-la-presa-in-carico-sul-piano-nutrizionale-del-paziente-anziano]]></loc><lastmod>2024-07-22T15:04:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/20500-amiloidosi-cardiaca-presentazione-della-guida-ai-diritti-esigibili-dei-pazienti]]></loc><lastmod>2024-01-10T13:42:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/20379-amiloidosi-cardiaca-ecco-la-guida-ai-diritti-esigibili-dei-pazienti]]></loc><lastmod>2024-01-10T08:03:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/20336-amiloidosi-cardiaca-omar-necessario-diffondere-cultura-del-sospetto-clinico-e-istituzionalizzare-rapporti-tra-medici-di-base-e-specialisti]]></loc><lastmod>2023-11-14T10:36:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/20157-amiloidosi-cardiaca-la-fascia-d-eta-piu-colpita-e-fra-i-74-e-i-90-anni]]></loc><lastmod>2023-09-28T17:47:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/20167-giornata-mondiale-del-cuore-mai-sottovalutare-i-primi-campanelli-di-allarme]]></loc><lastmod>2023-09-28T07:51:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/19827-amiloidosi-cardiaca-cinque-nuovi-farmaci-anti-fibrille-in-sperimentazione]]></loc><lastmod>2023-05-23T10:19:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/19467-amiloidosi-cardiaca-un-breve-documentario-spiega-cosa-significhi-vivere-con-la-patologia]]></loc><lastmod>2023-01-20T11:05:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/19124-giornata-mondiale-del-cuore-omar-presenta-l-anteprima-di-un-documentario-sull-amiloidosi-cardiaca]]></loc><lastmod>2022-09-28T17:15:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/17848-amiloidosi-cardiaca-in-5-video-le-esperienze-di-vita-dei-pazienti-e-i-bisogni-medici-insoddisfatti]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/17828-amiloidosi-cardiaca-l-informazione-e-vita]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/17781-amiloidosi-cardiaca-le-preoccupazioni-per-la-possibile-ereditarieta]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/17724-amiloidosi-cardiaca-il-cardiologo-e-essenziale-per-superare-i-momenti-difficili]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/17648-amiloidosi-cardiaca-una-malattia-che-non-si-vede-e-non-si-sente]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/17599-amiloidosi-cardiaca-una-malattia-difficile-da-comprendere-spesso-anche-per-i-medici]]></loc><lastmod>2021-11-18T23:43:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/17547-amiloidosi-cardiaca-al-via-la-campagna-social-raccontamy]]></loc><lastmod>2021-11-18T23:43:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16887-malattie-rare-una-piattaforma-al-servizio-delle-associazioni]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16874-amiloidosi-cardiaca-serve-uniformita-nazionale-su-erogazione-di-farmaci-e-prestazioni]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16871-amiloidosi-cardiaca-indispensabile-una-rete-tra-medici-centri-di-riferimento-e-pazienti]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16851-amiloidosi-cardiaca-importante-diffondere-informazioni-sulla-patologia]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16833-amiloidosi-cardiaca-fondamentale-un-percorso-diagnostico-terapeutico-ben-delineato]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16728-amiloidosi-cardiaca-la-diagnosi-precoce-e-la-sola-vera-chiave-di-successo]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16717-amiloidosi-cardiaca-il-ritardo-diagnostico-nel-racconto-di-un-paziente]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16656-amiloidosi-cardiaca-per-una-pronta-diagnosi-serve-consapevolezza-della-malattia]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16555-amiloidosi-cardiaca-il-sostegno-delle-istituzioni-al-documento-di-consenso-delle-associazioni]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16546-amiloidosi-cardiaca-l-obiettivo-e-migliorare-la-diagnosi]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16500-amiloidosi-cardiaca-presentato-un-documento-di-consenso-tra-le-associazioni]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16277-amiloidosi-cardiaca-un-esempio-di-malattia-rara-dell-adulto]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/16249-malattie-rare-nell-adulto-tra-le-priorita-una-diagnosi-precoce-e-maggiore-conoscenza]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/15675-amiloidosi-cardiaca-approvazione-europea-per-tafamidis]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/15541-cardiomiopatia-amiloide-il-chmp-raccomanda-l-approvazione-di-tafamidis]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/14826-cardiomiopatia-amiloide-da-transtiretina-fda-approva-tafamidis-e-tafamidis-meglumine]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/14122-cardiomiopatia-amiloide-risultati-positivi-dallo-studio-attr-act-su-tafamidis]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/12248-amiloidosi-il-cuore-e-l-organo-piu-colpito]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/11508-cadiomiopatia-amiloidotica-familiare-alnylam-interrompe-lo-sviluppo-del-farmaco-revusiran]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/11145-cardiomiopatia-amiloidotica-familiare-pazienti-iscritti-nello-studio-di-fase-iii-su-revusiran]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/amiloidosi-cardiaca/6811-cardiomiopatia-familiare-amiloidotica-al-via-lo-studio-discovery]]></loc><lastmod>2021-11-18T23:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/22899-angioedema-ereditario-nuove-linee-guida-dedicate-ai-pazienti-pediatrici]]></loc><lastmod>2026-04-01T17:04:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/22860-angioedema-ereditario-ok-di-aifa-alla-rimborsabilita-di-garadacimab]]></loc><lastmod>2026-03-20T16:11:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/22674-angioedema-ereditario-rinnovato-il-consiglio-direttivo-di-itaca]]></loc><lastmod>2026-01-21T17:52:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/22681-angioedema-ereditario-donidalorsen-approvato-nellunione-europea]]></loc><lastmod>2026-01-22T09:34:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/22581-angioedema-ereditario-con-c1-inibitore-normale-lassenza-di-un-test-diagnostico-specifico-e-la-principale-criticita]]></loc><lastmod>2025-12-04T18:41:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/22067-angioedema-ereditario-nasce-un-programma-di-supporto-per-i-pazienti-psp]]></loc><lastmod>2025-06-09T17:44:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/22056-angioedema-ereditario-un-video-diario-di-bordo-racconta-il-viaggio-dei-pazienti-dalla-diagnosi-alla-presa-in-carico]]></loc><lastmod>2025-06-06T08:20:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/21986-angioedema-ereditario-una-patologia-dal-forte-impatto-sia-fisico-che-psicologico]]></loc><lastmod>2025-05-14T07:48:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/21914-angioedema-ereditario-alla-vigilia-del-mese-dedicato-alla-patologia-la-prima-proiezione-pubblica-del-corto-il-colloquio]]></loc><lastmod>2025-04-16T15:56:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/21732-angioedema-ereditario-la-commissione-europea-approva-garadacimab]]></loc><lastmod>2025-02-17T10:11:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/21593-angioedema-ereditario-necessario-garantire-un-accesso-uniforme-ai-farmaci-in-tutta-europa]]></loc><lastmod>2024-12-18T09:26:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/21583-angioedema-ereditario-parere-positivo-del-chmp-su-garadacimab]]></loc><lastmod>2024-12-16T11:24:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/21433-angioedema-academy-una-preziosa-occasione-di-aggiornamento-sull-angioedema-ereditario]]></loc><lastmod>2024-10-28T17:08:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/21255-angioedema-ereditario-un-cortometraggio-per-raccontarlo]]></loc><lastmod>2024-09-04T18:25:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/21119-angioedema-ereditario-positivi-i-risultati-di-fase-iii-su-donidalorsen]]></loc><lastmod>2024-06-26T10:11:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/21081-angioedema-ereditario-berotralstat-efficace-anche-in-pazienti-con-c1-inibitore-nella-norma]]></loc><lastmod>2024-06-14T11:12:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/20935-angioedema-a-milano-si-e-svolto-il-3-congresso-nazionale-del-network-itaca]]></loc><lastmod>2024-05-03T18:04:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/20868-angioedema-cup-un-concorso-per-conoscere-e-saper-riconoscere-la-patologia]]></loc><lastmod>2024-04-12T11:01:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/20810-angioedema-ereditario-arriva-in-italia-la-terapia-che-si-somministra-per-via-orale]]></loc><lastmod>2024-03-27T17:01:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/20653-angioedema-ereditario-disponibile-in-italia-il-nuovo-farmaco-berotralstat]]></loc><lastmod>2024-02-20T09:41:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/20557-angioedema-ereditario-l-associazione-itaca-lancia-il-tesserino-del-paziente]]></loc><lastmod>2024-01-26T15:51:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/20560-angioedema-ereditario-partita-la-procedura-per-la-registrazione-di-garadacimab-in-europa-e-usa]]></loc><lastmod>2024-01-26T15:50:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/20373-angioedema-ereditario-la-commissione-europea-approva-l-estensione-d-uso-di-lanadelumab]]></loc><lastmod>2023-11-21T18:15:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/20282-manifestazioni-neurologiche-dell-angioedema-ereditario-sintomi-rari-di-una-malattia-rara]]></loc><lastmod>2023-11-02T18:25:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/19912-angioedema-ereditario-la-priorita-e-un-accesso-alle-terapie-che-sia-uniforme-in-tutta-italia]]></loc><lastmod>2023-06-19T10:47:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/19521-angioedema-a-napoli-grande-successo-per-il-2-congresso-itaca]]></loc><lastmod>2023-02-08T15:52:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/19078-angioedema-ereditario-positivi-risultati-di-fase-iii-per-garadacimab]]></loc><lastmod>2022-09-17T20:48:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/18453-itaca-l-associazione-che-riunisce-i-centri-di-riferimento-italiani-per-l-angioedema]]></loc><lastmod>2023-09-25T17:29:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/18414-angioedema-ereditario-conoscere-le-comorbilita-per-una-migliore-gestione-della-malattia]]></loc><lastmod>2022-03-13T19:33:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/17730-angioedema-ereditario-la-divulgazione-e-imprescindibile-per-migliorare-la-diagnosi]]></loc><lastmod>2021-08-29T18:06:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/17709-angioedema-ereditario-il-covid-19-non-sembra-influire-sull-andamento-della-patologia]]></loc><lastmod>2021-08-06T19:47:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/17623-angioedema-ereditario-le-attuali-terapie-e-le-nuove-prospettive-di-trattamento]]></loc><lastmod>2021-08-06T11:10:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/17551-angioedema-ereditario-disponibile-anche-in-italia-la-siringa-preriempita-di-lanadelumab]]></loc><lastmod>2021-06-20T13:21:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/17517-angioedema-ereditario-le-difficolta-della-diagnosi]]></loc><lastmod>2021-06-06T21:20:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/17456-malattie-rare-difficolta-nella-diagnosi-e-nella-gestione-del-paziente-con-angioedema-ereditario-medici-e-pazienti-a-confronto-per-risolvere-anche-i-dubbi-sulle-vaccinazioni-anti-covid]]></loc><lastmod>2021-05-19T10:17:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/17256-angioedema-ereditario-takeda-lancia-la-campagna-vivi-la-vita]]></loc><lastmod>2021-04-03T16:35:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/17207-angioedema-ereditario-presentato-il-progetto-paradigma]]></loc><lastmod>2021-03-24T19:05:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/16836-angioedema-ereditario-buoni-risultati-per-lanadelumab-flyo-come-trattamento-preventivo]]></loc><lastmod>2020-12-22T15:32:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/16279-angioedema-ereditario-presentati-i-dati-clinici-di-fase-ii-su-garadacimab]]></loc><lastmod>2020-07-12T15:38:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/16094-angioedema-ereditario-lanadelumab-disponibile-in-italia]]></loc><lastmod>2020-05-24T15:20:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/15188-angioedema-ereditario-i-pazienti-italiani-ricordano-il-prof-marco-cicardi]]></loc><lastmod>2019-09-15T15:14:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/14535-angioedema-ereditario-con-l-autoinfusione-niente-piu-corse-all-ospedale]]></loc><lastmod>2019-03-04T18:19:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/14536-angioedema-ereditario-la-terapia-domiciliare-e-piu-vantaggiosa]]></loc><lastmod>2019-03-04T18:23:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/14370-angioedema-ereditario-scoperto-un-nuovo-potenziale-bersaglio-terapeutico]]></loc><lastmod>2019-01-18T10:40:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/14285-angioedema-ereditario-un-opuscolo-per-imparare-a-parlarne-con-i-bambini]]></loc><lastmod>2018-12-16T18:13:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/14286-angioedema-ereditario-livelli-di-stress-molto-elevati-nei-giovani-pazienti]]></loc><lastmod>2018-12-16T18:15:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/14254-angioedema-ereditario-lanadelumab-approvato-in-europa]]></loc><lastmod>2018-12-09T18:48:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/12553-angioedema-ereditario-scoperta-una-nuova-forma-genetica]]></loc><lastmod>2017-08-01T14:36:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/12298-angioedema-ereditario-a-palermo-il-nuovo-centro-per-i-pazienti-siciliani]]></loc><lastmod>2017-07-16T16:56:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/11608-angioedema-ereditario-le-linee-guida-per-i-pazienti-in-eta-pediatrica]]></loc><lastmod>2017-06-19T13:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/11607-angioedema-ereditario-servono-piu-dati-scientifici-per-migliorare-il-percorso-terapeutico]]></loc><lastmod>2017-06-19T13:53:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/11606-angioedema-l-alta-frequenza-degli-attacchi-e-determinante-per-la-scelta-della-terapia-domiciliare]]></loc><lastmod>2017-06-19T13:54:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/11476-angioedema-ereditario-presentato-alla-simi-il-registro-italiano-dei-pazienti]]></loc><lastmod>2017-06-19T13:54:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/11411-angioedema-ereditario-analizzare-i-costi-di-gestione-per-migliorare-la-qualita-di-cura-dei-pazienti]]></loc><lastmod>2016-10-10T12:25:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/11366-angioedema-ereditario-in-futuro-piu-attenzione-al-sistema-cardiovascolare]]></loc><lastmod>2016-10-03T12:49:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/11351-angioedema-ereditario-i-requisiti-dei-centri-di-riferimento]]></loc><lastmod>2016-10-01T10:41:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/11333-angioedema-ereditario-come-valutare-i-benefici-delle-terapie-farmacologiche]]></loc><lastmod>2016-09-29T09:55:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/11287-angioedema-ereditario-da-novembre-un-registro-unico-per-pazienti-e-farmaci]]></loc><lastmod>2016-09-21T09:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/11284-angioedema-ereditario-il-24-settembre-l-assemblea-dei-pazienti-a-roma]]></loc><lastmod>2016-09-20T10:11:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10658-angioedema-ereditario-grande-successo-per-la-campagna-sulla-rara-patologia]]></loc><lastmod>2016-09-21T14:50:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10655-angioedema-ereditario-grazie-all-associazione-aaee-onlus-una-vita-migliore-per-i-pazienti]]></loc><lastmod>2016-05-23T07:08:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10597-arianna-e-l-angioedema-ereditario-storia-di-una-convivenza-difficile]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10644-angioedema-ereditario-per-i-pazienti-disponibili-nuovi-servizi-domiciliari]]></loc><lastmod>2016-05-19T10:31:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10598-angioedema-ereditario-renata-non-giudicatemi-per-la-mia-malattia]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10609-angioedema-ereditario-tra-nuove-terapie-e-qualita-della-vita]]></loc><lastmod>2016-05-19T10:31:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10608-angioedema-ereditario-quando-si-deve-sospettare-la-malattia]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10607-angioedema-ereditario-le-terapie-disponibili-e-i-centri-di-riferimento-italiani]]></loc><lastmod>2019-03-04T16:40:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10604-angioedema-ereditario-conoscerlo-per-comprenderlo]]></loc><lastmod>2016-05-23T07:08:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10588-angioedema-ereditario-la-testimonianza-di-erling-negli-anni-70-nessuno-conosceva-la-malattia]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10585-angioedema-ereditario-il-cammino-di-santiago-per-conoscere-la-malattia]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10573-angioedema-ereditario-la-diagnosi-di-rachel-dopo-15-anni-di-sofferenza-ora-la-malattia-e-sotto-controllo]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10578-angioedema-ereditario-non-si-tratta-di-una-banale-allergia]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10572-angioedema-ereditario-viktar-per-25-anni-hanno-creduto-fosse-allergia]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10557-conosci-l-angioedema-ereditario]]></loc><lastmod>2016-05-23T07:08:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10537-angioedema-ereditario-clinici-e-pazienti-lavorano-insieme-per-obiettivi-comuni]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10498-angioedema-ereditario-la-rete-itaca-istituisce-il-primo-registro-di-malattia]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/10388-angioedema-ereditario-nuovi-termini-di-utilizzo-del-farmaco-ruconest-in-europa]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/8828-angioedema-ereditario-shire-incrementa-la-produzione-del-c-1-inibitore]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/8814-angioedema-ereditario-la-qualita-della-vita-migliora-con-l-home-therapy]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/8803-angioedema-da-ace-inibitori-il-trattamento-con-icatibant-puo-salvare-delle-vite]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/8796-angioedema-ereditario-diagnosticarlo-oggi-e-piu-facile]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/8765-angioedema-ereditario-di-tipo-iii-uno-studio-illustra-l-origine-proteica-dei-sintomi-di-gonfiore]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/8380-angioedema-ereditario-accordo-per-la-distribuzione-del-farmaco-in-america-latina]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/8054-angioedema-ereditario-dyax-anuncia-risultati-positivi-per-dx-2930]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/7779-angioedema-ereditario-studio-italiano-esegue-sondaggio-su-pazienti-con-carenza-dellinibitore-c1]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/7366-angioedema-ereditario-il-trattamento-con-danazolo-e-sicuro-anche-per-le-donne]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/6942-angioedema-ereditario-sono-due-i-nuovi-farmaci-per-controllare-gli-attacchi-acuti]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/6756-angioedema-ereditario-notevole-limpatto-sulla-vita-dei-pazienti-urgenti-nuove-strategie-di-trattamento]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/6451-angioedema-ereditario-approvato-negli-usa-il-trattamento-con-ruconest]]></loc><lastmod>2016-05-19T10:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/6371-angioedema-classificazione-diagnosi-e-terapia-la-consensus-internazionale]]></loc><lastmod>2019-06-18T18:08:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/5965-angioedema-ereditario-in-italia-i-centri-specializzati-sono-17]]></loc><lastmod>2026-04-09T07:47:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/5962-angioedema-ereditario-sintomi-simili-ad-allergia-ma-potenzialmente-mortali]]></loc><lastmod>2016-05-17T07:33:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/6002-angioedema-ereditario-ciclo-mestruale-e-stress-potrebbero-predisporre-agli-attacchi]]></loc><lastmod>2019-06-18T18:24:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/5968-angioedema-ereditario-una-diagnosi-difficile-per-una-patologia-pericolosa]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/5175-angioedema-ereditario-un-protocollo-per-la-gestione-delle-emergenze-in-pronto-soccorso]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/5174-angioedema-grazie-a-un-protocollo-di-emergenza-e-possibile-salvare-molte-vite]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/4903-angioedema-ereditario-il-farmaco-ecallantide-si-rivela-sicuro-nei-pazienti-adolescenti]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/4345-angioedema-ereditario-le-infezioni-virali-croniche-potrebbero-modularne-la-gravita]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/4213-angioedema-ereditario-in-italia-ora-disponibile-il-farmaco-c1-inibitore]]></loc><lastmod>2015-10-27T17:59:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/3540-angioedema-ereditario-al-via-la-sperimentazione-di-un-farmaco-per-prevenire-gli-attacchi]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/2144-angioedema-ereditario-al-via-la-sperimentazione-di-un-nuovo-trattamento-per-via-sottocutanea]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/1801-angioedema-ereditario-icatibant-permette-una-rapida-risoluzione-degli-attacchi-acuti]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/761-angioedema-ereditario-arriva-swell-documentario-sulla-vita-con-la-malattia]]></loc><lastmod>2020-09-22T10:51:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/721-angioedema-ereditario-la-regione-lazio-nega-il-farmaco]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/550-angioedema-ereditatio-lue-dice-si-allautosomministrazione-dellicatibant]]></loc><lastmod>2020-09-22T10:51:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/484-angioedema-ereditario-alla-fda-non-bastano-gli-studi-presentati-a-sostegno-del-rhucin]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/464-angioedema-ereditario-nuovo-trial-di-fase-iii-per-il-rhucin-noto-in-europa-come-ruconest]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/409-angioedema-ereditario-il-berinert-autorizzato-al-commercio-anche-in-italia]]></loc><lastmod>2020-09-22T10:49:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/94-angioedema-ereditario-studio-di-fase-tre-conferma-efficacia-dellecallantide-per-gli-attacchi-acuti-nei-pazienti-al-di-sopra-dei-16-anni]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/angioedema-ereditario-che-cose]]></loc><lastmod>2018-01-26T10:00:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/angioedema-ereditario/73-angioedema-ereditario-con-licatibant-si-possono-trattare-le-manifestazioni-acute]]></loc><lastmod>2015-05-25T11:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/22617-atassia-di-friedreich-ora-rimborsabile-in-italia-il-farmaco-omaveloxolone]]></loc><lastmod>2026-03-26T18:38:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/22135-terapie-geniche-piu-sicure-finanziamento-europeo-da-2-5-milioni-al-genetista-diego-di-bernardo-telethon]]></loc><lastmod>2025-06-27T13:07:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/21555-atassia-di-friedreich-la-difficolta-diagnostica-risiede-nella-variabilita-dei-sintomi-all-esordio]]></loc><lastmod>2024-12-04T18:59:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/21383-atassia-di-friedreich-l-omaveloxolone-e-finalmente-disponibile-anche-in-italia]]></loc><lastmod>2024-10-11T16:37:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/21328-atassia-di-friedreich-presentato-il-documentario-rassegnati-tu-io-ballo-con-friedreich]]></loc><lastmod>2024-09-27T09:29:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/20654-atassia-di-friedreich-approvazione-europea-per-omaveloxolone]]></loc><lastmod>2024-02-20T10:16:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/20363-atassia-di-friedreich-i-pazienti-chiedono-accesso-precoce-all-unico-farmaco-indicato-per-la-malattia]]></loc><lastmod>2023-11-20T14:31:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/20316-atassia-di-friedreich-dal-9-novembre-in-sala-il-film-cosi-volano-le-farfalle]]></loc><lastmod>2023-11-10T15:00:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/19969-atassia-di-friedreich-medici-e-associazione-aisa-impegnati-per-un-rapido-accesso-all-omaveloxolone]]></loc><lastmod>2023-07-05T07:29:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/19681-atassia-di-friedreich-negli-usa-arriva-la-prima-terapia-specifica-per-la-patologia]]></loc><lastmod>2023-04-04T19:33:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/19272-atassia-di-friedreich-i-pazienti-italiani-possono-contare-sull-associazione-aisa]]></loc><lastmod>2022-11-30T19:25:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/18114-la-denuncia-di-giorgia-musica-e-cultura-precluse-ai-disabili]]></loc><lastmod>2021-12-19T22:50:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/16553-atassia-di-friedreich-avviato-studio-clinico-con-farmaco-anti-aids]]></loc><lastmod>2020-10-11T21:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/15713-atassie-al-via-ad-aprilia-il-progetto-cadmo]]></loc><lastmod>2020-03-02T19:29:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/12332-atassia-di-friedreich-potenzialita-terapeutiche-dagli-oligonucleotidi-antisenso]]></loc><lastmod>2019-03-26T18:49:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/12033-atassia-di-friedreich-identificato-nuovo-target-terapeutico]]></loc><lastmod>2019-03-26T18:49:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/11372-atassia-di-friedreich-dall-universita-della-florida-e-gofar-un-programma-di-terapia-genica]]></loc><lastmod>2019-03-26T18:26:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/11261-atassia-di-friedreich-l-universita-della-florida-riceve-un-finanziamento-per-lo-sviluppo-di-un-programma-di-terapia-genica]]></loc><lastmod>2019-03-26T18:26:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/10555-atassia-di-friedrich-al-via-sperimentazione-con-interferone-gamma]]></loc><lastmod>2025-12-22T10:26:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/10179-atassia-di-friedreich-nuove-speranze-da-esperimenti-con-rna-sintetico]]></loc><lastmod>2019-03-26T18:27:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/9353-atassia-di-friedreich-in-norvegia-la-prevalenza-e-piu-bassa-rispetto-a-quella-dell-europa-centrale]]></loc><lastmod>2019-03-26T18:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/7646-atassia-di-friedreich-39-clinici-pubblicano-le-linee-guida-per-la-gestione-della-malattia]]></loc><lastmod>2019-03-26T18:29:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/7565-atassia-di-friedreich-al-via-studio-di-fase-ii-per-farmaco-rta-408]]></loc><lastmod>2019-03-26T18:30:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/5961-federica-combatte-contro-latassia-di-friedreich-e-supporta-attivamente-la-ricerca]]></loc><lastmod>2019-03-26T18:31:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/5611-atassia-di-friedreich-derivato-dellepo-in-fase-ii-positivo-per-sicurezza-non-per-efficacia]]></loc><lastmod>2019-03-26T18:36:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/3814-malattie-rare-qual-e-il-costo-dellatassia-di-friedreich]]></loc><lastmod>2019-03-26T18:36:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/2251-atassia-di-friedreich-nessuna-efficacia-per-leritropoietina]]></loc><lastmod>2019-03-26T18:37:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/1917-atassia-di-friedreich-partita-la-sperimentazione-di-prima-fase-con-rg2833]]></loc><lastmod>2019-03-26T18:39:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/1220-atassia-di-friedreich-viropharma-acquista-diritti-di-farmaco-sperimentale-ox1]]></loc><lastmod>2019-03-26T18:41:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/1064-atassia-di-friedreich-la-vita-per-filomena-e-una-meravigliosa-battaglia]]></loc><lastmod>2019-03-26T18:43:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/221-atassia-di-friedreich-lequipe-di-franco-pagani-dellicgeb-scopre-il-meccanismo-alla-base-della-malattia]]></loc><lastmod>2019-03-26T18:45:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/atassia-di-friedreich/22-atassia-di-friedreich-uno-studio-del-friedrich-miescher-institute-svela-il-meccanismo-patogenetico]]></loc><lastmod>2019-03-26T18:48:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22852-atrofia-muscolare-spinale-torna-la-sma-talent-school]]></loc><lastmod>2026-03-18T17:00:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22851-sma-cosa-insegna-lesperienza-italiana-sullaccesso-precoce-alla-terapia-genica]]></loc><lastmod>2026-03-17T18:48:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22750-atrofia-muscolare-spinale-la-malattia-inizia-gia-in-fase-embrionale]]></loc><lastmod>2026-02-16T23:01:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22651-atrofia-muscolare-spinale-una-diagnosi-che-non-puo-aspettare]]></loc><lastmod>2026-01-12T18:03:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22642-malattie-rare-neonato-con-sma-trattato-con-terapia-genica-in-abruzzo-prima-volta-nella-regione]]></loc><lastmod>2026-01-05T14:06:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22558-sma-approvata-negli-usa-la-nuova-somministrazione-intratecale-della-terapia-genica]]></loc><lastmod>2025-11-29T11:14:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22495-pet-therapy-al-besta-cani-accanto-ai-bambini-con-sma-per-ridurre-ansia-e-stress-dei-trattamenti]]></loc><lastmod>2025-11-13T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22454-vivere-la-sma-limpatto-della-presa-in-carico-territoriale-a-bari]]></loc><lastmod>2025-10-28T15:24:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22449-sma-apitegromab-dimostra-di-migliorare-la-funzionalita-motoria-in-bambini-e-adulti]]></loc><lastmod>2025-10-28T15:21:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22446-a-new-sma-life-un-progetto-per-aiutare-le-famiglie-con-bimbi-affetti-da-atrofia-muscolare-spinale]]></loc><lastmod>2025-10-28T15:12:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22443-screening-neonatale-per-la-sma-linserimento-nei-lea-una-svolta-storica-ora-avanti-con-lattuazione]]></loc><lastmod>2025-10-24T15:58:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22405-sma-lo-screening-neonatale-dovrebbe-essere-introdotto-in-tutte-le-regioni]]></loc><lastmod>2025-10-22T14:55:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22399-sma-limportanza-dellintervento-di-stabilizzazione-della-colonna-vertebrale]]></loc><lastmod>2025-10-16T17:05:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22409-sma-il-progetto-talent-school-ha-dato-ai-ragazzi-piu-consapevolezza-e-fiducia-in-se-stessi]]></loc><lastmod>2025-10-13T17:01:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22408-sma-talent-school-unacademy-per-valorizzare-le-abilita-delle-persone-con-atrofia-muscolare-spinale]]></loc><lastmod>2025-10-13T16:56:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22384-sma-i-farmaci-sono-solo-una-parte-della-presa-in-carico-che-devessere-mirata-e-continuativa]]></loc><lastmod>2025-10-13T11:18:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22375-sma-importante-non-trascurare-il-mondo-dellaffettivita-e-della-sessualita]]></loc><lastmod>2025-10-08T10:55:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22359-sma-tra-i-temi-oggi-cruciali-ci-sono-vita-quotidiana-socialita-e-inclusione-lavorativa]]></loc><lastmod>2025-10-02T07:35:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22338-sma-per-la-prima-volta-in-sardegna-somministrata-la-terapia-genica-a-una-piccola-paziente]]></loc><lastmod>2025-09-24T12:19:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22284-sma-dopo-la-rivoluzione-terapeutica-ora-quella-culturale-e-uno-scatto-sullo-screening]]></loc><lastmod>2025-09-08T14:59:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22244-sma-e-screening-neonatale-una-nuova-era-per-diagnosi-e-trattamento]]></loc><lastmod>2025-08-12T07:47:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22151-atrofia-muscolare-spinale-promettenti-i-risultati-di-fase-i-su-salanersen]]></loc><lastmod>2025-07-02T10:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/22105-sma-talent-school-conclusa-l-academy-dedicata-alle-persone-con-sma-e-al-loro-talento]]></loc><lastmod>2025-06-18T12:00:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21946-lo-screening-neonatale-per-la-sma-in-puglia-la-legge-che-e-nata-da-un-dolore-privato]]></loc><lastmod>2025-04-30T12:10:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21945-screening-neonatale-per-la-sma-in-puglia-l-esperienza-del-policlinico-di-bari]]></loc><lastmod>2025-05-02T07:03:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21953-screening-per-la-sma-online-la-mappa-aggiornata-in-tempo-reale]]></loc><lastmod>2025-05-03T10:30:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21935-screening-neonatale-per-la-sma-in-campania-la-prospettiva-del-santobono-pausilipon]]></loc><lastmod>2025-04-25T10:54:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21934-screening-neonatale-per-la-sma-in-campania-la-prospettiva-del-ceinge]]></loc><lastmod>2025-04-25T10:54:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21895-atrofia-muscolare-spinale-campania-e-puglia-modelli-replicabili-per-lo-screening-neonatale]]></loc><lastmod>2025-04-13T10:44:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21801-atrofia-muscolare-spinale-lo-screening-neonatale-e-attivato-in-13-regioni-italiane]]></loc><lastmod>2025-03-11T19:07:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21639-screening-neonatale-esteso-l-inclusione-della-sma-dovra-attendere-ancora]]></loc><lastmod>2025-01-16T16:56:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21633-screening-neonatale-sma-in-lombardia-identificati-7-casi-positivi-grazie-al-nuovo-programma-regionale]]></loc><lastmod>2025-01-15T12:38:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21577-screening-neonatale-sma-l-on-boschi-sollecita-la-pubblicazione-del-decreto-ministeriale-dedicato]]></loc><lastmod>2024-12-12T20:57:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21567-sma-inconcepibile-che-in-alcune-regioni-non-ci-sia-ancora-lo-screening-neonatale]]></loc><lastmod>2024-12-10T15:20:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21361-atrofia-muscolare-spinale-al-via-il-progetto-sma-talent-school-trova-la-tua-voce]]></loc><lastmod>2024-10-07T12:41:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21343-curcuma-contro-l-atrofia-muscolare-spinale-puo-produrre-benefici]]></loc><lastmod>2024-10-01T17:30:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21315-tutta-un-altra-sma-al-via-la-raccolta-fondi-per-il-numero-verde-stella]]></loc><lastmod>2024-09-23T14:42:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21269-atrofia-muscolare-spinale-l-importanza-di-migliorare-la-diagnosi]]></loc><lastmod>2024-09-09T13:41:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21159-sma-in-sicilia-trattata-con-la-terapia-genica-una-bimba-a-soli-27-giorni-di-vita]]></loc><lastmod>2024-07-09T11:08:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21156-screening-neonatale-per-la-sma-approvate-in-sicilia-le-modalita-per-partire]]></loc><lastmod>2024-07-08T13:58:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/21162-screening-neonatale-sardegna-a-piccoli-passi-verso-l-ampliamento-ora-tocca-ad-ares-agire-in-fretta]]></loc><lastmod>2024-07-10T06:53:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20907-sma-aifa-amplia-criteri-di-rimborsabilita-della-terapia-genica]]></loc><lastmod>2024-04-24T10:39:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20865-sport-e-malattie-neuromuscolari-ridisegnare-i-confini-della-salute-e-dell-inclusione]]></loc><lastmod>2024-04-11T10:53:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20825-sma-la-regione-puglia-accoglie-bambino-palestinese-per-assicurare-le-migliori-cure]]></loc><lastmod>2024-09-07T16:21:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20816-sma-niguarda-e-centro-nemo-milano-collaborano-per-rendere-possibile-un-delicato-intervento-chirurgico]]></loc><lastmod>2024-03-28T16:04:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20718-sma-al-meyer-gia-8-piccoli-pazienti-salvati-grazie-alla-terapia-genica]]></loc><lastmod>2024-03-05T16:51:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20651-alessandro-e-la-battaglia-per-il-diritto-allo-studio-ecco-il-suo-basta-essere-pazienti]]></loc><lastmod>2024-03-13T16:29:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20449-sma-aifa-rinnova-il-riconoscimento-di-innovativita-piena-a-onasemnogene-abeparvovec]]></loc><lastmod>2023-12-15T18:22:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20419-sma-si-conclude-il-percorso-didattico-della-campagna-educazionale-la-smagliante-ada]]></loc><lastmod>2023-12-07T14:29:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20351-screening-neonatale-esteso-sne-parlamentari-e-associazioni-dicono-basta-ai-ritardi-del-governo]]></loc><lastmod>2023-11-17T10:51:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20317-screening-neonatale-sma-cammina-la-bimba-diagnosticata-in-puglia-ad-aprile-2022]]></loc><lastmod>2023-11-13T07:36:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20315-sma-un-bambino-e-morto-dopo-soli-34-giorni-di-vita-nella-sua-regione-non-e-attivo-lo-screening-neonatale-specifico]]></loc><lastmod>2023-11-15T12:56:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20252-atrofia-muscolare-spinale-anche-la-sicilia-pronta-a-garantire-lo-screening-neonatale-in-regime-extra-lea]]></loc><lastmod>2023-10-23T09:25:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20144-atrofia-muscolare-spinale-torna-la-campagna-tutta-un-altra-sma]]></loc><lastmod>2023-09-22T13:38:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20140-sma-hai-mai-visto-un-unicorno-accende-i-riflettori-sulla-patologia]]></loc><lastmod>2023-09-29T10:07:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/20080-sma-risdiplam-approvato-in-europa-per-bambini-di-eta-inferiore-ai-2-mesi]]></loc><lastmod>2023-09-04T05:28:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19988-sma-dati-clinici-positivi-sull-impiego-di-nusinersen-dopo-la-terapia-genica]]></loc><lastmod>2023-07-10T10:48:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19981-atrofia-muscolare-spinale-dalle-relazioni-affettive-al-calcio-in-carrozzina-tornano-smaspace-e-smaspace-cup]]></loc><lastmod>2023-07-07T11:09:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19855-smaspace-8-9-luglio-2023-compila-il-modulo-per-la-partecipazione-alle-attivita]]></loc><lastmod>2023-06-06T11:53:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19819-trasporto-aereo-di-persone-con-disabilita-ancora-una-denuncia-da-parte-di-una-passeggera-affetta-da-sma]]></loc><lastmod>2023-05-19T11:25:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19804-sma-stilate-le-raccomandazioni-per-gestire-l-emergenza-in-pronto-soccorso]]></loc><lastmod>2023-05-31T08:27:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19672-sma-di-tipo-2-e-3-benefici-a-lungo-termine-con-risdiplam]]></loc><lastmod>2023-05-31T08:27:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19660-sma-la-terapia-genica-si-conferma-efficace-a-piu-di-7-anni-dalla-somministrazione]]></loc><lastmod>2023-05-31T08:27:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19457-atrofia-muscolare-spinale-studio-dell-universita-di-torino-individua-una-nuova-potenziale-terapia]]></loc><lastmod>2023-05-31T08:27:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19183-sma-nuovi-dati-positivi-per-risdiplam-dallo-studio-jewelfish]]></loc><lastmod>2023-05-31T08:27:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19155-atrofia-muscolare-spinale-al-via-sma-path-2-0]]></loc><lastmod>2022-10-07T15:38:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19090-atrofia-muscolare-spinale-al-via-la-campagna-tutta-un-altra-sma]]></loc><lastmod>2022-09-21T13:55:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/19074-sma-pubblicato-il-terzo-e-ultimo-volume-di-le-avventure-della-smagliante-ada]]></loc><lastmod>2022-09-17T19:53:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18966-giffoni-innovation-hub-grande-accoglienza-per-hai-mai-visto-un-unicorno-il-cortometraggio-che-parla-di-vita-e-di-sma]]></loc><lastmod>2022-07-27T10:21:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18944-sma-presentato-a-giffoni-next-generation-un-cortometraggio-dedicato-alla-patologia]]></loc><lastmod>2022-07-24T10:50:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18873-atrofia-muscolare-spinale-le-battaglie-del-tiktoker-emanuel]]></loc><lastmod>2022-07-04T08:37:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18854-smaspace-adolescenti-e-adulti-con-sma-famiglie-caregiver-e-clinici-si-incontrano-a-roma-sabato-2-luglio]]></loc><lastmod>2022-07-02T06:56:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18830-sma-aifa-riconferma-l-innovativita-piena-alla-terapia-onasemnogene-abeparvovec]]></loc><lastmod>2022-06-27T17:55:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18738-sma-fda-approva-risdiplam-per-i-bambini-di-eta-inferiore-a-due-mesi]]></loc><lastmod>2022-06-05T17:09:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18720-sma-in-abruzzo-l-associazione-progetto-noemi-si-batte-per-i-diritti-delle-famiglie]]></loc><lastmod>2022-06-01T15:13:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18713-atrofia-muscolare-spinale-pronto-il-primo-pdta-dedicato-alla-patologia]]></loc><lastmod>2022-05-31T13:32:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18599-sma-di-tipo-1-nuovi-dati-confermano-l-efficacia-a-lungo-termine-di-risdiplam]]></loc><lastmod>2022-05-01T19:55:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18472-sma-traguardi-evolutivi-adeguati-all-eta-per-i-bambini-trattati-precocemente-con-la-terapia-genica]]></loc><lastmod>2022-03-28T19:32:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18444-sma-al-via-la-seconda-edizione-del-comic-contest-de-la-smagliante-ada]]></loc><lastmod>2022-03-21T17:21:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18437-atrofia-muscolare-spinale-nuovi-dati-dimostrano-efficacia-e-sicurezza-a-lungo-termine-di-risdiplam]]></loc><lastmod>2022-03-21T14:34:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18377-sma-dall-ucraina-all-italia-il-viaggio-del-piccolo-erik]]></loc><lastmod>2022-03-03T14:10:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18113-atrofia-muscolare-spinale-al-via-la-campagna-natalizia-tutta-un-altra-sma]]></loc><lastmod>2021-12-19T22:36:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/18036-atrofia-muscolare-spinale-il-26-novembre-l-ultimo-appuntamento-con-smaspace]]></loc><lastmod>2021-11-25T15:08:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17988-al-via-sma-path-per-formare-i-professionisti-sui-nuovi-standard-di-cura-per-la-sma]]></loc><lastmod>2021-11-11T18:18:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17945-sma-lo-screening-neonatale-in-lazio-e-toscana-ha-cambiato-la-storia-di-malattia-per-15-bambini]]></loc><lastmod>2021-10-29T09:15:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17817-atrofia-muscolare-spinale-lanciata-la-campagna-tutta-un-altra-sma]]></loc><lastmod>2021-09-26T20:27:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17769-sma-arriva-il-secondo-volume-de-le-avventure-della-smagliante-ada]]></loc><lastmod>2021-09-14T11:24:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17768-sma-nel-lazio-e-in-toscana-prosegue-lo-screening-neonatale]]></loc><lastmod>2021-09-15T15:56:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17748-atrofia-muscolare-spinale-viaggiare-e-praticare-sport-e-possibile]]></loc><lastmod>2021-09-05T13:48:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17637-sma-una-diagnosi-precoce-puo-cambiare-radicalmente-il-decorso-della-patologia]]></loc><lastmod>2021-07-11T17:36:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17627-atrofia-muscolare-spinale-ryanair-ha-distrutto-la-mia-carrozzina]]></loc><lastmod>2021-07-07T11:53:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17616-sma-oggi-e-possibile-contare-su-ben-tre-terapie-efficaci]]></loc><lastmod>2021-07-03T15:21:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17593-sma-nuovi-dati-positivi-su-onasemnogene-abeparvovec]]></loc><lastmod>2021-07-01T08:27:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17550-atrofia-muscolare-spinale-prende-il-via-l-iniziativa-firma-il-sogno]]></loc><lastmod>2021-06-21T08:41:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17548-sma-e-terapia-genica-lanciato-il-programma-onegene]]></loc><lastmod>2021-06-17T16:31:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17376-sma-la-prima-causa-genetica-di-morte-infantile-in-italia-necessario-estendere-lo-screening-neonatale]]></loc><lastmod>2021-05-02T20:32:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17300-sma-sottoposto-a-terapia-genica-un-bimbo-siciliano-di-3-mesi]]></loc><lastmod>2021-04-15T15:30:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17259-sma-inizia-a-maggio-un-corso-per-diventare-assistente-personale]]></loc><lastmod>2021-04-03T15:14:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17248-atrofia-muscolare-spinale-approvazione-europea-per-risdiplam-primo-farmaco-orale-per-la-malattia]]></loc><lastmod>2021-04-01T09:14:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17235-sma-e-covid-19-per-i-pazienti-la-vera-sfida-non-e-il-lockdown-ma-il-ritorno-alla-socialita]]></loc><lastmod>2021-03-28T21:49:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17241-mattarella-nomina-i-nuovi-alfieri-tra-loro-c-e-luisa-rizzo-in-arte-leo-on-fire]]></loc><lastmod>2021-03-29T18:36:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17221-giochiamo-di-anticipo-contro-la-sma-il-video-de-le-coliche-per-lo-screening-neonatale]]></loc><lastmod>2021-03-25T10:49:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17198-sma-nuove-evidenze-confermano-l-efficacia-della-terapia-genica]]></loc><lastmod>2021-03-23T16:04:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/17166-atrofia-muscolare-spinale-aifa-approva-la-terapia-genica]]></loc><lastmod>2021-03-10T10:57:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16944-bambini-affetti-da-sma1-la-comunita-scientifica-fa-chiarezza]]></loc><lastmod>2021-01-28T09:39:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16909-sma-la-terapia-genica-sia-accessibile-oltre-i-6-mesi-d-eta-in-linea-con-l-europa]]></loc><lastmod>2021-03-04T12:19:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16846-sma-al-centro-nemo-di-milano-iniziata-la-somministrazione-della-terapia-genica]]></loc><lastmod>2020-12-27T17:45:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16783-atrofia-muscolare-spinale-famiglie-sma-screening-neonatale-su-tutto-il-territorio-nazionale]]></loc><lastmod>2020-12-08T20:33:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16780-sma-bambina-di-6-mesi-trattata-a-napoli-con-la-terapia-genica-e-la-prima-volta-in-italia]]></loc><lastmod>2020-12-07T18:10:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16758-newborn-sma-un-progetto-per-supportare-le-famiglie-che-affrontano-una-diagnosi-di-sma]]></loc><lastmod>2020-11-30T20:19:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16749-sma-online-il-video-la-domenica-secondo-nonna]]></loc><lastmod>2020-11-29T22:05:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16723-atrofia-muscolare-spinale-lo-screening-neonatale-e-cruciale-per-una-diagnosi-precoce]]></loc><lastmod>2020-11-25T09:36:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16731-sma-di-tipo-1-la-terapia-genica-e-realta-per-i-neonati-di-nuova-diagnosi]]></loc><lastmod>2020-11-24T14:39:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16692-sma-individuato-un-nuovo-meccanismo-alla-base-della-patologia]]></loc><lastmod>2020-11-15T18:48:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16684-sma-il-20-novembre-torna-la-piazza-virtuale-dedicata-alla-malattia]]></loc><lastmod>2020-11-13T11:13:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16664-atrofia-muscolare-spinale-le-nuove-frontiere-terapeutiche]]></loc><lastmod>2020-11-17T09:30:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16557-malattie-rare-l-impatto-devastante-della-diagnosi-e-il-progetto-newborn-sma]]></loc><lastmod>2020-10-13T11:00:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16554-sma-nuovi-dati-di-fase-iii-sulla-terapia-genica]]></loc><lastmod>2020-10-11T22:12:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16524-atrofia-muscolare-spinale-lanciata-la-campagna-non-c-e-sma-che-tenga]]></loc><lastmod>2020-10-04T16:48:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16520-atrofia-muscolare-spinale-esteso-l-uso-compassionevole-di-risdiplam]]></loc><lastmod>2020-10-04T15:27:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16518-atrofia-muscolare-spinale-di-tipo-1-nuovi-dati-positivi-sul-farmaco-risdiplam]]></loc><lastmod>2020-10-04T15:30:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16505-atrofia-muscolare-spinale-storia-clinica-e-rivoluzione-terapeutica]]></loc><lastmod>2020-09-29T09:03:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16430-sma-la-smagliante-ada-un-progetto-dedicato-ai-piu-piccoli]]></loc><lastmod>2020-09-12T16:28:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16391-atrofia-muscolare-spinale-risdiplam-approvato-negli-usa]]></loc><lastmod>2020-08-30T15:31:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16380-sma-e-covid-19-le-agevolazioni-in-ambito-lavorativo-per-pazienti-e-familiari]]></loc><lastmod>2020-08-23T17:33:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16374-atrofia-muscolare-spinale-e-sessualita-serve-dialogo-per-spezzare-i-pregiudizi]]></loc><lastmod>2020-08-16T19:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16372-atrofia-muscolare-spinale-la-gestione-delle-difficolta-di-linguaggio-e-alimentazione]]></loc><lastmod>2020-08-16T19:07:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16274-screening-neonatale-per-la-sma-nel-lazio-e-in-toscana-oltre-30-000-neonati-arruolati]]></loc><lastmod>2020-07-09T12:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16263-sma-la-dimensione-relazionale-e-affettiva-nella-malattia]]></loc><lastmod>2020-08-11T10:37:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16258-atrofia-muscolare-spinale-come-gestire-la-gravidanza]]></loc><lastmod>2020-07-06T08:35:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16243-sma-le-terapie-attualmente-disponibili-per-la-malattia]]></loc><lastmod>2020-06-30T10:54:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16176-atrofia-muscolare-spinale-conferme-di-efficacia-per-nusinersen-in-pazienti-pre-sintomatici]]></loc><lastmod>2020-06-14T21:50:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16107-atrofia-muscolare-spinale-nasce-smaspace-la-piazza-virtuale-dedicata-alla-malattia]]></loc><lastmod>2020-07-05T19:41:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16098-sma-nuovi-dati-su-nusinersen-confermano-efficacia-e-sicurezza-nel-lungo-periodo]]></loc><lastmod>2020-06-14T21:36:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16086-atrofia-muscolare-spinale-approvazione-europea-per-la-terapia-genica]]></loc><lastmod>2020-06-14T21:47:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16032-sma-nuovi-dati-sui-benefici-di-nusinersen-negli-adulti]]></loc><lastmod>2020-05-05T16:32:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16016-sma-di-tipo-1-con-risdiplam-miglioramenti-in-sopravvivenza-e-sviluppo-motorio]]></loc><lastmod>2020-05-03T18:23:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/16001-atrofia-muscolare-spinale-asamsi-lancia-il-fisiote-delle-17-00]]></loc><lastmod>2020-04-27T18:19:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15917-sma-la-terapia-genica-arriva-in-giappone-e-si-avvicina-all-europa]]></loc><lastmod>2020-04-06T18:18:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15735-sma-al-centro-nemo-di-roma-inizia-il-progetto-chilometri-di-vite]]></loc><lastmod>2020-03-08T14:43:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15709-atrofia-muscolare-spinale-il-2019-e-stato-un-anno-rivoluzionario]]></loc><lastmod>2020-07-06T14:22:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15644-sma-di-tipo-2-e-3-miglioramenti-significativi-della-funzione-motoria-con-risdiplam]]></loc><lastmod>2020-02-10T21:41:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15617-screening-neonatale-per-la-sma-dal-progetto-pilota-all-estensione-a-livello-nazionale]]></loc><lastmod>2020-01-31T19:15:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15604-sma-di-tipo-1-risdiplam-raggiunge-endpoint-primario-nello-studio-firefish]]></loc><lastmod>2020-01-27T21:40:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15581-atrofia-muscolare-spinale-la-diagnosi-precoce-non-riguarda-solo-il-paziente-ma-tutta-la-famiglia]]></loc><lastmod>2020-01-15T22:17:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15574-atrofia-muscolare-spinale-con-risdiplam-arriva-una-terapia-anche-per-chi-ne-era-escluso]]></loc><lastmod>2020-01-14T15:28:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15546-atrofia-muscolare-spinale-online-il-video-il-natale-piu-importante-e-sempre-il-prossimo]]></loc><lastmod>2019-12-31T16:11:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15515-atrofia-muscolare-spinale-di-tipo-2-il-declino-progressivo-inizia-a-5-anni]]></loc><lastmod>2019-12-20T14:38:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15459-sma-revisione-prioritaria-per-risdiplam-negli-stati-uniti]]></loc><lastmod>2019-11-28T16:16:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15415-sma-a-milano-si-e-tenuto-il-primo-hackaton-dedicato-alla-malattia]]></loc><lastmod>2019-11-18T22:28:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15427-sma-aderire-allo-screening-neonatale-significa-cambiare-il-decorso-della-malattia]]></loc><lastmod>2019-11-18T22:29:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15411-sma-di-tipo-2-o-3-raggiunto-l-endpoint-primario-nello-studio-registrativo-di-risdiplam]]></loc><lastmod>2019-11-16T22:53:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15390-sma-la-terapia-genica-si-dimostra-efficace-anche-nella-malattia-di-tipo-2]]></loc><lastmod>2019-11-09T20:50:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15358-screening-neonatale-per-la-sma-l-adesione-passa-per-una-corretta-informazione]]></loc><lastmod>2019-10-29T17:03:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15349-atrofia-muscolare-spinale-al-via-la-campagna-giochiamodianticipo]]></loc><lastmod>2019-10-28T15:16:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15276-atrofia-muscolare-spinale-pubblicati-i-dati-di-nusinersen-in-neonati-pre-sintomatici]]></loc><lastmod>2019-10-07T20:09:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15283-screening-neonatale-per-la-sma-un-cortometraggio-per-comprenderne-l-urgenza]]></loc><lastmod>2019-10-07T20:10:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15171-atrofia-muscolare-spinale-iniziata-la-campagna-di-famiglie-sma-regala-il-futuro]]></loc><lastmod>2019-09-10T08:53:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15138-sma-da-settembre-lo-screening-neonatale-e-attivo-nei-punti-nascita-del-lazio]]></loc><lastmod>2019-10-01T10:46:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15136-sma-la-prossima-sfida-e-lo-screening-neonatale-per-tutti-i-nuovi-nati]]></loc><lastmod>2019-08-26T20:37:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15124-sma-l-obiettivo-dello-screening-neonatale-e-la-diagnosi-pre-sintomatica]]></loc><lastmod>2019-08-19T18:00:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15082-sma-importantissimo-il-trattamento-in-fase-pre-sintomatica]]></loc><lastmod>2019-07-28T22:43:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15074-sma-il-progetto-di-screening-neonatale-e-un-esempio-di-proficua-collaborazione]]></loc><lastmod>2019-07-27T10:59:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15056-sma-la-presentazione-del-progetto-di-screening-neonatale-al-gemelli-di-roma]]></loc><lastmod>2019-07-21T10:01:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15048-sma-la-speranza-e-che-lo-screening-neonatale-arrivi-presto-in-tutta-italia]]></loc><lastmod>2019-07-19T16:57:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15028-sma-la-toscana-e-una-delle-due-regioni-in-cui-partira-lo-screening-neonatale]]></loc><lastmod>2019-07-15T13:08:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/15022-sma-lo-screening-neonatale-e-un-banco-di-prova-per-il-farmaco-nusinersen]]></loc><lastmod>2019-07-15T13:08:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14994-sma-lo-screening-neonatale-nel-lazio-e-un-modello-per-il-paese]]></loc><lastmod>2019-07-15T13:07:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14992-atrofia-muscolare-spinale-l-importanza-della-diagnosi-in-fase-presintomatica]]></loc><lastmod>2019-07-09T17:33:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14989-atrofia-muscolare-spinale-la-malattia-raccontata-attraverso-le-immagini]]></loc><lastmod>2019-07-06T15:08:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14985-sma-nuovi-dati-positivi-sull-impiego-di-nusinersen-in-pazienti-pre-sintomatici]]></loc><lastmod>2019-07-05T21:19:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14972-sma-biogen-a-fianco-dei-piccoli-malati-con-un-libro-di-favole-sulla-malattia]]></loc><lastmod>2019-07-06T15:08:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14966-sma-un-libro-di-favole-racconta-a-grandi-e-piccini-che-cos-e-la-malattia]]></loc><lastmod>2019-07-06T15:08:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14901-atrofia-muscolare-spinale-al-via-lo-screening-neonatale-in-lazio-e-in-toscana]]></loc><lastmod>2019-09-10T14:21:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14855-sma-che-brutti-quei-titoli-sulla-pillola-piu-costosa-al-mondo]]></loc><lastmod>2019-05-28T18:05:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14850-sma-a-terapia-genica-approvata-dalla-fda-e-un-grande-passo-non-una-cura-miracolosa]]></loc><lastmod>2019-05-27T15:40:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14840-atrofia-muscolare-spinale-tutti-i-progetti-di-screening-neonatale-in-europa]]></loc><lastmod>2019-05-23T16:16:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14799-sma-nuovi-risultati-positivi-per-il-farmaco-risdiplam]]></loc><lastmod>2019-05-13T18:19:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14796-atrofia-muscolare-spinale-la-terapia-genica-mostra-benefici-in-ampio-spettro-di-pazienti]]></loc><lastmod>2019-05-13T15:55:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14797-atrofia-muscolare-spinale-conferme-sulla-sicurezza-e-la-durata-d-azione-di-nusinersen]]></loc><lastmod>2019-05-13T16:34:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14738-atrofia-muscolare-spinale-promettenti-i-primi-dati-di-fase-i-del-farmaco-srk-015]]></loc><lastmod>2019-04-17T08:44:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14606-atrofia-muscolare-spinale-nusinersen-arriva-anche-in-cina]]></loc><lastmod>2019-03-21T18:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14355-sma-un-nuovo-modello-cellulare-in-3d-riproduce-i-motoneuroni-dei-pazienti]]></loc><lastmod>2019-01-13T15:10:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14270-atrofia-muscolare-spinale-tipo-1-fda-valuta-l-approvazione-della-terapia-genica]]></loc><lastmod>2018-12-12T15:28:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14246-atrofia-muscolare-spinale-messo-a-punto-un-nuovo-test-per-lo-screening-neonatale]]></loc><lastmod>2018-12-06T16:59:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14004-il-farmaco-per-la-sma-la-dr-ssa-valeria-sansone-necessaria-cautela-nel-parlare-di-benefici-negli-adulti-ma-grandi-speranze]]></loc><lastmod>2018-10-07T15:24:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/14000-atrofia-muscolare-spinale-evidenze-di-beneficio-clinico-per-risdiplam]]></loc><lastmod>2018-10-05T10:52:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13990-sma-il-prof-eugenio-mercuri-racconta-le-ultime-novita-sui-trial-in-corso]]></loc><lastmod>2018-10-03T16:40:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13986-screening-neonatale-per-la-sma-daniela-lauro-famiglie-sma-nel-lazio-e-in-toscana-tutti-i-neonati-saranno-sottoposti-al-test]]></loc><lastmod>2018-10-03T09:24:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13965-sma-un-disegno-di-legge-per-lo-screening-neonatale]]></loc><lastmod>2018-10-01T08:03:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13974-sma-ora-la-priorita-e-la-qualita-di-vita-pubblicato-il-primo-libro-bianco-sull-atrofia-muscolare-spinale]]></loc><lastmod>2018-09-26T17:55:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13915-atrofia-muscolare-spinale-il-test-di-screening-neonatale-individua-tutte-le-forme]]></loc><lastmod>2018-09-12T18:14:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13916-atrofia-muscolare-spinale-ai-nastri-di-partenza-lo-screening-neonatale-in-lazio-e-toscana]]></loc><lastmod>2018-09-12T18:14:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13904-atrofia-muscolare-spinale-fino-al-6-ottobre-la-nuova-raccolta-fondi-nazionale-di-famiglie-sma]]></loc><lastmod>2018-09-10T12:15:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13902-sma-il-positivo-impatto-di-nusinersen-sulla-qualita-di-vita]]></loc><lastmod>2018-09-10T20:36:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13900-sma-incoraggianti-risultati-clinici-preliminari-per-il-farmaco-risdiplam]]></loc><lastmod>2018-09-10T20:37:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13901-atrofia-muscolare-spinale-al-convegno-di-famiglie-sma-occhi-puntati-sulla-terapia-genica]]></loc><lastmod>2018-09-09T10:20:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13899-sma-con-il-farmaco-nusinersen-benefici-anche-nei-neonati-presintomatici]]></loc><lastmod>2018-09-10T20:37:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13793-sma-un-algoritmo-per-prevedere-la-gravita-della-malattia]]></loc><lastmod>2018-07-30T17:20:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13791-atrofia-muscolare-spinale-sma-parte-la-sperimentazione-clinica-della-terapia-genica-in-italia]]></loc><lastmod>2018-07-26T10:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13762-sma-il-segretario-alla-salute-alex-azar-raccomanda-lo-screening-neonatale-negli-usa]]></loc><lastmod>2018-07-18T15:58:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13724-sma-di-tipo-1-nusinersen-mostra-benefici-anche-nei-pazienti-di-eta-piu-avanzata]]></loc><lastmod>2018-07-04T11:11:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13690-sma-di-tipo-1-con-il-farmaco-risdiplam-miglioramenti-nel-91-dei-bambini-trattati]]></loc><lastmod>2018-06-25T10:39:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13630-atrofia-muscolare-spinale-sicilia-in-prima-linea-nella-lotta-alla-patologia]]></loc><lastmod>2018-06-06T17:27:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13466-sma-il-trattamento-precoce-e-fondamentale-quindi-lo-e-anche-lo-screening-neonatale]]></loc><lastmod>2018-07-18T15:56:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13455-sma-in-lazio-sara-avviato-un-progetto-pilota-per-lo-screening-neonatale]]></loc><lastmod>2018-07-18T15:51:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13351-aifa-135-i-bimbi-in-cura-con-il-nuovo-farmaco-per-la-sma-eleggibili-altri-190]]></loc><lastmod>2018-03-17T17:52:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13328-atrofia-muscolare-spinale-nusinersen-gia-disponibile-in-11-regioni]]></loc><lastmod>2018-03-12T02:56:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13244-atrofia-muscolare-spinale-continua-la-campagna-di-crowdfunding-di-famiglie-sma]]></loc><lastmod>2019-08-18T17:23:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/13242-sma-nusinersen-efficace-anche-nella-malattia-a-insorgenza-infantile-o-adolescenziale]]></loc><lastmod>2018-02-16T15:57:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/12954-sma-al-burlo-garofalo-di-trieste-la-prima-infusione-di-nusinersen]]></loc><lastmod>2018-02-16T16:22:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/12900-atrofia-muscolare-spinale-raccolti-300mila-euro-da-famiglie-sma]]></loc><lastmod>2018-02-16T16:23:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/12707-svolta-epocale-per-la-sma-si-dell-aifa-al-farmaco-spinraza]]></loc><lastmod>2018-09-09T10:27:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/12684-atrofia-muscolare-spinale-fino-al-9-ottobre-la-raccolta-fondi-nazionale]]></loc><lastmod>2018-02-16T16:24:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/12621-atrofia-muscolare-spinale-il-farmaco-nusinersen-apre-una-nuova-era]]></loc><lastmod>2018-02-16T16:24:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/12394-sma-risultati-clinici-incoraggianti-da-olesoxime]]></loc><lastmod>2018-02-16T16:24:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/12355-approvato-in-europa-il-primo-farmaco-per-il-trattamento-della-sma]]></loc><lastmod>2018-02-16T16:25:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/12229-atrofia-muscolare-spinale-via-libera-del-chmp-al-farmaco-nusinersen]]></loc><lastmod>2019-01-17T17:36:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/12096-atrofia-muscolare-spinale-il-farmaco-nusinersen-disponibile-presso-il-centro-clinico-nemo]]></loc><lastmod>2018-02-16T16:25:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11960-atrofia-muscolare-spinale-identificato-nuovo-bersaglio-biologico-per-un-possibile-trattamento]]></loc><lastmod>2018-02-16T16:26:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11761-atrofia-muscolare-spinale-al-via-un-nuovo-studio-di-fase-ii-per-la-molecola-rg7916]]></loc><lastmod>2018-02-16T16:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11770-atrofia-muscolare-spinale-il-farmaco-nusinersen-e-ufficialmente-approvato-negli-stati-uniti]]></loc><lastmod>2018-02-16T16:26:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11633-atrofia-muscolare-spinale-nuovi-dati-clinici-favorevoli-per-il-candidato-farmaco-nusinersen]]></loc><lastmod>2018-02-16T16:27:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11524-atrofia-muscolare-spinale-da-sma-europe-un-bando-per-i-progetti-di-ricerca]]></loc><lastmod>2018-02-16T16:28:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11433-atrofia-muscolare-conclusa-con-successo-la-campagna-di-famiglie-sma]]></loc><lastmod>2018-02-16T16:29:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11421-sma-farmaco-sperimentato-sui-topi-aumenta-la-sopravvivenza-di-38-volte]]></loc><lastmod>2018-02-16T16:29:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11370-atrofia-muscolare-spinale-in-italia-arriva-il-farmaco-per-i-pazienti-piu-gravi]]></loc><lastmod>2018-02-16T16:30:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11202-sma-in-arrivo-un-farmaco-per-200-pazienti-gravi]]></loc><lastmod>2018-02-16T16:30:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11123-atrofia-muscolare-spinale-farmaco-nusinersen-pronto-per-procedure-normative-globali]]></loc><lastmod>2018-02-16T16:31:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/11084-atrofia-muscolare-spinale-di-tipo-1-farmaco-avxs-101-giudicato-terapia-fortemente-innovativa]]></loc><lastmod>2018-02-16T16:32:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/10858-screening-neonatale-per-la-sma-piu-efficace-se-associato-a-quello-per-la-scid]]></loc><lastmod>2016-06-24T13:50:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/10666-sma-il-costo-medio-della-malattia-e-di-70-566-euro-l-anno]]></loc><lastmod>2016-05-20T13:14:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/10285-atrofia-muscolare-spinale-dagli-usa-un-finanziamento-di-225mila-dollari-al-centro-di-trieste]]></loc><lastmod>2016-04-04T07:42:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/10271-atrofia-muscolare-spinale-positive-previsioni-per-il-candidato-farmaco-nusinersen]]></loc><lastmod>2016-03-29T13:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/10180-atrofia-muscolare-spinale-forse-individuato-un-nuovo-potenziale-obiettivo-terapeutico]]></loc><lastmod>2016-03-11T13:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/9910-il-cammino-di-santiago-di-marta-affetta-da-sma-e-del-suo-amico-francesco]]></loc><lastmod>2016-02-08T10:55:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/9869-sma-2-la-vita-intensa-della-piccola-yuliya-nonostante-la-malattia]]></loc><lastmod>2016-02-01T11:34:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/9856-giuseppe-27-anni-e-affetto-sma-non-si-arrende-e-arriva-alle-nazionali-di-wheelchair-hockey]]></loc><lastmod>2016-01-29T15:30:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/9763-atrofia-muscolare-spinale-di-tipo-1-arruolamento-completato-nella-sperimentazione-di-fase-i-su-avxs-101]]></loc><lastmod>2016-08-02T18:17:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/9214-sma-il-sogno-di-eleonora-e-un-progetto-gratuito-dedicato-ai-pazienti-pediatrici]]></loc><lastmod>2015-10-23T09:51:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/8957-sma-fino-al-4-ottobre-campagna-di-raccolta-fondi-di-famiglie-sma-onlus]]></loc><lastmod>2015-09-22T08:47:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/8886-sma-ecco-i-primi-risultati-sulla-terapia-genica-e-farmacologica]]></loc><lastmod>2015-09-09T10:30:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/7896-atrofia-muscolare-con-distress-respiratorio-uno-studio-dimostra-efficacia-di-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/7656-atrofia-muscolare-spinale-il-progetto-smart-a-servizio-dei-malati-e-dei-loro-familiari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/7463-malattie-neuromuscolari-roche-ha-acquistato-trophos]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/7333-atrofia-muscolare-sponale-sma-1-avviata-a-genova-la-sperimentazione-del-farmaco-isis]]></loc><lastmod>2015-09-21T14:41:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/7164-atrofia-muscolare-spinale-asamsi-contattata-da-importante-azienda-famaceutica-per-unintervista-telefonica-a-genitori-e-caregivers]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/7112-atrofia-muscolare-spinale-avviato-oggi-il-trial-clinico-sulla-nuova-molecola-di-roche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/6979-atrofia-muscolare-spinale-disponibile-il-video-della-conferenza-di-presentazione-dei-nuovi-trial-clinici-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/6878-atrofia-muscolare-spinale-si-conclude-con-soddisfazione-la-quarta-campagna-sociale-di-famiglie-sma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/6804-sma-al-via-in-italia-due-tra-le-piu-promettenti-sperimentazioni-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/6749-atrofia-muscolare-spinale-procede-la-campagna-di-raccolta-fondi-di-famiglie-sma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/6297-atrofia-muscolare-spinale-la-sperimentazione-clinica-arrivera-presto-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/6293-sma-concluso-con-successo-il-convegno-nazionale-famiglie-sma-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/6294-sma-concluso-con-successo-il-convegno-nazionale-famiglie-sma-onlus-537109]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/6204-atrofia-muscolare-spinale-sma-una-lettera-per-aiutare-a-conoscerla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/6192-atrofia-muscolare-spinale-la-ricerca-entra-in-una-fase-decisiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/6059-atrofia-muscolare-spinae-arruolato-il-primo-paziente-per-la-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/4504-atrofia-muscolare-spinale-ptc-e-roche-impegnati-nella-ricerca-insieme-alla-fondazione-sma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/3915-atrofia-muscolare-spinale-sma-studio-americano-torna-a-valutare-lutilita-del-riluzolo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/3944-caso-stamina-mercuri-gemelli-ora-litalia-e-vista-come-un-far-west-scientifico-a-rischio-partecipazione-ai-trial-internazionali]]></loc><lastmod>2015-08-03T08:04:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/3515-atrofia-muscolare-spinale-pfizer-e-repligen-avviano-il-programma-chinazolina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/3254-atrofia-muscolare-spinale-per-sostenerla-le-maglie-autografate-dai-calciatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/3205-il-grande-impegno-di-famiglie-sma-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/3041-muoviti-tu-che-puoi-seconda-campagna-sociale-di-famiglie-sma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2763-atrofia-muscolare-spinale-sma-un-farmaco-italiano-riaccende-le-speranze]]></loc><lastmod>2026-01-15T13:44:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2659-atrofia-muscolare-spinale-i-trattamenti-respiratori-aiutano-i-pazienti-a-vivere-piu-a-lungo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2669-atrofia-muscolare-spinale-chiarezza-sul-caso-della-piccola-celeste-celeste]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2653-atrofia-muscolare-spinale-prof-mercuri-q-non-ci-sono-informazioni-sufficienti-per-pensare-che-la-terapia-con-le-staminali-possa-avere-effettoq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2593-atrofia-muscolare-spinale-di-tipo-i-ancora-nessun-farmaco-ha-dimostrato-di-essere-efficace]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2594-atrofia-muscolare-spinale-di-tipo-i-ancora-nessun-farmaco-ha-dimostrato-di-essere-efficace-70306396]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2585-atrofia-muscolare-spinale-potenziale-cura-da-una-proteina-sintetizzata-dal-fegato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2573-atrofia-muscolare-spinale-trenta-esperti-europei-si-sono-incontrati-grazie-a-sma-europe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2549-atrofia-muscolare-spinale-al-via-la-campagna-una-maglietta-per-una-speranza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2209-atrofia-muscolare-spinale-identificata-la-mutazione-che-causa-una-forma-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2186-sma-ausili-e-integratori-di-primaria-importanza-inaccessibili-ai-malati]]></loc><lastmod>2020-09-22T10:55:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2073-atrofia-muscolare-spinale-primi-successi-per-il-trattamento-sperimentale-con-rg3039]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/2029-atrofia-muscolare-spinale-identificata-una-possibile-causa-dei-difetti-di-movimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/1772-atrofia-muscolare-spinale-asamsi-qper-essere-disabili-bisogna-essere-ricchiq]]></loc><lastmod>2017-06-16T15:30:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/1495-sma-al-via-trial-di-fase-i-con-isis-smnrx-che-agisce-sullo-splicing-del-gene-smn2]]></loc><lastmod>2015-12-15T11:55:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/1473-sma-christian-e-nato-grazie-allaiuto-di-asamsi-i-suoi-genitori-stavano-valutando-laborto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/1484-sma-da-oggi-e-fino-a-capodanno-la-raccolta-fondi-muoviti-tu-che-puoi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/1177-atrofia-muscolare-spinale-sma-che-cose-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/483-sma-alla-cattolica-di-roma-messo-a-punto-un-nuovo-biomarcatore-basato-sul-gene-smn2]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/225-sma-nasce-a-palermo-il-centro-nathan-per-dare-aiuto-alle-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sma-atrofia-muscolare-spinale/164-sma-a-breve-una-sperimentazione-di-fase-due-su-pazienti-under-25]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/22176-cheratite-neurotrofica-un-solo-farmaco-approvato-diverse-terapie-sperimentali-in-attesa-di-conferme]]></loc><lastmod>2025-07-13T13:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/21878-cheratite-neurotrofica-quando-la-patologia-insorge-come-conseguenza-di-un-tumore]]></loc><lastmod>2025-04-07T11:35:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/21310-cheratite-neurotrofica-l-approccio-terapeutico-va-stabilito-in-base-allo-stadio-della-malattia]]></loc><lastmod>2024-09-20T17:51:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/21026-fattore-di-crescita-nervoso-una-ricerca-dalle-radici-italiane]]></loc><lastmod>2024-05-28T12:19:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/20802-cheratite-neurotrofica-una-patologia-che-puo-provocare-seri-danni-alla-vista]]></loc><lastmod>2024-03-25T14:46:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/16157-cheratite-neurotrofica-l-incredibile-storia-del-collirio-che-ripara-la-cornea]]></loc><lastmod>2024-03-06T15:22:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/14253-cheratite-neurotrofica-rec-0559-riceve-designazione-di-farmaco-orfano-dalla-fda]]></loc><lastmod>2023-12-20T18:45:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/13148-in-commercio-il-collirio-salva-vista-di-rita-levi-montalcini]]></loc><lastmod>2023-12-20T18:40:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/12483-cheratite-neurotrofica-via-libera-dell-ema-al-collirio-italiano-cenegermin]]></loc><lastmod>2024-06-05T16:48:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/11665-cheratite-neurotrofica-il-ruolo-dei-nervi-della-cornea-nella-genesi-e-nel-trattamento-della-patologia]]></loc><lastmod>2024-06-05T16:57:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/9514-cheratite-neurotrofica-la-molecola-biotecnologica-rhngf-designata-farmaco-orfano-dall-ema]]></loc><lastmod>2024-06-05T16:58:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/6481-cheratite-neurotrofica-negli-usa-rhngf-designato-farmaco-orfano]]></loc><lastmod>2024-06-05T17:03:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/6478-dompe-annuncia-la-designazione-di-farmaco-orfano-per-rhngf-nel-trattamento-della-cheratite-neurotrofica]]></loc><lastmod>2024-06-05T17:06:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/6025-cheratite-neurotrofica-disponibli-i-primi-risultati-sul-trattamento-con-rhngf]]></loc><lastmod>2024-06-05T17:08:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/3662-cheratite-neurotrofica-e-nerve-growth-factor-al-via-la-sperimentazione]]></loc><lastmod>2024-06-05T17:09:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cheratite-neurotrofica/2781-cheratite-neutrofica-al-via-lo-studio-italiano-sul-nerve-growth-factor]]></loc><lastmod>2024-06-05T17:10:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/21708-cistinosi-nefropatica-rispetto-crescita-e-collaborazione-i-punti-chiave-per-una-corretta-fase-di-transizione]]></loc><lastmod>2025-02-10T16:49:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/21690-cistinosi-nefropatica-le-strategie-terapeutiche-attuali-e-quelle-in-via-di-sperimentazione]]></loc><lastmod>2025-02-04T17:13:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/21677-cistinosi-nefropatica-una-malattia-da-accumulo-lisosomiale-che-porta-a-insufficienza-renale]]></loc><lastmod>2025-01-30T16:42:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/21668-cistinosi-nefropatica-serve-diagnosi-precoce-continuita-terapeutica-e-attenzione-alla-transizione]]></loc><lastmod>2025-01-27T16:47:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/20269-cistinosi-negli-usa-si-tenta-la-strada-della-terapia-genica]]></loc><lastmod>2023-10-31T09:52:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/19196-cistinosi-nefropatica-arriva-in-italia-nuovo-farmaco-a-base-di-cisteamina-a-rilascio-ritardato]]></loc><lastmod>2022-10-21T16:42:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/19014-cistinosi-nefropatica-mille-chilometri-in-bici-per-far-conoscere-la-malattia]]></loc><lastmod>2022-09-02T10:53:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/17765-cistinosi-nefropatica-uno-studio-retrospettivo-conferma-la-validita-della-terapia-con-cisteamina]]></loc><lastmod>2021-09-11T21:48:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/17021-cistinosi-nefropatica-l-aderenza-alla-terapia-e-cruciale-per-prevenire-il-danno-renale]]></loc><lastmod>2021-02-14T20:50:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/12436-malattie-rare-chiesi-acquisisce-diritti-su-due-nuove-molecole]]></loc><lastmod>2024-06-17T10:03:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/4356-cistinosi-nefropatica-parere-positivo-del-chmp-per-il-farmaco-procysbi]]></loc><lastmod>2024-06-17T09:54:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cistinosi-nefropatica/2408-cistinosi-nefropatica-presto-un-potenziale-trattamento-a-disposizione-dei-pazienti]]></loc><lastmod>2024-06-17T10:00:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/22604-colestasi-intraepatica-familiare-progressiva-finalmente-abbiamo-dei-farmaci-per-il-sintomo-peggiore-della-malattia-il-prurito]]></loc><lastmod>2025-12-14T23:50:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/22561-colestasi-intraepatica-familiare-progressiva-al-via-il-programma-di-home-delivery-ipsen-for-rare]]></loc><lastmod>2025-11-29T11:39:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/22467-colestasi-intraepatica-familiare-progressiva-ad-oggi-sono-stati-individuati-13-associati-alla-malattia]]></loc><lastmod>2025-10-31T11:37:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/22415-colestasi-intraepatica-familiare-progressiva-maralixibat-rimborsabile-in-italia]]></loc><lastmod>2025-10-16T22:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/22275-dall-afghanistan-a-palermo-per-le-cure-la-piccola-ayeda-ce-l-ha-fatta]]></loc><lastmod>2025-11-18T18:09:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/22143-pfic-italia-network-chiede-aiuto-per-salvare-una-bimba-afghana-con-colestasi-intraepatica-familiare-progressiva]]></loc><lastmod>2025-06-27T18:05:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/22114-colestasi-intraepatica-familiare-progressiva-necessario-migliorare-la-conoscenza-delle-forme-dell-adulto]]></loc><lastmod>2025-06-21T09:51:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/21713-colestasi-intraepatica-familiare-progressiva-odevixibat-riduce-il-prurito-e-migliora-la-qualita-di-vita]]></loc><lastmod>2025-02-13T18:28:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/21628-colestasi-intraepatica-familiare-progressiva-studio-real-world-italiano-conferma-l-efficacia-di-odevixibat]]></loc><lastmod>2025-01-13T15:18:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/21518-colestasi-intraepatica-familiare-progressiva-positivi-i-dati-a-lungo-termine-su-odevixibat]]></loc><lastmod>2024-11-25T16:01:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/21347-colestasi-intraepatica-familiare-progressiva-il-trattamento-con-inibitori-di-ibat-va-iniziato-il-prima-possibile]]></loc><lastmod>2024-10-16T16:59:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/21349-colestasi-intraepatica-familiare-progressiva-una-fiaba-illustrata-per-parlare-della-patologia]]></loc><lastmod>2024-10-02T14:25:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/21325-epatopatia-colestatica-ora-disponibile-vitamina-e-idrosolubile-ad-alto-assorbimento]]></loc><lastmod>2024-09-26T09:06:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/21178-colestasi-intraepatica-familiare-progressiva-maralixibat-approvato-in-europa]]></loc><lastmod>2024-07-18T12:08:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/21049-colestasi-intraepatica-familiare-progressiva-parere-positivo-del-chmp-per-maralixibat]]></loc><lastmod>2024-06-04T12:50:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/20599-colestasi-intraepatica-familiare-progressiva-nasce-l-alleanza-internazionale-delle-associazioni]]></loc><lastmod>2024-02-07T16:06:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/20425-colestasi-intraepatica-familiare-progressiva-al-liver-meeting-nuovi-dati-positivi-su-maralixibat]]></loc><lastmod>2023-12-07T13:43:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/19864-colestasi-intraepatica-familiare-progressiva-l-esperienza-dei-primi-pazienti-italiani-trattati-con-odevixibat]]></loc><lastmod>2023-09-28T15:04:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/19845-colestasi-intraepatica-familiare-progressiva-almeno-12-le-forme-di-malattia-oggi-note]]></loc><lastmod>2025-06-05T10:01:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/19742-colestasi-intraepatica-familiare-progressiva-richiesta-l-approvazione-europea-per-maralixibat]]></loc><lastmod>2023-09-28T15:08:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/19622-colestasi-intraepatica-familiare-progressiva-in-italia-e-disponibile-il-nuovo-farmaco-odevixibat]]></loc><lastmod>2023-09-28T15:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/19417-colestasi-intraepatica-familiare-progressiva-al-papa-giovanni-xxiii-avviata-la-prima-terapia-con-odevixibat]]></loc><lastmod>2023-09-28T15:11:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/19333-colestasi-intraepatica-familiare-progressiva-positivi-dati-di-fase-iii-su-maralixibat]]></loc><lastmod>2023-09-28T15:13:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/16839-colestasi-intraepatica-familiare-progressiva-in-italia-e-appena-nata-l-associazione-dei-pazienti]]></loc><lastmod>2023-09-28T17:32:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/colestasi-intraepatica-familiare-progressiva/1590-colestasi-intraepatica-progressiva-familiare-scoperta-possibile-strategia-farmacologica]]></loc><lastmod>2023-09-28T15:27:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/22788-deficit-di-alfa-1-antitripsina-primi-passi-verso-la-realizzazione-di-un-pdta-in-umbria]]></loc><lastmod>2026-02-24T08:30:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/22568-deficit-di-alfa-1-antitripsina-la-formazione-del-personale-medico-e-il-primo-passo-verso-la-diagnosi]]></loc><lastmod>2025-12-01T17:32:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/22333-deficit-di-alfa-1-antitripsina-necessario-indagare-a-fondo-le-varianti-rare-del-gene-serpina1]]></loc><lastmod>2025-09-30T21:42:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/22049-disturbi-respiratori-ostruttivi-non-va-trascurata-la-possibilita-che-dietro-si-nasconda-un-deficit-di-alfa-1-antitripsina]]></loc><lastmod>2025-06-04T20:19:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/21998-deficit-di-alfa-1-antitripsina-in-alcune-delle-persone-affette-e-piu-alto-il-rischio-di-declino-polmonare]]></loc><lastmod>2025-05-16T17:44:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/21038-deficit-di-alfa-1-antitripsina-non-vanno-sottovalutati-i-risvolti-psicologici-della-malattia]]></loc><lastmod>2024-05-31T17:38:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/20786-deficit-di-alfa-1-antitripsina-importante-indagarne-la-presenza-nei-pazienti-con-bronchiectasie]]></loc><lastmod>2024-03-28T11:35:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/20542-deficit-di-alfa-1-antitripsina-i-consigli-alimentari-per-i-pazienti]]></loc><lastmod>2024-01-24T11:59:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/20359-deficit-di-alfa-1-antitripsina-i-vaccini-raccomandati-per-i-pazienti]]></loc><lastmod>2023-11-20T14:01:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/20254-deficit-di-alfa-1-antitripsina-dall-associazione-alfa1-at-una-serie-di-video-pillole-per-conoscere-la-malattia]]></loc><lastmod>2023-10-23T10:00:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/18577-deficit-di-alfa-1-antitripsina-i-benefici-della-terapia-riabilitativa]]></loc><lastmod>2022-04-24T19:44:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/18558-deficit-di-alfa-1-antitripsina-multidisciplinarieta-e-precocita-d-intervento-le-chiavi-per-un-trattamento-ottimale]]></loc><lastmod>2022-04-21T09:51:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/18541-deficit-di-alfa-1-antitripsina-una-patologia-rara-gravemente-sottodiagnosticata]]></loc><lastmod>2022-04-12T18:21:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/18240-deficit-di-alfa-1-antitripsina-i-consigli-per-rinunciare-alla-cattiva-abitudine-della-sigaretta]]></loc><lastmod>2022-01-30T23:44:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/18178-deficit-di-alfa-1-antitripsina-una-diagnosi-tempestiva-e-fondamentale]]></loc><lastmod>2022-01-20T12:59:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/18009-diagnosi-precoce-e-disassuefazione-dal-fumo-step-importanti-per-gestire-il-deficit-di-alfa1-antitripsina]]></loc><lastmod>2021-11-16T15:43:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/17494-deficit-di-alfa-1-antitripsina-prosegue-il-servizio-di-terapia-domiciliare-gricarealfa1]]></loc><lastmod>2021-05-30T18:22:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/17384-deficit-di-alfa-1-antitripsina-tenendo-sotto-controllo-la-malattia-diventare-mamma-si-puo]]></loc><lastmod>2021-05-02T21:53:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/17279-deficit-di-alfa-1-antitripsina-la-testimonianza-di-enrico-grazie-alla-terapia-non-ho-dovuto-rinunciare-alla-mia-vita]]></loc><lastmod>2021-04-11T19:09:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/17267-deficit-di-alfa-1-antitripsina-in-sardegna-a-rischio-la-continuita-terapeutica-dei-pazienti]]></loc><lastmod>2021-04-09T14:58:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/17201-deficit-di-alfa-1-antitripsina-nasce-un-algoritmo-per-la-gestione-dei-pazienti]]></loc><lastmod>2021-03-21T20:02:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/17126-deficit-di-alfa-1-antitripsina-servono-diagnosi-tempestive-e-rapido-accesso-alla-terapia]]></loc><lastmod>2025-11-21T18:18:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/17087-deficit-di-alfa-1-antitripsina-assistere-e-informare-questo-l-obiettivo-dell-associazione-alfa1-at]]></loc><lastmod>2021-02-28T15:36:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/16982-deficit-di-alfa-1-antitripsina-si-indaga-la-sovrapposizione-con-le-forme-piu-gravi-di-covid-19]]></loc><lastmod>2021-02-07T19:27:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/16826-deficit-di-alfa-1-antitripsina-la-continuita-terapeutica-e-un-aspetto-fondamentale]]></loc><lastmod>2020-12-20T22:45:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/16671-deficit-di-alfa-1-antitripsina-la-terapia-enzimatica-e-efficace-ma-va-iniziata-presto]]></loc><lastmod>2020-11-10T13:43:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/16552-deficit-di-alfa-1-antitripsina-solo-un-quinto-dei-pazienti-italiani-riceve-una-diagnosi]]></loc><lastmod>2020-10-11T21:41:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/16219-deficit-di-alfa-1-antitripsina-da-grifols-un-servizio-di-domiciliazione-della-terapia]]></loc><lastmod>2020-06-24T11:16:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/16138-deficit-di-alfa-1-antitripsina-csl-behring-attiva-il-servizio-respeera-home]]></loc><lastmod>2020-06-07T20:22:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/16085-deficit-di-alfa-1-antitripsina-una-patologia-genetica-sotto-diagnosticata]]></loc><lastmod>2020-05-24T10:23:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/11312-deficit-di-alfa-1-antitripsina-al-via-studio-di-fase-ii-su-farmaco-contro-effetti-epatici]]></loc><lastmod>2020-05-12T16:25:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/10520-deficit-di-alfa-1-antitripsina-il-farmaco-respreeza-ora-disponibile-in-italia]]></loc><lastmod>2020-05-12T16:32:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/9908-deficit-di-alfa-1-antitripsina-ema-attribuisce-ad-arc-aat-la-designazione-di-farmaco-orfano]]></loc><lastmod>2020-05-12T16:38:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/9261-deficit-di-alfa-1-antitripsina-inibitore-dell-alfa-1-proteinasi-puo-rallentarne-la-progressione]]></loc><lastmod>2020-05-12T16:42:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/8761-deficit-di-alfa-1-antitripsina-in-avvio-lo-studio-di-fase-i-ii-su-aln-aat-terapia-per-la-malattia-epatica-associata]]></loc><lastmod>2020-05-12T16:47:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/8629-deficit-di-alfa-1-antitripsina-prosegue-lo-studio-di-fase-i-del-farmaco-sperimentale-arc-aat]]></loc><lastmod>2020-05-12T16:55:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/7822-malattie-respiratorie-correlate-a-deficit-di-alfa1-antritripsina-in-arrivo-documento-dellaipo]]></loc><lastmod>2020-05-12T17:36:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/5284-deficit-di-alfa-1-antitripsina-risultati-incoraggianti-ottenuti-dallimpiego-di-aat-inalatoria]]></loc><lastmod>2020-05-12T16:58:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/4239-deficit-da-alfa1-antitripsina-aat-risultati-positivi-per-linibitore-prolastin-c]]></loc><lastmod>2020-05-12T17:07:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/3624-telethon-funziona-in-laboratorio-la-terapia-genica-per-una-rara-malattia-epatica]]></loc><lastmod>2020-05-12T17:42:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/3285-deficit-da-alfa-1-antitripsina-disponibili-le-linee-guida-orphanet-per-la-gestione-delle-emergenze]]></loc><lastmod>2020-05-12T17:12:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/3277-deficit-da-alfa-1-antitripsina-nuove-speranze-per-la-malattia-epatica-correlata]]></loc><lastmod>2020-05-12T17:22:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-alfa-1-antitripsina/2177-il-deficit-di-alfa-1-antitripsina-aatd-malattia-rara-del-polmone-puo-essere-trattata-con-la-terapia-sostitutiva]]></loc><lastmod>2020-05-12T17:30:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-ormone-della-crescita]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-ormone-della-crescita/22589-deficit-ormone-della-crescita-una-malattia-dal-duro-impatto-psicologico]]></loc><lastmod>2025-12-09T08:18:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-ormone-della-crescita/22286-buona-crescita-buona-salute-torna-la-campagna-di-sensibilizzazione-sulla-crescita-dei-bambini]]></loc><lastmod>2025-12-10T18:47:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-ormone-della-crescita/20131-deficit-dell-ormone-della-crescita-oggi-20-settembre-la-giornata-mondiale]]></loc><lastmod>2025-12-10T18:52:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/22380-deficit-di-piruvato-chinasi-tra-le-possibili-complicanze-anche-i-disturbi-cardiopolmonari]]></loc><lastmod>2025-10-08T10:54:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/22167-deficit-di-piruvato-chinasi-sempre-piu-solide-le-evidenze-sull-efficacia-di-mitapivat-nei-pazienti-pediatrici]]></loc><lastmod>2025-07-07T20:47:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/22110-malattie-ematologiche-rare-avanzanite-annuncia-accordo-con-agios-per-la-commercializzazione-di-mitapivat-in-europa]]></loc><lastmod>2025-06-19T15:41:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/21954-deficit-di-piruvato-chinasi-pubblicato-l-aggiornamento-delle-linee-guida-sulla-gestione-della-patologia]]></loc><lastmod>2025-05-05T12:23:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/19802-deficit-di-piruvato-chinasi-con-mitapivat-e-possibile-ridurre-il-bisogno-di-trasfusioni]]></loc><lastmod>2023-05-12T15:58:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/19448-deficit-di-piruvato-chinasi-il-presente-e-il-futuro-della-terapia]]></loc><lastmod>2023-01-17T22:01:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/19328-deficit-di-piruvato-chinasi-approvazione-europea-per-il-farmaco-mitapivat]]></loc><lastmod>2022-11-24T18:30:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/19159-deficit-di-piruvato-chinasi-la-chiave-e-la-diagnosi-differenziale]]></loc><lastmod>2022-10-07T17:47:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/18905-deficit-di-piruvato-chinasi-dagli-esperti-italiani-un-algoritmo-per-individuare-prima-la-malattia]]></loc><lastmod>2022-07-09T21:22:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/18763-deficit-di-piruvato-chinasi-una-malattia-piu-diffusa-di-quanto-si-pensi]]></loc><lastmod>2022-06-13T13:01:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/deficit-di-piruvato-chinasi/18529-deficit-di-piruvato-chinasi-quando-la-mancanza-di-un-enzima-compromette-la-sopravvivenza-dei-globuli-rossi]]></loc><lastmod>2025-06-12T16:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/difetti-della-sintesi-degli-acidi-biliari]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/difetti-della-sintesi-degli-acidi-biliari/22538-una-traccia-nelle-urine-il-valore-della-spettrometria-per-la-diagnosi-dei-difetti-della-sintesi-degli-acidi-biliari]]></loc><lastmod>2025-11-23T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/difetti-della-sintesi-degli-acidi-biliari/22313-difetti-della-sintesi-degli-acidi-biliari-la-storia-a-lieto-fine-di-andrea-nato-con-un-enzima-mancante]]></loc><lastmod>2025-09-16T10:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/difetti-della-sintesi-degli-acidi-biliari/22077-difetti-della-sintesi-degli-acidi-biliari-un-gruppo-di-rarissime-malattie-epatiche-di-origine-genetica]]></loc><lastmod>2025-06-11T18:13:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22934-duchenne-givinostat-e-ufficialmente-rimborsabile-in-italia]]></loc><lastmod>2026-04-14T18:04:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22933-duchenne-ritirata-la-richiesta-di-approvazione-di-ataluren-negli-stati-uniti]]></loc><lastmod>2026-04-14T16:17:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22814-distrofia-muscolare-di-duchenne-aifa-approva-la-rimborsabilita-di-givinostat]]></loc><lastmod>2026-03-03T13:11:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22813-distrofia-di-duchenne-traiettorie-di-cambiamento-alla-conferenza-internazionale-di-parent-project]]></loc><lastmod>2026-03-03T12:56:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22801-duchenne-il-dramma-di-abdel-rahman-un-ponte-sanitario-mancato-tra-gaza-e-litalia]]></loc><lastmod>2026-02-28T16:30:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22641-scoperto-un-nuovo-biomarcatore-della-rigenerazione-muscolare-nelle-distrofinopatie]]></loc><lastmod>2026-01-02T18:42:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22489-distrofia-muscolare-di-duchenne-favorevoli-risultati-a-lungo-termine-per-vamorolone]]></loc><lastmod>2025-11-07T11:50:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22316-distrofia-muscolare-di-duchenne-cresce-il-progetto-parent-project-on-the-road]]></loc><lastmod>2025-09-17T12:10:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22274-giornata-mondiale-della-distrofia-di-duchenne-al-via-la-campagna-con-tutta-la-forza-che-ho]]></loc><lastmod>2025-09-04T21:04:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22267-duchenne-positivi-i-dati-clinici-a-lungo-termine-su-givinostat]]></loc><lastmod>2025-09-02T14:45:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22240-distrofia-muscolare-di-duchenne-il-chmp-dice-no-alla-terapia-genica]]></loc><lastmod>2025-08-05T18:32:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22224-duchenne-incontro-tra-pazienti-e-aifa-per-discutere-delle-problematiche-sorte-in-merito-all-importazione-di-ataluren]]></loc><lastmod>2025-07-29T09:48:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22202-distrofia-di-duchenne-interrogazione-per-garantire-la-continuita-terapeutica-ai-pazienti-in-trattamento]]></loc><lastmod>2025-07-18T10:23:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22103-duchenne-secondo-decesso-in-un-trial-di-terapia-genica]]></loc><lastmod>2025-06-18T08:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22101-duchenne-aifa-autorizza-la-fornitura-di-ataluren-per-garantire-la-continuita-terapeutica-dei-pazienti-in-trattamento]]></loc><lastmod>2025-07-29T09:29:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/22042-duchenne-il-position-paper-di-aim-sul-ritiro-dal-mercato-europeo-di-ataluren-pubblicato-su-rivista-internazionale]]></loc><lastmod>2025-06-03T14:38:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21947-duchenne-ricorso-alla-corte-di-giustizia-europea-per-mantenere-in-commercio-ataluren]]></loc><lastmod>2025-04-30T14:41:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21940-distrofia-muscolare-di-duchenne-parere-positivo-del-chmp-su-givinostat]]></loc><lastmod>2025-04-29T11:01:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21867-duchenne-revocata-l-autorizzazione-alla-commercializzazione-di-ataluren-in-europa]]></loc><lastmod>2025-04-02T10:30:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21798-duchenne-nasce-una-piattaforma-dedicata-alla-patologia]]></loc><lastmod>2025-03-11T16:23:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21688-duchenne-ataluren-una-nuova-lettera-aperta-alla-commissione-europea-da-parte-dei-pazienti]]></loc><lastmod>2025-02-04T15:02:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21606-duchenne-la-precisazione-di-parent-project-vamorolone-non-e-ancora-rimborsabile-in-italia]]></loc><lastmod>2024-12-20T16:13:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21596-distrofia-muscolare-di-duchenne-aifa-approva-vamorolone]]></loc><lastmod>2024-12-20T09:39:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21569-distrofia-di-duchenne-dall-aim-il-position-paper-contrari-alla-decisione-di-ema-su-ataluren]]></loc><lastmod>2024-12-11T10:27:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21502-distrofia-muscolare-come-si-fa-a-diventare-genitori]]></loc><lastmod>2024-11-20T17:49:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21444-distrofia-muscolare-di-duchenne-fda-valutera-l-approvazione-di-ataluren]]></loc><lastmod>2024-10-31T09:31:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21410-distrofia-muscolare-di-duchenne-concluso-il-progetto-parent-project-on-the-road]]></loc><lastmod>2025-09-17T12:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21413-duchenne-il-chmp-conferma-parere-negativo-su-ataluren-dopo-il-riesame]]></loc><lastmod>2024-10-26T15:12:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21382-duchenne-pazienti-e-clinici-rivolgono-nuovo-appello-all-ema-su-ataluren]]></loc><lastmod>2024-10-11T08:33:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21264-duchenne-sabato-7-settembre-torna-la-giornata-mondiale-dedicata-alla-patologia]]></loc><lastmod>2024-09-06T14:43:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21131-duchenne-nuova-bocciatura-del-chmp-per-ataluren]]></loc><lastmod>2024-07-02T18:08:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21137-duchenne-la-fda-estende-l-uso-della-terapia-genica-di-sarepta]]></loc><lastmod>2024-07-02T18:01:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/21139-duchenne-lo-studio-di-fase-iii-sulla-terapia-genica-di-pfizer-non-raggiunge-l-endpoint-primario]]></loc><lastmod>2024-07-03T10:58:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20997-duchenne-le-associazioni-accolgono-con-soddisfazione-la-decisione-della-commissione-europea-sul-farmaco-ataluren]]></loc><lastmod>2024-05-21T10:36:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20996-duchenne-la-commissione-europea-rigetta-il-parere-negativo-del-chmp-su-ataluren]]></loc><lastmod>2024-05-20T15:44:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20970-duchenne-ancora-in-attesa-della-decisione-definitiva-su-ataluren-ma-aifa-garantisce-la-continuita-ai-pazienti-attualmente-in-terapia]]></loc><lastmod>2024-06-24T09:24:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20965-duchenne-un-bambino-e-morto-durante-la-sperimentazione-clinica-della-terapia-genica-cosa-vuol-dire]]></loc><lastmod>2024-05-13T11:27:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20866-duchenne-le-famiglie-ancora-in-attesa-di-una-decisione-europea-sul-farmaco-translarna]]></loc><lastmod>2024-10-30T13:28:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20793-distrofia-di-duchenne-il-farmaco-givinostat-ha-dimostrato-di-ritardare-la-progressione-di-malattia]]></loc><lastmod>2024-03-22T12:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20690-distrofia-di-duchenne-le-famiglie-si-appellano-al-presidente-mattarella-non-togliamo-tempo-e-speranza-ai-nostri-figli]]></loc><lastmod>2024-02-28T17:45:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20681-distrofia-di-duchenne-e-becker-conclusa-la-xxi-conferenza-internazionale-di-parent-project]]></loc><lastmod>2024-02-26T22:12:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20652-distrofia-di-duchenne-la-comunita-medica-e-associativa-italiana-si-appella-a-commissione-europea-e-ema-per-translarna]]></loc><lastmod>2024-02-21T16:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20558-duchenne-il-chmp-conferma-il-proprio-no-sul-farmaco-ataluren]]></loc><lastmod>2024-01-26T11:17:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20551-duchenne-rientra-l-allarme-fornitura-farmaco-ma-si-attende-ancora-parere-chmp-per-ataluren]]></loc><lastmod>2024-01-26T11:22:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20546-duchenne-l-appello-di-mamma-elena-senza-il-farmaco-ataluren-il-futuro-ci-fa-paura]]></loc><lastmod>2024-01-23T09:29:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20503-distrofia-di-duchenne-800-famiglie-in-attesa-della-decisione-del-chmp-su-translarna]]></loc><lastmod>2024-01-12T09:01:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20487-distrofia-muscolare-di-duchenne-in-europa-arriva-il-farmaco-vamorolone]]></loc><lastmod>2023-12-29T16:38:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20372-distrofia-muscolare-di-duchenne-parere-positivo-del-chmp-per-vamorolone]]></loc><lastmod>2023-11-21T17:58:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20138-duchenne-dal-chmp-una-decisione-negativa-su-translarna-ma-per-ora-nessuno-stop-alla-somministrazione-del-farmaco]]></loc><lastmod>2024-10-30T13:27:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/20095-distrofia-muscolare-di-duchenne-il-7-settembre-si-celebra-la-giornata-mondiale]]></loc><lastmod>2023-09-06T21:37:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/19963-duchenne-approvata-negli-usa-la-prima-terapia-genica-indicata-per-la-malattia]]></loc><lastmod>2023-06-28T17:07:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/19914-duchenne-serve-piu-attenzione-alla-transizione-del-paziente-da-eta-pediatrica-ad-adulta]]></loc><lastmod>2023-06-19T10:48:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/19575-distrofia-muscolare-di-duchenne-conclusa-la-xx-conferenza-di-parent-project]]></loc><lastmod>2023-02-28T16:01:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/19585-therareside-2023-diritti-al-lavoro-la-storia-di-mattia]]></loc><lastmod>2023-03-01T20:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/19508-distrofia-muscolare-di-duchenne-al-via-la-nona-edizione-del-programma-strive-awards]]></loc><lastmod>2023-02-03T18:16:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/19470-distrofia-muscolare-uildm-lancia-il-nuovo-sito-dedicato-al-servizio-civile]]></loc><lastmod>2023-01-21T12:24:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/18846-duchenne-nuovi-dati-positivi-sul-trattamento-con-givinostat-da-studio-di-fase-3]]></loc><lastmod>2022-06-27T13:10:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/18595-duchenne-la-testimonianza-di-francesco-grazie-a-uildm-ho-scoperto-me-stesso]]></loc><lastmod>2022-05-01T16:22:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/18386-vivere-con-una-malattia-rara-nell-era-covid-l-infografica-di-parent-project]]></loc><lastmod>2022-03-06T21:46:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/18353-distrofia-muscolare-di-duchenne-e-becker-conclusa-la-xix-conferenza-di-parent-project]]></loc><lastmod>2022-02-27T18:41:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/18233-distrofia-muscolare-di-duchenne-pubblicato-il-libro-tutto-di-me]]></loc><lastmod>2022-01-30T17:46:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/18184-distrofia-muscolare-di-duchenne-al-via-l-ottava-edizione-degli-strive-awards]]></loc><lastmod>2022-01-18T14:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/18136-malattie-neuromuscolari-uildm-chiarisce-alcuni-dubbi-rispetto-alla-vaccinazione-anti-covid-nei-bambini]]></loc><lastmod>2021-12-27T14:08:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17995-distrofia-di-duchenne-e-becker-la-nuova-campagna-poteva-andarmi-peggio-diventa-virale]]></loc><lastmod>2021-11-13T19:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17753-distrofia-muscolare-di-duchenne-oggi-la-giornata-mondiale-2]]></loc><lastmod>2021-09-07T10:58:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17685-distrofie-muscolari-da-fondazione-telethon-e-uildm-oltre-900mila-euro-per-la-ricerca]]></loc><lastmod>2021-07-25T17:59:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17669-duchenne-ataluren-rimborsabile-in-italia-per-pazienti-a-partire-da-due-anni-di-eta]]></loc><lastmod>2021-07-19T09:45:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17635-duchenne-parent-project-scrive-una-lettera-ad-aifa-in-merito-al-farmaco-eteplirsen]]></loc><lastmod>2021-07-11T16:13:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17617-distrofie-muscolari-e-miopatie-nasce-il-registro-italiano]]></loc><lastmod>2021-07-04T15:12:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17214-duchenne-la-diagnosi-arriva-all-eta-di-6-anni-la-asl-risarcisce-la-famiglia]]></loc><lastmod>2021-03-23T12:40:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17175-distrofia-muscolare-di-duchenne-e-becker-per-pasqua-fai-una-sorpresa-alla-ricerca]]></loc><lastmod>2021-03-14T15:25:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17132-distrofia-muscolare-di-becker-parent-project-presenta-le-prime-linee-guida-al-mondo]]></loc><lastmod>2021-03-06T22:42:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17051-duchenne-al-policlinico-gemelli-la-prima-somministrazione-italiana-di-terapia-genica]]></loc><lastmod>2021-02-21T15:53:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/17037-duchenne-il-farmaco-che-potrebbe-migliorare-la-vita-di-lele-ma-che-ema-non-ha-approvato]]></loc><lastmod>2021-02-17T11:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16910-duchenne-al-via-la-settima-edizione-degli-strive-awards]]></loc><lastmod>2021-01-20T17:38:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16899-distrofia-di-duchenne-e-becker-volge-al-termine-il-progetto-ri-gene-rare]]></loc><lastmod>2021-01-19T21:52:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16840-duchenne-terapia-genica-in-sperimentazione-anche-in-italia]]></loc><lastmod>2020-12-23T10:38:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16814-duchenne-pubblicato-un-libro-bianco-che-racconta-il-cambiamento-epocale]]></loc><lastmod>2022-05-24T16:40:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16804-distrofia-di-duchenne-e-becker-lanciata-l-edizione-2020-de-il-natale-di-parent-project]]></loc><lastmod>2020-12-13T23:44:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16541-duchenne-stop-allo-sviluppo-clinico-del-farmaco-idebenone]]></loc><lastmod>2020-10-08T10:02:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16473-duchenne-scoperto-un-nuovo-promettente-approccio-terapeutico]]></loc><lastmod>2020-09-23T18:09:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16463-duchenne-la-lettera-aperta-di-parent-project-al-ministro-dell-istruzione]]></loc><lastmod>2020-09-20T17:05:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16408-distrofia-muscolare-di-duchenne-si-celebra-oggi-la-giornata-mondiale]]></loc><lastmod>2020-09-07T10:37:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16106-duchenne-arruolamento-completato-nello-studio-sideros-sul-farmaco-idebenone]]></loc><lastmod>2020-05-25T15:49:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16108-distrofia-muscolare-scoperte-le-cellule-che-impediscono-ai-muscoli-di-indebolirsi]]></loc><lastmod>2020-05-26T21:05:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16074-distrofia-di-duchenne-e-becker-nasce-un-nuovo-portale-dedicato]]></loc><lastmod>2020-05-18T14:11:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16033-duchenne-buone-notizie-dal-programma-di-sviluppo-clinico-di-givinostat]]></loc><lastmod>2020-05-05T16:58:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/16013-duchenne-il-1-maggio-la-maratona-di-parent-project-per-finanziare-la-ricerca]]></loc><lastmod>2020-04-29T14:25:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15769-coronavirus-la-lettera-di-uildm-per-rimettere-al-centro-la-persona]]></loc><lastmod>2020-03-17T17:25:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15730-malattie-neuromuscolari-un-team-di-donne-per-una-diagnosi-precoce]]></loc><lastmod>2020-03-08T00:26:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15673-distrofia-muscolare-di-duchenne-lanciata-la-nuova-edizione-degli-strive-awards]]></loc><lastmod>2020-02-18T13:20:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15627-distrofia-muscolare-di-duchenne-ataluren-rallenta-la-perdita-della-capacita-di-deambulazione]]></loc><lastmod>2020-02-03T22:56:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15595-distrofia-muscolare-nasce-il-progetto-a-scuola-di-inclusione-giocando-si-impara]]></loc><lastmod>2020-01-20T19:28:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15507-distrofia-di-duchenne-golodirsen-approvato-negli-stati-uniti]]></loc><lastmod>2019-12-14T15:40:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15481-distrofia-muscolare-di-duchenne-in-italia-colpiti-oltre-2-000-giovani]]></loc><lastmod>2019-12-05T16:17:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15464-distrofia-di-duchenne-a-natale-il-panettone-diventa-influencer-per-la-ricerca]]></loc><lastmod>2019-12-01T20:42:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15418-distrofia-di-duchenne-in-bici-da-roma-a-berlino-per-abbattere-il-muro-della-malattia]]></loc><lastmod>2019-11-18T14:27:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15412-distrofia-muscolare-di-duchenne-interrotto-lo-sviluppo-del-farmaco-rg6206]]></loc><lastmod>2019-11-16T23:20:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15381-duchenne-il-film-new-lives-selezionato-dal-festival-disorder]]></loc><lastmod>2019-11-06T21:53:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15329-malattie-neuromuscolari-dalla-federazione-pediatri-il-primo-spot-per-genitori]]></loc><lastmod>2019-11-14T11:46:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15331-distrofia-muscolare-di-duchenne-la-diagnosi-precoce-e-essenziale]]></loc><lastmod>2019-10-20T18:32:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15282-distrofia-muscolare-di-duchenne-ataluren-rallenta-la-progressione-della-malattia]]></loc><lastmod>2019-10-08T09:41:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15259-distrofia-di-duchenne-in-italia-uno-studio-pilota-su-diagnosi-neonatale-e-infantile]]></loc><lastmod>2019-10-02T10:12:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15230-distrofia-di-duchenne-attivato-in-italia-un-programma-di-uso-compassionevole-per-ataluren]]></loc><lastmod>2019-09-23T17:20:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15168-distrofia-di-duchenne-annunciati-i-vincitori-degli-strive-awards-2019]]></loc><lastmod>2019-09-09T11:48:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15127-duchenne-fda-dice-no-all-approvazione-accelerata-di-golodirsen]]></loc><lastmod>2019-08-21T15:34:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15122-duchenne-il-prossimo-7-settembre-si-celebra-la-giornata-mondiale]]></loc><lastmod>2019-10-31T16:11:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15102-distrofia-di-duchenne-parent-project-lancia-un-nuovo-servizio-per-i-pazienti]]></loc><lastmod>2019-08-03T17:25:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/15008-duchenne-il-chmp-europeo-boccia-l-impiego-di-ataluren-in-pazienti-non-deambulanti]]></loc><lastmod>2019-07-08T17:15:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14954-distrofie-muscolari-vertex-mira-all-editing-del-genoma]]></loc><lastmod>2019-06-25T18:47:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14802-distrofia-di-duchenne-ptc-annuncia-i-tre-beneficiari-del-programma-priority]]></loc><lastmod>2019-09-10T14:20:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14723-duchenne-al-via-la-campagna-di-parent-project-il-paziente-al-centro]]></loc><lastmod>2019-10-31T16:11:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14699-distrofia-muscolare-di-duchenne-battaglia-legale-per-una-diagnosi-tardiva]]></loc><lastmod>2019-04-07T16:40:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14549-duchenne-l-obiettivo-e-ridurre-i-tempi-di-diagnosi-da-5-a-2-anni]]></loc><lastmod>2019-09-10T14:18:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14544-duchenne-intesa-centogene-sarepta-per-l-identificazione-di-pazienti]]></loc><lastmod>2019-03-06T11:59:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14479-distrofia-di-duchenne-via-libera-della-fda-alla-revisione-prioritaria-di-golodirsen]]></loc><lastmod>2019-02-18T19:13:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14476-distrofia-di-duchenne-e-becker-grande-successo-per-la-xvii-conferenza-internazionale]]></loc><lastmod>2019-02-18T17:30:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14462-duchenne-ptc-lancia-la-quinta-edizione-degli-strive-grant-awards]]></loc><lastmod>2019-09-10T14:18:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14359-distrofia-muscolare-di-duchenne-ancora-troppi-ritardi-nella-diagnosi]]></loc><lastmod>2019-01-16T11:52:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14278-come-funziona-la-rigenerazione-muscolare-quattro-video-per-capirlo]]></loc><lastmod>2018-12-13T17:09:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14217-duchenne-risultati-positivi-dai-primi-pazienti-trattati-con-micro-distrofina]]></loc><lastmod>2018-11-28T18:53:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14204-distrofia-di-duchenne-al-via-la-campagna-di-raccolta-fondi-in-viaggio-con-luca]]></loc><lastmod>2019-10-31T16:14:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/distrofia-di-duchenne-che-cose]]></loc><lastmod>2019-08-06T10:45:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14045-duchenne-sarepta-si-accorda-con-paragon-per-produrre-la-terapia-genica]]></loc><lastmod>2018-11-04T18:43:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14054-duchenne-troppe-diagnosi-in-ritardo-al-via-il-progetto-peter-pan]]></loc><lastmod>2018-10-17T11:26:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14042-distrofia-muscolare-di-duchenne-interrotto-lo-sviluppo-clinico-di-domagrozumab]]></loc><lastmod>2018-10-17T08:36:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/14007-duchenne-ptc-therapeutics-annuncia-i-dati-preliminari-dal-registro-pazienti-stride]]></loc><lastmod>2018-10-11T14:19:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13972-duchenne-fda-annulla-sospensione-dello-studio-clinico-sulla-terapia-genica]]></loc><lastmod>2019-01-17T15:32:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13956-distrofia-di-duchenne-parere-sfavorevole-del-chmp-per-eteplirsen]]></loc><lastmod>2018-09-23T16:56:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13920-duchenne-nuovo-studio-getta-luce-sul-processo-di-degenerazione-muscolare]]></loc><lastmod>2018-09-13T17:09:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13893-distrofia-muscolare-di-duchenne-oggi-la-giornata-mondiale]]></loc><lastmod>2018-09-06T18:21:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13894-distrofia-muscolare-di-duchenne-la-malattia-rara-piu-comune-nei-bambini]]></loc><lastmod>2018-09-06T18:00:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13825-distrofia-muscolare-di-duchenne-si-conclude-il-progetto-autonoimia]]></loc><lastmod>2018-08-06T10:33:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13819-distrofia-di-duchenne-e-becker-da-parent-project-finanziamenti-per-la-ricerca]]></loc><lastmod>2018-08-06T10:34:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13796-duchenne-sospeso-il-trial-di-terapia-genica-di-sarepta]]></loc><lastmod>2018-09-26T15:14:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13788-distrofia-di-duchenne-nuovi-dati-dimostrano-il-beneficio-clinico-di-deflazacort]]></loc><lastmod>2018-07-25T15:26:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13748-distrofia-di-duchenne-dati-positivi-per-ataluren-a-partire-dai-due-anni-di-eta]]></loc><lastmod>2018-07-10T14:47:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13673-distrofia-di-duchenne-quali-sono-i-campanelli-d-allarme-prima-dei-2-anni]]></loc><lastmod>2018-06-19T07:54:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13632-distrofia-di-becker-al-via-a-milano-un-nuovo-trial-clinico]]></loc><lastmod>2018-06-06T17:20:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13625-duchenne-l-ema-raccomanda-ataluren-per-bambini-dai-2-ai-5-anni]]></loc><lastmod>2018-06-05T11:47:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13613-distrofia-di-becker-cosa-significa-vivere-nell-imprevedibilita]]></loc><lastmod>2018-06-04T10:20:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13587-distrofia-di-becker-l-importanza-di-una-gestione-clinica-multidisciplinare]]></loc><lastmod>2018-05-25T15:44:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13588-distrofia-muscolare-di-becker-essenziale-la-diagnosi-genetica]]></loc><lastmod>2018-05-25T16:19:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13561-distrofia-di-duchenne-e-becker-trenta-sogni-in-arrivo-per-i-bambini-di-parent-project]]></loc><lastmod>2018-05-19T10:50:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13549-distrofia-di-duchenne-sarepta-e-invitae-ampliano-la-partnership-per-la-ricerca]]></loc><lastmod>2018-05-11T15:58:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13555-duchenne-partita-da-catania-la-task-force-early-diagnosis-voluta-da-ptc-therapeutics]]></loc><lastmod>2018-05-14T10:00:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13540-distrofia-di-duchenne-e-becker-da-parent-project-una-masterclass-interattiva-per-caregiver-e-pazienti]]></loc><lastmod>2018-05-11T11:56:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13485-distrofia-di-duchenne-crispr-cas9-cura-o-solo-terapia]]></loc><lastmod>2018-04-24T23:12:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13474-distrofia-di-duchenne-la-nuova-generazione-degli-oligonucleotidi-antisenso]]></loc><lastmod>2018-04-20T13:23:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13471-distrofia-di-duchenne-da-parent-project-usa-2-5-milioni-di-dollari-per-la-terapia-genica]]></loc><lastmod>2018-11-28T18:39:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13470-distrofia-di-duchenne-le-potenzialita-e-i-limiti-della-terapia-genica]]></loc><lastmod>2018-11-28T18:42:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13433-duchenne-utilizzata-per-la-prima-volta-su-un-bimbo-la-terapia-genica-con-mini-distrofina-sperimentale]]></loc><lastmod>2018-04-13T09:29:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13401-distrofia-di-duchenne-elaborati-geni-artificiali-a-scopo-terapeutico]]></loc><lastmod>2019-01-23T12:32:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13307-bambini-duchenne-gli-ambiti-neuropsicologici-in-cui-hanno-difficolta]]></loc><lastmod>2018-03-05T10:35:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13306-distrofia-di-duchenne-per-i-bambini-minore-velocita-nell-apprendere-dall-esperienza]]></loc><lastmod>2018-03-05T10:36:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13295-distrofia-di-duchenne-e-becker-ricerca-e-quotidianita-alla-xvi-conferenza-di-parent-project-onlus]]></loc><lastmod>2018-03-01T01:00:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13290-ptc-therapeutics-ricorda-i-150-anni-dalla-descrizione-della-distrofia-muscolare-di-duchenne]]></loc><lastmod>2018-02-27T23:58:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13224-distrofia-di-duchenne-buoni-risultati-dallo-studio-di-fase-ii-su-ezutromid]]></loc><lastmod>2018-02-13T19:48:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13225-duchenne-pazienti-usa-potranno-accedere-al-farmaco-sperimentale-idebenone]]></loc><lastmod>2018-02-12T19:49:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13086-duchenne-con-ataluren-beneficio-motorio-per-specifici-pazienti]]></loc><lastmod>2018-01-09T02:15:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/13015-duchenne-omar-e-parent-project-insieme-per-offrire-consigli-alle-famiglie]]></loc><lastmod>2017-12-11T14:53:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12888-duchenne-parte-la-campagna-il-natale-goloso-di-parent-project]]></loc><lastmod>2017-11-12T16:15:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12868-distrofia-di-duchenne-da-parent-project-un-nuovo-progetto-di-teleconsulenza]]></loc><lastmod>2017-11-07T21:26:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12660-distrofia-di-duchenne-medici-sentinella-per-ridurre-i-tempi-della-diagnosi]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12625-giornata-mondiale-duchenne-ptc-therapeutics-annuncia-i-vincitori-degli-strive-awards-e-le-iniziative-italiane]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12580-distrofia-di-duchenne-oggi-il-problema-piu-grave-e-l-insufficienza-cardiaca]]></loc><lastmod>2017-10-12T22:55:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12532-distrofia-di-duchenne-nuovi-dati-da-uno-studio-di-fase-iii-sul-farmaco-ataluren]]></loc><lastmod>2017-10-12T22:56:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12472-distrofia-di-duchenne-attivo-il-servizio-esperto-risponde]]></loc><lastmod>2017-10-12T22:56:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12188-distrofia-di-duchenne-becker-parent-project-pubblica-una-guida-per-le-donne-portatrici]]></loc><lastmod>2017-10-12T22:56:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12155-distrofia-di-duchenne-il-progetto-di-carlo-per-garantire-ai-disabili-l-accessibilita-ai-cinema]]></loc><lastmod>2017-10-12T22:56:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12147-distrofia-di-duchenne-in-commercio-la-prima-terapia-per-le-mutazioni-nonsenso]]></loc><lastmod>2017-10-12T22:56:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12138-distrofia-muscolare-al-via-oggi-la-giornata-nazionale-uildm]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12112-distrofia-muscolare-di-duchenne-e-becker-inaugurato-nuovo-centro-di-ascolto-a-potenza]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12088-distrofia-di-duchenne-online-i-lavori-della-xv-conferenza-di-parent-project-onlus]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12036-distrofia-di-duchenne-dall-italia-una-nuova-strategia-che-mira-a-preservare-il-tessuto-muscolare]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/12020-distrofia-muscolare-di-duchenne-ptc-therapeutics-lancia-la-terza-edizione-degli-strive-grant-awards]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11969-duchenne-ricerca-e-nuove-sfide-al-centro-della-xv-conferenza-internazionale-di-parent-project-onlus]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11959-distrofie-muscolari-al-via-la-campagna-di-raccolta-fondi-di-parent-project-onlus]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11952-distrofia-di-duchenne-l-interesse-della-ricerca-60-studi-in-corso-nel-mondo]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11913-duchenne-i-cortisonici-ufficialmente-inseriti-nell-elenco-648]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11859-distrofia-di-duchenne-givinostat-soddisfa-in-fase-ii-e-dimostra-di-poter-contrastare-la-progressione-della-patologia]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11841-integrando-si-impara-il-progetto-di-parent-project-per-una-scuola-a-prova-di-duchenne]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11834-malattie-rare-online-tu-e-duchenne-un-portale-che-aiuta-le-famiglie]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11710-distrofia-di-duchenne-procede-lo-sviluppo-clinico-di-ezutromid-modulatore-dell-utrofina]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11662-distrofia-muscolare-di-duchenne-e-becker-al-via-il-progetto-p-a-s-s-a-p-a-r-o-l-a]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11652-distrofia-di-duchenne-avviato-studio-clinico-su-due-nuove-terapie-exon-skipping]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11605-duchenne-rinnovo-dell-autorizzazione-all-immissione-in-commercio-per-il-farmaco-ataluren]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11570-distrofia-muscolare-di-duchenne-revisione-cochrane-non-scioglie-i-dubbi-sull-uso-dei-corticosteroidi]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11547-l-ingegnere-con-la-duchenne-che-studia-la-propria-malattia]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11531-duchenne-giorgio-ha-avuto-la-diagnosi-a-10-mesi-poi-a-5-anni-finalmente-una-terapia]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11512-distrofia-di-duchenne-presentati-risultati-clinici-sul-farmaco-sperimentale-cat-1004]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11494-distrofia-di-duchenne-mio-figlio-stabile-da-piu-di-3-anni-grazie-al-farmaco]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11285-distrofia-di-duchenne-negli-usa-approvato-exondys-51-eteplirsen-il-primo-farmaco-modificante-la-malattia]]></loc><lastmod>2017-10-12T22:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11072-distrofia-muscolare-una-convenzione-tra-parent-project-onlus-e-village-for-4all-per-il-turismo-accessibile]]></loc><lastmod>2016-08-03T10:21:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/11056-quanto-costa-la-distrofia-muscolare-di-duchenne]]></loc><lastmod>2016-08-02T08:52:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10976-distrofia-muscolare-di-duchenne-sul-cammino-di-santiago-per-fermarla]]></loc><lastmod>2016-07-14T15:31:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10942-distrofia-di-duchenne-sviluppo-in-avvio-per-candidato-farmaco-che-agisce-sull-utrofina]]></loc><lastmod>2016-07-14T08:21:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10755-distrofia-di-duchenne-nuovi-dati-clinici-evidenziano-benefici-broncopolmonari-dalla-terapia-con-raxone-idebenone]]></loc><lastmod>2018-02-15T00:13:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10746-distrofia-muscolare-di-duchenne-comitato-fda-boccia-il-farmaco-eteplirsen]]></loc><lastmod>2016-06-06T08:33:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10457-distrofia-di-duchenne-parere-favorevole-del-nice-alla-rimborsabilita-di-ataluren]]></loc><lastmod>2016-04-26T15:01:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10431-distrofia-di-duchenne-ataluren-rimborsabile-anche-nel-regno-unito]]></loc><lastmod>2016-04-22T15:00:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10364-distrofia-di-duchenne-primi-risultati-dallo-studio-movedmd-sul-farmaco-cat-1004]]></loc><lastmod>2016-04-12T13:52:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10306-distrofia-di-duchenne-il-farmaco-vamorolone-avanza-alla-fase-ii-di-sperimentazione]]></loc><lastmod>2016-04-04T15:29:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10304-duchenne-terapia-con-l-arginina-e-metformina-potrebbe-rallentare-la-malattia]]></loc><lastmod>2016-04-05T07:34:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10278-distrofia-di-duchenne-pubblicata-una-guida-per-la-costruzione-di-edifici-accessibili-ai-pazienti]]></loc><lastmod>2016-03-30T13:19:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10122-distrofia-di-duchenne-avviata-in-italia-nuova-sperimentazione]]></loc><lastmod>2016-04-16T13:11:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10120-distrofia-di-duchenne-la-proteina-cd49d-indagata-come-biomarcatore-di-progressione-della-malattia]]></loc><lastmod>2016-03-04T14:18:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10111-editing-genomico-la-tencologia-crispr-cas9-spiegata-da-rhonda-bassel-duby]]></loc><lastmod>2016-06-27T07:01:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/10005-duchenne-tutte-le-novita-e-lo-stato-dell-arte-dalla-conferenza-internazionale-di-parent-project-onlus]]></loc><lastmod>2016-02-22T11:58:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9968-distrofia-di-duchenne-al-via-la-seconda-fase-del-trial-per-il-nuovo-farmaco-cat-1004]]></loc><lastmod>2016-02-15T08:46:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9889-distrofia-di-duchenne-scoperto-un-nuovo-fattore-per-future-potenziali-terapie]]></loc><lastmod>2016-02-02T17:15:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9879-distrofia-muscolare-di-duchenne-declino-di-deambulazione-rallentata-con-eteplirsen]]></loc><lastmod>2016-02-02T09:04:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9806-distrofia-muscolare-di-duchenne-e-becker-nuovo-protocollo-di-intesa-tra-parent-project-e-associazione-italiana-fisioterapisti]]></loc><lastmod>2016-01-22T14:39:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9804-distrofia-di-duchenne-fda-non-concede-approvazione-al-farmaco-drisapersen]]></loc><lastmod>2016-01-22T14:30:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9803-distrofia-di-duchenne-le-sperimentazioni-con-la-terapia-genetica-crispr-cas9]]></loc><lastmod>2016-01-22T14:27:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9816-torino-due-genitori-attendono-da-oltre-un-anno-una-nuova-carrozzina-per-il-figlio-affetto-da-duchenne]]></loc><lastmod>2016-01-26T10:29:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9752-distrofia-di-duchenne-negli-usa-grande-attesa-per-i-nuovi-trattamenti-sperimentali]]></loc><lastmod>2016-01-15T16:14:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9736-distrofia-muscolare-di-duchenne-un-antileucemico-sperimentato-su-modello-animale]]></loc><lastmod>2016-01-13T08:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9664-distrofia-di-duchenne-al-via-le-prime-fasi-della-sperimentazione-del-farmaco-cat-1004]]></loc><lastmod>2015-12-22T14:48:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9527-distrofia-di-duchenne-canada-belgio-germania-e-galles-gia-effettuano-lo-screening-neonatale]]></loc><lastmod>2015-12-07T13:25:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9547-distrofia-di-duchenne-oggi-c-e-una-terapia-specifica-ataluren-di-ptc]]></loc><lastmod>2015-12-07T13:23:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9452-distrofia-di-duchenne-giudizio-negativo-da-fda-su-drisapersen]]></loc><lastmod>2015-11-30T07:52:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9420-distrofia-muscolare-di-duchenne-dalle-cellule-di-maiale-una-potenziale-terapia]]></loc><lastmod>2015-11-24T08:05:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9350-distrofia-di-duchenne-importanti-passi-avanti-nella-ricerca-di-nuove-possibilita-terapeutiche]]></loc><lastmod>2015-11-13T10:06:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9328-distrofia-di-duchenne-fondamentale-la-diagnosi-precoce-della-funzionalita-respiratoria]]></loc><lastmod>2015-11-12T08:21:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9255-distrofia-di-duchenne-un-comitato-consultivo-della-fda-valutera-il-farmaco-sperimentale-drisapersen]]></loc><lastmod>2015-10-29T16:01:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9247-duchenne-i-pazienti-sentenziano-priorita-a-terapie-per-sintomatologia-cardiaca-e-polmonare]]></loc><lastmod>2015-10-29T12:33:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9198-distrofia-di-duchenne-nuove-conferme-per-translarna-ataluren-in-un-trial-su-228-pazienti]]></loc><lastmod>2024-10-30T13:29:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/9010-distrofia-di-duchenne-fda-ha-riconosciuto-al-farmaco-eteplirsen-la-designazione-per-malattia-pediatrica-rara]]></loc><lastmod>2015-09-29T09:38:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/8965-distrofia-di-duchenne-biomarin-lancia-il-progetto-knowyourduchenne-dedicato-ai-pazienti]]></loc><lastmod>2015-09-22T13:54:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/8941-alla-maratona-di-new-york-per-la-distrofia-di-duchenne]]></loc><lastmod>2015-09-17T12:38:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/8840-distrofia-di-duchenne-fda-rilascia-designazione-di-rara-malattia-pediatrica-per-il-farmaco-sperimentale-drisapersen]]></loc><lastmod>2015-08-28T09:53:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/8830-distrofia-di-duchenne-fda-prossima-alla-valutazione-del-farmaco-sperimentale-deflazacort]]></loc><lastmod>2015-08-27T15:20:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/8674-distrofia-di-duchenne]]></loc><lastmod>2015-07-23T11:17:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/8607-distrofia-di-duchenne-l-ema-valutera-l-approvazione-del-farmaco-sperimentale-drisapersen]]></loc><lastmod>2015-07-10T13:58:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/8568-distrofia-di-duchenne-in-avvio-uno-studio-di-fase-i-ii-del-farmaco-cat-1004]]></loc><lastmod>2015-12-22T13:26:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/8378-duchenne-ok-di-fda-per-rolling-marketing-application-di-eteplirsen]]></loc><lastmod>2015-06-04T15:47:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/8078-distrofia-di-duchenne-il-trattamento-con-idebenone-riduce-la-perdita-della-funzione-respiratoria]]></loc><lastmod>2016-05-06T16:33:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/8098-dangelo-lidebenone-rallenta-il-decorso-della-distrofia-muscolare-di-duchenne]]></loc><lastmod>2015-10-29T10:47:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/7957-duchenne-il-farmaco-ataluren-disponibile-anche-per-i-fratelli-dei-pazienti-che-affrontano-la-sperimentazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/7886-distrofia-muscolare-di-duchenne-biomarin-aggiorna-sul-programma-di-ri-somministrazione-di-drisapersen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/7778-qual-e-il-costo-sanitario-di-una-malattia-rara-lesempio-tedesco-con-le-distrofie-muscolari-di-duchenne-e-becker]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/7663-distrofia-di-duchenne-risultati-positivi-per-sperimentazione-del-farmaco-givinostat]]></loc><lastmod>2016-03-09T16:26:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/7470-distrofia-di-duchenne-ema-rivede-il-dossier-del-farmaco-ataluran]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/7332-un-diploma-per-saverio-marinelli-a-6-mesi-dalla-sua-scomparsa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/7025-distrofia-muscolare-di-duchenne-ritardo-nella-registrazione-di-eteplirsen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/7006-distrofia-di-duchenne-translarna-primo-farmaco-per-la-malattia-ottiene-parere-favorevole-da-aifa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6815-distrofia-muscolare-duchenne-e-becker-al-via-anche-il-cuore-e-un-muscolo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6620-anche-in-italia-si-celebra-la-prima-giornata-internazionale-della-duchenne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6554-distrofia-muscolare-di-duchenne-ptc-therapeutics-riceve-approvazione-condizionata-nellunione-europea-per-translarna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6549-distrofia-muscolare-di-duchenne-negli-usa-arriva-la-guida-allorientamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6289-distrofia-muscolare-di-duchenne-i-risultati-del-programma-di-screening-neonatale-in-galles]]></loc><lastmod>2019-06-18T18:12:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6301-duchenne-il-nostro-saluto-a-saverio-marinelli-mancato-allaffetto-dei-suoi-cari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6110-martina-giovanissima-neodottoressa-combatte-tutti-i-giorni-la-distrofia-di-duchenne-in-laboratorio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6126-duchenne-parere-positivo-dal-chmp-per-translarnatm-primo-trattamento-diretto-contro-la-causa-stessa-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6081-distrofia-di-duchenne-parent-project-al-giro-ditalia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6083-distrofia-muscolare-di-duchenne-isofen-verso-il-trial-clinico-di-fase-2]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6016-distrofia-di-duchenne-i-muscoli-distrofici-negli-stadi-precoci-conservano-un-potenziale-rigenerativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/6004-distrofia-muscolare-di-duchenne-a-breve-sara-presentata-richiesta-di-approvazione-accelerata-per-eteplirsen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/5901-distrofia-di-duchenne-una-nuova-classe-di-farmaci-potrebbe-rigenerare-i-muscoli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/5866-distrofia-di-duchenne-e-becker-il-13-aprile-lorenzo-tiveron-correra-la-prima-tappa-di-un-lungo-campionato-con-i-colori-di-parent-project]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/5665-distrofia-muscolare-duchenne-e-becker-inaugurazione-del-centro-di-ascolto-della-regione-liguria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/5553-distrofia-di-duchenne-alla-conferenza-parent-project-in-messaggio-di-papa-francesco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/5368-distrofia-di-duchenne-non-approvato-il-farmaco-ataluren]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/5269-distrofia-di-duchenne-e-becker-si-e-svolta-la-5d-edizione-della-qpedalata-di-solidarietaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/5074-distrofia-di-duchenne-la-storia-di-pietro-che-grazie-al-sostegno-economico-di-due-associazioni-ha-potuto-sottoporsi-ad-una-visita-in-lombardia]]></loc><lastmod>2019-06-19T08:08:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4979-distrofia-di-duchenne-a-milano-apre-una-sede-del-centro-ascolto-di-parent-project-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4899-distrofia-di-duchenne-alla-maratona-di-new-york-si-corre-per-le-famiglie-che-lottano-contro-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4816-distrofia-di-duchenne-mario-e-la-sua-lotta-a-colpi-di-rock]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4758-al-34d-rally-citta-di-pistoia-il-pilota-luca-artino-corre-per-aiutare-i-bambini-affetti-dalla-distrofia-muscolare-di-duchenne-e-becker]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4651-distrofia-di-duchenne-delude-la-sperimentazione-con-il-farmaco-drisapersen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4502-distrofia-di-duchenne-il-registro-dei-pazienti-raccoglie-dati-da-13-paesi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4466-distrofia-di-duchenne-il-biker-da-lio-corre-quattromila-chilometri-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4435-distrofia-muscolare-di-duchenne-iniziato-lo-studio-del-farmaco-sperimentale-ht-100]]></loc><lastmod>2019-06-19T08:30:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4357-distrofia-di-duchenne-drisapersen-gsk-riconosciuta-terapia-fortemente-innovativa-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4227-distrofia-di-duchenne-la-vita-oltre-alla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4193-duchenne-il-nuovo-obiettivo-e-inserire-nei-trial-anche-pazienti-che-non-riescono-piu-a-camminare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4103-distrofia-di-duchenne-e-becker-nuova-sede-campana-per-parent-project-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4066-distrofia-di-duchenne-e-becker-ema-pubblica-le-nuove-linee-guida-per-la-valutazione-dei-medicinali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/4023-distrofia-di-duchenne-a-roma-un-grande-esempio-di-solidarieta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3834-distrofia-di-duchenne-un-test-innovativo-per-valutarne-la-progressione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3786-distrofia-di-duchenne-grazie-ad-assofly-onlus-apre-a-pisa-una-sede-di-parent-project-onlus-che-assiste-le-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3708-duchenne-in-italia-si-sperimenta-un-nuovo-farmaco-givinostat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3694-duchenne-un-nuovo-approccio-farmacologico-potrebbe-trattare-i-disordini-degenerativi-muscolari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3686-distrofia-di-duchenne-presentato-laccordo-tra-bambino-gesu-policlinico-gemelli-e-parent-project-onlus-per-creare-un-modello-dassistenza-per-prevenire-lo-scompenso-cardiaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3666-duchenne-in-diretta-streaming-lxi-conferenza-internazionale-di-parent-project-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3620-duchenne-risultati-positivi-per-la-sperimentazione-con-isofen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3619-duchenne-le-cellule-pluripotenti-ipsc-cambieranno-il-futuro-delle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3593-distrofia-di-duchenne-dal-10-al-24-febbraio-sms-al-45503-per-parent-project-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3582-distrofia-di-duchenne-per-i-nostri-ragazzi-un-lavoro-e-un-progetto-di-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3579-distrofia-di-duchenne-un-farmaco-anticancro-potrebbe-migliorarne-i-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3559-duchenne-con-parent-project-onlus-gestire-la-malattia-e-piu-facile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3551-exon-skipping-per-la-cura-delle-distrofie-muscolari-di-ullrich-e-duchenne]]></loc><lastmod>2016-03-09T08:03:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3538-distrofia-di-duchenne-vivere-la-scuola-serenamente-e-possibile-per-ragazzi-e-genitori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3513-distrofia-di-duchenne-andrea-studia-alla-sapienza-ma-lassistenza-a-cui-ha-diritto-non-ce]]></loc><lastmod>2016-02-19T09:27:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3465-distrofia-di-duchenne-xi-conferenza-internazionale-di-parent-project-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3425-distrofia-di-duchenne-il-diritto-al-lavoro-per-le-persone-con-disabilita-non-e-reale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3383-distrofia-muscolare-di-duchenne-prime-ipotesi-per-un-nuovo-farmaco-basato-sullutrofina]]></loc><lastmod>2016-07-13T17:32:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3336-distrofia-muscolare-di-becker-un-farmaco-per-la-disfunzione-erettile-puo-aiutare-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3330-distrofia-di-duchenne-nuove-speranze-da-una-terapia-sperimentale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3316-distrofia-di-duchenne-prosegue-lo-sviluppo-del-farmaco]]></loc><lastmod>2016-01-15T15:44:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3261-distrofia-di-duchenne-per-natale-i-regali-solidali-di-parent-project-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3226-duchenne-per-i-ragazzi-con-distrofia-un-piano-di-vita-prima-di-tutto]]></loc><lastmod>2015-11-19T13:58:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3225-distrofia-di-duchenne-a-scuola-conoscere-la-patologia-per-progettare-lintegrazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/3197-duchenne-i-ragazzi-hanno-diritto-a-un-progetto-di-vita-scuola-e-lavoro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2903-duchenne-buoni-risultati-per-il-farmaco-basato-sullexon-skipping]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2758-duchenne-alla-24h-di-roma-partecipa-il-team-parent-project-bikers-partecipa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2675-distrofia-di-duchenne-spiegata-la-degenerazione-muscolare-da-uno-studio-americano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2444-duchenne-il-sisma-emiliano-rischiava-di-fermare-la-speranza-del-cuore-artificiale-la-famiglia-del-primo-paziente-laiuta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2423-distrofia-muscolare-nuova-strategia-terapeutica-basata-sulle-cellule-staminali-indotte-alla-pluripotenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2404-distrofia-duchenne-e-becker-modello-sperimentale-puo-individuare-anche-le-mutazioni-piu-rare-senza-biopsia-muscolare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2234-distofia-di-duchenne-a-brindisi-lauditorium-intitolato-a-giorgio-amico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2135-distrofia-di-duchenne-trial-clinici-per-il-primo-trattamento-farmacologico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2119-distrofia-di-duchenne-in-lombardia-la-primavera-solidale-e-dedicata-alle-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2070-distrofia-di-duchenne-un-derivato-della-nicotina-potrebbe-ridurre-il-danno-muscolare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2123-parent-project-onlus-ascoltata-dalla-commissione-igiene-e-sanita-del-senato-nellambito-delle-procedure-dellinvalidita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2021-distrofia-di-duchenne-e-solidarieta-la-scavolini-siviglia-pesaro-ospita-parent-project-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/2012-distrofia-di-duchenne-in-campania-si-lavora-a-una-rete-dassistenza-integrata-per-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1960-distrofia-di-duchenne-una-proteina-potrebbe-migliorare-lattivita-muscolare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1922-distrofia-di-duchenne-in-campania-una-nuova-sede-di-parent-project-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1671-duchenne-luca-ha-21-anni-e-le-idee-chiare-e-stato-il-suo-lintervento-piu-applaudito-alla-conferenza-internazionale-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1661-duchenne-linsufficienza-respiratoria-e-un-rischio-grave-ma-si-puo-combattere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1659-distrofia-di-duchenne-in-diretta-streaming-la-x-conferenza-internazionale-di-parent-project-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1610-duchenne-da-oggi-e-fino-al-20-febbraio-basta-un-sms-al-45504-per-sostenere-il-diritto-allassistenza-e-al-futuro-dei-giovani-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1570-duchenne-la-terapia-cellulare-segue-due-strade-che-partono-dai-mesangioblasti-il-prof-cossu-ha-gia-avviato-a-milano-una-prima-sperimentazione-di-trapianto-allogenico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1573-distrofia-di-duchenne-e-becker-dal-17-al-19-febbraio-a-roma-la-x-conferenza-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1566-distrofia-duchenne-dalla-combinazione-di-due-generici-una-possibile-nuova-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1526-distrofia-duchennebecker-sempre-piu-pazienti-arrivano-alleta-adulta-la-scuola-e-un-punto-chiave-per-non-escluderli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1431-malattie-rare-duchenne-e-altre-nove-malattie-piu-vicine-alla-cura-grazie-a-telethon]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1299-distrofia-di-duchenne-modulare-i-telomeri-per-arrestare-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1239-duchenne-in-val-sortino-si-corre-in-cronoscalata-per-aiutare-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1203-duchenne-studio-condotto-alla-sapienza-scopre-meccanismo-antisabotaggio-delle-cellule]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1172-duchenne-da-oggi-e-fino-al-30-ottobre-con-un-sms-al-45505-si-sostiene-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1142-duchenne-vive-da-un-anno-con-il-cuore-artificiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/1060-duchenne-oggi-consegna-del-saturimetro-acquistato-grazie-alle-iniziative-estive-in-sicilia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/990-distrofia-duchenne-studio-italiano-correla-evoluzione-del-male-al-tipo-di-trattamento-steroideo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/945-distrofia-duchenne-terapia-sperimentale-sembra-riattivare-la-produzione-di-distrofina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/919-distrofia-duchenne-parent-project-sicilia-organizza-una-corsa-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/905-distrofia-duchenne-tempi-dattesa-troppo-lunghi-per-la-carrozzina-elettrica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/738-duchenne-provincia-di-roma-e-parent-project-insieme-per-lintegrazione-scolastica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/699-duchenne-vincenzo-nibali-e-giovanni-visconti-al-giro-ditalia-per-aiutare-i-piccoli-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/700-duchenne-il-concorso-qfrancesco-guccini-cantando-la-nostra-storiaq-si-conclude-con-una-raccolta-fondi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/645-distrofia-di-duchenne-studio-italiano-mostra-il-ruolo-dellinterluchina-6-nel-danno-osseo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/637-distrofia-duchenne-oggi-si-studia-un-cromosoma-artificiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/615-distrofia-di-duchenne-la-sperimentazione-con-le-staminali-e-solo-allinizio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/595-distrofia-di-duchenne-somministrazione-di-oliglonucleotidie-antisenso-pro051-e-ben-tollerata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/547-duchenne-lultima-frontiera-dei-farmaci-epigenetici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/496-distrofia-di-duchenne-trovati-tre-nuovi-marker-per-valutare-risultati-delle-sperimentazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/434-duchenne-nella-prossima-conferenza-internazionale-a-roma-si-fa-il-punto-della-situazione]]></loc><lastmod>2015-06-08T10:42:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/369-distrofia-di-duchenne-ricercatori-della-sapienza-scoprono-micro-rna-utile-per-la-terapia-genican]]></loc><lastmod>2024-10-08T17:02:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/345-distrofia-di-duchenne-al-bambino-gesu-cuore-artificiale-permanente-a-un-15enne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/323-distrofia-di-duchenne-la-malattia-dipende-anche-dalle-staminali-muscolari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/315-distrofia-di-duchenne-iniettare-la-laminina-111-puo-prevenire-la-perdita-muscolare-ed-essere-utile-anche-per-il-trapianto-di-mioblasti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/138-distrofia-di-duchenne-la-farmaceutica-shire-sigla-accordo-con-linglese-acceleron-per-nuovo-farmaco-sperimentale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/distrofia-muscolare-di-duchenne/131-distrofia-di-duchenne-un-cromosoma-artificiale-per-aprire-la-strada-ao-trapianti-di-staminali-autologhe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/22770-emoglobinuria-parossistica-notturna-crovalimab-disponibile-in-italia]]></loc><lastmod>2026-02-20T18:30:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/22620-emoglobinuria-parossistica-notturna-gestire-lanemia-residua-per-migliorare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2025-12-22T21:02:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/22585-ospedale-santa-corona-di-pietra-ligure-un-percorso-dedicato-ai-pazienti-con-epn-in-emergenza]]></loc><lastmod>2025-12-09T08:16:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/22459-emoglobinuria-parossistica-notturna-danicopan-rimborsabile-in-italia]]></loc><lastmod>2025-10-29T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/22392-giornata-mondiale-dellepn-12-g-dl-di-emoglobina-come-obiettivo-terapeutico]]></loc><lastmod>2025-10-12T14:52:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/22222-emergenze-ematologiche-al-policlinico-gemelli-un-modello-integrato-24-ore-su-24]]></loc><lastmod>2025-07-29T09:15:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/22104-emoglobinuria-parossistica-notturna-iptacopan-rimborsabile-in-italia]]></loc><lastmod>2025-06-18T17:44:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/22044-un-modello-di-presa-in-carico-per-i-pazienti-ematologici-fragili-l-esperienza-del-policlinico-umberto-i-e-il-sostegno-di-aiepn]]></loc><lastmod>2025-06-03T15:00:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21856-emoglobinuria-parossistica-notturna-la-fatigue-e-un-sintomo-cruciale-ma-spesso-sottovalutato-dai-pazienti]]></loc><lastmod>2025-05-21T15:47:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21834-al-policlinico-di-milano-un-percorso-dedicato-ai-pazienti-con-emoglobinuria-parossistica-notturna]]></loc><lastmod>2025-03-24T18:12:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21810-commemorazione-e-sensibilizzazione-la-donazione-di-aiepn-per-ricordare-pier-paolo-padovan]]></loc><lastmod>2025-03-13T12:00:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21709-da-aiepn-onlus-un-finanziamento-per-una-gestione-piu-efficiente-dell-accesso-ai-pronto-soccorso-dei-pazienti-con-epn]]></loc><lastmod>2025-02-10T16:51:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21648-emoglobinuria-parossistica-notturna-un-evento-per-fare-il-punto-sul-trattamento]]></loc><lastmod>2025-02-04T17:04:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21579-emoglobinuria-parossistica-notturna-positivi-i-nuovi-dati-di-fase-iii-su-iptacopan]]></loc><lastmod>2024-12-13T08:49:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21443-epn-al-via-il-progetto-ridefiniamo-l-inclusione-il-focus-group-dedicato-il-12-novembre-2024]]></loc><lastmod>2024-11-08T17:56:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21430-emoglobinuria-parossistica-notturna-all-omar-talk-si-parla-di-inclusione-e-qualita-di-vita-dei-pazienti]]></loc><lastmod>2024-10-28T17:11:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21365-la-vita-con-emoglobinuria-parossistica-notturna-pazienti-caregiver-e-medici-si-raccontano]]></loc><lastmod>2024-10-11T08:46:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21359-giornata-mondiale-di-sensibilizzazione-sull-epn-il-presidente-ferini-strambi-parla-di-qualita-della-vita]]></loc><lastmod>2024-10-09T17:40:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21364-vivere-con-l-epn-pazienti-e-clinici-concordano-lavorare-su-ritardo-diagnostico-e-su-una-presa-in-carico-globale]]></loc><lastmod>2024-10-11T08:43:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21369-emoglobinuria-parossistica-notturna-il-12-ottobre-si-celebra-la-prima-giornata-mondiale-dedicata]]></loc><lastmod>2024-10-11T08:44:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21279-la-storia-di-veronica-diventata-mamma-nonostante-l-emoglobinuria-parossistica-notturna]]></loc><lastmod>2024-09-11T13:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21244-emoglobinuria-parossistica-notturna-approvazione-europea-per-crovalimab]]></loc><lastmod>2024-08-29T17:14:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21084-emoglobinuria-parossistica-notturna-si-ampliano-le-prospettive-terapeutiche]]></loc><lastmod>2024-08-12T11:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/21002-emoglobinuria-parossistica-notturna-iptacopan-approvato-in-europa]]></loc><lastmod>2024-05-22T10:49:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/20805-emoglobinuria-parossistica-notturna-parere-positivo-del-chmp-per-iptacopan]]></loc><lastmod>2024-03-26T11:13:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/20795-emoglobinuria-parossistica-notturna-fondamentale-un-attento-monitoraggio-dei-pazienti]]></loc><lastmod>2024-03-25T16:53:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/20697-emoglobinuria-parossistica-notturna-ok-del-chmp-per-danicopan]]></loc><lastmod>2024-02-28T17:48:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/20524-emoglobinuria-parossistica-notturna-lanciato-in-italia-il-progetto-pantera]]></loc><lastmod>2024-01-17T16:11:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/20385-emoglobinuria-parossistica-notturna-dagli-esperti-italiani-le-raccomandazioni-sulla-gestione-del-rischio-infettivo]]></loc><lastmod>2023-11-27T15:18:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/19985-aiepn-associazione-solidale-l-ultima-impresa-e-l-aiuto-ai-pazienti-fragili-colpiti-dall-alluvione-in-emilia-romagna]]></loc><lastmod>2023-07-10T10:36:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/19952-emoglobinuria-parossistica-notturna-al-via-la-campagna-what-ai-feel]]></loc><lastmod>2023-06-25T21:21:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/19793-emoglobinuria-parossistica-notturna-risultati-positivi-dallo-studio-di-fase-iii-su-iptacopan]]></loc><lastmod>2023-05-10T17:56:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/19522-emoglobinuria-parossistica-notturna-dati-positivi-per-crovalimab]]></loc><lastmod>2023-02-10T11:33:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/19056-emoglobinuria-parossistica-notturna-pegcetacoplan-rimborsabile-in-italia]]></loc><lastmod>2022-09-14T17:20:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/19055-emoglobinuria-parossistica-notturna-conclusa-con-successo-l-iniziativa-notti-rare]]></loc><lastmod>2022-09-14T16:31:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/18866-emoglobinuria-parossistica-notturna-al-via-l-iniziativa-notti-rare]]></loc><lastmod>2022-07-03T17:23:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/18225-emoglobinuria-parossistica-notturna-ravulizumab-rimborsabile-in-italia]]></loc><lastmod>2022-01-27T12:21:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/17629-epn-patient-day-2021-una-panoramica-a-360-gradi-sull-emoglobinuria-parossistica-notturna]]></loc><lastmod>2021-07-07T16:05:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/15054-emoglobinuria-parossistica-notturna-approvazione-europea-per-ravulizumab]]></loc><lastmod>2019-07-21T18:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/14892-emoglobinuria-parossistica-notturna-pazienti-medici-e-ricercatori-in-campo-per-il-patient-s-day]]></loc><lastmod>2023-10-23T17:02:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/10985-emoglobinuria-parossistica-notturna-pronto-nuovo-trial-clinico-su-candidato-farmaco-coversin]]></loc><lastmod>2016-09-16T08:41:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/10814-emoglobinuria-parossistica-notturna-novita-positive-da-sperimentazione-su-farmaco-aln-cc5]]></loc><lastmod>2016-09-16T08:41:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/10810-emoglobinuria-parossistica-notturna-primi-risultati-dallo-studio-clinico-sul-farmaco-alxn1210]]></loc><lastmod>2016-09-16T08:42:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/9413-emoglobinuria-parossistica-notturna-i-positivi-dati-sull-uso-di-eculizumab-in-gravidanza]]></loc><lastmod>2016-09-16T08:42:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/7738-emoglobinuria-parossistica-notturna-parere-favorevole-del-chmp-per-aggiornamenti-a-eculizumab]]></loc><lastmod>2016-09-16T09:28:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/7075-emoglobinuria-parossistica-notturna-il-farmaco-amy-101-riceve-lo-status-di-orfano-dallfda]]></loc><lastmod>2016-09-16T09:28:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/4122-emoglobinuria-parossistica-notturna-disponibile-le-raccomandazioni-per-la-gestione-dei-pazienti]]></loc><lastmod>2019-03-26T17:51:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/3581-emoglobinuria-parossistica-notturna-nei-casi-con-tromboembolismo-meglio-evitare-il-trapianto-di-cellule-ematopoietiche]]></loc><lastmod>2016-09-16T08:39:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/3362-emoglobinuria-parossistica-notturna-nuove-conferme-per-soliris-r]]></loc><lastmod>2023-10-23T17:05:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/emoglobinuria-parossistica-notturna/2564-emoglobinuria-parossistica-notturna-in-italia-si-studia-una-terapia]]></loc><lastmod>2016-09-16T08:39:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/22614-epidermolisi-bollosa-le-forme-piu-gravi-sono-quelle-associate-a-un-coinvolgimento-multi-organo]]></loc><lastmod>2025-12-19T10:52:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/22371-epidermolisi-bollosa-distrofica-recessiva-pubblicato-il-primo-documento-di-consenso-italiano]]></loc><lastmod>2025-10-05T22:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/22237-al-congresso-sidemast-adoi-un-importante-aggiornamento-sull-epidermolisi-bollosa]]></loc><lastmod>2025-08-06T18:38:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/22063-epidermolisi-bollosa-almeno-571-i-pazienti-seguiti-negli-ospedali-italiani]]></loc><lastmod>2025-06-06T16:57:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/21963-epidermolisi-bollosa-la-terapia-genica-in-gel-approda-in-europa]]></loc><lastmod>2025-05-08T16:03:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/21543-epidermolisi-bollosa-speranze-dal-trapianto-di-pelle-geneticamente-modificata]]></loc><lastmod>2024-12-11T10:30:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/21055-epidermolisi-bollosa-l-impegno-di-chiesi-nostro-obiettivo-e-migliorare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2024-06-12T08:38:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/21039-epidermolisi-bollosa-l-adolescenza-e-il-periodo-piu-critico]]></loc><lastmod>2024-06-12T08:39:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/21036-epidermolisi-bollosa-occorre-garantire-il-trattamento-per-tutte-le-forme-di-malattia]]></loc><lastmod>2024-06-12T08:40:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/21029-epidermolisi-bollosa-poter-accelerare-la-guarigione-delle-ulcere-croniche-e-un-grande-passo-avanti]]></loc><lastmod>2024-06-12T08:41:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/20943-epidermolisi-bollosa-distrofica-recessiva-da-oggi-disponibile-in-italia-il-nuovo-gel-topico]]></loc><lastmod>2025-12-09T16:24:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/20824-i-grandi-successi-di-eddie-vedder-60-milioni-di-album-venduti-con-i-pearl-jam-e-60-milioni-di-dollari-raccolti-per-l-epidermolisi-bollosa]]></loc><lastmod>2024-04-01T16:40:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/20782-epidermolisi-bollosa-distrofica-recessiva-filsuvez-gel-rimborsabile-in-italia]]></loc><lastmod>2025-04-28T12:36:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/20725-epidermolisi-bollosa-la-terapia-genica-in-gel-funziona-anche-sull-occhio]]></loc><lastmod>2024-03-06T20:49:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/20486-epidermolisi-bollosa-arrivano-le-terapie-avanzate]]></loc><lastmod>2023-12-29T16:22:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/20371-epidermolisi-bollosa-e-deficit-di-cellule-staminali-limbari-corneali-a-rischio-le-terapie-di-holostem]]></loc><lastmod>2023-11-27T10:13:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/20038-epidermolisi-bollosa-il-problema-della-transizione-dall-eta-pediatrica-a-quella-adulta]]></loc><lastmod>2023-08-07T08:51:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/19967-epidermolisi-bollosa-distrofica-negli-usa-arriva-la-prima-terapia-genica-in-gel]]></loc><lastmod>2023-06-30T17:31:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/19818-perfettamente-imperfetta-cosi-e-la-mia-vita-con-l-epidermolisi-bollosa]]></loc><lastmod>2023-05-19T12:22:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/19815-epidermolisi-bollosa-la-forma-giunzionale-puo-essere-piu-grave-della-distrofica]]></loc><lastmod>2023-05-18T11:28:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/19200-epidermolisi-bollosa-tutti-i-progetti-di-debra-italia-e-fondazione-reb]]></loc><lastmod>2023-11-10T20:19:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/19160-epidermolisi-bollosa-il-21-22-ottobre-a-milano-il-congresso-nazionale]]></loc><lastmod>2022-10-10T10:33:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/18824-epidermolisi-bollosa-approvato-in-europa-il-primo-farmaco-specifico-per-la-patologia]]></loc><lastmod>2023-06-30T17:33:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/18430-epidermolisi-bollosa-accolte-a-modena-due-ragazze-farfalla-ucraine-in-fuga-dalla-guerra]]></loc><lastmod>2022-03-18T16:27:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/18087-epidermolisi-bollosa-positivi-i-risultati-a-lungo-termine-della-terapia-genica]]></loc><lastmod>2021-12-12T16:27:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/17419-epidermolisi-bollosa-2-5-milioni-di-euro-per-studiare-la-terapia-genica]]></loc><lastmod>2021-05-11T14:27:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/15476-epidermolisi-bollosa-dalla-corteccia-di-betulla-un-potenziale-farmaco-per-le-ferite]]></loc><lastmod>2020-10-19T14:35:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/16464-epidermolisi-bollosa-risultati-positivi-per-filsuvez-nello-studio-ease]]></loc><lastmod>2020-09-20T19:20:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/16056-epidermolisi-bollosa-la-malattia-non-aumenta-il-rischio-d-infezione-da-coronavirus]]></loc><lastmod>2020-06-25T14:42:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/15601-epidermolisi-bollosa-a-modena-nasce-un-centro-per-diagnosi-terapia-e-ricerca]]></loc><lastmod>2020-01-23T23:46:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/15504-epidermolisi-bollosa-fda-concede-status-orfano-al-farmaco-apr-td011]]></loc><lastmod>2019-12-11T11:54:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/15274-epidermolisi-bollosa-il-registro-della-fondazione-reb-punto-di-partenza-per-la-ricerca]]></loc><lastmod>2019-10-06T21:19:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/15190-epidermolisi-bollosa-non-esiste-una-cura-ma-sono-tante-le-sperimentazioni-in-corso]]></loc><lastmod>2019-09-15T16:40:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/13574-jonathan-e-hassan-i-due-simboli-dell-epidermolisi-bollosa]]></loc><lastmod>2018-05-20T11:16:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/12544-epidermolisi-bollosa-debra-italia-onlus-lancia-lo-spot-senza-difese]]></loc><lastmod>2019-09-10T14:23:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/12479-epidermolisi-bollosa-da-fda-status-orfano-per-eb-101]]></loc><lastmod>2019-01-17T17:30:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/12163-epidermolisi-bollosa-amicus-completa-l-iscrizione-allo-studio-clinico-di-fase-iii-essence]]></loc><lastmod>2017-06-19T14:08:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/12091-epidermolisi-bollosa-il-farmaco-ap101-pronto-per-iniziare-un-trial-di-fase-iii]]></loc><lastmod>2017-06-19T14:09:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/11853-epidermolisi-bollosa-fast-track-per-la-molecola-fcx-007]]></loc><lastmod>2017-06-19T14:09:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/11707-epidermolisi-bollosa-fda-concede-status-orfano-alla-molecola-txa127]]></loc><lastmod>2017-06-19T14:10:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/11465-epidermolisi-bollosa-distrofica-recessiva-la-terapia-con-fibroblasti-inverte-il-fenotipo-della-malattia]]></loc><lastmod>2017-06-19T14:11:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/11273-epidermolisi-bollosa-abeona-therapeutics-arruola-il-quinto-paziente-nel-suo-studio-di-fase-1-2]]></loc><lastmod>2016-09-17T16:18:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/11270-bambini-farfalla-i-pazienti-raccontano-cosa-significa-nascere-senza-difese]]></loc><lastmod>2016-09-17T16:16:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/11078-epidermolisi-bollosa-calcolate-l-incidenza-e-la-prevalenza-negli-usa-19-57-e-11-07-casi-su-un-milione]]></loc><lastmod>2017-06-19T14:12:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/11052-epidermolisi-bollosa-milano-unico-centro-italiano-per-la-sperimentazione-della-crema-zorblisa]]></loc><lastmod>2016-08-01T13:19:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/11051-epidermolisi-bollosa-ereditaria-al-bambino-gesu-i-carcinomi-vengono-trattati-con-l-elettrochemioterapia]]></loc><lastmod>2016-08-01T13:20:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/11050-debra-italia-onlus-il-punto-di-riferimento-per-i-bambini-farfalla]]></loc><lastmod>2016-08-03T14:52:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/10774-epidermolisi-bollosa-in-europa-il-costo-medio-annuo-per-paziente-e-di-31-390-euro]]></loc><lastmod>2016-06-09T15:16:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/10117-l-azienda-farmaceutica-chiesi-sviluppa-una-nuova-terapia-per-l-epidermolisi-bollosa]]></loc><lastmod>2016-06-09T07:27:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/8605-epidermolisi-bollosa-dati-preclinici-incoraggianti-per-il-farmaco-sperimentale-fcx-007]]></loc><lastmod>2016-06-09T07:28:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/7927-epidermolisi-bollosa-simplex-ac-203-riceve-la-designazione-di-farmaco-orfano-a-taiwan]]></loc><lastmod>2016-06-09T07:28:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/5574-epidermolisi-bollosa-da-londra-la-dolorosa-storia-di-rhys-williams-e-di-sua-madre]]></loc><lastmod>2019-06-18T18:29:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/4261-epidermolisi-bollosa-distrofica-le-nuove-direttive-della-ricerca]]></loc><lastmod>2016-12-02T15:23:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/1636-epidermiolisi-bollosa-inaugurato-il-primo-centro-multidisciplinare-del-nord-italia]]></loc><lastmod>2016-06-09T07:29:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/188-epidermolisi-bollosa-presentati-risultati-di-uno-studio-sulla-terapia-genica]]></loc><lastmod>2016-06-09T07:29:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/100-epidermolisi-bollosa-si-studia-per-arrivare-a-una-terapia-genica-che-consenta-il-trapianto-definitivo-di-pelle]]></loc><lastmod>2016-06-09T07:20:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/epidermolisi-bollosa/15-epidermolisi-bollosa-al-bambino-gesu-di-roma-una-stanza-di-degenza-dedicata]]></loc><lastmod>2016-06-09T07:20:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22889-fenilchetonuria-dalla-diagnosi-alla-qualita-di-vita-la-sfida-di-una-presa-in-carico-davvero-continua]]></loc><lastmod>2026-03-30T14:59:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22867-pku-oggi-ecco-perche-lapproccio-vincente-e-quello-integrato]]></loc><lastmod>2026-03-24T12:10:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22791-pku-le-terapie-in-arrivo-e-le-sperimentazioni-cliniche-in-corso-il-punto-sulla-gestione-della-fenilchetonuria]]></loc><lastmod>2026-02-24T17:36:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22713-nuove-prospettive-per-la-pku-il-primo-webinar-dedicato-alla-gestione-personalizzata-della-fenilchetonuria]]></loc><lastmod>2026-02-03T18:21:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22613-fenilchetonuria-lo-screening-neonatale-salva-il-cervello-ma-non-basta]]></loc><lastmod>2025-12-19T10:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22296-fenilchetonuria-con-una-diagnosi-precoce-e-un-trattamento-adeguato-chi-ne-e-affetto-puo-condurre-una-vita-piena]]></loc><lastmod>2025-09-12T14:37:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22187-fenilchetonuria-alberto-burlina-dalla-dieta-ai-nuovi-farmaci-il-futuro-del-trattamento-e-nella-combinazione-terapeutica]]></loc><lastmod>2025-07-22T17:13:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22152-fenilchetonuria-a-determinare-il-fenotipo-e-la-tolleranza-alimentare]]></loc><lastmod>2025-07-02T10:13:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22145-fenilchetonuria-grandi-aspettative-dei-pazienti-per-l-arrivo-della-sepiapterina]]></loc><lastmod>2025-07-01T21:08:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22127-giornata-mondiale-per-la-fenilchetonuria-riflettori-accesi-sulla-malattia-metabolica-rara]]></loc><lastmod>2025-06-25T14:45:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22126-fenilchetonuria-riparte-la-campagna-conoscere-la-pku]]></loc><lastmod>2025-08-04T14:37:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22118-fenilchetonuria-ok-all-immissione-in-commercio-per-il-farmaco-sepiapterina-in-europa]]></loc><lastmod>2025-08-04T14:35:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/22000-fenilchetonuria-l-83-dei-padri-si-sente-coinvolto-nella-gestione-della-malattia]]></loc><lastmod>2025-05-19T13:43:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/21938-fenilchetonuria-il-chmp-raccomanda-l-approvazione-della-sepiapterina]]></loc><lastmod>2025-04-28T17:50:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/21619-pku-pubblicato-un-documento-congiunto-che-evidenzia-i-bisogni-medici-insoddisfatti]]></loc><lastmod>2025-01-13T14:43:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/21481-fenilchetonuria-al-femminile-necessario-programmare-una-gravidanza-con-tre-mesi-d-anticipo]]></loc><lastmod>2024-11-11T18:47:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/21249-fenilchetonuria-il-racconto-di-pierluca-cosi-ho-imparato-a-gestire-la-dieta-di-mio-figlio]]></loc><lastmod>2024-09-02T08:48:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/21175-fenilchetonuria-storie-di-pazienti-e-caregiver-per-dare-piu-attenzione-all-impatto-della-patologia]]></loc><lastmod>2024-07-16T12:43:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/21172-fenilchetonuria-il-prof-burlina-le-terapie-attuali-sono-efficaci-e-presto-arrivera-l-home-monitoring-test]]></loc><lastmod>2024-07-12T15:51:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/21116-pku-day-2024-veronica-accettate-la-malattia-oggi-si-puo-vivere-serenamente]]></loc><lastmod>2024-07-01T10:21:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/21094-fenilchetonuria-pratiche-dietetiche-sempre-piu-ottimizzate-per-il-benessere-dei-pazienti]]></loc><lastmod>2024-06-24T07:08:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/20876-fenilchetonuria-all-ospedale-buzzi-di-milano-parte-il-progetto-pku-in-rosa]]></loc><lastmod>2024-04-15T14:36:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/20656-fenilchetonuria-per-la-maggior-parte-dei-pazienti-l-impatto-sulla-qualita-di-vita-e-minimo]]></loc><lastmod>2024-02-20T12:31:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/20431-pku-per-parlare-di-diversita-ai-piu-giovani-nasce-il-gioco-da-tavolo-fenilcity]]></loc><lastmod>2025-02-25T11:32:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/20327-fenilchetonuria-si-avvicina-l-editing-genomico-crispr-potrebbe-cambiare-la-storia-della-malattia]]></loc><lastmod>2023-11-14T22:43:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/20310-screening-neonatale-per-le-malattie-metaboliche-l-ospedale-buzzi-di-milano-nuovo-centro-di-riferimento]]></loc><lastmod>2023-11-07T19:08:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/20108-pku-disponibile-nuovo-farmaco-a-base-di-sapropterina-dicloridrato]]></loc><lastmod>2025-02-25T11:34:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/19959-fenilchetonuria-e-malattie-metaboliche-quattro-albi-illustrati-per-raccontare-ai-bambini-le-loro-malattie]]></loc><lastmod>2023-06-28T09:01:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/19958-giornata-internazionale-pku-2023-l-impegno-della-asl-di-pescara]]></loc><lastmod>2023-06-28T07:03:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/19918-pku-i-risultati-della-sperimentazione-di-fase-3-sulla-sepiapterina-sintetica]]></loc><lastmod>2023-06-29T08:23:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/19885-fenilchetonuria-oggi-con-questa-malattia-genetica-rara-e-possibile-diventare-genitori]]></loc><lastmod>2023-06-14T14:18:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/19636-fenilchetonuria-ora-disponibile-pku-golike-bar-sostituto-proteico-di-nuova-generazione]]></loc><lastmod>2023-03-16T19:38:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/19449-fenilchetonuria-sempre-piu-rilevante-il-ruolo-degli-lnaa]]></loc><lastmod>2024-05-29T18:18:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/19378-fenilchetonuria-nuova-indagine-mette-in-luce-i-bisogni-di-pazienti-e-caregiver]]></loc><lastmod>2022-12-10T19:16:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/19323-fenilchetonuria-l-innovazione-nel-campo-degli-alimenti-a-fini-medici-speciali-le-news-dal-convegno-sea-iem]]></loc><lastmod>2022-11-23T16:48:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/19318-apr-applied-pharma-research-finalista-al-rare-disease-international-film-festival-2022]]></loc><lastmod>2022-11-22T14:56:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/18961-fenilchetonuria-cometa-asmme-insieme-ad-alleanza-malattie-rare-e-fondazione-allianz-per-aiutare-pazienti-ucraini-rifugiati-in-italia]]></loc><lastmod>2022-07-26T14:24:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/18813-fenilchetonuria-presentata-l-iniziativa-pkuisine-per-ristoranti-in-grado-di-servire-anche-apro]]></loc><lastmod>2023-02-10T19:29:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/18829-fenilchetonuria-oggi-la-giornata-mondiale-2022]]></loc><lastmod>2022-06-27T12:40:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/18843-fenilchetonuria-c-e-bisogno-di-altri-medici-che-se-ne-occupino]]></loc><lastmod>2022-06-27T10:50:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/18777-fenilchetonuria-la-dietoterapia-per-ogni-eta-ma-sempre-personalizzata]]></loc><lastmod>2022-06-22T14:38:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/18663-fenilchetonuria-in-ucraina-i-pazienti-non-hanno-piu-una-terapia]]></loc><lastmod>2022-05-19T15:43:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/18579-fenilchetonuria-il-ceo-di-apr-galfetti-ho-cambiato-l-azienda-per-migliorare-la-vita-di-mio-figlio]]></loc><lastmod>2022-04-26T20:48:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/18519-fenilchetonuria-l-importanza-di-fare-sport-e-vivere-una-vita-attiva]]></loc><lastmod>2022-04-06T05:20:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/18397-fenilchetonuria-recenti-acquisizioni-terapeutiche-e-prospettive-future]]></loc><lastmod>2022-03-24T08:48:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/18252-fenilchetonuria-i-clinici-sulla-serie-rai-doc-benissimo-trattare-un-tema-cosi-poco-noto-serve-pero-piu-attenzione-ai-dettagli]]></loc><lastmod>2022-02-06T10:33:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/17954-fenilchetonuria-mantenere-sotto-controllo-la-malattia-in-eta-precoce-minimizza-i-problemi-cognitivi]]></loc><lastmod>2021-10-31T21:28:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/17761-fenilchetonuria-ora-la-sostituzione-proteica-puo-essere-assunta-come-una-caramella]]></loc><lastmod>2021-09-13T08:06:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/17580-fenilchetonuria-i-sostituti-proteici-essenziali-nella-gestione-della-pku-compiono-70-anni]]></loc><lastmod>2021-06-27T21:13:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/17582-pku-day-2021-la-campagna-golike-pkupassiton-passa-il-favore-e-accresci-la-consapevolezza]]></loc><lastmod>2021-06-27T21:12:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/17583-fenilchetonuria-al-san-paolo-di-milano-la-telemedicina-diventa-parte-del-processo-di-cura-e-assistenza-ai-pazienti]]></loc><lastmod>2021-06-27T20:50:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/17584-fenilchetonuria-oggi-28-giugno-si-celebra-la-giornata-mondiale]]></loc><lastmod>2021-06-28T08:30:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/17577-fenilchetonuria-non-sono-diverso-dagli-altri-ho-una-diversita-alimentare]]></loc><lastmod>2021-06-24T14:25:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/17509-fenilchetonuria-ptc923-riceve-designazione-di-farmaco-orfano-da-fda-e-ce]]></loc><lastmod>2021-06-06T16:50:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/17213-fenilchetonuria-necessario-prendere-in-carico-i-pazienti-adulti-e-in-transizione]]></loc><lastmod>2021-03-23T09:53:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/16821-fenilchetonuria-i-dietisti-metabolici-impegnati-per-non-abbandonare-i-pazienti]]></loc><lastmod>2021-01-14T07:53:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/16812-fenilchetonuria-i-pazienti-telemedicina-usata-poco-troppi-controlli-rimandati-all-infinito]]></loc><lastmod>2020-12-16T08:03:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/16361-fenilchetonuria-imparare-dall-emergenza-coronavirus-per-guardare-al-futuro]]></loc><lastmod>2020-08-09T17:23:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/16224-fenilchetonuria-arriva-una-miscela-di-aminoacidi-facile-da-bere]]></loc><lastmod>2020-06-28T17:07:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/16043-fenilchetonuria-prossima-la-sperimentazione-di-fase-iii-sulla-sepiapterina]]></loc><lastmod>2020-05-10T20:37:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/15906-fenilchetonuria-da-fda-orphan-drug-designation-per-la-miscela-di-aminoacidi-di-apr]]></loc><lastmod>2020-04-05T18:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/15540-fenilchetonuria-dietisti-esperti-riuniti-a-bologna-per-discutere-di-terapia]]></loc><lastmod>2019-12-26T22:40:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/15386-fenilchetonuria-tra-le-principali-criticita-la-gestione-del-paziente-adulto]]></loc><lastmod>2019-11-09T10:46:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/15176-fenilchetonuria-nuovi-dati-evidenziano-i-benefici-degli-aminoacidi-a-rilascio-prolungato]]></loc><lastmod>2019-09-10T20:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/15009-fenilchetonuria-il-problema-dell-aderenza-alla-dieta-si-puo-risolvere-2]]></loc><lastmod>2019-07-09T08:56:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14969-fenilchetonuria-in-toscana-nascera-il-primo-centro-per-pazienti-adulti]]></loc><lastmod>2019-07-09T10:26:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14959-fenilchetonuria-la-malattia-metabolica-piu-diffusa-oggi-il-world-pku-day]]></loc><lastmod>2019-10-31T16:15:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14793-fenilchetonuria-approvazione-europea-per-la-terapia-enzimatica-sostitutiva]]></loc><lastmod>2019-05-12T20:13:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14304-fenilchetonuria-per-una-vita-normale-la-consapevolezza-e-tutto]]></loc><lastmod>2018-12-20T12:27:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14299-fenilchetonuria-con-i-dovuti-controlli-medici-via-libera-allo-sport]]></loc><lastmod>2018-12-18T18:42:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14294-vivere-con-la-fenilchetonuria-oggi-il-racconto-di-emanuele-per-pkuheroes]]></loc><lastmod>2018-12-18T12:24:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14273-fenilchetonuria-dall-esperienza-della-malattia-in-famiglia-all-innovazione-farmaceutica]]></loc><lastmod>2018-12-12T21:09:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14256-fenilchetonuria-grazie-allo-screening-neonatale-e-all-innovazione-farmacologica-una-vita-normale]]></loc><lastmod>2018-12-10T09:51:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14238-fenilchetonuria-disponibile-in-italia-la-nuova-linea-di-alimenti-speciali-di-apr]]></loc><lastmod>2018-12-04T20:57:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14220-fenilchetonuria-quando-la-dieta-e-tutto]]></loc><lastmod>2018-11-29T12:11:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14177-fenilchetonuria-presentata-una-ricerca-qualitativa-sui-pazienti-adulti]]></loc><lastmod>2018-11-21T17:56:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14185-fenilchetonuria-avviata-la-campagna-pkuheroes]]></loc><lastmod>2018-11-22T09:13:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14169-fenilchetonuria-la-nuova-generazione-di-miscele-aminoacidiche]]></loc><lastmod>2018-11-21T12:41:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14149-fenilchetonuria-la-conquista-di-giulia-ora-andare-a-mangiare-al-ristorante-non-e-piu-un-problema]]></loc><lastmod>2018-11-13T12:24:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14137-fenilchetonuria-la-storia-di-lisa-diventata-mamma-nonostante-la-malattia]]></loc><lastmod>2018-11-08T09:55:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14135-fenilchetonuria-le-nuove-sfide-per-la-gestione-della-patologia-nell-adulto]]></loc><lastmod>2018-11-08T10:01:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/14111-fenilchetonuria-oggi-con-questa-malattia-si-diventa-adulti]]></loc><lastmod>2018-11-05T10:47:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/13952-fenilchetonuria-nuovi-alimenti-medici-da-apr-per-maggior-efficacia-e-aderenza-alla-terapia]]></loc><lastmod>2018-09-23T09:22:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/13953-fenilchetonuria-pku-golike-fa-il-suo-debutto-al-convegno-ssiem-2018]]></loc><lastmod>2018-09-21T11:57:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/13876-fenilchetonuria-al-convegno-ssiem-la-nuova-linea-di-alimenti-a-fini-medici-di-apr]]></loc><lastmod>2018-09-03T10:23:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/13775-fenilchetonuria-riscoprire-il-gusto-del-cibo-e-possibile]]></loc><lastmod>2018-07-20T15:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/13708-fenilchetonuria-oggi-e-il-world-pku-day]]></loc><lastmod>2018-06-27T15:46:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/13426-fenilchetonuria-l-ema-accetta-la-domanda-di-immissione-in-commercio-per-pegvaliase]]></loc><lastmod>2018-04-11T16:43:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/11842-fenilchetonuria-pubblicate-le-prime-linee-guida-europee]]></loc><lastmod>2018-06-27T15:48:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/10264-fenilchetonuria-l-italia-e-prima-in-europa-per-la-varieta-degli-alimenti-a-basso-contenuto-di-proteine]]></loc><lastmod>2018-06-27T15:49:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/9219-fenilchetonuria-biomarin-acquista-da-merck-serono-i-diritti-su-due-importanti-terapie]]></loc><lastmod>2018-06-27T15:51:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/8734-fenilchetonuria-approvato-in-europa-l-utilizzo-di-kuvan-nei-bambini-al-di-sotto-dei-4-anni-d-eta]]></loc><lastmod>2018-06-27T15:51:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/8617-fenilchetonuria-un-nuovo-questionario-specifico-valuta-l-impatto-emotivo-della-malattia-sulla-qualita-di-vita-dei-pazienti]]></loc><lastmod>2018-06-27T15:52:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/8244-fenilchetonuria-come-valutare-la-qualita-della-vita-di-pazienti-e-genitori]]></loc><lastmod>2018-06-27T15:52:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/8132-fenilchetonuria-la-salute-delle-ossa-al-centro-di-uno-studio-di-revisione-e-di-meta-analisi]]></loc><lastmod>2018-06-27T15:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/7746-fenilchetonuria-merck-serono-spa-lancia-un-sito-dedicato]]></loc><lastmod>2018-06-27T15:55:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/3192-fenilchetonuria-core-food-e-non-core-food-e-la-nuova-strategia]]></loc><lastmod>2018-06-27T15:55:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/3066-fenilchetonuria-pku-a-breve-le-line-guida-per-la-gestione-di-screening-e-terapia]]></loc><lastmod>2018-06-27T15:56:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/2957-fenilchetonuria-biomarin-sviluppa-un-nuovo-farmaco]]></loc><lastmod>2018-06-27T15:56:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/2539-fenilchetonuria-una-nuova-speranza-dai-chaperoni-farmacologici-per-ora-testati-solo-sui-topi]]></loc><lastmod>2018-06-27T15:57:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/2397-fenilchetonuria-pku-sandra-vuole-un-bimbo-e-cerca-altre-donne-per-condividere-dubbi-ed-esperienze]]></loc><lastmod>2018-06-27T16:00:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/1902-fenilchetonuria-test-neonatale-e-una-terapia-adeguata-permettono-una-vita-normale]]></loc><lastmod>2018-06-27T16:00:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fenilchetonuria-pku/588-fenilchetonuria-valutare-di-routine-la-salute-mentale-dei-pazienti-potrebbe-aiutare-la-terapia]]></loc><lastmod>2018-06-27T16:02:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/22703-fibrosi-cistica-aifa-approva-lestensione-duso-del-farmaco-ivacaftor-tezacaftor-elexacaftor]]></loc><lastmod>2026-02-01T16:49:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/22654-quando-la-dakar-incontra-la-fibrosi-cistica-correre-nel-deserto-come-scelta-di-vita]]></loc><lastmod>2026-01-19T14:11:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/22545-fibrosi-cistica-nasce-nutriamo-il-respiro-la-guida-per-una-corretta-alimentazione]]></loc><lastmod>2025-11-25T09:43:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/22484-fibrosi-cistica-le-novita-dalla-convenzione-con-il-coni-a-un-tavolo-parlamentare]]></loc><lastmod>2025-11-07T11:56:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/22293-fibrosi-cistica-risultato-storico-per-lifc-nella-giornata-mondiale-dedicata-alla-malattia]]></loc><lastmod>2025-09-11T16:50:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/22260-fibrosi-cistica-aifa-estende-l-uso-di-due-farmaci-modulatori-di-cftr]]></loc><lastmod>2025-08-29T08:54:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/22061-fibrosi-cistica-a-milano-una-mostra-sulla-malattia]]></loc><lastmod>2025-06-06T15:13:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/22017-fibrosi-cistica-presentato-a-roma-l-intergruppo-parlamentare-sulla-patologia]]></loc><lastmod>2025-05-23T10:53:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21974-fibrosi-cistica-la-gravidanza-diviene-una-possibilita-sempre-piu-concreta-con-le-nuove-terapie]]></loc><lastmod>2025-05-11T06:15:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21944-fibrosi-cistica-ok-del-chmp-a-un-nuovo-modulatore-di-cftr]]></loc><lastmod>2025-04-30T12:07:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21941-fibrosi-cistica-esteso-l-uso-del-farmaco-ivacaftor-tezacaftor-elexacaftor-in-europa]]></loc><lastmod>2025-04-30T12:07:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21844-fibrosi-cistica-nuove-frontiere-terapeutiche-e-prospettive-per-la-prevenzione]]></loc><lastmod>2025-03-26T18:48:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21767-fibrosi-cistica-progressi-nella-comprensione-della-patologia-dagli-studi-targati-ffc-ricerca]]></loc><lastmod>2025-02-28T16:52:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21705-fibrosi-cistica-intitolato-al-prof-gianni-mastella-il-centro-regionale-del-veneto]]></loc><lastmod>2025-02-10T15:48:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21522-fibrosi-cistica-e-nutrizione-un-delicato-equilibrio]]></loc><lastmod>2024-11-25T17:12:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21496-fibrosi-cistica-da-ema-status-di-farmaco-orfano-a-un-nuovo-agente-antinfiammatorio]]></loc><lastmod>2024-11-15T16:32:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21469-fibrosi-cistica-dal-congresso-nazionale-sifc-novita-sugli-alimenti-a-fini-medici-speciali]]></loc><lastmod>2024-11-08T08:43:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21320-fibrosi-cistica-necessario-far-si-che-il-test-del-portatore-sano-diventi-realta-in-tutta-italia]]></loc><lastmod>2024-09-24T11:35:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/21256-giornata-mondiale-della-fibrosi-cistica-ffc-ricerca-finanzia-due-giovani-ricercatori]]></loc><lastmod>2024-09-04T10:11:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/20962-fibrosi-cistica-al-via-domani-il-xxii-seminario-di-primavera-di-ffc-ricerca]]></loc><lastmod>2024-05-10T12:54:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/20783-fibrosi-cistica-aifa-estende-la-rimborsabilita-di-lumacaftor-ivacaftor]]></loc><lastmod>2024-03-21T11:00:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/20762-fibrosi-cistica-al-via-la-campagna-di-pasqua-di-ffc-ricerca]]></loc><lastmod>2024-03-15T16:38:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/20575-l-allarme-parte-da-fedez-introvabili-gli-enzimi-pancreatici]]></loc><lastmod>2024-02-06T12:35:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/20451-fibrosi-cistica-aperti-i-bandi-2024-di-fibrosi-cistica-ricerca-rivolti-alla-comunita-scientifica-italiana]]></loc><lastmod>2023-12-18T09:17:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/20306-fibrosi-cistica-quanto-sta-cambiando-la-malattia-grazie-ai-progressi-nelle-terapie]]></loc><lastmod>2023-11-10T18:37:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/20197-fibrosi-cistica-al-via-la-xxi-campagna-nazionale-del-ciclamino-della-ricerca]]></loc><lastmod>2023-10-06T17:43:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/20094-fibrosi-cistica-1-su-30-e-portatore-sano-e-non-lo-sa-oggi-la-giornata-mondiale]]></loc><lastmod>2023-09-08T10:57:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19923-fibrosi-cistica-partita-la-traversata-del-tirreno-125-miglia-per-un-resipiro]]></loc><lastmod>2023-06-20T08:46:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19820-fibrosi-cistica-presentata-alla-camera-una-mozione-per-la-gestione-uniforme-in-tutte-le-regioni]]></loc><lastmod>2023-05-25T08:28:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19780-fibrosi-cistica-possibilita-di-falsi-negativi-nello-screening-neonatale-di-bimbi-nati-da-pazienti-in-terapia-con-specifici-farmaci]]></loc><lastmod>2023-05-08T18:34:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19763-fibrosi-cistica-ok-del-chmp-all-uso-di-lumacaftor-ivacaftor-nei-bambini-da-1-a-2-anni]]></loc><lastmod>2023-04-29T16:03:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19668-fibrosi-cistica-una-mozione-chiede-di-aggiornare-le-misure-per-la-cura-dei-pazienti]]></loc><lastmod>2023-03-30T17:25:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19490-fibrosi-cistica-online-tre-nuovi-bandi-di-ffc-ricerca]]></loc><lastmod>2023-02-01T11:04:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19317-fibrosi-cistica-ministero-salute-dispone-autorizzazione-in-deroga-per-garantire-il-test-del-sudore]]></loc><lastmod>2022-11-22T08:19:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19227-fibrosi-cistica-lifc-e-seltis-hub-insieme-per-favorire-l-inserimento-lavorativo-dei-pazienti]]></loc><lastmod>2022-10-30T11:33:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19135-fibrosi-cistica-test-del-sudore-incontro-chiarificatore-tra-lifc-e-ministero-della-salute]]></loc><lastmod>2024-11-15T15:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19131-fibrosi-cistica-al-via-la-xx-campagna-di-raccolta-fondi-di-ffc-ricerca]]></loc><lastmod>2022-09-30T13:15:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19129-fibrosi-cistica-ivacaftor-tezacaftor-elexacaftor-ora-disponibile-anche-per-i-pazienti-pediatrici]]></loc><lastmod>2022-10-03T20:01:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19115-fibrosi-cistica-problemi-burocratici-per-il-test-del-sudore-stop-a-nuove-diagnosi-e-terapie]]></loc><lastmod>2022-09-27T07:25:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19026-fibrosi-cistica-la-lifc-ricevuta-in-udienza-dal-papa]]></loc><lastmod>2022-09-07T17:53:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/19027-giornata-mondiale-della-fibrosi-cistica-esce-oggi-il-video-della-canzone-naufrago]]></loc><lastmod>2022-09-07T17:54:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18984-fibrosi-cistica-rinnovato-l-accordo-tra-lifc-e-randstad-per-l-inserimento-lavorativo-dei-pazienti]]></loc><lastmod>2022-08-05T11:01:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18900-fibrosi-cistica-firmato-un-protocollo-d-intesa-tra-lifc-e-coni]]></loc><lastmod>2022-07-09T19:52:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18795-fibrosi-cistica-alla-conferenza-ecfs-i-risultati-clinici-aggiornati-dei-farmaci-di-vertex]]></loc><lastmod>2022-06-18T13:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18762-fibrosi-cistica-ffc-ricerca-lancia-la-prima-campagna-per-i-lasciti-testamentari-solidali]]></loc><lastmod>2022-06-13T11:45:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18528-fibrosi-cistica-lanciato-lo-spot-di-ffc-ricerca-per-la-campagna-5x1000]]></loc><lastmod>2022-04-09T20:55:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18506-fibrosi-cistica-carlo-castellani-e-il-nuovo-direttore-scientifico-di-ffc-ricerca]]></loc><lastmod>2022-04-03T13:08:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18497-fibrosi-cistica-il-farmaco-kaftrio-rimborsabile-per-pazienti-con-almeno-una-mutazione-f508del]]></loc><lastmod>2022-04-01T10:40:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18432-fibrosi-cistica-kither-biotech-raccoglie-18-milioni-di-euro-per-lo-sviluppo-di-una-potenziale-terapia]]></loc><lastmod>2022-03-21T08:48:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18407-fibrosi-cistica-le-associazioni-italiane-unite-per-fornire-assistenza-ai-pazienti-in-arrivo-dall-ucraina]]></loc><lastmod>2022-03-11T16:47:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18293-fibrosi-cistica-al-via-la-prima-edizione-del-gianni-mastella-starting-grant]]></loc><lastmod>2022-02-13T14:38:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18146-fibrosi-cistica-doppio-trapianto-di-fegato-e-polmoni-per-un-ragazzo-di-16-anni]]></loc><lastmod>2021-12-30T18:47:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/18001-fibrosi-cistica-chmp-dice-si-all-uso-di-kaftrio-in-pazienti-tra-i-6-e-gli-11-anni]]></loc><lastmod>2021-11-13T20:57:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17843-fibrosi-cistica-al-via-la-xix-campagna-di-raccolta-fondi-di-ffc-ricerca]]></loc><lastmod>2021-10-03T16:12:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17755-fibrosi-cistica-la-ricerca-italiana-punta-a-una-cura-per-tutti]]></loc><lastmod>2021-09-08T23:36:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17742-fibrosi-cistica-aperto-il-bando-per-l-assegnazione-della-borsa-di-studio-luigi-maiuri]]></loc><lastmod>2021-09-05T12:09:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17660-fibrosi-cistica-la-sfida-di-alessandro-dall-italia-alla-croazia-in-kayak]]></loc><lastmod>2021-07-18T21:01:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17601-fibrosi-cistica-il-farmaco-kaftrio-rimborsabile-in-italia]]></loc><lastmod>2021-06-29T13:22:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17374-fibrosi-cistica-esteso-l-uso-di-ivacaftor-tezacaftor-elexacaftor-in-europa]]></loc><lastmod>2021-05-02T16:40:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17283-fibrosi-cistica-al-via-la-raccolta-fondi-noi-senza-respiro-da-sempre-fa-che-non-sia-per-sempre]]></loc><lastmod>2021-04-11T21:02:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17254-fibrosi-cistica-lanciata-la-raccolta-fondi-per-il-progetto-case-lifc]]></loc><lastmod>2021-04-03T14:32:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17125-fibrosi-cistica-rachele-somaschini-vince-il-premio-europeo-young-patient-advocate]]></loc><lastmod>2021-03-06T20:29:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17085-fibrosi-cistica-verso-la-rimborsabilita-italiana-del-nuovo-triplo-modulatore-di-cftr]]></loc><lastmod>2021-02-28T13:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/17047-fibrosi-cistica-individuato-un-potenziale-farmaco-con-doppia-azione-di-cura]]></loc><lastmod>2021-02-21T14:03:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16969-il-saluto-di-omar-al-prof-gianni-mastella-padre-della-ricerca-italiana-sulla-fibrosi-cistica]]></loc><lastmod>2021-02-05T10:18:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16859-fibrosi-cistica-al-via-il-bando-di-ricerca-una-cura-per-tutti]]></loc><lastmod>2020-12-30T18:29:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16715-fibrosi-cistica-prosegue-la-campagna-una-cura-per-tutti]]></loc><lastmod>2020-11-22T15:47:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16669-fibrosi-cistica-ulteriormente-esteso-l-uso-di-ivacaftor-in-europa]]></loc><lastmod>2021-06-29T13:32:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16614-fibrosi-cistica-convivere-con-la-malattia-nell-anno-della-pandemia]]></loc><lastmod>2020-10-26T10:49:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16525-fibrosi-cistica-dal-21-ottobre-nelle-sale-il-film-sul-piu-bello]]></loc><lastmod>2020-10-06T15:08:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16508-fibrosi-cistica-al-via-la-campagna-una-cura-per-tutti]]></loc><lastmod>2020-09-29T16:44:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16410-fibrosi-cistica-pazienti-a-rischio-covid-19-il-ruolo-della-telemedicina-e-novita-terapeutiche-la-lifc-celebra-la-giornata-mondiale-nell-anno-della-pandemia]]></loc><lastmod>2020-09-07T15:34:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16384-fibrosi-cistica-approvazione-europea-per-ivacaftor-tezacaftor-elexacaftor]]></loc><lastmod>2020-08-24T15:30:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16371-fibrosi-cistica-nuovi-dati-clinici-favorevoli-per-elexacaftor-tezacaftor-ivacaftor]]></loc><lastmod>2020-08-16T18:54:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16343-fibrosi-cistica-nel-2013-e-2014-nessuno-stanziamento-a-favore-della-ricerca]]></loc><lastmod>2022-06-22T14:34:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16255-fibrosi-cistica-sull-assistenza-domiciliare-troppe-disparita-regionali]]></loc><lastmod>2020-07-05T16:52:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16246-fibrosi-cistica-il-4-5-luglio-corri-alla-gazzetta-marathone-e-sostieni-lifc]]></loc><lastmod>2020-07-02T09:28:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16226-fibrosi-cistica-via-libera-del-chmp-alla-tripla-molecola-ivacaftor-tezacaftor-elexacaftor]]></loc><lastmod>2020-06-28T19:41:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16181-fibrosi-cistica-nuova-estensione-d-indicazione-per-ivacaftor]]></loc><lastmod>2020-06-15T10:59:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16172-fibrosi-cistica-al-via-la-campagna-di-raccolta-fondi-oggi-lo-sai]]></loc><lastmod>2020-06-14T20:12:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/16020-covid-19-la-testimonianza-di-margherita-dottoressa-e-mamma-di-una-bambina-con-fibrosi-cistica]]></loc><lastmod>2020-05-04T18:35:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/15969-fibrosi-cistica-la-ricerca-deve-rimanere-viva-anche-nell-emergenza-coronavirus]]></loc><lastmod>2020-04-19T22:01:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/15760-fibrosi-cistica-e-coronavirus-la-sen-binetti-chiede-congedo-lavorativo-per-i-pazienti]]></loc><lastmod>2020-03-15T21:44:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/15726-fibrosi-cistica-e-coronavirus-accolto-l-ordine-del-giorno-della-senatrice-binetti]]></loc><lastmod>2020-03-10T14:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/15616-fibrosi-cistica-i-pazienti-attendono-un-nuovo-farmaco-gia-approvato-in-america]]></loc><lastmod>2022-06-22T14:36:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/15527-fibrosi-cistica-grazie-alla-ricerca-italiana-camilla-ha-potuto-avere-una-terapia-tutta-per-lei]]></loc><lastmod>2019-12-18T15:14:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/15460-fibrosi-cistica-tante-le-novita-sul-fronte-del-trattamento]]></loc><lastmod>2019-12-09T15:40:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/15431-fibrosi-cistica-inizia-domani-la-vii-edizione-del-forum-lifc]]></loc><lastmod>2019-11-20T16:18:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/15242-fibrosi-cistica-al-via-la-nuova-campagna-con-i-volti-degli-scienziati-dei-malati-e-dei-volontari]]></loc><lastmod>2019-09-29T18:46:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/15139-fibrosi-cistica-fda-accetta-domanda-di-approvazione-di-elexacaftor-tezacaftor-ivacaftor]]></loc><lastmod>2019-08-28T18:09:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14929-fibrosi-cistica-il-nuovo-correttore-vx-445-e-pronto-per-l-approvazione-globale]]></loc><lastmod>2019-06-17T11:45:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14896-fibrosi-cistica-vertex-presente-con-sei-abstract-alla-conferenza-ecfs]]></loc><lastmod>2019-06-09T17:49:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14874-fibrosi-cistica-vicina-la-sperimentazione-clinica-di-un-farmaco-brevettato-da-ffc-onlus]]></loc><lastmod>2019-06-02T18:17:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14775-fibrosi-cistica-un-antimicotico-come-possibile-terapia-universale]]></loc><lastmod>2019-05-05T17:41:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14768-fibrosi-cistica-a-parigi-un-evento-per-giornalisti-dedicato-alla-patologia]]></loc><lastmod>2019-05-01T15:26:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14598-fibrosi-cistica-da-oggi-nelle-sale-il-film-a-un-metro-da-te]]></loc><lastmod>2019-03-19T17:20:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14580-fibrosi-cistica-positivi-i-risultati-di-fase-iii-del-farmaco-vx-445]]></loc><lastmod>2019-03-15T17:18:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14382-fibrosi-cistica-lumacaftor-ivacaftor-approvato-in-europa-per-i-bambini-da-2-a-5-anni]]></loc><lastmod>2019-01-22T15:46:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14377-fibrosi-cistica-a-roma-500-pazienti-attendono-il-centro-adulti-da-anni-ora-un-interrogazione-parlamentare]]></loc><lastmod>2019-01-21T10:34:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14298-fibrosi-cistica-la-malattia-modifica-il-microbiota-intestinale-dei-bambini]]></loc><lastmod>2018-12-18T17:59:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14249-fibrosi-cistica-la-tripla-combinazione-con-vx-659-migliora-la-funzione-polmonare]]></loc><lastmod>2018-12-06T22:06:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14236-fibrosi-cistica-esteso-in-europa-l-uso-di-ivacaftor-a-partire-da-un-anno-di-eta]]></loc><lastmod>2018-12-04T19:20:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14230-fibrosi-cistica-nella-sola-umbria-70-pazienti]]></loc><lastmod>2018-12-03T18:34:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14211-fibrosi-cistica-al-forum-lifc-le-nuove-prospettive-di-vita-e-di-cura]]></loc><lastmod>2018-11-27T16:10:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14150-fibrosi-cistica-approvazione-europea-per-il-nuovo-correttore-di-vertex]]></loc><lastmod>2018-12-04T16:21:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/14142-fibrosi-cistica-da-patologia-pediatrica-a-malattia-dell-eta-adulta]]></loc><lastmod>2018-11-11T22:06:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13944-fibrosi-cistica-arruolamento-completato-nei-due-studi-di-fase-iii-sul-correttore-vx-659]]></loc><lastmod>2018-09-19T21:13:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13843-fibrosi-cistica-boehringer-stipula-partnership-per-la-terapia-genica]]></loc><lastmod>2018-08-16T13:43:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13806-fibrosi-cistica-parere-positivo-del-chmp-per-la-combinazione-tezacaftor-ivacaftor]]></loc><lastmod>2018-07-31T16:09:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13760-fibrosi-cistica-l-impresa-di-sebastiano-arlotta-tarino-a-sostegno-di-donazione-di-organi-e-trapianto-di-polmone]]></loc><lastmod>2018-07-16T10:37:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13691-fibrosi-cistica-scoperta-una-nuova-mutazione-tipica-della-toscana]]></loc><lastmod>2018-06-22T16:06:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13661-fibrosi-cistica-dati-clinici-aggiornati-sui-farmaci-di-vertex]]></loc><lastmod>2018-06-14T14:41:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13476-fibrosi-cistica-l-impegno-di-vertex-nel-ricercare-nuove-terapie]]></loc><lastmod>2018-05-07T15:12:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13504-fibrosi-cistica-vertex-avvia-studi-di-fase-iii-sulla-nuova-molecola-vx-445]]></loc><lastmod>2018-04-28T22:32:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13499-fibrosi-cistica-l-importanza-del-trapianto-di-polmoni]]></loc><lastmod>2018-04-28T15:27:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13472-fibrosi-cistica-parte-a18annipuoi-la-campagna-di-sensibilizzazione-e-raccolta-fondi-sulla-donazione-di-organi]]></loc><lastmod>2018-04-20T12:43:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13416-fibrosi-cistica-online-la-nuova-campagna-io-odio-la-fc]]></loc><lastmod>2018-04-09T14:15:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13375-fibrosi-cistica-vertex-avvia-due-studi-di-fase-iii-sul-farmaco-vx-659]]></loc><lastmod>2019-01-17T15:56:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13246-fibrosi-cistica-approvata-negli-usa-la-combinazione-tezacaftor-ivacaftor]]></loc><lastmod>2019-01-17T15:58:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13201-fibrosi-cistica-vertex-progetta-studi-di-fase-iii-per-due-nuove-molecole]]></loc><lastmod>2018-02-06T19:39:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13090-fibrosi-cistica-approvazione-ue-per-lumacaftor-ivacaftor-in-bambini-di-6-11-anni]]></loc><lastmod>2019-01-17T16:00:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/13007-fibrosi-cistica-risultati-positivi-con-ivacaftor-nei-bambini-da-1-a-2-anni]]></loc><lastmod>2017-12-09T10:28:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12982-fibrosi-cistica-lanciata-la-campagna-fclamiavittoria]]></loc><lastmod>2017-12-02T15:58:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12908-fibrosi-cistica-opinione-positiva-del-chmp-per-l-uso-di-orkambi-nei-bambini]]></loc><lastmod>2017-11-16T16:08:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12892-fibrosi-cistica-pubblicati-i-risultati-di-fase-iii-di-tezakaftor-piu-ivacaftor]]></loc><lastmod>2019-01-17T17:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12836-fibrosi-cistica-disponibile-in-italia-una-nuova-terapia-inalatoria]]></loc><lastmod>2017-10-28T22:07:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12698-fibrosi-cistica-i-pazienti-ancora-senza-farmaco]]></loc><lastmod>2017-09-26T10:52:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12601-fibrosi-cistica-ema-e-fda-accettano-le-domande-per-tezacaftor-piu-ivacaftor]]></loc><lastmod>2017-08-29T21:35:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12561-fibrosi-cistica-fda-approva-ivacaftor-per-cinque-nuove-mutazioni]]></loc><lastmod>2017-08-03T14:15:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12522-fibrosi-cistica-lifc-raccoglie-fondi-per-l-acquisto-di-un-macchinario-per-il-ricondizionamento-dei-polmoni]]></loc><lastmod>2017-07-20T15:07:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12505-fibrosi-cistica-la-rivoluzione-copernicana-dei-nuovi-farmaci]]></loc><lastmod>2017-07-15T10:06:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12503-fibrosi-cistica-i-nuovi-farmaci-cambiano-la-percezione-di-malattia-letale]]></loc><lastmod>2017-07-14T15:08:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12498-fibrosi-cistica-orkambi-finalmente-disponibile-in-italia]]></loc><lastmod>2017-07-13T10:52:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12395-fibrosi-cistica-buoni-esiti-pediatrici-da-combinazione-lumacaftor-ivacaftor]]></loc><lastmod>2017-06-19T15:43:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12327-fibrosi-cistica-negli-usa-l-uso-di-ivacaftor-esteso-ulteriormente]]></loc><lastmod>2017-06-19T14:16:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12186-fibrosi-cistica-in-futuro-un-unico-farmaco-potrebbe-curare-sia-la-causa-che-i-sintomi]]></loc><lastmod>2017-06-16T08:07:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/12154-fibrosi-cistica-risultati-positivi-per-la-combinazione-di-tezacaftor-e-ivacaftor]]></loc><lastmod>2017-06-19T14:16:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11991-giacomo-baruchello-vertex-investiamo-in-terapie-innovative-per-i-pazienti-con-fibrosi-cistica]]></loc><lastmod>2017-06-19T14:16:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11762-fibrosi-cistica-e-malattie-concomitanti-diabete-tumori-al-colon-problemi-epatici-e-disturbi-ossei]]></loc><lastmod>2017-06-16T08:08:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11760-fibrosi-cistica-in-germania-vertex-ha-raggiunto-l-accordo-per-il-rimborso-di-orkambi]]></loc><lastmod>2017-06-16T08:08:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11737-fibrosi-cistica-l-impegno-di-vertex-per-lo-sviluppo-di-nuove-terapie]]></loc><lastmod>2017-06-16T08:08:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11714-fibrosi-cistica-un-infezione-ultraresistente-si-sta-diffondendo-a-livello-globale]]></loc><lastmod>2017-06-16T08:08:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11685-fibrosi-cistica-il-progetto-il-mondo-di-martino-trionfa-al-grandprix-relational-strategies]]></loc><lastmod>2017-06-16T08:09:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11602-fibrosi-cistica-il-centro-provinciale-di-rovereto-e-ora-certificato-secondo-gli-standard-lifc]]></loc><lastmod>2017-06-16T08:09:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11595-fibrosi-cistica-nuovi-dati-positivi-per-orkambi]]></loc><lastmod>2017-06-16T08:09:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11591-fibrosi-cistica-all-umberto-i-un-nuovo-reparto-dedicato-agli-adulti]]></loc><lastmod>2017-06-16T08:09:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11568-fibrosi-cistica-cystic-fibrosis-foundation-apre-un-laboratorio-per-la-scoperta-di-nuovi-medicinali]]></loc><lastmod>2017-06-16T08:09:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11545-fibrosi-cistica-vertex-annuncia-l-avvio-di-quattro-trial-sui-correttori-di-nuova-generazione]]></loc><lastmod>2017-06-16T08:09:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11464-fibrosi-cistica-l-eccellenza-del-centro-pediatrico-di-napoli]]></loc><lastmod>2017-06-16T08:10:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11453-fibrosi-cistica-nel-2025-la-meta-dei-pazienti-sara-adulta-negli-anni-70-era-ancora-una-malattia-pediatrica]]></loc><lastmod>2017-06-16T08:10:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11404-fibrosi-cistica-ffc-onlus-lancia-la-xiv-campagna-nazionale-per-la-ricerca]]></loc><lastmod>2017-06-16T08:10:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11402-fibrosi-cistica-fda-approva-combinazione-lumacaftor-ivacaftor-per-bambini-da-6-a-11-anni]]></loc><lastmod>2017-06-16T08:10:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11369-fibrosi-cistica-unife-lancia-innovativo-progetto-di-ricerca]]></loc><lastmod>2017-06-16T08:10:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11154-fibrosi-cistica-il-punto-sul-programma-di-sviluppo-clinico-di-vx-661-in-combinazione-con-ivacaftor]]></loc><lastmod>2017-06-16T08:10:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/11101-fibrosi-cistica-qual-e-il-costo-della-malattia]]></loc><lastmod>2017-06-16T08:11:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10996-fibrosi-cistica-vertex-e-moderna-avviano-una-collaborazione-per-lo-sviluppo-di-mrna-terapeutico]]></loc><lastmod>2017-06-16T08:11:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10897-fibrosi-cistica-le-linee-guida-per-la-diagnosi-preinpianto]]></loc><lastmod>2017-06-16T08:11:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10888-fibrosi-cistica-il-nice-non-raccomanda-l-uso-del-farmaco-orkambi-nel-regno-unito]]></loc><lastmod>2017-06-16T08:11:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10834-fibrosi-cistica-nuove-assunzioni-al-centro-regionale-della-calabria]]></loc><lastmod>2017-06-16T08:11:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10792-fibrosi-cistica-dalla-conferenza-europea-nuovi-dati-su-efficacia-e-sicurezza-di-kalydeco-e-orkambi]]></loc><lastmod>2017-06-16T08:11:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10723-fibrosi-cistica-arianna-la-mia-generazione-ha-fatto-da-cavia-i-bambini-di-oggi-avranno-una-vita-migliore]]></loc><lastmod>2017-06-16T08:12:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10664-fibrosi-cistica-premiato-agli-strive-awards-il-progetto-italiano-di-lifc-onlus]]></loc><lastmod>2017-06-16T08:12:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10645-fibrosi-cistica-dagli-usa-il-brevetto-per-la-trimetilangelicina-scoperta-in-italia]]></loc><lastmod>2017-06-16T08:12:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10596-fibrosi-cistica-solo-la-meta-dei-pazienti-adulti-comprende-correttamente-la-frequenza-dei-trattamenti]]></loc><lastmod>2017-06-16T08:21:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10561-fibrosi-cistica-veronica-vivo-con-lei-vado-a-trovare-zio-umberto-e-vivo-la-mia-vita]]></loc><lastmod>2017-06-16T08:22:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10548-fibrosi-cistica-tra-fisioterapia-respiratoria-e-nuovi-farmaci]]></loc><lastmod>2017-06-16T08:22:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10547-fibrosi-cistica-quando-la-genetica-determina-la-malattia]]></loc><lastmod>2017-06-16T08:22:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10542-fibrosi-cistica-una-patologia-multiorgano-screening-neonatale-e-screening-al-portatore]]></loc><lastmod>2017-06-16T08:23:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10532-fibrosi-cistica-concesso-dagli-usa-il-brevetto-per-l-uso-della-molecola-tma]]></loc><lastmod>2017-06-16T08:23:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10502-fibrosi-cistica-un-sondaggio-sulla-morte-dopo-la-cessazione-del-trattamento]]></loc><lastmod>2017-06-16T08:23:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10471-fibrosi-cistica-tra-genetica-ed-epidemiologia]]></loc><lastmod>2017-06-16T08:24:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10470-fibrosi-cistica-il-peso-della-terapia]]></loc><lastmod>2017-06-16T08:26:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10472-fibrosi-cistica-non-si-tratta-solo-di-una-malattia-polmonare]]></loc><lastmod>2017-06-16T08:24:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10473-fibrosi-cistica-consegnata-la-borsa-di-studio-unibas-alla-dott-ssa-scieuzo]]></loc><lastmod>2017-06-16T08:24:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10441-fibrosi-cistica-ecco-le-bellissime-salty-girl-e-il-progetto-fotografico-just-breathe]]></loc><lastmod>2017-06-16T08:26:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10412-senza-fiato-in-un-monologo-la-vita-con-la-fibrosi-cistica]]></loc><lastmod>2017-06-16T08:29:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10406-fibrosi-cistica-i-benefici-del-farmaco-ivacaftor-sulla-muscolatura-liscia-dei-polmoni]]></loc><lastmod>2017-06-16T08:30:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10385-fibrosi-cistica-l-attivita-fisica-e-possibile-anche-con-una-grave-insufficienza-respiratoria]]></loc><lastmod>2017-06-16T08:30:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10359-fibrosi-cistica-il-cammino-italiano-di-christian-per-raccogliere-fondi-in-memoria-della-moglie]]></loc><lastmod>2017-06-16T08:30:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10323-fibrosi-cistica-la-sardegna-pronta-a-dare-il-via-agli-screening-neonatali]]></loc><lastmod>2017-06-16T08:31:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10181-invecchiare-bene-con-una-malattia-genetica-rara-sara-possibile-l-esempio-della-fibrosi-cistica]]></loc><lastmod>2016-03-11T14:02:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10124-test-del-sudore-per-la-fibrosi-cistica-il-dr-marco-salvatore-iss-il-nostro-progetto-pilota-per-il-controllo-esterno-di-qualita-e-un-esempio-da-seguire]]></loc><lastmod>2017-06-16T08:31:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10123-fibrosi-cistica-il-dr-marco-salvatore-iss-il-test-del-sudore-e-il-gold-standard-per-la-diagnosi]]></loc><lastmod>2017-06-16T08:31:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10115-fibrosi-cistica-sviluppato-un-nuovo-test-di-screening-piu-veloce-e-preciso]]></loc><lastmod>2017-06-16T08:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10075-fibrosi-cistica-e-trapianti-troppi-pazienti-in-lista-d-attesa-l-impegno-della-lifc]]></loc><lastmod>2017-06-16T08:32:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10076-fibrosi-cistica-riparte-la-campagna-unrespiroinpiu-2016-di-lifc]]></loc><lastmod>2017-06-16T08:31:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10065-fibrosi-cistica-vertex-dona-un-milione-di-dollari-a-18-associazioni-non-profit]]></loc><lastmod>2017-06-16T08:32:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10031-fibrosi-cistica-il-rischio-di-esacerbazione-polmonare-aumenta-in-presenza-di-streptococchi]]></loc><lastmod>2017-06-16T08:32:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/10024-fibrosi-cistica-vantaggi-fiscali-a-chi-finanzia-la-ricerca]]></loc><lastmod>2017-06-16T08:32:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9999-fibrosi-cistica-al-bambino-gesu-di-roma-un-laboratorio-di-riabilitazione-fisica-dedicato-ai-bambini]]></loc><lastmod>2017-06-16T08:32:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9954-fibrosi-cistica-il-piccolo-domenic-diventa-iron-boy-per-un-giorno]]></loc><lastmod>2017-06-16T08:32:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9921-fibrosi-cistica-gli-usa-ancora-in-attesa-per-ulteriori-estensioni-all-uso-di-ivacaftor]]></loc><lastmod>2017-06-16T08:32:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9829-fibrosi-cistica-il-canada-approva-il-primo-farmaco-per-la-doppia-mutazione-f508del]]></loc><lastmod>2017-06-16T08:32:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9825-fibrosi-cistica-ulteriori-conferme-per-l-uso-pediatrico-dell-ivacaftor]]></loc><lastmod>2017-06-16T08:57:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9773-fibrosi-cistica-proposto-in-umbria-un-nuovo-modello-assistenziale]]></loc><lastmod>2017-06-16T08:57:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9646-fibrosi-cistica-ecco-perche-la-geriatria-dovrebbe-occuparsene]]></loc><lastmod>2017-06-16T08:58:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9645-fibrosi-cistica-il-farmaco-ivacaftor-ha-cambiato-la-vita-dei-pazienti]]></loc><lastmod>2017-06-16T08:58:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9553-fibrosi-cistica-ivacaftor-e-il-primo-farmaco-a-vincere-il-forbes-breakthrough-drug-award]]></loc><lastmod>2017-06-16T08:58:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9523-fibrosi-cistica-al-via-la-nuova-campagna-di-natale-fondazione-ricerca-fibrosi-cistica-onlus]]></loc><lastmod>2017-06-16T08:58:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9443-fibrosi-cistica-ue-approva-orkambi-per-il-trattamento-delle-cause-della-malattia-in-pazienti-con-due-copie-della-mutazione-f508del]]></loc><lastmod>2018-11-14T09:13:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9436-fibrosi-cistica-ivacaftor-ora-disponibile-per-i-pazienti-dai-2-ai-5-anni-con-9-mutazioni-gating-e-adulti-con-mutazione-r117h]]></loc><lastmod>2017-06-16T08:58:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9389-fibrosi-cistica-conferme-per-ivacaftor-anche-al-di-la-degli-studi-clinici]]></loc><lastmod>2017-06-16T08:58:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9371-fibrosi-cistica-ptc-therapeutics-lancia-strive-il-programma-che-finanzia-l-impegno-delle-associazioni-di-pazienti]]></loc><lastmod>2017-06-16T09:00:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9385-fibrosi-cistica-dal-21-novembre-a-fiuggi-il-iii-forum-lifc]]></loc><lastmod>2017-06-16T09:00:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9380-fibrosi-cistica-il-dr-manca-bari-con-ivacaftor-migliora-la-funzione-polmonare-e-si-normalizza-il-test-del-sudore-salato]]></loc><lastmod>2017-06-16T09:00:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9357-fibrosi-cistica-il-dr-cimino-roma-con-ivacaftor-la-malattia-e-sotto-controllo-e-la-qualita-di-vita-migliora]]></loc><lastmod>2017-06-16T09:00:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9300-fibrosi-cistica-il-centro-della-calabria-non-chiudera]]></loc><lastmod>2015-11-06T10:08:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9276-fibrosi-cistica-un-app-per-migliorare-l-assistenza-dei-pazienti]]></loc><lastmod>2015-11-02T14:49:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9253-fibrosi-cistica-e-anemia-falciforme-nuove-speranze-dall-editing-genetico]]></loc><lastmod>2017-06-16T09:00:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9245-fibrosi-cistica-futuro-incerto-per-il-centro-di-lamezia-terme]]></loc><lastmod>2015-10-28T16:46:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9210-fibrosi-cistica-e-trapianto-polmonare-all-ers-gli-esperti-propongono-variazioni-sulle-linee-guida]]></loc><lastmod>2017-06-16T09:02:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9128-fibrosi-cistica-all-italiano-luis-galietta-il-premio-robert-j-beall-award]]></loc><lastmod>2017-06-16T09:02:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9126-fibrosi-cistica-l-ema-esaminera-il-dossier-sul-farmaco-ataluren]]></loc><lastmod>2017-06-16T09:02:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9082-fibrosi-cistica-dalla-conferenza-annuale-del-nord-america-le-novita-terapeutiche-del-futuro]]></loc><lastmod>2016-02-01T10:45:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/9064-fibrosi-cistica-al-via-la-xiii-campagna-nazionale-per-la-ricerca-ffc-onlus]]></loc><lastmod>2017-06-16T09:03:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8992-fibrosi-cistica-mozione-in-trentino-per-avviare-screening-su-popolazione-in-eta-riproduttiva]]></loc><lastmod>2017-06-16T09:03:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8995-fibrosi-cistica-parere-positivo-del-chmp-per-la-commercializzazione-di-orkambi-di-vertex]]></loc><lastmod>2017-06-16T09:03:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8946-fibrosi-cistica-un-progetto-europeo-finanziera-lo-sviluppo-di-nuovi-farmaci]]></loc><lastmod>2017-06-16T09:03:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8807-fibrosi-cistica-l-importanza-dello-sport-per-i-trapiantati]]></loc><lastmod>2017-06-16T09:03:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8806-fibrosi-cistica-domani-la-prima-giornata-di-sensibilizzazione-su-trapianto-e-sport]]></loc><lastmod>2017-06-16T09:03:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8680-fibrosi-cistica-la-terapia-genica-ha-un-effetto-positivo-sulla-stabilizzazione-della-funzione-polmonare]]></loc><lastmod>2017-06-16T09:03:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8697-fibrosi-cistica-in-basilicata-8000-bambini-sottoposti-a-screening-neonatale]]></loc><lastmod>2017-06-16T09:03:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8566-fibrosi-cistica-negli-usa-approvata-la-combinazione-farmacologica-per-mutazione-f508-in-omozigosi]]></loc><lastmod>2016-10-05T20:08:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8475-fibrosi-cistica-da-bruxelles-nuovi-dati-sul-farmaco-per-mutazione-f508del]]></loc><lastmod>2017-06-16T09:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8433-fibrosi-cistica-cosa-accade-quando-lo-screening-neonatale-fornisce-risultati-dubbi]]></loc><lastmod>2017-06-16T09:13:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8456-fibrosi-cistica-anche-lifc-nel-board-internazionale-di-cf-europe]]></loc><lastmod>2017-06-16T09:13:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8429-fibrosi-cistica-vertex-e-parion-collaborano-per-lo-sviluppo-di-nuove-terapie]]></loc><lastmod>2017-06-16T09:13:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8419-fibrosi-cistica-anche-in-sicilia-arriva-il-nuovo-farmaco-garantita-la-massima-attenzione-ai-pazienti]]></loc><lastmod>2017-06-16T09:13:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8410-fibrosi-cistica-il-microbiota-potenziale-predittore-di-gravita]]></loc><lastmod>2017-06-16T09:13:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8291-fibrosi-cistica-un-documento-per-il-riconoscimento-di-invalidita-civile-e-disabilita]]></loc><lastmod>2017-06-16T09:13:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8253-fibrosi-cistica-pubblicati-dati-positivi-sulla-combinazione-di-farmaci-per-doppia-mutazione-f508del]]></loc><lastmod>2015-05-25T12:04:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8212-fibrosi-cistica-dagli-usa-primo-ok-al-farmaco-per-i-pazienti-con-mutazione-f508del]]></loc><lastmod>2015-06-03T16:09:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8169-approvato-ivacaftor-per-la-fibrosi-cistica-minicucci-gaslini-qmolto-soddisfatta-per-lapprovazione-del-farmacoq]]></loc><lastmod>2016-05-06T16:31:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8168-fibrosi-cistica-approvato-farmaco-kalydeco-dr-salvatore-potenza-qun-nostro-paziente-ha-potuto-riprendere-addirittura-lattivita-sportivaq]]></loc><lastmod>2015-06-03T16:11:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8164-fibrosi-cistica-prof-francesco-blasi-qivacaftor-prima-vera-terapia-personalizzata-per-la-grave-patologia-genetica]]></loc><lastmod>2015-06-03T16:10:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8166-fibrosi-cistica-prof-gianni-mastella-qkalydeco-incide-sul-decorso-della-malattiaq]]></loc><lastmod>2015-08-24T09:10:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8159-fibrosi-cistica-lifc-qgrande-soddisfazione-per-lapprovazione-del-farmaco-kalydecoq]]></loc><lastmod>2015-08-24T09:11:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8158-fibrosi-cistica-drssa-lucidi-opbg-qapprovazione-di-kalydeco-svolta-epocaleq]]></loc><lastmod>2015-06-03T16:10:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8156-vertex-riceve-lapprovazione-in-italia-per-kalydeco-ivacaftor-primo-farmaco-idoneo-a-trattare-la-causa-della-fibrosi-cistica-in-persone-con-nove-specifiche-mutazioni-genetiche]]></loc><lastmod>2015-12-09T16:50:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8032-fibrosi-cistica-premiato-dalla-european-cystic-fibrosis-society-il-dott-carlo-castellani]]></loc><lastmod>2017-06-16T09:14:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8004-fibrosi-cistica-valeria-e-rinata-dopo-il-trapianto-oggi-e-madre-e-sta-bene]]></loc><lastmod>2017-06-16T09:15:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8029-fibrosi-cistica-dallinps-arriva-la-svolta-per-tutela-sociale-dei-pazienti]]></loc><lastmod>2017-06-16T09:14:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/8001-fibrosi-cistica-ecco-perche-sono-necessari-dei-centri-dedicati-ai-pazienti-adulti]]></loc><lastmod>2017-06-16T09:16:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7997-fibrosi-cistica-limportanza-di-una-diagnosi-tempestiva-e-corretta]]></loc><lastmod>2017-06-16T09:16:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7975-fibrosi-cistica-ue-approva-limmissione-in-commercio-di-vantobra]]></loc><lastmod>2017-06-16T09:16:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7916-fibrosi-cistica-confermata-la-sicurezza-della-combinazione-di-vx-661-e-ivacaftor]]></loc><lastmod>2017-06-16T09:16:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7870-fibrosi-cistica-vertex-riceve-lapprovazione-della-fda-per-il-farmaco-kalydeco-destinato-ai-bambini-dai-2-ai-5-anni-con-mutazioni-specifiche-nel-gene-cftr]]></loc><lastmod>2017-06-16T09:17:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7887-fibrosi-cistica-aumentano-le-possibilita-di-trapianto-grazie-alla-campagna-unrespiroinpiu-di-lifc]]></loc><lastmod>2017-06-16T09:17:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7815-fibrosi-cistica-e-adolescenza-presentati-i-risultati-del-progetto-linfa]]></loc><lastmod>2017-06-16T09:17:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7799-fibrosi-cistica-screening-neonatale-strategia-efficace-per-la-diagnosi]]></loc><lastmod>2017-06-16T09:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7772-fibrosi-cistica-non-piu-solo-pazienti-bambini-lemergenza-dei-centri-per-la-cura-delladulto]]></loc><lastmod>2017-06-16T09:17:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7771-fibrosi-cistica-limpegno-della-lifc-per-la-tutela-dei-pazienti]]></loc><lastmod>2017-06-16T09:40:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7766-fibrosi-cistica-lifc-e-sifc-ascoltati-dal-ministro-lorenzin-in-merito-a-fondi-legge-54893]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7711-fibrosi-cistica-troppo-pochi-i-trapianti-che-salvano-le-vite-possibile-aumentarle-il-numero-sostenendo-un-progetto-lifc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7530-2015-02-04-11-53-22]]></loc><lastmod>2015-06-03T16:13:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7545-lega-italiana-fibrosi-cistica-il-via-alla-nuova-campagna-di-sensibilizzazione]]></loc><lastmod>2015-06-03T16:13:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7494-fibrosi-cistica-si-rischia-una-forte-diminuzione-dei-fondi]]></loc><lastmod>2015-06-03T16:13:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7415-fibrosi-cistica-nuove-autorizzazioni-e-future-sperimentazioni-per-kalydeco-ivacaftor]]></loc><lastmod>2016-05-06T16:26:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7397-fibrosi-cistica-accolto-lappello-di-lifc-e-omar-il-senato-ha-salvato-la-legge-54893]]></loc><lastmod>2015-06-03T16:13:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7360-fibrosi-cistica-arriva-in-italia-industry-liaison-office-ilo-per-incentivare-gli-investimenti-farmaceutici]]></loc><lastmod>2015-06-03T16:13:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7353-fibrosi-cistica-la-cisteamina-sara-un-trattamento-efficace]]></loc><lastmod>2015-06-03T16:13:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7357-fibrosi-cistica-fda-statunitense-approva-ivacaftor-kalydeco-per-la-mutazione-r117h]]></loc><lastmod>2015-06-03T16:13:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7318-fibrosi-cistica-la-cystic-fibrosis-foundation-therapeutics-collaborera-con-shire-per-lo-sviluppo-di-una-nuova-terapia]]></loc><lastmod>2015-06-03T16:13:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7286-sardegna-stanziati-80000-per-la-rete-dedicata-alla-fibrosi-cistica]]></loc><lastmod>2015-05-25T12:02:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7272-fibrosi-cistica-binetti-qce-il-rischio-che-si-buttino-via-20-anni-di-risultatiq]]></loc><lastmod>2015-05-25T12:02:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7254-fibrosi-cistica-omar-qdistruggere-un-modello-che-ha-dato-ottimi-risultati-e-un-atto-irresponsabileq]]></loc><lastmod>2015-05-25T12:02:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7253-fibrosi-cistica-il-sistema-modello-nato-con-la-legge-548-messo-a-rischio-con-la-legge-di-stabilita]]></loc><lastmod>2015-05-25T12:02:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7195-fibrosi-cistica-xii-convention-dei-ricercatori-promossa-da-ffc-onlus]]></loc><lastmod>2015-05-25T12:02:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7186-fibrosi-cistica-attiviato-il-nuovo-servizio-gratuito-qlesperto-rispondeq]]></loc><lastmod>2015-06-30T07:57:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7185-fibrosi-cistica-chiuso-il-forum-lifc-nuovi-antibiotici-terapia-genica-somministrazione-di-enzimi-pancreatici-trapianto-di-polmone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7172-fibrosicistica-pazienti-e-aziende-uniti-per-nuove-cure-il-modello-vincente-della-venture-philantropy]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7148-fibrosi-cistica-e-sindrome-metabolica-cftr-correlata-un-caso-emblematico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7092-fibrosi-cistica-in-abruzzo-la-prima-somministrazione-del-farmaco-innovativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7089-fibrosi-cistica-vertex-presenta-in-europa-e-usa-richiesta-di-approvazione-per-terapia-combinataper-mutazione-f508del]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7073-fibrosi-cistica-da-uno-studio-clinico-pilota-condotto-in-italia-arrivano-innovative-strategie-di-terapia-contro-la-forma-piu-comune-della-malattia]]></loc><lastmod>2016-03-17T00:39:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7016-fibrosi-cistica-la-presenza-di-batteri-resistenti-agli-antibiotici-richiede-nuove-soluzioni-terapeutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/7012-fibrosi-cistica-parere-favorevole-dellfda-sulluso-di-ivacaftor-in-pazienti-con-mutazione-r117h]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6977-fibrosi-cistica-il-centro-di-riferimento-conferma-necessario-nuovo-reparto-e-finanziamento-per-terapie-domiciliari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6976-fibrosi-cistica-lifc-in-lazio-serve-un-centro-per-pazienti-adulti-e-piu-terapia-domiciliare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6975-fibrosi-cistica-in-lazio-la-lifc-denuncia-centro-di-riferimento-non-adeguato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6898-fibrosi-cistica-vertex-annuncia-nuovi-trattamenti-basati-sullassociazione-di-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6872-fibrosi-cistica-claire-racconta-la-sua-malattia-per-abbattere-i-pregiudizi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6853-fibrosi-cistica-serie-a-beko-e-lega-italiana-fibrosi-cistica-insieme-per-vincere-questa-partita]]></loc><lastmod>2017-06-16T09:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6824-fibrosi-cistica-gravidanza-un-percorso-possibile]]></loc><lastmod>2017-06-16T09:46:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6816-fibrosi-cistica-lo-stato-stanzia-87-milioni-di-euro]]></loc><lastmod>2015-05-26T16:18:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6740-fibrosi-cistica-lo-screening-neonatale-e-quello-del-portatore-sono-complementari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6626-fibrosi-cistica-stimata-laspettativa-di-vita-nei-pazienti-pediatrici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6615-fibrosi-cistica-dal-cnr-nuove-tecniche-per-terapie-piu-mirate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6561-fibrosi-cistica-nuovo-metodo-diagnostico-non-invasivo-permette-di-differeziarla-dalla-discinesia-ciliare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6522-fibrosi-cistica-ora-il-farmaco-ivacaftor-disponibile-per-i-pazienti-dai-6-anni-in-su-per-otto-mutazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6515-fibrosi-cistica-non-colpisce-solo-i-polmoni-scoperta-una-forma-priva-di-coinvolgimento-polmonare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6367-fibrosi-cistica-la-societa-ecfs-chiede-maggiore-cooperazione-e-nuove-linee-guida-internazionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6333-fibrosi-cistica-miglioramenti-della-funzionalita-polmonare-grazie-alla-combinazione-ivacaftor-lumacafator]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6246-la-fibrosi-cistica-diventa-adulta-autonomia-e-socializzazione-le-armi-vincenti-per-superare-il-modello-pediatrico-nella-gestione-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6160-fibrosi-cistica-buoni-i-risultati-per-la-terapia-di-ripristino-proteico-con-ataluren]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/6045-fibrosi-cistica-lesomeprazolo-non-riduce-le-riacutizzazioni-polmonari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/5792-fibrosi-cistica-al-via-il-progetto-italiano-task-force-for-cystic-fibrosis]]></loc><lastmod>2019-06-02T18:23:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/5596-fibrosi-cistica-negli-usa-approvata-nuova-indicazione-di-ivacaftor]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/5342-fibrosi-cistica-e-gravidanza-il-bambino-gesu-di-potenza-viene-in-aiuto-alle-donne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/5246-fibrosi-cistica-ivacaftor-delude-nei-pazienti-giovani-buoni-risultati-per-gli-adulti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/5027-i-pazienti-con-fibrosi-cistica-ricevuti-dal-papa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4994-fibrosi-cistica-dallo-screening-neonatale-alla-prospettiva-di-vita-adulta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4995-fibrosi-cistica-durante-ladolescenza-seguire-la-terapia-e-piu-difficile-fondamentale-il-ruolo-dei-centri-di-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4969-diventare-grandi-con-la-fibrosi-cistica-adolescenti-e-genitori-a-confronto-nel-primo-laboratorio-interattivo-linfa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4912-fibrosi-cistica-lo-screening-neonatale-e-le-cure-precoci-permettono-un-miglioramento-di-alcuni-parametri-polmonari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4897-fibrosi-cistica-matteo-marzotto-fa-visita-ad-una-paziente-ricoverata-al-centro-di-cura-per-la-fibrosi-cistica-di-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4830-fibrosi-cistica-prossimi-allavvio-due-importanti-progetti-di-ricerca-in-abruzzo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4767-xi-campagna-nazionale-per-la-ricerca-sulla-fibrosi-cistica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4639-fibrosi-cistica-grazie-al-sequenziamento-di-nuova-generazione-messo-a-punto-un-nuovo-metodo-diagnostico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4520-fibrosi-cistica-in-australia-stop-alla-sovvenzione-per-kalydeco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4489-fibrosi-cistica-positiva-la-sperimentazione-di-ivacaftor-per-pazienti-con-mutazioni-diverse-da-g551d]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4360-screening-neonatale-per-la-fibrosi-cistica-in-svizzera-obbligatorio-dal-2011]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/4005-fibrosi-cistica-limportanza-di-unalimentazione-corretta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3995-fibrosi-cistica-dal-4-al-12-maggio-qda-rosa-nasce-cosa-fai-sbocciare-il-futuro-con-una-rosaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3972-fibrosi-cistica-3-milioni-di-euro-per-prevenzione-e-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3929-fibrosi-cistica-pubblicato-il-position-paper-di-aifa-si-alla-terapia-antibiotica-domiciliare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3883-fibrosi-cistica-in-aumento-le-infezioni-trasmesse-tra-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3824-fibrosi-cisticada-24-marzo-al-7-aprile-lo-sport-diventa-strumento-di-sensibilizzazione-e-di-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3795-fibrosi-cistica-fino-al-7-aprile-un-sms-per-sostenere-la-lega-italiana-fibrosi-cistica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3703-fibrosi-cistica-nasce-il-primo-archivio-bibliografico-digitale-dedicato-alla-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3644-fibrosi-cistica-il-progetto-vivi-wireless-arriva-anche-a-roma-piu-aderenza-alle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3611-fibrosi-cistica-una-nuova-strategia-per-combattere-le-infezioni-mortali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3541-fibrosi-cistica-in-gran-bretagna-approvato-ivacaftor-per-la-mutazione-g551d]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3554-fibrosi-cistica-grande-successo-per-lasta-charity-ffc-al-sole-24-ore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3353-fibrosi-cistica-con-vivi-wireless-esercizio-fisico-in-liberta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3278-fibrosi-cistica-status-orfano-negli-usa-il-primo-antibiotico-per-via-inalatoria-contro-lo-stafilococco-aureo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3200-fibrosi-cistica-assegnati-i-fondi-per-lassistenza-la-ricerca-deve-attendere-ma-sara-di-nuovo-un-finanziamento-a-pioggia]]></loc><lastmod>2015-05-28T13:23:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3107-fibrosi-cistica-ivacaftor-potrebbe-trattare-altre-forme-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/3092-fibrosi-cistica-il-trattamento-con-mannitolo-in-polvere-aiuta-i-pazienti-con-pseudomonas-aeruginosa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2947-fibrosi-cistica-uno-studio-europeo-apre-nuovi-spiragli-terapeutici]]></loc><lastmod>2018-05-05T14:11:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2944-fibrosi-cistica-matteo-marzotto-vicepresidente-e-testimonial-ffc-onlus-corro-per-mantenere-alta-lattenzione-sulla-malattiaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2865-fibrosi-cistica-confermata-la-correlazione-con-il-diabete-colpisce-circa-la-meta-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2674-la-corte-di-strasburgo-lega-italiana-fibrosi-cistica-sulla-legge-40]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2602-fibrosi-cistica-ivacaftor-e-ora-approvato-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2521-fibrosi-cistica-laddio-alla-piccola-rebecca-di-savona]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2509-fibrosi-cistica-la-lifc-apre-le-porte-sul-network-etwoocom]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2458-fibrosi-cistica-troppa-confusione-sui-farmaci-di-vertex]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2357-fibrosi-cistica-valeria-non-ha-smesso-di-lottare-dopo-il-trapianto-la-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2329-fibrosi-cistica-approvato-finanziamento-di-1-milione-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2293-fibrosi-cistica-fondazione-veneto-banca-finanzia-un-importante-progetto-di-screening]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2288-fibrosi-cistica-a-roma-avviata-la-sperimentazione-sulla-telemedicina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2287-fibrosi-cistica-laglio-puo-aiutare-a-combatterne-i-batteri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2260-fibrosi-cistica-ivacaftor-ottiene-parere-positivo-del-comitato-ue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2270-fibrosi-cistica-errati-i-dati-dello-studio-su-ivacaftor-e-vx-809]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2257-fibrosi-cistica-ecco-perche-le-donne-sono-colpite-piu-gravemente-dalla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2247-fibrosi-cistica-e-tumori-disponibile-myriapod-per-la-diagnosi-personalizzata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2188-fibrosi-cistica-firmata-lintesa-tra-fondazione-per-la-ricerca-fc-e-lega-italiana-fibrosi-cistica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2160-fibrosi-cistica-una-combinazione-di-farmaci-per-migliorare-la-funzione-polmonare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2154-trapianto-di-polmone-tra-vivi-potra-aiutare-i-pazienti-con-fibrosi-cistica-e-fibrosi-polmonare-idiopatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2148-fibrosi-cistica-garavaglia-pd-a-rischio-prevenzione-e-cure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2109-fibrosi-cistica-disponibile-in-europa-il-bronchitol]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/2093-fibrosi-cistica-una-pianta-per-il-centro-toscano-fibrosi-cistica-del-meyer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1928-fibrosi-cistica-dagli-usa-un-farmaco-che-corregge-il-difetto-genetico-di-una-forma-rarissima]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1915-fibrosi-cistica-la-fondazione-per-la-ricerca-concorda-con-glaxosmithkline-un-piano-di-collaborazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1889-fibrosi-cistica-marcia-di-solidarieta-per-un-piccolo-italocanadese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1892-fibrosi-cistica-mozione-al-senato-sui-i-tagli-al-finanziamento-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1861-fibrosi-cistica-aspetti-diagnostici-e-genetici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1860-fibrosi-cistica-lesercizio-fisico-e-fondamentale-per-la-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1859-fibrosi-cistica-e-torbamicina-wireless-prof-magazzu-un-salto-di-qualita-per-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1855-malattie-rare-marzotto-qserve-ponte-con-industria-per-le-nuove-terapieq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1844-fibrosi-cistica-aderire-meglio-alla-terapia-divertendosi-arriva-la-terapia-wireless]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1815-fibrosi-cistica-per-ripristinare-lanomalia-genetica-sono-necessarie-due-diverse-azioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1598-fibrosi-cistica-lindice-di-clearance-polmonare-e-un-marcatore-per-la-diagnosi-infantile]]></loc><lastmod>2016-10-05T20:17:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1596-fibrosi-cistica-la-lega-italiana-denuncia-il-rischio-dei-tagli-ai-finanziamenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1579-fibrosi-cistica-progressi-importanti-con-un-potenziatore-di-proteina-cftr-nei-pazienti-con-mutazioni-in-g551d]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1481-fibrosi-cistica-fino-al-31-dicembre-si-puo-aiutare-respiro-sommerso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1396-fibrosi-cistica-lo-screening-e-obbligatorio-dal-93-ma-5-regioni-non-lo-fanno-ancora]]></loc><lastmod>2015-06-05T16:08:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1403-fibrosi-cistica-ricordiamo-chiara-e-daniela-che-non-ce-lanno-fatta]]></loc><lastmod>2018-08-16T15:51:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1375-fibrosi-cistica-sempre-piu-stretta-la-relazione-con-il-mondo-dello-sport]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1200-fibrosi-cistica-gianluca-genoni-che-ha-polmoni-da-record-si-allea-con-la-lifc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1158-fibrosi-cistica-la-lifc-scelta-dai-clienti-vodafone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1152-fibrosi-cistica-luso-di-azitromicina-predispone-i-pazienti-ad-infezioni-da-micobatteri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/1068-fibrosi-cistica-fino-al-27-settembre-si-puo-sostenere-il-progetto-sport-e-fibrosi-cistica-perche-no]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/998-fibrosi-cistica-guerra-batteriologica-contro-le-infezioni-da-pseudomonas-aeruginosa]]></loc><lastmod>2016-09-27T14:27:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/980-fibrosi-cistica-la-malattia-si-affaccia-nella-casa-reale-olandese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/962-fibrosi-cistica-si-cerca-una-molecola-che-mimi-leffetto-benefico-del-freddo-su-cftr]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/933-fibrosi-cistica-nuove-conferme-per-un-possibile-uso-del-miglustat-contro-linfiammazione-polmonare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/801-fibrosi-cistica-grande-successo-per-extreme-airshow-2011-raccolta-fondi-per-lifc-veneta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/790-fibrosi-cistica-italiani-scoprono-che-la-pentraxina-3-potrebbe-combattere-lo-pseudomonas]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/775-fibrosi-cistica-ecco-il-burkholderia-ambifaria-il-batterio-buono-contro-le-infezioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/723-fibrosi-cistica-in-basilicata-compie-20-anni-il-centro-regionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/714-fibrosi-cistica-i-pazienti-dellumberto-i-in-agitazione-per-il-rischio-chiusura]]></loc><lastmod>2015-06-08T09:31:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/643-fibrosi-cistica-un-antibiotico-unito-ad-un-antidiarroico-potrebbe-combattere-le-infezione-resistenti-alla-terapie-tradizionali]]></loc><lastmod>2015-06-08T09:46:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/607-fibrosi-cistica-i-pazienti-infettati-dal-les-devono-essere-separati-dagli-altri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/377-fibrosi-cistica-stop-dellfda-alla-terapia-enzimatica-con-liprotamase]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/359-fibrosi-cistica-marcia-indietro-sul-denufosol-il-miglioramento-polmonare-e-insignificante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/357-fibrosi-cistica-il-ministero-ha-pubblicato-le-linee-guida-per-i-prodotti-dietetici]]></loc><lastmod>2015-06-08T16:20:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/355-fibrosi-cistica-inibitori-della-ceramide-potrebbero-costituire-terapie-su-misura-contro-il-danno-polmonare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/338-fibrosi-cistica-provata-lefficacia-del-denufosol-farmaco-che-agisce-sui-canali-ionici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/296-fibrosi-cistica-per-chi-ha-mutazioni-di-classe-tre-potrebbe-presto-arrivare-un-nuovo-farmaco]]></loc><lastmod>2025-09-20T10:28:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/273-fibrosi-cistica-si-riapre-la-possibilita-di-utilizzare-lormone-della-crescita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/274-fibrosi-cistica-potrebbe-essere-la-carenza-di-ormone-della-crescita-a-generare-i-ritardi-di-crescita-in-alcuni-soggetti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/259-fibrosi-cistica-allicgeb-di-trieste-si-studia-lo-splicing-per-mettere-a-punto-una-possibile-terapia-molecolare]]></loc><lastmod>2019-01-03T19:05:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/244-fibrosi-cistica-dagli-stati-uniti-nuove-speranze-per-limpiego-di-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/219-fibrosi-cistica-gilead-annuncia-i-risultati-della-studio-di-fase-tre-del-cayston]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/195-fibrosi-cistica-contro-ordine-sulle-infezioni-da-maltophilia-possono-danneggiare-i-polmoni-irreparabilmente-fino-ad-oggi-non-se-ne-conoscevano-gli-effetti-di-lungo-termine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/194-fibrosi-cistica-uno-studio-francese-conferma-lutilita-dei-potenziali-nasali-nelle-diagnosi-incerte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/191-fibrosi-cistica-il-centro-del-gaslini-di-genova-apre-la-strada-per-organizzare-in-liguria-lassistenza-dei-pazienti-adulti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/114-peter-oxford-convivo-con-la-fibrosi-cistica-ma-nella-mia-vita-ho-fatto-tutto-quello-che-volevo-67611694]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/64-fibrosi-cistica-ricercatori-italiani-mettono-a-punto-un-nuova-tecnica-di-imaging-per-stabilire-il-ph-cellulare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/fibrosi-cistica/56-fibrosi-cistica-il-rosiglitazone-riduce-i-sintomi-della-malattia-negli-animali]]></loc><lastmod>2024-04-18T07:54:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/glomerulopatia-da-c3]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/glomerulopatia-da-c3/22903-glomerulopatia-da-c3-iptacopan-rimborsabile-in-italia]]></loc><lastmod>2026-04-01T17:02:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/glomerulopatia-da-c3/22521-glomerulopatia-da-c3-e-soprattutto-lalbuminuria-a-guidare-diagnosi-e-terapia]]></loc><lastmod>2025-11-17T15:03:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/glomerulopatia-da-c3/22122-glomerulopatia-da-c3-identificati-i-parametri-per-valutare-l-efficacia-di-nuove-terapie]]></loc><lastmod>2025-06-24T15:29:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/glomerulopatia-da-c3/21874-malattie-rare-del-complemento-presentato-documento-su-epn-e-c3g]]></loc><lastmod>2025-04-03T14:14:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/glomerulopatia-da-c3/21751-glomerulopatia-da-c3-un-approccio-diagnostico-integrato-puo-fare-la-differenza]]></loc><lastmod>2026-03-05T17:13:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/glomerulopatia-da-c3/21526-glomerulopatia-da-c3-passi-avanti-verso-una-terapia-di-precisione]]></loc><lastmod>2024-11-26T19:04:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/glomerulopatia-da-c3/21339-glomerulopatia-da-c3-il-percorso-di-caterina-che-oggi-si-sente-un-adolescente-come-tutte-le-altre]]></loc><lastmod>2024-09-30T16:13:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/glomerulopatia-da-c3/20568-glomerulopatia-da-c3-i-pazienti-italiani-possono-contare-sull-associazione-progetto-ddd-onlus]]></loc><lastmod>2024-05-21T14:31:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/glomerulopatia-da-c3/20455-glomerulopatia-da-c3-una-malattia-rarissima-che-aggredisce-i-reni]]></loc><lastmod>2023-12-19T09:06:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22946-immunodeficienze-primitive-al-via-la-settimana-mondiale-2026-focus-su-diagnosi-e-nuove-terapie]]></loc><lastmod>2026-04-22T13:12:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22886-apds-il-chmp-da-parere-positivo-a-leniolisib-verso-lautorizzazione-europea-per-la-terapia-orale-mirata]]></loc><lastmod>2026-03-30T15:05:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22652-sindrome-di-wiskott-aldrich-oggi-nuove-speranze-per-una-malattia-rara-e-complessa]]></loc><lastmod>2026-01-20T09:33:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22634-la-cura-come-fatto-sociale-aip-racconta-la-comunita-invisibile-delle-malattie-rare]]></loc><lastmod>2026-01-02T18:35:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22535-sindrome-di-wiskott-aldrich-il-chmp-dice-si-alla-terapia-genica-di-telethon]]></loc><lastmod>2025-11-19T16:15:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22460-sindrome-da-attivazione-di-pi3k-delta-clinici-e-pazienti-a-confronto-per-migliorare-diagnosi-cura-e-qualita-di-vita]]></loc><lastmod>2025-10-29T20:43:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22433-diagnosi-rare-la-sfida-quotidiana-delle-famiglie-di-pazienti-con-apds]]></loc><lastmod>2025-10-22T14:54:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22413-plasmaderivati-necessario-intervento-strutturato-in-legge-di-bilancio]]></loc><lastmod>2025-10-16T07:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22295-un-raro-caso-di-leaky-scid-in-un-bambino-proveniente-da-gaza]]></loc><lastmod>2025-09-12T14:44:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22188-immunodeficienze-il-valore-delle-immunoglobuline-nella-vita-quotidiana-delle-persone]]></loc><lastmod>2025-07-21T17:20:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22183-immunodeficienze-la-terapia-con-immunoglobuline-per-via-sottocutanea-puo-migliorare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2025-10-13T18:20:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22169-apds-il-coraggio-di-vivere-con-una-malattia-rara-la-storia-di-sara]]></loc><lastmod>2025-07-21T11:04:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22128-apds-la-rara-immunodeficienza-che-si-nasconde-tra-sintomi-comuni]]></loc><lastmod>2025-10-13T18:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/22113-dal-sospetto-alla-diagnosi-il-lungo-percorso-dei-pazienti-con-apds]]></loc><lastmod>2025-06-24T15:55:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/21881-sindrome-da-attivazione-di-pi3k-delta-dalla-diagnosi-alla-terapia-mirata]]></loc><lastmod>2025-04-07T15:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/21814-sindrome-da-attivazione-di-pi3k-delta-segnali-diagnosi-e-il-ruolo-cruciale-dei-clinici]]></loc><lastmod>2025-03-14T11:51:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/21778-sindrome-da-attivazione-di-pi3k-delta-nuove-prospettive-terapeutiche-per-una-rara-immunodeficienza]]></loc><lastmod>2025-03-05T22:37:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/21699-sindrome-di-wiskott-aldrich-telethon-presenta-all-ema-la-richiesta-di-approvazione-della-terapia-genica]]></loc><lastmod>2025-02-05T18:51:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/21638-sindrome-da-attivazione-di-pi3k-delta-quando-il-sistema-immunitario-non-funziona-come-deve]]></loc><lastmod>2025-01-18T09:42:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/20835-immunodeficienza-combinata-grave-la-sopravvivenza-e-migliorata-nettamente-grazie-allo-screening-neonatale]]></loc><lastmod>2024-04-04T13:19:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/20714-sindrome-di-wiskott-aldrich-telethon-si-impegna-a-rendere-disponibile-la-terapia-genica]]></loc><lastmod>2024-03-05T13:18:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/20659-ada-scid-positivi-i-risultati-a-lungo-termine-della-terapia-genica]]></loc><lastmod>2024-02-22T12:52:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/20219-immunodeficienze-primitive-pazienti-e-medici-raccontano-la-loro-esperienza-con-la-malattia]]></loc><lastmod>2023-10-12T09:20:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/20107-malattie-rare-fondazione-telethon-prima-charity-al-mondo-responsabile-della-produzione-di-un-farmaco]]></loc><lastmod>2023-09-12T10:42:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/19398-immunodeficienze-covid-e-fragilita-al-centro-di-un-convegno-promosso-da-aip]]></loc><lastmod>2022-12-18T16:39:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/17653-plasmaderivati-l-appello-di-aip-per-garantire-l-accesso-alle-terapie]]></loc><lastmod>2021-07-18T17:17:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/17054-immunodeficienze-un-alterazione-genetica-lascia-l-organismo-senza-difese]]></loc><lastmod>2021-02-21T17:23:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/16919-immunodeficienze-primitive-occorre-agevolare-la-transizione-dei-pazienti-dall-eta-pediatrica-a-quella-adulta]]></loc><lastmod>2021-01-23T23:59:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/16914-sindrome-iper-igm-nuove-speranze-di-cura-grazie-all-editing-genomico]]></loc><lastmod>2021-01-23T22:00:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/16891-immunodeficienza-primitiva-l-ultimo-paziente-dello-studio-cares10-ha-completato-il-trattamento-con-ivig]]></loc><lastmod>2021-01-17T21:33:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/16577-immunodeficienze-segnalata-carenza-di-immunoglobuline-umane-salvavita]]></loc><lastmod>2020-10-18T21:11:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/16149-malattia-granulomatosa-cronica-legata-all-x-speranze-dalla-terapia-genica]]></loc><lastmod>2020-06-09T15:00:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/16110-immunodeficienze-primitive-arriva-lino-globulino-un-supereroe-al-fianco-dei-bimbi]]></loc><lastmod>2020-05-26T21:36:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/15752-immunodeficienze-e-coronavirus-i-pazienti-chiedono-al-governo-indicazioni-piu-chiare]]></loc><lastmod>2020-03-12T11:45:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/15629-immunodeficienza-scid-indagine-francese-evidenzia-i-vantaggi-dello-screening-neonatale]]></loc><lastmod>2020-02-05T20:49:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/15593-immunodeficienze-primitive-all-umberto-i-200-bambini-senza-assistenza-specialistica]]></loc><lastmod>2020-01-20T18:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/14942-immunodeficienze-una-proposta-di-legge-per-affrontare-un-emergenza-pediatrica]]></loc><lastmod>2019-06-23T13:44:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/14943-malattia-granulomatosa-cronica-una-diagnosi-complicata-ma-ora-una-vita-normale]]></loc><lastmod>2019-06-26T08:53:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/14902-malattia-granulomatosa-cronica-speranze-da-una-nuova-tecnica-di-trapianto-del-cromosoma]]></loc><lastmod>2019-06-11T14:17:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/14865-immunodeficienze-presentata-proposta-di-legge-per-un-percorso-assistenziale-completo]]></loc><lastmod>2019-10-31T16:09:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/14772-sindrome-di-wiskott-aldrich-la-terapia-genica-si-dimostra-efficace]]></loc><lastmod>2019-05-03T17:47:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/14758-immunodeficienza-scid-x1-nuove-speranze-dalla-terapia-genica]]></loc><lastmod>2019-04-25T18:02:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/13999-sindrome-di-wiskott-aldrich-svelato-l-albero-genealogico-delle-staminali-del-sangue]]></loc><lastmod>2018-10-04T15:36:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/13823-immunodeficienze-primitive-la-soddisfazione-di-aip-onlus-per-il-programma-nazionale-sangue-2018]]></loc><lastmod>2018-08-04T15:44:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/13827-immunodeficienze-aip-l-autocertificazione-dei-vaccini-potrebbe-non-tutelarci-a-sufficienza]]></loc><lastmod>2018-08-06T12:57:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/13780-vaccini-i-pazienti-con-immunodeficienza-non-possono-vaccinarsi-necessaria-la-solidarieta-di-tutti]]></loc><lastmod>2018-08-06T12:57:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/13514-immunodeficienze-primitive-presentato-da-aip-onlus-il-position-paper-5-proposte-per-5-bisogni]]></loc><lastmod>2018-05-04T15:40:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/13280-ada-scid-ok-del-nice-inglese-alla-terapia-genica-strimvelis]]></loc><lastmod>2018-05-09T16:54:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/13044-nasce-a-treviso-il-nuovo-centro-per-malattie-rare-immunologiche]]></loc><lastmod>2017-12-18T10:54:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/12800-immunodeficienza-scid-x1-l-editing-del-genoma-vicino-alla-sperimentazione-clinica]]></loc><lastmod>2017-10-21T09:45:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/12403-scoperta-una-nuova-forma-di-immunodeficienza-combinata-grave]]></loc><lastmod>2017-07-16T17:00:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/12352-immunodeficienze-primitive-aip-onlus-migliora-la-consulenza-per-pazienti]]></loc><lastmod>2017-06-19T14:24:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/12220-immunodeficienze-primitive-ancora-troppe-le-diagnosi-assenti-o-ritardate]]></loc><lastmod>2017-06-19T14:25:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/12203-immunodeficienze-primitive-dal-22-al-29-aprile-la-settimana-mondiale-2]]></loc><lastmod>2017-06-19T14:25:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/12187-immunodeficienze-primitive-aip-chiede-al-friuli-venezia-giulia-di-garantire-l-assistenza-ai-pazienti]]></loc><lastmod>2017-06-19T14:25:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/11498-immunodeficienze-ufficializzata-l-autorizzazione-all-immissione-in-commercio-del-farmaco-cuvitru]]></loc><lastmod>2016-10-20T14:34:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/11493-immunodeficienze-primitive-al-parlamento-europeo-il-settimo-forum-sulla-patologia]]></loc><lastmod>2016-12-07T14:08:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/11307-immunodeficienze-primarie-negli-usa-approvato-nuovo-trattamento-sottocute]]></loc><lastmod>2016-09-24T10:55:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/11227-immunodeficienze-primitive-i-linfociti-t-specifici-per-il-virus-sono-sicuri-ed-efficaci-per-il-trattamento-delle-infezioni-virali]]></loc><lastmod>2016-09-14T10:09:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/11142-immunodeficienze-primarie-qual-e-l-impatto-della-terapia-con-igg-sulla-qualita-di-vita-dei-pazienti]]></loc><lastmod>2016-09-07T18:02:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10908-la-prima-terapia-genica-e-italiana-l-alleanza-tra-gsk-telethon-e-s-raffaele]]></loc><lastmod>2018-05-09T16:55:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10872-strimvelis-una-vicenda-unica-che-puo-portare-a-una-piccola-rivoluzione-nel-comparto-farmaceutico]]></loc><lastmod>2016-06-28T14:09:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10865-ada-scid-il-piccolo-rafael-e-rinato-grazie-alla-terapia-genica]]></loc><lastmod>2016-06-27T15:49:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10864-ada-scid-la-prima-terapia-genica-italiana-e-ora-realta]]></loc><lastmod>2018-05-09T16:45:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10815-immunodeficienze-il-farmaco-cuvitru-prossimo-all-approvazione-europea]]></loc><lastmod>2016-06-17T12:03:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10707-ada-scid-approvata-in-europa-la-prima-terapia-genica-per-i-bambini-colpiti-da-questa-rara-malattia]]></loc><lastmod>2018-05-09T16:56:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10691-staminali-il-viaggio-delle-cellule-dopo-il-trapianto-per-curare-una-malattia-rara]]></loc><lastmod>2019-03-27T10:07:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10615-immunodeficienze-primitive-al-via-la-campagna-ciaksivivebene]]></loc><lastmod>2016-05-17T10:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10540-immunodeficienze-il-farmaco-hyqvia-raccomandato-da-ema-per-uso-pediatrico]]></loc><lastmod>2016-05-06T10:27:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10427-settimana-mondiale-delle-immunodeficienze-primitive-baxalta-sostiene-una-ricerca-sul-peso-del-trattamento-per-pazienti-e-caregiver]]></loc><lastmod>2016-04-22T08:44:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10426-immunodeficienze-primitive-in-onda-lo-spot-di-sensibilizzazione-di-aip-onlus]]></loc><lastmod>2016-04-22T08:38:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10303-ada-scid-opinione-positiva-dal-chmp-per-strimvelis]]></loc><lastmod>2016-04-04T10:16:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/10060-immunodeficienze-primitive-ancora-poco-diagnosticate-oggi-disponibile-nuova-terapia-sottocutanea-facilitata]]></loc><lastmod>2016-02-26T16:15:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/9988-malattie-rare-il-25-dei-pazienti-aspetta-fino-a-30-anni-per-una-diagnosi]]></loc><lastmod>2016-02-18T15:09:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/9853-immunodeficienze-per-kedrion-si-apre-il-mercato-usa]]></loc><lastmod>2016-01-29T15:21:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/9642-sindrome-di-wiskott-aldrich-terapia-genica-offre-beneficio-clinico-nei-bambini]]></loc><lastmod>2015-12-18T11:05:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/9388-immunodeficienze-molte-sottodiagnosi-tra-i-pazienti-con-patologie-respiratorie-croniche]]></loc><lastmod>2015-11-20T07:42:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/9384-immunodeficienze-primitive-necessaria-la-collaborazione-tra-immunologia-e-pneumologia]]></loc><lastmod>2015-11-18T17:25:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/9347-immunodeficienze-primitive-a-palermo-nasce-una-struttura-di-supporto-per-pazienti-e-famiglie]]></loc><lastmod>2015-11-16T10:24:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8949-immunodeficienze-l-ema-estende-l-impiego-del-farmaco-hyqvia]]></loc><lastmod>2015-09-18T17:45:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8479-immunodeficienze-aip-onlus-oggi-si-possono-curare-e-la-terapia-nella-maggior-parte-dei-casi-permette-una-vita-normale]]></loc><lastmod>2015-06-22T07:34:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8401-immunodeficienze-primitive-al-meyer-i-test-per-la-diagnosi-precoce]]></loc><lastmod>2015-06-08T08:43:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8386-immunodeficienze-primitive-domani-un-evento-speciale-al-meyer-dedicato-ai-genitori]]></loc><lastmod>2015-06-05T09:55:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8192-sindrome-di-wiskott-aldrich-la-terapia-genica-e-efficace-contro-leczema-e-le-infezioni-gravi]]></loc><lastmod>2019-03-27T10:24:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8182-immunodeficienze-primitive-a-verona-e-al-lavoro-la-rete-ipinet-italian-primary-immunodeficiences-network]]></loc><lastmod>2015-06-08T11:27:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8154-immunodeficienze-primitive-il-ruolo-delle-reti-regionali-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8153-immunodeficienze-primitive-in-eta-pediatrica-ne-parla-il-dr-alberto-tommasini]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8152-immunodeficienze-primitive-lintervista-al-dr-de-carli]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8160-sindrome-di-immunodeficienza-combinata-grave-da-deficit-di-adenosin-deaminasi-gsk-fondazione-telethon-e-ospedale-san-raffaele-hanno-presentato-richiesta-per-la-terapia-genica]]></loc><lastmod>2018-05-09T16:59:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8151-immunodeficienza-comune-variabile-il-prof-carlo-agostini-spiega-che-cose]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8150-immunodeficienze-primitive-limportanza-di-diffondere-la-loro-conoscenza]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8149-immunodeficienze-primitive-lapertura-della-settimana-mondiale]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8072-immunodeficienze-primitive-la-settimana-mondiale-aperta-ieri-a-udine]]></loc><lastmod>2015-05-25T15:06:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/8050-immunodeficienze-primitive-al-via-la-settimana-mondiale]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/7962-immunodeficienza-combinata-ezn-2279-ottiene-designazione-di-farmaco-orfano-negli-usa]]></loc><lastmod>2018-05-09T17:01:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/7920-immunologia-clinica-a-udine-un-corso-su-percorsi-clinici-e-protocolli-diagnostici]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/7853-terapia-sostitutiva-delle-immunoglobuline-presto-gli-infusori-saranno-forniti-dal-ssn]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/7707-terapia-sostitutiva-sottocutanea-delle-immunoglobuline-aip-chiede-al-sistema-sanitario-nazionale-la-fornitura-degli-infusori]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/7612-malattia-granulomatosa-cronica-attivo-il-nuovo-sito-livingwithcgd-org]]></loc><lastmod>2019-06-11T14:09:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/7053-immunodeficienze-primarie-nuove-conferme-per-lutilizzo-di-hizentra]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6848-immunodeficienza-combinata-grave-individuato-un-biomarcatore-che-facilitera-la-diagnosi-precoce]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6205-immunodeficienze-primitive-in-italia-il-ritardo-medio-diagnostico-e-di-9-anni]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6178-immunodeficienze-quali-opzioni-terapeutiche-la-parola-al-prof-carlo-agostini]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6179-immunodeficienze-primitive-la-presa-in-carico-del-paziente-devessere-globale]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6191-immunodeficienze-primitive-la-nuova-terapia-sottocutanea-sara-presto-disponibile-in-italia]]></loc><lastmod>2015-05-25T15:05:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6177-immunodeficienze-migliorare-la-vita-dei-pazienti-e-lobiettivo-di-aip-onlus]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6111-immunodeficienze-negli-usa-operativo-il-pidtc]]></loc><lastmod>2019-03-27T10:03:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6085-immunodeficienze-per-corretta-terapia-necessaria-diagnosi-tempestiva]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6098-immunodeficienze-primitive-i-10-campanelli-dallarme]]></loc><lastmod>2017-04-24T13:54:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6096-immunodeficienze-primitive-ne-soffrono-6-milioni-di-persone-nel-mondo-piu-di-5000-in-italia]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6097-immunodeficienze-oggi-la-terapia-sostitutiva-sottocutanea-disponibile-anche-a-domicilio]]></loc><lastmod>2016-08-04T17:54:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6100-immunodeficienze-primitive-test-diagnosi-trattamento]]></loc><lastmod>2021-09-07T17:48:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6082-immunodeficienze-lassociaione-pro-idp-onlus-si-batte-per-migliorare-la-vita-dei-pazienti]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/6030-immunodeficienza-severa-combinata-dimostrata-la-possibilita-di-diagnosi-alla-nascita-per-la-forma-pnp-scid]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/5976-immunodeficienze-primitive-laip-vince-la-walk-of-life]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/5930-immunodeficienze-primitive-solo-la-diagnosi-precoce-pua-prevenire-danni-irreparabili]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/5474-immunodeficienze-primarie-conclusa-la-prima-conferenza-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/5470-immunodeficienze-negli-usa-con-lo-screening-neonatale-salvate-molte-vite]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/5235-immunodeficienze-nuovo-studio-dimostra-che-i-linfociti-t-possono-svilupparsi-anche-in-fegato-ed-intestino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/4298-immunodeficienze-primarie-in-aumento-un-aiuto-nella-diagnosi-potrebbe-provenire-dalla-classificazione-fenotipica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/4102-immunodeficienze-congenite-il-test-neonatale-precoce-del-meyer-di-firenze-riceve-doppio-premio]]></loc><lastmod>2015-05-25T15:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/3951-immunodeficienze-primitive-dal-22-al-29-aprile-la-settimana-mondiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/3877-immunodeficienza-severa-combinata-scid-nel-trapianto-di-midollo-ce-ancora-unalta-mortalita]]></loc><lastmod>2018-05-09T17:03:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/3872-immunodeficienze-ue-approva-nuova-soluzione-a-base-di-immunoglobuline-meno-somministrazioni-mensili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/3549-sindrome-di-wiskott-aldrich-la-ricerca-italiana-fa-grandi-passi-avanti]]></loc><lastmod>2019-03-27T10:15:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/2898-immunodeficienze-anche-al-meyer-la-diagnosi-molecolare-per-la-sindrome-ipex]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/2896-immunodeficienze-a-firenze-il-meeting-europeo-a-presiederlo-la-giovane-ricercatrice-eleonora-gambineri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/2854-immunodeficienze-primitive-pediatriche-il-meyer-di-firenze-e-oggi-parte-del-network-internazionale-jeffrey-modell]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/865-immunodeficienze-primitive-laip-organizza-corsi-di-formazione-per-i-medici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/281-sindrome-di-wiskott-aldrich-was-in-germania-primo-successo-della-terapia-genica]]></loc><lastmod>2019-03-27T10:14:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/immunodeficienze/53-al-policlinico-umberto-i-il-primo-il-primo-centro-di-eccellenza-dedicato-alla-diagnosi-e-cura-delle-immunodeficienze-primitive]]></loc><lastmod>2020-01-19T18:07:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/21782-ipofosfatasia-alfotase-alfa-rimborsabile-in-italia]]></loc><lastmod>2025-03-06T09:51:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/21441-ipofosfatasia-fino-a-dieci-anni-per-la-diagnosi-di-questa-rara-malattia-dello-scheletro]]></loc><lastmod>2024-10-30T10:05:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/20275-ipofosfatasia-l-appello-dei-pazienti-prima-di-tutto-e-necessario-migliorare-la-diagnosi]]></loc><lastmod>2023-10-30T16:25:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/15140-ipofosfatasia-la-perdita-precoce-dei-denti-e-la-manifestazione-piu-frequente]]></loc><lastmod>2019-08-28T18:08:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/14971-ipofosfatasia-identificata-una-nuova-mutazione]]></loc><lastmod>2019-06-30T09:44:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/13991-ipofosfatasia-adolescenziale-in-quali-pazienti-e-indicata-la-terapia-enzimatica]]></loc><lastmod>2018-10-03T16:40:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/11573-ipofosfatasia-la-terapia-genica-sui-topi-mostra-benefici-su-sopravvivenza-e-dentatura]]></loc><lastmod>2017-06-19T14:17:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/11460-ipofosfatasia-nice-raccomanda-asfotase-alfa-per-pazienti-in-eta-pediatrica]]></loc><lastmod>2017-06-19T14:18:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/11417-ipofosfatasia-senza-terapia-la-malattia-diventa-gravemente-disabilitante]]></loc><lastmod>2017-06-19T14:18:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/10114-ipofosfatasia-nuovi-dati-confermano-l-efficacia-della-terapia-sostitutiva]]></loc><lastmod>2017-06-19T14:18:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/9711-ipofosfatasia-in-uno-studio-italiano-la-panoramica-sulla-malattia-e-sul-trattamento]]></loc><lastmod>2017-06-19T14:19:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/9663-ipofosfatasia-nuove-prospettive-per-la-terapia-di-sostituzione-enzimatica]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/9252-ipofosfatasia-negli-usa-autorizzata-la-vendita-del-farmaco-strensiq-asfotase-alfa]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/9038-ipofosfatasia-strensiq-e-l-unica-terapia-efficace-approvata-in-europa]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/8854-ipofosfatasia-la-ce-concede-l-autorizzazione-alla-commercializzazione-per-asfotase-alfa]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/8545-ipofosfatasia-l-ema-raccomanda-l-approvazione-del-farmaco-sperimentale-asfotase-alfa]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/7742-ipofosfatasia-asfotase-alfa-ottiene-licenza-bla-negli-stati-uniti]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/7647-ipofosfatasia-nuovi-dati-disponibili-su-terapia-e-qualita-di-vita-dei-pazienti]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/7512-ipofosfatasia-alexion-pharma-completa-la-presentazione-della-bla-per-asfotase-alfa]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/6706-ipofosfatasia-grave-osservato-aumento-della-sopravvivenza-in-pazienti-pediatrici-trattati-con-asfotase-alfa]]></loc><lastmod>2019-06-18T17:59:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/4775-ipofosfatasia-presentati-nuovi-risultati-sul-trattamento-pediatrico-con-asfotase-alfa]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/1802-ipofosfatasia-risultati-definiti-impressionanti-per-uno-dei-primi-trial-clinici-con-enb-0040]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipofosfatasia/1490-ipofosfatasia-alexion-acquisisce-enobia]]></loc><lastmod>2016-01-08T08:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/22800-ipoparatiroidismo-alla-scuola-holden-la-presentazione-del-progetto-raccontare-linvisibile]]></loc><lastmod>2026-02-28T10:08:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/22522-malattie-endocrinologiche-rare-un-anno-di-crescita-in-italia-per-ascendis-pharma]]></loc><lastmod>2025-11-17T13:23:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/22466-ipoparatiroidismo-la-cronicita-che-non-si-vede-ma-si-gestisce-ogni-giorno]]></loc><lastmod>2025-11-03T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/22457-ipoparatiroidismo-da-oggi-e-disponibile-online-gratuitamente-la-guida-ai-diritti]]></loc><lastmod>2025-10-28T18:19:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/22436-ipoparatiroidismo-chiara-troppe-volte-mi-sono-sentita-sola-e-inascoltata]]></loc><lastmod>2025-10-22T14:55:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/22024-giornata-mondiale-dell-ipoparatiroidismo-una-malattia-rara-ancora-poco-conosciuta]]></loc><lastmod>2025-05-28T08:49:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/21965-ipoparatiroidismo-quali-sono-i-sintomi-e-come-si-diagnostica]]></loc><lastmod>2025-05-08T17:38:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/21906-ipoparatiroidismo-in-italia-si-attende-un-farmaco-che-puo-cambiare-la-vita-dei-pazienti]]></loc><lastmod>2025-04-14T17:21:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/21897-ipoparatiroidismo-al-via-la-campagna-si-puo-parlare-di-normalita]]></loc><lastmod>2025-04-11T12:29:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/21879-l-impatto-dell-ipoparatiroidismo-e-le-nuove-prospettive-di-trattamento]]></loc><lastmod>2025-04-04T18:11:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/21788-27-marzo-2025-milano-ipoparatiroidismo-inquadramento-epidemiologico-e-clinico-nuove-prospettive-di-trattamento-e-burden-della-patologia]]></loc><lastmod>2025-03-14T08:59:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/21379-farmaci-ascendis-pharma-apre-una-sede-operativa-in-italia]]></loc><lastmod>2025-03-14T08:59:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/13636-ipoparatiroidismo-l-impegno-di-appi-per-le-nuove-frontiere-di-cura]]></loc><lastmod>2025-03-14T08:57:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/ipoparatiroidismo/12359-ipoparatiroidismo-presto-una-nuova-terapia]]></loc><lastmod>2025-03-14T09:02:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/22648-linfoistiocitosi-emofagocitica-e-linfoma-a-cellule-t-periferiche-le-malattie-rare-che-hanno-causato-la-morte-di-bret-hanna-hanna-shuford]]></loc><lastmod>2026-01-09T16:44:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/21419-linfoistiocitosi-emofagocitica-una-rara-malattia-che-puo-colpire-a-tutte-le-eta]]></loc><lastmod>2024-10-23T10:06:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/18704-linfoistiocitosi-emofagocitica-secondaria-al-bambino-gesu-un-test-per-riconoscere-la-patologia]]></loc><lastmod>2022-05-29T22:54:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/16062-linfoistiocitosi-emofagocitica-buoni-risultati-da-emapalumab]]></loc><lastmod>2020-05-12T19:35:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/15659-linfoistiocitosi-emofagocitica-arrivano-i-cacciatori-di-arcobaleno-per-aiutare-i-piccoli-pazienti]]></loc><lastmod>2020-02-14T17:21:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/14307-linfoistiocitosi-emofagocitica-eseguito-il-trapianto-di-midollo-sul-piccolo-alex]]></loc><lastmod>2018-12-23T21:20:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/14271-linfoistiocitosi-emofagocitica-primaria-emapalumab-approvato-dalla-fda]]></loc><lastmod>2018-12-12T21:10:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/14207-linfoistiocitosi-emofagocitica-alex-ricevera-il-midollo-da-uno-dei-genitori]]></loc><lastmod>2018-11-26T18:44:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/14151-linfoistiocitosi-emofagocitica-al-piccolo-alessandro-serve-un-trapianto-di-midollo]]></loc><lastmod>2018-11-14T12:03:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/12718-istiocitosi-in-italia-a-fianco-dei-pazienti-c-e-l-associazione-airi]]></loc><lastmod>2017-09-30T10:15:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/10383-linfoistiocitosi-emofagocitica-fda-assegna-lo-status-di-terapia-fortemente-innovativa-al-candidato-farmaco-ni-0501]]></loc><lastmod>2017-09-12T12:05:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/8007-istiocitosi-delle-cellule-di-langerhans-ecco-perche-smettere-di-fumare]]></loc><lastmod>2017-09-12T12:05:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/7651-istiocitosi-polmonare-delle-cellule-di-langerhans-la-terapia-con-cladribina-e-efficace]]></loc><lastmod>2025-02-04T13:09:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/5903-malattie-immunologiche-al-sraffaele-scoperta-la-causa-dellistiocitosi-di-erdheim-chester]]></loc><lastmod>2017-09-12T12:06:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/4333-linfoistiocitosi-emofagocitica-familiare-salvi-due-gemelli-grazie-al-trapianto-simultaneo-di-midollo]]></loc><lastmod>2017-09-12T12:07:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/4285-istiocitosi-a-cellule-langherhans-pubblicate-le-linee-guida-per-la-gestione-dei-pazienti-adulti]]></loc><lastmod>2017-09-12T16:55:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/2007-istiocitosi-il-punto-sulla-diagnosi-e-la-terapia-grazie-con-dottsa-giona-de-la-sapienza]]></loc><lastmod>2017-09-12T16:57:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/1947-istiocitosi-a-cellule-di-langerhans-ornella-paziente-adulta-ha-atteso-la-diagnosi-per-4-anni]]></loc><lastmod>2017-09-12T12:08:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/istiocitosi/60-istiocitosi-di-langherans-studio-svedese-ipotizza-una-maggiore-incidenza-per-i-bimbi-in-provetta]]></loc><lastmod>2017-09-12T17:01:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/22639-leucodistrofia-metacromatica-la-svolta-e-possibile-grazie-allo-screening-neonatale]]></loc><lastmod>2026-01-13T18:46:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/21803-screening-neonatale-per-la-leucodistrofia-metacromatica-in-lombardia-gia-testati-11mila-bambini]]></loc><lastmod>2025-03-12T18:44:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/21799-nek-e-voa-voa-uniti-per-lo-screening-neonatale-della-leucodistrofia-metacromatica-in-emilia-romagna]]></loc><lastmod>2025-03-12T08:48:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/21626-l-impegno-di-mamma-beatrice-per-estendere-lo-screening-neonatale-alla-leucodistrofia-metacromatica]]></loc><lastmod>2025-01-22T10:15:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/21133-leucodistrofia-metacromatica-al-via-in-lombardia-un-progetto-per-lo-screening-neonatale]]></loc><lastmod>2024-07-01T13:45:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/20797-leucodistrofia-metacromatica-via-libera-alla-terapia-genica-negli-usa]]></loc><lastmod>2024-03-25T12:15:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/20361-screening-neonatale-per-la-leucodistrofia-metacromatica-in-toscana-prosegue-il-progetto-pilota]]></loc><lastmod>2023-11-20T14:00:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/19682-leucodistrofia-metacromatica-per-le-famiglie-dei-pazienti-la-priorita-e-chiara-serve-lo-screening-neonatale]]></loc><lastmod>2023-04-04T19:45:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/19653-leucodistrofia-metacromatica-al-via-la-sperimentazione-del-test-di-screening-neonatale]]></loc><lastmod>2023-03-21T11:02:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/18391-leucodistrofia-metacromatica-lanciata-una-campagna-di-sensibilizzazione-rivolta-ai-neuropsichiatri-infantili]]></loc><lastmod>2022-03-06T23:00:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/18201-leucodistrofia-metacromatica-studio-a-lungo-termine-dimostra-efficacia-e-sicurezza-della-terapia-genica]]></loc><lastmod>2022-01-23T17:59:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/17956-leucodistrofia-metacromatica-da-deficit-di-prosaposina-mamma-chiara-lancia-un-appello-per-cercare-altre-famiglie]]></loc><lastmod>2021-10-31T22:04:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/17872-leucodistro-a-metacromatica-50mila-euro-al-meyer-per-diagnosi-e-screening-neonatale]]></loc><lastmod>2021-10-09T19:07:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/17847-leucodistrofia-metacromatica-uno-studio-italiano-indaga-a-fondo-le-varie-forme-della-patologia]]></loc><lastmod>2021-10-03T17:23:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/17493-leucodistrofia-metacromatica-i-primi-150mila-euro-dall-associazione-voa-voa-al-meyer]]></loc><lastmod>2021-05-30T18:04:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/16835-leucodistrofia-metacromatica-approvata-la-prima-terapia-genica-per-la-malattia]]></loc><lastmod>2020-12-22T11:16:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/16592-leucodistrofia-metacromatica-il-chmp-dice-si-alla-terapia-genica]]></loc><lastmod>2020-10-19T18:13:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/15448-leucodistrofia-metacromatica-valutazione-accelerata-per-la-terapia-genica-otl-200]]></loc><lastmod>2019-11-26T21:35:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/15177-leucodistrofia-metacromatica-la-terapia-genica-otl-200-migliora-funzionalita-cognitiva-e-motoria]]></loc><lastmod>2019-09-10T20:46:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/14921-leucodistrofia-metacromatica-raccolta-fondi-per-introdurre-lo-screening-neonatale-in-toscana]]></loc><lastmod>2019-09-04T15:03:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/8449-malattie-metaboliche-al-meyer-un-progetto-per-individuare-un-test-precoce]]></loc><lastmod>2019-09-04T15:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/6472-leucodistrofia-metacromatica-studio-analizza-laspetto-cognitivo-e-linguistico-nei-pazienti-affetti-da-questa-patologia]]></loc><lastmod>2019-09-04T15:08:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/4478-leucodistrofia-metacromatica-mohammad-in-italia-e-tornato-a-vivere]]></loc><lastmod>2019-09-04T14:53:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/4363-malattie-rare-genetiche-leucodistrofia-metacromatica-e-sindrome-di-wiskott-aldrich-sono-curabili-con-il-virus-hiv]]></loc><lastmod>2026-01-09T15:34:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/leucodistrofia-metacromatica/1605-leucodistrofia-metacromatica-per-orientare-la-diagnosi-e-necessaria-la-risonanza-magnetica]]></loc><lastmod>2019-09-04T14:58:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/21461-linfangioleiomiomatosi-nuove-speranze-dal-farmaco-nintedanib]]></loc><lastmod>2024-11-06T10:11:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/10109-lam-e-sclerosi-tuberosa-individuati-nuovi-bersagli-farmacologi]]></loc><lastmod>2016-03-04T10:47:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/9212-linfangioleiomiomatosi-un-appello-dall-associazione-delle-pazienti-per-favorire-ricerca-e-assistenza]]></loc><lastmod>2015-10-23T09:21:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/9177-lam-alison-ha-ripreso-a-respirare-normalmente-grazie-ad-una-nuova-terapia]]></loc><lastmod>2015-10-19T15:41:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/8532-linfangioleiomiomatosi-approvato-dalla-fda-il-farmaco-rapamune-sirolimus]]></loc><lastmod>2015-07-01T10:14:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/8348-linfangioleiomiomatosi-tutti-gli-studi-e-le-sperimentazioni-del-205]]></loc><lastmod>2015-06-03T09:07:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/6370-linfangioleiomiomatosi-lam-europe-lam-federation-attiva-da-quasi-cinque-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/5915-linfangioleiomiomatosi-lam-per-la-malattia-rara-di-marie-ce-una-nuova-alleanza-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/4607-linfangioleiomiomatosi-lassociazione-ailam-promuove-un-network-nazionale-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/4055-lifangioleoiomiomatosi-una-ricerca-statunitense-suggerisce-un-approccio-metabolico-alla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/3477-linfangioleiomiomatosi-e-sclerosi-tuberosa-troppe-inutili-asportazioni-di-rene]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/3350-linfangioleiomiomatosi-un-esame-del-sangue-per-diagnosticarla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/3335-linfangioleiomiomatosi-facciamo-chiarezza-sulluso-dellossigeno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/3218-linfangioleiomatosi-limportanza-dei-biomarcatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/3217-linfangioleiomiomatosi-gli-aggiornamenti-dalla-conferenza-europea-di-barcellona]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/2977-lam-nuova-raccolta-di-campioni-di-saliva-per-lo-studio-gwas]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/2924-lam-due-nuovi-farmaci-potrebbero-trattare-la-malattia-un-antibiotico-e-una-statina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/2941-lam-grande-successo-per-la-conferenza-europea-a-barcellona]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/2712-linfangioleiomiomatosi-da-ailam-onlus-una-borsa-di-studio-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/2628-linfangioleiomiomatosi-da-lam-italia-suggerimenti-e-aggiornamenti-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/2122-linfagioleiomiomatosi-dopo-il-trapianto-il-giro-del-mondo-a-vela]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1933-linfangioleiomiomatosi-novita-terapeutiche-da-pneumotrieste-2012]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1800-linfangioleiomiomatosi-lam-la-speranza-arriva-dalla-ricostruzione-degli-organi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1799-linfangioleiomiomatosi-lam-necessario-un-registro-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1685-linfangioleiomiomatosi-al-via-una-nuova-ricerca-presso-il-brigham-and-women-s-hospital-di-boston]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1486-lam-cominciano-i-lavori-per-una-federazione-europea-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1404-lam-dalla-neozelanda-speranze-per-nuove-terapie-in-grado-di-riparare-i-polmoni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1370-lam-si-guarda-alla-medicina-rigenerativa-per-riparare-i-danni-polmonari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1366-lam-ambulatorio-del-santorsola-passa-al-dottor-stefano-nava]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1362-trovare-la-forza-di-lottare-contro-la-malattia-la-preziosa-testimonianza-di-gill-hollis-e-la-sua-avventura-in-kayak-nel-mare-scozzese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1268-lam-studi-epidemiologici-suggeriscono-una-malattia-fortemente-sottodiagnosticata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1179-lam-elena-lesma-si-studiano-i-meccanismi-alla-base-dellinsorgenza-per-cercare-le-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/1178-la-linfangioleiomiomatosi-che-cose-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/762-lam-conferme-per-luso-combinato-di-rapamicina-e-simvastatina]]></loc><lastmod>2018-12-16T11:08:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/756-lam-qmeditazione-attraverso-il-respiroq-un-libro-che-aiuta-a-stare-meglio-e-raccogliere-fondi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/531-lam-al-via-al-san-giuseppe-di-milano-la-sperimentazione-clinica-di-everolimus]]></loc><lastmod>2018-12-16T11:14:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/295-lam-si-cercano-malati-disposti-ad-inviare-campioni-di-saliva-per-uno-studio-americano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/198-lampromettenti-i-risultati-di-alcuni-immunosoppressori-se-ne-e-parlato-alla-prima-conferenza-europea-sulla-malattia-organizzata-ad-udine]]></loc><lastmod>2015-06-08T16:49:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/lam-linfangioleiomiomatosi/5335-linfangioleimiomatosi-a-milano-un-ambulatorio-dedicato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/18396-linfedema-molto-piu-di-un-semplice-gonfiore]]></loc><lastmod>2022-03-07T21:26:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/16458-linfedemi-primari-cronici-il-ministero-entro-6-mesi-risposte-concrete]]></loc><lastmod>2020-09-17T10:22:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/15046-linfedema-presentata-un-interrogazione-alla-camera]]></loc><lastmod>2019-07-17T14:14:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/12027-linfedema-i-maggiori-esperti-riuniti-oggi-al-gemelli-per-la-giornata-mondiale]]></loc><lastmod>2019-06-10T10:24:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/11888-linfedema-primario-in-piemonte-un-campo-estivo-dedicato-ai-piccoli-pazienti]]></loc><lastmod>2019-06-10T10:22:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/10874-linfedema-a-siena-ottimi-risultati-conseguiti-grazie-al-percorso-dedicato]]></loc><lastmod>2016-06-28T14:36:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/10851-linfedema-al-policlinico-a-gemelli-di-roma-attivo-il-centro-specializzato]]></loc><lastmod>2016-06-24T12:37:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/10029-linfedema-la-protesta-dei-pazienti-via-web]]></loc><lastmod>2016-02-24T16:03:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/8776-l-importanza-della-diagnosi-delle-malattie-genetiche-rare]]></loc><lastmod>2015-08-07T13:20:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/7780-linfedema-secondario-quando-colpisce-dopo-un-trattamento-antitumorale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/7640-linfedema-nasce-in-sicilia-lassociazione-italian-lymmphodema-framework]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/7345-linfedema-e-lipema-attivo-il-nuovo-servizio-omar-esperto-risponde]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/7181-lindedema-ereditario-limportanza-della-ricerca-genetica-limpegno-di-magi-euregio]]></loc><lastmod>2015-05-27T08:58:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/7180-linfedema-ereditario-il-prof-michelini-ci-spiega-la-patologia]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/7179-linfedemadalla-ricerca-genetica-la-sooperta-forse-un-gene-in-comune-con-il-rischio-tumore]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/7178-linfedema-ereditario-patologia-non-riconosciuta-in-italia-i-pazienti-non-hanno-diritto-alle-cure]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/7137-linfedema-si-e-svolta-la-giornata-nazionale-contro-la-patologia]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/5786-linfedema-inguinale-morto-il-paziente-con-lo-scroto-piu-grande-del-mondo]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/4629-linfedema-per-i-pazienti-italiani-necessario-il-test-genetico-e-linclusione-delle-prestazioni-sanitarie-nei-lea]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/4201-linfedema-il-nostro-ssn-paga-allestero-cio-che-non-rimborsa-in-italia]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/3638-linfedema-e-malformazioni-vascolari-limportanza-dei-test-genetici]]></loc><lastmod>2015-05-28T13:08:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/2540-lobesita-puo-causare-il-linfedema-lallarme-da-uno-studio-americano]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/1412-linfedema-parte-la-prima-rete-completa-al-servizio-del-paziente-dalla-diagnosi-alla-terapia]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/linfedema-ereditario/1389-linfedema-e-quello-italiano-della-magi-uno-dei-4-laboratori-europei-che-esegue-il-test]]></loc><lastmod>2015-05-27T08:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/22453-mucopolisaccaridosi-di-tipo-i-lo-screening-neonatale-fondamentale-anche-in-previsione-della-terapia-genica]]></loc><lastmod>2025-10-28T15:24:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/21591-mucopolisaccaridosi-di-tipo-i-a-che-punto-e-la-ricerca-sulla-terapia-genica]]></loc><lastmod>2024-12-18T11:57:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/21241-mucopolisaccaridosi-la-gravita-della-malattia-e-cio-che-incide-maggiormente-sulla-qualita-di-vita]]></loc><lastmod>2024-08-29T17:18:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/20967-malattie-lisosomiali-diagnosi-precoce-e-assistenza-territoriale-necessita-disattese]]></loc><lastmod>2024-05-13T14:24:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/20844-sindrome-di-hurler-da-ricercatori-italiani-un-organoide-d-osso-per-lo-studio-della-patologia]]></loc><lastmod>2024-04-09T08:48:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/20619-mucopolisaccaridosi-di-tipo-i-primi-test-clinici-per-una-nuova-terapia-cellulare]]></loc><lastmod>2024-02-09T17:41:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/20174-mucopolisaccaridosi-i-pazienti-chiedono-una-gestione-piu-efficace-del-dolore]]></loc><lastmod>2023-09-29T17:20:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/19683-mucopolisaccaridosi-e-mucolipidosi-frequenti-le-anomalie-orofacciali]]></loc><lastmod>2023-04-05T18:51:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/19666-mucopolisaccaridosi-diagnosi-precoce-e-terapia-domiciliare-sono-la-via-da-seguire]]></loc><lastmod>2023-03-31T08:42:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/18116-mucopolisaccaridosi-negli-stati-uniti-l-incidenza-e-sotto-la-media-mondiale]]></loc><lastmod>2021-12-20T15:02:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/18021-sindrome-di-hurler-dalla-terapia-genica-arrivano-i-primi-risultati-positivi]]></loc><lastmod>2021-11-21T21:09:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/16984-mucopolisaccaridosi-i-in-veneto-la-malattia-colpisce-un-neonato-ogni-80-000]]></loc><lastmod>2021-02-10T20:50:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/16738-mucopolisaccaridosi-bertoglio-senza-terapia-domiciliare-e-adi-i-pazienti-rischiano-troppo-in-tempo-di-covid]]></loc><lastmod>2020-11-25T17:02:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/16317-mucopolisaccaridosi-di-tipo-i-fda-concede-status-orfano-alla-terapia-genica-otl-203]]></loc><lastmod>2020-07-22T09:38:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/16071-mucopolisaccaridosi-e-covid-19-non-si-puo-rischiare-la-vita-per-poter-fare-un-trattamento-salvavita]]></loc><lastmod>2020-05-16T10:08:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/16067-mucopolisaccaridosi-lanciata-la-campagna-chase-the-signs]]></loc><lastmod>2020-05-14T19:02:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/15628-mucopolisaccaridosi-i-gli-esperti-consigliano-lo-screening-neonatale]]></loc><lastmod>2020-02-03T23:10:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/15592-mucopolisaccaridosi-i-vantaggi-del-trapianto-di-cellule-staminali-ematopoietiche]]></loc><lastmod>2020-01-20T18:39:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/15180-mucopolisaccaridosi-i-dati-clinici-incoraggianti-per-la-terapia-genica-otl-203]]></loc><lastmod>2019-09-11T21:06:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/14801-mucopolisaccaridosi-oggi-la-giornata-mondiale-bertoglio-aimps-piu-attenzione-ai-bisogni-dei-pazienti]]></loc><lastmod>2019-05-15T09:43:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/13650-mucopolisaccaridosi-autorizzati-due-trial-clinici-nel-regno-unito]]></loc><lastmod>2018-08-06T12:19:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/13546-mucopolisaccaridosi-perche-lo-screening-neonatale-per-malattie-lisosomiali-non-e-legge]]></loc><lastmod>2018-06-11T11:00:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/12270-mucopolisaccaridosi-oggi-la-giornata-mondiale]]></loc><lastmod>2018-05-11T15:03:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/11362-mucopolisaccaridosi-molti-i-vantaggi-della-terapia-di-sostituzione-enzimatica]]></loc><lastmod>2017-06-19T14:52:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/11211-mucopolisaccaridosi-di-tipo-i-le-malattie-delle-vie-aeree-dei-propri-figli-rappresentano-la-principale-preoccupazione-dei-genitori]]></loc><lastmod>2017-06-19T14:53:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/11107-mucopolisaccaridosi-quanto-costa-il-costo-medio-annuo-per-pazienti-arriva-a-209-420-euro]]></loc><lastmod>2017-06-19T14:53:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/11055-mucopolisaccaridosi-di-tipo-i-gli-anticorpi-inibiscono-l-assorbimento-dell-enzima-laronidasi-nella-terapia-sostitutiva]]></loc><lastmod>2017-06-19T14:54:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/10700-mucopolisaccaridosi-di-tipo-i-il-regime-di-dosaggio-dell-ert-ogni-due-settimane-e-una-valida-alternativa]]></loc><lastmod>2018-05-11T15:04:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/10656-mucopolisaccaridosi-iniziativa-di-shire-a-sostegno-dell-mps-awareness-day]]></loc><lastmod>2018-05-11T15:05:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/9412-sindrome-di-hurler-il-farmaco-sperimentale-agt-181-riceve-la-denominazione-di-rara-malattia-pediatrica-dalla-fda]]></loc><lastmod>2018-05-11T15:05:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/8422-mucopolisaccaridosi-i-uno-studio-fa-il-punto-sui-disturbi-del-sonno]]></loc><lastmod>2018-05-11T15:06:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/8426-chaperoni-molecolari-anti-infiammatori-e-terapia-genica-le-prospettive-future-per-le-mucopolisaccaridosi]]></loc><lastmod>2018-05-11T15:06:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/7928-malattie-rare-annunciata-la-collaborazione-tra-ptc-therapeutics-e-lorphan-disease-center-delluniversita-della-pennsylvania]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/7245-sindrome-di-hurler-il-sangue-del-cordone-ombelicale-protegge-il-cervello-del-paziente]]></loc><lastmod>2018-05-11T15:08:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/6897-sindrome-di-hurler-trapianto-di-staminali-ematopoietiche-potrebbe-prevenire-malformazioni-ossee]]></loc><lastmod>2018-05-11T15:09:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/6885-mucopolisaccaridosi-di-tipo-1-buoni-i-risultati-della-terapia-genica-con-vettori-aav]]></loc><lastmod>2018-05-11T15:09:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/6505-sindrome-di-hurler-scheie]]></loc><lastmod>2015-05-25T15:23:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/6470-mucopolisaccaridosi-i-dal-registro-internazionale-dati-positivi-sulla-terapia]]></loc><lastmod>2015-05-25T15:23:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/4815-mps-1-i-primi-5-anni-del-progetto-pilota-di-screening-neonatale-a-taiwan]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/4492-mucopolisaccaridosi-i-sviluppato-un-nuovo-algoritmo-predittivo-per-stabilire-la-severita-della-malattia]]></loc><lastmod>2015-05-25T15:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/3650-mucopolisaccaridosi-una-nuova-tecnica-potrebbe-curare-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/2797-mucopolisaccaridosi-i-lagricoltura-molecolare-potrebbe-aprire-la-strada-a-terapie-piu-economiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/2704-terapie-domiciliari-per-chi-ha-malattie-lisosomiali-genzyme-metta-disposizione-il-progetto-tutor]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/2353-mucopolisaccaridosi-di-hurler-il-piccolo-ali-e-stato-curato-a-padova-ora-e-tornato-a-bagdad]]></loc><lastmod>2019-09-11T17:39:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/2179-mucopolisaccaridosi-i-che-cos-e]]></loc><lastmod>2018-03-22T15:00:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/2055-mucopolisaccaridosi-di-tipo-1-le-cellule-staminali-hanno-ottenuto-benefici-sul-modello-animale]]></loc><lastmod>2019-09-11T17:47:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/1031-mucopolisaccaridosi-1-nuova-consensus-sulle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/1033-mucopolisaccaridosi-1-rovelli-crescono-i-successi-del-trapianto-grazie-anche-al-cordone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mucopolisaccaridosi-mps/1032-mucopolisaccardosi-1-parini-screening-neonatale-utile-per-un-migliore-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/20789-malattie-da-accumulo-lisosomiale-torna-la-campagna-raro-chi-trova]]></loc><lastmod>2024-03-21T18:16:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/16265-sindrome-di-hunter-la-terapia-enzimatica-migliora-la-sopravvivenza-nei-bambini]]></loc><lastmod>2020-07-05T19:57:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/16076-sindrome-di-hunter-le-domande-che-il-pediatra-dovrebbe-porsi-per-la-diagnosi]]></loc><lastmod>2020-05-17T21:47:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/16068-sindrome-di-hunter-il-pediatra-e-essenziale-per-una-diagnosi-precoce]]></loc><lastmod>2020-05-13T22:15:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/15926-sindrome-di-hunter-l-otorino-e-il-primo-che-puo-fare-la-diagnosi]]></loc><lastmod>2020-04-08T16:32:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/13927-sindrome-di-hunter-risultati-clinici-preliminari-per-l-editing-genomico]]></loc><lastmod>2019-01-11T11:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/13812-mps-ii-sangamo-annuncia-i-dati-preliminari-di-un-trial-di-editing-del-genoma]]></loc><lastmod>2018-08-01T16:54:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/13089-mucopolisaccaridosi-di-tipo-ii-molteplici-benefici-da-terapia-con-idursulfasi]]></loc><lastmod>2018-01-10T00:37:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/12962-sindrome-di-hunter-primo-intervento-di-editing-genomico-in-vivo-sull-uomo]]></loc><lastmod>2018-09-12T17:43:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/11222-sindrome-di-hunter-la-vitamina-e-rallenta-la-neurodegenerazione]]></loc><lastmod>2017-11-27T21:50:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/11121-sindrome-di-hunter-terapia-genica-rgx-121-ottiene-status-di-rara-malattia-pediatrica]]></loc><lastmod>2016-08-11T13:42:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/10224-sindrome-di-hunter-come-la-terapia-sostitutiva-ha-migliorato-le-vite-dei-pazienti]]></loc><lastmod>2016-03-18T14:49:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/8081-la-sindrome-di-hunter-nel-sistema-sanitario-francese-la-qualita-della-vita-migliora-con-l-ert]]></loc><lastmod>2016-05-06T16:34:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/7608-sindrome-di-hunter-riconosciuta-la-designazione-fast-track-a-idursulfasi-it]]></loc><lastmod>2017-08-10T10:52:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/7531-sindrome-di-hunter-fda-concede-revisione-accelerata-per-nuova-formulazione-di-idursulfasi]]></loc><lastmod>2015-05-25T15:30:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/6807-mucopolisaccaridosi-di-tipo-ii-lazienda-farmaceutica-bioasis-technologies-ha-dato-il-via-ad-un-nuovo-studio-con-la-collaborazione-del-prof-maurizio-scarpa-e-della-fondazione-brains-for-brain]]></loc><lastmod>2019-06-18T17:56:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/6909-sindrome-di-hunter-pubblicato-studio-italiano-sullefficacia-della-terapia-enzimatica-sostitutiva]]></loc><lastmod>2025-10-31T08:14:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/6509-sindrome-di-hunter-alto-il-rischio-di-stress-respiratorio-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/6473-sindrome-di-hunter-terapia-sostitutiva-conferma-la-sua-efficacia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/6466-sindrome-di-hunter-il-successo-del-trattamento-domiciliare-in-italia]]></loc><lastmod>2015-05-25T15:31:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/6464-sindrome-di-hunter-shire-commercializzera-una-nuova-terapia-di-sostituzione-enzimatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/4977-malattie-metaboliche-ereditarie-in-queste-patologie-lorologio-biologico-a-livello-cellulare-e-alterato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/4475-sindrome-di-hunter-in-usa-riconosciuto-un-nuovo-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/4395-sindrome-di-hunter-mps-ii-studiato-limpatto-sulla-qualita-della-vita-in-eta-pediatrica]]></loc><lastmod>2019-06-19T08:32:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/4393-mucopolisaccaridosi-tipo-2mpsii-anche-le-portatrici-sane-della-potrebbero-sviluppare-alcuni-sintomi-della-sindrome-di-hunter]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/3395-sindrome-di-hunter-la-terapia-ce-ma-la-diagnosi-e-ancora-un-problema]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/3394-terapia-domiciliare-9-regioni-non-rispondono-allappello-dei-pazienti-con-hunter-fabry-e-gaucher]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/3393-terapie-domiciliari-adesso-il-programma-erthome-e-anche-per-la-sindrome-di-hunter]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/2040-mucopolisaccaridosi-le-terapie-in-corso-di-sperimentazione-per-i-pazienti-mps-ii-e-mps-iii]]></loc><lastmod>2017-11-09T18:30:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/2039-sindrome-di-hunter-la-terapia-domiciliare-e-un-modello-positivo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/1357-sindrome-di-hunter-ecco-le-raccomandazioni-europee-per-una-diagnosi-precisa-e-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/1359-sindrome-di-hunter-difficile-valutare-la-possibilita-di-terapie-con-cellule-staminali]]></loc><lastmod>2019-03-28T15:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-hunter-mps-ii/1358-sindrome-di-hunter-lunica-terapia-efficace-e-lidursulfasi-in-alcuni-paesi-si-fa-a-domicilio]]></loc><lastmod>2018-12-24T12:35:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/22514-sindrome-di-sanfilippo-il-16-novembre-e-la-giornata-mondiale-2]]></loc><lastmod>2025-11-14T13:21:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/22442-sindrome-di-sanfilippo-aifa-approva-lutilizzo-off-label-del-farmaco-anakinra]]></loc><lastmod>2025-10-31T18:22:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/21487-sindrome-di-sanfilippo-fra-terapia-genica-e-pinzette-molecolari-la-speranza-e-tutta-nella-ricerca]]></loc><lastmod>2026-04-08T16:39:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/21265-sindrome-di-sanfilippo-i-pazienti-italiani-chiedono-l-uso-off-label-del-farmaco-anakinra]]></loc><lastmod>2024-09-07T16:17:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/20348-sindrome-di-sanfilippo-il-16-novembre-e-la-giornata-mondiale]]></loc><lastmod>2023-11-16T14:15:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/19880-sindrome-di-sanfilippo-concluso-il-primo-congresso-italiano-dedicato-alla-patologia]]></loc><lastmod>2023-06-09T14:25:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/19038-un-giorno-alla-volta-un-ora-alla-volta-un-libro-nato-per-raccontare-la-sindrome-di-sanfilippo]]></loc><lastmod>2022-09-09T11:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/16063-sindrome-di-sanfilippo-a-somministrata-al-primo-paziente-la-terapia-genica-otl-201]]></loc><lastmod>2020-05-12T19:58:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/14508-sindrome-di-sanfilippo-a-iniziato-lo-studio-di-fase-ii-iii-sulla-terapia-genica]]></loc><lastmod>2019-02-25T18:44:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/13161-sindrome-di-sanfilippo-verso-la-sperimentazione-della-prima-terapia-di-sostituzione-enzimatica]]></loc><lastmod>2018-01-29T17:38:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/12322-sindrome-di-sanfilippo-a-nuovi-dati-da-studio-in-corso-sulla-terapia-abo-102]]></loc><lastmod>2019-01-17T17:41:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/11553-sindrome-di-sanfilippo-di-tipo-a-primi-risultati-clinici-per-la-terapia-genica-abo-102]]></loc><lastmod>2018-01-29T18:42:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/10734-sindrome-di-sanfilippo-b-inizia-il-programma-di-sviluppo-clinico-della-terapia-sperimentale-abo-101]]></loc><lastmod>2018-01-29T18:43:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/10661-sindrome-di-sanfilippo-nuova-terapia-genica-pronta-per-la-sperimentazione-umana]]></loc><lastmod>2018-01-29T18:44:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/10144-mucopolisaccaridosi-iiib-dati-clinici-incoraggianti-per-il-farmaco-sperimentale-sbc-103]]></loc><lastmod>2018-01-29T18:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/9077-sindrome-di-sanfilippo-b-esiti-incoraggianti-dalla-sperimentazione-della-terapia-amt-110]]></loc><lastmod>2018-01-29T18:42:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/8391-sindrome-di-sanfilippo-due-nuovi-prodotti-sperimentali-ricevono-la-designazione-di-farmaco-orfano]]></loc><lastmod>2018-01-29T18:46:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/7468-mucopolisaccaridosi-iiib-synageva-annuncia-nuovi-studi-per-il-farmaco-sbc-103]]></loc><lastmod>2018-01-29T18:43:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/5887-sindrome-di-sanfilippo-primi-risultati-positivi-per-la-terapia-genica]]></loc><lastmod>2018-01-29T18:44:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/2032-sindrome-di-sanfilippo-mps-iii-la-terapia-con-genisteina-non-e-efficace]]></loc><lastmod>2018-01-29T18:45:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/1091-sindrome-di-sanfilippo-a-parigi-sta-per-partire-la-sperimentazione-sulla-terapia-genica]]></loc><lastmod>2018-01-29T18:45:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iii-sindrome-di-sanfilippo/489-sindrome-di-sanfilippo-dalla-california-un-passo-avanti-nella-conoscenza-della-malattia]]></loc><lastmod>2017-11-09T18:51:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/19060-sindrome-di-morquio-a-il-farmaco-elosulfase-alfa-raccomandato-per-l-uso-di-routine-nel-regno-unito]]></loc><lastmod>2022-09-15T15:06:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/9694-sindrome-di-morquio-a-il-farmaco-vimizim-elosulfase-alfa-ottiene-il-consenso-del-nice]]></loc><lastmod>2016-01-04T11:40:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/9529-sindrome-di-morquio-a-pazienti-inglesi-prossimi-all-accesso-al-farmaco-vimizim-elosulfase-alfa]]></loc><lastmod>2015-12-24T08:47:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/7598-sindrome-di-morquio-a-per-una-corretta-diagnosi-non-bisogna-sottovalutare-la-presenza-di-sintomi-atipici-o-lievi-50698852]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/7282-sindrome-di-morquio-a-le-difficolta-di-scoprirne-la-prevalenza]]></loc><lastmod>2015-12-02T12:03:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/6359-sindrome-di-morquio-la-terapia-sostitutiva-finalmente-disponibile-in-italia]]></loc><lastmod>2019-06-18T18:08:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/6040-mucopolisaccaridosi-domani-linternational-mps-awarness-day]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/5955-sindrome-di-morquio-che-qualita-di-vita-per-i-pazienti-adulti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/5977-sindrome-di-morquio-lema-approva-vimizim-primo-farmaco-specifico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/5895-mucopolisaccaridosi-tipo-iv-a-aifa-nega-ai-pazienti-la-terapia-salvavita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/5785-sindrome-di-morquio-approvato-negli-usa-un-nuovo-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/5561-mucopolisaccaridosi-tipo-iv-il-chmp-favorevole-alla-nuova-terapia-enzimatica-sostitutiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/5498-sindrome-di-morquio-fda-approva-il-farmaco-vimizim]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/5081-sindrome-di-morquio-fda-rilascia-parere-positivo-per-prima-la-cura-enzimatica-sostitutiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/3131-sindrome-di-morquio-ottimi-risultati-per-il-farmaco-di-biomarin-nella-sperimentazione-di-fase-iii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/2031-sindorme-di-morquio-mps-di-tipo-iv-a-nuove-prospettive-terapeutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/1498-sindrome-di-morquio-individuati-tre-marker-per-misurare-la-risposta-alla-terapia-enzimatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/964-sindrome-di-morquio-promettenti-i-risultati-di-uno-studio-di-estensione-con-galns]]></loc><lastmod>2018-08-16T15:50:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-iv-sindrome-di-morquio/414-malattia-di-morquio-al-via-nuovi-trial-al-san-gerardo-di-monza-saranno-arruolati-una-ventina-di-bimbi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vi-sindrome-maroteaux-lamy]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vi-sindrome-maroteaux-lamy/18828-sindrome-di-maroteaux-lamy-risultati-positivi-dalla-terapia-genica]]></loc><lastmod>2022-06-24T16:26:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vi-sindrome-maroteaux-lamy/12636-sindrome-di-maroteaux-lamy-la-terapia-con-galsulfasi-migliora-la-crescita]]></loc><lastmod>2017-09-11T20:18:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vi-sindrome-maroteaux-lamy/314-mucopisaccaridosi-6-ricercatori-di-telethon-compiono-passi-avanti-nella-terapia-genica]]></loc><lastmod>2017-09-11T20:18:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vii-malattia-di-sly]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vii-malattia-di-sly/17789-malattia-di-sly-disponibile-in-italia-il-farmaco-vestronidasi-alfa]]></loc><lastmod>2021-09-17T13:52:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vii-malattia-di-sly/14146-il-sogno-di-emil-kakkis-trovare-una-terapia-per-ogni-forma-di-mucopolisaccaridosi]]></loc><lastmod>2021-09-17T13:33:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vii-malattia-di-sly/13870-malattia-di-sly-la-terapia-enzimatica-approda-in-europa]]></loc><lastmod>2018-08-29T15:58:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vii-malattia-di-sly/11181-mucopolisaccaridosi-di-tipo-vii-altissima-correlazione-con-idrope-fetale-non-immune]]></loc><lastmod>2018-08-25T13:03:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vii-malattia-di-sly/8831-mucopolisaccaridosi-7-in-avvio-lo-studio-pediatrico-di-fase-ii-sulla-terapia-sperimentale-rhgus]]></loc><lastmod>2018-08-25T13:06:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vii-malattia-di-sly/7653-mucopolisaccaridosi-7-presentati-i-dati-sulla-terapia-enzimatico-sostitutiva-rhgus]]></loc><lastmod>2018-11-13T10:31:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vii-malattia-di-sly/4503-sindrome-di-sly-avviata-la-sperimentazione-clinica-del-primo-farmaco]]></loc><lastmod>2018-08-25T13:06:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vii-malattia-di-sly/4148-mucopolisaccaridosi-vii-la-terapia-genica-ha-permesso-ai-cani-di-camminare-per-tutta-la-vita]]></loc><lastmod>2018-08-25T13:05:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mps-vii-malattia-di-sly/1501-mps-viii-o-malattia-di-sly-ultragenyx-si-fa-carico-del-programma-di-studio-sulla-terapia-enzimatica]]></loc><lastmod>2018-08-25T12:44:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/20602-sindromi-pros-pubblicato-il-primo-studio-italiano-che-fornisce-indicazioni-su-diagnosi-e-trattamento]]></loc><lastmod>2024-02-07T14:53:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/19903-sindromi-pik3ca-correlate-nasce-in-italia-il-primo-registro-di-patologia-al-mondo]]></loc><lastmod>2023-06-16T13:29:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/19548-sindromi-pros-nasce-la-prima-guida-per-la-diagnosi-e-presa-in-carico-dei-pazienti]]></loc><lastmod>2023-02-22T11:14:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/19246-sindromi-pros-parte-anche-in-italia-la-sperimentazione-sul-farmaco-alpelisib]]></loc><lastmod>2022-11-05T11:54:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/18439-e-italiano-il-primo-studio-completo-sulle-sindromi-pros]]></loc><lastmod>2022-03-21T15:26:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/15489-macrodattilia-l-associazione-italiana-ora-include-tutte-le-sindromi-pros]]></loc><lastmod>2019-12-10T17:10:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/14239-sindromi-da-iperaccrescimento-al-bambino-gesu-e-al-gemelli-la-sperimentazione-di-un-nuovo-farmaco]]></loc><lastmod>2018-12-04T21:28:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/13073-macrodattilia-isolata-o-sindromica-per-saperlo-si-osserva-l-andamento-clinico]]></loc><lastmod>2018-12-07T19:26:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/13066-macrodattilia-al-primo-evento-nazionale-uno-sguardo-a-tutto-tondo-sulla-malattia]]></loc><lastmod>2017-12-23T14:39:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/13039-macrodattilia-e-psicologicamente-difficile-affrontare-la-malattia-e-i-trattamenti]]></loc><lastmod>2017-12-19T10:14:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/13025-macrodattilia-oggi-si-celebra-la-prima-giornata-nazionale]]></loc><lastmod>2017-12-12T16:36:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/12979-macrodattilia-il-16-dicembre-a-monza-la-prima-giornata-nazionale]]></loc><lastmod>2017-12-01T18:53:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/12957-malattie-da-iperaccrescimento-in-corso-a-roma-e-catania-uno-studio-per-una-possibile-terapia-farmacologica]]></loc><lastmod>2017-11-28T20:23:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/12945-macrodattilia-quando-le-dita-delle-mani-o-dei-piedi-crescono-troppo]]></loc><lastmod>2017-12-04T08:56:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/macrodattilia/12946-macrodattilia-quattro-studi-clinici-in-corso-ma-per-ora-la-chirurgia-e-l-unica-opzione]]></loc><lastmod>2017-11-29T14:39:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/encefalopatia-epilettica-gnao1]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/encefalopatia-epilettica-gnao1/19945-gnao1-tutte-le-novita-dalla-conferenza-europea-sulla-malattia]]></loc><lastmod>2023-06-28T16:41:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/encefalopatia-epilettica-gnao1/17618-gnao1-partono-i-primi-progetti-di-ricerca-sostenuti-dall-associazione-italiana]]></loc><lastmod>2021-07-04T15:05:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/encefalopatia-epilettica-gnao1/13318-encefalopatia-epilettica-gnao1-la-storia-di-madeleine-e-la-nascita-della-bow-foundation]]></loc><lastmod>2019-07-12T18:06:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/encefalopatia-epilettica-gnao1/13317-gnao1-la-storia-di-elena-e-la-ricerca-di-altre-famiglie-con-la-rara-encefalopatia-epilettica]]></loc><lastmod>2019-07-12T18:10:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/encefalopatia-epilettica-gnao1/13316-gnao1-una-rara-encefalopatia-epilettica-che-causa-ritardo-psicomotorio-e-sintomi-neurologici]]></loc><lastmod>2019-07-12T18:12:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-dupuytren]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-dupuytren/12066-malattia-di-dupuytren-addio-alla-chirurgia-basta-un-iniezione]]></loc><lastmod>2017-06-19T14:35:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-dupuytren/12285-dupuytren-all-istituto-humanitas-di-milano-oltre-200-casi-trattati-con-collagenasi]]></loc><lastmod>2017-06-19T14:34:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-dupuytren/11571-malattia-di-dupuytren-con-la-collagenasi-meno-recidive-e-maggiore-compliance-del-paziente]]></loc><lastmod>2017-06-19T14:35:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-dupuytren/12284-malattia-di-dupuytren-al-paolo-giaccone-di-palermo-i-primi-interventi-con-collagenasi]]></loc><lastmod>2017-06-19T14:34:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-dupuytren/6982-malattia-di-dupuytren-anche-litalia-e-allavanguardia-nella-sperimentazione-della-collagenasi]]></loc><lastmod>2017-06-19T14:35:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-dupuytren/6981-malattia-di-dupuytren-anche-nel-nostro-paese-arriva-la-terapia-a-base-di-collagenasi]]></loc><lastmod>2017-03-13T16:34:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/22896-disturbi-del-movimento-quando-la-fotografia-rompe-il-silenzio]]></loc><lastmod>2026-04-01T10:38:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/21956-huntington-positivi-i-nuovi-dati-clinici-sulla-molecola-sperimentale-ptc518]]></loc><lastmod>2025-05-07T08:51:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/21927-dietro-la-parola-huntington-persone-storie-e-vite-che-cambiano]]></loc><lastmod>2025-04-19T11:03:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/21928-malattia-di-huntington-nasce-that-disorder-dare-un-nome-rompere-il-silenzio]]></loc><lastmod>2025-04-19T11:03:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/21808-huntington-l-associazione-italiana-that-disorder-sensibilizza-attraverso-l-arte-e-la-cultura]]></loc><lastmod>2025-03-17T11:59:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/20941-malattia-di-huntington-l-appassionante-testimonianza-di-charles-sabine-sulla-malattia]]></loc><lastmod>2024-05-07T13:20:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/19929-malattia-di-huntigton-promettenti-i-primi-risultati-clinici-di-fase-ii-su-ptc518]]></loc><lastmod>2024-05-31T09:04:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/19596-malattia-di-huntington-primi-test-preclinici-sull-impiego-della-tecnica-crispr]]></loc><lastmod>2023-03-07T10:01:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/19273-huntington-dalla-famiglia-aprea-un-contributo-finanziario-per-pazienti-in-difficolta-economica]]></loc><lastmod>2022-11-12T15:44:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/18470-malattia-di-huntington-nasce-lirh-sardegna]]></loc><lastmod>2022-03-28T18:11:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/18202-malattia-di-huntington-nuova-speranza-dalla-sperimentazione-di-tominersen]]></loc><lastmod>2022-12-12T11:52:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/18157-huntington-la-mutazione-all-origine-della-patologia-anche-in-alcuni-pazienti-con-sla]]></loc><lastmod>2022-01-05T15:40:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/18026-huntington-la-ricerca-punta-ad-approfondire-il-ruolo-dei-geni-modificatori-della-malattia]]></loc><lastmod>2021-11-21T23:48:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17896-malattia-di-huntington-l-incredibile-storia-della-scoperta-del-gene]]></loc><lastmod>2021-10-17T20:08:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17844-malattia-di-huntington-necessario-potenziare-l-assistenza-domiciliare]]></loc><lastmod>2021-10-04T10:32:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17743-malattia-di-huntington-un-webinar-dedicato-al-tema-della-genitorialita]]></loc><lastmod>2021-09-05T12:34:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17644-huntington-quando-la-malattia-irrompe-nella-coppia]]></loc><lastmod>2021-07-17T14:56:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17587-malattia-di-huntington-il-valore-di-un-attenta-comunicazione-all-interno-della-famiglia]]></loc><lastmod>2021-07-09T14:10:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17535-malattia-di-huntington-occorrono-strutture-per-la-presa-in-carico-dei-pazienti]]></loc><lastmod>2021-06-27T14:19:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17515-malattia-di-huntington-non-bisogna-temere-di-parlarne]]></loc><lastmod>2021-06-06T21:03:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17501-malattia-di-huntington-le-terapie-in-fase-di-studio]]></loc><lastmod>2021-06-03T14:26:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17435-huntington-una-malattia-che-colpisce-la-famiglia]]></loc><lastmod>2021-05-24T12:32:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17434-huntington-una-malattia-rara-genetica-ereditaria-che-colpisce-corpo-psiche-e-le-capacita-cognitive]]></loc><lastmod>2021-05-14T21:59:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17433-malattia-di-huntington-da-affare-di-famiglia-a-questione-pubblica]]></loc><lastmod>2021-05-24T12:34:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17354-malattia-di-huntington-i-familiari-troppo-spesso-soli-nel-prendersi-cura-dei-pazienti]]></loc><lastmod>2021-04-29T10:21:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17348-huntington-una-famiglia-unita-non-puo-essere-sconfitta-dalla-malattia]]></loc><lastmod>2021-04-27T11:37:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17346-huntington-l-impatto-della-malattia-e-la-paura-di-trasmetterla-ai-propri-figli]]></loc><lastmod>2021-04-27T10:51:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17345-huntington-una-malattia-che-mette-a-dura-prova-la-vita-di-coppia]]></loc><lastmod>2021-04-27T10:51:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17344-malattia-di-huntington-la-difficile-scelta-di-fare-il-test-presintomatico]]></loc><lastmod>2021-04-27T12:35:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17343-malattia-di-huntington-la-scelta-di-diventare-genitori]]></loc><lastmod>2021-04-27T10:32:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17226-malattia-di-huntington-interrotta-la-sperimentazione-clinica-del-farmaco-tominersen]]></loc><lastmod>2021-03-30T14:51:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/17106-malattia-di-huntington-dalla-lirh-la-campagna-diamo-colore-alle-nostre-voci]]></loc><lastmod>2021-03-01T11:34:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16915-malattia-di-huntington-arruolati-i-primi-due-pazienti-italiani-nello-studio-proof-hd]]></loc><lastmod>2021-01-25T12:07:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16900-malattia-di-huntington-online-il-ritratto-testimonianza-di-nicola]]></loc><lastmod>2021-01-19T22:15:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16721-malattia-di-huntington-arruolati-i-primi-pazienti-nello-studio-proof-hd]]></loc><lastmod>2020-11-27T18:57:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16635-huntington-una-mostra-fotografica-per-guardare-in-faccia-la-malattia]]></loc><lastmod>2020-10-31T18:34:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16556-malattia-di-huntington-la-storia-di-clotilde-moglie-e-madre]]></loc><lastmod>2020-10-11T23:01:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16402-huntington-necessario-rivalutare-la-frequenza-globale-della-malattia]]></loc><lastmod>2020-09-03T15:13:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16404-huntington-uno-studio-in-medio-oriente-cambia-i-numeri-della-patologia]]></loc><lastmod>2020-09-07T10:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16296-huntington-identificata-l-origine-della-malattia-presente-in-area-medio-orientale]]></loc><lastmod>2020-07-15T19:40:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16262-malattia-di-huntington-somministrata-ai-primi-due-pazienti-la-terapia-genica-amt-130]]></loc><lastmod>2020-07-05T18:59:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16229-huntington-si-apre-la-prospettiva-della-sperimentazione-conclusiva-per-la-pridopidina]]></loc><lastmod>2020-06-29T09:16:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16150-malattia-di-huntington-il-lockdown-visto-con-gli-occhi-dei-pazienti]]></loc><lastmod>2020-06-09T15:16:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16124-huntington-il-racconto-di-una-mamma-nella-sua-partita-a-scacchi-con-la-malattia]]></loc><lastmod>2020-05-31T20:11:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/16048-malattia-di-huntington-da-sconosciuta-a-protagonista-della-tv]]></loc><lastmod>2020-05-12T10:09:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/15764-malattia-di-huntington-pubblicato-il-libro-il-tempo-di-dire]]></loc><lastmod>2020-03-17T19:50:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/15524-malattia-di-huntington-in-3-sperimentazioni-la-speranza-di-vincerla]]></loc><lastmod>2019-12-17T11:17:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/15361-malattia-di-huntington-basta-un-piccolo-impegno-per-partecipare-allo-studio-enroll-hd]]></loc><lastmod>2019-10-30T11:33:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/15340-malattia-di-huntington-online-un-nuovo-webinar-della-fondazione-lirh]]></loc><lastmod>2019-10-23T20:28:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/15338-huntington-in-studio-una-strategia-per-bloccare-la-proteina-che-causa-la-malattia]]></loc><lastmod>2019-10-23T09:17:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/15045-malattia-di-huntington-dall-accordo-lirh-bambino-gesu-nasce-spazio-huntington]]></loc><lastmod>2019-07-16T15:41:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/14877-malattia-di-huntington-esiste-anche-la-forma-pediatrica-piu-rara-e-aggressiva]]></loc><lastmod>2019-06-04T11:12:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/14852-malattia-di-huntington-la-dura-adolescenza-di-marco-trascorsa-a-prendersi-cura-della-mamma]]></loc><lastmod>2019-05-28T09:32:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/14851-hd-on-the-bike-una-gita-in-bici-per-sconfiggere-lo-stigma-verso-la-malattia-di-huntington]]></loc><lastmod>2019-05-27T08:29:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/14832-malattia-di-huntington-pediatrica-non-e-solo-una-questione-di-nome]]></loc><lastmod>2019-05-20T17:04:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/14686-huntington-i-nuovi-approcci-terapeutici-al-meeting-di-chdi-foundation]]></loc><lastmod>2019-04-05T14:56:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/14440-huntington-giovanile-la-campagna-lirh-per-promuovere-la-conoscenza-della-malattia]]></loc><lastmod>2019-02-07T21:14:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/14320-malattia-di-huntington-un-libro-che-narra-le-storie-di-chi-ha-incontrato-la-malattia]]></loc><lastmod>2019-01-02T18:49:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13946-malattia-di-huntington-scoperta-una-nuova-variante-giovanile-della-patologia]]></loc><lastmod>2018-09-20T09:02:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13737-malattia-di-huntington-concluso-il-progetto-huntingtonstories]]></loc><lastmod>2018-07-07T09:47:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13705-huntington-il-gene-msh3-influisce-sulla-progressione-della-malattia]]></loc><lastmod>2018-07-02T10:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13700-malattia-di-huntington-altri-due-nuovi-episodi-per-il-progetto-huntingtonstories]]></loc><lastmod>2018-06-25T17:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13649-malattia-di-huntington-creato-un-modello-suino-della-patologia]]></loc><lastmod>2018-06-11T09:27:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13575-malattia-di-huntington-una-patologia-rara-ma-piu-diffusa-di-quanto-si-pensi]]></loc><lastmod>2018-05-20T19:23:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13570-malattia-di-huntington-prosegue-il-progetto-huntingtonstories]]></loc><lastmod>2018-05-19T15:54:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13543-malattia-di-huntington-i-pazienti-si-raccontano-in-un-progetto-di-storytelling]]></loc><lastmod>2018-05-11T11:48:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13309-malattia-di-huntington-nasce-la-rete-italiana-huntington-onlus]]></loc><lastmod>2018-03-06T00:55:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13278-malattia-di-huntington-la-ricerca-mondiale-lavora-a-360-gradi]]></loc><lastmod>2018-02-25T19:19:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13261-malattia-di-huntington-lirh-premia-studio-sulla-fosforilazione-dell-huntingtina]]></loc><lastmod>2018-02-21T22:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13181-la-battaglia-di-papa-francesco-contro-lo-stigma-della-malattia-di-huntington]]></loc><lastmod>2018-01-31T20:50:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13143-la-maschera-dell-huntington-incontro-con-jimmy-pollard]]></loc><lastmod>2018-01-23T19:30:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13026-malattia-di-huntington-le-prossime-sfide-del-farmaco-ionis-httrx]]></loc><lastmod>2017-12-12T18:37:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/13024-svolta-nella-malattia-di-huntington-un-nuovo-farmaco-sembra-rallentarne-la-progressione]]></loc><lastmod>2017-12-12T14:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/12805-malattia-di-huntington-i-pazienti-presentano-disturbi-del-ritmo-circadiano]]></loc><lastmod>2017-10-21T14:45:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/12745-malattia-di-huntington-nasce-l-alleanza-mondiale-hd-cope]]></loc><lastmod>2017-10-07T14:07:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/12519-malattia-di-huntington-scoperto-un-nuovo-potenziale-bersaglio-per-terapie-innovative]]></loc><lastmod>2017-10-07T14:07:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/12465-malattia-di-huntington-continua-studio-clinico-su-terapia-antisenso]]></loc><lastmod>2017-07-03T14:25:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/12293-malattia-di-huntington-l-italiana-biorep-ai-vertici-della-ricerca]]></loc><lastmod>2017-10-07T14:07:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/12250-malattia-di-huntington-e-atassie-cerebellari-entrambe-accomunate-da-un-meccanismo-di-morte-cellulare]]></loc><lastmod>2017-10-07T14:08:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/12217-malattia-di-huntington-fda-approva-deutetrabenazina-per-la-corea-associata]]></loc><lastmod>2019-01-17T17:44:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/11882-malattia-di-huntington-trent-anni-di-ricerca-in-un-libro]]></loc><lastmod>2017-10-07T14:08:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/11715-malattia-di-huntington-la-ricerca-non-si-ferma-tanti-farmaci-in-sperimentazione-per-un-futuro-diverso]]></loc><lastmod>2017-10-07T14:09:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/11551-malattia-di-huntington-il-trattamento-con-sd-809-riduce-il-sintomo-corea]]></loc><lastmod>2017-10-07T14:09:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/11203-huntington-il-cinema-prova-a-spiegare-i-dilemmi-di-chi-si-trova-in-condizione-di-rischio]]></loc><lastmod>2017-10-07T14:09:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/10863-corea-di-huntington-uno-studio-italiano-potra-favorire-l-arrivo-di-nuove-terapie-in-futuro]]></loc><lastmod>2017-10-07T14:11:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/10130-malattia-di-huntington-test-preclinici-confermano-la-validita-del-candidato-farmaco-ionis-httrx]]></loc><lastmod>2017-10-07T14:11:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/9659-malattia-di-huntington-nuovi-dati-dalla-sperimentazione-a-lungo-termine-del-farmaco-rp103]]></loc><lastmod>2017-10-07T14:12:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/9266-malattia-di-huntington-trattati-i-primi-pazienti-nella-sperimentazione-di-fase-i-iia-di-isis-httrx]]></loc><lastmod>2017-10-07T14:12:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/8839-malattia-di-huntington-fda-accetta-di-valutare-l-approvazione-del-farmaco-sperimentale-sd-809]]></loc><lastmod>2017-10-07T14:13:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/7729-28-febbraio-milano-laich-partecipera-alla-marcia-dei-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/7674-malattia-di-huntington-prima-stima-del-numero-di-casi-in-italia-dopo-la-scoperta-del-gene]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/7416-malattia-di-huntington-nuove-ipotesi-sulluso-del-trieptanoato-di-glicerina]]></loc><lastmod>2019-06-18T17:50:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/6806-upgrade-in-tema-di-malattia-di-huntington-e-sindrome-di-tourette]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/6546-malattia-di-huntington-lema-concede-la-designazione-di-farmaco-orfano-a-cisteamina-bitartrato]]></loc><lastmod>2015-12-16T16:42:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/6396-malattia-di-huntinfton-e-altre-malattie-rare-neurodegenerative-assistenza-in-medio-oriente]]></loc><lastmod>2015-05-24T07:00:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/6101-malattia-di-huntington-e-italiano-il-primo-centro-in-europa-a-dare-il-via-allo-studio-clinico-di-fase-ii-pride-hd]]></loc><lastmod>2016-01-22T12:29:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/6026-huntington-la-tappa-italiana-della-qcrosso-country-for-huntington-diseaseq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/5854-malattia-di-huntington-i-nuovi-studi-e-la-neuroprotezione-nei-portatori-presintomatici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/5292-huntington-la-toscana-chiede-che-i-pazienti-siano-inseriti-nella-rete-assistenziale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/5130-malattia-di-huntington-nuove-prospettive-terapeutiche-da-fingolimod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/5056-la-scienza-italiana-al-servizio-dei-pazienti-rari-in-medio-oriente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/4476-malattia-di-huntington-il-potenziale-ruolo-della-dopamina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/4286-huntington-omeros-prepara-due-studi-clinici-per-il-farmaco-oms824]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/4249-malattia-di-huntington-il-governo-si-impegni-a-migliorare-la-conoscenza-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/4120-huntington-nuove-valutazioni-cliniche-per-testare-lefficacio-di-farmaci-preventivi-per-ritardare-la-comparsa-dei-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/3963-huntington-alice-sa-che-la-malattia-arrivera-quattro-anni-di-buio-poi-la-spinta-per-reagire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/3911-malattia-di-huntington-nuovi-dati-positivi-su-huntexil-pridopidine]]></loc><lastmod>2016-01-22T12:24:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/3722-huntington-storia-di-un-gene-e-di-un-futuro-diverso-92651367]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/3721-huntington-storia-di-un-gene-e-di-un-futuro-diverso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/3359-malattia-di-huntington-nuova-speranza-per-il-trattamento-clinico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/3317-malattia-di-huntington-richiesto-al-governo-un-nuovo-impegno-nei-confronti-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/3190-huntington-possibile-combatterlo-con-la-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/3125-malattia-di-huntington-delude-il-farmaco-latrepirdina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/2942-huntington-al-via-la-terza-fase-di-sperimentazione-del-farmaco-huntexil]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/2725-malattia-di-huntington-le-dieci-regole-doro-per-leggere-un-articolo-scientifico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/2551-huntington-fermare-la-malattia-grazie-a-dispositivo-nel-cervello-eseguiti-i-primi-test-sul-modello-animale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/2571-huntington-individuate-due-proteine-responsabili-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/2355-malattia-di-huntington-labuso-di-alcol-fumo-e-droghe-puo-causare-lesordio-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/2356-malattia-di-huntington-a-milano-una-rete-territoriale-di-supporto-alle-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/2280-malattia-di-huntington-uno-studio-per-accrescere-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/2086-malattia-di-huntington-linee-guida-per-lassistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/2028-malattia-di-huntington-i-pazienti-meno-a-rischio-di-tumori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1969-malattia-di-huntington-siena-biotech-e-chdi-foundation-insieme-per-vincere-la-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1810-huntington-a-bergamo-uno-sportello-dedicato-e-lavvio-di-gruppo-di-auto-aiuto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1724-malattia-di-huntington-identificato-un-possibile-nuovo-target-terapeutico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1647-huntington-la-regione-lombardia-chiede-maggiore-assistenza-ai-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1625-malattia-di-hntington-e-nato-hdyoorg-il-sito-internazionale-dei-giovani-affetti-dalla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1580-malattia-di-huntington-la-proteina-huntingtina-e-fondamentale-per-la-cigliogenesi-alterata-nella-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1564-huntington-la-tecnica-dellrna-interference-apre-le-porte-alla-terapia-genica]]></loc><lastmod>2017-01-16T10:38:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1457-maratona-telethon-questa-sera-su-rai-due-la-storia-di-elena-figlia-di-un-paziente-huntington]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1219-huntington-al-via-sperimentazione-fase-due-con-selisistar-coinvolge-anche-4-centri-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1174-huntington-studio-americano-scopre-nel-sangue-una-potenziale-spia-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/1049-malattia-di-huntington-scoperto-nuovo-meccanismo-coinvolto-nella-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/759-huntington-due-studi-sugli-animali-mostrano-utilita-di-spengere-il-gene-kmo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/656-huntington-al-via-studio-di-seconda-fase-con-sirtuina-1realizzato-da-siena-biotech]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/602-atrofia-ottica-e-huntington-ricerca-telethon-scopre-meccanismo-che-aiuta-le-cellule]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/469-huntington-la-morte-delle-cellule-nervose-causata-dalliperattivita-della-proteina-drp1]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/451-huntington-siena-biotech-insieme-alla-statunitense-chdi-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/393-huntington-sono-10-in-italia-i-centri-accreditati-allehdn]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/382-morbo-di-huntington-pisa-diventa-nuovo-centro-di-eccellenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/265-huntington-da-una-ricerca-telethon-utili-suggerimenti-su-come-salvare-le-cellule-nervose]]></loc><lastmod>2026-04-08T16:45:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/155-huntington-la-dieta-anaplerotica-puo-essere-daiuto-per-correggere-il-problema-metabolico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/116-malatti-di-huntington-studio-europeo-mostra-ruolo-della-proteina-htt-nella-morte-neuronale]]></loc><lastmod>2021-11-17T12:27:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/101-malattia-di-huntington-ricerca-portoghese-spiega-perche-i-malati-divengono-impacciati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/83-huntington-test-per-disturbi-cognitivi-lievi-potrebbero-aiutare-a-predire-linsorgere-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-huntington/122-malattia-di-huntington-a-breve-un-nuovo-farmaco-in-grado-di-migliorare-il-coordinamento-motorio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-kennedy]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-kennedy/21170-l-associazione-aimak-invita-i-pazienti-con-malattia-di-kennedy-al-coming-out]]></loc><lastmod>2024-07-12T14:29:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-kennedy/19447-malattia-di-kennedy-nuovo-studio-approfondisce-i-meccanismi-alla-base-della-patologia]]></loc><lastmod>2023-01-13T15:28:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-kennedy/8389-malattia-di-kennedy-dr-ssa-pennuto-speranze-per-la-cura-sono-il-clenbuterolo-e-la-proteina-igf1]]></loc><lastmod>2023-01-13T10:05:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-kennedy/8388-vivere-la-malattia-di-kennedy-due-pazienti-si-raccontano]]></loc><lastmod>2023-01-13T10:05:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-kennedy/8390-malattia-di-kennedy-dr-soraru-non-esiste-una-terapia-ma-la-ricerca-va-avanti]]></loc><lastmod>2023-01-13T10:06:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-kennedy/4085-atrofia-muscolare-spino-bulbale-a-padova-si-arruolano-pazienti-per-sperimentare-il-clenbuterol2]]></loc><lastmod>2023-01-13T10:04:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/22232-justin-timberlake-rivela-di-avere-la-malattia-di-lyme]]></loc><lastmod>2025-08-04T11:20:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/18576-malattia-di-lyme-pubblicati-i-risultati-di-un-indagine-che-ha-coinvolto-pazienti-e-caregiver]]></loc><lastmod>2022-04-24T19:34:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/17900-malattia-di-lyme-nasce-il-progetto-babel-per-la-definizione-di-terapie-mirate]]></loc><lastmod>2021-10-17T21:19:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/15450-malattia-di-lyme-c-e-disaccordo-sulla-forma-cronica-si-auspica-una-consensus-a-riguardo]]></loc><lastmod>2019-11-26T21:38:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/15383-malattia-di-lyme-attenzione-alle-false-credenze]]></loc><lastmod>2019-11-07T10:43:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/14308-malattia-di-lyme-pubblicata-la-versione-italiana-delle-linee-guida-nice]]></loc><lastmod>2018-12-23T21:21:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/13489-malattia-di-lyme-l-incubo-che-nasce-dal-morso-di-una-zecca]]></loc><lastmod>2018-05-03T10:09:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/13488-sindrome-della-malattia-di-lyme-post-trattamento-ptlds-quando-i-sintomi-gravi-persistono-per-mesi-o-anni]]></loc><lastmod>2018-04-27T11:02:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/11229-malattia-di-lyme-il-trattamento-antibiotico-a-lungo-termine-non-migliora-la-qualita-di-vita-rispetto-a-quello-a-breve-termine]]></loc><lastmod>2018-05-03T10:09:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/10883-malattia-di-lyme-pericolo-anche-in-europa-a-causa-dei-cambiamenti-climatici]]></loc><lastmod>2018-05-03T10:09:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/10187-malattia-di-lyme-prime-prove-di-un-innovativo-test-per-la-diagnosi-precoce]]></loc><lastmod>2018-04-27T11:14:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/10186-malattia-di-lyme-scoperto-nuovo-batterio-responsabile-della-malattia]]></loc><lastmod>2018-04-27T11:15:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/4174-malattia-di-lyme-si-cercano-terapie-e-vaccino-ma-intanto-va-prevenuta]]></loc><lastmod>2018-04-27T11:15:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/4139-malattia-di-lyme-risultati-promettenti-per-il-vaccino-sperimentale]]></loc><lastmod>2018-04-27T11:16:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/512-malattia-di-lyme-la-cura-antibiotica-puo-guarire-anche-i-casi-trascurati-per-anni]]></loc><lastmod>2018-04-27T11:16:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-lyme/149-malattia-di-lyme-quanto-e-frequente-la-diagnosi-e-il-trattamento-della-sua-forma-cronica-secondo-uno-studio-americano-lo-e-assai-meno-di-quanto-alcuni-vogliano-far-credere]]></loc><lastmod>2018-04-27T11:17:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/22719-malattia-di-niemann-pick-di-tipo-c-approvazione-europea-per-la-levacetilleucina]]></loc><lastmod>2026-02-06T09:27:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/22471-associazione-italiana-niemann-pick-ventanni-di-impegno-e-speranza-insieme-per-aprire-la-strada-al-domani]]></loc><lastmod>2025-11-06T15:53:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/22217-niemann-pick-di-tipo-c-novita-terapeutiche-dagli-usa-ma-l-italia-resta-in-attesa]]></loc><lastmod>2025-07-28T17:55:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/21840-deficit-di-sfingomielinasi-acida-di-tipo-a-b-e-b-in-bambini-e-adolescenti-le-manifestazioni-piu-comuni-sono-quelle-epatiche-ed-ematologiche]]></loc><lastmod>2025-03-25T14:45:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/21456-malattia-di-niemann-pick-lo-speciale-giornata-mondiale-2024]]></loc><lastmod>2024-11-04T18:50:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/21455-malattia-di-niemann-pick-un-intervento-tempestivo-e-essenziale-per-migliorare-la-prognosi]]></loc><lastmod>2024-11-04T18:52:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/21454-giornata-niemann-pick-lionello-lavorare-insieme-per-migliorare-la-qualita-della-vita-di-pazienti-e-famiglie]]></loc><lastmod>2024-11-04T18:39:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/21453-deficit-di-sfingomielinasi-acida-asmd-e-tempo-di-inserirla-nel-panel-di-screening-neonatale]]></loc><lastmod>2024-11-04T18:40:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/21198-deficit-di-sfingomielinasi-acida-nei-pazienti-affetti-dalle-forme-croniche-la-sopravvivenza-media-e-di-circa-45-anni]]></loc><lastmod>2024-07-25T15:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/20946-malattia-di-niemann-pick-di-tipo-c-un-nuovo-farmaco-sotto-la-lente-della-fda]]></loc><lastmod>2024-05-08T16:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/20544-deficit-di-sfingomielinasi-acida-due-biomarcatori-si-rivelano-affidabili-per-lo-screening-neonatale]]></loc><lastmod>2024-01-26T10:59:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/20450-asmd-come-riconoscere-e-gestire-il-deficit-di-sfingomielinasi-acida-tra-bisogni-e-nuove-sfide]]></loc><lastmod>2023-12-18T06:58:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/20407-deficit-di-sfingomielinasi-acida-olipudasi-alfa-disponibile-in-italia]]></loc><lastmod>2023-12-01T16:56:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/20241-giornata-mondiale-niemann-pick-i-pazienti-italiani-attendono-l-arrivo-di-un-nuovo-farmaco]]></loc><lastmod>2023-10-18T10:35:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/20154-deficit-di-sfingomielinasi-acida-la-forma-di-malattia-piu-diffusa-in-italia-e-quella-viscerale-cronica]]></loc><lastmod>2023-09-25T15:46:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/19661-malattia-di-niemann-pick-a-e-b-una-terapia-esiste-occorre-eliminare-il-ritardo-diagnostico]]></loc><lastmod>2023-03-26T08:59:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/19238-malattia-di-niemann-pick-a-e-b-il-punto-su-stato-dell-arte-e-novita-terapeutiche]]></loc><lastmod>2022-11-03T16:06:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/18864-malattia-di-niemann-pick-a-e-b-olipudasi-alfa-approvato-dalla-commissione-europea]]></loc><lastmod>2022-07-04T09:06:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/18672-malattia-di-niemann-pick-a-e-b-il-chmp-raccomanda-l-approvazione-di-olipudasi-alfa]]></loc><lastmod>2022-05-22T16:32:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/18296-malattia-di-niemann-pick-a-e-b-miglioramenti-clinici-duraturi-con-olipudasi-alfa]]></loc><lastmod>2022-02-13T15:37:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/18110-malattia-di-niemann-pick-a-e-b-ema-valuta-l-approvazione-di-olipudasi-alfa]]></loc><lastmod>2021-12-19T18:04:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/17977-niemann-pick-di-tipo-c-farmaci-ma-non-solo-i-possibili-approcci-per-limitare-la-neurodegenerazione]]></loc><lastmod>2021-11-17T12:20:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/17895-malattia-di-niemann-pick-oggi-e-la-giornata-internazionale]]></loc><lastmod>2021-10-19T13:01:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/16634-niemann-pick-a-e-b-olipudasi-alfa-migliora-funzione-polmonare-e-volume-della-milza]]></loc><lastmod>2021-02-15T11:35:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/16588-malattia-di-niemann-pick-oggi-e-la-giornata-mondiale-dedicata-alla-patologia]]></loc><lastmod>2021-02-15T11:35:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/15642-malattia-di-niemann-pick-risultati-clinici-positivi-per-olipudasi-alfa]]></loc><lastmod>2021-02-15T11:36:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/15170-malattia-di-niemann-pick-di-tipo-a-dati-preclinici-promettenti-per-la-terapia-genica]]></loc><lastmod>2021-02-15T11:39:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/11755-malattia-di-niemann-pick-di-tipo-c1-la-molecola-vts-270-riceve-status-di-rara-malattia-pediatrica]]></loc><lastmod>2021-02-15T11:39:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/11511-malattia-di-niemann-pick-di-tipo-c1-dosato-il-primo-paziente-tedesco-nello-studio-su-vts-270]]></loc><lastmod>2021-02-15T11:39:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/11214-malattia-di-niemann-pick-allo-studio-nanovettori-per-portare-la-terapia-al-cervello-con-minori-effetti-collaterali]]></loc><lastmod>2021-02-15T11:39:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/10956-malattia-di-niemann-pick-di-tipo-b-in-atto-nuovo-trial-clinico-su-olipudase-alfa]]></loc><lastmod>2021-02-15T11:42:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/10190-malattia-di-niemann-pick-di-tipo-c-test-preclinici-su-una-nuova-formulazione-del-farmaco-vorinostat]]></loc><lastmod>2021-02-15T11:42:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/9712-nei-pazienti-affetti-da-malattia-di-niemann-pick-la-chiave-per-sconfiggere-l-ebola]]></loc><lastmod>2021-02-15T11:42:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/8822-malattia-di-niemann-pick-di-tipo-c1-npc1-nuovo-biomarcatore-per-la-diagnosi-dei-pazienti]]></loc><lastmod>2021-02-15T11:42:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/8632-malattia-di-niemann-pick-di-tipo-c1-scoperto-un-nuovo-biomarcatore-altamente-sensibile-e-specifico]]></loc><lastmod>2021-02-15T11:46:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/8529-malattia-di-niemann-pick-di-tipo-b-iniziato-uno-studio-pediatrico-di-fase-i-ii-per-olipudase-alfa]]></loc><lastmod>2021-02-15T11:46:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/8082-malattia-niemann-pick-di-tipo-c-studio-italiano-valuta-lefficacia-del-trattamento-con-miglustat]]></loc><lastmod>2021-02-15T11:46:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/7638-malattia-di-niemann-pick-di-tipo-b-primi-risultati-per-la-terapia-con-olipudase-alfa]]></loc><lastmod>2021-02-15T11:49:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/7396-malattia-niemann-pick-di-tipo-c-firmato-accordo-nhi-vtesse-per-nuovi-farmaci]]></loc><lastmod>2021-02-15T11:49:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/7327-malattia-di-niemann-pick-tipo-c-i-sintomi-caratteristici-sono-di-natura-neuro-psichiatrica]]></loc><lastmod>2021-02-15T11:49:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/7147-ebola-e-malattia-di-niemann-pick-tipo-c-sono-legate-alla-mutazione-dello-stesso-gene]]></loc><lastmod>2021-02-15T11:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/6855-malattia-di-niemann-pick-tipo-c-al-via-la-campagna-globale-npc-ci-hai-mai-pensato]]></loc><lastmod>2021-02-15T11:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/6840-malattia-di-niemann-pick-di-tipo-c-scoperto-un-deficit-nei-processi-multisensoriali]]></loc><lastmod>2021-02-15T11:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/5314-malattia-di-niemann-pick-nuova-terapia-combinata-dagli-stai-uniti]]></loc><lastmod>2021-02-15T11:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/4465-malattia-di-niemann-pick-accordo-gallus-genzyme-per-nuova-terapia]]></loc><lastmod>2021-02-15T11:57:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/4405-niemann-pick-c-negli-usa-approvato-un-nuovo-farmaco-orfano-ljpc-0712]]></loc><lastmod>2021-02-15T11:57:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/3937-niemman-pick-c-luniversita-di-udine-ricrea-il-modello-umano-della-malattia]]></loc><lastmod>2021-02-15T11:57:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/3905-niemann-pick-tipo-c-si-studia-una-terapia-basata-su-uno-zucchero-gia-usato-in-molti-farmaci]]></loc><lastmod>2021-02-15T12:01:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/3576-malattia-di-niemann-pick-tipo-a-si-studia-la-terapia-genica-con-vettori-adenovirali]]></loc><lastmod>2021-02-15T12:01:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/3175-niemann-pick-la-terapia-con-miglustat-riduce-la-disfagia-e-allunga-la-vita]]></loc><lastmod>2021-02-15T12:01:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/2694-malattia-di-niemann-pick-a-udine-sara-testato-sui-pazienti-il-nuovo-farmaco-di-genzyme]]></loc><lastmod>2021-02-15T12:01:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/918-niemann-pick-tipo-c-ad-udine-si-studieranno-i-meccanismi-della-neurodegenerazione]]></loc><lastmod>2021-02-15T12:08:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-niemann-pick/559-niemann-pick-c-studi-preclinici-mostrano-che-inibitori-hdac-guariscono-le-cellule-dagli-accumuli]]></loc><lastmod>2021-02-15T12:08:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-still]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-still/22890-malattia-di-still-un-semplice-esame-del-sangue-puo-predirne-levoluzione-nei-bambini]]></loc><lastmod>2026-03-30T16:09:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-still/16182-malattia-di-still-dell-adulto-perche-a-volte-cala-l-efficacia-di-anakinra]]></loc><lastmod>2020-06-15T11:36:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-still/13617-malattia-di-still-l-enigma-di-una-diagnosi-la-storia-di-elisa]]></loc><lastmod>2018-06-02T15:41:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-still/13517-malattia-di-still-il-crollo-e-la-risalita-di-raffaele-dopo-10-anni-in-sedia-a-rotelle]]></loc><lastmod>2020-02-27T14:23:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-still/13410-malattia-di-still-come-si-convive-con-febbre-alta-e-dolori]]></loc><lastmod>2020-02-27T14:45:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-still/13312-malattia-di-still-parere-positivo-dal-chmp-per-anakira]]></loc><lastmod>2018-06-02T15:42:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-still/5563-malattia-di-still-delladulto-studio-mostra-che-tocilizumab-migliora-sintomi-articolari-e-sistemici]]></loc><lastmod>2018-06-02T15:42:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/21345-malattia-di-von-willebrand-pubblicate-le-linee-guida-italiane-sulla-diagnosi-e-la-terapia]]></loc><lastmod>2024-10-01T17:32:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/16026-malattia-di-von-willebrand-octapharma-italy-lancia-il-progetto-wicare]]></loc><lastmod>2020-05-05T13:59:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/11418-malattia-di-von-willebrand-vonicog-alfa-dimostra-un-alto-profilo-di-efficacia]]></loc><lastmod>2016-10-08T10:42:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/11144-malattia-di-von-willebrand-shire-lancia-il-farmaco-vonvendi-negli-stati-uniti]]></loc><lastmod>2016-08-26T11:48:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/9871-malattia-di-von-willebrand-e-tumori-un-indagine-dell-associazione-italiana-centri-emofilia-aice]]></loc><lastmod>2016-02-01T12:03:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/9615-malattia-di-von-willebrand-approvazione-dell-fda-per-vonvendi]]></loc><lastmod>2015-12-15T11:17:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/9481-malattia-di-von-willebrand-eseguito-a-pisa-eccezionale-trapianto-di-fegato-su-giovane-affetto-da-questa-malattia]]></loc><lastmod>2015-11-30T15:22:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/9355-malattia-di-von-willebrand-tipo-3-in-corso-uno-studio-internazionale-con-pazienti-da-europa-e-iran]]></loc><lastmod>2015-11-13T12:14:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/8756-malattia-di-von-willebrand-pubblicati-i-dati-dello-studio-di-fase-iii-sul-farmaco-sperimentale-bax-111]]></loc><lastmod>2015-08-06T10:09:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/8384-malattia-di-von-willebrand-come-gestire-la-terapia-per-i-pazienti-di-tipo-2]]></loc><lastmod>2015-08-05T07:51:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/8084-malattia-di-von-willebrand-dati-completi-provenienti-da-studi-su-bax-111-supportano-il-suo-potenziale-ruolo-terapeutico]]></loc><lastmod>2015-08-05T07:51:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/7511-malattia-di-von-willebrand-studio-italiano-propone-nuovo-approccio-terapeutico]]></loc><lastmod>2016-05-06T16:30:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/6054-malattia-di-von-willebrand-nuovi-dati-di-efficacia-per-il-trattamento-sperimentale-bax111]]></loc><lastmod>2015-12-15T11:20:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/5939-malattia-di-von-willebrand-trattamento-sperimentale-supera-la-fase-3]]></loc><lastmod>2015-08-05T07:51:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-di-von-willebrand/336-malattia-von-willebrand-arriva-un-nuovo-fattore-sostitutivo-orfano]]></loc><lastmod>2015-08-05T07:51:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/21924-malattia-di-wilson-in-sardegna-la-prevalenza-piu-alta-al-mondo]]></loc><lastmod>2025-05-03T10:27:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/18929-malattia-di-wilson-il-gemelli-presenta-il-proprio-percorso-clinico-assistenziale-dedicato-alla-patologia]]></loc><lastmod>2022-07-16T21:23:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/16829-malattia-di-wilson-scoperto-un-nuovo-bersaglio-terapeutico]]></loc><lastmod>2020-12-21T18:13:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/14636-malattia-di-wilson-pfizer-si-aggiudica-diritto-di-acquisizione-di-vivet-therapeutics]]></loc><lastmod>2019-03-25T18:34:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/13643-malattia-di-wilson-il-pdta-presentato-a-napoli]]></loc><lastmod>2018-06-08T16:09:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/10455-malattia-di-wilson-presentati-dati-clinici-sul-farmaco-sperimentale-decuprate-wtx101]]></loc><lastmod>2018-06-08T16:12:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/7208-malattia-di-wilson-nasce-wwwmalattiadiwilsoninfo-portale-dedicato-a-medici-e-pazienti]]></loc><lastmod>2018-06-08T16:12:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/6649-malattia-di-wilson-i-problemi-neurologici-potrebbero-essere-legati-a-uno-squilibrio-del-colesterolo-nel-cervello]]></loc><lastmod>2018-06-08T16:13:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/5584-malattia-di-wilson-la-terapia-chelante-del-rame-e-efficace-e-sicura]]></loc><lastmod>2018-06-08T16:16:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/5062-malattia-di-wilson-valentina-puo-tornare-a-sperare-nel-futuro]]></loc><lastmod>2018-06-08T16:17:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/3272-malattia-di-wilson-grande-successo-per-il-secondo-convegno-nazionale]]></loc><lastmod>2018-06-08T16:18:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/2732-malattia-di-wilson-un-questionario-per-migliorare-la-gestione-dei-pazienti]]></loc><lastmod>2018-06-08T16:19:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/1879-malattia-di-wilson-gli-anelli-di-kayser-fleischer-aiutano-la-diagnosi-e-indicano-la-progressione]]></loc><lastmod>2018-06-08T16:19:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/1395-malattia-di-wilson-la-disparita-di-trattamento-nelle-diverse-regioni-e-il-problema-piu-sentito]]></loc><lastmod>2018-06-08T16:20:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/wilson-malattia-di/1321-malattie-rare-contro-le-carenze-di-farmaci-accordo-tra-il-farmaceutico-militare-e-noventia-pharma]]></loc><lastmod>2018-06-08T16:20:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/18787-malattia-polmonare-da-micobatteri-non-tubercolari-proposto-l-inserimento-nei-lea-e-il-riconoscimento-dell-invalidita]]></loc><lastmod>2022-06-17T16:15:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/18686-malattia-polmonare-ntm-il-parlamento-chiede-che-la-patologia-sia-riconosciuta-come-rara]]></loc><lastmod>2022-05-23T11:14:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/17785-malattia-polmonare-ntm-un-indagine-per-migliorare-la-qualita-di-vita]]></loc><lastmod>2021-09-16T15:07:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/17309-malattia-polmonare-ntm-amantum-in-prima-linea-per-l-inserimento-della-patologia-nei-lea]]></loc><lastmod>2021-04-18T14:08:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/16629-malattia-polmonare-ntm-approvazione-europea-per-amikacina-inalatoria]]></loc><lastmod>2020-10-31T17:54:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/16545-malattia-polmonare-ntm-riprendono-gli-incontri-del-progetto-ntm-dare]]></loc><lastmod>2020-10-11T19:09:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/16369-malattia-polmonare-ntm-chmp-raccomanda-l-uso-di-amikacina-inalatoria]]></loc><lastmod>2020-08-10T16:21:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/15676-malattia-polmonare-ntm-l-impatto-psicologico-e-sociale-puo-essere-schiacciante]]></loc><lastmod>2020-02-19T09:34:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/15636-malattia-polmonare-ntm-il-rischio-di-morte-non-dipende-soltanto-dal-micobatterio-coinvolto]]></loc><lastmod>2020-02-06T09:45:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/15576-malattia-polmonare-ntm-una-patologia-che-sembra-non-aver-mai-fine]]></loc><lastmod>2020-01-14T18:43:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/15552-mycobacterium-chimaera-il-ministero-aggiorna-le-indicazioni-utili]]></loc><lastmod>2020-01-05T10:46:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/15491-malattia-polmonare-ntm-francesco-all-inizio-pensavo-fosse-un-virus-stagionale]]></loc><lastmod>2019-12-08T23:32:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/15356-malattia-polmonare-ntm-amantum-chiede-che-sia-inserita-tra-le-malattie-rare-esenti]]></loc><lastmod>2019-10-29T13:29:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/15355-malattia-polmonare-ntm-presentato-al-senato-il-libro-bianco]]></loc><lastmod>2019-10-29T12:03:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/15319-bronchiectasie-polmonari-in-italia-nasce-la-prima-associazione-di-pazienti]]></loc><lastmod>2025-11-21T18:19:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14986-malattia-polmonare-ntm-commissione-lea-ne-valutera-l-inserimento-tra-le-patologie-rare-esenti]]></loc><lastmod>2019-07-05T21:24:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14672-malattia-polmonare-ntm-importante-segnalare-i-possibili-casi-alle-autorita-sanitarie]]></loc><lastmod>2019-04-03T09:50:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14568-malattia-polmonare-da-micobatteri-non-tubercolari-difficile-da-pronunciare-difficile-da-curare]]></loc><lastmod>2019-03-12T22:32:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14454-roberta-e-la-vita-con-la-malattia-polmonare-da-micobatteri-non-tubercolari]]></loc><lastmod>2019-02-13T14:16:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14390-infezione-da-mycobacterium-chimaera-nella-regione-veneto-i-pazienti-richiamati-sono-1400]]></loc><lastmod>2019-01-25T12:08:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14325-mycobacterium-chimaera-dal-veneto-una-duplice-risposta-all-infezione]]></loc><lastmod>2019-01-04T14:43:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14295-malattia-polmonare-ntm-alcuni-pazienti-possono-finire-in-perenne-terapia]]></loc><lastmod>2018-12-17T21:25:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14264-mycobacterium-chimaera-ingiustificato-parlare-di-epidemia-da-batterio-killer]]></loc><lastmod>2018-12-11T09:33:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14263-le-5-cose-da-sapere-sull-infezione-da-mycobacterium-chimaera]]></loc><lastmod>2018-12-11T09:34:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14072-malattia-polmonare-ntm-nasce-il-network-italiano-irene]]></loc><lastmod>2024-03-14T19:31:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14023-malattia-polmonare-ntm-due-anni-per-avere-una-diagnosi-che-si-poteva-fare-subito]]></loc><lastmod>2018-10-10T17:07:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/14009-malattia-polmonare-ntm-approvazione-usa-per-l-amikacina-inalatoria]]></loc><lastmod>2020-08-10T10:56:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/13978-malattia-polmonare-ntm-nelle-marche-un-laboratorio-di-analisi-specializzato]]></loc><lastmod>2018-09-30T22:28:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/13834-malattia-polmonare-ntm-voto-favorevole-da-comitato-fda-per-il-farmaco-alis]]></loc><lastmod>2018-08-09T17:22:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/13697-malattia-polmonare-ntm-la-forma-dovuta-al-micobatterio-mac-e-tra-le-piu-pericolose]]></loc><lastmod>2019-03-26T17:28:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/13551-malattia-polmonare-ntm-maggiori-benefici-con-i-farmaci-per-via-inalatoria]]></loc><lastmod>2018-05-19T17:13:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/13383-malattia-polmonare-ntm-una-patologia-silenziosa-e-pericolosa]]></loc><lastmod>2018-03-27T22:46:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/13361-malattia-polmonare-da-micobatteri-non-tubercolari-su-omar-l-esperto-risponde]]></loc><lastmod>2018-04-04T23:09:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/13332-malattia-polmonare-ntm-per-la-conferma-diagnostica-occorre-piu-di-un-mese]]></loc><lastmod>2018-03-13T02:55:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/13139-malattie-polmonari-ntm-incidenza-in-aumento-per-queste-gravi-infezioni]]></loc><lastmod>2018-02-15T14:34:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/13096-malattia-polmonare-ntm-conferme-positive-dagli-studi-di-fase-iii-su-amikacina-inalatoria]]></loc><lastmod>2019-01-17T16:01:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/12752-l-uso-di-cortisonici-inalati-aumenta-il-rischio-di-polmonite]]></loc><lastmod>2018-02-15T14:35:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/12668-malattia-polmonare-non-tubercolare-positivi-risultati-di-fase-iii-per-amikacina-inalatoria]]></loc><lastmod>2019-01-17T17:24:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattia-polmonare-da-micobatteri-non-tubercolari/11546-malattie-respiratorie-aipo-lancia-una-survey-su-infezioni-da-mycobatteri-non-tubercolari]]></loc><lastmod>2018-01-16T11:39:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/22657-retinite-pigmentosa-individuati-nuovi-geni-coinvolti-nella-malattia]]></loc><lastmod>2026-01-15T15:13:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/21959-retinite-pigmentosa-scoperto-un-nuovo-gene-legato-alla-malattia]]></loc><lastmod>2025-05-08T10:11:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/20428-distrofie-ereditarie-della-retina-online-il-sito-geni-in-vista]]></loc><lastmod>2023-12-11T11:03:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/19961-malattia-di-stargardt-in-test-di-laboratorio-si-valuta-l-uso-dalla-tecnica-crispr]]></loc><lastmod>2023-06-28T16:04:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/19861-distrofia-maculare-di-best-un-unica-patologia-tante-manifestazioni-cliniche]]></loc><lastmod>2023-06-01T15:26:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/19720-distrofia-retinica-due-fratelli-padovani-recuperano-la-vista-grazie-alla-terapia-genica]]></loc><lastmod>2023-04-17T20:57:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/19140-malattie-rare-della-retina-stanziati-500-000-euro-per-percorsi-di-diagnosi-e-assistenza]]></loc><lastmod>2022-10-04T15:32:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/18970-distrofie-retiniche-ereditarie-in-sicilia-e-disponibile-il-test-genetico]]></loc><lastmod>2022-07-29T11:13:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/18901-retinite-pigmentosa-legata-al-cromosoma-x-speranze-dalla-terapia-genica]]></loc><lastmod>2022-07-11T06:57:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/18492-distrofie-retiniche-ereditarie-da-oggi-e-possibile-riacquistare-la-vista-grazie-alla-terapia-genica]]></loc><lastmod>2022-03-30T10:33:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/18047-a-occhi-aperti-un-cortometraggio-sulla-retinite-pigmentosa]]></loc><lastmod>2021-11-27T23:10:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/17955-retinite-pigmentosa-al-gemelli-uno-storico-passo-avanti-verso-la-vista-bionica]]></loc><lastmod>2021-10-31T21:46:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/17925-distrofia-della-retina-a-napoli-dieci-bimbi-trattati-con-successo-con-la-terapia-genica]]></loc><lastmod>2021-10-23T20:09:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/17897-retinopatia-del-prematuro-aifa-approva-la-rimborsabilita-di-ranibizumab]]></loc><lastmod>2021-10-17T20:23:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/17726-paralimpiadi-carlotta-gilli-affetta-da-malattia-di-stargardt-conquista-due-medaglie-nel-nuoto]]></loc><lastmod>2021-09-03T14:16:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/17681-distrofia-della-retina-al-gemelli-sottoposta-a-terapia-genica-la-prima-paziente-adulta]]></loc><lastmod>2021-07-25T17:04:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/17656-retinopatia-del-prematuro-nuove-possibilita-diagnostiche-e-un-farmaco-salva-vista]]></loc><lastmod>2021-07-18T18:12:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/17589-malattie-retiniche-rare-nasce-una-start-up-per-lo-sviluppo-della-prima-retina-artificiale-liquida]]></loc><lastmod>2021-06-27T22:33:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/17381-amaurosi-congenita-di-leber-la-storia-di-rosa-una-mamma-che-non-si-arrende]]></loc><lastmod>2021-05-10T17:31:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/17104-malattie-rare-della-retina-approvata-una-legge-su-finanziamento-di-centri-di-cura-e-riabilitazione]]></loc><lastmod>2021-03-25T11:02:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/16912-distrofia-della-retina-arriva-in-italia-la-prima-terapia-genica]]></loc><lastmod>2021-01-21T11:59:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/16540-valentina-petrillo-la-velocista-trans-e-ipovedente-vi-racconto-la-mia-malattia-di-stargardt]]></loc><lastmod>2020-10-08T08:53:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/16539-giornata-della-vista-900-le-malattie-rare-dell-occhio-ma-si-contano-sulle-dita-quelle-che-hanno-terapie]]></loc><lastmod>2020-10-08T10:12:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/16234-malattie-rare-della-retina-la-frontiera-della-terapia-genica]]></loc><lastmod>2020-07-01T09:17:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/16208-retinite-pigmentosa-grazie-a-protesi-artificiali-i-pazienti-ciechi-possono-tornare-a-vedere]]></loc><lastmod>2020-07-01T09:15:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/16189-malattie-della-retina-per-trovare-nuove-terapie-occorre-svelare-i-segreti-della-visione]]></loc><lastmod>2020-06-24T08:00:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/15523-distrofia-retinica-ereditaria-per-la-prima-volta-effettuata-la-terapia-genica-in-italia]]></loc><lastmod>2019-12-17T10:04:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/15428-malattia-di-stargardt-farmaco-a-base-di-zafferano-sembra-bloccare-la-degenerazione-retinica]]></loc><lastmod>2019-11-19T17:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/15178-retinite-pigmentosa-sabrina-non-puo-vedere-ma-vola-piu-in-alto-della-malattia]]></loc><lastmod>2019-09-11T09:46:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/15113-malattie-rare-della-retina-ptc-e-odylia-avviano-partnership-sulla-terapia-genica]]></loc><lastmod>2019-08-12T17:39:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/14995-retinopatia-del-prematuro-avviato-studio-di-fase-iii-su-aflibercept]]></loc><lastmod>2019-07-06T17:06:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/14196-distrofia-della-retina-approvata-in-europa-la-prima-terapia-genica-una-tantum]]></loc><lastmod>2018-11-24T10:04:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/13984-retinopatia-del-prematuro-domanda-di-approvazione-per-ranibizumab]]></loc><lastmod>2018-10-02T09:29:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/13980-malattie-rare-della-retina-opinione-positiva-del-chmp-su-voretigene-neparvovec]]></loc><lastmod>2018-10-01T18:01:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/13754-retinite-pigmentosa-realizzato-il-52-impianto-di-protesi-epiretinica]]></loc><lastmod>2018-07-13T16:28:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/13545-cecita-a-milano-effettuato-un-intervento-di-retina-artificiale-con-dimissione-in-24-ore]]></loc><lastmod>2018-05-11T14:30:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/13187-distrofia-della-retina-novartis-acquisice-diritti-sulla-prima-terapia-genica-oftalmologica]]></loc><lastmod>2018-02-04T23:05:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/13107-distrofia-della-retina-negli-usa-la-terapia-genica-costera-850-000-dollari-per-paziente]]></loc><lastmod>2018-02-04T23:06:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/13053-distrofia-della-retina-approvazione-usa-per-la-terapia-genica]]></loc><lastmod>2019-01-17T17:18:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/12554-arjola-e-campionessa-mondiale-la-retinite-pigmentosa-non-e-un-limite]]></loc><lastmod>2018-02-04T23:06:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/12168-retinopatia-al-via-una-campagna-per-sostenere-i-neonati-prematuri]]></loc><lastmod>2018-02-04T23:07:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/12090-malattie-della-retina-impiantata-la-prima-retina-artificiale-organica-in-un-modello-sperimentale]]></loc><lastmod>2018-02-04T23:07:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/11916-retinite-pigmentosa-in-italia-raggiunto-il-traguardo-di-30-protesi-epiretiniche-impiantate]]></loc><lastmod>2018-02-04T23:08:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/11856-retinite-pigmentosa-apre-a-milano-un-nuovo-sportello-dell-associazione-retina-italia]]></loc><lastmod>2018-02-04T23:08:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/11074-malattie-della-retina-annunciati-i-risultati-a-5-anni-della-protesi-retinica-argus-ii]]></loc><lastmod>2018-02-04T23:08:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/10893-malattia-di-stargardt-a-firenze-il-primo-caso-al-mondo-trattato-con-protesi-epiretinica-argus-ii]]></loc><lastmod>2018-02-04T23:09:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/10812-la-terapia-genica-mostra-benefici-a-lungo-termine-nella-cura-di-una-rara-forma-di-cecita]]></loc><lastmod>2018-02-04T23:09:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/10784-retinite-pigmentosa-dopo-15-anni-di-cecita-nicola-torna-a-vedere]]></loc><lastmod>2018-02-04T23:10:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/10362-retinite-pigmentosa-ufficialmente-iniziata-la-sperimentazione-clinica-sul-farmaco-rst-001]]></loc><lastmod>2016-05-03T21:00:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/10243-retinopatia-neonati-prematuri-da-tutta-italia-al-centro-di-riferimento-torinese-del-maria-vittoria]]></loc><lastmod>2016-03-22T16:18:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/10121-retina-artificiale-effettuato-al-careggi-di-firenze-il-25esimo-impianto]]></loc><lastmod>2016-03-04T14:32:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/9905-retinite-pigmentosa-riscontri-positivi-dalla-protesi-retinica-argus-ii]]></loc><lastmod>2016-02-05T11:23:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/9870-retinite-pigmentosa-nuove-prospettive-di-cura-dalla-tecnica-crispr]]></loc><lastmod>2018-07-31T16:48:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/9859-staminali-ottenuta-in-laboratorio-la-crescita-di-cellule-nervose-retiniche]]></loc><lastmod>2016-04-15T17:53:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/9333-neovascolarizzazione-coroideale-secondaria-a-miopia-patologica-l-europa-approva-il-farmaco-eylea-aflibercept]]></loc><lastmod>2015-11-11T14:10:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/9249-malattie-genetiche-della-retina-siglato-accordo-tra-magi-euregio-e-national-eye-institute]]></loc><lastmod>2015-10-29T14:20:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/9143-distrofie-retiniche-ereditarie-la-terapia-genica-sperimentale-di-spark-therapeutics-supera-la-fase-iii]]></loc><lastmod>2015-10-14T09:09:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/9013-retinite-pigmentosa-previsto-l-inizio-del-primo-studio-clinico-sulla-terapia-sperimentale-rst-001]]></loc><lastmod>2015-09-29T10:14:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/8921-malattie-della-retina-second-sight-partecipa-al-xv-congresso-euretina-a-nizza]]></loc><lastmod>2015-09-15T13:32:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/8259-shire-e-la-fondazione-fighting-blindness-annunciano-un-nuovo-accordo-di-ricerca-per-la-reti-nite-pigmentosa-autosomica-dominante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/8167-retinite-pigmentosa-il-punto-sulle-sperimentazioni-del-nuovo-collirio-a-base-di-nerve-growth-factor]]></loc><lastmod>2018-11-21T16:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/7457-retinite-pigmentosa-oltre-250-le-chiamate-al-nuovo-numero-verde]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/6875-retinite-pigmentosa-la-storia-di-un-paziente-che-ora-riesce-a-tirare-con-larco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/6810-amaurosi-congenita-di-leber-genzyme-annuncia-lavvio-di-una-nuova-collaborazione-per-la-messa-a-punto-di-una-terapia-genica]]></loc><lastmod>2019-06-18T17:55:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/6511-retinite-pigmentosa-nasce-il-numero-verde-per-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/6099-retinite-pigmentosa-non-abbandoniamoci-alla-demagogia-popolare-sul-tema-dei-falsi-ciechi]]></loc><lastmod>2019-06-18T18:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/5927-retinite-pigmentosa-cinque-i-centri-italiani-che-sperimentano-rhngf]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/5874-retinite-pigmentosa-e-italiana-la-nuova-ricerca-sul-fattore-rhngf]]></loc><lastmod>2019-06-18T18:27:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/5770-retinoblastoma-affidata-presso-listituto-curie-di-parigi-allaou-senese-la-responsabilita-scientifica-di-un-progetto-internazionale-nel-network-euretino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/5305-retinite-pigmentosa-buoni-risultati-dai-primi-impianti-del-sistema-argus-ii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/5266-retinite-pigmentosa-scoperto-un-meccanismo-di-interazione-tra-i-fotorecettori-della-retina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/5023-retinoblastoma-semplici-fotografie-possono-aiutare-la-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/4599-retinite-pigmentosa-rhngf-nerve-growth-factor-ricombinante-umano-approvato-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/4565-retinite-pigmentosa-la-terapia-a-base-di-staminali-riceve-lo-status-di-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/4302-retinite-pigmentosa-nuova-designazione-di-farmaco-orfano-per-rhngf]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/3925-neuropatia-di-leber-lhon-e-retinite-pigmentosa-gensight-ottiene-32-milioni-di-euro-per-lo-sviluppo-di-terapie-geniche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/3679-malattie-rare-della-retina-gli-usa-approvano-limpianto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/3668-a-pisa-i-primi-impianti-di-protesi-retinica-al-mondo-8-pazienti-con-retinite-pigmentosa-grave-recuperano-la-funzionalita-visiva]]></loc><lastmod>2020-06-19T09:52:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/3457-retinite-pigmentosa-due-nuovi-potenziali-trattamenti-terapeutici-con-staminali-e-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/3210-retinite-pigmentosa-le-novita-su-riabilitazione-e-ausili-tecnologici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/2842-retinite-pigmentosa-autosomica-recessiva-identificate-le-mutazioni-in-abca4]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/2785-malattia-di-stargardt-nonostante-la-patologia-fabio-lavora-come-reporter-internazionale]]></loc><lastmod>2019-09-11T16:50:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/2764-retinite-pigmentosa-a-sidney-impiantato-un-occhio-bionico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/2702-cecita-genetica-scoperta-la-causa-dellamaurosi-congenita-di-leber]]></loc><lastmod>2019-08-12T16:35:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/2655-distrofie-retiniche-ereditarie-al-careggi-di-firenze-arriva-bioruptor-per-una-diagnosi-genetica-piu-veloce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/2522-sindrome-di-stargart-a-18-anni-connor-concorre-per-il-titolo-di-miss-florida-2012]]></loc><lastmod>2021-10-06T11:29:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/2118-malattie-della-retina-pronto-locchio-bionico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/1977-malattie-rare-della-retina-il-san-paolo-di-milano-e-parte-della-rete-deccellenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/1976-malattie-rare-della-retina-al-gemelli-di-roma-in-corso-un-trial-clinico-per-la-malattia-di-stargardt]]></loc><lastmod>2019-11-19T17:44:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/1975-rete-per-le-malattie-rare-della-retina-la-dottsa-oldani-ora-siamo-in-grado-di-dare-ai-pazienti-una-diagnosi-certa-e-un-consulto-genetico]]></loc><lastmod>2023-06-28T16:06:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/1978-rete-per-le-malattie-rare-della-retina-bertelli-vogliamo-essere-punto-di-riferimento-per-assicurare-assistenza-di-alto-livello-a-tutti-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/1974-malattie-rare-della-retina-al-gemelli-e-al-san-paolo-si-studiano-nuovi-farmaci-due-su-tre-sono-di-origine-naturale]]></loc><lastmod>2015-05-29T08:47:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/1972-malattie-rare-della-retina-non-profit-e-centri-ospedalieri-alleati-per-dare-il-meglio-di-diagnosi-cure-e-riabilitazione-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/1973-malattie-rare-della-retina-fare-rete-per-dare-i-migliori-servizi-al-nord-come-al-sud]]></loc><lastmod>2015-05-29T08:48:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/malattie-rare-della-retina/488-uveiti-e-malattie-rare-dellocchio-a-pisa-apre-lambulatorio-dedicato-ad-assistenza-e-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/22605-mastocitosi-sistemiche-il-ruolo-di-asimas-tra-informazione-rete-e-supporto-ai-pazienti]]></loc><lastmod>2025-12-15T10:20:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/22566-al-ministero-della-salute-un-evento-su-medicina-di-precisione-in-malattie-rare-e-oncologia]]></loc><lastmod>2025-12-02T12:02:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/22465-giornata-mondiale-per-la-mastocitosi-un-viaggio-di-consapevolezza-dialogo-e-speranza]]></loc><lastmod>2025-11-03T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/22451-un-alleato-digitale-per-la-mastocitosi-nasce-maia-il-chatbot-che-aiuta-medici-e-pazienti]]></loc><lastmod>2025-11-04T10:53:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/22350-diagnosi-e-cura-della-mastocitosi-perche-lequipe-multidisciplinare-fa-la-differenza]]></loc><lastmod>2025-09-26T12:43:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/22179-mastocitosi-l-importanza-di-un-corretto-dialogo-tra-medico-e-paziente]]></loc><lastmod>2025-08-01T11:44:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/22091-mastocitosi-la-malattia-rara-che-coinvolge-il-sistema-immunitario]]></loc><lastmod>2025-06-13T14:34:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/22003-mastocitosi-cutanee-o-sistemiche-sono-patologie-rare-complesse]]></loc><lastmod>2025-05-21T07:43:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/21967-mastocitosi-quando-le-cellule-immunitarie-diventano-nemiche]]></loc><lastmod>2025-05-09T17:18:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/21427-mastocitosi-un-video-per-raccontare-in-tre-minuti-una-malattia-dai-tanti-volti]]></loc><lastmod>2025-03-04T13:31:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/20234-mastocitosi-sistemica-dalla-diagnosi-alla-terapia-ecco-i-vantaggi-dei-farmaci-di-nuova-generazione]]></loc><lastmod>2025-02-04T10:42:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/19617-tumori-stromali-gastrointestinali-e-mastocitosi-sistemica-avapritinib-approvato-in-italia]]></loc><lastmod>2025-02-04T10:26:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/17915-mastocitosi-oggi-si-celebra-la-giornata-internazionale]]></loc><lastmod>2025-02-04T10:31:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/13926-leucemia-mieloide-acuta-anche-in-italia-e-disponibile-il-farmaco-midostaurina]]></loc><lastmod>2025-02-04T11:59:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/10935-mastocitosi-sistemica-il-farmaco-sperimentale-midostaurin-mostra-un-tasso-di-risposta-globale-del-60]]></loc><lastmod>2025-02-04T10:39:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/10694-mastocitosi-sistemica-aggressiva-e-istocitosi-di-langherans-arriva-un-nuovo-farmaco]]></loc><lastmod>2025-02-04T13:07:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/mastocitosi/4359-mastocitosi-asimas-finanzia-progetti-di-ricerca]]></loc><lastmod>2025-02-04T13:18:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/22861-miastenia-gravis-oculare-risultati-positivi-dallo-studio-di-fase-iii-su-efgartigimod-alfa]]></loc><lastmod>2026-03-20T16:10:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/22702-in-sicilia-la-miastenia-gravis-si-cura-a-casa-la-svolta-della-terapia-domiciliare]]></loc><lastmod>2026-02-01T16:47:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/22622-miastenia-gravis-si-conclude-con-successo-road4mg-iniziativa-di-aim-sul-territorio-nazionale]]></loc><lastmod>2025-12-30T10:44:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/22593-equita-di-accesso-alle-cure-sostenibilita-e-qualita-di-vita-ecco-i-nodi-che-condizionano-laccesso-alle-terapie]]></loc><lastmod>2025-12-10T12:01:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/22592-miastenia-gravis-efgartigimod-alfa-ora-disponibile-anche-per-la-modalita-di-autosomministrazione]]></loc><lastmod>2026-03-18T13:16:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/22559-miastenia-un-corso-di-educazione-terapeutica-disponibile-anche-online]]></loc><lastmod>2025-11-29T11:15:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/22556-quello-che-non-vedi-nasce-un-progetto-per-raccontare-la-miastenia-gravis-attraverso-immagini-e-parole]]></loc><lastmod>2025-11-27T17:27:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/22537-miastenia-gravis-la-patologia-come-paradigma-per-rafforzare-le-politiche-sulle-malattie-rare-in-italia]]></loc><lastmod>2025-11-26T08:18:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/22486-miastenia-gravis-in-sardegna-colpisce-almeno-3-volte-piu-che-altrove]]></loc><lastmod>2025-11-13T09:10:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21964-in-puglia-un-alleanza-per-la-miastenia-gravis]]></loc><lastmod>2025-05-08T17:06:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21832-miastenia-gravis-quando-la-malattia-costringe-a-rinunciare-al-lavoro]]></loc><lastmod>2025-03-21T18:44:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21819-calabria-finalmente-un-centro-per-i-pazienti-con-miastenia-gravis]]></loc><lastmod>2025-03-17T18:43:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21679-miastenia-grave-rimborsabile-in-italia-la-nuova-formulazione-sottocutanea-di-efgartigimod-alfa]]></loc><lastmod>2026-03-18T13:14:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21474-miastenia-gravis-ravulizumab-disponibile-in-italia]]></loc><lastmod>2024-11-07T18:40:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21472-miastenia-gravis-risultati-positivi-dallo-studio-di-fase-iii-su-inebilizumab]]></loc><lastmod>2024-11-07T16:40:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21395-miastenia-gravis-on-ilenia-malavasi-per-le-istituzioni-e-fondamentale-ascoltare-i-pazienti]]></loc><lastmod>2024-10-16T17:45:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21381-miastenia-gravis-l-impegno-di-argenx-per-la-comunita-dei-pazienti]]></loc><lastmod>2024-10-11T13:15:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21357-miastenia-gravis-il-ruolo-fondamentale-delle-associazioni-di-pazienti]]></loc><lastmod>2024-10-10T16:31:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21358-miastenia-gravis-all-omar-talk-si-incontrano-associazioni-di-pazienti-aziende-e-istituzioni]]></loc><lastmod>2024-10-10T16:30:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21181-miastenia-gravis-cosa-avviene-in-uno-studio-clinico]]></loc><lastmod>2024-07-17T14:45:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21166-dalla-storia-di-giuseppe-e-marta-continua-il-viaggio-di-gmg-your-way-un-podcast-per-informare-sulla-miastenia-grave]]></loc><lastmod>2024-07-12T14:26:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21148-miastenia-gravis-per-raggiungere-il-posto-di-lavoro-devo-guidare-2-ore-e-mezzo-al-giorno]]></loc><lastmod>2024-07-06T17:42:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/21104-miastenia-gravis-la-gravidanza-e-possibile-ma-fondamentale-la-gestione-multidisciplinare]]></loc><lastmod>2024-06-21T13:04:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20894-miastenia-gravis-in-sardegna-la-maggior-prevalenza-al-mondo]]></loc><lastmod>2025-06-24T14:09:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20787-miastenia-gravis-in-adolescenza-una-scomoda-compagna-di-viaggio]]></loc><lastmod>2024-06-21T11:44:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20737-miastenia-gravis-all-united-for-mg-lancia-una-petizione-per-un-cambio-di-rotta-nella-gestione-della-patologia]]></loc><lastmod>2024-03-11T12:29:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20685-la-malattia-mi-ha-costretta-al-silenzio-per-un-anno-e-mezzo-ora-dico-basta-essere-pazienti]]></loc><lastmod>2024-02-27T15:53:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20576-miastenia-gravis-due-nuovi-farmaci-approvati-in-europa-zilucoplan-e-rozanolixizumab]]></loc><lastmod>2025-10-23T10:20:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20564-miastenia-gravis-l-importanza-di-una-corretta-comunicazione-tra-medico-e-paziente]]></loc><lastmod>2024-01-29T20:45:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20527-miastenia-grave-il-senso-di-solitudine-e-una-costante-nella-vita-dei-pazienti]]></loc><lastmod>2024-01-17T16:48:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20460-miastenia-gravis-torna-il-podcats-gmgyourway-ecco-la-storia-di-roberta]]></loc><lastmod>2023-12-20T09:00:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20397-miastenia-grave-avere-una-malattia-invisibile-ti-fa-sentire-incompreso-dagli-altri]]></loc><lastmod>2023-11-29T17:01:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20352-miastenia-ecco-la-guida-ai-diritti-dei-pazienti-come-orientarsi-tra-esenzioni-legge-104-e-invalidita-civile]]></loc><lastmod>2023-11-20T10:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20268-miastenia-grave-15mila-le-persone-colpite-in-italia]]></loc><lastmod>2023-10-31T11:14:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20215-miastenia-gravis-non-c-e-un-nome-adatto-per-la-stanchezza-che-provoca-la-malattia]]></loc><lastmod>2023-11-29T16:52:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20171-miastenia-gravis-generalizzata-parere-positivo-dal-chmp-dell-ema-per-il-farmaco-zilucoplan]]></loc><lastmod>2023-09-29T09:01:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20162-miastenia-grave-all-inizio-la-diagnosi-mi-ha-sopraffatto-ma-poi-ho-capito-di-dover-reagire]]></loc><lastmod>2023-10-11T15:26:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20112-miastenia-gravis-a-lecce-puglia-ora-disponibile-la-ricerca-degli-autoanticorpi-per-i-pazienti-sieronegativi]]></loc><lastmod>2023-09-13T08:55:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/20023-miastenia-gravis-ok-di-aifa-alla-rimborsabilita-di-efgartigimod-alfa]]></loc><lastmod>2023-07-20T10:12:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19940-espressioni-rare-quante-ne-sai-arriva-l-esperimento-sociale-di-omar-e-fanpage-it-sulla-miastenia-grave]]></loc><lastmod>2023-06-26T08:34:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19932-miastenia-gravis-realizzato-un-volume-di-medicina-narrativa]]></loc><lastmod>2023-06-23T09:32:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19875-miastenia-gravis-il-fondamentale-ruolo-del-supporto-psicologico-nella-gestione-dei-pazienti]]></loc><lastmod>2023-06-23T09:33:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19858-una-storia-di-speciale-rarita-la-mia-vita-con-la-miastenia-gravis]]></loc><lastmod>2023-06-01T10:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19857-miastenia-gravis-oggi-la-giornata-mondiale-ed-europea-dedicata-alla-sensibilizzazione-sulla-malattia]]></loc><lastmod>2023-06-01T10:33:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19850-malattie-rare-il-disegno-come-cura-per-la-miastenia-grave]]></loc><lastmod>2023-06-01T08:01:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19849-maya-digital-artist-e-paziente-disegna-la-miastenia-gravis-per-vincere-l-invisibilita]]></loc><lastmod>2025-06-24T15:01:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19768-miastenia-grave-online-il-questionario-per-valutare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2023-06-22T08:13:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19749-miastenia-gravis-generalizzata-pubblicati-gli-studi-di-fase-iii-su-rozanolixizumab-e-zilucoplan]]></loc><lastmod>2023-04-26T19:13:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19435-miastenia-gravis-il-ruolo-del-centro-di-riferimento-in-relazione-alla-presa-in-carico-territoriale]]></loc><lastmod>2023-01-12T08:43:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19385-miastenia-gravis-l-importanza-del-rapporto-con-il-medico-nella-gestione-della-vita-con-la-malattia]]></loc><lastmod>2022-12-29T18:22:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19389-miastenia-gravis-si-puo-tornare-al-lavoro-dopo-la-diagnosi]]></loc><lastmod>2022-12-29T18:21:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19355-miastenia-gravis-esenzioni-e-diritti-esigibili-quali-le-difficolta-principali]]></loc><lastmod>2022-12-29T18:22:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19330-miastenia-gravis-l-importanza-del-registro-pazienti-nazionale]]></loc><lastmod>2022-12-13T15:16:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19291-miastenia-gravis-l-impatto-psicologico-di-una-malattia-che-non-si-vede]]></loc><lastmod>2022-11-22T15:20:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19258-miastenia-gravis-tante-le-difficolta-sul-lavoro-dopo-la-diagnosi]]></loc><lastmod>2024-10-03T14:41:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19085-miastenia-gravis-una-diagnosi-difficile-per-una-malattia-che-non-si-vede]]></loc><lastmod>2022-11-07T14:05:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19092-miastenia-gravis-con-la-giusta-cura-si-puo-vivere-una-vita-piena]]></loc><lastmod>2022-11-07T14:43:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19084-speciale-miastenia-gravis]]></loc><lastmod>2023-01-12T09:00:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19225-miastenia-grave-un-libro-bianco-per-migliorare-la-gestione-a-tutto-tondo-della-patologia]]></loc><lastmod>2022-11-07T08:37:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19215-miastenia-gravis-in-un-podcast-la-prospettiva-del-caregiver]]></loc><lastmod>2022-11-07T08:37:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19197-miastenia-grave-pazienti-e-caregiver-chiedono-piu-informazioni-e-supporto]]></loc><lastmod>2022-11-07T08:37:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19191-miastenia-gravis-generalizzata-refrattaria-approvato-in-italia-il-farmaco-eculizumab]]></loc><lastmod>2022-11-07T08:37:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19139-miastenia-grave-l-impatto-della-patologia-sulla-qualita-di-vita-dei-caregiver]]></loc><lastmod>2022-11-07T08:37:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/19128-un-podcast-dedicato-alla-miastenia-gravis-generalizzata-ecco-gmg-your-way]]></loc><lastmod>2022-11-07T08:37:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18957-disabilita-pronuncia-decisiva-per-riconoscerla-sul-lavoro-non-servono-certificazioni-o-percentuali]]></loc><lastmod>2022-11-07T08:37:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18920-miastenia-gravis-online-un-podcast-per-aumentare-la-consapevolezza-della-malattia]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18850-miastenia-gravis-comprendere-i-bisogni-dei-pazienti-e-l-unico-modo-per-attuare-politiche-sanitarie-efficaci]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18743-miastenia-grave-pubblicate-le-raccomandazioni-di-indirizzo-politico-per-gestire-al-meglio-la-patologia]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18718-miastenia-gravis-oggi-2-giugno-la-giornata-mondiale-per-la-conoscenza-della-malattia]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18673-miastenia-la-lotta-quotidiana-di-chiara-con-la-sua-disabilita-invisibile]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18119-miastenia-grave-affrontare-la-patologia-e-difficile-per-il-paziente-ma-anche-per-il-caregiver]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18073-miastenia-grave-i-caregiver-dedicano-in-media-8-ore-al-giorno-all-assistenza-dei-pazienti]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18053-miastenia-grave-la-qualita-di-vita-dei-pazienti-e-strettamente-connessa-alla-severita-della-patologia]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18028-miastenia-grave-la-diagnosi-arriva-in-media-dopo-piu-di-un-anno-dall-insorgenza-dei-primi-sintomi]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18030-miastenia-gravis-e-qualita-della-vita-la-registrazione-dell-evento-dedicato-alla-nascita-dell-alleanza-per-lamiastenia-gravis]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18020-scarica-gratuitamente-il-libro-miastenia-una-malattia-che-non-si-vede]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/18016-miastenia-gravis-nasce-un-alleanza-per-migliorare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/17986-miastenia-gravis-la-vita-dopo-la-diagnosi-il-racconto-di-pazienti-e-clinici-in-un-libro-presto-online]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/17889-miastenia-grave-un-anno-dal-lancio-dell-app-myrealworldmg]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/17661-miastenia-gravis-troppe-difficolta-per-il-riconoscimento-di-invalidita-e-legge-104]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/17590-miastenia-grave-fondamentale-valutare-l-impatto-della-malattia-anche-sui-caregiver]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/17528-miastenia-grave-l-impegno-dell-associazione-aim-nel-progetto-myrealworld-mg]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/17495-miastenia-grave-il-2-giugno-la-giornata-mondiale]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/17379-miastenia-grave-i-dati-preliminari-dello-studio-myrealworld-mg]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/17229-miastenia-grave-tra-i-pazienti-il-tasso-di-occupazione-e-del-50]]></loc><lastmod>2022-11-07T08:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/17186-miastenia-grave-il-tasso-di-positivita-al-covid-19-e-in-linea-con-quello-della-popolazione-generale]]></loc><lastmod>2021-03-18T08:33:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/17041-miastenia-grave-in-arrivo-sull-app-myrealworld-mg-uno-studio-rivolto-ai-caregiver]]></loc><lastmod>2021-02-19T15:54:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/16961-miastenia-grave-i-pazienti-fondamentale-partecipare-allo-studio-myrealworld-mg]]></loc><lastmod>2021-02-03T08:24:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/16754-miastenia-grave-circa-un-terzo-dei-pazienti-non-incorre-in-miglioramenti-clinici]]></loc><lastmod>2020-11-29T23:19:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/16734-myrealworld-mg-un-app-che-monitora-la-vita-quotidiana-con-la-miastenia-grave]]></loc><lastmod>2020-11-25T19:02:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/16648-miastenia-grave-in-corso-uno-studio-per-valutare-l-impatto-della-patologia]]></loc><lastmod>2020-11-24T17:27:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/16486-miastenia-grave-un-webinar-per-facilitare-il-dialogo-tra-specialisti-e-pazienti]]></loc><lastmod>2020-09-23T10:05:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/12591-miastenia-gravis-nuova-indicazione-per-eculizumab-nell-unione-europea]]></loc><lastmod>2019-06-10T10:27:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/12579-miastenia-gravis-ema-raccomanda-eculizumab]]></loc><lastmod>2019-01-17T17:26:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/11857-miastenia-gravis-buoni-risultati-da-rituximab]]></loc><lastmod>2017-01-29T17:12:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/11269-miastenia-gravis-sospendere-la-terapia-a-base-di-micofenolato-puo-provocare-esacerbazioni]]></loc><lastmod>2016-09-17T16:16:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/10949-miastenia-gravis-presentati-dati-aggiuntivi-dallo-studio-regain-su-eculizumab]]></loc><lastmod>2016-07-11T10:44:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/10781-miastenia-gravis-buoni-ma-non-statisticamente-significativi-i-risultati-del-farmaco-soliris-eculizumab]]></loc><lastmod>2016-06-12T17:32:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/10001-miastenia-gravis-procede-il-programma-di-sviluppo-clinico-del-farmaco-cv-mg01]]></loc><lastmod>2017-08-11T14:27:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/6518-miastenia-grave-designazione-di-farmaco-orfano-per-solirisr-eculizumab]]></loc><lastmod>2017-08-11T14:29:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/6011-neuromielite-ottica-e-miastenia-grave-al-via-due-studi-sperimentali-per-valutare-efficacia-e-sicurezza-di-eculizumab]]></loc><lastmod>2019-06-18T18:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/5788-miastenia-grave-giovanile-plasmaferesi-e-immunoglobuline-mostrano-alti-tassi-di-risposta-nei-pazienti]]></loc><lastmod>2015-05-27T09:03:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/4454-miastenia-leccellenza-e-a-pisa-ma-lambulatorio-della-dottoressa-ricciardi-rischia-di-chiudere]]></loc><lastmod>2015-05-27T09:04:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/3078-miastenia-attenzione-alle-variazione-olfattive-e-gustative]]></loc><lastmod>2015-05-27T09:05:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/1999-miastenia-gravis-il-primo-intervento-di-chirurgia-robotica-alle-scotte-di-siena]]></loc><lastmod>2015-05-27T09:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/1556-miastenia-la-dottoressa-ricciardi-e-la-terapia-medica-umana]]></loc><lastmod>2015-05-27T09:04:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/miastenia/63-miastenia-gravis-due-studi-rafforzano-lipotesi-di-una-causa-virale]]></loc><lastmod>2015-05-27T09:04:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/22328-nuove-terapie-orexinergiche-promettono-una-svolta-nella-cura-della-narcolessia]]></loc><lastmod>2025-09-23T19:45:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/22038-narcolessia-piu-a-rischio-gli-uomini]]></loc><lastmod>2025-05-30T17:57:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/20753-giornata-mondiale-del-sonno-12-milioni-gli-italiani-che-non-dormono-bene]]></loc><lastmod>2024-03-14T09:42:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/19106-narcolessia-al-via-campagna-createforsleep]]></loc><lastmod>2022-09-24T18:36:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/15652-narcolessia-via-libera-in-europa-a-farmaco-contro-la-sonnolenza-diurna]]></loc><lastmod>2020-02-11T22:39:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/11741-narcolessia-avviato-studio-clinico-avanzato-sulla-molecola-jzp-110]]></loc><lastmod>2016-12-17T15:27:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/11033-narcolessia-mazindolo-riceve-designazione-di-farmaco-orfano-da-fda]]></loc><lastmod>2016-07-26T13:45:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/5350-narcolessia-la-patologia-potrebbe-dipendere-da-cause-genetiche]]></loc><lastmod>2019-06-19T08:02:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/5111-narcolessia-risultati-positivi-per-il-trattamento-con-pitolisant]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/3957-narcolessia-in-studio-una-nuova-terapia-a-base-di-carnitina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/3851-narcolessia-al-congresso-europeo-di-madrid-premiata-la-ricerca-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/3535-narcolessia-in-sicilia-procedure-piu-snelle-e-forse-un-centro-regionale-dedicato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/narcolessia/2677-narcolessia-la-neonata-fondazione-europea-pensa-ad-un-centro-unico-a-bologna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/22600-neurofibromatosi-di-tipo-1-selumetinib-approvato-in-europa-anche-per-pazienti-adulti]]></loc><lastmod>2025-12-14T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/22182-neurofibromatosi-selumetinib-efficace-anche-negli-adulti-lo-studio-guidato-dall-istituto-besta]]></loc><lastmod>2025-08-22T22:11:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/22035-neurofibromatosi-a-napoli-una-giornata-di-consapevolezza-dedicata-al-paziente]]></loc><lastmod>2025-05-29T20:14:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/21753-neurofibromatosi-si-e-spento-cesare-zambon]]></loc><lastmod>2025-02-25T13:09:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/21671-neurofibromatosi-al-via-il-progetto-superare-con-linfa]]></loc><lastmod>2025-01-27T16:49:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/21629-neurofibromatosi-di-tipo-1-un-test-valido-per-rilevare-la-trasformazione-maligna-dei-neurofibromi]]></loc><lastmod>2025-01-15T09:08:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/20981-giornata-delle-neurofibromatosi-presentata-la-campagna-siamo-infinite-sfumature]]></loc><lastmod>2024-05-20T17:10:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/20763-neurofibromatosi-tipo-1-almeno-20-000-in-italia-i-pazienti-in-italia-con-questa-malattia-genetica]]></loc><lastmod>2024-03-18T09:43:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/20727-neurofibromatosi-di-tipo-1-selumetinib-rimborsabile-in-italia]]></loc><lastmod>2024-03-07T10:46:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/16654-neurofibromatosi-dietro-macchie-cutanee-si-cela-una-malattia-rara-e-pericolosa]]></loc><lastmod>2020-11-07T18:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/16653-neurofibromatosi-per-la-diagnosi-e-il-follow-up-servirebbero-linee-guida-nazionali]]></loc><lastmod>2020-11-07T18:00:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/16315-neurofibromatosi-di-tipo-1-speranze-dal-farmaco-selumetinib]]></loc><lastmod>2020-07-21T08:39:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/16171-neurofibromatosi-identificata-una-nuova-molecola-con-attivita-antitumorale]]></loc><lastmod>2020-06-14T19:53:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/15780-coronavirus-i-pazienti-con-neurofibromatosi-non-corrono-rischi-maggiori]]></loc><lastmod>2020-03-17T18:10:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/14731-neurofibromatosi-al-via-il-progetto-mamme-di-rara-bellezza]]></loc><lastmod>2019-04-15T14:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/14662-neurofibromatosi-linfa-odv-e-ananas-onlus-insieme-per-sostenere-nf-summer-camp]]></loc><lastmod>2019-04-01T09:29:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/13969-neurofibromatosi-linfa-onlus-e-club-ignoranti-di-padova-insieme-per-nuove-cure]]></loc><lastmod>2018-09-26T10:25:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/13502-neurofibromatosi-linfa-onlus-e-ananas-onlus-aderiscono-all-iniziativa-shine-a-light-on-nf]]></loc><lastmod>2018-04-28T18:44:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/12581-neurofibromatosi-nasce-il-network-nf-patients-united]]></loc><lastmod>2017-08-16T14:34:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/12317-neurofibromatosi-linfa-ananas-e-anf-assieme-per-la-ricerca]]></loc><lastmod>2017-08-16T12:42:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/12165-neurofibromatosi-antonella-ruggiero-testimonial-dell-associazione-linfa-onlus]]></loc><lastmod>2017-08-16T12:44:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/12087-neurofibromatosi-linfa-onlus-avvia-un-progetto-di-sostegno-ai-fratelli-di-bambini-speciali]]></loc><lastmod>2017-08-16T12:47:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/11822-neurofibromatosi-svelato-il-meccanismo-di-formazione-tumorale]]></loc><lastmod>2017-08-16T12:50:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/11326-neurofibromatosi-e-i-tumori-pediatrici-le-officine-facco-sostengono-linfa-onlus]]></loc><lastmod>2017-08-16T12:52:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/10697-neurofibromatosi-1-e-2-i-progressi-terapeutici-e-le-domande-ancora-aperte]]></loc><lastmod>2017-08-16T12:53:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/10290-neurofibromatosi-e-tumori-pediatrici-la-campagna-di-linfa-onlus]]></loc><lastmod>2017-08-16T12:55:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/7776-neurofibromatosi-1-un-nuovo-metodo-per-quantificare-i-neurofibromi-cutanei-utilizzando-riquadri-di-carta]]></loc><lastmod>2017-08-16T12:57:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/6595-neurofibromatosi-di-tipo-1-nuova-scoperta-potrebbe-migliorare-la-crescita-ossea-e-la-forza]]></loc><lastmod>2017-08-16T13:00:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/6243-neurofibromatosi-di-tipo-1-urgente-laggiornamento-delle-linee-guida]]></loc><lastmod>2019-06-18T18:14:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/5479-scoperto-un-target-terapeutico-per-il-neurilemmoma-maligno]]></loc><lastmod>2017-08-16T13:05:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/3314-neurofibromatosi-le-pazienti-sono-piu-a-rischio-di-tumore-al-seno]]></loc><lastmod>2017-08-16T13:08:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/2996-neurofibromatosi-i-nei-bambini-e-nei-pazienti-con-grandi-volumi-tumorali-i-neurofibromi-plessiformi-crescono-piu-velocemente]]></loc><lastmod>2017-08-16T13:10:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/1022-neurofibromatosi-i-in-alcuni-casi-potrebbe-essere-sindrome-di-legius]]></loc><lastmod>2017-08-16T13:17:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/879-neurofibromatosi-1-individuato-marcatore-in-grado-di-scovare-i-caratteristici-tumori-fin-dallesordio]]></loc><lastmod>2017-08-16T13:18:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/732-neurofibromatosi-ii-domani-a-siena-in-diretta-mondiale-rimozione-di-tumore-al-nervo-acustico]]></loc><lastmod>2017-08-16T13:21:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neurofibromatosi/698-neurofibromatosi-lassociazione-io-ci-sono-con-lo-ior-di-bologna-per-percorsi-assistenziali]]></loc><lastmod>2017-08-16T13:23:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/16095-neuropatia-motoria-multifocale-il-prof-nobile-orazio-non-sappiamo-se-ezio-bosso-ne-fosse-affetto]]></loc><lastmod>2020-05-24T15:37:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/14698-neuropatie-disimmuni-acquisite-quali-criticita-nella-diagnosi-e-nell-accesso-alle-terapie]]></loc><lastmod>2019-04-07T16:05:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/14667-le-neuropatie-disimmuni-acquisite-che-cosa-sono]]></loc><lastmod>2019-04-02T18:45:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/14572-neuropatie-disimmuni-acquisite-intervista-alla-sen-paola-binetti]]></loc><lastmod>2019-03-13T19:25:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/10366-rarebox-un-database-interattivo-paziente-medico-dedicato-a-due-neuropatie-rare]]></loc><lastmod>2016-04-13T16:35:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/6512-neuropatia-motoria-multifocale-si-indaga-ancora-sui-meccanismi-che-causano-la-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/5252-neuropatia-motoria-multifocale-limportanza-dei-registri-europei-di-malattia]]></loc><lastmod>2017-10-30T11:43:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/5234-neuropatia-motoria-multifocale-in-futuro-la-terapia-sara-sottocutanea-e-domiciliare]]></loc><lastmod>2017-10-30T11:49:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/5232-neuropatia-motoria-multifocale-i-criteri-diagnostici-per-la-malattia]]></loc><lastmod>2017-10-30T11:54:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/5156-neuropatia-motoria-multifocale-non-confondiamola-con-la-sla]]></loc><lastmod>2017-10-30T11:56:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/5155-neuropatia-motoria-multifocale-quale-diagnosi-e-quale-terapia]]></loc><lastmod>2017-10-30T11:59:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/5154-neuropatia-moltoria-multifocale-che-cose-e-come-e-possibile-curarla]]></loc><lastmod>2017-10-30T12:00:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/5076-neuropatia-motoria-multifocale-una-malattia-scambiata-per-sla]]></loc><lastmod>2017-10-30T12:01:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/5078-intervista-prof-eduardo-nobile-orazio]]></loc><lastmod>2015-11-06T11:09:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-motoria-multifocale/5079-neuropatia-multifocale-motoria-la-parola-al-prof-gabriele-siciliano]]></loc><lastmod>2017-10-30T19:23:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/22181-neuropatia-ottica-ereditaria-di-leber-e-sordita-un-raro-caso-di-coesistenza-clinica]]></loc><lastmod>2025-07-21T09:50:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/20632-neuropatia-ottica-ereditaria-di-leber-quali-prospettive-dalla-ricerca]]></loc><lastmod>2024-02-14T18:54:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/19997-lhon-ritirata-la-richiesta-di-commercializzazione-della-terapia-genica-in-europa]]></loc><lastmod>2023-07-12T17:09:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/19964-lhon-mitocon-chiede-ad-aifa-chiarimenti-sulla-revisione-dell-idebenone]]></loc><lastmod>2023-09-05T08:41:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/19739-neuropatia-ottica-ereditaria-di-leber-conferme-di-efficacia-per-la-terapia-genica-lenadogene-nolparvovec]]></loc><lastmod>2023-04-20T20:48:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/19376-neuropatia-ottica-ereditaria-di-leber-nuove-prospettive-grazie-alla-terapia-genica]]></loc><lastmod>2022-12-10T19:00:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/19375-neuropatia-ottica-ereditaria-di-leber-risultati-positivi-dagli-studi-di-fase-iii-sulla-terapia-genica]]></loc><lastmod>2022-12-10T18:55:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/18463-lhon-ricerca-tecnologia-e-associazioni-sono-la-chiave-per-il-futuro]]></loc><lastmod>2022-03-27T22:36:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/18464-lhon-la-testimonianza-di-rosella-la-mia-speranza-e-la-terapia-genica]]></loc><lastmod>2022-03-27T22:36:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/18340-io-sono-raro-una-poesia-per-ricordare-al-mondo-cosa-significhi-vivere-la-rarita]]></loc><lastmod>2022-02-27T12:23:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/16901-neuropatia-ottica-ereditaria-di-leber-sorprendenti-risultati-con-la-terapia-genica]]></loc><lastmod>2021-01-20T09:01:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/15135-neuropatia-ottica-ereditaria-di-leber-chiesi-acquisisce-i-diritti-sul-farmaco-idebenone]]></loc><lastmod>2019-08-26T20:34:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/14066-lhon-ancora-un-altra-condanna-per-normalita]]></loc><lastmod>2018-10-22T09:38:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/14057-lhon-condannata-perche-in-grado-di-condurre-una-vita-quasi-normale]]></loc><lastmod>2021-01-12T15:32:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/13419-lhon-il-disappunto-di-mitocon-in-merito-alla-falsa-notizia-su-paula-morandi-treu]]></loc><lastmod>2018-10-18T09:53:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/12763-neuropatie-ottiche-ancora-ai-margini-della-ricerca-come-altri-disturbi-visivi]]></loc><lastmod>2017-10-12T17:40:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/12631-neuropatia-ottica-di-leber-ok-di-aifa-al-rimborso-di-idebenone]]></loc><lastmod>2019-01-17T17:23:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/12441-fabrizio-sottile-e-il-suo-quotidiano-percorso-a-ostacoli]]></loc><lastmod>2018-10-18T09:19:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/11513-lhon-scoperta-una-nuova-mutazione-che-causa-la-neuropatia-ottica-di-leber]]></loc><lastmod>2017-03-08T14:24:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/11321-lhon-papaverina-e-zolpidem-potranno-curarla]]></loc><lastmod>2016-09-24T11:02:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/10940-lhon-al-via-anche-in-italia-la-sperimentazione-con-la-terapia-genica]]></loc><lastmod>2021-01-12T15:33:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/10937-lhon-a-bologna-parte-un-trial-randomizzato-in-doppio-cieco]]></loc><lastmod>2017-10-12T13:21:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/10729-lhon-conclusa-la-prima-fase-sperimentale-per-la-terapia-genica-negli-usa]]></loc><lastmod>2016-06-01T16:03:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/10462-lhon-il-punto-su-questa-patologia-rara]]></loc><lastmod>2020-10-07T12:23:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/10355-neuropatia-ottica-di-leber-intervista-al-dr-carelli]]></loc><lastmod>2020-10-07T12:22:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/10294-neuropatia-ottica-di-leber-benefici-visivi-dalla-sperimentazione-di-una-nuova-terapia-genica]]></loc><lastmod>2016-04-04T15:48:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/10261-cosa-vuol-dire-vivere-con-la-lhon]]></loc><lastmod>2016-03-30T07:34:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/10217-neuropatia-ottica-ereditaria-di-leber-fondamentale-la-presa-in-carico-dei-pazienti]]></loc><lastmod>2016-03-21T07:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/10215-lhon-quando-la-vista-si-spegne-all-improvviso-la-patologia-spiegata-dal-prof-carelli]]></loc><lastmod>2016-03-18T14:33:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/10221-lhon-una-diagnosi-difficile-per-la-cecita-improvvisa]]></loc><lastmod>2016-03-18T16:37:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/9778-neuropatia-di-leber-lhon-il-farmaco-raxone-ora-disponibile-per-i-pazienti-italiani]]></loc><lastmod>2018-02-15T00:14:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/9686-atrofia-ottica-ereditaria-di-leber-un-occhio-sul-futuro-terapeutico]]></loc><lastmod>2016-03-02T14:04:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/9652-neuropatia-ottica-ereditaria-di-leber-una-panoramica-sulle-prospettive-attuali]]></loc><lastmod>2016-01-27T10:01:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/8892-neuropatia-ottica-ereditaria-di-leber-lhon-autorizzata-l-immissione-in-commercio-in-europa-per-il-raxone]]></loc><lastmod>2018-02-15T00:15:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/8601-neuropatia-di-leber-ema-raccomanda-l-approvazione-del-farmaco-idebenone-in-europa]]></loc><lastmod>2015-12-28T09:41:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/928-neuropatia-ottica-di-leber-al-medea-di-conegliano-la-ricerca-grazie-a-telethon]]></loc><lastmod>2015-12-28T09:41:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/neuropatia-ottica-ereditaria-di-leber-lhon/929-neuropatia-ottica-di-leber-al-medea-di-conegliano-la-ricerca-grazie-a-telethon-77661132]]></loc><lastmod>2015-12-28T09:41:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/18618-nevralgia-del-pudendo-e-vulvodinia-presentata-proposta-di-legge-per-il-riconoscimento-delle-patologie-nei-lea]]></loc><lastmod>2022-05-06T16:46:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/7277-nevralgia-del-nervo-pudendo-come-schiaffi-nel-corpo-e-nellanima]]></loc><lastmod>2021-08-19T16:37:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/6001-nevralgia-del-nervo-pudendo-un-questionario-online-realizzato-da-ainpu-onlus-per-comprendere-la-patologia-e-aiutare-i-medici-nella-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/2505-nevralgia-del-pudendo-e-malattie-delle-pelvi-un-portale-per-facilitare-la-conoscenza]]></loc><lastmod>2016-11-29T11:32:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/2127-dolore-pelvico-cronico-il-futuro-sono-le-unita-pelviche]]></loc><lastmod>2016-11-29T11:33:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/2126-dolore-pelvico-cronico-e-neuropatia-del-pudendo-sono-patologie-reali-e-curabili]]></loc><lastmod>2016-11-29T11:33:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/1751-neuropatia-del-pudendo-la-neuromodulazione-e-sicura-ma-non-e-per-tutti]]></loc><lastmod>2016-11-29T11:34:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/1739-nevraglia-del-pudendo-ostardo-non-e-una-malattia-somatoforme-ma-reale-e-puo-essere-curata]]></loc><lastmod>2016-11-29T11:34:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/1740-nevralgia-del-pudendo-per-i-pazienti-ce-anche-la-strada-delle-neuro-modulazione]]></loc><lastmod>2016-11-29T11:34:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/921-nevralgia-del-pudendo-silvia-prima-della-diagnosi-cure-inutili-e-visite-superficiali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/867-nevralgia-del-pudendo-gianna-tante-operazioni-e-moltissimi-farmaci-alcune-terapie-le-avrei-evitate-se-avessi-incontrato-prime-altri-con-il-mio-stesso-male]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/823-nevralgia-del-pudendo-elena-il-mio-medico-mi-ha-bollato-come-ipocondriaca-la-diagnosi-dopo-10-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/824-nevralgia-del-pudendo-angelica-e-cominciato-tutto-con-una-banale-operazione-di-emorroidi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/822-nevralgia-del-pudendo-pazienti-divorati-dal-dolore-cronico-e-spesso-presi-per-pazzi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/nevralgia-del-pudendo/834-nevralgia-del-pudendo-nantonella-il-male-si-e-preso-tutta-la-mia-giovinezza-ma-alla-fine-mi-sono-ripresa-la-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/22494-osteogenesi-imperfetta-e-scuola-asitoi-servono-protocolli-chiari-per-tutelare-gli-alunni-fragili]]></loc><lastmod>2025-11-07T15:15:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/21479-luca-una-vita-con-l-osteogenesi-imperfetta-piu-che-la-disabilita-fisica-il-problema-piu-grande-e-come-la-societa-si-pone]]></loc><lastmod>2024-11-11T17:57:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/21478-osteogenesi-imperfetta-non-solo-fratture-il-vero-problema-e-il-dolore-cronico]]></loc><lastmod>2024-11-11T17:57:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/20439-osteogenesi-imperfetta-a-11-anni-bimbo-puo-finalmente-camminare-grazie-a-equipe-del-meyer]]></loc><lastmod>2023-12-14T11:28:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/20084-osteogenesi-imperfetta-setrusumab-mostra-benefici-sulla-salute-delle-ossa]]></loc><lastmod>2023-09-04T07:08:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/19777-ossa-fragili-potrebbe-trattarsi-di-osteogenesi-imperfetta]]></loc><lastmod>2023-05-05T12:19:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/18999-sono-nato-cosi-ma-non-ditelo-in-giro-il-racconto-ironico-della-vita-delle-persone-con-disabilita]]></loc><lastmod>2022-08-18T09:45:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/17747-osteogenesi-imperfetta-enzo-ha-visitato-14-stati-ma-il-diritto-alla-piena-mobilita-e-ancora-lontano]]></loc><lastmod>2021-09-05T13:28:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/16156-osteogenesi-imperfetta-a-rischio-la-filiera-di-intervento-all-umberto-i-di-roma]]></loc><lastmod>2020-06-09T23:18:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/14690-osteogenesi-imperfetta-la-storia-di-chiara-performer-che-dona-il-suo-corpo-a-servizio-della-scena]]></loc><lastmod>2019-04-05T16:57:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/12526-osteogenesi-imperfetta-in-italia-l-unica-terapia-e-il-neridronato]]></loc><lastmod>2017-07-21T12:40:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/12404-osteopatie-rare-una-continua-minaccia-di-fratture]]></loc><lastmod>2017-06-17T14:01:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/11230-osteogenesi-imperfetta-o-abusi-sui-minori-lo-chiarisce-il-test-molecolare]]></loc><lastmod>2016-09-11T10:02:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/11178-osteogenesi-imperfetta-il-pamidronato-aumenta-la-densita-minerale-ossea-e-riduce-la-frequenza-delle-fratture]]></loc><lastmod>2016-09-01T16:59:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/11162-osteogenesi-imperfetta-il-parto-cesareo-non-diminuisce-il-rischio-di-fratture-alla-nascita]]></loc><lastmod>2016-08-30T14:26:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/10983-la-battaglia-di-caterina-affetta-da-osteogenesi-imperfetta-contro-l-inps-che-rivuole-72mila-euro]]></loc><lastmod>2016-07-15T12:29:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/9957-diventare-mamma-nonostante-l-osteogenesi-si-puo-la-storia-di-sara]]></loc><lastmod>2016-02-12T14:52:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/9113-osteogenesi-imperfetta-al-via-la-prima-sperimentazione-con-cellule-staminali-in-utero]]></loc><lastmod>2016-02-10T16:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/7132-osteogenesi-imperfetta-il-trattamento-con-denosumab-e-efficace-e-sicuro-anche-a-lungo-termine]]></loc><lastmod>2016-05-06T16:17:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/6171-osteogenesi-imperfetta-e-algodistrofia-concluso-accordo-per-la-commercializzazione-del-neridronato-in-cina]]></loc><lastmod>2016-02-10T16:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/6109-osteogenesi-imperfetta-nuova-scoperta-italiana-aiuta-a-migliorare-il-trattamento-clinico]]></loc><lastmod>2019-06-18T18:18:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/5733-osteogenesi-imperfetta-le-ossa-di-cristallo-che-si-rompono-solo-a-guardarle]]></loc><lastmod>2016-02-10T16:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/5427-osteogenesi-imperfetta-teriparatide-migliora-la-formazione-ossea]]></loc><lastmod>2016-02-10T16:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/5300-osteogenesi-imperfetta-e-violenza-domestica-limportanza-di-una-corretta-diagnosi]]></loc><lastmod>2016-02-10T16:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/2626-osteogenesi-imperfetta-30-anni-di-ricerca]]></loc><lastmod>2016-02-10T16:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/974-salvina-da-25-soffro-di-diverse-malattie-tra-cui-losteogenesi-imperfetta-ma-per-ora-niente-prepensionamento]]></loc><lastmod>2016-02-10T16:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/osteogenesi-imperfetta/863-osteogenesi-imperfetta-questa-sera-fabiano-loi-racconta-la-sua-storia-a-invincibili]]></loc><lastmod>2016-02-10T16:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/22430-approvato-in-europa-nuovo-trattamento-sottocutaneo-per-la-cidp]]></loc><lastmod>2025-10-21T22:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/22283-cidp-in-piu-del-50-dei-casi-la-patologia-comporta-un-certo-grado-di-disabilita]]></loc><lastmod>2025-09-12T07:41:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/22272-nuove-prospettive-terapeutiche-per-la-cidp-il-ruolo-delle-immunoglobuline-sottocutanee]]></loc><lastmod>2025-09-03T20:19:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/22265-il-valore-delle-immunoglobuline-per-le-persone-con-cidp]]></loc><lastmod>2025-08-31T12:35:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/22208-cidp-una-patologia-disabilitante-che-necessita-una-presa-in-carico-globale]]></loc><lastmod>2025-07-25T09:52:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/22191-cidp-la-piu-comune-tra-le-neuropatie-infiammatorie-rare-fondamentale-disporre-di-tutte-le-opzioni-terapeutiche]]></loc><lastmod>2025-07-22T17:59:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/22170-plasmaderivati-e-immunoglobuline-da-takeda-una-pubblicazione-sul-valore-delle-terapie-presentata-al-senato]]></loc><lastmod>2025-07-11T06:31:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/21701-cidp-approvata-in-italia-la-terapia-sottocutanea-con-immunoglobulina-e-ialuronidasi]]></loc><lastmod>2025-02-07T10:05:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/21248-polineuropatia-demielinizzante-infiammatoria-cronica-giovanile-nel-nord-sardegna-la-frequenza-piu-alta-mai-descritta]]></loc><lastmod>2024-09-02T16:10:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/16129-neuropatie-disimmuni-cidp-italia-punta-sulla-ricerca-assegnando-due-borse-di-studio]]></loc><lastmod>2020-05-31T22:09:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/14757-polineuropatia-demielinizzante-infiammatoria-cronica-l-esperienza-svedese-di-patrizia-fino-alla-diagnosi-italiana]]></loc><lastmod>2019-04-23T17:33:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/14743-polineuropatia-demielinizzante-infiammatoria-cronica-la-grinta-di-nunzia-nonostante-la-malattia]]></loc><lastmod>2019-04-17T16:20:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/14732-polineuropatia-demielinizzante-infiammatoria-cronica-la-storia-di-moira]]></loc><lastmod>2019-04-15T15:07:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/14641-come-si-convive-con-le-neuropatie-disimmuni-la-testimonianza-di-patrizia-garzena]]></loc><lastmod>2019-03-26T16:03:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/14609-neuropatie-disimmuni-acquisite-la-campagna-lenostrestorie]]></loc><lastmod>2019-03-20T16:02:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/14558-malattie-del-sistema-nervoso-periferico-l-importanza-di-associazioni-dedicate]]></loc><lastmod>2019-03-10T18:40:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/14428-neuropatie-disimmuni-italia-al-top-per-diagnosi-ma-restano-difformita-di-cura-tra-le-regioni]]></loc><lastmod>2019-02-06T12:38:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/14426-al-via-lenostrestorie-la-campagna-di-sensibilizzazione-sulle-neuropatie-disimmuni-di-cidp-onlus]]></loc><lastmod>2019-02-06T11:21:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/14424-neuropatie-disimmuni-l-86-dei-pazienti-risponde-bene-alle-terapie]]></loc><lastmod>2019-02-05T22:17:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/14417-neuropatie-disimmuni-rare-ma-non-sconosciute-il-tempo-per-la-diagnosi-e-di-pochi-mesi]]></loc><lastmod>2019-02-05T22:18:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/13074-polineuropatia-cidp-buoni-risultati-da-studio-di-fase-iii-su-immunoglobuline-sottocute]]></loc><lastmod>2017-12-28T17:45:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/10376-rarebox-uno-strumento-per-la-condivisione-tra-medico-e-paziente-cidp]]></loc><lastmod>2016-04-13T16:05:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/6773-polineuropatia-demielinizzante-infiammatoria-cronica-cidp-da-ottobre-sara-disponibile-in-italia-la-terapia-con-privigen]]></loc><lastmod>2016-12-02T11:01:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/3939-polineuropatia-cronica-demielinizzante-cidp-ema-autorizza-la-commercializzazione-di-privigen-csl-behring]]></loc><lastmod>2016-12-02T11:02:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/3137-cidp-finalmente-giungono-dal-governo-le-risposte-per-laccesso-e-la-reperibilita-delle-cure]]></loc><lastmod>2016-04-12T14:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/2449-polineuropatia-cronica-infiammatoria-demielinizzante-cidp-alla-camera-uninterrogazione-per-laccesso-alle-immunoglobuline]]></loc><lastmod>2016-12-02T11:02:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/1641-polineuropatia-cronica-infiammatoria-demilienizzante-cidp-un-sito-web-a-disposizione-dei-pazienti]]></loc><lastmod>2016-12-02T11:02:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/cidp-polineuropatia-demielinizzante-infiammatoria-cronica/1582-polineuropatia-cidp-i-pazienti-hanno-difficolta-ad-ottenere-la-terapia-con-immunoglobuline]]></loc><lastmod>2018-11-30T16:39:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/22914-porfiria-epatica-acuta-una-malattia-che-si-nasconde-dietro-sintomi-comuni]]></loc><lastmod>2026-04-08T17:11:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/22374-porfiria-interrogazione-alla-camera-sul-riconoscimento-dellinvalidita-civile]]></loc><lastmod>2025-10-06T11:36:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/21991-giornata-mondiale-delle-porfirie-2025-monumenti-illuminati-di-viola-per-dare-voce-ai-pazienti]]></loc><lastmod>2025-05-16T15:02:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/21604-porfiria-le-ricadute-psico-sociali-della-malattia-sono-spesso-trascurate]]></loc><lastmod>2024-12-20T12:22:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/21602-vivi-porfiria-un-associazione-impegnata-a-fornire-ai-pazienti-un-supporto-a-360-gradi]]></loc><lastmod>2024-12-20T12:22:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/21589-porfiria-troppe-le-difficolta-nel-riconoscimento-dell-invalidita-civile]]></loc><lastmod>2024-12-19T08:35:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/21584-porfiria-le-tante-forme-della-patologia-rendono-complessa-la-diagnosi]]></loc><lastmod>2024-12-16T14:56:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/20966-porphyria-awareness-week-otto-giorni-per-parlare-delle-otto-forme-della-malattia]]></loc><lastmod>2024-05-13T14:12:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/20572-porfiria-epatica-acuta-il-caso-di-laila-che-aveva-perso-l-uso-di-gambe-e-braccia-a-causa-della-patologia]]></loc><lastmod>2024-02-02T12:51:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/20421-porfiria-un-webinar-per-fare-il-punto-sulla-patologia]]></loc><lastmod>2024-02-02T12:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/20033-porfiria-epatica-acuta-la-qualita-di-vita-non-dipende-solo-dalla-frequenza-degli-attacchi]]></loc><lastmod>2023-08-07T09:06:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/19724-vivi-porfiria-nella-giornata-dedicata-alla-malattia-nasce-in-italia-una-nuova-associazione]]></loc><lastmod>2023-04-19T13:50:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/19270-porfiria-l-esperienza-del-san-gallicano-piu-di-mille-pazienti-in-sessant-anni-di-attivita]]></loc><lastmod>2023-02-23T10:53:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/19247-porfiria-epatica-acuta-dopo-15-anni-roberta-ha-ricominciato-a-vivere]]></loc><lastmod>2022-11-09T16:08:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/18682-porfiria-epatica-acuta-come-e-migliorata-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2022-06-03T17:22:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/18504-porfiria-epatica-acuta-fino-a-quindici-anni-per-ottenere-una-diagnosi]]></loc><lastmod>2022-04-04T12:57:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/18091-porfiria-epatica-acuta-gli-effetti-di-givosiran-dal-laboratorio-al-letto-del-paziente]]></loc><lastmod>2021-12-12T17:37:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/17934-protoporfiria-eritropoietica-la-lotta-dei-pazienti-per-uscire-dall-ombra]]></loc><lastmod>2021-10-26T13:12:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/17876-porfiria-epatica-acuta-complesse-manifestazioni-neurologiche-trattate-con-givosiran]]></loc><lastmod>2021-10-09T19:47:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/17818-neuropatia-da-porfiria-l-importanza-della-diagnosi-differenziale]]></loc><lastmod>2021-09-26T20:49:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/17720-porfiria-epatica-acuta-troppe-persone-affette-non-sanno-di-esserlo]]></loc><lastmod>2021-08-21T11:20:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/17639-porfiria-la-lotta-di-valentina-contro-il-dolore-per-riprendere-il-mare]]></loc><lastmod>2021-07-12T11:41:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/17498-porfiria-acuta-intermittente-sintomi-cronici-anche-nelle-forme-sporadiche-e-latenti]]></loc><lastmod>2021-05-31T18:35:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/17255-porfiria-epatica-acuta-da-oggi-il-farmaco-givosiran-e-rimborsabile-in-italia]]></loc><lastmod>2021-04-03T14:34:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/17156-protoporfiria-attivo-anche-in-italia-lo-studio-di-fase-iii-sulla-molecola-mt-7117]]></loc><lastmod>2021-03-09T12:19:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/17044-porfiria-epatica-acuta-al-san-gallicano-prima-somministrazione-del-farmaco-givosiran]]></loc><lastmod>2021-02-21T13:03:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/16889-porfiria-epatica-acuta-con-givosiran-meno-attacchi-di-malattia]]></loc><lastmod>2021-01-17T21:08:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/16847-porfiria-i-sintomi-piu-comuni-durante-un-attacco-sono-convulsioni-e-disturbi-della-coscienza]]></loc><lastmod>2020-12-27T17:58:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/16775-porfiria-epatica-acuta-dalla-tecnica-rnai-un-nuovo-farmaco-a-disposizione-dei-pazienti]]></loc><lastmod>2020-12-07T18:02:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/16638-porfiria-epatica-acuta-in-media-si-verificano-sei-attacchi-l-anno]]></loc><lastmod>2020-11-04T09:30:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/16009-porfiria-epatica-acuta-una-mostra-virtuale-per-raccontare-la-malattia]]></loc><lastmod>2020-04-29T10:34:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/16008-porfiria-bisogna-essere-dei-combattenti-per-affrontare-la-malattia]]></loc><lastmod>2020-04-28T09:29:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/15994-porfiria-in-tutto-il-mondo-si-e-celebrata-la-settimana-dedicata-alla-malattia]]></loc><lastmod>2020-04-27T21:54:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/15912-porfiria-epatica-acuta-approvazione-europea-per-givosiran]]></loc><lastmod>2020-04-06T16:25:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/15621-porfiria-epatica-acuta-parere-positivo-del-chmp-per-givosiran]]></loc><lastmod>2020-02-02T22:03:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/15492-porfiria-si-e-tenuto-a-milano-il-piu-importante-congresso-internazionale]]></loc><lastmod>2019-12-12T22:44:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/15465-porfiria-epatica-acuta-givosiran-approvato-negli-stati-uniti]]></loc><lastmod>2019-12-01T21:39:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/15167-porfiria-epatica-acuta-le-infusioni-di-eme-ad-alta-frequenza-dovrebbero-essere-evitate]]></loc><lastmod>2019-09-09T13:34:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/15105-porfiria-acuta-intermittente-nonostante-il-nome-e-una-malattia-cronica]]></loc><lastmod>2019-08-06T22:18:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/14951-porfiria-epatica-acuta-in-arrivo-un-farmaco-per-trattare-i-pazienti-difficili]]></loc><lastmod>2019-06-26T08:46:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/14567-porfiria-epatica-acuta-dati-positivi-per-givosiran-nello-studio-di-fase-iii-envision]]></loc><lastmod>2019-03-12T18:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/14456-porfiria-epatica-acuta-pubblicati-i-dati-clinici-di-fase-i-su-givosiran]]></loc><lastmod>2019-02-13T16:22:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/14181-protoporfiria-eritropoietica-quando-la-luce-del-sole-fa-paura]]></loc><lastmod>2018-11-22T09:13:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/14164-porfirie-acute-la-diagnosi-e-complicata-ma-il-futuro-del-trattamento-sembra-piu-roseo]]></loc><lastmod>2018-11-18T16:53:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/14155-porfiria-l-associazione-dei-pazienti-che-combatte-contro-la-burocrazia]]></loc><lastmod>2018-11-14T21:19:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/14103-protoporfiria-eritropoietica-un-interrogazione-per-agevolare-l-accesso-all-afamelanotide]]></loc><lastmod>2018-10-31T09:40:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/14017-porfirie-epatiche-acute-risultati-positivi-per-il-farmaco-givosiran]]></loc><lastmod>2018-10-09T16:45:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/13869-porfirie-epatiche-acute-arruolamento-completato-nello-studio-di-fase-iii-su-givosiran]]></loc><lastmod>2018-08-29T15:40:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/13738-porfiria-o-ma-r-inaugura-il-servizio-l-esperto-risponde]]></loc><lastmod>2018-07-12T07:39:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/13516-porfirie-epatiche-acute-givosiran-riduce-dell-83-gli-attacchi]]></loc><lastmod>2018-05-04T15:39:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/13508-porfirie-a-padova-pazienti-e-medici-a-confronto]]></loc><lastmod>2018-05-02T15:41:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/13335-porfirie-al-congresso-mondiale-il-punto-sulle-ultime-scoperte]]></loc><lastmod>2018-03-13T23:14:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/13106-porfirie-epatiche-acute-le-linee-guida-del-national-institutes-of-health]]></loc><lastmod>2018-01-15T22:28:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/12932-porfirie-acute-l-impegno-della-simi-per-la-formazione-dei-medici]]></loc><lastmod>2017-11-21T16:29:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/12871-porfirie-epatiche-acute-alnylam-avvia-studio-di-fase-iii-su-givosiran]]></loc><lastmod>2017-11-08T18:24:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/12632-porfiria-una-malattia-multiforme-con-meccanismi-e-sintomi-differenti]]></loc><lastmod>2017-09-09T15:17:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/12370-porfiria-givosiran-tra-i-protagonisti-del-prossimo-congresso-icpp]]></loc><lastmod>2017-06-19T14:58:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/12369-protoporfiria-il-caso-scenesse-ancora-aperto-avere-la-terapia-dipende-dalla-regione-di-appartenenza]]></loc><lastmod>2017-06-19T14:59:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/12353-porfiria-epatica-acuta-fda-riconosce-l-innovativita-di-givosiran]]></loc><lastmod>2017-06-19T14:59:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/12012-porfirie-acute-epatiche-il-farmaco-givosiran-inserito-dall-ema-nel-programma-prime]]></loc><lastmod>2017-06-19T14:59:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/11039-protoporfiria-eritropoietica-san-gallicano-di-roma-garantisce-la-distribuzione-del-farmaco]]></loc><lastmod>2017-06-19T15:00:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/10921-protoporfiria-eritropoietica-i-pazienti-rimasti-senza-farmaco-l-intervento-di-aifa]]></loc><lastmod>2017-04-05T15:44:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/8642-protoporfiria-eritropoietica-dati-clinici-incoraggianti-dall-impiego-di-afamelanotide]]></loc><lastmod>2017-04-05T15:45:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/7084-protoporfiria-eritropoietica-lema-da-il-via-libera-al-primo-farmaco]]></loc><lastmod>2017-04-05T15:47:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/7021-protoporfiria-eritropoietica-il-chmp-dellema-dice-si-al-farmaco-a-base-di-afamelanotide]]></loc><lastmod>2017-04-05T15:49:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/6406-porfiria-acuta-intermittente-in-via-di-sperimentazione-una-nuova-terapia-genica]]></loc><lastmod>2019-06-18T18:07:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/4998-malattia-di-guenther-nuove-potenziali-strategie-terapeutiche-da-uno-studio-spagnolo]]></loc><lastmod>2019-06-19T08:11:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/4263-porfiria-una-nuova-possibilita-terapeutica-grazie-alla-tecnica-di-rna-interference]]></loc><lastmod>2017-04-05T15:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/2112-protoprofiria-eritopoietica-epp-in-svizzera-approvato-il-trattamento-profilattico]]></loc><lastmod>2017-04-05T15:57:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porfiria/37-protoporfiria-eritropoietica-uno-spiraglio-di-luce-per-i-malati-al-san-gallicano-raggiunta-una-tappa-storica-nella-terapia]]></loc><lastmod>2017-04-05T16:03:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/21199-porpora-trombotica-trombocitopenica-la-risposta-del-ministero-su-linee-guida]]></loc><lastmod>2024-07-26T07:29:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/20000-porpora-trombotica-trombocitopenica-alla-camera-un-interrogazione-per-applicazione-e-monitoraggio-delle-linee-guida]]></loc><lastmod>2023-07-13T15:21:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/19641-porpora-trombotica-trombocitopenica-una-diagnosi-tempestiva-puo-salvare-la-vita-del-paziente]]></loc><lastmod>2023-03-20T20:07:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/18884-porpora-trombotica-trombocitopenica-le-storie-e-i-bisogni-dei-pazienti-raccontati-in-un-convegno]]></loc><lastmod>2022-07-05T11:27:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/18862-porpora-trombotica-trombocitopenica-acquisita-il-dosaggio-dell-enzima-adamts13-e-l-unico-modo-per-una-diagnosi-tempestiva]]></loc><lastmod>2022-07-01T13:52:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/18766-porpora-trombotica-trombocitopenica-acquisita-nuove-linee-guida-dalla-societa-italiana-di-ematologia]]></loc><lastmod>2024-07-02T12:24:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/18104-porpora-trombotica-trombocitopenica-acquisita-l-appello-dei-pazienti-alle-istituzioni-fissare-una-giornata-nazionale]]></loc><lastmod>2021-12-16T11:46:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/15603-porpora-trombotica-trombocitopenica-acquisita-disponibile-in-italia-la-prima-terapia-specifica]]></loc><lastmod>2020-01-25T15:14:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/15512-porpora-attp-un-nuovo-farmaco-e-la-possibilita-di-gravidanza-miglioreranno-la-vita-dei-pazienti]]></loc><lastmod>2019-12-14T19:42:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/14810-porpora-trombotica-trombocitopenica-acquisita-alto-tasso-di-recidive-ed-elevata-mortalita]]></loc><lastmod>2019-10-31T18:47:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/14363-porpora-trombotica-trombocitopenica-acquisita-nuovi-dati-positivi-su-caplacizumab]]></loc><lastmod>2019-10-31T18:52:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/13911-porpora-trombotica-trombocitopenica-acquisita-caplacizumab-approvato-in-europa]]></loc><lastmod>2019-10-31T18:51:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/10856-porpora-trombotica-trombocitopenica-acquisita-caplacizumab-induce-una-piu-rapida-risoluzione-dell-episodio-acuto]]></loc><lastmod>2019-08-30T14:23:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/porpora-trombotica-trombocitopenica-acquisita/10000-porpora-trombotica-trombocitopenica-indagata-nuova-opzione-terapeutica-per-la-malattia-in-fase-acuta]]></loc><lastmod>2019-08-30T14:50:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/22943-pseudo-ostruzione-intestinale-cronica-cosa-dicono-le-nuove-raccomandazioni-internazionali]]></loc><lastmod>2026-04-19T22:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/22843-pseudo-ostruzione-intestinale-pediatrica-elia-e-la-storia-della-sua-rinascita]]></loc><lastmod>2026-03-13T17:24:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/22748-pseudo-ostruzione-intestinale-cronica-la-nutrizione-artificiale-come-terapia-salvavita]]></loc><lastmod>2026-02-12T18:29:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/22402-pseudo-ostruzione-intestinale-cronica-da-esperti-italiani-una-guida-pratica-per-terapie-piu-mirate]]></loc><lastmod>2025-10-15T17:26:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/21630-pseudo-ostruzione-intestinale-cronica-una-malattia-che-distrugge-il-rapporto-con-il-cibo]]></loc><lastmod>2025-01-16T19:24:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/21405-pseudo-ostruzione-intestinale-cronica-da-una-chirurgia-demolitiva-a-una-piu-conservativa]]></loc><lastmod>2024-10-19T10:15:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/20845-pseudo-ostruzione-intestinale-cronica-una-malattia-tanto-crudele-quanto-invisibile]]></loc><lastmod>2024-04-10T07:38:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/20664-la-storia-di-veronica-la-malattia-e-nascosta-nel-mio-zaino]]></loc><lastmod>2024-02-21T15:10:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/20480-pseudo-ostruzione-intestinale-cronica-all-universita-di-ferrara-si-studia-il-ruolo-del-gene-rad21]]></loc><lastmod>2023-12-22T18:18:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/19431-pseudo-ostruzione-intestinale-cronica-convivo-con-una-patologia-devastante-ma-la-mia-arma-e-il-sorriso]]></loc><lastmod>2023-01-11T12:47:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/18796-pseudo-ostruzione-intestinale-cronica-la-mia-vita-con-lo-zaino-per-la-nutrizione-parenterale]]></loc><lastmod>2026-02-09T14:45:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/18560-pseudo-ostruzione-intestinale-cronica-con-la-nutrizione-artificiale-ho-potuto-riguadagnare-la-mia-vita]]></loc><lastmod>2022-04-15T22:38:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/18384-pseudo-ostruzione-intestinale-cronica-serve-piu-consapevolezza-e-conoscenza-della-patologia]]></loc><lastmod>2022-03-08T11:25:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/pseudo-ostruzione-intestinale-cronica/18137-pseudo-ostruzione-intestinale-cronica-quando-l-intestino-si-blocca-senza-una-causa-organica]]></loc><lastmod>2024-10-17T15:08:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/22447-giornata-mondiale-della-psoriasi-e-tempo-di-riconoscere-la-giusta-dignita-alla-patologia]]></loc><lastmod>2025-10-28T15:21:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/22331-psoriasi-pustolosa-generalizzata-una-patologia-della-pelle-potenzialmente-letale]]></loc><lastmod>2025-09-23T19:45:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/21771-psoriasi-pustolosa-generalizzata-arriva-in-italia-la-prima-terapia-specifica-per-questa-patologia]]></loc><lastmod>2025-03-03T12:07:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/21724-psoriasi-pustolosa-generalizzata-spesolimab-rimborsabile-in-italia]]></loc><lastmod>2025-02-13T18:26:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/21655-psoriasi-pustolosa-generalizzata-necessario-migliorare-e-uniformare-il-percorso-di-cura-del-paziente]]></loc><lastmod>2025-01-23T09:28:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/21528-psoriasi-pustolosa-generalizzata-necessaria-un-azione-di-sensibilizzazione-a-360-gradi]]></loc><lastmod>2024-11-26T19:07:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/21452-psoriasi-pressing-di-apiafco-per-l-inserimento-della-patologia-nel-piano-nazionale-cronicita]]></loc><lastmod>2024-11-01T18:40:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/21370-psoriasi-pustolosa-generalizzata-le-priorita-diagnosi-precoce-e-accesso-a-trattamento-mirato]]></loc><lastmod>2024-10-08T17:09:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/21355-psoriasi-apiafco-rinnova-l-appello-ad-inserire-la-patologia-nel-piano-nazionale-cronicita]]></loc><lastmod>2024-10-04T10:38:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/21132-psoriasi-pustolosa-generalizzata-una-malattia-che-pesa-sui-pazienti-e-sul-sistema-sanitario]]></loc><lastmod>2024-07-02T18:20:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/20677-la-pelle-nascosta-il-racconto-di-una-vita-con-la-psoriasi-pustolosa]]></loc><lastmod>2024-02-26T19:52:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/20430-psoriasi-pustolosa-generalizzata-individuati-i-punti-di-intervento-per-migliorare-la-gestione-della-malattia]]></loc><lastmod>2023-12-11T15:41:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/20295-psoriasi-per-chi-ne-e-affetto-parlare-della-malattia-e-anche-una-cura]]></loc><lastmod>2023-11-06T11:12:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/20260-giornata-mondiale-della-psoriasi-uniti-per-un-equo-accesso-ai-trattamenti]]></loc><lastmod>2023-10-27T12:01:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/20142-psoriasi-pustolosa-generalizzata-l-arte-e-la-moda-in-mostra-a-milano-per-raccontare-il-vissuto-dei-pazienti-che-convivono-con-una-malattia-rara]]></loc><lastmod>2023-09-22T06:58:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/19996-malattie-rare-senza-esenzione-c-e-anche-la-psoriasi-pustolosa-generalizzata]]></loc><lastmod>2023-07-12T16:33:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/19962-psoriasi-pustolosa-generalizzata-nasce-un-alleanza-tra-associazioni-esperti-e-istituzioni]]></loc><lastmod>2023-06-28T16:37:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/19879-psoriasi-pustolosa-generalizzata-l-osservazione-clinica-e-la-chiave-per-una-corretta-diagnosi]]></loc><lastmod>2023-06-09T14:22:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/19843-psoriasi-pustolosa-generalizzata-una-malattia-imprevedibile]]></loc><lastmod>2023-05-29T21:37:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/19842-psoriasi-un-sondaggio-apiafco-fotografa-il-vissuto-dei-pazienti]]></loc><lastmod>2023-05-26T12:30:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/psoriasi-pustolosa-generalizzata/19593-psoriasi-pustolosa-generalizzata-spesso-inefficaci-le-terapie-che-funzionano-per-altre-forme-di-psoriasi]]></loc><lastmod>2023-03-07T09:47:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/purpura-fulminans]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/purpura-fulminans/13275-purpura-fulminans-neonatale-scoperta-una-nuova-mutazione]]></loc><lastmod>2018-02-25T11:24:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/purpura-fulminans/13245-purpura-fulminans-un-processo-di-necrosi-rapido-e-irreversibile]]></loc><lastmod>2018-02-19T00:26:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/purpura-fulminans/13062-purpura-fulminans-il-quadro-clinico-del-paziente-in-shock-settico]]></loc><lastmod>2017-12-23T12:04:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/purpura-fulminans/13054-le-tre-forme-della-purpura-fulminans-neonatale-autoimmune-e-acquisita]]></loc><lastmod>2017-12-22T10:20:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/purpura-fulminans/12894-purpura-fulminans-il-tempo-e-vita]]></loc><lastmod>2017-11-13T11:39:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/purpura-fulminans/12873-purpura-fulminans-la-temibile-complicanza-di-un-infezione]]></loc><lastmod>2017-11-14T21:00:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/21420-ipofosfatemia-legata-all-x-importante-non-sottovalutare-le-problematiche-dentali-associate]]></loc><lastmod>2024-10-24T08:36:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/21209-ipofosfatemia-legata-alla-x-al-via-l-edizione-2024-di-shine-a-light-on-xlh]]></loc><lastmod>2024-07-30T09:35:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/21145-ipofosfatemia-legata-all-x-la-patologia-va-gestita-in-un-ottica-multidisciplinare]]></loc><lastmod>2024-07-04T08:54:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/20827-ipofosfatemia-legata-all-x-aismme-offre-sostegno-psicologico-con-il-progetto-aurora-xlh]]></loc><lastmod>2024-04-03T14:42:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/20246-ipofosfatemia-legata-all-x-oggi-e-la-giornata-mondiale]]></loc><lastmod>2023-10-20T12:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/19767-ipofosfatemia-legata-all-x-ora-anche-per-gli-adulti-c-e-una-terapia-mirata-alla-causa-della-patologia]]></loc><lastmod>2023-05-02T18:30:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/19674-ipofosfatemia-legata-all-x-burosumab-disponibile-in-italia-anche-per-pazienti-adulti]]></loc><lastmod>2023-03-30T10:32:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/19606-therareside-2023-un-rapporto-speciale-la-storia-di-sara]]></loc><lastmod>2023-03-10T09:36:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/19399-ipofosfatemia-legata-all-x-al-paziente-adulto-va-garantito-un-adeguato-modello-di-presa-in-carico]]></loc><lastmod>2022-12-18T17:30:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/19222-ipofosfatemia-legata-all-x-arriva-anche-in-italia-la-campagna-shine-a-light-on-xlh]]></loc><lastmod>2022-10-28T09:42:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/18991-ipofosfatemia-legata-all-x-aismme-attiva-un-servizio-psicologico-a-distanza]]></loc><lastmod>2022-08-10T14:45:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/18527-rachitismo-ipofosfatemico-autosomico-recessivo-di-tipo-2-laura-a-13-anni-avevo-gia-subito-7-interventi-alle-gambe]]></loc><lastmod>2022-04-09T20:35:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/18485-ipofosfatemia-legata-all-x-la-forza-di-sara-nonostante-la-fragilita-delle-sue-ossa]]></loc><lastmod>2022-03-31T09:05:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/18350-giornata-mondiale-delle-malattie-rare-kyowa-kirin-rinnova-l-impegno-per-la-cura-dell-ipofosfatemia-legata-all-x]]></loc><lastmod>2022-02-28T15:05:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/18172-rachitismo-ipofosfatemico-autosomico-recessivo-di-tipo-2-una-malattia-difficile-da-diagnosticare]]></loc><lastmod>2022-01-15T15:28:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/18048-ipofosfatemia-legata-all-x-nuovi-dati-confermano-i-benefici-a-lungo-termine-di-burosumab-negli-adulti]]></loc><lastmod>2021-11-27T23:21:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/17923-ipofosfatemia-legata-all-x-il-23-ottobre-si-celebra-la-giornata-mondiale]]></loc><lastmod>2021-10-22T18:35:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/17922-ipofosfatemia-legata-all-x-problematiche-ancora-aperte-nella-gestione-del-paziente]]></loc><lastmod>2021-10-22T18:27:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/17887-rachitismo-ipofosfatemico-toscana-e-campania-presentano-in-anteprima-il-modello-di-ptda]]></loc><lastmod>2021-10-15T13:59:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/17487-ipofosfatemia-legata-all-x-il-caso-della-numerosa-famiglia-di-brindisi]]></loc><lastmod>2021-08-30T14:17:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/17560-ipofosfatemia-legata-all-x-i-pazienti-pagano-un-esame-che-dovrebbe-essere-gratuito]]></loc><lastmod>2021-06-23T07:27:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/17559-ipofosfatemia-legata-all-x-da-una-terapia-sintomatica-a-una-eziologica]]></loc><lastmod>2021-06-24T09:46:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/17474-xlh-parere-positivo-dal-chmp-per-l-autosomministrazione-di-burosumab]]></loc><lastmod>2021-07-22T17:04:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/17043-ipofosfatemia-legata-all-x-lanciata-la-campagna-shine-a-light-on-xlh]]></loc><lastmod>2021-03-17T18:55:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/16589-ipofosfatemia-legata-all-x-oggi-ricorre-la-giornata-mondiale]]></loc><lastmod>2020-10-19T14:26:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/16537-ipofosfatemia-legata-all-x-burosumab-approvato-in-europa-anche-per-pazienti-adulti]]></loc><lastmod>2020-10-07T09:21:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/16358-ipofosfatemia-legata-all-x-dal-chmp-parere-favorevole-all-estensione-d-uso-di-burosumab]]></loc><lastmod>2020-08-03T13:51:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/16200-ipofosfatemia-legata-all-x-burosumab-piu-sicuro-ed-efficace-della-terapia-convenzionale]]></loc><lastmod>2020-06-21T19:18:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/16096-ipofosfatemia-legata-all-x-disponibile-un-servizio-di-terapia-domiciliare]]></loc><lastmod>2020-05-24T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/15689-ipofosfatemia-legata-all-x-esperti-italiani-a-convegno-per-parlare-di-diagnosi-e-terapia]]></loc><lastmod>2020-02-23T23:30:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/15423-ipofosfatemia-legata-all-x-una-malattia-con-implicazioni-endocrine-renali-e-ossee]]></loc><lastmod>2019-11-19T19:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/15363-rachitismo-ipofosfatemico-al-via-su-omar-il-servizio-l-esperto-risponde]]></loc><lastmod>2019-10-30T21:08:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/15359-ipofosfatemia-legata-all-x-via-libera-di-aifa-all-impiego-di-burosumab]]></loc><lastmod>2019-10-29T17:59:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/15078-ipofosfatemia-legata-all-x-le-criticita-diagnosi-ritardate-e-pochi-centri-specializzati]]></loc><lastmod>2019-07-28T21:06:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/15050-ipofosfatemia-legata-all-x-omar-lancia-l-iniziativa-xlh-raccontaci-la-tua-storia]]></loc><lastmod>2019-07-21T18:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/14953-ipofosfatemia-legata-all-x-il-23-giugno-si-e-svolta-la-prima-giornata-mondiale]]></loc><lastmod>2021-10-23T14:10:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/14697-ipofosfatemia-legata-all-x-nuovi-dati-di-fase-iii-confermano-l-efficacia-di-burosumab]]></loc><lastmod>2019-04-07T15:44:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/14250-ipofosfatemia-legata-all-x-online-c-e-anche-un-gruppo-facebook-di-pazienti]]></loc><lastmod>2018-12-07T09:42:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/14176-ipofosfatemia-legata-all-x-ora-in-italia-c-e-l-associazione-aifosf]]></loc><lastmod>2018-12-07T09:48:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/14147-ipofosfatemia-legata-all-x-la-proteina-fgf23-e-le-nuove-prospettive-terapeutiche]]></loc><lastmod>2018-12-07T09:43:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/14134-ipofosfatemia-legata-all-x-accade-che-sia-scambiata-per-carenza-di-vitamina-d]]></loc><lastmod>2018-12-07T09:44:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/14120-ipofosfatemia-legata-all-x-dall-albania-all-italia-per-potersi-curare]]></loc><lastmod>2018-12-07T09:44:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/14087-ipofosfatemia-legata-all-x-come-si-vive-tra-dolori-malformazioni-e-interventi-chirurgici]]></loc><lastmod>2018-12-07T09:47:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/14086-ipofosfatemia-legata-all-x-i-medici-mi-dicevano-che-il-rachitismo-in-italia-non-esisteva-piu]]></loc><lastmod>2018-12-14T17:39:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/13938-un-nuovo-farmaco-in-commercio-e-altri-in-via-di-sviluppo-kyowa-kirin-entra-nel-settore-malattie-rare]]></loc><lastmod>2019-06-22T16:40:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/13912-ipofosfatemia-legata-all-x-in-inghilterra-via-libera-all-impiego-di-burosumab]]></loc><lastmod>2018-09-11T18:03:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/13701-rachitismo-ipofosfatemico-legato-all-x-le-prospettive-del-trattamento-con-burosumab]]></loc><lastmod>2018-06-25T15:12:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/13646-ipofosfatemia-legata-all-x-pubblicati-i-risultati-clinici-di-burosumab]]></loc><lastmod>2019-01-17T15:42:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/13614-ipofosfatemia-legata-all-x-burosumab-superiore-alla-terapia-standard]]></loc><lastmod>2019-01-23T12:28:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/13592-rachitismo-ipofosfatemico-legato-all-x-a-firenze-un-trial-sul-farmaco-burosumab]]></loc><lastmod>2018-05-26T14:36:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/13542-rachitismo-ipofosfatemico-legato-all-x-approvazione-usa-per-burosumab]]></loc><lastmod>2019-01-17T15:52:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/13400-rachitismo-ipofosfatemico-legato-all-x-burosumab-approvato-in-europa]]></loc><lastmod>2018-04-01T08:39:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/13048-ipofosfatemia-legata-all-x-parere-positivo-del-chmp-per-burosumab]]></loc><lastmod>2018-03-31T02:27:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/11810-ipofosfatemia-x-linked-l-ema-valutera-l-immissione-in-commercio-di-krn23]]></loc><lastmod>2018-03-31T02:27:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/7924-ipofosfatemia-x-linked-presentati-i-risultati-del-sondaggio-condotto-da-ultragenyx]]></loc><lastmod>2018-03-31T02:28:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/5538-rachitismo-ipofosfatemico-resistente-alla-vitamina-d-la-storia-a-lieto-fine-del-piccolo-francesco]]></loc><lastmod>2018-03-31T02:28:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/rachitismo-ipofosfatemico/3815-rachitismo-studio-internazionale-scopre-il-ruolo-dellosteopontina]]></loc><lastmod>2018-03-31T02:29:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22953-sla-con-recross-un-corso-da-80-ore-e-un-manuale-europeo-sullassistenza-domiciliare]]></loc><lastmod>2026-04-22T17:28:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22769-sla-e-scomparso-eric-dane-lattore-che-aveva-scelto-di-raccontare-la-malattia]]></loc><lastmod>2026-02-20T09:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22764-sla-pubblicato-il-nuovo-bando-per-la-ricerca-di-fondazione-arisla]]></loc><lastmod>2026-02-17T16:54:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22584-sclerosi-laterale-amiotrofica-da-arisla-830mila-euro-per-6-nuovi-progetti-di-studio]]></loc><lastmod>2025-12-05T11:56:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22481-sla-in-basilicata-ripristinato-lassegno-di-cura]]></loc><lastmod>2025-11-06T15:54:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22472-basilicata-senza-fondo-per-la-sla-aisla-si-condanna-alla-solitudine-chi-lotta-per-vivere]]></loc><lastmod>2025-10-31T15:47:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22423-sla-il-dna-libero-circolante-come-nuova-frontiera-per-la-diagnosi-precoce]]></loc><lastmod>2025-10-22T09:19:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22404-sla-incoraggianti-i-dati-clinici-di-fase-ii-sullanticorpo-ap-101]]></loc><lastmod>2025-10-13T17:02:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22303-giornata-nazionale-della-sla-ledizione-2025-entra-nella-storia]]></loc><lastmod>2025-09-15T17:23:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22254-sla-proteomica-e-intelligenza-artificiale-per-una-diagnosi-precoce]]></loc><lastmod>2025-08-25T12:52:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22221-aisla-incontra-la-regione-basilicata-nasce-un-percorso-partecipato-per-la-sla]]></loc><lastmod>2025-07-29T08:20:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22106-sla-global-day-2025-aisla-guida-la-mobilitazione-nazionale-con-eventi-in-tutta-italia]]></loc><lastmod>2025-06-18T17:34:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22109-la-coalizione-italiana-per-la-sla-presente-all-encals-meeting-2025-di-torino]]></loc><lastmod>2025-06-20T12:01:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/22037-sla-sorprendenti-risultati-dall-uso-compassionevole-del-farmaco-sperimentale-ulefnersen]]></loc><lastmod>2025-05-30T17:59:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21774-sla-e-demenza-individuato-il-meccanismo-che-protegge-la-proteina-tdp-43-dallo-stress]]></loc><lastmod>2025-03-04T19:34:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21745-sla-arisla-pubblica-il-bando-2025-per-la-ricerca]]></loc><lastmod>2025-02-22T11:21:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21615-sla-interfacce-cervello-computer-per-ridare-voce-ai-pazienti]]></loc><lastmod>2025-01-09T10:17:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21570-la-neonata-coalizione-italiana-per-la-sla-presente-al-simposio-internazionale-sulla-patologia]]></loc><lastmod>2024-12-11T20:26:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21564-sla-tre-motivi-per-cui-il-test-genetico-e-essenziale]]></loc><lastmod>2024-12-06T18:31:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21552-sla-fondamentale-una-presa-in-carico-precoce-e-multidisciplinare]]></loc><lastmod>2024-12-03T18:58:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21545-sla-arisla-annuncia-nuovo-finanziamento-di-840mila-euro-per-la-ricerca]]></loc><lastmod>2024-12-02T15:49:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21451-sla-a-pollenzo-un-convegno-su-metabolismo-e-nutrizione]]></loc><lastmod>2024-11-01T18:50:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21287-sla-fondamentale-la-collaborazione-tra-le-comunita-dei-pazienti-e-dei-ricercatori]]></loc><lastmod>2024-09-16T10:26:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21286-sla-il-14-e-15-settembre-torna-la-giornata-nazionale-dedicata-alla-patologia]]></loc><lastmod>2024-09-16T09:51:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21276-sla-uno-speciale-ricettario-per-restituire-ai-pazienti-la-gioia-della-tavola]]></loc><lastmod>2024-09-10T17:16:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21268-sla-dagli-usa-un-importante-finanziamento-al-lavoro-di-ricerca-del-prof-marco-peviani]]></loc><lastmod>2024-09-07T17:10:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21228-aisla-si-trasforma-in-aps-e-annuncia-la-xvii-giornata-nazionale-sla]]></loc><lastmod>2024-08-09T18:41:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21093-sla-oggi-la-giornata-mondiale-la-notizia-svelata-una-delle-possibili-cause-della-malattia]]></loc><lastmod>2024-06-18T17:19:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21082-giornata-mondiale-della-sla-le-iniziative-organizzate-da-aisla-in-tutta-italia]]></loc><lastmod>2024-06-14T11:10:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21056-sla-studio-italiano-rivela-bisogni-e-priorita-dei-pazienti]]></loc><lastmod>2024-06-07T13:06:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21061-sla-i-centri-nemo-dimostrano-l-impatto-positivo-di-tofersen]]></loc><lastmod>2024-06-07T17:16:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21033-sclerosi-laterale-amiotrofica-approvazione-europea-per-tofersen]]></loc><lastmod>2024-05-31T08:51:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21022-sclerosi-laterale-amiotrofica-sla-in-puglia-approvata-una-legge-per-lo-screening-genetico]]></loc><lastmod>2024-05-29T15:34:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/21015-sla-nasce-la-piu-grande-fonte-di-dati-sulla-patologia]]></loc><lastmod>2024-05-24T16:31:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20989-sla-in-calabria-un-innovativo-programma-di-formazione-per-professionisti-sanitari]]></loc><lastmod>2024-05-20T07:05:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20914-sla-arriva-l-ok-del-ministero-della-giustizia-sul-diritto-alla-comunicazione-non-verbale]]></loc><lastmod>2024-04-24T15:09:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20898-sla-al-via-studio-nazionale-sulla-relazione-tra-genetica-e-ambiente-nello-sviluppo-della-malattia]]></loc><lastmod>2024-04-22T14:35:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20833-sla-negativi-i-risultati-dello-studio-di-fase-iii-sull-acido-tauroursodesossicolico]]></loc><lastmod>2024-04-04T10:48:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20790-sla-disponibile-in-italia-la-nuova-formulazione-orodispersibile-di-riluzolo]]></loc><lastmod>2024-03-21T18:37:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20754-sla-deludenti-i-risultati-di-fase-iii-su-amx0035]]></loc><lastmod>2024-03-14T18:15:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20735-sla-al-via-il-bando-arisla-2024-per-la-ricerca]]></loc><lastmod>2024-03-08T18:05:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20734-8-marzo-aisla-valorizza-il-ruolo-delle-donne-caregiver]]></loc><lastmod>2024-03-08T22:59:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20698-sla-al-meeting-encals-verranno-presentati-i-dati-di-fase-iii-sull-acido-tauroursodesossicolico]]></loc><lastmod>2024-02-28T17:37:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20684-sclerosi-laterale-amiotrofica-ema-raccomanda-l-approvazione-del-farmaco-tofersen]]></loc><lastmod>2024-02-27T09:56:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20605-sclerosi-laterale-amiotrofica-oltre-400-ospiti-all-evento-uno-slavadent-alla-sla]]></loc><lastmod>2024-02-08T09:47:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20600-sla-percorsi-assistenziali-e-cure-domiciliari-sono-i-bisogni-principali-dei-pazienti]]></loc><lastmod>2024-02-07T14:26:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20565-sla-le-scarse-terapie-attualmente-disponibili-e-il-percorso-dei-pazienti-dopo-la-diagnosi]]></loc><lastmod>2024-01-29T20:47:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20553-sla-presentato-il-manifesto-sui-bisogni-di-pazienti-e-familiari]]></loc><lastmod>2024-01-25T09:55:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20554-sla-verso-una-coalizione-italiana-contro-la-patologia]]></loc><lastmod>2024-01-25T09:54:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20548-sla-aisla-presenta-la-nuova-commissione-medico-scientifica]]></loc><lastmod>2024-01-24T16:51:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20512-sla-da-arisla-un-milione-di-euro-per-7-nuovi-progetti-di-studio]]></loc><lastmod>2024-01-12T16:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20501-sla-quasi-un-milione-di-dollari-per-la-ricerca-su-un-nuovo-farmaco-la-sperimentazione-anche-in-italia]]></loc><lastmod>2024-01-10T09:16:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20360-sla-aisla-promuove-la-gentilezza-di-cura-a-il-tempo-della-salute]]></loc><lastmod>2023-11-20T14:01:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20265-sla-comprendere-i-meccanismi-dell-invecchiamento-per-combattere-la-patologia]]></loc><lastmod>2023-10-27T18:04:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20243-sla-l-ema-conferma-il-proprio-no-al-farmaco-amx0035]]></loc><lastmod>2023-10-18T16:56:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20117-sla-necessario-indagare-a-fondo-le-manifestazioni-non-motorie-della-malattia]]></loc><lastmod>2023-09-18T09:57:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20119-sla-il-17-settembre-e-la-giornata-nazionale]]></loc><lastmod>2023-09-18T09:56:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20116-sla-concluso-lo-studio-di-fase-iii-sull-acido-tauroursodesossicolico]]></loc><lastmod>2023-09-15T09:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20078-sassari-malato-di-sla-da-un-anno-senza-comunicatore-oculare-ma-la-asl-smentisce-non-puo-usarlo]]></loc><lastmod>2023-08-31T18:22:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20068-sla-identificata-firma-molecolare-per-la-diagnosi-della-patologia]]></loc><lastmod>2023-08-24T16:43:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/20064-sla-la-rivista-frontiers-pubblica-articolo-sul-positivo-impatto-della-ricerca-targata-arisla]]></loc><lastmod>2023-08-23T16:57:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19986-sla-paziente-italiano-sottoposto-con-successo-a-un-intervento-di-cataratta]]></loc><lastmod>2023-07-10T10:40:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19973-sla-la-regione-calabria-accoglie-l-appello-di-aisla-per-un-adeguata-presa-in-carico-delle-famiglie]]></loc><lastmod>2023-07-07T14:36:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19968-sla-da-ema-parere-negativo-in-merito-all-approvazione-di-amx0035]]></loc><lastmod>2023-07-01T15:51:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19924-sla-la-denuncia-dell-associazione-viva-la-vita-a-roma-una-famiglia-abbandonata-dal-sistema]]></loc><lastmod>2023-06-20T13:48:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19911-sla-global-day-da-osservatorio-arisla-emerge-un-quadro-positivo-sulla-ricerca-italiana]]></loc><lastmod>2023-06-19T10:47:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19909-sla-il-ruolo-del-caregiver-donna-in-un-evento-dedicato]]></loc><lastmod>2023-06-19T10:43:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19897-sla-ema-potrebbe-dire-no-al-farmaco-amx0035-le-associazioni-protestano]]></loc><lastmod>2023-06-14T07:44:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19882-sla-il-21-giugno-e-la-giornata-mondiale]]></loc><lastmod>2023-06-12T10:18:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19870-sla-conoscere-la-malattia-per-massimizzare-l-efficacia-dei-trial-clinici]]></loc><lastmod>2023-06-04T13:23:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19783-sclerosi-laterale-amiotrofica-nasce-l-associazione-slafood]]></loc><lastmod>2023-05-10T14:44:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19779-sclerosi-laterale-amiotrofica-aisla-compie-40-anni-di-attivita]]></loc><lastmod>2023-05-08T10:24:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19770-sla-studio-clinico-italiano-valuta-le-potenzialita-terapeutiche-del-trapianto-di-microbiota-intestinale]]></loc><lastmod>2023-05-05T07:33:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19775-sla-pubblicate-le-nuove-guida-valutative-inps-per-invalidita-e-legge-104]]></loc><lastmod>2023-05-31T11:58:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19754-sclerosi-laterale-amiotrofica-il-farmaco-tofersen-approvato-negli-stati-uniti]]></loc><lastmod>2023-04-26T15:08:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19727-sclerosi-laterale-amiotrofica-al-via-anche-in-italia-lo-studio-clinico-fusion]]></loc><lastmod>2023-04-20T19:48:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19655-turista-affetta-da-sla-bloccata-in-stazione-metro-impossibile-per-lei-raggiungere-il-colosseo]]></loc><lastmod>2023-03-22T10:58:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19623-sclerosi-laterale-amiotrofica-nasce-aisla-lazio]]></loc><lastmod>2023-03-12T10:24:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19566-giornata-mondiale-malattie-rare-arisla-lancia-la-campagna-ricercaepresente]]></loc><lastmod>2023-02-23T16:05:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19527-sclerosi-laterale-amiotrofica-quali-prospettive-in-ambito-diagnostico]]></loc><lastmod>2023-02-12T18:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19373-sclerosi-laterale-amiotrofica-al-via-la-campagna-my-voice]]></loc><lastmod>2022-12-10T18:34:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19358-sla-oltre-200mila-euro-erogati-nel-2022-con-l-operazione-sollievo-di-aisla]]></loc><lastmod>2022-12-04T18:43:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19304-sla-al-centro-nemo-una-giornata-di-formazione-sui-trial-clinici]]></loc><lastmod>2022-11-20T11:40:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19301-sla-si-rinnova-la-collaborazione-tra-lega-nazionale-dilettanti-e-aisla]]></loc><lastmod>2022-11-20T10:55:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19268-sclerosi-laterale-amiotrofica-arisla-finanzia-sei-nuovi-progetti-di-ricerca]]></loc><lastmod>2022-11-12T14:35:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19243-sclerosi-laterale-amiotrofica-al-via-la-campagna-di-natale-aisla]]></loc><lastmod>2022-11-05T11:33:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19205-sclerosi-laterale-amiotrofica-donati-ad-aisla-24-abiti-da-sposa]]></loc><lastmod>2022-10-25T13:51:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19176-sclerosi-laterale-amiotrofica-fda-approva-il-farmaco-amx0035]]></loc><lastmod>2022-10-14T16:41:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19108-sla-studio-sul-farmaco-tofersen-evidenzia-un-rallentamento-nella-progressione-di-malattia]]></loc><lastmod>2022-09-24T19:40:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19058-giornata-nazionale-sla-aisla-annuncia-un-contributo-straordinario-per-i-propri-soci]]></loc><lastmod>2022-09-15T11:07:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18986-sla-1500-canarini-gialli-per-la-casa-sollievo-bimbi-di-vidas]]></loc><lastmod>2022-08-05T11:35:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18968-sla-studio-italiano-spiega-uno-dei-meccanismi-che-la-causa-della-malattia-chiarito-ruolo-della-proteina-tdp-43]]></loc><lastmod>2022-10-28T18:16:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18949-sla-il-12-luglio-si-e-svolta-l-assemblea-nazionale-di-aisla]]></loc><lastmod>2022-07-24T15:15:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18925-sla-i-pazienti-hanno-bisogno-di-accedere-alle-informazioni-sui-nuovi-farmaci-in-sviluppo]]></loc><lastmod>2022-07-16T20:48:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18889-sla-giovanile-studio-internazionale-svela-il-ruolo-del-sistema-immunitario-in-diagnosi-e-trattamento]]></loc><lastmod>2022-07-05T12:49:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18793-sla-oggi-la-giornata-mondiale-dedicata-alla-patologia]]></loc><lastmod>2022-06-20T16:44:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18803-sclerosi-laterale-amiotrofica-torna-in-presenza-il-convegno-scientifico-di-arisla]]></loc><lastmod>2022-06-20T15:59:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18790-sclerosi-laterale-amiotrofica-aisla-dietro-il-tempo-che-scorre-c-e-sempre-una-persona]]></loc><lastmod>2022-06-17T14:58:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18753-sla-dati-clinici-di-fase-iii-confermano-l-efficacia-del-farmaco-tofersen]]></loc><lastmod>2022-06-11T11:18:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18739-sla-la-risposta-delle-autorita-europee-alla-petizione-di-post-fata-resurgo]]></loc><lastmod>2022-06-05T17:23:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18697-sclerosi-laterale-amiotrofica-l-appello-di-aisla-in-occasione-della-giornata-del-sollievo]]></loc><lastmod>2022-05-26T12:22:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18569-sla-quali-prospettive-in-ambito-terapeutico]]></loc><lastmod>2022-04-24T16:28:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18570-sla-il-ruolo-della-proteina-tdp-43-al-centro-degli-studi-sulla-patologia]]></loc><lastmod>2022-04-26T08:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18521-giornata-mondiale-della-salute-l-appello-di-aisla-firenze]]></loc><lastmod>2022-04-07T16:29:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18460-sla-pubblicato-il-nuovo-bando-arisla-per-la-ricerca-scientifica]]></loc><lastmod>2022-03-27T21:25:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18346-registro-nazionale-sla-alleanza-tra-aisla-e-istituto-mario-negri]]></loc><lastmod>2022-02-26T09:17:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18345-sla-aisla-lazio-e-centro-nemo-roma-lanciano-il-gruppo-di-sostegno-psicoeducativo-gratuito]]></loc><lastmod>2022-02-25T17:56:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18339-giornata-mondiale-delle-malattie-rare-arisla-lancia-la-campagna-social-ricercaefiducia]]></loc><lastmod>2022-02-24T22:39:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18210-sclerosi-laterale-amiotrofica-apre-il-magazzino-solidale-aisla]]></loc><lastmod>2022-01-23T21:53:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18148-sla-dall-analisi-del-metabolismo-nuove-informazioni-sulla-prognosi-della-patologia]]></loc><lastmod>2021-12-31T12:09:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18130-sla-individuato-un-nuovo-componente-molecolare-degli-aggregati-patologici]]></loc><lastmod>2021-12-24T11:57:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18090-sla-studio-italiano-identifica-un-nuovo-potenziale-bersaglio-terapeutico]]></loc><lastmod>2021-12-12T17:09:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18100-sclerosi-laterale-amiotrofica-annunciati-i-vincitori-del-bando-arisla-2021]]></loc><lastmod>2021-12-13T17:31:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/18042-sla-presentato-lo-studio-baobab-sui-figli-dei-pazienti]]></loc><lastmod>2021-11-27T21:40:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17832-sla-parte-il-progetto-solidale-dona-di-slancio]]></loc><lastmod>2021-09-28T17:32:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17784-sla-il-19-settembre-si-celebra-la-giornata-nazionale]]></loc><lastmod>2021-09-16T11:54:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17549-sclerosi-laterale-amiotrofica-il-21-giugno-e-lo-sla-global-day]]></loc><lastmod>2021-06-18T21:52:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17510-sla-una-petizione-indirizzata-ai-vertici-delle-istituzioni-europee]]></loc><lastmod>2021-06-06T17:06:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17467-sla-oltre-100-candidature-al-bando-2021-di-fondazione-arisla]]></loc><lastmod>2021-05-23T19:11:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17411-sla-dimostrato-un-rallentamento-nella-progressione-della-malattia-con-guanabenz]]></loc><lastmod>2021-05-10T17:31:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17263-sla-arisla-pubblica-il-nuovo-bando-per-progetti-di-ricerca-scientifica-2]]></loc><lastmod>2021-04-03T15:38:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17203-sla-aisla-lancia-il-suo-nuovo-video-manifesto-per-me-questo-non-e-un-gioco]]></loc><lastmod>2021-03-21T21:15:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17090-pasquale-centrone-il-ristoratore-malato-di-sla-che-invoca-l-eutanasia-ho-bisogno-di-un-assistenza-stabile-e-duratura]]></loc><lastmod>2021-02-28T16:17:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17066-rare-disease-day-arisla-aderisce-all-evento-con-la-campagna-ricercaesperanza]]></loc><lastmod>2021-02-23T19:10:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/17020-sla-una-favola-ritrovata-dopo-30-anni-a-sostegno-della-ricerca]]></loc><lastmod>2021-02-14T20:19:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/16937-sla-identificati-i-potenziali-biomarcatori-prognostici-della-patologia]]></loc><lastmod>2021-01-26T19:10:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/16882-sla-dal-parlamento-una-serie-di-proposte-per-migliorare-l-assistenza]]></loc><lastmod>2021-01-14T22:16:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/16771-sclerosi-laterale-amiotrofica-arisla-annuncia-i-vincitori-della-call-for-projects-2020]]></loc><lastmod>2020-12-06T18:35:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/16379-sclerosi-laterale-amiotrofica-farmaci-a-domicilio-per-i-pazienti-fiorentini]]></loc><lastmod>2020-08-23T17:12:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/15999-sclerosi-laterale-amiotrofica-arisla-pubblica-il-nuovo-bando-di-ricerca]]></loc><lastmod>2020-04-26T20:46:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/15996-sla-individuato-bersaglio-farmacologico-associato-alla-perdita-di-mielina]]></loc><lastmod>2020-04-26T17:35:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/15759-sla-attivo-un-servizio-telefonico-e-di-videochat-per-l-emergenza-covid-19]]></loc><lastmod>2020-03-15T18:46:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/15606-sla-dopo-la-morte-di-anastasi-aisla-firenze-fa-chiarezza-sulla-patologia]]></loc><lastmod>2020-01-28T21:22:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/15451-sla-nominati-i-vertici-della-prima-biobanca-nazionale]]></loc><lastmod>2019-11-26T15:38:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/15212-sla-nella-giornata-nazionale-raccolti-250-000-euro]]></loc><lastmod>2019-09-21T20:26:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/15186-sclerosi-laterale-amiotrofica-domenica-e-la-giornata-nazionale]]></loc><lastmod>2019-09-13T15:09:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/15049-sclerosi-laterale-amiotrofica-i-nuovi-recapiti-telefonici-di-viva-la-vita-onlus]]></loc><lastmod>2019-07-21T18:14:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14983-sla-il-discorso-di-noemie-al-premio-eurordis-black-pearl-2019]]></loc><lastmod>2019-07-05T21:19:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14947-sla-dietro-front-per-paolo-palumbo-nessuna-sperimentazione-per-lui]]></loc><lastmod>2019-06-26T10:21:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14872-sclerosi-laterale-amiotrofica-si-prepara-partire-il-primo-studio-clinico-su-cellule-staminali-adulte]]></loc><lastmod>2019-06-03T14:32:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14805-sla-la-posizione-della-societa-italiana-di-neurologia-sulla-terapia-con-cellule-staminali]]></loc><lastmod>2019-05-16T12:04:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14795-sla-presentati-dati-intermedi-di-fase-i-ii-sul-farmaco-sperimentale-biib067]]></loc><lastmod>2019-05-13T16:53:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14767-sla-paolo-palumbo-ricevera-la-terapia-cellulare-sperimentale]]></loc><lastmod>2019-04-29T17:45:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14762-cellule-mesenchimali-per-la-sla-la-lotta-di-paolo-palumbo]]></loc><lastmod>2019-04-27T16:45:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14563-sla-la-toscana-e-la-prima-regione-italiana-a-varare-le-linee-di-indirizzo]]></loc><lastmod>2019-03-11T19:22:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14548-sla-in-calabria-50-milioni-di-fondi-per-disabili-bloccati-da-4-anni]]></loc><lastmod>2019-03-08T08:11:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14446-sla-al-via-il-progetto-baobab-di-aisla-per-i-figli-dei-pazienti]]></loc><lastmod>2019-02-11T09:52:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14214-sla-i-vincitori-della-call-for-projects-2018-di-arisla]]></loc><lastmod>2018-11-28T18:53:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14069-sla-un-libro-che-racconta-il-vissuto-dei-pazienti-italiani]]></loc><lastmod>2018-10-22T11:21:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14040-sla-al-centro-clinico-nemo-un-nuovo-servizio-di-analisi-della-visione-per-i-pazienti]]></loc><lastmod>2018-10-15T09:42:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/14010-sla-la-ricerca-riparte-dal-paziente-per-arrivare-a-terapie-efficaci]]></loc><lastmod>2018-10-09T10:28:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13824-sla-da-test-su-oligonucleotidi-una-concreta-speranza-per-i-pazienti]]></loc><lastmod>2018-08-06T13:28:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13689-sla-al-via-il-programma-di-accesso-esteso-di-biohaven-per-bhv-0223]]></loc><lastmod>2018-06-22T15:05:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13629-sla-aifa-rinnova-l-autorizzazione-alla-somministrazione-dell-edaravone]]></loc><lastmod>2018-06-06T15:48:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13599-sla-crispr-cas9-in-azione-per-trovare-la-causa-della-malattia]]></loc><lastmod>2018-05-26T20:58:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13367-sla-nuovo-gene-implicato-nella-malattia-precoce]]></loc><lastmod>2019-01-17T15:55:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13340-mario-sabatelli-il-medico-italiano-che-curo-stephen-hawking]]></loc><lastmod>2018-03-14T18:49:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13333-sla-l-appello-di-viva-la-vita-alla-nuova-amministrazione-del-lazio]]></loc><lastmod>2018-03-13T13:58:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13308-sla-arisla-lancia-slavoriamoperte-a-sostegno-della-ricerca]]></loc><lastmod>2018-03-06T00:40:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13260-sla-humanitas-coordina-studio-clinico-su-un-nuovo-farmaco]]></loc><lastmod>2018-02-21T21:07:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13141-sla-annunciati-da-aisla-i-vincitori-della-call-for-projects-2017]]></loc><lastmod>2018-01-23T10:23:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13123-sla-da-aisla-tre-borse-di-studio-per-giovani-medici]]></loc><lastmod>2018-01-23T10:23:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/13033-legge-biotestamento-aisla-bene-l-approvazione-ma-l-assistenza-per-la-sla-e-insufficiente]]></loc><lastmod>2018-01-23T10:24:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12992-sla-una-mostra-per-aiutare-la-ricerca-scientifica]]></loc><lastmod>2018-01-23T10:24:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12984-sla-al-via-unaparolapernemo-per-donare-la-propria-voce-a-chi-l-ha-persa]]></loc><lastmod>2018-01-23T10:24:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12960-sla-in-liguria-la-pet-therapy-entra-in-reparto]]></loc><lastmod>2018-01-23T10:25:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12949-sla-avviata-un-indagine-per-realizzare-il-primo-registro-nazionale-di-medici-e-pazienti]]></loc><lastmod>2018-01-23T10:25:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12940-reggio-calabria-140-medici-e-infermieri-formati-per-assistere-le-persone-con-sla]]></loc><lastmod>2018-01-23T10:25:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12809-sclerosi-laterale-amiotrofica-la-ricerca-avanza-verso-nuovi-trattamenti]]></loc><lastmod>2018-01-23T10:26:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12717-simposio-nazionale-sla-i-passi-avanti-della-ricerca-e-i-nuovi-trattamenti]]></loc><lastmod>2018-01-23T10:26:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12680-sla-raccolti-120-000-euro-nelle-piazze-italiane]]></loc><lastmod>2018-01-23T10:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12585-sla-un-progetto-che-mette-internet-al-servizio-di-pazienti-e-familiari]]></loc><lastmod>2018-01-23T10:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12547-sla-in-calabria-un-progetto-per-la-gestione-delle-emergenze]]></loc><lastmod>2018-01-23T10:27:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12477-sclerosi-laterale-amiotrofica-in-italia-arriva-il-farmaco-edaravone]]></loc><lastmod>2018-01-23T10:27:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12318-sindrome-locked-in-nella-sla-un-chip-cerebrale-per-aiutare-i-pazienti-a-comunicare]]></loc><lastmod>2017-05-28T18:15:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12276-sclerosi-laterale-amiotrofica-approvato-in-america-il-nuovo-farmaco-edaravone]]></loc><lastmod>2019-01-17T17:39:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12116-sla-pubblicato-il-nuovo-bando-arisla-per-progetti-di-ricerca-scientifica]]></loc><lastmod>2017-03-25T17:37:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12118-stephen-hillenburg-il-creatore-del-celebre-cartone-spongebob-ha-la-sla]]></loc><lastmod>2017-03-28T09:15:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12054-sla-il-centro-clinico-nemo-entra-nel-network-dei-maggiori-istituti-di-ricerca-del-mondo]]></loc><lastmod>2017-03-11T18:54:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12053-biotestamento-nasce-un-nuovo-servizio-di-consulenza-per-i-malati-di-sla]]></loc><lastmod>2017-03-11T17:12:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/12014-sla-arisla-racconta-le-storie-delle-persone-che-ogni-giorno-fanno-ricerca]]></loc><lastmod>2017-03-06T10:35:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/11848-sla-arisla-annuncia-i-progetti-vincitori-della-call-for-projects-2016]]></loc><lastmod>2017-01-28T11:01:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/11779-sla-individuato-un-nuovo-meccanismo-alla-base-della-malattia]]></loc><lastmod>2017-01-09T10:07:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/11753-sla-individuato-il-ruolo-del-sistema-nervoso-periferico-nella-progressione-della-malattia]]></loc><lastmod>2016-12-22T15:29:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/11736-sclerosi-laterale-amiotrofica-previsto-studio-proof-of-concept-sull-uso-terapeutico-di-corticotropina]]></loc><lastmod>2016-12-17T11:47:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/11483-sla-al-via-la-campagna-di-arisla-per-la-ricerca]]></loc><lastmod>2016-10-18T13:27:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/11472-sla-la-comunita-scientifica-italiana-si-confronta-sul-futuro-della-ricerca]]></loc><lastmod>2016-10-17T09:38:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/11217-sla-nuovi-traguardi-grazie-anche-all-ice-bucket-challenge]]></loc><lastmod>2016-09-10T10:55:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/11009-sclerosi-laterale-amiotrofica-fda-approva-uso-compassionevole-del-farmaco-masitinib]]></loc><lastmod>2016-07-21T13:41:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/10945-sla-mexiletina-efficace-nel-ridurre-la-frequenza-e-l-intensita-dei-crampi-muscolari]]></loc><lastmod>2016-07-08T20:13:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/10825-giornata-mondiale-sla-aisla-lancia-una-campagna-sui-7-diritti-fondamentali-dei-pazienti]]></loc><lastmod>2016-06-20T15:09:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/10647-sclerosi-laterale-amiotrofica-la-terapia-genica-apre-nuove-possibilita]]></loc><lastmod>2016-05-19T18:39:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/10501-sclerosi-laterale-amiotrofica-le-principali-questioni-etiche-da-affrontare]]></loc><lastmod>2016-04-29T12:40:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/10395-sla-nuovo-studio-identifica-i-muscoli-come-potenziale-bersaglio-terapeutico]]></loc><lastmod>2016-04-20T10:58:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/10370-sla-confermata-la-manifestazione-di-protesta-del-15-aprile]]></loc><lastmod>2016-04-13T13:49:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/10356-sla-sgomberata-la-sede-romana-dell-associazione-viva-la-vita-onlus]]></loc><lastmod>2016-04-11T16:03:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/10218-umbria-decisa-a-migliorare-i-servizi-per-i-malati-di-sla]]></loc><lastmod>2016-03-18T14:01:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/10191-sla-la-malattia-aggredisce-i-muscoli-fin-dalle-prime-fasi-la-scoperta-italiana]]></loc><lastmod>2016-03-14T08:24:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/10030-sla-arisla-pubblica-il-nuovo-bando-per-progetti-di-ricerca-scientifica]]></loc><lastmod>2016-02-24T16:24:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9953-sla-promettenti-risultati-da-test-preclinici-su-nuova-terapia]]></loc><lastmod>2016-04-15T18:04:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9947-ezio-bosso-il-pianista-con-la-sla-che-emoziona-l-italia]]></loc><lastmod>2016-02-12T10:20:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9858-sla-in-sardegna-senza-tracheotomia-non-hai-diritto-ai-fondi-la-denuncia]]></loc><lastmod>2016-01-29T15:38:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9854-sla-arriva-la-carrozzina-comandata-con-lo-sguardo]]></loc><lastmod>2016-01-29T15:24:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9699-sla-quattro-i-progetti-vincitori-dei-due-bandi-arisla]]></loc><lastmod>2016-01-07T08:21:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9690-sla-identificato-nuovo-meccanismo-molecolare-che-causa-la-morte-dei-neuroni]]></loc><lastmod>2015-12-30T10:16:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9658-sla-familiare-nuova-sperimentazione-clinica-per-il-farmaco-isis-sod1rx]]></loc><lastmod>2015-12-22T11:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9605-sla-da-aisla-3-borse-di-studio-per-giovani-infermieri]]></loc><lastmod>2015-12-11T13:32:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9486-sla-scoperti-nuovi-bersagli-terapeutici-la-ricerca-non-si-ferma]]></loc><lastmod>2015-12-01T11:20:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9451-sla-al-via-la-campagna-di-arisla-insiemecontrolasla]]></loc><lastmod>2015-11-26T11:13:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9124-sla-ok-al-trapianto-di-staminali-cerebrali-umane-si-apre-la-seconda-fase-della-sperimentazione-italiana]]></loc><lastmod>2015-10-13T14:26:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/9024-sla-e-sm-uno-studio-italiano-svela-un-importante-meccanismo-alla-base-delle-patologie]]></loc><lastmod>2015-10-01T15:12:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8985-sla-il-parere-sulla-situazione-sanitaria-italiana-dell-ex-ministro-sirchia]]></loc><lastmod>2015-09-24T14:45:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8950-sla-fino-al-29-settembre-raccolta-fondi-per-l-ospedale-a-domicilio-di-viva-la-vita-onlus]]></loc><lastmod>2015-09-21T10:48:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8897-sla-aisla-celebra-la-giornata-nazionale-in-150-piazze-italiane]]></loc><lastmod>2015-09-11T08:49:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8868-sla-una-nuova-scoperta-sulle-forme-patologiche-ereditarie]]></loc><lastmod>2015-09-16T16:13:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8630-sclerosi-laterale-amiotrofica-scoperto-un-legame-tra-il-sistema-immunitario-e-la-morte-dei-motoneuroni]]></loc><lastmod>2015-07-16T10:22:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8593-sla-arisla-pubblica-bando-per-prodotti-e-servizi-di-tecnologia-assistenziale]]></loc><lastmod>2015-07-09T09:36:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8385-sla-in-sperimentazione-la-terapia-con-immunoregolatore-np001]]></loc><lastmod>2015-06-05T09:52:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8270-sla-il-sollievo-delle-scelte-terapeutiche]]></loc><lastmod>2015-05-28T08:44:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8228-sla-la-denuncia-dei-pazienti-geraldina-non-abbiamo-diritto-a-niente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8227-sla-la-battaglia-quotidiana-di-gigi-e-di-sua-moglie-gina-che-lo-assiste]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8226-sla-la-denuncia-dei-familiari-antonietta-assisto-mio-padre-completamente-da-sola]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8214-sla-in-lazio-la-iii-conferenza-regionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8213-sla-aisla-in-corsa-alla-mille-miglia]]></loc><lastmod>2024-10-31T16:16:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7818-sla-notizie-positive-per-un-nuovo-farmaco-made-in-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/8088-sla-un-antiepilettico-sara-studiato-come-nuova-potenziale-terapia]]></loc><lastmod>2015-06-08T11:30:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7993-sclerosi-laterale-amiotrofica-chiellini-testimonial-della-campagna-5x1000-di-arisla]]></loc><lastmod>2024-10-31T16:16:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7964-sla-pubblicati-risultati-della-sperimentazione-con-staminali-cerebrali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7932-sclerosi-laterale-amiotrofica-e-demenza-frontotemporale-il-ruolo-del-gene-chchd10]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7922-sla-masitinib-riceve-la-designazione-di-farmaco-orfano-da-parte-dellfda]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7902-la-ricetta-aisla-per-una-buona-pasqua]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7847-sla-sheila-essey-award-2015-ad-adriano-chio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7819-sclerosi-laterale-amiotrofica-delude-luso-delleritropoietina-umana-ricombinante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7749-a-venezia-avviata-la-sperimentazione-del-teleconsulto-a-domicilio-per-i-pazienti-sla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7654-sla-scoperto-nuovo-gene-associato-alla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7642-sclerosi-laterale-amiotrofica-decifrabili-sulla-pelle-dei-pazienti-tanti-segreti-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7576-sla-arisla-bandisce-nuovo-concorso-per-progetti-clinici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7427-sla-proseguono-le-ricerche-su-masitinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7203-sla-viva-la-vita-onlus-finanzia-due-progetti-di-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/7182-sla-arisla-raddoppia-i-finanziamenti-per-nuovi-progetti-di-ricerca-sulla-malattia-anche-grazie-alle-donazione-dellice-bucket-challenge]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6954-sla-avviato-a-udine-il-progetto-biobanca-finanziato-dallaisla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6944-sla-lo-studio-di-fase-iii-su-ceftriaxone-non-da-i-risultati-sperati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6948-sla-aisla-denuncia-qil-taglio-dei-fondi-del-governo-per-i-malati-non-autosufficienti-e-una-vergognaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6939-sla-identificato-un-nuovo-gene-importante-contributo-dei-ricercatori-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6847-sla-il-trattamento-con-cellule-staminali-adulte-di-brainstorm-cell-therapeutics-riconosciuto-come-fast-track]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6767-sla-24-milioni-di-euro-raccolti-grazie-all-ice-bucket-challenge-e-alla-giornata-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6724-sla-in-libreria-ogni-volta-che-chiudo-gli-occhi-la-storia-del-leone-antonio-e-della-sua-battaglia-contro-la-sla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6714-sla-al-via-il-registro-di-patologia-nella-regione-lazio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6622-staminali-entro-fine-anno-gli-esiti-della-sperimentazione-del-prof-vescovi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6602-sla-zingaretti-si-impegna-per-i-malati-della-regione-lazio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6601-sla-lettera-aperta-di-luigi-brunori-paziente-romano-a-renzi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6594-sla-pichezzi-qnessuna-riforma-puo-eguagliare-una-rivoluzioneq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6588-associazione-luca-coscioni-qdopo-le-secchiate-dacqua-devono-arrivare-politiche-per-malati-slaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6586-ice-bucket-challenge-erminia-manfredi-sfida-il-sindaco-marino-favino-e-servillo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6576-le-cifre-dellice-bucket-challenge-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6575-sla-aisla-benedice-lice-bucket-challenge-e-lancia-nuove-nomination]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6567-sla-nuova-scoperta-italia-usa-sulle-basi-comuni-con-la-demenza-frontotemporale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6503-sla-ricerca-italiana-porta-a-progressi-nel-processo-di-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6295-sla-la-denuncia-famiglia-indebitata-col-nuovo-guru-delle-presunte-staminali]]></loc><lastmod>2016-01-11T08:30:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6281-sla-convenzione-tra-croce-rossa-e-viva-la-vita-onlus-per-i-trasporti-dei-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6279-sla-domani-la-giornata-mondiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6257-sla-familiari-scrivono-a-giorgio-napolitano-qsiamo-disperatiq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6150-vincere-la-sla-un-impegno-per-tutti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6057-sla-a-venezia-pazienti-e-ulss-insieme-per-offrire-unassistenza-migliore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/6005-sla-risultati-deludenti-per-tirasemtiv]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5940-sla-la-scoperta-del-gene-matrin-3-la-parola-ad-adriano-chio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5902-sla-viva-la-vita-denuncia-chi-non-vuole-essere-intubato-e-costretto-a-tornare-a-casa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5877-sclerosi-laterale-amiotrofica-studio-italiano-indaga-il-rapporto-tra-la-malattia-e-la-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5825-sla-il-riluzolo-diventa-liquido-finisce-la-paura-della-compressa-che-va-di-traverso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5809-sla-identificato-gene-coinvolto-nellesordio-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5725-luigi-brunori-malato-di-sla-partecipa-alla-maratona-di-roma-per-viva-la-vita-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5638-sla-e-prospettive-terapeutiche-uno-sguardo-al-futuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5408-sla-pubblicato-il-bando-di-concorso-annuale-di-arilsa-per-finanziare-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5131-sla-nasce-un-nuovo-sistema-di-telemonitoraggio-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5133-sla-al-via-sette-nuovi-progetti-di-ricerca-grazie-ad-arisla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5084-sla-risultati-deludenti-per-quanto-riguarda-limpiego-di-eritropoietina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5061-sla-a-vercelli-si-progetta-una-nuova-struttura-sanitaria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5026-sla-paziente-disabile-denuncia-la-pazzesca-anomalia-della-riforma-fornero]]></loc><lastmod>2019-06-19T08:10:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5018-sla-avviato-lo-studio-clinico-di-masitinib-un-inibitore-della-tirosina-chinasi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4906-sla-esito-negativo-per-la-sperimentazione-del-farmaco-dexpramipexolo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4676-sla-rete-di-supporto-ai-malati-e-ai-loro-familiari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4672-sla-al-mario-negri-scoperti-i-meccanismi-che-ne-regolano-il-decorso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4581-sla-a-potenza-si-puo-far-richiesta-per-un-contributo-economico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4576-sla-la-denuncia-di-stefano-lascensore-e-stretto-sono-bloccato-in-casa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4550-sla-i-malati-di-roma-sono-ancora-in-attesa-dei-fondi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4497-sla-uno-studio-italiano-scopre-possibili-cause-ambientali-della-malattia]]></loc><lastmod>2019-06-19T08:26:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4501-sla-aperta-la-consultazione-pubblica-ema-sulle-sperimentazione-cliniche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4513-sla-la-calvizie-maschile-correlata-alla-patologia-la-spiegazione-potrebbe-essere-nel-recettore-degli-androgeni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4461-sla-la-multinazionale-lo-licenzia-la-denuncia-ho-una-moglie-e-una-figlia-a-carico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4445-sla-daniele-torna-a-solcare-il-suo-mare-al-largo-della-toscana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4443-sla-ricerca-assistenza-sociale-solidarieta-litalia-non-si-ferma-di-fronte-alla-bastarda]]></loc><lastmod>2019-06-19T08:28:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4444-sla-ricerca-assistenza-sociale-solidarieta-litalia-non-si-ferma-di-fronte-alla-bastarda-26046752]]></loc><lastmod>2019-06-19T08:28:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4376-sla-studio-condotto-al-gemelli-fa-nuova-luce-sul-ruolo-della-proteina-che-avvelena-i-motoneuroni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4273-sla-positivi-i-primi-risultati-della-sperimentazione-con-staminali-del-prof-vescovi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4260-sla-dalla-ricerca-tecnologica-le-ultime-novita-presto-a-disposizione-dei-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4253-sla-la-risposta-della-regione-lazio-i-fondi-ci-sono-e-non-verranno-toccati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4252-sla-le-casse-regionali-del-lazio-sono-vuote-le-famiglie-non-hanno-ricevuto-nulla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4164-sla-individuate-25-nuove-mutazioni-sospette-per-la-forma-sporadica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4170-sla-un-video-sulla-malattia-vince-la-dodicesima-edizione-dello-spot-school-award]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/4131-sla-la-toscana-finanzia-lassistenza-domiciliare-con-lassegno-di-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3966-sla-trovato-nel-moscerino-della-frutta-un-gene-che-se-rotto-salva-i-motoneuroni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3984-sla-i-malati-protestano-a-cagliari-la-promessa-delle-istituzionipotenzieremo-lattivita-assistenziale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3959-sclerosi-laterale-amiotrofica-la-causa-potrebbe-dipendere-da-una-mutazione-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3910-sla-sui-pazienti-con-mutazione-sod1-si-tenta-un-nuovo-approccio-terapeutico]]></loc><lastmod>2015-12-16T16:39:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3893-sclerosi-laterale-amiotrofica-individuata-la-potenziale-causa-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3889-sla-fino-al-21-aprile-con-un-sms-e-possibile-sostenere-la-ricerca-di-arisla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3756-sla-approvata-negli-usa-la-sperimentazione-con-fingolimod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3723-sla-il-comitato-16-novembre-chiede-spiegazioni-al-dr-melazzini-sulluso-delle-staminali-autologhe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3656-sla-da-arisla-nuovo-concorso-per-finanziare-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3633-sla-il-comitato-16-novembre-incontra-il-candidato-premier-ingroia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3511-sla-nel-calcio-in-lombardia-avviato-uno-studio-sugli-ex-professionisti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3510-sla-da-studio-pilota-del-mario-negri-speranze-per-il-trattamento-combinato-l-acetilcarnitina-e-riluzolo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3504-sla-i-calciatori-professionisti-non-sono-piu-a-rischio]]></loc><lastmod>2016-03-29T13:13:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3468-sla-a-napoli-il-comunicatore-e-un-miraggio-vincenzo-attende-da-4-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3436-sla-in-lombardia-arrivano-le-nuove-erogazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3435-sla-fallisce-la-sperimentazione-del-dexpramipexolo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3387-sla-scoperto-il-gene-che-regola-la-progressione-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3357-sla-necessita-assistenziali-e-terapeutiche-in-italia-la-situazione-ancora-troppo-precaria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3354-slavenerdi-14-dicembre-a-milano-il-vi-convegno-nazionale-aisla-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3322-sla-procede-la-sperimentazione-con-le-cellule-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3290-sla-nuove-prove-a-favore-dellipotesi-di-una-base-oligogenica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3221-sla-nuove-speranze-terapeutiche-dai-lieviti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3207-sla-mina-welby-date-fiducia-al-ministro-balduzzi-e-chiedete-alle-regioni-i-fondi-che-vi-spettano-per-legge]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3206-sla-il-governo-sciopera-sui-diritti-dei-disabili-gravissimi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3199-sla-nuovi-finanziamenti-alla-ricerca-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3178-sla-usala-da-mercoledi-in-presidio-a-roma-ecco-lelenco-delle-richieste-del-comitato-16-novembre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3140-sla-dal-ministero-nessuna-risposta-concreta-i-malati-ricominciano-lo-sciopero-della-fame]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3138-sla-e-assistenza-a-casa-franca-da-due-anni-segue-il-marito-e-dice-si-alle-cure-domiciliari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3113-sla-aisla-qbene-ogni-progetto-per-lassistenza-a-casa-lavoriamo-sui-tavoli-regionali-per-i-contributi-alle-famiglieq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3112-sla-la-regione-lazio-stanzia-i-fondi-per-i-comunicatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3106-sla-lamannna-del-comitato-16-novembre-invitiamo-le-altre-associazioni-al-dialogo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3105-sla-lamanna-le-promesse-non-ci-bastano-vogliamo-un-piano-per-la-non-autosufficienza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3073-sla-di-inguaribile-solo-la-voglia-di-vivere-le-questioni-aperte-per-malati-e-familiari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/3015-arisla-in-tre-anni-investiti-in-ricerca-oltre-4-milioni-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2932-sla-bicchiere-di-vino-aiuta-la-ricerca-un-successo-la-raccolta-fondi-aisla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2912-atrofia-muscolare-spinale-e-sla-individuato-un-collegamento-molecolare-tra-le-due-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2885-sla-i-malati-del-lazio-condannati-al-silenzio-la-denuncia-dellassociazione-viva-la-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2845-sla-grazie-alla-tecnologia-io-parlo-di-nuovo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2735-sla-i-pazienti-italiani-sono-stati-coinvolti-nella-ricerca-sulla-mutazione-che-aggrava-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2682-sla-identificato-un-nuovo-gene-che-influenza-la-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2718-sla-si-svolgera-domani-linterrogazione-presentanta-dallon-coscioni-sul-coinvolgimeto-dei-pazienti-italiani-nella-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2638-sla-i-globuli-bianchi-come-biomarcatori-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2589-sla-ricerca-internazionale-individua-un-gene-coinvolto-nellinsorgere-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2553-giovanna-ha-la-sla-e-la-continuita-della-fisioterapia-le-e-negata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2554-assistenza-ai-malati-di-sla-coscioni-interroga-i-ministri-nessuna-irregolarita-previsti-20-milioni-di-euro-per-la-non-autosufficienza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2544-sla-muore-la-mamma-il-figlio-distribuisce-la-fornitura-di-ausili-rimasti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2426-sla-effettuato-in-italia-il-primo-trapianto-di-staminali-cerebrali-nel-midollo-spinale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2383-sla-on-coscioni-lo-studio-irlandese-sulla-sla-familiare-ha-riguardato-anche-pazienti-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2351-sla-global-day-tra-ricerca-e-assistenza-a-giugno-si-parla-di-sclerosi-laterale-amiotrofica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2345-sla-nuove-frontiere-per-loperazione-di-tracheotomia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2268-sla-proseguono-gli-studi-sul-gene-c9orf72]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2239-sla-line-guida-per-la-gestione-clinica-dei-pazienti-della-federazione-europea-delle-societa-di-neurologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2213-sclerosi-laterale-amiotrofica-sla-il-ruolo-delleccitotossicita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2245-sla-la-sen-biondelli-chiede-chiarezza-sulluso-fatto-del-100-milioni-destinati-nel-2010]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2227-sla-in-lombardia-il-contributo-ai-malati-sale-a-2000-euro-mensili-o-piu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2143-sla-un-endocannabinoide-potrebbe-aiutare-i-pazienti-a-mantenere-la-muscolatura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/2104-sla-a-caserta-un-focus-sulla-malattia-partecipazione-gratuita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1932-sla-apomorfina-qualificata-farmaco-orfano-per-il-trattamento-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1918-sla-presentato-oggi-a-benevento-un-progetto-per-le-cure-in-ambito-pneumologico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1906-sla-non-ancora-dimostrata-lorigine-genetica-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1827-sclerosi-laterale-amiotrofica-al-via-il-nuovo-bando-arisla-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1771-sla-avviata-la-campagna-sms-solidale-qprendi-il-tuo-posto-nella-lotta-contro-la-slaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1769-sla-a-disposizione-dei-pazienti-un-brain-computer-interface-traduce-il-pensiero-in-azioni]]></loc><lastmod>2017-05-22T09:49:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1780-sla-sovvenzioni-sugli-ausili-alla-comunicazione-da-parte-del-ministero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1695-sclerosi-laterale-amiotrofica-fingolimod-come-possibile-trattamento-farmacologico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1688-sla-lacido-urico-come-indicatore-della-sopravvivenza-dei-pazienti-maschi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1679-sla-oggi-premiata-palmina-giannini-che-da-anni-lotta-in-prima-persona-per-i-diritti-delle-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1574-sla-il-ruolo-terapeutico-del-litio-puo-essere-rivalutato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1536-sla-la-possibile-terapia-con-cellule-staminali-del-midollo-supera-la-fase-1]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1542-sla-giovanile-familiare-causata-da-una-mutazione-del-gene-sigmar1]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1464-sla-spenta-nei-topi-la-proteina-tdp-43-causa-della-forma-familiare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1463-sla-sperimentazione-prof-vescovi-ecco-i-parametri-per-larruolamento-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1425-sla-franca-non-vorrei-che-toni-dicesse-di-non-voler-piu-vivere-come-walter-bellini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1413-sla-forse-meglio-la-morte-di-una-vita-senza-dignita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1276-sla-trovato-in-conferenza-stato-regioni-laccordo-per-il-riparto-dei-100-milioni-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1218-sla-possibile-una-maggiore-diffusione-del-disturbo-cognitivo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1155-sla-identificate-proteine-alterate-nel-sangue-dei-malati-si-pensa-a-marcatori-per-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1130-sla-oggi-la-quarta-giornata-nazionale-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1117-sla-trovato-il-gene-responsabile-della-forma-sporadica-40237426]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1118-sla-il-possibile-ruolo-delle-staminali-nella-lotta-alla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1008-sla-studio-americano-conferma-che-gli-astrociti-avvelenano-il-motoneurone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/1004-sla-trovato-malfunzionamento-che-causa-accumulo-di-sostenze-neurodegenerative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/815-sla-il-21-giugno-la-giornata-mondiale-indetta-dallinternational-alliance]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/734-sla-tutti-i-progetti-di-ricerca-e-assistenza-avviati-da-aisla-nel-2011]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/708-sla-per-chi-e-affetto-da-questa-malattia-il-soprappeso-puo-essere-un-vantaggio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/689-sla-27-centri-italiani-arruolano-pazienti-per-il-trial-con-lepo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/646-sla-al-via-il-nuovo-bando-arisla-per-la-ricerca-scade-il-15-giugno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/639-sla-bloccare-la-proteina-anomala-fus-nel-nucleo-della-cellula-potrebbe-arrestare-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/594-sla-il-litio-puo-essere-una-terapia-facciamo-il-punto-con-il-prof-fornai]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/592-sla-sopravvivono-meno-i-pazienti-che-presentano-anche-demenza-frontotemporale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/579-sla-stimolazione-elettrica-transcranica-per-individuarla-fino-a-8-mesi-prima-dei-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/571-sla-via-libera-delliss-per-la-sperimentazione-con-le-staminali-cerebrali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/562-sla-fumare-puo-essere-un-fattore-di-rischio-che-cresce-con-il-numero-di-bionde]]></loc><lastmod>2015-06-08T09:58:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/540-sla-lagenzia-di-ricerca-ha-stanziato-25-milioni-di-euro-per-8-progetti-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/504-sla-un-retrovirus-potrebbe-essere-coinvolto-nella-forma-sporadica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/428-sla-laisla-torna-a-chiedere-notizie-sullutilizzo-dei-100-milioni-di-euro-per-i-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/397-premio-il-campione-tra-i-premiati-mario-melazzini-dellaisla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/396-sla-melazzini-aisla-chiede-nuovi-chiarimenti-al-governo-sugli-stanziamenti]]></loc><lastmod>2015-06-08T11:16:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/376-sla-studio-dellistituto-mario-negri-conferma-che-i-traumi-sono-un-fattore-di-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/351-sla-ricerca-inglese-scopre-che-il-danno-assonale-precede-ogni-sintomo-in-paio-danni-un-marker-per-gli-uomini]]></loc><lastmod>2015-06-08T16:24:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/348-sla-nasce-il-forum-dedicato-di-arisla-dedicato-alla-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/347-sla-mangiare-lalga-spirulina-potrebbe-rallentare-la-morte-dei-motoneuroni]]></loc><lastmod>2015-06-08T16:26:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/321-sla-ricerca-italo-americana-conferma-che-la-morte-dei-neuroni-e-causata-da-un-processo-di-accumulo]]></loc><lastmod>2018-12-13T17:30:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/301-sla-in-alcune-forme-di-una-biopsia-del-nervo-motorio-potrebbe-risolvere-le-diagnosi-incerte]]></loc><lastmod>2015-06-08T16:40:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/276-sla-nasce-allebri-un-centro-di-ricerca-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/264-sla-lassociazione-aldo-perini-onlus-e-la-borsa-italiana-di-milano-avviano-un-nuovo-servizio-di-idroterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/174-sla-il-3-ottobre-e-la-giornata-nazionale-ma-lassistenza-ai-malati-continua-ad-essere-diversa-da-regione-a-regione]]></loc><lastmod>2023-09-27T09:19:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/166-sla-si-puo-prevenire-la-paralisi-bloccando-la-morte-programmata-delle-cellule]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/137-sla-individuato-il-gene-che-organizza-i-motoneuroni-potrebbe-essere-li-lorigine-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/128-sla-scoperto-nuovo-fattore-di-rischio-che-accomuna-la-malattia-allatassia-spinocerebellare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/110-sla-scoperta-la-sede-della-mutazione-genetica-che-la-provoca-e-nel-cromosoma-9p21]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/93-sla-mario-sabatelli-pol-gemelli-quella-di-lou-gehrig-e-borgonovo-non-e-ctem]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/92-e-se-non-fosse-sla-uno-studio-americano-ha-scoperto-una-nuova-patologia-simile-ma-causata-principalmente-dai-traumi-cranici-che-colpirebbe-soprattutto-sportivi-professionisti-e-veterani-di-guerra-e-forse-anche-lou-gehrig-che-ha-dato-il-suo-nome-al-morb]]></loc><lastmod>2018-12-13T17:36:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/88-sla-un-passo-avanti-per-prevedere-la-malattia-prima-che-insorgano-i-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/82-sla-cadono-le-speranza-sul-litio-troppi-effetti-tossici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/86-sla-cause-e-terapie-del-dott-massimo-corbo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/87-sla-la-malattia-e-il-suo-impatto-di-vincenzo-silani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/27-sla-ereditaria-ricerca-italo-americana-svela-il-ruolo-di-un-nuovo-gene-mutante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/5-test-2]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sla/19-sla-lon-vanucci-interroga-il-ministero-della-salute-in-merito-al-protocollo-melazzini]]></loc><lastmod>2016-10-25T07:09:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/22598-dare-voce-ai-diritti-la-sclerosi-sistemica-e-le-tutele-per-i-malati-rari]]></loc><lastmod>2025-12-12T19:08:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/22590-sclerosi-sistemica-fira-ancora-troppo-elevato-il-ritardo-diagnostico]]></loc><lastmod>2025-12-09T18:08:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/22340-fenomeno-di-raynaud-il-27-settembre-controlli-gratuiti-al-papa-giovanni-xxiii-di-bergamo]]></loc><lastmod>2025-09-24T11:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/22117-29-giugno-2025-domenica-si-celebra-la-xvi-giornata-mondiale-della-sclerosi-sistemica]]></loc><lastmod>2025-06-27T07:12:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/21625-sclerosi-sistemica-per-la-prima-volta-in-italia-trattata-con-car-t-una-paziente-adulta]]></loc><lastmod>2025-01-13T14:50:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/21117-sclerosi-sistemica-il-29-giugno-e-la-xv-giornata-mondiale]]></loc><lastmod>2024-06-27T17:16:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/21124-sclerodermia-professionisti-sanitari-e-assistiti-a-confronto]]></loc><lastmod>2024-06-27T17:34:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/20901-crisi-renale-sclerodermica-e-ace-inibitori-il-chiarimento-dell-aifa]]></loc><lastmod>2024-04-22T18:07:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/20841-crisi-renale-sclerodermica-l-unica-terapia-efficace-e-irreperibile]]></loc><lastmod>2024-04-08T08:21:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/20755-sclerosi-sistemica-a-bergamo-percorso-ad-accessi-programmati-grazie-alla-scleroderma-unit]]></loc><lastmod>2024-03-15T16:36:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/20573-malattie-reumatiche-il-fenomeno-di-raynaud-e-spesso-un-campanello-d-allarme]]></loc><lastmod>2024-01-29T11:55:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/20526-sclerosi-sistemica-10-video-testimonianze-per-parlare-della-malattia]]></loc><lastmod>2024-01-17T16:29:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/20467-sclerodermia-giovanile-assegnato-a-due-giovani-ricercatori-il-premio-alessio-mustich]]></loc><lastmod>2023-12-19T18:16:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/20438-sclerosi-sistemica-mosca-una-diagnosi-precoce-e-fondamentale-per-ottenere-una-prognosi-migliore]]></loc><lastmod>2023-12-13T10:26:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/20409-sclerodermia-avviata-la-campagna-di-sensibilizzazione-promossa-da-gils-liss-e-amrer]]></loc><lastmod>2023-12-04T11:46:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/19990-sclerodermia-giovanile-al-via-il-premio-di-ricerca-under-40-alessio-mustich]]></loc><lastmod>2023-07-10T10:50:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/19947-sclerosi-sistemica-oggi-la-giornata-mondiale]]></loc><lastmod>2023-06-27T18:05:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/19342-sclerosi-sistemica-all-ospedale-sandro-pertini-un-corso-di-formazione-sul-tema-pdta]]></loc><lastmod>2022-11-28T14:45:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/18893-sclerosi-sistemica-un-interrogazione-sulla-presa-in-carico-multidisciplinare-e-la-necessita-di-aggiornamento-su-diagnosi-e-trattamento]]></loc><lastmod>2022-07-07T09:31:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/18833-sclerosi-sistemica-sono-stata-licenziata-per-via-della-patologia]]></loc><lastmod>2022-06-25T10:50:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/18832-sclerosi-sistemica-troppo-spesso-i-diritti-dei-pazienti-sono-calpestati-da-una-burocrazia-cieca]]></loc><lastmod>2022-06-25T10:50:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/18831-sclerosi-sistemica-il-29-giugno-e-la-giornata-mondiale]]></loc><lastmod>2022-06-25T10:49:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/18459-malattie-fibrosanti-polmonari-nintedanib-disponibile-in-italia]]></loc><lastmod>2022-03-27T19:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/17913-malattia-polmonare-interstiziale-associata-a-sclerosi-sistemica-il-farmaco-non-e-rimborsato]]></loc><lastmod>2021-10-19T17:26:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/17678-sclerosi-sistemica-aifa-promuove-la-terapia-infusionale-domiciliare-con-iloprost]]></loc><lastmod>2021-07-25T16:15:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/17586-sclerosi-sistemica-oggi-e-la-giornata-mondiale]]></loc><lastmod>2021-06-27T21:55:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/17530-interstiziopatie-polmonari-e-malattie-reumatologiche-necessaria-una-gestione-multidisciplinare]]></loc><lastmod>2021-06-15T17:22:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/17496-sclerosi-sistemica-la-terapia-infusiva-domiciliare-ora-e-realta-in-molte-regioni]]></loc><lastmod>2021-05-31T18:09:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/17170-sclerosi-sistemica-inizia-il-progetto-academy-newsletter-lessons]]></loc><lastmod>2021-03-11T14:46:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/16225-sclerosi-sistemica-l-appello-dei-pazienti-per-la-giornata-mondiale-della-malattia]]></loc><lastmod>2020-06-28T19:29:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/15993-sclerosi-sistemica-approvazione-europea-per-nintedanib]]></loc><lastmod>2022-03-23T16:34:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/15743-sclerosi-sistemica-parere-positivo-del-chmp-per-nintedanib]]></loc><lastmod>2020-03-10T19:31:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/15619-sclerosi-sistemica-pubblicata-la-prima-indagine-epidemiologica-nazionale]]></loc><lastmod>2020-02-02T17:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/15020-un-sorriso-raro-un-libro-che-insegna-ad-affrontare-le-malattie-rare-con-positivita]]></loc><lastmod>2019-07-14T20:18:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/14960-sclerosi-sistemica-il-29-giugno-e-il-10-anniversario-della-giornata-mondiale]]></loc><lastmod>2019-06-26T17:42:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/14845-sclerosi-sistemica-nintedanib-rallenta-la-perdita-di-funzionalita-polmonare]]></loc><lastmod>2019-05-25T15:53:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/14635-sclerosi-sistemica-depositata-in-europa-e-usa-la-domanda-di-approvazione-di-nintedanib]]></loc><lastmod>2019-03-25T17:39:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/13845-sclerodermia-identificata-una-molecola-chiave-nello-sviluppo-della-malattia]]></loc><lastmod>2018-08-16T14:38:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/11504-sclerosi-sistemica-sabato-capillaroscopie-gratuite-in-piazza-a-tempio-pausania]]></loc><lastmod>2018-08-16T14:37:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/11216-sclerosi-sistemica-i-problemi-legati-al-design-della-sperimentazione-clinica]]></loc><lastmod>2018-08-16T14:40:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/11242-sclerodermia-e-malattia-polmonare-interstiziale-associata-nintedanib-ottiene-la-designazione-di-farmaco-orfano]]></loc><lastmod>2018-08-16T14:39:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/11160-sclerosi-sistemica-fondamentale-la-diagnosi-precoce]]></loc><lastmod>2018-08-16T14:41:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/11106-sclerosi-sistemica-i-costi-per-la-malattia-rara-possono-arrivare-a-30-797-euro-annui]]></loc><lastmod>2016-08-08T17:47:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/11098-sclerosi-sistemica-l-efficacia-del-sildenafil-nella-guarigione-delle-ulcere-digitali-ischemiche]]></loc><lastmod>2016-08-05T12:49:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/11043-paul-klee-l-eclettico-artista-affetto-da-sclerodermia]]></loc><lastmod>2016-07-29T06:59:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/10971-sclerosi-sistemica-un-team-di-ricercatori-italiani-alla-scoperta-dei-meccanismi-che-attivano-la-malattia]]></loc><lastmod>2016-07-13T15:08:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/10875-sclerodermia-oggi-la-giornata-mondiale]]></loc><lastmod>2016-06-29T08:29:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/10850-sclerodermia-lo-spot-della-lega-italiana-sclerosi-sistemica-onlus-per-la-giornata-mondiale]]></loc><lastmod>2016-06-27T08:43:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/10244-sclerodermia-la-malattia-e-riconosciuta-solo-in-due-regioni-italiane]]></loc><lastmod>2016-03-22T16:41:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/10174-sclerosi-sistemica-cutanea-diffusa-anche-in-italia-si-arruolano-pazienti-per-sperimentazione-con-riociguat]]></loc><lastmod>2016-03-11T12:00:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/9624-sclerosi-sistemica-in-lombardia-diagnosi-e-terapie-finalmente-disciplinate-da-un-pdta]]></loc><lastmod>2015-12-15T15:05:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/9621-sclerosi-sistemica-nuova-sperimentazione-clinica-avanzata-per-il-farmaco-nintedanib]]></loc><lastmod>2015-12-15T10:35:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/9543-sclerodermia-le-giornate-di-sensibilizzazione-di-as-ma-ra-onlus-a-roma]]></loc><lastmod>2015-12-07T09:57:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/9311-sclerodermia-inaugurato-all-aou-senese-un-percorso-assistenziale-multidisciplinare-dedicato]]></loc><lastmod>2015-11-06T12:18:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/9159-sclerosi-sistemica-ad-ottobre-due-appuntamenti-organizzati-da-ails]]></loc><lastmod>2015-10-14T15:31:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/8993-sclerosi-sistemica-il-rituximab-migliora-la-fibrosi-cutanea-e-previene-il-peggioramento-di-quella-polmonare]]></loc><lastmod>2015-09-29T07:56:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/8611-sclerosi-sistemica-i-pazienti-mostrerebbero-una-caratteristica-alterazione-del-microbiota]]></loc><lastmod>2015-07-13T12:38:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/8484-sclerosi-sistemica-tocilizumab-classificato-terapia-fortemente-innovativa-dalla-fda]]></loc><lastmod>2016-08-09T19:03:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/8493-giornata-mondiale-della-sclerodermia-le-associazioni-chiamano-all-azione]]></loc><lastmod>2015-06-23T13:41:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/8438-sclerosi-sistemica-tocilizumab-ottiene-la-breakthrough-terapy-designation-dall-fda]]></loc><lastmod>2015-06-12T13:49:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/8233-sclerosi-sistemica-risultati-incoraggianti-per-tocilizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/7974-sclerosi-sistemica-nasce-a-siena-la-scleroderma-unit]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/7893-sclerodermia-terapie-mirate-possono-rallentare-il-decorso-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/7564-sclerodermia-il-rituximab-ridurrebbe-ispessimento-cutaneo-e-fibrosi-polmonare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/7561-sclerosi-sistemica-cutanea-diffusa-attiva-efficace-terapia-aggiuntiva-con-ivig]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/7479-sclerosi-sistemica-il-trattamento-con-immunoglobuline-e-una-valida-alternativa-terapeutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/7378-sclerodermia-localizzata-il-pirfenidone-in-gel-sembra-essere-efficace]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/7093-sclerosi-sistemica-diffusa-la-terapia-con-rituximab-e-efficace-per-linteressamento-cutaneo-e-la-funzione-polmonare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/7013-sclerosi-sistemica-grandi-passi-in-avanti-grazie-alle-iniziative-della-lega-italiana-sclerosi-sistemica-e-dellassociazione-amrer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/6726-sclerosi-sistemica-team-italiano-scopre-i-meccanismi-molecolari-correlati-alla-fibrosi]]></loc><lastmod>2019-06-18T17:58:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/6358-sclerosi-sistemica-confronto-di-esperienze-per-celebrare-la-giornata-mondiale-dedicata-alla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/6345-sclerosi-sistemica-bilancio-2014-positivo-per-la-ricerca-scientifica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/6198-sclerosi-sistemica-indagato-luso-di-bosentan-nel-trattamento-delle-ulcere-digitali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/5896-sclerosi-sistemica-disponibile-la-mappa-de-centri-di-cura-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/5783-sclerosi-sistemica-individuati-i-fattori-predittivi-alla-base-della-comorbidita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/5684-sclerosi-sistemica-lassociazione-ails-e-il-suo-impegno-per-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/5685-sclerodermia-1-paziente-su-2-soffre-di-ulcere-digitali-da-oggi-ce-una-speranza-in-piu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/5706-sclerodermia-limportanza-della-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/5609-sclerosi-sistemica-primo-ok-per-il-nuovo-anticorpo-monoclonale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/5455-3d-systemic-sclerosis-world-congress-il-congresso-sulla-sclerosi-sistemica-che-si-e-tenuto-a-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/5271-sclerodermia-dopo-la-lombardia-anche-la-regione-lazio-riconosce-la-malattia-come-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/5245-sclerodermia-la-lombardia-chiede-il-riconoscimento-di-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/5144-sclerodermia-ancora-troppo-pochi-i-diritti-dei-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/4865-sclerodermia-limportanza-della-capillaroscopia-periungueale]]></loc><lastmod>2019-06-19T08:16:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/4662-sclerodermia-il-gils-compie-20-anni-e-resta-a-fianco-degli-ammalati-con-una-campagna-di-raccolta-fondi-con-numero-solidale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/4612-sclerosi-sistemica-ora-disponibile-il-quaderno-rosa-realizzato-dalla-lega-italiana-sclerosi-sistemica-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/4322-sclerosi-sistemica-si-studia-luso-di-tocilizumab-e-abatacept-per-migliorare-la-vita-dei-pazienti]]></loc><lastmod>2019-06-19T08:34:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/3809-sclerosi-sistemica-e-disfunzione-erettile-prevenzione-e-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/3702-sclerosi-sistemica-limportanza-della-ricerca-e-delle-associazioni-di-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/3647-sclerosi-sistemica-a-pisa-un-nuovo-metodo-per-la-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/3530-sclerosi-sistemica-attenzione-al-rischio-di-malnutrizione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/3430-sclerosi-sistemica-scoperto-il-ruolo-dellosteopontina-da-uno-studio-senese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/3219-sclerodermia-i-farmaci-ace-inibitori-possono-aumentare-la-mortalita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/3039-la-sclerosi-sistemica-si-puo-riconoscere-e-capirne-i-sintomi-e-il-primo-passo-per-iniziare-a-combatterla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/2886-sclerosi-sistemica-progressiva-disponibili-le-raccomandazioni-italiane]]></loc><lastmod>2015-05-28T13:24:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/2733-sclerosi-sistemica-la-gravidanza-e-possibile-ma-ce-rischio-di-nascite-pretermine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/1594-sclerodermia-si-e-concluso-ieri-il-secondo-congresso-mondiale-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/1583-sclerosi-sistemica-con-malattia-polmonare-interstiziale-limatinib-ad-altoalto-e-troppo-rischioso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/1092-sclerodermia-domenica-25-torna-la-giornata-del-ciclamino-per-sostenere-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/510-sclerodermia-una-guida-pratica-alla-malattia]]></loc><lastmod>2015-06-08T10:17:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/251-sclerodermia-a-lecco-parte-il-progetto-oltre-il-gelo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sclerosi-sistemica/45-sclerosi-sistemica-nuova-promettente-terapia-da-una-ricerca-delluniversita-cattolica-di-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/7542-2015-02-05-14-41-32]]></loc><lastmod>2018-03-31T14:27:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/7505-2015-02-02-14-28-07]]></loc><lastmod>2016-03-10T15:45:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/6574-sensibilita-chimica-multipla-silvana-ha-vinto-la-sua-battaglia-anche-per-gli-altri-pazienti]]></loc><lastmod>2018-03-31T14:29:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/5958-sensibilita-chimica-multipla-la-malattia-mette-a-dura-prova-i-pazienti-e-le-asl]]></loc><lastmod>2018-03-31T14:29:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/5583-sensibilita-chimica-multipla-in-veneto-patologia-riconosciuta-ma-nessun-protocollo-attuativo]]></loc><lastmod>2018-03-31T14:31:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/5063-sensibilita-chimica-multipla-in-umbria-i-pazienti-chiedono-linserimento-nei-protocolli-di-assistenza-sanitaria]]></loc><lastmod>2018-03-31T14:31:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/3773-sensibilita-chimica-multipla-in-veneto-riconosciuta-come-malattia-rara]]></loc><lastmod>2018-03-31T14:31:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/2612-sensibilita-chimica-multipla-la-regione-veneto-avra-un-suo-centro-di-riferimento]]></loc><lastmod>2018-03-31T14:32:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/2043-sensibilita-chimica-multipla-allumberto-i-di-roma-una-stanza-dedicata]]></loc><lastmod>2018-03-31T14:33:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/2044-sensibilita-chimica-multipla-allumberto-i-di-roma-una-stanza-dedicata-28668212]]></loc><lastmod>2018-03-31T14:32:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/1010-sensibilita-chimica-multipla-in-veneto-istituita-commissione-scientifica-apposita]]></loc><lastmod>2018-07-06T08:54:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/997-sensibilita-chimica-multipla-a-treviso-due-sorelline-sono-malate-e-la-famiglia-e-in-difficolta]]></loc><lastmod>2019-11-18T15:45:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sensibilita-chimica-multipla-mcs/146-sensibilita-chimica-multipla-una-donna-di-bergamo-rischia-di-dover-vivere-in-auto-per-non-morire]]></loc><lastmod>2018-03-31T14:34:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/17204-sindrome-da-chilomicronemia-familiare-volanesorsen-ora-disponibile-anche-in-italia]]></loc><lastmod>2021-03-21T21:25:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/17199-sindrome-da-chilomicronemia-familiare-un-webinar-sulla-malattia-per-e-con-i-pazienti]]></loc><lastmod>2021-03-21T19:28:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/15130-sindrome-da-chilomicronemia-familiare-volanesorsen-riduce-i-trigliceridi]]></loc><lastmod>2019-08-25T20:28:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/14849-sindrome-da-chilomicronemia-familiare-fcs-approvato-il-farmaco-volanesorsen-prima-terapia-in-europa]]></loc><lastmod>2019-06-10T10:36:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/14538-sindrome-da-chilomicronemia-familiare-parere-positivo-del-chmp-per-volanesorsen]]></loc><lastmod>2019-03-05T17:59:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/13849-sindrome-da-chilomicronemia-familiare-i-vantaggi-della-comunicazione-fra-i-pazienti]]></loc><lastmod>2018-08-17T10:32:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/13573-chilomicronemia-familiare-l-onere-mentale-ed-emotivo-della-malattia]]></loc><lastmod>2018-08-17T11:22:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/13454-sindrome-da-chilomicronemia-familiare-fcs-primo-incontro-globale-delle-associazioni-pazienti]]></loc><lastmod>2018-05-20T10:30:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/12218-deficit-della-lipoproteina-lipasi-ritirata-la-richiesta-di-rinnovo-dell-autorizzazione-all-immissione-al-commercio-di-glybera]]></loc><lastmod>2018-05-20T10:31:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/11806-iperchilomicronemia-gli-omega-3-associati-a-una-dieta-povera-di-grassi-riducono-i-trigliceridi]]></loc><lastmod>2018-05-20T10:32:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/9612-malattie-genetiche-cardiovascolari-in-arrivo-nuove-terapie]]></loc><lastmod>2018-08-30T16:30:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/8661-che-cos-e-l-iperchilomicronemia]]></loc><lastmod>2018-08-30T16:29:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/8906-iperchilomicronemia-tutti-i-metodi-per-ottenere-una-diagnosi]]></loc><lastmod>2018-08-30T16:28:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/8905-iperchilomicronemia-glybera-e-il-primo-farmaco-di-terapia-genica-al-mondo-approvato-per-la-somministrazione-nell-uomo]]></loc><lastmod>2018-08-30T16:26:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/8871-iperchilomicronemia-il-primo-paziente-europeo-sperimentera-la-terapia-genica-unica-opzione-efficace-e-risolutiva]]></loc><lastmod>2018-08-30T16:26:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/8870-iperchilomicronemia-la-qualita-di-vita-dei-pazienti-e-molto-bassa]]></loc><lastmod>2018-08-30T16:26:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/8841-iperchilomicronemia-quando-i-trigliceridi-vanno-alle-stelle]]></loc><lastmod>2018-05-20T10:35:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/8842-iperchilomicronemia-la-nuova-prospettiva-e-la-terapia-genica]]></loc><lastmod>2018-05-20T10:35:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/8739-ipertrigliceridemia-le-tecniche-extracorporee-e-le-nuove-terapie]]></loc><lastmod>2018-05-20T10:41:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/8682-chilomicronemia-familiare-volanesorsen-designato-farmaco-orfano-dalla-fda]]></loc><lastmod>2018-05-20T10:36:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/8713-iperchilomicronemia-in-italia-sono-tre-i-centri-di-riferimento]]></loc><lastmod>2018-05-20T10:36:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/7987-iperchilomicronemia-familiare-in-italia-presto-disponibile-nuova-terapia-genica]]></loc><lastmod>2018-05-20T10:37:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/7379-sindrome-da-chilomicronemia-familiare]]></loc><lastmod>2018-08-31T13:42:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/4779-deficit-di-lipoproteina-lipasi-farmaco-sperimentale-sembra-efficace-nel-contrastare-laccumulo-di-trigliceridi]]></loc><lastmod>2018-05-20T10:37:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/3088-deficit-di-lipoproteina-lipasi-approvata-in-europa-la-prima-terapia-genica]]></loc><lastmod>2018-05-20T10:38:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/iperchilomicronemia/2106-deficit-di-lipoproteina-lipase-lema-boccia-nuovamente-glybera]]></loc><lastmod>2018-05-20T10:39:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/21976-sindrome-da-fatica-cronica-annunciati-i-vincitori-del-concorso-frammenti-di-vita-con-la-cfs-me]]></loc><lastmod>2025-05-12T15:43:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/20969-online-una-serie-di-video-per-fare-informazione-sulla-sindrome-da-fatica-cronica]]></loc><lastmod>2024-05-15T09:30:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/19796-sindrome-da-fatica-cronica-oggi-e-la-giornata-internazionale]]></loc><lastmod>2023-05-11T10:24:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/19581-sindrome-da-fatica-cronica-noi-pazienti-troppo-spesso-dimenticati-anche-tra-le-patologie-rare]]></loc><lastmod>2023-02-28T12:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/18967-encefalomielite-mialgica-presentata-al-senato-un-interrogazione-per-inserirla-nei-lea]]></loc><lastmod>2022-07-29T15:33:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/18637-sindrome-da-stanchezza-cronica-il-12-maggio-e-la-giornata-mondiale-dedicata-alla-patologia]]></loc><lastmod>2022-05-11T15:52:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/17512-sindrome-da-stanchezza-cronica-uno-studio-italiano-valuta-possibili-alterazioni-del-microbiota]]></loc><lastmod>2021-06-09T08:46:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/17386-sindrome-da-stanchezza-cronica-se-ne-e-discusso-in-commissione-sanita-del-veneto]]></loc><lastmod>2021-05-05T11:08:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/16947-sindrome-da-stanchezza-cronica-l-europa-in-ritardo-sulla-ricerca]]></loc><lastmod>2021-01-30T23:04:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/16059-sindrome-da-fatica-cronica-ricorre-oggi-la-giornata-mondiale]]></loc><lastmod>2020-05-12T14:11:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/15946-sindrome-da-stanchezza-cronica-con-il-giusto-supporto-lo-studio-e-l-universita-sono-possibili]]></loc><lastmod>2020-04-13T18:25:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/7156-sindrome-da-fatica-cronica-il-prof-tirelli-scrive-un-libro-per-spiegarla]]></loc><lastmod>2016-11-29T21:19:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/6029-sindrome-da-fatica-cronica-oggi-e-la-giornata-mondiale-dedicata-a-questa-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/5549-sindrome-da-fatica-cronica-il-coordinamento-nazionale-associazioni-patologie-ambientali-contesta-le-linee-guida-per-la-cfs-di-agenas-e-chiede-chiarezza]]></loc><lastmod>2019-06-10T10:32:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/5478-sindrome-da-fatica-cronica-a-disposizione-le-linee-guida-per-la-gestione-della-malattia]]></loc><lastmod>2019-11-07T11:18:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/3743-stanchezza-cronica-terapia-cognitivo-comportamentale-ed-esercizi-fisici-graduali-uniti-alle-cure-specialistiche-aumentano-possibilita-di-recupero]]></loc><lastmod>2016-11-29T21:21:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/3331-sindrome-da-fatica-cronica-scoperto-un-possibile-biomarcatore-per-alcune-forme-della-malattia-94125366]]></loc><lastmod>2016-11-29T21:21:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/3324-sindrome-da-fatica-cronica-scoperto-un-possibile-biomarcatore-per-alcune-forme-della-malattia]]></loc><lastmod>2016-11-29T21:22:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/3275-sindrome-da-fatica-cronica-confermato-il-coinvolgimento-delle-funzioni-autonomiche]]></loc><lastmod>2016-11-29T21:22:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/2792-sindrome-da-fatica-cronica-la-conferma-non-e-causata-da-un-virus]]></loc><lastmod>2016-11-29T21:23:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/2599-sindrome-da-fatica-cronica-ruggiero-ora-il-danno-da-cadmio-e-misurabile-presto-anche-a-firenze-potremo-visitare-i-pazienti]]></loc><lastmod>2016-11-29T21:23:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/2556-sindrome-da-fatica-cronica-sembra-evidente-il-legame-con-i-metalli-pesanti]]></loc><lastmod>2016-11-29T21:24:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/2317-sindrome-da-fatica-cronica-con-il-prof-ruggiero-il-punto-su-diagnosi-e-trattamento]]></loc><lastmod>2016-11-29T21:24:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/2316-sindome-da-fatica-cronica-un-convegno-per-una-malattia-misconosciuta]]></loc><lastmod>2016-11-29T21:25:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/2243-sindrome-da-fatica-cronica-prof-tirelli-diagnosi-complessa-ma-la-depressione-deve-essere-esclusa]]></loc><lastmod>2016-11-29T21:25:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/2242-sindrome-da-fatica-cronica-i-pazienti-si-raccontano-in-un-libro]]></loc><lastmod>2016-11-29T21:26:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/2131-sindrome-da-stanchezza-cronica-e-fibromialgia-oggi-la-giornata-mondiale-per-i-malati-fantasma]]></loc><lastmod>2016-11-29T21:26:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/1381-sindrome-da-fatica-cronica-o-encefalomielite-mialgica-me-i-criteri-internazionali-ora-in-5-lingue]]></loc><lastmod>2016-11-29T21:27:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/1133-stanchezza-cronica-nessun-rischio-legato-al-retrovirus-xmrv-si-puo-donare-il-sangue]]></loc><lastmod>2016-11-29T21:28:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/1030-sindrome-da-stanchezza-cronica-cfs-il-punto-degli-esperti-sulle-possibili-cause]]></loc><lastmod>2016-11-29T21:30:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/1029-sindrome-da-stanchezza-cronica-cfs-komaroff-anomalie-nel-sistema-nervoso-chi-ritiene-che-le-cause-siano-solo-psicologiche-non-e-ben-informato]]></loc><lastmod>2016-11-29T21:31:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/stanchezza-cronica-sindrome-da/460-sindrome-di-stanchezza-cronica-adesso-si-pensa-alla-terapia-sul-web]]></loc><lastmod>2016-11-29T21:33:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/22926-a-ciampino-la-nuova-sede-dellassociazione-italiana-sindrome-x-fragile]]></loc><lastmod>2026-04-12T14:28:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/22388-sindrome-dellx-fragile-il-10-ottobre-e-la-giornata-internazionale]]></loc><lastmod>2025-10-09T15:03:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/21372-giornata-x-fragile-2024-oggi-la-sfida-e-allargare-lo-sguardo-alla-famiglia]]></loc><lastmod>2024-10-09T18:11:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/17806-sindrome-dell-x-fragile-al-via-l-indagine-nazionale-mettici-una-x]]></loc><lastmod>2021-09-22T15:43:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/17552-sindrome-dell-x-fragile-la-malattia-non-ci-ha-tolto-nulla-ci-ha-dato-tante-opportunita]]></loc><lastmod>2021-06-20T13:13:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/17080-x-fragile-il-cortometraggio-pedala-per-la-giornata-delle-malattie-rare]]></loc><lastmod>2021-02-26T19:38:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/16597-sindrome-dell-x-fragile-il-colosseo-vestito-di-blu-per-rendere-visibile-la-malattia]]></loc><lastmod>2020-10-21T16:25:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/15885-coronavirus-le-iniziative-dell-associazione-italiana-sindrome-x-fragile]]></loc><lastmod>2020-03-31T18:14:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/14547-sindrome-dell-x-fragile-al-gemelli-di-roma-un-centro-dedicato-ai-pazienti-adulti]]></loc><lastmod>2019-03-06T13:43:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/14123-sindrome-dell-x-fragile-in-umbria-un-piano-d-azione-a-favore-dei-pazienti]]></loc><lastmod>2018-11-09T14:48:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/13568-x-fragile-a-padova-tre-giornate-di-studio-sulla-malattia]]></loc><lastmod>2018-05-19T15:31:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/13526-sindrome-dell-x-fragile-l-importanza-del-progetto-vedo-curriculum-per-l-inclusione-lavorativa-dei-pazienti]]></loc><lastmod>2018-05-05T13:58:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/13484-sindrome-dell-x-fragile-bpn14770-ottiene-la-designazione-usa-di-farmaco-orfano]]></loc><lastmod>2018-05-05T14:00:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/11807-sindrome-dell-x-fragile-designazione-orfana-della-fda-per-il-farmaco-ganaxolone]]></loc><lastmod>2019-01-17T17:50:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/11780-sindrome-x-fragile-dieci-video-curriculum-per-entrare-nel-mondo-del-lavoro]]></loc><lastmod>2018-05-05T14:01:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/11108-sindrome-dell-x-fragile-il-costo-medio-annuo-per-paziente-raggiunge-gli-58-862-euro-in-svezia]]></loc><lastmod>2018-05-05T14:01:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/8261-sindrome-dellx-fragile-anche-i-portatori-possono-avere-disturbi-cognitivi-e-comportamentali]]></loc><lastmod>2018-05-05T14:01:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/8080-sindrome-x-fragile-sara-avviato-nuovo-studio-sperimentale]]></loc><lastmod>2018-05-05T14:02:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/6164-x-fragile-un-libro-per-costruire-lautonomia]]></loc><lastmod>2018-05-05T14:03:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/5517-sindrome-x-fragile-la-campagna-promozionale-dellassociazione-italiana-onlus-sbarca-alla-rai]]></loc><lastmod>2018-05-05T14:03:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/4491-x-fragile-pubblicate-le-linee-guida-per-i-test-genetici]]></loc><lastmod>2018-05-05T14:04:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/3958-x-fragile-due-farmaci-usati-per-altre-patologie-potrebbero-ridurre-alcuni-sintomi]]></loc><lastmod>2018-05-05T14:04:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/3789-x-fragile-nuovo-studio-chiarisce-la-patogenesi-della-rara-malattia]]></loc><lastmod>2018-05-05T14:05:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/3744-x-fragile-donatella-bertelli-racconta-la-malattia-lassociazione-italiana]]></loc><lastmod>2018-05-05T14:07:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/3502-x-fragile-bertelli-occorre-investire-sulla-consapevolezza-anche-lo-screening-puo-essere-una-strada]]></loc><lastmod>2018-05-05T14:08:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/3499-x-fragile-partecipare-alle-sperimentazioni-e-importante-ma-lorganizzazione-fa-la-differenza]]></loc><lastmod>2018-05-05T14:08:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/3421-sindrome-dellx-fragile-uno-studio-ne-svela-la-stretta-correlazione-con-lautismo]]></loc><lastmod>2018-05-05T14:09:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/3356-sindrome-dellx-fragile-scoperto-un-nuovo-meccanismo-molecolare]]></loc><lastmod>2018-05-05T14:10:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/2878-x-fragile-possibile-sostenere-la-ricerca-con-un-sms-dal-6-al-12-ottobre]]></loc><lastmod>2018-05-05T14:11:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/2806-x-fragile-sperimentato-su-pazienti-il-primo-farmaco-che-agisce-sui-sintomi]]></loc><lastmod>2018-05-05T14:12:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/2729-x-fragile-una-potenziale-terapia-dalla-florida]]></loc><lastmod>2018-05-05T14:13:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/2425-x-fragile-la-pre-mutazione-genetica-tra-gli-americani-e-piu-diffusa-di-quel-che-non-si-credesse-anche-questi-soggetti-possono-avere-problemi-di-salute-di-tipo-neurologico-e-riproduttivo]]></loc><lastmod>2018-05-05T14:13:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/1458-x-fragile-il-dottor-pietro-chiurazzi-e-uno-degli-eroi-di-telethon]]></loc><lastmod>2018-05-05T14:14:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/1374-x-fragile-dopo-la-scuola-il-nulla-luniversita-di-bologna-sperimenta-un-protocollo-educativo]]></loc><lastmod>2018-05-05T14:14:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/1332-x-fragile-il-19-novembre-giornata-europea-il-18-a-roma-lassociazione-incontra-gli-studenti]]></loc><lastmod>2018-05-05T14:15:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/1204-x-fragile-appena-conclusi-a-roma-gli-incontri-del-progetto-filo-darianna]]></loc><lastmod>2018-05-05T14:16:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/1003-sindrome-x-fragile-ragazzi-a-spasso-per-la-val-di-fassa]]></loc><lastmod>2018-05-05T14:16:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/387-x-fragile-al-via-larruolamento-dei-pazienti-per-i-trial-con-lafq056]]></loc><lastmod>2018-05-05T14:17:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/366-x-fragile-studio-europeo-mostra-una-prima-efficacia-della-nuova-molecola-afq056-di-novartis]]></loc><lastmod>2018-05-05T14:17:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-dellx-fragile/127-x-fragile-e-possibile-che-una-semplice-cura-antibiotica-per-lacne-abbia-effetti-benefici]]></loc><lastmod>2018-05-05T14:18:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/22707-sindrome-di-alagille-odevixibat-rimborsabile-in-italia]]></loc><lastmod>2026-02-03T08:54:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/22602-sindrome-di-alagille-dalla-cura-del-bambino-a-quella-delladulto-tra-complessita-clinica-e-sfide-aperte]]></loc><lastmod>2025-12-14T23:26:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/22220-sindrome-di-alagille-grazie-ai-nuovi-farmaci-la-chirurgia-di-diversione-biliare-e-ormai-desueta]]></loc><lastmod>2025-07-29T08:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/22083-sindrome-di-alagille-ufficialmente-costituita-l-associazione-italiana-dei-pazienti]]></loc><lastmod>2025-06-12T14:48:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/22019-ibat-inibitori-un-nuovo-orizzonte-terapeutico-per-i-piccoli-pazienti-con-sindrome-di-alagille]]></loc><lastmod>2025-05-23T10:58:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/21794-sindrome-di-alagille-maralixibat-e-efficace-e-ben-tollerato-anche-negli-adolescenti]]></loc><lastmod>2025-03-11T08:32:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/21642-sindrome-di-alagille-attivo-in-italia-un-servizio-per-la-consegna-a-domicilio-del-farmaco-marilixibat]]></loc><lastmod>2025-01-20T18:45:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/21519-sindrome-di-alagille-nuovi-dati-clinici-confermano-l-efficacia-prolungata-di-odevixibat]]></loc><lastmod>2024-11-25T16:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/21388-sindrome-di-alagille-maralixibat-rallenta-il-danno-epatico-e-riduce-la-necessita-di-trapianto]]></loc><lastmod>2024-10-14T16:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/21334-sindrome-di-alagille-approvazione-europea-per-odevixibat]]></loc><lastmod>2024-09-27T16:41:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/20836-sindrome-di-alagille-quest-anno-potrebbe-nascere-la-prima-associazione-italiana]]></loc><lastmod>2024-04-05T08:09:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/20671-sindrome-di-alagille-una-patologia-sistemica-di-gravita-estremamente-variabile]]></loc><lastmod>2024-02-23T12:38:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/20411-sindrome-di-alagille-il-farmaco-maralixibat-ora-disponibile-in-italia-per-il-trattamento-del-prurito-colestatico]]></loc><lastmod>2024-08-21T17:13:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/20272-sindrome-di-alagille-ora-i-medici-hanno-un-arma-per-contrastare-il-prurito]]></loc><lastmod>2023-12-01T12:26:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/20314-sindrome-di-alagille-l-ema-nega-la-designazione-orfana-a-odevixibat]]></loc><lastmod>2023-11-09T17:14:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/19419-sindrome-di-alagille-approvazione-europea-per-maralixibat]]></loc><lastmod>2024-08-21T17:08:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/19199-sindrome-di-alagille-risultati-positivi-dallo-studio-di-fase-iii-su-odevixibat]]></loc><lastmod>2023-09-12T16:41:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/19198-sindrome-di-alagille-ok-del-chmp-all-impiego-di-maralixibat]]></loc><lastmod>2023-09-12T18:06:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/15055-sindrome-di-alagille-retrophin-avvia-partnership-per-la-ricerca-di-terapie]]></loc><lastmod>2023-09-12T16:43:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/8079-sindrome-di-alagille-shire-pubblica-i-risultati-dello-studio-di-fase-ii-su-shp625-lum001]]></loc><lastmod>2023-09-12T16:54:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alagille/4863-malattie-colestatiche-del-fegato-lum001-riceve-la-designazione-di-farmaco-orfano]]></loc><lastmod>2023-09-12T17:26:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/20641-sindrome-di-alport-online-un-questionario-sulla-qualita-della-vita-dei-pazienti]]></loc><lastmod>2024-02-15T18:18:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/17620-sindrome-di-alport-da-asal-onlus-il-bando-alport-research]]></loc><lastmod>2021-07-05T14:41:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/16954-sindrome-di-alport-asal-onlus-lancia-il-progetto-mai-piu-soli]]></loc><lastmod>2021-01-31T00:24:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/12577-sindrome-di-alport-bardoxolone-migliora-la-funzionalita-renale-dei-pazienti]]></loc><lastmod>2019-01-17T17:25:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/2027-sindrome-di-alport-pubblicate-le-raccomandazioni-per-la-pratica-clinica]]></loc><lastmod>2016-11-29T11:45:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/1870-sindrome-alport-al-bambino-gesu-di-roma-lunico-centro-di-riferimento-italiano]]></loc><lastmod>2020-09-22T10:10:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/1871-sindrome-di-alport-massella-la-terapia-principale-sono-gli-ace-i-meglio-se-dati-precocementeq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/1845-sindrome-di-alport-la-gravidanza-e-possibile-ma-possono-insorgere-complicanze-renali]]></loc><lastmod>2016-11-29T11:46:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/1701-sassari-oggi-grazie-ad-asal-onlus-si-e-fatto-il-punto-sulla-sindrome-di-alport]]></loc><lastmod>2015-06-03T14:57:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/1553-sindrome-di-alport-alle-scotte-di-siena-nuovo-macchinario-per-indagini-genetiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-alport/1369-sindrome-di-alport-ora-litalia-ha-una-associazione-asal-onlus-sorta-in-sardegna]]></loc><lastmod>2015-06-05T16:18:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/22732-il-costo-invisibile-della-sindrome-di-angelman-tra-sanita-famiglie-e-welfare-che-non-basta]]></loc><lastmod>2026-02-12T18:03:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/20637-sindrome-di-angelman-la-giornata-mondiale-2024]]></loc><lastmod>2024-02-15T17:40:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/20202-sindrome-di-angelman-assegnata-nuova-borsa-di-studio-da-from-e-associazione-angelman]]></loc><lastmod>2023-10-08T20:01:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/17032-sindrome-di-angelman-oggi-e-la-giornata-mondiale]]></loc><lastmod>2021-02-15T11:07:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/16300-sindrome-di-angelman-angelini-pharma-si-aggiudica-i-diritti-europei-sul-farmaco-ov101]]></loc><lastmod>2020-07-19T17:25:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/16140-sindrome-di-angelman-a-promuovere-la-ricerca-nazionale-c-e-fast-italia-onlus]]></loc><lastmod>2020-06-07T21:09:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/15664-sindrome-di-angelman-il-15-febbraio-e-la-giornata-mondiale]]></loc><lastmod>2020-02-13T22:33:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/14950-sindrome-di-angelman-e-ufficialmente-al-via-il-registro-nazionale]]></loc><lastmod>2019-06-26T09:09:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/14461-sindrome-di-angelman-oggi-la-giornata-mondiale]]></loc><lastmod>2019-02-14T18:58:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/13457-sindrome-di-angelman-il-punto-sulla-ricerca]]></loc><lastmod>2018-05-03T10:02:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/13456-sindrome-di-angelman-l-importanza-del-trattamento-riabilitativo-per-la-qualita-della-vita]]></loc><lastmod>2018-05-03T10:02:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/12985-sindrome-di-angelman-il-primo-registro-italiano-e-una-realta]]></loc><lastmod>2018-05-03T10:02:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/10286-sindrome-di-angelman-la-disabilita-raccontata-da-una-mamma]]></loc><lastmod>2018-05-03T10:03:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/9411-sindrome-di-angelman-agil-as-designato-farmaco-orfano-negli-usa]]></loc><lastmod>2018-05-03T10:03:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/7976-sindrome-di-angelman-la-denuncia-in-lazio-non-esiste-un-protocollo-diagnostico-terapeutico]]></loc><lastmod>2018-05-03T10:04:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/7861-28-marzo-2015-roma-sindrome-di-angelman-ricerca-e-tecniche-di-riabilitazione]]></loc><lastmod>2018-05-03T10:05:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/7605-sindrome-di-angelman-alcuni-sintomi-causati-dal-rallentamento-dellorologio-biologico]]></loc><lastmod>2018-05-03T10:05:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/5461-15-febbraio-2014-milano-qla-sindrome-di-angelmanq]]></loc><lastmod>2018-05-03T10:06:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/3224-sindrome-di-angelman-luso-della-l-dopa-funziona-ma-attenzione-ai-risultati-inattesi]]></loc><lastmod>2018-05-03T10:07:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-angelman/2348-sindrome-di-angelman-individuate-la-probabile-causa-delle-crisi-epilettiche]]></loc><lastmod>2018-05-03T10:07:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar/20067-sindrome-di-crigler-najjar-la-terapia-genica-si-conferma-efficace-a-un-anno-e-mezzo-dal-trattamento]]></loc><lastmod>2025-02-04T17:25:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar/19256-aumento-dei-costi-dell-energia-chi-usa-macchinari-salvavita-rischia-di-spegnere-le-terapie]]></loc><lastmod>2025-02-04T17:37:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar/17943-sindrome-di-crigler-najjar-con-la-terapia-genica-arriva-finalmente-una-cura-efficace]]></loc><lastmod>2025-02-04T17:26:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar/17926-sindrome-di-crigler-najjar-l-elenco-delle-apparecchiature-salvavita-deve-essere-rivisto]]></loc><lastmod>2025-02-04T17:28:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar/17607-sindrome-di-crigler-najjar-a-bergamo-tre-pazienti-curate-con-successo-con-la-terapia-genica]]></loc><lastmod>2025-02-04T17:29:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar/17566-sindrome-di-crigler-najjar-oggi-e-la-giornata-internazionale]]></loc><lastmod>2025-02-04T17:31:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar/16199-sindrome-di-crigler-najjar-oltre-2-milioni-di-euro-investiti-da-telethon-nella-ricerca]]></loc><lastmod>2025-02-04T17:33:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar/14092-ciami-onlus-da-trent-anni-al-fianco-dei-pazienti-con-sindrome-di-crigler-najjar]]></loc><lastmod>2025-02-04T17:34:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar/14093-la-speranza-di-gaia-spegnere-le-luci-blu-grazie-alla-terapia-genica]]></loc><lastmod>2025-02-04T17:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-crigler-najjar/13670-sindrome-di-crigler-najjar-al-via-la-sperimentazione-della-terapia-genica]]></loc><lastmod>2025-02-04T17:47:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/20525-sindrome-di-cushing-quando-il-cortisolo-supera-i-limiti]]></loc><lastmod>2024-01-18T19:00:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/20044-sindrome-di-cushing-gli-ultimi-aggiornamenti-dal-congresso-nazionale-della-sie]]></loc><lastmod>2023-08-07T08:50:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/19599-malattia-di-cushing-e-acromegalia-con-gluconet-pazienti-agevolati-nel-monitoraggio-glicemico]]></loc><lastmod>2023-03-09T11:21:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/13864-sindrome-di-cushing-quando-gli-ormoni-sconvolgono-la-vita]]></loc><lastmod>2019-03-13T15:49:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/10058-acromegalia-e-sindrome-di-cushing-le-linee-guida-per-il-trattamento-dell-iperglicemia]]></loc><lastmod>2016-02-26T14:32:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/9392-malattia-di-cushing-e-malattie-endocrine-ipsen-e-interprotein-corporation-collaboreranno-per-lo-svuluppo-di-nuovi-farmaci]]></loc><lastmod>2015-11-19T16:16:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/9332-malattia-di-cushing-al-via-l-alleanza-europea-con-il-gruppo-arcus]]></loc><lastmod>2015-11-11T12:29:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/7892-malattia-di-cushing-a-napoli-il-corso-di-aggiornamento-per-endocrinologi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/7789-sindrome-di-cushing-e-insufficienza-surrenalica-ad-ancona-il-corso-di-aggiornamento-di-endocrinologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/7716-malattia-di-cushing-una-sostanza-estratta-dai-semi-del-cardo-si-propone-come-nuova-strategia-di-trattamento-non-invasivo]]></loc><lastmod>2015-05-25T15:29:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/7037-malattia-di-cushingapprovato-in-italia-il-primo-farmaco-per-questa-patologia]]></loc><lastmod>2019-05-23T17:56:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/6871-acromegalia-e-sindrome-di-cushing-quando-la-diagnosi-puo-arrivare-dal-medico-di-famiglia]]></loc><lastmod>2025-02-07T10:17:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/6687-malattia-di-cushing-nasce-la-prima-web-community-italiana-dei-pazienti-affetti-da-questa-rara-patologia]]></loc><lastmod>2015-05-25T15:29:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/6596-sindrome-di-cushing-difficilmente-prevedibili-i-profili-di-sicurezza-nel-caso-di-combinazione-tra-vari-farmaci]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/6504-malattia-di-cushing-trattamento-con-mifepristone-aumenta-acth]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/6356-sindrome-di-cushing-la-malattia-e-nettamente-sottodiagnosticata]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/6292-sindrome-di-cushing-i-sintomi-della-malattia]]></loc><lastmod>2024-01-09T12:47:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/6278-centri-di-riferimento-regionali-per-la-sindrome-di-cushing]]></loc><lastmod>2020-10-14T06:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/5840-sindrome-di-cushing-dallaumento-di-peso-alla-ricerca-del-tumore-ipofisario]]></loc><lastmod>2015-05-29T08:18:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/5839-malattia-di-cushing-10-anni-di-esami-e-sofferenze-prima-della-diagnosi]]></loc><lastmod>2015-05-29T08:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/4728-sindrome-di-cushing-generale-miglioramento-clinico-osservato-nei-pazienti-trattati-con-mifepristone]]></loc><lastmod>2019-06-19T08:19:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/4035-malattia-di-cushing-scoperta-la-proteina-che-causa-leccesso-di-ormone-adrenocorticotropo]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/3621-malattia-di-cushing-acido-retinoico-utile-nel-trattamento]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/3184-sindrome-di-cushing-il-pasireotide-approvato-anche-negli-usa]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/2817-malattia-di-cushing-disponibile-una-review]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/2788-sindrome-di-cushing-testati-i-benefici-del-mifepristone]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/2468-malattia-di-cushing-e-acromegalia-meno-bisturi-grazie-ai-farmaci-innovativi]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/2421-sindrome-di-cushing-presentato-il-registro-europeo]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/2068-malattia-di-cushing-approvato-il-farmaco-pasireotide-per-il-trattamento-dei-pazienti-adulti]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/1676-sindrome-di-cusching-approvato-il-mifepristone-per-il-trattamento-delliperglicemia-associata]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/1656-sindrome-di-cushing-presentato-a-napoli-un-nuovo-farmaco-per-il-trattamento-terapeutico]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-cushing/237-malattia-di-cushing-bioterapia-con-nuovo-analogo-della-somatostatina-riduce-leccesso-di-cortisolo]]></loc><lastmod>2015-05-25T15:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre/14689-neuropatie-disimmuni-acquisite-i-traguardi-raggiunti-dai-pazienti-e-le-loro-speranze-future]]></loc><lastmod>2024-07-04T16:24:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre/14583-neuropatie-disimmuni-l-impegno-di-agenas-per-le-associazioni-dei-pazienti]]></loc><lastmod>2024-07-04T16:22:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre/14425-la-causa-della-morte-di-alessandro-magno-fu-la-sindrome-di-guillain-barre]]></loc><lastmod>2019-02-06T12:39:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre/11349-virus-zika-si-rafforza-ipotesi-di-legame-con-la-sindrome-di-guillain-barre]]></loc><lastmod>2016-10-02T08:48:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre/11176-sindrome-di-guillain-barre-la-proteina-cd11b-potrebbe-rappresentare-un-potenziale-bersaglio-terapeutico]]></loc><lastmod>2016-09-01T16:58:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre/9926-la-sindrome-di-guillain-barre-l-altra-malattia-mortale-in-agguato-nelle-zanzare-zika]]></loc><lastmod>2016-02-09T09:19:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre/2809-sindrome-di-guillain-barre-il-punto-su-diagnosi-e-terapia]]></loc><lastmod>2016-08-30T09:44:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre/2542-sindrome-di-guillain-barre-il-vaccino-h1n1-aumenta-il-rischio-ma-solo-negli-over-50]]></loc><lastmod>2016-08-30T09:47:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre/2457-sindrome-di-guillain-barre-combatterla-con-yoga-e-meditazione]]></loc><lastmod>2016-08-30T09:45:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-guillain-barre/214-sindrome-di-guillain-barre-il-dolore-e-troppo-spesso-sottovalutato]]></loc><lastmod>2026-01-16T16:58:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/21506-sindrome-di-lennox-gastaut-fenfluramina-approvata-in-italia-in-regime-di-rimborsabilita]]></loc><lastmod>2024-11-19T10:29:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/20620-sindrome-di-lennox-gastaut-una-delle-epilessie-rare-piu-difficili-da-trattare]]></loc><lastmod>2024-02-12T09:05:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/20618-sindrome-di-lennox-gastaut-fino-a-cento-crisi-epilettiche-al-giorno]]></loc><lastmod>2024-02-09T17:50:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/17581-sindromi-di-lennox-gastaut-e-di-dravet-cannabidiolo-rimborsabile-in-italia]]></loc><lastmod>2021-06-27T17:33:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/16527-epilessia-farmaco-resistente-il-cannabidiolo-riduce-le-crisi-di-oltre-il-50]]></loc><lastmod>2020-10-24T14:29:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/13719-lennox-gastaut-e-dravet-negli-usa-approvata-la-terapia-con-cannabidiolo]]></loc><lastmod>2019-01-17T15:38:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/13548-sindrome-di-lennox-gastaut-e-dravet-si-avvicina-l-approvazione-usa-per-il-cannabidiolo]]></loc><lastmod>2018-05-18T10:06:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/13337-sindrome-di-lennox-gastaut-la-rufinamide-e-d-aiuto-nel-trattamento-delle-crisi-epilettiche]]></loc><lastmod>2018-05-03T10:14:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/13323-sindrome-di-lennox-gastaut-il-cannabidiolo-riduce-del-44-le-crisi-epilettiche]]></loc><lastmod>2018-05-18T09:10:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/9802-sindrome-di-lennox-gastaut-rufinamide-ben-tollerato-anche-da-pazienti-pediatrici]]></loc><lastmod>2018-05-02T10:58:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/2529-sindrome-di-lennox-gastaut-david-non-parlava-non-giocava-e-non-aveva-attenzione-ma-per-3-anni-nessuno-ha-creduto-alle-preoccupazioni-di-mamma-simona]]></loc><lastmod>2018-05-03T10:12:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-lennox-gastaut/1757-sindrome-di-lennox-gastaut-non-e-nella-lista-delle-patologie-rare-le-spese-mediche-sono-a-carico-delle-famiglie]]></loc><lastmod>2018-05-03T10:13:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/21391-malattie-cardiache-rare-progressi-nella-diagnosi-genetica-e-nel-trattamento]]></loc><lastmod>2024-10-15T08:11:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/20127-dissecazione-aortica-e-sindrome-di-marfan-l-informazione-mi-ha-salvato-la-vita]]></loc><lastmod>2023-09-18T17:49:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/19512-sindrome-di-marfan-e-patologie-correlate-i-15-anni-di-attivita-del-policlinico-tor-vergata]]></loc><lastmod>2025-02-07T18:40:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/19380-sindrome-di-marfan-concluso-il-corso-di-formazione-del-policlinico-tor-vergata]]></loc><lastmod>2022-12-10T19:28:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/17698-sindrome-di-marfan-luca-ward-racconto-la-malattia-di-mia-figlia-per-sensibilizzare-le-persone]]></loc><lastmod>2021-08-01T13:45:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/17472-sindrome-di-marfan-conviverci-significa-non-dover-mai-abbassare-la-guardia]]></loc><lastmod>2021-05-30T17:33:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/17447-sindrome-di-marfan-l-associazione-italiana-subito-la-vaccinazione-anti-covid]]></loc><lastmod>2021-05-16T16:42:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/17421-sindrome-di-marfan-i-progressi-della-chirurgia-hanno-allungato-notevolmente-l-aspettativa-di-vita]]></loc><lastmod>2021-05-31T08:55:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/17397-sindrome-di-marfan-eseguito-a-bergamo-un-complesso-intervento-chirurgico]]></loc><lastmod>2021-05-05T11:05:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/14139-sindrome-di-marfan-test-promettenti-sull-evoluzione-della-tecnica-crispr]]></loc><lastmod>2018-11-08T19:12:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/10772-sindrome-di-marfan-esiti-clinici-equivalenti-per-i-farmaci-losartan-e-atenololo]]></loc><lastmod>2016-06-09T15:02:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/7977-sindrome-di-marfan-i-pazienti-chiedono-piu-formazione-tra-i-medici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/7551-sindrome-di-marfan-orphanet-pubblica-i-criteri-diagnostici-internazionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/7280-sindrome-di-marfan-dagli-usa-i-dati-piu-recenti-sullefficacia-dei-farmaci]]></loc><lastmod>2016-06-07T17:43:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/6755-sindrome-di-marfan-grazie-ad-unattenta-analisi-dei-costi-e-possibile-gestire-meglio-le-risorse]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/6376-sindrome-di-marfan-conoscere-la-patologia-per-curarla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/6147-sindrome-di-marfan-informazione-e-ricerca-raddoppiano-la-speranza-di-vita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/5844-paganini-affetto-da-malattia-rara-la-sindrome-di-marfan-forse-era-il-suo-segreto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/4642-sindrome-di-marfan-il-farmaco-losartan-sembra-rallentare-la-dilatazione-aortica]]></loc><lastmod>2016-06-08T22:28:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/3129-sindrome-di-marfan-gli-antipertensivi-possono-aiutare-i-pazienti-pediatrici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/623-sindrome-di-marfan-le-molecole-erk-e-jnk-agiscono-sulla-progressione-del-danno-allaorta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-marfan/622-sindrome-di-marfan-studio-dimostra-che-bloccare-langiorensina-e-meglio-delluso-degli-ace-inibitori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-ondine]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-ondine/20539-sindrome-di-ondine-quando-dormire-diventa-un-incubo]]></loc><lastmod>2024-01-22T12:01:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-ondine/8778-sindrome-di-ondine-quando-il-sonno-e-una-minaccia-per-la-vita]]></loc><lastmod>2015-08-17T07:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-ondine/8779-sindrome-di-ondine-30-anni-fa-i-pazienti-passavano-la-notte-nel-polmone-d-acciaio-oggi-a-casa]]></loc><lastmod>2015-08-17T10:07:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-ondine/7575-malattie-rare-la-sindrome-di-ondine-in-un-cortometraggio-candidato-agli-oscar]]></loc><lastmod>2015-06-22T07:14:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-ondine/4718-inaugurato-oggi-al-meyer-di-firenzeil-primo-centro-nazionale-per-la-cura-della-sindrome-di-ondine-inserito-nel-network-europeo-consortium]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-ondine/4496-sindrome-di-ondine-il-meyer-apre-un-nuovo-centro-per-la-cura-della-rara-patologia]]></loc><lastmod>2019-06-19T08:26:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-ondine/1322-sindrome-ondine-dai-meccanismi-di-risveglio-forzato-alla-ricerca-farmacologica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-ondine/1323-sindrome-di-ondine-ai-bimbi-serve-assistenza-continua-ma-spesso-le-famiglie-sono-sole]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/22624-sentenced-la-campagna-che-da-voce-a-chi-vive-con-la-sindrome-di-prader-willi]]></loc><lastmod>2025-12-23T11:35:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/21611-sindrome-di-prader-willi-passi-avanti-nello-sviluppo-di-una-terapia-epigenetica]]></loc><lastmod>2024-12-27T11:09:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/21447-sindrome-di-prader-willi-grande-partecipazione-al-congresso-della-federazione-italiana-dei-pazienti]]></loc><lastmod>2024-11-01T17:01:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/20377-con-giorgio-fornasier-va-in-scena-il-racconto-della-sindrome-di-prader-willi]]></loc><lastmod>2023-11-23T17:58:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/19828-obesita-genetiche-la-testimonianza-di-maria-mamma-di-un-bimbo-con-sindrome-di-prader-willi]]></loc><lastmod>2023-05-26T10:32:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/19707-prader-willi-sicilia-l-associazione-nata-per-evitare-odissee-diagnostiche-e-viaggi-per-le-terapie]]></loc><lastmod>2023-04-13T18:16:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/18415-sindrome-di-prader-willi-sulle-colline-di-salerno-i-ragazzi-vivono-in-fattoria]]></loc><lastmod>2022-03-13T19:55:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/16774-sindrome-di-prader-willi-dall-ascolto-nasce-la-richiesta-di-supporto-multidisciplinare-alla-cura]]></loc><lastmod>2020-12-06T19:42:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/15605-sindrome-di-prader-willi-risvegliare-alcuni-geni-per-una-possibile-terapia]]></loc><lastmod>2020-01-27T21:40:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/14627-sindrome-di-prader-willi-i-sintomi-e-la-vita-quotidiana-dei-pazienti-raccontati-in-un-video]]></loc><lastmod>2019-04-10T18:11:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/13118-sindrome-di-prader-willi-non-conclusivi-i-risultati-di-fase-iia-sul-farmaco-tesomet]]></loc><lastmod>2019-01-17T17:15:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/11109-sindrome-di-prader-willi-qual-e-il-costo-annuo-della-malattia]]></loc><lastmod>2016-08-08T19:11:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/10830-sindrome-di-prader-willi-ricerca-americana-getta-nuova-luce-sui-meccanismi-cerebrali-che-influenzano-la-malattia]]></loc><lastmod>2016-06-21T14:15:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/8800-sindrome-di-prader-willi-il-dr-marzullo-verbania-alterazioni-congenite-e-una-voracita-incoercibile-conducono-a-grave-obesita-e-problemi-cardiorespiratori]]></loc><lastmod>2015-08-21T09:45:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/8799-sindrome-di-prader-willi-la-terapia-con-ormone-della-crescita-aumenta-la-massa-cardiaca]]></loc><lastmod>2015-08-21T09:34:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/8392-sindrome-di-prader-willi-collaborazione-tra-nord-e-fpwr-per-promuovere-la-ricerca]]></loc><lastmod>2015-06-05T13:18:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/5318-sindrome-prader-willi-lefficacia-della-terapia-con-fattore-di-crescita]]></loc><lastmod>2017-04-04T16:29:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/4704-prader-willi-scoperta-una-mutazione-correlata-alla-patologia]]></loc><lastmod>2015-06-04T08:38:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/3334-sindrome-di-prader-willi-togliere-le-tonsille-puo-aiutare-a-risolvere-le-apnee-ostruttive-del-sonno]]></loc><lastmod>2015-06-04T08:38:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-prader-willi/2740-sindrome-di-prader-willi-la-storia-di-nadia-e-del-piccolo-giona]]></loc><lastmod>2016-12-02T10:28:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/22912-sindrome-di-rett-a-che-punto-e-la-ricerca-e-cosa-aspettarci-per-il-2026]]></loc><lastmod>2026-04-04T10:14:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/22802-trattare-la-sindrome-di-rett-con-un-antidepressivo-una-sfida-tutta-italiana]]></loc><lastmod>2026-02-28T12:07:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/22273-sindrome-di-rett-aperto-il-reclutamento-di-pazienti-per-la-sperimentazione-mirtarett]]></loc><lastmod>2025-09-04T12:30:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/22130-una-vita-a-colori-l-eredita-di-una-madre-oltre-il-dolore]]></loc><lastmod>2025-06-27T14:09:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/20132-sindrome-di-rett-trattata-in-canada-la-prima-paziente-con-la-terapia-genica]]></loc><lastmod>2023-09-21T13:47:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/20133-sindrome-di-rett-approvata-la-prima-terapia-farmacologica]]></loc><lastmod>2023-09-20T07:43:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/16416-sindrome-di-rett-pediatri-e-neuropsichiatri-infantili-sono-gli-specialisti-di-riferimento]]></loc><lastmod>2020-09-07T16:27:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/13776-sindrome-di-rett-dalla-fda-la-designazione-di-farmaco-orfano-per-amo-04]]></loc><lastmod>2018-07-20T15:57:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/13272-sindrome-di-rett-fino-al-4-marzo-una-raccolta-fondi-per-il-rett-innovation-centre]]></loc><lastmod>2018-02-25T00:17:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/13163-sindrome-di-rett-una-pagina-facebook-per-la-ricerca-sulla-terapia-genica]]></loc><lastmod>2018-01-29T19:45:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/12742-sindrome-di-rett-un-nuovo-progetto-terapeutico-dalla-sissa-di-trieste]]></loc><lastmod>2017-10-07T10:28:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/11953-sindrome-di-rett-a-siena-parte-una-nuova-sperimentazione-clinica]]></loc><lastmod>2017-02-19T12:11:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/10188-sindrome-di-rett-comunicati-gli-incoraggianti-risultati-preclinici-del-composto-sperimentale-anavex-2-73]]></loc><lastmod>2016-03-11T15:04:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/9819-sindrome-di-rett-un-antidepressivo-potrebbe-migliorare-i-sintomi-delle-pazienti]]></loc><lastmod>2016-01-26T11:02:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/9749-sindrome-di-rett-scoperto-nuovo-target-molecolare]]></loc><lastmod>2016-01-15T10:09:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/8916-sindrome-di-rett-parte-la-raccolta-fondi-di-airett-onlus-per-la-ricerca-scientifica]]></loc><lastmod>2015-09-15T07:27:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/8775-sindrome-di-rett-individuati-nuovi-meccanismi-che-possono-provocare-la-malattia]]></loc><lastmod>2015-08-07T10:31:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/7074-sindrome-di-rett-revive-therapeutics-richiede-alla-fda-la-designazione-di-farmaco-orfano-per-il-rev-003]]></loc><lastmod>2016-05-06T16:01:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/6808-sindrome-di-rett-qmia-figlia-e-una-paziente-scomoda-rischiano-di-lasciarla-morireq]]></loc><lastmod>2015-12-03T11:55:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/6694-sindrome-di-rett-al-via-la-campagna-solidale-a-favore-della-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/6315-sindrome-di-rett-i-farmaci-impiegati-per-il-parkinson-sono-utili-nel-ridurre-i-sintomi-associati-alla-patologia]]></loc><lastmod>2019-06-18T18:11:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/6146-sindrome-di-rett-studio-italiano-dimostra-causalita-con-lo-stresso-ossidativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/6047-sindrome-di-rett-dimostrata-limportanza-della-serotonina-come-terapia-potenziale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/5212-sindrome-di-rett-telethon-sostiene-la-speranza-per-giorgia-e-tutte-le-bambine-affette-dalla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/5096-sindrome-di-rett-avviato-un-consorzio-di-ricerca-airett-research-team]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/4925-sindrome-di-rett-la-piccola-noemi-torna-a-casa-dopo-il-ricovero-al-centro-di-eccellenza-di-houston]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/4224-sindrome-di-rett-individuato-nuovo-meccanismo-metabolico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/4160-sindrome-di-rett-proposta-di-legge-per-migliorare-lassistenza-chiesti-30-milioni-in-tre-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/4096-sindrome-di-rett-dal-20-maggio-al-23-giugno-un-sms-al-45509-per-sostenere-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/4064-sindrome-di-rett-si-ipotizza-che-la-malattia-sia-legata-al-genoma-oscuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/3901-sindrome-di-rett-ricerca-unica-al-mondo-individua-alterazioni-nel-microcircolo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/3796-sindrome-di-rett-dovigo-airett-lapproccio-integrato-migliora-la-vita-delle-ragazze-attendiamo-i-finanziamenti-per-il-protocollo-riabilitativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/3767-premio-omar-per-la-categoria-stampa-vince-chiara-ludovisi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/3570-sindrome-di-rett-prof-giustetto-to-tanta-ricerca-e-grandi-risultati-ma-i-fondi-sono-pochi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/3572-sindrome-di-rett-prima-di-un-fare-un-viaggio-della-speranza-e-bene-chiedere-agli-esperti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/3571-sindrome-di-rett-ora-ci-sono-le-linee-guida-per-la-ricerca-preclinica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/3556-sindrome-di-rett-prof-hayek-non-ci-sono-cure-miracolose-in-nessun-paese]]></loc><lastmod>2018-06-23T15:45:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/3348-sindrome-di-rett-a-siena-avviata-una-sperimentazione-unica-al-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/3164-sindrome-di-rett-disponibili-le-linee-guida-per-la-ricerca-preclinica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/2943-sindrome-di-rett-sul-modello-animale-si-studiano-i-possibili-benefici-della-ketamina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/2336-sindrome-di-rett-gli-omega-3-possono-migliorare-le-funzioni-respiratorie-motorie-e-comunicative-nelle-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/1984-sindrome-di-rett-una-tossina-di-escherichia-coli-come-possibile-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/1866-sindrome-di-rett-si-guarda-al-trapianto-di-midollo-per-arrestarne-i-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/1500-sindrome-di-rett-nuova-importante-scoperta-dalle-scotte-di-siena-i-globuli-rossi-hanno-forma-anomala]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/1364-sindrome-di-rett-studio-senese-individua-disfunzione-colpisce-il-cuore-delle-bimbe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/1206-sindrome-di-rett-da-siena-un-marker-per-la-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/1170-sindrome-di-rett-studio-condotto-dallcnr-mostra-cosa-rallenta-il-cervello-delle-bimbe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/814-sindrome-di-rett-al-san-raffaele-laboratorio-specializzato-per-la-ricerca-lo-sostiene-anche-pro-rett-ricerca-onlus]]></loc><lastmod>2015-06-05T17:51:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/833-sindrome-di-rett-e-bastata-unanalisi-del-sangue-per-risolvere-un-dubbio-lungo-38-anni]]></loc><lastmod>2020-09-02T10:11:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/794-sindrome-di-rett-nuova-luce-sul-funzionamento-della-proteina-mecp2]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/781-sindrome-di-rett-intervista-a-lucia-dovigoairett-su-benessere-in-radio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/577-sindrome-di-rett-e-autismo-alle-scotte-di-siena-si-sperimenta-la-poesia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/543-nsindrome-di-rett-studio-italiano-trova-nuovo-bersaglio-terapeutico-per-riattivare-il-cervello]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/524-sindrome-di-rett-la-professoressa-landsberger-nominata-commendatore-al-merito]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/452-huntington-e-sindrome-rett-studio-italiano-scopre-proteina-implicata-nello-sviluppo-dei-neuroni-gabaergici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/426-sindrome-di-rett-a-siena-ancora-un-esperimento-musicale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/422-sindrome-di-rett-aperto-il-bando-di-ricerca-dellair-2011]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/368-sindrome-di-rett-i-polmoni-delle-bimbe-possono-avere-gli-stessi-problemi-di-un-fumatore-accanito]]></loc><lastmod>2021-09-17T15:11:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/353-sindrome-di-rett-alle-scotte-di-siena-esperimenti-sensoriali-con-i-profumi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/306-sindrome-di-rett-due-studi-fanno-luce-sui-meccanismi-del-danno-neurologico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-rett/178-sindrome-di-rett-230mila-euro-per-la-ricerca-assegnati-al-policlinico-le-scotte-di-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-williams]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-williams/22603-sindrome-di-williams-uno-studio-cinese-segnala-perdite-uditive-gia-nei-primi-mesi-di-vita]]></loc><lastmod>2025-12-14T23:38:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-williams/18664-sindrome-di-williams-l-autonomia-e-possibile-e-passa-anche-per-il-lavoro]]></loc><lastmod>2022-05-20T13:59:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-williams/18665-sindrome-di-williams-oggi-si-celebra-la-giornata-mondiale]]></loc><lastmod>2022-05-20T13:08:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-williams/12578-sindrome-di-williams-un-progetto-per-potenziare-le-abilita-dei-pazienti]]></loc><lastmod>2017-08-09T16:06:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-williams/11588-sindrome-di-williams-e-nata-l-associazione-persone-williams-italia-onlus]]></loc><lastmod>2016-11-10T08:57:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-williams/3271-sindrome-di-williams-bambino-gesu-e-deutsche-bank-danno-valore-allesperienza]]></loc><lastmod>2017-08-09T15:45:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-williams/2662-sindrome-di-williams-ecco-come-la-malattia-colpisce-il-cervello]]></loc><lastmod>2016-11-29T11:16:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-di-williams/2607-sindrome-di-williams-dimostrato-il-ruolo-chiave-dellossitocina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/21312-sindrome-emolitico-uremica-atipica-oggi-la-giornata-di-sensibilizzazione]]></loc><lastmod>2024-09-23T17:58:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/21174-sindrome-emolitico-uremica-atipica-la-gestione-della-patologia-in-eta-pediatrica]]></loc><lastmod>2024-07-15T17:29:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/21109-sindrome-emolitico-uremica-atipica-il-trapianto-di-rene-e-oggi-un-intervento-evitabile]]></loc><lastmod>2024-06-24T14:44:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/20872-sindrome-emolitico-uremica-atipica-la-gestione-della-patologia-in-fase-acuta]]></loc><lastmod>2024-04-15T17:27:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/20589-sindrome-emolitico-uremica-atipica-le-sfide-della-diagnosi-differenziale]]></loc><lastmod>2024-02-11T12:30:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/20149-sindrome-emolitico-uremica-atipica-il-24-settembre-e-la-giornata-dedicata-alla-malattia]]></loc><lastmod>2024-09-19T17:26:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/19817-sindrome-emolitico-uremica-atipica-ravulizumab-rimborsabile-in-italia]]></loc><lastmod>2023-05-24T10:27:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/18348-sindrome-emolitico-uremica-atipica-annunciati-i-vincitori-di-rare-hack-for-new-ideas]]></loc><lastmod>2022-02-27T12:19:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/18086-sindrome-emolitico-uremica-atipica-alexion-e-h-farm-lanciano-rare-hack-for-new-ideas]]></loc><lastmod>2021-12-12T16:08:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/12429-sindrome-emolitico-uricemica-atipica-le-priorita-d-indagine-indicate-dai-pazienti]]></loc><lastmod>2023-05-24T10:28:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/9971-sindrome-emolitico-uremica-atipica-salva-la-neonata-svizzera-grazie-alle-nuove-terapie]]></loc><lastmod>2023-05-24T10:29:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/9917-sindrome-emolitico-uremica-atipica-trattata-con-successo-una-neonata-colpita-dalla-malattia]]></loc><lastmod>2023-05-24T10:29:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/9290-porpora-trombotica-trombocitopenica-e-sindrome-emolitico-uremica-atipica-nuovi-strumenti-di-laboratorio-per-una-complessa-diagnosi-differenziale]]></loc><lastmod>2023-05-24T10:30:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/8966-sindrome-emolitico-uremica-atipica-nuove-linee-guida-sulla-gestione-clinica-dei-pazienti]]></loc><lastmod>2023-05-24T10:31:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/7288-sindrome-emolitico-uremica-atipica-il-nice-approva-soliris]]></loc><lastmod>2023-05-24T10:40:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/7205-sindrome-emolitico-uremica-sindrome-da-anticorpi-antifosfolipidi-e-caps-il-successo-di-eculizumab]]></loc><lastmod>2023-05-24T10:36:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/7096-sindrome-emolitico-uremica-il-trattamento-sembra-ben-tollerato-anche-in-gravidanza]]></loc><lastmod>2023-05-24T10:39:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/6994-sindrome-emolitica-uremica-atipica-alexion-pharmaceuticals-annuncia-la-presentazione-in-dettaglio-dei-risultati-su-eculizumab]]></loc><lastmod>2023-05-24T10:40:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/6653-sindrome-emolitica-uremica-atipica-nice-raccomanda-il-commissionamento-in-inghilterra-di-eculizumab-per-tutti-i-pazienti]]></loc><lastmod>2023-05-24T10:41:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/6105-sindrome-emolitico-uremica-ulteriore-approvazione-per-eculizumab-negli-usa]]></loc><lastmod>2023-05-24T10:43:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/5924-sindrome-emolitico-uremica-atipica-confermata-la-superiorita-di-eculizumab-rispetto-alla-terapia-plasmatica]]></loc><lastmod>2023-05-24T10:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/5166-sindrome-emoltico-uremica-atipica-e-emoglobinuria-parossistica-notturna-nuovi-dati-sullefficacia-di-soliris]]></loc><lastmod>2023-05-24T10:48:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/4870-sindrome-emolitica-uremica-atipica-alexion-presentera-nuovi-dati-su-soliris-alla-riunione-annuale-della-societa-americana-di-nefrologia]]></loc><lastmod>2023-05-24T10:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/4783-sindrome-emolitica-uremica-atipica-anche-il-giappone-autorizza-luso-di-eculizumab]]></loc><lastmod>2023-05-24T10:48:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/4643-sindrome-emolitico-uremica-atipica-approvato-nel-regno-unito-luso-di-eculizumab]]></loc><lastmod>2023-05-24T10:48:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/4499-sindrome-emolitico-uremica-allarme-in-puglia-i-casi-saliti-a-16]]></loc><lastmod>2023-05-24T10:49:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/4183-sindrome-emolitico-uremica-atipica-conferme-per-il-soliris-di-alexion]]></loc><lastmod>2023-05-24T10:50:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/3742-sindrome-emolitico-uremica-atipica-uno-studio-italiano-individua-le-mutazioni-genetiche-che-ne-innalzano-il-rischio]]></loc><lastmod>2023-05-24T10:51:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/1782-sindrome-emolitico-uremica-salvato-un-piccolo-paziente-grazie-a-eculizumab-un-farmaco-recentemente-approvato-per-questa-indicazione]]></loc><lastmod>2023-05-24T10:52:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/882-sindrome-emolitica-uremica-atipica-il-soliris-sara-erogato-dal-ssn-fino-ad-approvazione-definitiva]]></loc><lastmod>2023-05-24T10:53:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-emolitico-uremica-atipica/340-sindrome-emolitico-uremica-uno-studio-del-mario-negri-individua-i-geni-responsabili]]></loc><lastmod>2023-05-24T10:55:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila/21556-sindrome-ipereosinofila-verso-un-codice-di-esenzione-univoco-per-la-corretta-presa-in-carico-dei-pazienti]]></loc><lastmod>2024-12-05T08:30:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila/21317-sindrome-ipereosinofila-renato-da-reggio-calabria-a-milano-per-giungere-a-una-diagnosi]]></loc><lastmod>2024-09-25T11:30:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila/21045-sindrome-ipereosinofila-la-storia-di-barbara-da-una-dermatite-alla-diagnosi-di-miocardite-eosinofila]]></loc><lastmod>2024-06-04T14:15:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila/21031-sindrome-ipereosinofila-un-pdta-per-ottimizzare-la-presa-in-carico-dei-malati]]></loc><lastmod>2024-05-30T17:02:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila/20904-sindrome-ipereosinofila-il-momento-della-diagnosi-quale-nodo-cruciale-del-percorso]]></loc><lastmod>2024-05-02T08:48:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila/20877-sindrome-ipereosinofila-sotto-questo-cappello-diverse-malattie-rare]]></loc><lastmod>2024-04-15T14:42:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila/20828-sindrome-ipereosinofila-esiste-anche-una-variante-neoplastica]]></loc><lastmod>2024-04-03T14:48:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila/20808-sindrome-ipereosinofila-una-malattia-rara-per-la-quale-e-necessaria-una-presa-in-carico-multidisciplinare]]></loc><lastmod>2024-03-27T12:46:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila/19702-granulomatosi-eosinofilica-con-poliangioite-disponibile-in-italia-la-prima-terapia-specifica-per-la-patologia]]></loc><lastmod>2024-03-13T15:35:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindrome-ipereosinofila/17824-malattie-da-eosinofili-parere-positivo-del-chmp-per-mepolizumab]]></loc><lastmod>2024-03-13T15:36:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/22693-sindrome-delle-febbri-ricorrenti-indifferenziate-il-gaslini-identifica-i-segnali-clinici-per-riconoscere-la-patologia]]></loc><lastmod>2026-02-12T10:54:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/20216-malattie-reumatiche-necessario-agevolare-il-passaggio-del-paziente-dalle-cure-pediatriche-a-quelle-dell-adulto]]></loc><lastmod>2023-10-11T10:18:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/19752-malattie-reumatologiche-in-eta-pediatrica-quali-sono-i-campanelli-d-allarme]]></loc><lastmod>2023-04-29T16:07:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/19249-malattie-autoinfiammatorie-myfever-un-applicazione-progettata-da-clinici-e-pazienti]]></loc><lastmod>2022-11-11T11:21:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/19177-febbri-periodiche-tutti-i-vantaggi-dell-app-myfever]]></loc><lastmod>2022-10-18T16:37:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/18943-myfever-un-diario-digitale-per-gestire-al-meglio-le-febbri-periodiche]]></loc><lastmod>2022-10-18T16:36:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/18782-malattie-autoinfiammatorie-quando-la-febbre-non-ha-una-causa-apparente]]></loc><lastmod>2022-10-18T16:30:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/18554-myfever-la-prima-app-dedicata-ai-pazienti-con-malattie-autoinfiammatorie]]></loc><lastmod>2022-10-18T16:33:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/18121-malattie-autoinfiammatorie-arriva-myfever-il-primo-diario-digitale-per-i-pazienti]]></loc><lastmod>2022-10-18T16:34:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/13602-al-bambino-gesu-identificata-una-terapia-per-tre-rare-malattie-autoinfiammatorie]]></loc><lastmod>2022-10-18T16:50:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/12614-la-storia-di-rosanna-mi-e-stato-prescritto-il-farmaco-ma-nessuno-me-lo-eroga]]></loc><lastmod>2022-10-19T14:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/12437-fcas2-la-malattia-rara-che-arriva-dal-freddo]]></loc><lastmod>2022-10-19T14:57:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/12277-febbre-mediterranea-familiare-il-problema-principale-resta-quello-di-una-corretta-diagnosi]]></loc><lastmod>2022-10-18T15:40:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/12260-febbre-mediterranea-familiare-la-malattia-e-inclusa-nei-nuovi-lea]]></loc><lastmod>2022-10-18T15:41:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/11763-sindromi-da-febbre-periodica-novartis-riceve-dal-chmp-una-raccomandazione-positiva-per-canakinumab]]></loc><lastmod>2022-10-18T15:54:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/11403-sindrome-da-febbre-periodica-fda-autorizza-l-uso-di-canakinumab-per-tre-varianti-della-malattia]]></loc><lastmod>2022-10-18T15:57:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/10722-sindrome-da-febbre-periodica-negli-usa-il-farmaco-ilaris-designato-breakthrough-therapy]]></loc><lastmod>2022-10-18T16:00:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/9958-febbre-mediterranea-pubblicate-raccomandazioni-eular-su-gestione-e-trattamento]]></loc><lastmod>2022-10-18T15:43:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/9789-febbre-al-policlinico-dell-universita-degli-studi-di-milano-nasce-un-centro-dedicato]]></loc><lastmod>2022-10-18T16:05:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/8640-febbre-mediterranea-familiare-la-leucemia-mielomonocitica-cronica-puo-esserne-la-causa]]></loc><lastmod>2022-10-18T15:44:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/8131-febbre-mediterranea-familiare-senza-mutazioni-mefv-il-fenotipo-e-molto-simile-a-quello-classico-della-malattia]]></loc><lastmod>2022-10-18T15:47:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/5534-sindrome-traps-lynn-racconta-ne-sono-affetti-mio-marito-e-mio-figlio]]></loc><lastmod>2022-10-19T14:47:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/4828-sindrome-di-schnitzler-ottenuti-esiti-promettenti-dalla-sperimentazione-del-farmaco-canakinumab]]></loc><lastmod>2022-10-19T14:34:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/4766-malattie-autoinfiammatorie-sistemiche-lesperienza-senese-porta-frutti-in-brasile]]></loc><lastmod>2022-10-18T16:52:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/4727-caps-concesso-in-europa-parere-positivo-allutilizzo-del-farmaco-anakinra]]></loc><lastmod>2022-10-18T16:59:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/3938-febbri-periodiche-in-molte-regioni-pazienti-ancora-senza-riconoscimento]]></loc><lastmod>2022-10-18T16:07:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/3181-febbri-periodiche-il-farmaco-di-novartis-gia-usato-per-le-caps-potrebbe-servire-anche-ad-altre-malattie]]></loc><lastmod>2022-10-18T16:11:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/2831-lassociazione-italiana-febbri-periodiche-aifp-annuncia-la-creazione-del-comitato-scientifico]]></loc><lastmod>2022-10-18T16:22:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/2524-caps-sindromi-periodiche-associate-alla-criopirina-si-attende-lapprovazione-di-anakinra]]></loc><lastmod>2022-10-18T17:02:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/2459-sindrome-di-schnitzler-primi-risultati-positivi-per-canakinumab]]></loc><lastmod>2022-10-19T14:29:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/2105-febbri-periodichelassociaizone-aifp-chiede-attenzione-alle-istituzioni]]></loc><lastmod>2022-10-18T16:24:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/1673-malattia-infiammatoria-multisistemica-ad-esordio-neonatale-il-farmaco-anakinra-ne-puo-bloccare-la-progressione]]></loc><lastmod>2022-10-19T14:12:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/712-caps-roberto-non-riuscivo-nemmeno-a-scrivere-ora-esco-anche-con-gli-amici]]></loc><lastmod>2022-10-18T17:12:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/711-caps-arriva-il-farmaco-che-spegne-linterruttore-dellinfiammazione-e-non-e-cortisone]]></loc><lastmod>2022-10-18T17:06:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/558-febbri-periodiche-caps-al-via-campagna-per-riconoscere-questa-malattia-genetica]]></loc><lastmod>2022-10-18T16:29:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/sindromi-da-febbri-periodiche/327-febbre-mediterranea-familiare-sabato-un-convegno-a-reggio-calabria]]></loc><lastmod>2022-10-18T15:49:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22915-talassemia-trasfusione-dipendente-e-sarcopenia-un-legame-ancora-da-esplorare]]></loc><lastmod>2026-04-08T17:13:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22807-dallintuizione-alla-pratica-clinica-lo-yoga-per-i-pazienti-con-talassemia]]></loc><lastmod>2026-03-02T18:35:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22808-yoga-e-talassemia-lincontro-virtuoso-per-stare-meglio]]></loc><lastmod>2026-03-02T18:35:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22756-alfa-talassemia-una-malattia-rara-sempre-piu-globale]]></loc><lastmod>2026-02-17T09:17:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22512-terapie-innovative-sulla-talassemia-un-milione-di-euro-a-palermo-per-fondazione-cutino]]></loc><lastmod>2025-11-14T08:54:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22469-garden-la-rete-globale-che-unisce-ricerca-formazione-e-pazienti-nelle-malattie-ematologiche-rare]]></loc><lastmod>2025-11-04T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22429-talassemia-dal-chmp-parere-positivo-per-il-farmaco-mitapivat]]></loc><lastmod>2025-10-21T16:05:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22323-beta-talassemia-e-anemia-falciforme-ora-la-terapia-genica-e-approvata-in-italia]]></loc><lastmod>2025-09-19T13:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22184-talassemia-e-anemia-falciforme-tutti-gli-aggiornamenti-dal-congresso-della-european-hematology-association]]></loc><lastmod>2025-07-14T10:10:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22058-alfa-e-beta-talassemia-risultati-promettenti-da-due-studi-clinici-su-mitapivat]]></loc><lastmod>2025-06-06T10:40:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/22050-talassemia-grande-successo-per-il-progetto-opportunita-e-rischi-del-cambiamento]]></loc><lastmod>2025-06-04T20:19:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21960-8-maggio-giornata-mondiale-della-talassemia-i-talk-di-fondazione-cutino-tutti-i-venerdi-del-mese]]></loc><lastmod>2025-09-22T15:27:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21890-talassemia-aurelio-maggio-e-il-nuovo-presidente-della-fondazione-franco-e-piera-cutino]]></loc><lastmod>2025-04-08T15:21:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21877-talassemia-al-centro-di-ferrara-e-attivo-un-pdta-dedicato-ai-pazienti]]></loc><lastmod>2025-04-04T18:17:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21822-talassemia-l-avvento-dei-nuovi-farmaci]]></loc><lastmod>2025-03-29T17:32:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21795-talassemia-oggi-la-vita-dei-pazienti-e-sempre-piu-simile-a-quella-di-chi-non-ha-la-malattia]]></loc><lastmod>2025-03-15T11:54:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21776-talassemia-prevenire-le-complicanze-della-malattia-e-migliorare-la-qualita-di-vita]]></loc><lastmod>2025-03-29T17:31:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21689-talassemia-l-esperienza-del-prof-aurelio-maggio-al-servizio-dei-pazienti]]></loc><lastmod>2025-02-04T17:13:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21157-beta-talassemia-il-sistema-crispr-rivoluziona-la-vita-di-un-giovane-paziente-italiano]]></loc><lastmod>2024-07-09T10:55:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21153-talassemia-con-l-arrivo-di-terapie-innovative-sempre-piu-importante-il-dialogo-medico-paziente]]></loc><lastmod>2024-07-08T09:43:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21141-beta-talassemia-e-drepanocitosi-la-carenza-di-sangue-e-ancora-un-problema]]></loc><lastmod>2024-07-03T12:45:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21083-talassemia-il-quadro-genetico-muta-sulla-spinta-dei-flussi-migratori]]></loc><lastmod>2024-06-15T16:06:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21080-donazione-di-sangue-gli-addetti-ai-lavori-serve-ricambio-generazionale]]></loc><lastmod>2024-06-13T16:20:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21057-talassemia-in-sardegna-nasce-l-associazione-ates-con-l-obiettivo-primario-della-prevenzione]]></loc><lastmod>2024-06-10T09:53:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/21042-dalla-chimica-clinica-alle-analisi-genetiche-il-percorso-diagnostico-delle-talassemie]]></loc><lastmod>2024-06-03T10:59:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20929-al-via-il-maggio-della-talassemia-della-fondazione-franco-e-piera-cutino]]></loc><lastmod>2024-05-03T12:06:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20899-talassemia-united-velocizzare-approvazione-di-terapie-innovative-e-mantenere-alta-attenzione-su-disponibilita-sangue]]></loc><lastmod>2024-04-23T09:29:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20771-talassemie-ed-emoglobinopatie-verso-la-concretizzazione-della-rete-nazionale-e-del-registro-di-patologia]]></loc><lastmod>2024-03-18T16:22:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20770-le-terapie-innovative-nelle-talassemie-ed-emoglobinopatie-a-che-punto-siamo]]></loc><lastmod>2024-03-18T16:36:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20723-8-marzo-la-fondazione-cutino-celebra-le-donne-con-talassemia]]></loc><lastmod>2024-03-06T16:20:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20704-beta-talassemia-l-impatto-delle-trasfusioni-sottrae-tempo-e-aggiunge-fatica-ai-pazienti]]></loc><lastmod>2024-02-29T18:56:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20682-carenza-sangue-un-problema-ormai-cronico-per-i-pazienti-talassemici-e-non-solo]]></loc><lastmod>2024-02-28T17:45:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20629-talassemia-approvazione-europea-per-la-terapia-di-editing-genomico-exa-cel]]></loc><lastmod>2024-02-13T20:34:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20555-beta-talassemia-un-indagine-svela-il-peso-della-malattia-su-pazienti-e-caregiver]]></loc><lastmod>2024-01-25T10:24:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20375-talassemia-e-anemia-falciforme-via-libera-in-uk-alla-prima-terapia-crispr-in-assoluto]]></loc><lastmod>2023-11-23T09:05:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20180-talassemia-ed-emergenza-sangue-necessario-un-piano-strutturato-di-sensibilizzazione]]></loc><lastmod>2023-10-02T11:30:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/20126-la-rete-talassemie-e-realta-pubblicato-il-decreto-in-gazzetta-ufficiale]]></loc><lastmod>2023-09-18T07:39:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19890-beta-talassemia-circa-settemila-le-persone-affette-dalla-patologia-in-italia]]></loc><lastmod>2023-06-12T10:21:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19865-celocentesi-la-storia-della-tecnica-di-diagnosi-prenatale-precoce-per-la-talassemia-e-non-solo]]></loc><lastmod>2023-06-04T08:48:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19866-talassemia-e-diagnosi-prenatale-precoce-la-celocentesi-sicura-gia-dal-secondo-mese-di-gravidanza]]></loc><lastmod>2023-06-13T10:03:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19835-la-rete-talassemie-sta-per-diventare-realta-la-soddisfazione-di-united]]></loc><lastmod>2023-09-18T07:18:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19798-rete-talassemie-ed-emoglobinopatie-pronta-la-bozza-di-decreto-attuativo-per-renderla-effettiva]]></loc><lastmod>2023-05-12T10:28:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19725-talassemia-indagato-l-uso-degli-anticoagulanti-orali-diretti-per-ridurre-gli-accessi-venosi]]></loc><lastmod>2023-04-19T20:47:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19637-talassemia-oggi-il-futuro-fa-meno-paura]]></loc><lastmod>2023-03-20T11:33:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19474-talassemia-eseguito-a-bergamo-il-primo-trapianto-di-polmone-da-vivente-in-italia]]></loc><lastmod>2023-01-25T12:07:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19480-terapia-genica-per-beta-talassemia-e-anemia-falciforme-ema-valutera-immissione-in-commercio-di-nuovo-farmaco]]></loc><lastmod>2023-11-21T11:11:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19411-talassemia-associazione-piera-cutino-e-sportello-legale-omar-insieme-per-la-guida-ai-diritti-dei-talassemici]]></loc><lastmod>2023-02-23T10:55:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19260-talassemia-e-emoglobinopatie-avviato-a-catania-il-primo-master-italiano-di-i-livello]]></loc><lastmod>2022-11-09T13:59:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/18956-talassemia-trapianto-di-midollo-da-donatore-compatibile-per-la-guarigione-dalla-malattia]]></loc><lastmod>2023-02-23T10:56:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/18801-talassemia-l-esperienza-di-giuseppe-e-simona-guariti-con-la-terapia-genica]]></loc><lastmod>2023-02-23T10:57:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/18792-beta-talassemia-con-luspatercept-il-50-dei-pazienti-dimezza-il-fabbisogno-di-sangue]]></loc><lastmod>2022-06-18T13:01:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/18786-estate-emergenza-sangue-pazienti-talassemici-non-dimenticatevi-di-noi]]></loc><lastmod>2022-06-17T11:03:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/18744-talassemia-l-importanza-del-supporto-psicologico-per-pazienti-e-famiglie]]></loc><lastmod>2022-06-08T15:58:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/18547-beta-talassemia-al-via-la-prima-campagna-nazionale-di-sensibilizzazione]]></loc><lastmod>2022-04-14T13:15:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/18111-terapie-trasfusionali-italia-modello-europeo-nel-patient-blood-management]]></loc><lastmod>2021-12-19T18:48:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/18043-beta-talassemia-e-sindromi-mielodisplastiche-luspatercept-rimborsabile-in-italia]]></loc><lastmod>2021-11-27T22:10:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17958-covid-19-e-fabbisogno-di-sangue-l-impatto-della-pandemia-sulle-terapie-trasfusionali]]></loc><lastmod>2021-10-31T22:42:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/19099-beta-talassemia-la-terapia-genica-beti-cel-ritirata-dall-europa]]></loc><lastmod>2022-09-22T18:00:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17827-talassemia-in-sardegna-non-solo-carenza-di-sangue-ma-anche-di-personale]]></loc><lastmod>2021-09-28T10:24:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17794-talassemia-e-malattie-genetiche-la-diagnosi-preimpianto-e-realta-solo-per-pochi]]></loc><lastmod>2021-09-29T13:31:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17793-talassemia-ad-alghero-nasce-la-banca-delle-emazie-rare]]></loc><lastmod>2021-09-17T16:29:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17684-talassemia-e-anemia-falciforme-blood-artists-arriva-a-palermo]]></loc><lastmod>2021-07-25T17:50:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17674-talassemia-un-interrogazione-chiede-il-rispetto-dei-100-giorni-per-l-approvazione-della-terapia-genica]]></loc><lastmod>2021-07-22T15:20:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17404-due-mondi-a-confronto-la-talassemia-vista-con-gli-occhi-di-carlo-e-valentino]]></loc><lastmod>2021-05-07T11:36:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17402-talassemia-i-piu-importanti-esperti-nel-convegno-dell-associazione-piera-cutino]]></loc><lastmod>2021-05-06T20:32:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17202-terapie-per-la-talassemia-il-punto-di-vista-dei-pazienti]]></loc><lastmod>2021-03-21T20:14:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17136-talassemia-bluebird-bio-presenta-un-cortometraggio-sulla-quotidianita-dei-pazienti]]></loc><lastmod>2021-03-09T14:01:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17131-malattie-ematologiche-rare-al-via-la-campagna-donare-la-colomba-rende-felici-come-una-pasqua]]></loc><lastmod>2021-03-06T22:17:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/17094-talassemia-si-puo-ancora-parlare-di-malattia-rara]]></loc><lastmod>2021-03-02T14:52:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16798-emoglobinopatie-al-congresso-ash-gli-ultimi-dati-clinici-sulla-terapia-genica]]></loc><lastmod>2020-12-13T12:07:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16789-talassemia-primo-paziente-italiano-trattato-con-crispr]]></loc><lastmod>2020-12-09T16:54:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16782-emoglobinopatie-novartis-lancia-la-campagna-blood-artists]]></loc><lastmod>2020-12-08T20:22:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16519-beta-talassemia-buoni-risultati-dalla-terapia-genica-beti-cel]]></loc><lastmod>2020-12-10T16:58:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16365-talassemia-in-sardegna-il-percorso-che-ha-portato-ad-un-unica-associazione]]></loc><lastmod>2020-08-10T16:19:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16344-talassemia-la-protesta-dei-pazienti-sardi-trasfusioni-a-rischio-per-mancanza-di-personale]]></loc><lastmod>2020-07-30T16:39:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16320-rete-nazionale-talassemia-ed-emoglobinopatie-il-ministro-speranza-firma-il-decreto-attuativo]]></loc><lastmod>2022-03-25T14:31:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16222-talassemia-l-associazione-piera-cutino-racconta-il-campus-di-ematologia-di-palermo]]></loc><lastmod>2020-06-25T14:51:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16209-talassemia-fda-concede-designazione-orfana-al-farmaco-mitapivat]]></loc><lastmod>2020-06-21T22:04:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16188-beta-talassemia-nuovi-dati-dagli-studi-di-fase-iii-sulla-terapia-genica]]></loc><lastmod>2020-06-16T15:52:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16091-talassemia-e-covid-19-nessun-caso-di-contagio-virale-con-le-trasfusioni]]></loc><lastmod>2020-05-20T16:54:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16052-beta-talassemia-riduzione-delle-trasfusioni-con-il-farmaco-sottocute-luspatercept]]></loc><lastmod>2020-05-11T00:39:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/16041-thalassemia-day-si-celebra-oggi-la-decima-edizione]]></loc><lastmod>2020-05-07T20:40:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15750-coronavirus-le-misure-del-governo-non-vietano-le-donazioni-di-sangue]]></loc><lastmod>2020-03-12T08:59:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15731-talassemia-la-covid-19-non-deve-fermare-le-donazioni-di-sangue]]></loc><lastmod>2020-03-11T10:49:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15633-talassemia-a-thalathon-trionfa-il-progetto-di-sensibilizzazione-bloodartists]]></loc><lastmod>2020-02-04T22:19:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15591-talassemia-la-terza-sfida-di-thalathon-riguardera-la-gestione-della-patologia]]></loc><lastmod>2020-01-20T17:34:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15587-talassemia-in-germania-arriva-la-terapia-genica]]></loc><lastmod>2020-01-19T17:58:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15584-talassemia-con-il-progetto-thalathon-si-puntera-anche-alla-sensibilizzazione]]></loc><lastmod>2020-01-17T11:26:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15533-talassemia-tra-le-sfide-di-thalathon-la-valorizzazione-del-tempo-da-passare-in-ospedale]]></loc><lastmod>2019-12-22T17:18:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15511-beta-talassemia-nuovi-risultati-a-lungo-termine-per-lentiglobin]]></loc><lastmod>2021-02-23T12:11:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15518-talassemia-aperte-le-iscrizioni-per-thalathon-il-primo-hackaton-dedicato-alla-malattia]]></loc><lastmod>2019-12-16T14:55:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15440-talassemia-una-proposta-per-rendere-sostenibile-la-terapia-genica]]></loc><lastmod>2019-11-24T18:36:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/15088-talassemia-la-comunita-scientifica-si-prepara-ad-accogliere-la-terapia-genica]]></loc><lastmod>2019-07-30T14:54:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14977-talassemia-nasce-una-banca-dati-internazionale-per-la-ricerca]]></loc><lastmod>2019-07-03T08:41:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14931-beta-talassemia-con-la-terapia-genica-alcuni-pazienti-liberi-da-trasfusioni-dopo-3-8-anni]]></loc><lastmod>2019-06-20T10:23:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14900-beta-talassemia-trasfusione-dipendente-il-valore-aggiunto-della-terapia-genica]]></loc><lastmod>2019-06-11T12:13:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14876-beta-talassemia-approvata-in-europa-la-prima-terapia-genica-per-la-patologia]]></loc><lastmod>2019-06-04T10:10:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14792-talassemia-partira-a-giugno-a-milano-la-prima-scuola-di-alta-formazione]]></loc><lastmod>2019-05-12T20:14:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14781-beta-talassemia-trasfusione-dipendente-la-battaglia-quotidiana-dei-pazienti]]></loc><lastmod>2019-05-07T14:57:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14783-talassemia-trasfusione-dipendente-designazione-fast-track-per-ctx001]]></loc><lastmod>2019-05-07T14:59:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14784-talassemia-oggi-la-giornata-mondiale-le-voci-dei-pazienti-informarsi-per-non-temere]]></loc><lastmod>2019-05-07T15:05:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14707-talassemia-dal-vanvitelli-di-napoli-speranza-su-nuove-prospettive-terapeutiche]]></loc><lastmod>2019-04-12T09:30:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14704-talassemia-united-onlus-finalmente-la-terapia-che-aspettavamo-da-decenni]]></loc><lastmod>2019-04-08T17:44:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14670-beta-talassemia-parere-favorevole-del-chmp-per-la-terapia-genica]]></loc><lastmod>2019-04-02T18:46:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14664-terapie-avanzate-prof-drago-grande-occasione-ma-manca-strategia-serve-tavolo-con-gli-stakeolder]]></loc><lastmod>2019-04-02T13:20:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14552-talassemia-fondazione-cutino-cerca-sponsor-per-presentare-un-nuovo-studio]]></loc><lastmod>2019-03-10T10:12:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14522-beta-talassemia-un-indagine-per-far-conoscere-il-vissuto-dei-pazienti]]></loc><lastmod>2019-02-27T15:43:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14395-beta-talassemia-uno-studio-clinico-dimostra-sicurezza-ed-efficacia-della-terapia-genica]]></loc><lastmod>2019-09-10T14:18:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14301-talassemia-trent-anni-di-successi-in-un-documentario]]></loc><lastmod>2019-09-10T14:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14293-beta-talassemia-presentati-nuovi-dati-dagli-studi-di-fase-iii-sulla-terapia-genica]]></loc><lastmod>2018-12-17T19:07:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14268-talassemia-con-la-celocentesi-una-diagnosi-prenatale-molto-precoce]]></loc><lastmod>2018-12-11T19:18:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/14003-beta-talassemia-ema-accetta-la-richiesta-di-approvazione-per-la-terapia-genica]]></loc><lastmod>2018-10-05T18:09:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13892-beta-talassemia-avviata-in-europa-la-prima-sperimentazione-clinica-con-crispr]]></loc><lastmod>2018-10-05T18:06:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13821-beta-talassemia-trasfusione-dipendente-valutazione-accelerata-dell-ema-per-la-terapia-genica]]></loc><lastmod>2021-02-23T12:01:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13781-talassemia-ed-emoglobinopatie-avviati-il-registro-e-la-rete-nazionale]]></loc><lastmod>2018-07-25T10:55:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13761-talassemie-trasfusione-dipendenti-cosa-sono-e-quali-le-novita-in-arrivo]]></loc><lastmod>2018-08-02T16:49:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13707-beta-talassemia-la-terapia-genica-contrasta-la-dipendenza-da-trasfusione]]></loc><lastmod>2021-02-23T12:00:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13659-talassemia-hbe-bt-promettente-il-binomio-crispr-e-terapia-cellulare]]></loc><lastmod>2018-06-13T14:23:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13606-talassemia-major-la-bimba-salvata-dal-trapianto-di-midollo-in-utero]]></loc><lastmod>2018-05-31T11:04:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13475-beta-talassemia-addio-alle-trasfusioni-anche-per-i-pazienti-con-assenza-totale-di-emoglobina]]></loc><lastmod>2018-08-02T18:08:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13468-la-terapia-genica-e-sempre-piu-reale-per-la-beta-talassemia-funziona-ecco-i-dati]]></loc><lastmod>2018-08-02T18:13:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13465-beta-talassemia-stop-alle-trasfusioni-con-la-nuova-terapia-genica]]></loc><lastmod>2025-12-05T16:49:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13439-talassemia-i-40-anni-di-esperienza-del-microcitemico-di-cagliari-in-una-pubblicazione]]></loc><lastmod>2018-04-16T12:15:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/13029-anemia-falciforme-e-beta-talassemia-presto-il-trattamento-di-editing-genomico-crispr-cas9]]></loc><lastmod>2017-12-14T02:16:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/12269-talassemia-e-drepanocitosi-nasce-l-italian-associations-advocacy-council]]></loc><lastmod>2017-05-13T08:48:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/11860-beta-talassemia-buoni-risultati-da-luspatercept]]></loc><lastmod>2017-01-29T18:25:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/11189-beta-talassemia-attenzione-al-rischio-osteoporosi-i-consigli-dell-esperto-per-la-diagnosi-precoce]]></loc><lastmod>2016-09-02T11:10:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/10982-beta-talassemia-qual-e-il-miglior-trattamento-per-l-osteoporosi]]></loc><lastmod>2016-07-15T12:09:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/10589-talassemia-centri-esperti-a-rischio-per-tagli-e-carenza-di-personale-specializzato]]></loc><lastmod>2016-05-13T10:17:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/10603-talassemia-i-malati-della-campania-sono-vittime-della-disorganizzazione-della-rete-assistenziale]]></loc><lastmod>2016-05-15T07:29:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/10433-talassemia-diventa-anche-tu-testimonial-della-campagna-5x1000-dell-associazione-cutino]]></loc><lastmod>2016-04-22T15:07:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/9995-talassemia-la-dr-ssa-donatella-baronciani-cagliari-il-trapianto-deve-essere-eseguito-il-prima-possibile]]></loc><lastmod>2016-02-19T11:19:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/9927-talassemia-villa-sofia-di-palermo-capofila-di-una-rete-per-migliorare-la-qualita-della-vita-dei-pazienti]]></loc><lastmod>2016-02-09T09:19:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/9438-talassemia-la-terapia-genica-non-ha-avuto-successo-su-ivano-argiolas]]></loc><lastmod>2015-11-25T15:51:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/8488-beta-talassemia-un-paziente-siciliano-a-new-york-per-la-terapia-genica]]></loc><lastmod>2015-06-19T13:55:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/8509-talassemia-la-denuncia-al-microcitemico-di-cagliari-due-stanze-sottratte-ai-pazienti]]></loc><lastmod>2015-06-24T11:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/8187-talassemia-gli-eventi-proposti-dallassociazione-piera-cutino-per-la-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/8040-anemia-falciforme-e-beta-talassemia-nuovi-risultati-su-pglg]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/7600-beta-talassemia-la-fda-accetta-la-domanda-ind-per-il-nuovo-approccio-terapeutico-sb-bclmr-hspc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/7595-talassemia-il-farmaco-lentiglobin-bb305-ottiene-la-designazione-di-terapia-innovativa]]></loc><lastmod>2021-02-23T12:08:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/7324-talassemia-maior-un-nuovo-software-rende-piu-precisa-e-veloce-la-misurazione-del-ferro-nel-cuore-e-nel-fegato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/6258-talassemia-i-bifosfonati-nella-terapia-dellosteoporosi-associata-alla-patologia]]></loc><lastmod>2019-06-18T18:13:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/5966-talassemia-che-cose-il-trapianto-di-midollo-osseo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/5967-talassemia-dopo-il-trapianto-una-vita-completamente-normale]]></loc><lastmod>2015-06-24T11:09:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/5999-talassemia-protocollo-dintesa-tra-lazienda-ospedaliera-civico-e-fondazione-monasterio-di-pisa-per-la-cardiorisonanza-magnetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/5540-talassemia-pazienti-a-rischio-di-una-seconda-malattia-rara-lipertensione-polmonare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/5488-talassemia-ivano-torna-a-new-york-per-la-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/5202-anemia-mediterranea-sotatercept-diventa-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/5169-anemia-falciforme-e-talassemia-al-via-il-nuovo-progetto-europeo-commitment]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/5097-bambini-affetti-da-anemia-mediterranea-risonanza-magnetica-anche-prima-dei-10-anni-per-personalizzare-le-cure-e-prevenire-i-problemi-cardiaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/5053-talassemia-protesta-dei-pazienti-al-centro-trasfusionale-dellospedale-di-cosenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/5047-talassemia-grazie-alla-rete-miot-in-puglia-un-nuovo-centro-per-lo-studio-delle-cardiomiopatie-da-accumulo-di-ferro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/4558-talassemia-nuove-speranze-dalla-terapia-genica-sperimentale]]></loc><lastmod>2019-06-19T08:25:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/4484-beta-talassemia-telethon-investe-sui-ricercatori-sardi-per-la-ricerca-di-una-terapia-efficace]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/4350-talassemia-i-flussi-migratori-e-la-gestione-della-malattia-il-libro-bianco-della-thalassemia-international-federation]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/4141-beta-talassemia-un-nuovo-metodo-di-diagnosi-prenatale-non-invasiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/4045-morto-il-prof-renzo-galanello-una-vita-spesa-nella-lotta-alla-talassemia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/4025-malattie-ematiche-inaugurato-il-campus-franco-e-piera-cutino-allospedale-cervello-di-palermo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/3527-talassemia-da-firenze-un-progetto-per-la-terapia-personalizzata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/3458-talassemia-i-risparmiatori-del-banco-di-sardegna-finanziano-uno-studio-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/3431-talassemia-approvata-in-europa-la-terapia-con-deferasirox]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/2998-talassemia-conferme-per-il-trapianto-allogenico-di-staminali-ematopoietiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/2871-anemia-falciforme-al-via-la-terza-fase-della-sperimentazione-dell-l-glutammina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/2456-talassemia-troppi-pazienti-con-sovraccarico-di-ferro-necessaria-la-risonanza-magnetica-cardiovascolare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/2271-talassemia-in-sicilia-istituita-la-consulta-tecnica-permanente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/2250-talassemia-domani-in-sicilia-2500-pazienti-in-piazza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/2145-talassemia-le-associazioni-di-pazienti-insieme-per-la-nascita-di-united-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/2116-talassemia-oggi-la-giornata-mondiale-i-pazienti-continuano-a-denunciare-la-difficolta-di-accesso-alle-cure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/1883-talassemia-a-palermo-parte-il-progetto-qospedale-a-domicilioq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/1471-talassemia-la-sicilia-si-riorganizza-il-coordinamento-allematologia-ii-del-cervello-di-palermo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/1283-talassemia-metanalisi-evidenzia-insufficienza-di-dati-a-supporto-di-terapia-combinata]]></loc><lastmod>2015-06-05T16:34:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/1062-talassemia-in-india-23-bambini-contagiati-da-hiv-con-le-trasfusioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/1027-sangue-pochi-donatori-destate-e-in-sicilia-si-va-verso-lesaurimento-delle-scorte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/878-talassemia-il-galliera-di-genova-aiuta-il-marocco-a-progredire-sulla-strada-del-trapianto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/862-staminali-ematopoietiche-i-sardi-primi-per-donazioni-di-midollo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/678-anemia-mediterranea-oggi-ci-si-puo-convivere-ma-lobiettivo-e-la-guarigione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/661-fondazione-cutino-e-cemsi-insieme-per-la-lotta-alla-talessemia-nel-mediterraneo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/660-thalassemia-day-un-progetto-per-la-vita-sabato-7-e-domenica-8-maggio-test-del-portatore-sano-in-33-centri-della-regione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/655-talassemia-l8-maggio-la-giornata-internazionale-in-italia-la-migrazione-fa-aumentare-i-casi]]></loc><lastmod>2015-06-08T09:44:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/554-talassemia-parte-dal-cardarelli-di-napoli-una-scelta-di-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/527-talassemia-pubblicato-sul-british-journal-haematology-studio-italiano-sulla-celocentesi-nuova-tecnica-di-diagnosi-prenatale]]></loc><lastmod>2015-06-08T10:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/456-talassemia-se-ne-e-parlato-allo-sportello-di-altrevoci-di-rai-news-24]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/361-talassemia-dagli-usa-un-riconoscimento-scientifico-alla-rete-italiana-miot]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/313-talassemia-luzzatto-il-futuro-e-nella-terapia-genica-ma-la-strada-passa-per-le-staminali-riprogrammate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/312-talassemia-oggi-mette-meno-paura-e-ormai-una-malattia-a-diagnosi-aperta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/311-la-celocentesi-eccellenza-della-ricerca-siciliana-ed-esempio-della-collaborazione-pubblico-privato]]></loc><lastmod>2015-06-08T16:36:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/310-talassemia-la-diagnosi-prenatale-si-fa-con-la-celocentesi-risultati-al-secondo-mese-e-niente-ago-nel-pancione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/277-talassemia-ce-un-nuovo-metodo-per-scegliere-il-donatore-evitando-la-reazione-gvhd]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/213-talassemia-dal-san-matteo-di-pavia-passi-avanti-per-limpiego-di-staminali-lospedale-e-una-delle-27-strutture-di-tutto-il-mondo-accreditate-per-le-terapie-cellulari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/206-talassemia-cianciulli-site-il-prossimo-passo-della-t2-saranno-gli-studi-sul-pancreas]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/205-talassemia-e-il-deferiprone-il-farmaco-piu-efficace-contro-gli-accumuli-di-ferro-nel-cuore-dai-6-anni-in-poi-basta-iniezioni-e-si-a-compresse-e-sciroppo]]></loc><lastmod>2015-06-08T16:46:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/204-talassemia-arriva-il-t2-star-multislice-il-sistema-non-invasivo-per-quantificare-l-accumulo-di-ferro-nel-cuore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/190-talassemia-il-flusso-dei-migranti-fa-crescere-i-numeri-sempre-piu-casi-anche-nelle-regioni-del-nord]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/187-talassemia-al-meyer-parte-un-progetto-per-luso-estensivo-di-concentrati-da-aferesi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/150-talassemia-lasso-e-la-terapia-genica-intervento-del-prof-lucio-luzzatto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/145-beta-talassemia-liberi-dalle-trasfusioni-grazie-alla-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/119-yes-we-care-attivato-il-progetto-di-assistenza-globale-per-i-pazienti-talassemici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/112-talassemia-passo-avanti-nella-terapia-genica-la-notizia-dei-ricercatori-del-san-raffaele-telethon]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/talassemia/30-talassemia-alfa-dalla-thailandia-un-nuovo-e-piu-veloce-test-diagnostico-per-individuare-la-mutazione-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/22668-trombocitopenia-immune-approvazione-europea-per-rilzabrutinib]]></loc><lastmod>2026-01-16T15:48:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/22549-trombocitopenia-immune-i-farmaci-tpo-mimetici-sono-una-risorsa-importante-ma-occorre-valutare-il-rischio-di-trombosi]]></loc><lastmod>2025-11-25T09:42:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/22425-trombocitopenia-immune-ok-del-chmp-allimpiego-di-rilzabrutinib]]></loc><lastmod>2025-10-21T09:17:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/21786-trombocitopenia-immune-dati-sperimentali-e-di-real-world-evidenziano-l-efficacia-di-avatrombopag]]></loc><lastmod>2025-03-07T12:04:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/21587-trombocitopenia-immune-refrattaria-fostamatinib-e-una-valida-opzione-terapeutica]]></loc><lastmod>2024-12-17T22:10:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/21580-trombocitopenia-immune-positivi-i-risultati-dello-studio-registrativo-di-rilzabrutinib]]></loc><lastmod>2024-12-13T09:41:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/20945-trombocitopenia-immune-lo-studio-di-fase-iii-su-rilzabrutinib-raggiunge-l-endpoint-primario]]></loc><lastmod>2024-05-29T10:21:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/20203-trombocitopenia-immune-pubblicato-il-volume-passata-e-la-tempesta]]></loc><lastmod>2023-10-08T20:10:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/19219-trombocitopenia-immune-arriva-itp-app-il-diario-digitale-pensato-per-i-pazienti]]></loc><lastmod>2022-10-26T17:08:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/18735-trombocitopenia-immune-al-via-il-progetto-itp-in-viaggio-con-werlhof]]></loc><lastmod>2022-06-05T14:45:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/17875-trombocitopenia-immune-avviata-la-commercializzazione-di-fostamatinib-in-italia-francia-e-spagna]]></loc><lastmod>2021-10-09T19:34:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/17663-trombocitopenia-immune-qualita-della-vita-compromessa-dall-uso-prolungato-dei-corticosteroidi]]></loc><lastmod>2021-07-18T21:44:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/16925-trombocitopenia-immune-nasce-l-iniziativa-emocromo-a-domicilio]]></loc><lastmod>2021-01-24T20:32:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/16805-trombocitopenia-immune-nel-paziente-anziano-occorre-considerare-eventuali-patologie-associate]]></loc><lastmod>2020-12-14T13:07:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/16759-itp-e-covid-la-scuola-e-un-diritto-irrinunciabile-soprattutto-in-eta-pediatrica]]></loc><lastmod>2020-11-30T20:58:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/16435-trombocitopenia-immune-e-coronavirus-tanti-i-dubbi-dei-pazienti]]></loc><lastmod>2020-09-12T20:57:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/16394-trombocitopenia-immune-l-isolamento-sociale-e-comune-nei-pazienti-adolescenti]]></loc><lastmod>2020-08-30T19:10:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/16348-trombocitopenia-immune-viaggiare-in-sicurezza-e-possibile]]></loc><lastmod>2020-08-02T13:37:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/16244-trombocitopenia-immune-al-paziente-adolescente-puo-mancare-un-medico-di-riferimento]]></loc><lastmod>2020-07-01T09:13:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/16109-trombocitopenia-immune-i-consigli-per-gestire-l-alimentazione]]></loc><lastmod>2020-05-26T21:19:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/16002-trombocitopenia-immune-le-raccomandazioni-al-tempo-del-coronavirus]]></loc><lastmod>2020-04-27T18:20:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/15977-trombocitopenia-immune-per-i-pazienti-e-online-il-nuovo-sito-my-itp-life]]></loc><lastmod>2024-04-29T09:19:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/15226-piastrinopenia-immune-il-rapporto-medico-paziente-e-alla-base-di-un-corretto-approccio-alla-malattia]]></loc><lastmod>2020-04-20T10:45:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/15223-piastrinopenia-immune-la-diagnosi-si-ricava-principalmente-per-esclusione]]></loc><lastmod>2020-04-20T10:45:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/15217-piastrinopenia-immune-la-qualita-di-vita-migliora-grazie-a-nuove-terapie]]></loc><lastmod>2020-04-20T10:45:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/15214-piastrinopenia-immune-una-malattia-che-lascia-i-pazienti-nell-incertezza-di-averla-superata]]></loc><lastmod>2020-04-20T10:46:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/13693-piastrinopenia-immune-in-avvio-uno-studio-sulla-gestione-della-malattia-in-italia]]></loc><lastmod>2020-04-20T10:46:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/13218-piastrinopenia-immune-per-la-terapia-e-essenziale-seguire-le-linee-guida]]></loc><lastmod>2020-04-20T10:46:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/13194-piastrinopenia-immune-nei-bambini-la-malattia-va-valutata-caso-per-caso]]></loc><lastmod>2020-04-20T10:47:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/12950-piastrinopenia-immune-duraturo-controllo-di-malattia-con-eltrombopag]]></loc><lastmod>2020-04-20T10:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/12455-piastrinopenia-immune-il-costo-per-i-pazienti-e-di-13-000-euro-l-anno]]></loc><lastmod>2020-04-20T10:48:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/12400-piastrinopenia-immune-come-combattere-il-rischio-di-emorragie]]></loc><lastmod>2020-04-20T10:48:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/12378-piastrinopenia-immune-finalmente-inserita-nei-nuovi-lea]]></loc><lastmod>2020-04-20T10:48:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/10821-trombocitopenia-immune-nuovi-dati-di-sicurezza-su-revolade-eltrombopag]]></loc><lastmod>2020-04-20T10:49:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/10387-trombocitopenia-immune-il-farmaco-eltrombopag-approvato-in-europa-per-pazienti-pediatrici]]></loc><lastmod>2020-04-20T10:49:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/8833-trombocitopenia-immune-fda-estende-l-uso-di-eltrombopag-ai-bambini-di-almeno-1-anno]]></loc><lastmod>2020-04-20T10:50:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/7462-trombocitopenia-immune-studio-ipotizza-il-coinvolgimento-dei-linfociti-t-splenici]]></loc><lastmod>2020-04-20T10:50:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/4082-trombocitopenia-immune-primaria-cronica-pubblicate-le-linee-guida-europee]]></loc><lastmod>2020-04-20T10:50:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/3916-porpora-trombocitopenica-autoimmune-desametasone-piu-efficace-se-associato-a-rituximab]]></loc><lastmod>2017-06-19T14:56:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/3808-trombocitopenia-cronica-autoimmune-buoni-i-risultati-sulluso-di-eltrombopag]]></loc><lastmod>2018-02-12T16:58:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/2156-porpora-trombocitopenica-autoimmune-duraturi-i-benefici-del-trattamento-con-rituximab]]></loc><lastmod>2020-04-20T10:54:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/1874-trombocitopenica-autoimmune-il-primo-registro-mondiale-della-malattia]]></loc><lastmod>2018-02-12T16:57:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/1554-porpora-ricercatori-di-napoli-individuano-ruolo-di-un-la-recettore-cannabinoide-mutato]]></loc><lastmod>2020-04-20T10:53:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/753-porpora-pubblicate-le-nuove-linee-guida-per-la-malattia]]></loc><lastmod>2020-04-20T10:52:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/piastrinopenia-immune/608-porpora-trombocitopenica-il-revolade-stimola-la-crescita-delle-piastrine-riducendo-le-emoraggie]]></loc><lastmod>2020-04-20T10:51:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/22619-storie-di-vita-con-egpa-quando-i-pazienti-diventano-motore-del-cambiamento]]></loc><lastmod>2025-12-22T21:06:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/22562-vasculopatia-associata-a-sting-una-malattia-rara-che-si-manifesta-nella-prima-infanzia]]></loc><lastmod>2025-11-29T11:43:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/22257-individuato-il-meccanismo-patologico-alla-base-della-savi-una-rara-vasculite-a-esordio-infantile]]></loc><lastmod>2025-08-28T21:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/21979-vasculiti-il-15-maggio-e-la-giornata-internazionale-di-sensibilizzazione]]></loc><lastmod>2025-05-14T17:19:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/21983-i-tre-pilastri-delle-vasculiti-anca-associate-medicina-di-precisione-multidisciplinarieta-e-ascolto-dei-pazienti]]></loc><lastmod>2025-05-14T17:20:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/21982-vasculiti-anca-associate-la-conoscenza-e-il-primo-strumento-di-cura]]></loc><lastmod>2025-05-14T17:20:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/21981-vasculiti-anca-associate-necessario-colmare-le-disparita-territoriali-nell-accesso-alle-cure]]></loc><lastmod>2025-05-14T17:19:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/21910-arterite-a-cellule-giganti-approvazione-europea-per-upadacitinib]]></loc><lastmod>2025-04-15T12:36:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/21777-la-gestione-delle-vasculiti-anca-associate-alla-luce-delle-piu-recenti-novita-terapeutiche]]></loc><lastmod>2025-03-05T22:36:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/21603-malattia-di-behcet-uno-nuovo-studio-valuta-le-terapie-piu-efficaci]]></loc><lastmod>2024-12-20T12:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/21463-vasculiti-anca-associate-serve-maggior-consapevolezza-di-queste-patologie]]></loc><lastmod>2024-11-07T19:04:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/21205-vasculiti-anca-associate-nasce-l-associazione-a-i-v-a]]></loc><lastmod>2024-08-05T09:32:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/21074-vasculiti-anca-associate-avacopan-rimborsabile-in-italia]]></loc><lastmod>2024-06-12T12:06:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/20842-sindrome-di-behcet-una-patologia-complessa-dall-origine-multifattoriale]]></loc><lastmod>2025-10-21T19:55:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/20227-vasculiti-anca-associate-tanti-i-fattori-che-incidono-sulla-qualita-di-vita-dei-pazienti]]></loc><lastmod>2023-10-14T11:24:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/19989-sindrome-di-churg-strauss-pubblicate-le-prime-linee-guida-europee-su-diagnosi-e-terapia]]></loc><lastmod>2023-07-10T10:49:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/19643-vasculiti-anca-associate-in-quasi-la-meta-dei-casi-e-presente-una-malattia-polmonare-correlata]]></loc><lastmod>2023-03-21T20:59:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/19242-vasculiti-anca-associate-quali-fattori-sono-predittivi-di-una-prognosi-sfavorevole]]></loc><lastmod>2022-12-14T18:50:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/18024-malattie-da-eosinofili-mepolizumab-approvato-in-europa]]></loc><lastmod>2022-04-07T13:33:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/17178-malattia-di-behcet-online-una-piattaforma-di-attivita-educazionali-per-medici-e-pazienti]]></loc><lastmod>2022-04-06T16:55:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/14244-porpora-di-henoch-schoenlein-ignazio-dopo-25-anni-di-visite-in-tutta-italia-ha-trovato-nella-sua-sicilia-tutto-cio-che-cercava]]></loc><lastmod>2022-04-07T14:01:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/13598-sindrome-di-churg-strauss-in-italia-e-attiva-l-associazione-apacs]]></loc><lastmod>2022-04-07T16:39:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/12942-sindrome-di-churg-strauss-nasce-apacs-la-nuova-associazione-pazienti]]></loc><lastmod>2022-04-07T13:41:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/12861-arterite-di-takayasu-gli-effetti-benefici-dell-esercizio-fisico]]></loc><lastmod>2022-04-06T16:39:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/12736-arterite-a-cellule-giganti-approvazione-europea-per-tocilizumab]]></loc><lastmod>2022-04-06T16:31:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/12340-arterite-a-cellule-giganti-tocilizumab-di-roche-approvato-dalla-fda]]></loc><lastmod>2022-04-06T16:33:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/11410-arterite-a-cellule-giganti-l-fda-concede-la-designazione-di-terapia-breakthrough-a-tocilizumab]]></loc><lastmod>2022-04-06T16:35:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/11267-paralimpiadi-oro-nella-corsa-e-record-per-david-brown]]></loc><lastmod>2022-04-07T16:36:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/11147-porpora-di-henoch-schoenlein-con-grave-coinvolgimento-gastrointestinale-le-immunoglobuline-rappresentano-una-buona-opzione-terapeutica]]></loc><lastmod>2022-04-07T14:00:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/10896-malattia-di-behcet-nuove-raccomandazioni-sulla-patologia-da-eular-2016]]></loc><lastmod>2022-04-06T16:57:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/10762-arterite-a-cellule-giganti-buoni-risultati-da-tocilizumab-nel-mantenimento-della-remissione]]></loc><lastmod>2022-04-06T16:37:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/10258-granulomatosi-di-wegener-la-storia-di-elisa-ho-aspettato-la-diagnosi-per-15-anni]]></loc><lastmod>2022-04-07T13:26:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/9810-malattia-di-behcet-realizzato-uno-strumento-di-valutazione-per-le-ulcere-genitali]]></loc><lastmod>2022-04-06T17:00:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/9801-malattia-di-behcet-risultati-promettenti-da-nuovo-anticorpo-dlx105]]></loc><lastmod>2022-04-06T17:03:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/9587-malattia-di-behcet-nuove-possibili-terapie-per-prevenire-le-trombosi]]></loc><lastmod>2022-04-06T17:07:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/8912-malattia-di-behcet-il-peginterferone-alfa-2b-riduce-la-necessita-di-corticosteroidi]]></loc><lastmod>2022-04-06T17:37:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/8735-malattia-di-behcet-gevokizumab-non-supera-l-endpoint-principale-in-fase-iii]]></loc><lastmod>2022-04-06T17:49:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/8188-malattia-di-behcet-il-farmaco-apremilast-e-efficace-contro-le-ulcere-orali]]></loc><lastmod>2022-04-06T18:23:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/7350-malattia-di-behcet-importante-scoperta-dallateneo-fiorentino]]></loc><lastmod>2022-04-07T11:09:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/6535-malattia-di-behcet-adalimumab-sicuro-ed-efficace]]></loc><lastmod>2022-04-07T11:10:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/5850-malattia-di-kawasaki-laggiunta-del-farmaco-sperimentale-infliximab-alla-terapia-standard-mostra-effetti-benefici]]></loc><lastmod>2022-04-07T14:15:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/5636-beethoven-era-affetto-da-una-malattia-rara]]></loc><lastmod>2022-04-07T13:23:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/5569-addio-allacchiappafantasmi-harold-ramis-affetto-da-una-malattia-rara]]></loc><lastmod>2022-04-07T14:09:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/5536-malattia-di-behcet-perche-il-maggior-numero-di-pazienti-e-in-sardegna]]></loc><lastmod>2022-04-07T12:58:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/5535-malattia-di-behcet-i-pazienti-sardi-chiedono-maggior-coordinamento-tra-i-centri-specializzati]]></loc><lastmod>2022-04-07T12:55:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/5400-collaborazione-tra-la-reumatologia-dellaou-senese-e-la-onlus-simba-nasce-il-centro-per-la-cura-della-malattia-di-bechet]]></loc><lastmod>2022-04-07T12:59:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/4275-malattia-di-behcet-risultati-positivi-per-il-trattamento-con-apremilast]]></loc><lastmod>2022-04-07T13:02:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/3799-sindrome-di-behcet-individuate-4-nuove-zone-cromosomiche-coinvolte]]></loc><lastmod>2022-04-07T13:08:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/3784-sindrome-neuro-behcet-la-diagnosi-precoce-evita-danni-permanenti]]></loc><lastmod>2022-04-07T13:13:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/3454-malattia-di-kawasaki-scoperti-nuovi-marcatori-diagnostici-si-rilevano-nelle-urine]]></loc><lastmod>2022-04-07T14:17:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/3243-vasculiti-alcune-forme-hanno-origine-genetica]]></loc><lastmod>2022-04-07T14:04:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/3080-malattia-di-behcet-gli-immunosoppressori-riducono-le-trombosi-venose]]></loc><lastmod>2022-04-07T13:16:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/3028-malattia-di-takayasu-disponibile-un-documento-su-diagnosi-terapie-e-assistenza]]></loc><lastmod>2022-04-06T16:46:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/2598-malattia-di-kawasaki-lefficacia-di-immunoglobuline-e-prednisolone]]></loc><lastmod>2022-04-07T14:19:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/2455-malattia-di-bechet-con-le-giuste-diagnosi-e-terapie-la-gravidanza-e-possibile]]></loc><lastmod>2022-04-07T13:19:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/2159-malattia-di-kawasaki-se-resistente-alle-immunoglobuline-potrebbero-essere-utili-inibitori-della-calcineurina]]></loc><lastmod>2022-04-07T14:25:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattie-rare/vasculiti/1349-malattia-di-kawasaki-studio-americano-ipotizza-che-si-diffonda-attraverso-le-correnti-ventose]]></loc><lastmod>2022-04-07T16:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas]]></loc><lastmod>2016-12-02T11:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/22956-tumore-al-pancreas-necessaria-la-rete-nazionale-dei-centri-specializzati]]></loc><lastmod>2026-04-20T17:20:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/22907-tumore-del-pancreas-fondazione-veronesi-e-ficog-lanciano-un-bando-per-la-ricerca]]></loc><lastmod>2026-04-02T16:05:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/22831-tumore-al-pancreas-la-corsa-di-carlo-vanzini-e-la-rivoluzione-dello-studio-cassandra]]></loc><lastmod>2026-03-10T20:57:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/22715-tumore-al-pancreas-tra-nuovi-farmaci-approvati-e-trattamenti-in-via-di-sviluppo]]></loc><lastmod>2026-02-03T22:24:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/22536-tumore-al-pancreas-in-italia-aumenta-il-numero-di-pazienti-vivi-dopo-la-diagnosi]]></loc><lastmod>2025-11-20T19:03:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/22080-tumore-al-pancreas-studio-italiano-potrebbe-cambiare-le-linee-guida-sul-trattamento-della-patologia]]></loc><lastmod>2025-06-12T17:19:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/21515-tumore-al-pancreas-e-in-aumento-il-numero-dei-decessi]]></loc><lastmod>2024-11-22T13:22:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/20900-tumore-al-pancreas-scoperta-l-impronta-molecolare-delle-lesioni-cistiche-pre-cancerose]]></loc><lastmod>2024-04-22T15:05:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/20743-tumore-al-pancreas-metastatico-nuove-opportunita-di-trattamento-grazie-alle-nanotecnologie]]></loc><lastmod>2024-03-12T14:49:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/20516-tumore-al-pancreas-ecco-perche-si-trasforma-in-metastasi]]></loc><lastmod>2024-01-15T11:46:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/20307-tumore-al-pancreas-scoperto-un-meccanismo-chiave-nella-patogenesi-della-malattia]]></loc><lastmod>2023-11-09T17:07:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/20032-tumore-al-pancreas-pieve-skin-chiede-di-attivare-le-pancreas-unit-anche-in-emilia-romagna]]></loc><lastmod>2023-07-26T07:59:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/18727-tumore-al-pancreas-in-lombardia-nascono-le-pancreas-units]]></loc><lastmod>2022-06-04T14:57:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/18015-tumore-al-pancreas-il-18-novembre-e-la-giornata-mondiale]]></loc><lastmod>2021-11-17T22:38:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/17754-tumore-al-pancreas-un-approccio-rivoluzionario-riapre-la-strada-all-immunoterapia]]></loc><lastmod>2021-09-07T15:24:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/17281-tumore-al-pancreas-fondazione-humanitas-lancia-una-raccolta-fondi-per-la-ricerca]]></loc><lastmod>2021-04-11T19:46:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/17128-tumore-al-pancreas-il-9-dei-pazienti-sotto-i-74-anni-di-eta-presenta-mutazioni-nei-geni-brca]]></loc><lastmod>2021-03-06T21:14:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/16228-tumore-del-pancreas-al-gemelli-di-roma-un-pca-e-un-centro-chirurgico-dedicati]]></loc><lastmod>2020-06-29T08:37:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/15672-tumore-al-pancreas-scoperta-una-nuova-mutazione-associata]]></loc><lastmod>2020-02-17T19:11:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/15389-adenocarcinoma-al-pancreas-entro-il-2030-sara-la-seconda-causa-di-morte-tra-i-tumori]]></loc><lastmod>2019-11-09T14:17:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/14837-tumore-al-pancreas-fda-accoglie-la-domanda-di-registrazione-dell-eriaspasi]]></loc><lastmod>2019-05-21T18:22:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/14148-tumore-al-pancreas-in-italia-studio-clinico-su-adroterapia-piu-chemioterapia]]></loc><lastmod>2018-11-14T12:26:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/14133-tumore-al-pancreas-inaugurato-il-gemelli-pancreatic-advanced-research-center]]></loc><lastmod>2018-11-07T18:24:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/13243-tumore-al-pancreas-ora-i-pazienti-sardi-potranno-essere-operati-a-cagliari]]></loc><lastmod>2018-02-18T23:17:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/13200-tumore-al-pancreas-risultati-incoraggianti-per-il-farmaco-nab-paclitaxel]]></loc><lastmod>2018-02-06T19:29:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/12432-tumore-al-pancreas-complesso-intervento-eseguito-con-successo-a-torino]]></loc><lastmod>2017-06-26T16:39:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/11610-tumore-al-pancreas-oggi-la-giornata-mondiale-2]]></loc><lastmod>2016-11-16T10:51:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/11544-tumore-al-pancreas-approvata-l-immissione-in-commercio-dell-irinotecan-liposomiale-pegilato]]></loc><lastmod>2016-10-29T16:30:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/11530-cancro-del-pancreas-pubblicate-le-nuove-linee-guida-delineano-il-corretto-iter-terapeutico]]></loc><lastmod>2016-10-26T15:29:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/11139-tumore-al-pancreas-con-mutazioni-al-gene-brca-efficace-la-terapia-con-rucaparib]]></loc><lastmod>2016-08-25T10:25:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/11138-tumore-al-pancreas-nuove-conferme-per-terapia-con-nab-paclitaxel-e-gemcitabina]]></loc><lastmod>2016-08-25T10:23:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/10876-tumore-al-pancreas-pubblicate-le-nuove-linee-guida-dell-asco]]></loc><lastmod>2016-06-29T09:10:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/10847-tumore-al-pancreas-dati-positivi-per-combinazione-di-capecitabina-e-gemcitabina]]></loc><lastmod>2016-06-24T12:16:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/10594-tumore-al-pancreas-i-pazienti-sono-consapevoli-delle-opzioni-di-trattamento-e-delle-sperimentazioni-cliniche]]></loc><lastmod>2016-05-13T10:54:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/10556-tumore-al-pancreas-gli-esperti-va-curato-solo-in-centri-di-riferimento]]></loc><lastmod>2016-05-09T08:30:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/10534-tumore-al-pancreas-a-verona-un-flash-mob-a-favore-della-prevenzione]]></loc><lastmod>2016-05-06T08:45:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/10291-tumore-al-pancreas-continuano-gli-studi-su-un-potenziale-vaccino-terapeutico]]></loc><lastmod>2016-04-01T08:24:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/10238-tumore-al-pancreas-in-italia-molti-interventi-chirurgici-ma-poca-esperienza]]></loc><lastmod>2016-03-22T15:12:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/10084-cancro-al-pancreas-sono-quattro-le-varianti-possibili]]></loc><lastmod>2016-03-02T09:39:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/9970-tumore-al-pancreas-interrotta-sperimentazione-su-ruxolitinib-per-scarsa-efficacia]]></loc><lastmod>2016-02-15T14:33:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/9950-tumore-al-pancreas-risultati-deludenti-da-tarexumab]]></loc><lastmod>2016-02-12T13:49:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/9940-carcinoma-al-pancreas-metastatico-nab-paclitaxel-e-gemcitabina-si-confermano-terapia-backbone-di-riferimento]]></loc><lastmod>2016-02-11T13:50:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/9795-tumore-al-pancreas-la-diagnosi-precoce-con-un-semplice-esame-del-sangue]]></loc><lastmod>2016-01-22T11:22:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/9341-tumore-al-pancreas-oggi-la-giornata-mondiale]]></loc><lastmod>2015-11-12T14:21:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/9231-tumore-del-pancreas-in-stadio-avanzato-fda-approva-trattamento-con-onivyde-in-combinazione]]></loc><lastmod>2015-10-28T08:28:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/8940-tumore-al-pancreas-risultati-positivi-per-combinazione-ruxolitinib-piu-capecitabina]]></loc><lastmod>2015-09-17T12:34:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/8614-carcinoma-pancreatico-la-fda-valutera-l-approvazione-del-farmaco-sperimentale-mm-398]]></loc><lastmod>2015-07-13T13:23:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/8241-baxter-e-merrimack-presentano-una-domanda-per-lapprovazione-europea-di-mm-398-un-trattamento-sperimentale-per-il-cancro-del-pancreas]]></loc><lastmod>2016-05-06T16:38:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/8239-adenocarcinoma-del-dotto-pancreatico-metformina-non-migliorerebbe-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/8089-carcinoma-metastatico-del-pancreas-nab-paclitaxel-e-gemcitabina-migliorano-la-sopravvivenza-a-lungo-termine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/7897-tumore-al-pancreas-al-pascale-di-napoli-risultati-soddisfacenti-per-elettrochemioterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/6996-tumore-del-pancreas-il-progetto-pancrea-per-sensibilizzare-i-cittadini-su-questa-patologia]]></loc><lastmod>2019-06-18T17:53:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/6917-tumore-del-pancreas-nuvilex-richiede-la-designazione-di-farmaco-orfano-per-il-suo-trattamento-cell-in-a-boxr]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/6904-adenocarcinoma-del-pancreas-conoscere-le-mutazioni-generiche-per-diagnosticare-il-tumore-prima-che-sia-troppo-tardi]]></loc><lastmod>2020-02-17T17:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/6813-carcinoma-pancreatico-metastatico-accordo-per-la-commercializzazione-di-mm-398]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/6789-tumore-al-pancreas-una-nuova-speranza-terapeutica-nella-vitamina-d-modificata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/6663-tumore-al-pancreas-unaspirina-al-giorno-riduce-la-probabilita-di-sviluppare-questa-patologia]]></loc><lastmod>2019-06-18T18:00:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/6401-tumore-al-pancreas-al-cerms-si-studia-un-vaccino-rivoluzionario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/6382-tumore-al-pancreas-luso-di-aspirina-dimezza-il-rischio-di-insorgenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/6132-tumore-al-pancreas-un-test-sulla-saliva-per-identificarlo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/5865-tumore-al-pancreas-litalia-impegnata-per-allargare-laccessibilita-alle-cure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/5784-tumore-al-pancreas-conferme-positive-per-limmunoterapia-algenpantucel-l]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/5758-tumore-al-pancreas-litalia-indietro-nellapprovazione-della-nuova-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/5291-tumore-al-pancreas-metastatico-approvato-in-europa-luso-di-abraxabe-piu-gemcitabina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/5247-adenocarcinoma-metastatico-del-pancreas-approvato-in-europa-un-nuovo-trattamento-terapeutico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/5145-cancro-pancreas-il-fumo-aumenta-il-rischio-del-70]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/5065-adenocarcinoma-metastatico-del-pancreas-parere-favorevole-dellema-per-il-trattamento-con-abraxane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/4610-fda-approva-paclitaxel-per-il-tumore-metastatico-del-pancreas]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/3123-tumore-al-pancreas-dalla-medicina-cinese-un-farmaco-che-potrebbe-migliorare-la-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/1711-cancro-del-pancreas-positivi-i-risultati-della-sperimentazione-con-th-302-con-gemcitabina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-al-pancreas/1629-cancro-del-pancreas-in-stadio-avanzato-piu-chance-di-guarigione-se-trattato-in-centri-di-eccellenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma]]></loc><lastmod>2015-02-17T18:10:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/22595-morta-la-scrittrice-sophie-kinsella-era-affetta-da-glioblastoma]]></loc><lastmod>2025-12-11T16:21:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/22339-glioblastoma-nuovo-anticorpo-sperimentale-sembra-in-grado-di-rallentare-la-progressione-del-tumore]]></loc><lastmod>2025-09-25T14:32:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/20882-la-scrittrice-sophie-kinsella-annuncia-di-essere-malata-e-affetta-da-glioblastoma]]></loc><lastmod>2024-04-18T08:03:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/20249-glioblastoma-via-libera-in-campania-a-un-nuovo-percorso-diagnostico-terapeutico-assistenziale]]></loc><lastmod>2023-10-23T08:35:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/20185-glioblastoma-da-nuovo-studio-emerge-un-promettente-farmaco-biologico]]></loc><lastmod>2023-10-02T17:22:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/19806-glioblastoma-alta-tecnologia-per-una-gestione-della-malattia-sempre-piu-personalizzata]]></loc><lastmod>2023-05-14T13:01:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/18995-glioblastoma-multiforme-nuova-potenziale-terapia-per-il-trattamento-delle-recidive]]></loc><lastmod>2022-08-12T17:05:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/14375-glioblastoma-accertata-l-esposizione-a-radiazioni-ionizzanti-come-fattore-di-rischio]]></loc><lastmod>2019-01-18T11:33:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/12528-glioblastoma-scoperto-un-anticorpo-potenzialmente-in-grado-di-bloccarne-la-crescita]]></loc><lastmod>2017-07-27T14:26:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/12213-glioblastoma-riprodotto-in-provetta-il-tumore-per-studiare-nuove-cure-personalizzate]]></loc><lastmod>2017-04-23T09:40:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/11096-glioblastoma-attenzione-all-uso-di-corticosteroidi]]></loc><lastmod>2016-08-05T12:14:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/9704-glioblastoma-scoperta-proteina-che-ne-favorisce-sviluppo-e-progressione]]></loc><lastmod>2016-01-07T12:24:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/9525-gliobastoma-combinazione-rindopepimut-a-bevacizumab-migliora-la-sopravvivenza]]></loc><lastmod>2015-12-03T15:37:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/8041-glioblastoma-secondario-avanzato-il-talidomide-sembra-un-valido-trattamento-palliativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/7641-glioblastoma-identificati-tre-geni-responsabili-della-resistenza-alle-radiazioni]]></loc><lastmod>2018-05-19T17:07:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/7571-2015-02-11-16-21-25]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/7252-glioblastoma-bevacizumab-combinato-con-lomustina-ha-dimostrato-maggiore-efficacia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/6984-glioblastoma-luso-eccessivo-del-cellulare-puo-essere-un-fattore-di-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/6553-glioblastoma-multiforme-nuovo-farmaco-orfano-disponibile-in-europa-e-usa]]></loc><lastmod>2016-07-18T15:42:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/6440-glioblastoma-multiforme-risultati-incoraggianti-con-nuovo-vaccino-autologo-antitumorale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/6265-glioblastoma-parere-negativo-dellema-per-il-trattamento-con-bevacizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/6173-glioblastoma-il-farmaco-sperimentale-bevacizumab-bocciato-dallema]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/5700-glioblastoma-risultati-deludenti-per-bevacizumab-nella-terapia-di-prima-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/5402-glioblastoma-due-nuovi-bersagli-terapeutici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/5299-glioblastoma-nuovo-vaccino-migliora-sopravvivenza-libera-da-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/5150-glioblastoma-possibile-un-legame-con-il-papillomavirus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/4959-glioblastoma-multiforme-dallrna-interference-nuove-prospettive-terapeutiche-per-il-futuro]]></loc><lastmod>2019-06-19T08:13:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/4913-glioblastoma-al-besta-quattro-sperimentazioni-con-due-diversi-vaccini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/4878-glioblastoma-individuata-proteina-per-il-suo-sviluppo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/4733-glioblastoma-multiforme-un-vaccino-attualmente-in-fase-di-sperimentazione-sembra-rallentare-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/4692-un-virus-contro-il-glioblastoma-primi-esperimenti-su-modello-animale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/4613-glioblastoma-un-farmaco-usato-per-il-citomegalovirus-potrebbe-migliorare-la-sopravvivenza-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/4596-glioblastoma-e-malattie-cerebrovascolari-una-tecnica-innovativa-per-cure-personalizzate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/glioblastoma/4262-glioblastoma-promettenti-risultati-da-una-terapia-sperimentale-che-agisce-sul-polivirus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali]]></loc><lastmod>2024-03-13T12:39:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/18651-tumori-gastrointestinali-un-indagine-svela-i-bisogni-prioritari-dei-pazienti]]></loc><lastmod>2022-05-14T14:39:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/16364-tumori-stromali-gastrointestinali-avapritinib-riceve-parere-positivo-dal-chmp]]></loc><lastmod>2020-08-10T16:20:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/9544-tumori-stromali-gastrointestinali-gist-imatinib-migliorerebbe-la-sopravvivenza-libera-da-recidiva]]></loc><lastmod>2015-12-07T10:18:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/9493-tumori-stromali-gastrointestinali-gist-imatinib-ottiene-migliori-risultati-dopo-3-anni-di-terapia]]></loc><lastmod>2015-12-01T14:09:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/6499-tumori-stromali-gastrointesinali-gist-approvato-in-europa-il-trattamento-con-regorafenib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/6349-tumori-stromali-gastrointestinali-gist-regorafenib-di-bayer-raccomandato-per-lapprovazione-nellunione-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/5846-tumori-stromali-gastrointestinali-gist-nuovi-risultati-per-la-terapia-con-imatinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/5476-gist-una-combinazione-di-farmaci-per-inibirne-la-crescita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/5405-tumori-gist-scarsa-la-risposta-al-farmaco-pazopanib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/4519-gist-approvato-il-farmaco-stivarga-anche-in-giappone-ora-manca-lok-europeo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/3904-gist-nuovo-anticorpo-monoclonale-si-dimostra-efficace-nei-pazienti-resistenti-allimatinib]]></loc><lastmod>2015-05-27T08:14:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/3215-gist-e-tumore-metastatico-del-colon-retto-nuovi-dati-positivi-per-regorafenib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/2646-gist-a-palermo-e-attivo-il-programma-di-uso-compassionevole-del-regorafenib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/2311-tumori-gastrointestinali-stromali-gist-regorafenib-aumenta-la-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/2267-tumori-stromali-gastrointestinali-gist-come-valutare-il-rischio-di-recidiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/1968-tumori-stromali-gastorintestinali-metastatici-gist-regorafenib-migliora-la-sopravvivenza-libera-da-progressione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/908-gist-casali-limatinib-e-in-grado-di-ridurre-la-recidiva-nei-pazienti-a-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/gist-tumori-stromali-gastrointestinali/909-gist-i-pazienti-chiedono-linclusione-nellelenco-delle-malattie-rare-la-toscana-lha-gia-fatto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto]]></loc><lastmod>2022-10-31T14:43:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/21281-tumore-del-colon-retto-lo-screening-e-fondamentale-in-italia-necessaria-ancora-piu-attenzione]]></loc><lastmod>2024-09-16T07:14:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/20726-tumore-al-colon-retto-il-2-5-dei-casi-e-associato-a-sindromi-familiari-a-carattere-ereditario]]></loc><lastmod>2024-03-06T20:48:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/19250-tumore-al-colon-retto-nuova-potenziale-strategia-per-prevenire-le-metastasi-al-fegato]]></loc><lastmod>2022-11-05T15:05:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/17633-poliposi-adenomatosa-familiare-in-friuli-venezia-giulia-un-pdta-dedicato-alla-malattia]]></loc><lastmod>2022-10-31T15:00:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/17465-tumore-colon-retto-al-via-la-campagna-di-sensibilizzazione-ti-spiego-la-colon]]></loc><lastmod>2021-05-23T17:46:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/15866-covid-19-supporto-a-distanza-ai-pazienti-con-cancro-al-colon-retto]]></loc><lastmod>2022-10-31T14:46:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/14673-oncologia-a-milano-due-giorni-dedicati-a-progressi-scientifici-e-pratica-clinica]]></loc><lastmod>2022-10-31T14:47:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/14388-tumore-metastatico-del-colon-retto-confermata-la-sicurezza-ed-efficacia-della-combinazione-di-encorafenib-binimetinib-e-cetuximab]]></loc><lastmod>2022-10-31T14:47:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/14162-tumore-colon-retto-torna-la-campagna-di-prevenzione-io-non-rischio]]></loc><lastmod>2018-11-18T16:55:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/12837-tumore-colon-retto-maggior-sopravvivenza-con-tas-102-nei-pazienti-che-hanno-gia-ben-risposto-a-regorafenib]]></loc><lastmod>2022-10-31T14:47:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/12406-tumore-colon-retto-messaggi-dalle-cellule-malate-stimolano-la-crescita-del-cancro]]></loc><lastmod>2022-10-31T14:48:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/12190-tumore-al-colon-retto-acido-acetilsalicilico-per-la-prevenzione-primaria-della-malattia]]></loc><lastmod>2022-10-31T14:48:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/11430-tumore-colon-retto-nintedanib-migliora-la-sopravvivenza-libera-da-progressione-ma-non-quella-globale]]></loc><lastmod>2022-10-31T14:48:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/11299-tumori-del-retto-percorsi-terapeutici-conservativi-anche-per-i-pazienti-con-linfonodi-metastatici]]></loc><lastmod>2022-10-31T14:49:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/11044-tumore-colon-retto-la-diagnosi-precoce-permette-guarigione-nel-90-dei-casi]]></loc><lastmod>2022-10-31T14:49:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/10827-tumore-del-colon-retto-partita-dalla-sicilia-la-campagna-di-prevenzione-irun2]]></loc><lastmod>2022-10-31T14:49:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/10140-cancro-colon-retto-rischio-di-recidiva-ridotto-con-aggiunta-di-oxaliplatino-alla-chemio]]></loc><lastmod>2022-10-31T14:50:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/10103-tumore-colon-retto-novita-diagnostiche-il-test-non-invasivo-su-dna-e-emoglobina-fecale]]></loc><lastmod>2022-10-31T14:51:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/9782-tumore-colon-retto-dalla-terapia-genica-un-nuovo-approccio-terapeutico-contro-le-metastasi-al-fegato]]></loc><lastmod>2022-10-31T14:51:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/9470-tumore-colon-retto-primato-mondiale-per-programma-italiano-di-terapie-personalizzate]]></loc><lastmod>2022-10-31T14:51:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/9402-tumore-colon-retto-arriva-il-primo-test-per-lo-screening-basato-sulla-tecnologia-del-dna-fecale]]></loc><lastmod>2022-10-31T14:52:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/8865-cancro-colon-retto-i-fans-potrebbero-ridurne-il-rischio]]></loc><lastmod>2022-10-31T14:53:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/8738-tumore-del-colon-retto-da-uno-studio-emerge-che-un-terzo-dei-casi-diagnosticati-prima-dei-35-anni-ha-origine-ereditaria]]></loc><lastmod>2022-10-31T14:53:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/8518-tumore-del-colon-retto-un-pannello-di-biomarcatori-puo-predire-l-esito-clinico-dei-pazienti-in-trattamento-con-cetuximab]]></loc><lastmod>2022-10-31T14:53:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/8206-carcinoma-colon-retto-avanzato-o-metastatico-ramucirumab-approvato-da-fda]]></loc><lastmod>2022-10-31T14:54:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/8025-cancro-colon-retto-panitumumab-adesso-e-incluso-come-terapia-di-prima-linea]]></loc><lastmod>2022-10-31T14:56:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/7866-poliposi-adenomatosa-familiare-fap-il-rischio-di-tumore-colon-retto-e-altissimo]]></loc><lastmod>2022-10-31T15:00:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/7830-cancro-colon-retto-presentata-in-europa-la-domanda-di-registrazione-per-antitumorale-tas-102]]></loc><lastmod>2022-10-31T14:57:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/6973-la-terapia-mirata-nel-tumore-del-colon-retto-il-contributo-italiano-alla-ricerca-sugli-anticorpi-monoclonali]]></loc><lastmod>2022-10-31T14:58:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/6967-tumore-metastatico-colorettale-studio-italiano-sancisce-lutilita-della-terapia-combinata-con-folfoxiri-e-bevacizumab]]></loc><lastmod>2022-10-31T14:59:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/6841-tumore-del-colon-retto-la-terapia-con-cetuximab-e-trastuzumab-inibisce-la-crescita-delle-cellule-cancerogene]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/6580-tumore-metastatico-colorettale-cetuximab-preferibile-a-bevacizumab-come-trattamento-di-prima-linea-associato-alla-chemioterapia]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/6585-cancro-metastatico-del-colon-retto-potenzialmente-resecabile-maggior-sopravvivenza-globale-con-luso-degli-anticorpi-monoclonali-anti-egfr]]></loc><lastmod>2022-10-31T15:00:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/6392-cancro-al-colon-lazio-al-secondo-posto-in-italia-per-mortalita-quarto-per-incidenza]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/6321-cancro-del-colon-retto-metastatico-risultati-positivi-per-laggiunta-di-cetuximab-alla-chemio]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/6162-cancro-al-colon-metastatico-esiti-positivi-dalla-sperimentazione-dellantitumorale-tas-102]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/5842-cancro-del-colon-retto-nuovo-test-sul-dna-fecale-si-mostra-piu-predittivo-del-fit]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/5761-test-genetici-e-terapie-su-misura-per-il-carcinoma-del-colon-retto-metastatico]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/5754-tumore-del-colon-lo-screening-gastroenterologico-ne-salva-uno-su-quattro]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/5691-tumori-rari-tumore-metastatico-colon-retto]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/5435-cancro-al-colon-retto-la-chemio-adiuvante-non-aumenta-la-sopravvivenza]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/5409-tumore-del-colon-retto-la-prevenzione-riduce-la-mortalita-necessario-lo-screening]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/5381-cancro-colon-retto-terapia-combinata-per-gli-over-70]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/5120-cancro-colon-retto-metastatico-concluso-lo-studio-con-lenalidomide]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/5071-cancro-colorettale-necessari-controlli-precoci-anche-per-i-famigliari]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/5060-tumore-al-colon-retto-nuovi-dati-sul-ruolo-protettivo-dellaspirina]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/4764-tumore-del-colon-retto-svelato-uno-dei-meccanismi-con-cui-si-diffonde]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/4549-carcinoma-metastatico-del-colon-retto-regorafenib-di-bayer-approvato-nellunione-europea]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/4346-carcinoma-colorettale-metastatico-risultati-promettenti-da-nuovo-immunomodulatore]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/4344-carcinoma-colorettale-aflibercept-e-ora-disponibile-in-italia]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/4220-tumore-del-colon-retto-al-via-la-campagna-pronto-a-chiamare-del-policlinico-gemenelli]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/3150-tumore-metastatico-del-colon-retto-limportanza-della-multisciplinarieta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/2852-tumore-del-colon-retto-metastiatico-approvato-negli-usa-regorafenib-in-compresse]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/2801-tumore-del-colon-retto-metastatico-cetuximab-a-prezzo-ridotto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/2442-cancro-al-colon-retto-con-regorafenib-un-mese-in-piu-per-i-pazienti-molte-le-prospettive-per-i-ricercatori]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/2262-cancro-colon-retto-metastatico-richiesta-lapprovazione-di-regorafenib]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/1547-cancro-colon-retto-metastatico-regorafenib-aumenta-sopravvivenza-globale-dei-pazienti]]></loc><lastmod>2015-05-26T08:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumore-metastatico-colon-retto/1371-cancro-colon-retto-metastatico-positivi-gli-studi-di-fase-tre-su-regorafenib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide]]></loc><lastmod>2019-05-24T15:31:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/21870-tumore-della-tiroide-dietro-i-casi-in-aumento-c-e-un-problema-di-sovra-diagnosi]]></loc><lastmod>2025-04-02T15:11:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/14020-tumore-alla-tiroide-nuove-linee-guida-per-individuare-i-soggetti-a-rischio]]></loc><lastmod>2019-06-10T10:45:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/12407-tumore-della-tiroide-generalmente-curabile-raramente-piu-aggressivo]]></loc><lastmod>2018-10-10T16:29:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/11785-tumore-alla-tiroide-dieci-anni-di-esperienza-con-le-terapie-mirate]]></loc><lastmod>2017-06-19T15:20:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/11368-tumori-tiroidei-40-000-gli-interventi-all-anno]]></loc><lastmod>2017-06-19T15:20:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/10953-cancro-tiroideo-avanzato-e-ora-disponibile-in-italia-lenvatinib]]></loc><lastmod>2018-10-10T16:30:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/10898-carcinoma-midollare-della-tiroide-una-nuova-speranza-terapeutica-dalle-chinasi-aurora]]></loc><lastmod>2018-10-10T16:30:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/9397-tumori-tiroidei-presentata-la-nuova-classificazione-citologica-delle-lesioni]]></loc><lastmod>2018-10-10T16:31:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/8579-tumore-differenziato-della-tiroide-negli-anziani-la-tiroidectomia-totale-e-l-operazione-chirurgica-di-scelta]]></loc><lastmod>2018-10-10T16:32:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/8171-tumori-tiroidei-a-roma-tre-giorni-con-i-maggiori-esperti-mondiali]]></loc><lastmod>2018-10-10T16:32:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/8039-carcinoma-tiroideo-refrattario-allo-iodio-radioattivo-lenvatinib-mesilato-riceve-parere-positivo-dal-chmp]]></loc><lastmod>2018-10-10T16:33:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/7032-tumore-della-tiroide-gli-inibitori-della-chinasi-sono-efficaci-ma-hanno-unelevata-tossicita]]></loc><lastmod>2018-10-10T16:34:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/7027-cancro-della-tiroide-concessa-la-priority-review-al-farmaco-lenvatinib-mesilato]]></loc><lastmod>2018-10-10T16:34:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/7019-tumore-della-tiroide-scoperte-due-mutazioni-correlate-alla-resistenza-al-farmaco-everolimus]]></loc><lastmod>2018-10-10T16:35:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/6943-cancro-della-tiroide-lus-fda-concede-la-revisione-prioritaria-della-nda-per-lagente-anticancerogeno-lenvatinib]]></loc><lastmod>2018-10-10T16:37:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/6785-carcinoma-differenziato-della-tiroide-langiopoietina-2-e-un-buon-fattore-predittivo-per-la-risposta-del-paziente-a-lenvatinib]]></loc><lastmod>2018-10-10T16:37:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/6180-tumore-differenziato-della-tiroide-approvato-in-europa-il-farmaco-orale-sorafenib]]></loc><lastmod>2018-10-10T16:38:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/6012-tumore-della-tiroide-dallo-studio-decision-risultati-positivi-per-sorafenib]]></loc><lastmod>2018-10-10T16:38:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/5979-tumore-differenziato-della-tiroide-sorafenib-ha-ottenuto-la-raccomandazione-per-lapprovazione-nellunione-europea]]></loc><lastmod>2018-10-10T16:39:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/5466-tumori-rari-tumori-differenziati-della-tiroide]]></loc><lastmod>2018-10-10T16:39:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/5210-tumore-papillifero-della-tiroide-e-in-aumento-tra-le-cause-radiazioni-e-alimentazione]]></loc><lastmod>2018-10-10T16:40:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/5046-tumore-differenziato-della-tiroide-negli-usa-approvato-il-trattamento-con-sorafenib]]></loc><lastmod>2018-10-10T16:40:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/4528-tumore-differenziato-della-tiroide-sorafenib-ha-ottenuto-la-revisione-prioritaria-dellfda-statunitense]]></loc><lastmod>2018-10-10T16:41:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/4312-tumore-differenziato-della-tiroide-bayer-deposita-a-ema-e-fda-la-domanda-di-registrazione-per-sorafenib]]></loc><lastmod>2018-10-10T16:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/4169-carcinoma-differenziato-della-tiroide-aumenta-lo-sopravvivenza-con-sorafenib]]></loc><lastmod>2015-05-26T08:03:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-differenziati-della-tiroide/3443-tumore-differenziato-della-tiroide-successo-per-lo-studio-di-fase-iii-su-sorafenib]]></loc><lastmod>2018-10-10T16:42:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd]]></loc><lastmod>2024-03-13T12:39:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/22564-sindromi-mielodisplastiche-aifa-approva-limpiego-di-luspatercept-come-terapia-di-prima-linea-per-lanemia]]></loc><lastmod>2025-12-01T17:28:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/22116-sindromi-mielodisplastiche-buone-premesse-per-la-terapia-orale-per-pazienti-ad-alto-rischio]]></loc><lastmod>2025-06-22T14:42:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/18764-sindromi-mielodisplastiche-studio-italiano-analizza-il-rischio-di-evoluzione-in-leucemia-acuta]]></loc><lastmod>2022-06-13T14:29:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/17338-sindromi-mielodisplastiche-trattamenti-piu-personalizzati-grazie-allo-studio-del-genoma]]></loc><lastmod>2021-04-25T21:32:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/15337-sindromi-mielodisplastiche-ail-e-aipasim-fanno-il-punto-della-situazione]]></loc><lastmod>2019-10-22T15:41:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/14788-sindromi-mielodisplastiche-il-duro-percorso-di-sandra-per-avere-una-diagnosi]]></loc><lastmod>2019-05-08T11:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/14316-sindromi-mielodisplastiche-presentati-i-risultati-di-fase-iii-di-luspatercept]]></loc><lastmod>2018-12-30T21:16:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/13856-sindromi-mielodisplastiche-cruciale-il-ruolo-di-associazioni-e-reti-di-patologia]]></loc><lastmod>2018-08-24T14:07:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/13854-sindromi-mielodisplastiche-realizzata-la-prima-mappatura-italiana]]></loc><lastmod>2018-08-22T08:46:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/13619-sindromi-mielodisplastiche-e-leucemia-dai-farmaci-epigenetici-al-futuro-del-trattamento]]></loc><lastmod>2018-06-04T12:01:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/13083-sindromi-mielodisplastiche-buon-controllo-dell-anemia-con-luspatercept]]></loc><lastmod>2018-01-05T10:49:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/11258-sindromi-mielodisplastiche-l-analisi-del-genoma-puo-predire-la-risposta-dei-pazienti-al-trapianto-di-staminali]]></loc><lastmod>2017-06-19T15:09:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/10811-sindromi-mielodisplastiche-nuovi-esiti-clinici-per-il-farmaco-sperimentale-luspatercept]]></loc><lastmod>2017-06-19T15:10:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/10635-sindromi-mielodisplastiche-humanitas-cancer-center-ora-e-centro-di-eccellenza-internazionale]]></loc><lastmod>2017-06-19T15:10:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/9601-sindromi-mielodisplastiche-il-farmaco-sperimentale-luspatercept-accede-al-programma-fast-track-della-fda]]></loc><lastmod>2017-06-19T15:10:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/9596-sindromi-mielodisplastiche-nuovi-dati-dalla-sperimentazione-clinica-di-fase-ii-di-luspatercept]]></loc><lastmod>2017-06-19T15:11:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/8260-sindromi-mielodisplastiche-lenalidomide-raggiunge-lendpoint-secondario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/8257-celgene-e-acceleron-entro-la-fine-del-2015-parte-la-fase-3-del-luspatercept-per-le-sindromi-mielodisplastiche-e-la-beta-talassemia]]></loc><lastmod>2020-05-04T09:19:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/7343-sindromi-mielodisplastiche-meno-anemia-e-trasfusioni-con-sotatercept]]></loc><lastmod>2015-05-26T07:56:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/6812-sindromi-mielodisplastiche-un-altro-si-per-il-farmaco-orale-lenalidomide]]></loc><lastmod>2019-10-22T14:54:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/6786-sindromi-mielodisplastiche-nice-sostiene-il-farmaco-lenalidomide-di-celgene]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/6603-malattia-infiammatoria-intestinale-la-terapia-puo-aumentare-il-rischio-di-leucemia-mieloide-acuta-e-sindromi-mielodisplastiche]]></loc><lastmod>2019-06-18T18:03:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/6587-sindromi-mielodisplastiche-con-delezione-5q-il-punto-sul-ruolo-della-lenalidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/6308-tumori-rari-al-via-un-nuovo-studio-sulla-combinazione-terapeutica-tosedostat-citarabina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/6313-sindromi-mielodisplastiche-piu-diffuse-di-quanto-si-pensi-e-spesso-sottodiagnosticate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/6290-sindromi-mielodisplastiche-colpiscono-prevalentemente-gli-anziani-non-curarle-e-discriminazione]]></loc><lastmod>2016-12-27T19:31:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/6283-sindromi-mielodisplastiche-migliorare-la-diagnosi-per-ottimizzare-la-terapia]]></loc><lastmod>2015-08-10T07:41:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/6163-sindromi-mielodisplastiche-associate-a-del5q-gli-effetti-positivi-del-trattamento-con-lenalidomide]]></loc><lastmod>2019-06-18T18:16:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/5843-sindromi-mielodisplastiche-patogenesi-diagnosi-e-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/5674-sindromi-mielodisplastiche-rigosertib-non-ha-raggiunto-il-risultato-previsto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/5640-sindromi-mielodisplastiche-troppe-difficolta-per-i-pazienti-che-non-accedono-alle-terapie-adeguate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/5352-tumori-del-sangue-li-innesca-una-mutazione-nelle-cellule-ossee]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/5308-sindromi-mielodisplastiche-trapianto-anche-per-i-piu-anziani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/5126-sindromi-mielodisplastiche-primi-risultati-del-trattamento-con-azaticidina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/5121-sindromi-mielodisplastiche-piu-aggressive-con-le-mutazioni-driver]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/5127-sindromi-mielodisplastiche-associate-a-5q-con-lenalidomide-stop-alle-trasfusioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/5038-sindromi-mielodisplastiche-santini-non-discriminare-in-base-alleta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/5037-ageism-quando-i-pazienti-molto-anziani-non-accedono-alle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/4908-sindromi-mielodisplastiche-la-terapia-chelante-evita-liron-overload-il-danno-da-ferro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/4251-sindromi-mielodisplastiche-con-delezione-5q-la-commissione-europea-approva-la-terapia-orale-con-lenalidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/3971-sindrome-mielodisplastica-con-delezione-5q-parere-positivo-dellema-per-la-terapia-orale-con-lenalidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/sindromi-mielodisplastiche-smd/3862-sindromi-mielodisplastiche-identificato-gene-associato-ad-accumulo-di-ferro-per-le-trasfusioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide]]></loc><lastmod>2018-01-31T22:12:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/14397-carcinoma-midollare-tiroideo-all-istituto-oncologico-della-svizzera-italiana-un-percorso-specifico-per-individuarlo-in-fretta]]></loc><lastmod>2019-01-29T11:45:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/14396-carcinoma-midollare-della-tiroide-l-importanza-il-dosaggio-della-procalcitonina-per-la-diagnosi]]></loc><lastmod>2019-01-29T11:35:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/12862-carcinoma-midollare-della-tiroide-il-test-della-calcitonina-puo-facilitarne-la-diagnosi]]></loc><lastmod>2017-11-05T14:49:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/11317-un-epidemia-mondiale-di-cancro-alla-tiroide]]></loc><lastmod>2017-11-05T14:52:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/10201-carcinoma-midollare-della-tiroide-sara-ipsen-a-commercializzare-il-farmaco-cabozantinib]]></loc><lastmod>2017-11-05T14:51:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/9796-carcinoma-midollare-della-tiroide-disponibili-le-raccomandazioni-sul-pdta]]></loc><lastmod>2017-11-05T14:52:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/8873-carcinoma-midollare-della-tiroide-a-pisa-proseguono-le-ricerche-sulla-diagnosi-precoce]]></loc><lastmod>2017-11-05T14:53:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/8758-carcinoma-midollare-della-tiroide-genzyme-acquista-il-farmaco-vandetanib-da-astrazeneca]]></loc><lastmod>2017-11-05T14:53:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/8615-carcinoma-follicolare-della-tiroide-massima-attenzione-ai-tumori-di-dimensioni-superiori-a-4-cm]]></loc><lastmod>2015-07-13T13:29:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/8430-carcinoma-tiroideo-refrattario-allo-iodio-radioattivo-lenvatinib-approvato-in-europa]]></loc><lastmod>2015-06-12T10:05:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/7597-obesita-associata-a-maggior-rischio-di-tumore-alla-tiroide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/7425-carcinoma-midollare-della-tiroide-ecografia-sospetta-e-aggressivita-del-tumore-sono-correlate]]></loc><lastmod>2015-05-26T08:04:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/7213-carcinoma-alla-tiroide-al-secondo-posto-tra-i-tumori-femminili-piu-frequenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/7173-carcinoma-midollare-della-tiroide-puo-colpire-anche-i-bambini-a-pisa-leccellenza-italiana]]></loc><lastmod>2015-06-12T12:38:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/5795-carcinoma-midollare-della-tiroide-in-commercio-il-farmaco-cabozantinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/5250-tumore-della-tiroide-scoperta-lefficacia-di-un-farmaco-anti-diabetico]]></loc><lastmod>2015-05-26T08:05:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4898-carcinoma-midollare-tiroide-un-nuovo-farmaco-prolunga-la-sopravvivenza]]></loc><lastmod>2015-05-26T08:06:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4773-carcinoma-midollare-della-tiroide-cosa-dice-la-biopsia-con-ago-aspirato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4769-carcinoma-midollare-della-tiroide-individuata-una-nuova-mutazione-che-causa-il-tumore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4627-terapia-e-prevenzione-del-carcinoma-midollare-della-tiroide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4626-carcinoma-midollare-della-tiroide-il-punto-sulla-diffusione-della-rara-patologia-oncologica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4625-carcinoma-midollare-della-tiroide-come-si-diagnostica-e-quali-sono-le-opzioni-terapeutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4617-carcinoma-midollare-della-tiroide-gaetano-convive-da-anni-con-la-malattia-grazie-al-jazz-non-ha-mai-perso-la-speranza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4616-tumore-midollare-della-tiroide-disponibile-anche-in-italia-il-primo-farmaco-per-la-rara-malattia-oncologica]]></loc><lastmod>2015-05-28T12:14:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4621-manifesto-del-tumore-midollare-della-tiroide-10-punti-per-conoscere-e-riconoscere-una-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4593-sindrome-di-cushing-associata-a-tumore-midollare-della-tiroide-e-efficace-il-vandetanib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/4377-carcinoma-midollare-della-tiroide-vandetanib-piu-efficace-se-luso-e-selettivo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/3332-carcinoma-midollare-della-tiroide-negli-usa-approvato-cabozantinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/2794-carcinoma-midollare-della-tiroide-in-italia-presto-la-prima-terapia-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/1710-carcinoma-midollare-della-tiroide-approvato-dalla-commissione-europea-il-trattamento-con-vandetanib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/617-carcinoma-midollare-tiroideo-negli-usa-approvato-vandetanib-per-i-casi-inoperabili-e-metastatici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-midollare-della-tiroide/318-carcinoma-midollare-della-tiroide-apertura-della-fda-a-nuovo-farmaco-oncologico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma]]></loc><lastmod>2015-02-17T18:10:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/20917-mesotelioma-il-raro-e-aggressivo-tumore-che-ha-colpito-lo-stimato-giornalista-franco-di-mare]]></loc><lastmod>2024-05-24T07:54:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/20905-mesotelioma-il-tumore-dell-amianto-che-continua-a-colpire-in-italia]]></loc><lastmod>2024-04-29T10:29:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/13594-mesotelioma-pubblicati-i-risultati-completi-di-ngr-htnf]]></loc><lastmod>2018-05-26T15:22:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/12818-mesotelioma-studio-made-in-italy-su-nuova-immunoterapia-di-combinazione]]></loc><lastmod>2018-05-26T17:53:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/12379-mesotelioma-pleurico-incoraggianti-dati-di-sopravvivenza-per-nintedanib]]></loc><lastmod>2018-05-26T17:54:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/11768-mesotelioma-ema-accetta-domanda-di-conditional-marketing-authorisation-per-la-molecola-ngr-htnf]]></loc><lastmod>2018-05-26T17:54:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/11706-mesotelioma-depositata-la-domanda-di-conditional-marketing-authorisation-in-europa-per-ngr-htnf]]></loc><lastmod>2018-05-26T17:54:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/11256-mesotelioma-dal-1993-il-numero-di-casi-da-amianto-continua-a-crescere-anche-fra-i-familiari-dei-lavoratori]]></loc><lastmod>2018-05-26T17:55:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/11010-mesotelioma-indicazioni-positive-da-sperimentazione-clinica-sul-farmaco-avelumab]]></loc><lastmod>2018-05-26T17:55:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/10687-mesotelioma-presentato-primo-studio-clinico-su-due-farmaci-immunoterapici]]></loc><lastmod>2018-05-26T17:56:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/10659-mesotelioma-pleurico-iniziato-il-reclutamento-di-pazienti-per-la-sperimentazione-avanzata-del-farmaco-nintedanib]]></loc><lastmod>2018-05-26T17:57:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/10671-mesotelioma-non-solo-amianto-possibile-una-predisposizione-genetica]]></loc><lastmod>2018-05-26T17:57:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/10185-mesotelioma-delude-la-sperimentazione-di-tremelimumab-utilizzato-come-terapia-unica]]></loc><lastmod>2018-05-26T17:57:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/9504-mesotelioma-pleurico-maligno-le-statistiche-sulla-gestione-clinica-della-malattia-in-francia]]></loc><lastmod>2018-05-26T17:58:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/9044-mesotelioma-maligno-mtg-201-denominato-farmaco-orfano-dalla-fda]]></loc><lastmod>2018-05-26T17:58:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/8635-mesotelioma-maligno-un-indagine-sull-esposizione-non-professionale-all-amianto-in-italia]]></loc><lastmod>2018-05-26T17:58:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/8318-mesotelioma-promettenti-i-risultati-di-uno-studio-italiano-di-immunoncologia]]></loc><lastmod>2018-05-26T17:59:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/8242-mesotelioma-lfda-concede-la-designazione-di-farmaco-orfano-allimmunoterapico-crs-207]]></loc><lastmod>2018-05-26T17:59:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/8240-mesotelioma-pleurico-pembrolizumab-blocca-la-crescita-tumorale]]></loc><lastmod>2018-05-26T18:00:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/8223-mesotelioma-molmed-ad-asco-2015-con-tre-studi-sui-progressi-della-terapia-sperimentale-ngr-htnf]]></loc><lastmod>2018-05-26T18:00:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/8135-mesotelioma-maligno-fda-concede-designazione-di-farmaco-orfano-a-tremelimumab]]></loc><lastmod>2018-05-26T18:01:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/7652-mesotelioma-vs-5584-riceve-la-designazione-di-farmaco-orfano]]></loc><lastmod>2018-05-26T18:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/6381-mesotelioma-dallestratto-di-carciofo-nuove-possibilita-contro-il-tumore]]></loc><lastmod>2018-05-26T18:02:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/6254-mesotelioma-buoni-risultati-per-il-trattamento-con-tremelimumab]]></loc><lastmod>2018-05-26T18:02:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/6125-mesotelioma-pleurico-maligno-molmed-annuncia-i-risultati-di-ngr-htnf-nello-studio-di-fase-iii]]></loc><lastmod>2018-05-26T18:03:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/5473-nel-mesotelioma-prognosi-migliore-con-radio-pre-operatoria]]></loc><lastmod>2018-05-26T18:03:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/5386-tumore-dellamianto-le-promesse-di-due-studi-italiani]]></loc><lastmod>2018-05-26T18:04:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/5313-tumore-da-amianto-si-muore-ancora-e-si-prevede-un-aumento-di-casi]]></loc><lastmod>2018-05-26T18:04:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/4818-mesotelioma-attivo-lambulatorio-oncologico-online-ona]]></loc><lastmod>2018-05-26T18:05:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/4657-mesotelioma-pleurico-pubblicati-i-risultati-di-una-nuova-possibile-cura]]></loc><lastmod>2018-05-26T18:08:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/4416-mesotelioma-avviati-ad-alessandria-due-sperimentazioni-cliniche]]></loc><lastmod>2018-05-26T18:11:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/4297-mesotelioma-presentati-i-dati-della-lung-sparing-tecnica-che-risparmia-la-parte-sana-del-polmone]]></loc><lastmod>2018-05-26T18:12:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/4293-mesotelioma-nuova-designazione-di-farmaco-orfano-per-il-vs-6063]]></loc><lastmod>2018-05-26T18:12:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/3976-mesotelioma-il-rischio-potrebbe-essere-connesso-al-processo-di-estrazione-del-ferro-dalla-taconite]]></loc><lastmod>2018-05-26T18:13:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/3758-mesotelioma-la-ricerca-italiana-propone-una-nuova-strategia-terapeutica]]></loc><lastmod>2018-05-26T18:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/3386-tumori-rari-anche-alessandria-fa-parte-della-rete-di-eccellenza-nazionale]]></loc><lastmod>2018-05-26T18:13:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/3238-mesotelioma-in-italia-sara-costituita-una-rete-deccellenza]]></loc><lastmod>2018-05-26T18:14:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/3032-mesotelioma-pleurico-misurando-il-livello-di-una-proteina-nel-sangue-si-puo-individuare-la-malattia]]></loc><lastmod>2018-05-26T18:14:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/2762-mesotelioma-il-senato-approva-due-mozioni-per-una-maggiore-sorveglianza-e-ricerca]]></loc><lastmod>2018-05-26T18:16:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/2559-mesotelioma-e-amianto-i-militari-si-ammalano-troppo-di-frequente]]></loc><lastmod>2018-05-26T18:16:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/2541-mesotelioma-negli-usa-un-nuovo-farmaco-orfano-per-il-trattamento-della-neoplasia]]></loc><lastmod>2018-05-26T18:16:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/1994-mesotelioma-la-speranza-potrebbe-arrivare-da-un-vaccino-terapeutico]]></loc><lastmod>2018-05-26T18:17:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mesotelioma/1024-mesotelioma-veterani-della-marina-americana-a-rischio-da-soli-rappresentano-un-terzo-dei-casi]]></loc><lastmod>2018-05-26T18:17:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo]]></loc><lastmod>2024-03-13T12:40:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/22731-mieloma-multiplo-duplice-terapia-mostra-risultati-promettenti-nelle-forme-extra-midollari]]></loc><lastmod>2026-02-10T15:41:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/22677-mieloma-multiplo-scoperto-un-nuovo-meccanismo-di-resistenza-alle-terapie]]></loc><lastmod>2026-01-20T14:13:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/22673-giovanni-allevi-torna-in-tour-il-mieloma-multiplo-non-lo-ferma]]></loc><lastmod>2026-01-20T17:58:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/22115-mieloma-multiplo-aifa-approva-la-rimborsabilita-di-elranatamab]]></loc><lastmod>2025-06-22T14:44:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/21292-mieloma-multiplo-con-il-progetto-mmarea-un-podcast-per-informare-sulla-patologia]]></loc><lastmod>2024-09-17T11:28:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/21283-mieloma-multiplo-progressi-nel-trattamento-di-questo-raro-tumore]]></loc><lastmod>2024-09-13T16:02:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/20862-mieloma-multiplo-oltre-25mila-euro-all-anno-spesi-per-ogni-paziente]]></loc><lastmod>2024-04-10T16:21:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/20776-mieloma-multiplo-al-via-la-campagna-di-informazione-mmarea]]></loc><lastmod>2024-03-18T18:13:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/20775-mieloma-multiplo-approvazione-europea-per-elranatamab]]></loc><lastmod>2024-03-18T17:22:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/20720-mieloma-multiplo-un-tumore-senza-una-cura-definitiva-oppure-no]]></loc><lastmod>2024-03-11T12:38:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/20607-sanremo-2024-giovanni-allevi-parla-del-mieloma-multiplo-il-tumore-che-lo-ha-colpito]]></loc><lastmod>2024-02-08T16:23:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/19805-mieloma-multiplo-arriva-in-italia-il-farmaco-teclistamab]]></loc><lastmod>2023-05-14T12:53:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/19298-mieloma-multiplo-oltre-10-000-euro-i-costi-annuali-per-pazienti-e-caregiver]]></loc><lastmod>2022-11-22T08:22:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/18118-mieloma-multiplo-al-via-il-bando-research-to-care]]></loc><lastmod>2021-12-20T19:03:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/18112-mieloma-multiplo-disponibile-in-italia-la-formulazione-sottocutanea-di-daratumumab]]></loc><lastmod>2026-04-09T14:18:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/18084-mieloma-multiplo-presentata-la-carta-dei-diritti-del-paziente-di-cittadinanzattiva]]></loc><lastmod>2021-12-12T15:25:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/18068-mieloma-multiplo-il-farmaco-belantamab-mafodotin-approvato-anche-in-italia]]></loc><lastmod>2021-12-05T16:51:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/18027-mieloma-multiplo-il-golf-come-strumento-per-promuovere-il-benessere-dei-pazienti]]></loc><lastmod>2021-11-21T23:59:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/17892-mieloma-multiplo-recidivato-refrattario-isatuximab-disponibile-in-italia]]></loc><lastmod>2021-10-16T21:58:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/17464-mieloma-multiplo-il-primo-studio-su-sicurezza-e-immunogenicita-del-vaccino-anti-sars-cov-2]]></loc><lastmod>2021-11-15T16:39:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/17335-mieloma-multiplo-la-ce-autorizza-la-seconda-indicazione-di-isatuximab]]></loc><lastmod>2021-11-15T16:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/17139-mieloma-multiplo-ok-del-chmp-a-isatuximab-in-combinazione-con-carfilzomib-e-desametasone]]></loc><lastmod>2021-03-07T13:43:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/17096-mieloma-multiplo-daratumumab-ottiene-la-rimborsabilita-in-italia]]></loc><lastmod>2021-02-28T17:41:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/16849-mieloma-multiplo-in-italia-si-stimano-circa-6-000-nuovi-casi-all-anno]]></loc><lastmod>2022-05-11T11:52:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/16761-mieloma-multiplo-dallo-sport-un-aiuto-contro-la-malattia]]></loc><lastmod>2020-11-30T21:23:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/16744-mieloma-multiplo-la-battaglia-piu-ardua-e-contro-le-continue-recidive-di-malattia]]></loc><lastmod>2020-11-29T21:02:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/16327-covid-19-e-mieloma-multiplo-avviato-uno-studio-osservazionale-europeo]]></loc><lastmod>2020-07-26T15:47:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/16180-mieloma-multiplo-approvato-in-europa-il-farmaco-isatuximab]]></loc><lastmod>2020-06-14T23:24:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/15944-mieloma-multiplo-parere-positivo-del-chmp-per-isatuximab]]></loc><lastmod>2020-04-13T17:52:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/15738-mieloma-multiplo-approvazione-usa-per-isatuximab]]></loc><lastmod>2020-03-09T13:37:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/15655-mieloma-multiplo-al-san-raffaele-parte-il-trial-clinico-sulla-terapia-car-t]]></loc><lastmod>2020-02-12T18:26:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/15462-mieloma-multiplo-in-italia-parte-uno-studio-su-carfilzomib-lenalidomide-e-desametasone]]></loc><lastmod>2019-12-01T22:06:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/15244-mieloma-multiplo-presentati-i-risultati-del-programma-ridisegnare-insieme-il-percorso-terapeutico-dei-pazienti]]></loc><lastmod>2019-09-30T19:37:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/14903-mieloma-multiplo-risultati-promettenti-da-combinazione-isatuximab-pomalidomide-e-desametasone]]></loc><lastmod>2019-06-11T14:57:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/14693-mieloma-multiplo-parere-positivo-del-chmp-per-lenalidomide-e-pomalidomide]]></loc><lastmod>2019-04-05T17:46:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/14630-mieloma-multiplo-ixazomib-ora-e-disponibile-anche-in-italia]]></loc><lastmod>2019-03-25T17:40:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/14439-mieloma-multiplo-raggiunto-l-endpoint-primario-nello-studio-di-fase-iii-su-isatuximab]]></loc><lastmod>2019-02-07T21:15:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/14312-mieloma-multiplo-dall-europa-2-milioni-di-euro-per-un-nuovo-progetto-di-ricerca]]></loc><lastmod>2018-12-26T18:48:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/14241-mieloma-multiplo-in-liguria-si-fa-rete-per-garantire-percorsi-di-cura-e-assistenza]]></loc><lastmod>2019-03-26T17:25:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/13710-mieloma-multiplo-in-italia-estesa-la-rimborsabilita-di-lenalidomide]]></loc><lastmod>2018-06-29T15:32:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/13438-mieloma-multiplo-bluebird-bio-e-celgene-sviluppano-insieme-una-terapia-basata-sulle-car-t]]></loc><lastmod>2018-08-02T16:44:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/13412-mieloma-multiplo-ogni-anno-in-italia-5-mila-nuovi-casi]]></loc><lastmod>2019-09-10T14:23:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/13034-mieloma-multiplo-recidivato-o-refrattario-carfilzomib-aumenta-la-sopravvivenza-globale]]></loc><lastmod>2017-12-16T16:07:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/12566-mieloma-multiplo-risultati-positivi-dalla-terapia-di-mantenimento-con-lenalidomide]]></loc><lastmod>2017-08-03T16:04:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/12431-mieloma-multiplo-risultati-clinici-di-fase-i-dalla-terapia-bb2121]]></loc><lastmod>2018-08-02T18:16:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11887-mieloma-multiplo-al-via-fase-i-su-sgn-cd352a-per-la-forma-recidiva-o-refrattaria]]></loc><lastmod>2019-01-17T17:48:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11766-mieloma-multiplo-per-la-raccolta-dei-dati-genomici-nasce-myeloma-genome-project]]></loc><lastmod>2017-06-19T15:05:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11682-mieloma-multiplo-ixazomib-riceve-l-autorizzazione-condizionata-della-commissione-europea]]></loc><lastmod>2017-06-19T15:05:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11661-mieloma-multiplo-via-libera-dell-aifa-alla-rimborsabilita-di-lenalidomide]]></loc><lastmod>2017-06-19T15:06:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11667-mieloma-multiplo-test-clinici-favorevoli-per-il-composto-immunoterapico-galinpepimut-s]]></loc><lastmod>2017-06-19T15:06:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11581-mieloma-multiplo-con-carfilzomib-nuova-sfida-in-ematologia]]></loc><lastmod>2016-11-08T22:01:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11577-mieloma-multiplo-oggi-la-malattia-si-puo-fermare]]></loc><lastmod>2016-11-12T15:17:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11580-mieloma-multiplo-con-carfilzomib-piu-prolungata-inibizione-del-proteasoma-e-piu-elevata-attivita-antitumorale]]></loc><lastmod>2016-11-08T22:00:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11572-mieloma-multiplo-30-000-i-pazienti-in-italia-incidenza-maggiore-negli-over-65]]></loc><lastmod>2016-11-08T08:09:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11569-mieloma-multiplo-arriva-in-italia-il-farmaco-carfilzomib]]></loc><lastmod>2016-11-05T11:50:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11298-mieloma-multiplo-takeda-riceve-l-opinione-positiva-del-chmp-per-l-approvazione-condizionata-di-ixazomib]]></loc><lastmod>2016-09-22T14:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11197-mieloma-multiplo-takeda-avvia-studio-osservazionale-globale-su-5000-pazienti]]></loc><lastmod>2016-09-05T14:49:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11180-mieloma-multiplo-carfilzomib-efficace-ma-attenzione-a-possibili-effetti-cardiotossici]]></loc><lastmod>2016-09-01T17:00:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/11095-mieloma-multiplo-ricorrente-e-refrattario-elotuzumab-migliora-la-sopravvivenza-libera-da-progressione]]></loc><lastmod>2016-08-05T12:07:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10990-mieloma-multiplo-l-aggiunta-di-ixazomib-a-un-regime-di-lenalidomide-e-desametasone-aumenta-la-sopravvivenza-libera-da-progressione]]></loc><lastmod>2016-07-15T13:14:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10939-mieloma-multiplo-i-livelli-della-proteina-cd38-influenzano-la-risposta-al-farmaco-daratumumab]]></loc><lastmod>2016-07-08T17:33:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10836-mieloma-multiplo-buoni-risultati-da-lenalidomide-anche-dopo-il-trapianto]]></loc><lastmod>2016-06-23T07:21:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10759-mieloma-multiplo-carfilzomib-migliora-la-sopravvivenza-libera-da-progressione]]></loc><lastmod>2016-06-08T15:38:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10732-mieloma-multiplo-parere-negativo-del-chmp-per-ixazomib]]></loc><lastmod>2019-03-22T19:43:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10711-mieloma-multiplo-approvato-daratumumab-dalla-commissione-europea]]></loc><lastmod>2016-05-30T15:27:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10709-mieloma-multiplo-ok-del-chmp-per-l-estensione-delle-indicazioni-di-carfilzomib]]></loc><lastmod>2016-05-30T14:56:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10309-mieloma-multiplo-parere-positivo-del-chmp-per-daratumumab]]></loc><lastmod>2016-04-04T15:44:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10308-mieloma-multiplo-buoni-risultati-da-plitidepsina-in-studio-di-fase-iii]]></loc><lastmod>2016-04-04T15:42:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10259-mieloma-multiplo-molmed-e-genenta-insieme-per-lo-sviluppo-di-una-terapia-genica]]></loc><lastmod>2016-03-25T10:23:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10056-mieloma-multiplo-ok-la-combinazione-pomalidomide-e-desametasone]]></loc><lastmod>2016-02-26T14:20:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10053-mieloma-multiplo-buoni-risultati-da-melfalan-piu-trapianto-autologo-di-staminali]]></loc><lastmod>2016-02-26T13:52:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/10011-malattie-rare-i-progressi-dell-ematologia]]></loc><lastmod>2016-02-23T17:22:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9965-mieloma-multiplo-aggiunta-di-carfilzomib-a-terapia-di-salvataggio-aumenta-la-risposta]]></loc><lastmod>2016-02-12T15:38:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9798-mieloma-multiplo-nessun-vantaggio-dal-triplo-regime-per-pazienti-anziani]]></loc><lastmod>2016-01-22T11:40:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9772-mieloma-multiplo-daratumumab-sicuro-e-ben-tollerato]]></loc><lastmod>2016-01-19T16:46:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9696-mieloma-multiplo-il-modello-brasiliano-dei-centri-di-riferimento]]></loc><lastmod>2016-01-04T11:58:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9643-mieloma-multiplo-malattia-eradicata-per-la-prima-volta-grazie-all-immunoterapia]]></loc><lastmod>2015-12-18T11:07:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9614-mieloma-multiplo-melfalan-con-trapianto-autologo-di-staminali-piu-efficace-di-chemio-piu-lenalidomide]]></loc><lastmod>2015-12-14T11:46:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9546-mieloma-multiplo-efficace-la-combinazione-elotuzumab-con-lenalidomide-e-desametasone]]></loc><lastmod>2015-12-07T10:24:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9478-mieloma-multiplo-approvato-dall-fda-ixazomib-di-takeda]]></loc><lastmod>2015-11-30T09:58:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9465-mieloma-multiplo-e-leucemia-linfoblastica-acuta-in-arrivo-importanti-novita-terapeutiche]]></loc><lastmod>2015-11-27T09:15:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9342-mieloma-multiplo-il-42-dei-pazienti-italiani-e-vivo-a-5-anni]]></loc><lastmod>2015-11-12T15:33:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9250-mieloma-multiplo-una-terapia-continuativa-migliora-la-sopravvivenza]]></loc><lastmod>2015-10-29T15:10:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/9156-mieloma-multiplo-fda-apre-al-farmaco-elotuzumab-in-combinazione]]></loc><lastmod>2017-06-19T15:07:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8996-mieloma-multiplo-la-dr-ssa-menard-spiega-il-lungo-iter-di-un-farmaco-dal-laboratorio-al-paziente]]></loc><lastmod>2015-09-28T12:57:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8997-mieloma-multiplo-prof-pane-le-nuove-terapie-sono-piu-tollerabili-per-questi-pazienti-per-lo-piu-anziani]]></loc><lastmod>2015-09-28T13:02:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8976-mieloma-multiplo-rimborsabilita-approvata-da-aifa-per-pomalidomide]]></loc><lastmod>2015-09-23T20:22:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8872-mieloma-multiplo-risultati-positivi-da-daratumumab]]></loc><lastmod>2015-09-04T13:40:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8809-mieloma-multiplo-stipulato-accordo-tra-pharmamar-e-sta-per-commercializzazione-di-plitidepsin]]></loc><lastmod>2015-08-24T10:17:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8808-mieloma-multiplo-ema-concede-a-takeda-l-immissione-in-commercio-di-ixazomib]]></loc><lastmod>2019-03-25T14:33:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8750-mieloma-multiplo-l-ema-concede-la-valutazione-accelerata-del-farmaco-sperimentale-ixazomib]]></loc><lastmod>2015-08-03T09:47:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8695-mieloma-multiplo-dal-san-raffaele-e-harvard-un-potenziale-e-innovativo-trattamento-combinato]]></loc><lastmod>2015-07-27T10:00:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8638-mieloma-multiplo-ricorrente-e-refrattario-la-terapia-con-lenalidomide-piu-desametasone-prolunga-la-sopravvivenza-globale]]></loc><lastmod>2015-07-21T08:58:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8637-la-terapia-di-prima-linea-con-lenalidomide-nei-pazienti-con-nuova-diagnosi-di-mieloma-multiplo]]></loc><lastmod>2015-07-17T10:25:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8650-mieloma-multiplo-nuovi-studi-chiariscono-l-efficacia-delle-terapie-farmacologiche]]></loc><lastmod>2015-07-21T08:09:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8644-mieloma-multiplo-takeda-presenta-una-richiesta-di-nuovo-farmaco-per-ixazomib]]></loc><lastmod>2015-07-20T10:34:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8536-mieloma-multiplo-parere-positivo-di-ema-a-nuova-combinazione]]></loc><lastmod>2015-06-29T10:09:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8446-mieloma-multiplo-presentati-i-risultati-di-studio-di-fase-iii-su-lenalidomide]]></loc><lastmod>2015-06-15T09:46:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8222-mieloma-multiplo-al-via-lo-studio-di-fase-iii-per-la-terapia-di-mantenimento-con-ixazomib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8186-immunologia-oncologica-accordo-tra-astrazeneca-e-celgene-per-lo-sviluppo-di-nuovi-farmaci]]></loc><lastmod>2015-11-09T20:35:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8134-mieloma-multiplo-laifa-divulga-nota-informativa-sul-pomalidomide]]></loc><lastmod>2015-05-26T07:38:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8061-mieloma-multiplo-i-consigli-per-ottimizzare-il-trattamento-dei-pazienti-con-insufficienza-renale]]></loc><lastmod>2015-05-26T07:38:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8046-mieloma-multiplo-recidivato-la-terapia-con-carfilzomib-lenalidomide-e-desametasone-migliora-la-sopravvivenza-libera-da-progressione]]></loc><lastmod>2015-05-26T07:38:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/8024-mieloma-multiplo-nuovi-orizzonti-di-terapia-da-uno-studio-palermitano-sugli-esosomi]]></loc><lastmod>2015-05-26T07:39:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7889-mieloma-multiplo-approvato-da-fda-panobinostat-combinato-con-bortezomib-e-desametasone]]></loc><lastmod>2025-02-25T18:52:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7786-mieloma-multiplo-carfilzomib-piu-efficace-di-bortezomib-in-studio-di-fase-iii]]></loc><lastmod>2015-05-26T07:39:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7644-mieloma-multiplo-richiesta-allema-la-registrazione-di-carfilzomib-18536376]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7664-mieloma-multiplo-approvato-da-ue-lenalidomide]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7601-trattamento-del-mieloma-multiplo-risultati-promettenti-dagli-anticorpi-monoclonali-anti-cd38]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7618-mieloma-multiplo-ixazomib-orale-raggiunge-endpoint-primario-nello-studio-clinico-di-fase-3-tourmaline-mm1]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7617-mieloma-multiplo-richiesta-allema-la-registrazione-di-carfilzomib]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7510-2015-02-02-14-48-44]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7506-trapianto-di-staminali-emopoietiche-record-a-treviso-curato-soprattutto-il-mieloma-multiplo]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7487-mieloma-multiplo-al-via-i-trial-per-la-molecola-dtp3-potente-quando-il-bortezomib-ma-100-volte-piu-selettiva]]></loc><lastmod>2016-05-06T16:27:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7464-mileloma-multiplo-daratumumab-mostra-un-profilo-di-sicurezza-elevato]]></loc><lastmod>2015-05-26T07:38:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7460-mieloma-multiplo-presentati-nuovi-risultati-sugli-anticorpi-monoclonali-anti-cd38]]></loc><lastmod>2015-05-26T07:38:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7390-mieloma-multiplo-buoni-risultati-per-lanticorpo-monoclonale-daratumumab-in-aggiunta-alle-terapie-tradizionali]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7339-mileloma-multiplo-lenalidomide-come-trattamento-di-prima-linea-parere-positivo-dallema]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7279-mieloma-multiplo-con-un-mix-di-tre-farmaci-la-sopravvivenza-libera-da-progressione-arriva-a-263-mesi]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7219-mieloma-multiplo-linternational-myeloma-foundation-deluso-dalla-decisione-odac]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7117-mieloma-multiplo-la-ricaduta-precoce-dopo-il-trapianto-di-cellule-staminali-e-indice-di-minor-sopravvivenza]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7116-mieloma-multiplo-il-no-dellfda-alluso-di-panobinostat-in-combinazione-con-bortezomib-e-desametasone]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7125-mieloma-multiplo-celgene-si-aggiudica-il-premio-pmea-per-il-farmaco-imnovid]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7033-mieloma-multiplo-la-terapia-con-bortezomib-talidomide-desametasone-induce-neuropatia-periferica-quasi-sempre-reversibile]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/7018-mieloma-multiplo-la-somministrazione-di-melfalan-riduce-gli-effetti-collaterali-della-chemioterapia]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6845-mieloma-multiplo-i-vantaggi-della-terapia-continua]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6727-mieloma-multiplo-la-combinazione-carfilzomib-desametasone-e-sicura-ed-efficace]]></loc><lastmod>2015-05-26T07:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6668-mieloma-multiplo-trattamento-con-bortezomib-meglio-per-via-sottocutanea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6665-mieloma-multiplo-limpatto-di-anomalie-cromosomiche-immunofenotipo-e-nuove-terapie-sulla-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6691-mieloma-multiplo-la-sopravvivenza-raddoppia-se-il-trapianto-viene-eseguito-alla-diagnosi]]></loc><lastmod>2016-02-09T12:10:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6652-mieloma-multiplo-linternational-myeloma-foundation-annuncia-la-pubblicazione-di-dati-provenienti-da-uno-studio-su-revlimid]]></loc><lastmod>2019-06-18T18:01:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6471-mieloma-recidivato-o-refrattario-carfilzomib-ad-alto-dosaggio-potrebbe-essere-piu-efficace]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6327-mieloma-multiplo-refrattario-presentati-i-risultati-dello-studio-su-panobinostat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6323-mieloma-multiplo-refrattario-risultati-incoraggianti-per-il-regime-composto-a-quattro-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6324-mieloma-multiplo-nuove-speranze-dal-virus-del-morbillo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6317-mileloma-multiplo-grazie-ai-nuovi-farmaci-orali-la-prospettiva-di-vita-e-raddoppiata]]></loc><lastmod>2015-08-10T07:26:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6285-mieloma-multiplo-fda-concede-status-breakthrough-therapy-a-nivolumab-ed-elotuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6282-mieloma-multiplo-patologia-diagnosi-e-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6256-mieloma-multiplo-allonco-ematologia-di-terni-attrezzatura-allavanguardia-donata-in-ricordo-di-un-amico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6158-mieloma-multiplo-la-fondazione-internazionale-presenta-una-nuova-viroterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/6154-mieloma-multiplo-il-farmaco-sperimentale-elotuzumab-designato-terapia-fortemente-innovativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/5797-mieloma-multiplo-risposta-positiva-dei-pazienti-in-ricaduta-al-mix-bortezomib-lenalidomide-desametasone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/5787-mieloma-multiplo-a-breve-uno-studio-comparativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/5481-mieloma-multiplo-pomalidomide-e-desametasone-migliorano-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/5465-mieloma-multiplo-pomalidomide-approvata-anche-in-canada]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/5426-mieloma-multiplo-in-un-solo-tumore-scoperte-diverse-mutazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/5351-flanesib-terapia-promettente-per-il-mieloma-multiplo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/5362-tumori-rai-il-successo-di-celgene-che-ha-cambiato-la-prognosi-del-mieloma-multiplo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/5256-mieloma-multiplo-da-nuovo-studio-confermata-la-superiorita-dellacido-zoledronico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/5149-mieloma-multiplo-nuova-strategia-contro-lesioni-ossee]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/5094-premiata-la-compagnia-farmaceutica-celgene-per-il-trattamento-del-mieloma-multiplo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4970-mieloma-multiplo-nuovi-inibitori-per-i-casi-resistenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4746-leucemia-mieloide-acuta-e-mieloma-multiplo-dal-san-raffaele-di-milano-arrivano-i-super-linfociti-t]]></loc><lastmod>2020-02-12T15:01:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4606-mieloma-multiplo-pubblicati-su-the-lancet-oncology-gli-ultimi-risultati-sulla-lenalidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4562-leucemia-plasmacellulare-il-trattamento-con-lenalidomide-migliora-possibilita-di-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4559-mieloma-multiplo-la-curcumina-potrebbe-rendere-efficace-la-talidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4495-mieloma-multiplo-nuovi-dati-confermano-che-lenalidomide-ritarda-linsorgenza-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4487-mieloma-multiplo-la-terapia-con-pomalidomide-approvata-dalla-commissione-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4432-mieloma-multiplo-successo-per-la-sperimentazione-di-fase-iii-con-lenalidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4364-mieloma-multiplo-lenalinomide-migliora-sopravvivenza-anche-nei-nuovi-casi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4358-mieloma-multiplo-il-chmp-approva-le-variazioni-delluso-di-bortezomib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4214-mieloma-multiplo-pomalidomide-e-desametasone-per-una-sopravvivenza-maggiore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4221-mieloma-multiplo-pazienti-over-75-quale-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4168-mieloma-multiplo-piu-vicina-lapprovazione-europea-di-pomalidomide]]></loc><lastmod>2019-03-22T19:47:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4081-mileloma-multiplo-due-studi-confermano-lefficacia-di-pomalidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/4044-mieloma-multiplo-al-via-a-bergamo-la-sperimentazione-per-un-nuovo-antitumorale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/3895-mieloma-multiplo-aifa-raccomanda-attenzione-nel-trattamento-con-talidomide]]></loc><lastmod>2018-08-20T16:30:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/3866-mieloma-multiplo-dal-regno-unito-nuovo-impulso-alla-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/3837-mieloma-multiplo-approvato-in-cina-lenalidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/3838-mieloma-multiplo-nuovo-approccio-terapeutico-proposto-da-un-team-italiano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/3459-mieloma-multiplo-studio-europeo-individua-i-fattori-di-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/2835-mieloma-multiplo-in-europa-disponibili-le-iniezioni-sottocutanee-di-bortezomib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/2633-mieloma-multiplo-carfizomib-approvato-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/1979-mieloma-refrattario-il-trapianto-autologo-di-cellule-staminali-sembra-funzionare-solo-su-malattia-stabile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mieloma-multiplo/688-linfomi-e-mielomi-dal-gimo-una-consensus-italiana-che-aiutera-lautotrapianto-di-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari]]></loc><lastmod>2015-04-08T16:18:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22927-glioma-un-sistema-sperimentale-in-3d-per-valutare-possibili-terapie]]></loc><lastmod>2026-04-13T17:31:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22825-tumori-rari-infantili-un-progetto-per-ridurre-le-disuguaglianze-nella-cura]]></loc><lastmod>2026-03-09T17:36:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22730-tumori-aifa-approva-luso-di-pembrolizumab-in-tre-nuove-indicazioni]]></loc><lastmod>2026-02-10T15:40:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22706-cordoma-un-tumore-di-cui-bisogna-approfondire-il-profilo-genetico]]></loc><lastmod>2026-02-03T08:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22688-tumore-del-polmone-disponibile-in-italia-una-nuova-combinazione-di-terapie-mirate]]></loc><lastmod>2026-01-24T11:09:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22665-cordoma-la-malattia-che-ha-causato-la-morte-della-figlia-di-freddy-mercury]]></loc><lastmod>2026-01-16T15:09:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22637-tumore-desmoide-nuove-prospettive-di-trattamento-dagli-inibitori-della-gamma-secretasi]]></loc><lastmod>2026-01-02T18:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22539-leucemia-mieloide-acuta-quizartinib-rimborsabile-in-italia]]></loc><lastmod>2025-11-23T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22497-epatocarcinoma-aumentano-in-casi-correlati-a-disfunzione-metabolica]]></loc><lastmod>2025-11-07T16:57:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22435-melanoma-uveale-le-nuove-possibilita-terapeutiche-ridisegnano-il-percorso-dei-pazienti]]></loc><lastmod>2025-10-22T14:55:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22378-blood-cancer-summit-si-e-svolto-a-roma-il-primo-vertice-dedicato-ai-tumori-ematologici]]></loc><lastmod>2025-10-08T10:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22357-glioma-di-basso-grado-idh-mutato-vorasidenib-approvato-in-europa]]></loc><lastmod>2025-09-29T11:16:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22355-tumori-del-sangue-ail-accende-i-riflettori-sullimportanza-della-comunicazione-medico-paziente]]></loc><lastmod>2025-09-28T16:47:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22266-melanoma-oculare-al-cnao-di-pavia-trattati-piu-di-600-pazienti-con-la-protonterapia]]></loc><lastmod>2025-08-31T19:46:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22100-con-il-sopraggiungere-dell-estate-cresce-l-attenzione-verso-i-melanomi]]></loc><lastmod>2025-06-17T15:46:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/22059-tumori-pediatrici-cresce-la-speranza-ma-restano-le-disuguaglianze-territoriali]]></loc><lastmod>2025-06-06T15:59:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21993-idea4rc-un-alleanza-europea-per-rivoluzionare-la-ricerca-sui-tumori-rari]]></loc><lastmod>2025-05-16T17:13:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21955-tumore-alla-gola-la-prevenzione-primaria-puo-abbattere-il-numero-di-casi]]></loc><lastmod>2025-05-08T15:42:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21958-leiomiosarcoma-al-san-camillo-effettuato-con-successo-un-intervento-chirurgico-all-avanguardia]]></loc><lastmod>2025-05-07T14:32:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21787-sarcomi-la-diagnosi-e-tardiva-per-un-paziente-su-due]]></loc><lastmod>2025-03-07T15:46:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21617-epatocarcinoma-linee-guida-aggiornate-su-prevenzione-diagnosi-e-trattamento]]></loc><lastmod>2025-01-08T11:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21562-tumori-arriva-in-italia-la-prima-immunoterapia-sottocute]]></loc><lastmod>2024-12-06T18:31:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21550-tumore-ovarico-approvazione-della-commissione-europea-per-mirvetuximab-soravtansine]]></loc><lastmod>2024-12-05T19:19:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21421-linfoma-mantellare-aifa-approva-la-rimborsabilita-di-pirtobrutinib]]></loc><lastmod>2024-10-24T12:42:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21258-adenocarcinoma-del-piccolo-intestino-l-associazione-con-celiachia-e-morbo-di-crohn]]></loc><lastmod>2024-09-04T18:11:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21247-tumori-ematologici-pediatrici-fiagop-e-admo-siglano-protocollo-d-intesa]]></loc><lastmod>2024-09-02T08:32:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21126-successo-dell-immunoterapia-contro-i-tumori-delle-vie-biliari]]></loc><lastmod>2024-06-29T11:21:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21111-sarcomi-presentato-il-primo-libro-bianco]]></loc><lastmod>2024-06-25T11:16:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21068-tumori-pediatrici-in-italia-quali-sono-e-dove-curarli]]></loc><lastmod>2024-06-11T07:15:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21064-tumori-pediatrici-e-rete-nazionale-tumori-rari-ecco-dove-curarsi]]></loc><lastmod>2024-06-10T13:11:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21063-tumori-in-adolescenza-una-fascia-d-eta-critica-per-la-quale-e-necessaria-maggiore-attenzione]]></loc><lastmod>2024-06-10T13:12:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21065-la-presa-in-carico-dei-tumori-pediatrici-il-modello-piemontese]]></loc><lastmod>2024-06-10T13:12:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21066-tumori-pediatrici-in-italia-quasi-2500-diagnosi-ogni-anno]]></loc><lastmod>2024-06-10T13:11:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21062-tumori-pediatrici-circa-il-50-dei-bambini-viene-curato-fuori-dalla-propria-regione]]></loc><lastmod>2024-06-11T07:21:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/21009-oncologia-di-precisione-il-futuro-della-lotta-ai-tumori]]></loc><lastmod>2024-05-24T15:32:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20995-sarcomi-del-retroperitoneo-la-chirurgia-e-la-scelta-terapeutica-principale]]></loc><lastmod>2024-05-23T12:14:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20903-leucemia-promielocitica-acuta-la-terapia-orale-per-migliorare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2024-04-24T16:31:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20846-tumori-del-sangue-un-evento-per-fare-il-punto-sui-nuovi-orizzonti-terapeutici]]></loc><lastmod>2024-04-08T17:59:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20812-pseudomixoma-peritonei-un-tumore-che-cresce-all-interno-dell-addome]]></loc><lastmod>2024-03-28T11:16:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20807-quando-il-sesso-fa-la-differenza-il-carcinoma-alla-mammella-maschile]]></loc><lastmod>2024-03-29T18:15:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20806-sarcomi-al-policlinico-gemelli-nasce-un-centro-dedicato]]></loc><lastmod>2024-03-26T15:47:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20707-sarcoma-la-cantante-cat-janice-si-e-spenta-per-un-tumore-raro]]></loc><lastmod>2024-05-29T10:35:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20658-adenomi-ipofisari-serve-un-sistema-di-classificazione-aggiornato]]></loc><lastmod>2024-02-26T13:52:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20646-test-genomici-per-il-cancro-quando-ha-senso-farli]]></loc><lastmod>2024-03-29T18:21:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20647-salvo-testa-dalla-diagnosi-di-mutazione-brca1-alla-fondazione-mutagens]]></loc><lastmod>2024-02-16T16:33:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20638-cancro-infantile-il-15-febbraio-e-la-giornata-mondiale]]></loc><lastmod>2024-02-15T17:41:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20628-colangiocarcinoma-oggi-la-giornata-mondiale-la-notizia-messo-a-punto-in-italia-un-modello-tridimensionale-del-tumore]]></loc><lastmod>2024-02-14T12:54:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20532-tumori-del-sangue-un-algoritmo-potrebbe-migliorare-diagnosi-e-trattamenti]]></loc><lastmod>2024-01-18T19:40:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20493-tumori-del-fegato-irccs-de-bellis-e-fujifilm-insieme-per-la-diagnosi-precoce]]></loc><lastmod>2024-02-08T11:38:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20433-tumori-ginecologici-prevenzione-e-farmaci-mirati-possono-sconfiggerli]]></loc><lastmod>2023-12-12T15:03:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20415-oncologia-glucarpidasi-e-da-oggi-rimborsabile-in-italia]]></loc><lastmod>2023-12-06T10:36:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20326-sarcoma-epitelioide-pubblicato-uno-studio-sulle-prospettive-di-cura-future]]></loc><lastmod>2023-11-12T21:23:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20270-sarcomi-il-policlinico-gemelli-punta-alla-creazione-di-un-centro-di-riferimento]]></loc><lastmod>2023-10-29T13:07:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20264-sam-neill-protagonista-di-jurassic-park-e-affetto-da-un-linfoma-a-cellule-t]]></loc><lastmod>2023-10-27T18:06:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20184-tumori-testa-collo-al-gemelli-si-e-svolto-il-9-congresso-nazionale-aiocc]]></loc><lastmod>2023-10-02T17:21:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20101-linfomi-i-gruppi-pazienti-ail-per-la-tutela-dell-informazione-e-dei-diritti-del-malato]]></loc><lastmod>2023-09-15T08:07:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20102-linfomi-sapere-cosa-sono-per-affrontarli-nel-migliore-dei-modi]]></loc><lastmod>2023-09-09T07:52:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/20030-sarcoma-al-via-indagine-nazionale-rivolta-ai-pazienti]]></loc><lastmod>2023-07-24T10:01:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19927-giornata-nazionale-contro-le-leucemie-l-impegno-di-ail-in-ricerca-e-assistenza]]></loc><lastmod>2023-06-21T14:49:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19809-leucemia-mieloide-acuta-e-colangiocarcinoma-idh1-mutati-approvazione-europea-per-ivosidenib]]></loc><lastmod>2023-05-18T16:48:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19703-leucemia-mielomonocitica-cronica-la-malattia-che-sembra-aver-colpito-silvio-berlusconi]]></loc><lastmod>2023-04-07T18:13:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19670-leucemia-mieloide-acuta-identificate-cellule-tumorali-responsabili-delle-ricadute-di-malattia]]></loc><lastmod>2023-03-28T16:55:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19654-l-eredita-di-sofia-sacchitelli-un-contributo-allo-studio-dell-angiosarcoma]]></loc><lastmod>2023-03-21T15:46:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19620-leucemia-mieloide-acuta-e-colangiocarcinoma-parere-positivo-del-chmp-per-ivosidenib]]></loc><lastmod>2023-03-12T10:02:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19542-tumore-alle-tube-nuove-opportunita-terapeutiche-grazie-alla-ricerca]]></loc><lastmod>2023-02-17T16:00:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19485-leucemia-mieloide-acuta-nasce-la-rete-nazionale-palm]]></loc><lastmod>2023-01-27T22:08:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19377-colangiocarcinoma-al-gemelli-un-percorso-clinico-assistenziale-dedicato]]></loc><lastmod>2022-12-10T19:11:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19278-glioma-terapia-sperimentale-aumenta-l-aspettativa-di-vita-dei-piccoli-pazienti]]></loc><lastmod>2022-11-15T18:26:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/19057-linfomi-la-maggior-parte-degli-italiani-conosce-solo-superficialmente-questi-tumori]]></loc><lastmod>2024-10-16T15:31:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18906-leucemia-a-grandi-linfociti-granulati-t-individuati-nuovi-marcatori-di-progressione-della-patologia]]></loc><lastmod>2022-07-09T21:37:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18871-linfoma-follicolare-approvata-in-europa-la-terapia-car-t-axicabtagene-ciloleucel]]></loc><lastmod>2022-07-03T19:11:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18834-colangiocarcinoma-intraepatico-pemigatinib-ora-disponibile-in-italia]]></loc><lastmod>2022-06-25T13:26:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18751-epatocarcinoma-a-napoli-la-prima-tappa-del-roadshow-di-roche]]></loc><lastmod>2022-06-11T10:43:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18711-tumori-rari-dentro-all-acceleratore-di-particelle-sviluppato-per-combatterli]]></loc><lastmod>2025-08-31T19:46:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18652-colangiocarcinoma-una-patologia-in-progressiva-crescita]]></loc><lastmod>2022-05-14T15:02:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18615-gliomi-diffusi-della-linea-mediana-tumori-cerebrali-tanto-rari-quanto-pericolosi]]></loc><lastmod>2022-11-15T18:11:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18596-leucemia-mieloide-acuta-pubblicati-i-dati-dell-indagine-un-viaggio-da-fare-insieme]]></loc><lastmod>2022-05-01T17:23:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18573-tumori-rari-al-cnao-di-pavia-corsi-di-arte-musica-e-yoga-per-pazienti-e-caregiver]]></loc><lastmod>2022-04-24T17:54:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18571-linfomi-fil-e-credit-agricole-italia-insieme-per-la-ricerca]]></loc><lastmod>2022-04-24T17:13:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18572-leucemia-mieloide-acuta-rapida-nel-decorso-e-ad-alto-rischio-di-recidiva]]></loc><lastmod>2022-04-24T17:32:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18555-carcinoma-epatocellulare-nuovo-studio-chiarisce-il-meccanismo-d-azione-del-farmaco-5-azacitidina]]></loc><lastmod>2022-04-15T21:53:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18457-sarcomi-dei-tessuti-molli-nasce-l-associazione-sarknos]]></loc><lastmod>2022-03-25T15:28:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18416-linfomi-nasce-fil-club-una-squadra-di-aziende-e-soggetti-privati-uniti-per-la-ricerca]]></loc><lastmod>2022-03-13T20:35:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18417-tumori-rari-il-centro-nazionale-di-adroterapia-oncologica-entra-nella-rete-europea-euracan]]></loc><lastmod>2022-03-13T20:56:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18411-leucemia-mieloide-acuta-scoperto-silenziatore-molecolare-che-nasconde-il-tumore-al-sistema-immunitario]]></loc><lastmod>2022-03-13T18:26:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18408-melanoma-il-coenzima-q10-sostiene-la-sopravvivenza-delle-cellule-tumorali]]></loc><lastmod>2022-03-13T17:08:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18227-tumori-rari-l-istituzionalizzazione-della-rete-nazionale-e-ancora-un-miraggio]]></loc><lastmod>2022-01-28T10:59:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18190-tumori-ematologici-e-online-il-nuovo-portale-gimema-alliance]]></loc><lastmod>2022-01-19T10:51:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18156-sinovialsarcoma-all-istituto-regina-elena-effettuato-un-raro-e-delicato-intervento]]></loc><lastmod>2022-01-05T14:41:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18117-epatocarcinoma-i-pazienti-servono-informazioni-chiare-e-percorsi-terapeutico-assistenziali-adeguati]]></loc><lastmod>2021-12-20T18:52:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18108-tumori-solidi-rari-lo-iov-entra-nel-network-euracan]]></loc><lastmod>2021-12-19T17:37:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/18089-carcinoma-ovarico-avanzato-via-libera-in-italia-a-niraparib]]></loc><lastmod>2021-12-12T16:57:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17973-oncologia-aifa-approva-il-biosimilare-di-bevacizumab]]></loc><lastmod>2021-11-06T23:20:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17874-linfoma-anaplastico-e-di-hodgkin-nuove-indicazioni-rimborsate-in-italia-per-brentuximab-vedotin]]></loc><lastmod>2021-10-09T19:24:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17873-adenoma-ipofisario-ne-era-affetta-anche-la-venere-di-botticelli]]></loc><lastmod>2021-10-09T19:16:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17796-tumori-testa-collo-torna-la-campagna-make-sense]]></loc><lastmod>2021-09-21T21:03:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17791-tumori-ematologici-lanciata-la-campagna-diamo-voce-al-futuro]]></loc><lastmod>2021-09-17T15:08:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17721-armare-il-sistema-immunitario-per-combattere-le-leucemie]]></loc><lastmod>2021-08-21T11:20:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17716-leucemia-mieloide-acuta-per-lo-sviluppo-di-nuove-terapie-e-utile-studiare-il-microambiente-tumorale]]></loc><lastmod>2021-08-16T11:21:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17702-medulloblastoma-scoperto-il-meccanismo-che-ne-scatena-la-forma-piu-aggressiva]]></loc><lastmod>2021-08-01T15:02:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17697-linfomi-al-via-l-edizione-2021-del-bando-giovani-ricercatori-e-del-premio-brusamolino]]></loc><lastmod>2021-08-01T13:34:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17686-adroterapia-un-approccio-innovativo-per-il-trattamento-dei-tumori-rari]]></loc><lastmod>2021-07-25T18:09:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17677-tumori-cerebrali-e-spinali-attivato-un-nuovo-pdta-al-san-giovanni-addolorata-di-roma]]></loc><lastmod>2021-07-25T15:57:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17614-lanciata-la-campagna-facciamo-rete-contro-i-sarcomi]]></loc><lastmod>2021-07-03T15:18:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17554-leucemia-mieloide-acuta-approvazione-europea-per-venetoclax-in-combinazione-con-un-agente-ipometilante]]></loc><lastmod>2021-06-20T13:38:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17516-tumori-in-stadio-avanzato-cemiplimab-ottiene-doppio-parere-positivo-dal-chmp]]></loc><lastmod>2021-06-06T21:12:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17442-melanoma-scoperta-la-proteina-che-controlla-la-formazione-di-metastasi]]></loc><lastmod>2021-05-16T16:03:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17334-colangiocarcinoma-dall-oncologia-di-precisione-una-concreta-speranza-per-i-pazienti]]></loc><lastmod>2021-04-27T18:38:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17313-carcinoma-epatocellulare-si-e-concluso-con-successo-l-hackathon-hack-for-hcc]]></loc><lastmod>2021-04-18T15:53:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17253-colangiocarcinoma-approvazione-europea-per-pemigatinib]]></loc><lastmod>2021-04-03T14:29:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17071-tumori-rari-discusso-ieri-un-ordine-del-giorno-presentato-dall-on-pagano]]></loc><lastmod>2021-02-24T11:56:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/17016-tumori-oculari-rari-e-ad-alta-incidenza-di-metastasi]]></loc><lastmod>2021-02-14T18:35:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16979-colangiocarcinoma-il-chmp-raccomanda-l-approvazione-di-pemigatinib]]></loc><lastmod>2021-02-07T17:26:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16953-linfomi-cerebrali-risultati-incoraggianti-dallo-studio-internazionale-marietta]]></loc><lastmod>2021-01-31T00:18:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16917-carcinoma-epatocellulare-con-atezolizumab-piu-bevacizumab-migliora-la-sopravvivenza-globale]]></loc><lastmod>2021-01-23T23:00:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16916-colangiocarcinoma-dalla-genetica-indizi-per-lo-studio-di-nuove-possibilita-terapeutiche]]></loc><lastmod>2021-01-23T22:47:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16809-leucemia-mieloide-acuta-elevati-tassi-di-risposta-con-magrolimab-piu-azacitidina]]></loc><lastmod>2020-12-15T11:08:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16793-tumori-rari-occorre-definire-la-rete-nazionale-e-investire-in-telemedicina-e-precision-medicine]]></loc><lastmod>2020-12-11T10:47:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16729-premio-brusamolino-2020-premiati-progetti-innovativi-nella-cura-dei-linfomi]]></loc><lastmod>2020-11-23T13:07:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16359-piu-forti-del-sarcoma-grande-successo-per-la-campagna-di-sensibilizzazione]]></loc><lastmod>2020-08-03T22:00:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16330-tumore-fibroso-solitario-risultati-incoraggianti-dall-impiego-di-pazopanib]]></loc><lastmod>2020-07-26T17:54:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16335-al-via-bersaglio-melanoma-pazienti-e-specialisti-alleati-per-la-prevenzione-e-la-diagnosi-precoce]]></loc><lastmod>2020-07-28T08:55:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16301-sarcoma-cinque-storie-di-ragazzi-per-raccontare-la-malattia]]></loc><lastmod>2020-07-20T16:08:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16278-carcinoma-epatocellulare-il-trapianto-di-fegato-si-conferma-la-miglior-terapia]]></loc><lastmod>2020-07-12T15:25:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16142-carcinoma-cutaneo-a-cellule-squamose-cemiplimab-disponibile-in-italia]]></loc><lastmod>2020-06-08T19:59:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/16050-carcinoma-basocellulare-avanzato-risposte-significative-e-durature-con-cemiplimab]]></loc><lastmod>2020-05-11T00:20:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15925-linfoma-anaplastico-sistemico-parere-favorevole-del-chmp-per-brentuximab-vedotin]]></loc><lastmod>2020-04-08T16:10:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15911-leucemia-mieloide-acuta-gilteritinib-disponibile-in-italia]]></loc><lastmod>2020-04-06T15:44:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15671-leucemie-e-linfomi-in-humanitas-una-car-t-unit-per-la-nuova-terapia-cellulare]]></loc><lastmod>2020-02-17T19:11:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15649-colangiocarcinoma-oggi-e-la-giornata-mondiale]]></loc><lastmod>2020-02-11T19:17:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15635-tumori-testa-collo-il-gene-p53-influenza-la-risposta-al-farmaco-alpelisib]]></loc><lastmod>2020-02-05T20:44:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15575-colangiocarcinoma-convalidata-la-domanda-di-approvazione-di-pemigatinib-in-europa]]></loc><lastmod>2020-02-26T22:21:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15510-colangiocarcinoma-un-tumore-raro-a-cui-la-ricerca-sta-dedicando-piu-attenzione]]></loc><lastmod>2020-01-09T18:40:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15488-colangiocarcinoma-un-nuovo-farmaco-in-sperimentazione]]></loc><lastmod>2019-12-08T20:56:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15472-colangiocarcinoma-le-mutazioni-genetiche-sono-la-chiave-di-volta-per-le-future-terapie]]></loc><lastmod>2019-12-02T13:23:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15468-leucemie-e-neoplasie-ematologiche-con-favo-i-pazienti-italiani-possono-fare-rete]]></loc><lastmod>2019-12-02T11:42:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15421-carcinoma-ovarico-recidivante-rucaparib-rimborsabile-in-italia]]></loc><lastmod>2019-11-20T17:48:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15391-carcinoma-renale-avanzato-approvata-in-europa-la-terapia-con-avelumab-piu-axitinib]]></loc><lastmod>2019-11-09T15:32:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15377-leucemia-mieloide-acuta-la-commissione-europea-approva-gilteritinib]]></loc><lastmod>2019-11-05T18:52:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15310-colangiocarcinoma-presentati-i-risultati-di-fase-ii-di-pemigatinib]]></loc><lastmod>2019-10-15T16:15:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15301-leucemia-mieloide-acuta-ad-alto-rischio-da-oggi-disponibile-in-italia-un-nuovo-farmaco]]></loc><lastmod>2019-10-13T17:17:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15250-carcinoma-renale-avanzato-il-chmp-esprime-parere-positivo-per-l-associazione-di-avelumab-piu-axitinib]]></loc><lastmod>2019-10-02T09:55:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15221-carcinoma-cutaneo-a-cellule-squamose-l-immuno-oncologia-rappresenta-una-svolta]]></loc><lastmod>2019-09-21T23:29:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15211-melanoma-al-via-la-campagna-oltre-la-pelle]]></loc><lastmod>2019-09-21T20:12:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15144-osteosarcoma-non-ce-l-ha-fatta-la-figlia-dell-allenatore-luis-enrique]]></loc><lastmod>2019-08-30T13:41:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15125-glioma-recidivante-il-carboplatino-offre-benefici-in-termini-di-sopravvivenza]]></loc><lastmod>2019-08-20T15:42:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15115-linfomi-in-italia-100mila-euro-a-favore-della-ricerca]]></loc><lastmod>2019-08-13T21:18:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15079-tumori-studiato-un-nuovo-farmaco-in-grado-di-addormentare-le-cellule-neoplastiche]]></loc><lastmod>2019-07-30T14:27:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/15021-sarcomi-conclusa-la-campagna-di-sensibilizzazione-sarcoma-senza-confini]]></loc><lastmod>2019-07-12T15:59:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14968-tumore-desmoide-fin-da-bambina-enrica-lotta-contro-questa-aggressiva-neoplasia]]></loc><lastmod>2019-07-01T21:34:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14922-linfoma-follicolare-messa-a-punto-una-nuova-strategia-immunoterapica]]></loc><lastmod>2019-06-15T17:32:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14847-linfoma-primitivo-del-sistema-nervoso-centrale-farmaco-sperimentale-testato-al-san-raffaele]]></loc><lastmod>2019-05-26T08:54:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14718-tumori-delle-ghiandole-salivari-a-pavia-il-punto-su-diagnosi-e-trattamento]]></loc><lastmod>2019-04-13T18:50:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14644-leucemia-mieloide-acuta-scoperto-perche-la-malattia-puo-tornare-dopo-il-trapianto-di-midollo]]></loc><lastmod>2019-03-26T11:44:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14624-linfoma-follicolare-obinutuzumab-e-rimborsabile-in-italia]]></loc><lastmod>2019-03-22T18:01:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14398-carcinoma-a-cellule-renali-approvata-in-europa-l-associazione-di-nivolumab-con-ipilimuma]]></loc><lastmod>2019-01-30T16:01:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14356-melanoma-cutaneo-studio-iss-ne-misura-l-aggressivita-tramite-approccio-funzionale]]></loc><lastmod>2019-01-13T15:11:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14330-linfoma-indolente-presentati-i-dati-su-lenalidomide-in-combinazione-con-rituximab]]></loc><lastmod>2019-01-06T18:24:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14235-colangiocarcinoma-dall-istituto-nazionale-dei-tumori-una-nuova-prospettiva-farmacologica]]></loc><lastmod>2018-12-04T21:47:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14210-tumore-ovarico-in-italia-una-paziente-su-3-non-accede-al-test-genetico-brca]]></loc><lastmod>2018-11-27T12:18:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14166-linfomi-conclusa-la-riunione-nazionale-fil]]></loc><lastmod>2018-11-18T17:36:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14136-neurinoma-del-nervo-acustico-nuovi-benefici-dalla-radiochirurgia]]></loc><lastmod>2018-11-08T19:14:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14132-linfoma-le-dr-sse-pighi-e-spina-si-aggiudicano-il-premio-brusamolino]]></loc><lastmod>2018-11-07T18:11:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/14118-melanoma-i-microrna-sono-molecole-chiave-nella-resistenza-alla-terapia]]></loc><lastmod>2018-11-05T19:15:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13936-linfomi-fil-ottiene-nuovi-fondi-per-il-completamento-della-biobanca]]></loc><lastmod>2019-10-31T16:12:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13925-tumori-testa-collo-al-via-la-make-sense-campaign]]></loc><lastmod>2018-09-16T18:21:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13863-sarcoma-la-corsa-contro-il-tempo-per-diagnosi-piu-precise-e-terapie-innovative]]></loc><lastmod>2018-08-25T08:58:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13792-oncologia-nuovo-accordo-tra-molmed-e-gsk-per-lo-sviluppo-e-la-fornitura-di-vettori-lentivirali]]></loc><lastmod>2018-07-26T15:07:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13753-melanoma-metastatico-approvazione-usa-per-encorafenib-piu-binimetinib]]></loc><lastmod>2018-07-13T16:28:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13739-cordoma-in-avvio-uno-studio-clinico-su-una-potenziale-terapia-farmacologica]]></loc><lastmod>2018-07-07T16:26:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13671-macroglobulinemia-di-waldenstrom-pubblicato-studio-sulla-terapia-con-ibrutinib-rituximab]]></loc><lastmod>2018-06-16T13:51:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13672-linfoma-cerebrale-nuovi-dati-sul-potenziale-terapeutico-di-ngr-htnf]]></loc><lastmod>2018-06-16T14:12:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13639-rabdomiosarcoma-nuova-strategia-terapeutica-aumenta-le-probabilita-di-cura]]></loc><lastmod>2018-06-07T16:39:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13566-leucemia-mieloide-acuta-il-paziente-anziano-subisce-il-peso-della-chemioterapia]]></loc><lastmod>2018-05-19T14:24:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13453-tumori-del-sangue-malattie-infettive-e-del-fegato-da-gilead-sciences-oltre-un-milione-di-euro-per-la-ricerca]]></loc><lastmod>2018-04-17T14:49:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13396-leucemia-acuta-mieloide-ok-dell-aifa-per-azacitidina-nei-pazienti-con-piu-del-30-di-blasti-midollari]]></loc><lastmod>2018-05-09T14:22:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13105-linfoma-mantellare-confermata-l-efficacia-di-lenalidomide-piu-rituximab]]></loc><lastmod>2018-01-15T22:29:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13104-cordoma-sviluppata-nuova-linea-cellulare-per-lo-studio-di-questo-tumore]]></loc><lastmod>2018-01-14T21:53:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13072-carcinoma-a-cellule-renali-avanzato-cabozantinib-approvato-da-fda]]></loc><lastmod>2017-12-27T17:12:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13069-carcinoma-cutaneo-a-cellule-squamose-risultati-clinici-positivi-per-cemiplimab]]></loc><lastmod>2017-12-27T15:06:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13061-tumori-testa-collo-nel-2030-un-malato-su-2-sara-over-65]]></loc><lastmod>2017-12-23T10:52:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/13050-cordoma-del-sacro-in-italia-primo-studio-al-mondo-su-chirurgia-e-adroterapia]]></loc><lastmod>2017-12-19T11:50:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12955-sarcoma-di-ewing-il-presidente-mattarella-premia-i-datori-di-lavoro-di-steven-babbi]]></loc><lastmod>2017-11-26T12:00:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12827-steven-ha-il-sarcoma-di-ewing-l-inps-non-lo-indennizza-ma-ci-pensa-l-azienda]]></loc><lastmod>2017-10-26T08:39:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12803-epatocarcinoma-cabozantinib-raggiunge-l-endpoint-primario-di-sopravvivenza-globale]]></loc><lastmod>2017-10-21T14:12:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12688-linfoma-follicolare-fda-approva-copanlisib]]></loc><lastmod>2017-09-24T21:01:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12655-carcinoma-renale-ema-valuta-nuova-indicazione-per-cabozantinib]]></loc><lastmod>2017-09-16T16:10:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12599-leucemia-mieloide-acuta-fda-approva-enasidenib]]></loc><lastmod>2019-01-17T17:29:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12587-epatocarcinoma-approvazione-europea-per-regorafenib]]></loc><lastmod>2019-01-17T17:28:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12524-in-italia-900mila-persone-vivono-con-un-tumore-raro-ma-manca-ancora-una-rete]]></loc><lastmod>2017-07-21T10:25:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12463-epatocarcinoma-parere-positivo-dell-ema-su-regorafenib]]></loc><lastmod>2017-07-03T13:03:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12401-glioma-pubblicate-le-nuove-linee-guida-sulle-cure-palliative]]></loc><lastmod>2017-06-17T12:51:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12402-leucemia-mieloide-acuta-recidivante-o-refrattaria-buone-risposte-da-enasidenib]]></loc><lastmod>2017-06-17T13:26:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12304-carcinoma-a-cellule-squamose-testa-collo-omologazione-europea-per-nivolumab]]></loc><lastmod>2017-05-21T16:38:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/12246-epatocarcinoma-bayer-ottiene-l-approvazione-fda-per-regorafenib]]></loc><lastmod>2017-05-05T16:53:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11852-leucemia-megacarioblastica-individuate-alterazioni-molecolari-responsabili-della-malattia-nei-bambini]]></loc><lastmod>2017-01-28T15:18:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11833-tumori-testa-collo-positivo-il-parere-scientifico-dell-ema-sul-candidato-farmaco-sgx942]]></loc><lastmod>2017-01-23T15:19:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11752-leucemia-promielocitica-acuta-in-europa-la-malattia-potra-essere-affrontata-senza-la-chemioterapia]]></loc><lastmod>2016-12-28T18:49:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11689-sarcoma-dei-tessuti-molli-approvata-in-europa-la-molecola-olaratumab]]></loc><lastmod>2016-12-03T13:31:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11674-tumori-solidi-inaugurata-in-italia-la-prima-piattaforma-per-mappatura-e-monitoraggio-di-geni-e-mutazioni-coinvolti]]></loc><lastmod>2016-12-01T16:30:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11555-sarcomi-l-esempio-del-database-nazionale-francese]]></loc><lastmod>2016-11-01T09:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11556-lartruvo-un-nuovo-trattamento-per-i-pazienti-con-sarcoma-dei-tessuti-molli]]></loc><lastmod>2016-11-02T19:06:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11492-leucemia-mieloide-acuta-celgene-agios-e-abbot-insieme-per-sviluppare-nuove-tecnologie-diagnostiche]]></loc><lastmod>2016-10-19T15:11:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11439-sarcomi-dei-tessuti-molli-chemioterapia-neoadiuvante-aumenterebbe-la-sopravvivenza]]></loc><lastmod>2016-10-11T14:34:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11438-carcinoma-della-tiroide-ancora-buoni-risultati-per-levatinib]]></loc><lastmod>2016-10-11T14:30:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11437-leucemia-linfatica-cronica-buoni-risultati-da-terapia-con-car-t-cells]]></loc><lastmod>2016-10-11T14:24:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11436-carcinoma-testa-collo-l-aggiunta-di-buparlisib-a-chemioterapia-rallenta-la-progressione-della-malattia]]></loc><lastmod>2016-10-11T14:21:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11440-carcinoma-renale-avanzato-maggiori-i-benefici-di-cabozantinib-rispetto-a-sunitinib]]></loc><lastmod>2016-10-11T17:02:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11338-adroterapia-e-melanoma-oculare-trattati-i-primi-pazienti-al-cnao]]></loc><lastmod>2016-09-27T14:47:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11226-glioma-a-basso-grado-la-sopravvivenza-globale-aumenta-con-la-chemioterapia-in-aggiunta-alla-radioterapia]]></loc><lastmod>2016-09-14T10:09:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11210-leucemia-mieloide-acuta-recidiva-il-sorafenib-potrebbe-rappresentare-un-valido-trattamento]]></loc><lastmod>2019-05-21T15:08:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11177-linfoma-di-burkitt-l-aggiunta-di-rituximab-alla-chemioterapia-migliora-la-sopravvivenza-libera-da-eventi]]></loc><lastmod>2016-09-01T16:59:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11148-linfoma-di-hodgkin-nice-non-raccomanda-l-uso-del-farmaco-adcetris-brentuximab-vedotin]]></loc><lastmod>2019-05-21T17:17:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11141-carcinoma-a-cellule-squamose-approvato-farmaco-keytruda-pembrolizumab-negli-usa]]></loc><lastmod>2019-09-15T18:21:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11085-leucemia-promielocitica-acuta-emergono-nuove-mutazioni-correlate-alla-malattia]]></loc><lastmod>2016-12-19T15:35:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11079-leucemia-mieloide-acuta-testato-con-successo-metodo-diagnostico-basato-su-filter-card]]></loc><lastmod>2016-08-04T09:10:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11069-linfoma-mantellare-la-commissione-europea-approva-lenalidomide]]></loc><lastmod>2016-08-02T09:40:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/11030-glioma-pontino-intrinseco-diffuso-composto-sperimentale-abt-414-ottiene-denominazione-di-rara-malattia-pediatrica]]></loc><lastmod>2016-07-26T13:31:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10994-tumori-rari-l-istituto-tumori-della-romagna-entra-nella-rete-europea-euracan]]></loc><lastmod>2016-07-19T13:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10988-melanoma-i-consigli-per-prendere-il-sole-in-sicurezza]]></loc><lastmod>2016-07-15T13:02:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10977-linfoma-di-hodgkin-approvazione-europea-per-brentuximab-vedotin-come-terapia-di-consolidamento]]></loc><lastmod>2016-07-14T15:39:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10955-tumore-del-fegato-non-resecabile-regorafenib-migliora-in-modo-significativo-la-sopravvivenza-globale]]></loc><lastmod>2016-07-12T14:22:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10866-astrocitoma-anaplastico-eflornitina-denominata-farmaco-orfano-da-ema]]></loc><lastmod>2016-06-28T07:20:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10846-tumori-testa-collo-al-via-la-seconda-edizione-del-premio-aiom]]></loc><lastmod>2016-06-24T12:13:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10799-tumore-svelata-proteina-che-regola-la-capacita-difensiva-del-sistema-immunitario]]></loc><lastmod>2016-06-16T13:31:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10771-tumori-pediatrici-in-europa-ancora-troppe-disparita-nella-cura-dei-pazienti]]></loc><lastmod>2016-06-09T14:58:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10753-tumori-ereditari-mammella-e-ovaio-l-importanza-dei-test-genetici-per-la-prevenzione]]></loc><lastmod>2016-06-07T13:48:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10758-carcinoma-tiroideo-e-tumori-renali-buoni-risultati-da-lenvatinib]]></loc><lastmod>2016-06-08T15:27:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10741-linfoma-follicolare-migliori-risultati-da-obinutuzumab-rispetto-a-rituximab]]></loc><lastmod>2016-06-03T10:18:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10757-carcinoma-renale-avanzato-dall-asco-di-chicago-nuovi-dati-positivi-su-cabozantinib]]></loc><lastmod>2016-06-08T13:11:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10735-tumore-gastrico-olaparib-non-supera-l-endpoint-di-fase-iii]]></loc><lastmod>2016-06-03T09:53:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10702-sarcoma-dei-tessuti-molli-ema-assegna-status-orfano-al-composto-sperimentale-trc105]]></loc><lastmod>2016-05-27T13:23:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10699-carcinoma-papillare-della-tiroide-l-analisi-molecolare-serve-ad-orientare-la-terapia]]></loc><lastmod>2016-07-06T14:17:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10698-carcinoma-cortico-surrenalico-indagine-internazionale-individua-nuovi-fattori-genetici-alla-base-della-malattia]]></loc><lastmod>2016-07-06T14:16:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10679-carcinoma-renale-avanzato-cabozantinib-migliora-significativamente-la-progressione-libera-da-malattia]]></loc><lastmod>2016-05-25T09:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10668-onco-ematologia-in-arrivo-farmaci-innovativi-per-combattere-leucemie-linfomi-e-loro-varianti-rare]]></loc><lastmod>2016-05-23T07:27:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10650-ipertensione-in-eta-pediatrica-e-deficit-di-attenzione-possono-essere-sintomo-di-un-tumore-raro]]></loc><lastmod>2016-05-20T07:20:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10590-tumore-epatico-non-resecabile-buoni-risultati-da-trattamento-con-regorafenib]]></loc><lastmod>2016-05-13T10:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10560-carcinoma-delle-paratirotidi]]></loc><lastmod>2019-05-24T16:40:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10549-linfoma-a-cellule-mantellari-il-farmaco-ibrutinib-mostra-vantaggi-rispetto-a-temsirolimus]]></loc><lastmod>2016-05-06T12:14:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10544-linfoma-follicolare-ok-di-ema-all-approvazione-di-gazyvaro-obinutuzumab]]></loc><lastmod>2019-03-22T17:38:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10515-carcinoma-renale-avanzato-fda-approva-terapia-con-cabozantinib]]></loc><lastmod>2016-05-03T09:41:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10518-tumori-alleanza-contro-il-cancro-e-md-anderson-cancer-center-insieme-per-sconfiggerli]]></loc><lastmod>2016-05-03T11:17:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10485-carcinoma-renale-nivolumab-approvato-in-europa]]></loc><lastmod>2016-04-29T07:53:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10459-tumori-del-cavo-orale-le-sei-regole-per-l-autodiagnosi]]></loc><lastmod>2016-04-26T15:07:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10439-tumori-rari-in-italia-nel-2015-diagnosticati-quasi-90mila-nuovi-casi]]></loc><lastmod>2016-04-22T15:54:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10424-leucemia-acuta-promielocitica-diagnosi-precoce-fondamentale-per-la-guarigione]]></loc><lastmod>2016-04-21T08:59:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10416-linfoma-mantellare-buoni-risultati-da-lenalidomide]]></loc><lastmod>2016-04-20T13:22:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10390-melanoma-inizia-la-stagione-a-rischio-quando-e-necessario-il-test-genetico]]></loc><lastmod>2016-04-15T15:14:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10380-tumore-ovarico-arriva-un-nuovo-farmaco-contro-questo-killer-silenzioso]]></loc><lastmod>2016-04-15T07:09:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10363-liposarcoma-il-farmaco-halaven-vicino-all-approvazione-europea]]></loc><lastmod>2016-04-12T13:46:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10358-sarcoma-di-ewing-la-storia-della-piccola-combattente-scarlett]]></loc><lastmod>2017-10-19T11:02:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10292-linfoma-non-hodgkin-buoni-risultati-da-blinatumomab]]></loc><lastmod>2016-04-04T15:49:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10297-tumori-rari-del-fegato-e-del-colon-come-il-sistema-immunitario-interagisce-con-la-neoplasia]]></loc><lastmod>2016-04-01T10:25:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10183-tumori-testa-e-collo-tra-i-fattori-di-rischio-fumo-alcol-e-virus-comuni]]></loc><lastmod>2016-03-16T08:24:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10182-tumori-testa-e-collo-l-approccio-multidisciplinare-e-essenziale]]></loc><lastmod>2016-03-11T14:20:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10118-leucemia-a-cellule-capellute-l-universita-di-perugia-studia-il-trattamento-con-vemurafenib]]></loc><lastmod>2016-03-04T14:03:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10119-leucemia-a-cellule-capellute-un-percorso-verso-la-remissione-completa-senza-la-chemioterapia]]></loc><lastmod>2016-03-04T14:02:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10057-leucemia-mieloide-acuta-presenza-di-malattia-minima-residua-e-fattore-predittivo-di-recidiva]]></loc><lastmod>2016-02-26T14:23:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10052-sarcoma-dei-tessuti-molli-aumento-di-sopravvivenza-con-eribulina]]></loc><lastmod>2016-02-26T13:50:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10073-leucemia-mieloide-acuta-ema-concede-la-designazione-di-farmaco-orfano-a-venetoclax]]></loc><lastmod>2016-03-01T08:52:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/10016-tumori-un-super-microscopio-permettera-la-diagnosi-3d]]></loc><lastmod>2016-02-23T15:21:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9959-leucemia-mieloide-acuta-buoni-risultati-da-gemtuzumab-ozogamicin-su-anziani]]></loc><lastmod>2016-02-12T15:08:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9955-mesotelioma-pleurico-maligno-risultati-positivi-da-aggiunta-di-bevacizumab-a-chemioterapia]]></loc><lastmod>2016-02-12T14:42:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9949-carcinoma-epatico-risultati-promettenti-da-sorafenib]]></loc><lastmod>2016-02-12T13:46:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9929-tumori-cerebrali-nuova-tecnica-analizza-in-tempo-reale-il-rapporto-funzione-cervello]]></loc><lastmod>2016-02-09T11:46:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9907-melanoma-uveale-la-terapia-sperimentale-imcgp100-dichiarata-farmaco-orfano-negli-usa]]></loc><lastmod>2016-02-05T13:13:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9904-linfoma-di-hodgkin-la-commissione-europea-approva-la-variazione-della-scheda-tecnica-per-brentuximab-vedotin]]></loc><lastmod>2019-05-21T17:19:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9883-linfoma-mantellare-promettente-il-trattamento-con-ibrutinib]]></loc><lastmod>2016-02-02T11:09:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9881-tumori-solidi-cerebrali-al-gemelli-una-sala-di-tecno-consulto-integrata]]></loc><lastmod>2016-02-02T11:04:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9887-glioma-angiocentrico-uno-studio-internazionale-ne-svela-l-origine]]></loc><lastmod>2016-02-02T15:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9748-glioma-con-un-collirio-riparati-parzialmente-i-danni-visivi-dei-pazienti]]></loc><lastmod>2016-01-15T10:05:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9709-melanoma-metastatico-imlygic-e-la-prima-immunoterapia-oncolitica-approvata-in-europa]]></loc><lastmod>2016-01-08T11:35:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9722-leucemia-linfocitica-cronica-buoni-risultati-da-combinazione-di-obinutuzumab-e-venetoclax]]></loc><lastmod>2016-01-11T11:41:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9720-glioma-maligno-immunoterapia-citotossica-gene-mediata-migliorerebbe-la-sopravvivenza]]></loc><lastmod>2016-01-11T10:27:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9719-melanoma-risultati-promettenti-per-pembrolizumab-su-pazienti-con-metastasi-cerebrale]]></loc><lastmod>2016-01-11T10:13:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9680-leucemia-mieloide-acuta-sperimentazione-sui-farmaci-ag-221-e-ag-120-in-combinazione-con-chemioterapia-intensiva]]></loc><lastmod>2015-12-28T11:26:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9608-oncoematologia-presentati-nuove-terapie-innovative]]></loc><lastmod>2015-12-12T08:38:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9607-tumore-della-mammella-triplo-negativo-lo-studio-frida-apre-la-strada-ad-una-possibile-terapia]]></loc><lastmod>2015-12-11T13:46:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9632-ematologia-alleanza-italia-usa-contro-i-tumori-del-sangue]]></loc><lastmod>2015-12-17T08:51:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9526-carcinoma-renale-per-nivolumab-nuove-indicazioni-dall-fda]]></loc><lastmod>2016-05-03T20:58:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9522-carcinoma-epatico-combinazione-di-vitamina-k-e-sorafenib-migliorerebbe-la-sopravvivenza]]></loc><lastmod>2015-12-03T15:19:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9491-leucemia-pfizer-e-servier-collaborano-nello-sviluppo-di-un-innovativa-terapia-con-linfociti-t-car]]></loc><lastmod>2015-12-01T14:03:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9489-leucemia-mieloide-acuta-un-trapianto-con-condizionamento-di-minore-intensita-sembra-efficace-per-una-remissione-duratura-negli-anziani]]></loc><lastmod>2015-12-01T13:57:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9480-melanoma-presentati-i-risultati-preliminari-di-pembrolizumab-con-nuove-combinazioni-di-immunoterapia]]></loc><lastmod>2015-11-30T14:46:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9454-linfoma-mantellare-risposte-durature-dalla-terapia-con-lenalidomide-e-rituximab]]></loc><lastmod>2015-11-26T13:37:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9398-tumori-della-testa-e-del-collo-il-dr-numico-e-il-vincitore-del-premio-per-il-miglior-progetto-di-management-multidisciplinare]]></loc><lastmod>2015-11-20T11:15:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9374-leucemia-mieloide-acuta-via-libera-ue-per-azacitidina]]></loc><lastmod>2015-11-17T17:03:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9331-linfoma-di-hodgkin-recidivante-refrattario-takeda-presentera-a-dicembre-i-dati-relativi-al-suo-studio-di-fase-3-su-ixazomib]]></loc><lastmod>2015-11-10T16:57:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9315-tumori-la-loro-crescita-dipende-dallo-splicing-alternativo]]></loc><lastmod>2015-11-06T13:55:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9306-linfomi-il-loro-sviluppo-potrebbe-essere-attribuibile-all-azione-diretta-del-virus-hiv]]></loc><lastmod>2015-11-06T11:56:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9309-retinoblastoma-studio-cinese-individua-un-biomarcatore-per-la-prognosi]]></loc><lastmod>2015-11-06T12:09:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9269-aspirina-contro-il-tumore-avviato-uno-studio-per-scoprirlo]]></loc><lastmod>2015-10-30T10:43:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9263-leucemia-mieloide-acuta-boehringer-ingelheim-e-philogen-collaboreranno-per-lo-studio-di-nuove-terapie]]></loc><lastmod>2015-10-30T09:50:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9254-carcinoma-al-fegato-sospensione-della-terapia-con-sorafenib-migliorerebbe-la-sopravvivenza]]></loc><lastmod>2015-10-29T15:58:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9251-melanoma-metastatico-scoperti-nuovi-possibili-biomarker-predittivi-di-risposta-a-pembrolizumab]]></loc><lastmod>2015-10-29T15:32:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9259-tumori-pediatrici-sabato-31-ottobre-a-siena-la-seconda-giornata-atl]]></loc><lastmod>2015-10-30T08:58:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9218-linfoma-di-hodgkin-brentuximab-vedotin-efficace-in-prima-linea-anche-per-anziani]]></loc><lastmod>2015-10-23T10:25:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9178-tumori-epatici-avanzati-risultati-promettenti-dalla-radiologia-interventistica]]></loc><lastmod>2015-10-19T15:58:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9157-leucemia-mieloide-cronica-un-possibile-aiuto-terapeutico-dai-glitazioni-farmaci-oggi-usati-per-il-diabete]]></loc><lastmod>2015-10-14T14:02:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9050-tumori-la-ricerca-si-concentra-sull-immunoterapia]]></loc><lastmod>2015-10-06T16:01:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9040-tumori-aumenta-la-sopravvivenza-in-europa-ma-rimangono-differenze-tra-i-paesi]]></loc><lastmod>2015-10-05T10:14:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/9039-grant-for-oncology-innovation-merck-premia-i-ricercatori-piu-innovativi-con-1-milione-di-euro]]></loc><lastmod>2015-10-05T06:45:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8964-tumori-e-interventi-chirurgici-la-valutazione-del-programma-nazionale-esiti-di-agenas]]></loc><lastmod>2015-09-22T13:49:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8938-tumori-testa-collo-nuovi-dati-per-la-terza-settimana-europea-di-sensibilizzazione]]></loc><lastmod>2015-09-17T12:12:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8929-melanoma-parte-a-siena-il-1-studio-al-mondo-che-combina-due-nuovi-farmaci]]></loc><lastmod>2015-09-16T13:20:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8915-linfoma-oggi-la-giornata-mondiale-per-la-consapevolezza-wlad]]></loc><lastmod>2015-09-15T07:13:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8901-melanoma-metastatico-approvata-in-europa-combinazione-di-dabrafenib-e-trametinib]]></loc><lastmod>2015-09-11T10:14:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8858-cancro-al-seno-recidive-e-mortalita-ridotte-con-un-inibitore-dell-aromatasi]]></loc><lastmod>2015-09-04T13:06:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8835-leucemia-mieloide-acuta-inecalcitol-diventa-farmaco-orfano-negli-stati-uniti]]></loc><lastmod>2015-08-28T08:23:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8798-tumore-tenosinoviale-a-cellule-giganti-risultati-positivi-per-il-farmaco-sperimentale-plx3397]]></loc><lastmod>2015-08-21T08:43:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8763-carcinoma-a-cellule-basali-fda-approva-il-farmaco-sonidegib]]></loc><lastmod>2015-08-06T18:03:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8764-anemia-aplastica-grave-ema-raccomanda-approvazione-del-farmaco-eltrombopag]]></loc><lastmod>2015-08-06T18:04:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8743-melanoma-metastatico-valutato-non-futile-lo-studio-di-fase-iii-del-farmaco-sperimentale-masitinib]]></loc><lastmod>2015-07-31T12:44:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8737-melanoma-uveale-risultati-negativi-dalla-sperimentazione-di-fase-iii-di-selumetinib]]></loc><lastmod>2015-07-31T10:30:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8526-non-solo-melanoma-in-crescita-i-tumori-della-pelle]]></loc><lastmod>2018-06-16T15:40:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8541-sarcomi-dei-tessuti-molli-al-gemelli-esperti-a-confronto]]></loc><lastmod>2015-06-30T13:27:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8524-macroglobulinemia-di-waldenstrom-ema-raccomanda-ibrutinib]]></loc><lastmod>2015-07-01T10:24:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8453-farmaci-oncologici-in-italia-arriva-il-questionario-per-valutarne-la-tossicita]]></loc><lastmod>2015-06-16T09:24:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8437-linfoma-non-hodgkin-obinutuzumab-associato-a-bendamustina-ritarderebbe-la-progressione]]></loc><lastmod>2015-06-12T13:42:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8462-tumori-della-pelle-la-dermatologia-italiana-e-le-istituzioni-insieme-per-la-prevenzione]]></loc><lastmod>2015-06-17T13:17:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8428-carcinoma-a-cellule-renali-esiti-positivi-dalla-combinazione-terapeutica-di-lenvatinib-ed-everolimus]]></loc><lastmod>2015-06-12T09:33:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8412-tumori-rari-primo-bambino-in-italia-avviato-alla-protonterapia]]></loc><lastmod>2015-06-09T15:57:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8344-tumore-di-wilms-modulare-la-terapia-aumenta-il-tasso-di-cura-per-i-bambini-affetti-dalla-malattia]]></loc><lastmod>2015-05-29T09:45:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8298-melanoma-giudicata-sicura-la-combinazione-di-tre-farmaci-di-astrazeneca-e-novartis-per-il-trattamento-della-malattia]]></loc><lastmod>2015-05-29T08:13:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8297-leucemia-mieloide-acuta-la-profilassi-antibiotica-dopo-la-chemioterapia-ridurrebbe-le-infezioni-nei-bambini]]></loc><lastmod>2015-05-29T08:17:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8296-melanoma-metastatico-migliore-qualita-della-vita-per-i-pazienti-trattati-con-trametinib-piu-dabrafenib]]></loc><lastmod>2019-06-11T16:10:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8235-tumori-rari-160-mila-pazienti-si-curano-fuori-regione]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8232-leucemie-nuova-tecnica-al-bambino-gesu-per-ridurre-infezioni-e-ricadute-post-trapianto]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8204-tumori-rari-e-immunoterapia-roche-firma-accordo-con-curadev]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8202-melanoma-avanzato-chmp-approva-lanti-pd-1-nivolumab]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8176-leucemia-mieloide-acuta-e-tumori-gastrointestinali-nuovi-trattamenti-personalizzati-in-studio]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8045-leucemia-mieloide-acuta-la-terapia-con-citarabina-per-i-pazienti-adulti-in-prima-remissione-completa]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8059-tumori-ologrammi-e-smartphone-rendono-piu-facile-e-veloce-la-diagnosi-precoce]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/8013-tumori-ematologici-molmed-esercita-il-diritto-di-opzione-per-il-progetto-di-immuno-gene-therapy]]></loc><lastmod>2020-02-12T15:06:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7949-tumori-del-sistema-emolinfopoietico-allistituto-europeo-di-oncologia-nasce-una-nuova-unita-ad-hoc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7941-cancro-del-fegato-scoperto-meccanismo-con-cui-tumore-sfugge-alla-terapia-oggi-in-uso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7841-carcinoma-gastrico-avanzato-efficace-laggiunta-di-trastuzumab-alla-terapia-di-prima-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7828-carcinoma-renale-terapia-con-inibitori-del-vegf-inefficace-in-fase-iii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7718-tumori-rari-pubblicata-la-sintesi-annuale-2013-dellattivita-oncogeneticaq-in-francia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7660-sarcoma-dei-tessuti-molli-fda-concede-priority-review-a-trabectedina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7693-carcinoma-del-pancreas-disponibile-in-italia-nuova-terapia-intelligente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7650-sarcoma-sinoviale-studio-italiano-individua-potenziale-bersaglio-terapeutico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7645-tumori-ecco-perche-alcune-neoplasie-sono-resistenti-ai-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7672-leucemia-e-mielomi-a-verona-ematologi-a-confronto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7639-tumori-rari-da-singapore-oncoimpact-strumento-per-la-mappatura-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7613-cancro-alla-tiroide-levatib-potrebbe-ritardarne-la-progressione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7610-tumori-rari-firmato-accordo-tiziana-life-sciences-nerviano-medical-sciences-group]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7622-tumori-testa-collo-individuato-biomarcatore-per-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7606-sarcoma-di-ewing-trovata-correlazione-con-mutazioni-del-gene-pten-e-pik3r3]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7596-carcinoma-timico-risultati-positivi-per-studio-di-fase-ii-di-sunitinib-93640136]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7563-macroglobulinemia-di-waldenstrom-approvato-da-fda-trattamento-con-ibrutinib]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7553-leucemia-positiva-al-cromosoma-philadelphia-un-nuovo-farmaco-supera-la-resistenza-al-trattamento]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7513-sarcoma-di-ewing-attiva-lassociazione-un-sorriso-con-luca]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7534-sarcoma-di-ewing-creato-un-nuovo-anticorpo-che-porta-alla-morte-delle-cellule-tumorali]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7533-giornata-mondiale-contro-il-cancro-troppi-i-pazienti-che-non-si-sottopongono-ai-giusti-esami-diagnostici]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7473-tumore-al-timo-colpiti-piu-di-un-paziente-per-milione]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7467-adenocarcinoma-gastrico-il-si-della-commissione-europea-a-ramucirumab]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7434-osteosarcoma-ricerca-italiana-valuta-nuova-combinazione-di-farmaci]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7431-tumori-rari-nata-in-italia-la-prima-associazione-medica-dedicata]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7405-linfoma-di-hodgkin-dati-positivi-sulluso-di-adcetris-dallash-annual-meeting]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7406-linfoma-anaplastico-a-grandi-cellule-nuovi-dati-di-efficacia-per-il-farmaco-adcetris]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7364-linfoma-mantellare-dallema-via-libera-al-trattamento-di-bortezomib-in-combinazione]]></loc><lastmod>2015-05-26T08:51:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7323-linfomi-non-hodgkin-e-tumori-solidi-men1309-nuova-molecola-dal-gruppo-menarini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7315-tumori-legge-di-stabilita-approva-il-finanziamento-del-cnao-centro-avanzato-per-la-cura-dei-tumori-piu-aggressivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7204-carcinoma-epatocellulare-novita-terapeutiche-dalleuropean-cancer-symposium]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7141-mieloma-multiplo-la-terapia-di-mantenimento-con-lenalidomide-migliora-la-risposta-nei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7146-carcinoma-papillare-della-tiroide-la-terapia-con-iodio-radioattivo-aumenta-la-sopravvivenza]]></loc><lastmod>2025-11-20T08:26:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7091-tumori-chemioterapia-piu-efficace-se-favorisce-la-cooperazione-del-sistema-immunitario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/7041-malattie-oncologiche-attivo-un-nuovo-portale-a-supporto-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6882-tumori-infantili-una-giornata-studio-per-intensificare-la-collaborazione-ospedale-e-territorio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6846-linfoma-di-hodgkin-risultati-positivi-per-lo-studio-di-fase-3-aethera-su-brentuximab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6748-tumori-oculari-a-congresso-sioo-il-punto-sulle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6729-meningioma-buoni-i-risultati-per-sunitinib-ma-resta-da-superare-il-problema-della-tossicita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6713-primo-simposio-internazionale-per-il-rare-cancer-network-la-rete-mondiale-degli-esperti-di-radioterapia-oncologica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6548-rabdomiosarcoma-scoperta-mutazione-associata-alle-forme-aggressive]]></loc><lastmod>2018-06-07T16:33:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6468-tumore-tiroideo-avanzato-axitinib-promosso-in-fase-ii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6465-carcinoma-epatocellulare-insorge-anche-senza-cirrosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6439-carcinoma-pancreatico-metastatico-mm-398-aggiunto-alla-chemio-migliora-la-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6391-carcinoma-papillare-della-tiroide-scoperta-una-molecola-che-intossica-le-cellule-tumorali-fino-ad-ucciderle]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6389-linfoma-di-hodgkin-e-da-linfoma-anaplastico-a-grandi-cellule-sistemico-ora-il-farmaco-adcetris-e-rimborsabile-in-classe-h]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6346-carcinoma-epatocellulare-cosa-provoca-laumento-del-tasso-dincidenza-e-come-intervenire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6352-tumori-rari-fondamentale-la-corretta-presa-in-carico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6328-neoplasie-ematologiche-nuovo-farmaco-dimostra-effetto-antiproliferativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6334-osteosarcoma-limportanza-della-formazione-e-dellaggiornamento-nella-terapia-medica-e-chirurgica-di-questa-patologia]]></loc><lastmod>2023-01-17T22:12:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6138-cancro-orale-un-mese-di-visite-dentistiche-gratuite-per-prevenirlo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6106-melanoma-come-combattere-i-danni-provocati-dal-sole]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6107-tumori-maligni-800-mila-italiani-costretti-a-cambiare-regione-per-curarsi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6124-tumori-i-pazienti-over-60-si-raccontano-per-un-concorso-letterario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6062-cancro-metastatico-alla-tiroide-pubblicati-su-the-lancet-i-risultati-dello-studio-decision]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6017-tumori-rari-uno-studio-indaga-lesperienza-di-fine-vita-dei-pazienti-in-stadio-terminale]]></loc><lastmod>2019-06-18T18:22:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6013-carcinoma-epatocellulare-molte-le-novita-emerse-durante-il-congresso-easl]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/6008-tumori-della-testa-e-del-collo-le-5-regole-per-affrontarli]]></loc><lastmod>2019-06-18T18:24:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5981-leucemia-mieloide-acuta-volasertib-riceve-la-designazione-di-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5852-malattia-di-waldenstrom-definizione-della-patologia-e-nuove-prospettive-di-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5702-carcinoma-epatico-fibrolamellare-la-formazione-di-una-chimera-accomuna-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5693-sarcomi-retroperitoneali-poche-le-opzioni-terapeutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5694-sarcoma-dei-tessuti-molli-in-stadio-avanzato-individuate-le-caratteristiche-dei-responder-a-lungo-termine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5688-cancro-tiroideo-nei-giovani-prognosi-peggiore-se-e-secondario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5675-tumori-rari-dalluniversita-di-verona-una-nuova-tecnica-diagnostica]]></loc><lastmod>2019-05-24T16:32:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5662-tumori-rari-premiato-lifo-di-roma-per-la-campagna-di-comunicazione-sui-sarcomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5598-linfoma-non-hodgkin-anche-il-nice-approva-pixantrone]]></loc><lastmod>2024-10-16T15:28:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5531-leucemia-linfatica-nuova-terapia-combinata-per-i-pazienti-anziani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5548-tumori-rari-serve-un-network-per-diagnosi-migliori]]></loc><lastmod>2017-01-15T13:46:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5490-rimuovere-lastrocitoma-con-successo-possibile-se-ce-una-mutazione-genetica-specifica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5467-leucemia-mieloide-acuta-inibitori-delle-proteasi-in-grado-di-ridurre-stress-proteotossico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5414-tumori-come-le-nanoparticelle-cambieranno-diagnosi-e-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5355-craniofaringioma-una-scoperta-scientifica-apre-la-strada-a-nuova-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5341-melanoma-negli-usa-procede-la-domanda-di-registrazione-del-farmaco-lambrolizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5363-tumori-testa-e-collo-grazie-a-un-prelievo-del-sangue-scopriremo-i-soggetti-a-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5261-cancro-alla-tiroide-sospensione-ormonale-causa-gravi-disturbi-ma-solo-al-37-e-stata-offerta-lalternativa-dellrhtsh]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5188-leucemia-mieloide-acuta-sembra-ottenere-esiti-positivi-limpiego-di-gemtuzumab-unito-alla-chemioterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5112-melanoma-il-si-della-commissione-europea-per-il-farmaco-ipilimumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5107-tumori-rari-baxter-international-e-cell-therapeutics-firmano-un-accordo-d-licenza-esclusiva-per-il-farmaco-pacritinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5032-carcinoma-pancreatico-primo-si-dellema-al-nabpaclitaxel-in-combinazione-con-gemcitabina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4996-sostanze-naturali-in-oncologia-terapie-integrate-non-alternative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/5011-carcinoma-pancreatico-deluse-le-speranze-dei-pazienti-aifa-dice-no-al-nabpaclitaxel-albumina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4982-cancro-papillare-della-tiroide-il-ruolo-incerto-del-gene-braf]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4951-carcinoma-renale-papillare-metastatico-risultati-promettenti-per-everolimus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4952-sarcoma-dei-tessuti-molli-metastatico-risultati-deludenti-per-la-combinazione-palifosfamide-doxorubicina]]></loc><lastmod>2019-06-19T08:14:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4872-tumori-cerebrali-il-primo-registro-di-popolazione-e-italiano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4861-carcinoma-papillare-della-tiroide-vemurafenib-sperimentato-nel-trattamento-di-pazienti-portatori-della-mutazione-brafv600e]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4844-carcinoma-pancreatico-metastatico-positivi-i-risultati-della-sperimentazione-di-un-nuovo-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4765-tumore-renale-metastatico-sancita-la-pari-efficacia-per-sunitinib-e-pazopani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4730-leucemia-mieloide-acuta-parere-positivo-dellfda-per-il-farmaco-volasertib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4403-tumori-gastrointestinali-in-piemonte-la-nuova-tecnica-di-rimozione-endoscopica-in-grado-di-preservare-gli-organi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4388-leucemia-neutrofila-cronica-cnl-usato-per-la-prima-volta-il-ruxolitinib-in-un-paziente-con-mutazione-nel-gene-csf3r]]></loc><lastmod>2019-06-19T08:33:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4380-tumore-del-timo-essenziale-rivolgersi-a-centri-specializzati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4101-sarcoma-alveolare-asps-risultati-positivi-con-cediranib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/4033-leucemia-mieloide-acuta-nuove-speranze-dalla-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3965-cancro-colorettale-completato-il-reclutamento-pazienti-dello-studio-di-valutazione-delle-sir-spheresr]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3964-osteosarcoma-al-via-un-innovativo-progetto-di-ricerca-grazie-a-aisos-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3945-rabdomiosarcoma-e-leucemia-mieloide-acuta-dallema-una-guida-per-migliorare-i-trial]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3892-tumori-rari-nei-bimbi-se-la-madre-vive-in-ambiente-inquinato-il-rischio-aumenta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3869-tumori-rari-pediatrici-ema-apre-una-consultazione-pubblica]]></loc><lastmod>2018-06-07T16:36:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3857-melanoma-a-siena-si-sperimenta-una-terapia-combinata-contro-le-metastasi-cerebrali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3853-melanoma-cutaneo-da-studio-italo-americano-passi-avanti-per-la-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3764-alla-prima-edizione-del-premio-giornalistico-omar-assegnato-il-premio-celgene-per-i-tumori-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3766-premio-omar-il-premio-speciale-celgene-assegnato-a-lidia-scognamiglio]]></loc><lastmod>2024-03-28T11:25:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3720-tumori-rari-pediatrici-locatelli-grandi-progressi-grazie-alla-nuova-normativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3584-tumori-rari-in-italia-ancora-troppe-le-disuguaglianze-nella-diagnosi-e-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3418-leucemia-mieloide-acuta-buone-notizie-dal-congresso-dellash]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3363-carcinoma-mammario-infiammatorio-un-nuovo-sistema-di-coltura-3d-per-capire-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3364-sarcoma-di-ewing-si-studia-un-nuovo-potenziale-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3223-leucemia-acuta-megacarioblastica-scoperto-uno-dei-geni-responsabili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3244-tumori-rari-presentata-una-memoria-al-senato-un-gruppo-di-lavoro-ad-hoc-chiede-linclusione-nellelenco-delle-malattie-rare-e-piu-attenzione-ai-farmaci-orfani-dedicati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3067-leucemia-mieloide-cronica-approvata-dalla-fda-la-terapia-con-omacetaxina-mepesuccinato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3019-tumori-rari-i-pazienti-invitati-a-partecipare-al-sondaggio-di-rare-cancers-europe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/3016-carcinoma-colorettale-non-operabile-studio-tedesco-spiega-i-vantaggi-della-radioembolizzazione-con-sir-spheres]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2951-tumore-del-rene-il-parere-del-paziente-la-scelta-delloncologo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2864-carcinoma-della-tiroide-troppa-variabilita-nei-trattamenti-chirurgici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2784-retinoblastoma-primi-risultati-positivi-per-il-protocollo-delle-scotte-di-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2766-leucemia-mieloide-acuta-lobesita-non-aumenta-i-rischi-del-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2734-leucemia-linfocitaria-cronica-attenzione-alle-combinazioni-di-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2627-cancro-al-colon-metastatico-fda-approva-afibercept-come-terapia-di-seconda-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2603-tumore-al-colon-retto-al-via-uno-studio-sulla-combinazione-di-capecitabina-e-celecoxib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2587-colon-retto-se-il-tumore-resiste-ai-farmaci-ci-sono-i-nuovi-test-diagnostici-con-loncogene-kras]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2481-leucemia-linfoide-bcr-abl-scoperto-il-ruolo-di-una-proteina-potrebbe-essere-il-nuovo-bersaglio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2424-carcinoma-metastatico-del-colon-retto-concessa-da-fda-la-revisione-prioritaria-a-regorafenib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2417-tumori-della-testa-e-del-collo-privo-di-senso-senseless-ed-ancora-troppo-elevato-il-numero-di-vite-perse-a-causa-della-scarsa-conoscenza-di-questa-neoplasia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2363-leucemia-mieloide-acuta-lassociazione-di-tre-farmaci-sembra-dare-ottimi-risultati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2361-il-ginseng-puo-migliorare-il-senso-di-affaticamento-nei-pazienti-oncologici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2155-tumori-neuroendrocrini-leccellenza-e-a-monza-qui-uno-studio-sul-trattamento-con-panitumumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2141-sarcoma-dei-tessuti-molli-approvato-da-fda-luso-di-pazopanib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2113-tumori-renali-non-cancerosi-nella-sclerosi-tuberosa-approvato-dallfda-il-trattamento-con-everolimus]]></loc><lastmod>2016-05-03T21:03:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2057-sindromi-mielodisplastiche-la-somministrazione-del-solo-infliximab-non-e-efficace]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/2011-linfoma-di-hodgking-lespressione-delloncogene-c-met-e-un-predittore-favorevole]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1989-melanoma-con-metastasi-cerebrali-a-siena-la-prima-sperimentazione-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1919-tumori-rari-tcr-gene-editing-e-una-nuova-tecnologia-per-la-cura-delle-leucemie]]></loc><lastmod>2018-02-09T10:17:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1880-aspirina-tre-studi-confermano-il-potenziale-ruolo-preventivo-su-cancro-e-metastasi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1877-sarcoma-dei-tessuti-molli-respinto-il-farmaco-sperimentale-di-merckaco-accettato-quello-di-glaxo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1833-leucemia-mieloide-acuta-alla-base-cloni-fondatori-di-cellule-nelle-sindromi-mielodisplastiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1767-leucemia-mieloide-acuta-decitabina-come-trattamento-di-prima-linea-per-i-pazienti-non-idonei-alla-chemioterapia-di-induzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1753-leucemia-mieloide-cronica-imatinib-puo-migliorare-la-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1762-tumori-nanodispositivi-per-la-prognosi-precoce-dalla-sissa-di-trieste]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1712-melanoma-metastatico-il-trattamento-con-vemurafenib-puo-aumentare-la-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1585-carcinoma-della-colecisti-gli-errori-che-possono-impedire-la-giusta-diagnosi]]></loc><lastmod>2024-03-28T11:01:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1530-carcinoma-a-piccole-cellule-della-vescica-il-punto-su-diagnosi-e-terapie]]></loc><lastmod>2021-11-02T15:33:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1429-tumori-neuroendrocrini-everolimus-sembra-rallentare-la-progressione]]></loc><lastmod>2018-12-16T10:26:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/1072-tumori-della-testa-e-del-collo-la-conoscenza-in-europa-e-troppo-bassa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/972-epatocarcinoma-al-gemelli-la-radioembolizzazione-tratto-con-successo-il-primo-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/954-tumori-novita-sul-legame-tra-virus-e-malattie-e-su-possibile-terapie-innovative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/887-osteosarcoma-un-sms-al-45506-fino-al-17-luglio-per-sostenere-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/832-leucemie-oggi-la-giornata-nazionale-attivo-fino-a-stasera-numero-verde-dellail-800226524]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/797-leucemia-mieloide-cronica-il-desanitib-si-avvicina-sempre-piu-ad-essere-trattamento-di-prima-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/686-retinoblastoma-grazie-allattore-peppe-quintale-alle-scotte-di-siena-nuovo-laser-per-la-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/576-leucemia-mieloide-acuta-sono-tre-i-gruppi-di-geni-che-collaborano-alla-sviluppo-del-cancro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/536-linfoma-anaplasico-a-grandi-cellule-due-pazienti-italiani-con-recidiva-trattati-con-crizonitib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/521-carcinoma-tiroideo-avanzato-pacini-raccomandare-la-target-therapy-ai-pazienti-e-un-dovere]]></loc><lastmod>2015-06-08T10:13:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/503-tumori-rari-del-polmone-nasce-un-sito-dedicato-coordinato-da-modena]]></loc><lastmod>2021-11-02T17:06:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/317-leucemia-mieloide-cronica-messo-a-punto-in-italia-un-nuovo-farmaco-intelligente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/316-leucemia-mieloide-acuta-ricerca-americana-scopre-meccanismo-di-avvelenamento-generato-da-una-mutazione-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/290-retinoblastoma-nuova-tecnica-messa-a-punto-a-le-scotte-di-siena-ha-guarito-il-60-per-cento-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/278-tumori-a-siena-un-corso-di-immunobioterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/252-tumori-rari-allistituto-scientifico-romagnolo-per-la-cura-dei-tumori-nuove-ricerche-sul-carcinoma-della-mammella-maschile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/248-carcinoma-follicolare-della-tiroide-grazie-ad-un-approccio-multidisciplinare-dellospedale-di-perugia-rimuove-enorme-massa-tumorale-da-una-paziente-salvandole-la-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/186-macroglobulinemia-di-waldenstrom-mw-il-niguarda-e-centro-di-riferimento-europeo-tre-due-sui-ricercatori-riceveranno-il-young-investigator-award]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/184-tumori-rari-litt-avvia-un-focus-specifico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/altri-tumori-rari/118-il-nobel-capecchi-sfida-i-tumori-rari-infantili-con-il-gene-targeting]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net]]></loc><lastmod>2025-03-25T19:15:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/22834-neuroblastoma-la-sfida-di-chieti-e-londra-bloccare-il-gene-che-alimenta-il-tumore]]></loc><lastmod>2026-03-11T19:00:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/22546-neuroblastoma-al-gemelli-un-nuovo-approccio-per-il-monitoraggio-delle-masse-surrenaliche-neonatali]]></loc><lastmod>2025-11-25T09:40:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/22249-tumori-neuroendocrini-la-terapia-radiorecettoriale-con-lutezio-177-si-puo-fare-in-day-hospital]]></loc><lastmod>2025-08-18T21:11:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/22165-tumori-neuroendocrini-semaforo-verde-da-parte-dell-ema-per-cabozantinib]]></loc><lastmod>2025-07-07T15:19:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/21911-neuroblastoma-al-san-camillo-operata-con-successo-una-neonata-di-soli-5-mesi]]></loc><lastmod>2025-04-15T12:37:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/21299-neuroblastoma-libera-da-malattia-dopo-3-anni-grazie-a-un-farmaco-innovativo]]></loc><lastmod>2024-09-18T13:52:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/20861-neuroblastoma-come-la-genetica-sta-migliorando-le-possibilita-di-trattamento]]></loc><lastmod>2024-04-10T16:17:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/20729-preme-un-progetto-per-colpire-in-maniera-mirata-il-neuroblastoma]]></loc><lastmod>2024-03-08T18:04:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/20472-tumori-neuroendocrini-la-chirurgia-e-un-opzione-importante-ma-va-attentamente-pianificata]]></loc><lastmod>2023-12-21T16:29:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/20466-tumori-neuroendocrini-le-prospettive-future-della-terapia-con-radiofarmaci]]></loc><lastmod>2023-12-19T18:11:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/20435-tumori-neuroendocrini-l-obiettivo-e-estendere-la-terapia-con-radioligandi-a-un-maggior-numero-di-pazienti]]></loc><lastmod>2023-12-12T19:33:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/20420-tumori-neuroendocrini-il-ruolo-delle-associazioni-ascoltare-le-necessita-dei-pazienti-e-riportarle-ai-medici]]></loc><lastmod>2023-12-06T15:07:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/20387-tumori-neuroendocrini-conclusa-con-successo-la-x-edizione-del-congresso-itanet]]></loc><lastmod>2023-11-27T15:48:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/20305-tumori-neuroendocrini-oggi-la-giornata-mondiale-tra-consolidamenti-diagnostici-e-novita-terapeutiche]]></loc><lastmod>2023-11-06T23:24:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/19514-tumore-neuroendocrino-polmonare-si-esplorano-potenzialita-della-medicina-nucleare]]></loc><lastmod>2023-02-08T19:17:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/19331-tumori-neuroendocrini-trattamenti-sempre-piu-efficaci-e-con-minor-tossicita]]></loc><lastmod>2022-11-27T11:14:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/19303-neuroblastoma-parte-la-campagna-di-natale-dono-ricerca-ridono-la-vita]]></loc><lastmod>2022-11-25T16:51:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/19300-neuroblastoma-i-regali-natalizi-dell-associazione-enea-sostengono-la-ricerca]]></loc><lastmod>2022-11-20T10:50:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/19259-tumori-neuroendocrini-i-pazienti-vanno-supportati-e-orientati-nel-loro-percorso-di-cura]]></loc><lastmod>2022-11-09T15:56:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/19261-tumori-neuroendocrini-il-10-novembre-e-la-giornata-mondiale]]></loc><lastmod>2022-11-09T15:56:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/18598-tumori-neuroendocrini-una-web-radio-per-dare-voce-ai-pazienti]]></loc><lastmod>2022-05-01T17:46:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/18441-neuroblastoma-sviluppato-modello-predittivo-che-evita-la-biopsia-ai-piccoli-pazienti]]></loc><lastmod>2022-03-21T16:28:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/18149-il-musicista-chad-gilbert-operato-d-urgenza-dopo-una-diagnosi-di-feocromocitoma]]></loc><lastmod>2021-12-31T12:16:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/18049-tumori-neuroendocrini-un-libro-per-raccontare-le-storie-dei-pazienti]]></loc><lastmod>2021-11-27T23:38:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/17336-insulinoma-una-paziente-curata-al-gemelli-con-un-intervento-in-ecoendoscopia]]></loc><lastmod>2021-04-25T20:51:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/16918-neuroblastoma-individuati-due-marcatori-che-predicono-le-possibilita-di-sopravvivenza]]></loc><lastmod>2021-01-23T23:44:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/16230-tumori-neuroendocrini-per-la-diagnosi-e-importante-saper-riconoscere-la-sindrome-da-carcinoide]]></loc><lastmod>2020-06-29T09:29:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/16064-tumori-neuroendocrini-la-terapia-radiorecettoriale-ritarda-la-progressione-di-malattia]]></loc><lastmod>2020-05-12T20:11:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/16028-tumori-neuroendocrini-il-cinema-indiano-piange-irrfan-khan]]></loc><lastmod>2020-05-05T15:19:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/15874-tumori-neuroendocrini-come-comportarsi-nell-emergenza-covid-19]]></loc><lastmod>2020-03-30T17:31:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/15720-neuroblastoma-ospedale-meyer-ed-enea-onlus-lanciano-un-progetto-di-ricerca]]></loc><lastmod>2020-03-04T16:31:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/15594-tumori-neuroendocrini-il-san-gerardo-di-monza-in-prima-linea-nella-ricerca]]></loc><lastmod>2020-06-26T09:10:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/15463-neoplasia-endocrina-multipla-un-calendario-per-far-conoscere-la-malattia]]></loc><lastmod>2026-02-19T09:25:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/15453-tumori-neuroendocrini-il-ritardo-diagnostico-e-uno-degli-scogli-piu-difficili-da-superare]]></loc><lastmod>2019-11-28T16:19:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14809-tumori-neuroendocrini-per-un-approccio-multidisciplinare-servono-centri-di-riferimento]]></loc><lastmod>2019-05-16T08:28:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14803-tumori-neuroendocrini-la-terapia-radiorecettoriale-per-una-miglior-qualita-di-vita]]></loc><lastmod>2019-05-14T10:04:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14787-tumori-neuroendocrini-gep-net-fondamentale-l-approccio-multidisciplinare]]></loc><lastmod>2019-05-08T11:27:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14780-tumori-neuroendocrini-cosa-sono-e-come-possono-essere-trattati]]></loc><lastmod>2019-05-08T11:27:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14774-tumori-neuroendocrini-i-passi-avanti-della-medicina-nucleare]]></loc><lastmod>2019-05-05T17:02:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14745-tumori-neuroendocrini-cos-e-la-teragnostica-e-come-sta-cambiando-la-medicina-nucleare]]></loc><lastmod>2022-11-25T17:08:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14733-sindrome-di-von-hippel-lindau-in-toscana-una-mozione-per-istituire-un-pdta]]></loc><lastmod>2019-04-15T15:19:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14722-tumori-neuroendocrini-da-oggi-disponibile-una-terapia-innovativa]]></loc><lastmod>2019-04-15T14:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14721-tumori-neuroendocrini-matteo-benedetta-e-federico-storie-diverse-per-la-stessa-diagnosi]]></loc><lastmod>2019-04-13T18:20:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14713-tumori-neuroendocrini-aifa-autorizza-l-immissione-in-commercio-di-lutathera]]></loc><lastmod>2019-04-13T11:42:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14631-tumori-neuroendrocini-in-italia-si-attende-a-breve-l-arrivo-del-lutezio-177lu-oxodotreotide]]></loc><lastmod>2019-03-28T15:50:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14465-neoplasie-endocrine-multiple-cruciale-che-il-paziente-giunga-presto-dallo-specialista]]></loc><lastmod>2019-05-24T10:27:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14457-neuroblastoma-a-genova-si-studia-l-impiego-della-rna-interference]]></loc><lastmod>2019-05-24T08:57:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14445-tumori-neuroendocrini-dello-stomaco-forme-rare-da-non-sottovalutare]]></loc><lastmod>2019-02-10T21:23:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14434-neoplasia-endocrina-multipla-di-tipo-1-piu-attenzione-alle-forme-familiari]]></loc><lastmod>2019-05-24T10:21:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14372-sindrome-di-von-hippel-lindau-sviluppato-un-algoritmo-per-valutare-il-rischio-di-net-pancreatici]]></loc><lastmod>2019-02-02T19:18:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14345-tumori-neuroendocrini-il-net-cancer-day-come-occasione-per-riunire-esperti-e-pazienti]]></loc><lastmod>2019-01-09T19:16:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14064-feocromocitomi-e-paragangliomi-metastatici-comprenderli-per-trovare-nuove-cure]]></loc><lastmod>2018-10-21T18:01:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/14046-neuroblastoma-dinutuximab-beta-rimborsabile-in-italia]]></loc><lastmod>2019-05-24T08:59:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/13644-neuroblastoma-l-immunoterapia-e-una-delle-strategie-di-trattamento-piu-promettenti]]></loc><lastmod>2019-05-24T09:01:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/13329-von-hippel-lindau-la-sindrome-che-predispone-a-un-numero-incredibile-di-tumori]]></loc><lastmod>2019-05-24T14:45:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/13315-tumori-neuroendocrini-alla-conferenza-enets-la-star-e-la-terapia-radiorecettoriale]]></loc><lastmod>2018-03-09T14:02:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/13227-feocromocitoma-un-tumore-raro-che-mima-comuni-attacchi-d-ansia]]></loc><lastmod>2018-02-12T23:25:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/13207-feocromocitoma-il-tumore-solido-con-la-piu-estesa-base-genetica]]></loc><lastmod>2018-03-12T03:30:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/13156-tumori-neuroendocrini-nuove-linee-di-consenso-per-trattamento-e-follow-up]]></loc><lastmod>2018-01-29T10:36:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/13070-neuroblastoma-la-genetica-e-fondamentale-per-lo-studio-di-nuovi-trattamenti]]></loc><lastmod>2019-05-24T09:02:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/12952-tumori-neuroendocrini-con-le-radiazioni-e-possibile-coniugare-diagnosi-e-terapia]]></loc><lastmod>2017-11-28T20:25:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/12893-tumori-neuroendocrini-un-ptda-impedisce-che-i-pazienti-si-disperdano-in-cerca-di-diagnosi]]></loc><lastmod>2019-03-26T17:24:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/12856-tumori-neuroendocrini-la-terapia-radiorecettoriale-efficace-nella-malattia-in-fase-avanzata]]></loc><lastmod>2017-11-02T16:54:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/12857-tumori-neuroendocrini-approda-in-europa-nuovo-radiofarmaco-mirato]]></loc><lastmod>2017-11-02T16:57:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/12119-tumori-neuroendocrini-studiale-le-mutazioni-genetiche-correlate-puo-aiutare-a-scegliere-la-terapia]]></loc><lastmod>2017-07-16T17:06:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/11735-tumori-neuroendocrini-net-con-anticorpi-monoclonali-come-everolimus-e-sunitinib-sempre-piu-pazienti-hanno-una-chance-terapeutica-valida]]></loc><lastmod>2017-06-19T15:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/11150-tumori-neuroendocrini-net-grazie-a-diagnostica-e-terapia-oggi-sono-patologie-gestibili]]></loc><lastmod>2023-02-01T12:32:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/11019-tumori-net-gastrointestinali-e-polmonari-canada-concede-via-libera-al-farmaco-afinitor-everolimus]]></loc><lastmod>2017-06-19T15:25:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/11026-tumori-neuroendocrini-ema-autorizza-l-uso-di-telotristat-etiprate-per-la-sindrome-carcinoide]]></loc><lastmod>2020-06-26T09:16:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10786-tumori-neuroendocrini-fda-approva-nuovo-agente-per-la-diagnosi-radiologica-di-queste-rare-neoplasie]]></loc><lastmod>2016-06-15T09:10:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10669-tumori-neuroendocrini-in-mille-ai-nastri-di-partenza-della-zoomzebra-run4net]]></loc><lastmod>2016-05-23T09:33:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10546-tumori-neuroendocrini-solo-il-20-e-sintomatico]]></loc><lastmod>2016-05-12T08:22:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10541-tumori-neuroendocrini-gli-analoghi-della-somatostatina-sono-il-cardine-del-trattamento]]></loc><lastmod>2016-05-06T10:36:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10419-tumori-neuroendocrini-a-milano-arriva-zoomzebra-run4net]]></loc><lastmod>2016-04-20T14:28:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10391-una-malattia-rara-poca-informazione-e-una-sanita-inadeguata-la-storia-di-alessandra-e-la-lotta-contro-la-men]]></loc><lastmod>2019-05-24T08:34:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10397-tumori-neuroendocrini-gli-analoghi-della-somatostatina-hanno-un-effetto-antineoplastico]]></loc><lastmod>2016-04-19T08:01:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10372-tumori-neuroendocrini-fondamentale-la-corretta-terapia]]></loc><lastmod>2016-04-13T13:59:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10369-tumori-neuroendocrini-in-italia-sei-centri-d-eccellenza]]></loc><lastmod>2016-04-13T09:03:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10368-approvata-la-nuova-indicazione-per-lanreotide-come-farmaco-ad-attivita-antiproliferativa-nel-trattamento-di-tumori-neuroendocrini-gastroenteropancreatici]]></loc><lastmod>2016-04-14T08:35:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10367-tumori-neuroendocrini-tutte-le-novita-terapeutiche]]></loc><lastmod>2016-04-13T08:42:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10333-neuroblastoma-test-preclinici-incoraggianti-sulla-terapia-sperimentale-abt-199]]></loc><lastmod>2019-05-24T09:06:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10313-alla-riscoperta-dei-tumori-neuroendocrini-net-l-8-e-9-aprile-gli-esperti-sono-all-ifo-di-roma]]></loc><lastmod>2016-04-07T07:20:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10173-tumori-net-gastrointestinali-e-polmonari-fda-approva-l-uso-di-afinitor-everolimus]]></loc><lastmod>2016-03-11T11:57:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/10072-tumori-neuroendocrini-gastrointestinali-everolimus-sembra-rallentare-la-progressione-della-malattia]]></loc><lastmod>2016-03-01T08:48:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/9865-tumori-neuroendocrini-dell-intestino-buoni-risultati-terapeutici-da-un-nuovo-radiofarmaco]]></loc><lastmod>2016-02-01T10:08:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/9323-tumori-neuroendocrini-net-oggi-la-giornata-mondiale-dedicata-alla-sensibilizzazione]]></loc><lastmod>2015-11-10T09:06:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/9175-tumori-neuroendocrini-gastrointestinali-e-polmonari-presentati-gli-incoraggianti-risultati-di-everolimus]]></loc><lastmod>2016-02-29T19:49:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/8789-neuroblastoma-approvato-dall-ema-dinutuximab-per-pazienti-pediatrici]]></loc><lastmod>2019-05-24T09:13:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/8398-neuroblastoma-ad-alto-rischio-ema-raccomanda-l-approvazione-del-farmaco-unituxin]]></loc><lastmod>2019-05-24T09:20:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/8397-tumori-neuroendocrini-gastrointestinali-e-polmonari-risultati-positivi-per-everolimus]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/8396-tumori-neuroendocrini-pancreatici-avviato-studio-sul-farmaco-dcr-myc]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/8062-neuroblastoma-ad-alto-rischio-incertezza-sulluso-dellacido-retinoico]]></loc><lastmod>2019-05-24T09:22:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/8037-tumori-rari-neuroendocrini-individuata-nuova-mutazione-sul-gene-mdh2]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/7963-neuroblastoma-ad-alto-rischio-approvato-dinutuximab-come-terapia-di-prima-linea]]></loc><lastmod>2019-05-24T09:24:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/7142-neuroblastoma-lanticorpo-hu1418k322a-migliore-del-ch1418]]></loc><lastmod>2019-05-24T09:27:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/6908-neoplasie-endocrine-multiple-men-le-pazienti-rischiano-il-tumore-al-seno]]></loc><lastmod>2019-05-24T08:40:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/6924-tumori-neuroendocrini-pancreatici-il-trattamento-con-everolimus-prolunga-la-sopravvivenza-globale]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/6507-tumori-neuroendocrini-lanreotide-prolunga-sopravvivenza-libera-da-progressione]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/6437-tumori-neuroendocrini-gastrointestinali-e-pancreatici-ipsen-deposita-domanda-per-lanreotide-120-mg]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/5666-tumori-neuroendocrini-del-tratto-gastro-entero-pancreatico-gallio-68-dotatate-ottiene-la-denominazione-di-farmaco-orfano]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/5429-neoplasia-endocrina-multipla]]></loc><lastmod>2019-05-24T10:26:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/5420-dallospedale-psichiatrico-alla-diagnosi-di-malattia-rara-i-medici-credevano-fosse-depressione]]></loc><lastmod>2019-05-24T16:11:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/5337-tumori-neuroendocrini-nuove-conferme-dal-trattamento-combinato]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/4965-tumori-neuroendocrini-si-e-celebrata-la-qnet-cancer-dayq-giornata-di-solidarieta-per-i-pazienti-affetti-da-tali-patologie]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/4882-tumori-neuroendocrini-il-dialogo-come-cura-domani-al-gemelli-lincontro-tra-medici-pazienti-e-familiari]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/4819-tumori-neuroendocrini-100-mila-casi-in-europa-negli-ultimi-cinque-anni]]></loc><lastmod>2023-11-23T17:54:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/4811-tumori-neuroendocrini-dellintestino-tenue-raggiunta-quota-100-pazienti-nella-fase-iii-di-sperimentazione-clinica-del-radiofarmaco-italiano-lutathera]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/3868-tumore-neuroendocrino-ileale-a-perugia-effettuato-con-successo-intervento-di-chirurgia-radioguidata]]></loc><lastmod>2019-05-24T08:32:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/3111-tumori-neuroendocrini-ricorre-domani-il-net-cancer-day]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/2867-tumori-neuroendocrini-dellintestino-tenue-continua-la-sperimentazione-per-il-radiofarmaco-lutathera]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/2837-tumori-rari-scoperta-la-mutazione-che-alimenta-alcuni-tipi-di-cancro]]></loc><lastmod>2019-05-24T15:55:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/701-tumori-neuroendocrini-domani-alle-scotte-di-siena-il-summit-nazionale]]></loc><lastmod>2026-04-04T13:49:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/580-neuroblastoma-al-gemelli-nuova-strategia-contro-il-tumore-radio-e-chemio-fin-dal-principio]]></loc><lastmod>2019-05-24T09:34:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/523-tumori-neuroendocrini-il-gruppo-oncologico-multidisciplinare-dellumbria-nominato-centro-di-eccellenza]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/443-tumori-neuroendocrini-pancreatici-leverolimus-puo-ridurre-fino-al-65-per-cento-la-progressione]]></loc><lastmod>2018-12-16T10:16:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/339-neuroblastoma-studio-italiano-scopre-la-mutazione-genetica-collegata-al-tumore]]></loc><lastmod>2019-05-24T09:58:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/325-tumori-neuroendocrini-lassociazione-umbra-vivere-la-speranza-ha-assegnato-due-borse-di-studio]]></loc><lastmod>2015-11-03T16:39:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/226-sindromi-men-lassociazione-vivere-la-speranza-premia-il-dottor-diego-ferone-di-genova]]></loc><lastmod>2019-05-24T10:36:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/220-sindromi-men-la-combinazione-di-farmaci-target-e-terapia-biologica-possono-aprire-la-strada-per-la-regressione]]></loc><lastmod>2019-05-24T11:16:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/172-neuroblastoma-un-farmaco-di-uso-comune-potrebbe-evitare-la-chemioterapia]]></loc><lastmod>2024-10-08T16:59:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/157-neoplasia-endocrina-multipla-clara-ha-atteso-la-diagnosi-per-dieci-anni]]></loc><lastmod>2019-05-24T10:18:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/tumori-neuroendocrini-net/139-neoplasie-endocrine-multiple-troppo-tempo-per-arrivare-alla-diagnosi]]></loc><lastmod>2019-05-24T10:44:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel]]></loc><lastmod>2025-04-07T15:20:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/22468-carcinoma-a-cellule-di-merkel-approvato-in-italia-un-nuovo-farmaco]]></loc><lastmod>2025-11-04T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/15454-carcinoma-a-cellule-di-merkel-la-radioterapia-adiuvante-e-utile]]></loc><lastmod>2019-11-26T17:22:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/14988-carcinoma-a-cellule-di-merkel-a-padova-gli-specialisti-a-confronto]]></loc><lastmod>2019-07-06T14:59:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/14765-carcinoma-a-cellule-di-merkel-la-terapia-con-gli-inibitori-dei-checkpoint-immunitari]]></loc><lastmod>2026-04-02T15:30:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/14063-carcinoma-a-cellule-di-merkel-avelumab-disponibile-in-italia]]></loc><lastmod>2018-10-21T18:01:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/13338-carcinoma-a-cellule-di-merkel-tra-le-cause-l-infezione-da-poliomavirus]]></loc><lastmod>2018-03-14T12:07:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12951-carcinoma-a-cellule-di-merkel-e-un-tumore-raro-ma-il-dermatologo-puo-facilmente-diagnosticarlo]]></loc><lastmod>2017-12-08T16:45:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12961-carcinoma-a-cellule-di-merkel-come-si-ottiene-la-diagnosi]]></loc><lastmod>2017-12-01T15:59:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12929-carcinoma-a-cellule-di-merkel-quali-sono-i-fattori-di-rischio]]></loc><lastmod>2017-11-21T10:09:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12927-carcinoma-a-cellule-di-merkel-a-differenza-del-melanoma-se-ne-parla-ancora-troppo-poco]]></loc><lastmod>2017-11-21T10:10:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12916-carcinoma-a-cellule-di-merkel-scopriamo-di-cosa-si-tratta]]></loc><lastmod>2017-11-19T14:03:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12747-carcinoma-a-cellule-di-merkel-la-commissione-europea-approva-avelumab]]></loc><lastmod>2017-10-10T16:52:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12574-carcinoma-a-cellule-di-merkel-con-la-chemioterapia-breve-la-risposta-e-scarsa-la-sopravvivenza]]></loc><lastmod>2017-08-09T15:12:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12552-carcinoma-a-cellule-di-merkel-parere-positivo-del-chmp-per-avelumab]]></loc><lastmod>2017-08-02T15:28:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12252-carcinoma-a-cellule-di-merkel-approvazione-usa-per-avelumab]]></loc><lastmod>2019-01-17T17:38:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12060-carcinoma-a-cellule-di-merkel-due-nuovi-farmaci-ne-rallentano-la-progressione]]></loc><lastmod>2017-06-19T15:02:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/12057-carcinoma-a-cellule-di-merkel-due-volte-piu-aggressivo-del-melanoma]]></loc><lastmod>2017-06-19T15:02:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/11968-carcinoma-a-cellule-di-merkel-l-effetto-del-poliomavirus-sullo-sviluppo-del-tumore]]></loc><lastmod>2017-06-19T15:03:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/11967-le-cellule-di-merkel-aumentano-notevolmente-con-le-lesioni-della-rasatura]]></loc><lastmod>2017-06-19T15:03:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/11957-carcinoma-a-cellule-di-merkel-in-italia-240-nuovi-casi-all-anno]]></loc><lastmod>2017-02-22T00:12:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/11955-carcinoma-a-cellule-di-merkel-un-tumore-della-pelle-raro-e-aggressivo]]></loc><lastmod>2017-02-20T10:45:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/11951-carcinoma-a-cellule-di-merkel-quando-usare-la-radioterapia]]></loc><lastmod>2017-02-19T19:24:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/10494-carcinoma-a-cellule-di-merkel-un-caso-italiano-di-regressione-spontanea]]></loc><lastmod>2016-12-07T16:15:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/carcinoma-a-cellule-di-merkel/9524-carcinoma-a-cellule-di-merkel-il-farmaco-sperimentale-avelumab-designato-terapia-fortemente-innovativa]]></loc><lastmod>2016-12-07T16:16:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera]]></loc><lastmod>2024-03-13T12:41:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/21076-al-via-la-campagna-la-policitemia-e-vera-io-non-aspetto]]></loc><lastmod>2024-06-13T15:43:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/20567-policitemia-vera-le-prospettive-terapeutiche-aggiornate-al-2024]]></loc><lastmod>2024-03-12T14:43:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/20518-policitemia-vera-al-congresso-ash-nuovi-dati-su-ropeginterferone-alfa-2b]]></loc><lastmod>2024-01-15T12:24:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/19667-policitemia-vera-continuita-terapeutica-a-rischio-per-i-pazienti-arruolati-in-uno-studio-clinico]]></loc><lastmod>2023-03-27T18:18:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/18971-policitemia-vera-positivi-i-dati-finali-su-ropeginterferone-alfa-2b]]></loc><lastmod>2022-07-29T11:44:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/18761-policitemia-vera-ropeginterferone-alfa-2-b-rimborsabile-in-italia]]></loc><lastmod>2022-06-12T12:25:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/17389-policitemia-vera-necessario-incrementare-la-formazione-di-specialisti-e-medici-di-base]]></loc><lastmod>2021-05-04T13:01:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/13735-policitemia-vera-ruxolitinib-associato-a-un-minor-rischio-di-trombosi-e-morte]]></loc><lastmod>2018-07-07T09:46:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/13427-policitemia-vera-quale-terapia-per-la-rara-neoplasia-mieloproliferativa]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/13428-policitemia-vera-come-si-arriva-alla-diagnosi-i-sintomi-gli-accertamenti-e-i-criteri-diagnostici]]></loc><lastmod>2021-05-03T18:33:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/13362-policitemia-vera-la-risposta-a-ruxolitinib-persiste-a-distanza-di-anni]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/13158-neoplasie-mieloproliferative-in-alcuni-pazienti-la-malattia-evolve-in-un-altra]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/13035-policitemia-vera-presentati-i-dati-clinici-di-fase-i-e-ii-su-givinostat]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/12978-policitemia-vera-la-scoperta-della-causa-genetica-ha-rivoluzionato-diagnosi-e-terapia]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/11713-policitemia-vera-presentati-dati-clinici-di-fase-iii-sul-farmaco-ropeginterferon-alfa-2b]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/10819-policitemia-vera-dati-positivi-su-farmaco-ruxolitinib]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/10695-policitemia-vera-e-beta-talassemia-test-preclinici-promettenti-su-un-nuovo-tipo-di-peptide-sintetico]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/9651-mielofibrosi-e-policitemia-vera-presentati-i-dati-di-successo-del-farmaco-jakavi-ruxolitinib]]></loc><lastmod>2018-04-19T18:19:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/8477-policitemia-vera-dati-positivi-sull-efficacia-a-lungo-termine-del-farmaco-ruxolitinib]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/8193-policitemia-vera-buoni-risultati-col-trattamento-con-ruxolitinib-ora-approvato-anche-da-ema]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/7923-policitemia-vera-novartis-riceve-lapprovazione-europea-per-jakavi]]></loc><lastmod>2018-04-19T18:19:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/7514-policitemia-vera-parere-positivo-dal-chmp-dellema-per-il-farmaco-di-novartis-jakavi-r]]></loc><lastmod>2018-04-19T18:19:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/7290-policitemia-vera-fda-approva-ruxolitinib]]></loc><lastmod>2018-04-19T18:19:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/7098-policitemia-vera-prosegue-la-ricerca-genetica-fondamentale-per-elaborare-una-terapia-mirata]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/6344-policitemia-vera-risultati-positivi-per-ruxolitinib-dallo-studio-response]]></loc><lastmod>2018-04-19T18:19:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/5716-policitemia-vera-il-farmaco-ruloxitinib-supera-la-fase-iii-della-sperimentazione]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/3813-policitemia-vera-il-livello-di-ematocrito-puo-determinare-la-sopravvivenza]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/policitemia-vera/487-policitemia-vera-trovato-il-gene-sano-coinvolto-nellinsorgere-della-malattia]]></loc><lastmod>2018-04-17T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi]]></loc><lastmod>2026-02-10T18:35:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/22709-mielofibrosi-momelotinib-migliora-lanemia-e-riduce-il-bisogno-di-trasfusioni]]></loc><lastmod>2026-02-03T08:54:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/22362-presentato-a-roma-il-progetto-uniti-per-la-mielofibrosi]]></loc><lastmod>2025-09-29T14:42:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/21734-mielofibrosi-momelotinib-rimborsabile-in-italia]]></loc><lastmod>2025-02-18T17:54:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/21245-mielofibrosi-il-racconto-di-marinella-la-mia-milza-era-cresciuta-tanto-da-comprimere-gli-altri-organi]]></loc><lastmod>2024-08-30T09:47:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/21208-mielofibrosi-a-volte-la-diagnosi-puo-arrivare-come-un-fulmine-a-ciel-sereno]]></loc><lastmod>2024-08-05T07:41:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/21171-mielofibrosi-nuove-possibilita-terapeutiche-grazie-agli-anticorpi-farmaco-coniugati]]></loc><lastmod>2024-07-12T14:49:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/21158-mielofibrosi-la-storia-di-nazzareno-da-30-anni-alle-prese-con-la-malattia]]></loc><lastmod>2024-07-09T11:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/21140-mielofibrosi-il-trattamento-va-definito-sulla-condizione-del-singolo-paziente]]></loc><lastmod>2024-07-03T12:32:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/21115-mielofibrosi-occorre-saper-riconoscere-la-malattia-per-giungere-a-una-diagnosi-tempestiva]]></loc><lastmod>2024-07-01T10:30:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/20578-mielofibrosi-via-libera-della-commissione-europea-a-momelotinib]]></loc><lastmod>2024-01-30T13:02:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/19993-tumori-ematologici-una-guida-per-migliorare-l-interazione-dei-pazienti-con-medici-e-familiari]]></loc><lastmod>2023-07-10T10:50:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/13795-mielofibrosi-risultati-positivi-in-termini-di-efficacia-e-tollerabilita-per-terapia-con-ruxolinitb]]></loc><lastmod>2018-07-30T17:02:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/13527-mielofibrosi-ritardo-diagnostico-e-rischio-di-depressione-ma-con-la-giusta-terapia-una-vita-di-qualita]]></loc><lastmod>2018-05-05T14:54:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/13450-mielofibrosi-quali-possibilita-terapeutiche-per-questa-neoplasia]]></loc><lastmod>2018-04-16T16:17:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/13449-mielofibrosi-fondamentale-la-diagnosi-precoce-la-parola-all-esperto]]></loc><lastmod>2018-05-22T06:54:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/13142-neoplasie-mieloproliferative-il-peso-della-malattia-puo-spingere-i-pazienti-ad-isolarsi]]></loc><lastmod>2018-01-24T16:16:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/13036-mielofibrosi-ruxolitinib-e-una-possibile-alternativa-al-trapianto-di-staminali]]></loc><lastmod>2018-01-04T11:56:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/13017-mielofibrosi-una-sola-malattia-ma-contraddistinta-da-diversi-gradi-di-rischio]]></loc><lastmod>2017-12-11T16:33:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/10785-mielofibrosi-il-farmaco-ruxolitinib-evidenzia-benefici-nella-sopravvivenza-dei-pazienti]]></loc><lastmod>2018-04-24T10:30:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/8474-mielofibrosi-confermati-i-risultati-positivi-provenienti-dallo-studio-di-fase-iii-di-pacritinib]]></loc><lastmod>2017-10-08T17:18:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/7910-milelofibrosi-cti-biopharma-e-baxter-annunciano-risultati-positivi-per-pacritinib]]></loc><lastmod>2018-04-24T10:30:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/7876-mielofibroma-risultati-positivi-in-studio-fase-iii-per-pacritinib]]></loc><lastmod>2018-04-24T10:30:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/7362-malattie-mieloproliferative-ph-negative-luso-degli-interferoni-e-limportanza-dei-fattori-genetici]]></loc><lastmod>2018-04-24T10:30:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/7361-patologie-mieloproliferative-croniche-le-novita-terapeutiche-dallaash-di-s-francisco]]></loc><lastmod>2018-04-24T10:30:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/6555-mielofibrosi-negli-usa-procedura-abbreviata-per-il-farmaco-pacritinib]]></loc><lastmod>2017-10-08T18:23:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/5732-mielofibrosi-lfda-sospende-lla-sperimentazione-clinica-del-farmaco-imetelstat]]></loc><lastmod>2017-10-08T18:24:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/5601-mielofibrosi-cell-terapeutics-apre-larruolamento-dello-studio-di-fase-3-per-il-farmaco-pacritinib]]></loc><lastmod>2017-10-08T18:30:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/4609-terapia-con-ruxolitinib-aumenta-la-sopravvivenza-dei-pazienti-con-mielofibrosi]]></loc><lastmod>2017-10-08T18:33:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/3962-mileofibrosi-terapie-sintomatiche-in-attesa-di-scoprirne-i-meccanismi-molecolari]]></loc><lastmod>2017-10-08T23:00:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/2700-mielofibrosi-approvato-in-europa-un-nuovo-trattamento]]></loc><lastmod>2017-10-08T23:02:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/2265-terapia-con-ruxolitinib-per-la-mielofibrosi-efficacia-confermata-da-due-nuovi-studi-clinici]]></loc><lastmod>2017-10-08T23:06:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/2072-mielofibrosi-comitato-ue-approva-ruxolitinib-per-i-pazienti-in-pericolo-di-vita]]></loc><lastmod>2017-10-08T23:10:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/1764-mielofibrosi-ruxolitinib-in-grado-di-contrastare-i-sintomi-della-malattia]]></loc><lastmod>2017-10-08T23:12:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/634-malattie-mieloproliferative-i-farmaci-a-disposizione-non-sono-la-cura-ma-migliorano-la-vita]]></loc><lastmod>2017-10-08T23:21:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/mielofibrosi/159-mielofibrosi-promette-bene-il-nuovo-anti-jak2]]></loc><lastmod>2017-10-08T23:27:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla]]></loc><lastmod>2024-03-13T12:41:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/22708-nuove-prospettive-per-la-leucemia-linfoblastica-acuta-a-cellule-t]]></loc><lastmod>2026-02-03T22:58:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/21336-leucemia-linfoblastica-acuta-neonatale-dimostrata-l-origine-prenatale-e-non-ereditaria-di-una-nuova-alterazione-genetica]]></loc><lastmod>2024-09-30T15:52:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/21232-leucemia-linfoblastica-acuta-agire-sul-microambiente-tumorale-per-combattere-la-malattia]]></loc><lastmod>2024-08-13T15:28:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/20137-leucemia-linfoblastica-acuta-scoperte-alterazioni-genetiche-che-ne-influenzano-l-esito-nei-bimbi-con-sindrome-di-down]]></loc><lastmod>2023-09-18T15:06:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/19356-leucemia-linfoblastica-acuta-nuovo-marcatore-orienta-la-terapia-nei-bambini]]></loc><lastmod>2024-08-13T10:16:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/18876-tumori-ematologici-nei-bambini-due-varianti-di-un-gene-potrebbero-aumentarne-il-rischio]]></loc><lastmod>2022-07-03T20:15:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/18151-leucemia-linfoblastica-acuta-di-tipo-t-decifrato-il-linguaggio-delle-cellule-tumorali]]></loc><lastmod>2022-01-02T14:57:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/17557-leucemia-linfoblastica-acuta-dimostrata-l-efficacia-della-terapia-senza-chemioleucemia-linfoblastica-acuta-dimostrata-l-efficacia-della-terapia-senza-chemio]]></loc><lastmod>2021-06-23T08:02:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/17514-leucemia-linfoblastica-acuta-di-tipo-t-un-anticorpo-sentinella-e-in-grado-di-riconoscere-le-cellule-tumorali]]></loc><lastmod>2021-06-06T20:36:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/16955-leucemia-linfoblastica-acuta-ph-in-sperimentazione-una-nuova-terapia-di-combinazione]]></loc><lastmod>2021-01-31T00:34:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/16868-leucemia-linfoblastica-acuta-due-geni-aiutano-a-prevederne-la-gravita-nei-neonati]]></loc><lastmod>2021-01-07T19:06:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/16658-leucemia-linfoblastica-acuta-verso-una-terapia-chemio-free]]></loc><lastmod>2020-11-09T10:41:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/16529-leucemia-linfoblastica-acuta-aifa-approva-l-estensione-d-uso-di-blinatumomab]]></loc><lastmod>2020-10-04T18:20:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/15394-leucemia-pediatrica-al-via-l-iniziativa-scuola-e-giochi-in-corsia]]></loc><lastmod>2019-11-09T22:56:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/15114-leucemia-lla-e-linfoma-dlbcl-la-terapia-car-t-arriva-in-italia]]></loc><lastmod>2019-08-12T17:40:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/14455-leucemia-linfoblastica-acuta-la-commissione-europea-estende-l-uso-di-blinatumomab]]></loc><lastmod>2019-02-13T14:11:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/14292-leucemia-linfoblastica-acuta-ph-da-un-nuovo-studio-clinico-una-speranza-di-guarigione]]></loc><lastmod>2018-12-17T18:10:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/14032-leucemia-linfoblastica-acuta-inotuzumab-ozogamicin-disponibile-in-italia]]></loc><lastmod>2018-10-14T17:03:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/13932-leucemia-linfoblastica-acuta-blinatumomab-approvato-in-europa-per-pazienti-pediatrici]]></loc><lastmod>2018-09-17T20:05:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/13868-leucemia-linfoblastica-acuta-la-terapia-car-t-arriva-anche-in-europa]]></loc><lastmod>2019-01-17T15:36:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/13313-leucemia-lla-analizzando-le-cellule-tumorali-si-riuscirebbe-a-stimare-il-rischio-di-ricaduta]]></loc><lastmod>2018-03-06T17:55:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/13190-leucemia-linfoblastica-acuta-piccolo-paziente-curato-al-bambino-gesu-con-terapia-car-t]]></loc><lastmod>2018-02-04T23:30:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/13189-leucemia-linfoblastica-acuta-pubblicati-i-risultati-clinici-di-tisagenlecleucel]]></loc><lastmod>2018-02-04T23:43:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/12941-leucemia-linfoblastica-acuta-pegaspargasi-disponibile-in-italia-da-gennaio-2018]]></loc><lastmod>2017-11-24T18:10:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/12517-leucemia-linfoblastica-acuta-risultati-positivi-dalla-pegasparaginasi]]></loc><lastmod>2017-07-20T14:07:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/12159-leucemia-linfoblastica-acuta-arriva-in-italia-blinatumomab-anticorpo-bispecifico-che-neutralizza-le-cellule-maligne]]></loc><lastmod>2017-04-06T08:18:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/11146-leucemia-linfoblastica-acuta-pediatrica-il-desametasone-e-piu-efficace-del-prednisone-contro-le-recidive]]></loc><lastmod>2016-08-26T12:51:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/10486-leucemia-linfoblastica-acuta-buoni-risultati-per-blinatumomab]]></loc><lastmod>2016-04-29T07:55:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/9882-leucemia-linfoblastica-acuta-risultati-promettenti-da-rituximab-combinato-a-chemio]]></loc><lastmod>2016-02-02T11:06:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/9811-leucemia-linfoblastica-acuta-peg-asparaginasi-approvato-in-europa]]></loc><lastmod>2016-01-25T08:56:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/9421-leucemia-linfoblastica-acuta-parere-favorevole-dell-ema-per-l-uso-di-oncospar-in-terapia-combinata]]></loc><lastmod>2015-11-30T09:38:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/9104-leucemia-linfoblastica-acuta-parere-favorevole-del-chmp-per-blinatumomab]]></loc><lastmod>2015-10-12T12:41:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/8726-leucemia-linfoblastica-acuta-baxalta-conclude-l-acquisto-del-farmaco-oncaspar]]></loc><lastmod>2015-11-30T09:41:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/8347-leucemia-linfoblastica-acuta-sicuro-il-trattamento-con-blinatumomab]]></loc><lastmod>2015-05-29T09:57:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/8295-leucemia-linfoblastica-acuta-esiti-incoraggianti-per-i-bambini-trattati-con-immunoterapia-ctl019]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/8304-leucemia-linfoblastica-acuta-baxter-acquista-il-farmaco-oncaspar-di-sigma-tau]]></loc><lastmod>2015-05-28T08:46:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/7604-leucemia-linfoblastica-acuta-ottimi-risultati-per-limmunoterapia-cellulare-ctl019-su-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/7291-leucemia-linfoblastica-acuta-lfda-approva-blinatumomab]]></loc><lastmod>2019-02-13T14:15:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/7026-leucemia-linfoblastica-acuta-pubblicati-su-the-lancet-i-risultati-dellimmunoterapia-cellulare-anti-cd19]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/6990-leucemia-linfoblastica-acuta-non-colpisce-solo-i-bambini-e-puo-essere-trattata-con-la-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/6925-leucemia-linfoblastica-acuta-remissione-completa-con-la-terapia-ctl019]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/6438-leucemia-linfatica-cronica-ue-autorizza-uso-ofatumumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/6284-leucemia-linfoblastica-acuta-scoperto-nuovo-possibile-bersaglio-per-le-cellule-resistenti-alla-chemio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/6152-leucemia-linfoblastica-acuta-scoperto-nuovo-bersaglio-nelle-cellule-resistenti-alla-chemioterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/5856-leucemia-linfoblastica-acuta-negli-adulti-il-tasso-di-sopravvivenza-negli-ultimi-anni-e-aumentato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/5689-leucemia-linfoblastica-acuta-risultati-promettenti-nellimmunoterapia-cellulare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/3832-leucemia-linfoblastica-acuta-grande-successo-per-una-terapia-sperimentale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/3639-leucemia-linfoblastica-acuta-scoperto-il-punto-debole-del-tumore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/3521-leucemia-linfoblastica-acuta-ulteriori-conferme-per-vincristina-liposomiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/3424-leucemia-linfoblastica-acuta-un-nuovo-farmaco-da-recordati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/3416-leucemia-linfoblastica-acuta-la-causa-potrebbe-essere-in-un-difetto-genetico-ereditario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/3239-leucemia-linfoblastica-acuta-presto-disponibile-un-nuovo-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/2660-leucemia-linfoblastica-acuta-vincristina-liposomiale-approvata-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/2211-leucemia-linfoblastica-acuta-lla-approvato-in-ue-il-mercaptopurine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/1766-leucemia-linfoblastica-acuta-linattivazione-epigenetica-di-twist2-puo-aggravare-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/552-leucemia-linfoblastica-acuta-status-orfano-per-un-farmaco-che-rompe-le-cellule-tumorali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/419-leucemia-linfoblastica-acuta-nuove-conferme-per-limatinib]]></loc><lastmod>2019-02-13T19:48:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/208-leucemia-linfoide-acuta-individuate-mutazioni-che-caratterizzano-le-forme-piu-resistenti-alle-cure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/200-leucemia-linfoblastica-il-meyer-al-centro-di-uno-studio-internazionale-porte-aperte-per-i-trial-sui-farmaci-intelligenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfoblastica-acuta-lla/199-leucemia-linfoblastica-acuta-ricerca-internazionale-guidata-dal-meyer-fa-il-punto-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica]]></loc><lastmod>2024-03-13T12:41:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/22571-leucemia-mieloide-cronica-asciminib-approvato-in-europa-anche-per-i-pazienti-di-nuova-diagnosi]]></loc><lastmod>2025-12-01T17:33:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/21899-leucemia-mieloide-cronica-da-due-nuove-indagini-emerge-il-racconto-di-una-malattia-non-ancora-risolta]]></loc><lastmod>2025-04-13T11:29:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/21588-leucemia-mieloide-cronica-nuovi-dati-a-lungo-termine-avvalorano-l-efficacia-di-asciminib]]></loc><lastmod>2024-12-18T09:07:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/19109-leucemia-mieloide-cronica-un-cortometraggio-per-conoscerla-e-non-temerla]]></loc><lastmod>2022-09-24T19:51:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/16785-leucemia-mieloide-cronica-cml-percorso-di-vita-e-claude-vincono-il-cml-innovation-hub]]></loc><lastmod>2020-12-08T22:19:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/11728-leucemia-mieloide-cronica-identificate-cellule-staminali-leucemiche-nel-sangue-dei-pazienti]]></loc><lastmod>2016-12-16T17:08:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/11687-leucemia-mieloide-cronica-studi-sulla-proteina-gab2-aprono-a-nuove-alternative-terapeutiche]]></loc><lastmod>2024-08-13T15:37:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/10740-leucemia-mieloide-cronica-alcune-mutazioni-influenzano-la-risposta-a-ponatinib]]></loc><lastmod>2016-06-03T10:16:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/10154-leucemia-mieloide-cronica-radotinib-migliore-di-imatinib-in-studio-di-fase-iii]]></loc><lastmod>2016-03-09T15:20:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/9750-leucemia-mieloide-cronica-sopravvivenza-globale-migliore-con-ponatinib-rispetto-a-trapianto-di-staminali]]></loc><lastmod>2016-01-15T11:42:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/9560-leucemia-mieloide-cronica-ariad-annuncia-studio-di-fase-3-su-ponatinib]]></loc><lastmod>2015-12-10T12:21:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/9490-leucemia-mieloide-cronica-gli-esiti-del-trapianto-di-staminali-sono-paragonabili-a-quelli-dei-farmaci]]></loc><lastmod>2015-12-01T13:59:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/9299-leucemia-mieloide-cronica-con-il-progetto-euriclea-nasce-una-nuova-figura-d-infermieri-specializzati]]></loc><lastmod>2015-11-06T08:48:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/9225-leucemia-mieloide-cronica-ok-a-trattamento-intermittente-con-imatinib-nell-anziano]]></loc><lastmod>2015-10-26T10:27:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/9224-leucemia-mieloide-cronica-l-uso-di-ponatinib-e-la-sicurezza-cardiovascolare]]></loc><lastmod>2015-10-26T10:08:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/8649-leucemia-mieloide-cronica-un-progetto-per-predire-le-mutazioni-genetiche]]></loc><lastmod>2015-07-22T07:40:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/8554-leucemia-mieloide-acuta-un-lipide-estratto-dall-avocado-potrebbe-aiutare-a-combatterla]]></loc><lastmod>2015-07-02T13:42:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/7918-leucemia-mieloide-cronica-e-leucemia-linfoblastica-acuta-de-filippo-garantisce-su-accesso-a-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/7659-leucemia-mieloide-cronica-e-leucemia-linfatica-acuta-axitinib-nuova-possibile-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/7459-leucemia-mieloide-cronica-e-leucemia-linfoblastica-acuta-ottenuta-approvazione-ema-per-il-farmaco-ponatinib]]></loc><lastmod>2024-08-13T10:27:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/7359-leucemina-mieloide-cronica-entro-la-meta-del-2015-avvio-della-sperimentazione-su-iclusig]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/6441-leucemia-mieloide-acuta-recidivatarefrattaria-nessun-beneficio-da-elacitarabina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/5187-leucemia-mieloide-cronica-dasatinib-sembra-dimostrarsi-superiore-a-imatinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/4732-leucemia-mieloide-cronica-la-terapia-con-imatinib-puo-essere-interrotta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/3881-leucemia-mieloide-cronica-la-commissione-europea-approva-il-trattamento-con-bosutinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/3462-leucemia-mieloide-cronica-approvato-il-trattamento-con-ponatinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/3365-leucemia-mieloide-cronica-un-nuovo-farmaco-sperimentale-sembra-funzionare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/1308-leucemia-mieloide-cronica-a-ferrara-ora-ce-un-sequenziatore-genomico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/267-leucemia-mieloide-cronica-scoperta-la-mutazione-che-fa-fallire-la-chemioterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/246-leucemia-mieloide-cronica-il-farmaco-intelligente-imatinib-potrebbe-proteggere-dalle-ricadute-anche-dopo-due-anni-e-prendersi-una-vacanza-dal-farmaco-non-genera-resistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-mieloide-cronica/240-leucemia-mieloide-cronica-il-dasanitib-potra-essere-usato-anche-nella-fase-iniziale-di-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica]]></loc><lastmod>2024-03-13T12:42:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/20809-leucemia-linfatica-cronica-la-dieta-mima-digiuno-abbinata-ai-farmaci-puo-contribuire-alla-regressione-tumorale]]></loc><lastmod>2024-03-27T16:53:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/20408-leucemia-linfatica-cronica-e-linfoma-della-zona-marginale-aifa-approva-zanubrutinib]]></loc><lastmod>2023-12-04T11:40:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/20225-long-covid-nei-pazienti-affetti-da-leucemia-linfatica-cronica-le-nuove-evidenze-scientifiche]]></loc><lastmod>2023-10-14T11:02:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/20179-leucemia-linfatica-cronica-al-via-faccia-a-faccia-con-la-llc]]></loc><lastmod>2023-10-02T11:24:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/18574-leucemia-linfatica-cronica-individuati-i-marcatori-associati-al-rischio-di-sviluppo-di-sindrome-di-richter]]></loc><lastmod>2022-04-24T18:56:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/18131-malattie-oncoematologiche-da-fondazione-quattropani-un-servizio-di-medical-coaching-per-i-pazienti]]></loc><lastmod>2021-12-24T12:00:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/17423-leucemia-linfatica-cronica-con-venetoclax-piu-rituximab-miglioramenti-nella-qualita-di-vita]]></loc><lastmod>2021-05-11T15:59:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/16354-leucemia-linfatica-cronica-chmp-dice-si-all-estensione-d-indicazione-per-ibrutinib-piu-rituximab]]></loc><lastmod>2020-08-02T15:44:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/16201-leucemia-linfatica-cronica-confermati-i-benefici-della-terapia-con-venetoclax-piu-rituximab]]></loc><lastmod>2020-06-21T19:40:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/15915-leucemia-linfatica-cronica-approvazione-europea-per-venetoclax-in-combinazione-con-obinutuzumab]]></loc><lastmod>2020-04-06T17:56:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/15555-leucemia-linfatica-cronica-aifa-concede-rimborsabilita-a-venetoclax-in-combinazione-con-rituximab]]></loc><lastmod>2020-01-07T16:05:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/14438-leucemia-linfatica-cronica-il-nice-inglese-raccomanda-venetoclax-in-combinazione-con-rituximab]]></loc><lastmod>2019-02-07T21:15:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/12646-leucemia-linfatica-cronica-venetoclax-ottiene-la-rimborsabilita-da-aifa]]></loc><lastmod>2018-03-15T03:06:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/11718-leucemia-linfatica-cronica-approvato-in-europa-il-farmaco-orale-venetoclax]]></loc><lastmod>2016-12-12T18:19:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/11497-leucemia-linfatica-cronica-chmp-raccomanda-venetoclax-per-pazienti-difficili-da-trattare]]></loc><lastmod>2016-10-20T12:33:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/10153-leucemia-linfatica-cronica-approvato-da-fda-ibrutinib]]></loc><lastmod>2020-07-31T14:24:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/10048-leucemia-linfatica-cronica-nuova-terapia-a-base-di-macrofagi]]></loc><lastmod>2016-02-26T11:30:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/9885-leucemia-linfatica-cronica-avviato-studio-di-fase-iii-su-combinazione-ibrutinib-e-ublituximab]]></loc><lastmod>2016-02-02T11:14:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/9884-leucemia-linfatica-cronica-arriva-il-nuovo-e-promettente-inibitore-acalabrutinib]]></loc><lastmod>2016-02-02T11:11:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/9771-leucemia-linfatica-cronica-e-linfoma-mantellare-anche-in-italia-e-arrivato-ibrutinib]]></loc><lastmod>2016-01-19T16:44:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/9754-leucemia-linfatica-cronica-risultati-positivi-da-ibrutinib-su-pazienti-anziani]]></loc><lastmod>2016-01-15T12:57:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/9545-leucemia-linfatica-cronica-le-nuove-terapie-emergenti]]></loc><lastmod>2015-12-07T10:21:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/9542-leucemia-arriva-in-italia-ibrutinib-terapia-orale-alternativa-alla-chemio]]></loc><lastmod>2015-12-07T09:49:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/9258-leucemia-linfatica-cronica-risposta-duratura-con-ibrutinib-in-monoterapia]]></loc><lastmod>2015-10-29T16:37:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/9108-leucemia-linfatica-cronica-e-linfoma-follicolare-disponibile-nuovo-antitumorale-idelalisib]]></loc><lastmod>2015-10-12T13:24:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/8234-leucemia-linfatica-cronica-venetoclax-ottiene-da-fda-designazione-di-terapia-fortemente-innovativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/8130-leucemia-linfocitica-cronica-novartis-presenta-gli-ultimi-risultati-positivi-sulla-combinazione-ofatumumab-clorambucile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/7840-leucemia-linfatica-cronica-scoperti-fattori-legati-allinterruzione-della-terapia-con-ibrutinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/7556-leucemia-linfatica-cronica-scoperta-la-causa-delle-recidive-dopo-il-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/7387-leucemia-linfatica-cronica-nuovo-studio-presentato-al-congresso-ash]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/6809-leucemia-linfatica-cronica-e-linfoma-follicolare-nuova-approvazione-per-il-farmaco-idelalisib-di-gilead]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/6534-leucemia-linfatica-cronica-e-linfoma-mantellare-ema-approva-ibrutinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/6463-leucemia-linfatica-cronica-enalidomide-e-rituximab-in-fase-ii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/6307-leucemia-linfatica-cronica-ibrutinib-superiore-rispetto-a-ofatumumab-nella-terapia-di-seconda-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/6212-leucemia-linfatica-cronica-parere-chmp-positivo-per-obinutuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/5982-leucemia-linfatica-cronica-fda-approva-ofatumumab-come-terapia-di-prima-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/5799-leucemia-linfatica-cronica-limportanza-dindividuare-le-caratteristiche-cliniche-e-biologiche-nel-singolo-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/5484-leucemia-linfatica-cronica-gli-anticorpi-anti-cd20-approvati-dalla-food-and-drug-administration]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/5497-leucemia-linfatica-cronica-fda-approva-ibrutinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/5377-leucemia-linfatica-cronica-obinutuzumab-e-rituximab-a-confronto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/5347-leucemia-linfatica-cronica-nuove-prospettive-dal-farmaco-otlertuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/5196-leucemia-linfatica-cronica-il-trattamento-con-obinutuzumab-allunga-il-periodo-di-sopravvivenza-di-un-anno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/5195-leucemia-linfatica-cronica-conferme-per-il-farmaco-ibrutinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/5193-leucemia-linfoblastica-acuta-e-leucemia-linfatica-cronica-esiti-incoraggianti-da-una-nuova-terapia-sperimentale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/5184-leucemia-linfatica-cronica-nuova-strategia-terapeutica-basata-sulluso-del-complesso-bendamustina-rituximab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/4390-leucemia-linfocitica-cronica-celgene-interrompe-lo-studio-con-lenalidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/3288-leucemia-maggiore-rischio-per-i-lavoratori-che-hanno-ripulito-chernobyl]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/2030-leucemia-linfatica-cronica-il-citomegalovirus-potrebbe-esserne-la-causa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/1274-leucemia-linfatica-cronica-arriva-ofatumumab-nuova-arma-contro-i-casi-resistenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/leucemia-linfatica-cronica-che-cos-e]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/leucemia-linfatica-cronica/486-leucemia-linfocitica-cronica-llc-lunga-sopravvivenza-grazie-a-rituximab-e-fludarabine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t]]></loc><lastmod>2026-02-02T10:47:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/22752-linfoma-cutaneo-a-cellule-t-il-valore-della-radioterapia-per-ridurre-le-lesioni-della-cute]]></loc><lastmod>2026-02-17T08:51:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/21665-linfoma-cutaneo-a-cellule-t-un-tumore-multiforme-che-rende-complessa-la-diagnosi]]></loc><lastmod>2025-01-28T17:43:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/20977-linfoma-cutaneo-a-cellule-t-arrivera-anche-la-terapia-con-car-t]]></loc><lastmod>2024-05-15T15:24:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/20888-linfoma-cutaneo-a-cellule-t-presentati-i-primi-risultati-dello-studio-prosper-su-mogalizumab]]></loc><lastmod>2024-04-19T14:46:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/20593-linfoma-cutaneo-a-cellule-t-il-rischio-di-sepsi-sembra-essere-piu-alto-nei-pazienti-afroamericani]]></loc><lastmod>2024-02-06T08:25:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/20294-linfoma-cutaneo-a-cellule-t-il-ruolo-chiave-dell-anatomo-patologo-nella-diagnosi-di-malattia]]></loc><lastmod>2023-11-06T20:24:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/19503-linfoma-cutaneo-a-cellule-t-un-video-spiega-cosa-significhi-affrontare-una-diagnosi-di-tumore-raro]]></loc><lastmod>2023-02-03T18:35:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/19352-linfoma-cutaneo-a-cellule-t-il-prurito-alla-pelle-puo-essere-un-indicatore-della-qualita-di-vita]]></loc><lastmod>2022-12-02T17:49:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/17783-linfoma-cutaneo-a-cellule-t-fino-a-7-anni-per-una-diagnosi-corretta]]></loc><lastmod>2021-09-16T10:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/17611-linfoma-cutaneo-a-cellule-t-con-mogamulizumab-migliore-qualita-di-vita-nei-pazienti-con-coinvolgimento-del-sangue]]></loc><lastmod>2021-07-03T14:49:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/16803-linfoma-cutaneo-a-cellule-t-mogamulizumab-rimborsabile-in-italia]]></loc><lastmod>2020-12-13T21:56:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/16610-linfoma-cutaneo-a-cellule-t-nuove-conferme-di-efficacia-per-mogamulizumab]]></loc><lastmod>2020-10-24T11:14:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/16581-linfoma-cutaneo-a-cellule-t-la-gestione-dei-pazienti-in-emergenza-covid-19]]></loc><lastmod>2020-10-18T22:42:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/16311-linfomi-cutanei-necessario-un-percorso-diagnostico-e-terapeutico-multidisciplinare]]></loc><lastmod>2020-07-20T10:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/16206-linfoma-cutaneo-a-cellule-t-mogamulizumab-in-commercio-in-europa]]></loc><lastmod>2020-06-21T21:23:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/15471-linfoma-cutaneo-a-cellule-t-le-terapie-cambiano-a-seconda-delle-forme-di-malattia]]></loc><lastmod>2019-12-02T12:48:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/15452-linfoma-cutaneo-a-cellule-t-aifa-autorizza-la-rimborsabilita-di-brentuximab-vedotin]]></loc><lastmod>2019-11-26T15:52:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/15285-linfoma-cutaneo-a-cellule-t-a-brescia-un-ambulatorio-che-unisce-ematologia-e-dermatologia]]></loc><lastmod>2019-10-08T18:07:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/15246-linfoma-cutaneo-a-cellule-t-come-distinguerlo-da-una-semplice-dermatite]]></loc><lastmod>2019-09-30T19:34:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/14223-linfoma-cutaneo-a-cellule-t-approvazione-europea-per-mogamulizumab]]></loc><lastmod>2019-06-14T18:18:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/13162-linfoma-cutaneo-a-cellule-t-la-commissione-europea-approva-brentuximab-vedotin]]></loc><lastmod>2019-06-14T18:18:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/12953-linfoma-cutaneo-a-cellule-t-opinione-positiva-del-chmp-per-brentuximab-vedotin]]></loc><lastmod>2019-05-21T15:55:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/5872-linfoma-cutaneo-a-cellule-t-resiquimod-efficace-sulle-lesioni]]></loc><lastmod>2019-05-21T16:11:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-cutaneo-a-cellule-t/3333-linfomi-a-cellule-t-approvato-in-usa-il-nuovo-farmaco-orfano-adcetris]]></loc><lastmod>2019-05-21T16:24:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile]]></loc><lastmod>2026-01-12T16:37:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18992-emangioma-infantile-i-genitori-devono-poter-disporre-di-informazioni-chiare-e-affidabili]]></loc><lastmod>2022-08-10T14:58:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18955-emangioma-infantile-fondamentale-individuare-i-centri-di-riferimento-presenti-sul-territorio]]></loc><lastmod>2022-07-24T17:45:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18950-emangioma-infantile-un-modello-di-organizzazione-per-la-corretta-presa-in-carico-del-paziente]]></loc><lastmod>2022-07-24T15:31:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18927-emangioma-infantile-se-necessario-il-paziente-va-inviato-al-centro-di-riferimento-gia-nel-primo-mese-di-vita]]></loc><lastmod>2022-07-16T21:04:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18907-emangioma-infantile-la-chiave-e-una-diagnosi-accurata]]></loc><lastmod>2022-07-09T21:47:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18836-emangioma-infantile-a-volte-e-la-manifestazione-di-una-sindrome-piu-grave]]></loc><lastmod>2022-06-25T15:08:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18708-emangiomi-infantili-un-pediatra-adeguatamente-formato-puo-prendere-decisioni-giuste-e-tempestive]]></loc><lastmod>2022-05-30T11:05:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18593-emangiomi-infantili-in-circa-il-15-dei-casi-necessitano-di-opportune-terapie]]></loc><lastmod>2022-05-17T14:48:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18471-emangioma-infantile-fondamentale-che-il-pediatra-sappia-valutare-questo-tumore-benigno]]></loc><lastmod>2022-04-01T17:02:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18297-emangiomi-infantili-una-diagnosi-tempestiva-massimizza-i-benefici-di-un-eventuale-trattamento]]></loc><lastmod>2022-02-13T16:18:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18262-emangiomi-infantili-al-via-la-campagna-di-sensibilizzazione-con-influencer-e-mamme-blogger]]></loc><lastmod>2022-03-14T16:19:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/18231-emangioma-infantile-una-neoplasia-benigna-da-saper-riconoscere-e-gestire]]></loc><lastmod>2022-01-31T12:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/10432-emangiomi-infantili-l-importanza-della-sinergia-e-della-diagnosi-precoce]]></loc><lastmod>2021-10-11T11:19:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/10296-emangiomi-infantili-online-un-nuovo-sito-di-supporto-ai-genitori]]></loc><lastmod>2021-10-11T11:20:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/9895-emangioma-infantile-uso-improprio-della-terminologia-aumenta-rischio-di-diagnosi-errata]]></loc><lastmod>2021-10-11T11:21:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/9381-emangioma-infantile-presto-anche-in-italia-il-primo-farmaco-destinato-ai-bambini]]></loc><lastmod>2021-10-11T11:21:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/8527-emangiomi-infantili-arrivano-le-prime-raccomandazioni-europee]]></loc><lastmod>2021-10-11T11:22:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/8457-emangioma-infantile-necessaria-una-rete-nazionale-di-centri-plurispecialistici]]></loc><lastmod>2021-10-11T11:23:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/emangioma-infantile/5614-emangiomi-infantili-ok-del-chmp-per-il-propranololo]]></loc><lastmod>2021-10-11T11:24:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche]]></loc><lastmod>2025-03-04T11:06:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche/21686-neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche-la-diagnosi-e-frutto-di-un-lavoro-di-squadra]]></loc><lastmod>2025-02-03T17:31:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche/21613-neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche-il-trapianto-di-midollo-e-l-obiettivo-per-guarire]]></loc><lastmod>2025-01-09T14:52:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche/21600-neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche-un-intervento-tempestivo-puo-fare-la-differenza]]></loc><lastmod>2024-12-20T11:51:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche/21553-neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche-la-diagnosi-ha-inizio-dalle-lesioni-della-cute]]></loc><lastmod>2024-12-02T18:20:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche/21501-neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche-promuovere-la-conoscenza-della-patologia-serve-a-non-far-sentire-isolato-chi-ne-e-affetto]]></loc><lastmod>2024-11-18T17:37:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche/21307-neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche-un-nuovo-farmaco-mirato-aiuta-a-definire-lo-schema-terapeutico]]></loc><lastmod>2024-09-25T11:30:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche/21191-neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche-un-tumore-ematologico-raro-e-aggressivo]]></loc><lastmod>2024-11-19T10:06:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche/16951-neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche-approvazione-europea-per-tagraxofusp]]></loc><lastmod>2024-06-05T14:37:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b]]></loc><lastmod>2024-10-16T10:44:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/22679-linfoma-diffuso-a-grandi-cellule-b-il-recettore-bcr-influisce-sullaggressivita-del-tumore]]></loc><lastmod>2026-01-20T18:01:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/22452-linfoma-diffuso-a-grandi-cellule-b-la-stadiazione-e-una-tappa-indispensabile-nel-percorso-di-cura]]></loc><lastmod>2025-10-28T15:22:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/21813-linfoma-diffuso-a-grandi-cellule-b-prospettive-di-cura-migliorate-grazie-alla-ricerca]]></loc><lastmod>2025-03-17T09:38:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/21445-linfomi-al-via-il-progetto-ridefiniamo-l-inclusione-il-focus-group-dedicato-il-7-novembre-2024]]></loc><lastmod>2024-11-08T17:55:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/21351-linfoma-diffuso-a-grandi-cellule-b-aifa-approva-la-rimborsabilita-di-epcoritamab]]></loc><lastmod>2024-10-16T10:35:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/20799-thebigb-una-performance-artistica-per-sensibilizzare-sul-linfoma-a-grandi-cellule-b-dlcbl]]></loc><lastmod>2024-10-16T12:14:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/20779-linfoma-diffuso-a-grandi-cellule-b-disponibile-in-italia-loncastuximab-tesirine]]></loc><lastmod>2024-10-16T10:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/20622-linfoma-diffuso-a-grandi-cellule-b-polatuzumab-approvato-in-italia-come-trattamento-di-prima-linea]]></loc><lastmod>2024-10-16T10:46:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/20010-linfoma-diffuso-a-grandi-cellule-b-approvazione-europea-per-glofitamab]]></loc><lastmod>2024-10-16T10:49:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/19332-linfoma-diffuso-a-grandi-cellule-b-via-libera-di-aifa-al-rimborso-di-tafasitamab]]></loc><lastmod>2024-10-16T10:52:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/18200-linfoma-diffuso-a-grandi-cellule-b-polatuzumab-vedotin-rimborsabile-in-italia]]></loc><lastmod>2024-10-16T10:55:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/17728-linfoma-diffuso-a-grandi-cellule-b-approvazione-europea-per-tafasitamab]]></loc><lastmod>2024-10-16T11:00:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/17680-linfomi-a-cellule-b-da-uno-studio-italiano-una-potenziale-nuova-terapia]]></loc><lastmod>2024-10-16T15:07:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/17206-linfomi-pubblicato-uno-studio-fil-sul-primo-indice-prognostico-per-pazienti-anziani]]></loc><lastmod>2024-10-16T15:42:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/16806-linfoma-diffuso-a-grandi-cellule-b-nuovi-dati-a-supporto-di-polatuzumab-vedotin-piu-bendamustina-e-rituximab]]></loc><lastmod>2024-10-16T11:52:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/15553-linfoma-non-hodgkin-da-uno-studio-fil-un-nuovo-approccio-terapeutico-per-pazienti-anziani]]></loc><lastmod>2024-10-16T16:14:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/14242-linfoma-diffuso-a-grandi-cellule-b-benefici-duraturi-dalla-terapia-con-polatuzumab-vedotin]]></loc><lastmod>2024-10-16T11:55:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/13871-linfoma-a-grandi-cellule-b-approvazione-europea-per-la-terapia-car-t]]></loc><lastmod>2024-10-16T12:18:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/13740-leucemia-lla-e-linfoma-dlbcl-parere-positivo-del-chmp-per-tisagenlecleucel]]></loc><lastmod>2024-10-16T15:49:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/13117-linfoma-buoni-risultati-dal-trattamento-con-le-car-t-cells-liso-cel]]></loc><lastmod>2024-10-16T15:15:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/11063-linfoma-diffuso-a-grandi-cellule-b-dati-di-parziale-efficacia-per-il-farmaco-lenalidomide]]></loc><lastmod>2024-10-16T11:58:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/10049-linfoma-a-grandi-cellule-b-efficace-terapia-con-blinatumomab]]></loc><lastmod>2024-10-16T12:22:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/6730-linfoma-diffuso-a-grandi-cellule-b-una-carenza-di-vitamina-d-interferisce-con-lazione-del-rituximab]]></loc><lastmod>2024-10-16T12:03:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/6728-linfoma-diffuso-a-grandi-cellule-b-risultati-promettenti-per-lenalidomide-in-aggiunta-al-regime-r-chop]]></loc><lastmod>2024-10-16T12:05:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/6578-linforma-diffuso-a-grandi-cellule-b-studio-italiano-indaga-sulla-dose-massima-tollerata]]></loc><lastmod>2024-10-16T12:11:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/linfoma-diffuso-a-grandi-cellule-b/5132-linfoma-diffuso-a-cellule-b-tre-studi-con-lenalidomide]]></loc><lastmod>2024-10-16T14:59:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/8525-tumori-cutanei-pierpaolo-vargiu-prevenzione-e-diagnosi-precoce-portano-benefici-per-tutti]]></loc><lastmod>2015-06-26T10:40:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-tumori-rari/8517-carcinoma-gastrico-rilotumumab-non-ne-migliorerebbe-la-sopravvivenza]]></loc><lastmod>2015-06-26T09:42:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22952-malattie-cardio-cerebrovascolari-nasce-cardio-hub-il-laboratorio-per-migliorare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2026-04-22T17:28:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22951-deficit-di-proteina-c-neonata-salvata-al-gaslini-grazie-ad-un-approccio-allavanguardia]]></loc><lastmod>2026-04-20T15:26:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22945-malattie-rare-al-via-la-nuova-edizione-del-corso-di-formazione-sulla-nomenclatura-di-orphanet]]></loc><lastmod>2026-04-17T09:37:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22944-malattie-rare-implementati-al-gaslini-i-pdta-per-le-sindromi-seu-e-vod]]></loc><lastmod>2026-04-17T09:01:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22936-malattie-rare-arriva-argo-22-indicatori-per-abbattere-del-60-i-tempi-della-diagnosi]]></loc><lastmod>2026-04-15T09:16:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22938-covid-19-la-pandemia-e-il-lockdown-hanno-compromesso-le-funzioni-esecutive-nei-bambini]]></loc><lastmod>2026-04-16T07:33:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22935-farmacogenetica-in-italia-test-diffusi-ma-accesso-disomogeneo]]></loc><lastmod>2026-04-15T09:45:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22928-sindrome-della-persona-rigida-il-ritorno-di-celine-dion-passa-da-parigi-e-dalle-sue-canzoni]]></loc><lastmod>2026-04-13T17:31:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22924-malattie-immunologiche-rare-nasce-a-brescia-lambulatorio-pediatrico-marin]]></loc><lastmod>2026-04-10T11:06:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22906-test-farmacogenetici-e-chemioterapia-prevedere-gli-effetti-collaterali-prima-di-iniziare-la-cura]]></loc><lastmod>2026-04-09T15:32:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22904-malattia-igg4-correlata-un-camaleonte-che-inganna-tutti]]></loc><lastmod>2026-04-01T17:50:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22901-trasporto-aereo-e-disabilita-formazione-tecnologia-e-intermodalita-per-un-sistema-piu-accessibile]]></loc><lastmod>2026-04-01T17:06:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22893-farmacogenetica-uno-degli-strumenti-chiave-della-medicina-personalizzata]]></loc><lastmod>2026-04-01T12:45:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22894-tubercolosi-una-malattia-antica-ancora-da-sconfiggere]]></loc><lastmod>2026-03-30T16:08:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22891-aifa-semplifica-le-procedure-per-la-rimborsabilita-dei-farmaci]]></loc><lastmod>2026-03-30T16:10:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22883-ho-scelto-me-la-canzone-di-mamma-sara-per-la-piccola-diana-affetta-da-xia-gibbs]]></loc><lastmod>2026-03-27T18:47:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22885-sindrome-di-xia-gibbs-una-patologia-del-neurosviluppo-che-conta-circa-530-casi-nel-mondo]]></loc><lastmod>2026-03-27T18:49:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22882-influenza-aviaria-un-caso-umano-in-lombardia-e-il-primo-in-europa]]></loc><lastmod>2026-03-26T16:53:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22876-interventi-assistiti-con-animali-il-piemonte-ha-una-commissione-per-garantire-la-qualita]]></loc><lastmod>2026-03-26T10:28:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22874-oltre-lo-schermo-il-progetto-che-promuove-un-uso-sano-di-smartphone-e-tablet-da-parte-dei-piu-giovani]]></loc><lastmod>2026-03-25T19:28:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22871-malattie-epatiche-in-crescita-tra-le-cause-labuso-di-alcol-e-le-alterazioni-metaboliche]]></loc><lastmod>2026-03-25T19:26:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22873-testo-unico-malattie-rare-chieste-tempistiche-certe-per-i-decreti-mancanti]]></loc><lastmod>2026-03-25T15:25:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22859-caregiver-familiari-in-sardegna-nessun-passo-avanti-sulla-legge-regionale-n-12-2023]]></loc><lastmod>2026-03-20T19:01:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22865-paralisi-sopranucleare-progressiva-una-malattia-rara-tra-parkinson-e-demenza]]></loc><lastmod>2026-03-23T18:05:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22863-jasmine-operata-a-soli-40-giorni-di-vita-e-salvata-da-un-raro-tumore-al-fegato]]></loc><lastmod>2026-03-23T18:07:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22855-pisa-festeggia-i-mille-impianti-cocleari-tecnologia-cura-e-presa-in-carico-a-vita]]></loc><lastmod>2026-03-18T17:03:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22850-malattie-neuromuscolari-il-21-marzo-ricorre-la-ix-giornata-nazionale]]></loc><lastmod>2026-03-17T18:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22846-disabilita-coordown-lancia-la-campagna-just-evolve-contro-il-linguaggio-abilista]]></loc><lastmod>2026-03-16T09:28:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22842-malattie-rare-in-abruzzo-una-delibera-per-riorganizzare-la-rete-e-garantire-cure-continue]]></loc><lastmod>2026-03-13T17:21:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22845-paralimpiadi-milano-cortina-2026-giacomo-bertagnolli-ottiene-5-medaglie-nello-sci-alpino]]></loc><lastmod>2026-03-15T13:24:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22840-al-prof-eugenio-mercuri-il-premio-di-teoria-e-tecnica-della-medicina]]></loc><lastmod>2026-03-13T13:23:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22837-barriere-architettoniche-litalia-resta-indietro]]></loc><lastmod>2026-03-11T19:02:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22835-lo-chiamava-rock-roll-al-cinema-si-parla-di-inclusione-e-accessibilita]]></loc><lastmod>2026-03-11T19:01:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22839-addio-a-enrica-bonaccorti-volto-storico-della-televisione-italiana-aveva-un-tumore-al-pancreas]]></loc><lastmod>2026-03-12T12:40:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22827-vi-racconto-una-storia-al-via-il-concorso-dedicato-a-poesie-e-racconti-sulle-malattie-rare]]></loc><lastmod>2026-03-11T19:00:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22824-rarementi-2026-a-sorrento-un-confronto-multidisciplinare-sulle-malattie-rare]]></loc><lastmod>2026-03-09T17:35:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22821-la-cardiologia-mondiale-parla-italiano]]></loc><lastmod>2026-03-06T11:18:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22822-dalla-guerra-in-iraq-alla-neve-delle-dolomiti-la-sfida-paralimpica-di-marco-pisani]]></loc><lastmod>2026-03-06T11:18:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22820-paralimpiadi-invernali-2026-le-malattie-rare-nelle-storie-degli-atleti-italiani-di-milano-cortina]]></loc><lastmod>2026-03-05T10:12:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22819-sindrome-chops-37-casi-in-tutto-il-mondo-e-una-famiglia-italiana-in-prima-linea]]></loc><lastmod>2026-03-06T09:52:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22818-neuromielite-ottica-una-malattia-autoimmune-rara-ancora-poco-conosciuta]]></loc><lastmod>2026-03-04T18:54:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22809-intervento-in-utero-salvata-una-bimba-con-una-rarissima-malformazione-polmonare]]></loc><lastmod>2026-03-04T18:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22815-al-via-le-paralimpiadi-invernali-di-milano-cortina-in-gara-665-atleti-45-gli-italiani]]></loc><lastmod>2026-03-03T18:09:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22816-salute-uditiva-ricerca-e-diagnosi-precoce-il-contributo-della-rete-clinica-italiana-nel-world-hearing-day-2026]]></loc><lastmod>2026-03-05T08:40:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22810-premio-don-giulio-tarra-torna-il-riconoscimento-dedicato-alla-ricerca-sulla-sordita]]></loc><lastmod>2026-03-02T18:32:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22806-3-marzo-la-giornata-nazionale-sio-siaf-richiama-lattenzione-sulla-sordita]]></loc><lastmod>2026-03-02T23:01:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22799-malattie-rare-prosegue-la-collaborazione-tra-omar-e-cgm-fablab]]></loc><lastmod>2026-02-27T19:07:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22790-accademia-delle-libere-abilita-a-udine-luniversita-apre-alle-disabilita-cognitive]]></loc><lastmod>2026-02-24T08:31:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22793-giornata-delle-malattie-rare-in-piemonte-tre-giorni-di-eventi]]></loc><lastmod>2026-02-25T14:53:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22780-dallinfanzia-alleta-adulta-il-delicato-passaggio-dei-pazienti-con-insufficienza-intestinale]]></loc><lastmod>2026-02-24T16:38:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22779-umbria-per-tutti-la-regione-presenta-il-piano-dazione-per-i-diritti-delle-persone-con-disabilita]]></loc><lastmod>2026-02-24T08:30:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22777-xantinuria-ereditaria-quando-i-dolori-muscolari-nascondono-una-patologia-rara]]></loc><lastmod>2026-02-24T08:29:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22775-malaria-una-bambina-e-ricoverata-in-terapia-intensiva]]></loc><lastmod>2026-02-23T14:46:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22774-malattie-rare-unalleanza-tra-medici-di-famiglia-e-internisti-per-migliorare-diagnosi-e-assistenza]]></loc><lastmod>2026-02-20T18:01:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22763-malattie-rare-assegnati-i-premi-della-xii-edizione-del-premio-omar]]></loc><lastmod>2026-02-19T08:55:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22727-insufficienza-intestinale-cronica-benigna-cose-e-come-si-manifesta-nei-bambini]]></loc><lastmod>2026-02-13T11:47:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22762-al-via-la-campagna-la-riforma-conta-il-rispetto-passa-anche-dalle-parole]]></loc><lastmod>2026-02-18T18:26:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22753-maria-luisa-scattoni-alla-guida-del-centro-nazionale-malattie-rare-cnmr-ricerca-reti-e-diritti-al-centro-della-nuova-direzione]]></loc><lastmod>2026-02-16T13:40:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22734-quando-la-tecnologia-va-verso-il-futuro-il-nuovo-impianto-cocleare-smart]]></loc><lastmod>2026-02-09T14:49:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22735-cardiopatie-congenite-e-patente-di-guida-noi-pazienti-discriminati-dalle-commissioni-mediche]]></loc><lastmod>2026-02-09T15:00:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22744-piacenza-diagnosi-tempestiva-di-malattia-da-igg4-avviata-terapia-con-farmaco-disponibile-solo-negli-usa]]></loc><lastmod>2026-02-12T09:54:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22741-la-riforma-conta-il-rispetto-passa-anche-dalle-parole]]></loc><lastmod>2026-02-11T10:52:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22724-chikungunya-arrivano-i-vaccini-le-nuove-indicazioni-simvim-per-viaggiatori-e-categorie-a-rischio]]></loc><lastmod>2026-02-09T16:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22716-nipah-cose-il-virus-sotto-osservazione-e-perche-continua-a-preoccupare]]></loc><lastmod>2026-02-03T22:53:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22700-mav-cerebrale-rarissima-salvato-un-neonato-al-policlinico-di-milano]]></loc><lastmod>2026-01-30T10:08:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22694-aceruloplasminemia-lema-riconosce-il-valore-di-una-nuova-terapia-sperimentale]]></loc><lastmod>2026-01-27T14:38:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22695-aceruloplasminemia-capire-una-malattia-rara-e-complessa]]></loc><lastmod>2026-01-27T14:47:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22696-sindrome-col4a1-a2-pubblicate-le-prime-raccomandazioni-specifiche-per-la-patologia]]></loc><lastmod>2026-02-02T20:55:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22692-raccolta-plasma-nuovo-record-nel-2025-superate-le-919-tonnellate-raccolte]]></loc><lastmod>2026-01-26T08:47:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22690-curarsi-con-lintelligenza-artificiale-le-novita-in-ambito-salute-tra-limiti-e-benefici]]></loc><lastmod>2026-01-26T08:09:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22687-malattie-neuromuscolari-con-nemo-e-oro-nasce-un-modello-di-salute-orale]]></loc><lastmod>2026-01-23T16:05:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22689-tumori-tornano-le-arance-della-salute-di-fondazione-airc]]></loc><lastmod>2026-01-24T11:20:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22672-fine-vita-il-testo-condiviso-ancora-non-ce-restano-tre-nodi-da-sciogliere]]></loc><lastmod>2026-01-23T17:43:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22680-napoli-la-robotica-che-restituisce-ludito-cronaca-di-un-intervento-allavanguardia]]></loc><lastmod>2026-01-23T08:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22663-a-giuseppe-novelli-il-premio-ambasciatori-deccellenza-per-il-settore-ricerca-e-universita]]></loc><lastmod>2026-01-15T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22655-cani-guida-e-da-assistenza-a-scandicci-la-scuola-piu-antica-ditalia]]></loc><lastmod>2026-01-12T18:06:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22658-covid-19-la-fotografia-a-inizio-gennaio-contagi-in-calo-e-pressione-ospedaliera-sotto-controllo]]></loc><lastmod>2026-01-13T14:09:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22656-addio-a-claudia-frizzarin-amica-e-collaboratrice-di-osservatorio-malattie-rare]]></loc><lastmod>2026-01-13T09:57:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22649-un-italiano-ai-vertici-della-pneumologia-europea-venerino-poletti-e-presidente-eletto-della-eabip]]></loc><lastmod>2026-01-09T17:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22644-crans-montana-e-lemergenza-ustioni-perche-servono-piani-e-farmaci-dedicati]]></loc><lastmod>2026-01-05T15:14:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22629-la-diffusione-di-cibi-ultra-processati-mette-a-rischio-la-salute-gli-scienziati-invocano-una-riforma-politica-mondiale]]></loc><lastmod>2025-12-23T13:08:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22630-a-udine-lanfamiv-con-i-cani-guida-punta-sullautonomia]]></loc><lastmod>2025-12-23T13:10:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22631-malattie-genetiche-rare-telethon-chiude-il-2025-con-una-raccolta-fondi-di-oltre-70-milioni-di-euro]]></loc><lastmod>2025-12-23T14:03:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22621-virus-tropicali-sempre-piu-presenti-in-italia-anche-nei-mesi-invernali]]></loc><lastmod>2025-12-23T12:50:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22628-il-miglior-regalo-di-natale-per-i-bambini-giocare-insieme-ai-genitori]]></loc><lastmod>2025-12-23T12:50:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22615-disegno-di-legge-sulla-disforia-di-genere-critiche-dalle-societa-scientifiche-italiane]]></loc><lastmod>2025-12-19T10:52:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22610-malattie-epatiche-rare-mirum-pharmaceuticals-acquisisce-la-biotech-bluejay]]></loc><lastmod>2025-12-17T09:03:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22601-lupus-tra-diagnosi-difficile-e-disparita-di-cura-a-livello-nazionale]]></loc><lastmod>2025-12-15T23:05:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22597-paola-drigo-maestra-della-neurologia-pediatrica-un-titolo-che-parla-di-cura]]></loc><lastmod>2025-12-11T19:06:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22599-malattie-rare-al-via-la-iv-edizione-del-master-delluniversita-vanvitelli-di-napoli]]></loc><lastmod>2025-12-12T13:03:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22587-non-chiamatela-pet-therapy-ecco-come-funzionano-gli-interventi-assistiti-con-animali]]></loc><lastmod>2025-12-09T08:17:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22576-spasticita-voce-ai-pazienti-tra-stigma-diritti-negati-e-bisogni-irrisolti]]></loc><lastmod>2025-12-05T08:39:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22572-vicini-anche-in-corsia-il-valore-degli-animali-da-affezione-nella-cura]]></loc><lastmod>2025-12-01T17:33:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22575-disabilita-discriminata-ai-colloqui-di-lavoro-ora-il-telefono-non-smette-di-squillare]]></loc><lastmod>2025-12-04T17:56:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22563-genetica-umana-insediato-il-nuovo-consiglio-direttivo-sigu-la-presidente-della-societa-e-paola-grammatico]]></loc><lastmod>2025-12-01T17:27:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22565-resistenza-antimicrobica-la-guerra-peggiora-le-cose]]></loc><lastmod>2025-12-01T17:30:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22550-dal-dentista-senza-paura-il-progetto-basta-una-zampa-per-i-bambini-con-disabilita]]></loc><lastmod>2025-11-25T09:42:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22551-un-decesso-negli-stati-uniti-accende-i-riflettori-sulla-sindrome-alfa-gal]]></loc><lastmod>2025-11-25T12:30:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22557-interrogazione-urgente-al-senato-sul-caso-di-m-bambino-senza-diagnosi-e-a-rischio-vita]]></loc><lastmod>2025-11-27T10:36:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22544-dl-caregiver-la-ministra-locatelli-conferma-limpegno-per-una-legge-nazionale]]></loc><lastmod>2025-11-24T12:10:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22527-malattie-rare-del-tessuto-connettivo-un-sondaggio-europeo-per-fare-il-punto-sulla-transizione]]></loc><lastmod>2025-11-19T17:07:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22525-una-rivoluzione-silenziosa-la-voce-di-liberi-di-sentire]]></loc><lastmod>2025-11-18T18:05:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22531-malattie-rare-nella-legge-di-bilancio-2026-cosa-prevede-il-testo-base-e-cosa-chiedono-i-senatori]]></loc><lastmod>2025-11-18T17:02:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22519-cure-palliative-necessaria-maggiore-attenzione-allambito-neurologico]]></loc><lastmod>2025-11-17T15:02:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22523-nascere-prima-del-tempo-il-cervello-del-prematuro-tra-vulnerabilita-e-resilienza]]></loc><lastmod>2025-11-17T14:54:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22516-malattie-rare-uno-sguardo-raro-celebra-dieci-anni-di-cinema-e-inclusione]]></loc><lastmod>2025-11-14T17:30:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22507-addio-a-mirella-antonione-casale-madre-dellinclusione-scolastica-in-italia]]></loc><lastmod>2025-11-12T13:58:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22491-gaslini-nasce-il-primo-registro-internazionale-sulla-malformazione-della-vena-di-galeno]]></loc><lastmod>2025-11-07T13:19:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22485-volare-senza-barriere-le-iniziative-di-enac-per-laccessibilita-del-trasporto-aereo]]></loc><lastmod>2025-11-10T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22493-malattie-rare-e-disabilita-selicorni-necessario-costruire-reti-in-grado-di-farsi-carico-di-pazienti-e-famiglie]]></loc><lastmod>2025-11-10T10:23:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22501-i-farmacisti-ospedalieri-fanno-il-punto-sullintelligenza-artificiale-in-sanita]]></loc><lastmod>2025-11-08T10:37:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22492-consulte-per-i-diritti-delle-persone-con-disabilita-a-milano-e-roma-denunciati-fragilita-e-blocchi]]></loc><lastmod>2025-11-08T08:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22499-tumori-tornano-i-giorni-della-ricerca-di-fondazione-airc]]></loc><lastmod>2025-11-07T21:46:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22498-farmaci-lazienda-merck-nomina-dario-floris-nuovo-country-lead-rare-tumors-italy]]></loc><lastmod>2025-11-07T18:28:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22476-ciao-silvia-la-tua-battaglia-non-si-ferma-qui]]></loc><lastmod>2025-11-03T08:31:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22462-la-sifo-si-da-appuntamento-a-genova-per-il-46esimo-congresso-nazionale]]></loc><lastmod>2025-11-02T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22473-lospedale-bambino-gesu-festeggia-i-40-anni-come-irccs]]></loc><lastmod>2025-11-01T17:01:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22450-malattie-rare-a-torino-un-progetto-concreto-per-un-nuovo-irccs]]></loc><lastmod>2025-10-28T15:22:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22448-fine-vita-il-grido-di-aiuto-dei-pazienti-allassociazione-luca-coscioni]]></loc><lastmod>2025-10-28T15:21:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22445-distrofia-muscolare-dei-cingoli-online-una-guida-pratica-pensata-per-le-famiglie]]></loc><lastmod>2025-10-28T15:12:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22437-linfermiere-scolastico-una-figura-chiave-per-la-salute-in-eta-evolutiva]]></loc><lastmod>2025-10-22T15:14:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22431-viaggiare-con-una-disabilita-enac-al-lavoro-su-misure-operative]]></loc><lastmod>2025-10-22T14:52:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22432-fine-vita-lopinione-dei-professionisti-della-cura]]></loc><lastmod>2025-10-22T14:54:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22418-bullismo-in-classe-cani-gatti-e-conigli-diventano-alleati-dei-piu-fragili]]></loc><lastmod>2025-10-19T22:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22419-malattie-rare-del-neurosviluppo-elisa-fazzi-sinpia-serve-continuita-nelle-cure]]></loc><lastmod>2025-10-16T14:49:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22414-farmaci-plasmaderivati-un-bene-prezioso-da-proteggere]]></loc><lastmod>2025-10-16T07:40:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22401-la-stamperia-braille-della-toscana-verso-i-100-anni-il-codice-e-ancora-vivo]]></loc><lastmod>2025-10-13T16:59:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22389-malattie-rare-sigu-premia-i-giovani-ricercatori-per-le-innovazioni-in-campo-genetico]]></loc><lastmod>2025-10-10T14:33:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22390-malattie-rare-per-gli-animali-da-compagnia-la-strada-verso-terapie-mirate-e-ancora-lunga]]></loc><lastmod>2025-10-10T14:35:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22381-malattie-rare-al-via-il-corso-di-formazione-gratuito-sulla-nomenclatura-di-orphanet]]></loc><lastmod>2025-10-08T07:20:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22377-il-tempo-e-adesso-il-9-ottobre-torna-la-gionata-mondiale-pans-pandas]]></loc><lastmod>2025-10-07T18:10:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22376-malattie-rare-da-oggi-e-possibile-candidarsi-alla-xii-edizione-del-premio-omar]]></loc><lastmod>2025-10-06T17:08:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22367-viaggiare-con-una-disabilita-il-caso-di-elisa-costantino-e-della-carrozzina-danneggiata-due-volte]]></loc><lastmod>2025-10-03T08:41:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22349-autismo-paracetamolo-e-vaccini-la-voce-della-scienza-contro-la-disinformazione]]></loc><lastmod>2025-09-26T09:34:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22342-genetica-medica-e-intelligenza-artificiale-a-che-punto-siamo]]></loc><lastmod>2025-09-26T07:52:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22347-aaa-cercasi-attori-volontari-segnanti-per-spettacolo-teatrale-inclusivo]]></loc><lastmod>2025-09-25T18:58:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22332-fine-vita-cappato-il-testo-di-legge-cancella-i-diritti-gia-conquistati]]></loc><lastmod>2025-09-23T19:43:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22326-candida-auris-limpennata-di-infezioni-preoccupa-i-sistemi-sanitari]]></loc><lastmod>2025-09-21T10:16:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22322-litalia-si-illumina-di-verde-per-le-malattie-mitocondriali]]></loc><lastmod>2025-09-19T10:28:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22319-orecchio-bionico-come-la-tecnologia-aiuta-a-superare-la-sordita]]></loc><lastmod>2025-09-18T21:16:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22320-il-colera-non-e-storia-nuove-epidemie-e-vecchie-fragilita-globali]]></loc><lastmod>2025-09-18T21:35:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22307-dal-governo-260-milioni-per-linclusione-scolastica-degli-studenti-con-disabilita]]></loc><lastmod>2025-09-18T21:01:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22297-la-valigia-della-liberta-quando-il-teatro-civile-porta-il-fine-vita-sul-palco]]></loc><lastmod>2025-09-12T15:53:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22308-diritto-a-stare-bene-omar-al-fianco-della-proposta-di-legge-popolare-per-il-benessere-psicologico]]></loc><lastmod>2025-09-16T07:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22294-diagnosi-precoce-e-percorsi-integrati-la-chiave-per-cambiare-la-vita-dei-bambini-con-sordita]]></loc><lastmod>2025-09-12T14:38:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22288-stratus-la-nuova-variante-covid-che-domina-in-italia]]></loc><lastmod>2025-09-10T18:29:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22290-malattie-rare-unindagine-nazionale-per-esplorare-cause-e-impatto-del-ritardo-diagnostico]]></loc><lastmod>2025-09-12T07:43:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22285-zero-alcol-in-gravidanza-il-messaggio-della-giornata-internazionale-sulla-sindrome-feto-alcolica]]></loc><lastmod>2025-09-08T20:55:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22278-oltre-lis-e-sottotitoli-capire-la-diversita-delle-persone-sorde-per-costruire-vera-inclusione]]></loc><lastmod>2025-09-05T17:39:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22279-malattie-neuromuscolari-il-policlinico-gemelli-accende-i-riflettori-sul-mondo-dei-bambini]]></loc><lastmod>2025-09-05T17:41:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22264-le-malattie-rare-negli-animali-una-sfida-che-riguarda-anche-noi]]></loc><lastmod>2025-10-10T11:19:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22258-gaza-nasce-la-cabina-di-regia-per-i-bambini-con-disabilita-e-patologie-gravi]]></loc><lastmod>2025-08-28T21:17:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22256-sordita-di-carlo-ans-basta-assistenzialismo-serve-vera-integrazione-produttiva]]></loc><lastmod>2025-08-26T20:13:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22250-divieto-di-panino-in-spiaggia-il-rischio-per-chi-segue-una-dietoterapia-nelle-malattie-rare]]></loc><lastmod>2025-08-19T13:44:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22247-monica-seles-e-i-sintomi-della-miastenia-gravis-vedevo-due-palline-da-tennis]]></loc><lastmod>2025-08-13T14:31:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22238-malattie-virali-trasmesse-dagli-insetti-pronta-la-task-force-dei-medici-di-famiglia]]></loc><lastmod>2025-08-04T21:37:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22236-farmacia-una-fonte-di-opportunita-per-rispondere-ai-bisogni-complessi-sul-territorio]]></loc><lastmod>2025-08-06T18:36:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22234-emilia-romagna-800mila-euro-per-cure-di-alta-specialita-a-persone-extra-ue-con-patologie-gravi]]></loc><lastmod>2025-08-05T11:14:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22225-fiumicino-senza-barriere-l-aeroporto-diventa-sempre-piu-inclusivo-smart-e-digitale]]></loc><lastmod>2025-07-29T11:29:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22230-chikungunya-cos-e-dove-si-diffonde-e-come-ci-si-protegge-dalla-malattia-trasmessa-dalle-zanzare]]></loc><lastmod>2025-10-29T12:25:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22218-febbre-dengue-in-italia-incidenza-sfide-e-sorveglianza]]></loc><lastmod>2025-07-28T17:37:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22215-west-nile-virus-crescono-i-casi-in-italia-rafforzate-le-misure-di-prevenzione]]></loc><lastmod>2025-07-29T08:23:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22209-bruce-willis-condizioni-in-peggioramento-la-demenza-frontotemporale-progredisce]]></loc><lastmod>2025-07-25T09:52:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22206-venus-williams-vince-ancora-a-45-anni-e-nonostante-la-sindrome-di-sjoegren]]></loc><lastmod>2025-07-23T17:10:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22189-reti-oncologiche-a-che-punto-siamo]]></loc><lastmod>2025-07-21T09:37:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22203-addio-a-edoardo-boncinelli-padre-dei-geni-architetto-e-protagonista-della-divulgazione-scientifica]]></loc><lastmod>2025-07-21T08:03:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22172-commissione-dei-cittadini-per-le-cure-palliative-un-nuovo-modello-di-partecipazione-democratica-dal-basso]]></loc><lastmod>2025-07-12T16:05:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22197-simone-cristicchi-prosegue-il-tour-nonostante-una-paresi-al-nervo-facciale]]></loc><lastmod>2025-07-18T08:05:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22186-alberto-siracusano-alla-guida-del-consiglio-superiore-di-sanita]]></loc><lastmod>2025-07-14T09:40:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22201-a-napoli-nasce-una-nuova-unita-operativa-per-le-malattie-genetiche-e-rare-cardiovascolari]]></loc><lastmod>2025-07-17T16:25:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22195-cittadinanza-italiana-il-ragazzo-non-puo-parlare-a-causa-di-una-malattia-rara-istanza-respinta]]></loc><lastmod>2025-07-15T18:24:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22177-centro-nazionale-sangue-la-nuova-direttrice-e-la-prof-ssa-luciana-teofili]]></loc><lastmod>2025-07-13T13:48:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22168-che-fine-ha-fatto-covid-19-in-questa-estate-2025]]></loc><lastmod>2025-07-07T21:11:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22161-educazione-delle-persone-sorde-roma-ospita-la-24-conferenza-internazionale-iced]]></loc><lastmod>2025-07-07T08:50:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22159-i-veri-supereroi-indossano-la-neurotuta-neurostimolazione-e-quotidianita-nelle-malattie-rare]]></loc><lastmod>2025-07-15T16:20:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22160-live-for-all-in-senato-la-richiesta-di-una-legge-per-garantire-l-accesso-allo-spettacolo-dal-vivo-alle-persone-con-disabilita]]></loc><lastmod>2025-07-04T16:11:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22157-antonio-gasbarrini-nuovo-direttore-scientifico-del-policlinico-gemelli]]></loc><lastmod>2025-07-03T16:31:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22147-la-prof-ssa-elisa-fazzi-eletta-membro-dell-accademia-francese-di-medicina]]></loc><lastmod>2025-07-01T08:55:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22141-malattie-rare-nasce-la-rete-delle-associazioni-di-piemonte-e-valle-d-aosta]]></loc><lastmod>2025-06-27T12:56:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22132-bruno-dallapiccola-il-grande-precursore-della-genetica-riceve-il-sigillo-accademico-dell-universita-di-urbino]]></loc><lastmod>2025-06-27T12:25:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22124-scabbia-il-ritorno-di-un-infezione-antica-casi-in-aumento-in-italia]]></loc><lastmod>2025-07-03T16:31:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22121-come-e-cambiata-l-advocacy-nel-campo-della-salute-i-pazienti-sempre-piu-protagonisti-nella-ricerca]]></loc><lastmod>2025-06-24T15:29:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22112-le-malattie-rare-non-hanno-eta-garantire-equita-e-cure-anche-per-gli-anziani]]></loc><lastmod>2025-06-20T18:21:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22097-disturbi-dell-ipofisi-al-gemelli-un-ambulatorio-specializzato]]></loc><lastmod>2025-06-18T17:43:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22108-carrozzine-elettriche-la-senatrice-paita-interroga-il-governo-chiarire-chi-deve-pagare-per-batterie-e-ricambi]]></loc><lastmod>2025-06-19T09:12:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22093-disponibile-il-corso-gratuito-nomenclatura-di-orphanet-per-la-codifica-delle-malattie-rare]]></loc><lastmod>2025-06-13T20:08:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22089-disabilita-da-uildm-la-piattaforma-per-trovare-caregiver-professionali]]></loc><lastmod>2025-06-13T12:04:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22090-la-neurotuta-exopulse-mollii-suit-l-importanza-di-una-configurazione-personalizzata]]></loc><lastmod>2025-06-13T13:43:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22096-suicidio-assistito-per-la-sin-cure-palliative-fondamentali-per-i-pazienti-neurologici]]></loc><lastmod>2025-06-16T10:00:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22082-intelligenza-artificiale-e-una-nuova-mascotte-al-servizio-dei-piu-piccoli-con-paralisi-cerebrale]]></loc><lastmod>2025-06-12T14:09:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22079-nasce-sardgen-50-milioni-di-euro-per-contrastare-le-malattie-genetiche-e-migliorare-la-salute-dei-cittadini-sardi]]></loc><lastmod>2025-06-12T07:29:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22084-giornata-mondiale-del-donatore-di-sangue-al-via-la-campagna-di-fondazione-cutino]]></loc><lastmod>2025-06-12T17:18:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22074-il-futuro-del-biofarmaceutico-tra-plasma-e-nuove-terapie]]></loc><lastmod>2025-06-11T15:29:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22068-disabilita-e-intelligenza-artificiale-una-nuova-alleanza-per-l-inclusione]]></loc><lastmod>2025-06-09T17:40:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22071-luk3-e-alessia-pecchia-da-amici-portano-musica-e-sorrisi-ai-bambini-dell-ospedale-di-pescara]]></loc><lastmod>2025-06-10T04:52:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22064-disability-manager-un-ruolo-strategico-per-l-inclusione]]></loc><lastmod>2025-06-06T16:59:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22066-farmaci-a-base-di-semaglutide-l-ema-segnala-un-raro-effetto-collaterale]]></loc><lastmod>2025-06-09T14:36:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22057-impianto-cocleare-a-torino-e-siena-i-primi-interventi-di-chirurgia-robotica-di-precisione]]></loc><lastmod>2025-06-06T08:29:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22052-adhd-un-nuovo-modello-di-presa-in-carico-il-caso-virtuoso-della-regione-lazio]]></loc><lastmod>2025-06-05T20:42:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22047-giornata-mondiale-dell-ambiente-la-natura-e-di-tutti-anche-delle-persone-con-disabilita]]></loc><lastmod>2025-06-04T20:16:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22032-comunicazione-e-percezione-delle-malattie-rare-una-riflessione-a-partire-dalle-parole-di-papa-leone-xiv]]></loc><lastmod>2025-05-29T17:16:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22034-prima-donazione-a-cuore-fermo-nel-lazio-successo-al-policlinico-umberto-i]]></loc><lastmod>2025-05-29T17:00:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22031-a-palazzo-merulana-le-opere-di-10-illustratori-ispirate-dalla-ridefinizione-del-concetto-di-inclusione-secondo-le-persone-che-vivono-con-una-malattia-rara]]></loc><lastmod>2025-05-28T08:34:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22020-paralisi-cerebrale-un-fumetto-per-informare-bambini-e-adolescenti]]></loc><lastmod>2025-05-23T11:00:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22018-accesso-alle-tecnologie-innovative-il-ruolo-del-supporto-legale-per-i-pazienti-rari]]></loc><lastmod>2025-05-23T10:56:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22016-malattie-rare-in-lombardia-nasce-il-forum-delle-associazioni]]></loc><lastmod>2025-05-23T09:06:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/22014-salute-in-attesa-nascite-in-ritardo-l-italia-che-non-riesce-piu-a-curarsi-ne-a-guardare-al-futuro]]></loc><lastmod>2025-05-22T17:20:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21996-il-latte-materno-protegge-dall-enterocolite-necrotizzante]]></loc><lastmod>2025-05-16T17:18:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21985-scomparso-lorenzo-sala-presidente-dell-associazione-italiana-pazienti-addison-aipad]]></loc><lastmod>2025-05-14T08:07:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21966-malattie-rare-serve-un-vero-ecosistema-europeo-per-ricerca-e-innovazione]]></loc><lastmod>2025-05-09T07:56:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21950-la-neurotuta-exopulse-mollii-suit-un-aiuto-per-affrontare-la-rigidita-muscolare]]></loc><lastmod>2025-05-08T17:09:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21916-quando-il-sorriso-e-un-diritto-per-tutti-a-gubbio-un-servizio-odontoiatrico-dedicato-alle-persone-con-disabilita]]></loc><lastmod>2025-04-19T11:01:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21932-papa-francesco-una-voce-amica-delle-persone-con-malattia-rara]]></loc><lastmod>2025-04-21T18:41:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21920-giornata-mondiale-del-fegato-in-aumento-le-malattie-epatiche-metaboliche]]></loc><lastmod>2025-11-05T17:23:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21915-master-di-ii-livello-in-malattie-rare-consorzio-universitario-humanitas-di-roma-ultimi-giorni-per-iscriversi]]></loc><lastmod>2025-04-16T16:06:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21913-genetica-sempre-piu-al-centro-della-medicina-contemporanea]]></loc><lastmod>2025-04-16T07:44:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21896-malattie-endocrine-rare-gli-obiettivi-della-rete-di-riferimento-europea-endo-ern]]></loc><lastmod>2025-04-10T17:43:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21891-la-difficolta-di-essere-una-caregiver-gigliola-alvisi-nel-mio-libro-riconosco-la-rabbia-e-la-frustrazione]]></loc><lastmod>2025-04-09T16:57:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21892-montascale-rotto-evento-negato-a-lisa-noja-non-e-solo-un-disservizio-e-discriminazione-quotidiana]]></loc><lastmod>2025-04-09T17:11:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21885-malattie-rare-endocrino-metaboliche-le-societa-scientifiche-puntano-sulla-formazione]]></loc><lastmod>2025-04-08T14:41:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21883-la-neurotuta-exopulse-mollii-suit-un-supporto-per-la-mobilita-e-il-benessere]]></loc><lastmod>2025-04-07T15:18:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21871-accessibilita-ai-concerti-un-manifesto-c-e-ma-la-strada-e-ancora-lunga]]></loc><lastmod>2025-04-02T15:12:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21861-servizio-tobia-a-roma-un-nuovo-modello-di-cura-per-le-persone-con-disabilita]]></loc><lastmod>2025-04-01T07:47:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21866-giornata-mondiale-dell-autismo-sinpia-necessari-inclusione-e-nuovi-modelli-di-cura]]></loc><lastmod>2025-03-31T18:22:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21860-sindromi-pans-pandas-entro-aprile-la-richiesta-di-inserimento-formale-nei-lea]]></loc><lastmod>2025-03-31T18:26:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21833-al-via-il-progetto-vippstar-un-supporto-per-l-autonomia-dei-ragazzi-con-disabilita-visiva]]></loc><lastmod>2025-03-24T18:11:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21831-malattie-rare-il-master-dell-universita-vanvitelli-si-e-rivelato-una-preziosa-opportunita-di-approfondimento]]></loc><lastmod>2025-03-21T18:42:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21829-malattie-rare-il-genere-puo-fare-la-differenza]]></loc><lastmod>2025-03-19T18:33:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21827-tumore-al-seno-l-italia-si-distingue-per-accesso-alle-terapie-ma-prevenzione-e-screening-ancora-sotto-la-soglia]]></loc><lastmod>2025-03-19T18:32:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21817-malattie-reumatologiche-pediatriche-la-carenza-cronica-di-specialisti-limita-l-accesso-alle-cure]]></loc><lastmod>2025-03-18T09:00:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21815-la-neurotuta-exopulse-mollii-suit-il-paziente-al-centro-del-proprio-percorso-di-cura]]></loc><lastmod>2025-03-15T11:49:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21820-commissione-lancet-malattie-rare-il-prof-giuseppe-remuzzi-l-unico-italiano]]></loc><lastmod>2025-03-17T18:36:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21811-malattie-rare-endocrino-metaboliche-l-impegno-congiunto-delle-societa-scientifiche-sie-e-siedp]]></loc><lastmod>2025-03-13T19:05:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21807-istituita-la-consulta-delle-malattie-neuromuscolari-ets]]></loc><lastmod>2025-03-13T18:18:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21805-settimana-mondiale-del-cervello-2025-un-nuovo-impegno-per-la-salute-mentale]]></loc><lastmod>2025-03-12T18:56:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21804-malattie-rare-si-avvia-verso-la-conclusione-la-iii-edizione-del-master-dell-universita-vanvitelli]]></loc><lastmod>2025-03-12T18:47:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21796-lutto-nella-famiglia-reale-del-lussemburgo-morto-il-principe-frederik-a-22-anni-era-affetto-da-polg]]></loc><lastmod>2025-06-13T16:53:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21792-13-marzo-giornata-mondiale-del-rene-screening-gratuiti-nelle-piazze-e-negli-ospedali-d-italia]]></loc><lastmod>2025-03-10T19:11:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21779-disabilita-e-viaggi-aerei-l-edf-chiede-regole-piu-forti-per-i-diritti-dei-passeggeri]]></loc><lastmod>2025-03-04T16:54:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21773-world-obesity-day-nel-2035-le-persone-obese-potrebbero-essere-1-9-miliardi]]></loc><lastmod>2025-03-03T18:41:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21769-lichen-scleroatrofico-al-san-gallicano-nasce-un-network-dedicato]]></loc><lastmod>2025-02-28T18:21:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21766-malattie-rare-nasce-cpms-2-0-il-sistema-che-facilita-diagnosi-e-cure-in-tutta-europa]]></loc><lastmod>2025-02-28T16:49:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21762-malattie-rare-pediatriche-il-monito-dei-neuropsichiatri-infantili-prioritario-garantire-la-continuita-di-cura]]></loc><lastmod>2025-02-28T16:46:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21763-malattie-neurologiche-rare-la-sin-occorre-puntare-su-ricerca-innovazione-e-valorizzazione-dei-centri-di-riferimento]]></loc><lastmod>2025-02-28T16:48:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21761-giornata-delle-malattie-rare-2025-telethon-in-prima-linea-nello-sviluppo-di-nuovi-trattamenti]]></loc><lastmod>2025-02-28T10:11:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21760-giornata-delle-malattie-rare-2025-sanofi-lancia-la-campagna-chiamalepernome]]></loc><lastmod>2025-02-28T16:03:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21756-malattie-rare-una-collaborazione-strategica-per-diagnosi-precoci-e-informazione-affidabile]]></loc><lastmod>2025-02-27T08:42:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21757-malattie-rare-in-sardegna-riguardano-14mila-persone]]></loc><lastmod>2025-02-27T14:31:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21746-malattie-rare-una-rete-nazionale-per-i-pazienti-senza-diagnosi]]></loc><lastmod>2025-02-25T12:17:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21738-ma-i-disabili-fanno-sesso-un-libro-di-iacopo-melio]]></loc><lastmod>2025-02-18T17:56:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21735-l-ascensore-c-e-ma-non-si-puo-usare-l-odissea-di-alia-bibi-ed-essa-a-piedi-per-cinque-piani]]></loc><lastmod>2025-02-17T16:01:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21715-comunicazione-tra-medico-e-paziente-fondamentale-per-la-qualita-delle-cure-e-della-vita]]></loc><lastmod>2025-02-18T17:55:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21739-malattie-rare-annunciati-i-vincitori-dell-xi-edizione-del-premio-omar]]></loc><lastmod>2025-02-19T08:58:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21711-malattie-neuromuscolari-al-via-i-percorsi-formativi-match-point]]></loc><lastmod>2025-02-13T10:52:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21693-disabilita-intellettiva-e-disturbi-dello-spettro-autistico-quale-ruolo-per-la-genetica-medica]]></loc><lastmod>2025-02-07T08:14:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21703-messina-grande-successo-per-lo-sportello-dedicato-alle-malattie-rare]]></loc><lastmod>2025-02-07T11:07:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21704-plasmaderivati-a-roma-una-mostra-per-raccontarne-il-processo-di-produzione]]></loc><lastmod>2025-02-07T18:32:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21667-tumore-alla-prostata-cresce-la-terapia-di-precisione-con-radioligandi]]></loc><lastmod>2025-02-04T09:44:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21684-deficit-di-enpp1-aismme-offre-sostegno-ai-pazienti-italiani-e-alle-loro-famiglie]]></loc><lastmod>2025-02-03T17:36:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21681-arriva-a-roma-la-mostra-il-viaggio-del-plasma]]></loc><lastmod>2025-01-31T10:25:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21674-malattie-tropicali-neglette-un-emergenza-globale-che-non-puo-piu-essere-ignorata]]></loc><lastmod>2025-01-29T18:25:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21675-malattie-rare-peggiorano-i-servizi-per-i-pazienti-in-abruzzo]]></loc><lastmod>2025-01-29T18:32:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21672-malattie-rare-omar-e-fondazione-sisa-firmano-un-accordo-di-collaborazione]]></loc><lastmod>2025-01-29T09:19:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21643-sindrome-foxg1-a-taranto-nasce-un-associazione-di-pazienti]]></loc><lastmod>2025-01-20T18:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21622-ritardo-dei-nuovi-lea-nuova-interrogazione-parlamentare-per-fare-chiarezza]]></loc><lastmod>2025-01-10T17:24:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21605-morte-cardiaca-improvvisa-in-campania-il-primo-percorso-multidisciplinare-e-olistico-dedicato]]></loc><lastmod>2024-12-20T15:40:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21586-a-padova-il-primo-trapianto-cardiaco-al-mondo-effettuato-con-cuore-battente]]></loc><lastmod>2024-12-17T22:11:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21566-malattie-rare-al-via-la-tradizionale-campagna-di-raccolta-fondi-di-telethon]]></loc><lastmod>2024-12-11T10:21:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21571-malattie-rare-biogen-dal-1978-al-fianco-dei-pazienti]]></loc><lastmod>2024-12-13T14:55:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21559-cheratite-da-acanthamoeba-curarla-e-oggi-possibile-ma-meglio-prevenirla]]></loc><lastmod>2024-12-06T18:30:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21548-malattie-rare-conclusa-la-nona-edizione-di-uno-sguardo-raro]]></loc><lastmod>2024-12-02T19:15:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21539-necessario-un-riconoscimento-ufficiale-per-la-figura-dello-specialista-in-emostasi-e-trombosi]]></loc><lastmod>2024-11-29T11:59:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21542-payback-dispositivi-medici-a-rischio-la-salute-dei-pazienti]]></loc><lastmod>2024-11-29T19:03:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21529-malattie-neurologiche-ci-ha-lasciati-il-prof-giancarlo-comi]]></loc><lastmod>2024-11-27T12:08:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21505-sicilia-attivo-nuovo-sportello-informativo-dedicato-a-chi-ha-una-malattia-rara]]></loc><lastmod>2024-11-18T17:42:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21495-prematurita-oggi-e-la-giornata-mondiale]]></loc><lastmod>2024-11-15T16:12:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21485-caregiver-familiare-la-legge-della-regione-sardegna-ancora-senza-linee-guida-ne-finanziamento]]></loc><lastmod>2024-11-13T18:35:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21482-carta-di-solfagnano-la-svolta-nell-impegno-internazionale-nella-tutela-delle-persone-con-disabilita]]></loc><lastmod>2024-11-12T18:01:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21480-malattie-rare-al-via-ridefiniamo-l-inclusione-parole-e-azioni-per-la-health-equity]]></loc><lastmod>2024-11-11T18:46:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21465-progetto-ridefiniamo-l-inclusione-on-valentina-grippo-e-tempo-di-concentraci-su-ambito-lavorativo]]></loc><lastmod>2024-11-05T16:42:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21460-malattie-genetiche-rare-esperti-pazienti-e-istituzioni-a-confronto-sulle-necessita-piu-urgenti]]></loc><lastmod>2024-11-12T11:57:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21435-caregiver-familiare-presentato-il-manifesto-appello-per-una-legge-inclusiva-e-di-equita-sociale]]></loc><lastmod>2024-10-28T17:09:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21428-iss-insediato-il-nuovo-comitato-scientifico]]></loc><lastmod>2024-10-28T17:13:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21422-vaccinazione-anti-covid-19-i-dati-statunitensi-impongono-un-sollecito-all-immunizzazione-piu-capillare]]></loc><lastmod>2024-10-24T17:15:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21409-giornata-delle-sindromi-pten-correlate-celebrazione-in-sordina-per-la-scomparsa-della-prof-ssa-eng]]></loc><lastmod>2024-10-22T14:12:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21406-g7-disabilita-in-italia-aisla-uildm-famiglie-sma-e-centri-nemo-uniti-per-l-inclusione]]></loc><lastmod>2024-10-19T09:27:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21403-congresso-sifo-dall-intelligenza-artificiale-un-aiuto-per-i-malati-rari]]></loc><lastmod>2024-10-18T11:32:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21385-al-via-la-quarta-edizione-del-master-in-comunicazione-scientifica-dell-universita-di-parma]]></loc><lastmod>2024-10-14T11:29:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21400-al-via-a-napoli-il-congresso-2024-della-societa-italiana-farmacisti-ospedalieri]]></loc><lastmod>2024-10-17T09:34:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21384-salute-mentale-il-60-degli-italiani-sotto-pressione-adolescenti-in-difficolta]]></loc><lastmod>2024-10-13T09:22:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21371-giornata-della-salute-mentale-starace-occorre-riformare-il-sistema-dei-servizi]]></loc><lastmod>2024-10-09T18:13:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21377-il-nobel-per-la-medicina-2024-va-a-due-scienziati-dei-microrna]]></loc><lastmod>2024-10-08T16:57:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21366-cheratocono-attenzione-ai-sintomi-da-non-confondere-con-quelli-dell-astigmatismo]]></loc><lastmod>2024-10-08T08:44:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21354-genetica-medica-mattia-gentile-screening-neonatale-cardiogenetica-e-intelligenza-artificiale-sono-punti-chiave]]></loc><lastmod>2024-10-08T09:28:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21360-sammy-basso-addio-al-biologo-che-ha-dedicato-la-vita-alla-divulgazione-scientifica]]></loc><lastmod>2025-08-25T10:29:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21353-smart-working-per-lavoratori-fragili-un-nuovo-appello-alla-regolamentazione-stabile]]></loc><lastmod>2024-10-03T11:03:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21350-terapie-intensive-neonatali-e-genetica-oggi-si-arriva-alla-diagnosi-in-5-giorni]]></loc><lastmod>2024-10-02T14:45:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21352-farmaci-chiesi-inaugura-a-parma-il-biotech-center-of-excellence]]></loc><lastmod>2024-10-02T15:23:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21342-atresia-biliare-in-italia-centri-di-eccellenza-ma-successi-terapeutici-inferiori-a-quelli-di-altri-paesi]]></loc><lastmod>2024-10-01T17:29:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21318-paraplegia-spastica-ereditaria-nasce-un-registro-dedicato]]></loc><lastmod>2024-09-25T11:30:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21314-alopecia-areata-via-libera-di-aifa-alla-rimborsabilita-di-ritlecitinib]]></loc><lastmod>2024-09-25T07:24:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21311-sardegna-nominato-il-comitato-tecnico-scientifico-malattie-rare]]></loc><lastmod>2024-09-23T09:16:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21303-le-priorita-per-la-giornata-del-cuore-2024-prevenzione-diagnosi-precoce-e-aderenza-alle-terapie]]></loc><lastmod>2024-09-18T17:08:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21305-presentato-il-manifesto-sul-rischio-cardiovascolare-residuo-per-garantire-ai-pazienti-l-accesso-alle-migliori-opzioni-di-cura]]></loc><lastmod>2024-09-19T11:38:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21297-vaccino-anti-covid-19-per-anziani-2024-2025-gratuita-e-raccomandata-per-malati-rari-e-persone-con-disabilita]]></loc><lastmod>2024-09-18T07:27:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21293-test-ngs-per-malattie-rare-fondamentali-per-accorciare-tempi-di-diagnosi-e-migliorare-gestione-fondi-ssn]]></loc><lastmod>2024-09-17T11:33:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21294-terapie-avanzate-gli-esperti-necessario-affrontare-la-sostenibilita-a-360-gradi-per-accelerarne-lo-sviluppo-e-garantirne-l-accesso]]></loc><lastmod>2024-09-17T13:58:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21296-malformazioni-ano-rettali-aimar-festeggia-i-trent-anni-di-attivita]]></loc><lastmod>2024-09-17T16:57:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21288-maternita-e-disabilita-verso-una-nuova-cultura-dell-inclusione]]></loc><lastmod>2024-09-16T15:12:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21284-sindrome-di-pierpont-oggi-la-giornata-mondiale-i-pazienti-italiani-salgono-a-dieci]]></loc><lastmod>2024-09-13T16:08:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21251-addio-a-michele-cargiolli-autore-attivo-nella-comunicazione-delle-malattie-rare]]></loc><lastmod>2024-09-04T09:55:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21239-paralimpiadi-parigi-2024-tutto-quello-che-c-e-da-sapere-sulle-gare]]></loc><lastmod>2024-08-29T07:37:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21219-sindrome-di-klinefelter-l-importanza-del-sostegno-psicologico-ai-pazienti]]></loc><lastmod>2024-08-12T12:38:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21211-giornata-mondiale-dell-alopecia-tre-donne-raccontano-la-sofferenza-della-malattia]]></loc><lastmod>2024-08-02T08:53:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21200-cronicita-e-non-autosufficienza-online-il-nuovo-sondaggio-di-corriere-salute]]></loc><lastmod>2024-07-26T10:00:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21196-paralimpiadi-parigi-2024-ambra-sabatini-e-luca-mazzone-saranno-i-portabandiera-azzurri]]></loc><lastmod>2024-07-26T09:17:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21186-ricerca-medico-scientifica-ican-e-pfizer-insieme-per-valorizzare-la-voce-di-bambini-e-ragazzi]]></loc><lastmod>2024-07-19T12:26:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21180-neuropsichiatria-infantile-verso-un-nuovo-modello-di-continuita-delle-cure]]></loc><lastmod>2024-07-17T14:39:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21173-caregiver-le-associazioni-rappresentanti-il-mondo-della-disabilita-in-audizione-alla-camera]]></loc><lastmod>2024-07-15T13:05:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21168-salute-pubblicata-una-guida-per-la-valorizzazione-del-paziente-esperto]]></loc><lastmod>2024-07-15T07:40:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21101-la-gestione-e-il-trattamento-delle-obesita-genetiche]]></loc><lastmod>2024-07-05T11:34:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21167-nasce-la-patient-association-academy-per-una-sanita-sempre-piu-partecipata-e-aperta-ai-pazienti]]></loc><lastmod>2024-07-11T18:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21154-insufficienza-aortica-salvata-al-gaslini-una-paziente-di-4-anni]]></loc><lastmod>2024-07-09T11:59:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21163-malattie-genetiche-e-rare-test-genomici-e-genetista-sempre-piu-determinanti-nel-percorso-del-paziente]]></loc><lastmod>2024-07-10T09:20:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21164-fondazione-telethon-ilaria-villa-e-il-nuovo-direttore-generale]]></loc><lastmod>2024-07-10T09:12:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21151-l-agenzia-italiana-del-farmaco-lancia-una-nuova-banca-dati-nasce-aifa-medicinali]]></loc><lastmod>2024-07-08T09:32:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21149-la-gestione-dell-obesita-genetica-nella-sindrome-di-bardet-biedl]]></loc><lastmod>2024-07-06T17:45:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21144-malattia-da-agglutinine-fredde-rara-poco-conosciuta-e-con-elevata-mortalita-intraospedaliera]]></loc><lastmod>2024-07-03T13:01:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21143-la-gestione-e-il-trattamento-delle-obesita-ipotalamiche-acquisite]]></loc><lastmod>2024-07-03T12:55:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21142-caregiver-presentata-la-carta-dei-diritti]]></loc><lastmod>2024-07-03T12:51:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21134-la-multidisciplinarieta-nella-gestione-delle-obesita-genetiche]]></loc><lastmod>2024-07-01T13:53:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21135-dal-1-luglio-2024-stop-alle-mascherine-anche-nei-reparti-con-pazienti-fragili]]></loc><lastmod>2024-07-02T08:55:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21127-donazione-sangue-concluso-il-progetto-sii-come-donny-ogni-goccia-e-importante]]></loc><lastmod>2024-06-30T12:14:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21129-malattie-rare-al-via-le-candidature-alla-xi-edizione-del-premio-omar]]></loc><lastmod>2024-07-08T15:07:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21110-distrofia-facio-scapolo-omerale-aggiornate-le-linee-guida-internazionali-per-la-diagnosi]]></loc><lastmod>2024-06-25T11:09:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21100-l-inquadramento-diagnostico-delle-obesita-genetiche]]></loc><lastmod>2024-07-01T10:20:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21105-al-via-la-seconda-edizione-del-patient-engagement-award]]></loc><lastmod>2024-06-22T09:56:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21102-torna-il-festival-uno-sguardo-raro-online-il-bando-di-concorso-2024]]></loc><lastmod>2024-06-21T09:13:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21092-malattie-dermatologiche-rare-la-sofferenza-dei-pazienti-e-sottovalutata]]></loc><lastmod>2024-06-18T15:57:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21090-malattie-rare-omar-sigla-accordo-di-collaborazione-con-la-societa-italiana-di-endocrinologia]]></loc><lastmod>2024-06-18T10:56:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21078-sangue-e-plasma-straordinari-strumenti-di-cura-per-l-intera-popolazione]]></loc><lastmod>2024-06-13T14:51:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21070-sarcoidosi-al-via-indagine-internazionale-sugli-effetti-collaterali-degli-steroidi]]></loc><lastmod>2024-06-10T17:16:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21054-salute-necessario-garantire-accesso-equo-alle-cure-anche-per-le-malattie-rare]]></loc><lastmod>2024-06-07T10:07:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21052-alopecia-areata-grave-con-baricitinib-c-e-oggi-una-terapia-specifica-ed-efficace]]></loc><lastmod>2024-06-06T15:41:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21043-rare-siblings-in-regione-lombardia-una-giornata-e-un-convegno-dedicati]]></loc><lastmod>2024-06-03T12:50:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21035-farmaci-italiani-poco-informati-ma-pronti-a-supportare-politiche-innovative]]></loc><lastmod>2024-06-03T10:00:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21030-la-malattia-della-testa-che-scivola-sul-collo-come-riconoscerla-e-trattarla]]></loc><lastmod>2024-05-30T11:03:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21016-spiagge-accessibili-per-persone-con-disabilita-da-salerno-parte-un-progetto-dedicato-all-autonomia]]></loc><lastmod>2024-05-28T14:53:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21008-malattie-renali-ariela-benigni-si-aggiudica-l-era-award]]></loc><lastmod>2024-05-23T12:12:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21003-ricomincia-da-te-un-format-per-caregiver-ideato-da-una-psicologa-a-sua-volta-caregiver]]></loc><lastmod>2024-05-22T17:34:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20991-malattie-rare-dermatologiche-e-vascolari-troppe-sono-ancora-senza-nome]]></loc><lastmod>2024-05-20T11:10:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20987-intelligenza-artificiale-che-cosa-sta-facendo-l-europa-per-regolamentarne-l-uso]]></loc><lastmod>2024-06-18T14:06:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20982-donne-con-disabilita-online-un-questionario-sulle-condizioni-di-lavoro]]></loc><lastmod>2024-05-16T14:00:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20974-pfbc-la-malattia-che-trasforma-i-neuroni-in-osso]]></loc><lastmod>2024-05-29T10:27:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20973-pfbc-complessita-diagnostica-e-presa-in-carico-del-paziente]]></loc><lastmod>2024-05-15T14:57:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20978-sclerosi-tuberosa-al-bambino-gesu-oltre-150-pazienti-in-3-anni]]></loc><lastmod>2024-05-15T15:51:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20972-mucopolissaccaridosi-oggi-si-celebra-la-giornata-mondiale]]></loc><lastmod>2024-05-29T19:52:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20960-eliminazione-bonus-barriere-architettoniche-preoccupa-la-disparita-delle-misure]]></loc><lastmod>2024-05-10T12:13:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20951-plasma-in-italia-raccolta-da-record-ma-l-autosufficienza-e-lontana]]></loc><lastmod>2024-05-09T08:58:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20950-cheratiti-periferiche-l-aimo-patologie-ostiche-anche-per-i-piu-esperti]]></loc><lastmod>2024-05-09T08:59:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20948-virus-respiratorio-sinciziale-nuovi-dati-real-world-confermano-l-efficacia-di-nirsevimab]]></loc><lastmod>2024-05-09T08:42:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20947-di-che-sangue-sei-al-via-il-progetto-blood-inclusivity-di-sobi]]></loc><lastmod>2024-05-09T08:26:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20940-accessibilita-degli-eventi-dal-vivo-presentato-il-primo-manifesto-per-rivendicarne-il-diritto]]></loc><lastmod>2025-11-03T08:33:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20936-gruppo-chiesi-nel-2023-superati-i-3-miliardi-di-euro-di-fatturato]]></loc><lastmod>2024-05-06T15:17:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20932-sarcoidosi-al-iii-congresso-nazionale-la-prima-grande-scuola-per-i-pazienti]]></loc><lastmod>2024-05-06T07:45:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20930-inclusione-presentato-il-diversity-media-report-2024]]></loc><lastmod>2024-05-03T14:46:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20933-malattie-genetiche-torna-io-per-lei-la-campagna-di-telethon-che-celebra-le-mamme-rare]]></loc><lastmod>2024-05-03T15:52:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20924-accademia-del-paziente-esperto-eupati-l-importanza-del-paziente-esperto]]></loc><lastmod>2024-05-02T17:47:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20916-malattia-dell-occhio-secco-al-via-la-campagna-apri-gli-occhi]]></loc><lastmod>2024-04-29T16:15:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20915-malattie-cardiovascolari-annunciati-i-vincitori-del-contest-aderire-per-vincere]]></loc><lastmod>2024-04-24T16:30:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20909-malattia-da-agglutinine-fredde-presentato-il-libro-una-vita-senza-inverno]]></loc><lastmod>2024-04-24T16:37:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20890-malattie-rare-specialisti-pediatri-e-medici-di-medicina-generale-insieme-in-direzione-futuro]]></loc><lastmod>2024-04-19T15:10:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20892-telethon-cambio-al-vertice-del-tigem]]></loc><lastmod>2024-04-21T09:22:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20875-tumore-alla-prostata-al-via-la-campagna-men-s-pro]]></loc><lastmod>2024-04-15T14:30:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20881-malattia-avventiziale-cistica-dell-arteria-poplitea-la-patologia-del-35-enne-operato-a-monza]]></loc><lastmod>2024-04-17T10:03:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20874-human-genome-meeting-hgm-2024-le-novita-sulla-genetica-da-tutto-il-mondo]]></loc><lastmod>2024-04-15T14:11:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20873-la-mano-del-musicista-in-lombardia-un-convegno-sulle-malattie-degli-strumentisti]]></loc><lastmod>2024-04-15T13:59:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20847-sindrome-di-pitt-hopkins-in-italia-sono-almeno-70-le-persone-con-una-diagnosi]]></loc><lastmod>2024-04-08T17:47:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20843-malattie-neuromuscolari-inaugurati-i-primi-quattro-posti-letto-del-centro-nemo-bologna]]></loc><lastmod>2024-04-08T08:52:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20840-giornata-internazionale-dello-sport-aisla-e-coni-insieme-per-celebrarla]]></loc><lastmod>2024-04-08T08:09:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20838-il-centro-per-le-malattie-rare-al-gemelli-un-accoglienza-a-360-gradi]]></loc><lastmod>2024-04-05T12:02:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20817-aifa-insediata-la-nuova-commissione-scientifica-ed-economica]]></loc><lastmod>2024-03-28T15:30:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20800-malattie-rare-gli-auguri-di-omar-al-neo-forum-delle-associazioni-abruzzesi]]></loc><lastmod>2024-03-25T13:41:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20791-omar-entra-a-far-parte-della-rete-fish-per-i-diritti-delle-persone-con-disabilita]]></loc><lastmod>2024-03-22T11:17:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20785-disforia-di-genere-al-gemelli-apre-un-ambulatorio-dedicato]]></loc><lastmod>2024-03-21T13:03:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20781-sindrome-di-ehlers-danlos-a-milano-un-centro-di-riferimento-d-eccellenza-ma-manca-personale]]></loc><lastmod>2026-02-16T10:10:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20761-un-mese-per-ricordare-i-disturbi-dello-spettro-della-neuromielite-ottica]]></loc><lastmod>2024-03-15T16:08:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20758-virus-respiratorio-sinciziale-nasce-l-alleanza-per-un-infanzia-libera-dall-rsv]]></loc><lastmod>2024-03-15T13:18:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20752-malattie-rare-omar-sigla-accordo-e-diventa-media-partner-di-eupati]]></loc><lastmod>2024-03-14T09:08:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20747-giornata-mondiale-del-rene-tutte-le-iniziative-previste-per-oggi]]></loc><lastmod>2024-03-13T14:40:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20746-malattia-di-kienbock-la-patologia-rara-che-ha-colpito-francesco-panarella-di-mare-fuori]]></loc><lastmod>2024-03-13T15:37:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20717-sindrome-di-brugada-prof-brugada-un-elettrocardiogramma-puo-salvarti-la-vita]]></loc><lastmod>2024-04-12T12:16:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20703-giornata-mondiale-malattie-rare-sanofi-riaccende-i-riflettori-sul-valore-della-ricerca]]></loc><lastmod>2024-02-29T19:00:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20687-malattie-rare-la-campania-accelera-sull-attuazione-del-piano-nazionale]]></loc><lastmod>2024-02-27T18:52:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20686-malattie-rare-omar-e-fablab-cgm-rinnovano-la-loro-partnership-per-una-diagnosi-precoce]]></loc><lastmod>2024-02-27T17:23:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20689-giornata-mondiale-malattie-rare-l-impegno-di-kyowa-kirin-al-fianco-dei-pazienti]]></loc><lastmod>2024-02-28T11:21:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20680-malattie-rare-un-convegno-per-parlare-di-assistenza-e-qualita-della-vita]]></loc><lastmod>2024-02-26T22:02:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20675-caregiver-familiare-le-associazioni-chiedono-riconoscimento-e-tutela-di-questa-figura]]></loc><lastmod>2024-02-26T19:52:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20679-malattie-rare-omar-e-sigu-firmano-accordo-di-collaborazione]]></loc><lastmod>2024-02-27T09:27:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20678-giornata-mondiale-delle-malattie-rare-le-iniziative-in-abruzzo]]></loc><lastmod>2024-02-26T15:29:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20674-la-vita-con-un-figlio-disabile-la-toccante-lettera-di-marco-macri-alle-istituzioni]]></loc><lastmod>2024-02-24T10:52:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20668-carenze-di-farmaci-il-database-drughost-si-conferma-un-prezioso-strumento-predittivo]]></loc><lastmod>2024-02-22T18:14:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20669-malattie-e-tumori-rari-importante-riconoscere-e-sostenere-le-figure-del-caregiver-e-del-sibling]]></loc><lastmod>2024-02-23T09:31:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20665-rare-sibling-anche-la-regione-lazio-istituisce-la-giornata-dedicata]]></loc><lastmod>2024-02-22T15:27:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20655-malattie-neuromuscolari-nasce-la-consulta-della-liguria]]></loc><lastmod>2024-02-20T11:13:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20650-malattie-rare-al-bambino-gesu-18-nuovi-geni-malattia-e-piu-di-18-000-pazienti-seguiti-nel-2023]]></loc><lastmod>2024-02-20T18:58:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20640-taglio-fondi-per-disabilita-gravi-e-gravissime-i-pazienti-pronti-a-manifestare-contro-regione-lombardia]]></loc><lastmod>2024-02-19T16:21:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20642-i-laboratori-pierre-fabre-e-la-fondazione-esperare-riceveranno-il-premio-aziendale-di-eurordis-per-il-coinvolgimento-dei-pazienti-2024]]></loc><lastmod>2024-02-16T07:59:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20630-giornata-mondiale-malattie-rare-al-via-basta-essere-pazienti-la-campagna-di-comunicazione-di-omar]]></loc><lastmod>2024-03-07T10:49:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20604-trapianto-di-staminali-emopoietiche-online-un-podcast-di-accompagnamento-per-pazienti-e-donatori]]></loc><lastmod>2024-02-08T09:43:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20609-al-gemelli-un-meeting-scientifico-sulla-sindrome-dell-intestino-corto]]></loc><lastmod>2024-02-08T18:55:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20596-nipt-test-test-dna-fetale-ora-gratuito-in-valle-d-aosta-per-le-donne-in-gravidanza]]></loc><lastmod>2024-02-07T09:45:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20590-disabilita-e-viaggi-in-aereo-una-petizione-per-poter-volare-con-la-propria-carrozzina]]></loc><lastmod>2024-02-05T15:39:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20574-trapianto-di-rene-per-le-pazienti-sottoposte-all-intervento-la-gravidanza-e-possibile]]></loc><lastmod>2025-11-07T09:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20583-world-cancer-day-l-importanza-di-preservare-la-fertilita-nei-pazienti-in-eta-riproduttiva]]></loc><lastmod>2024-02-01T16:01:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20582-tumori-rari-il-4-febbraio-ricorre-il-world-cancer-day]]></loc><lastmod>2024-02-03T12:32:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20566-tumore-del-polmone-non-a-piccole-cellule-ok-da-aifa-per-lorlatinib]]></loc><lastmod>2024-01-29T10:33:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20563-carcinoma-uroteliale-dati-positivi-dall-impiego-real-world-di-avelumab]]></loc><lastmod>2024-01-29T09:56:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20556-sanita-in-italia-a-rischio-l-equita-del-sistema-salute]]></loc><lastmod>2024-01-25T14:08:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20552-tumore-al-seno-le-raccomandazioni-asco-sottolineano-l-importanza-delle-analisi-genetiche]]></loc><lastmod>2024-01-24T16:16:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20535-pouchite-a-roma-un-evento-per-informare-la-comunita-scientifica-sulle-novita-terapeutiche]]></loc><lastmod>2024-01-20T11:10:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20528-autismo-definiti-dalle-regioni-500-progetti-grazie-a-fondo-per-l-inclusione]]></loc><lastmod>2024-01-18T19:44:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20514-displasia-broncopolmonare-chiesi-e-oak-hill-bio-insieme-per-lo-sviluppo-di-un-nuovo-farmaco]]></loc><lastmod>2024-01-13T22:06:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20507-cambio-al-vertice-di-confindustria-dispositivi-medici-nuovi-obiettivi-in-linea-col-pnrr]]></loc><lastmod>2024-01-11T13:53:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20502-farmaci-alfasigma-si-aggiudica-i-diritti-europei-su-filgotinib]]></loc><lastmod>2024-01-10T18:59:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20485-ipolipidemie-pediatriche-malattie-genetiche-rarissime-e-poco-conosciute]]></loc><lastmod>2023-12-27T12:19:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20464-verso-la-nascita-di-un-registro-italiano-per-le-piastrinopatie-e-piastrinopenie-congenite]]></loc><lastmod>2023-12-27T12:04:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20482-nomenclatore-della-specialistica-ambulatoriale-per-l-operativita-dei-lea-bisogna-aspettare-aprile-2024]]></loc><lastmod>2023-12-26T10:16:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20478-malattie-genetiche-rare-telethon-chiude-il-2023-con-una-raccolta-fondi-di-oltre-60-milioni-di-euro]]></loc><lastmod>2023-12-22T14:58:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20475-a-chiesi-il-59-oscar-di-bilancio-per-la-categoria-societa-benefit]]></loc><lastmod>2023-12-22T11:32:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20458-raggiungimento-dell-autonomia-per-le-persone-con-disabilita-l-appello-di-paola-tricomi-al-presidente-mattarella]]></loc><lastmod>2023-12-19T12:37:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20454-accessibilita-degli-eventi-culturali-la-battaglia-di-silvia-per-entrare-al-concerto-di-taylor-swift]]></loc><lastmod>2025-11-03T08:32:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20448-eurordis-photo-award-possibile-partecipare-fino-al-31-gennaio-2024]]></loc><lastmod>2023-12-15T17:24:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20423-cheratocono-aimo-il-cross-linking-e-un-trattamento-standardizzato-e-sicuro]]></loc><lastmod>2023-12-07T17:02:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20424-malattie-rare-torna-la-campagna-di-sensibilizzazione-e-raccolta-fondi-di-telethon]]></loc><lastmod>2023-12-06T19:09:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/21842-malattie-rare-alla-scienza-serve-tempo-ma-per-chi-ha-bisogno-di-una-terapia-l-attesa-e-devastante]]></loc><lastmod>2025-03-25T14:53:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20412-malattie-rare-x-edizione-per-il-premio-omar-per-la-comunicazione]]></loc><lastmod>2025-02-17T12:14:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20413-malattie-rare-paola-binetti-nominata-prima-omar-ambassador]]></loc><lastmod>2023-12-05T17:25:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20392-universita-di-torino-al-via-il-master-in-comunicazione-della-scienza]]></loc><lastmod>2023-11-29T07:53:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20404-giornata-internazionale-delle-persone-con-disabilita-il-32-1-e-a-rischio-poverta-in-italia]]></loc><lastmod>2023-12-01T12:49:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20398-holostem-sara-salvata-dal-ministero-arrivato-l-ok-per-acquisizione]]></loc><lastmod>2023-11-30T08:54:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20389-caso-holostem-presentata-interrogazione-ai-ministeri-delle-imprese-e-made-in-italy-e-della-salute]]></loc><lastmod>2023-11-28T16:05:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20378-trapianti-circa-il-10-19-dei-pazienti-esce-da-liste-di-attesa-perche-non-piu-idoneo]]></loc><lastmod>2023-11-23T18:32:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20382-bronchiectasie-gruppo-chiesi-e-haisco-pharmaceutical-insieme-per-lo-sviluppo-di-un-nuovo-farmaco]]></loc><lastmod>2025-11-21T18:20:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20357-misure-anti-contagio-da-covid-19-quali-sono-i-comportamenti-da-adottare]]></loc><lastmod>2023-11-20T13:55:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20367-in-occasione-della-giornata-internazionale-per-l-infanzia-e-l-adolescenza-omar-pubblica-il-libro-dedicato-ai-fratelli-e-alle-sorelle-che-combattono-le-malattie-rare]]></loc><lastmod>2024-02-22T17:16:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20353-abruzzo-contributo-di-10mila-euro-per-i-caregiver-che-assistono-minori-con-malattia-rara-e-disabilita-gravissima]]></loc><lastmod>2023-11-17T12:18:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20334-sensuability-comics-al-via-la-sesta-edizione]]></loc><lastmod>2023-11-13T14:36:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20333-mind-the-gap-un-libro-che-va-alle-radici-della-discriminazione]]></loc><lastmod>2023-11-13T14:03:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20328-fondazione-ircss-san-giovanni-dei-tintori-monza-un-modello-per-la-transizione-nelle-malattie-rare]]></loc><lastmod>2023-12-11T09:03:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20341-in-lombardia-ufficialmente-istituita-la-giornata-dei-rare-sibling]]></loc><lastmod>2023-11-15T08:31:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20337-medicina-trasfusionale-a-torino-attivi-due-nuovi-master-di-primo-livello]]></loc><lastmod>2023-11-14T17:59:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20313-indi-gregory-oggi-verra-interrotto-il-supporto-vitale]]></loc><lastmod>2023-11-13T13:44:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20312-malattie-rare-e-disabilita-90-associazioni-di-pazienti-chiedono-il-rispetto-delle-normative-che-integrano-i-sistemi-d-assistenza-nel-territorio]]></loc><lastmod>2023-11-09T10:30:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20309-indi-gregory-trasferita-in-italia-nessuna-cura-per-la-sua-malattia-rara-in-uk-volevano-staccare-la-spina]]></loc><lastmod>2023-11-10T12:09:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20292-malattie-rare-chiesi-pubblica-un-rapporto-sugli-oneri-per-la-loro-cura]]></loc><lastmod>2023-11-06T10:52:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20299-legge-delega-in-materia-di-disabilita-approvati-due-decreti-attuativi-operativi-dal-2025]]></loc><lastmod>2023-11-06T15:52:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20291-sangue-e-plasma-ad-ancona-un-incontro-dedicato-al-valore-della-donazione]]></loc><lastmod>2023-11-04T17:48:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20284-caregiver-istituito-il-tavolo-che-dovrebbe-definire-la-figura-ed-elaborare-una-legge-dedicata]]></loc><lastmod>2023-11-06T11:04:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20290-farmaci-alfasigma-punta-ad-acquisire-i-diritti-europei-su-filgotinib]]></loc><lastmod>2023-11-04T14:57:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20273-aboutpharma-digital-awards-candidature-aperte-fino-al-7-dicembre]]></loc><lastmod>2023-10-31T18:22:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20271-cheratosi-attinica-e-malattie-dermatologiche-rare-l-impegno-di-sidemast]]></loc><lastmod>2023-10-29T13:30:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20274-vaccino-anti-covid-19-campagna-a-rilento-ma-la-priorita-restano-disabili-e-fragili]]></loc><lastmod>2023-10-30T09:04:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20253-sordita-genetiche-un-insieme-di-malattie-diffuse-ma-ancora-troppo-trascurate]]></loc><lastmod>2023-10-25T07:49:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20251-malattie-rare-il-3-novembre-prende-il-via-l-ottava-edizione-di-uno-sguardo-raro]]></loc><lastmod>2023-11-06T10:46:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20245-sindromi-pten-correlate-tre-date-simboliche-per-parlarne-di-piu]]></loc><lastmod>2024-10-23T09:52:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20236-accessibilita-e-turismo-avviato-il-progetto-padova-in-lis]]></loc><lastmod>2023-10-20T16:47:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20232-malattie-rare-delle-piastrine-il-policlinico-gemelli-di-roma-e-centro-di-riferimento-regionale]]></loc><lastmod>2023-10-14T19:38:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20247-farmaci-l-azienda-eli-lilly-sigla-nuovo-patto-con-l-italia]]></loc><lastmod>2023-10-20T16:08:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20238-trapianti-la-cultura-del-dono-prezioso-da-non-sprecare-recepita-da-piemonte-e-valle-d-aosta]]></loc><lastmod>2023-10-18T06:57:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20207-dolore-fotografato-in-italia-il-bias-della-bua]]></loc><lastmod>2023-10-08T21:13:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20206-neuromielite-ottica-i-pazienti-rischiano-di-sviluppare-gravi-disabilita]]></loc><lastmod>2023-10-08T21:01:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20217-domani-12-ottobre-la-giornata-mondiale-della-vista-ecco-i-principali-eventi-nazionali]]></loc><lastmod>2023-10-11T08:06:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20200-disabilita-si-e-svolto-a-roma-il-fiabaday-2023]]></loc><lastmod>2023-10-09T08:14:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20199-takeda-italia-nominato-il-nuovo-general-manager]]></loc><lastmod>2023-10-09T08:13:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20190-virus-dengue-approvato-in-italia-il-primo-vaccino]]></loc><lastmod>2023-10-03T17:04:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20182-a-trento-un-laboratorio-sulla-distanza-comunicativa-tra-ricerca-scientifica-e-societa]]></loc><lastmod>2023-10-02T17:21:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20193-paralisi-cerebrale-il-6-ottobre-ricorre-la-giornata-mondiale]]></loc><lastmod>2023-10-04T14:31:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20178-tumore-al-seno-hellofresh-partecipa-alla-campagna-nastro-rosa]]></loc><lastmod>2023-10-02T14:57:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20173-lombardia-villa-santa-maria-di-como-entra-a-far-parte-della-rete-regionale-malattie-rare]]></loc><lastmod>2023-09-29T17:48:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20160-plasma-la-raccolta-insufficiente-costera-all-italia-179-milioni-di-euro]]></loc><lastmod>2023-09-28T17:22:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20168-cheratosi-attinica-al-via-la-campagna-derma-point]]></loc><lastmod>2023-09-28T08:56:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20164-osservatorio-malattie-rare-compie-13-anni-nuova-linea-editoriale-e-nuovo-comitato-scientifico-per-continuare-a-dare-voce-a-un-mondo-che-cambia]]></loc><lastmod>2025-10-08T13:29:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20152-giornata-mondiale-del-turismo-per-chi-ha-malattie-rare-e-disabilita-un-diritto-sempre-a-rischio]]></loc><lastmod>2023-09-25T14:52:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20150-trasporto-aereo-persone-con-disabilita-l-odissea-di-michela-malata-di-fibrosi-polmonare-idiopatica]]></loc><lastmod>2023-09-25T15:22:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20143-in-partenza-la-terza-edizione-del-master-di-ii-livello-in-malattie-rare-dell-universita-vanvitelli]]></loc><lastmod>2023-09-22T09:05:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20130-sordita-genetica-regeneron-punta-sulle-terapie-avanzate]]></loc><lastmod>2023-09-18T14:23:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20105-tumori-testa-collo-torna-anche-quest-anno-la-make-sense-campaign]]></loc><lastmod>2023-09-09T12:33:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20099-ern-reconnet-soddisfatti-del-lavoro-svolto-e-pronti-per-altri-cinque-anni-di-attivita]]></loc><lastmod>2023-09-08T20:00:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20097-spiagge-italiane-meno-del-10-degli-stabilimenti-e-accessibile-per-le-persone-con-disabilita]]></loc><lastmod>2023-09-08T11:01:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20098-malattie-neuromuscolari-nasce-la-consulta-del-sud]]></loc><lastmod>2023-09-08T14:43:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20088-farmaci-paolo-gasparini-nominato-rappresentante-per-l-italia-del-chmp-europeo]]></loc><lastmod>2023-09-11T08:05:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20077-eurordis-inaugura-il-gruppo-dei-giovani-ambasciatori-per-la-giornata-delle-malattie-rare]]></loc><lastmod>2023-08-29T09:55:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20073-sindrome-della-persona-rigida-tanti-trattamenti-sintomatici-ma-ancora-nessuna-cura]]></loc><lastmod>2023-08-29T11:27:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20071-sindrome-della-persona-rigida-celine-dion-verso-il-ritiro-dalle-scene]]></loc><lastmod>2023-08-23T16:54:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20059-malattie-rare-annunciati-i-destinatari-del-finanziamento-rareis-global-advocate-grant-per-il-2023]]></loc><lastmod>2023-08-14T15:05:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20058-tumore-al-polmone-al-giffoni-il-docufilm-di-sanofi-oltre-il-mare]]></loc><lastmod>2023-08-07T09:14:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20057-malattie-inguaribili-a-milano-vidas-non-si-ferma-neanche-in-estate]]></loc><lastmod>2023-08-07T09:12:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20056-malattie-neuromuscolari-nasce-il-centro-clinico-nemo-bologna]]></loc><lastmod>2023-08-14T18:00:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20061-vicenda-di-cosenza-arrivano-le-spiegazioni-una-richiesta-sbagliata-da-parte-della-farmacia]]></loc><lastmod>2023-08-09T07:58:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20043-prestazioni-sanitarie-il-lazio-ancora-indietro-rispetto-al-2019]]></loc><lastmod>2023-08-07T08:51:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20054-carta-dei-malati-rari-senza-diagnosi-e-disponibile-il-testo-definitivo]]></loc><lastmod>2023-08-02T16:33:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20049-farmaci-per-malattie-rare-lo-strano-caso-di-cosenza-che-chiede-l-isee-ad-una-paziente-esente]]></loc><lastmod>2023-08-02T22:17:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20041-malattie-rare-e-ai-un-progetto-in-friuli-venezia-giulia]]></loc><lastmod>2023-07-27T20:34:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20039-trani-ragazza-con-disabilita-costretta-in-casa-da-un-ascensore-guasto]]></loc><lastmod>2023-07-25T09:21:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20026-paraparesi-spastica-ereditaria-spg35-un-video-appello-per-sostenere-la-ricerca]]></loc><lastmod>2023-07-21T10:06:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20025-biotecnologie-in-italia-un-comparto-in-crescita-con-oltre-13-miliardi-di-fatturato]]></loc><lastmod>2023-07-21T09:47:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20014-malattie-respiratorie-45-7-miliardi-di-euro-e-il-loro-costo-sociale-in-italia]]></loc><lastmod>2023-07-17T08:51:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20024-covid-19-richiamo-vaccinale-annuale-obbligatorio-per-fragili-e-over-50]]></loc><lastmod>2023-07-21T08:24:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20022-malattie-rare-concluso-il-master-dell-universita-vanvitelli-di-napoli]]></loc><lastmod>2023-07-20T09:57:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20007-malattie-rare-30mila-i-pazienti-inseriti-nel-registro-della-campania]]></loc><lastmod>2023-07-17T08:48:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20008-iperinsulinismo-congenito-a-milano-intervento-record-su-neonato]]></loc><lastmod>2023-07-17T08:49:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20004-diagnostica-roche-presenta-docuserie-sul-viaggio-del-campione-biologico]]></loc><lastmod>2023-07-17T08:47:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20016-premio-omar-ancora-due-settimane-per-candidarsi-alla-x-edizione]]></loc><lastmod>2023-10-23T11:15:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/20001-la-carta-dei-malati-rari-senza-diagnosi-un-documento-open]]></loc><lastmod>2023-07-14T07:51:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19974-disabilita-l-appello-di-casa-al-plurale-al-sindaco-di-roma]]></loc><lastmod>2023-07-02T21:34:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19980-malattie-rare-in-campania-asl-napoli-2-nord-adotta-12-nuovi-pdta]]></loc><lastmod>2023-07-04T15:43:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19979-regione-umbria-aperto-fino-a-fine-mese-il-bando-per-i-progetti-di-vita-indipendente-per-persone-con-disabilita]]></loc><lastmod>2023-07-04T15:15:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19978-malattie-rare-aperte-le-candidature-all-ottava-edizione-del-festival-uno-sguardo-raro]]></loc><lastmod>2023-07-04T14:45:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19955-terapie-avanzate-a-roma-oltre-40-tra-i-massimi-esperti-riuniti-per-il-retreat]]></loc><lastmod>2023-06-27T16:10:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19942-turismo-accessibile-il-forum-europeo-sulla-disabilita-chiede-diritti-garantiti-per-il-trasporto-aereo]]></loc><lastmod>2023-06-25T21:16:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19943-trasporto-ferroviario-di-persone-con-disabilita-approvato-il-regolamento-ue]]></loc><lastmod>2023-06-25T21:16:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19917-disabilita-nasce-una-nuova-partnership-a-sostegno-della-vela-paralimpica]]></loc><lastmod>2023-06-19T10:49:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19916-malattie-neuromuscolari-riparte-il-progetto-anima-libera]]></loc><lastmod>2023-06-19T10:49:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19913-farmaci-takeda-punta-altri-22-milioni-di-euro-sullo-stabilimento-di-rieti]]></loc><lastmod>2023-06-19T10:48:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19919-distrofia-facio-scapolo-omerale-oggi-la-giornata-mondiale-world-fshd-day-2023]]></loc><lastmod>2023-06-20T06:55:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19908-terapia-genica-aavantgarde-chiude-un-finanziamento-di-serie-a-da-61-milioni-di-euro]]></loc><lastmod>2023-06-19T10:57:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19891-al-via-la-quarta-edizione-del-bando-fondazione-roche-per-i-pazienti]]></loc><lastmod>2023-06-12T10:21:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19884-il-nido-del-pettirosso-una-raccolta-di-testimonianze-dal-mondo-delle-malattie-genetiche-rare-pediatriche]]></loc><lastmod>2023-06-12T10:19:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19871-medicina-burocratizzata-governance-o-limite-per-l-accesso-alle-cure-per-i-cittadini]]></loc><lastmod>2023-06-04T13:43:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19860-biotecnologie-il-ministro-urso-al-lavoro-per-il-piano-nazionale]]></loc><lastmod>2023-06-01T10:03:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19859-malattie-rare-alla-fondatrice-di-omar-l-onorificenza-di-cavaliere-al-merito-della-repubblica-italiana]]></loc><lastmod>2023-06-01T09:18:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19844-health-care-nasce-il-patient-engagement-award]]></loc><lastmod>2023-05-30T20:57:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19856-giornata-europea-dei-sibling-in-campidoglio-un-evento-dedicato-alle-sorelle-e-ai-fratelli-di-persone-con-malattia-rara]]></loc><lastmod>2023-05-31T16:53:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19829-obesita-infantile-non-e-mai-questione-costituzionale-potrebbe-trattarsi-di-una-malattia-rara]]></loc><lastmod>2023-05-26T10:33:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19830-obesita-genetiche-malattie-rare-a-tutti-gli-effetti-di-cui-si-parla-troppo-poco]]></loc><lastmod>2023-05-26T10:33:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19839-disabilita-aperte-le-candidature-a-make-to-care]]></loc><lastmod>2023-05-26T09:33:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19838-a-padova-il-primo-trapianto-con-cuore-fermo-da-piu-di-20-minuti]]></loc><lastmod>2023-05-25T10:49:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19824-disabilita-valentina-tomirotti-all-eurovision-italia-al-1-posto-nella-narrazione-abilista]]></loc><lastmod>2023-05-22T13:34:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19825-malattia-di-addison-imparando-a-gestirla-si-puo-condurre-una-vita-normale]]></loc><lastmod>2023-05-22T13:33:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19810-malattie-dermatologiche-giuseppe-argenziano-eletto-a-capo-della-sidemast]]></loc><lastmod>2023-05-18T10:14:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19794-carcinoma-polmonare-non-a-piccole-cellule-capmatinib-rimborsabile-in-italia]]></loc><lastmod>2023-05-12T15:58:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19792-disability-pride-dopo-il-successo-di-torino-nuovo-appuntamento-domani-a-genova]]></loc><lastmod>2023-05-09T17:18:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19787-premio-omar-aperte-le-candidature-alla-x-edizione]]></loc><lastmod>2023-10-23T11:15:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19778-tumori-del-sangue-a-milano-il-secondo-incontro-del-progetto-bridge-the-gap]]></loc><lastmod>2023-05-05T15:00:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19766-malattie-rare-senza-diagnosi-pubblicata-la-carta-per-il-riconoscimento-dei-diritti-dei-pazienti]]></loc><lastmod>2023-05-02T16:56:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19757-malattie-oncoematologiche-700-chilometri-in-bici-per-sottolineare-i-benefici-dell-attivita-fisica]]></loc><lastmod>2023-04-29T16:00:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19753-malattie-rare-al-via-la-terza-edizione-del-premio-horizon]]></loc><lastmod>2023-04-29T16:00:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19765-ustioni-in-italia-manca-un-piano-per-la-gestione-delle-maxiemergenze]]></loc><lastmod>2023-04-29T15:27:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19756-malattie-rare-senza-diagnosi-necessario-costruire-ampie-alleanze-per-non-lasciare-soli-pazienti-e-famiglie]]></loc><lastmod>2023-04-28T09:50:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19755-donne-controcorrente-un-libro-che-accende-i-riflettori-sull-onda-rosa-in-sanita]]></loc><lastmod>2023-04-28T11:10:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19747-sindrome-di-kabuki-matteo-ha-fondato-l-associazione-filo-raro-per-garantire-a-sua-figlia-la-speranza-nel-futuro]]></loc><lastmod>2023-04-24T16:39:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19746-sindrome-di-kabuki-al-bambino-gesu-di-roma-un-percorso-dedicato-a-pazienti-e-famiglie]]></loc><lastmod>2023-04-24T16:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19745-la-bambina-di-vetro-un-albo-illustrato-che-racconta-la-difficolta-di-essere-diversi]]></loc><lastmod>2023-04-21T19:42:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19729-malattie-neuromuscolari-costituita-la-consulta-regionale-del-lazio]]></loc><lastmod>2023-04-20T19:51:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19726-ematologia-a-bologna-l-incontro-tra-sie-e-associazioni-di-pazienti]]></loc><lastmod>2023-04-20T19:48:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19738-tutela-degli-alunni-con-disabilita-l-interpellanza-dell-on-sportiello]]></loc><lastmod>2023-04-20T17:36:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19740-rare-sibling-approvata-in-campidoglio-una-mozione-per-istituire-la-giornata-nazionale]]></loc><lastmod>2023-04-20T17:34:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19733-disability-pride-2023-e-partito-da-torino-l-evento-itinerante-che-e-un-inno-all-orgoglio-disabile]]></loc><lastmod>2023-04-20T08:28:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19722-malattie-rare-chiesi-farmaceutici-completa-l-acquisizione-di-amryt-pharma]]></loc><lastmod>2023-04-18T22:05:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19723-malattie-neuromuscolari-una-raccolta-fondi-per-potenziare-lo-sportello-uildm-risponde]]></loc><lastmod>2023-04-18T22:05:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19713-trapianto-di-polmoni-nel-70-dei-casi-organi-destinati-a-persone-con-malattie-rare]]></loc><lastmod>2023-04-13T08:25:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19695-ossigenoterapia-e-trasporto-aereo-soluzione-potrebbe-essere-ossigeno-fornito-dalle-compagnie-aeree]]></loc><lastmod>2023-04-06T10:10:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19696-trapianti-gli-organi-destinati-possono-viaggiare-su-tutte-le-tratte-nazionali-delle-principali-compagnie-aeree]]></loc><lastmod>2023-04-06T10:11:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19694-trasporto-aereo-negato-a-paziente-in-attesa-di-trapianto-polmonare-la-battaglia-di-ferruccio-che-non-ce-l-ha-fatta]]></loc><lastmod>2023-04-12T08:40:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19686-malattie-reumatologiche-inaugurato-a-pisa-il-centro-ricerche-fira]]></loc><lastmod>2023-04-05T18:54:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19684-sindrome-dell-intestino-corto-nasce-la-piattaforma-referral-to-care]]></loc><lastmod>2023-04-06T09:05:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19685-io-guenda-e-il-gene-matto-la-storia-di-una-donna-alle-prese-con-un-tumore-rarissimo]]></loc><lastmod>2023-04-05T18:53:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19697-malattie-rare-ecco-il-nuovo-piano-regionale-della-regione-lazio-2023]]></loc><lastmod>2023-04-06T08:28:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19624-intelligenza-artificiale-nelle-malattie-rare-quanto-possiamo-fidarci]]></loc><lastmod>2024-06-18T14:05:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19688-nutrizione-clinica-nutrisens-acquisisce-la-societa-torinese-pharmaelle]]></loc><lastmod>2023-04-03T17:50:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19669-neuromielite-ottica-nasce-l-associazione-ainmo]]></loc><lastmod>2023-03-30T14:19:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19673-malattie-dell-occhio-83enne-recupera-la-vista-grazie-ad-autotrapianto-della-superficie-oculare]]></loc><lastmod>2023-03-30T10:11:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19671-farmaci-bayer-accelera-l-innovazione-nella-salute]]></loc><lastmod>2023-03-28T17:49:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19662-demenza-frontotemporale-una-malattia-piu-rara-dell-alzheimer-ma-altrettanto-grave]]></loc><lastmod>2023-03-28T17:50:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19663-trapianti-d-organo-quasi-sempre-la-causa-e-una-malattia-rara-ecco-i-dati-italiani]]></loc><lastmod>2023-03-27T08:05:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19648-cheratocono-filippo-volandri-testimonial-su-tiktok-per-la-campagna-aimo]]></loc><lastmod>2023-03-19T12:50:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19644-malattie-neurologiche-un-numero-solidale-per-il-completamento-del-centro-tog-di-milano]]></loc><lastmod>2023-03-22T19:22:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19645-incontinenza-e-stomia-i-pazienti-non-hanno-diritto-a-dispositivi-personalizzati]]></loc><lastmod>2023-03-23T09:24:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19650-partecipa-all-indagine-online-di-omar-compila-il-questionario-per-aiutarci-a-raccogliere-le-priorita-di-pazienti-caregiver-e-associazioni]]></loc><lastmod>2023-03-31T21:18:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19639-malattie-genetiche-rare-genomeup-si-aggiudica-piu-di-un-milione-di-euro-di-finanziamento]]></loc><lastmod>2023-03-17T16:27:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19632-malattie-rare-il-tempo-e-cio-che-i-pazienti-non-possono-permettersi-di-perdere]]></loc><lastmod>2023-03-16T18:40:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19629-malattia-di-norrie-tommaso-e-la-sua-famiglia-isolati-in-un-hotel-perche-disturbavano-i-clienti]]></loc><lastmod>2023-06-06T10:53:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19616-malattie-endocrine-rare-a-taormina-un-convegno-su-accesso-a-diagnosi-e-cure]]></loc><lastmod>2023-03-10T23:42:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19615-la-casa-di-matteo-una-famiglia-al-di-fuori-della-famiglia-per-bimbi-con-patologie-gravissime]]></loc><lastmod>2023-03-10T23:36:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19607-malattie-rare-gli-highlights-del-ix-premio-omar]]></loc><lastmod>2023-03-09T11:14:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19594-malattie-rare-aperte-le-candidature-per-il-rareis-global-advocate-grant]]></loc><lastmod>2023-03-07T09:49:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19592-malattie-rare-le-associazioni-della-rete-a-ma-re-puglia-lanciano-un-manifesto]]></loc><lastmod>2023-03-07T14:44:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19583-giornata-delle-malattie-rare-sanofi-lancia-la-campagna-ilvaloredeltempo]]></loc><lastmod>2023-02-28T17:39:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19582-malattie-rare-in-sardegna-piu-di-11mila-pazienti-di-cui-piu-di-2mila-sono-bambini]]></loc><lastmod>2023-02-28T18:41:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19584-ilaria-ciancaleoni-bartoli-nominata-cavaliere-dell-ordine-al-merito-della-repubblica-italiana]]></loc><lastmod>2023-03-01T12:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19571-malattie-rare-in-italia-il-70-dei-pazienti-e-under-18]]></loc><lastmod>2023-02-27T21:31:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19572-malattie-rare-la-luce-dopo-il-buio]]></loc><lastmod>2023-02-27T21:30:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19567-giornata-mondiale-malattie-rare-al-bambino-gesu-una-tavola-rotonda-sulle-reti-ern]]></loc><lastmod>2023-02-26T19:26:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19579-therareside-2023-liberta-fa-rima-con-accessibilita-un-giorno-con-valentina]]></loc><lastmod>2023-03-01T17:42:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19552-malattie-rare-arriva-il-fumetto-il-paese-delle-rarita]]></loc><lastmod>2023-03-14T08:49:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19547-malattie-neuromuscolari-i-centri-clinici-nemo-compiono-15-anni]]></loc><lastmod>2023-02-22T11:15:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19560-giornata-mondiale-malattie-rare-con-therareside-omar-porta-al-cinema-la-real-life]]></loc><lastmod>2023-03-09T09:21:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19563-demenza-frontotemporale-cos-e-la-malattia-rara-che-ha-colpito-bruce-willis]]></loc><lastmod>2023-02-23T13:03:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19558-smart-working-per-i-lavoratori-fragili-prorogato-fino-al-30-giugno-2023]]></loc><lastmod>2023-02-28T09:57:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19544-malattie-rare-medici-e-pediatri-costantemente-aggiornati-grazie-a-un-tool-intelligente]]></loc><lastmod>2023-02-17T18:36:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19525-spina-bifida-al-gemelli-nata-in-salute-una-bimba-operata-in-utero]]></loc><lastmod>2023-02-12T18:27:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19524-cardiopatie-congenite-oggi-la-giornata-mondiale]]></loc><lastmod>2023-02-12T18:20:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19518-tra-i-nuovi-alfieri-della-repubblica-tanti-giovani-impegnati-nell-ambito-della-disabilita]]></loc><lastmod>2023-02-07T10:39:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19517-nello-nominato-alfiere-della-repubblica-per-la-sua-battaglia-contro-la-distrofia]]></loc><lastmod>2023-02-07T10:42:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19507-tumori-in-italia-piu-di-390-000-nuove-diagnosi-nel-2022]]></loc><lastmod>2023-02-03T17:08:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19487-pelle-un-libro-che-racconta-le-malattie-rare-dell-epidermide-attraverso-la-voce-dei-pazienti]]></loc><lastmod>2023-01-28T11:49:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19482-sanita-pubblica-troppo-pochi-gli-investimenti-ed-e-allarme-organici-per-medici-e-infermieri]]></loc><lastmod>2023-01-26T19:17:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19481-bologna-pazienti-con-patologie-neurodegenerative-in-piazza-contro-chiusura-centro-il-bene-dell-irccs-bellaria]]></loc><lastmod>2023-01-26T10:14:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19456-disabilita-narrata-in-tv-a-stefano-buttafuoco-il-premio-antenna-d-oro]]></loc><lastmod>2023-01-18T12:20:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19454-vaccino-anti-covid-19-autorizzato-il-bivalenti-comirnaty-anche-come-richiamo-per-i-bambini-di-fascia-5-11]]></loc><lastmod>2023-01-17T08:51:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19446-disabilita-grave-e-diritto-alla-scuola-rigettato-il-ricorso-presentato-dalla-famiglia-di-roberta]]></loc><lastmod>2023-01-17T22:04:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19439-disabilita-il-cacciatore-di-sogni-torna-su-rai3-con-una-nuova-stagione]]></loc><lastmod>2023-01-10T16:42:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19430-malattie-rare-nasce-il-progetto-europeo-rare-disease-moonshot]]></loc><lastmod>2023-01-02T11:02:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19433-contagi-da-covid-19-e-contatti-stretti-ecco-le-nuove-regole-su-isolamento-e-tamponi]]></loc><lastmod>2023-01-04T18:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19423-malattie-neuromuscolari-donati-96-000-euro-ai-centri-clinici-nemo]]></loc><lastmod>2022-12-27T11:51:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19406-celine-dion-una-voce-per-le-malattie-rare]]></loc><lastmod>2022-12-23T19:18:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19420-sindrome-da-trasfusione-feto-fetale-due-gemelline-operate-in-utero-dai-medici-del-bambino-gesu]]></loc><lastmod>2022-12-27T15:23:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19418-tumore-alla-mammella-il-test-genetico-e-importante-ma-non-puo-prescindere-da-una-consulenza-esperta]]></loc><lastmod>2022-12-27T15:22:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19402-farmaci-celebrati-i-125-anni-di-presenza-di-roche-in-italia]]></loc><lastmod>2022-12-18T17:57:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19413-vaccino-anti-covid-19-ema-raccomanda-vaccinazioni-pediatriche-dai-6-mesi]]></loc><lastmod>2022-12-27T08:53:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19412-smart-working-per-i-lavoratori-fragili-in-arrivo-la-proroga-al-31-marzo-2023]]></loc><lastmod>2023-01-10T08:38:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19401-sindrome-di-helsmoortel-van-der-aa-nasce-l-associazione-italiana-dei-pazienti]]></loc><lastmod>2026-04-08T16:43:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19408-rare-sibling-mezzo-milione-di-altri-figli-chiede-attenzione]]></loc><lastmod>2022-12-22T14:04:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19409-rare-sibling-il-ruolo-del-pediatra-di-famiglia-e-fondamentale]]></loc><lastmod>2022-12-21T14:52:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19396-malattie-rare-presentato-il-testo-divulgativo-siamo-rari-non-invisibili]]></loc><lastmod>2022-12-16T21:32:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19379-disabilita-annunciati-i-vincitori-della-settima-edizione-di-make-to-care]]></loc><lastmod>2022-12-16T15:35:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19395-malattie-rare-omar-assegna-i-premi-connessioni]]></loc><lastmod>2022-12-16T09:52:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19394-malattie-rare-premiati-i-vincitori-della-nona-edizione-del-premio-omar]]></loc><lastmod>2022-12-16T09:25:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19366-disabilita-presentato-l-intergruppo-guidato-dalla-sen-versace]]></loc><lastmod>2022-12-07T09:51:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19365-scienze-omiche-per-la-corte-costituzionale-il-sequenziamento-dell-esoma-e-legittimo]]></loc><lastmod>2022-12-07T09:34:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19351-disabilita-l-italia-resta-indietro-nell-accessibilita-alle-cure]]></loc><lastmod>2022-12-01T18:12:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19350-biofarmaci-un-mercato-che-si-stima-triplichera-entro-il-2028]]></loc><lastmod>2022-11-30T19:22:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19337-sindrome-di-lynch-lo-screening-universale-e-una-strategia-vincente]]></loc><lastmod>2022-11-27T12:25:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19327-il-futuro-della-sanita-fondazione-roche-presenta-un-libro-bianco-sul-tema]]></loc><lastmod>2022-11-24T18:27:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19325-alimentazione-e-prevenzione-dei-tumori-nasce-il-progetto-umberto]]></loc><lastmod>2022-11-23T18:23:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19306-nasce-persone-oltre-la-malattia-il-magazine-che-parla-di-salute-dal-punto-di-vista-del-paziente]]></loc><lastmod>2022-11-23T18:04:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19324-disabilita-centri-nemo-e-biogen-presentano-il-progetto-abitiamo-nuovi-spazi-di-liberta]]></loc><lastmod>2022-11-23T17:23:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19297-dall-associazione-italiana-medici-oculisti-il-riconoscimento-alla-carriera-al-direttore-della-banca-degli-occhi-del-veneto]]></loc><lastmod>2022-11-21T18:10:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19314-uno-sguardo-raro-rare-disease-international-film-festival-conclusa-ieri-a-roma-l-edizione-2022]]></loc><lastmod>2022-11-21T15:41:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19292-sanita-da-50-associazioni-un-piano-d-azione-a-misura-di-paziente]]></loc><lastmod>2022-11-18T12:59:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19290-esofagite-eosinofila-per-gli-adulti-finalmente-un-farmaco-che-aiuta-a-spengere-l-infiammazione]]></loc><lastmod>2022-11-21T17:55:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19296-caregiver-l-onu-ha-condannato-l-italia-per-la-mancanza-di-tutela-giuridica-ma-la-ministra-locatelli-promette-interventi-tempestivi]]></loc><lastmod>2022-11-19T12:16:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19286-oncologia-grazie-alle-scienze-omiche-si-sviluppa-il-modello-mutazionale]]></loc><lastmod>2022-11-16T18:39:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19285-scienze-omiche-un-ambito-d-incontro-tra-laboratorio-clinica-e-terapie-avanzate]]></loc><lastmod>2022-11-16T18:35:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19280-scienze-omiche-una-svolta-nella-diagnosi-di-malattie-rare-e-senza-nome]]></loc><lastmod>2022-11-16T16:12:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19279-scienze-omiche-clinici-e-pazienti-chiedono-alla-politica-azioni-concrete]]></loc><lastmod>2022-11-16T16:36:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19264-endocrinologia-la-prof-ssa-maria-luisa-brandi-si-aggiudica-la-european-hormone-medal]]></loc><lastmod>2022-11-11T11:19:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19262-revisione-invalidita-civile-accelerata-la-procedura-di-sospensione-dell-assegno-in-caso-di-assenza]]></loc><lastmod>2022-11-10T18:16:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19263-permessi-legge-104-online-la-nuova-procedura-telematica-per-la-rinuncia]]></loc><lastmod>2022-11-10T18:19:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19245-malattie-rare-annunciati-i-vincitori-di-hack-e-rare-2022]]></loc><lastmod>2022-11-05T11:50:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19253-terapie-avanzate-torna-in-scena-lo-scienze-show-at2]]></loc><lastmod>2022-11-07T18:08:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19229-tumori-testa-collo-un-app-per-dare-voce-a-chi-non-ne-ha]]></loc><lastmod>2022-10-30T12:42:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19231-malattia-di-marchiafava-bignami-l-abuso-di-alcol-non-e-la-sola-causa]]></loc><lastmod>2022-10-30T12:42:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19230-disabilita-dal-progetto-sipuo-le-linee-guida-per-un-turismo-accessibile-ed-inclusivo]]></loc><lastmod>2022-10-30T12:43:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19237-obbligo-di-mascherina-prorogato-nelle-strutture-sanitarie-fino-al-31-dicembre-2022]]></loc><lastmod>2023-01-03T17:39:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19224-giornata-nazionale-uildm-distribuiti-150-000-euro-per-il-diritto-alla-mobilita]]></loc><lastmod>2022-10-28T14:23:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19226-l-amore-ci-fa-volare-la-storia-di-una-famiglia-alle-prese-con-una-malattia-rarissima]]></loc><lastmod>2022-10-28T14:25:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19210-locatelli-neo-ministra-per-le-disabilita-priorita-ai-decreti-attuativi-della-legge-delega]]></loc><lastmod>2022-10-25T08:52:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19195-farmaci-proclamati-i-vincitori-del-prix-galien-italia-2022]]></loc><lastmod>2022-10-21T16:41:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19194-malattie-rare-al-via-il-10-novembre-il-settimo-festival-cinematografico-uno-sguardo-raro]]></loc><lastmod>2022-10-24T15:08:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19174-anomalie-del-cuore-al-bambino-gesu-nuova-procedura-diagnostica-senza-raggi-x]]></loc><lastmod>2022-10-18T18:18:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19184-gaci-una-rara-malattia-genetica-che-causa-la-calcificazione-delle-arterie]]></loc><lastmod>2022-10-19T13:59:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19190-disturbi-dello-spettro-autistico-il-fondo-per-l-inclusione-delle-persone-con-disabilita-finanziera-interventi-regionali]]></loc><lastmod>2022-10-20T12:53:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19187-vaccino-anti-covid-19-e-antinfluenzale-possono-essere-somministrati-insieme]]></loc><lastmod>2022-10-19T14:50:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19180-gravidanza-e-allattamento-le-raccomandazioni-sulla-quarta-dose-di-vaccino-anti-covid-19]]></loc><lastmod>2022-10-19T10:24:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19175-malattie-cardiovascolari-il-27-28-ottobre-a-caserta-il-simposio-cardioupdate]]></loc><lastmod>2022-10-14T16:46:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19170-malattie-rare-a-modugno-ba-un-sostegno-economico-per-famiglie-con-pazienti-minori-di-14-anni]]></loc><lastmod>2022-10-14T15:51:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19169-miopatie-a-trento-un-convegno-scientifico-per-parlare-di-continuita-di-cura]]></loc><lastmod>2022-10-14T15:50:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19179-malattie-neuromuscolari-dal-17-al-23-ottobre-la-giornata-nazionale-uildm-2022]]></loc><lastmod>2022-10-17T17:52:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19157-atresia-esofagea-al-bambino-gesu-effettuato-trattamento-di-magneto-anastomosi]]></loc><lastmod>2022-10-12T20:37:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19166-giornata-mondiale-della-vista-la-cecita-pediatrica-colpisce-da-3-a-10-bambini-su-10-000]]></loc><lastmod>2022-10-13T11:35:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19156-malattie-neurologiche-infantili-raccolta-fondi-per-aprire-un-polo-di-riferimento-a-milano]]></loc><lastmod>2022-10-07T17:06:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19154-atassia-telangiectasia-concluso-il-convegno-annuale-anat]]></loc><lastmod>2022-10-07T14:05:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19148-caso-eriksen-occorre-rivedere-i-protocolli-cardiologici-per-l-idoneita-allo-sport-agonistico]]></loc><lastmod>2022-10-13T11:46:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19153-malattie-rare-e-sibling-omar-bambino-gesu-e-sip-insieme-per-la-formazione-dei-pediatri]]></loc><lastmod>2022-10-10T08:51:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19158-centralita-del-paziente-le-associazioni-mettono-pfizer-al-primo-posto-tra-le-big-pharma]]></loc><lastmod>2022-10-07T17:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19150-giornalismo-redattore-sociale-rischia-la-chiusura-la-perdita-sarebbe-gravissima]]></loc><lastmod>2022-10-07T10:19:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19146-tumore-al-seno-avanzato-dalle-testimonianze-delle-pazienti-nasce-la-guida-note-di-vita]]></loc><lastmod>2022-10-05T18:21:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19147-sindromi-pans-pandas-domenica-ricorre-la-giornata-mondiale]]></loc><lastmod>2022-10-05T18:19:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19096-regno-unito-lanciato-il-primo-piano-d-azione-per-le-malattie-rare]]></loc><lastmod>2022-09-30T11:20:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19133-mascherine-stop-a-obbligo-sui-mezzi-di-trasporto-dal-1-ottobre-ancora-necessarie-in-strutture-sanitarie]]></loc><lastmod>2022-10-01T09:08:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19122-malattie-rare-operativo-il-nuovo-comitato-scientifico-regolatorio-di-irdirc]]></loc><lastmod>2022-09-27T16:11:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19121-giornata-mondiale-del-cuore-necessario-migliorare-l-aderenza-terapeutica]]></loc><lastmod>2022-09-27T15:45:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19097-sindrome-di-noonan-primo-paziente-italiano-trattato-con-il-farmaco-trametinib]]></loc><lastmod>2022-09-22T15:31:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19116-vaccino-anti-covid-19-dal-ministero-della-salute-via-libera-a-quarte-e-quinte-dosi]]></loc><lastmod>2022-10-18T13:17:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19081-sindromi-atassiche-oggi-e-la-giornata-mondiale]]></loc><lastmod>2022-09-17T21:23:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19080-malattie-respiratorie-il-24-settembre-e-la-giornata-nazionale]]></loc><lastmod>2022-09-19T18:07:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19101-legge-aiuti-bis-tutte-le-misure-per-il-comparto-sanitario-e-per-il-sociale]]></loc><lastmod>2022-09-23T13:13:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19100-legge-aiuti-bis-arriva-la-proroga-dello-smart-working-per-i-lavoratori-fragili-e-per-i-genitori-con-figli-under-14]]></loc><lastmod>2022-09-23T08:23:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19077-malattie-neurologiche-oggi-e-la-prima-giornata-nazionale-della-neurologia]]></loc><lastmod>2022-09-17T20:32:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19067-io-e-il-drago-un-libro-per-parlare-di-disabilita-ai-piu-giovani]]></loc><lastmod>2022-09-17T20:18:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19091-disabilita-assistenza-negata-a-scuola-i-genitori-di-roberta-presentano-ricorso-al-tribunale]]></loc><lastmod>2022-10-19T15:21:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19064-sindrome-feto-alcolica-pubblicato-il-primo-manuale-per-famiglie-e-operatori]]></loc><lastmod>2022-09-19T16:06:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19088-malattie-mitocondriali-dal-18-al-24-settembre-si-celebra-la-settimana-mondiale-di-sensibilizzazione]]></loc><lastmod>2022-09-21T14:58:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19062-emoglobinopatie-le-raccomandazioni-della-site-sulla-gestione-delle-complicanze-endocrinologiche]]></loc><lastmod>2022-09-19T16:07:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19086-lea-ecco-la-sintesi-del-nuovo-decreto-tariffe-trasmesso-alla-conferenza-stato-regioni]]></loc><lastmod>2022-09-28T08:43:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19040-farmaci-andrea-degiorgi-e-il-nuovo-rare-business-unit-head-di-takeda]]></loc><lastmod>2022-09-11T13:57:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19041-malattie-neuromuscolari-al-via-il-progetto-anima-libera]]></loc><lastmod>2022-09-11T14:07:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19048-sordita-e-ipoacusia-dal-governo-i-criteri-di-ripartizione-di-8-milioni-di-fondi]]></loc><lastmod>2022-09-12T12:48:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19047-piano-nazionale-per-la-non-autosufficienza-previsto-stanziamento-di-2-6-miliardi-per-il-triennio-2022-2024]]></loc><lastmod>2022-12-22T11:46:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19046-sindrome-di-beckwith-wiedemann-la-piccola-isabel-protagonista-della-terza-puntata-di-dottori-in-corsia]]></loc><lastmod>2022-09-12T11:53:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19028-vaccinazioni-anti-covid-19-cosa-ci-aspetta-per-l-autunno-2022-vaccini-bivalenti-quarta-dose-e-obblighi-per-categoria]]></loc><lastmod>2024-09-18T07:26:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19011-plasmaderivati-bpl-e-kedrion-si-fondono-in-un-unica-societa]]></loc><lastmod>2022-09-01T16:26:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19009-malattie-respiratorie-rare-a-settembre-parte-il-master-di-ii-livello-dell-universita-federico-ii-di-napoli]]></loc><lastmod>2022-09-01T16:07:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19012-covid-19-ridotto-da-7-a-5-giorni-il-periodo-d-isolamento-dei-positivi-asintomatici-da-settembre-2022]]></loc><lastmod>2022-09-02T08:02:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/19004-cardiopatie-congenite-al-bambino-gesu-utilizzate-nuove-protesi-valvolari-polmonari]]></loc><lastmod>2022-08-26T17:37:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18997-cheratocono-dagli-oculisti-un-video-di-sensibilizzazione-rivolto-ai-giovani]]></loc><lastmod>2022-08-12T17:06:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18993-sindrome-pandas-in-arrivo-un-film-italiano-dedicato-alla-patologia]]></loc><lastmod>2023-03-27T09:14:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18988-tumori-ematologici-al-via-un-indagine-online]]></loc><lastmod>2022-08-08T15:31:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18990-sindrome-di-malan-pubblicate-le-prime-linee-guida]]></loc><lastmod>2022-08-08T15:28:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18975-rare-siblings-un-evento-di-formazione-dedicato]]></loc><lastmod>2022-08-03T10:36:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18948-malattie-neuromuscolari-online-il-documentario-crescere-insieme]]></loc><lastmod>2022-07-24T14:58:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18963-farmaceutica-italiana-piam-completa-acquisizione-di-bruschettini]]></loc><lastmod>2022-07-27T09:33:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18958-bonus-psicologo-2022-chi-ne-ha-diritto-quando-e-come-richiederlo]]></loc><lastmod>2022-11-07T14:53:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18919-disabilita-torna-make-to-care-con-la-sua-call-for-makers]]></loc><lastmod>2022-07-16T19:24:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18908-salute-pubblicato-il-rapporto-di-crea-sanita-le-performance-regionali]]></loc><lastmod>2022-07-09T21:56:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18909-policlinico-tor-vergata-il-nostro-impegno-per-i-malati-rari]]></loc><lastmod>2022-07-09T22:09:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18913-vaccinazione-anti-covid-19-al-via-la-quarta-dose-per-tutti-gli-over-60-e-i-fragili-over-12]]></loc><lastmod>2022-07-13T15:15:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18872-alopecia-areata-via-libera-dalla-fda-al-farmaco-baricitinib]]></loc><lastmod>2022-07-03T19:19:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18890-regione-toscana-apre-al-coinvolgimento-del-paziente-esperto-nelle-gare-di-acquisto-dei-farmaci]]></loc><lastmod>2022-07-05T16:19:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18887-smart-working-per-i-lavoratori-fragili-le-tutele-scadute-il-30-giugno]]></loc><lastmod>2022-07-08T13:47:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18839-special-olympics-a-torino-la-festa-dello-sport-in-gara-piu-di-3-000-atleti-con-disabilita]]></loc><lastmod>2022-06-25T17:31:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18848-festival-uno-sguardo-raro-per-partecipare-c-e-tempo-fino-al-30-giugno]]></loc><lastmod>2022-06-27T17:52:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18852-premio-omar-2022-ancora-un-mese-per-candidarsi]]></loc><lastmod>2022-06-28T14:48:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18812-tumori-pubblicata-la-guida-per-orientarsi-al-meglio-nel-mondo-delle-car-t]]></loc><lastmod>2022-06-23T12:56:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18807-a-milano-piu-trasparenza-sulle-opere-da-realizzare-per-l-abbattimento-delle-barriere-architettoniche]]></loc><lastmod>2022-06-23T06:08:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18778-covid-19-mascherine-ancora-obbligatorie-per-trasporto-pubblico-e-strutture-sanitarie-ma-non-a-scuola]]></loc><lastmod>2022-06-16T16:24:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18760-salute-al-via-la-decima-edizione-del-premio-letterario-zanibelli]]></loc><lastmod>2022-06-12T12:19:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18754-alopecia-areata-speranza-dai-nuovi-farmaci-biologici-jak-inibitori]]></loc><lastmod>2022-06-14T09:06:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18746-elezioni-e-referendum-2022-le-regole-anti-contagio-e-il-voto-assistito]]></loc><lastmod>2022-06-09T14:02:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18731-sindrome-di-sotos-presentato-il-glossario-della-malattia]]></loc><lastmod>2022-06-05T13:29:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18732-malattie-neuromuscolari-necessario-un-centro-clinico-nemo-anche-in-puglia]]></loc><lastmod>2022-06-05T13:49:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18729-malattie-rare-takeda-ottiene-la-certificazione-best-in-media-communication-per-il-terzo-anno-consecutivo]]></loc><lastmod>2022-06-05T12:18:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18730-capisciame-una-app-per-riconoscere-le-parole-delle-persone-con-disartria]]></loc><lastmod>2022-06-05T12:31:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18707-malattie-genetiche-rare-lanciata-la-campagna-facciamoli-diventare-grandi]]></loc><lastmod>2022-05-30T10:46:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18714-lavoratori-fragili-che-non-possono-svolgere-smart-working-in-arrivo-un-contributo-da-1-000-euro]]></loc><lastmod>2022-05-31T14:14:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18700-malattie-rare-al-via-hackerare-2022]]></loc><lastmod>2022-05-29T21:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18702-il-31-maggio-si-celebra-il-sibling-day-la-giornata-europea-dei-fratelli-e-sorelle]]></loc><lastmod>2022-05-30T08:31:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18699-salute-digestiva-domenica-29-maggio-e-la-giornata-mondiale]]></loc><lastmod>2022-05-27T21:21:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18683-biotecnologie-fabrizio-greco-e-il-nuovo-presidente-di-assobiotec-federchimica]]></loc><lastmod>2022-05-22T20:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18680-ittiosi-lamellare-la-storia-di-mamma-tiziana-una-vita-dedicata-all-unicita-della-sua-cloe]]></loc><lastmod>2022-05-22T20:59:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18687-covid-2022-da-fine-maggio-nuove-misure-anti-contagio-per-i-settori-lavoro-e-scuola]]></loc><lastmod>2022-05-24T08:53:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18674-malattie-ultra-rare-associazioni-e-istituzioni-a-confronto-per-capire-i-bisogni-dei-pazienti]]></loc><lastmod>2022-05-23T10:30:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18656-ustioni-gravi-mediwound-dona-il-farmaco-nexobrid-all-ospedale-di-leopoli]]></loc><lastmod>2022-05-16T10:47:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18650-arresto-cardiaco-improvviso-negli-atleti-in-un-podcast-le-voci-di-chi-e-sopravvissuto]]></loc><lastmod>2022-05-14T14:23:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18648-sindrome-del-qt-lungo-sei-casi-in-un-paese-del-veneto-al-via-lo-screening-sui-residenti]]></loc><lastmod>2022-05-14T13:43:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18655-malattie-rare-presentata-la-ii-edizione-del-master-dell-universita-vanvitelli-di-napoli]]></loc><lastmod>2023-07-20T09:35:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18642-giornata-dell-infermiere-della-gatta-anif-grazie-ai-veri-angeli-dei-nostri-ospedali]]></loc><lastmod>2022-05-13T16:29:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18633-ustione-e-malattia-rara-non-riconosciuta-troppi-i-bisogni-assistenziali-privi-di-risposta]]></loc><lastmod>2022-05-24T09:38:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18620-tumori-nasce-la-piattaforma-oncowellness]]></loc><lastmod>2022-05-07T20:08:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18621-malattie-rare-pubblicato-il-booklet-del-master-di-ii-livello-dell-universita-vanvitelli]]></loc><lastmod>2022-05-07T21:26:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18602-disabilita-al-femminile-stefania-pedroni-si-racconta-a-therareside]]></loc><lastmod>2022-05-06T09:10:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18610-premio-omar-aperte-le-candidature-alla-ix-edizione]]></loc><lastmod>2022-11-28T19:18:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18597-malattie-rare-al-via-il-progetto-noi-e-la-disabilita-per-l-inclusione-lavorativa]]></loc><lastmod>2022-05-01T17:33:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18591-biotecnologie-in-italia-un-settore-in-crescita-capace-di-reggere-la-crisi-pandemica]]></loc><lastmod>2022-05-01T14:49:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18592-disabilita-l-associazione-nessuno-e-escluso-scrive-una-lettera-aperta-a-mario-draghi]]></loc><lastmod>2022-05-01T15:20:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18585-malattie-senza-nome-i-100mila-fantasmi-delle-patologie-rare]]></loc><lastmod>2022-04-29T09:58:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18584-malati-rari-senza-diagnosi-in-italia-sono-piu-di-100-000]]></loc><lastmod>2022-04-28T11:43:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18578-vaccini-green-pass-e-mascherine-dal-1-maggio-2022-le-nuove-regole-in-materia-di-prevenzione-covid]]></loc><lastmod>2022-05-02T11:44:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18557-carcinoma-uroteliale-approvazione-europea-per-enfortumab-vedotin]]></loc><lastmod>2022-04-20T18:27:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18553-malattie-rare-polmonari-al-via-a-napoli-un-master-di-ii-livello]]></loc><lastmod>2022-04-15T21:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18533-malattie-neuromuscolari-un-anno-di-nemo-trento]]></loc><lastmod>2022-04-10T12:53:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18544-malattie-rare-polmonari-tutto-esaurito-per-la-serata-inaugurale-del-progetto-un-respiro-in-musica]]></loc><lastmod>2022-04-13T17:38:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18543-malattia-di-lafora-la-speranza-di-carola-e-in-un-farmaco-mai-utilizzato-per-la-sua-patologia]]></loc><lastmod>2022-04-14T10:42:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18530-disabilita-e-diritti-sessuali-cosa-ne-pensano-gli-italiani]]></loc><lastmod>2022-04-11T21:50:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18539-cardiomiopatie-rare-dagli-esperti-italiani-le-raccomandazioni-per-la-diagnosi-e-il-trattamento]]></loc><lastmod>2022-04-11T21:48:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18540-vaccino-anti-covid-ok-alla-quarta-dose-anche-per-over-80-ospiti-rsa-e-persone-fragili-in-fascia-60-79-anni]]></loc><lastmod>2022-09-29T07:07:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18510-la-sanita-del-futuro-ecco-come-la-vedono-gli-italiani]]></loc><lastmod>2022-04-03T14:41:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18511-lichen-vulvare-solo-il-tipo-sclerosus-e-considerato-malattia-rara]]></loc><lastmod>2022-05-13T16:54:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18505-carenza-di-sangue-e-plasma-il-grido-di-allarme-delle-associazioni-dei-pazienti]]></loc><lastmod>2022-04-04T21:56:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18507-malattie-neuromuscolari-al-via-il-progetto-e-re-esistenze-resilienti]]></loc><lastmod>2022-04-03T13:40:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18503-policlinico-tor-vergata-presentato-il-portale-del-network-malattie-rare]]></loc><lastmod>2022-04-03T11:33:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18514-ad-abetone-cutigliano-una-giornata-sugli-sci-per-promuovere-il-tema-dello-sport-accessibile]]></loc><lastmod>2022-04-04T12:08:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18496-nuove-modalita-di-gestione-di-isolamenti-e-quarantene-in-vigore-dal-oggi-1-aprile]]></loc><lastmod>2022-04-01T08:04:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18491-terapie-avanzate-il-percorso-dalla-sperimentazione-alla-pratica-clinica]]></loc><lastmod>2022-03-30T10:35:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18462-ospedale-bambino-gesu-apre-a-fiumicino-il-centro-di-cure-palliative-pediatriche]]></loc><lastmod>2022-03-27T21:58:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18476-lavoratori-fragili-assenza-equiparata-a-ricovero-fino-al-31-marzo-ma-non-per-tutti]]></loc><lastmod>2022-04-12T10:39:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18450-disabilita-grave-in-toscana-un-bonus-economico-destinato-ai-minori]]></loc><lastmod>2022-03-23T15:40:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18449-disabilita-da-regione-umbria-uno-stanziamento-di-900mila-euro]]></loc><lastmod>2022-03-23T15:07:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18447-giulio-pompilo-nominato-presidente-del-comitato-scientifico-di-osservatorio-terapie-avanzate]]></loc><lastmod>2022-03-23T11:12:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18433-sindrome-del-vomito-ciclico-in-italia-esiste-un-associazione-di-pazienti]]></loc><lastmod>2022-03-20T22:09:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18434-sindrome-del-vomito-ciclico-un-disturbo-che-colpisce-anche-gli-adulti-non-solo-i-bambini]]></loc><lastmod>2022-03-20T21:58:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18428-emergenza-ucraina-bambino-gesu-e-reti-ern-uniti-per-i-malati-rari-in-difficolta]]></loc><lastmod>2022-03-18T12:40:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18419-long-covid-quando-i-sintomi-del-sars-cov-2-si-protraggono-per-mesi]]></loc><lastmod>2022-03-13T21:33:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18425-assistenza-sanitaria-ai-profughi-ucraini-con-malattia-rara-cronica-o-disabilita-dall-on-noja-la-richiesta-di-procedure-uniformi-a-livello-nazionale]]></loc><lastmod>2022-03-16T14:56:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18421-lavoratori-fragili-arriva-la-proroga-al-31-marzo-di-smart-working-e-assenza-equiparata-a-ricovero]]></loc><lastmod>2022-03-28T16:22:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18409-malattie-neurologiche-dal-14-al-20-marzo-torna-la-settimana-del-cervello]]></loc><lastmod>2022-03-13T17:25:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18390-sindromi-atassiche-al-via-la-campagna-solidale-pasquale-di-acaref]]></loc><lastmod>2022-03-06T22:39:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18385-nevralgia-del-trigemino-al-centro-diagnostico-italiano-oltre-10-anni-di-terapie-con-cyberknife]]></loc><lastmod>2022-03-06T21:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18387-malattie-rare-presentato-il-centro-interdipartimentale-del-policlinico-umberto-i]]></loc><lastmod>2022-03-06T21:59:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18382-malattie-neuromuscolari-inaugurato-ad-ancona-un-nuovo-centro-clinico-nemo]]></loc><lastmod>2022-03-06T20:09:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18359-associazioni-di-pazienti-conclusa-la-prima-edizione-di-raise-the-patients-voice]]></loc><lastmod>2022-02-27T20:18:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18308-ma-dal-cancro-si-guarisce-un-medico-e-un-paziente-dialogano-sul-tema]]></loc><lastmod>2022-03-03T21:19:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18272-15-febbraio-2022-therareside-storie-ai-confini-della-rarita]]></loc><lastmod>2022-03-31T09:06:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18372-ospedale-bambino-gesu-ricoverato-il-primo-piccolo-paziente-ucraino]]></loc><lastmod>2022-03-02T12:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18352-carcinoma-polmonare-non-a-piccole-cellule-approvazione-europea-per-tepotinib]]></loc><lastmod>2022-02-27T18:09:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18370-le-associazioni-di-malattie-rare-in-ucraina-siamo-sotto-le-bombe-stanno-uccidendo-i-bambini]]></loc><lastmod>2022-03-01T17:03:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18367-giornata-mondiale-delle-malattie-rare-sin-il-25-dei-pazienti-attende-da-5-a-30-anni-per-una-diagnosi]]></loc><lastmod>2022-02-28T17:52:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18366-giornata-mondiale-delle-malattie-rare-installato-a-roma-il-monumento-invisibile]]></loc><lastmod>2022-02-28T17:51:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18349-giornata-mondiale-delle-malattie-rare-sinpia-un-paziente-su-5-e-un-bambino]]></loc><lastmod>2022-02-28T17:49:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18365-giornata-mondiale-delle-malattie-rare-la-voce-e-il-punto-delle-istituzioni-italiane]]></loc><lastmod>2022-02-28T17:48:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18362-giornata-mondiale-delle-malattie-rare-i-supereroi-si-calano-dai-tetti-del-bambino-gesu]]></loc><lastmod>2022-02-28T14:59:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18325-tumori-un-video-animato-per-spiegare-l-importanza-della-medicina-di-precisione]]></loc><lastmod>2022-02-24T11:27:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18322-sindromi-atassiche-al-via-la-campagna-condividi-la-vita-2]]></loc><lastmod>2022-02-21T16:41:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18336-giornata-mondiale-delle-malattie-rare-circa-25-000-pazienti-seguiti-al-bambino-gesu]]></loc><lastmod>2022-02-24T14:41:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18333-vaccino-anti-covid19-arriva-anche-in-italia-nuvaxovid-di-novavax]]></loc><lastmod>2022-02-23T14:59:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18334-terapie-avanzate-pubblicata-la-prima-consensus-italiana]]></loc><lastmod>2022-02-23T15:26:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18321-displasia-fibromuscolare-una-patologia-delle-arterie-fortemente-sottodiagnosticata]]></loc><lastmod>2022-02-21T16:25:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18316-covid-19-ok-anche-in-italia-al-primo-trattamento-preventivo-destinato-agli-immunosoppressi]]></loc><lastmod>2022-02-21T13:14:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18312-malattie-rare-diventano-20-le-reti-di-riferimento-europee-per-il-bambino-gesu]]></loc><lastmod>2022-02-18T17:28:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18299-medicina-digitale-stipulato-accordo-tra-universita-unitelmasapienza-e-pharmastar]]></loc><lastmod>2022-02-13T16:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18298-viii-premio-omar-pfizer-aspiriamo-a-portare-valore-e-innovazione-nelle-malattie-rare]]></loc><lastmod>2022-02-15T17:11:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18306-malattie-rare-online-il-trailer-del-cortometraggio-fame-d-aria]]></loc><lastmod>2022-02-15T17:33:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18292-viii-premio-omar-amryt-vogliamo-portare-terapie-a-pazienti-che-hanno-poco-o-nulla-a-disposizione]]></loc><lastmod>2022-02-13T14:23:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18304-giornata-mondiale-delle-malattie-rare-torna-therareside-il-social-talk-di-omar]]></loc><lastmod>2022-02-15T15:40:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18287-festival-uno-sguardo-raro-lanciato-il-bando-2022]]></loc><lastmod>2022-02-13T11:59:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18260-viii-premio-omar-sanofi-non-solo-terapie-per-le-malattie-rare-ma-anche-supporto-concreto-ai-pazienti]]></loc><lastmod>2022-02-08T09:37:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18264-la-luna-del-mattino-un-romanzo-che-racconta-lo-xeroderma-pigmentoso]]></loc><lastmod>2022-02-09T09:46:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18274-smart-working-e-diritto-solo-fino-a-fine-mese-per-poche-patologie-grande-confusione-su-esenzioni-vaccinali]]></loc><lastmod>2022-02-09T12:07:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18255-viii-premio-omar-roche-vogliamo-promuovere-l-inclusione-nelle-malattie-rare-ma-non-solo]]></loc><lastmod>2022-02-08T09:59:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18267-quarantene-e-green-pass-le-nuove-misure-in-vigore-dal-4-febbraio]]></loc><lastmod>2022-04-11T15:03:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18256-neuropatia-a-piccole-fibre-una-condizione-che-puo-essere-associata-a-patologie-rare-e-alla-fibromialgia]]></loc><lastmod>2022-02-07T14:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18268-esenzione-vaccinale-covid-finalmente-ok-a-digitalizzazione-dei-certificati]]></loc><lastmod>2022-02-10T08:46:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18253-sindromi-atassiche-rudy-bandiera-e-il-nuovo-volto-di-fondazione-acaref]]></loc><lastmod>2022-02-06T11:21:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18238-viii-premio-omar-l-impegno-di-ptc-nella-duchenne-e-nel-deficit-di-aadc]]></loc><lastmod>2022-01-30T23:17:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18248-contributo-per-genitori-single-e-disoccupati-con-figli-con-invalidita-sopra-al-60]]></loc><lastmod>2022-03-13T11:44:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18247-coronavirus-cittadinanzattiva-occorre-abbattere-la-burocrazia-da-covid]]></loc><lastmod>2022-02-02T13:45:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18232-viii-premio-omar-i-benefici-della-terapia-genica-per-la-sma]]></loc><lastmod>2022-01-30T17:35:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18213-viii-premio-omar-chiesi-serve-una-scienza-medica-che-si-prenda-cura-della-societa-e-delle-persone]]></loc><lastmod>2022-01-23T22:20:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18212-malattie-rare-nasce-l-azienda-aop-health]]></loc><lastmod>2022-01-24T21:17:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18223-societa-italiana-di-pneumologia-carlo-vancheri-e-il-nuovo-presidente]]></loc><lastmod>2022-01-26T11:40:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18224-esenzione-vaccinale-e-super-green-pass-si-equivalgono-poca-chiarezza-dalla-normativa]]></loc><lastmod>2022-01-26T17:38:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18205-viii-premio-omar-biogen-auspichiamo-che-lo-screening-neonatale-per-la-sma-diventi-una-realta-nazionale]]></loc><lastmod>2022-01-24T21:14:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18203-malattie-rare-kedrion-biopharma-si-unisce-con-bio-products-laboratory]]></loc><lastmod>2022-01-24T21:14:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18177-viii-premio-omar-amicus-i-bisogni-dei-malati-rari-alla-base-delle-nostre-terapie]]></loc><lastmod>2022-01-15T16:40:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18189-malattie-rare-nasce-red-rareducando-educazione-digitale]]></loc><lastmod>2022-01-20T11:23:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18195-covid-e-dad-tra-mancata-inclusione-scolastica-e-polemica-serrata-sulle-quarantene]]></loc><lastmod>2022-01-20T16:21:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18175-tumore-al-polmone-con-mutazione-kras-g12c-sotorasib-approvato-dalla-ce]]></loc><lastmod>2022-01-15T16:22:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18173-viii-premio-omar-alexion-aziende-e-istituzioni-ascoltino-sempre-piu-la-voce-dei-malati-rari]]></loc><lastmod>2022-01-18T11:43:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18187-legge-di-bilancio-2022-bonus-di-1-000-euro-per-i-lavoratori-fragili]]></loc><lastmod>2022-08-27T11:41:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18186-legge-di-bilancio-2022-stanziamenti-e-misure-a-tutela-della-disabilita-e-delle-categorie-piu-fragili]]></loc><lastmod>2022-01-18T09:44:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18183-emiplegia-alternante-oggi-la-giornata-mondiale]]></loc><lastmod>2022-01-17T21:18:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18185-livelli-essenziali-delle-prestazioni-sociali-tutto-sulla-nuova-misura-assistenziale]]></loc><lastmod>2022-01-18T09:19:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18181-caregiver-i-contributi-della-regione-toscana-e-dei-comuni-umbri]]></loc><lastmod>2022-01-17T11:45:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18180-congedo-parentale-covid-rinnovato-fino-a-fine-marzo-2022-per-ora-solo-per-i-dipendenti]]></loc><lastmod>2022-01-24T09:25:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18171-carcinoma-polmonare-non-a-piccole-cellule-approvazione-europea-per-amivantamab]]></loc><lastmod>2022-01-15T14:43:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18168-visite-rimandate-e-controlli-slittati-a-data-da-destinarsi-troppi-malati-rari-e-cronici-abbandonati]]></loc><lastmod>2022-01-17T11:53:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18159-brutto-e-cattivo-l-appassionante-autobiografia-di-un-giovane-con-sindrome-di-treacher-collins]]></loc><lastmod>2022-01-05T17:46:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18153-sindrome-di-pierpont-decolla-l-associazione-italiana-dei-pazienti]]></loc><lastmod>2024-09-11T17:04:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18163-obbligo-vaccinale-e-super-green-pass-tutte-le-misure-in-vigore-da-oggi]]></loc><lastmod>2022-01-10T18:42:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18155-malattie-rare-in-puglia-le-associazioni-protestano-per-la-mancata-assunzione-di-tre-medici]]></loc><lastmod>2022-01-04T11:50:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18147-poste-italiane-per-dipendenti-e-pensionati-un-contributo-in-caso-di-handicap-e-malattia-rara]]></loc><lastmod>2021-12-30T18:48:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18150-quarantena-e-super-green-pass-agevolazioni-per-vaccinati-e-guariti-con-poca-attenzione-ai-fragili-e-alle-famiglie]]></loc><lastmod>2022-01-10T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18138-malattie-neuromuscolari-conclusa-la-campagna-si-donare-rende-felici]]></loc><lastmod>2021-12-29T17:50:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18122-la-normalita-e-sopravvalutata-il-diario-di-una-famiglia-che-convive-con-la-disabilita]]></loc><lastmod>2021-12-29T17:50:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18135-malattie-rare-l-ospedale-papa-giovanni-di-bergamo-fara-parte-di-tre-reti-ern]]></loc><lastmod>2021-12-27T12:46:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18142-decreto-vigilia-mascherina-all-esterno-green-pass-piu-breve-e-smart-working]]></loc><lastmod>2022-02-21T08:46:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18133-malattie-rare-nasce-la-piattaforma-reti-rare]]></loc><lastmod>2021-12-24T14:05:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18129-tumori-pediatrici-l-oms-pubblica-un-libro-blu]]></loc><lastmod>2021-12-24T11:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18126-festival-della-scienza-2022-aperta-la-call-for-proposal]]></loc><lastmod>2021-12-22T16:16:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18115-disturbi-del-neurosviluppo-lanciato-il-progetto-tablet-toscana]]></loc><lastmod>2021-12-20T14:43:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18125-malattie-genetiche-telethon-chiude-il-2021-con-una-raccolta-fondi-che-supera-i-54-milioni-di-euro]]></loc><lastmod>2021-12-22T14:50:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18127-approvata-in-via-definitiva-la-legge-delega-sulle-disabilita]]></loc><lastmod>2024-03-08T10:01:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18106-presentato-il-xix-rapporto-di-cittadinanzattiva-sulle-politiche-della-cronicita]]></loc><lastmod>2021-12-16T15:23:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18088-disabilita-e-diritti-umani-pubblicato-il-libro-abili-disabili-ma-tutti-diversamente-abili]]></loc><lastmod>2021-12-12T16:46:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18085-tromboastenia-di-glanzmann-nuove-opportunita-terapeutiche-per-una-patologia-orfana-di-cura]]></loc><lastmod>2021-12-12T15:47:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18079-ristori-per-il-terzo-settore-fino-all-11-dicembre-aperta-la-procedura-di-richiesta]]></loc><lastmod>2021-12-09T17:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18072-carcinoma-polmonare-alk-lorlatinib-disponibile-in-italia]]></loc><lastmod>2021-12-05T21:47:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18064-ok-di-aifa-alla-vaccinazione-con-pfizer-per-i-bambini-dai-5-agli-11-anni]]></loc><lastmod>2021-12-02T14:25:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18050-acondroplasia-presentato-il-libro-il-tetto-del-mondo]]></loc><lastmod>2021-11-27T23:49:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18063-malattie-rare-premiati-i-vincitori-della-viii-edizione-del-premio-omar]]></loc><lastmod>2021-12-02T16:41:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18065-malattie-rare-a-sei-rappresentanti-delle-istituzioni-il-riconoscimento-connessioni]]></loc><lastmod>2021-12-02T15:24:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18044-malattie-rare-takeda-italia-istituisce-una-business-unit-dedicata]]></loc><lastmod>2021-11-27T22:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18045-disabilita-la-battaglia-dell-associazione-il-sorriso-di-riccardo-per-il-seggiolino-omologato-in-aereo]]></loc><lastmod>2021-11-27T22:41:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18041-malattie-rare-pubblicato-il-bando-del-premio-alessandra-bisceglia]]></loc><lastmod>2021-11-27T21:25:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18039-vaccino-covid-19-terza-dose-aperta-a-tutti-i-maggiorenni-raccomandata-priorita-ai-piu-fragili-e-vulnerabili]]></loc><lastmod>2021-11-26T13:39:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18029-caregiver-pubblicato-il-report-dell-indagine-di-cittadinanzattiva]]></loc><lastmod>2021-11-22T00:32:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18035-super-green-pass-e-obbligo-vaccinale-cosa-cambia-per-i-fragili]]></loc><lastmod>2021-12-13T14:02:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18010-miopatia-gne-valeria-e-federica-pace-nominate-cavalieri-dell-ordine-al-merito-della-repubblica-italiana]]></loc><lastmod>2021-11-16T17:55:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18007-disability-card-dopo-l-ok-del-garante-della-privacy-e-sempre-piu-vicina]]></loc><lastmod>2022-02-22T14:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18006-malattie-rare-ne-paziente-ne-caregiver-cosa-significa-essere-tutti-i-giorni-un-rare-sibling]]></loc><lastmod>2021-11-15T10:59:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17994-in-veneto-nasce-la-consulta-delle-malattie-neuromuscolari]]></loc><lastmod>2021-11-13T19:38:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17997-sindrome-di-brown-vialetto-van-laere-oggi-e-la-giornata-di-sensibilizzazione]]></loc><lastmod>2021-11-13T20:18:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17980-malattie-neuromuscolari-riparte-la-campagna-donare-rende-felici]]></loc><lastmod>2021-11-08T11:57:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17974-atassia-spinocerebellare-tornano-i-dolci-solidali-della-fondazione-acaref]]></loc><lastmod>2021-11-06T23:29:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17971-prix-galien-italia-2021-premiata-la-terapia-genica-onasemnogene-abeparvovec]]></loc><lastmod>2021-11-06T22:27:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17964-il-serpente-invisibile-un-libro-che-racconta-di-come-l-amore-guarisca-dalla-disperazione]]></loc><lastmod>2021-11-01T21:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17959-tumore-polmonare-non-a-piccole-cellule-parere-positivo-dal-chmp-per-amivantamab]]></loc><lastmod>2021-10-31T22:52:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17961-tromboastenia-di-glanzmann-nasce-la-prima-associazione-italiana]]></loc><lastmod>2021-10-31T23:30:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17965-disabilita-l-assegno-per-le-famiglie-monoparentali-fino-a-500-euro-al-mese]]></loc><lastmod>2022-03-13T11:35:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17957-disabilita-e-sessualita-al-via-le-candidature-per-sensuability-comics]]></loc><lastmod>2021-10-31T22:17:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17838-premio-omar-2021-la-cerimonia-di-premiazione-e-prevista-per-il-prossimo-2-dicembre]]></loc><lastmod>2021-11-08T15:34:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17950-strisce-blu-per-i-disabili-saranno-gratis-approvati-gli-emendamenti-alla-camera]]></loc><lastmod>2021-10-29T10:36:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17931-encefalopatia-epilettica-slc6a1-nasce-la-prima-associazione-italiana-dei-pazienti]]></loc><lastmod>2021-10-26T13:10:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17948-covid-19-quale-impatto-sull-assistenza-ai-malati-rari-l-indagine-di-orphanet-italia-e-opbg]]></loc><lastmod>2021-10-28T13:32:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17929-malattie-rare-al-via-il-progetto-migliorare]]></loc><lastmod>2021-10-23T21:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17927-malattie-rare-premiati-i-vincitori-della-sesta-edizione-di-uno-sguardo-raro]]></loc><lastmod>2021-10-23T20:47:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17941-festival-uno-sguardo-raro-menzione-speciale-per-therareside]]></loc><lastmod>2021-11-02T12:36:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17938-stop-ad-assegno-invalidita-se-lavori-solo-per-invalidi-74-99-o-per-tutti]]></loc><lastmod>2021-12-30T10:03:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17918-assegno-invalidita-ora-erogato-solo-a-chi-non-lavora-la-denuncia-siamo-disabili-non-soprammobili]]></loc><lastmod>2021-12-30T10:03:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17899-associazioni-di-pazienti-un-vademecum-per-il-tempo-della-pandemia]]></loc><lastmod>2021-10-17T20:52:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17917-glicogenosi-dalla-terapia-nutrizionale-alla-terapia-genica]]></loc><lastmod>2021-10-20T17:04:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17894-societa-italiana-di-neonatologia-luigi-orfeo-e-il-nuovo-presidente]]></loc><lastmod>2021-10-16T22:36:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17891-disabilita-entro-il-29-ottobre-e-possibile-partecipare-al-premio-giornalistico-bomprezzi]]></loc><lastmod>2021-10-16T21:40:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17893-malattie-rare-un-libro-che-racconta-la-lotta-quotidiana-dei-pazienti-per-il-riconoscimento-sociale]]></loc><lastmod>2021-10-16T22:14:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17884-arriva-in-italia-reshape-il-primo-podcast-dedicato-alle-terapie-avanzate]]></loc><lastmod>2021-10-14T10:22:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17882-malattie-rare-online-un-corso-di-formazione-dedicato-al-tema-della-diagnosi]]></loc><lastmod>2021-10-12T15:17:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17869-malattie-rare-nasce-un-nuovo-modello-d-intervento-patient-and-family-centered-care]]></loc><lastmod>2021-10-09T18:14:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17880-vaccino-covid-19-terza-dose-anche-per-over-60-e-fragili-senza-specifica-sul-malattie-rare]]></loc><lastmod>2021-12-09T15:21:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17866-sindromi-pans-pandas-il-9-ottobre-e-la-giornata-mondiale-dedicata-alla-patologia]]></loc><lastmod>2021-10-08T18:40:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17857-malattie-rare-e-croniche-cittadinanzattiva-promuove-un-questionario-online-per-i-pazienti]]></loc><lastmod>2021-10-06T20:27:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17841-festival-della-scienza-la-nuova-edizione-torna-in-presenza-per-gli-studenti]]></loc><lastmod>2021-10-03T15:49:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17835-disability-pride-dal-1-al-3-ottobre-torna-la-grande-manifestazione-sulla-disabilita]]></loc><lastmod>2021-09-30T10:04:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17833-vaccino-covid-19-si-parte-con-terza-dose-per-ultraottantenni-e-ospiti-residenze-anziani]]></loc><lastmod>2021-12-09T15:26:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17819-associazioni-di-pazienti-al-via-il-progetto-raise-the-patients-voice]]></loc><lastmod>2021-09-26T21:18:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17815-industria-farmaceutica-pfizer-ancora-sul-podio-per-la-migliore-reputazione-tra-le-associazioni-di-pazienti]]></loc><lastmod>2021-09-26T19:34:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17823-esenzione-vaccino-covi-19-prorogata-al-30-novembre-la-validita-delle-certificazioni-di-esenzione]]></loc><lastmod>2021-11-25T15:16:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17809-farmaci-alfasigma-inaugura-a-pomezia-un-nuovo-centro-di-ricerca-sviluppo]]></loc><lastmod>2021-09-23T11:28:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17807-malattie-genetiche-nasce-genome-access-la-prima-piattaforma-digitale-di-counseling]]></loc><lastmod>2021-09-22T15:33:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17802-disabilita-allarme-sull-ossido-di-etilene-nella-sterilizzazione-delle-sacche-per-nutrizione-artificiale]]></loc><lastmod>2021-09-22T11:01:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17804-terza-dose-vaccino-covid-la-lista-dei-farmaci-per-capire-chi-deve-sottoporsi-a-somministrazioneaggiuntiva]]></loc><lastmod>2021-10-11T14:20:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17792-disabilita-a-milano-nasce-il-nuovo-polo-per-bambini-di-fondazione-tog]]></loc><lastmod>2022-10-07T16:01:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17798-malattie-mitocondriali-al-via-la-settimana-mondiale]]></loc><lastmod>2021-09-20T17:23:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17790-salute-mentale-al-via-una-campagna-di-sensibilizzazione-nazionale]]></loc><lastmod>2021-09-17T15:11:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17786-green-pass-obbligatorio-per-tutti-i-lavoratori-a-tutela-dei-piu-fragili]]></loc><lastmod>2021-10-06T12:09:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17778-vaccino-covid-19-al-via-la-terza-dose-per-immunodeficienze-trapiantati-e-altre-specifiche-condizioni]]></loc><lastmod>2021-11-13T15:12:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17756-neuroscienze-al-via-oggi-il-congresso-nazionale-sins]]></loc><lastmod>2021-09-09T15:30:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17744-sindrome-di-sj-gren-il-film-la-sabbia-negli-occhi-e-ora-su-amazon-prime]]></loc><lastmod>2022-03-28T14:06:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17740-green-pass-e-esenzione-da-vaccino-troppa-confusione-necessarie-specifiche-tutele-ma-solo-per-chi-le-necessita-davvero]]></loc><lastmod>2021-09-30T09:02:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17731-in-friuli-venezia-giulia-e-attivo-un-pdta-specifico-per-l-acalasia-esofagea]]></loc><lastmod>2021-08-29T18:19:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17723-afadoc-lancia-la-campagna-di-sensibilizzazione-la-crescita-dei-bambini]]></loc><lastmod>2021-08-22T16:08:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17722-hermes-university-lancia-il-primo-corso-in-italia-per-community-engagement-consultant]]></loc><lastmod>2021-08-23T14:29:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17713-festival-della-scienza-al-via-dal-21-ottobre-la-diciannovesima-edizione]]></loc><lastmod>2021-08-14T17:26:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17719-vacanze-un-toccasana-anche-per-la-fertilita]]></loc><lastmod>2021-08-16T12:17:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17718-terapia-fotodinamica-un-opportunita-per-la-malattia-di-hailey-hailey]]></loc><lastmod>2021-08-16T11:44:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17710-malattie-neurologiche-rare-tra-medici-e-pazienti-diversa-prospettiva-sulle-priorita-della-ricerca]]></loc><lastmod>2021-08-06T19:58:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17707-certificazione-di-esenzione-dal-vaccino-anti-covid-chi-ne-ha-diritto-e-come-funziona]]></loc><lastmod>2022-11-14T14:24:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17701-malattie-rare-e-disturbi-del-sistema-nervoso-nasce-il-fondo-angelini-lumira-biosciences]]></loc><lastmod>2021-08-01T14:45:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17699-atassia-spinocerebellare-iniziata-la-raccolta-fondi-di-acaref-per-la-ricerca]]></loc><lastmod>2021-08-01T13:52:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17700-gerstmann-straeussler-scheinker-una-sindrome-neurodegerativa-che-si-trasmette-facilmente-da-genitore-a-figlio]]></loc><lastmod>2021-08-01T14:38:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17694-sindromi-di-sotos-e-malan-nasce-il-primo-glossario-dedicato]]></loc><lastmod>2021-07-29T19:38:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17667-atassia-di-charlevoix-saguenay-da-arsacs-odv-un-sostegno-per-i-pazienti-che-aderiscono-al-progetto-prospax]]></loc><lastmod>2021-07-18T22:16:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17655-premio-letterario-angelo-zanibelli-2021-c-e-tempo-fino-al-15-settembre-per-candidarsi]]></loc><lastmod>2021-07-18T18:01:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17650-atresia-esofagea-realizzato-a-pavia-un-delicato-intervento-chirurgico-su-paziente-di-10-mesi]]></loc><lastmod>2021-07-15T18:35:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17642-oncologia-e-oncoematologia-al-via-un-indagine-per-raccogliere-le-opinioni-dei-pazienti]]></loc><lastmod>2021-07-13T11:05:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17649-vaccino-covid-19-in-quasi-tutte-le-regioni-via-a-prenotazioni-dai-12-anni-le-societa-scientifiche-vacciniamo-i-nostri-bambini-e-ragazzi]]></loc><lastmod>2021-07-14T07:49:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17619-divulgazione-scientifica-al-via-la-campagna-social-bayerperlascienza]]></loc><lastmod>2021-07-06T17:21:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17621-salute-paziente-esperto-eupati-entra-a-far-parte-del-comitato-etico-del-san-raffaele]]></loc><lastmod>2021-07-06T17:24:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17615-malattie-rare-siglato-accordo-d-intesa-fra-oms-e-rare-diseases-international]]></loc><lastmod>2021-07-06T00:00:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17612-disabilita-al-via-la-call-for-makers-2021-per-make-to-care]]></loc><lastmod>2021-07-03T15:14:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17613-sindrome-da-delezione-2q37-una-patologia-cromosomica-dalla-prognosi-assai-variabile]]></loc><lastmod>2021-07-03T15:17:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17595-telemedicina-dalla-piattaforma-welcare-un-esempio-di-successo]]></loc><lastmod>2021-06-28T00:36:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17592-sindrome-di-beckwith-wiedemann-a-milano-un-eccellenza-per-curare-l-eterometria]]></loc><lastmod>2021-06-27T23:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17588-oncoematologia-pediatrica-al-via-il-progetto-piccoli-eroi]]></loc><lastmod>2021-06-27T23:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17591-lipedema-colpisce-le-donne-e-provoca-un-accumulo-di-grasso-ma-non-e-obesita]]></loc><lastmod>2021-06-28T14:40:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17585-salute-nasce-i-cantieri-della-sanita-del-futuro]]></loc><lastmod>2021-06-27T21:41:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17561-malattie-cardiopolmonari-alfasigma-acquisisce-la-licenza-europea-per-bentracimab-da-phasebio]]></loc><lastmod>2021-06-20T17:10:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17538-disabilita-permessi-e-congedi-per-i-familiari-acquisiti-solo-per-chi-e-sposato]]></loc><lastmod>2021-06-13T19:26:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17544-spina-bifida-in-italia-nasce-il-registro-nazionale-dei-pazienti]]></loc><lastmod>2021-06-16T10:32:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17513-salute-e-ricerca-al-via-il-nuovo-podcast-voci-per-la-salute]]></loc><lastmod>2021-06-06T20:07:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17520-malattie-rare-le-famiglie-chiedono-una-giornata-nazionale-per-i-rare-sibling]]></loc><lastmod>2021-06-07T10:30:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17504-decreto-sostegni-bis-fino-al-31-luglio-i-liberi-professionisti-disabili-possono-richiedere-il-reddito-di-ultima-istanza]]></loc><lastmod>2021-12-09T15:29:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17497-malattie-rare-al-via-il-concorso-nazionale-le-meravigliose-rarita]]></loc><lastmod>2021-05-31T18:08:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17491-malattie-rare-oltre-il-50-dei-casi-resta-senza-diagnosi]]></loc><lastmod>2021-05-30T17:07:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17488-sanita-dagli-atenei-italiani-dieci-proposte-per-implementare-efficacemente-il-pnrr]]></loc><lastmod>2021-05-30T16:30:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17490-malattie-rare-in-italia-si-chiede-di-istituire-un-rare-sibling-day]]></loc><lastmod>2021-05-30T17:08:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17483-vaccino-anti-covid19-astrazeneca-e-johnson-da-aifa-le-precisazioni-si-a-seconda-dose-per-tutti]]></loc><lastmod>2021-12-09T15:29:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17469-giovani-e-covid-19-il-78-chiede-una-comunicazione-piu-chiara]]></loc><lastmod>2021-05-23T19:52:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17475-malattie-rare-avviato-ieri-alla-camera-il-nuovo-testo-unico-ora-tocca-al-senato]]></loc><lastmod>2021-11-30T15:13:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17461-tiroide-la-settimana-mondiale-dal-24-al-30-maggio-2021]]></loc><lastmod>2021-05-23T16:40:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17439-malattie-rare-aperte-le-iscrizioni-per-il-volo-di-pegaso]]></loc><lastmod>2021-05-16T11:20:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17431-sclerosi-tuberosa-il-15-maggio-si-celebra-la-giornata-mondiale-di-sensibilizzazione-sulla-patologia]]></loc><lastmod>2021-05-14T22:05:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17437-mucopolisaccaridosi-il-15-maggio-e-la-giornata-mondiale]]></loc><lastmod>2021-05-14T22:04:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17422-carcinoma-polmonare-non-a-piccole-cellule-la-commissione-europea-approva-atezolizumab]]></loc><lastmod>2021-11-02T14:46:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17418-malattie-da-accumulo-lisosomiale-al-via-la-caccia-al-tesoro-digitale-raro-chi-trova]]></loc><lastmod>2021-05-11T10:17:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17410-sarcoidosi-online-un-questionario-dedicato-ai-vaccini-anti-covid]]></loc><lastmod>2021-05-09T19:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17412-reti-di-riferimento-europee-probabile-il-ricorso-a-fondi-privati]]></loc><lastmod>2021-05-11T14:35:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17409-l-amministrazione-di-sostegno-al-tempo-della-pandemia-le-difficolta-di-chi-deve-tutelare-i-fragili]]></loc><lastmod>2021-05-10T09:02:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17403-caregiver-e-familiari-nuova-ordinanza-garantisce-priorita-vaccinale-a-2-persone-per-ogni-fragilissimo]]></loc><lastmod>2021-12-09T15:31:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17399-vaccinazioni-covid-anche-il-lazio-estende-la-priorita-alle-malattie-rare]]></loc><lastmod>2021-05-05T14:49:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17390-vaccinazioni-anti-covid-19-le-proposte-operative-dell-omar-sulle-priorita]]></loc><lastmod>2021-05-04T11:23:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17387-vaccino-anti-covid-campania-prima-regione-a-dare-massima-priorita-a-tutti-i-malati-rari]]></loc><lastmod>2021-05-03T16:54:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17373-oncologia-anna-maria-bencini-nominata-oncology-country-head-di-takeda-italia]]></loc><lastmod>2021-05-02T16:24:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17356-rare-sibling-il-progetto-di-omar-quest-anno-ha-al-suo-fianco-quattro-diverse-societa-scientifiche]]></loc><lastmod>2021-05-04T13:08:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17351-vaccino-covid-sie-e-gitmo-chiedono-priorita-vaccinale-per-pazienti-con-malattie-ematologiche]]></loc><lastmod>2021-04-28T10:46:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17347-congedi-legge-104-ufficializzati-gli-importi-massimi-di-indennita-e-retribuzione-per-il-2021]]></loc><lastmod>2021-04-27T11:52:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17332-farmaci-a-domicilio-janssen-a-casa-tua-diventa-2-0]]></loc><lastmod>2021-04-25T16:36:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17333-malattie-neuromuscolari-e-neurodegenerative-a-milano-inaugurato-il-nemolab]]></loc><lastmod>2021-04-27T11:16:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17342-malattie-rare-le-tre-direzioni-dell-impegno-di-sanofi]]></loc><lastmod>2021-04-26T15:26:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17329-ricerca-farmaceutica-ad-alfathon-due-team-italiani-in-finale]]></loc><lastmod>2021-04-25T15:07:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17315-sindrome-di-sotos-nasce-a-roma-il-primo-ambulatorio-italiano-dedicato]]></loc><lastmod>2021-04-18T16:18:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17316-malattie-da-accumulo-lisosomiale-fino-a-14-anni-il-ritardo-diagnostico]]></loc><lastmod>2021-04-18T16:39:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17310-long-covid-occorre-dare-riconoscimento-alla-sindrome]]></loc><lastmod>2021-04-18T15:04:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17311-oncologia-ed-ematologia-nasce-il-programma-switch-on]]></loc><lastmod>2021-04-18T15:20:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17306-tutele-ai-genitori-di-figli-con-disabilita-e-bes-approvato-emendamento-sollecitato-dall-omar]]></loc><lastmod>2021-04-16T12:08:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17294-malattie-rare-la-regione-campania-lancia-un-iniziativa-di-sensibilizzazione-sul-sospetto-diagnostico]]></loc><lastmod>2021-04-15T13:25:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17297-trapianti-da-biotest-italia-100mila-euro-al-cnt-per-sostenere-la-donazione-di-organi-ai-tempi-del-covid-19]]></loc><lastmod>2021-04-15T13:40:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17298-angiola-incalza-il-governo-priorita-vaccinali-a-malati-rari-e-loro-caregiver-serve-attenzione-e-trasparenza]]></loc><lastmod>2021-04-15T13:16:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17295-vii-premio-omar-grazie-all-informazione-le-malattie-rare-diventano-meno-rare]]></loc><lastmod>2021-04-14T15:53:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17284-ti-sento-in-libreria-un-romanzo-che-parla-di-insensibilita-congenita-al-dolore]]></loc><lastmod>2021-04-11T21:12:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17291-vaccini-figliuolo-tira-le-orecchie-alle-regioni-e-le-richiama-al-rispetto-delle-priorita]]></loc><lastmod>2021-12-09T15:32:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17280-cure-domiciliari-in-oncologia-nasce-il-progetto-pilota-oncohome]]></loc><lastmod>2021-04-11T19:35:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17278-disabilita-dalla-fish-un-manifesto-denuncia-ad-un-anno-da-inizio-pandemia]]></loc><lastmod>2021-04-11T18:48:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17273-vaccini-covid-19-disabili-gravi-troppe-difficolta-di-accesso-alla-prenotazione-la-denuncia-dal-veneto]]></loc><lastmod>2021-12-09T15:32:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17271-bufalavirus-i-vaccini-anti-covid-19-non-contengono-feti-umani]]></loc><lastmod>2021-04-12T09:20:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17270-malattie-rare-l-impegno-di-sobi-non-e-solo-in-ambito-farmacologico]]></loc><lastmod>2021-04-08T10:21:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17269-vaccino-astrazeneca-raccomandato-uso-over-60-assicurata-la-seconda-dose-a-tutti]]></loc><lastmod>2021-04-14T08:47:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17252-farmaci-annarita-egidi-e-il-nuovo-general-manager-di-takeda-italia]]></loc><lastmod>2021-04-03T14:28:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17264-malattie-rare-e-vaccino-covid-19-ecco-i-codici-di-esenzione-delle-patologie-con-la-massima-priorita]]></loc><lastmod>2021-05-03T08:32:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17234-sindrome-dell-intestino-corto-da-takeda-una-virtual-media-academy]]></loc><lastmod>2021-03-28T21:32:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17245-vaccino-astrazeneca-nessuna-controindicazione-di-per-malattie-trombotiche-ed-emorragiche]]></loc><lastmod>2021-03-31T07:11:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17230-covid-19-aipo-its-pubblica-una-guida-ai-vaccini]]></loc><lastmod>2021-03-28T20:04:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17227-covid-19-come-funzionano-i-test-diagnostici]]></loc><lastmod>2021-03-28T18:59:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17239-vaccino-anti-covid-la-questione-astrazeneca]]></loc><lastmod>2021-03-29T14:00:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17224-caregiver-da-cittadinazattiva-un-questionario-dedicato]]></loc><lastmod>2021-03-28T17:54:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17225-sindrome-charge-parte-la-nuova-fase-del-progetto-aria]]></loc><lastmod>2021-03-28T18:18:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17220-malattie-rare-online-il-bando-della-vi-edizione-di-uno-sguardo-raro]]></loc><lastmod>2021-03-24T19:05:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17212-le-linee-programmatiche-del-ministro-per-le-disabilita-gli-obiettivi-da-realizzare]]></loc><lastmod>2021-12-09T15:34:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17211-dl-sostegni-per-i-fragili-assenza-da-lavoro-giustificata-fino-al-30-giugno-ecco-tutte-le-novita]]></loc><lastmod>2021-07-07T14:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17197-covid-19-urgente-rafforzare-le-vaccinazioni-per-i-pazienti-oncologici]]></loc><lastmod>2021-03-21T16:46:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17196-vaccino-covid-19-astrazeneca-domande-e-risposte-sulla-ripresa-della-vaccinazione]]></loc><lastmod>2021-04-14T09:03:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17192-vaccino-astrazeneca-ema-benefici-maggiori-dei-rischi-riprendono-le-vaccinazioni-in-italia]]></loc><lastmod>2021-03-19T10:03:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17181-coronavirus-le-fake-news-sulle-cure-dal-carvativir-di-maduro-all-ayurveda-di-modi]]></loc><lastmod>2021-03-17T15:36:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17191-salute-osservatorio-terapie-avanzate-pubblica-la-prima-tabella-sulle-terapie-digitali-approvate-nel-mondo]]></loc><lastmod>2023-09-26T16:42:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17180-malattie-rare-gastrointestinali-ed-epatiche-allo-studio-diagnosi-piu-celeri-e-nuovi-farmaci]]></loc><lastmod>2021-03-14T16:31:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17173-malattie-neurologiche-al-via-la-settimana-del-cervello]]></loc><lastmod>2021-03-14T14:53:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17174-vaccini-anti-covid-anche-l-europa-chiede-priorita-per-100-milioni-di-persone-con-disabilita]]></loc><lastmod>2021-03-16T08:51:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17172-covid-19-approvazione-europea-per-il-vaccino-a-dose-singola-di-johnson-johnson]]></loc><lastmod>2021-03-12T12:05:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17171-vaccinazioni-covid-19-nuove-raccomandazioni-priorita-per-disabili-gravi-e-loro-cargiver]]></loc><lastmod>2021-03-12T13:29:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17135-malattie-rare-sanofi-lancia-la-campagna-se-ne-parli-non-e-raro]]></loc><lastmod>2021-03-07T12:31:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17169-plasma-effetto-covid-a-gennaio-la-raccolta-cala-del-13-5]]></loc><lastmod>2021-03-10T11:43:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17168-vaccino-covid-19-disabilita-e-persone-fragili-speranza-assicura-la-priorita]]></loc><lastmod>2021-03-10T11:49:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17133-disabilita-la-regione-calabria-nega-i-fondi-per-l-assistenza]]></loc><lastmod>2021-03-06T22:42:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17163-molise-vaccinazioni-aperte-agli-over-80-e-ai-soggetti-vulnerabili]]></loc><lastmod>2023-01-11T10:23:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17162-marche-gia-in-atto-la-vaccinazione-per-i-soggetti-piu-fragili]]></loc><lastmod>2023-01-11T10:15:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17161-liguria-per-gli-ultravulnerabili-gia-prenotabile-la-vaccinazione]]></loc><lastmod>2023-01-11T10:12:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17160-emilia-romagna-partita-la-vaccinazione-anti-covid-per-over-80-e-persone-con-disabilita]]></loc><lastmod>2023-01-11T10:06:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17159-vaccino-covid-19-il-piano-vaccinale-della-regione-puglia]]></loc><lastmod>2023-01-11T17:24:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17158-vaccini-anti-covid-19-in-lombardia-nessuna-data-certa-per-le-categorie-piu-fragili]]></loc><lastmod>2023-01-11T17:45:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17157-vaccino-covid-19-la-campagna-vaccinale-della-valle-d-aaosta]]></loc><lastmod>2023-01-11T17:00:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17155-vaccinazione-covid-19-la-campagna-della-umbria-e-le-modalita-di-accesso]]></loc><lastmod>2023-01-11T17:14:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17153-vaccino-covid-19-la-campagna-vaccinale-della-regione-basilicata]]></loc><lastmod>2022-09-07T13:00:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17152-vaccinazione-covid-19-la-campagna-della-regione-calabria-e-le-modalita-di-accesso]]></loc><lastmod>2022-09-07T13:00:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17151-vaccinazione-anti-covid-in-piemonte-ancora-nessuna-notizia-ufficiale-per-i-malati-rari]]></loc><lastmod>2023-01-11T17:30:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17150-vaccino-covid-a-trento-e-bolzano-la-campagna-vaccinale-in-trentino-alto-adige]]></loc><lastmod>2023-01-17T09:15:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17149-vaccinazioni-covid-19-per-soggetti-fragili-dalla-toscana-segnali-positivi-ma-ancora-molte-criticita]]></loc><lastmod>2023-01-11T17:22:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17148-vaccino-covid-19-tutte-le-informazioni-dedicate-a-malati-rari-persone-con-disabilita-e-caregiver]]></loc><lastmod>2023-01-17T08:57:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17147-covid-19-in-sardegna-obiettivo-vaccinare-tutti-entro-agosto]]></loc><lastmod>2023-01-11T10:30:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17146-vaccinazione-covid-19-la-campagna-vaccinale-della-regione-campania]]></loc><lastmod>2022-09-07T13:07:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17145-vaccinazione-covid-e-persone-con-fragilita-come-funziona-in-abruzzo]]></loc><lastmod>2022-09-30T12:45:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17144-vaccinazioni-covid-19-ecco-le-modalita-della-campagna-vaccinale-in-sicilia]]></loc><lastmod>2023-01-11T10:32:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17127-malattie-rare-takeda-italia-vince-l-eurordis-black-pearl-award-per-il-patient-engagement]]></loc><lastmod>2021-03-06T20:52:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17129-atassie-spinocerebellari-al-via-la-raccolta-fondi-pasquale-di-acaref]]></loc><lastmod>2021-03-06T21:33:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17143-vaccinazioni-covid-19-il-veneto-li-estende-anche-ai-conviventi-dei-soggetti-fragili]]></loc><lastmod>2023-01-11T16:44:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17142-vaccinazione-covid-per-malati-rari-e-persone-con-disabilita-la-campagna-vaccinale-in-friuli-venezia-giulia]]></loc><lastmod>2023-01-17T09:27:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17141-8-marzo-lavoro-a-rischio-licenziamento-migliaia-di-lavoratrici-caregiver-di-persone-con-disabilita-e-malattie-rare]]></loc><lastmod>2021-03-08T12:29:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17119-vaccino-anti-covid-la-bella-storia-sara-quando-decideranno-di-proteggere-chi-e-fragile]]></loc><lastmod>2021-03-04T12:27:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17118-sindrome-di-beckwith-wiedemann-a-lezione-di-malattie-rare-con-aibws-odv]]></loc><lastmod>2021-03-04T10:38:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17117-vaccinazioni-covid-19-per-malati-rari-e-persone-con-disabilita-come-funziona-nel-lazio]]></loc><lastmod>2023-01-17T09:31:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17095-malattie-rare-nasce-il-coordinamento-delle-associazioni-della-sardegna]]></loc><lastmod>2021-02-28T17:31:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17116-da-brad-pitt-a-rafa-nadal-le-star-che-vivono-con-una-malattia-rara]]></loc><lastmod>2021-03-03T12:02:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17114-malattie-rare-alexion-lancia-il-portale-alexionrare]]></loc><lastmod>2021-03-03T10:03:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17092-malattie-neuromuscolari-inaugurato-il-centro-clinico-nemo-di-trento]]></loc><lastmod>2021-02-28T16:46:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17093-coronavirus-come-gestire-la-pandemia-nei-prossimi-mesi]]></loc><lastmod>2021-03-03T14:45:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17113-malattie-rare-premiati-i-vincitori-di-hackerare]]></loc><lastmod>2021-03-03T14:55:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17110-priorita-nella-vaccinazione-delle-persone-con-disabilita-e-dei-loro-familiari]]></loc><lastmod>2021-03-04T08:54:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17109-malattie-rare-lo-sportello-legale-dalla-parte-dei-rari-dell-omar-compie-3-anni]]></loc><lastmod>2021-12-09T16:03:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17067-giornata-delle-malattie-rare-la-torre-di-pisa-torna-ad-accendersi-per-l-occasione]]></loc><lastmod>2021-02-23T19:09:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17084-malattie-rare-oltre-il-50-ha-una-componente-neurologica-2]]></loc><lastmod>2021-02-27T19:21:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17081-malattie-rare-nella-giornata-mondiale-ucb-conferma-e-rilancia-il-suo-impegno]]></loc><lastmod>2021-02-27T14:10:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17083-il-lockdown-delle-famiglie-con-figli-affetti-da-malattie-rare-la-docu-survey-della-simgeped]]></loc><lastmod>2021-02-27T14:58:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17079-giornata-delle-malattie-rare-sip-simgeped-e-omar-insieme-per-i-rare-sibling]]></loc><lastmod>2021-02-26T14:33:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17055-disabilita-quinta-edizione-del-memorial-letterario-antonietta-rongone]]></loc><lastmod>2021-02-21T17:32:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17049-festival-della-scienza-2021-aperta-la-call-per-le-proposte-progettuali]]></loc><lastmod>2021-02-21T15:26:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17052-sindrome-di-pierpont-in-italia-nasce-l-associazione-dei-pazienti]]></loc><lastmod>2024-09-11T17:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17026-malattie-dermatologiche-rare-i-benefici-terapeutici-della-luce]]></loc><lastmod>2021-08-11T17:28:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17019-tromboembolismo-venoso-ema-dice-si-all-uso-di-rivaroxaban-nei-bambini]]></loc><lastmod>2021-02-14T19:56:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17030-malattie-rare-arriva-sulla-rete-il-social-talk-live-therareside]]></loc><lastmod>2021-10-26T10:51:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17017-covid-19-e-caccia-alle-nuove-varianti]]></loc><lastmod>2021-02-14T18:54:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17018-disabilita-blocco-assunzioni-delle-categorie-protette-fino-al-30-marzo-2021]]></loc><lastmod>2022-04-01T13:17:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16994-disabilita-e-sessualita-il-14-febbraio-inizia-la-terza-edizione-di-sensuability]]></loc><lastmod>2021-02-12T10:26:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/17013-scuola-e-disabilita-battaglia-sul-nuovo-pei-in-corso-la-mobilitazione-noesonero]]></loc><lastmod>2021-02-11T13:05:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16877-vaccino-covid-19-malattie-rare-e-disabilita-tutto-quello-che-c-e-da-sapere]]></loc><lastmod>2021-12-02T14:46:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16981-bambini-con-disabilita-parte-la-campagna-inclusione-un-gioco-da-ragazzi]]></loc><lastmod>2021-02-07T18:28:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16993-malattie-rare-al-via-therareside-il-social-talk-di-omar]]></loc><lastmod>2021-10-26T10:45:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16978-sindromi-atassiche-al-via-la-campagna-condividi-la-vita]]></loc><lastmod>2021-02-07T16:57:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16975-xiv-giornata-delle-malattie-rare-online-lo-spot-uniamoleforze]]></loc><lastmod>2021-02-07T15:49:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16966-terapie-avanzate-disponibile-online-corso-di-formazione-a-distanza-per-giornalisti]]></loc><lastmod>2021-02-03T12:31:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16950-vaccinazione-anti-covid-19-le-raccomandazioni-airo-per-i-pazienti-oncologici]]></loc><lastmod>2021-02-11T11:56:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16949-glassboy-esce-oggi-sulle-piattaforme-online-la-pellicola-per-ragazzi-che-parla-di-malattie-rare]]></loc><lastmod>2021-01-30T23:02:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16927-covid-19-pubblicato-documento-d-indirizzo-per-la-gestione-della-malattia]]></loc><lastmod>2021-01-24T21:09:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16921-carcinoma-polmonare-brigatinib-disponibile-in-italia-per-pazienti-alk-non-trattati-con-inibitori-di-alk]]></loc><lastmod>2021-11-02T15:37:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16942-sanita-oltre-l-emergenza-verso-una-nuova-vision-del-nostro-ssn]]></loc><lastmod>2021-01-27T16:58:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16922-anziani-disabili-e-caregiver-nella-pandemia-un-libro-racconta-le-loro-difficolta]]></loc><lastmod>2021-01-24T00:38:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16923-reti-di-riferimento-europee-la-visione-di-eurordis-per-un-sistema-maturo-entro-il-2030]]></loc><lastmod>2021-01-27T16:27:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16903-infermieri-a-viso-aperto-una-mostra-sui-volti-di-chi-ogni-giorno-e-a-fianco-dei-pazienti]]></loc><lastmod>2021-01-19T23:46:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16893-rete-italiana-per-le-malattie-rare-non-diagnosticate-i-risultati-di-tre-anni-di-attivita]]></loc><lastmod>2021-01-17T22:06:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16895-malattie-rare-l-universita-luigi-vanvitelli-inaugura-il-master-annuale-di-ii-livello]]></loc><lastmod>2021-01-18T12:07:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16876-dislessia-premiata-l-app-leggo-facile-alla-maker-faire-rome-2020]]></loc><lastmod>2021-01-09T21:04:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16869-viii-premio-omar-prorogata-la-scadenza-per-la-presentazione-delle-candidature]]></loc><lastmod>2021-09-02T11:19:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16862-coronavirus-necessario-fare-rete-per-supportare-al-meglio-malati-rari-e-cronici]]></loc><lastmod>2020-12-30T21:57:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16861-malattie-rare-il-progetto-sempre-al-tuo-fianco-si-arricchisce-di-nuovi-video-tutorial]]></loc><lastmod>2020-12-30T18:29:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16850-malattie-rare-e-croniche-takeda-premiata-ai-life-science-excellence-awards-2020]]></loc><lastmod>2020-12-30T18:27:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16852-paralisi-cerebrale-ora-l-action-observation-therapy-sara-possibile-anche-a-casa]]></loc><lastmod>2020-12-28T18:35:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16860-onorificenze-al-merito-della-repubblica-mattarella-premia-anche-il-mondo-delle-malattie-rare]]></loc><lastmod>2020-12-30T11:14:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16855-coronavirus-il-piano-strategico-dimentica-i-caregiver-e-non-e-chiaro-sui-disabili-in-comunita]]></loc><lastmod>2020-12-30T16:50:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16854-corso-di-perfezionamento-in-malattie-rare-le-iscrizioni-terminano-il-31-dicembre]]></loc><lastmod>2020-12-29T09:49:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16848-covid-19-nasce-aiforcovid-imaging-archive]]></loc><lastmod>2020-12-28T15:02:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16845-malattie-rare-con-la-maratona-telethon-raccolti-46-milioni-di-euro-per-la-ricerca]]></loc><lastmod>2020-12-27T17:09:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16828-covid-19-e-disabilita-nasce-una-guida-per-salvaguardare-salute-e-rischio-di-contagio]]></loc><lastmod>2020-12-22T15:49:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16827-malattie-rare-ancora-due-settimane-per-candidarsi-al-premio-omar-2021]]></loc><lastmod>2021-09-02T11:19:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16816-telemedicina-un-app-per-parlare-con-il-proprio-medico-di-famiglia]]></loc><lastmod>2020-12-16T14:05:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16802-disabilita-proclamati-i-vincitori-di-make-to-care]]></loc><lastmod>2020-12-14T09:04:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16801-vii-premio-omar-takeda-in-prima-linea-nel-campo-delle-malattie-rare]]></loc><lastmod>2021-01-05T12:28:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16787-telemedicina-merck-lancia-il-progetto-me-t]]></loc><lastmod>2020-12-14T09:10:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16797-malattie-rare-al-via-l-hackaton-virtuale-hackerare]]></loc><lastmod>2020-12-15T11:11:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16792-coronavirus-al-san-camillo-forlanini-un-servizio-tamponi-per-persone-disabili]]></loc><lastmod>2020-12-11T09:49:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16770-deficit-del-fibrinogeno-nuovo-farmaco-disponibile-in-italia]]></loc><lastmod>2020-12-06T18:07:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16760-next-generation-health-le-priorita-per-la-sanita-del-futuro]]></loc><lastmod>2020-11-30T21:07:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16752-coronavirus-il-collutorio-e-inutile-contro-l-infezione]]></loc><lastmod>2020-11-29T22:47:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16748-sindrome-di-beckwith-wiedemann-al-via-la-campagna-natalizia-panettoni-rock]]></loc><lastmod>2020-11-29T21:57:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16743-premio-omar-2021-ancora-un-mese-per-candidarsi]]></loc><lastmod>2021-09-02T11:21:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16725-atassia-spinocerebellare-lanciata-la-raccolta-fondi-natalizia-di-acaref]]></loc><lastmod>2020-11-23T11:16:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16724-malattie-rare-i-principi-che-guidano-l-impegno-di-chiesi]]></loc><lastmod>2020-11-23T10:12:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16710-disabilita-make-to-care-2020-apre-le-votazioni-online]]></loc><lastmod>2020-11-19T17:54:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16711-scuola-ministero-risponde-su-familiari-fragili-dad-non-e-obbligo-ma-attivarla-si-puo]]></loc><lastmod>2020-11-19T18:59:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16707-rare-sibling-equilibristi-tra-senso-di-responsabilita-e-voglia-di-autonomia]]></loc><lastmod>2020-11-19T09:32:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16706-medicina-territoriale-osservatorio-malattie-rare-in-audizione-al-senato]]></loc><lastmod>2020-11-18T15:45:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16694-disviolenza-una-tavola-rotonda-per-combattere-la-violenza-sulle-donne-con-disabilita]]></loc><lastmod>2020-11-15T19:40:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16696-arnold-chiari-di-tipo-1-mille-chilometri-in-bici-nonostante-la-malattia]]></loc><lastmod>2020-11-16T12:55:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16691-malattie-neurologiche-un-premio-per-migliorare-l-accesso-alle-cure-in-era-covid]]></loc><lastmod>2020-11-15T18:31:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16689-rare-disease-hackathon-2020-vince-un-progetto-per-la-diagnostica-a-distanza]]></loc><lastmod>2020-11-15T15:47:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16683-deficit-del-trasportare-di-riboflavina-l-appello-dei-pazienti-abbiamo-bisogno-di-voi]]></loc><lastmod>2020-11-15T09:56:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16682-vii-premio-omar-biogen-in-prima-linea-per-i-pazienti-sma]]></loc><lastmod>2020-11-13T17:09:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16670-coronavirus-la-bufala-dei-termoscanner-che-cancellano-la-memoria]]></loc><lastmod>2020-11-10T11:18:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16662-scuola-dad-per-figli-di-genitori-fragili-qualcosa-si-muove-ora-serve-documento-ufficiale]]></loc><lastmod>2020-11-19T17:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16661-vii-premio-omar-il-sostegno-di-roche-alla-comunita-dei-malati-rari]]></loc><lastmod>2021-01-03T18:16:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16652-idrosadenite-e-covid-19-l-appello-dei-dermatologi-non-sospendete-le-cure]]></loc><lastmod>2020-11-07T17:59:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16651-scuola-niente-dad-per-i-figli-dei-malati-rari-la-denuncia-dell-omar-sul-sole24-ore]]></loc><lastmod>2020-11-19T17:33:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16642-oncologia-mutazionale-presentato-il-documento-di-consenso-acc-aiom]]></loc><lastmod>2020-11-04T18:45:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16643-terapie-car-t-la-strada-dal-laboratorio-al-letto-del-paziente]]></loc><lastmod>2020-11-04T12:17:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16641-covid-19-l-appello-dei-medici-azioni-immediate-ma-le-scuole-restino-aperte]]></loc><lastmod>2020-11-03T20:43:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16640-vii-premio-omar-l-impegno-di-pfizer-per-i-pazienti-con-malattie-rare]]></loc><lastmod>2020-12-09T14:00:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16633-malati-di-cancro-piu-resistenti-al-coronavirus-un-ipotesi-che-ha-bisogno-di-conferme]]></loc><lastmod>2020-10-31T18:12:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16630-covid-19-governo-faccia-chiarezza-su-assenze-dei-lavoratori-immunodepressi]]></loc><lastmod>2020-11-03T08:51:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16612-tumori-pediatrici-arriva-il-progetto-te-lo-spiego-io]]></loc><lastmod>2020-10-24T16:50:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16613-sindrome-del-cri-du-chat-l-impatto-della-pandemia-sui-pazienti]]></loc><lastmod>2020-10-27T18:11:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16608-leucemia-trapianto-di-staminali-a-budapest-grazie-a-cordone-ombelicale-donato-in-italia]]></loc><lastmod>2020-10-24T11:24:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16600-sindrome-charge-prosegue-il-progetto-aria-nato-durante-il-lockdown]]></loc><lastmod>2020-10-21T17:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16606-coronavirus-oscurati-11-siti-web-che-vendevano-presunti-farmaci-anti-covid]]></loc><lastmod>2020-10-23T15:52:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16583-malattie-scheletriche-rare-riconoscimento-per-la-helpline-covid-dell-istituto-rizzoli]]></loc><lastmod>2020-10-19T10:42:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16579-covid-19-mortalita-fino-a-10-volte-piu-elevata-per-le-persone-con-sindrome-di-down]]></loc><lastmod>2020-10-18T21:48:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16580-malattie-rare-firmata-intesa-tra-irccs-casa-sollievo-della-sofferenza-e-amaram]]></loc><lastmod>2020-10-18T22:04:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16575-sindrome-dicer1-a-napoli-operato-con-successo-un-bambino-di-5-anni]]></loc><lastmod>2020-10-18T20:32:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16549-malattie-rare-al-via-la-seconda-edizione-di-piu-unici-che-rari]]></loc><lastmod>2020-10-11T20:35:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16560-scuola-didattica-a-distanza-per-alunni-fragili-con-malattie-rare-nessun-diritto-se-fragili-sono-i-genitori]]></loc><lastmod>2020-10-12T14:39:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16526-malattie-neuromuscolari-inaugurato-il-centro-clinico-nemo-di-brescia]]></loc><lastmod>2020-10-04T17:45:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16530-paralisi-cerebrale-oggi-la-giornata-mondiale]]></loc><lastmod>2020-10-05T21:32:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16474-l-oleandro-e-velenoso-e-non-cura-il-coronavirus]]></loc><lastmod>2020-09-29T13:46:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16517-festival-uno-sguardo-raro-tra-i-vincitori-hand-in-the-cap-di-adriano-morelli]]></loc><lastmod>2020-10-04T15:28:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16515-vii-premio-omar-la-migliore-campagna-di-comunicazione-e-di-parent-project]]></loc><lastmod>2020-10-01T11:09:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16513-vii-premio-omar-tra-i-vincitori-la-fiaba-illustrata-l-elefante-blu]]></loc><lastmod>2020-09-30T14:33:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16507-vii-premio-omar-nella-categoria-stampa-e-web-trionfa-anna-spena]]></loc><lastmod>2020-09-29T14:11:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16506-covid-19-gli-ultimi-test-per-la-ricerca-del-virus-sars-cov-2]]></loc><lastmod>2020-09-29T10:42:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16502-vii-premio-omar-la-dedica-di-laura-berti-alla-vincitrice-lidia-scognamiglio]]></loc><lastmod>2020-09-28T15:20:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16503-vii-premio-omar-premiato-il-servizio-di-tg2-medicina33-sullo-screening-neonatale-per-la-sma]]></loc><lastmod>2020-09-28T21:30:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16499-vii-premio-omar-vincenzo-manes-vince-il-premio-eugenio-aringhieri]]></loc><lastmod>2020-09-28T10:52:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16488-omar-compie-10-anni-un-decennio-al-servizio-dei-malati-rari]]></loc><lastmod>2020-09-25T16:00:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16496-vii-premio-omar-il-premio-della-giuria-ad-un-articolo-sul-tema-dei-rare-sibling]]></loc><lastmod>2020-09-25T15:00:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16477-disabilita-al-via-la-docuserie-storie-straordinariamente-normali]]></loc><lastmod>2020-09-25T09:29:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16492-viceministro-sileri-ospite-dell-osservatorio-malattie-rare-entro-sei-mesi-il-piano-nazionale-malattie-rare-e-annuncia-la-sua-delega-sul-tema]]></loc><lastmod>2020-09-24T13:57:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16487-malattie-rare-premiati-i-vincitori-della-vii-edizione-del-premio-omar]]></loc><lastmod>2020-09-23T16:22:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16470-tumori-del-sangue-al-via-la-campagna-stiamo-percorrendo-nuove-strade]]></loc><lastmod>2020-09-21T18:27:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16483-malattie-rare-e-scuola-dad-e-istruzione-domiciliare-sono-un-diritto-in-tempo-di-covid]]></loc><lastmod>2020-09-22T16:51:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16466-essere-all-altezza-e-davvero-questione-di-centimetri-ecco-bonsai-una-storia-per-i-bambini-con-nanismo-ipofisario]]></loc><lastmod>2020-09-21T17:09:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16461-farmaci-l-azienda-gw-annuncia-l-apertura-della-sua-sede-in-italia]]></loc><lastmod>2020-09-20T16:16:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16436-disabilita-la-quinta-edizione-di-make-to-care-sara-interamente-online]]></loc><lastmod>2020-09-13T22:43:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16451-malattie-rare-rinnovato-in-sicilia-il-coordinamento-regionale]]></loc><lastmod>2020-09-14T17:38:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16434-covid-19-scoperta-la-causa-della-risposta-infiammatoria-nei-bambini]]></loc><lastmod>2020-09-12T20:44:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16446-malattie-renali-rare-e-covid-19-l-esperienza-di-un-centro-di-riferimento]]></loc><lastmod>2020-09-14T15:16:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16441-malattie-rare-il-valore-dei-farmaci-plasmaderivati]]></loc><lastmod>2020-09-17T11:05:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16424-malattie-rare-dimenticate-tra-i-progetti-del-recovery-fund]]></loc><lastmod>2020-09-09T16:41:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16420-malattie-rare-presentata-la-relazione-programmatica-dell-intergruppo-parlamentare]]></loc><lastmod>2020-09-09T08:40:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16413-sindrome-feto-alcolica-oggi-ricorre-la-giornata-mondiale]]></loc><lastmod>2020-09-07T15:35:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16419-sanita-tra-recovery-fund-e-mes-pioggia-di-fondi-sulla-sanita-ma-nulla-per-i-malati-rari]]></loc><lastmod>2020-09-07T17:26:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16377-covid-19-l-appello-degli-esperti-bisogna-indossare-le-mascherine-e-saperle-usare]]></loc><lastmod>2020-08-23T16:39:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16370-coronavirus-verso-un-nuovo-lockdown-o-verso-la-fine-della-pandemia]]></loc><lastmod>2020-08-10T16:46:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16360-sindrome-di-beckwith-wiedemann-aibws-lancia-l-iniziativa-adotta-una-genetista]]></loc><lastmod>2020-08-09T17:09:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16353-malattie-rare-si-rafforza-l-asse-regione-toscana-forum-delle-associazioni]]></loc><lastmod>2020-08-02T15:34:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16352-coronavirus-e-importante-mantenere-alta-la-guardia]]></loc><lastmod>2020-08-05T07:46:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16346-malattie-rare-al-via-la-xiii-edizione-del-concorso-il-volo-di-pegaso]]></loc><lastmod>2020-08-02T12:35:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16329-covid-19-accordo-kedrion-columbia-university-per-lo-sviluppo-di-una-terapia-con-igg]]></loc><lastmod>2020-07-26T16:32:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16337-malattie-rare-aperte-le-candidature-al-premio-omar-2021]]></loc><lastmod>2021-09-02T11:21:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16326-cisti-di-tarlov-i-pazienti-ancora-piu-invisibili-durante-la-crisi-coronavirus]]></loc><lastmod>2020-07-26T15:37:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16308-policlinico-umberto-i-l-allarme-delle-associazioni-pazienti-cronici-e-rari-trascurati]]></loc><lastmod>2020-07-21T07:42:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16314-malattie-dell-occhio-sono-tante-e-possono-colpire-a-tutte-le-eta]]></loc><lastmod>2020-07-21T08:42:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16305-sindrome-di-beckwith-wiedemann-le-storie-delle-famiglie-raccontate-in-un-video]]></loc><lastmod>2020-07-19T18:57:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16302-r-esistere-il-progetto-nato-durante-il-lockdown-per-raccontare-storie-di-coronavirus]]></loc><lastmod>2020-07-19T18:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16298-malattie-rare-e-coronavirus-l-appello-delle-associazioni-pugliesi]]></loc><lastmod>2020-07-19T16:50:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16292-idrosadenite-suppurativa-oltre-400-pazienti-in-cura-all-idi-di-roma]]></loc><lastmod>2020-07-14T17:54:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16285-malattie-neuromuscolari-ora-il-centro-clinico-nemo-di-napoli-e-realta]]></loc><lastmod>2020-07-15T19:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16286-malattie-rare-dell-osso-le-associazioni-chiedono-la-riapertura-del-centro-all-umberto-i]]></loc><lastmod>2020-07-13T09:37:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16282-malattie-genetiche-rare-cresce-la-ricerca-di-fondazione-telethon]]></loc><lastmod>2020-07-12T18:40:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16283-covid-19-e-sarcoidosi-prosegue-l-indagine-internazionale]]></loc><lastmod>2020-07-12T18:53:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16280-tumori-rari-10-raccomandazioni-per-migliorarne-la-gestione-in-europa]]></loc><lastmod>2020-07-12T17:30:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16276-malattie-mitocondriali-lo-chef-kevin-gaddi-lancia-un-piatto-per-la-ricerca]]></loc><lastmod>2020-07-12T14:08:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16259-malattie-rare-le-associazioni-della-puglia-unite-in-un-incontro-virtuale]]></loc><lastmod>2020-07-05T17:52:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16257-encefalopatia-epilettica-correlata-a-smc1a-cerchiamo-famiglie-con-questa-rara-malattia]]></loc><lastmod>2020-07-07T07:03:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16250-malattie-rare-il-pdta-come-strumento-per-una-migliore-gestione]]></loc><lastmod>2020-07-03T11:23:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16235-covid-19-piu-vicini-ai-pazienti-con-il-progetto-di-telemedicina-ti-video-visito]]></loc><lastmod>2020-06-29T12:15:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16236-oncologia-e-malattie-rare-al-via-un-bando-per-finanziare-progetti-dedicati-ai-pazienti]]></loc><lastmod>2020-06-29T12:29:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16232-malattie-neuromuscolari-nasce-il-progetto-donnenmd-dedicato-alle-donne]]></loc><lastmod>2020-06-29T10:19:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16233-lichen-scleroatrofico-un-libro-per-spiegare-ai-bambini-la-vita-con-la-malattia]]></loc><lastmod>2020-06-29T10:40:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16216-coronavirus-il-boom-della-medicina-digitale-durante-e-oltre-l-emergenza]]></loc><lastmod>2020-06-23T11:39:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16179-tumori-gastrointestinali-i-pazienti-reclamano-un-assistenza-equa-e-di-qualita]]></loc><lastmod>2020-06-16T15:18:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16196-malattie-immunomediate-nasce-la-federazione-italiana-relacare]]></loc><lastmod>2020-06-18T10:48:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16186-malattie-rare-confermate-le-date-del-festival-uno-sguardo-raro]]></loc><lastmod>2020-06-16T10:34:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16174-covid-19-una-madre-racconta-la-sua-malattia-in-un-libro]]></loc><lastmod>2020-06-14T21:20:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16154-covid-19-le-indicazioni-degli-pneumologi-per-affrontare-i-mesi-successivi-all-infezione]]></loc><lastmod>2020-06-09T21:50:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16155-ricerca-biomedica-ad-alessandro-aiuti-il-premio-else-kroener-fresenius]]></loc><lastmod>2020-06-09T23:06:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16148-sindrome-charge-nasce-aria-per-i-bambini-a-cui-il-covid-19-ha-sottratto-servizi-essenziali]]></loc><lastmod>2020-06-09T14:47:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16130-coronavirus-le-proposte-per-la-tutela-dei-pazienti-oncologici-e-onco-ematologici]]></loc><lastmod>2020-05-31T22:22:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16135-coronavirus-a-settembre-si-torna-a-scuola-quali-tutele-per-disabili-e-malati-rari]]></loc><lastmod>2020-06-03T17:16:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16125-malattie-rare-e-covid-19-un-webinar-per-fare-il-punto-sulla-presa-in-carico-dei-pazienti]]></loc><lastmod>2020-05-31T20:21:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16128-malattie-rare-degli-occhi-il-cheratocono-e-la-piu-frequente-e-colpisce-molti-giovani]]></loc><lastmod>2020-06-05T08:47:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16112-tumori-gastrointestinali-da-takeda-un-premio-per-la-ricerca]]></loc><lastmod>2020-05-28T19:30:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16120-il-31-maggio-e-il-sibling-day-giornata-europea-dei-fratelli-di-malati-rari]]></loc><lastmod>2020-05-28T14:43:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16105-covid-19-grifols-scommette-sul-plasma-iperimmune]]></loc><lastmod>2020-05-25T14:56:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16099-malattie-rare-dell-occhio-e-covid-19-tutte-le-risposte-degli-esperti]]></loc><lastmod>2020-05-24T17:19:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16100-malattie-rare-dell-occhio-la-rete-europea-ern-eye-nasce-per-non-lasciare-soli-i-pazienti]]></loc><lastmod>2020-06-05T08:49:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16101-malattie-rare-dell-occhio-sono-piu-di-900-quelle-attualmente-identificate]]></loc><lastmod>2020-05-24T17:46:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16083-malattie-immunologiche-attenzione-al-continuo-cambio-di-farmaci-biosimilari]]></loc><lastmod>2020-05-20T00:15:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16077-covid-19-da-boehringer-ingelheim-un-iniziativa-per-il-personale-medico-sanitario]]></loc><lastmod>2020-05-17T21:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16082-favismo-rischio-di-crisi-emolitiche-con-due-farmaci-anti-coronavirus]]></loc><lastmod>2020-05-19T21:20:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16078-cure-palliative-pediatriche-in-italia-solo-il-5-dei-minori-usufruisce-dei-servizi-previsti]]></loc><lastmod>2020-05-18T13:58:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16069-covid-19-e-medicina-narrativa-nasce-il-progetto-r-esistere]]></loc><lastmod>2020-05-15T10:28:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16073-coronavirus-vaccino-si-o-no-e-se-si-quando]]></loc><lastmod>2020-05-17T18:05:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16051-covid-19-e-rischio-coagulazione-nasce-il-primo-registro-italiano-dei-pazienti]]></loc><lastmod>2020-05-11T00:19:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16061-covid-19-paola-binetti-donne-e-malati-rari-trascurati]]></loc><lastmod>2020-05-12T15:14:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16058-covid-19-l-appello-delle-associazioni-malattie-rare-della-sardegna]]></loc><lastmod>2020-05-12T10:32:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16046-covid-19-al-via-il-terzo-sprint-della-maratona-di-donazioni-di-msd-italia]]></loc><lastmod>2020-05-10T22:06:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16049-coronavirus-la-tromboembolia-polmonare-puo-essere-causa-di-tanti-decessi]]></loc><lastmod>2020-05-10T23:47:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16053-coronavirus-l-esperto-risponde-al-via-in-radio-la-rubrica-di-omar-per-i-malati-rari]]></loc><lastmod>2020-05-11T08:41:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16042-malattie-neuromuscolari-la-consulta-di-piemonte-e-valle-d-aosta-scrive-alle-istituzioni]]></loc><lastmod>2020-05-10T20:26:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16025-covid-19-alfasigma-al-fianco-di-caritas-per-un-aiuto-concreto]]></loc><lastmod>2020-05-05T14:02:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16038-malattia-di-kawasaki-e-covid-19-possibile-un-nesso-tra-le-due-patologie]]></loc><lastmod>2020-05-06T18:24:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16037-coronavirus-e-informazione-grande-successo-per-il-webinar-di-rarelab]]></loc><lastmod>2020-05-06T10:43:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16029-coronavirus-nessun-contagio-dagli-animali-domestici-all-uomo]]></loc><lastmod>2020-05-05T15:42:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15995-covid-19-l-impegno-di-alexion-attraverso-la-propria-charitable-foundation]]></loc><lastmod>2020-05-02T11:29:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16017-coronavirus-caotica-la-situazione-dei-test-sierologici-in-italia]]></loc><lastmod>2020-05-03T19:37:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15998-riabilitazione-respiratoria-pneumologi-e-fisioterapisti-scrivono-al-ministro-della-salute]]></loc><lastmod>2020-04-28T17:17:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/16012-covid-19-esperti-riuniti-in-un-webinar-sull-informazione-ai-tempi-del-coronavirus]]></loc><lastmod>2020-04-29T16:46:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15985-coronavirus-speranze-dall-approccio-terapeutico-con-plasma-iperimmune]]></loc><lastmod>2020-04-27T16:09:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15992-covid-19-e-sarcoidosi-lanciata-un-indagine-internazionale]]></loc><lastmod>2020-04-26T15:42:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15980-covid-19-da-ausl-reggio-emilia-materiale-di-supporto-per-pazienti-e-famiglie]]></loc><lastmod>2020-04-20T16:56:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15981-coronavirus-occorre-proteggere-le-persone-con-malattie-rare]]></loc><lastmod>2020-04-20T17:43:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15975-covid-19-alleanza-sanofi-gsk-per-lo-sviluppo-di-un-vaccino-adiuvato]]></loc><lastmod>2020-04-20T15:25:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15978-covid-19-necessaria-una-corretta-comunicazione-basata-su-fonti-affidabili]]></loc><lastmod>2020-04-20T16:01:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15986-coronavirus-non-possiamo-fidarci-neppure-di-un-premio-nobel]]></loc><lastmod>2020-04-21T10:03:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15967-covid-19-online-le-indicazioni-per-le-persone-con-enzimopenia-g6pd]]></loc><lastmod>2020-04-19T20:59:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15968-covid-19-e-oncologia-su-nature-le-linee-guida-della-rete-cancer-core-europe]]></loc><lastmod>2020-04-19T21:34:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15948-covid-19-presentato-un-position-paper-sulle-cure-palliative]]></loc><lastmod>2020-04-16T13:47:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15965-covid-19-l-impegno-di-takeda-con-l-iniziativa-for-you-with-you]]></loc><lastmod>2020-04-19T17:54:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15966-covid-19-i-test-sierologici-sono-affidabili-per-la-diagnosi]]></loc><lastmod>2020-04-30T09:56:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15964-malattie-rare-il-rischio-e-di-sacrificare-i-pazienti-sull-altare-della-lotta-al-coronavirus]]></loc><lastmod>2020-04-17T14:14:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15962-covid-19-come-gestire-la-paura-incontro-online-con-gli-psicologi-di-vidas]]></loc><lastmod>2020-04-16T18:00:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15947-coronavirus-e-oncologia-appello-congiunto-di-aiom-airo-e-sie]]></loc><lastmod>2020-04-14T09:31:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15943-covid-19-le-iniziative-di-incyte-a-sostegno-dei-pazienti-ematologici-e-oncologici]]></loc><lastmod>2020-04-13T17:05:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15945-covid-19-l-emergenza-non-sembra-compromettere-piu-di-tanto-le-terapie-avanzate]]></loc><lastmod>2020-04-13T18:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15956-il-coronavirus-e-democratico-o-nazista]]></loc><lastmod>2020-04-15T15:38:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15939-coronavirus-da-sifo-il-quadro-sulla-carenza-di-farmaci-e-dispositivi]]></loc><lastmod>2020-04-12T22:58:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15942-covid-19-ruxolitinib-entra-nel-programma-di-uso-compassionevole]]></loc><lastmod>2020-04-12T23:37:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15935-coronavirus-donate-21mila-mascherine-ai-pazienti-con-sla-sma-e-distrofie-muscolari]]></loc><lastmod>2020-04-12T21:42:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15938-coronavirus-gli-ace-inibitori-inaspriscono-davvero-l-infezione]]></loc><lastmod>2020-04-12T22:37:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15924-malattie-rare-il-festival-uno-sguardo-raro-migra-su-un-nuovo-sito-web]]></loc><lastmod>2020-04-09T09:06:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15930-covid-19-al-san-raffaele-apre-un-reparto-per-la-riabilitazione]]></loc><lastmod>2020-04-08T19:54:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15932-covid-19-carenza-idrossiclorochina-a-rischio-le-terapie-per-malattie-autoimmuni]]></loc><lastmod>2020-04-09T14:34:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15919-covid-19-chiesi-aumenta-le-misure-in-atto-e-annuncia-nuovi-fondi]]></loc><lastmod>2020-04-08T14:46:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15921-coronavirus-difficolta-per-i-malati-rari-nel-veder-riconosciuti-i-propri-diritti-sul-lavoro]]></loc><lastmod>2020-04-08T08:43:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15916-covid-19-aifa-autorizza-l-uso-di-antimalarici-e-anti-aids]]></loc><lastmod>2020-04-06T18:04:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15908-covid-19-al-via-il-progetto-aiutiamoglieroi-di-gsk-italia]]></loc><lastmod>2020-04-06T14:30:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15910-coronavirus-un-vademecum-per-i-lavoratori-affetti-da-patologie-oncologiche]]></loc><lastmod>2020-04-06T15:15:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15913-coronavirus-tutti-i-falsi-consigli-da-ignorare]]></loc><lastmod>2020-04-06T16:53:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15871-covid-19-sanofi-in-campo-con-noicisiamo]]></loc><lastmod>2020-03-31T15:46:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15903-coronavirus-al-via-un-concorso-artistico-dedicato-ai-bambini]]></loc><lastmod>2020-04-05T17:06:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15904-coronavirus-contro-le-carenze-di-ossigeno-agevolare-il-ritiro-delle-bombole]]></loc><lastmod>2020-04-05T17:42:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15905-malattie-rare-dalle-associazioni-una-lettera-al-governo-contro-la-selezione-nelle-terapie-intensive]]></loc><lastmod>2020-04-05T18:09:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15907-coronavirus-sars-cov-2-come-si-effettua-la-diagnosi]]></loc><lastmod>2020-04-06T13:49:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15902-coronavirus-omar-boom-di-domande-per-il-servizio-l-esperto-risponde]]></loc><lastmod>2020-04-04T15:18:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15896-covid-19-boehringer-ingelheim-italia-amplia-l-offerta-di-servizi-per-i-dipendenti]]></loc><lastmod>2020-04-02T14:11:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15883-covid-19-l-impegno-di-csl-behring]]></loc><lastmod>2020-03-31T12:11:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15884-malattie-rare-al-via-il-progetto-sempre-al-tuo-fianco]]></loc><lastmod>2020-03-31T12:33:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15888-coronavirus-il-vaccino-per-la-tubercolosi-non-protegge-dall-infezione]]></loc><lastmod>2020-03-31T19:04:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15873-coronavirus-da-bari-appello-alle-aziende-farmaceutiche-non-dimenticateci]]></loc><lastmod>2020-03-30T12:41:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15876-covid-19-una-pandemia-nel-2020]]></loc><lastmod>2020-04-01T08:09:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15865-coronavirus-l-impegno-di-gilead]]></loc><lastmod>2020-03-29T17:56:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15867-covid-19-un-questionario-per-conoscere-i-bisogni-dei-malati-rari]]></loc><lastmod>2020-03-29T19:30:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15872-coronavirus-il-farmaco-giapponese-avigan-sara-il-nuovo-caso-stamina]]></loc><lastmod>2020-03-30T13:24:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15861-coronavirus-aifi-messaggi-equivoci-e-scorretti-dal-mondo-dell-osteopatia]]></loc><lastmod>2020-03-29T16:58:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15862-covid-19-perche-si-usano-farmaci-autorizzati-per-altre-patologie]]></loc><lastmod>2020-03-29T17:17:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15863-coronavirus-nasce-una-help-line-grazie-a-ern-bond]]></loc><lastmod>2020-03-30T10:12:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15847-coronavirus-sifo-chiede-reclutamento-straordinario-di-personale-farmacista]]></loc><lastmod>2020-03-25T12:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15849-coronavirus-sigo-attendere-prima-iniziare-nuovi-cicli-di-fecondazione-assistita]]></loc><lastmod>2020-03-25T13:57:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15838-coronavirus-aisla-uildm-e-famiglie-sma-lanciano-distantimavicini]]></loc><lastmod>2020-03-24T19:17:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15839-coronavirus-rischio-di-malnutrizione-per-i-pazienti-in-ospedale]]></loc><lastmod>2020-03-24T21:47:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15841-coronavirus-aifa-proroghi-anche-i-piani-terapeutici-con-farmaci-innovativi]]></loc><lastmod>2020-03-24T22:20:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15842-coronavirus-i-consigli-per-chi-e-in-attesa-di-intervento-di-artroprotesi]]></loc><lastmod>2020-03-25T09:39:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15818-malattie-rare-sabato-28-marzo-lo-spazio-raro-sulla-fisioterapia]]></loc><lastmod>2020-03-23T22:31:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15837-covid-19-non-ci-sono-prove-che-ibuprofene-peggiori-il-decorso-della-malattia]]></loc><lastmod>2020-03-25T18:19:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15823-arbidol-il-farmaco-russo-che-non-cura-il-coronavirus]]></loc><lastmod>2020-03-30T16:11:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15812-coronavirus-urgente-risolvere-il-conflitto-di-interesse-nelle-sperimentazioni-cliniche]]></loc><lastmod>2020-03-23T17:55:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15809-coronavirus-da-aipo-informazioni-utili-per-fronteggiarlo]]></loc><lastmod>2020-03-22T20:32:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15773-covid-19-l-impegno-dei-fisioterapisti-respiratori-in-italia-e-nelle-aree-critiche]]></loc><lastmod>2020-03-17T10:27:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15775-fecondazione-assistita-quali-gli-effetti-del-coronavirus-sulla-gravidanza]]></loc><lastmod>2020-03-17T10:55:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15768-covid-19-i-farmacisti-ospedalieri-in-azione-per-assicurare-terapie-salvavita]]></loc><lastmod>2020-03-17T17:27:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15770-covid-19-su-facebook-gli-esperti-rispondono-alle-domande-dei-pazienti-oncologici]]></loc><lastmod>2020-03-16T17:31:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15781-coronavirus-simg-i-pazienti-con-ipertensione-non-modifichino-la-terapia]]></loc><lastmod>2020-03-17T19:51:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15761-coronavirus-un-vademecum-per-trattare-i-pazienti-positivi-a-casa]]></loc><lastmod>2020-03-15T20:49:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15762-covid-19-le-associazioni-di-pazienti-oncologici-incontrano-le-istituzioni]]></loc><lastmod>2020-03-15T21:24:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15763-coronavirus-hugonin-per-prendersi-cura-di-una-persona-fragile-c-e-bisogno-di-tutti]]></loc><lastmod>2020-03-15T21:43:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15765-coronavirus-omar-mette-a-disposizione-dei-cittadini-oltre-25-esperti-online]]></loc><lastmod>2020-03-19T09:50:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15742-farmaci-giuseppe-pompilio-e-il-nuovo-patient-access-head-di-novartis]]></loc><lastmod>2020-03-11T19:15:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15751-solidarieta-digitale-tutti-i-servizi-gratuiti-per-l-emergenza-coronavirus]]></loc><lastmod>2020-03-12T13:29:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15739-malattie-scheletriche-rare-il-rizzoli-di-bologna-potenzia-il-suo-centro]]></loc><lastmod>2020-03-09T17:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15734-covid-19-speranze-dall-antivirale-remdesivir]]></loc><lastmod>2020-03-11T10:46:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15732-carcinoma-polmonare-non-a-piccole-cellule-parere-favorevole-dal-chmp-per-brigatinib]]></loc><lastmod>2021-11-02T15:09:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15721-distrofia-muscolare-uildm-rinnova-protocollo-d-intesa-con-avis]]></loc><lastmod>2020-03-03T13:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15727-coronavirus-i-pazienti-oncologici-scrivono-al-ministro-speranza]]></loc><lastmod>2020-03-10T14:19:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15717-coronavirus-le-regole-da-seguire-per-i-malati-rari]]></loc><lastmod>2020-03-10T14:23:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15718-malattie-rare-l-appello-sin-aumentare-i-livelli-sicurezza-sociale]]></loc><lastmod>2020-03-03T16:52:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15711-malattie-rare-oltre-il-50-ha-una-componente-neurologica]]></loc><lastmod>2020-03-01T20:39:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15712-sindrome-di-sjogren-aifi-e-animass-unite-per-la-giornata-delle-malattie-rare]]></loc><lastmod>2020-03-01T20:56:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15708-malattie-rare-nel-7-dei-casi-si-tratta-di-disordini-endocrino-metabolici]]></loc><lastmod>2020-03-01T20:56:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15710-coronavirus-un-emergenza-che-tocca-anche-il-mondo-delle-malattie-rare]]></loc><lastmod>2020-03-10T14:25:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15707-malattie-rare-l-emergenza-coronavirus-non-ci-ferma]]></loc><lastmod>2020-03-01T17:35:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15706-malattie-rare-e-importante-che-la-voce-dei-pazienti-non-si-spenga]]></loc><lastmod>2020-03-01T17:35:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15705-malattie-rare-fondazione-telethon-ospite-del-quirinale-per-i-suoi-30-anni-di-attivita]]></loc><lastmod>2020-03-03T14:50:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15702-malattie-rare-nasce-il-nuovo-portale-interistituzionale]]></loc><lastmod>2020-02-27T17:27:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15696-malattie-rare-l-audio-documentario-faire-avec-in-onda-su-rai-radio-3]]></loc><lastmod>2020-02-25T19:57:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15691-paralisi-cerebrale-infantile-al-via-il-progetto-europeo-borntogetthere]]></loc><lastmod>2020-02-24T20:58:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15690-malattie-rare-rimandata-la-cerimonia-del-vii-premio-omar]]></loc><lastmod>2020-02-28T19:35:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15687-malattie-rare-il-29-febbraio-e-la-tredicesima-giornata-mondiale]]></loc><lastmod>2020-02-26T16:44:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15679-tumori-e-online-internos-il-blog-dell-int-di-milano]]></loc><lastmod>2020-02-19T22:54:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15674-malattie-rare-decretati-i-vincitori-del-vii-premio-omar]]></loc><lastmod>2020-02-19T09:37:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15658-disabilita-e-sessualita-a-roma-apre-la-mostra-di-fumetti-sensuability]]></loc><lastmod>2020-02-13T22:34:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15654-malattie-virali-l-immunoterapia-viralym-m-riceve-designazione-prime-dall-ema]]></loc><lastmod>2020-02-12T12:42:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15632-malattie-rare-al-via-gli-spazi-rari-percorsi-di-formazione-e-supporto-per-i-pazienti]]></loc><lastmod>2020-02-04T22:17:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15630-malattie-rare-serve-una-rete-di-alleanze-per-non-lasciare-isolati-i-pazienti]]></loc><lastmod>2020-02-04T14:51:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15615-tumori-rari-necessario-che-la-rete-nazionale-raggiunga-piena-operativita]]></loc><lastmod>2020-01-30T15:20:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15600-disabilita-l-asd-oltre-sport-in-campo-per-un-amichevole-di-calcio-in-carrozzina-elettrica]]></loc><lastmod>2020-01-23T11:33:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15598-atassia-spinocerebellare-parte-la-campagna-condividi-la-vita]]></loc><lastmod>2020-01-22T21:33:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15599-malattie-genetiche-rare-in-italia-una-rete-di-esperti-per-fare-luce-sulla-loro-origine]]></loc><lastmod>2020-01-22T22:00:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15590-malattie-neuromuscolari-nasce-una-consulta-per-i-pazienti-di-piemonte-e-valle-d-aosta]]></loc><lastmod>2020-01-20T17:40:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15579-ricerca-medico-scientifica-ritorna-il-programma-amgen-scholars]]></loc><lastmod>2020-01-14T18:56:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15585-malattie-genetiche-rare-individuate-due-patologie-in-tre-bambini-italiani]]></loc><lastmod>2020-01-17T17:40:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15563-malattie-neuromuscolari-a-brescia-una-nuova-sede-del-centro-clinico-nemo]]></loc><lastmod>2020-01-11T18:42:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15551-malattie-genetiche-rare-nel-2019-telethon-ha-raccolto-45-milioni-di-euro-per-la-ricerca]]></loc><lastmod>2020-01-05T10:47:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15537-tumori-rari-in-italia-nasce-l-associazione-con-gabriele]]></loc><lastmod>2019-12-26T14:02:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15530-malattie-rare-telethon-presenta-19-bambini-curati-grazie-alla-ricerca-scientifica-della-fondazione]]></loc><lastmod>2019-12-20T10:42:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15516-tromboembolismo-venoso-presentata-all-ema-la-richiesta-per-l-uso-di-rivaroxaban-nei-bambini]]></loc><lastmod>2019-12-20T10:48:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15505-malattie-rare-ai-nastri-di-partenza-la-maratona-rai-di-fondazione-telethon]]></loc><lastmod>2019-12-12T22:36:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15490-broncomalacia-al-bambino-gesu-impiantato-il-primo-bronco-3d-su-un-piccolo-paziente]]></loc><lastmod>2019-12-08T22:54:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15482-malattie-cardiache-pediatriche-per-individuarle-puo-bastare-un-semplice-elettrocardiogramma]]></loc><lastmod>2019-12-06T10:38:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15449-malattie-rare-un-associazione-di-volontariato-nata-per-offrire-un-primo-aiuto-ai-pazienti]]></loc><lastmod>2019-11-26T21:36:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15433-rare-sibling-il-41-si-ritiene-ben-trattato-dai-genitori-ma-il-35-ammette-sentimenti-negativi-verso-di-loro]]></loc><lastmod>2019-11-21T17:12:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15434-rare-sibling-la-realta-raccontata-dalla-voce-dei-protagonisti]]></loc><lastmod>2019-11-21T17:12:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15432-malattie-rare-la-riscossa-dei-fratelli-presentato-oggi-il-libro-sui-rare-sibling]]></loc><lastmod>2019-11-21T15:07:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15414-malattie-rare-endocrino-metaboliche-a-messina-riuniti-i-massimi-esperti]]></loc><lastmod>2019-11-18T22:28:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15417-malattie-rare-senza-diagnosi-nasce-spazio-hopen-una-casa-per-i-pazienti]]></loc><lastmod>2019-11-18T22:28:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15397-fertilita-lanciata-la-quarta-edizione-di-che-fine-ha-fatto-la-cicogna]]></loc><lastmod>2019-11-09T23:04:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15393-sindrome-dicer1-una-malattia-rara-che-provoca-tumori-rari]]></loc><lastmod>2019-11-09T21:33:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15404-malattie-rare-iii-rapporto-ossfor-si-allargano-le-esenzioni-ma-non-i-costi-del-ssn]]></loc><lastmod>2019-11-12T10:36:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15382-malattie-neuromuscolari-presentato-il-progetto-del-nuovo-centro-nemo-di-trento]]></loc><lastmod>2019-11-06T21:53:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15380-ittiosi-arlecchino-il-piccolo-giovannino-e-in-cerca-di-una-famiglia]]></loc><lastmod>2019-11-07T16:03:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15376-malattie-rare-takeda-premiata-ai-life-science-excellence-awards]]></loc><lastmod>2019-11-05T18:54:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15374-neuroscienze-a-milano-il-congresso-brayn-dal-14-al-16-novembre]]></loc><lastmod>2019-11-04T21:41:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15360-malattie-neurologiche-uno-studio-rileva-benefici-e-svantaggi-del-giocare-a-calcio]]></loc><lastmod>2019-10-30T21:09:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15348-megalouretra-congenita-effettuato-a-napoli-un-innovativo-impianto-di-protesi-peniena]]></loc><lastmod>2019-10-27T22:55:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15345-make-to-care-letismart-e-tourist-eyes-i-vincitori-della-quarta-edizione]]></loc><lastmod>2019-10-24T15:53:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15339-neurologia-gioacchino-tedeschi-a-capo-della-societa-italiana]]></loc><lastmod>2019-10-23T15:47:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15336-malattie-rare-a-bari-tre-progetti-dedicati-ai-pazienti-e-ai-loro-familiari]]></loc><lastmod>2019-10-23T09:18:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15335-malattie-rare-un-recente-studio-ne-ha-stimato-la-prevalenza-globale]]></loc><lastmod>2019-10-21T20:10:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15328-piu-unici-che-rari-al-via-la-campagna-educativa-che-promuove-il-valore-della-diversita-nelle-scuole]]></loc><lastmod>2020-02-27T13:47:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15330-malattie-rare-per-affrontare-le-criticita-aiuta-il-playdecide]]></loc><lastmod>2019-10-20T18:34:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15317-malattie-rare-puntare-alla-diagnosi-differenziale-per-evitare-ritardi]]></loc><lastmod>2019-10-16T20:45:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15308-paraparesi-spastica-ereditaria-una-malattia-rara-che-danneggia-gli-arti-inferiori]]></loc><lastmod>2023-02-19T22:34:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15309-disabilita-gli-otto-finalisti-del-concorso-make-to-care]]></loc><lastmod>2019-10-14T17:49:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15304-malattie-rare-90-giorni-per-candidarsi-alla-vii-edizione-del-premio-omar]]></loc><lastmod>2020-02-03T13:53:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15293-malattie-rare-il-direttore-di-omar-premiato-dall-associazione-a-i-net]]></loc><lastmod>2019-10-14T13:11:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15286-malattie-rare-ptc-e-aldevron-collaborano-per-la-produzione-di-plasmidi-gmp]]></loc><lastmod>2019-10-08T18:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15271-malattie-rare-aperte-fino-al-30-novembre-le-iscrizioni-alle-ern]]></loc><lastmod>2019-10-06T21:20:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15268-malattie-rare-biotech-ed-empowerment-hanno-cambiato-la-vita-dei-pazienti]]></loc><lastmod>2019-10-04T09:54:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15249-biotecnologie-parte-la-nuova-edizione-di-amgen-biotech-experience]]></loc><lastmod>2019-10-01T14:50:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15245-disfunzione-sessuale-post-ssri-quando-gli-antidepressivi-lasciano-il-segno]]></loc><lastmod>2019-09-30T20:01:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15238-huntington-seconda-edizione-del-contributo-carmine-aprea-a-supporto-di-pazienti-e-famiglie]]></loc><lastmod>2019-09-26T11:46:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15243-malattie-neuromuscolari-nasce-il-nemo-institute-of-neuromuscular-research]]></loc><lastmod>2019-09-29T19:37:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15236-le-malattie-rare-entrano-nella-dichiarazione-onu-ciancaleoni-omar-italia-traduca-in-atti-concreti-piena-attuazione-piano-nazionale-decreti-lea-e-screening]]></loc><lastmod>2019-09-25T15:21:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15218-distrofia-miotonica-di-tipo-1-presentata-la-prima-scala-di-valutazione-compilata-dal-medico]]></loc><lastmod>2019-09-21T22:42:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15219-sindrome-post-finasteride-in-italia-esiste-un-associazione-di-pazienti]]></loc><lastmod>2019-09-21T23:16:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15220-sindrome-post-finasteride-una-malattia-connessa-a-un-farmaco-per-la-calvizie]]></loc><lastmod>2019-10-02T17:00:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15215-tumori-testa-collo-presentata-in-senato-la-campagna-tieni-la-testa-sul-collo]]></loc><lastmod>2019-09-21T21:35:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15201-malattie-neuromuscolari-nasce-la-competizione-google-assistant-for-good]]></loc><lastmod>2019-09-18T19:50:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15203-tumori-pediatrici-rari-le-baby-pelones-per-sostenere-la-ricerca]]></loc><lastmod>2019-09-18T19:53:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15192-linfomi-10mila-euro-per-ricerche-innovative-con-il-premio-brusamolino-2019]]></loc><lastmod>2019-09-17T13:36:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15193-malattie-rare-nasce-l-alleanza-omar-compugroup-medical]]></loc><lastmod>2019-09-17T10:31:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15191-tumori-una-nuova-convenzione-tra-ifo-e-sapienza]]></loc><lastmod>2019-09-16T17:10:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15189-tumori-italia-giappone-e-austria-insieme-per-il-trattamento-con-ioni-carbonio]]></loc><lastmod>2019-09-15T16:41:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15179-ricerca-scientifica-conclusa-la-nona-edizione-del-premio-internazionale-arrigo-recordati]]></loc><lastmod>2019-09-11T21:05:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15172-ricerca-biomedica-sette-talenti-italiani-al-progetto-amgen-scholars]]></loc><lastmod>2019-09-09T19:47:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15169-sindrome-feto-alcolica-oggi-e-il-fasd-awareness-day]]></loc><lastmod>2019-09-09T16:43:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15165-industria-farmaceutica-marcello-cattani-nuovo-general-manager-di-sanofi-genzyme]]></loc><lastmod>2019-09-08T17:42:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15146-sindromi-pten-correlate-italia-e-stati-uniti-danno-vita-ad-un-registro-dei-pazienti]]></loc><lastmod>2024-10-23T09:53:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15120-sindrome-di-sjogren-si-alla-fisioterapia-di-iniziativa]]></loc><lastmod>2019-08-18T16:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15118-tecnologia-e-salute-al-via-il-premio-innovazione-in-pediatria]]></loc><lastmod>2019-08-14T16:55:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15117-ci-ha-lasciati-il-prof-marco-cicardi-una-vita-al-servizio-dei-pazienti-con-angioedema-ereditario]]></loc><lastmod>2019-08-14T09:52:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15110-salute-e-innovazione-tornano-gli-aboutpharma-digital-awards]]></loc><lastmod>2019-08-09T16:44:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15107-sindrome-charge-in-italia-esiste-una-rete-per-i-piccoli-pazienti]]></loc><lastmod>2019-08-07T21:20:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15103-comitato-scientifico-di-omar-morto-il-prof-maurizio-botta]]></loc><lastmod>2019-08-05T10:06:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15087-anoressia-solo-l-8-e-di-origine-psicologica]]></loc><lastmod>2019-07-30T14:43:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15090-fine-vita-cappato-onore-al-comitato-di-bioetica-per-dibattito-sul-tema]]></loc><lastmod>2019-07-31T09:35:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15089-fine-vita-sen-binetti-necessario-aumentare-le-tutele-per-malati-e-caregiver]]></loc><lastmod>2019-07-31T09:41:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15073-malattie-rare-costituito-il-comitato-epag-italia]]></loc><lastmod>2019-07-29T09:47:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15076-elena-santarelli-e-il-suicidio-dello-zio-la-sindrome-di-prader-willi-mi-ha-consumato]]></loc><lastmod>2019-07-30T11:18:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15071-insufficienza-respiratoria-definita-la-proposta-di-percorso-clinico-assistenziale-di-presa-in-carico-dei-pazienti]]></loc><lastmod>2019-07-29T10:36:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15051-malattie-rare-al-via-anche-quest-anno-il-concorso-il-volo-di-pegaso]]></loc><lastmod>2025-09-03T08:41:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15033-malattie-croniche-e-diritti-presentato-il-xvii-rapporto-di-cittadinanzattiva]]></loc><lastmod>2019-07-12T20:27:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15024-malattie-rare-online-il-bando-della-v-edizione-di-uno-sguardo-raro]]></loc><lastmod>2019-07-12T17:17:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15025-malattie-rare-nuovi-finanziamenti-alle-ern-per-lo-sviluppo-di-registri]]></loc><lastmod>2019-07-12T17:30:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15026-cisti-di-tarlov-il-limbo-dei-pazienti-malati-e-rari-ma-non-ancora-riconosciuti]]></loc><lastmod>2019-07-12T17:52:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/15037-malattie-rare-aperte-le-candidature-alla-vii-edizione-del-premio-omar]]></loc><lastmod>2019-07-29T18:01:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14991-farmaci-non-reperibili-la-sifo-lancia-piattaforma-per-mappare-il-fenomeno]]></loc><lastmod>2019-07-08T16:58:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14987-ricerca-scientifica-conto-alla-rovescia-per-il-bando-research-to-care]]></loc><lastmod>2019-08-08T15:20:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14981-malattie-genetiche-rare-da-telethon-oltre-11-milioni-di-euro-alla-ricerca-italiana]]></loc><lastmod>2019-07-04T17:09:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14982-malattie-rare-non-neoplastiche-avviato-il-primo-working-party-sulle-patologie]]></loc><lastmod>2019-07-04T17:08:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14978-malattie-rare-presentato-il-nuovo-rapporto-monitorare]]></loc><lastmod>2019-07-03T12:39:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14970-malattie-rare-mario-bengala-entra-nel-centro-di-coordinamento-del-lazio]]></loc><lastmod>2019-06-30T09:22:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14949-parita-di-genere-va-a-novartis-italia-il-premio-mela-d-oro-2019]]></loc><lastmod>2019-06-30T21:01:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14944-malattie-rare-uniamo-presenta-al-ministero-le-problematiche-delle-associazioni]]></loc><lastmod>2019-06-23T14:07:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14940-terapie-avanzate-3-sulle-prime-4-approvate-in-europa-sono-nate-in-italia]]></loc><lastmod>2019-06-21T11:43:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14925-ricerca-scientifica-proclamati-i-vincitori-del-concorso-scolastico-telethon-pearson-italia]]></loc><lastmod>2019-06-15T15:52:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14919-progeria-sammy-basso-nominato-cavaliere-della-repubblica]]></loc><lastmod>2019-06-16T14:21:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14905-distonia-di-torsione-idiopatica-in-un-libro-gli-esercizi-di-scrittura-e-disegno-di-carlo-iacomucci]]></loc><lastmod>2019-06-12T09:00:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14898-riforma-del-terzo-settore-online-la-guida-pratica-dedicata-alle-associazioni]]></loc><lastmod>2019-06-12T13:11:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14893-ricerca-scientifica-si-avvicina-la-chiusura-del-bando-roche]]></loc><lastmod>2019-06-09T10:01:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14889-malattie-rare-e-terapie-car-t-aifa-finanzia-la-ricerca-indipendente]]></loc><lastmod>2019-06-06T18:00:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14881-premio-giornalistico-alessandra-bisceglia-i-vincitori-della-terza-edizione]]></loc><lastmod>2019-06-04T17:02:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14878-malattie-genetiche-rare-riparte-la-collaborazione-tra-fondazione-telethon-e-mercato-centrale]]></loc><lastmod>2019-06-04T14:16:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14879-terapia-genica-l-intesa-amicus-penn-si-estende-a-nuove-malattie-rare]]></loc><lastmod>2019-06-05T20:34:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14875-l-appello-di-eurordis-per-i-malati-rari-un-assistenza-globale-entro-il-2030]]></loc><lastmod>2019-06-04T09:38:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14858-biosimilari-la-posizione-del-collegio-dei-reumatologi-italiani]]></loc><lastmod>2019-05-28T18:36:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14863-distrofia-dei-cingoli-2a-sarepta-si-aggiudica-l-opzione-sulla-terapia-genica]]></loc><lastmod>2019-05-29T18:07:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14848-biotecnologie-riccardo-palmisano-rieletto-presidente-di-assobiotec]]></loc><lastmod>2019-05-26T09:17:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14830-tumori-una-sana-alimentazione-e-buone-abitudini-possono-ridurne-il-rischio]]></loc><lastmod>2019-05-21T11:22:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14841-campionati-mondiali-di-joelette-tre-i-team-in-partenza-per-rappresentare-l-italia]]></loc><lastmod>2019-05-23T14:45:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14833-malattie-rare-l-ospedale-san-martino-preoccupa-i-pazienti-liguri]]></loc><lastmod>2019-05-20T18:10:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14820-disabilita-al-via-la-quarta-edizione-di-make-to-care]]></loc><lastmod>2019-05-18T16:24:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14821-idrosadenite-suppurativa-abbvie-lancia-un-app-per-tracciare-l-impatto-della-malattia]]></loc><lastmod>2019-05-18T16:34:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14814-malattie-oncoematologiche-in-provincia-di-pavia-sorge-la-casa-dei-melograni]]></loc><lastmod>2019-05-15T17:39:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14804-carcinoma-cutaneo-a-cellule-squamose-il-chmp-esprime-parere-favorevole-per-cemiplimab]]></loc><lastmod>2019-05-15T15:14:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14791-false-cure-con-staminali-allerta-per-i-pazienti-dall-ucraina-torna-lo-spettro-di-stamina]]></loc><lastmod>2019-05-09T09:27:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14763-riforma-del-terzo-settore-cosa-cambia-per-le-associazioni-dei-malati-rari]]></loc><lastmod>2019-04-28T15:15:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14759-malattie-rare-l-impegno-di-pfizer-italia]]></loc><lastmod>2019-10-31T16:09:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14744-malattie-della-tiroide-a-roma-gli-esperti-hanno-fatto-il-punto-su-ricerca-e-nuove-terapie]]></loc><lastmod>2019-04-17T16:58:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14746-vi-premio-omar-spot-per-la-duchenne-vince-come-migliore-campagna-di-comunicazione]]></loc><lastmod>2019-04-17T18:10:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14734-donazioni-di-sangue-la-sfida-delle-infezioni-emergenti-per-evitare-carenze]]></loc><lastmod>2019-04-15T15:28:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14735-anomalie-del-battito-cardiaco-la-telemedicina-riduce-mortalita-e-ospedalizzazioni]]></loc><lastmod>2019-04-15T16:33:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14730-alcaptonuria-prosegue-l-attivita-di-ricerca-dell-aou-senese]]></loc><lastmod>2019-04-15T14:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14726-medicina-nucleare-a-rimini-il-xiv-congresso-dell-associazione-italiana]]></loc><lastmod>2019-04-16T11:53:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14714-malattie-neuromuscolari-medici-e-pediatri-poco-informati]]></loc><lastmod>2019-04-12T09:29:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14700-disabilita-a-roma-aperto-un-dialogo-tra-istituzioni-e-famiglie]]></loc><lastmod>2019-04-07T17:04:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14708-vi-premio-omar-le-malattie-rare-si-possono-raccontare-senza-pietismo]]></loc><lastmod>2019-04-11T15:22:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14692-innovazione-tecnologica-parte-l-appello-scienzainparlamento]]></loc><lastmod>2019-04-05T17:48:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14691-oncologia-esperti-d-accordo-occorre-adeguare-i-processi-di-governance-sanitaria]]></loc><lastmod>2019-04-05T17:34:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14687-malattia-di-paget-pubblicate-le-nuove-linee-guida-su-diagnosi-e-trattamento]]></loc><lastmod>2019-04-05T15:13:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14688-fondazione-cnao-lisa-licitra-e-il-nuovo-direttore-scientifico]]></loc><lastmod>2019-04-05T15:18:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14685-sobi-la-forza-rara-che-fa-progredire-la-ricerca]]></loc><lastmod>2019-04-08T08:12:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14682-donata-al-bambino-gesu-un-elettroencefalografia-ad-alta-densita]]></loc><lastmod>2019-04-09T07:52:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14679-ern-reconnet-presente-al-piu-importante-congresso-europeo-di-reumatologia]]></loc><lastmod>2019-04-17T09:23:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14675-malattie-rare-costruire-un-percorso-terapeutico-attraverso-il-racconto-delle-patologie]]></loc><lastmod>2019-04-04T10:52:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14661-trapianti-al-policlinico-di-milano-per-la-prima-volta-i-polmoni-sopravvivono-30-ore-fuori-dal-corpo]]></loc><lastmod>2019-04-01T09:14:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14640-l-ospedale-pediatrico-bambino-gesu-compie-150-anni]]></loc><lastmod>2019-03-28T15:13:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14646-vi-premio-omar-ilaria-ciancaleoni-bartoli-anche-quest-anno-un-grande-successo]]></loc><lastmod>2019-10-16T14:50:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14637-malattie-rare-la-comunicazione-come-valore-aggiunto-per-i-pazienti]]></loc><lastmod>2019-04-10T18:15:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14638-vi-premio-omar-dallapiccola-per-le-malattie-rare-serve-giornalismo-di-qualita]]></loc><lastmod>2019-10-16T14:50:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14633-l-importanza-della-comunicazione-scientifica-nel-quotidiano-le-parole-della-sen-binetti]]></loc><lastmod>2019-04-10T18:12:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14634-on-bologna-rendere-il-paziente-consapevole-e-l-obiettivo-dell-informazione-scientifica]]></loc><lastmod>2019-04-10T18:13:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14626-malattie-rare-l-importanza-e-l-impegno-delle-agenzie-di-stampa-come-fonte-di-notizie]]></loc><lastmod>2025-07-28T17:38:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14611-ematologia-la-societa-italiana-stila-il-suo-primo-codice-etico]]></loc><lastmod>2019-03-21T16:57:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14607-al-premio-omar-presentato-il-progetto-osservatorio-terapie-avanzate]]></loc><lastmod>2019-10-16T14:49:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14597-tumori-il-cane-supereroe-che-aiuta-i-bambini-ad-affrontare-la-malattia]]></loc><lastmod>2019-03-20T10:09:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14605-sindrome-di-sjoegren-a-n-i-ma-s-s-onlus-la-patologia-sia-considerata-rara]]></loc><lastmod>2019-03-20T14:39:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14595-b-side-quando-il-teatro-racconta-una-malattia-rara-come-l-emofilia-b]]></loc><lastmod>2019-04-10T18:06:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14601-sergio-lai-sobi-non-solo-farmaci-dobbiamo-diffondere-il-concetto-di-rarita]]></loc><lastmod>2019-03-21T10:35:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14602-rita-cataldo-takeda-il-nostro-impegno-in-tutte-le-aree-delle-malattie-rare]]></loc><lastmod>2019-03-20T12:33:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14592-ricerca-l-associazione-coscioni-sulla-proposta-gallo-la-svolta-c-e-ma-non-basta]]></loc><lastmod>2019-03-18T19:16:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14594-malattie-rare-quando-il-giornalista-fa-da-stimolo-alla-politica]]></loc><lastmod>2019-03-19T16:10:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14596-terapie-2-0-al-vi-premio-omar-la-menzione-speciale-va-a-cristina-tognaccini]]></loc><lastmod>2019-04-10T18:05:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14599-i-tre-pilastri-di-chiesi-ricerca-dialogo-con-i-pazienti-e-sostenibilita]]></loc><lastmod>2019-03-19T19:29:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14587-malattie-genetiche-rare-molmed-estende-la-collaborazione-con-rocket-pharma]]></loc><lastmod>2019-03-18T16:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14588-reumatologia-eular-premia-l-eccellenza-pisana-nella-diagnostica-per-immagini]]></loc><lastmod>2019-03-18T17:24:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14589-il-prof-paolo-rossi-bambino-gesu-gli-ostacoli-allo-sviluppo-dei-farmaci-orfani]]></loc><lastmod>2019-04-10T18:00:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14590-vi-premio-omar-sanofi-genzyme-ha-sostenuto-l-importante-iniziativa]]></loc><lastmod>2019-03-20T15:46:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14591-crispr-raccontato-in-un-blog-premiata-la-giornalista-e-scrittrice-anna-meldolesi]]></loc><lastmod>2019-04-10T18:03:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14582-l-impegno-di-baxter-per-la-malattia-intestinale-infiammatoria-cronica]]></loc><lastmod>2019-03-15T17:55:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14578-vi-premio-omar-il-genome-editing-raccontato-dalla-giornalista-adriana-bazzi]]></loc><lastmod>2019-09-10T14:19:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14573-stop-a-dna-modificato-sugli-embrioni-perche-una-moratoria-internazionale]]></loc><lastmod>2019-03-14T14:17:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14570-malattie-neuromuscolari-al-centro-clinico-nemo-i-primi-iperspecialisti]]></loc><lastmod>2019-03-13T18:48:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14571-roche-vicini-ai-malati-rari-non-solo-con-la-ricerca]]></loc><lastmod>2019-03-13T19:07:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14565-distrofia-muscolare-online-il-video-promozionale-della-campagna-lasciti-solidali]]></loc><lastmod>2019-03-12T16:51:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14566-biogen-tutti-i-progetti-a-favore-dei-pazienti-con-sma]]></loc><lastmod>2019-03-13T19:10:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14559-oncologia-attivo-al-regina-elena-il-molecular-tumor-board]]></loc><lastmod>2019-03-10T18:41:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14560-l-istituto-dei-tumori-di-milano-diventa-digitale-con-il-progetto-e-health]]></loc><lastmod>2019-03-10T18:40:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14561-distrofia-muscolare-dei-cingoli-sarepta-decide-di-acquisire-myonexus]]></loc><lastmod>2019-03-10T18:41:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14556-malattie-rare-dallapiccola-propone-una-piattaforma-che-riunisca-gli-specialisti]]></loc><lastmod>2019-06-27T11:13:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14557-malattie-rare-colmare-raccoglie-e-rilancia-l-appello-dei-pazienti]]></loc><lastmod>2019-03-10T18:39:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14551-ricerca-gilead-sciences-italia-lancia-i-bandi-di-concorso-2019]]></loc><lastmod>2019-03-07T18:03:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14542-nasce-l-osservatorio-terapie-avanzate-stop-alle-fake-news-sulle-tecnologie-biomediche]]></loc><lastmod>2019-03-06T10:18:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14537-giornata-delle-malattie-rare-2019-telethon-chiede-una-maggiore-accessibilita-alle-cure]]></loc><lastmod>2019-03-05T17:19:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14540-empowerment-informazione-accesso-alle-cure-le-armi-dell-anppi-contro-le-malattie-bollose-autoimmuni]]></loc><lastmod>2021-02-09T16:44:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14533-ricerca-il-report-dell-associazione-coscioni-sulle-violazioni-dell-italia]]></loc><lastmod>2019-03-03T19:18:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14534-rare-disease-day-2019-i-servizi-e-le-iniziative-del-ministero-della-salute]]></loc><lastmod>2019-03-04T17:05:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14531-malattie-rare-al-vi-premio-omar-vincono-le-terapie-avanzate]]></loc><lastmod>2019-04-10T18:21:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14518-malattie-genetiche-al-prof-mirko-pinotti-fondi-ue-per-la-ricerca]]></loc><lastmod>2019-02-26T17:19:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14527-malattie-rare-indagine-demoscopica-conferma-ancora-troppe-fake-news]]></loc><lastmod>2019-02-28T09:27:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14524-giornata-mondiale-delle-malattie-rare-al-via-il-rare-disease-hackathon-2019]]></loc><lastmod>2019-02-27T16:57:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14525-giornata-delle-malattie-rare-2019-orphanet-italia-lancia-scatti-di-realta]]></loc><lastmod>2019-02-27T17:07:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14526-malattie-rare-ptc-therapeutics-partecipa-con-orgoglio-alla-giornata-mondiale]]></loc><lastmod>2019-02-27T17:33:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14523-giornata-mondiale-delle-malattie-rare-l-impegno-di-chiesi-per-i-pazienti-rari]]></loc><lastmod>2026-02-11T11:39:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14510-sindrome-di-usher-l-importanza-degli-amici-raccontata-in-un-cortometraggio]]></loc><lastmod>2020-11-04T10:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14506-pisa-concerie-italiane-e-stella-maris-insieme-per-il-nuovo-ospedale-dei-bambini]]></loc><lastmod>2019-02-25T16:06:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14502-franco-locatelli-e-il-nuovo-direttore-del-consiglio-superiore-di-sanita]]></loc><lastmod>2019-02-25T12:00:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14501-premio-omar-un-riconoscimento-speciale-in-ricordo-di-eugenio-aringhieri]]></loc><lastmod>2019-02-25T11:25:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14497-malattie-neuromuscolari-al-via-il-progetto-del-centro-clinico-nemo-napoli]]></loc><lastmod>2019-02-22T17:19:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14478-raccolta-di-plasma-nel-2018-centrati-gli-obiettivi-del-programma-nazionale]]></loc><lastmod>2019-02-18T18:04:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14475-sanita-merck-ottiene-anche-quest-anno-la-certificazione-top-employers-italia]]></loc><lastmod>2019-02-18T16:21:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14466-malattie-rare-e-innovazione-chiesi-vince-il-company-award-for-innovation]]></loc><lastmod>2019-02-17T19:32:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14463-malattie-genetiche-rare-telethon-e-fir-insieme-per-la-ricerca]]></loc><lastmod>2019-02-17T19:31:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14458-fertilita-al-via-la-terza-edizione-di-che-fine-ha-fatto-la-cicogna]]></loc><lastmod>2019-02-14T10:21:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14450-malattie-genetiche-al-bambino-gesu-uno-nuovo-strumento-per-l-analisi-del-genoma]]></loc><lastmod>2019-02-13T11:49:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14448-malattie-del-tessuto-connettivo-i-progetti-della-rete-di-riferimento-europea]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14432-malattie-rare-conclusa-a-monza-la-mostra-rare-lives-di-aldo-soligno]]></loc><lastmod>2019-02-06T22:54:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14423-il-policlinico-gemelli-irccs-entra-nella-rete-irccs-delle-neuroscienze-e-della-neuroriabilitazione]]></loc><lastmod>2019-02-05T22:17:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14414-uno-sguardo-raro-tutti-i-vincitori-del-festival]]></loc><lastmod>2019-02-04T17:16:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14411-malattie-rare-ptc-therapeutics-lancia-un-programma-annuale-per-sostenere-progetti-di-ricerca]]></loc><lastmod>2019-02-04T14:19:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14403-transitional-care-delle-molinette-un-interrogazione-per-conoscere-i-motivi-della-chiusura]]></loc><lastmod>2019-01-30T16:15:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14385-torino-l-appello-non-chiudete-l-ambulatorio-transitional-care-delle-molinette]]></loc><lastmod>2019-01-25T09:28:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14374-giacomo-leopardi-non-era-affetto-da-depressione-ma-da-spondilite-anchilopoietica-giovanile]]></loc><lastmod>2019-01-21T14:58:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14373-tempi-di-attesa-20-milioni-di-italiani-aspettano-troppo-per-prestazioni-e-servizi-sanitari]]></loc><lastmod>2019-01-18T11:14:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14369-ern-reconnet-dal-terzo-meeting-plenario-risultati-e-prospettive-future]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14358-istituto-nazionale-dei-tumori-il-dr-marco-luigi-votta-e-il-nuovo-presidente]]></loc><lastmod>2019-01-15T16:41:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14364-malattie-genetiche-in-italia-nasce-l-associazione-patforgene]]></loc><lastmod>2019-01-15T17:54:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14357-tumori-a-reggio-emilia-un-progetto-per-aiutare-i-pazienti-a-tornare-al-lavoro]]></loc><lastmod>2019-01-13T15:12:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14360-malattie-rare-presentato-pensavo-di-essere-diverso-documentario-sulla-xlpdr]]></loc><lastmod>2019-01-14T17:31:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14354-maratona-telethon-2018-raccolti-oltre-31-milioni-di-euro-per-la-ricerca]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14349-medicina-e-innovazione-i-life-science-excellence-awards-approdano-in-italia]]></loc><lastmod>2019-01-10T21:00:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14343-vi-premio-omar-si-puo-partecipare-fino-al-17-gennaio]]></loc><lastmod>2019-01-09T10:46:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14334-aderenza-terapeutica-post-trapianto-la-nuova-edizione-della-graphic-novel-aderisco-perche]]></loc><lastmod>2019-01-07T21:22:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14314-ictus-dalla-sin-le-raccomandazioni-per-i-pazienti-in-occasione-del-natale]]></loc><lastmod>2018-12-27T18:45:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14336-omar-si-unisce-al-meyer-nel-ricordare-la-dott-ssa-elisabetta-pasquini]]></loc><lastmod>2019-01-23T12:07:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14306-farmaci-il-commento-di-apmar-sulla-nuova-governance-italiana]]></loc><lastmod>2020-02-27T12:31:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14296-malattie-rare-il-policlinico-di-milano-apre-il-piu-grande-centro-di-ricerca-internazionale]]></loc><lastmod>2018-12-18T12:08:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14283-sindrome-feto-alcolica-a-i-d-e-f-a-d-chiede-che-non-sia-chiuso-il-centro-alcologico-del-lazio]]></loc><lastmod>2018-12-16T18:13:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14276-adroterapia-accordo-cnao-marina-militare-per-far-conoscere-la-terapia]]></loc><lastmod>2018-12-13T15:17:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14266-fake-news-c-e-una-ragione-scientifica-se-il-nostro-cervello-vuole-crederci]]></loc><lastmod>2018-12-11T17:32:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14267-malattie-rare-a-monza-la-mostra-rare-lives-per-tutto-dicembre]]></loc><lastmod>2018-12-11T17:41:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14252-science-for-democracy-chiede-all-ue-la-finanziabilita-della-modificazione-genetica-dell-embrione]]></loc><lastmod>2018-12-09T17:06:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14251-sindrome-di-down-arriva-un-nuovo-test-di-screening-prenatale-non-invasivo]]></loc><lastmod>2018-12-07T18:56:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14247-infezioni-correlate-all-assistenza-ospedaliera-piu-di-500-i-casi-annui-in-italia]]></loc><lastmod>2018-12-07T16:16:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14248-malattie-rare-takeda-punta-all-acquisizione-di-shire]]></loc><lastmod>2018-12-06T21:34:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14231-tumori-cerebrali-una-canzone-per-supportare-la-ricerca]]></loc><lastmod>2018-12-03T21:12:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14232-insonnia-familiare-fatale-l-associazione-afiff-a-fianco-di-pazienti-e-familiari]]></loc><lastmod>2018-12-03T18:34:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14227-oggi-la-giornata-internazionale-delle-persone-con-disabilita]]></loc><lastmod>2018-12-02T20:27:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14229-insonnia-familiare-fatale-una-malattia-che-priva-della-capacita-di-dormire]]></loc><lastmod>2018-12-04T10:21:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14219-ambrogino-d-oro-ad-alberto-fontana-presidente-del-centro-clinico-nemo]]></loc><lastmod>2018-11-29T12:11:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14221-emiplegia-alternante-un-caffe-per-supportare-la-ricerca]]></loc><lastmod>2018-11-30T11:58:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14203-donazione-di-sangue-aip-onlus-indiscutibile-il-principio-di-volontarieta-del-dono]]></loc><lastmod>2018-11-25T17:41:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14202-paziente-esperto-al-via-il-1-corso-eupati-in-lingua-italiana]]></loc><lastmod>2018-11-26T09:59:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14192-malattie-rare-al-via-il-progetto-fatto-x-arte]]></loc><lastmod>2018-11-23T10:32:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14191-european-reference-networks-concluso-a-bruxelles-il-meeting-erns-in-action]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14183-glaucoma-presentato-il-libro-bianco-sulla-malattia]]></loc><lastmod>2018-11-21T17:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14182-rare-sibling-l-indagine-informativa-di-o-ma-r-dedicata-a-fratelli-e-sorelle-di-malati-rari]]></loc><lastmod>2018-11-21T17:55:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14172-sanita-e-comunicazione-medico-paziente-le-nuove-frontiere-della-tecnologia]]></loc><lastmod>2018-11-20T15:38:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14168-erns-in-action-la-quarta-conferenza-sulle-reti-di-riferimento-europee]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14158-festival-uno-sguardo-raro-prorogata-al-7-dicembre-la-scadenza-del-bando]]></loc><lastmod>2018-11-15T16:38:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14153-malattie-rare-appello-alla-regione-liguria-dal-gruppo-mr-e-dal-comitato-imi]]></loc><lastmod>2018-11-14T18:08:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14154-rare-sibling-il-progetto-ragazzi-all-arrembaggio-dell-ospedale-bambino-gesu]]></loc><lastmod>2018-11-15T09:57:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14143-acalasia-esofagea-per-i-pazienti-c-e-l-associazione-alma-onlus]]></loc><lastmod>2018-11-12T21:56:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14144-acalasia-esofagea-pubblicate-le-prime-linee-guida-internazionali]]></loc><lastmod>2018-11-11T21:59:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14125-fibrodisplasia-ossificante-progressiva-sentirsi-imprigionati-in-una-gabbia-ossea]]></loc><lastmod>2018-11-06T22:15:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14121-rare-sibling-in-italia-soltanto-gli-under-16-sono-piu-di-400-000]]></loc><lastmod>2018-11-06T10:51:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14108-nutrizione-artificiale-domiciliare-35-di-esperienza-in-liguria]]></loc><lastmod>2018-11-05T10:49:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14094-malattie-rare-all-ospedale-giovanni-bosco-di-torino-attivo-un-centro-di-ascolto]]></loc><lastmod>2018-10-30T11:12:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14091-cistite-interstiziale-la-denuncia-di-aici-onlus]]></loc><lastmod>2018-10-29T16:47:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14082-terapia-intensiva-da-baxter-un-sistema-di-trattamento-di-ultima-generazione]]></loc><lastmod>2018-10-25T16:52:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14076-oftalmologia-i-vincitori-di-h4o-hackathon-for-ophthalmology]]></loc><lastmod>2018-10-24T21:26:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14075-home-therapy-patto-d-intesa-tra-associazioni-e-istituzioni-con-l-obiettivo-di-uniformare-la-situazione-in-italia]]></loc><lastmod>2019-03-03T19:06:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14062-ricerca-scientifica-nasce-research-to-care-un-bando-da-500mila-euro]]></loc><lastmod>2018-10-21T18:01:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14058-vi-premio-omar-ferpi-entra-a-far-parte-della-giuria]]></loc><lastmod>2018-10-18T14:25:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14043-bambino-gesu-nasce-la-casa-del-supereroe-per-l-accoglienza-dei-pazienti]]></loc><lastmod>2018-10-15T12:07:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14035-malattie-rare-in-svolgimento-la-terza-edizione-del-premio-bisceglia]]></loc><lastmod>2018-10-14T18:45:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14033-malattie-rare-amicus-punta-sulla-terapia-genica]]></loc><lastmod>2020-07-14T16:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14031-malattie-rare-cloudia-vince-il-rare-disease-hackathon]]></loc><lastmod>2018-10-12T09:15:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14022-immunoterapia-oncologica-una-ricerca-da-nobel]]></loc><lastmod>2018-10-10T17:07:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14011-premio-zanibelli-2018-vince-l-opera-una-vita-in-gioco-l-amore-il-calcio-la-sla]]></loc><lastmod>2018-10-09T11:37:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13998-paralisi-cerebrale-il-6-ottobre-la-giornata-mondiale]]></loc><lastmod>2018-10-04T15:36:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13983-sindrome-di-fowler-una-malattia-rarissima-quasi-sempre-letale-in-utero]]></loc><lastmod>2018-10-01T18:00:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13976-malattie-rare-o-ma-r-compie-8-anni-e-raggiunge-il-traguardo-dei-10-000-lettori-giornalieri]]></loc><lastmod>2018-09-28T13:47:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13973-innovazione-e-nuove-tecnologie-come-sara-il-medico-del-futuro]]></loc><lastmod>2018-09-26T16:20:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13966-tumori-bluebird-bio-e-gritstone-oncology-alleate-per-lo-sviluppo-di-terapie-cellulari]]></loc><lastmod>2018-09-25T18:04:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13958-chirurgia-della-retina-dott-ssa-pertile-prima-donna-premiata-dalla-european-vitreo-retinal-society]]></loc><lastmod>2018-09-24T17:41:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13960-malattie-rare-amicus-therapeutics-acquisisce-celenex-e-punta-sulla-terapia-genica]]></loc><lastmod>2020-07-14T16:49:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13955-biotecnologie-da-oggi-al-via-la-biotech-week]]></loc><lastmod>2018-09-23T16:27:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13945-sviluppo-del-bambino-a-fa-d-o-c-lancia-una-campagna-di-sensibilizzazione]]></loc><lastmod>2018-09-19T21:49:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13930-editing-genomico-l-associazione-luca-coscioni-promuove-la-merenda-crispr]]></loc><lastmod>2018-09-17T20:05:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13931-malattie-neurodegenerative-una-marcia-per-sostenere-la-ricerca-del-bambino-gesu]]></loc><lastmod>2018-09-17T20:05:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13917-atassia-spinocerebellare-di-tipo-i-un-progetto-di-biobanca-per-lo-sviluppo-di-una-terapia]]></loc><lastmod>2018-09-13T17:09:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13914-malattie-rare-al-via-la-seconda-edizione-del-rare-disease-hackathon]]></loc><lastmod>2018-09-12T16:30:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13895-sindrome-feto-alcolica-puo-accadere-che-sia-scambiata-per-un-disturbo-psichiatrico]]></loc><lastmod>2018-09-12T08:23:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13879-carcinoma-polmonare-parere-positivo-del-chmp-per-durvalumab]]></loc><lastmod>2021-11-02T15:47:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13877-approvazione-europea-delle-terapie-car-t-il-commento-di-alleanza-contro-il-cancro]]></loc><lastmod>2018-09-07T17:13:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13874-medicina-di-precisione-vertex-e-genomics-verso-la-scoperta-di-nuovi-farmaci]]></loc><lastmod>2018-09-01T18:22:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13861-terapia-genica-ptc-completa-l-acquisizione-di-agilis]]></loc><lastmod>2018-08-27T13:43:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13853-emicrania-arriva-in-europa-il-primo-farmaco-specifico-per-la-prevenzione-degli-attacchi]]></loc><lastmod>2019-01-17T15:35:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13850-bambino-gesu-accordo-con-asl-roma-1-su-percorsi-di-cura-e-assistenza-per-bambini-e-adolescenti]]></loc><lastmod>2018-08-17T15:52:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13848-stomaterapia-presentato-un-progetto-per-migliorare-la-qualita-della-vita-dei-pazienti]]></loc><lastmod>2018-08-16T17:34:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13839-neuropatie-disimmuni-da-cidp-italia-premi-per-le-migliori-tesi-relative-alle-patologie]]></loc><lastmod>2018-08-10T17:21:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13840-malattie-rare-sarepta-acquisisce-i-programmi-di-terapia-genica-di-lacerta]]></loc><lastmod>2018-08-10T17:20:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13837-oncologia-accordo-scientifico-tra-aimac-e-alleanza-contro-il-cancro]]></loc><lastmod>2018-08-10T15:20:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13832-malattie-neuromuscolari-al-centro-clinico-nemo-attivo-un-consulente-alla-pari]]></loc><lastmod>2018-08-09T08:39:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13836-il-coaching-un-supporto-anche-nelle-malattie-rare]]></loc><lastmod>2018-08-13T09:33:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13829-al-via-il-festival-uno-sguardo-raro-omar-e-media-partner-dell-evento-cinematografico]]></loc><lastmod>2018-08-07T10:24:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13826-mucopolisaccaridosi-un-premio-internazionale-per-il-presidente-di-aimps-flavio-bertoglio]]></loc><lastmod>2018-08-06T13:27:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13817-procreazione-assistita-e-genetica-pre-impianto-la-relazione-al-parlamento]]></loc><lastmod>2018-08-02T17:30:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13816-al-via-il-bando-della-vi-edizione-del-premio-omar-riconoscimento-dedicato-alla-comunicazione-sulle-malattie-e-i-tumori-rari]]></loc><lastmod>2018-08-02T14:47:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13810-linfomi-dalla-fil-10-000-euro-per-i-giovani-ricercatori-italiani]]></loc><lastmod>2018-08-01T13:44:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13813-malattie-rare-e-terapia-genica-dalla-fda-arrivano-le-linee-guida-per-ora-in-bozza]]></loc><lastmod>2018-08-01T16:53:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13805-associazioni-di-pazienti-altems-lancia-il-patient-advocacy-lab]]></loc><lastmod>2018-07-31T15:54:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13779-uniamo-chiede-con-forza-il-nuovo-piano-nazionale-malattie-rare]]></loc><lastmod>2018-07-30T09:31:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13783-bambino-gesu-pazienti-e-familiari-in-mare-aperto-a-bordo-di-nave-italia]]></loc><lastmod>2018-07-24T08:51:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13773-malattie-rare-ptc-acquisisce-agilis-e-i-suoi-quattro-programmi-di-terapia-genica]]></loc><lastmod>2018-07-20T14:47:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13771-iv-rapporto-monitorare-in-italia-la-spesa-per-i-farmaci-orfani-e-cresciuta-del-74-in-3-anni]]></loc><lastmod>2019-09-10T14:16:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13772-malattie-rare-uniamo-presenta-il-iv-rapporto-monitorare]]></loc><lastmod>2018-07-30T09:31:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13763-emiplegia-alternante-in-uscita-il-secondo-libro-bianco-con-le-ultime-scoperte-e-le-linee-guida]]></loc><lastmod>2018-07-17T08:54:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13764-ospedale-bambino-gesu-nel-2017-scovate-16-nuove-malattie-rare]]></loc><lastmod>2019-09-10T14:19:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13759-uso-dei-farmaci-in-italia-presentato-il-rapporto-nazionale-2017]]></loc><lastmod>2018-07-16T10:23:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13756-sla-a-roma-fondi-dimezzati-e-mesi-di-scoperto]]></loc><lastmod>2018-07-16T10:24:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13743-tumori-siglato-tra-molmed-e-abcheck-un-master-agreement-di-tre-anni-per-lo-sviluppo-di-car-innovativi]]></loc><lastmod>2018-07-07T16:24:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13744-sindrome-di-gorham-stout-quando-l-osso-scompare-senza-motivo]]></loc><lastmod>2018-07-07T16:24:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13749-terapie-avanzate-nelle-malattie-rare-occorre-interrogarsi-sui-possibili-problemi-organizzativi-ed-economici]]></loc><lastmod>2018-08-02T16:50:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13736-linfoma-non-hodgkin-attivato-un-progetto-di-ricerca-sui-marcatori-genetici]]></loc><lastmod>2018-07-07T09:47:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13731-malattie-rare-concluso-con-successo-il-progetto-social-rare-di-uniamo]]></loc><lastmod>2018-07-05T10:52:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13720-biofarmaceutica-intercept-vince-il-premio-internazionale-le-fonti-awards-2018]]></loc><lastmod>2018-07-04T10:14:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13721-malattie-rare-conclusa-la-season-school-rare-disease-organizzata-da-uniamo-goldin]]></loc><lastmod>2018-07-04T10:13:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13713-pavia-rinnovato-al-san-matteo-il-reparto-di-oncoematologia-pediatrica]]></loc><lastmod>2018-07-02T10:40:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13716-malattie-rare-molmed-e-orchard-therapeutics-estendono-la-collaborazione-nel-campo-della-terapia-genica]]></loc><lastmod>2018-07-02T10:40:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13704-malattia-di-chagas-come-si-trasmette-l-infezione]]></loc><lastmod>2018-06-25T17:38:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13688-linfomi-100-mila-euro-per-sostenere-un-innovativo-progetto-di-ricerca]]></loc><lastmod>2018-06-22T14:47:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13676-cannabis-terapeutica-l-ass-coscioni-all-onu-proibizionismo-mondiale-viola-diritto-alla-salute-e-alla-scienza]]></loc><lastmod>2018-06-16T16:30:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13675-cheratosi-attinica-disponibile-un-nuovo-portale-per-conoscere-la-malattia]]></loc><lastmod>2018-06-16T16:10:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13674-oncologia-il-policlinico-gemelli-entra-a-far-parte-di-alleanza-contro-il-cancro]]></loc><lastmod>2018-06-16T15:08:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13668-oncologia-a-negrar-le-metastasi-alla-colonna-si-debellano-con-la-radiochirurgia]]></loc><lastmod>2018-06-15T14:26:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13669-oncologia-accordo-molmed-e-glycostem-per-lo-sviluppo-di-terapie-car-nk]]></loc><lastmod>2018-06-15T14:25:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13658-malattie-rare-in-italia-online-lo-speciale-di-aboutpharma]]></loc><lastmod>2018-06-13T13:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13652-malattia-di-chagas-la-puntura-di-una-cimice-e-i-suoi-rischi-silenziosi]]></loc><lastmod>2018-06-25T15:56:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13648-il-28-settembre-2018-torna-la-notte-europea-dei-ricercatori]]></loc><lastmod>2018-06-10T15:52:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13647-ictus-perinatale-la-storia-di-clara-oggi-artista-emergente]]></loc><lastmod>2018-06-10T15:07:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13637-trasporto-neonatale-in-emergenza-in-sardegna-ancora-non-e-attivo]]></loc><lastmod>2018-06-07T14:58:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13635-malattia-come-opportunita-il-progetto-di-corriere-it-salute]]></loc><lastmod>2018-06-07T13:36:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13626-idrosadenite-suppurativa-oggi-la-giornata-mondiale]]></loc><lastmod>2018-06-06T08:06:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13616-diritti-del-bambino-inguaribile-al-bambino-gesu-stilato-un-decalogo]]></loc><lastmod>2018-06-02T15:21:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13618-rnai-e-innovazione-inclusiva-la-chiave-di-alnylam-per-la-lotta-alle-malattie-rare]]></loc><lastmod>2018-06-02T16:10:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13607-distrofia-dei-cingoli-myonexus-e-sarepta-si-alleano-per-la-terapia-genica]]></loc><lastmod>2018-05-29T17:30:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13593-tumori-al-via-il-programma-quadriennale-di-ricerca]]></loc><lastmod>2018-05-26T15:07:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13589-malattie-della-tiroide-il-punto-in-occasione-della-settimana-mondiale]]></loc><lastmod>2018-05-25T17:13:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13590-apre-a-roma-casa-san-raffaele-per-ospitare-gratuitamente-i-familiari-dei-pazienti-oncologici]]></loc><lastmod>2018-05-25T17:10:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13584-bambino-gesu-i-piccoli-pazienti-partecipano-alle-attivita-del-museo]]></loc><lastmod>2018-05-25T09:38:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13569-rnai-un-quaderno-spiega-questo-approccio-terapeutico-per-le-malattie-rare]]></loc><lastmod>2018-05-19T15:44:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13564-disabilita-al-via-la-terza-edizione-di-maketocare]]></loc><lastmod>2018-05-19T13:38:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13565-malattie-rare-nasce-a-padova-uno-sportello-di-supporto-e-ascolto]]></loc><lastmod>2018-05-19T13:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13567-tentava-di-testare-sui-pazienti-una-finta-terapia-per-il-cancro]]></loc><lastmod>2018-05-19T14:45:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13560-omar-vince-l-inspiringpr-award-per-la-miglior-campagna-di-relazioni-pubbliche]]></loc><lastmod>2018-05-18T11:01:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13550-ipovisione-e-cecita-arriva-h4o-il-progetto-per-migliorare-la-qualita-della-vita-dei-pazienti]]></loc><lastmod>2018-05-11T16:50:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13544-la-sindrome-di-sj-gren-parlano-i-medici-del-crei]]></loc><lastmod>2018-05-11T14:16:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13556-sclerosi-tuberosa-oggi-la-giornata-internazionale-di-sensibilizzazione]]></loc><lastmod>2018-05-14T12:27:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13528-stomia-il-decalogo-del-gruppo-gesto]]></loc><lastmod>2018-05-05T15:12:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13535-sarcoglicanopatia-speranza-di-una-potenziale-terapia-dall-universita-di-padova]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13521-malattie-rare-dell-occhio-la-guida-di-g-o-a-l-per-riconoscerle]]></loc><lastmod>2018-05-04T16:28:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13522-raccontare-le-malattie-rare-e-la-ricerca-scientifica-elena-dusi-di-repubblica-vince-il-premio-omar-2018]]></loc><lastmod>2019-09-10T14:15:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13518-terapia-genica-per-la-malattia-ada-scid-il-servizio-di-enrica-majo-tg1-vince-il-premio-omar-2018]]></loc><lastmod>2019-09-10T14:14:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13515-malattia-di-lesch-nyhan-michele-cargiolli-vince-il-premio-omar-2018]]></loc><lastmod>2019-06-11T14:13:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13512-premio-omar-2018-la-soddisfazione-del-direttore-ilaria-ciancaleoni-bartoli]]></loc><lastmod>2018-05-03T10:09:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13498-fegato-grasso-al-bambino-gesu-nasce-il-registro-europeo-pediatrico]]></loc><lastmod>2018-04-28T15:08:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13493-al-bambino-gesu-un-mini-cuore-artificiale-salva-la-vita-di-una-bimba-di-3-anni]]></loc><lastmod>2018-04-28T16:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13494-malattie-rare-e-ricerca-la-situazione-in-italia]]></loc><lastmod>2018-04-28T15:28:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13495-in-ricordo-della-dottoressa-ida-milanesi-una-vita-a-fianco-dei-malati-rari]]></loc><lastmod>2018-04-28T16:03:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13486-alfie-evans-e-vivo-ma-negato-il-trasferimento-in-italia]]></loc><lastmod>2018-04-25T05:29:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13458-nascite-pretermine-al-buzzi-di-milano-al-via-una-raccolta-fondi-per-l-acquisto-di-una-culla-termoregolata]]></loc><lastmod>2018-04-18T14:29:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13448-terapie-geniche-accordo-molmed-orchard-per-proseguire-la-ricerca-gsk-tiget]]></loc><lastmod>2019-06-18T17:22:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13437-oncologia-il-dr-antonelli-assume-l-incarico-di-head-of-oncology-region-europe-per-novartis]]></loc><lastmod>2018-04-13T09:48:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13418-enzimopenia-g6pd-il-prof-lucio-luzzatto-l-unico-alimento-da-evitare-sono-le-fave]]></loc><lastmod>2021-01-27T11:50:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13417-ricerca-oncologica-un-italiana-ai-vertici-dell-american-association-for-cancer-research]]></loc><lastmod>2018-04-09T14:21:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13411-firenze-il-prof-donzelli-nominato-membro-del-comitato-nazionale-per-la-bioetica]]></loc><lastmod>2018-04-06T13:05:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13409-tumori-le-sfide-e-opportunita-terapeutiche-della-medicina-di-precisione]]></loc><lastmod>2018-04-06T12:49:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13385-malattie-croniche-al-via-il-progetto-vicini-di-salute-di-pfizer-e-philips]]></loc><lastmod>2018-03-29T17:55:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13384-autismo-precoce-e-dei-disturbi-alimentari-nei-bambini-due-nuovi-centri-specializzati-allo-stella-maris-di-pisa]]></loc><lastmod>2018-03-29T16:35:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13393-v-premio-omar-medicina-rigenerativa-terapia-genica-e-oligonucleotidi-antisenso]]></loc><lastmod>2018-03-30T06:35:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13394-cultura-del-dono-speranza-e-inclusione-social-ecco-i-premi-omar-2018]]></loc><lastmod>2018-03-30T07:45:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13380-festa-della-mamma-telethon-e-uildm-insieme-per-la-ricerca-sulle-malattie-genetiche-rare]]></loc><lastmod>2018-03-27T21:00:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13387-malattie-rare-al-v-premio-omar-vince-la-comunicazione-su-ricerca-terapie-avanzate-e-qualita-della-vita]]></loc><lastmod>2018-03-30T07:25:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13377-policlinico-gemelli-giovanni-scambia-nominato-direttore-scientifico]]></loc><lastmod>2018-03-26T15:57:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13378-terapia-genica-e-cellulare-il-punto-della-situazione-all-advanced-therapies-summit]]></loc><lastmod>2018-03-26T16:25:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13379-quindici-anni-di-lavoro-per-le-malattie-rare-in-campania-il-bilancio-del-prof-generoso-andria]]></loc><lastmod>2018-03-26T18:37:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13373-fecondazione-eterologa-in-italia-mancano-donatori-e-donatrici]]></loc><lastmod>2018-03-25T22:48:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13374-tumori-intesa-tra-gilead-e-sangamo-per-nuove-terapie-cellulari]]></loc><lastmod>2018-03-25T22:55:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13369-al-fatebenefratelli-nuova-terapia-intensiva-neonatale-ad-alta-tecnologia]]></loc><lastmod>2018-03-25T20:55:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13370-sindrome-del-cri-du-chat-concluso-a-folgaria-il-corso-di-sci-per-i-piccoli-pazienti]]></loc><lastmod>2018-03-25T21:35:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13371-brayn-a-genova-il-congresso-dei-giovani-neuroscienziati]]></loc><lastmod>2018-03-25T21:52:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13360-craniosinostosi-da-piu-di-10-anni-in-italia-e-attiva-l-associazione-il-cigno]]></loc><lastmod>2018-03-21T01:40:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13359-oncologia-disponibile-in-italia-un-nuovo-servizio-di-profilazione-genomica]]></loc><lastmod>2018-03-21T00:39:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13355-craniosinostosi-possono-essere-semplici-o-complesse-isolate-o-sindromiche]]></loc><lastmod>2018-03-20T15:09:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13354-craniosinostosi-un-gruppo-di-rare-malformazioni-craniche-del-neonato]]></loc><lastmod>2018-03-20T00:00:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13349-pediatria-a-firenze-inaugurato-il-meyer-health-campus]]></loc><lastmod>2018-03-17T17:17:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13346-terapia-genica-la-rivoluzione-evocas9-made-in-trento-e-le-malattie-rare]]></loc><lastmod>2020-01-08T16:49:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13336-tumore-alla-base-cranica-al-meyer-eseguito-intervento-non-invasivo-grazie-alla-stampa-3d]]></loc><lastmod>2018-03-14T10:18:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13341-stephen-hawking-addio-al-grande-conoscitore-del-cosmo]]></loc><lastmod>2018-03-14T19:24:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13330-tumore-del-testicolo-e-del-pene-prevenzione-e-diagnosi-precoce-ancora-sconosciute-in-italia]]></loc><lastmod>2018-03-13T01:56:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13327-registro-tumori-del-veneto-un-esempio-di-efficienza-e-funzionalita]]></loc><lastmod>2018-03-12T02:42:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13314-malattie-rare-15-gli-ambulatori-di-riferimento-negli-istituti-fisioterapici-ospedalieri]]></loc><lastmod>2018-03-06T22:35:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13310-patto-di-collaborazione-tra-le-onlus-anap-e-inversa]]></loc><lastmod>2018-03-06T01:42:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13304-malattie-rare-350-le-diagnosi-ottenute-grazie-alla-campagna-vite-coraggiose]]></loc><lastmod>2018-03-05T04:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13302-elezioni-2018-ecco-cosa-propongono-i-partiti-in-tema-di-malattie-rare]]></loc><lastmod>2018-03-02T17:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13300-dieta-vegetariana-e-vegana-un-rischio-per-lo-sviluppo-neurocognitivo-del-bambino]]></loc><lastmod>2018-03-02T01:23:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13292-insufficienza-intestinale-cronica-benigna-a-roma-il-1-marzo-un-flash-mob-per-difendere-i-diritti-di-questi-pazienti]]></loc><lastmod>2018-02-28T17:10:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13293-insufficienza-intestinale-cronica-benigna-iicb-uno-spot-per-farla-conoscere]]></loc><lastmod>2018-02-28T17:08:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13294-giornata-nazionale-dell-insufficienza-intestinale-cronica-benigna-una-campagna-per-riconoscere-la-iicb]]></loc><lastmod>2018-02-28T19:31:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13281-x-fragile-huntington-e-distrofia-muscolare-le-patologie-piu-individuate-con-l-analisi-genetica-preimpianto]]></loc><lastmod>2018-02-26T13:18:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13283-malattie-rare-nasce-lo-sportello-legale-gratuito-di-o-ma-r]]></loc><lastmod>2018-02-27T02:41:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13284-xi-giornata-delle-malattie-rare-in-italia-oltre-100-eventi-e-70-citta-coinvolte]]></loc><lastmod>2018-02-27T11:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13276-malattie-rare-novartis-riceve-l-eurordis-company-award-for-innovation]]></loc><lastmod>2018-02-25T12:08:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13279-avviso-rimandata-la-cerimonia-del-v-premio-omar]]></loc><lastmod>2018-02-26T10:42:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13273-xi-giornata-delle-malattie-rare-parte-la-seconda-edizione-della-campagna-social-conlaricercasipuo]]></loc><lastmod>2018-02-25T02:14:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13259-trapianto-di-rene-crociato-impiegata-per-la-prima-volta-in-italia-la-tecnica-ab0-incompatibile]]></loc><lastmod>2018-02-22T14:38:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13255-distrofia-miotonica-per-i-pazienti-italiani-arriva-la-carta-per-la-vita]]></loc><lastmod>2019-01-17T15:59:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13253-ricerca-farmacologica-scade-il-31-marzo-il-bando-grants4targets]]></loc><lastmod>2018-02-21T02:03:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13251-emofilia-in-abruzzo-nasce-il-progetto-a-ma-r-e-per-conoscere-nemo]]></loc><lastmod>2019-08-18T17:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13249-lotta-ai-tumori-e-tutela-dei-pazienti-le-associazioni-chiamano-a-confronto-i-politici]]></loc><lastmod>2018-02-19T18:56:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13228-trasporto-neonatale-d-emergenza-il-servizio-e-ora-attivo-in-tutta-italia]]></loc><lastmod>2018-02-16T15:58:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13240-l-impegno-di-sobi-per-le-malattie-rare]]></loc><lastmod>2018-02-15T14:25:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13241-cagliari-la-tavola-rotonda-raccoglie-piu-di-800-euro]]></loc><lastmod>2018-02-15T16:13:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13229-tumori-epatici-incoraggianti-risultati-da-nuove-tecniche-di-radiologia-interventistica]]></loc><lastmod>2018-02-13T00:30:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13234-editing-genomico-gli-usa-finanziano-ampio-programma-di-studio]]></loc><lastmod>2018-02-14T18:27:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13223-glicogenosi-al-via-il-concorso-poetico-nazionale-poesie-per-aig]]></loc><lastmod>2018-02-12T19:05:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13226-a-livorno-un-corso-gratuito-sulla-diversita-estetica]]></loc><lastmod>2018-02-12T23:00:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13230-festival-uno-sguardo-raro-tutti-i-cortometraggi-premiati]]></loc><lastmod>2018-02-13T15:22:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13216-nasce-partner-il-registro-europeo-dei-tumori-rari-in-eta-pediatrica]]></loc><lastmod>2018-02-11T23:17:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13208-plasma-per-uso-farmaceutico-in-italia-raccolti-830mila-chili-nel-2017]]></loc><lastmod>2018-02-07T17:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13204-sindrome-di-brugada-a-torino-il-primo-intervento-robotico-di-ablazione-in-italia]]></loc><lastmod>2018-02-09T04:39:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13205-distrofia-dei-cingoli-gfb-onlus-lancia-la-nuova-campagna-curiamoli-4-0]]></loc><lastmod>2018-02-07T10:56:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13199-biotestamento-gli-ospedali-evangelici-italiani-dicono-si]]></loc><lastmod>2018-02-06T19:13:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13202-torna-uno-sguardo-raro-il-primo-film-festival-dedicato-alle-malattie-rare]]></loc><lastmod>2018-02-06T21:01:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13191-carcinosi-peritoneale-speranze-di-guarigione-con-le-nuove-tecniche-di-chirurgia]]></loc><lastmod>2018-02-05T22:35:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13192-malata-di-sla-sceglie-la-morte-assistita-primo-caso-dopo-la-legge-sul-biotestamento]]></loc><lastmod>2018-02-05T22:56:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13186-malattie-rare-e-online-il-nuovo-servizio-di-teleconsulto-malatirari-live]]></loc><lastmod>2018-02-02T16:45:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13183-donne-e-ictus-pillola-anticoncezionale-fumo-ed-emicrania-possono-essere-un-associazione-pericolosa]]></loc><lastmod>2018-02-01T12:04:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13179-malattie-rare-le-iniziative-di-eurordis-per-il-2018]]></loc><lastmod>2018-01-31T17:36:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13157-cagliari-un-evento-benefico-per-sclerosi-multipla-fibrosi-cistica-e-lupus]]></loc><lastmod>2018-01-29T18:19:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13160-malattia-di-fabry-e-di-pompe-amicus-therapeutics-al-prossimo-worldsymposium]]></loc><lastmod>2019-01-17T17:17:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13145-disabilita-un-gigantesco-pulcinella-contro-le-barriere-architettoniche]]></loc><lastmod>2018-01-24T16:33:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13137-cannabis-terapeutica-collaborazione-piu-intensa-fra-regione-toscana-e-scfm]]></loc><lastmod>2018-01-22T18:19:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13129-salute-e-ricerca-scientifica-nasce-fondazione-roche]]></loc><lastmod>2019-08-18T17:22:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13126-malattie-rare-avviato-s-a-i-o-il-servizio-di-ascolto-di-uniamo-fimr-onlus]]></loc><lastmod>2018-02-02T16:46:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13125-malattie-rare-una-scuola-per-l-empowerment-di-pazienti-e-loro-rappresentanti]]></loc><lastmod>2018-01-19T15:30:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13120-virus-letali-negli-usa-riaprono-le-attivita-di-ricerca]]></loc><lastmod>2018-01-17T19:25:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13108-tumori-rari-celgene-acquisisce-la-biotech-americana-impact-biomedicines]]></loc><lastmod>2018-01-14T17:13:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13109-ern-lung-la-critica-del-coordinatore-non-abbiamo-ancora-affrontato-la-nostra-missione]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13113-roche-torna-alle-neuroscienze-sclerosi-multipla-neuromielite-ottica-alzheimer-e-huntington-nel-mirino]]></loc><lastmod>2018-01-15T23:40:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13103-terapie-rnai-alnylam-e-sanofi-rivedono-accordo-di-partnership]]></loc><lastmod>2018-01-14T21:45:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13112-melazzini-la-ricerca-sull-alzheimer-prosegue-singole-scelte-aziendali-non-devono-spegnere-la-speranza]]></loc><lastmod>2018-01-15T22:52:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13111-v-premio-omar-prorogate-le-iscrizioni-fino-al-23-gennaio]]></loc><lastmod>2018-01-24T11:02:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13098-v-premio-omar-candidature-possibili-fino-al-14-gennaio]]></loc><lastmod>2018-01-24T11:02:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13099-malattie-neurodegenerative-pfizer-chiude-con-alzheimer-e-parkinson]]></loc><lastmod>2018-01-11T21:44:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13088-terapie-avanzate-la-ce-adotta-le-linee-guida-sulle-buone-pratiche-di-fabbricazione]]></loc><lastmod>2018-01-10T00:04:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13087-biotecnologie-polo-ggb-cerca-esperto-di-genetica-medica]]></loc><lastmod>2018-01-09T23:53:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13084-annuario-istat-2017-il-39-degli-italiani-e-affetto-da-una-malattia-cronica]]></loc><lastmod>2018-01-09T00:59:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13081-roma-al-bambino-gesu-separate-due-gemelline-siamesi-del-burundi]]></loc><lastmod>2018-01-04T18:06:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13071-farmaceutica-accordo-di-partnership-tra-bayer-e-peptidream]]></loc><lastmod>2017-12-27T16:38:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13068-immunoterapia-oncologica-nasce-il-working-group-di-alleanza-contro-il-cancro]]></loc><lastmod>2017-12-27T16:28:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13064-cardiologia-al-congresso-sic-i-temi-di-prevenzione-e-nuove-tecniche-di-intervento]]></loc><lastmod>2017-12-23T14:00:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13060-investimenti-su-ricerca-e-sviluppo-chiesi-prima-in-italia]]></loc><lastmod>2017-12-23T10:19:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13056-neuromielite-ottica-aifa-approva-rituximab]]></loc><lastmod>2017-12-22T11:35:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13041-salute-al-crossthink-lab-di-takeda-italia-si-guarda-al-futuro]]></loc><lastmod>2017-12-19T11:53:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13046-antibiotici-nuove-iniziative-per-promuoverne-un-uso-corretto]]></loc><lastmod>2017-12-18T12:32:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13038-tumori-oculari-all-istituto-nazionale-tumori-nasce-un-nuovo-polo]]></loc><lastmod>2017-12-18T19:21:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13051-al-via-il-v-premio-omar-dedicato-alle-malattie-e-tumori-rari]]></loc><lastmod>2018-01-24T11:04:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13037-sarcoidosi-e-glomerulopatie-le-nuove-malattie-rare-dei-reni-inserite-nei-lea]]></loc><lastmod>2017-12-17T14:54:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13047-vittime-del-talidomide-solo-una-settimana-per-richiedere-l-indennizzo]]></loc><lastmod>2017-12-18T15:19:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13030-fine-vita-approvata-la-legge-sul-biotestamento]]></loc><lastmod>2019-01-17T17:18:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13008-fertilita-al-via-la-seconda-edizione-di-che-fine-ha-fatto-la-cicogna]]></loc><lastmod>2017-12-09T14:36:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13014-ambrogino-d-oro-2017-tra-i-premiati-gli-oncologi-dell-istituto-dei-tumori-di-milano]]></loc><lastmod>2017-12-10T21:29:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13009-ricerca-premiati-i-4-progetti-vincitori-di-celgene-research-award-2017]]></loc><lastmod>2017-12-09T14:35:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13011-farmaci-biosimilare-non-significa-identico-al-biologico]]></loc><lastmod>2020-02-27T14:29:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13006-ipoparatiroidismo-al-via-la-campagna-social-4piccolecose]]></loc><lastmod>2017-12-08T18:58:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13016-rare-disease-day-2018-uniamo-invita-tutti-a-partecipare-all-evento]]></loc><lastmod>2017-12-11T15:42:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13002-antibiotico-resistenza-le-misure-da-adottare-per-fronteggiare-l-emergenza]]></loc><lastmod>2017-12-08T16:45:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/13000-disabilita-e-malattie-invalidanti-istituito-il-fondo-per-il-sostegno-del-caregiver-familiare]]></loc><lastmod>2017-12-07T16:07:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12996-sindrome-di-phelan-mcdermid-oggi-la-prima-giornata-nazionale-sulla-patologia]]></loc><lastmod>2017-12-07T11:02:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12991-premio-le-fonti-awards-takeda-italia-vince-per-il-secondo-anno-consecutivo]]></loc><lastmod>2017-12-05T11:24:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12983-oncologia-interventistica-nuovo-centro-al-gemelli-di-roma]]></loc><lastmod>2017-12-02T18:20:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12980-maketocare-2017-due-team-romagnoli-i-vincitori-del-premio]]></loc><lastmod>2017-12-02T15:21:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12975-tumori-della-tiroide-meno-chirurgia-con-le-nuove-linee-guida]]></loc><lastmod>2017-12-01T19:08:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12956-tumori-rari-l-europa-si-mobilita-e-mette-i-pazienti-al-centro-dell-azione]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12958-malattie-rare-e-farmaci-orfani-le-scoperte-scientifiche-modificheranno-il-percorso-gestionale-del-paziente]]></loc><lastmod>2017-11-26T21:15:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12959-bambino-gesu-effettuati-i-primi-trapianti-pediatrici-di-microbiota-intestinale]]></loc><lastmod>2017-11-26T21:41:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12964-farmaci-orfani-la-sifo-si-dota-di-un-laboratorio-sull-hta-garanzie-per-i-piccoli-numeri]]></loc><lastmod>2017-11-27T17:53:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12963-cri-du-chat-l-associazione-abc-a-sostegno-dei-piccoli-pazienti-e-delle-loro-famiglie]]></loc><lastmod>2017-12-03T15:58:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12948-carcinoma-renale-avanzato-da-oggi-rimborsato-anche-in-italia-cabozantinib]]></loc><lastmod>2017-11-25T16:41:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12944-tumori-accordo-bayer-loxo-oncology-per-lo-sviluppo-di-nuove-terapie]]></loc><lastmod>2017-11-24T20:52:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12933-malattie-endocrine-dal-congresso-ame-nuovi-obiettivi-clinici]]></loc><lastmod>2017-11-21T16:54:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12931-terapie-apmar-segnala-casi-di-sostituzione-arbitraria-di-farmaci-con-biosimilari]]></loc><lastmod>2020-02-27T12:39:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12915-malattie-neurologiche-gli-ultimi-successi-in-neuro-genetica-e-diagnostica-avanzata]]></loc><lastmod>2017-11-20T12:28:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12922-tumore-al-pancreas-entro-il-2030-sara-la-seconda-causa-di-morte-nel-mondo]]></loc><lastmod>2017-11-20T15:48:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12926-nevo-melanocitico-gigante-l-unico-trattamento-risolutivo-e-la-chirurgia]]></loc><lastmod>2017-11-20T18:14:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12909-formazione-gratuita-online-per-i-pazienti-due-webinar-di-eupati-il-20-e-21-novembre]]></loc><lastmod>2017-11-17T09:10:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12906-tromboembolismo-venoso-rivaroxaban-riceve-l-approvazione-da-fda]]></loc><lastmod>2017-11-16T11:46:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12899-innovazione-tecnologica-annunciati-i-vincitori-dell-hackathon-merck]]></loc><lastmod>2017-11-15T18:07:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12891-biotecnologie-di-nuovo-al-via-il-programma-abe-site-italy]]></loc><lastmod>2017-11-12T18:37:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12887-disabilita-uildm-aderisce-a-liberidifare]]></loc><lastmod>2017-11-12T16:09:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12889-amartomatosi-multiple-sindromi-pten-correlate-ora-c-e-il-codice-di-esenzione]]></loc><lastmod>2024-10-23T09:54:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12890-quale-ruolo-dei-pazienti-nelle-ern-ecco-cosa-significa-essere-un-epag]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12881-cancro-alla-prostata-al-via-movemen-campagna-di-prevenzione-al-maschile]]></loc><lastmod>2017-11-10T11:23:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12882-sindrome-di-sjoegren-esce-al-cinema-la-sabbia-negli-occhi]]></loc><lastmod>2017-11-10T11:32:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12872-malattie-rare-intesa-orphanet-gard-per-una-migliore-informazione]]></loc><lastmod>2019-01-17T17:19:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12867-ricostruzione-della-laringe-a-torino-i-due-centri-di-riferimento-italiani]]></loc><lastmod>2017-11-07T21:10:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12859-tumore-della-prostata-anche-quest-anno-torna-movember]]></loc><lastmod>2017-11-04T15:49:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12845-bambino-gesu-nuova-casa-famiglia-per-i-piccoli-pazienti-oncologici]]></loc><lastmod>2017-10-30T18:09:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12847-farmaci-orfani-accordo-toscana-farmaceutico-militare-per-la-ricerca-sui-cannabinoidi]]></loc><lastmod>2017-10-31T11:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12842-ictus-un-milione-di-italiani-convive-con-conseguenze-invalidanti]]></loc><lastmod>2017-10-30T12:52:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12838-tumore-al-seno-e-fertilita-qualita-simile-per-embrioni-da-ovociti-vitrificati-o-freschi]]></loc><lastmod>2017-10-30T10:41:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12844-ematoidrosi-trattata-a-firenze-una-ragazza-che-suda-sangue]]></loc><lastmod>2019-06-12T10:17:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12823-insufficienza-intestinale-cronica-benigna-al-via-l-iniziativa-un-filo-per-crescere]]></loc><lastmod>2018-03-15T03:17:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12824-premio-merck-in-neurologia-annunciati-i-progetti-vincitori]]></loc><lastmod>2017-10-24T08:58:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12825-antibiotici-in-italia-il-primo-decalogo-per-correggerne-l-uso]]></loc><lastmod>2017-10-24T09:40:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12834-premio-giornalistico-alessandra-bisceglia-annunciati-i-vincitori]]></loc><lastmod>2017-10-26T21:27:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12817-societa-italiana-di-neurologia-gianluigi-mancardi-eletto-neo-presidente]]></loc><lastmod>2017-10-23T16:10:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12830-emoderivati-via-libera-alla-concorrenza-solo-per-aziende-che-garantiscono-su-rischio-contaminazioni]]></loc><lastmod>2017-10-30T12:06:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12808-trenitalia-e-ospedale-bambino-gesu-un-accordo-per-agevolare-il-viaggio-di-pazienti-e-famiglie]]></loc><lastmod>2017-10-21T16:35:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12811-disforia-di-genere-nasce-una-rete-endocrinologica-nazionale]]></loc><lastmod>2017-10-23T09:35:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12804-medicina-narrativa-le-storie-dei-pazienti-prendono-vita-con-l-iniziativa-viverla-tutta]]></loc><lastmod>2017-10-21T14:21:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12810-reti-ern-uniamo-presenta-il-coordinamento-nazionale-dei-rappresentanti-dei-pazienti]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12802-genitori-e-malattie-rare]]></loc><lastmod>2017-10-21T13:49:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12796-tubercolosi-in-carcere-la-meta-dei-detenuti-stranieri-e-positiva-al-test]]></loc><lastmod>2017-10-19T10:09:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12798-cannabis-per-uso-terapeutico-la-camera-approva-la-nuova-legge]]></loc><lastmod>2017-10-19T18:21:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12789-neurologia-roma-ospitera-il-congresso-mondiale-2021]]></loc><lastmod>2017-10-17T15:42:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12779-ricerca-da-gilead-un-milione-e-mezzo-di-euro-per-progetti-innovativi]]></loc><lastmod>2017-10-16T16:14:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12781-premio-zanibelli-leggi-in-salute-2017-decretati-i-vincitori]]></loc><lastmod>2017-10-16T17:06:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12774-oms-e-bambino-gesu-insieme-per-l-assistenza-specialistica-ai-bambini-siriani]]></loc><lastmod>2017-10-15T16:00:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12775-distress-respiratorio-ora-i-nati-pretermine-possono-respirare-grazie-al-metodo-lisa]]></loc><lastmod>2017-10-15T16:13:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12784-reti-ern-italia-key-player-in-europa-nella-lotta-alle-malattie-rare]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12778-joint-action-sui-tumori-rari-jarc-l-istituto-nazionale-dei-tumori-capofila-europeo]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12771-tumore-al-seno-avanzato-arriva-la-campagna-e-tempo-di-vita]]></loc><lastmod>2017-10-15T13:56:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12764-falsi-ciechi-accusa-archiviata-per-cinque-persone-realmente-non-vedenti]]></loc><lastmod>2017-10-12T13:29:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12748-farmaceutica-merck-investe-nello-stabilimento-di-modugno-bari]]></loc><lastmod>2017-10-07T16:19:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12744-cultura-processo-alla-medicina-e-ai-medici-il-nuovo-libro-di-giorgio-dobrilla]]></loc><lastmod>2017-10-07T10:57:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12741-tumore-al-seno-metastatico-una-malattia-di-cui-non-si-parla]]></loc><lastmod>2017-10-07T09:59:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12731-emodialisi-da-baxter-il-primo-sito-web-dedicato-alla-terapia-hdx]]></loc><lastmod>2017-10-04T10:34:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12732-tumori-rari-annunciato-il-vincitore-del-tomy-s-award]]></loc><lastmod>2017-10-03T17:09:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12722-tumori-una-app-per-aiutare-a-prevenirli]]></loc><lastmod>2017-10-03T10:11:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12724-european-biotech-week-tra-le-iniziative-un-focus-sulle-malattie-rare]]></loc><lastmod>2017-10-03T10:36:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12711-xxiii-congresso-sin-dai-vaccini-in-gravidanza-alle-cure-palliative]]></loc><lastmod>2017-09-29T14:00:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12713-a-d-m-o-sardegna-festeggia-i-30-anni]]></loc><lastmod>2017-09-29T15:28:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12696-insieme-verso-l-orizzonte-un-esempio-di-collaborazione-tra-pubblico-e-privato]]></loc><lastmod>2017-09-27T22:02:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12691-malattie-rare-piu-tempo-per-iscriversi-al-concorso-uno-sguardo-raro]]></loc><lastmod>2017-09-27T08:19:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12690-tumore-al-seno-le-pazienti-protagoniste-nelle-citta-italiane]]></loc><lastmod>2017-09-26T08:43:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12683-vivere-con-una-malattia-rara-la-sfida-della-complessita]]></loc><lastmod>2017-09-24T10:23:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12685-sindrome-di-klinefelter-una-patologia-curabile-se-diagnosticata-precocemente]]></loc><lastmod>2017-09-24T10:23:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12682-alla-notte-europea-dei-ricercatori-si-parla-anche-di-malattie-rare]]></loc><lastmod>2022-03-30T09:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12669-screening-pediatrici-la-guida-dei-medici-del-bambino-gesu]]></loc><lastmod>2017-09-20T22:03:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12661-tumori-necessario-un-rapido-accesso-ai-farmaci-di-precisione]]></loc><lastmod>2017-09-19T09:21:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12652-nevralgia-post-erpetica-una-patologia-evitabile-con-la-vaccinazione]]></loc><lastmod>2017-09-13T17:32:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12647-malattie-genetiche-al-via-la-campagna-telethon-andarelontano]]></loc><lastmod>2019-08-18T17:17:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12643-donne-con-disabilita-uildm-ratifica-il-secondo-manifesto-europeo]]></loc><lastmod>2017-09-12T16:02:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12630-disturbi-del-neurosviluppo-a-pisa-i-bambini-imparano-con-le-api-robot]]></loc><lastmod>2017-09-09T14:38:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12613-neuropsichiatria-le-ultime-frontiere-nel-campo-della-robotica]]></loc><lastmod>2017-09-02T10:42:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12611-tumori-le-priorita-nazionali-sui-farmaci-antiblastici]]></loc><lastmod>2017-09-02T08:40:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12608-comunicazione-medico-paziente-disponibile-una-nuova-soluzione-digitale]]></loc><lastmod>2017-12-05T11:05:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12609-carcinoma-mammario-approvazione-europea-per-il-farmaco-ribociclib]]></loc><lastmod>2017-08-30T16:55:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12589-carcinoma-polmonare-durvalumab-riconosciuto-terapia-innovativa-da-fda]]></loc><lastmod>2021-11-02T15:49:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12595-disabilita-in-toscana-prima-mappatura-multimediale-delle-spiagge-accessibili]]></loc><lastmod>2017-08-23T15:16:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12582-lazio-sospesa-la-cura-in-attesa-dell-attuazione-dei-nuovi-lea]]></loc><lastmod>2022-10-19T14:41:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12558-leucemie-buone-prospettive-dal-trapianto-di-cellule-staminali]]></loc><lastmod>2017-08-06T16:49:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12560-tumori-nuove-prospettive-terapeutiche-grazie-alla-radiochirurgia-robotica]]></loc><lastmod>2017-08-03T13:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12565-malattie-scheletriche-l-obiettivo-della-ern-bond-e-dimezzare-il-ritardo-diagnostico]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12573-le-associazioni-e-la-comunicazione-disponibili-le-linee-guida-dell-osservatorio-malattie-rare]]></loc><lastmod>2017-08-20T19:16:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12551-sindrome-ring-14-pubblicate-le-linee-guida-per-la-diagnosi-e-la-presa-in-carico]]></loc><lastmod>2017-07-31T12:50:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12546-pediatria-all-ospedale-meyer-nasce-il-parco-della-salute]]></loc><lastmod>2017-07-27T14:41:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12521-malattie-neuromuscolari-e-terapia-salvavita-le-norme-sulle-assenze-non-sempre-uniformi]]></loc><lastmod>2017-07-24T15:26:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12548-sobi-annuncia-i-risultati-finanziari-del-secondo-trimestre-2017]]></loc><lastmod>2017-07-28T09:42:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12540-quale-eredita-ci-lascia-charlie-gard-la-nota-dell-ospedale-bambino-gesu]]></loc><lastmod>2017-10-11T14:40:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12530-sindrome-da-distress-respiratorio-acuto-colpiti-anche-i-neonati]]></loc><lastmod>2017-07-21T13:09:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12539-malattie-rare-italia-e-eccellenza-europea-per-le-ern-ma-ancora-troppe-disparita-tra-nord-e-sud]]></loc><lastmod>2017-07-28T08:30:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12527-malattie-genetiche-rare-una-guida-ai-servizi-nel-territorio-di-varese]]></loc><lastmod>2017-07-21T12:47:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12525-ern-le-raccomandazioni-dalla-conferenza-di-vilnius]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12512-disabilita-irccs-fondazione-stella-maris-presenta-la-nuova-casa-verde]]></loc><lastmod>2017-07-26T08:50:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12533-charlie-gard-si-conclude-la-battaglia-legale-ormai-e-troppo-tardi]]></loc><lastmod>2017-10-11T14:40:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12509-oncologia-in-lazio-nascono-gli-ambulatori-dei-guariti]]></loc><lastmod>2017-07-18T10:05:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12518-nasce-il-manifesto-per-umanizzare-le-cure-in-oncologia]]></loc><lastmod>2017-07-21T09:16:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12513-disabilita-al-via-la-seconda-edizione-di-maketocare]]></loc><lastmod>2017-07-16T14:23:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12504-ospedale-di-norcia-inaugurato-il-nuovo-modulo-di-radiologia]]></loc><lastmod>2017-07-15T09:47:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12501-leucemia-accordo-tra-molmed-e-tty-per-i-diritti-su-terapia-cellulare]]></loc><lastmod>2017-08-03T10:06:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12502-morbo-di-basedow-nel-25-dei-pazienti-colpisce-anche-gli-occhi]]></loc><lastmod>2017-07-14T14:31:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12500-distress-respiratorio-neonatale-la-malattia-rara-del-figlio-dei-kennedy]]></loc><lastmod>2017-07-14T13:13:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12499-charlie-gard-il-giudice-chiede-nuovi-dati-entro-domani]]></loc><lastmod>2017-10-11T14:41:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12482-charlie-oggi-la-sentenza-definitiva-il-piccolo-potrebbe-arrivare-a-roma]]></loc><lastmod>2017-10-11T15:07:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12447-ictus-in-lombardia-un-progetto-pilota-di-sensibilizzazione]]></loc><lastmod>2017-06-29T14:03:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12462-healtcare-e-digitale-attiva-la-pagina-linkedin-di-merck-italia]]></loc><lastmod>2017-07-03T12:48:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12464-magi-il-gruppo-che-combatte-le-malattie-genetiche-nei-paesi-poveri]]></loc><lastmod>2017-07-03T13:54:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12457-ricerca-scientifica-al-via-il-research-award-2017]]></loc><lastmod>2017-07-02T21:34:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12458-malattie-neuromuscolari-centro-clinico-nemo-apre-un-nuovo-ambulatorio]]></loc><lastmod>2017-07-02T21:55:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12461-charlie-gard-una-resistenza-che-ci-riguarda-tutti]]></loc><lastmod>2017-10-11T15:08:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12454-l-endocrinologia-italiana-terza-al-mondo-nella-ricerca]]></loc><lastmod>2017-07-02T17:15:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12452-charlie-gard-i-macchinari-verranno-staccato-oggi]]></loc><lastmod>2017-10-11T15:09:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12449-ictus-nuovi-anticoagulanti-orali-una-scelta-valida-e-sostenibile]]></loc><lastmod>2017-06-27T15:17:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12435-malattie-rare-la-comunicazione-come-nodo-tra-ricerca-clinica-e-pubblico]]></loc><lastmod>2017-06-26T10:10:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12442-carcinoma-mammario-via-libera-dell-ema-al-farmaco-ribociclib]]></loc><lastmod>2017-06-26T16:38:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12438-linfedema-il-canottaggio-per-remare-contro-la-malattia]]></loc><lastmod>2017-06-26T13:09:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12427-endocrinologia-al-39-congresso-sie-presentato-l-endo-libro]]></loc><lastmod>2017-06-23T15:53:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12420-distrofia-facio-scapolo-omerale-ieri-la-giornata-mondiale]]></loc><lastmod>2017-06-21T16:56:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12418-falsi-ciechi-archiviata-indagine-a-latina-troppa-ignoranza-sulle-malattie-rare-della-vista]]></loc><lastmod>2017-06-20T20:33:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12417-charlie-vivra-ancora-la-corte-dei-diritti-dell-uomo-rimanda-la-decisione]]></loc><lastmod>2017-10-11T15:09:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12393-sangue-in-italia-una-donazione-ogni-10-secondi]]></loc><lastmod>2017-06-16T15:14:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12411-charlie-deve-morire-la-corte-dei-diritti-dell-uomo-decidera-oggi]]></loc><lastmod>2017-10-11T15:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12412-charlie-gard-davvero-non-c-e-una-cura-la-corte-britannica-ha-ordinato-di-staccare-la-spina]]></loc><lastmod>2017-10-11T15:10:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12377-innovazione-farmacologica-al-via-il-premio-giornalistico-riccardo-tomassetti]]></loc><lastmod>2017-06-12T11:18:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12371-neurofibromatosi-nasce-la-rete-ern-genturis]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12346-nascite-ad-alto-rischio-sta-bene-il-primo-nato-al-bambino-gesu]]></loc><lastmod>2017-06-04T17:04:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12345-la-proposta-del-neo-presidente-ese-il-passaporto-endocrino-europeo]]></loc><lastmod>2017-06-21T13:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12339-tumori-oculari-necessario-poter-contare-su-centri-ultra-specialistici]]></loc><lastmod>2017-06-01T17:51:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12319-a-firenze-nasce-echo-la-rete-degli-ospedali-pediatrici-europei]]></loc><lastmod>2017-06-01T10:19:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12300-disabilita-aisla-premia-tre-giovani-infermiere-neolaureate]]></loc><lastmod>2017-05-28T16:02:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12320-malattia-di-meniere-un-video-per-farla-conoscere]]></loc><lastmod>2025-08-26T19:36:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12325-i-bambini-crescono-al-via-a-napoli-il-73-congresso-sip]]></loc><lastmod>2017-05-28T20:27:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12308-legge-dopo-di-noi-disponibile-la-guida-per-il-cittadino]]></loc><lastmod>2017-05-23T18:40:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12306-tumori-rari-la-favo-chiede-di-istituire-subito-una-rete-nazionale]]></loc><lastmod>2017-05-23T22:14:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12302-sindromi-senza-nome-e-nata-la-federazione-swan-europe]]></loc><lastmod>2019-04-19T13:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12294-tumori-ematologici-sopravvivenza-in-aumento-con-le-combo-therapy]]></loc><lastmod>2017-05-19T15:49:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12282-trapianti-un-nuovo-metodo-permette-di-tenere-in-vita-gli-organi-a-lungo-dopo-l-espianto]]></loc><lastmod>2017-05-15T15:57:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12278-malattie-neuromuscolari-il-centro-clinico-nemo-presenta-l-app-my-voice]]></loc><lastmod>2017-05-15T13:09:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12280-distrofia-muscolare-dei-cingoli-una-malattia-rara-che-rende-i-pazienti-immuni-all-hiv]]></loc><lastmod>2017-05-18T09:35:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12271-sindrome-ring14-pubblicate-le-prime-linee-guida-internazionali]]></loc><lastmod>2017-05-13T10:07:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12259-endocrinologia-il-prof-giustina-eletto-presidente-della-european-society-of-endocrinology]]></loc><lastmod>2017-05-09T13:42:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12233-robert-greenberg-presidente-del-cda-di-second-sight-nominato-membro-della-national-academy-of-inventors]]></loc><lastmod>2017-05-03T15:54:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12236-transitional-care-un-aiuto-importante-per-i-giovani-che-si-trovano-a-dover-crescere-con-una-malattia-rara]]></loc><lastmod>2017-05-02T13:43:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12228-fondazione-telethon-ricevuta-in-udienza-al-quirinale-dal-presidente-della-repubblica-mattarella]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12223-caso-stamina-vannoni-e-nuovamente-in-stato-di-fermo]]></loc><lastmod>2018-01-31T20:52:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12214-cagliari-tre-associazioni-unite-per-la-ricerca-sulle-malattie-rare]]></loc><lastmod>2017-04-23T10:01:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12219-malattie-reumatiche-nasce-un-laboratorio-per-realizzare-oggetti-su-misura-dei-pazienti]]></loc><lastmod>2020-02-27T14:50:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12193-malattie-renali-a-milano-nuovo-polo-per-la-ricerca-e-la-cura-dei-piccoli-pazienti]]></loc><lastmod>2017-04-17T15:54:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12194-sicilia-dal-piano-di-riordino-scompare-la-reumatologia]]></loc><lastmod>2020-02-27T14:51:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12184-cure-palliative-anche-in-neurologia-gli-specialisti-triveneti-riuniti-per-affrontare-il-tema-del-fine-vita]]></loc><lastmod>2017-04-12T15:30:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12179-ipoparatiroidismo-da-patologia-rara-a-malattia-iatrogena]]></loc><lastmod>2017-04-13T08:18:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12182-il-nostro-saluto-a-mario-ciancaleoni-bartoli]]></loc><lastmod>2017-04-12T08:46:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12166-ricostruzione-tracheale-lanciato-a-genova-il-primo-network-mondiale-dedicato]]></loc><lastmod>2017-04-08T09:00:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12167-sindrome-di-moyamoya-una-nuvola-di-fumo-che-porta-all-ictus-cerebrale]]></loc><lastmod>2017-04-08T09:54:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12162-tumori-femminili-grande-successo-per-il-concorso-afiancodelcoraggio]]></loc><lastmod>2017-04-07T18:29:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12164-la-dg-sante-della-commissione-europea-vince-il-premio-del-mediatore-ue]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12161-malattie-rare-magi-assume-personale-specializzato-in-genetica-medica]]></loc><lastmod>2017-04-07T11:32:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12157-ictus-cerebrale-aprile-e-il-mese-della-prevenzione]]></loc><lastmod>2017-04-04T16:21:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12149-carcinoma-renale-un-killer-silenzioso-che-in-italia-colpisce-12-600-persone-l-anno]]></loc><lastmod>2017-04-04T11:11:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12150-nevo-melanocitico-congenito-gigante-la-difficolta-di-vivere-con-una-malformazione-nella-societa-dell-immagine]]></loc><lastmod>2017-04-06T16:30:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12142-fastweb-e-lilt-insieme-per-sostenere-il-progetto-di-reperibilita-telefonica-pediatrica-24h]]></loc><lastmod>2017-04-01T16:08:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12143-malattia-di-cadasil-difficile-diagnosticarla-perche-rara-e-occultata-da-una-sintomatologia-comune]]></loc><lastmod>2017-04-01T17:22:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12139-cancro-e-malattie-neurodegenerative-le-due-facce-dell-invecchiamento]]></loc><lastmod>2017-04-01T13:24:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12128-preeclampsia-per-le-future-mamme-un-arma-in-piu-contro-la-patologia]]></loc><lastmod>2017-04-01T16:09:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12132-fertilita-merck-premia-i-vincitori-della-terza-edizione-del-fertility-2-0-award]]></loc><lastmod>2017-03-29T09:18:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12120-centro-clinico-nemo-alberto-fontana-nuovo-presidente]]></loc><lastmod>2017-03-26T18:17:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12121-nuovi-farmaci-e-diagnosi-gsk-e-regeneron-annunciano-la-piu-grande-iniziativa-di-sequenziamento-genetico]]></loc><lastmod>2017-03-29T08:03:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12113-malattie-neurodegenerative-i-disturbi-del-sonno-possibili-marker-predittivi]]></loc><lastmod>2017-03-24T18:36:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12114-jean-pierre-mooney-e-la-sua-strana-vita-senza-fantasia]]></loc><lastmod>2017-03-24T18:58:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12115-metabern-la-rete-di-riferimento-europea-per-le-malattie-rare-metaboliche-ereditarie]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12104-malformazioni-facciali-congenite-nasce-una-smile-house-all-ospedale-san-filippo]]></loc><lastmod>2017-03-23T16:09:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12095-malattie-respiratorie-aipo-si-rinnova-per-allinearsi-ai-migliori-standard-internazionali-nella-ricerca]]></loc><lastmod>2017-03-20T11:17:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12092-tumore-del-polmone-non-a-piccole-cellule-nuova-opzione-di-prima-linea-per-i-pazienti-alk-positivi]]></loc><lastmod>2021-11-02T15:11:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12086-sport-al-via-il-passaporto-ematico-in-lega-pro]]></loc><lastmod>2017-03-19T18:41:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12089-orphanet-compie-20-anni-e-rinnova-il-sito-web]]></loc><lastmod>2017-03-19T19:57:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12083-salute-del-cervello-conclusa-la-settimana-mondiale]]></loc><lastmod>2017-03-19T11:27:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12084-fondazione-telethon-leader-nella-classifica-dei-grant-assegnati-dallo-european-research-council-nel-settore-biomedico]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12085-reti-di-riferimento-europee-le-implicazioni-saranno-enormi-non-solo-per-i-pazienti-ma-anche-per-le-aziende-farmaceutiche]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12068-l-antibiotico-resistenza-come-minaccia-del-secolo-700mila-i-decessi-ogni-anno]]></loc><lastmod>2017-03-14T11:17:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12063-assistenza-domiciliare-per-le-malattie-da-accumulo-lisosomiale-si-puo-fare]]></loc><lastmod>2017-03-17T10:47:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12076-medicina-di-precisione-da-roche-altri-800-mila-euro-per-la-ricerca]]></loc><lastmod>2017-03-16T14:41:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12059-marco-totis-amicus-e-la-partecipazione-dei-pazienti-allo-sviluppo-di-nuovi-farmaci]]></loc><lastmod>2017-03-13T12:12:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12070-alla-terza-conferenza-europea-le-ern-diventano-una-realta-share-care-cure]]></loc><lastmod>2019-04-17T09:23:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12055-ilaria-prato-biogen-e-l-impegno-per-le-malattie-neurologiche-croniche]]></loc><lastmod>2017-03-13T12:13:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12052-enrico-piccinini-sanofi-genzyme-spero-che-il-panel-dello-screening-sia-il-piu-esteso-possibile]]></loc><lastmod>2017-03-13T12:18:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12032-papillomavirus-arriva-in-italia-il-primo-vaccino-anti-hpv-9-valente]]></loc><lastmod>2017-03-08T09:30:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12037-immunosoppressione-dallo-smartphone-il-futuro-per-il-paziente-trapiantato]]></loc><lastmod>2017-03-07T17:11:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12042-sandra-petraglia-aifa-sperimentazioni-pediatriche-in-calo-dal-13-9-al-9-6]]></loc><lastmod>2017-03-14T10:13:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12034-un-posto-al-sole-vince-la-menzione-della-giuria-al-premio-o-ma-r]]></loc><lastmod>2017-03-13T12:21:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12022-malattie-rare-decine-di-migliaia-pazienti-salvati-da-sangue-e-plasma]]></loc><lastmod>2017-03-05T17:29:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12023-nasce-r-i-c-a-ma-re-la-rete-italiana-centri-di-ascolto-e-informazione-sulle-malattie-rare]]></loc><lastmod>2017-03-05T18:02:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12024-morbo-di-batten-la-lotta-di-una-madre-per-la-diagnosi-di-sua-figlia]]></loc><lastmod>2017-11-19T18:31:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12018-anemia-di-fanconi-molmed-e-rocket-pharma-firmano-un-accordo-di-collaborazione-nel-campo-della-terapia-genica]]></loc><lastmod>2017-03-04T19:00:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12019-malattie-rare-affaritaliani-it-e-shire-lanciano-una-nuova-rubrica-dedicata]]></loc><lastmod>2017-03-04T18:59:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12021-fondazione-hopen-un-aiuto-per-le-famiglie-con-una-malattia-senza-nome]]></loc><lastmod>2019-04-19T13:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12015-progeria-la-progeria-research-foundation-emette-un-bando-per-la-ricerca]]></loc><lastmod>2017-03-03T17:15:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12017-reti-ern-quasi-200-centri-italiani-ammessi-e-davvero-un-successo]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12011-malattie-neuromuscolari-il-4-marzo-eventi-in-14-citta-italiane]]></loc><lastmod>2017-03-02T09:21:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11994-andrea-chiesi-chiesi-farmaceutici-comunicare-le-terapie-avanzate-e-una-grande-responsabilita]]></loc><lastmod>2017-02-26T16:54:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11989-tumore-polmonare-non-a-piccole-cellule-ema-approva-alectinib]]></loc><lastmod>2021-11-02T15:12:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11992-on-paola-binetti-ricerca-assistenza-e-relazioni-con-famiglie-punti-decisivi-per-malattie-rare]]></loc><lastmod>2017-02-26T16:01:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12003-rdd-2017-uniamo-fimr-onlus-con-la-ricerca-le-possibilita-sono-infinite]]></loc><lastmod>2017-02-28T09:12:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12002-rdd-2017-l-universita-di-perugia-ospite-d-onore-al-quirinale]]></loc><lastmod>2017-02-28T09:04:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/12000-rdd-2017-telethon-ricerca-unica-arma-a-disposizione-per-permettere-ai-pazienti-un-futuro-migliore]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11986-rdd-2017-arriva-a-milano-rare-lives-la-mostra-dedicata-a-chi-vive-una-vita-rara]]></loc><lastmod>2017-02-26T11:47:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11987-rdd-2017-l-appello-della-sin-fondamentale-la-creazione-di-una-rete]]></loc><lastmod>2017-02-26T12:35:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11999-x-giornata-malattie-rare-incontro-iss-uniamo-e-intergruppo-parlamentare-sul-futuro-della-ricerca]]></loc><lastmod>2017-02-27T15:15:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11998-il-direttore-di-omar-invitata-al-quirinale-per-la-x-giornata-delle-malattie-rare]]></loc><lastmod>2017-02-27T14:41:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11972-ustioni-delle-cornee-promettente-il-trattamento-a-base-di-cellule-staminali-autologhe-coltivate-ex-vivo]]></loc><lastmod>2017-02-24T11:06:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11982-fibromi-uterini-arriva-una-pillola-per-curarli]]></loc><lastmod>2017-02-25T11:09:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11962-bayer-ritiro-precauzionale-di-alcuni-lotti-di-aspirina-500-mg-granulato-e-alka-effer-compresse-effervescenti]]></loc><lastmod>2017-02-20T14:44:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11974-rare-disease-day-2017-5-appuntamenti-in-5-citta-e-una-campagna-di-sensibilizzazione-sulla-ricerca]]></loc><lastmod>2017-02-22T08:30:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11975-sanita-italiana-come-conciliare-innovazione-e-sostenibilita]]></loc><lastmod>2017-02-22T10:07:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11946-malattie-reumatiche-quelle-rare-hanno-molto-da-insegnare-sulle-patologie-piu-comuni]]></loc><lastmod>2017-02-20T17:18:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11918-risorse-umane-merck-e-tra-le-top-employers-2017-italiane]]></loc><lastmod>2017-02-16T15:43:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11934-roche-anche-quest-anno-certificata-top-employer]]></loc><lastmod>2017-02-16T14:50:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11933-malattie-rare-il-28-febbraio-torna-la-giornata-mondiale-nella-sua-decima-edizione]]></loc><lastmod>2017-02-16T10:03:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11931-gene-editing-arrivano-le-prime-linee-guida-internazionali]]></loc><lastmod>2017-02-15T11:15:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11924-giornata-contro-il-cancro-infantile-soleterre-presenta-il-dossier-salute-e-giustizia-sociale]]></loc><lastmod>2017-02-13T16:15:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11915-fertilita-diventare-madri-dopo-un-tumore-e-possibile]]></loc><lastmod>2017-02-12T18:01:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11912-tumori-pediatrici-la-fondazione-umberto-veronesi-avvia-il-progetto-gold-for-kids]]></loc><lastmod>2017-02-14T10:36:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11908-malattie-rare-l-appello-di-papa-francesco-la-ricerca-presti-la-dovuta-attenzione]]></loc><lastmod>2017-02-10T17:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11885-donazioni-di-sangue-al-via-la-settima-edizione-del-premio-giornalistico-fidas-isabella-sturvi]]></loc><lastmod>2017-02-04T14:12:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11899-malattie-rare-vargiu-riformatori-pazienti-sardi-abbandonati-potenziare-il-centro-di-riferimento]]></loc><lastmod>2017-02-07T16:07:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11879-distrofia-muscolare-insediata-nuova-commissione-medico-scientifica-della-uildm-onlus]]></loc><lastmod>2017-02-03T17:59:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11878-oggi-e-la-giornata-mondiale-contro-il-cancro-i-consigli-degli-esperti]]></loc><lastmod>2017-02-04T10:17:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11876-roche-s-p-a-chiude-il-2016-superando-i-950-milioni-di-fatturato-e-con-una-crescita-del-2-9]]></loc><lastmod>2017-02-01T15:48:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11877-teresa-petrangolini-e-il-nuovo-ambassador-nazionale-di-eupati]]></loc><lastmod>2017-02-02T14:42:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11865-cannabis-una-revisione-internazionale-approfondisce-i-pro-e-i-contro-del-suo-utilizzo]]></loc><lastmod>2017-01-29T19:29:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11868-malattie-rare-al-via-la-raccolta-fondi-per-vite-coraggiose]]></loc><lastmod>2017-01-30T14:43:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11831-dolore-arriva-nelle-farmacie-la-guida-al-corretto-uso-degli-oppiacei]]></loc><lastmod>2017-01-23T11:13:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11836-malattie-rare-urban-vision-e-bambino-gesu-insieme-per-vite-coraggiose]]></loc><lastmod>2017-01-24T15:21:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11829-tumori-cerebrali-nasce-al-policlinico-gemelli-un-percorso-dedicato]]></loc><lastmod>2017-01-22T19:51:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11825-nevo-melanocitico-congenito-gigante-dieci-anni-di-battaglie-per-il-riconoscimento-di-malattia-rara]]></loc><lastmod>2017-01-23T15:28:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11821-trapianti-il-centro-specializzato-del-san-luigi-di-orbassano-sara-potenziato]]></loc><lastmod>2017-01-21T17:50:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11819-sindrome-feto-alcolica-in-italia-prevalenza-della-malattia-sorprendentemente-alta]]></loc><lastmod>2017-01-19T19:15:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11811-pediatria-al-via-una-campagna-per-finanziare-i-dottor-sogni]]></loc><lastmod>2017-01-16T16:13:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11802-disabilita-e-trasporti-a-volta-l-eliminazione-di-una-tratta-puo-mettere-a-rischio-le-terapie]]></loc><lastmod>2017-01-16T15:51:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11804-malattie-rare-approvate-le-reti-ern-l-italia-e-leader-in-europa]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11793-telethon-scoperto-quale-gene-controlla-l-attivita-fisica]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11792-italia-da-record-per-donazioni-e-trapianti]]></loc><lastmod>2017-01-11T13:38:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11791-undiagnosed-diseases-di-cosa-si-tratta]]></loc><lastmod>2021-01-08T11:14:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11787-neuroscienze-a-roma-nascera-un-laboratorio-intitolato-a-rita-levi-montalcini]]></loc><lastmod>2017-01-09T15:32:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11778-fondazione-monza-brianza-presentata-la-nuova-terapia-intensiva-all-interno-del-san-gerardo]]></loc><lastmod>2017-01-04T15:47:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11786-malattie-rare-non-diagnosticate-ecco-le-raccomandazioni-internazionali-congiunte-in-lingua-italiana]]></loc><lastmod>2019-04-19T13:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11777-malattie-neurodegenerative-celegene-ed-evotec-stipulano-un-accordo-per-screening-farmaci]]></loc><lastmod>2017-01-04T15:20:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11759-medicina-di-precisione-assegnati-da-roche-gli-800mila-euro-per-percorsi-innovativi]]></loc><lastmod>2016-12-22T16:32:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11771-lavoro-magi-cerca-5-figure-professionali-biomediche]]></loc><lastmod>2017-01-02T10:42:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11751-telethon-la-maratona-sulle-reti-rai-raccoglie-oltre-31-6-milioni-di-euro]]></loc><lastmod>2026-04-08T17:09:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11743-malattie-rare-ancora-troppe-differenze-tra-paesi-nell-applicazione-del-diritto-alla-diagnosi-e-cura]]></loc><lastmod>2016-12-17T15:44:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11738-malattie-rare-la-responsabilita-delle-case-farmaceutiche-nel-comunicare-le-terapie-avanzate]]></loc><lastmod>2016-12-17T12:02:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11748-pazienti-in-prima-linea-grande-successo-per-il-progetto-eupati-che-proseguira-fino-al-2019]]></loc><lastmod>2016-12-20T10:10:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11733-malattie-rare-l-importanza-della-ricerca-e-dell-assistenza]]></loc><lastmod>2016-12-17T10:43:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11724-disabilita-uditiva-al-via-a-torino-il-primo-laboratorio-di-visual-storytelling-per-ragazzi]]></loc><lastmod>2016-12-14T10:51:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11711-industria-farmaceutica-nuovi-traguardi-per-bayer]]></loc><lastmod>2016-12-10T12:09:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11708-industria-farmaceutica-le-grandi-multinazionali-puntano-all-italia]]></loc><lastmod>2016-12-10T11:50:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11705-influenza-quasi-la-meta-degli-anziani-non-si-vaccina-e-l-80-sottovaluta-i-rischi-della-polmonite]]></loc><lastmod>2016-12-09T10:04:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11696-ictus-cerebrale-a-l-i-ce-italia-onlus-e-simg-insieme-per-combatterla]]></loc><lastmod>2016-12-09T10:56:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11695-stomia-pazienti-e-infermieri-esperti-insieme-per-dare-visibilita-ai-portatori]]></loc><lastmod>2016-12-07T11:11:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11690-l-intrigo-del-dna-sardo-un-destino-incerto-per-230mila-campioni-biologici]]></loc><lastmod>2016-12-07T10:20:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11686-tumore-del-testicolo-a-roma-esperti-internazionali-a-confronto]]></loc><lastmod>2016-12-03T11:30:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11680-tumori-testa-collo-il-dr-paolo-bossi-premiato-agli-aiom-award-2016]]></loc><lastmod>2016-12-02T15:55:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11679-telethon-al-via-la-27esima-maratona-sulle-reti-rai]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11660-takeda-italia-si-aggiudica-il-premio-internazionale-le-fonti-come-digital-team-dell-anno]]></loc><lastmod>2016-11-30T14:46:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11670-tv-un-posto-al-sole-rai-3-vince-la-menzione-della-giuria-del-premio-omar-per-le-malattie-rare]]></loc><lastmod>2016-11-30T12:28:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11669-malattie-rare-assegnati-i-premi-giornalistici-omar-su-malattie-rare-del-polmone-diagnosi-precoce-e-percorsi-assistenziali]]></loc><lastmod>2016-11-30T10:57:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11668-malattie-rare-assegnati-al-senato-i-premi-giornalistici-omar]]></loc><lastmod>2020-02-27T14:57:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11659-re-act-community-la-ricerca-sulle-malattie-rare-si-finanzia-sul-web]]></loc><lastmod>2016-12-02T10:08:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11653-continuita-delle-cure-per-i-ragazzi-post-eta-pediatrica-proposti-i-voucher-della-salute]]></loc><lastmod>2016-11-25T17:46:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11664-iv-premio-giornalistico-o-ma-r-il-30-novembre-la-cerimonia-di-premiazione]]></loc><lastmod>2016-11-28T16:09:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11623-idrosadenite-suppurativa-abbvie-lancia-campagna-d-informazione]]></loc><lastmod>2016-11-19T18:52:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11641-nuovi-lea-oggi-il-direttore-dell-osservatorio-malattie-rare-in-audizione-alla-camera]]></loc><lastmod>2016-11-23T12:07:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11622-anemia-con-il-patient-blood-management-piu-sicurezza-e-minori-costi]]></loc><lastmod>2016-11-19T18:14:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11620-diagnostica-per-immagini-presentato-l-innovativo-imaging-ibrido]]></loc><lastmod>2016-11-19T17:21:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11621-oncologia-all-iss-il-primo-workshop-sulla-rete-nazionale]]></loc><lastmod>2016-11-19T17:40:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11617-neuropatie-periferiche-un-convegno-per-stabilire-il-corretto-approccio-diagnostico-terapeutico]]></loc><lastmod>2016-11-19T15:50:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11603-tumori-premio-h-ack-merck-for-healt-vincono-un-chatbot-e-un-videogioco-per-pazienti-oncologici]]></loc><lastmod>2016-11-12T11:21:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11604-insufficienza-intestinale-cronica-benigna-un-convegno-per-approfondire-la-vita-di-centinaia-di-malati]]></loc><lastmod>2018-03-01T01:07:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11613-nascite-pretermine-il-17-novembre-la-giornata-mondiale]]></loc><lastmod>2016-11-17T15:16:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11600-i-cold-case-in-laboratorio-il-dna-visto-alla-luce-del-progresso]]></loc><lastmod>2019-04-19T13:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11597-malattie-respiratorie-in-rete-un-nuovo-portale-dedicato-ai-pazienti]]></loc><lastmod>2016-11-11T18:34:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11590-centro-nazionale-trapianti-inaugurata-la-nuova-sede-presso-l-iss]]></loc><lastmod>2016-11-08T17:07:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11596-vulvodinia-oggi-la-giornata-internazionale-dedicata-alla-patologia]]></loc><lastmod>2016-11-10T19:32:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11579-oncologia-bellicum-e-bambino-gesu-insieme-per-lo-sviluppo-di-nuove-terapie-cellulari]]></loc><lastmod>2016-11-06T22:41:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11575-tumore-alla-prostata-novembre-e-il-mese-della-prevenzione]]></loc><lastmod>2016-11-05T17:49:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11576-innovazione-digitale-e-salute-msd-italia-si-aggiudica-il-premio-best-digital-company-2016]]></loc><lastmod>2016-11-05T18:08:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11567-oncologia-arriva-in-italia-l-azienda-biofarmaceutica-tesaro]]></loc><lastmod>2016-11-05T11:17:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11563-curarsi-all-estero-assistenza-transfrontaliera-in-italia-pochi-la-conoscono]]></loc><lastmod>2017-06-21T14:10:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11565-terapie-avanzate-la-ricerca-farmaceutica-italiana-al-vertice-del-settore-biotech]]></loc><lastmod>2016-11-03T18:37:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11550-dolore-ora-disponibile-in-italia-naprossene-sodico-a-rilascio-modificato]]></loc><lastmod>2016-10-31T10:00:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11552-eurordis-nuova-indagine-sull-impatto-delle-malattie-rare]]></loc><lastmod>2016-10-31T11:09:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11549-a-bruxelles-una-settimana-di-eventi-dedicati-alle-reti-ern]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11534-trapianti-troppi-i-pazienti-italiani-fermi-in-lista-d-attesa]]></loc><lastmod>2016-10-27T09:17:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11528-malattie-neurologiche-nuove-soluzioni-gestionali-per-favorire-assistenza-e-cura-ai-pazienti]]></loc><lastmod>2016-10-26T14:28:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11506-malattie-rare-un-bando-congiunto-iss-e-federsanita-anci-per-integrare-aspetti-sanitari-e-sociali]]></loc><lastmod>2016-10-21T12:17:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11509-malattie-rare-la-prof-ssa-illana-gozes-vince-il-rare-champion-of-hope-2016]]></loc><lastmod>2016-10-23T14:47:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11501-tumori-femminili-roche-presenta-il-premio-afiancodelcoraggio]]></loc><lastmod>2016-10-20T15:06:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11486-sordita-intervento-pionieristico-al-santobono-di-napoli-in-piccolo-paziente]]></loc><lastmod>2016-10-18T14:21:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11479-disabilita-a-palermo-il-20-ottobre-una-manifestazione-per-la-vita-indipendente]]></loc><lastmod>2016-10-17T15:27:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11478-immunoterapia-oncologica-appena-concluso-a-siena-il-congresso-internazionale]]></loc><lastmod>2016-10-17T15:17:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11452-che-fine-ha-fatto-la-cicogna-al-via-la-campagna-promossa-da-merck]]></loc><lastmod>2016-10-14T07:27:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11455-malattie-rare-senza-diagnosi-al-bambino-gesu-nasce-un-ambulatorio-dedicato]]></loc><lastmod>2016-10-26T14:51:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11454-vaccini-happyageing-lancia-vacci-a-vaccinarti-2016]]></loc><lastmod>2016-10-14T07:05:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11424-gravidanza-da-usa-nuove-linee-guida-per-la-diagnosi-di-spettro-dei-disturbi-feto-alcolici]]></loc><lastmod>2016-10-17T10:42:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11451-disabilita-premiati-i-vincitori-di-maketocare]]></loc><lastmod>2016-10-13T14:21:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11434-malattie-rare-c-e-tempo-fino-al-15-novembre-per-il-concorso-il-volo-di-pegaso]]></loc><lastmod>2016-10-11T13:59:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11423-dalla-fda-2-milioni-di-dollari-per-studiare-le-malattie-rare]]></loc><lastmod>2016-10-15T23:18:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11435-accordo-fra-insmed-e-astrazeneca-per-una-rara-malattia-polmonare]]></loc><lastmod>2016-10-11T14:14:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11431-premio-giornalistico-o-ma-r-c-e-tempo-fino-al-25-ottobre-per-partecipare]]></loc><lastmod>2016-10-11T09:04:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11416-il-sesto-senso-e-una-questione-genetica]]></loc><lastmod>2016-10-08T10:42:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11428-malattie-rare-l-istituto-neuromed-riconosciuto-centro-di-eccellenza-a-livello-europeo]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11394-vaccini-da-gsk-un-servizio-informativo-via-chat-ai-cittadini]]></loc><lastmod>2016-10-05T15:47:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11391-premio-zanibelli-vince-cristina-petit-con-il-libro-salgo-a-fare-due-chiacchiere]]></loc><lastmod>2016-10-05T14:45:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11393-malattie-respiratorie-le-raccomandazioni-per-il-tele-monitoraggio-di-pazienti-con-ventilazione-meccanica]]></loc><lastmod>2016-10-05T15:43:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11360-malattie-rare-a-trani-puglia-il-servizio-di-sostegno-psicologico-rare-sharing]]></loc><lastmod>2016-10-01T12:23:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11355-pfizer-acquista-portafoglio-di-molecole-anti-infettive-da-astrazeneca]]></loc><lastmod>2016-10-01T10:43:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11364-mielite-flaccida-acuta-una-malattia-rara-che-provoca-paralisi-improvvisa]]></loc><lastmod>2016-10-02T09:04:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11382-disabilita-a-formello-giocare-senza-barriere-ora-e-possibile]]></loc><lastmod>2016-10-04T13:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11367-malattie-rare-e-assistenza-domiciliare-sostenibile-la-partnership-tra-pubblico-e-privato]]></loc><lastmod>2016-10-03T13:13:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11373-il-nobel-per-la-medicina-al-pioniere-del-processo-dell-autofagia-yoshinori-ohsumi]]></loc><lastmod>2016-10-03T15:10:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11346-scende-nuovamente-in-piazza-la-mela-di-aism-per-la-lotta-alla-sclerosi-multipla]]></loc><lastmod>2016-09-30T17:06:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11339-la-sindrome-di-sjoegren-non-e-presente-nei-nuovi-lea-la-denuncia-di-animasss]]></loc><lastmod>2016-09-27T15:56:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11327-malattie-genetiche-e-rare-i-festeggiamenti-per-i-10-anni-di-magi]]></loc><lastmod>2016-09-27T14:35:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11322-checco-zalone-per-la-sma-regaliamo-un-sogno-sosteniamo-la-ricerca]]></loc><lastmod>2016-09-26T13:59:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11303-premio-giornalistico-merck-annunciati-i-vincitori]]></loc><lastmod>2016-09-23T10:41:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11297-sam-grewe-dopo-l-osteosarcoma-l-argento-nel-salto-in-alto-alle-paralimpiadi-2016]]></loc><lastmod>2023-01-17T22:10:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11288-meningite-bebe-vio-ci-ricorda-perche-dobbiamo-vaccinare-i-bambini]]></loc><lastmod>2016-09-21T13:47:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11268-alle-paralimpiadi-di-rio-terza-medaglia-d-oro-per-rebecca-meyers]]></loc><lastmod>2016-09-17T16:15:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11265-le-quattro-malattie-rare-degli-eroi-avatar-di-uncommon-strength]]></loc><lastmod>2016-09-18T22:12:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11266-crea-il-tuo-l-avatar-del-tuo-eroe-per-sostenere-chi-vive-con-una-malattia-rara]]></loc><lastmod>2016-09-18T22:12:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11260-allysa-seely-oro-alle-paralimpiadi-di-rio-e-affetta-da-ben-tre-malattie-rare]]></loc><lastmod>2016-09-15T20:09:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11224-allergan-acquisisce-retrosense-therapeutics-biotech-specializzata-in-malattie-rare-della-retina]]></loc><lastmod>2016-09-10T15:11:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11252-indisponibilita-di-medicinali-amministrazioni-e-associazioni-di-settore-sottoscrivono-un-documento]]></loc><lastmod>2016-09-13T13:43:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11212-disabilita-arriva-aiutiamoci-net-un-portale-web-per-lo-scambio-tra-domanda-e-offerta-di-assistenza]]></loc><lastmod>2016-09-10T10:02:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11244-beta-sarcoglicanopatia-gfb-onlus-finanzia-il-primo-trial-clinico-sulla-terapia-genica]]></loc><lastmod>2016-09-12T17:33:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11206-iss-alla-boa-degli-80-anni-il-rilancio-il-riordino-e-stato-un-successo-celebrato-ora-anche-dal-lancet]]></loc><lastmod>2016-09-09T08:04:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11201-stomia-nel-nord-italia-nasce-il-gruppo-gesto]]></loc><lastmod>2016-09-06T13:59:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11187-iperparatiroidismo-secondario-fda-non-approva-etelcalcetide]]></loc><lastmod>2016-09-02T09:47:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11175-shire-acquisisce-foresight-biotherapeutics-e-rafforza-la-propria-posizione-in-oftalmologia]]></loc><lastmod>2016-09-01T16:58:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11137-zika-virus-presente-nello-sperma-anche-dopo-sei-mesi-dai-sintomi]]></loc><lastmod>2016-08-25T09:58:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11129-malattie-genetiche-yenetics-lancia-la-campagna-di-crowdfunding-in-collaborazione-con-tim]]></loc><lastmod>2016-08-22T14:46:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11135-terremoto-in-centro-italia-il-cns-programmare-le-donazioni-contattando-il-servizio-trasfusionale-di-riferimento]]></loc><lastmod>2016-08-24T14:09:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11105-istiocitosi-quanto-costa-questa-malattia-rara]]></loc><lastmod>2017-09-12T12:04:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11094-la-nascita-della-prima-malattia-psichiatrica-orfana-la-psicosi-post-partum]]></loc><lastmod>2016-08-05T11:55:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11111-meningite-gsk-lancia-la-campagna-di-sensibilizzazione-take-5-for-meningitis]]></loc><lastmod>2016-08-09T12:55:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11114-terapia-genica-pfizer-acquisisce-bamboo-therapeutics]]></loc><lastmod>2016-08-10T09:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11113-giornalismo-aperto-il-bando-della-iv-edizione-del-premio-omar-dedicato-alle-malattie-e-ai-tumori-rari]]></loc><lastmod>2016-08-10T07:31:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11073-da-merck-una-piattaforma-multi-tematica-per-far-conoscere-agli-utenti-tutte-le-iniziative]]></loc><lastmod>2016-08-03T13:11:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11077-happyageing-positivo-via-libera-del-nuovo-piano-vaccini-a-settembre-pronti-a-raccogliere-segnalazioni-contro-medici-che-scoraggiano-immunizzazioni]]></loc><lastmod>2016-08-04T07:12:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11032-malattie-rare-il-modello-di-ricerca-collaborativa-del-network-statunitense-rdcrn]]></loc><lastmod>2016-07-26T13:42:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11023-ipotiroidismo-il-50-dei-pazienti-trattati-in-modo-non-appropriato]]></loc><lastmod>2016-07-26T13:49:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11029-malattie-del-motoneurone-nuovo-numero-per-l-ambulatorio-di-padova]]></loc><lastmod>2016-07-26T13:11:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11018-trapianti-di-rene-donazione-samaritana-in-italia-innesca-una-catena-cross-over]]></loc><lastmod>2016-07-22T13:34:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11027-malati-rari-in-italia-670-000-malati-presentato-il-rapporto-monitorare]]></loc><lastmod>2016-07-26T11:43:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11016-l-ospedale-bambino-gesu-si-conferma-centro-di-eccellenza-per-la-diagnosi-e-il-trattamento-delle-malattie-rare]]></loc><lastmod>2016-07-22T13:26:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11014-nuove-terapie-bayer-e-x-chem-rinnovano-collaborazione-in-ambito-ricerca-e-sviluppo]]></loc><lastmod>2016-07-22T13:14:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11008-nuovi-lea-il-commento-di-aipo]]></loc><lastmod>2016-07-21T13:38:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11006-malattie-rare-l-aou-senese-prima-in-toscana-per-progetti-presentati-all-european-reference-networks]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11005-osservatorio-malattie-rare-nel-board-scientifico-di-eupati-italia]]></loc><lastmod>2016-07-21T08:46:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/11002-la-tiziana-life-science-utilizzera-il-dna-dei-sardi-per-tentare-di-capire-come-sconfiggere-il-cancro-e-le-malattie-autoimmuni]]></loc><lastmod>2016-07-20T08:52:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10987-malattie-rare-e-gruppi-di-supporto-sul-web-l-82-6-li-usa-e-il-71-7-li-trova-utili]]></loc><lastmod>2016-07-15T12:56:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10992-la-tiziana-life-sciences-acquista-la-banca-dati-con-il-dna-dei-sardi-svilupperemo-nuove-terapie]]></loc><lastmod>2016-07-18T14:50:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10970-chimica-e-tecnologie-farmaceutiche-laurea-honoris-causa-ad-antonio-messina-di-merck-italia]]></loc><lastmod>2016-07-13T14:46:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10975-dismelia-solo-al-27-dei-pazienti-viene-offerto-un-valido-orientamento-nei-servizi-di-maternita]]></loc><lastmod>2016-07-14T15:26:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10969-cardiopatia-e-dolore-anche-aisd-promuove-un-impiego-piu-appropriato-di-analgesici]]></loc><lastmod>2016-07-13T14:07:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10968-reflusso-gastroesofageo-all-aou-senese-eccezionale-intervento-di-chirurgia-pediatrica-robotica]]></loc><lastmod>2016-07-13T13:41:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10980-ricerca-e-assistenza-l-evoluzione-del-ruolo-dei-pazienti]]></loc><lastmod>2016-07-15T08:52:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10967-infertilita-ne-soffre-una-coppia-italiana-su-cinque]]></loc><lastmod>2016-07-13T13:33:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10963-malattie-non-trasmissibili-a-napoli-si-discute-di-prevenzione-precoce-e-di-sviluppo-neurocognitivo]]></loc><lastmod>2016-07-13T10:11:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10927-per-il-prof-antonio-federico-arriva-il-secondo-mandato-alla-guida-del-comitato-scientifico-ean]]></loc><lastmod>2016-07-07T10:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10924-terapia-del-dolore-un-sorriso-per-chi-soffre-l-iniziativa-dedicata-ai-pazienti-pediatrici]]></loc><lastmod>2016-07-06T21:36:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10923-quando-l-abisso-e-il-tuo-corpo-anna-bartiromo-racconta-la-propria-vittoria-contro-il-tumore]]></loc><lastmod>2016-07-06T21:25:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10900-oncomoematologia-al-meyer-inaugurata-la-teen-room]]></loc><lastmod>2016-07-01T12:37:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10889-ema-nominato-nel-consiglio-di-amministrazione-yann-le-cam]]></loc><lastmod>2016-06-30T14:34:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10880-vaccini-coperture-sotto-la-soglia-di-sicurezza-e-salute-pubblica-a-rischio]]></loc><lastmod>2016-06-29T14:15:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10862-malattie-neuromuscolari-concluso-a-lecce-il-congresso-dell-aim]]></loc><lastmod>2016-06-27T10:02:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10845-andrea-lenzi-nuovo-presidente-del-comitato-nazionale-per-la-biosicurezza-le-biotecnologie-e-le-scienze-della-vita]]></loc><lastmod>2016-06-24T12:07:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10839-virus-zika-europa-a-rischio-basso-moderato-i-consigli-per-chi-viaggia]]></loc><lastmod>2016-06-23T10:06:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10826-tumori-del-sangue-oggi-la-giornata-nazionale-le-iniziative-dell-ail]]></loc><lastmod>2016-06-21T09:03:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10824-distrofia-facio-scapolo-omerale-oggi-la-giornata-nazionale]]></loc><lastmod>2016-06-20T08:39:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10805-hopen-e-telethon-alleati-per-dare-un-nome-alle-malattie-non-diagnosticate]]></loc><lastmod>2019-04-19T13:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10789-vaccini-un-alleato-fondamentale-per-rendere-sempre-piu-rare-infezioni-capaci-di-uccidere]]></loc><lastmod>2016-06-14T13:17:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10791-malattie-rare-apre-a-milano-la-sede-italiana-della-biotech-americana-amicus-therapeutics]]></loc><lastmod>2016-06-15T09:54:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10770-malattie-neuromuscolari-al-via-a-pescara-i-lavori-per-il-reparto-di-terapia-sub-intensiva]]></loc><lastmod>2016-06-09T14:52:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10768-teleangectasia-emorragica-ereditaria-a-roma-il-primo-percorso-clinico-dedicato]]></loc><lastmod>2016-06-09T14:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10761-leggere-per-crescere-il-progetto-di-gsk-si-rinnova-e-diventa-social]]></loc><lastmod>2016-06-08T15:57:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10766-malattie-respiratorie-le-richieste-delle-associazioni-italiane-nella-carta-di-nocera-umbra]]></loc><lastmod>2016-06-09T14:26:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10730-sanofi-genzyme-promuove-i-progetti-destinati-a-migliorare-la-qualita-della-vita-dei-malati-rari]]></loc><lastmod>2016-06-07T09:32:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10745-malattie-rare-shire-completa-la-combinazione-con-baxalta]]></loc><lastmod>2016-06-06T08:02:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10719-trapianto-di-midollo-e-terapie-cellulari-oncologiche-un-nuovo-reparto-per-l-opbg-di-roma]]></loc><lastmod>2016-06-01T14:56:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10692-malattie-rare-attivo-nuovo-sportello-informativo-all-ospedale-cervello-di-palermo]]></loc><lastmod>2016-05-27T10:56:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10682-donne-e-salute-al-via-il-primo-premio-giornalistico-onda-e-unamsi]]></loc><lastmod>2016-05-26T10:18:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10681-e-lisir-un-app-per-aiutare-le-persone-sorde-a-comunicare]]></loc><lastmod>2016-05-26T10:15:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10677-malattie-della-tiroide-oggi-la-giornata-mondiale]]></loc><lastmod>2016-05-24T14:52:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10663-commissione-europea-i-temi-affrontati-nell-ultima-riunione-del-gruppo-di-esperti-sulle-malattie-rare]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10652-consenso-informato-aifa-pazienti-siano-consapevoli-e-partecipativi]]></loc><lastmod>2016-05-20T08:45:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10599-ccsvi-nascera-a-ferrara-centro-pubblico-di-diagnosi-avanzata]]></loc><lastmod>2016-05-13T13:20:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10643-reti-di-riferimento-europee-annunciati-i-nomi-dei-rappresentanti-epag]]></loc><lastmod>2016-05-18T15:34:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10591-farmaceutica-crescono-le-start-up-innovative-in-italia]]></loc><lastmod>2016-05-13T10:44:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10586-ginecologia-oncologica-nasce-a-palermo-un-nuovo-centro-specializzato]]></loc><lastmod>2016-05-13T09:53:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10575-disabilita-al-via-un-concorso-di-idee-per-premiare-i-progetti-piu-innovativi]]></loc><lastmod>2016-05-11T14:28:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10571-liguria-il-comitato-imi-chiede-l-apertura-di-un-centro-clinico-per-malati-orfani-di-diagnosi]]></loc><lastmod>2016-05-11T10:44:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10559-olbia-riabilitazione-e-supporto-scolastico-negati-a-una-ragazza-disabile]]></loc><lastmod>2016-05-12T08:23:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10563-a-8-anni-non-puo-andare-in-gita-perche-ha-la-fibrosi-cistica-la-denuncia-della-madre]]></loc><lastmod>2016-05-09T15:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10535-market-access-award-2016-roche-vince-con-il-progetto-epica]]></loc><lastmod>2016-05-06T09:45:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10539-troppi-e-mal-distribuiti-sul-territorio-un-indagine-sui-servizi-genetici-in-italia]]></loc><lastmod>2016-05-06T10:24:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10499-fondazione-hopen-una-missione-alla-ricerca-della-diagnosi-perduta]]></loc><lastmod>2019-04-19T13:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10522-dolore-muscolo-scheletrico-e-dell-algodistrofia-nasce-la-prima-societa-scientifica-italiana]]></loc><lastmod>2016-05-03T13:11:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10505-il-papa-invita-a-non-trascurare-le-malattie-rare-fondamentale-far-crescere-l-empatia]]></loc><lastmod>2016-05-02T08:18:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10488-shaken-baby-mai-scuotere-un-bambino-per-calmarlo]]></loc><lastmod>2016-04-29T08:16:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10469-anziani-di-oggi-e-di-domani-esposti-all-incuria-delle-istituzioni-happyageing-servono-azioni-immediate-a-cominciare-dal-piano-vaccini]]></loc><lastmod>2016-04-27T13:19:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10466-vaccini-le-10-bufale-piu-diffuse-il-decalogo-sip-per-la-settimana-mondiale-delle-vaccinazioni]]></loc><lastmod>2016-04-27T08:37:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10465-farmaci-fondamentale-collaborazione-tra-pazienti-regolatori-e-aziende]]></loc><lastmod>2016-04-27T07:51:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10452-a-palermo-il-primo-disability-pride-italia]]></loc><lastmod>2016-04-27T14:43:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10450-sindrome-di-sjogren-il-cortometraggio-di-a-n-i-ma-s-s-onlus-finalista-al-festival-del-cinema-sociale]]></loc><lastmod>2016-04-26T13:41:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10449-giornata-nazionale-della-salute-della-donna-dall-aifa-una-ricerca-clinica-gender-oriented-sui-farmaci]]></loc><lastmod>2016-04-26T13:36:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10438-tumore-al-polmone-fda-avvia-revisione-prioritaria-per-il-farmaco-sperimentale-atezolizumab]]></loc><lastmod>2021-11-02T15:55:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10435-il-paziente-al-centro-del-percorso-terapeutico-assistenziale-al-via-il-premio-giornalistico-di-merck-serono]]></loc><lastmod>2016-04-22T15:20:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10434-ospedale-meyer-al-via-un-laboratorio-per-l-innovazione-con-google-for-work]]></loc><lastmod>2016-04-22T15:15:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10430-disabilita-in-ospedale-troppe-le-barriere-materiali-e-culturali-che-negano-l-accoglienza]]></loc><lastmod>2016-04-22T14:40:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10428-vaccini-italia-in-lista-nera-per-l-oms-necessario-approvare-il-nuovo-piano-vaccinale]]></loc><lastmod>2016-04-22T13:07:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10413-albinismo-conclusi-i-lavori-del-terzo-convegno-europeo]]></loc><lastmod>2016-04-20T10:11:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10396-deficit-del-trasportatore-della-creatina-roche-investe-nel-candidato-farmaco-di-lumos-pharma]]></loc><lastmod>2016-04-15T17:07:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10414-ricerca-e-sviluppo-dei-farmaci-concluso-oggi-il-workshop-dell-accademia-dei-pazienti-onlus]]></loc><lastmod>2016-04-20T13:59:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10386-reggio-calabria-il-primario-che-aiuta-i-bisognosi]]></loc><lastmod>2016-04-19T06:56:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10389-chiesi-farmaceutici-supera-il-traguardo-degli-80-anni-evidenziando-una-continua-crescita]]></loc><lastmod>2016-04-15T14:54:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10407-sindrome-di-poland-all-ospedale-san-martino-l-edizione-2016-dell-open-day-sulla-patologia]]></loc><lastmod>2016-04-18T18:49:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10402-al-via-domani-il-workshop-eupati-sulla-ricerca-e-sviluppo-dei-farmaci]]></loc><lastmod>2016-04-18T12:54:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10401-siena-diagnosticata-malattia-rara-a-un-bimbo-morto-dieci-anni-fa-grazie-a-sequenziamento-del-dna]]></loc><lastmod>2016-04-18T12:48:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10399-hopen-e-assogenerici-uniti-per-dare-voce-ai-pazienti-con-malattie-rare-senza-nome]]></loc><lastmod>2019-04-19T13:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10384-pazienti-3-0-consapevoli-e-attivi-nel-workshop-dell-accademia-dei-pazienti-a-roma-il-19-e-20-aprile]]></loc><lastmod>2016-04-15T10:25:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10371-ho-un-figlio-con-una-malattia-rara-il-video-che-commuove-il-web]]></loc><lastmod>2016-04-13T13:44:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10360-sindrome-di-roki-donne-nate-senza-utero-vogliamo-la-maternita-surrogata]]></loc><lastmod>2016-04-13T09:26:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10353-nuovi-farmaci-ema-rende-pubblici-i-dati-clinici-delle-registrazioni]]></loc><lastmod>2016-04-12T00:22:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10343-tumori-nuovo-farmaco-per-quello-al-polmone]]></loc><lastmod>2021-11-02T15:57:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10342-aifa-pazienti-sempre-piu-coinvolti-nel-procedimento-regolatorio]]></loc><lastmod>2016-04-09T07:32:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10317-malattie-rare-l-impatto-di-una-diagnosi-ritardata-e-le-difficolta-vissute-dai-pazienti]]></loc><lastmod>2016-04-08T08:31:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10302-malattie-rare-ripartono-i-corsi-di-uniamo-fimr-onlus-per-riconoscerle]]></loc><lastmod>2016-04-04T08:51:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10287-sport-all-aria-aperta-per-i-malati-rari-al-via-un-progetto-in-puglia]]></loc><lastmod>2016-03-31T15:44:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10284-editing-genetico-e-staminali-il-rischio-di-un-nuovo-turismo-medico]]></loc><lastmod>2016-03-31T10:56:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10270-tumore-del-polmone-fda-estende-l-uso-del-farmaco-crizotinib]]></loc><lastmod>2021-11-02T15:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10262-sindrome-degli-occhi-di-gatto-al-via-la-campagna-di-sensibilizzazione-di-cesi-onlus]]></loc><lastmod>2016-03-25T11:01:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10260-eurordis-identifica-similitudini-e-differenze-fra-tumori-rari-e-malattie-rare]]></loc><lastmod>2016-03-25T10:33:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10255-malattie-rare-in-emilia-romagna-sono-18mila-i-pazienti-per-un-totale-di-111-tipi-di-patologie]]></loc><lastmod>2016-03-25T09:17:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10241-usa-nfl-ammette-il-legame-tra-football-e-danni-cerebrali-permanenti]]></loc><lastmod>2016-03-22T15:59:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10239-anemia-di-diamond-blackfan-premiata-dalla-dbaf-la-ricercatrice-italiana-irma-dianzani]]></loc><lastmod>2016-03-22T15:16:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10247-sicilia-cresce-il-centro-regionale-per-le-malattie-rare-di-villa-sofia-cervello]]></loc><lastmod>2016-03-23T14:25:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10237-eliminare-le-malattie-genetiche-un-sogno-possibile]]></loc><lastmod>2016-03-22T10:33:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10236-carcinoma-polmonare-parere-positivo-dal-chmp-dell-ema-per-afatinib]]></loc><lastmod>2021-11-02T16:00:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10229-rene-policistico-farmaco-a-carico-dei-malati-la-denuncia-di-airp-onlus]]></loc><lastmod>2016-03-21T11:42:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10211-telethon-gli-auguri-per-la-festa-del-papa]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10210-virus-zika-uno-studio-dimostrerebbe-la-sua-trasmissione-sessuale]]></loc><lastmod>2016-03-18T09:41:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10193-malattie-neurologiche-l-importanza-di-diagnosi-precoce-e-intervento-tempestivo]]></loc><lastmod>2016-03-14T10:56:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10171-disabilita-il-progetto-pisano-e-rob-vince-il-bando-della-fondazione-telecom-italia]]></loc><lastmod>2016-03-11T09:59:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10155-firenze-nasce-al-meyer-il-nuovo-centro-specialistico-di-neuro-ortopedia-pediatrica]]></loc><lastmod>2016-03-09T15:23:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10161-arezzo-un-concerto-per-aiutare-il-piccolo-thomas-affetto-da-una-malattia-neurologica]]></loc><lastmod>2016-03-10T15:35:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10145-giornata-mondiale-del-rene-2016-baxter-e-tudisco-onlus-insieme-per-i-piccoli-pazienti-del-bambino-gesu]]></loc><lastmod>2016-03-09T08:51:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10147-alexion-dedica-il-nuovo-quartier-generale-ai-pazienti-con-malattie-rare]]></loc><lastmod>2016-03-09T11:15:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10125-trapianto-d-organi-qual-e-la-situazione-italiana]]></loc><lastmod>2016-03-04T15:01:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10139-malattie-rare-a-lecce-nasce-una-task-force-per-offrire-assistenza-a-3mila-pazienti]]></loc><lastmod>2016-03-08T15:00:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10135-policlinico-gemelli-inaugurato-il-centro-di-medicina-e-di-chirurgia-ricostruttiva-pelvica-femminile]]></loc><lastmod>2016-03-08T08:28:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10112-disabilita-la-denuncia-di-sfida-in-puglia-giunta-regionale-sottrae-6-mensilita-dell-assegno-di-cura]]></loc><lastmod>2016-03-08T15:54:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10107-gsk-e-save-the-children-premiano-le-innovazioni-prodotte-dai-paesi-in-via-di-sviluppo]]></loc><lastmod>2016-03-04T10:42:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10096-giornata-mondiale-dell-udito-l-importanza-di-diagnosi-e-cure-tempestive-delle-disabilita-uditive-nei-bambini]]></loc><lastmod>2016-03-02T15:01:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10086-assobiotec-il-nuvo-presidente-e-riccardo-palmisano]]></loc><lastmod>2016-03-02T08:48:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10079-audiologia-al-meyer-nuovo-centro-d-eccellenza-per-diagnosi-precoce-sordita]]></loc><lastmod>2016-03-01T11:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10067-sarcoidosi-a-padova-l-assemblea-dei-soci-acsi]]></loc><lastmod>2016-02-29T11:22:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10066-malattie-rare-piu-della-meta-sono-di-tipo-neurologico]]></loc><lastmod>2016-02-29T10:46:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10064-giornata-mondiale-delle-malattie-rare-2016-uniamolavoce]]></loc><lastmod>2016-02-29T08:22:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10045-sanita-la-gestione-integrata-e-i-farmaci-equivalenti-ne-migliorano-l-efficienza]]></loc><lastmod>2016-02-25T16:56:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10044-vaccinazioni-in-adulti-e-anziani-le-nuove-linee-guida-europee]]></loc><lastmod>2016-02-25T16:53:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10033-al-bambino-gesu-impiantato-un-cuore-artificiale-magnetico-in-una-ragazza-minorenne]]></loc><lastmod>2016-02-25T16:22:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10010-malattie-dell-ipofisi-apre-a-padova-lo-sportello-amico]]></loc><lastmod>2016-02-22T16:59:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10022-yenetics-i-test-prenatali-che-individuano-100-malattie-con-una-precisione-del-99]]></loc><lastmod>2016-02-24T09:22:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10021-yenetics-la-startup-punta-sui-test-prenatali-e-vince-il-contamination-lab-di-cagliari]]></loc><lastmod>2016-02-24T09:14:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10026-bruxelles-oggi-e-domani-la-tavola-rotonda-eurordis-sulle-malattie-rare]]></loc><lastmod>2016-02-24T15:22:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10017-malattie-congenite-premiato-in-inghilterra-il-progetto-della-ricercatrice-italiana-silvia-schievano]]></loc><lastmod>2016-02-23T15:50:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9996-reti-europee-di-riferimento-nuove-linee-guida-in-attesa-del-primo-bando]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10018-premi-eurordis-2016-premiata-renza-barbon-galluppi-presidente-di-uniamo-firm-onlus]]></loc><lastmod>2016-02-23T16:21:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/10002-telethon-1-9-milioni-di-euro-per-le-malattie-genetiche-sconosciute]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9993-shire-festeggia-30-anni-con-un-iniziativa-a-favore-dei-bambini-con-malattie-rare]]></loc><lastmod>2024-10-31T16:18:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9984-malattie-genetiche-rare-senza-nome-per-loro-c-e-la-fondazione-hopen]]></loc><lastmod>2019-04-19T13:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9997-yenetics-la-startup-bio-medica-sarda-approda-alla-finale-del-contamination-lab]]></loc><lastmod>2016-02-19T11:28:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9989-ricerca-sugli-embrioni-l-italia-e-in-attesa-di-un-verdetto]]></loc><lastmod>2016-02-19T10:23:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9978-19-e-20-febbraio-2016-a-roma-il-convegno-etica-in-riabilitazione-per-gli-80-anni-dell-istituto-vaccari]]></loc><lastmod>2016-02-16T10:41:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9964-pediatria-al-meyer-l-importanza-del-gioco-in-ospedale]]></loc><lastmod>2016-02-12T15:35:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9961-sindrome-di-hermansky-pudlak-innovativa-analisi-microscopica-potrebbe-migliorare-la-diagnosi]]></loc><lastmod>2016-02-12T15:16:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9956-trasporto-neonatale-indagine-sin-manca-in-5-regioni]]></loc><lastmod>2016-02-12T14:46:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9952-registro-lombardo-delle-malattie-rare-censiti-piu-di-28mila-pazienti]]></loc><lastmod>2016-02-12T14:00:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9948-meningite-casi-piu-che-raddoppiati-in-toscana-la-simit-chiede-un-maggiore-coinvolgimento-della-regione]]></loc><lastmod>2016-02-12T10:52:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9941-pneumologia-pubblicata-la-mappa-dei-centri-italiani]]></loc><lastmod>2016-02-11T14:00:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9919-rare-disease-day-2016-un-abbraccio-per-la-croatian-alliance-for-rare-diseases]]></loc><lastmod>2016-02-05T14:45:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9915-rare-disease-day-2016-online-il-video-ufficiale]]></loc><lastmod>2016-02-05T14:15:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9914-distonia-un-video-per-farla-conoscere]]></loc><lastmod>2016-02-05T14:12:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9923-virus-zika-sanofi-pronta-alla-sperimentazione-di-un-nuovo-vaccino]]></loc><lastmod>2016-02-08T15:48:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9922-genetica-nasce-in-russia-un-laboratorio-magi]]></loc><lastmod>2016-02-08T15:44:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9903-shire-completa-con-successo-l-acquisizione-di-dyax]]></loc><lastmod>2016-02-05T11:10:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9894-cancro-incoraggiare-le-vaccinazioni-per-scongiurare-complicanze-evitabili]]></loc><lastmod>2016-02-04T08:23:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9878-fecondazione-coscioni-anche-in-italia-embrioni-non-idonei-per-gravidanza-siano-donati-alla-ricerca]]></loc><lastmod>2016-02-02T08:51:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9857-oncologia-ricercatore-sardo-premiato-dalla-american-society-of-clinical-oncology]]></loc><lastmod>2016-01-29T15:34:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9855-reti-europee-di-riferimento-le-preoccupazioni-sul-ruolo-dell-industria]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9846-virus-zika-quali-sono-i-rischi]]></loc><lastmod>2016-01-29T14:23:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9838-terapia-del-dolore-nasce-pinhub-la-prima-rete-nazionale]]></loc><lastmod>2016-01-29T11:56:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9837-trapianto-di-cornea-nuova-tecnica-laser-al-bambino-gesu]]></loc><lastmod>2016-01-29T10:09:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9828-malattia-rara-giovane-paziente-muore-a-causa-di-un-errata-diagnosi]]></loc><lastmod>2016-01-27T15:49:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9826-farmaci-aifa-pubblica-il-rapporto-osmed-2015]]></loc><lastmod>2016-01-27T14:56:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9814-malattie-rare-superare-le-difficolta-delle-sperimentazioni-in-piccoli-gruppi]]></loc><lastmod>2016-01-25T14:07:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9797-discinesia-ciliare-primaria-disponibili-i-primi-dati-del-registro-internazionale]]></loc><lastmod>2016-01-22T11:35:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9815-sassari-chiude-il-centro-malattie-rare-dell-istituto-di-neuropsichiatria]]></loc><lastmod>2016-01-25T14:02:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9793-reti-di-riferimento-europee-per-le-malattie-rare-tutte-le-novita-degli-ultimi-mesi]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9775-malattie-rare-tre-premi-per-le-migliori-tesi-di-medicina]]></loc><lastmod>2016-01-20T14:51:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9787-il-paziente-sempre-piu-al-centro-stretto-accordo-tra-aifa-e-eupati]]></loc><lastmod>2016-01-21T09:52:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9777-malattie-rare-ancora-grande-disparita-tra-i-paesi-europei]]></loc><lastmod>2016-01-21T08:29:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9774-tumore-del-polmone-ok-del-chmp-per-estensione-di-erlotinib]]></loc><lastmod>2021-11-02T16:02:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9768-sindrome-di-down-col-nuovo-test-prenatale-basta-un-prelievo-di-sangue]]></loc><lastmod>2018-12-07T18:54:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9769-premio-louis-jeantet-2016-vince-ballabio-fondatore-e-direttore-del-tigem-di-napoli]]></loc><lastmod>2016-01-19T14:45:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9766-francia-incidente-biotral-il-farmaco-sperimentale-non-conteneva-cannabis]]></loc><lastmod>2016-01-19T08:11:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9764-sanofi-e-la-societa-vincitrice-del-premio-di-pharm-connect]]></loc><lastmod>2016-01-18T08:51:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9751-gravidanza-i-consigli-per-la-salute-di-mamma-e-bambino]]></loc><lastmod>2016-01-15T11:45:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9737-malattie-da-accumulo-lisosomiale-genzyme-ha-annunciato-i-vincitori-del-pal-awards-2015]]></loc><lastmod>2016-01-13T10:33:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9739-arriva-in-italia-intercept-pharmaceuticals-sviluppera-farmaci-per-la-cura-delle-epatopatie-non-virali]]></loc><lastmod>2016-10-04T13:33:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9726-sindrome-di-klinefelter-interessati-1-neonato-maschio-su-500]]></loc><lastmod>2016-01-11T14:51:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9697-tumori-in-piemonte-avviata-la-prima-rete-oncologica]]></loc><lastmod>2016-01-04T14:38:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9725-malattie-rare-shire-acquista-baxalta-per-32miliardi-di-dollari]]></loc><lastmod>2016-01-11T15:42:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9693-la-casa-farmaceutica-isis-cambia-nome-in-ionis-pharmaceuticals]]></loc><lastmod>2015-12-30T18:32:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9703-morti-materne-pre-parto-a-breve-nuove-linee-guida-su-gravidanze-a-rischio]]></loc><lastmod>2016-01-07T11:17:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9700-malattie-genetiche-rare-le-nuove-sfide-della-cooperativa-magi-euregio]]></loc><lastmod>2016-01-07T09:41:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9675-pediatria-accordo-tra-meyer-e-stella-maris-per-percorsi-integrati-di-assistenza-clinica-e-collaborazione-sulla-ricerca]]></loc><lastmod>2015-12-23T13:28:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9670-farmaci-equivalenti-da-aifa-una-guida-rapida-sulla-loro-qualita-sicurezza-ed-efficacia]]></loc><lastmod>2015-12-23T11:48:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9649-bambini-e-natale-attenzione-alle-infezioni-i-consigli-di-waidid]]></loc><lastmod>2015-12-21T09:25:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9668-genetica-medica-magi-cerca-un-biologo-un-genetista-e-un-tecnico-di-laboratorio]]></loc><lastmod>2015-12-23T10:15:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9650-maratona-telethon-raccolti-31-5-milioni-di-euro]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9606-ern-nel-2016-la-commissione-europea-invitera-a-presentare-nuove-proposte]]></loc><lastmod>2015-12-11T13:35:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9602-anticoagulanti-orali-idarucizumab-approvato-in-europa-per-l-inversione-degli-effetti-di-dabigatran-etexilato]]></loc><lastmod>2015-12-11T12:14:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9600-merck-lancia-il-suo-canale-youtube]]></loc><lastmod>2015-12-11T12:07:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9616-genetica-e-mancato-il-dr-zelante-primario-alla-casa-sollievo-della-sofferenza-di-san-giovanni-rotondo]]></loc><lastmod>2015-12-14T12:08:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9611-molmed-s-p-a-nominato-riccardo-palmisano-nuovo-amministratore-delegato]]></loc><lastmod>2015-12-14T09:21:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9589-lazio-attiva-la-riorganizzazione-dei-centri-malattie-rare]]></loc><lastmod>2015-12-11T10:39:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9588-ospedale-pediatrico-bambino-gesu-in-occasione-del-giubileo-aperta-la-porta-della-speranza]]></loc><lastmod>2015-12-11T09:40:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9559-telethon-al-via-la-campagna-per-la-ricerca-sulle-malattie-genetiche-rare]]></loc><lastmod>2024-10-31T16:17:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9531-terapie-astrazeneca-e-sanofi-aprono-a-un-nuovo-modello-di-collaborazione]]></loc><lastmod>2015-12-04T09:51:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9530-tumore-del-polmone-non-a-piccole-cellule-fda-approva-il-farmaco-tagrisso-azd9291]]></loc><lastmod>2021-11-02T15:15:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9539-carcinoma-polmonare-gli-oncologi-chiedono-un-miglioramento-della-gestione-del-test-per-la-ricerca-di-mutazioni-egfr]]></loc><lastmod>2021-11-02T16:04:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9519-depressione-la-maggior-parte-di-chi-ne-soffre-non-chiede-aiuto]]></loc><lastmod>2015-12-03T15:04:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9513-disabilita-oggi-ricorre-la-giornata-internazionale]]></loc><lastmod>2015-12-03T09:30:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9501-uso-sicuro-dei-medicinali-dall-ema-una-nuova-pagina-web-e-una-guida-per-le-buone-pratiche]]></loc><lastmod>2015-12-02T11:28:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9475-little-heroes-un-documentario-la-lotta-di-paola-leone-contro-la-malattia-di-canavan]]></loc><lastmod>2015-12-02T08:51:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9485-molmed-aifa-concede-l-autorizzazione-alla-produzione-di-terapie-geniche-destinate-alla-commercializzazione]]></loc><lastmod>2015-12-01T11:01:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9472-piano-nazionale-per-la-fertilita-merck-presenta-un-manifesto-a-sostegno]]></loc><lastmod>2015-11-27T15:50:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9471-bayer-e-terre-des-hommes-uniti-contro-l-infanticidio]]></loc><lastmod>2015-11-27T15:44:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9613-ipsen-uro-oncologia-endocrinologia-e-neurologia-i-tre-focus-dell-azienda-che-in-italia-festeggia-25-anni-di-attivita]]></loc><lastmod>2015-12-14T11:46:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9479-tumore-alla-prostata-grazie-ad-ipsen-un-passo-avanti-verso-la-prevenzione]]></loc><lastmod>2015-11-30T10:09:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9469-betasarcoglicanopatie-gfb-onlus-stanzia-200mila-dollari-per-iniziare-la-terapia-genica]]></loc><lastmod>2015-11-27T15:27:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9468-malattia-oncologica-fino-al-31-dicembre-il-concorso-espressioni-di-cura-parole-e-immagini-per-narrare-la-malattia-oncologica]]></loc><lastmod>2015-11-27T15:22:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9467-benessere-dal-cro-di-aviano-un-decalogo-per-la-buona-salute]]></loc><lastmod>2015-11-27T15:19:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9450-ricerca-boehringer-ingelheim-investira-11-miliardi-di-euro-entro-il-2020]]></loc><lastmod>2015-11-26T11:07:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9464-malattie-orfane-e-ultra-rare-al-via-la-campagna-vite-coraggiose-della-fondazione-bambino-gesu-per-la-ricerca]]></loc><lastmod>2015-11-27T08:31:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9440-cure-palliative-a-che-punto-siamo-in-italia]]></loc><lastmod>2015-11-25T15:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9449-malati-rari-l-associazione-dossetti-urge-decreto-legge]]></loc><lastmod>2015-11-26T11:03:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9400-liste-di-attesa-e-spesa-privata-presentato-il-xviii-rapporto-pit-salute-del-tribunale-per-i-diritti-del-malato-cittadinanzattiva]]></loc><lastmod>2015-11-20T11:25:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9415-malattie-rare-test-genetici-transfrontalieri-in-aumento-ma-ancora-troppe-disuguaglianze-nell-ue]]></loc><lastmod>2017-03-10T10:31:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9414-aciduria-metilmalonica-l-associazione-malattie-metaboliche-dona-10mila-euro-a-tls]]></loc><lastmod>2024-10-31T16:18:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9401-comitato-human-gene-editing-study-nominato-membro-il-prof-naldini-del-s-raffaele-telethon-di-milano]]></loc><lastmod>2015-11-20T11:30:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9369-anomalie-vascolari-al-3-congresso-sisav-premiato-il-dr-bertelli]]></loc><lastmod>2015-11-17T14:26:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9376-malattie-genetiche-la-selezione-degli-embrioni-non-e-piu-un-reato]]></loc><lastmod>2015-11-17T17:32:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9366-giornata-mondiale-del-neonato-pretermine-le-indicazioni-della-societa-italiana-di-neonatologia-sin]]></loc><lastmod>2015-11-17T09:31:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9348-patologie-del-cervello-all-international-focus-on-neurotranslation-nuove-tecnologie-di-cura]]></loc><lastmod>2015-11-13T09:56:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9344-aboutpharma-digital-awards-2015-premiata-merck-con-il-progetto-easypod-connect]]></loc><lastmod>2015-11-13T08:52:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9343-giornata-mondiale-del-diabete-domenica-a-romaest-prevenzione-in-piazza]]></loc><lastmod>2015-11-13T08:23:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9334-terapia-del-dolore-all-ospedale-meyer-adottata-la-tecnica-di-immaginazione-guidata]]></loc><lastmod>2015-11-11T15:28:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9317-all-ospedale-pediatrico-bambino-gesu-arriva-astro-tac-per-viaggiare-tra-stelle-e-pianeti]]></loc><lastmod>2015-11-06T14:04:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9338-malattie-da-accumulo-lisosomiale-a-roma-il-programma-di-formazione-specialistica-train-the-trainer]]></loc><lastmod>2015-11-12T11:02:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9337-oggi-12-novembre-e-la-giornata-mondiale-contro-le-polmoniti]]></loc><lastmod>2015-11-12T08:28:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9314-al-via-il-premio-giornalistico-merck-tema-di-quest-anno-il-paziente-al-centro-del-percorso-terapeutico-assistenziale]]></loc><lastmod>2015-11-06T13:50:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9310-acondroplasia-un-libro-illustrato-per-bambini-contro-i-pregiudizi]]></loc><lastmod>2015-11-06T12:13:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9308-esiste-una-definizione-univoca-di-malattia-rara]]></loc><lastmod>2015-11-06T12:02:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9304-malattie-rare-nord-lancia-l-iniziativa-state-progress-report-a-beneficio-dei-pazienti-usa]]></loc><lastmod>2015-11-06T11:37:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9294-tumore-alla-prostata-l-ospedale-san-raffaele-un-concorso-fotografico-per-sensibilizzare-alla-prevenzione]]></loc><lastmod>2015-11-05T09:15:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9265-diagnostica-menarini-e-meyer-uniti-nella-ricerca-e-nell-innovazione]]></loc><lastmod>2015-10-30T09:58:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9264-immuno-oncologia-nuovo-accordo-tra-bristol-myers-squibb-e-five-prime-therapeutics]]></loc><lastmod>2015-10-30T09:52:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9289-tumori-rari-parlamentari-pazienti-e-societa-scientifiche-chiedono-al-governo-reti-nazionali-ed-europee-dedicate]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9217-la-rivista-internazionale-journal-of-genetic-disorders-genetic-reports-dedica-un-articolo-al-network-ring14-international]]></loc><lastmod>2015-10-28T10:43:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9246-giornata-mondiale-dell-ictus-cerebrale-oggi-screening-gratuiti-a-milano]]></loc><lastmod>2015-10-29T08:46:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9220-registro-nazionale-malattie-rare-disponibile-il-rapporto-iss-2001-2012]]></loc><lastmod>2015-10-23T10:42:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9215-in-veneto-il-primo-medical-hotel-termale-accessibile-alle-persone-con-disabilita]]></loc><lastmod>2015-10-23T09:50:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9227-progetto-grandangolo-i-farmacisti-ospedalieri-ancora-poco-coinvolti-nel-sistema]]></loc><lastmod>2015-10-26T11:28:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9226-progetto-grandangolo-i-farmacisti-ospedalieri-aprono-al-loro-interno-un-osservatorio-sulle-malattie-rare]]></loc><lastmod>2015-10-26T11:30:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9196-influenza-il-vaccino-si-fa-in-4]]></loc><lastmod>2015-10-21T14:31:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9174-leishmaniosi-l-iss-partecipa-al-manuale-dell-oms]]></loc><lastmod>2015-10-19T14:32:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9172-european-biotech-week-numeri-da-record-in-italia]]></loc><lastmod>2015-10-19T13:45:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9173-i-biosimilari-in-italia-cosa-ne-pensano-medici-e-pazienti]]></loc><lastmod>2015-10-19T14:24:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9169-legge-219-05-sulle-attivita-trasfusionali-a-roma-oggi-un-convegno-a-dieci-anni-dalla-sua-approvazione]]></loc><lastmod>2015-10-19T09:56:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9168-piano-nazionale-malattie-rare-2013-2016-le-proposte-del-mir-un-anno-dopo]]></loc><lastmod>2015-10-19T09:40:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9167-concorso-il-volo-di-pegaso-raccontare-le-malattie-rare-entro-l-1-novembre-l-invio-delle-opere]]></loc><lastmod>2015-10-19T08:20:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9147-leandro-provinciali-e-il-nuovo-presidente-della-societa-italiana-di-neurologia]]></loc><lastmod>2015-10-14T09:20:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9163-tumori-epatici-al-gemelli-il-punto-sui-trattamenti-di-radiologia-interventistica]]></loc><lastmod>2015-10-15T09:29:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9152-merck-annuncia-un-rebranding-globale]]></loc><lastmod>2015-10-14T12:49:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9106-dolore-ok-dall-ue-per-immissione-in-commercio-di-zalviso-dispositivo-medico-non-invasivo]]></loc><lastmod>2015-10-12T13:15:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9121-stakeholder-engagement-massimizzare-il-soddisfacimento-di-interessi-convergenti-aumenta-il-benessere-dell-intera-comunita]]></loc><lastmod>2015-10-13T12:41:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9103-biotecnologia-memorandum-di-intesa-tra-assobiotec-e-l-austian-center-of-industrial-biotechnology]]></loc><lastmod>2015-10-12T12:36:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9110-ebw-tornano-i-play-decide-su-farmaci-orfani-screening-neonatali-e-cellule-staminali]]></loc><lastmod>2015-10-12T15:05:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9076-anziani-e-farmaci-una-ricerca-del-geriatric-working-group-dell-aifa-rivela-che-il-consumo-diminuisce-nell-eta-avanzata]]></loc><lastmod>2015-10-09T09:14:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9075-malattie-da-accumulo-lisosomiale-a-firenze-i-maggiori-esperti-riuniti]]></loc><lastmod>2015-10-09T09:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9056-prostatachannel-online-il-nuovo-sito-gsk-per-urologi-e-medici-di-famiglia]]></loc><lastmod>2015-10-07T14:54:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9062-choosing-wisely-farmacisti-clinici-in-prima-linea-sull-appropriatezza]]></loc><lastmod>2015-10-08T08:16:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9012-ricerca-il-rare-genomics-institute-ha-annunciato-i-vincitori-di-beheard-2015]]></loc><lastmod>2015-09-29T10:03:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/9008-malattie-rare-stabilito-il-programma-ufficiale-del-nord-rare-summit-2015]]></loc><lastmod>2015-09-29T09:30:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8988-salute-femminile-e-alimentazione-a-ottobre-h-open-month-in-115-ospedali-con-i-bollini-rosa]]></loc><lastmod>2015-09-25T09:10:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8984-admo-sabato-torna-l-iniziativa-ehi-tu-hai-midollo]]></loc><lastmod>2015-09-24T14:29:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8987-urologia-pediatrica-l-ospedale-meyer-si-apre-all-approccio-con-il-robot]]></loc><lastmod>2015-09-25T09:01:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8975-malattie-neuromuscolari-inaugurato-il-centro-nemo-a-roma]]></loc><lastmod>2015-09-23T20:00:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8960-sangamo-e-shire-interrompono-la-loro-collaborazione-nell-ambito-delle-terapie-geniche]]></loc><lastmod>2015-09-22T10:42:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8959-la-biotech-celgene-apre-le-porte-ai-giornalisti]]></loc><lastmod>2015-09-22T10:39:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8910-sordita-al-congresso-inner-ear-biology-le-nuove-terapie-per-la-sua-cura]]></loc><lastmod>2015-09-14T08:11:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8900-cancro-del-polmone-alectinib-ottiene-priority-review-da-fda]]></loc><lastmod>2021-11-02T16:26:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8876-trattamento-del-dolore-i-risultati-dei-progetti-di-ricerca-aumentano-le-speranze]]></loc><lastmod>2015-09-07T08:16:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8885-telethon-gli-auguri-di-buon-rientro-a-scuola-a-tutti-i-bambini-italiani]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8884-patologie-respiratorie-croniche-arriva-una-proposta-di-modello-per-una-gestione-integrata]]></loc><lastmod>2015-09-08T15:43:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8883-anemia-aplastica-eltrombopag-approvato-dalla-commissione-europea]]></loc><lastmod>2015-09-08T09:13:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8882-settore-chimico-da-bayer-nasce-covestro]]></loc><lastmod>2015-09-08T08:58:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8856-virus-respiratorio-sinciziale-esito-positivo-per-fase-ii-del-vaccino-sperimentale]]></loc><lastmod>2015-09-02T13:55:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8853-ospedale-e-fondazione-meyer-da-oggi-online-i-due-nuovi-siti]]></loc><lastmod>2015-09-01T14:37:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8845-carcinoma-polmonare-fda-ed-ema-accolgono-dossier-per-richiesta-di-registrazione-di-afatinib]]></loc><lastmod>2021-11-02T16:29:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8843-trapianti-al-bambino-gesu-un-fegato-per-due-bambini]]></loc><lastmod>2015-08-28T10:19:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8795-malattie-rare-abeona-therapeutics-ottiene-capitale-da-investire-per-nuovi-farmaci]]></loc><lastmod>2016-05-31T15:45:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8811-malattie-rare-lazio-recepisce-piano-nazionale-e-avvia-l-aggiornamento-dei-centri-di-riferimento]]></loc><lastmod>2015-08-24T10:24:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8810-malattie-rare-in-lombardia-i-pazienti-censiti-nel-registro-sono-piu-di-25-000]]></loc><lastmod>2015-08-24T10:21:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8794-ipoparatiroidismo-nuove-linee-guida-per-la-cura-dei-pazienti]]></loc><lastmod>2015-08-20T15:13:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8791-sindrome-di-pallister-killian-l-associazione-italiana-indice-una-selezione-pubblica]]></loc><lastmod>2015-08-20T14:01:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8804-telethon-scoperta-a-palermo-la-molecola-che-accende-il-dna]]></loc><lastmod>2019-02-18T15:53:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8770-terapia-ferrochelante-studio-internazionale-conferma-la-sicurezza-della-terapia-combinata]]></loc><lastmod>2015-08-06T21:06:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8777-cheratocongiuntivite-vernal-al-meyer-un-modello-di-assistenza-all-avanguardia]]></loc><lastmod>2015-08-17T07:43:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8757-bpco-zambon-investe-in-innovazione-acquisendo-eratech]]></loc><lastmod>2015-08-06T16:53:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8736-carcinoma-polmonare-accordo-tra-boehringer-ingelheim-e-hanmi-per-hm61713]]></loc><lastmod>2021-11-02T16:31:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8728-sindrome-di-sjogren-nuovo-kit-diagnostico-brevettato-da-enea-e-universita-di-verona]]></loc><lastmod>2015-07-31T08:59:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8733-malattie-rare-in-italia-i-pazienti-sono-oltre-670-000]]></loc><lastmod>2015-08-03T08:42:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8691-crioglobulinemie-alcri-promuove-due-premi-di-studio]]></loc><lastmod>2015-07-24T10:00:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8711-malaria-opinione-positiva-del-chmp-per-vaccino-rts-s]]></loc><lastmod>2015-07-28T08:13:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8719-malattie-rare-l-ospedale-bambino-gesu-offre-formazione-a-distanza]]></loc><lastmod>2015-07-30T10:02:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8690-test-in-laboratorio-in-usa-giuste-le-decisioni-dell-fda]]></loc><lastmod>2015-07-24T09:57:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8685-biotech-in-italia-in-costante-crescita-ecco-il-rapporto-assobiotec-2015]]></loc><lastmod>2015-07-24T08:47:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8678-malattie-rare-approvato-in-croazia-un-programma-nazionale]]></loc><lastmod>2015-07-23T13:51:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8676-vaccini-anti-pneumococcici-dall-iss-dati-ed-evidenze-per-l-utilizzo-nei-soggetti-a-rischio-e-negli-anziani]]></loc><lastmod>2015-07-23T13:44:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8675-spesa-farmaceutica-la-voce-piu-pesante-e-quella-dei-farmaci-oncologici]]></loc><lastmod>2015-07-23T13:37:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8664-istituto-neurologico-besta-renato-mantegazza-nuovo-direttore-scientifico]]></loc><lastmod>2015-07-22T08:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8663-malattie-della-tiroide-nei-maschi-da-non-sottovalutare]]></loc><lastmod>2015-07-22T08:52:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8645-giornata-mondiale-della-sindrome-di-sjoegren-a-n-i-ma-s-s-onlus-organizza-incontro-a-verona]]></loc><lastmod>2015-07-20T10:46:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8619-l-ospedale-bambino-gesu-tra-i-vincitori-dei-global-awards-for-excellence-in-case-management-2015]]></loc><lastmod>2015-07-14T10:45:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8624-malattie-genetiche-rare-da-telethon-oltre-9-milioni-di-euro-alla-ricerca-italiana]]></loc><lastmod>2026-04-08T17:07:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8622-cancro-al-polmone-non-a-piccole-cellule-fda-approva-gefitinib-come-terapia-di-prima-linea]]></loc><lastmod>2021-11-02T15:16:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8623-ema-apre-istruttoria-sul-vaccino-anti-hpv]]></loc><lastmod>2015-07-15T09:23:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8610-malattia-di-creutzfeldt-jakob-individuato-un-gene-responsabile-della-resistenza-umana-alla-patologia]]></loc><lastmod>2018-01-31T22:49:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8604-gli-anticorpi-pcsk9-i-farmaci-ipolipemizzanti-piu-efficaci-mai-sintetizzati]]></loc><lastmod>2015-07-10T10:49:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8602-acondroplasia-all-istituto-ortopedico-pini-presente-spazio-dedicato-alle-famiglie]]></loc><lastmod>2015-07-10T10:36:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8600-alexion-completa-l-acquisizione-di-synageva]]></loc><lastmod>2015-07-10T10:27:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8606-gangliosidosi-gm1-la-difficolta-della-ricerca-sulla-rara-patologia]]></loc><lastmod>2015-07-10T13:21:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8599-alexion-e-lonza-group-rafforzano-la-collaborazione-con-un-nuovo-accordo-a-lungo-termine]]></loc><lastmod>2015-07-10T10:19:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8587-malattie-pediatriche-firmato-protocollo-di-collaborazione-tra-fondazioni-meyer-e-collodi]]></loc><lastmod>2015-07-07T08:36:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8578-assistenza-sanitaria-transfrontaliera-il-rapporto-sul-primo-anno-di-applicazione]]></loc><lastmod>2015-07-06T09:54:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8575-registro-delle-malattie-rare-la-francia-definisce-il-set-minimo-di-dati]]></loc><lastmod>2015-07-06T09:44:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8571-egi-inspire-costruire-uno-spazio-europeo-della-ricerca-digitale]]></loc><lastmod>2015-07-06T07:33:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8585-industria-del-farmaco-italiana-in-ottima-salute]]></loc><lastmod>2015-07-07T06:59:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8582-malattie-rare-all-iss-il-primo-open-day-sugli-erns]]></loc><lastmod>2019-04-17T09:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8537-malattie-scheletriche-rare-pubblicata-una-classificazione-aggiornata-di-queste-patologie]]></loc><lastmod>2015-06-29T10:49:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8555-nasce-baxalta-gruppo-biofarmaceutico-globale-focalizzato-su-terapie-innovative-per-malattie-rare]]></loc><lastmod>2015-07-02T14:24:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8556-baxalta-a-rieti-e-pisa-due-realta-industriali-in-espansione]]></loc><lastmod>2015-07-02T14:26:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8540-vendita-di-farmaci-online-senza-prescrizione-presto-consentita-anche-in-italia]]></loc><lastmod>2015-06-30T07:57:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8534-malattie-genetiche-prima-coppia-fertile-accede-a-diagnosi-pre-impianto-in-ospedale-pubblico]]></loc><lastmod>2015-06-29T09:11:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8514-ipertrofia-prostatica-donato-al-gemelli-laser-al-tullio-made-in-italy]]></loc><lastmod>2024-10-31T16:19:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8500-ortopedia-pediatrica-al-rizzoli-avviata-ricerca-sul-piede-torto-congenito]]></loc><lastmod>2024-10-31T16:20:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8513-incontro-annuale-dei-membri-di-eurordis-al-centro-le-reti-di-riferimento-europee]]></loc><lastmod>2015-06-25T08:50:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8503-tumore-al-polmone-novita-terapeutiche-dal-viii-corso-nazionale-di-oncologia-toracica]]></loc><lastmod>2021-11-02T16:32:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8504-molmed-premiata-come-pmi-biotech-piu-innovativa-d-europa]]></loc><lastmod>2015-06-23T15:34:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8502-molmed-vincitrice-della-sesta-edizione-dell-annual-most-innovative-eu-biotech-sme-award]]></loc><lastmod>2015-06-23T15:30:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8489-farmaci-pediatrici-da-ema-iniziativa-pilota-per-sviluppo-piu-veloce]]></loc><lastmod>2015-06-22T09:10:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8472-malattie-genetiche-dr-matteo-bertelli-nominato-visiting-professor-all-universita-di-krasnoyarsk-siberia]]></loc><lastmod>2015-06-19T10:31:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8464-viaggiare-col-neonato-ecco-i-consigli-della-societa-italiana-di-neonatologia]]></loc><lastmod>2015-06-17T14:59:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8455-medicina-narrativa-presentata-a-milano-la-prima-piattaforma-digitale]]></loc><lastmod>2015-06-16T10:21:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8467-neonatologia-al-via-la-quarta-edizione-del-meeting-surfattante-2015]]></loc><lastmod>2015-06-18T08:51:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8434-neonatologia-inaugurato-a-parma-nuovo-reparto-per-produzione-di-farmaco-salvavita]]></loc><lastmod>2015-06-12T13:35:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8439-malattie-rare-disponibile-uno-sportello-d-ascolto-all-ospedale-di-trani]]></loc><lastmod>2015-06-12T14:25:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8450-giochi-nazionali-trapiantati-e-dializzati-un-weekend-di-gare-per-promuovere-l-attivita-sportiva]]></loc><lastmod>2015-06-15T14:07:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8445-disabilita-grave-un-presidio-per-richiedere-il-piano-nazionale-per-le-non-autosufficienze]]></loc><lastmod>2015-06-15T14:51:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8435-qual-e-il-costo-di-un-malato-raro-per-i-servizi-sanitari]]></loc><lastmod>2015-06-12T12:59:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8418-industria-farmaceutica-schott-presenta-una-nuova-generazione-di-packaging]]></loc><lastmod>2015-06-11T09:49:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8376-molmed-nominata-tra-le-5-piccole-e-medie-biotech-piu-innovative-in-europa]]></loc><lastmod>2015-06-04T13:50:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8374-oftalmologia-e-chirurgia-vetro-retinica-meeting-congiunto-del-gi-v-re-e-del-sot]]></loc><lastmod>2015-06-04T13:33:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8361-punto-terapia-del-dolore-del-niguarda-riceve-menzione-speciale-del-premio-gerbera-d-oro]]></loc><lastmod>2015-06-03T15:01:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8351-farmaci-anti-cancro-sempre-piu-cari-oncologi-italiani-chiedono-un-fondo-nazionale]]></loc><lastmod>2015-06-03T08:05:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8337-nuovo-antibiotico-approvato-per-la-terapia-della-peste-ormai-patologia-assai-rara]]></loc><lastmod>2015-05-28T14:40:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8329-cardiologia-a-milano-il-46-congresso-nazionale-anmco]]></loc><lastmod>2015-05-28T09:52:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8331-update-on-pain-specialisti-riuniti-per-approfondire-tutti-i-tipi-di-dolore]]></loc><lastmod>2015-06-01T09:13:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8323-emofilia-disponibile-anche-in-italia-tachosil-pre-rolled]]></loc><lastmod>2015-06-03T08:06:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8278-melarancia-il-nuovo-progetto-di-magi-euregio-per-le-malattie-rare-in-sicilia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8271-sindrome-della-x-fragile-inaugurata-a-roma-una-serra-per-giovani-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8269-malattie-respiratorie-parte-nuova-collaborazione-tra-simri-e-aipo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8310-malattie-rare-la-guida-ai-diritti-in-ambito-lavorativo-per-i-pazienti-di-uniamo-firm-onlus]]></loc><lastmod>2015-05-23T10:50:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8274-telethon-il-2-giugno-partita-del-cuore-per-la-mucopolisaccaridosi]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8256-la-casa-farmaceutica-kedrion-approda-anche-negli-stati-uniti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8254-nuovo-regolamento-europeo-sulla-sperimentazione-clinica-cosa-cambiera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8207-registro-per-le-distrofie-miotoniche-primi-dati-confortanti-ma-occorre-maggiore-informazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8205-alexion-pharmaceuticals-acquisisce-synageva-biopharma-per-84-miliardi-di-dollari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8203-ictus-ischemico-e-emorragico-del-giovane-lesperienza-di-ipsys-e-magi-euregio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8185-valutazione-di-farmaci-e-dispositivi-medici-la-metodologia-dellhta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8172-forum-mariano-la-madonna-di-fatima-si-trasferisce-a-roma-per-alcuni-giorni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8137-sindrome-di-olmsted-73-casi-al-mondo-e-nessuna-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8129-astrazeneca-e-patientslikeme-annunciano-la-loro-collaborazione-nel-campo-della-ricerca-globale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8109-farmaci-equivalenti-aifa-autorizza-linserimento-dei-farmaci-a-base-di-ciclosporina-nelle-liste-di-trasparenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8096-malattie-infettive-da-oggi-i-medici-di-tutto-il-mondo-potranno-aiutarsi-con-il-clinical-advice-di-waidid]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8110-centro-diagnostico-italiano-aperto-a-milano-un-nuovo-poliambulatorio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8094-prodotti-nutraceutici-l-italia-e-uno-dei-paesi-che-ne-acquista-di-piu]]></loc><lastmod>2015-06-08T11:29:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8092-tumore-della-prostata-ra-223-aumenta-del-30-la-sopravvivenza-globale]]></loc><lastmod>2021-02-20T19:07:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8071-settimana-europea-delle-vaccinazioni-l-italia-deve-fare-di-piu-per-gli-anziani]]></loc><lastmod>2015-06-08T11:30:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8065-questionario-sul-dolore-i-cittadini-esprimono-la-loro-conoscenza-del-tema]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8060-lam-dal-congresso-di-chicago-nuove-probabili-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8055-osservatorio-malattie-rare-ascoltato-dalla-commissione-affari-sociali]]></loc><lastmod>2015-05-25T14:53:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8052-sanita-scontro-aperto-tra-lo-stato-e-le-regioni-i-governatori-il-patto-per-la-salute-e-morto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8051-tagli-al-fsn-in-pericolo-le-forniture-di-sangue-ed-emoderivati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8036-disturbi-del-ciclo-dellurea-firmato-accordo-horizon-hyperion]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8035-progetto-eupati-i-pazienti-partecipano-attivamente-al-processo-di-sviluppo-dei-farmaci-innovativi]]></loc><lastmod>2020-02-27T15:00:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8002-malattie-rare-astrazeneca-firma-accordo-con-genomics-england]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/8031-diagnosi-pre-impianto-la-corte-costituzionale-pronta-a-cassare-la-norma-della-legge-40]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7999-conferenze-nazionali-europlan-ora-disponibili-anche-online]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7998-malattie-rare-avviata-collaborazione-tra-shire-e-lospedale-pediatrico-di-cincinnati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7995-malattie-rare-laustria-adotta-il-suo-piano-dazione-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7961-distrofia-miotonica-istituito-nuovo-registro-italiano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7953-biogen-idec-accorcia-il-suo-nome-in-biogen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7948-disabilita-motoria-la-denuncia-di-melazzini-milano-citta-inaccessibile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7947-rapporto-osservasalute-2014-migliora-la-salute-degli-italiani-ma-ritardi-e-carenza-dinvestimenti-la-minacciano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7930-brevetti-su-cellule-staminali-embrionali-in-europa-idee-ancora-non-chiare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7929-geneyenta-un-sito-per-mettere-a-confronto-i-fenotipi-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7926-ema-pubblicata-la-relazione-annuale-sulle-piccole-e-medie-imprese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7913-baxter-bioscience-acquisisce-la-societa-biofarmaceutica-suppremol]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7925-trapianti-al-galliera-di-genova-nuova-tecnologia-per-la-genotipizzazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7919-malattie-genetiche-rare-aou-senese-e-magi-euregio-collaborano-per-una-migliore-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7921-distrofia-muscolare-al-via-la-campagna-di-sensibilizzazione-dellassociazione-fshd-italia-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7906-malattie-rare-segnalate-i-vostri-eventi-nella-nostra-agenda]]></loc><lastmod>2020-03-13T07:48:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7905-disinformazione-riguardo-al-cibo-a-rischio-la-salute-pubblica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7901-sviluppo-di-nuovi-farmaci-gsk-lancia-il-concorso-discovery-fast-track-challenge-2015]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7895-al-via-un-trillo-per-ricordare-il-servizio-che-aiuta-i-pazienti-ad-attenersi-alle-prescrizioni-mediche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7888-ricerca-pre-clinica-assay-depot-e-astrazeneca-lanciano-una-piattaforma-di-commercio-elettronico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7880-sindrome-di-poland-un-libro-illustrato-per-spiegare-la-patologia-ai-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7908-senzafiato-anche-ali-di-porpora-trattiene-il-respiro-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7884-terapia-del-dolore-e-cure-palliative-un-quaderno-che-spiega-la-legge-38]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7878-malattie-rare-limpegno-di-eurordis-per-la-costruzione-delle-reti-europee]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7874-malattie-rare-il-problema-e-limportanza-della-continuita-assistenziale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7873-malattie-rare-caterina-simonsen-raccontata-da-daniele-mont-darpizio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7869-malattie-rare-il-ruolo-delle-istituzioni-e-le-richieste-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7868-malattie-rare-limportanza-di-una-corretta-comunicazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7867-bayer-alza-le-stime-grazie-a-5-prodotti-di-punta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7883-malattie-rare-in-eta-pediatrica-gli-esperti-dei-principali-centri-italiani-a-confronto-a-perugia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7864-la-ricerca-italiana-sulla-terapia-genica-lintervista-a-margherita-fronte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7862-baxter-compra-biotech-tedesca-partecipata-da-zcube]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7859-a-moncrivello-vc-la-nuova-rsa-virgo-potens]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7855-giornata-mondiale-della-sindrome-di-down-al-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7856-terapie-geniche-molmed-sottoscrive-un-accordo-di-collaborazione-strategica-con-gsk]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7849-rare-lives-le-malattie-rare-in-7-paesi-europei-raccontate-in-fotografie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7835-retinite-pigmentosa-un-convegno-per-presentare-le-terapie-disponibili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7834-malattie-genetiche-rare-i-rotaract-club-dellumbria-sostengono-la-ricerca-telethon]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7831-cancro-al-polmone-nab-paclitaxel-approvato-da-ue-come-trattamento-di-prima-linea]]></loc><lastmod>2021-11-02T16:39:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7845-stamina-ecco-come-e-possibile-un-giornalismo-dinchiesta-scientificamente-corretto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7825-tumore-al-polmone-8-italiani-su-10-ignorano-che-il-fumo-passivo-puo-provocarlo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7833-caterina-simonsen-racconta-i-controsensi-tutti-italiani-nel-mondo-delle-malattie-rare]]></loc><lastmod>2017-07-21T07:33:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7823-influenza-e-malattie-cardiovascolari-limportanza-del-vaccino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7814-call-for-grants-una-chiamata-globale-per-la-ricerca-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7811-giornata-mondiale-del-rene-baxter-e-onlus-andrea-tudisco-insieme-per-i-bambini-del-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7803-trapianto-di-flora-intestinale-contro-infezione-batterica-microbiota-inoculato-con-colonscopia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7801-diabete-di-tipo-2-takeda-conferma-la-sicurezza-di-alogliptin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7805-il-ministro-lorenzin-conferma-laggiornamento-dellelenco-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7802-malattie-neuromuscolari-un-incontro-a-brescia-per-diffonderne-la-conoscenza-tra-i-medici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7798-malattia-di-tay-sachs-successo-in-australia-per-lo-screening-genetico-preconcezionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7804-disabilita-e-media-i-risultati-dellultimo-rapporto-della-fondazione-giacomo-matteotti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7797-germania-disponibile-la-prima-versione-della-piattaforma-per-registri-osse]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7791-reti-di-riferimento-europee-per-le-malattie-rare-pubblicata-relazione-workshop-della-joint-action-eucerd]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7790-lagenzia-europea-dei-medicinali-compie-20-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7785-malattie-rare-arriva-in-italia-il-primo-servizio-privato-di-genomica-personalizzata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7784-malattie-genetiche-rare-convention-telethon-a-riva-del-garda]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7764-disabilita-sms-solidale-per-il-progetto-mecfes-della-fondazione-don-gnocchi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7769-il-meyer-di-firenze-e-un-ospedale-in-rosa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7781-maculive-oltre-150-oftalmologi-a-confronto-sulle-patologie-della-macula]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7724-patologie-respiratorie-astrazeneca-rileva-business-di-actaviss]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7723-pfizer-compra-hospira-per-17-milioni-di-dollari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7722-glaxo-verso-la-scissione-da-societa-hiv]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7757-5-marzo-rimini-quattro-ali-per-volare-spettacolo-di-teatro-e-danza-a-favore-dellaig]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7752-premio-malattie-rare-e-continuita-assistenziale-a-vincere-e-tamara-ferrari-di-vanity-fair]]></loc><lastmod>2015-06-08T11:33:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7750-premio-tumori-rari-2015-il-vincitore-e-enrico-orzes]]></loc><lastmod>2015-06-08T11:33:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7719-porpora-trombotica-trombocitopenia-a-chieti-nasce-unassociazione-nazionale]]></loc><lastmod>2019-08-29T16:50:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7733-premio-omar-2015-vincono-riccardo-iacona-presadiretta-rai3-e-margherita-fronte-focus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7717-dialisi-peritoneale-baxter-riconosce-nefrologia-di-giulianova-come-centro-deccellenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7740-rare-disease-day-il-video-della-fondazione-aiuti-per-la-ricerca-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7739-giornata-malattie-rare-il-video-del-comitato-i-malati-invisibili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7741-gsk-perfeziona-laccordo-su-tre-punti-con-novartis]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7735-the-rarest-ones-il-video-di-dompe-per-la-giornata-mondiale-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7732-domani-la-cerimonia-di-premiazione-del-premio-giornalistico-omar]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7712-esofagite-eosinofila-shire-acquisisce-meritage]]></loc><lastmod>2018-11-15T10:07:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7713-shire-completa-lacquisizione-di-nps-pharmaceuticals]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7730-genzyme-celebra-la-giornata-delle-malattie-rare-con-numerose-iniziative-in-italia-e-nel-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7708-giornata-delle-malattie-rare-le-iniziative-a-modena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7698-rare-disease-day-shire-sostiene-iniziative-educative-per-il-miglioramento-diagnostico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7684-mortalita-neonatale-le-proposte-di-sip-e-sin-per-ridurne-il-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7692-giornata-delle-malattie-rare-2015-il-video-di-orphanet-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7683-carcinoma-polmonare-breaktrough-designation-per-anti-pd-1-di-roche]]></loc><lastmod>2021-11-02T16:41:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7686-rare-disease-day-2015-ecco-gli-eventi-italiani]]></loc><lastmod>2020-03-13T07:47:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7630-siena-biotech-chiude-ad-un-passo-dalla-scoperta-di-un-farmaco-per-l-huntington]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7625-giornata-mondiale-delle-malattie-rare-online-il-video-ufficiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7599-donazioni-di-sangue-inaugurato-a-tirana-il-centro-magi-balkans]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7594-malattie-neurologiche-accordo-genzyme-e-voyager-per-nuove-terapie-geniche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7582-stati-vegetativi-prima-mappatura-dei-percorsi-di-cura-nelle-regioni-italiane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7588-giornata-mondiale-del-malato-i-numeri-dell-accoglienza-al-bambino-gesu]]></loc><lastmod>2015-06-08T11:36:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7584-gsk-rafforza-la-pipeline-di-ricerca-nei-vaccini-con-lacquisizione-di-glycovaxyn-ag]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7555-malattie-rare-disponibili-nuovi-criteri-diagnostici-su-orphanet]]></loc><lastmod>2018-12-07T19:21:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7570-al-meyer-il-robot-neurochirurgico-per-la-terapia-delle-malattie-cerebrali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7524-malattie-toraco-polmonari-nasce-lalleanza-tra-medici-di-famiglia-pneumologi-e-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7536-2015-02-04-15-49-40]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7539-2015-02-04-17-02-51]]></loc><lastmod>2021-11-02T16:42:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7547-2015-02-05-15-57-10]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7557-nuovi-lea-uniamo-fimr-onlus-qbene-i-nuovi-lea-ora-dobbiamo-realizzare-il-pnmrq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7543-ricerca-telethon-san-raffaele-qla-lunga-memoria-delle-staminaliq]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7529-farmaci-sospese-da-ema-sperimentazioni-in-india-in-italia-nessun-rischio-di-effetti-dannosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7528-2015-02-04-11-33-38]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7523-malattie-rare-attivo-lo-sportello-informativo-di-canosa-in-puglia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7526-2015-02-03-17-10-18]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7521-federfarma-e-gsk-insieme-per-nuovi-servizi-al-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7517-malformazioni-vascolari-congenite-pubblicato-il-protocollo-diagnostico-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7469-ema-ecco-come-accedere-ai-documenti-amministrativi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7471-ricerca-internazionale-sulle-malattie-rare-pubblicato-bando-di-finanziamento-erare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7482-reparto-qvirtuale-di-infettivologia-riduce-luso-improprio-di-antibiotici-e-fa-risparmiare-risorse]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7483-malattie-rare-in-viaggio-con-sammy-affetto-da-progeria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7458-vaccini-anti-virali-merck-firma-un-accordo-con-moderna-therapeutics]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7456-sanita-il-bambino-gesu-diventa-centro-di-formazione-dellamerican-heart-association]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7436-screening-dei-tumori-roche-chiude-accordo-con-foundation-medicine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7426-pubblicata-la-carta-internazionale-dei-principi-per-la-condivisione-di-campioni-biologici-e-dati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7422-malattie-rare-negli-usa-una-legge-per-incentivare-la-ricerca]]></loc><lastmod>2019-06-18T17:49:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7424-malattie-rare-aggiornato-il-database-do-human-disease-ontology]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7430-rare-disease-day-partecipa-alla-campagna-per-la-giornata-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7412-napoli-sede-del-id-congresso-nazionale-degli-ospedali-pediatrici-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7385-malattie-autoimmuni-del-tratto-gastrointestinale-firmato-laccordo-janssen-isis]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7402-bambino-gesu-profiti-lascia-dopo-7-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7400-ce-tempo-fino-al-25-gennaio-per-partecipare-al-premio-giornalistico-omar-per-le-malattie-e-i-tumori-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7376-malattie-rare-in-veneto-nasce-il-centro-territoriale-delle-malattie-rare]]></loc><lastmod>2019-06-18T17:51:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7375-malattie-neuromuscolari-il-centro-nemo-lavora-per-la-globale-presa-in-carico-del-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7351-malattie-rare-nuova-collaborazione-tra-uconn-e-alexion-pharmaceuticals-inc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7348-a-torino-prende-il-via-il-primo-master-universitario-in-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7347-il-catalogo-del-benessere-2015-per-iniziare-il-nuovo-anno-in-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7346-morbo-di-crohn-antibiotici-possono-aumentarne-il-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7344-leucemia-mieloide-acuta-sorafenib-migliora-la-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7329-biomarin-compra-prosensa-per-840-milioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7340-codifica-delle-malattie-rare-necessaria-a-livello-europeo-non-prevista-prima-del-2017]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7328-malattie-rare-nuovi-passi-avanti-verso-una-codifica-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7335-il-neonatologo-gianpaolo-donzelli-presidente-della-fondazione-meyer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7334-sla-in-veneto-due-borse-di-studio-alle-migliori-tesi-di-laurea-sul-benessere-psicologico-dei-pazienti-sla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7331-premio-giornalistico-omar-sono-tre-i-premi-speciali-delledizione-2014-15]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7320-a-napoli-leccellenza-italiana-per-i-piccoli-pazienti-con-gravi-disabilita-uditive]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7306-dal-1-gennaio-2015-ling-enrico-zampedri-sara-il-nuovo-direttore-del-policlinico-a-gemelli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7322-malattie-rare-ecco-i-vincitori-del-concorso-fotografico-eurordis]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7314-meyer-assegnati-premi-a-talenti-under-40-della-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7312-malattie-rare-dossetti-qal-sanit-ennesima-giostra-dei-numeri-mentre-attendiamo-risposte-da-decenniq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7310-one-valve-life-primo-programma-italiano-dedicato-alle-malattie-delle-valvole-cardiache]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7283-roche-presenta-infomedics-portale-rivolto-ai-professionisti-della-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7308-tachosil-festeggia-10-anni-di-successi-per-i-pazienti-e-la-classe-medica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7298-osservatorio-malattie-rare-sta-cercando-un-web-editor-full-time]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7295-telethon-gli-italiani-hanno-donato-313-milioni-di-euro]]></loc><lastmod>2026-04-08T17:11:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7293-programma-trapianto-di-fegato-regione-abruzzo-policlinico-gemelli-prima-paziente-trapiantata-con-successo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7287-artisticamente-un-laboratorio-musicale-allinterno-del-reparto-di-neuropsichiatria-infantile-del-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7275-mucopolisaccaridosi-vi-la-battaglia-di-raffaele-e-ogni-giorno-sostieni-la-campagna-telethon]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7273-malattie-rare-lomaggio-al-piccolo-ciccio-sostieni-la-campagna-telethon]]></loc><lastmod>2019-02-18T15:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7268-telethon-vincitore-delloscar-di-bilancio-2014]]></loc><lastmod>2019-02-18T15:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7265-tumore-ginecologico-al-gemelli-nasce-nuovo-centro-di-ecografia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7266-vaccinarsi-i-dubbi-delle-mamme-le-risposte-dellesperto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7269-nutrizione-parentrale-domiciliare-percorsi-di-qualita-e-innovazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7251-nutrizione-parentale-domiciliare-in-toscana-nasce-la-legge-regionale-580]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7249-farmaci-svilupparne-uno-nuovo-costa-fino-a-26-miliardi-di-dollari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7261-beta-talassemia-un-premio-per-migliorare-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7243-malattie-rare-in-via-di-sviluppo-un-nuovo-software-per-supportare-il-registro-globale-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7202-hiv-stabile-il-trend-delle-nuove-infezioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7231-dolore-neuropatico-periferico-il-patch-alla-lidocaina-e-efficace-e-da-sollievo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7200-malattie-rare-pubblicata-la-relazione-finale-della-prima-conferenza-sulle-reti-erns]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7209-una-ricercatrice-italiana-tra-i-vincitori-del-discovery-fast-track-challenge-2014-di-gsk]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7206-malattie-rare-presentazione-del-libro-dietro-la-sindrome-di-sjogren-con-proiezione-del-cortometraggio-lamante-sjogren]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7199-ass-luca-coscioni-cure-palliative-garantite-solo-al-5-per-cento-dei-bambini-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7183-presentati-al-meyer-i-primi-risultati-di-uno-studio-qin-presa-direttaq-su-oltre-3mila-neonati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7187-telethon-e-partito-il-progetto-natale-con-groupon]]></loc><lastmod>2019-02-18T15:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7192-premio-giornalistico-omar-al-via-la-terza-edizione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7190-adenoarcinoma-polmonare-approvato-nintedanib-per-trattamento-successivo-a-chemioterapia]]></loc><lastmod>2021-11-02T16:43:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7184-si-e-chiuso-il-secondo-appuntamento-degli-stati-generali-della-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7160-caterina-simonsen-insegna-i-malati-rari-non-passano-la-vita-a-stare-male]]></loc><lastmod>2017-07-21T07:32:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7163-i-clinical-trial-center-dei-principali-poli-sanitari-italiani-insieme-per-rilanciare-la-ricerca-clinica-su-farmaci-innovativi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7128-prende-il-via-il-natale-incartevole-di-parent-project]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7144-insieme-per-telethon-la-uildm-scende-in-campo]]></loc><lastmod>2019-02-18T15:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7145-ricerca-e-bambini-linee-guida-etiche-piu-severe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7129-gsk-e-ancora-al-vertice-della-graduatoria-dellindice-access-to-medicine-2014-e-lancia-nuove-proposte-di-sviluppo-per-la-ricerca-sulle-malattie-non-trasmissibili-nellafrica-sub-sahariana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7113-progetto-ospedale-senza-dolore-al-via-la-nuova-campagna-di-comunicazione-sociale-del-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7105-nati-prematuri-per-la-sin-troppe-diseguaglianze-regionali-nellassistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7071-malattie-rare-ereditarie-metaboliche-il-lions-clubs-di-padova-lancia-il-bando-di-concorso-per-le-tre-migliori-tesi-di-laurea-nel-campo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7056-premio-sciacca-2014-consegnati-i-riconoscimenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7080-malattie-rare-piano-nazionale-approvato-dalla-conferenza-stato-regioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7088-plasmaderivati-albumina-piu-sicurezza-e-meno-costi-grazie-allinnovazione-nella-modalita-di-infusione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7068-ematologia-ricerca-e-assistenza-sempre-piu-in-rete]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7054-centro-cardiologico-pediatrico-mediterraneo-di-taormina-oltre-2-mila-gli-interventi-effettuati-in-quattro-anni-piu-di-24-mila-le-visite-eseguite]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7055-arisla-fondazione-italiana-di-ricerca-per-la-sla-aderisce-alla-campagna-menotassepiuerogazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7062-sono-107976-i-malati-rari-in-italia-e-non-2-milioni-i-dati-del-registro-sono-bloccati-al-2011]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7052-malattie-rare-da-accumulo-lisosomiale-nelladulto-la-chiave-per-evitare-danni-irreversibili-e-la-diagnosi-tempestiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6988-giornata-delle-malattie-rare-2015-dedicata-ai-malati-alle-famiglie-e-a-chi-presta-loro-assistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7020-associazione-italiana-di-oncologia-medica-il-nuovo-presidente-e-il-prof-carmine-pinto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7010-sequenziamento-genico-di-nuova-generazione-specialisti-a-confronto-al-convegno-sigu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7009-rare-lives-viaggio-fotografico-attraverso-leuropa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7007-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6983-cifosi-scoliosi-lordosi-per-le-tre-patologie-nasce-lassociazione-nazionale-ais]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/7000-epidemia-di-ebola-12mila-casi-e-piu-di-6mila-morti-ma-litalia-non-e-a-rischio]]></loc><lastmod>2016-05-06T15:58:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6998-malattie-metaboliche-ereditarie-a-verona-un-corso-per-imparare-a-cucinare-senza-proteine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6963-glaucoma-in-italia-nasce-una-nuova-filiale-dellazienda-santen-pharmaceutical-che-si-occupa-da-tempo-della-patologia]]></loc><lastmod>2018-11-21T16:50:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6971-sindrome-di-poland-a-montecatini-terme-con-collaborare-per-crescere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6966-progetto-adolescenti-del-meyer-missione-compiuta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6956-tumore-al-polmone-i-primi-risultati-della-campagna-di-screening-gratuito-promossa-dal-gemelli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6922-concorso-artistico-letterario-il-volo-di-pegaso-raccontare-le-malattie-rare-ce-tempo-fono-al-3-novembre-per-partecipare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6931-bambino-gesu-al-via-il-nuovo-polo-per-la-ricerca-pediatrica-sara-tra-i-piu-grandi-deuropa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6906-sindrome-di-mayer-rokitansky-kuster-hauser-nata-la-prima-associazione-italiana-di-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6919-sindrome-da-porta-girevole-la-chiamano-cosi-e-riguarda-soprattutto-gli-anziani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6913-inaugurata-la-nuova-sede-milanese-di-shire-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6903-disordini-della-crescita-e-in-corso-il-progetto-diversamente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6902-piano-nazionale-malattie-rare-uniamo-fimr-onlus-soddisfatta-per-ladozione-dello-strumento-piu-atteso-dai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6900-malattie-rare-saltata-lacquisizione-di-shire-da-parte-di-abbvie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6889-malattie-rare-per-claudia-una-speranza-arriva-dal-gaslini-di-genova]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6886-primo-meeting-del-board-scientifico-delleupati-national-platform]]></loc><lastmod>2020-02-27T15:02:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6880-malattie-rare-lappello-per-scoprire-la-malattia-di-claudia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6870-sclerosi-tuberosa-e-autismo-un-libro-per-raccontare-la-malattia-la-disabilita-e-la-vita]]></loc><lastmod>2016-05-03T21:06:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6866-malattie-rare-lassociazione-asmara-onlus-lancia-un-appello-qpiu-attenzione-ai-bambini-colpiti-da-queste-malattieq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6844-il-2019-anno-europeo-delle-malattie-rare-eurordis-invita-tutti-a-sostenere-la-candidatura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6857-trapianti-pediatrici-da-donatore-vivente-una-chance-in-piu-per-i-piccoli-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6863-congresso-neonatologi-lorenzin-qnon-sottovalutare-late-preteremq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6864-neonatologia-nasce-il-neonatal-network-della-sin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6860-a-cagliari-il-45d-congresso-della-societa-italiana-di-neurologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6827-tumori-fino-all1-novembre-campagna-solidale-promossa-da-fondazione-ieo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6826-merck-serono-spa-societa-italiana-del-gruppo-merck-ha-aderito-alliniziativa-porte-aperte-promossa-da-assobiotec-nellambito-della-european-biotech-week]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6814-disabilita-criticita-linee-guida-e-buone-prassi-nellaccoglienza-delle-persone-con-disabilita-in-ospedale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6747-sindrome-pandaspans-primo-convegno-italiano-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6823-rene-policistico-si-e-svolto-a-roma-lincontro-arpkd-chiama-airp-risponde]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6820-sindrome-di-stevens-johnson-e-sindrome-di-lyell-continua-lattivita-della-sjli-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6818-la-sanita-che-verra-e-la-sanita-che-vorremmo-gemelli-diversi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6803-enrico-piccinini-e-il-nuovo-general-manager-genzyme-italia-e-malta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6784-embolia-polmonare-laifa-approva-la-rimborsabilita-di-rivaroxaban]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6791-malattie-rare-del-sangue-premiata-flora-peyvandi-con-il-grande-ippocrate-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6776-daiichi-sankyo-acquisisce-ambit-biosciences-annunciando-impegno-su-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6746-rare-ma-non-rari-le-malattie-rare-viste-dalla-pediatria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6725-odontostomatologia-e-disabilita-al-maria-vittoria-un-punto-di-riferimento-unico-sul-territorio-aslto2]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6707-sarcoidosi-al-via-il-progetto-dellacsi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6710-organi-artificiali-o-bioartificiali-da-fegato-a-pancreas-a-tiroide-e-cuore-al-gemelli-novita-sperimentali-e-cliniche-da-tutto-il-mondo-per-sostituzione-organi-o-tessuti-danneggiati-di-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6688-gravidanza-comportamenti-dei-papa-prima-del-concepimento-possono-condizionare-la-salute-dei-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6702-app-genuair-di-almirall-la-tecnologia-al-servizio-di-medici-e-farmacisti-per-migliorare-laderenza-alla-terapia-del-paziente-affetto-da-bpco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6701-la-magia-di-un-sorriso-che-aiuta-i-bambini-a-non-sentirsi-in-ospedale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6703-una-mappa-geografica-della-cornea-per-ripararla-punto-per-punto-in-modo-mirato-col-calore-ecco-come-si-potra-salvare-locchio-danneggiato-dal-cheratocono]]></loc><lastmod>2023-12-03T16:00:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6669-cancro-alla-prostata-collaborazione-advaxismerck-per-valutare-la-combinazione-adxs-psa-pembrolizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6670-craniosinostosi-combattere-le-malattie-rare-con-la-tecnologia-3d-printing]]></loc><lastmod>2019-06-18T18:00:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6704-sindrome-di-pitt-hopkins-nasce-lassociazione-italiana-sindrome-di-pitt-hopkins-insieme-di-piu]]></loc><lastmod>2024-04-08T17:55:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6666-malattia-di-creutzfeldt-jakob-messo-a-punto-test-non-invasivo-per-la-diagnosi-precoce]]></loc><lastmod>2019-06-18T18:00:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6692-malattie-neurodegenerative-e-demenza-sanofi-annuncia-un-contributo-di-25-milioni-di-dollari-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6700-7-10-ottobre-2014-sulle-frontiere-della-scienza-staminali-e-farmaci-orfani-quale-futuro-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6693-novartis-dimostra-la-sua-leadership-in-oftalmologia-con-nuovi-prodotti-e-oltre-40-abstract-presentati-al-congresso-euretina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6685-malformazioni-congenite-a-lucca-i-ventanni-dellaimar]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6659-malattie-rare-il-ministero-della-salute-risponde-ai-comitati-diritti-non-regali-per-i-malati-rari-e-i-malati-invisibili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6655-lesercito-produrra-la-cannabis-terapeutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6656-a-tirana-il-primo-centro-di-raccolta-sangue-e-di-ricerca-sulle-malattie-rare-genetiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6646-al-policlinico-di-milano-il-primo-intervento-al-mondo-sul-polmone-esofageo-di-un-neonato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6634-malattie-rare-della-coagulazione-questanno-il-premio-grande-ippocrate-va-alla-dottssa-flora-peyvandi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6619-sindrome-di-turner-12-runner-accettano-la-sfida-lanciata-da-afadoc-per-la-raccolta-fondi-a-favore-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6632-hpv-il-chmp-ha-approvato-una-variazione-riguardante-il-farmaco-gardasil-indicando-i-dati-di-protezione-a-lungo-termine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6633-google-investe-15-miliardi-di-dollari-nella-ricerca-sul-cancro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6625-insufficienza-venosa-cronica-cerebrospinale-e-sclerosi-multipla-la-ricerca-deve-continuare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6624-sarcoidosi-convegno-scientifico-sulla-malattia-ospitato-nellambito-della-manifestazione-verticale-solidale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6630-chiesi-lancia-un-fondo-di-investimento-per-la-ricerca-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6581-gli-occhi-dentro-otto-storie-per-raccontare-la-cecita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6570-qdiritti-non-regaliq-e-qi-malati-invisibiliq-a-ministro-lorenzin-qnormalizziamo-le-patologie-rareq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6569-bob-marley-ucciso-da-un-tumore-raro-la-scoperta-33-anni-dopo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6538-donazione-di-organi-in-italia-ledizione-2014-della-giornata-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6536-aderenza-terapeutica-per-migliorarla-nasce-interactive-monitoring-service]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6550-malattia-di-creutzfeld-jakob-dal-besta-il-primo-test-per-la-diagnosi-del-morbo-della-mucca-pazza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6531-menincococco-e-microencefalite-da-zecca-baxter-vende-i-vaccini-a-pfizer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6502-prima-conferenza-sulle-reti-di-riferimento-europee-presente-e-futuro-delle-ern]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6516-inaugurata-a-palermo-casamica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6514-e-nata-waidid-lassociazione-mondiale-per-le-malattie-infettive-e-i-disordini-immunologici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6497-legge-sul-dolore-troppo-pochi-gli-infermieri-preparati-sullargomento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6490-il-tiget-apre-le-porte-dei-laboratori-ad-aip-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6462-rapporto-osmed-2013-i-numeri-del-commercio-farmaceutico-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6475-asta-di-beneficenza-promossa-da-fondazione-pfizer-per-dynamo-camp]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6436-sindrome-di-alport-in-italia-e-attiva-lassociazine-asal-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6430-lokomat-arriva-un-nuovo-robot-al-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6409-tumore-polmonare-non-solo-fumo-di-sigaretta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6427-malattie-genetiche-destinati-580-mila-euro-al-friuli-venezia-giulia-dal-concorso-telethon-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6408-incontinentia-pigmenti-attiva-in-italia-la-prima-banca-dati-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6422-universita-cattolica-il-chirurgo-rocco-bellantone-confermato-preside-di-medicina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6403-dolore-pediatrico-se-ne-parlato-al-congresso-impact-proactive-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6420-plasma-infetto-negli-emoderivati-lotti-bloccati-grazie-alla-sorveglianza-di-kedrion]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6380-malattia-di-lafora-un-libro-in-ricordo-di-daniela-la-farfallina-libera-di-volare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6385-deficit-da-surfattante-esperti-a-confronto-alla-3dedizione-del-workshop-meeting-sulla-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6416-mai-piu-stamina-e-questo-cio-che-i-pazienti-chiedono-al-governo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6400-rapporto-istat-2014-aumentano-i-depressi-gli-obesi-e-i-tumori-maligni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6394-sangue-ed-emoderivati-pubblicate-le-nuove-linee-guida-per-la-sicurezza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6386-lorticaria-una-malattia-poco-conosciuta-che-affligge-tra-i-250000-e-i-500000-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6364-a-canestro-per-la-sla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6362-idrocefalo-normoteso-parte-da-roma-e-messina-la-campagna-promossa-da-federanziani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6363-roma-4-luglio-firmato-ieri-il-protocollo-dintesa-aifa-eupati-per-lempowerment-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6360-malattie-del-motoneurone-9d-fens-forum-di-neuroscienze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6326-malattie-rare-negli-usa-una-nuova-community-dedicata-ai-caregivers]]></loc><lastmod>2019-06-18T18:10:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6351-donazione-multiorgano-e-trapianto-di-cuore-nella-notte-a-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6337-malformazioni-anorettali-cure-e-trattamento-in-italia-al-sud-ce-ancora-tanto-da-fare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6338-sindrome-di-asperger-edizione-2014-di-asff]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6339-bioinformatica-nuovi-modelli-matematici-per-lo-studio-del-microbiota]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6314-medicina-narrativa-in-oncologia-prima-esperienza-a-siena-grazie-allimmunoterapia-oncologica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6311-cure-palliative-e-terapia-del-dolore-premio-giornalistico-38-volte-basta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6316-malattie-rare-bando-di-concorso-armr-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6318-bambino-gesu-nuovi-orari-per-prenotare-le-visite-via-telefono-in-caso-di-attesa-troppo-lunga-ce-la-possibilita-di-essere-richiamati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6310-arisla-aderisce-alla-campagna-one-global-team-one-goal]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6298-concluso-il-secondo-master-universitario-internazionale-in-clinical-pharmacy-esempio-di-integrazione-tra-accademia-e-impresa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6296-determinaziona-rara-dal-convegno-strumenti-utili-per-orientarsi-nelle-nuove-frontiere-di-ricerca-e-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6259-terapia-del-dolore-e-stato-presentato-il-progetto-italiano-europain]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6274-xeroderma-pigmetosum-un-film-per-conoscere-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6242-malattie-rare-una-lettera-presentata-da-nord-allfda-solleva-preoccupazioni-sulla-denominazione-dei-farmaci-biologici]]></loc><lastmod>2019-06-18T18:15:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6269-dislipidemie-anif-denuncia-bloccato-trattamento-aferetico-al-policlinico-umberto-id-si-rischia-la-morte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6238-malattie-rare-al-mondiale-di-calcio-facciamo-un-gol-per-kirian-e-vanessa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6234-piu-iodio-alle-mamme-bambini-piu-intelligenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6235-al-via-la-vii-edizione-del-concorso-artistico-letterario-il-volo-di-pegaso-raccontare-le-malattie-rare]]></loc><lastmod>2015-05-28T11:49:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6226-quando-il-neonato-arriva-destate-i-vero-e-falso-della-sin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6231-la-scienza-basata-sui-racconti-una-risorsa-per-la-pratica-clinica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6233-dolore-pediatrico-ancora-troppo-per-bambini-e-neonati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6255-sardegna-chiuso-il-centro-regionale-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6229-clownterapia-per-i-bambini-che-lottano-contro-i-gravi-tumori-oncoematologici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6223-trapianto-di-midollo-osseo-e-cellule-staminali-accreditamento-internazionale-per-il-programma-dellaou-senese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6225-farmaci-e-gravidanza-quando-curarsi-e-meglio-da-aifa-arriva-wwwfarmaciegravidanzagovit]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6220-per-i-100-anni-del-coni-sosteniamo-la-ricerca-telethon]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6219-allopen-day-del-bambin-gesu-il-test-della-saliva-per-individuare-la-predisposizione-genetica-al-fegato-grasso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6222-gastroenterologi-italiani-risparmio-di-180-milioni-di-euro-migliorando-le-cure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6199-malattie-rare-facebook-contribuisce-a-reclutare-persone-affette-da-questo-tipo-di-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6209-lazio-presso-idi-e-san-carlo-nuovi-ambulatori-dedicati-alle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6166-vaccinazione-le-linee-guida-escmid-la-consigliano-anche-negli-adulti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6167-alzheimer-astra-zeneca-in-cerca-di-partnership-per-il-suo-farmaco-azd3293]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6174-radiofarmaci-si-e-tenuto-a-milano-un-convegno-per-discutere-il-futuro-di-questo-settore-medico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6195-pneumologia-2014-medicina-e-arte-della-cura-sincontrano-a-milano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6172-tirosinemia-di-tipo-1-al-bambino-gesu-verranno-gratuitamente-monitorati-i-pazienti-in-terapia-con-nitisinone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6135-sindrome-di-poland-open-day-alla-quarta-edizione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6176-pneumologi-e-chirurghi-toracici-del-gemelli-per-la-giornata-del-respiro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6141-atrofia-muscolare-dai-pomodori-verdi-un-possibile-aiuto-terapeutico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6108-infezione-da-clostridium-difficile-dati-allarmanti-dal-congresso-eccmid]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6136-xiii-giornata-nazionale-del-sollievo-al-san-matteo-cura-comunicazione-e-relazione-insieme-per-un-sollievo-totale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6127-bambino-gesu-percorsi-dedicati-alla-misurazione-ed-al-controllo-del-dolore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6128-inaugurazione-nuova-sede-di-celgene-in-italia-tra-il-2013-e-il-2015-passeremo-da-120-a-200-persone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6103-malattie-rare-del-fegato-shire-acquista-lumena-pharmaceuticals]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6095-rigenerazione-delle-ossa-riparazione-dei-tessuti-e-stampa-di-organi-in-3d-con-il-bioprinting-da-oggi-non-solo-unidea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6078-parto-in-casa-in-sicurezza-un-assunto-non-dimostrabile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6061-dolore-nei-piccoli-pazienti-i-dati-sono-allarmanti-ecco-il-risultati-del-progetto-piper]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6094-malattie-del-vitreo-e-della-retina-al-gemelli-trattate-con-successo-due-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6092-malattie-rare-il-comitato-malati-invisibili-scrive-allinps]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6048-bayer-riceve-il-riconoscimento-ritratti-di-coraggio-dallorganizzazione-nazionale-delle-malattie-rare-nord]]></loc><lastmod>2019-06-18T18:21:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6050-malattie-polmonari-interstiziali-sotto-accusa-i-disinfettanti-per-gli-umidificatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6080-il-prof-giulio-cossu-tra-i-maggiori-esperti-di-cellule-staminali-nel-comitato-scientifico-di-omar]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6071-molmed-cinque-studi-sulle-terapie-sperimentali-ngr-htnf-e-tk-sono-stati-selezionati-per-presentazione-ad-asco-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6060-rene-policistico-airp-torna-a-milano-con-il-simposio-nazionale-focus-on-e-presenta-i-dati-preliminari-di-un-importante-progetto-di-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6024-malattie-neuromuscolari-concluso-il-14d-congresso-nazionale-dellassociazione-italiana-di-miologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6021-malattie-rare-costituito-il-comitato-i-malati-invisibili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6023-sindromi-malformative-e-malattie-metaboliche-ereditarie-specializzandi-in-pediatria-riuniti-a-milano-per-un-approfondimento-sulla-gestione-del-bambino-affetto-da-queste-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6038-sla-salvatore-usala-annuncia-un-nuovo-sciopero-della-fame]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/6000-le-malattie-rare-e-i-farmaci-orfani-sempre-al-centro-dellinteresse-dellema-anche-nel-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5987-sindrome-da-deficit-di-attenzione-e-iperattivita-shire-presentera-nuovi-dati-scientifici-relativi-al-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5921-malattia-rare-il-registro-del-veneto-attivo-da-piu-di-10-anni-preziosa-fonte-di-informazioni]]></loc><lastmod>2019-06-18T18:26:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5978-bambino-gesu-nuova-procedura-robotica-per-correggere-i-disturbi-del-movimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5973-si-chiude-linchiesta-su-stamina-truffati-piu-di-sessanta-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5933-vietnam-primo-trapianto-pediatrico-di-rene-eseguito-dai-chirurgi-del-bambino-gesu-nellambito-del-progetto-vespa-for-children]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5918-malattie-rare-creata-la-banca-dati-della-asl-di-pescara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5934-paziente-sla-si-rivolge-ad-asl-il-giorno-di-pasqua-qspiacenti-richiami-martediq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5916-sarcoidosi-acsi-onlus-si-appella-al-ministro-lorenzin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5914-leggere-per-crescere-la-community-raggiunge-i-10000-iscritti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5912-malattie-rare-polmonari-il-congresso-pneumologia-2014-si-svolgera-a-milano-dal-5-al-7-giugno]]></loc><lastmod>2015-05-28T11:55:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5897-qun-amore-cosi-grande-2014q-i-negramaro-per-aisla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5894-rapporto-osservasalute-2013-domani-la-presentazione-alla-stampa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5888-chirurgia-maxillo-facciale-primo-particolare-intervento-di-bipartizione-facciale-alle-scotte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5841-eurordis-raggiunto-grande-traguardo-revisionato-il-100d-documento-pubblico-ema]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5830-al-via-la-nuova-edizione-di-qbioinitaly-investment-forum-a-intesa-sanpaolo-start-up-initiativeq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5793-malattie-respiratorie-chiesi-farmaceutici-spa-ha-raggiunto-un-fatturato-superiore-a-1-236-milioni-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5796-malattie-rare-cittadinanzattiva-quadro-allarmante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5815-trapianti-midollo-osseo-premio-adoces-per-cortometraggi-sulla-donazione-di-cellule-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5818-acondroplasia-trionfa-la-grande-bellezza-della-piccola-giovanna-vignola]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5789-atassia-collaborazione-tra-societa-farmaceutiche-per-lo-sviluppo-di-un-nuovo-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5814-neuroriabilitazione-ad-alta-complessita-robotica-e-verticalizzazione-precoce-in-terapia-intensiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5808-le-malattie-rare-sono-una-priorita-di-sanita-pubblica-per-il-governo-italiano]]></loc><lastmod>2020-11-19T17:29:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5776-urologia-dopo-levento-organizzato-da-gsk-e-al-quale-hanno-partecipato-circa-300-specialisti-provenienti-da-tutta-italia-adesso-il-convegno-prosegue-su-twitter]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5779-cellule-staminali-un-premio-per-i-cortometraggi-dedicati-al-tema-della-donazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5746-vescica-iperattiva-idiopatica-tossina-botulinica-rimborsata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5741-uno-studio-congiunto-fiaso-politecnico-di-milano-studiera-il-contributo-dellinformatica-nella-gestione-dei-pdta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5745-tumori-presentato-il-laboratorio-di-oncogenetica-molecolare-allospedale-cardarelli-di-campobasso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5737-leucemie-e-linfomi-sono-tra-le-malattie-tumorali-piu-frequenti-a-milano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5739-malattie-infiammatorie-e-immunologiche-firmato-laccordo-celgene-abide-per-lo-sviluppo-di-nuove-molecole]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5762-parent-project-onlus-coordina-in-italia-il-national-liason-team-del-progetto-eupati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5760-oltre-il-metodo-stamina-limportanza-di-una-sicura-ed-etica-informazione-scientifica]]></loc><lastmod>2020-11-19T17:23:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5704-malattie-infiammatorie-intestinali-impariamo-a-conoscerle-con-una-mostra-darte]]></loc><lastmod>2016-10-23T17:55:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5718-emofilia-bayer-annuncia-lapertura-di-nuovi-siti-produttivi-in-germania]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5712-malattie-da-accumulo-lisosomiale-19-e-20-marzo-a-bologna-il-preimo-seminario-italiano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5707-il-caso-stamina-e-la-prova-dei-fatti-un-libro-per-riflettere]]></loc><lastmod>2016-01-11T08:29:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5683-cina-un-progetto-pilota-per-lassistenza-ai-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5668-nel-giorno-del-tuo-matrimonio-e-in-tutte-le-occasioni-piu-importanti-della-vita-sposa-la-ricerca-telethon]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5677-nasce-turnofarmacie-il-portale-dedicato-ai-turni-delle-farmacie-di-tutta-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5705-disturbi-nel-sonno-per-1-bimbo-su-4-sotto-i-tre-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5664-la-salute-come-priorita-in-italia-molta-teoria-e-poca-pratica-lo-studio-dellosservatorio-salute-astrazeneca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5667-terapia-genica-molmed-fornisce-un-aggiornamento-sulla-strategia-registrativa-per-la-tk-in-europa-e-negli-stati-uniti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5678-universita-e-ricerca-ancora-qualche-giorno-per-partecipare-allinnovation-cup-2014-di-merck-serono]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5647-morbo-di-addison-in-italia-e-attiva-lassociazione-aipad]]></loc><lastmod>2019-02-17T18:31:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5669-giornata-mondiale-del-rene-baxter-e-associazione-andrea-tudisco-insieme-per-i-bambini-dellospedale-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5660-polineuropatia-cronica-demielinizzante-cid-italia-onlus-chiede-migliore-accesso-alle-cure-basate-sullimpiego-di-immunoglobuline-umane]]></loc><lastmod>2019-02-04T12:53:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5656-donne-e-uomini-disparita-anche-nella-buona-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5661-presentato-a-torino-il-rapporto-assobiotec-ey-biotecnologie-in-italia-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5632-in-italia-la-spesa-farmaceutica-e-piu-bassa-del-resto-deuropa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5650-intermune-attira-gli-interessi-internazionali-grazie-al-successo-del-suo-farmaco-orfano-pirfenidone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5649-shire-offre-borse-di-studio-ai-pazienti-per-proseguire-listruzione-superiore-ai-pazienti-adhd]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5645-storie-piccine-al-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5642-malattie-rare-i-pazienti-allo-stesso-tavolo-dellistituto-superiore-di-sanita-con-le-regioni-per-la-crescita-del-registro-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5630-nasce-a-sassari-lo-sportello-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5628-sindrome-di-sjogren-grazie-ad-animass-attivate-collaborazioni-tra-strutture-universitarie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5606-i-premi-di-eurordis-2014-riconoscono-leccellenza-nel-campo-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5612-stamina-la-migliore-informazione-viene-dai-fumetti-che-vincono-sulla-tv]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5608-malattie-rare-polmonari-disabilicom-vince-il-premio-intermune-per-le-malattie-rare-del-polmone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5604-nasce-omni-weborg-il-portale-della-medicina-narrativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5599-rareconnect-annuncia-il-lancio-della-comunita-linfangioleiomiomatosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5597-malattie-rare-presentata-lofferta-assistenziale-dellaou-senese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5595-famiglie-sma-grazie-a-compass-sosteniamo-un-progetto-per-la-comunicazione-aumentativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5593-sifo-alcuni-farmaci-per-le-malattie-rare-sono-preparati-direttamente-in-ospedale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5576-i-malati-rari-a-lorenzin-e-stata-riconfermata-ora-attendiamo-una-legge-contro-le-discriminazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5591-a-milano-la-marcia-del-malati-rari-piu-di-200-pazienti-hanno-sfidato-pioggia-e-freddo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5590-malattie-neurologiche-rare-in-italia-necessaria-una-rete-per-diagnosi-e-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5573-piu-assenze-e-voti-bassi-per-i-bambini-allergici-i-sintomi-si-associano-a-distrazione-nel-40-dei-casi-e-calo-di-attenzione-nel-50]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5582-genzyme-celebra-la-giornata-internazionale-delle-malattie-rare-tante-iniziative-ed-un-concorso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5581-rare-disease-day-orphan-europe-rinnova-il-proprio-impegno-nel-campo-delle-patologie-orfane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5580-malattie-rare-nasce-il-network-italiano-per-la-condivisione-di-immagini-e-dati-clinici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5579-i-vincitori-del-premio-giornalistico-omar-su-malattie-e-tumori-rari-oggi-alla-camera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5572-lorganizzazione-europea-per-le-malattie-rare-premia-orphan-europe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5567-staminali-la-terapia-cellulare-senza-celluleq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5571-rare-disease-day-2014-papa-francesco-ha-incontrato-400-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5570-premio-giornalistico-omar-su-malattie-e-tumori-rari-ecco-i-vincitori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5565-inps-di-padova-conferma-grazie-a-caterina-ci-siamo-attivati-per-aiutare-i-pazienti-affetti-da-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5562-caterina-simonsen-insegna-allinps-di-padova-come-riconoscere-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5533-malattie-endocrine-on-line-la-nuova-enciclopedia-endowiki]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5552-asma-e-bcpo-facciamo-una-passeggiata-prima-chiedilo-allo-smartphone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5551-la-rete-di-imprese-crikhet-avvia-un-progetto-di-ricerca-con-lospedale-bambino-gesu-di-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5550-pediatria-neonatale-conoscere-la-salute-del-feto-attraverso-lanalisi-dello-stress-ossidativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5521-autismo-progetti-di-preparazione-allinserimento-lavorativo-dei-soggetti-in-eta-adulta-affetti-da-tale-disturbo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5518-pronto-salute-attiva-consulenza-medica-telefonica-per-chi-intende-vivere-vacanze-sicure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5520-i-neonatologi-italiani-si-uniscono-alla-protesta-di-ginecologi-e-ostetriche-per-la-mancata-chiusura-delle-strutture-con-meno-di-1000-nati-allanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5547-due-concerti-dellorchestra-sinfonica-di-roma-per-loncologia-pediatrica-del-policlinico-a-gemelli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5537-nasce-xellbiogene-joint-venture-tra-bambino-gesu-e-gemelli-per-la-sperimentazione-nel-campo-delle-biotecnologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5529-rare-disease-day-2014-tutti-gli-eventi-italiani]]></loc><lastmod>2020-03-13T07:47:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5526-vii-giornata-mondiale-delle-malattie-rare-insieme-per-unassistenza-migliore-il-calendario-degli-appuntamenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5487-malattia-di-crohn-anti-tnfalfa-efficaci-anche-nella-patologia-pediatrica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5525-plasmaderivati-lautosufficienza-ci-potrebbe-costare-tra-i-164-e-i-376-milioni-di-euro-allanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5522-informazioni-on-line-nuovo-canale-you-tube-per-roche-pharma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5516-caterina-simonsen-ci-spiega-le-malattie-rare-la-campagna-ioconoscolemr]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5507-premio-giornalistico-omar-la-cerimonia-di-premiazione-della-ii-edizione-il-27-febbraio-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5477-malattie-rare-negli-usa-si-attende-piu-di-7-anni-prima-della-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5504-premio-sapio-premiati-i-ricercatori-che-fanno-grande-litalia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5495-malattie-rare-orphanet-ha-aggiornato-lelenco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5469-biobanche-italiane-necessarie-linee-guida-condivise]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5471-lincontro-dei-senza-colore-obiettivo-diagnosi-per-tutti-la-ricerca-va-verso-la-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5462-lassociazione-italiana-sindrome-di-poland-entra-a-far-parte-del-network-telethon-di-biobanche-genetiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5428-farmaci-e-salute-wikipedia-e-la-principale-fonte-di-informazione-per-pazienti-e-professionisti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5459-lea-e-registro-malattie-rare-lassociazione-dossetti-annuncia-una-class-action]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5457-linfoma-scoperte-nuove-proteine-associate-allo-sviluppo-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5453-malattia-rara-senza-diagnosi-ci-pensa-il-dottor-house]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5424-cellule-staminali-embrionali-secondo-una-ricerca-giapponese-sarebbe-sufficiente-un-forte-stress-per-ottenerle]]></loc><lastmod>2019-06-19T08:02:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5449-obesita-infantile-al-bambino-gesu-il-palloncino-che-si-ingoia-per-ridurre-la-fame]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5451-irccs-neuromed-inaugurazione-del-punto-coma-per-essere-vicini-ai-familiari-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5447-malattie-mitocondriali-una-nuova-strategia-terapeutica-dalla-ricerca-di-telethon]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5419-terapia-del-dolore-anche-la-regione-puglia-approva-luso-di-farmaci-cannabinoidi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5444-8-febbraio-xiv-giornata-nazionale-di-raccolta-del-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5432-chiesi-farmaceutici-completa-lacquisizione-di-cornerstone-therapeutics]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5431-bambino-gesu-nasce-il-centro-clinico-chirurgico-di-itigi-tanzania]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5407-cure-miracolose-a-disposizione-la-guida-aifa-per-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5401-metodo-stamina-la-societa-italiana-di-farmacologia-solo-sperimentazione-clinica-rigorosa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5403-fotografrare-attraverso-larte-il-racconto-della-vita-da-malato-raro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5378-la-ricetta-degli-industriali-per-eliminare-la-carenza-di-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5375-la-rivoluzione-dellospedale-microcitemico-sara-il-polo-di-riferimento-per-la-pediatria-sarda]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5374-parlamento-da-oggi-on-line-nomoscspeu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5361-riuniti-a-palermo-i-maggiori-esperti-di-malattie-ematologiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5340-malattie-rare-al-san-carlo-di-potenza-presto-un-centro-pediatrico-bambino-gesuq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5339-tumori-infantili-limportanza-della-psicologia-clinica-in-ospedale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5345-sarcoidosi-a-bologna-presto-attivo-un-percorso-diagnostico-terapeutico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5349-operare-i-noduli-alla-tiroide-senza-cicatrici-con-un-nuovo-robot]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5336-emoglobinopatie-novita-dallaccordo-tra-biogen-e-sangamo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5344-al-gemelli-con-il-robot-da-vinci-si-opera-la-tiroide-di-una-paziente-senza-lasciare-segni-sul-collo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5315-sindrome-di-hajdu-cheney-dal-regno-unito-il-tentativo-di-determinarne-lincidenza]]></loc><lastmod>2019-06-19T08:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5311-malattie-rare-lorganizzazione-rare-voices-australia-a-favore-di-un-piano-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5312-a-200-anni-dalla-morte-arriva-la-diagnosi-di-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5304-malattie-rare-genzyme-chiede-di-entrare-a-far-parte-dellirdirc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5322-malattie-rare-e-screening-neonatale-a-pescara-un-convegno-per-discuterne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5298-malattie-rare-horizon-2020-annuncia-il-finanziamento-di-iniziative-a-favore-della-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5296-neonato-con-grave-malformazione-salvato-allospedale-santa-maria-alle-scotte-di-siena-grazie-a-un-grande-lavoro-di-squadra]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5293-malattie-genetiche-rare-genzyme-e-alnylam-rinnovano-il-proprio-impegno]]></loc><lastmod>2015-10-23T10:57:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5287-divulgazione-scientifica-nelle-scuole-superiori-al-via-il-progetto-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5286-il-direttore-del-centro-nazionale-malattie-rare-nominato-tra-gli-esperti-del-gruppo-di-lavoro-della-commissione-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5264-albania-da-febbraio-entra-in-funzione-il-nuovo-centro-trasfusionale-di-tirana-voluto-da-magi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5265-ecco-cose-il-banco-informatico-tecnologico-e-biomedico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5282-sindrome-di-cornelia-de-lange-martina-operata-con-successo-a-cefalu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5260-cellule-staminali-e-sperimentazione-animale-il-circo-mediatico-confonde-le-persone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5273-andrea-paolillo-nuovo-direttore-medico-di-biogen-idec-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5272-malattie-rare-alexion-pharmaceuticals-e-moderna-therapeutics-insieme-per-lo-sviluppo-di-messenger-rna-therapeutics]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5257-gruppo-aziende-emoderivati-farmindustria-il-nuovo-presidente-e-giuliano-tagliabue-amministratore-delegato-di-biotest]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5231-helicobacter-potrebbe-essere-coplpevole-di-molte-altre-malattie-come-lanemia]]></loc><lastmod>2018-08-30T09:34:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5244-oncologia-nuovo-accordo-tra-astrazeneca-e-horizon-discovery]]></loc><lastmod>2017-01-16T10:31:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5242-10-11-gennaio-2014-farmaci-off-label-tutto-quello-che-avrei-voluto-sapere-ma-non-ho-mai-osato-chiedere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5241-premio-giornalistico-omar-ce-tempo-fino-al-26-gennaio-per-partecipare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5201-sindrome-da-ipoventilazione-centrale-congenita-giulia-e-sopravvissuta-oltre-le-aspettative-grazie-alla-ricerca]]></loc><lastmod>2019-06-19T08:05:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5227-assobiotec-lacquisizione-di-gentium-da-parte-dellirlandese-jazz-pharma-ennesima-dimostrazione-delleccellenza-della-ricerca-e-dellindustria-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5214-encefalopatia-mitocondriale-la-storia-di-andrea-il-supporto-di-teltehon]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5217-malformazioni-anorettali-un-fumetto-aiuta-i-bambini-a-gestire-la-vita-quotidiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5211-telethon-una-storia-di-solidarieta-italiana]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5204-sindrome-di-angelman-grazie-a-telethon-aiutiamo-la-principessa-martina]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5182-indagine-doxa-gli-italiani-ricorrono-allautomedicazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5216-anche-noinati-per-donare-la-parita-di-accesso-alle-cure-passa-attraverso-la-donazione-del-sangue-cordonale-con-la-nuova-campagna-nazionale-adoces-dedicata-a-donne-immigrate-e-con-handicap-sensoriali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5200-traumi-oculari-eccellenza-italiana-lamerican-society-of-retina-specialists-asrs-premia-team-tutto-italiano-per-la-ricostruzione-del-bulbo-oculare-che-ha-restituito-la-vista-ad-una-giovane-donna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5213-annunciati-i-vincitori-della-seconda-edizione-del-premio-giornalistico-merck-serono-personalizzazione-sopravvivenza-e-qualita-di-vita-un-futuro-per-i-pazienti-oncologici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5180-stamina-uniamo-chiede-chiarezza-e-rispetto-per-i-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5176-auguri-di-buon-natale-da-qi-malati-invisibiliq-al-ministro-della-salute-on-beatrice-lorenzin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5173-per-natale-il-gemelli-fa-festa-con-i-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5171-malattie-rare-non-diagnosticate-genzyme-e-nord-hanno-istituito-un-nuovo-fondo-in-favore-dei-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5170-servizi-assistenziali-inaugurato-il-centro-privatassistenza-a-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5160-gli-studi-clinici-spiegati-da-un-cartone-animato-del-progetto-ecran]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5143-telethon-raccolti-piu-di-10-milioni-dalla-maratona-tv]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5137-farmaci-generici-e-brand-da-uno-studio-italiano-il-dato-nessuna-differenza-sostanziale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5110-malattie-rare-limportanza-dei-registri-ribadita-da-due-studi-internazionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5105-bambino-gesu-straniero-un-bambino-su-10-lincontro-con-la-comunita-musulmana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5117-i-chirurghi-italiani-si-confrontano-sui-primi-risultati-di-hemopatch-linnovativo-emostatico-sigillante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5099-bayer-tra-le-prime-a-certificare-la-sua-data-protection]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5100-stamina-il-tar-del-lazio-accoglie-il-ricorso-di-vannoni-sulla-nomina-degli-esperti-che-hanno-bocciato-la-sperimentazione]]></loc><lastmod>2016-01-11T08:29:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5095-il-gemelli-policlinico-rosa-un-ospedale-a-misura-di-donna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5039-sciarpe-made-in-italy-per-telethon]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5052-missione-sanitaria-per-i-bambini-siriani-in-libano-promossa-dallospedale-pediatrico-bambino-gesu-pontificio-consiglio-cor-unum-e-caritas-libano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5050-sardegna-arrivano-275000-euro-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5007-ermafroditismo-la-germania-riconosce-il-terzo-sesso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5022-malattie-rare-nasce-il-servizio-infohub-di-eurordis]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5033-al-via-la-seconda-edizione-del-premio-giornalistico-omar-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5020-assistenza-transfrontaliera-il-professor-dallapiccola-commenta-la-direttiva-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5030-noduli-tiroidei-la-nuova-classificazione-italiana-per-riconoscerne-la-pericolosita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4999-ipoplasia-del-nervo-ottico-lassociazione-sod-italia-onlus-a-disposizione-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/5002-carcinoma-della-prostata-approvato-nellue-il-trattamento-con-radio-ra-223-dicloruro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4978-la-farmaceutica-shire-acquista-viropharma-specializzata-in-farmaci-per-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4973-malati-rari-il-13-novembre-saranno-circa-3500-in-udienza-da-papa-francesco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4947-malattie-rare-in-cina-istituito-il-consorzio-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4953-malattie-rare-il-comitato-diritti-non-regali-per-i-malati-rari-scrive-al-ministro-lorenzin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4944-si-e-conclusa-la-gara-di-solidarieta-a-favore-della-fondazione-meyer-e-stato-il-giovane-marco-filippini-ad-aggiudicarsi-la-maglia-di-pepito-rossi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4938-il-gruppo-malati-rari-ditalia-incontra-il-papa-la-lettera-scritta-dai-responsabili-del-comitato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4931-nato-il-primo-bambino-italiano-da-ovocita-congelato-la-mamma-era-affetta-da-carcinoma-ovarico-e-rischiava-di-perdere-la-fertilita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4922-malattie-rare-disponibile-lelenco-aggiornato-delle-patologie-e-dei-sinonimi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4896-lasma-allergica-grave-si-racconta-da-marcel-proust-lo-spunto-per-un-nuovo-progetto-di-medicina-narrativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4895-san-matteo-di-pavia-tre-giorni-di-eventi-per-linaugurazione-del-nuovo-policlinico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4891-atrofia-muscolare-spinale-un-progetto-telethon-famiglie-sma-per-condividere-standard-di-cura]]></loc><lastmod>2019-02-18T16:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4893-sindrome-di-down-un-nuovo-test-genetico-permette-di-identificarla-senza-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4886-un-neonato-sano-puo-nascondere-patologie-subdole-ecco-le-raccomandazioni-della-sin-societa-italiana-di-neonatologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4881-dalle-terapie-innovative-al-supporto-psicologico-per-la-qualita-di-vita-limpegno-di-shire-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4883-allergie-alimentari-sei-persone-su-dieci-sbagliano-cure-a-causa-del-web]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4869-disturbi-psichiatrici-delleta-evolutiva-colpito-un-ragazzo-su-5]]></loc><lastmod>2019-06-19T08:16:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4871-ictus-cerebrale-dal-21-al-29-ottobre-screening-gratuiti-in-oltre-3000-farmacie-italiane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4848-sifo-congresso-record-a-torino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4854-supporto-psicologico-ai-malati-rari-de-angelis-q-in-ascolto-dei-pazienti-per-aiutarli-a-ritrovare-la-strada-interrotta-dalla-malattiaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4853-malattie-rare-al-via-il-primo-servizio-di-supporto-psicologico-per-i-pazienti-con-malattie-da-accumulo-lisosomiale-e-angioedema-ereditario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4852-firmato-un-protocollo-dintesa-tra-ministro-per-lintegrazione-e-universita-cattolica-a-favore-della-salute-dei-migranti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4849-firmato-a-napoli-durante-ifib-2013-il-protocollo-dintesa-tra-clib2021-e-assobiotec]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4846-terapia-del-dolore-nasce-il-progetto-yap-uniniziativa-che-mira-a-valorizzare-giovani-ricercatori-italiani]]></loc><lastmod>2018-01-17T23:01:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4842-campagna-della-fondazione-lalbero-della-vita-qnessun-bambino-esclusoq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4834-prevenzione-diagnosi-e-cura-dellictus-cerebrale-questi-i-temi-del-premio-giornalistico-alice-italia-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4812-tumori-i-piu-diagnosticati-in-italia-sono-quelli-al-colon-retto-alla-mammella-e-alla-prostata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4813-malattie-neurologiche-la-fondazione-together-to-go-festeggia-il-primo-compleanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4833-i-farmacisti-ospedalieri-sifo-a-fianco-dei-cittadini-per-risparmiare-e-contrastare-la-crisi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4804-insufficienza-surrenalica-il-piccolo-morgan-rischia-la-vita-ad-ogni-minimo-stress]]></loc><lastmod>2019-06-19T08:17:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4782-malattie-rare-del-sistema-immunitario-ora-disponibile-una-guida-per-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4793-bilancio-positivo-per-la-prima-settimana-europea-delle-biotecnologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4790-malattie-rare-autoimmuni-i-pazienti-qnon-siamo-invisibili-basta-con-i-viaggi-della-speranza-e-le-terapie-a-nostre-speseq]]></loc><lastmod>2016-06-29T11:02:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4792-bambino-gesu-3-trapianti-in-12-ore-gli-organi-da-un-unico-donatore-pediatrico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4787-al-via-la-settimana-dei-disturbi-osteoarticolari-lunedi-e-martedi-visite-gratuite-di-immunoreumatologia-al-san-giovanni-bosco-di-torino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4768-malattie-rare-neuromuscolari-a-palermo-istituito-il-centro-di-riferimento-regionale-per-la-sicilia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4756-malattie-genetiche-rare-nasce-il-nuovo-portale-diseasecard]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4757-malattie-rare-orphanet-approda-su-facebook]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4752-emofilia-kedrion-dona-1-milione-di-unita-internazionali-di-fattore-ix-della-coagulazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4742-dagli-usa-il-brevetto-per-bambini-senza-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4726-pandas-il-9-ottobre-la-giornata-mondiale-dedicata-a-questa-sindrome-ancora-non-riconosciuta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4717-eurordis-2013-un-concorso-fotografico-per-premiare-le-foto-migliori-sul-tema-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4715-immagini-digitali-dei-tumori-per-diagnosi-piu-accurate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4702-qnuovi-centri-specialistici-per-garantire-uniformita-di-trattamento-ai-pazienti-in-dialisiq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4709-giuseppe-novelli-e-il-nuovo-rettore-delluniversita-di-tor-vergata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4693-malattie-rare-in-europa-individuate-a-bolzano-le-basi-per-una-sanita-europea-attenta-ai-pazienti]]></loc><lastmod>2019-06-11T14:15:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4680-biotech-linnovazione-al-servizio-della-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4678-biotech-litalia-rischia-di-perdere-il-controllo-anche-di-questo-settore-come-accadde-gia-per-la-farmaceutica-tradizionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4653-antibiotico-resistenza-in-europa-25000-decessi-allanno-in-italia-troppe-prescrizioni-facili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4669-genetica-in-italia-500-tra-laboratori-e-servizi-oltre-580000-test-eseguiti-in-un-anno-aumentano-le-indagini-oncologiche-ma-la-medicina-personalizzata-non-decolla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4649-care-deeply-volunteer-day-in-biogen-idec-una-giornata-di-lavoro-dedicata-alla-solidarieta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4641-malattie-rare-la-commissione-europea-istituisce-il-nuovo-gruppo-di-esperti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4623-il-policlinico-a-gemelli-a-fianco-delle-donne-per-due-giorni-di-prevenzione-dei-tumori-femminili-a-piazza-re-di-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4601-al-congresso-mondiale-di-linfologia-magis-lab-presenta-un-progetto-per-vincere-il-linfedema]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4573-tumori-rari-il-presidente-europeo-dellattivita-trapianti-e-un-italiano-francesco-lanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4561-malattie-emorragiche-congenite-al-via-il-progetto-italiano-per-la-corretta-presa-in-carico-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4571-farmaci-dallaifa-il-divieto-di-utilizzare-medicinali-prodotti-da-geymonat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4551-la-professoressa-elena-cattaneo-nominata-senatrice-della-repubblica-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4548-approvato-anche-in-italia-rivaroxaban-il-nuovo-anticoagulante-orale-di-bayer-healthcare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4518-malattie-rare-shire-e-santaris-rinnovano-il-loro-sodalizio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4535-stamina-la-commissione-esperti-chiarisca-le-dichiarazioni-di-vannoni-e-sottragga-sperimentazione-dal-ssn]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4509-stamina-vannoni-a-radio-radicale-inutili-i-3-milioni-per-la-sperimentazione-non-si-arrivera-alla-fase-3]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4508-15d-congresso-internazionale-immunologia-a-milano-cinquemila-esperti-da-120-paesi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4485-farmaci-per-uso-perdiatrico-i-primi-5-anni-del-regolamento-ue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4488-emoderivati-in-toscana-ritirati-due-lotti-positivi-allepatite-c]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4472-malattie-rare-in-molise-cresce-il-registro-delle-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4457-autismo-ruzzle4autism-divertimento-e-solidarieta-anche-sotto-lombrellone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4481-stamina-sma-esclusa-da-sperimentazione-la-petizione-di-famiglie-sma-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4413-insoliti-mal-di-testa-potrebbero-essere-sintomo-di-un-raro-disordine-cerebrale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4415-sindorme-di-lowe-ora-una-nuova-community-su-rareconnect]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4438-un-cucciolo-di-cane-aiuta-la-sua-padroncina-a-uscire-dalla-terapia-intensiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4433-epigenetica-celgene-intende-acquisire-aceetylon]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4431-barriere-architettoniche-la-provincia-di-ancona-e-fuorilegge-la-denuncia-delle-associazioni]]></loc><lastmod>2019-06-19T08:30:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4429-metodo-stamina-vannoni-consegnera-mai-il-protocollo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4407-medicina-genomica-e-predittiva-litalia-dispone-di-un-piano-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4421-malattie-rare-avviata-la-collaborazione-tra-alexion-e-ensemble-therapeutics-per-lo-sviluppo-di-nuovi-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4426-metodo-stamina-da-giorni-i-malati-protestano-davanti-a-montecitorio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4412-malattia-di-haff-possibile-collegamento-tra-la-patologia-rara-ed-il-pesce-bufalo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4410-terapia-del-dolore-in-italia-le-reti-pediatriche-attive-solo-in-quattro-regioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4396-i-rapporto-sullinvalidita-civile-e-la-burocrazia-qveri-invalidi-penalizzatiq]]></loc><lastmod>2019-06-19T08:32:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4392-certificato-di-qualita-per-il-programma-trapianti-di-staminali-emopoietiche-del-gemelli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4378-epilessia-e-malformazioni-dello-sviluppo-corticare-la-banca-popolare-di-vicenza-aiuta-la-ricerca-del-meyer]]></loc><lastmod>2024-10-31T16:21:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4340-grazie-al-progetto-eupati-i-pazienti-europei-possono-finalmente-rivestire-un-ruolo-chiave-nelle-strategie-di-ricerca-e-sviluppo-dei-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4327-atassia-laquilone-di-claudio-un-film-per-raccontare-una-storia-vera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4342-malattie-rare-e-fecondazione-assistita-in-gran-bretagna-si-pensa-ai-tre-donatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4355-staminali-aisla-qnon-sottoponetevi-a-protocolli-non-sperimentatiq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4336-metodo-stamina-ministro-lorenzin-non-e-una-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4334-metodo-stamina-dietro-a-vannoni-ci-sono-interessi-economici-internazionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4314-crisi-convulsive-acute-prolungate-in-bambini-e-adolescenti-disponibile-midazolam-per-il-trattamento-di-emergenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4321-ricerca-scientifica-il-mayer-di-firenze-protagonista-italiano-in-ambito-pediatrico]]></loc><lastmod>2019-06-09T10:36:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4299-sindrome-mdp-ecco-il-nome-della-rarissima-malattia-che-affligge-il-campione-paralimpico-tom-staniford]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4316-assobiotec-eletto-il-comitato-di-presidenza-dellassociazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4315-stamina-gallo-e-corbellini-ass-coscioni-il-ministero-interrompa-ogni-rapporto-con-vannoni-cancelli-sperimentazione-e-apra-una-inchiesta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4311-stamina-vannoni-non-ha-ancora-consegnato-il-protocollo-la-rivista-nature-lo-accusa-di-plagio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4304-metodo-stamina-nominato-il-comitato-scientifico-che-supervisionera-la-sperimentazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4284-malattie-rare-lobiettivo-irdirc-e-sviluppare-200-nuove-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4283-metodo-stamina-liter-per-la-sperimentazione-prosegue-con-lok-del-ministero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4257-tumore-al-seno-unaltra-strada-da-seguire-prima-di-fare-come-angelina-jolie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4241-eurordis-grande-successo-per-lincontro-2013-a-dubrovnik]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4243-in-italia-nuovo-centro-di-collaborazione-oms-per-la-prevenzione-della-cecita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4237-sabato-22-giugno-il-bambino-gesu-di-roma-apre-le-porte-a-grandi-e-piccoli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4226-il-dodecalogo-contro-i-tumori-tutti-i-consigli-del-policlinico-a-gemelli-per-ridurre-il-proprio-rischio-di-ammalarsi-di-cancro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4223-schistosomiasi-merck-serono-sostiene-loms-nella-lotta-alla-malattia-parassitaria-tropicale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4231-lavoro-istituto-di-genetica-magi-cerca-diverse-figure-professionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4225-ipoplasia-alla-trachea-in-bimbi-con-un-solo-polmone-primato-mondiale-per-tecnica-endoscopico-mini-invasiva-al-meyer-di-firenze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4215-orphanet-ora-disponibile-la-app-per-iphone-e-ipad]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4212-donazione-sangue-raccolta-in-crescita-al-bambino-gesu-obiettivo-20-mila-sacche-per-il-2013-un-gesto-da-incoraggiare-tra-i-giovani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4211-giornata-mondiale-del-donatore-di-sangue-lorenzin-visita-lospedale-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4205-un-centro-trasfusionale-a-tirana-grazie-alla-collaborazione-magi-biteb]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4187-oncoematologia-2300-bimbi-e-adolescenti-colpiti-dal-tumore-litalia-tra-i-migliori-paesi-per-il-trapianto-di-staminali-ematopoietiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4189-distrofia-di-ullrich-grazie-a-telethon-al-via-un-nuovo-approccio-terapeutico]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4188-malattie-rare-oggi-a-venezia-si-gioca-in-acqua-per-uniamo-goldin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4181-integrazione-arriva-italy-amore-mio-lungometraggio-che-racconta-le-vite-dei-giovani-figli-di-immigrati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4167-assobiotec-award-2013-al-cnr-lassegnazione-ieri-a-milano-in-occasione-della-conferenza-annuale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4150-malattie-genetiche-listituto-magi-offre-formazione-ai-paesi-svantaggiati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4155-malattie-genetiche-in-russia-test-genetici-gratuiti-grazie-allistituto-magi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4156-malattie-genetiche-rare-magi-e-istituto-toscano-tumori-insieme-per-lafrica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4154-malattie-genetiche-magi-porta-in-russia-test-genetici-gratuiti-per-i-bambini-in-difficolta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4151-presentati-i-progetti-di-cooperazione-internazionale-dellistituto-di-genetica-magi-di-rovereto-tn]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4140-torna-walk-of-lifeil-2-giugno-si-corre-a-parma-per-la-ricerca-di-teletho1]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4130-malattie-rare-si-apre-domani-il-meeting-eurordis-2013]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4132-malattie-lisosomiali-shire-e-nimbus-discovery-unite-per-sviluppare-nuove-terapiere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4116-malattie-rare-le-famiglie-italiane-sempre-piu-attive-sul-web]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4115-niemman-pick-nascera-un-bambino-sano-dai-genitori-portatori-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4127-neurogenetica-il-premio-2013-dellinstitute-de-france-a-massimo-zeviani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4089-italia-unita-contro-la-disinformazione-scientifica-l8-giugno-liniziativa-di-pro-test-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4095-torna-walk-of-life-la-maratona-di-telethon-il-26-maggio-a-napoli]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4077-oncologia-dermatologica-in-umbria-visite-specialistiche-gratuite-dal-27-maggio-al-3-giugno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4080-cistinosi-premiata-sigma-tau-per-il-farmaco-cystaran-unica-terapia-oculare-ad-oggi-approvata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4087-stamina-vannoni-rifiuta-i-contributi-cattaneo-se-non-accetta-potrebbe-trattarsi-di-una-montatura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4086-staminali-ass-luca-coscioni-scrive-a-vannoni-e-ora-della-verita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4079-sindrome-dellintestino-corto-trattamento-innovativo-riconosciuto-approvato-da-fda]]></loc><lastmod>2024-02-08T15:09:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4076-oral-cancer-day-fino-al-20-giugno-visite-dentistiche-gratuite-grazie-all-associazione-nazionale-dentisti-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4078-biofarmaceutica-spetta-ad-aifa-la-decisione-su-equivalenza-dei-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4071-parent-project-onlus-al-13d-congresso-dellaim-per-la-giornata-europea-dei-diritti-del-malato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4057-malattie-rare-in-lombardia-il-16-per-cento-dei-pazienti-viene-da-fuori-regione-tanto-dal-vicino-piemonte-quanto-da-sicilia-e-puglia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4056-malattie-rare-in-lombardia-in-aumento-le-diagnosi-di-patologie-ematiche-e-metaboliche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4054-malattie-rare-in-lombardia-pubblicato-il-rapporto-2012-del-registro-regionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4050-malattie-rare-dal-policlinico-umberto-i-di-roma-una-campagna-di-informazione-nelle-scuole]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4042-combattere-la-polmonite-partnership-tra-gsk-e-save-the-children-per-salvare-la-vita-di-un-milione-di-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4036-al-via-novartis-biocamp-appuntamento-esclusivo-con-il-futuro-della-ricerca-farmaceutica-riservato-a-30-giovani-talenti-delle-universita-italiane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4039-le-nuove-frontiere-della-ricerca-oncologica-al-centro-del-14th-international-medical-education-workshop-on-molecular-targeted-therapy-of-cancer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4021-malattie-rare-genetiche-nuove-speranze-dal-gene-therapy-international-consortium]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4027-listituto-besta-di-milano-piu-vicino-ai-pazienti-di-tutta-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4024-malattie-metaboliche-metabeat-imparare-a-mangiare-non-sentendosi-diversi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4019-malattie-rare-per-una-diagnosi-si-attende-mediamente-6-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4018-biotecnologie-in-italia-presentati-i-rapporti-2013-di-farmindustria-e-assobiotec]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/4016-malattie-rare-disponibile-il-rapporto-2012-della-regione-lombardia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3974-malattie-rare-al-via-i-test-sul-nuovo-programma-connect-un-registro-ad-accesso-aperto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3970-oggi-giornata-mondiale-dellimmunologia-incontri-e-convegni-a-napoli-e-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3954-sport-internet-e-relax-allistituto-nazionale-dei-tumori-di-milano-nuovi-spazi-per-i-giovani-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3952-a-roma-in-cinquemila-corrono-per-la-ricerca-un-successo-la-prima-tappa-di-walk-of-life-2013]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3940-bioinitaly-investment-forum-a-intesa-sanpaolo-start-up-initiative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3933-cellule-staminali-in-italia-durissima-la-critica-di-nature]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3920-genzyme-promuove-la-formazione-di-dottori-in-genetica-clinica-in-india]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3930-lupus-erimatoso-sistemico-sara-prodotto-in-italia-il-primo-farmaco-per-curarlo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3919-corri-per-le-malattie-genetiche-torna-walk-of-life-maratona-di-solidarieta]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3903-tumore-al-seno-un-contact-center-a-disposizione-delle-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3913-arriva-eurordis-tv-raccoglie-il-meglio-dei-video-sulle-malattie-rare-e-i-farmaci-orfani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3902-morte-improvvisa-pediatrica-lo-screening-elettrocardiografico-puo-salvare-molte-vite]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3894-artrosi-e-malattie-reumatiche-al-via-la-campagna-di-sensibilizzazione-della-societa-italiana-di-reumatologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3896-aspirina-previene-il-cancro-e-allunga-la-vita-media-ma-costera-100-miliardi-in-pensioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3885-disponibile-lapp-di-pharmastar-da-oggi-le-news-sui-farmaci-in-tempo-reale-anche-in-mobilita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3876-neuropsichiatria-infantile-il-gemelli-inaugura-un-nuovo-reparto-totty-e-ilary-blasi-al-taglio-del-nastro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3875-caso-stamina-perche-non-fare-una-sperimentazione-la-domanda-e-senza-risposta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3874-staminali-prof-cerone-simmesn-come-medici-abbiamo-il-dovere-di-mantenere-viva-la-cultura-della-razionalita-ricorrere-allirrazionalita-della-piazza-e-costume-troppo-diffuso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3870-staminali-e-metodo-vannoni-stasera-lincontro-in-diretta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3856-malformazioni-anorettali-centinaia-di-pazienti-vivono-nascosti-tra-disagio-e-vergogna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3846-salute-preconcezionale-la-necessita-di-pensarci-per-tempo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3845-gravidanza-aprile-e-il-mese-della-prevenzione-dei-difetti-congeniti-e-della-prematurita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3842-emoderivati-aifa-ritira-alcuni-lotti-per-sospetta-encefalopatia-spongiforme-trasmissibile]]></loc><lastmod>2015-05-28T13:02:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3810-terapie-con-stamilali-famiglie-sma-onlus-le-campagne-mediatiche-stravolgono-i-fatti-chiediamo-informazione-seria-e-completa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3797-terapie-con-staminali-diventate-caso-mediatico-necessario-un-intervento-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3798-arriva-findzebra-dallapiccola-orphanet-utile-ma-destinato-ai-medici-esperti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3793-arriva-findzebra-il-google-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3757-dopo-la-malattia-ci-sono-anche-qle-seconde-viteq-un-libro-di-maurizio-righetti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3750-malattie-rare-come-nato-il-mir-movimento-italiano-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3745-malattie-rare-i-pazienti-si-incontrano-su-aidweb]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3780-inaugurato-oggi-lambulatorio-malattie-rare-di-la-spezia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3781-giornata-mondiale-del-rene-2013-molte-le-iniziative-in-corso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3778-malattie-rare-lerrore-diagnostico-non-e-giustificato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3771-malattie-rare-dieci-anni-di-attivita-per-lambulatorio-multidisciplinare-del-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3768-giornalismo-assegnato-il-premio-intermune-per-le-malattie-rare-pomonari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3769-riva-del-garda-ospita-il-meglio-della-ricerca-telethon-sulle-malattie-genetiche-rare-e-assegna-i-premi-giornalistici-omar]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3763-assegnati-ieri-i-premi-giornalistici-omar-per-le-malattie-e-i-tumori-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3738-malattie-rare-polmonari-e-malattie-remumatologiche-fondamentale-lapproccio-interdisciplinare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3760-sarcoidosi-acsi-diventa-onlus-e-sostiene-la-ricerca-scientifica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3739-fotografrare-fino-al-17-marzo-le-malattie-rare-sono-in-mostra-a-milano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3754-terapie-con-staminali-telethon-qsentiamo-il-dovere-di-mettere-in-guardia-tutti-contro-chi-illude-la-gente-promettendo-cure-miracolistiche-prive-di-concreti-fondamenti-scientifici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3727-sportello-malattie-rare-del-policlinico-umberto-i-di-roma-un-modello-di-successo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3748-terapie-con-le-staminali-aisla-mette-in-guardia-le-famiglie-su-ipotetiche-cure-potenzialmente-pericolose-e-non-supportate-da-evidenze-scientifiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3729-dolore-cronico-al-via-la-campagna-nazionale-link-up]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3718-giornata-malattie-rare-anche-alexion-ha-sostenuto-liniziativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3717-eurordis-premia-celgene-corporation-per-leccellenza-nellinnovazione-medica-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3715-malattie-rare-iss-alla-guida-di-tre-importanti-progetti-europei]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3713-genzyme-celebra-la-giornata-internazionale-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3712-giornata-delle-malattie-rare-shire-sostiene-liniziativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3695-28-febbraio-2013-firmo-offre-consulenza-gratuita-sulle-malattie-rare-dello-scheletro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3692-giornata-delle-malattie-rare-2013-tutti-gli-eventi-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3685-milano-fotografrare-per-riportare-attenzione-sui-malati-e-non-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3671-malattie-rare-shire-vince-il-primo-qnovel-treatment-awardq-al-9d-simposio-mondiale-del-lysosomal-disease-network]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3660-alzheimer-per-vincerlo-gli-usa-mapperanno-il-cervello-umano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3652-sesta-giornata-mondiale-delle-malattie-rare-questanno-qsenza-frontiereq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3653-carcinoma-della-prostata-resistente-alla-castrazione-con-metastasi-ossee-il-radio-223-dicloruro-ha-ottenuto-la-revisione-prioritaria-dalla-fda-negli-stati-uniti]]></loc><lastmod>2021-02-20T19:09:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3632-al-maria-vittoria-di-torino-il-primo-ambulatorio-integrato-che-restituisce-il-sorriso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3622-malattie-rare-del-polmone-grande-successo-per-il-5d-congresso-internazionale-di-malattie-respiratorie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3601-carcinoma-polmonare-non-a-piccole-cellule-da-boehringer-un-nuovo-farmaco]]></loc><lastmod>2021-11-02T15:21:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3616-esportazione-di-plasmaderivati-a-fini-umanitari-approvato-lo-schema-di-accordo-tra-governo-regioni-e-provincie-autonome]]></loc><lastmod>2024-06-04T10:48:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3608-malattie-rare-clegene-si-conferma-leader-nella-terapia-dei-tumori-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3598-epidermiolisi-bollosa-dalla-fusione-tra-tissue-repair-lotus-e-shire-potrebbero-nascere-terapie-innovative-per-riparare-la-pelle]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3603-chirurgia-pediatrica-intervento-unico-in-toscana-e-tra-i-pochi-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3604-rapporto-europeo-boccia-lutilita-dei-test-genetici-acquistabili-sul-web]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3577-donazione-degli-organi-funziona-il-modello-opposizione-o-consenso-sulla-carta-di-identita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3569-iss-al-via-un-progetto-pilota-di-sorveglianza-della-mortalita-materna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3568-sincope-pediatrica-al-bambino-gesu-di-palidoro-la-prima-unita-specializzata-ditalia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3585-telethon-da-una-rara-cecita-ereditaria-scoperto-meccanismo-di-protezione-dai-danni-da-metabolismo-dellossigeno]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3536-sindrome-di-beckwith-wiedemann-lesperienza-dellassociazione-aibws-onlus-a-disposizione-delle-famiglie]]></loc><lastmod>2019-12-31T17:49:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3529-recordati-conclusa-lacquisizione-di-un-portafoglio-di-prodotti-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3516-malattie-rare-monogeniche-accordo-tra-shire-ed-ethris-gmbh]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3503-ricerca-telethon-dallormone-dellappetito-una-strategia-salva-muscoli]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3495-al-via-determinazione-rara-attivamente-insieme-nella-ricerca-nuovo-progetto-di-uniamo-fimr-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3484-alessandro-fontana-partecipa-a-the-voice-of-italy-e-sostiene-la-ricerca-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3474-nasce-con-una-grave-malformazione-al-polmone-salvato-grazie-a-diagnosi-prenatale-chirurgia-pediatrica-e-assistenza-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3456-scoperti-41-nuovi-geni-malattia-grazie-al-progetto-canadese-forge]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3470-biomarin-acquisisce-zacharon-pharmaceuticals-specializzata-in-malattie-metaboliche]]></loc><lastmod>2017-11-09T18:29:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3432-deficit-adhd-approvato-in-8-paesi-europei-il-trattamento-con-lisdexamfetamine]]></loc><lastmod>2019-06-19T08:35:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3448-test-genetici-in-europa-la-qualita-non-e-garantita-ovunque]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3438-alloggio-gratuito-per-le-famiglie-dei-piccoli-pazienti-dellospedale-pediatrico-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3440-malattie-rare-e-assistenza-transfrontaliera-aperta-la-consultazione-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3439-malattie-croniche-e-malattie-rare-la-ricetta-medica-e-valida-in-tutta-lue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3429-merck-serono-ha-donato-la-centomilionesima-pillola-per-il-trattamento-della-schistosomiasi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3427-motalcini-limpegno-per-i-paesi-svantaggiati-la-lotta-per-aiutare-la-ricerca-in-italia-la-fiducia-nel-non-profit]]></loc><lastmod>2024-07-02T12:06:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3405-pandas-una-malattia-che-fa-discutere-la-diagnosi-per-ora-si-fa-solo-a-roma-firenze-e-messina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3413-morta-rita-levi-montalcini-grazie-a-lei-oggi-si-e-vicini-terapie-per-varie-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3401-atrofia-muscolare-spinale-uno-studio-italiano-corregge-la-malattia-con-le-cellule-staminali-riprogrammate-in-laboratorio]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3388-farmaci-aifa-mette-online-tutti-i-documenti-per-favorire-la-trasparenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3385-malattia-rare-recordati-annuncia-lacquisizione-di-un-portafoglio-prodotti-negli-usa]]></loc><lastmod>2018-06-07T16:36:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3384-telethon-raccoglie-301-milioni-gli-italiani-continuano-a-far-esistere-la-ricerca]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3378-doppio-trapianto-di-cuore-al-policlinico-santa-maria-alle-scotte-di-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3375-scienza-20-per-una-vita-migliore-il-nuovo-progetto-editoriale-per-tablet]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3372-ipovisione-al-gemelli-un-centro-per-accendere-la-speranza-negli-occhi-di-bimbi-e-genitori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3370-nasce-il-primo-polo-italiano-di-neuroscienze-pediatriche-al-bambino-gesu-di-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3358-sequenziamento-genico-nel-regno-unito-presto-una-banca-dati-di-tutti-i-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3369-ricerca-a-rischio-il-futuro-di-siena-biotech-i-problemi-della-fondazione-monte-dei-paschi-travolgono-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3355-giornalismo-nasce-il-premio-nazionale-omardedicato-alle-malattie-e-ai-tumori-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3352-tumori-dellocchio-a-genova-il-meeting-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3346-chirurgia-della-sordita-siena-e-lunico-centro-italiano-collegato-in-diretta-mondiale-via-web-dalla-sala-operatoria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3323-prematuri-lapproccio-multidisciplinare-indicato-nelle-nuove-linee-guida-aumenta-sopravvivenza-e-qualita-della-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3341-nasce-in-sardegna-il-sito-dedicato-alle-malattie-rare-e-un-numero-verde-per-pazienti-e-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3339-malattie-rare-a-genova-tre-nuovi-centri-di-riferimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3338-telethon-2012-dal-9-al-16-dicembre-la-maratona-di-solidarieta-in-tv-ma-anche-via-radio-e-web]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3329-primo-cuore-artificiale-al-gemelli-batte-in-un-uomo-di-64-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3328-malattie-genetiche-rare-pediatriche-nsce-a-siena-il-call-center-informativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3326-dynamo-camp-la-terapia-ricreativa-per-i-bambini-con-tumore-e-malattie-gravi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3307-i-sorrisi-e-le-qimmaginiq-che-migliorano-la-salute-telecom-italia-in-sostegno-dellospedale-pediatrico-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3280-medicina-narrativa-raccogliere-le-storie-dei-pazienti-per-migliorare-la-sanita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3296-premio-galeno-vincono-agomelatina-e-fingolimod]]></loc><lastmod>2015-11-30T10:00:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3293-malattie-rare-lo-sportello-del-policlinico-di-milano-rischia-la-chiusura-per-i-tagli-alla-sanita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3279-distrofia-muscolare-congenita-presto-disponibili-le-linee-guida-per-le-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3298-con-italo-la-ricerca-telethon-viaggia-ad-alta-velocita]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3295-farmaci-per-le-malattie-rare-la-denuncia-di-cittadinanzattiva-troppe-le-difficolta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3292-malattie-rare-in-toscana-un-numero-verde-dedicato-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3263-sarcoidosi-prima-candelina-per-lassociazione-acsi-amici-contro-la-sarcoidosi-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3273-gsk-in-cima-alla-graduatoria-dellaccess-to-medicines-index-2012]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3262-sla-alle-ore-14-viva-la-vita-onlus-ospite-di-gr-parlamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3255-malattie-reumatiche-il-prof-marco-matucci-cerinic-e-il-nuovo-presidente-sir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3256-telethon-i-malati-rari-gridano-io-esisto-e-chiedono-agli-italiani-di-far-avanzare-la-ricerca]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3247-test-genetici-i-database-privati-possono-ostacolare-la-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3240-celiachia-i-geni-della-malattia-rintracciati-in-uno-scheletro-del-i-secolo-ac]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3202-eccellenti-risultati-nella-cura-delle-patologie-tissutali-grazie-al-gel-piastrinico-in-ortopedia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3204-recupera-la-vista-grazie-al-trapianto-di-cellule-staminali-corneali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3231-microftalmia-individuato-nuovo-gene-correlato-alla-malattia]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3185-gigantismo-le-malattie-rare-esistevano-anche-nellantica-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3216-oncologia-le-terapie-integrate-sono-un-vantaggio-per-i-pazienti-e-per-il-ssn]]></loc><lastmod>2019-05-23T17:47:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3208-sangue-infetto-gli-emodanneggiati-pronti-ad-una-nuova-protesta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3173-milanopediatria-il-bambino-al-centro-delluniverso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3172-assobiotec-e-lassociazione-biotech-del-massachusetts-si-alleano-per-collaborare-nelle-scienze-della-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3171-la-cecita-fluviale-ogni-anno-provoca-40-mila-nuovi-ciechi-puo-essere-eradicata-entro-il-2020]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3160-malattie-rare-sui-registri-per-patologia-accordo-tra-europa-e-nord-america]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3154-tireotropina-alfagenzyme-annuncia-il-ripristino-della-piena-disponibilita-del-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3152-malattie-reumatiche-dal-ministero-nessun-progetto-per-listituzione-delle-reti-reumatologiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3079-malformazioni-anorettali-dalla-norvegia-un-software-per-la-vita-indipendente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3110-al-gemelli-il-reparto-virtuale-infettivologico-per-un-controllo-serrato-e-centralizzato-delle-infezioni-ospedaliere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3109-bioterapia-dei-tumori-sempre-piu-rilevante-limpegno-del-policlinico-santa-maria-alle-scotte-di-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3115-malattie-rare-neurodegenerative-accordo-quadro-fra-aou-meyer-irccs-fondazione-stella-maris-e-universita-di-firenze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3102-terapie-con-staminali-per-il-ministero-sono-pericolose-stop-alluso-compassionevole]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3076-app-e-malattie-rare-pronto-il-repertorio-europeo-delle-applicazioni-dedicate-alla-salute]]></loc><lastmod>2020-06-03T18:19:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3097-giornalismo-medico-scientifico-al-via-le-selezioni-per-la-borsa-di-studio-dedicata-a-monica-andreucci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3090-telethon-scoperto-un-nuovo-gene-malattia-per-una-rara-malattia-mitocondriale]]></loc><lastmod>2019-02-18T16:15:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3061-diagnosi-e-terapie-in-vitro-dalla-commissione-europea-la-proposta-di-revisione-della-normativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3084-il-premio-ruggeri-alla-chirurgia-oncologica-di-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3082-loculistica-senese-e-al-top-in-toscana-per-i-trapianti-di-cornea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3059-litaliana-chiesi-farmaceutici-annuncia-la-nuova-filiale-messicana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3055-effettuato-un-intervento-unico-in-toscana-su-un-bambino-nato-con-gli-organi-digerenti-nel-torace-accanto-al-cuore-anziche-nella-pancia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3072-uniamo-fimr-onlus-il-governo-ci-ripensi-litalia-deve-crescere-insieme-al-welfare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3051-balduzzi-e-fornero-promettono-piano-per-non-autosufficienza-sospeso-lo-sciopero-della-fame-per-disabili-e-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3045-ring14-onlus-diventa-un-modello-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3044-diaspro-rosso-ecco-i-dati-dellindagine-di-uniamo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3043-malattie-rare-costi-economici-disagi-e-diagnosi-difficile-tutta-italia-arranca-ma-sud-va-peggio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3042-allergologia-e-immunologia-clinica-i-risultati-delle-terapie-desensibilizzanti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3040-inaugurato-a-roma-il-nuovo-centro-dellospedale-pediatrico-bambino-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3038-malattie-genetiche-rare-accordo-tra-telethon-e-shire-per-finanziare-i-ricercatori-del-tigem-di-napoli]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3037-ricerca-genetica-e-medica-scopri-cosa-fa-il-tigem-di-napoli]]></loc><lastmod>2025-10-28T17:31:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3027-doppia-donazione-e-trapianto-di-rene-da-vivente-tra-due-coppie-di-coniugi-in-modalita-incrociata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3026-assobiotec-al-via-ieri-a-milano-la-seconda-edizione-del-forum-italiano-sulle-biotecnologie-industriali-e-la-bioeconomia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3013-disabilita-e-malattie-rare-al-via-lo-sciopero-della-fame]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2991-psoriasi-al-via-appelle-campagna-di-informazione-e-sensibilizzazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2974-individuato-in-uno-studio-a-opera-dei-microbiologi-delluniversita-cattolica-potrebbe-essere-la-chiave-per-ideare-nuove-terapie-contro-questo-microrganismo-resistente-alle-attuali-cure-antibiotiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2985-farmaci-glaxosimithkline-mettera-a-disposizione-tutti-i-dati-sui-test-clinici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/3004-trapianti-un-delicato-e-complesso-sistema-da-non-mettere-a-rischio-con-i-tagli-alla-spesa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2990-apre-allospedale-infantile-di-alessandria-la-family-room-finanziata-dalla-fondazione-ronald-mcdonald-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2987-lavoro-magis-lab-cerca-12-figure-professionali-tempo-fino-al-15-dicembre-per-le-candidature]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2960-malattie-rare-da-eurordis-un-nuovo-strumento-di-e-learning-a-disposizione-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2971-disabilita-intellettiva-una-app-scopre-se-si-tratta-di-una-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2938-una-chirurgia-a-tutela-della-femminilita-e-della-qualita-di-vita-delle-donne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2948-giornata-mondiale-dellalimentazione-le-iniziative-del-centro-di-nutrizione-umana-della-cattolica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2929-primi-risultati-del-progetto-di-studio-cardiovascolare-the-heart-of-mens-sana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2913-malattie-rare-accordo-tra-sanofi-e-cina-per-implementare-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2931-referti-online-alla-asl-to-2-di-torino-gli-esiti-degli-esami-arrivano-via-web]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2950-quante-sono-le-malattie-rare-in-attesa-di-riconoscimento-da-parte-dello-stato-italiano-nessuno-sembra-saperlo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2935-a-spasso-con-il-tuo-cuore-la-prevenzione-cardiovascolare-si-fa-anche-camminando]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2934-nasce-con-lapparato-digerente-esterno-al-corpo-neonato-salvato-grazie-ad-un-perfetto-lavoro-di-squadra]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2936-telethon-orphanet-e-bambino-gesu-insieme-un-per-uso-consapevole-di-internet]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2923-patologie-posturali-pediatriche-la-polizia-stradale-dona-una-pedana-baropodometrica-a-fondazione-ariel]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2868-disabilita-nelle-scuole-la-proposta-didattica-dellassociazione-ring-14-onlus]]></loc><lastmod>2019-06-19T08:37:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2892-angiodisplasie-alessandro-fontana-metto-la-mia-arte-al-servizio-della-ricerca-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2895-immunologia-una-disciplina-rivalutata-potrebbe-spiegare-anche-malattie-comuni-e-alcuni-tumori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2890-eutanasia-associazione-coscioni-al-via-la-campagna-qaaa-cerchiamo-malati-terminaliq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2881-autismo-progetto-ido-per-scoprirlo-prima-e-affrontarlo-meglio]]></loc><lastmod>2019-06-19T08:36:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2879-angels-onlus-arrivata-a-roma-bambina-palestinese-in-gravi-condizioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2887-malattie-rare-partecipa-al-sondaggio-di-eurordis-sui-registri-delle-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2880-allistituto-telethon-di-napoli-scoperto-un-sistema-per-i-trasporti-eccezionali]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2860-comunicare-le-biotecnologie-e-linnovazione-in-medicina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2856-biotecnologie-siglato-oggi-accordoaifa-iss-assobiotec-per-incentivare-la-sperimentazione-clinica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2841-malattie-reumatiche-prima-causa-di-dolore-e-disabilita-in-europa]]></loc><lastmod>2020-02-27T15:04:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2840-malattie-reumatiche-lassociazione-dei-malati-apmar-e-i-reumatologi-chiedono-terapie-appropriate]]></loc><lastmod>2020-02-27T15:06:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2830-il-granfondo-dei-trapiantati-fa-tappa-alle-scotte-di-siena-sabato-29-settembre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2826-contro-lautismo-scende-in-piazza-il-peperoncino-dal-28-al-30-settembre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2827-glaxosimithkline-presenta-il-suo-nuovo-general-manager-daniele-finocchiaro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2824-saranno-decise-in-italia-a-siena-le-linee-guida-per-la-chirurgia-otologica-europea-del-futuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2823-medicina-rigenerativa-nasce-a-torino-un-centro-per-le-terapie-staminali-si-parte-da-fegato-e-reni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2793-patologie-di-origine-ambientale-nasce-assimas-prima-associazione-italiana-di-medicina-ambientale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2814-morbo-di-chagas-un-decesso-al-san-giovanni-bosco-di-torino]]></loc><lastmod>2018-06-25T15:56:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2808-farmaci-per-uso-pediatrico-lema-ha-dato-il-via-alla-consultazione-pubblica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2812-al-via-la-campagna-di-coopi-per-salvare-dalla-malnutrizione-7000-bambini-in-niger]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2805-i-giovani-italiani-non-sono-affatto-smidollatioltre-3000-nuovi-iscritti-in-un-solo-giorno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2786-misurare-il-dolore-dei-pazienti-unapplicazione-migliora-la-comunicazione-tra-medico-e-malato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2791-neuroriabilitazione-al-bambino-gesu-arrivano-i-coach-a-quattro-zampe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2754-bandi-il-lions-club-vigonza-ne-apre-uno-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2755-farmaci-orfani-rappresentate-di-eurordis-eletta-vice-presidente-nel-comp]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2741-girare-mangiando-vita-indipendente-e-turismo-sociale-per-i-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2738-rimborso-di-cure-e-terapie-eseguite-allestero-ecco-la-guida-di-eurordis-in-lingua-italiana]]></loc><lastmod>2015-05-28T14:19:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2707-cardiovascolare-al-via-la-settima-edizione-del-premio-internazionale-arrigo-recordati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2723-trial-clinici-leuropa-sceglie-la-trasparenza-tutti-i-dati-saranno-pubblici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2722-valutazione-dei-farmaci-lema-cerca-rappresentanti-dei-pazienti-e-operatori-sanitari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2727-inaugurato-a-messina-il-centro-clinico-nemo-sud-punto-di-riferimento-per-le-malattie-neuromuscolari]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2717-alattie-rare-e-web-bambino-gesu-e-uniamo-lanciano-un-questionario-per-capire-abitudini-e-necessita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2683-la-sclerosi-tuberosa-malattia-genetica-paradigma-delle-malattie-rare]]></loc><lastmod>2018-12-16T11:04:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2690-atrofia-muscolare-spinale-la-piccola-celeste-potra-essere-curata-con-le-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2666-terapia-del-dolore-aumenta-il-consumo-di-farmaci-antalgici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2654-cancro-annunciata-una-nuova-terapia-con-i-raggi-ultravioletti-studiata-in-giappone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2645-sindrome-di-down-il-test-si-fa-in-casa-scoppia-la-polemica-incrementera-gli-aborti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2642-mielomeningocele-alla-spina-dorsale-salvata-bimba-di-sei-mesi-del-sierra-leone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2641-banca-del-latte-attivo-un-numero-verde-per-tutte-le-mamme-grazie-al-policlinico-santa-maria-alle-scotte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2623-donazioni-degli-organi-raddoppiano-i-consensi-per-le-dichiarazioni-su-carta-didentita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2640-al-gemelli-delegazione-cinese-di-federazione-persone-con-disabilita-per-visitare-centro-di-riferimento-per-riabilitazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2619-acondroplasia-a-catanzaro-apre-lo-sportello-dedicato-alla-rara-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2622-osservatorio-malattie-rare-va-in-vacanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2639-meningoencefalite-amebica-primaria-pam-negli-usa-la-sesta-morte-a-causa-della-rara-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2621-chemioterapia-gli-effetti-collaterali-ci-sono-sbagliato-dire-che-fa-male]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2618-emoderivati-un-documento-nazionale-per-gestire-meglio-la-sorveglianza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2606-malattie-rare-gli-azzurri-alle-olimpiadi-sostengono-telethon-e-la-ricerca]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2605-cittadinanzattiva-al-ministro-della-salute-impegno-urgente-per-un-piano-nazionale-e-vincolante-sulle-malattie-croniche-e-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2595-malattie-rare-un-progetto-dedicato-ai-fratelli-dei-pazienti-piu-giovani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2604-exit-il-legame-piu-stretto-per-salvare-la-vita-che-nasce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2563-pandas-in-italia-esiste-unassociazione-che-si-occupa-di-questa-malattia-quasi-sconosciuta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2586-olimpiadi-vezzali-dedica-la-sua-medaglia-a-una-bambina-gravemente-malata]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2576-telethon-alle-olimpiadi-per-far-vincere-la-ricerca]]></loc><lastmod>2019-02-18T16:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2568-orphanet-e-patientinform-insieme-per-un-migliore-aggiornamento-scientifico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2566-test-genetici-pronta-la-prima-bozza-delle-line-guida-europee]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2508-il-centro-nazionale-malattie-rare-promuove-la-medicina-narrativa-e-la-condivisione-tra-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2534-telethon-aumentano-i-progetti-finanziati-con-i-soldi-degli-italiani]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2520-malattie-rare-la-nuoto-pittura-da-alcatraz-a-san-francisco-per-rendere-omaggio-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2507-telemedicina-alle-scotte-di-siena-piu-di-200-pazienti-assistiti-a-distanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2461-malattie-polmonari-rare-ecco-le-risposte-alle-domande-piu-frequenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2502-malattie-rare-negli-usa-nuove-misure-a-favore-di-pazienti-e-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2501-donare-gli-organi-la-volonta-si-esprime-su-facebook-in-italia-non-e-possibile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2499-malattie-rare-i-piccoli-pazienti-del-bambino-gesu-navigano-da-civitavecchia-a-gaeta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2469-test-genetici-per-determinare-letnia-dura-la-condanna-di-eurordis]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2471-roma-capitale-angels-onlus-e-commissione-politiche-sociali-firmano-protocollo-di-solidarieta-a-tutela-dei-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2464-3d-siena-glaucoma-summer-school-due-giorni-di-approfondimento-e-aggiornamento-sul-glaucoma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2445-sindrome-di-rubinstein-taby-oggi-la-prima-giornata-mondiale]]></loc><lastmod>2023-06-08T16:48:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2441-energia-e-cronicita-la-solidarieta-sociale-per-labbattimento-della-fuel-poverty]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2427-malattie-rare-molti-i-casi-di-contenzioso-per-malasanita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2406-lalbinismo-ieri-e-oggi-professionisti-albini-e-loro-familiari-a-confronto]]></loc><lastmod>2015-05-29T08:25:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2422-telethon-alessandro-betti-nuovo-direttore-raccolta-fondi]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2428-medicina-predittiva-il-direttore-dello-stanford-prevention-research-center-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2411-quattro-trapianti-dorgano-in-72-ore-a-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2396-obesita-genetiche-fornari-malattie-e-avvelenamento-non-si-escludono-a-vicenda]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2393-tecnologia-nasce-oggi-scienza-20-per-una-vita-migliore-rivista-digitale-concepita-per-i-tablet]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2394-tecnologia-nasce-oggi-scienza-20-per-una-vita-migliore-rivista-digitale-concepita-per-i-tablet-43359375]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2391-obesita-genetiche-in-queste-potrebbe-essere-la-chiave-dellestinzione-della-famiglia-farnese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2385-obesita-genetiche-per-combatterle-serve-il-giusto-mix-di-dieta-movimento-farmaci-e-riabilitazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2384-obesita-genetiche-listituto-magi-promuove-iniziative-per-venire-incontro-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2382-ricerca-telethon-si-riunisce-in-sardegna-per-decidere-i-prossimi-progetti-da-finanziare]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2349-malattie-rare-infantili-in-piemonte-uno-spazio-di-ascolto-informazione-e-orientamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2341-malattie-polmonari-ricerca-e-assistenza-quale-futuro-per-il-nostro-paese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2369-malattie-rare-bertoglio-cndmr-qmolte-sono-le-criticita-legate-alla-malattie-rare-molto-ce-ancora-da-fareq]]></loc><lastmod>2018-08-06T10:09:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2360-malattie-rare-dalle-associazioni-di-pazienti-un-progetto-sulle-previsioni-di-spesa-9384155]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2354-malattie-rare-alla-ricerca-dellapprodo-un-volume-multidisciplinare-per-contribuire-alla-stesura-del-piano-nazionale-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2342-farmaci-un-sito-europeo-per-scoprirne-gli-effetti-collaterali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2352-trombocitopenia-idiopatica-ne-e-affetto-il-rugbista-australiano-will-chambers]]></loc><lastmod>2018-02-09T11:29:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2339-malattie-polmonari-rare-disponibile-un-numero-verde-per-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2313-il-medico-in-tasca-nuovo-libro-di-sergio-harari-non-dimentica-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2331-premio-sapio-per-la-ricerca-italiana-un-successo-la-cerimonia-conclusiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2312-sindrome-di-poland-la-nuova-sede-aisp-inaugurata-a-genova]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2292-terremoto-il-primo-aiuto-alle-aziende-colpite-sia-il-pagamento-dei-crediti-che-vantano-dallo-stato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2282-i-farmacisti-italiani-sempre-piu-vicini-alla-popolazione-colpita-dal-sisma-in-emilia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2264-malattie-rare-analisi-psicosociale-del-fenomeno-il-libro-di-simone-montagnoli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2277-leucemia-emofilia-e-malattie-ematologiche-per-i-pazienti-ce-il-numero-verde]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2273-allarme-terremoto-per-i-malati-rari-difficile-garantire-la-dialisi-e-le-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2248-malattie-rare-al-san-camillo-di-roma-apre-lo-sportello-dedicato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2175-trapianti-dorgani-gli-italiani-non-vogliono-donare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2217-colesterolo-misuralo-mentre-fai-shopping-a-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2232-discinesia-tardiva-importante-la-collaborazione-tra-neurologo-e-psichiatra]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2229-oggi-la-giornata-nazionale-del-terapista-occupazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2207-narcolessia-online-la-community-europea-grazie-a-rareconnectorg]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2203-celiachia-la-settimana-dell-informazione-ai-cittadini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2200-prima-giornata-della-ricerca-dellazienda-ospedaliero-universitaria-meyer-di-firenze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2202-malattie-neglette-il-ministro-balduzzi-allassemblea-oms]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2189-malattie-genetiche-rare-da-telethon-11-progetti-per-quelle-maggiormente-trascurate]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2176-oral-cancer-day-fino-al-7-giugno-un-mese-di-visite-gratuite-negli-studi-dentistici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2153-sindrome-di-poland-aisp-inaugura-una-nuova-sede-a-genova]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2166-malattie-rare-e-urgenze-un-vademecum-per-i-pronto-soccorso-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2164-plastica-e-autismo-ricercatori-italiani-individuano-una-possibile-relazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2124-sindrome-della-trasfusione-feto-fetale-la-chirurgia-fetoscopica-e-attualmente-il-miglior-trattamento-nonostante-le-complicazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2085-operazioni-fetali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2150-trapianti-tra-vivi-dallapiccola-uno-strumento-importante-nel-trattamento-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2149-trapianti-tra-vivi-approvati-anche-per-polmone-pancreas-e-intestino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2146-domani-14-maggio-2012-giornata-mondiale-ring14]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2128-maggio-di-informazione-psicologica-benessere-e-prevenzione-per-tutti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2115-nasce-iddn-italian-drug-discovery-network-ricerca-e-industria-italiane-insieme-per-rafforzare-la-scoperta-e-lo-sviluppo-di-nuovi-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2139-malattia-rara-diagnosticata-su-facebook-salva-la-vita-del-piccolo-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2117-malattie-genetiche-rare-assistenza-chiesa-e-istituzioni-locali-sostegno-il-progetto-di-magi-in-lombardia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2107-walk-of-life-in-16-mila-hanno-corso-per-la-ricerca-in-otto-citta-italiane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2102-malattie-rare-assistenza-ai-disabili-gravissimi-e-riabilitazione-per-le-malattie-linfatiche-e-ipovedenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2101-malattie-genetiche-e-rare-magi-crea-una-residenza-sanitaria-dedicata-in-lombardia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2052-angiomi-cavernosi-anche-siena-partecipa-al-network-di-ricercatori-clinici-e-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2091-giornata-per-la-ricerca-50d-anniversario-dellistituzione-della-facolta-di-medicina-e-chirurgia-a-gemelli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2090-sindrome-di-berdon-asl-di-lecce-nega-le-cure-a-una-piccola-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2075-ottodame-sostiene-la-fondazione-dellospedale-pediatrico-meyer-di-firenze-e-riceve-la-nomina-ufficiale-di-impresa-amica-del-meyer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2061-chirugia-maxillo-facciale-ottimi-i-risultati-alle-scotte-di-siena-grazie-a-giorgio-iannetti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2064-malattie-neurodegenerative-da-prioni-spiegate-da-uno-studio-telethon]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2041-rita-levi-montalcini-103-anni-compiuti-ieri-ai-tempi-della-persecuzione-lavoravo-in-una-piccola-camera-da-letto-quelle-ricerche-mi-hanno-condotta-a-stoccolma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1990-walk-of-life-in-8-citta-italiane-corse-aperte-a-tutti-per-aiutare-la-ricerca-di-telethon]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/2018-biotech-a-milano-bioinitaly-investment-forum-a-intesa-san-paolo-start-up-initative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1986-malati-rari-riunite-le-associazioni-amiche-di-telethon]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1966-fondazione-telethon-e-ring14-biobanche-genetiche-un-accordo-vincente]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1964-trombosi-il-18-aprile-la-prima-giornata-nazionale-con-un-sms-al-45505-e-possibile-finanziare-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1956-il-15-aprile-la-milano-city-marathon-si-corre-in-favore-della-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1970-autismo-e-vaccino-mpr-per-la-corte-ce-correlazione-per-i-medici-si-tratta-di-un-falso-scientifica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1940-miastenia-di-lambert-eaton-la-consulta-nazionale-delle-malattie-rare-denuncia-la-grave-discriminazione-nei-confronti-dei-pazienti]]></loc><lastmod>2020-07-16T16:46:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1936-baxter-dona-tremila-euro-alla-fondazione-abio-per-i-bambini-malati-in-ospedale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1912-eccellenza-sanitaria-al-meyer-pediatria-in-rete-e-due-nuove-camere-speciali-al-centro-ustioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1905-tumori-e-leucemie-infantili-pensionati-cna-finanziano-lospedale-meyer-di-firenze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1881-sarcoidosi-e-nata-lassociazione-amici-contro-la-sarcoidosi-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1822-orphanet-un-grande-progetto-per-le-malattie-rare-soprattutto-in-portogallo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1848-polmonite-censis-ancora-una-patologia-sottovalutata-in-italia-solo-1-su-2-ne-riconosce-i-fattori-di-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1857-tubercolosi-resistente-solo-il-10-per-cento-dei-malati-accedono-alle-cure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1843-dolore-cronico-al-via-la-campagna-hub2hub-per-informare-i-cittadini-sui-centri-di-terapia-antalgica-presenti-sul-territorio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1829-le-malattie-rare-in-eta-giovane-adulta-un-libro-a-disposizione-di-medici-specialisti-e-medici-di-base]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1826-oncoematologia-pediatrica-al-bambino-gesu-di-roma-il-male-si-combatte-a-colpi-di-karate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1812-malattie-ematiche-al-meyer-di-firenze-salvata-la-vita-a-un-bambino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1818-malattie-rare-al-via-una-consultazione-pubblica-ospitata-dal-portale-malatirariit-promossa-da-orphanet-e-dalla-consulta-nazionale-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1791-orphanet-italia-avviato-orphanet-urgenze-un-servizio-dedicato-alla-medicina-durgenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1785-le-infezioni-saranno-considerate-malattie-rare-antibiotici-come-farmaci-orfani-per-semplificarne-lapprovazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1776-fondazione-dellistituto-toscano-tumori-presentazione-ufficiale-a-pietrasanta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1783-settimana-del-cervello-alle-scotte-di-siena-il-dipartimento-discienze-neurologiche-e-neurosensoriali-apre-al-pubblico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1781-nel-giorno-della-festa-della-donna-la-prof-paola-romagnani-entra-in-academianet-database-delle-piu-qualificate-donne-europee-impegnate-in-ogni-disciplina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1761-officina-trasfusionale-e-nuovo-percorso-donatori-di-sangue-laou-senese-va-avanti-sul-progetto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1756-distonia-al-bambino-gesu-di-roma-si-puo-trattare-con-la-neurochirurgia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1758-strutture-italiane-di-genetica-medica-al-via-il-censimento-della-societa-italiana-di-genetica-umana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1759-strutture-italiane-di-genetica-medica-al-via-il-censimento-della-societa-italiana-di-genetica-umana-62814331]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1760-strutture-italiane-di-genetica-medica-al-via-il-censimento-della-societa-italiana-di-genetica-umana-60998535]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1737-distrofie-retiniche-malformazioni-venose-e-linfatiche-obesita-genetiche-risponde-matteo-bertelli-fondatore-di-qmagiq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1729-giornata-delle-malattie-rare-schifani-qun-prezioso-momento-di-riflessione-e-sensibilizzazioneq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1709-malattie-rare-inaugurato-oggi-uno-sportello-dedicato-al-policlinico-umberto-i-a-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1725-giornata-delle-malattie-rare-2012-a-napoli-in-piazza-pazienti-e-associazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1723-orphan-europe-gruppo-recordati-sceglie-la-strada-del-volontariato-con-dynamo-camp]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1707-lokomat-lultima-frontiera-della-neuroriabilitazione-motoria-per-le-lesioni-midollari-incomplete]]></loc><lastmod>2018-02-15T17:39:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1700-malattie-rare-oggi-a-milano-la-cndmr-organizza-una-corteo-pacifico-di-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1686-on-line-il-nuovo-portale-della-consulta-nazionale-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1681-trapianti-di-cornea-dalla-cheratoplastica-lamellare-allimpianto-di-staminali-nei-casi-piu-gravi-litalia-tra-i-leader-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1670-tre-trapianti-dorgano-a-siena-in-una-sola-notte-uniscono-siena-a-pisa-firenze-e-chiusi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1655-malattie-rare-non-ancora-riconosciute-prorogata-la-raccolta-firme]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1644-retinite-pigmentosa-finanziato-uno-studio-sulle-basi-molecolari-delle-distrofie-retiniche-con-la-tecnica-del-sequenziamento-genomico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1638-ospedale-pediatrico-meyer-porte-aperte-con-levento-kermesse-il-meyer-per-amico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1633-leucemia-mieloide-acuta-la-food-and-drug-administration-non-approva-la-decitabina]]></loc><lastmod>2015-11-09T20:36:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1635-fondazione-meyer-donati-105000-euro-dalla-banca-popolare-di-vicenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1628-dolore-cronico-in-italia-troppo-pochi-i-centri-specializzati-e-la-legge-38-non-viene-applicata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1616-malattie-rare-il-29-febbraio-la-giornata-dedicata-parola-dordine-del-2012-e-solidarieta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1591-giornata-mondiale-contro-il-cancro-tante-le-iniziative-nazionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1568-autismo-presentate-le-linee-guida-dellistituto-superiore-di-sanita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1531-dynamo-camp-bozza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1548-distrofia-muscolare-facio-scapolo-omerale-fshd-italia-onlus-rappresenta-le-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1541-basilicata-al-via-le-attivita-del-centro-pediatrico-bambino-gesu]]></loc><lastmod>2025-06-26T16:02:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1505-attende-un-figlio-ma-e-nano-cosi-lo-abbandona-in-ospedale-e-successo-nella-capitale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1488-emiplegia-alternante-aisea-ricerca-genica-biobanca-servizi-di-assistenza-e-stato-un-anno-davvero-ricco-di-iniziative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1487-protesi-pip-istituto-tumori-milano-da-noi-mai-usate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1485-malattie-neurologiche-conad-tirreno-dona-macchinari-al-pediatrico-meyer-di-firenze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1483-xeroderma-pigmentoso-regala-ai-bimbi-lunari-una-vacanza-al-camp-sundown]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1468-oncoematologia-pediatrica-alleanza-tra-il-santobono-pausilipum-e-il-gaslini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1479-malattie-rare-e-croniche-quando-la-terapia-viene-dal-paziente]]></loc><lastmod>2019-01-03T18:20:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1466-medicina-personalizzata-e-nata-la-prima-societa-scientifica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1465-cromosoma-22-ora-ce-un-libro-adatto-anche-ai-bimbi-la-fantastica-storia-del-signor-22]]></loc><lastmod>2025-06-26T16:03:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1476-cardiologia-bimbi-con-marfan-e-loyes-dietz-operati-con-successo-al-san-matteo-di-pavia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1470-telethon-maratona-chiusa-con-oltre-30-milioni-raccolti-ma-si-puo-ancora-donare]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1459-malattie-rare-nasce-la-fondazione-il-bene-allospedale-di-bellaria-di-bologna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1456-malattie-rare-la-newsletter-orphannews-europe-ora-disponibile-anche-in-italiano]]></loc><lastmod>2025-06-26T15:59:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1455-telethon-fino-a-domenica-la-maratona-televisiva-di-solidarieta]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1453-sla-a-claudio-rinaldi-della-gazzetta-di-parma-il-premio-giornalista-dellanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1452-cardiopatie-congenite-al-buzzi-di-milano-lindsey-allan-pioniera-della-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1448-solidarieta-il-rugby-italiano-sostiene-il-dipartimento-di-neuroscienze-del-meyer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1435-incontinentia-pigmenti-nasce-un-sito-web-dedicato-ai-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1428-malattie-rare-limportanza-di-fare-rete-per-pazienti-e-famiglie-ce-rareconnet]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1432-malattie-rare-duchenne-e-altre-nove-malattie-piu-vicine-alla-cura-grazie-a-telethon-84490966]]></loc><lastmod>2019-02-18T16:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1420-dolore-cronico-al-parlamento-europeo-unalleanza-per-combatterlo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1392-leggere-per-crescere-il-progetto-per-i-bimbi-ricoverati-e-per-quelli-disabili]]></loc><lastmod>2019-06-19T08:39:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1391-infanzia-cappuccetto-rosso-la-fiaba-piu-conosciuta-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1390-leggere-per-crescere-dieci-anni-di-racconti-ad-alta-voce-per-i-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1372-mediateca-della-ledha-dal-cinema-alla-letteratura-nasce-la-prima-biblioteca-dedicata-interamente-alla-disabilita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1365-lombardia-il-policlinico-di-milano-diventa-sempre-piu-lospedale-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1360-gravidanza-attivato-alle-scotte-di-siena-centro-di-medicina-materno-fetale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1351-trapianto-di-rene-da-vivente-al-gemelli-di-roma-ne-sono-stati-eseguiti-due-con-cicatrice-di-soli-6-cm]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1338-ricerca-a-mauro-giacca-direttore-dellicgeb-il-premio-san-giusto-doro-2011]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1342-abruzzo-al-via-dal-17-novembre-a-chieti-un-percorso-di-sensibilizzazione-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1350-xeroderma-pigmentoso-la-malattia-arriva-al-cinema-con-the-dark-side-of-the-sun]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1335-neuroscienze-presentato-oggi-a-washington-il-manuale-from-neuron-to-brain]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1336-diagnosi-prenatale-nuove-linee-guida-ministeriali-auspicano-modello-di-share-decision-making]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1311-malattie-rare-a-viareggio-cominciano-i-lavori-per-la-nascita-di-un-centro-specializzato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/941-la-resilienza-trovare-la-forza-di-andare-avanti-nonostante-tutto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1269-psoriasi-in-lombardia-corsia-preferenziale-per-accorciare-i-tempi-di-diagnosi-e-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1253-biofutura-si-rifa-il-look-on-line-piu-spazio-alla-nutraceutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1249-universita-a-laquila-master-di-ii-livello-in-neuropsichiatria-delleta-evolutiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1250-oncologia-sara-a-siena-la-prima-societa-scientifica-dedicata-allimmunoterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1256-ricerca-compie-20-anni-di-attivita-il-consortium-garr]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1241-malattie-rare-in-solitaria-sulla-rotta-di-cristoforo-colombo-con-il-gondoliere-tommaso-luppi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1248-ricerca-exploit-di-telethon-piu-pubblicazioni-in-un-anno-e-progressi-contro-malattie-genetiche]]></loc><lastmod>2019-03-27T10:32:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1238-sclerodermia-i-pazienti-chiedono-ai-medici-di-medicina-generale-di-collaborare-alla-diagnosi]]></loc><lastmod>2015-06-05T16:39:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1216-malattie-rare-dallospedale-di-udine-parte-il-progetto-del-portale-regionale-del-fvg]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1221-prevenzionedallo-screening-neonatale-a-quello-oncologico-passando-per-i-vaccini-litalia-e-divisa-e-distratta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1180-nasce-a-brescia-il-comitato-malattie-rare-infantili-per-dare-sostegno-alle-famiglie]]></loc><lastmod>2017-08-10T09:41:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1185-anemia-falciforme-dalla-boston-university-una-serie-di-indicatori-per-migliorare-lassistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1194-malattie-reumatiche-farmaci-biologici-terapie-personalizzate-e-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1193-malattie-reumatiche-voltan-anmar-sui-farmaci-biologici-litalia-e-molto-indietro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1196-progetto-informacancro-al-besta-scade-il-21-ottobre-il-termine-per-la-domanda-di-servizio-civile]]></loc><lastmod>2015-06-05T16:56:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1192-malattie-reumatiche-domani-al-senato-lappello-dei-malati-per-cure-migliori-e-uniformi]]></loc><lastmod>2015-06-05T16:58:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1188-vista-il-13-ottobre-la-giornata-mondiale-domani-al-senato-conferenza-degli-esperti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1166-malattie-rare-biomarin-sale-in-borsa-aspettative-positive-per-le-molecole-in-studio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1169-uniamo-lancia-il-progetto-conoscere-per-assitere-il-primo-incontro-domani-a-bari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1165-malattie-mitocondriali-se-ne-parla-oggi-e-domani-a-reggio-emilia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1128-sanita-gli-italiani-tra-i-piu-insoddisfatti-peggio-solo-il-polonia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1123-cromosoma-14-si-apre-oggi-ad-al-alba-cn-il-primo-workshop-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1125-sindromi-cromosoma-14-anche-le-fiabe-possono-aiutare]]></loc><lastmod>2015-06-05T17:19:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1120-malattie-rare-repubblicait-apre-uno-spazio-per-raccontarle]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1104-prevenzione-il-regina-elena-di-roma-effettua-il-cotest-per-proteggere-il-collo-dellutero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1100-sindrome-sjogren-questa-sera-a-farro-disonzo-serata-benefica-di-musica-e-danza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1096-terapia-del-dolore-fondazione-isal-per-la-promozione-di-terapie-antalgiche-e-palliative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1098-utero-didelfo-in-florida-nati-due-gemelli-sani-da-donna-affetta-dalla-malformazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1086-malattie-genetiche-rare-un-concorso-di-poesia-riservato-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1082-sindrome-di-poland-laisp-organizza-un-convegno-a-napoli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1080-solidarieta-tra-le-associazioni-sostenute-dagli-emmy-awards-anche-litaliana-ring-14]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1081-malattie-rare-ereditarie-metaboliche-premio-di-laurea-per-la-migliore-tesi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1063-malformazioni-facciali-a-milano-la-prima-smile-house-per-gli-interventi-e-la-riabilitazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1061-fshd-ricercatori-telethon-sono-riusciti-a-silenziare-in-laboratorio-i-geni-iperattivi]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1046-sindrome-feto-alcolica-secondo-gli-esperti-per-evitarla-e-meglio-non-bere-in-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1045-ricerca-la-ferrari-scende-in-pista-per-telethon-mettendo-allasta-lelefantino-nello-t]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1044-oncologia-alle-scotte-di-siena-cresce-il-progetto-clown-in-corsia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1040-malattie-rare-lazienda-orphan-europe-partecipa-al-progetto-europeo-sulle-malattie-metaboliche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1038-sangue-alloncologia-pediatrica-del-gemelli-ce-bisogno-urgente-d-donatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/1034-fibrosi-cistica-preoccupazione-per-la-sopravvivenza-del-centro-di-teramo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/995-trapianti-alle-scotte-di-siena-due-interventi-durante-il-week-end-di-ferragosto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/991-emoderivati-associazione-coscioni-chiede-stesse-precauzione-per-derivati-da-urine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/982-malformazioni-cardiache-congenite-si-possono-individuare-alla-nasciate-con-un-semplice-test-del-sangue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/970-talassemia-bimba-palestinesi-a-rischio-per-la-mancanza-di-farmaci-e-attrezzature]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/961-firenze-furto-allassociazione-noi-per-voi-per-il-meyer-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/958-gi-gvhd-sigma-tau-amplia-laccordo-con-solingenix-in-vista-della-commercializzazione-di-orbec]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/951-bronchiolite-costrittiva-impennata-di-casi-tra-i-militari-americani-in-ritorno-da-iraq-e-afghanistan]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/948-disabilita-e-vacanze-dal-6-al-14-agosto-le-famiglie-di-ring14-gratis-al-dynamo-camp]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/942-ras-di-martino-galileo-research-sara-un-soggetto-industriale-vero-e-proprio-due-progetti-intanto-sono-gia-avviati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/946-malattie-rare-arrivo-il-nuovo-sito-di-uniamo-firm-wwwmalatirariit]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/947-malattie-rare-scienza-e-aziende-chiedono-un-piano-nazionale-e-piu-aiuti-a-ricerca-e-sviluppo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/926-malattie-rare-nasce-sito-dedicato-di-cittadinanzattiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/913-sclerodermia-i-numeri-del-fenomeno-raccolti-dallassociazione-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/904-malattie-genetiche-rare-nel-2011-telethon-ha-stanziato-oltre-27-milioni-di-euro-per-101-laboratori]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/906-umbria-da-telethon-140-mila-euro-per-la-ricerca-sulle-malattie-genetiche-rare]]></loc><lastmod>2019-02-18T16:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/902-malattie-neuromuscolari-al-san-martino-di-messina-nasce-il-nemo-sud-fondazione-aurora-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/898-assobiotec-benatti-nominato-vice-presidente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/894-speciale-spoletoscienza-bianchi-come-affrontare-le-malattie-multifattoriali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/892-speciale-spoletoscienza-lo-stretto-legame-tra-metabolismo-e-medicina-personalizzata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/893-speciale-spoletoscienza-barbujani-non-esistono-le-razze-ma-sfumature-allinterno-di-una-variabilita-continua-nello-spazio-geografico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/890-speciale-spoletoscienza-kaput-ecco-perche-i-farmaci-non-funzionano-su-tutti-allo-stesso-modoq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/884-speciale-spoletoscienza-domenica-si-parla-della-sfida-della-medicina-personalizzata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/870-speciale-spoletoscienza-da-cosa-dipendono-aspettative-di-vita-e-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/871-speciale-spoletoscienza-pregliasco-qnon-possiamo-sperare-in-un-mondo-senza-microrganismi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/872-speciale-spoletoscienza-modiano-malaria-uno-storico-killer-sociale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/859-speciale-spoletoscienza-domani-si-parla-di-geografie-della-salute]]></loc><lastmod>2015-06-05T17:48:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/854-speciale-spoleto-scienza-la-globalizzazione-della-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/866-malattie-rare-le-donne-si-raccontano-gli-uomini-rimangono-in-silenzio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/850-3-luglio-2011-spoleto-geografie-della-salute-a-spoleto-scienza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/864-ras-siglato-laccordo-tra-assobiotec-e-pennsylvania-bio-leader-del-settore-a-livello-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/851-speciale-spoleto-scienza-fondazione-sigma-tau-porta-sul-palco-celine-medico-e-malato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/847-biobanche-leonardo-santi-nominato-presidente-del-comitato-scientifico-di-fondazione-abo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/835-telefonare-elettrizza-il-cervello-neuroni-eccitati-dalle-onde-dei-telefonini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/836-ricerca-prorogati-al-22-luglio-termini-per-borse-di-studio-al-consortium-garr]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/825-malformazioni-cavernose-cerebrali-nasce-un-sito-web-dedicato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/810-ricerca-la-prossima-settimana-telethon-sceglie-i-progetti-da-finanziare]]></loc><lastmod>2026-04-08T17:13:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/802-autismo-la-regione-lombardia-ha-firmato-un-accordo-con-israele]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/800-incontinentia-pigmenti-con-laiuto-di-telethon-nasce-ipassi-onlus]]></loc><lastmod>2019-02-18T16:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/784-oncocercosi-msd-continuera-a-donare-il-mectizan-necessario-per-sconfiggerla-fino-alleradicazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/768-malattie-congenite-secondo-i-pediatri-molte-si-potrebbero-prevenire-pensandoci-prima-del-concepimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/766-ras-ely-lill-potenzia-lo-stabilimento-di-firenze-per-la-produzione-di-insuline]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/754-eutanasia-moglie-chiede-sospensione-trattamenti-per-marito-abbandonato-dallo-stato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/751-terapia-del-dolore-lospedale-pediatrico-meyer-e-un-centro-allavanguardia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/749-malattie-metaboliche-al-via-domani-malattie-rare-nostrumda-civitavecchia-a-gaeta-in-baca-a-vela]]></loc><lastmod>2018-08-10T14:42:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/747-sla-lumbria-spinge-per-lassistenza-ma-genera-una-polemica-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/744-giornata-del-sollievo-un-network-nazionale-a-favore-della-radioterapia-sintomatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/743-giornata-del-sollievo-al-gemelli-la-premiazione-del-concorso-un-ospedale-con-piu-sollievo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/731-ras-investire-sul-biotech-puo-essere-la-chiave-di-volta-delleconomia-italiana]]></loc><lastmod>2015-06-08T09:26:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/730-ricerca-telethon-premiata-dallassobiotec-per-limpegno-nella-ricerca]]></loc><lastmod>2019-02-18T16:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/727-n-malattie-rare-la-societa-di-neurologia-ha-svolto-il-primo-corso-specifico-a-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/720-ricerca-telethon-raccoglie-fondi-con-walk-of-life]]></loc><lastmod>2019-02-18T16:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/717-sla-malati-e-famigliari-manifestano-a-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/706-associazioni-laich-milano-ha-ottenuto-dalla-chiesa-valdese-50-mila-euro-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/696-disabilita-intellettiva-la-diagnostica-evolve-ma-le-differenze-regionali-non-danno-uguali-opportunita]]></loc><lastmod>2019-06-19T08:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/684-r-a-s-tra-assobiotec-e-centro-nazionale-per-le-risorse-biologiche-accordo-di-collaborazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/672-staminali-al-via-adotta-una-cellula-la-raccolta-fondi-per-sostenere-la-ricerca-del-prof-vescovi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/671-sla-bertoglio-il-governo-ha-cambiato-la-scelta-dei-contribuenti-e-incostituzionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/670-sla-bertoglio-i-100-milioni-sono-un-furto-discriminazioni-inaccettabili-tra-malati-rari]]></loc><lastmod>2015-06-08T09:41:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/669-malattie-rare-telethon-e-rotary-club-milano-insieme-contro-le-malattie-rare]]></loc><lastmod>2019-02-18T16:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/668-biotecnologie-dompe-farmindustria-contro-delocalizzazioni-investimenti-e-norme-migliori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/667-biotecnologie-sidoli-assobiotec-potenzialita-inespresse-serve-una-strategia-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/665-staminali-sardi-e-veneti-i-piu-generosi-ma-da-lazio-campania-e-sicilia-poche-donazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/663-sla-il-danno-per-lassociazionismo-e-la-beffa-per-i-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/664-tumori-rari-bimbi-aieop-denuncia-trial-indipendenti-fermi-per-una-norma-che-fa-gli-interessi-degli-assicuratori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/659-fine-vita-il-musico-impertinente-pubblica-il-testamento-biologico-depositato-alla-chiesa-valdese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/644-toscana-al-careggi-di-firenze-un-centro-europeo-per-la-ricerca-dedicata-alle-vie-aeree]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/636-fertilita-grazie-alla-banca-del-tessuro-ovario-le-oncologiche-potranno-sperare-ancora-in-un-figlio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/614-malattie-rare-telethon-e-ferderparchi-insieme-per-sostenere-la-ricerca]]></loc><lastmod>2019-02-18T16:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/604-staminali-ematopoietiche-al-bambino-gesu-di-roma-un-nuovo-reparto-trapianti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/591-trapianti-a-siena-raggiunta-quota-500-per-il-rene]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/575-ricerca-accordo-tra-molmed-e-telethon-per-la-terapia-genica-di-sei-malattie-rare]]></loc><lastmod>2019-02-18T16:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/567-reni-in-13-anni-800-trapianti-allospedale-maggiore-di-novara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/564-giappone-tre-societa-mediche-assicurano-non-ci-sono-rischi-per-litalia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/561-ricerca-alleanza-tra-assobiotec-e-aifi-perr-far-crescere-gli-investimenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/541-osservatorio-malattie-rare-adesso-ce-anche-il-blog-ospitato-da-leiweb]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/518-ricerca-al-via-la-sedicesima-convention-scientifica-di-telethon]]></loc><lastmod>2019-02-18T16:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/515-locked-in-da-lisa-onlus-un-software-open-source-per-comunicare-con-i-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/514-locked-in-ferraro-lisa-onlus-la-voglia-di-vivere-aumento-con-le-adeguate-cure-domiciliari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/513-sindrome-locked-in-la-maggior-parte-dei-pazienti-si-dice-felice-e-in-pochi-sceglierebbero-leutanasia]]></loc><lastmod>2026-04-13T17:25:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/495-dolore-reumatologico-dal-7-marzo-alle-scotte-di-siena-un-centro-specifico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/474-rari-ma-ugali-dompe-farmindustria-aziende-italiane-molto-attive-sui-farmaci-orfani-ma-servono-interventi-sui-lea-e-sugli-iter-burocratici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/473-rari-ma-uguali-la-consulta-per-le-malattie-rare-detta-le-priorita-normative]]></loc><lastmod>2015-06-08T10:23:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/472-rari-ma-uguali-associazioni-e-istituzioni-daccordo-sulla-necessita-di-fare-rete-e-attivare-i-registri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/449-sanofi-genzyme-acquisizione-fatta-atteso-lo-sviluppo-di-nuovi-farmaci-biotech-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/439-malattie-rare-presentato-ieri-il-nuovo-annuario-di-orphanet]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/421-staminali-yamanaka-il-papa-delle-pluripotenti-indotte-premiato-in-spagna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/418-n-malattie-rare-ritardo-nella-diagnosi-male-comune-tra-italia-e-inghilterra]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/408-diagnosi-prenatale-il-prof-novelli-su-repubblica-prioritaria-la-consulenza-genetica-sui-genitori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/394-gsk-lazienda-annuncia-investimenti-in-italia-nel-piano-ce-anche-la-ricerca-sulle-malattie-rare]]></loc><lastmod>2021-07-06T09:16:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/391-assistenza-clinica-e-ricerca-al-via-la-collaborazione-tra-il-meyer-di-firenze-e-il-childrens-hospital-di-philadelphia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/375-sarcoidosi-una-malattia-trascurata-sta-nascendo-in-italia-unassociazione-di-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/374-diagnosi-prenatale-della-talassemia-su-avvenire-la-polemica-tra-il-prof-contu-e-il-prof-maggio]]></loc><lastmod>2015-06-08T11:25:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/362-in-umbria-grande-aumento-dei-fondi-raccolti-per-telethon-nel-2010]]></loc><lastmod>2019-02-18T16:19:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/358-trial-clinici-laifa-mette-on-line-lelenco-delle-sperimentazioni-condotte-in-italia]]></loc><lastmod>2015-06-08T11:31:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/322-telethon-sabato-17-parte-la-maratona-ma-il-numero-per-donare-con-un-sms-e-gia-attivo-45505]]></loc><lastmod>2019-02-18T16:19:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/319-leishmaniosi-grazie-alla-fondazione-di-bill-gates-i-paesi-poveri-potranno-avere-accesso-al-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/309-test-genetici-eurogentest-pubblica-una-nuova-catalogazione-le-clinical-utility-gene-cards]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/304-societa-italiana-di-reumatologia-il-nuovo-presidente-e-minisola-del-san-camillo-di-roma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/294-fibrosi-cistica-arriva-il-secondo-volumetto-informativo-e-dedicato-agli-adolescenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/285-malattia-di-krabbe-dal-san-raffaele-telethon-passi-avanti-nella-terapia-genica-piu-vicina-lapplicazione-sulluomo]]></loc><lastmod>2019-02-18T16:19:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/270-sanofi-aventis-ancora-interessata-a-genzyme]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/269-sla-brunello-allasta-per-aiutare-galdiolo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/262-diagnosi-prenatale-i-test-invasivi-potrebbero-andare-in-soffitta-a-favore-di-un-semplice-prelievo-di-sangue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/261-test-genetici-il-vero-problema-e-saper-leggere-correttamente-i-risultati-lallarme-al-congresso-internazionale-dei-biologi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/257-anemia-di-fanconi-una-malattia-campana-wikipedia-sbaglia-lo-spiega-la-professoressa-adriana-zatterale-responsabile-del-registro-italiano-della-malattia-presso-la-asl-1-di-napoli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/253-universita-bandito-premio-di-laurea-per-chi-ha-svolto-tesi-sulle-malattie-rare]]></loc><lastmod>2015-06-08T16:44:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/249-taminali-listituto-nanoscienze-del-cnr-di-lecce-vince-la-start-cup-cnr-il-sole-24-ore]]></loc><lastmod>2020-11-19T17:26:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/227-aifa-luca-pani-eletto-membro-del-sawp]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/222-staminali-il-meyer-ha-un-nuovo-sistema-informatico-per-gestire-la-criobanca-per-ottimizzare-la-gestione-dei-prodotti-cellulari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/217-fibrosi-cistica-allarme-in-umbria-lunico-centro-potrebbe-chiudere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/216-losservatorio-dei-diritti-dei-minori-propone-destinare-meta-del-jackpot-del-superanalotto-alla-ricerca-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/212-ricerca-genetica-il-direttore-generale-dellicgeb-sara-premiato-a-nova-gorica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/201-la-mano-ad-artiglio-o-la-sindrome-del-tunnel-carpale-in-un-bambino-possono-nascondere-malattie-rare-come-la-sindrome-di-scheie-la-gaucher-o-la-malattia-di-fabry]]></loc><lastmod>2025-03-21T09:13:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/197-premio-esmo-ad-oncologia-medica-del-gemelli-e-hospice-villa-speranza-della-cattolica-per-innovativo-programma-di-assistenza-al-malato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/185-alessandria-nuovi-locali-per-il-centro-emostasi-e-trombosi-alllao-santi-antonio-e-biagio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/182-beike-solo-il-cina-per-evitare-raggiri-e-speculazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/158-marsala-all-ospedale-borsellino-attivo-dal-primo-ottobre-centro-di-diagnosi-prenatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/151-malattia-di-rendu-osler-weber-un-centro-a-pavia-per-dire-basta-al-sangue-dal-naso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/140-tirosinemia-brevettato-al-mayer-di-firenze-marcatore-specifico-per-la-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/125-genzyme-sanofi-rilancia-e-offre-71-dollari-ad-azione-per-acquisire-la-casa-farmaceutica-americana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/123-autismo-dall8-al-10-ottobre-a-catania-il-nono-congresso-internazionale-di-autism-europe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/107-malattie-neurodegenerative-nasce-a-edimburgo-la-anne-rowling-regenerative-neurology-clinic]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/105-genzyme-dice-no-a-allofferta-di-sanofi-aventis-ma-la-partita-e-solo-allinizio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/104-ricerca-su-malattie-rare-e-staminali-il-ministero-finanzia-6-progetti-veneti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/78-prx-105-il-farmaco-nato-per-la-biodifesa-dal-gas-nervino-potrebbe-essere-utile-contro-alcune-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/66-telethon-nel-2010-piu-fondi-alla-ricerca-sulle-malattie-genetiche]]></loc><lastmod>2019-02-18T16:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/65-progeria-il-senatore-filippi-lega-nord-presenta-un-ddl-per-laiuto-alle-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/62-trombastenia-di-glanzman-a-un-gruppo-di-ricercatori-umbri-124-mila-euro-di-telethon-per-la-ricerca]]></loc><lastmod>2026-04-08T17:00:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/67-emofilici-e-talassemici-danneggiati-da-sangue-infetto-il-ministero-ripropone-il-trattamento-del-2003]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/58-smith-lemli-opitz-bimbo-sano-nato-a-padova-da-una-coppia-di-portatori-della-mutazione-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/54-da-il-giornaleit-a-washington-si-apprezza-lindustria-del-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/39-malattie-metaboliche-rare-in-eta-neonatale-allospedale-dei-bambini-di-milano-la-spettrometria-tandem-mass-per-la-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/38-orvieto-firmata-convenzione-per-avvio-del-centro-di-formazione-malattie-rare]]></loc><lastmod>2015-05-24T16:25:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/29-23-maggio-giornata-nazionale-di-sensibilizzazione-sullutilita-dellormone-della-crescita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/18-sindrome-di-loeys-dietz-perfetta-riuscito-alle-scotte-di-siena-del-primo-intervento-di-sostituzione-dellaorta-toracoaddominale-effettuato-con-la-protesti-siena-graft]]></loc><lastmod>2021-05-04T18:11:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/attualita/14-angiodisplasie-nessuna-chiusura-del-reparto-dedicato-allospedale-salvini-di-garbagnate-milanese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/22743-appalti-sanitari-la-corsia-veloce-del-pnrr-cosa-cambia-per-farmaci-e-forniture]]></loc><lastmod>2026-03-12T15:26:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/22701-chi-decide-il-valore-di-un-farmaco-orfano]]></loc><lastmod>2026-02-01T16:51:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/22669-la-malattia-di-menkes-una-corsa-contro-il-tempo-nei-primi-mesi-di-vita]]></loc><lastmod>2026-01-20T17:59:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/22616-farmaci-per-malattie-e-tumori-rari-aifa-approva-3-farmaci-orfani-due-generici-e-6-estensioni-di-indicazione-terapeutica]]></loc><lastmod>2025-12-22T10:29:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/22490-deficit-di-timidina-chinasi-2-negli-usa-disponibile-la-prima-terapia-autorizzata]]></loc><lastmod>2025-11-07T12:12:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/22502-congresso-sifo-farmacisti-ospedalieri-fondamentali-per-i-malati-rari]]></loc><lastmod>2025-11-10T09:51:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/22180-sindrome-di-pearson-una-malattia-mitocondriale-rara-che-colpisce-i-bambini]]></loc><lastmod>2025-07-13T14:56:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/22040-farmaci-orfani-presentato-il-report-explorare-3-0]]></loc><lastmod>2025-05-30T18:24:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/21841-pemfigoide-bolloso-risultati-positivi-dallo-studio-registrativo-su-dupilumab]]></loc><lastmod>2025-03-25T13:04:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/21800-progeria-rimborsabile-in-italia-il-primo-farmaco-specifico-per-la-patologia]]></loc><lastmod>2025-03-11T11:57:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/21563-decode-un-nuovo-progetto-per-sostenere-i-dispositivi-medici-per-malattie-pediatriche-e-rare]]></loc><lastmod>2024-12-06T18:31:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/21397-farmaci-orfani-l-indagine-in-fase-di-negoziazione-necessario-adeguare-i-comparatori-all-unicita-di-questi-medicinali]]></loc><lastmod>2024-10-16T09:11:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/21295-neuromielite-ottica-ravulizumab-ottiene-la-rimborsabilita-in-italia]]></loc><lastmod>2024-09-17T12:19:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/21184-dispositivi-orfani-dall-europa-le-linee-guida-per-i-produttori-di-ausili-destinati-ai-malati-rari]]></loc><lastmod>2024-07-19T13:42:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/21146-immunodeficienze-kedrion-distribuira-negli-usa-la-nuova-terapia-di-biotest]]></loc><lastmod>2024-07-04T09:52:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/21073-cheratite-da-acanthamoeba-il-chmp-raccomanda-l-approvazione-della-poliesanide]]></loc><lastmod>2024-06-11T17:52:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/20902-malattie-rare-la-sostenibilita-delle-cure-e-sempre-piu-difficile]]></loc><lastmod>2024-04-23T17:09:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/20702-nefropatia-da-iga-parere-positivo-del-chmp-per-sparsentan]]></loc><lastmod>2024-02-29T12:51:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/20595-carenza-enzimi-pancreatici-sbloccato-un-lotto-da-38mila-confezioni]]></loc><lastmod>2024-02-06T12:38:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/20587-il-comparatore-per-farmaci-orfani-una-survey-per-mettere-a-sistema-le-difficolta-nelle-negoziazioni]]></loc><lastmod>2024-02-05T13:55:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/20242-deficit-dell-ormone-della-crescita-ora-disponibile-il-nuovo-trattamento-a-somministrazione-settimanale]]></loc><lastmod>2023-10-18T11:02:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/20113-agenzia-italiana-del-farmaco-apre-le-porte-nasce-aifa-incontra]]></loc><lastmod>2024-02-22T19:01:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/20087-fibrodisplasia-ossificante-progressiva-palovarotene-approvato-dalla-fda]]></loc><lastmod>2023-09-08T14:46:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/19941-citomegalovirus-maribavir-rimborsabile-in-italia]]></loc><lastmod>2023-06-29T10:06:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/19677-disturbi-dello-spettro-della-neuromielite-ottica-inebilizumab-disponibile-in-italia]]></loc><lastmod>2023-03-31T11:25:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/19173-neuromielite-ottica-eculizumab-rimborsabile-in-italia]]></loc><lastmod>2022-10-14T15:57:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/19168-malattia-da-inclusioni-microvillari-crofelemer-ottiene-status-di-farmaco-orfano-in-europa]]></loc><lastmod>2022-10-13T16:56:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/19134-neuromielite-ottica-arriva-in-italia-il-farmaco-sottocutaneo-satralizumab]]></loc><lastmod>2022-09-30T13:34:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/19132-malattie-rare-nasce-il-consorzio-agora-access-to-gene-therapies-for-rare-disease]]></loc><lastmod>2022-09-30T13:26:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/19076-sclerosi-tuberosa-aifa-approva-l-uso-di-cannabidiolo]]></loc><lastmod>2022-09-21T13:24:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/18924-malattie-rare-a-rischio-terapie-geniche-efficaci]]></loc><lastmod>2022-07-21T10:46:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/18926-osteomalacia-oncogenica-parere-positivo-del-chmp-sull-impiego-di-burosumab]]></loc><lastmod>2022-07-19T14:32:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/18767-malattia-da-inclusioni-microvillari-richiesta-all-ema-la-designazione-di-farmaco-orfano-per-crofelemer]]></loc><lastmod>2022-06-13T15:26:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/18338-regolamento-europeo-sui-farmaci-orfani-e-testo-unico-malattie-rare-necessario-spingere-sull-acceleratore]]></loc><lastmod>2022-02-24T21:21:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/18300-malattia-delle-agglutinine-fredde-fda-approva-sutimlimab-jome]]></loc><lastmod>2022-02-13T16:48:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/18206-tubercolosi-multifarmaco-resistente-aifa-dice-si-alla-rimborsabilita-di-pretomanid]]></loc><lastmod>2022-01-23T20:10:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/18062-farmaci-orfani-fondo-5-aifa-dopo-il-blocco-arrivano-nuovi-e-piu-restrittivi-criteri-di-accesso]]></loc><lastmod>2021-12-01T18:14:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/17979-malattie-rare-l-ue-sta-lavorando-a-una-revisione-del-regolamento-sui-farmaci-orfani]]></loc><lastmod>2021-11-08T11:23:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/17978-malattie-rare-oggi-la-vi-edizione-dell-orphan-drug-day-dedicata-alle-novita-normative]]></loc><lastmod>2021-11-08T11:21:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/17683-nefropatia-da-iga-calliditas-e-stada-collaborano-per-portare-una-nuova-terapia-in-europa]]></loc><lastmod>2021-07-25T17:40:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/17446-sindrome-di-noonam-approvazione-per-la-somatropina-liquida]]></loc><lastmod>2021-05-26T08:11:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/17378-neuromielite-ottica-il-chmp-raccomanda-l-approvazione-di-satralizumab]]></loc><lastmod>2021-05-02T20:42:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/16858-carcinoma-uroteliale-ok-dell-ema-per-avelumab]]></loc><lastmod>2020-12-30T18:29:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/16773-pericardite-idiopatica-ricorrente-si-avvicina-la-possibilita-di-una-nuova-terapia]]></loc><lastmod>2020-12-06T20:42:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/16576-paralisi-sopranucleare-progressiva-pronto-a-partire-lo-studio-di-fase-iia-su-ezeprogind]]></loc><lastmod>2020-10-19T17:05:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/16362-acondroplasia-l-ema-valuta-l-immissione-in-commercio-del-farmaco-vosoritide]]></loc><lastmod>2020-08-10T16:19:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/16304-carcinoma-uroteliale-fda-approva-avelumab-come-terapia-di-mantenimento]]></loc><lastmod>2020-07-19T18:40:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/16030-bronchiolite-obliterante-designazione-fast-track-da-fda-per-la-ciclosporina-a-da-inalazione]]></loc><lastmod>2020-05-05T16:07:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/15979-farmaci-orfani-giuste-le-verifiche-regolatorie-ma-occorre-diminuire-i-tempi]]></loc><lastmod>2020-04-20T16:16:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/15941-farmaci-orfani-per-migliorarne-l-accesso-occorrono-negoziazioni-piu-snelle]]></loc><lastmod>2020-04-12T23:25:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/15744-farmaci-orfani-aumentano-di-numero-ma-in-italia-servono-piu-studi-clinici]]></loc><lastmod>2020-03-10T19:53:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/15737-farmaci-orfani-per-un-pronto-accesso-e-cruciale-il-contesto-normativo]]></loc><lastmod>2020-03-09T22:46:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/15719-cheratopatia-neurotrofica-grazie-a-nuovo-farmaco-e-possibile-il-ripristino-della-cornea]]></loc><lastmod>2020-03-03T16:53:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/15637-malattie-rare-e-accesso-alle-terapie-eterna-lotta-contro-il-tempo]]></loc><lastmod>2020-02-06T11:26:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/15484-terapie-avanzate-in-un-solo-giorno-doppio-successo-per-l-italia]]></loc><lastmod>2019-12-08T18:56:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/15405-malattie-rare-iii-rapporto-ossfor-i-farmaci-impiegano-ancora-troppo-tempo-per-giungere-sul-mercato]]></loc><lastmod>2019-11-12T12:14:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/15222-disturbi-dello-spettro-della-neuromielite-ottica-eculizumab-approvato-in-europa]]></loc><lastmod>2019-09-21T23:45:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/14407-farmaci-l-aifa-istituisce-un-tavolo-permanente-di-consultazione-con-le-associazioni-dei-pazienti]]></loc><lastmod>2019-01-31T18:23:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/14387-europa-84-nuovi-farmaci-approvati-dall-ema-nel-2018]]></loc><lastmod>2020-10-12T09:32:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/14282-sclerosi-tuberosa-everolimus-efficace-a-lungo-termine-contro-le-crisi-epilettiche]]></loc><lastmod>2018-12-16T18:14:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/14124-fibrodisplasia-ossificante-progressiva-domanda-di-approvazione-usa-per-palovarotene]]></loc><lastmod>2018-11-06T21:47:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/13887-malattie-neuromuscolari-quale-sara-la-terapia-del-futuro]]></loc><lastmod>2018-09-04T11:00:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/13467-malattie-rare-l-impegno-di-sobi-serieta-e-dedizione-per-migliorare-la-vita-dei-pazienti]]></loc><lastmod>2019-09-10T14:13:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/13459-batteri-multiresisteniti-disponibile-in-italia-la-combinazione-ceftazidima-avibactam]]></loc><lastmod>2018-04-18T14:33:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/13254-tumori-del-sangue-pubblicato-in-gazzetta-il-regime-di-rimborsabilita-per-zalmoxis]]></loc><lastmod>2018-02-21T02:20:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/13153-terapia-genica-e-immunoterapia-bluebird-bio-chiedera-l-approvazione-di-tre-farmaci]]></loc><lastmod>2021-02-23T11:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/13138-tumori-del-sangue-depositato-il-dossier-prezzo-rimborso-in-germania-per-zalmoxis]]></loc><lastmod>2018-01-30T17:31:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/12550-farmaci-orfani-a-luglio-5-nuove-approvazioni]]></loc><lastmod>2020-06-26T09:18:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/12549-farmaci-orfani-regole-e-regolamentazione-tutto-quello-che-bisogna-sapere]]></loc><lastmod>2017-07-31T08:57:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/12537-molmed-e-dompe-firmato-un-accordo-per-zalmoxis-in-europa]]></loc><lastmod>2017-07-26T13:44:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/12433-sclerosi-tuberosa-everolimus-efficace-nella-riduzione-di-tumori-associati]]></loc><lastmod>2017-07-02T18:29:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/12424-premio-galeno-2017-proclamati-i-vincitori]]></loc><lastmod>2017-06-23T14:56:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/12397-carcinoma-uroteliale-nivolumab-approvato-in-europa]]></loc><lastmod>2017-06-17T10:42:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/12375-c-e-solo-un-giusto-approccio-per-il-business-farmaceutico-ascoltare-i-pazienti]]></loc><lastmod>2017-06-12T10:04:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/12328-ipoparatiroidismo-autorizzata-la-commercializzazione-della-terapia-ormonale-sostitutiva]]></loc><lastmod>2017-05-29T08:52:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/12048-farmaci-orfani-un-giro-miliardario-farmaindustria-risponde-alle-accuse]]></loc><lastmod>2026-03-12T15:31:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11889-cistinosi-l-ue-autorizza-l-immissione-in-commercio-di-cisteamina-cloridrato-in-collirio]]></loc><lastmod>2017-02-04T16:29:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11803-cancro-ovarico-fda-approva-rucaparib]]></loc><lastmod>2017-01-15T16:28:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11729-farmaci-orfani-pediatrici-lanciata-una-consultazione-pubblica-europea]]></loc><lastmod>2016-12-16T17:17:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11643-mucopolisaccaridosi-i-la-molecola-elx-02-e-farmaco-orfano-in-europa-e-stati-uniti]]></loc><lastmod>2016-11-23T18:09:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11554-malattia-acuta-da-rigetto-l-anticorpo-sperimentale-alxn1007-riceve-status-orfano-da-fda]]></loc><lastmod>2016-11-02T11:55:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11469-farmaci-orfani-oggi-e-domani-l-aifa-ospita-il-meeting-del-comp]]></loc><lastmod>2016-10-17T08:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11313-miastenia-gravis-firdapse-amifampridina-fosfato-e-farmaco-orfano-negli-usa]]></loc><lastmod>2016-09-24T10:59:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11218-disturbi-del-ciclo-dell-urea-fda-concede-status-orfano-alla-molecola-synb1020-ora-in-fase-preclinica]]></loc><lastmod>2016-09-10T11:03:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11219-fibrosi-cistica-nuovo-antifungino-per-uso-inalatorio-designato-farmaco-orfano-negli-usa]]></loc><lastmod>2016-09-10T11:15:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11208-neuromielite-ottica-nmo-e-nmosd-fda-concede-status-orfano-a-ublituximab]]></loc><lastmod>2016-09-10T09:16:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11209-malattia-di-huntington-da-fda-status-di-farmaco-orfano-ad-anticorpo-monoclonale-vx15]]></loc><lastmod>2016-09-10T09:25:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11179-leucemia-linfatica-cronica-designazione-di-farmaco-orfano-per-terapia-tgr-1202]]></loc><lastmod>2016-09-01T16:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11155-malattia-acuta-da-rigetto-la-terapia-sperimentale-alxn1007-e-farmaco-orfano-in-europa]]></loc><lastmod>2016-08-30T09:41:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11143-fibrodisplasia-ossificante-progressiva-il-dipiridamolo-inibisce-il-gene-responsabile-della-malattia]]></loc><lastmod>2016-08-26T11:45:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11092-uveite-non-infettiva-refrattaria-infliximab-e-adalimumab-equivalenti-in-termini-di-efficacia]]></loc><lastmod>2016-08-05T10:55:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11086-iperinsulinismo-congenito-xoma-358-riceve-designazione-di-farmaco-orfano-da-ema]]></loc><lastmod>2016-08-04T14:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11054-sperimentazioni-sui-farmaci-aperta-la-consultazione-pubblica-europea-sul-rischio]]></loc><lastmod>2016-07-29T12:06:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11040-malattie-rare-parlamento-chiede-piu-attenzione-per-farmaci-orfani]]></loc><lastmod>2016-07-28T07:48:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/11011-encefalite-limbica-autoimmune-efficace-il-rituximab-come-trattamento-di-seconda-linea]]></loc><lastmod>2016-07-21T13:53:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10938-osteogenesi-imperfetta-il-composto-bps-804-e-farmaco-orfano-in-europa]]></loc><lastmod>2016-07-08T17:07:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10936-retinopatia-del-prematuro-sperimentazione-su-farmaco-shp607-non-raggiunge-l-endpoint-primario]]></loc><lastmod>2016-07-08T16:47:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10926-ittiosi-lamellare-positiva-la-prima-fase-di-sviluppo-clinico-del-farmaco-trifarotene]]></loc><lastmod>2016-07-06T21:57:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10895-farmaci-ema-eunethta-prosegue-la-collaborazione]]></loc><lastmod>2016-07-04T22:25:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10890-farmaci-orfani-nei-paesi-dell-europa-centrale-e-orientale-il-finanziamento-e-piu-costoso]]></loc><lastmod>2016-06-30T14:48:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10892-tumori-del-sangue-parere-positivo-del-comp-sulla-designazione-di-farmaco-orfano-per-zalmoxis]]></loc><lastmod>2016-07-01T08:51:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10886-produzione-di-medicinali-per-terapie-avanzate-certificata-dall-aifa-l-officina-farmaceutica-del-bambino-gesu]]></loc><lastmod>2016-06-30T14:04:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10857-spese-catastrofiche-l-impoverimento-dei-pazienti-affetti-da-una-malattia-rara-in-cina]]></loc><lastmod>2016-06-24T13:46:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10855-farmaci-orfani-la-collaborazione-fra-europa-stati-uniti-e-giappone]]></loc><lastmod>2016-06-24T13:30:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10829-antrace-il-vaccino-biothrax-e-farmaco-orfano-negli-usa]]></loc><lastmod>2016-06-21T13:50:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10832-arriva-il-rapporto-osmed-di-aifa-i-farmaci-orfani-sono-lo-0-04-per-cento-del-totale]]></loc><lastmod>2016-06-22T14:35:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10818-malattie-gastrointestinali-rare-da-fda-status-di-breakthrough-therapy-a-due-farmaci-sperimentali-di-shire]]></loc><lastmod>2016-06-17T12:25:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10828-farmaci-aifa-seconda-in-europea-per-tempistiche-a-rallentare-la-procedura-ci-pensano-le-regioni]]></loc><lastmod>2016-06-21T13:35:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10765-emoglobinuria-parossistica-notturna-assegnata-denominazione-orfana-a-farmaco-alxn1210-in-europa]]></loc><lastmod>2016-09-16T08:42:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10739-coccidioidomicosi-il-composto-vt-1598-e-farmaco-orfano-negli-usa]]></loc><lastmod>2016-06-03T10:06:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10738-atassia-spinocerebellare-il-composto-sperimentale-bhv-4157-dichiarato-farmaco-orfano-da-fda]]></loc><lastmod>2016-06-03T10:04:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10737-antitumorali-buone-prospettive-per-il-farmaco-entrectinib]]></loc><lastmod>2016-06-03T10:01:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10736-come-si-conservano-i-farmaci-d-estate-scarica-gratuitamente-la-guida-aifa]]></loc><lastmod>2016-06-03T09:59:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10733-uveite-non-infettiva-da-ema-parere-positivo-sull-uso-del-farmaco-humira-adalimumab]]></loc><lastmod>2020-01-20T15:08:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10728-sclerosi-tuberosa-risultati-positivi-da-studio-clinico-avanzato-su-afinitor-everolimus]]></loc><lastmod>2017-06-22T13:46:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10725-sindrome-da-intestino-corto-ema-raccomanda-l-uso-del-farmaco-revestive-anche-per-i-pazienti-piu-piccoli]]></loc><lastmod>2024-02-08T15:13:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10716-epatite-c-mieloma-multiplo-e-diabete-parere-positivo-del-chmp-per-sei-nuovi-farmaci]]></loc><lastmod>2016-06-01T14:10:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10706-farmaci-illegali-online-rivolgersi-al-web-e-pericoloso-e-illegale]]></loc><lastmod>2016-12-27T19:25:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10675-distrofie-muscolari-congenite-concessa-la-revisione-accelerata-per-omigapil]]></loc><lastmod>2016-05-24T13:40:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10660-candidosi-invasiva-negli-usa-status-di-farmaco-orfano-per-la-terapia-sperimentale-scy-078]]></loc><lastmod>2016-05-20T12:14:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10595-farmaci-orfani-sono-in-grado-di-soddisfare-le-soglie-di-rimborso-tradizionali]]></loc><lastmod>2016-05-18T09:56:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10510-farmaci-orfani-tre-nuove-terapie-in-fase-di-revisione-da-parte-dell-ema]]></loc><lastmod>2016-05-02T14:38:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10509-farmaci-orfani-ema-raccomanda-la-designazione-orfana-per-14-nuove-terapie]]></loc><lastmod>2016-05-02T13:29:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10454-status-epilepticus-ganaxolone-riceve-la-designazione-di-farmaco-orfano-da-fda]]></loc><lastmod>2016-04-26T14:32:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10344-arriva-il-primo-farmaco-prodotto-con-una-stampante-3d]]></loc><lastmod>2016-04-11T06:28:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10325-deficit-di-fattore-x-coagadex-approvato-dall-ema]]></loc><lastmod>2016-04-08T08:28:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10324-farmaci-orfani-ok-dal-chmp-dell-ema-per-infliximab]]></loc><lastmod>2016-04-08T07:58:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10321-narcolessia-l-ema-autorizza-l-uso-di-pitolisant]]></loc><lastmod>2016-04-07T15:04:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10189-sindrome-di-hallervorden-spatz-ema-dichiara-farmaco-orfano-la-terapia-sperimentale-re-024]]></loc><lastmod>2016-07-01T10:19:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10178-anemia-emolitica-autoimmune-in-europa-la-terapia-sperimentale-tnt009-diventa-farmaco-orfano]]></loc><lastmod>2016-03-11T13:38:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10136-farmaci-ema-lancia-il-programma-prime-per-i-bisogni-medici-non-soddisfatti]]></loc><lastmod>2016-03-08T08:33:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/10054-farmaci-che-agiscono-sul-cervello-un-nuovo-studio-apre-grandi-prospettive]]></loc><lastmod>2016-04-15T18:25:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9951-lesione-acuta-del-midollo-spinale-la-terapia-sperimentale-ast-opc1-e-farmaco-orfano-negli-usa]]></loc><lastmod>2016-02-12T13:52:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9913-malattia-di-krabbe-qualifica-di-rara-malattia-pediatrica-concessa-al-farmaco-mn-166-ibudilast]]></loc><lastmod>2016-02-05T14:10:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9863-farmaci-orfani-tre-nuove-approvazioni-dall-ema]]></loc><lastmod>2016-02-01T09:02:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9747-farmaci-orfani-cresce-il-sostegno-dell-italia-per-il-loro-sviluppo]]></loc><lastmod>2016-01-15T09:54:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9724-farmaci-autorizzati-nell-ue-l-ema-estendera-l-accesso-ai-report-sulle-sospette-reazioni-avverse]]></loc><lastmod>2016-01-11T12:05:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9723-ema-raccomandata-l-autorizzazione-all-immissione-in-commercio-per-nove-nuovi-farmaci]]></loc><lastmod>2016-01-11T12:02:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9718-il-47-dei-farmaci-approvati-dall-fda-nel-2015-sono-orfani]]></loc><lastmod>2016-01-11T09:19:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9717-u-s-a-quarantacinque-nuovi-farmaci-approvati-dalla-fda]]></loc><lastmod>2016-01-11T09:26:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9655-paralisi-periodica-fda-approva-il-farmaco-keveyis-dichlorphenamide]]></loc><lastmod>2015-12-21T16:16:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9554-farmaci-orfani-la-commissione-europea-avvia-una-consultazione-pubblica]]></loc><lastmod>2015-12-10T09:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9521-immunoterapia-oncologica-vincono-il-premio-galeno-2015-nivolumab-e-pembrolizumab]]></loc><lastmod>2015-12-03T15:14:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9476-narcolessia-parere-positivo-dell-ema-per-pitolisant]]></loc><lastmod>2015-11-27T16:17:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9444-farmaci-orfani-scoperto-effetto-pleiotropico-dell-anticoagulante-dabigatran]]></loc><lastmod>2015-11-25T16:23:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9439-discinesia-tardiva-fda-concede-a-farmaco-sperimentale-sd-809-lo-status-di-breakthrough-therapy]]></loc><lastmod>2015-11-25T15:56:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9305-farmaci-orfani-troppi-paesi-ancora-privi-di-una-legislazione-specifica]]></loc><lastmod>2015-11-06T11:40:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9303-distrofia-muscolare-oculofaringea-positivi-i-primi-dati-dalla-sperimentazione-sui-iv-trealosio]]></loc><lastmod>2015-11-10T18:10:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9270-trapianto-renale-fda-concede-una-valutazione-fast-track-al-farmaco-sperimentale-cinryze]]></loc><lastmod>2015-10-30T10:46:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9256-acondroplasia-presentati-i-primi-dati-dalla-sperimentazione-di-fase-ii-di-vosoritide-bmn-111]]></loc><lastmod>2015-10-29T16:04:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9207-farmaci-orfani-l-appello-di-eurodis-per-migliorarne-l-accesso]]></loc><lastmod>2015-12-15T14:40:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9067-idrosadenite-suppurativa-attiva-approvato-da-commissione-europea-adalimumab]]></loc><lastmod>2015-10-08T13:56:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9049-difetti-dell-ossidazione-degli-acidi-grassi-dati-incoraggianti-dalla-terapia-con-triheptanoin]]></loc><lastmod>2015-11-13T12:27:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/9037-aciduria-orotica-ereditaria-fda-approva-il-farmaco-orfano-xuriden-uridina-triacetato]]></loc><lastmod>2015-10-02T14:36:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8962-malattie-rare-l-aifa-analizza-la-nuova-guida-fda-per-lo-sviluppo-dei-farmaci]]></loc><lastmod>2015-09-22T10:48:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8863-polineuropatia-demielinizzante-infiammatoria-cronica-il-farmaco-sperimentale-gl-2045-designato-farmaco-orfano-dalla-fda]]></loc><lastmod>2015-09-04T11:08:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8768-sindrome-miastenica-di-lambert-eaton-avviata-la-richiesta-di-approvazione-del-farmaco-firdapse-in-america]]></loc><lastmod>2015-08-06T20:40:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8760-emofilia-a-acquisita-l-ema-raccomanda-l-approvazione-del-farmaco-obizur]]></loc><lastmod>2015-08-06T16:52:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8742-colangiocarcinoma-melfalan-designato-farmaco-orfano-dalla-fda]]></loc><lastmod>2015-07-31T12:35:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8730-farmaci-orfani-oftalmologia-e-trapiantologia-la-ricerca-dompe-sui-farmaci-orfani]]></loc><lastmod>2016-12-27T16:47:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8729-tumori-rari-l-eccellenza-della-ricerca-farmaceutica-italiana]]></loc><lastmod>2016-12-27T16:49:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8725-farmaci-orfani-l-accordo-di-collaborazione-e-ricerca-tra-shire-e-l-istituto-telethon-di-genetica-e-medicina-tigem]]></loc><lastmod>2016-12-27T16:49:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8727-infezioni-parere-positivo-del-chmp-per-l-antibiotico-sperimentale-zerbaxa]]></loc><lastmod>2018-12-07T19:23:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8708-come-si-fa-ricerca-sui-farmaci-orfani-ce-lo-spiega-il-prof-emilio-clementi]]></loc><lastmod>2016-12-27T16:53:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8689-australia-avviata-una-consultazione-sul-programma-sui-farmaci-orfani]]></loc><lastmod>2015-07-24T09:55:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8687-fibrodisplasia-ossificante-progressiva-clementia-pharm-investe-sullo-sviluppo-del-farmaco-palovarotene]]></loc><lastmod>2018-08-03T14:02:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8686-cirrosi-biliare-primitiva-l-iter-di-approvazione-dell-acido-obeticolico-procede-sia-in-europa-che-negli-stati-uniti]]></loc><lastmod>2015-07-24T09:10:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8706-farmaci-orfani-in-italia-la-ricerca-e-eccellente]]></loc><lastmod>2016-12-27T16:52:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8703-farmaci-orfani-il-ministero-vuole-agevolare-la-ricerca-e-lo-sviluppo]]></loc><lastmod>2016-12-27T16:54:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8647-idrosadenite-suppurativa-parere-positivo-del-chmp-per-adalimumab]]></loc><lastmod>2015-07-20T15:11:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8658-farmaci-da-federfarma-nuovo-servizio-di-consegna-a-domicilio-per-le-persone-piu-fragili]]></loc><lastmod>2015-07-21T10:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8591-farmaci-orfani-italia-in-prima-linea-nella-ricerca]]></loc><lastmod>2015-07-08T14:59:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8583-farmaci-orfani-davvero-non-c-e-ricerca]]></loc><lastmod>2016-02-08T15:55:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8553-sindrome-da-intestino-corto-ntra-9620-ottiene-da-fda-la-designazione-di-farmaco-orfano]]></loc><lastmod>2015-07-02T14:32:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8486-farmaci-per-le-malattie-da-accumulo-lisosomiale-l-effetto-dell-orphan-drug-act-negli-usa]]></loc><lastmod>2015-06-25T07:05:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8485-farmaci-orfani-in-usa-si-reintroduce-l-esclusivita-di-mercato]]></loc><lastmod>2015-06-19T13:31:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8427-spondilite-anchilosante-una-nuova-meta-analisi-conferma-l-efficacia-dei-farmaci-anti-tnf-alfa]]></loc><lastmod>2015-06-12T09:26:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8393-farmaci-innovativi-pubblicata-la-relazione-annuale-ema-2014]]></loc><lastmod>2015-06-05T13:29:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8381-disturbi-sonno-veglia-ema-raccomanda-la-prima-terapia-in-europa]]></loc><lastmod>2015-06-05T08:53:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8340-farmaci-orfani-in-europa-valutazione-del-valore-e-finanziamento-sostenibile]]></loc><lastmod>2015-05-28T14:57:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8248-farmaci-luca-pani-aifa-istituiamo-un-comitato-etico-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8087-melanoma-uveale-lfda-riconosce-la-designazione-di-farmaco-orfano-a-selumetinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8044-ipocalcemia-associata-a-ipoparatiroidismo-natpara-disponibile-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8043-enterocolite-necrotizzante-sigma-tau-riceve-la-designazione-di-farmaco-orfano-per-il-suo-stp-206]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8017-linfangioleiomiomatosi-fda-verso-lautorizzazione-del-farmaco-sirolimus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/8000-malattie-rare-fda-approva-luso-dellacido-colico-per-i-disturbi-perossisomiali-e-della-sintesi-degli-acidi-biliari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7991-sindrome-emolitico-uremica-atipica-aggiornamenti-sulluso-di-eculizumab-in-ue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7829-anticoaugulanti-orali-depositato-a-ema-e-fda-il-dossier-per-idarucizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7816-leucemia-mieloide-acuta-alvocidib-di-tolero-pharmaceuticals-riceve-la-designazione-di-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7737-immunoglobuline-inaugurato-nuovo-stabilimento-kendrion-in-toscana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7649-distrofia-facio-scapolo-omerale-resolaris-ottiene-la-designazione-di-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7648-malattie-autoimmuni-sanofi-firma-accordo-con-lead-pharma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7611-malattie-rare-accordo-shire-nps-pharmaceuticals]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7585-farmaci-orfani-molti-passi-avanti-ma-ancora-parecchio-lavoro-da-fare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7423-farmaci-orfani-consumo-in-crescita-in-olanda]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7418-malattie-rare-shire-acquisisce-nps-pharmaceuticals-e-punta-alla-produzione-di-farmaci-orfani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7413-malattie-rare-quando-le-aziende-puntano-sui-farmaci-orfani]]></loc><lastmod>2019-06-18T17:51:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7417-malattie-rare-bilancio-positivo-dellema-per-lanno-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7296-miastenia-gravis-in-giappone-soliris-ha-ottenuto-lo-status-di-farmaco-orfano-per-il-trattamento-della-malattia]]></loc><lastmod>2024-03-20T10:27:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7278-stabilita-un-emendamento-mette-a-rischio-i-farmaci-per-i-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7222-fibrodisplasia-ossificante-progressiva-il-farmaco-palovarotene-ottiene-il-riconoscimento-di-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7207-distrofia-di-duchenne-biomarin-impegnata-nello-sviluppo-di-nuova-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7045-entro-il-2020-i-farmaci-orfani-rappresenteranno-il-19-per-cento-del-mercato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/7044-lipodistrofia-aegerion-pharmaceuticals-acquista-myalept-da-astrazeneca]]></loc><lastmod>2017-04-12T13:09:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/6955-leucemie-il-chmp-dellema-conferma-parere-positivo-sulluso-di-ponatinib-in-pazienti-resistenti-o-intolleranti-ad-altri-inibitori-delle-tirosin-chinasi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/6874-sindrome-miastenica-di-lambert-eaton-presentati-nuovi-dati-su-firdapse]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/6613-colite-ulcerosa-il-farmaco-rosburix-riceve-la-designazione-di-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/6611-infezioni-necrotizzanti-dei-tessuti-molli-concessa-qualificazione-di-farmaco-orfano-al-ab103]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/6410-ittiosi-congenita-trifarotene-ottiene-la-designazione-di-farmaco-orfano]]></loc><lastmod>2016-07-06T22:17:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/6252-farmaci-orfani-da-cosa-dipende-il-prezzo-uno-studio-statistico-indaga-sulle-possibili-variabili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/6239-farmaci-orfani-vantaggi-e-svantaggi-delluso-off-label]]></loc><lastmod>2019-06-18T18:15:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5956-prevenzione-del-rigetto-dei-trapianti-concessa-la-designazione-di-farmaco-orfano-a-eculizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5936-bronchiectasia-non-legata-alla-fibrosi-cistica-approvato-negli-usa-il-trattamento-con-ciprofloxacina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5864-cellule-staminali-durante-il-festeggiamento-dei-40-anni-di-embt-lannuncio-di-un-nuovo-traguardo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5790-cheratocono-risposta-dellfda-alla-richiesta-nda-per-la-soluzione-oftalmica-riboflavina-kxlr-system]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5775-leucemie-ad-alto-rischio-lema-ha-validato-la-sottomissione-della-domanda-di-conditional-approval-per-la-terapia-genica-tk]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5769-farmaci-innovativi-ema-lancia-la-licenza-adattiva-per-accelerare-i-tempi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5697-linfoma-periferico-a-cellule-t-revisione-accelerata-per-belinostat]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5682-farmaci-orfani-aumentano-le-raccomandazioni-per-immissione-in-commercio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5588-status-di-farmaco-orfano-concesso-a-soliris-farmaco-che-previene-le-complicanze-dopo-un-trapianto-dorgano]]></loc><lastmod>2024-03-20T10:28:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5539-farmaci-orfani-serve-un-nuovo-approccio-europeo-allapprovazione-e-alla-registrazione-di-terapie-innovative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5398-diabete-di-tipo-1-nuova-immunoterapia-ottiene-il-riconoscimento-fda-come-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5354-immunoterapia-cytovir-adv-riceve-la-designazione-di-farmaco-orfano-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5302-bronchiectasie-il-farmaco-erdosteina-r-riceve-la-designazione-di-farmaco-orfano]]></loc><lastmod>2025-11-21T18:21:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5263-farmaci-orfani-nuova-collaborazione-di-ema-e-eunetht-per-valutarne-il-rapporto-costo-efficacia]]></loc><lastmod>2016-08-08T19:21:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5262-farmaci-orfanilema-offre-ulteriori-vantaggi-fiscali-per-incentivare-le-aziende]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5228-rene-policistico-lema-esamina-il-dossier-registrativo-di-tolvaptan]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5189-ipotiroidismo-pazienti-ed-esperti-preoccupati-dallintroduzione-del-farmaco-generico-levotiroxina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5146-farmaci-orfani-allarme-ema-4-prodotti-sono-carenti-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5106-farmaci-orfani-un-nuovo-strumento-per-valutarne-levidenza-clinica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/5073-lupus-eritematoso-discoide-il-farmaco-sperimentale-r333-delude-le-aspettative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4980-autoriapprovato-in-europa-il-farmaco-per-la-malattia-veno-occlusiva-epatica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4928-uveite-pediatrica-risultati-positivi-per-il-trattamento-con-il-farmaco-biologico-adalimumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4880-deficit-del-cofattore-molibdeno-tipo-a-negli-usa-via-livera-alla-terapia-sostitutica-cpmp]]></loc><lastmod>2025-04-18T09:23:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4788-farmaci-orfani-negli-usa-si-stanno-sviluppando-452-medicinali-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4686-malattie-rare-il-ruolo-chiave-dei-pazienti-e-familiari-sostenitori-nella-scoperta-di-nuovi-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4579-artrite-idiopatica-giovanile-sistemica-approvata-in-europa-la-terapia-con-canakinumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4408-trial-clinici-ema-apre-una-consultazione-pubblica-sulle-politiche-accesso-ai-dati-delle-sperimentazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4404-timoma-maligno-ora-a-disposizione-un-nuovo-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4290-neuromielite-ottica-eculizumab-riceve-la-designazione-di-farmaco-orfano-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4229-farmaci-orfani-entro-il-2018-previsto-il-raddoppio-delle-venditer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4195-eritromelalgia-em-status-orfano-della-fda-per-un-farmaco-non-oppiaceo-contro-il-dolore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4194-cistinosi-negli-usa-arriva-il-primo-collirio-studiato-per-il-trattamento-dei-depositi-di-cristalli-nella-cornea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4137-ipofosfatasia-hpp-la-fda-riconosce-valore-innovativo-al-farmaco-sperimentale-di-alexion]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4008-malattia-del-rene-policistico-presto-la-valutazione-fda-sul-farmaco-tolvaptan]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/4006-farmaci-orfani-ema-taglia-le-agevolazioni-fiscali-la-preoccupazione-delle-imprese-biofarmaceutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3967-farmaci-orfani-le-domande-di-autorizzazione-al-commercio-aumentate-del-36-per-cento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3673-disturbi-del-ciclo-dellurea-fda-approva-il-nuovo-farmaco-racivti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3605-farmaci-orfani-eurordis-incontra-il-parlamento-europeo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3583-nomid-la-fda-approva-luso-di-kineret-nei-bambini-il-farmaco-orfano-e-gia-usato-per-lartrite-reumatoide]]></loc><lastmod>2022-10-19T14:21:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3497-malattia-di-fabry-il-farmaco-di-amicus-therapeutics-non-ha-raggiunto-lendpoint-finale]]></loc><lastmod>2016-08-06T09:53:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3460-farmaci-utra-orfani-dagli-usa-un-programma-per-contenere-i-costi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3467-farmaci-orfani-troppo-costosi-ecco-la-proposta-di-nuovi-criteri-di-valutazione]]></loc><lastmod>2016-08-08T19:23:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3281-farmaci-orfani-le-politiche-nazionali-devono-essere-migliorate-serve-piu-attenzione-allefficacia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3183-artrite-reumatoide-dopo-16-anni-di-studi-approvato-negli-usa-il-farmaco-orale-di-pfizer]]></loc><lastmod>2017-08-24T08:17:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3180-mesotelioma-pleurico-maligno-status-orfano-per-l-amatuximab-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3162-angiomiolipomi-renali-associati-a-sclerosi-tuberosa-via-libera-alluso-di-everolimus-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3130-sindrome-miastenica-di-lambert-eaton-presto-firdapse-anche-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3101-farmaci-orfani-accordo-alexion-pharma-international-sarl-patheon-per-la-produzione-di-solirisr-a-monza]]></loc><lastmod>2024-03-20T10:30:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/3035-sindrome-dellintestino-corto-raccomandato-luso-di-teduglutide-per-gli-adulti]]></loc><lastmod>2016-05-31T15:44:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2965-neuromielite-ottica-si-studia-luso-di-eculizumab-potrebbe-prevenire-i-danni-irreversibili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2964-farmaci-orfani-eucerd-raccomanda-la-creazione-di-un-flusso-di-informazioni-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2968-sclerosi-tuberosa-con-astrocitoma-subependimale-a-cellule-giganti-fda-approva-everolimus-per-uso-pediatrico]]></loc><lastmod>2016-05-03T21:02:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2905-cistinosi-approvato-negli-usa-il-farmaco-di-sigma-tau-contro-le-conseguenze-oculari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2906-cistinosi-approvato-negli-usa-il-farmaco-di-sigma-tau-contro-le-conseguenze-oculari-79196166]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2872-sindrome-di-leigh-via-libera-dellema-a-un-nuovo-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2728-sclerosi-tuberosa-fda-approva-everolimus-per-luso-pediatrico]]></loc><lastmod>2018-12-16T10:23:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2731-farmaci-orfani-lema-mette-a-disposizione-dati-per-facilitare-il-lavoro-delle-aziende]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2596-farmaci-arriva-la-terapia-genica-assobiotec-una-svolta-decisiva-per-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2543-polineuropatia-amiloide-familiare-transtiretina-negli-usa-si-attende-ancora-tafamidis-meglumina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2512-anemia-aplastica-grave-il-trattamento-con-eltrombopag-sembra-promettente]]></loc><lastmod>2015-08-03T16:13:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2478-malattie-rare-presto-le-raccomandazioni-eucerd-sui-farmaci-orfani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2401-teleangectasia-emorragica-ereditaria-il-bevacizumab-e-efficace]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2389-obesita-genetiche-stop-a-studio-nuovo-farmaco-contro-deficit-del-recettore-della-melanocortina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2371-malattia-a-cellule-falciformi-parere-positivo-per-lo-status-orfano-in-ue-al-farmaco-sperimentale-enhoxy]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2343-sarcoma-osseo-e-dei-tessuti-molli-fda-non-approva-ridaforolimus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2358-farmaci-orfani-palmisano-assobiotec-e-lora-delle-alleanze-e-dei-progetti-pubblico-privato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2303-terapie-avanzate-aperta-la-consultazione-sui-farmaci-fino-al-31-luglio-2012]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2263-deficit-congenito-del-fattore-xiii-parere-positivo-dellue-per-catridecacog-farmaco-ricombinante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2261-rituximab-lema-conferma-il-bilancio-positivo-rischi-benefici]]></loc><lastmod>2024-10-16T16:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2223-farmaci-orfani-arrivano-le-early-drug-discovery-and-development-guidelines-linee-guida-internazionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2206-farmaci-orfani-in-europa-raggiunte-le-1000-designazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2136-peste-approvato-dalla-fda-statunitense-il-trattamento-con-levaquin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2137-biotecnologie-del-settore-farmaceutico-segnali-positivi-ma-necessita-di-semplificare-le-regole]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2071-sindrome-di-west-contro-le-crisi-epilettiche-si-guarda-al-carisbamate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/2013-sindrome-miastenica-di-lambert-eaton-on-binetti-presenta-interrogazione-al-ministro-della-salute]]></loc><lastmod>2020-07-16T16:44:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1939-sindrome-di-lambert-eaton-mantegazza-il-prodotto-industriale-garantisce-piu-sicurezza-ai-pazienti-rispetto-al-galenico]]></loc><lastmod>2020-07-16T16:50:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1938-sindrome-di-lamber-eaton-difficile-stabilire-se-lefficacia-del-galenico-sia-uguale-a-quella-del-firdapse]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1937-sindrome-di-lambert-eaton-in-italia-la-sicurezza-dei-pazienti-sacrificata-al-risparmio]]></loc><lastmod>2020-07-16T16:51:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1921-malattie-ultra-rare-concessa-dallema-designazione-di-farmaco-orfano-per-due-nuovi-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1784-sindrome-da-distress-respiratorio-in-usa-approvato-il-primo-surfattante-sintetico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1768-farmaci-orfani-i-tagli-mettono-a-rischio-la-loro-futura-disponibilita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1715-sclerosi-tuberosa-il-trattamento-farmacologico-puo-modificare-la-gravita-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1728-malattie-rare-dal-biotech-i-farmaci-e-le-terapie-del-futuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1442-farmaci-orfani-garattini-dare-questo-status-solo-a-quelli-per-malattie-veramente-rare]]></loc><lastmod>2015-06-05T15:53:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1443-malattie-rare-garattini-consulenza-genetica-e-farmaci-oncologi-orfani-i-nodi-da-sciogliere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1347-farmaci-orfani-il-regina-margherita-di-roma-si-attiva-per-i-preparati-galenici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1281-farmaci-orfani-entro-il-2020-costo-complessivo-in-europa-destinato-ad-assestati-al-4-5-per-cento-della-spesa-farmaceutica-totale]]></loc><lastmod>2016-08-08T19:24:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1245-sclerosi-tuberosa-leverolimus-approvato-dallema-per-il-trattamento-della-malattia]]></loc><lastmod>2018-12-16T10:20:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1244-artrite-idiopatica-giovanile-arriva-anche-in-europa-il-tocilizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1183-sindrome-whim-si-guarda-al-plerixafor-come-possibile-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1181-miopatia-ereditaria-da-corpi-inclusi-designazione-orfana-negli-usa-per-possibile-terapia-sostitutiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/1186-malattie-reumatiche-autoimmuni-sempre-piu-peso-agli-outcome-di-cura-nella-real-life]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/770-batterio-killer-farmaco-orfano-contro-variante-piu-grave-dellepidemia]]></loc><lastmod>2018-12-10T20:53:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/737-lupus-il-belimumab-sempre-piu-vicino-allapprovazione-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/735-acidemia-e-aciduria-il-carbaglu-poterebbe-essere-usato-anche-contro-queste-malattie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/687-staminali-ematopoietiche-per-aiutare-lo-scarso-mobilizzatore-ora-ce-plerixafor]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/666-farmaci-orfani-la-speranza-oggi-passa-dal-biotech]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/572-carcinoma-a-cellule-renali-laxitinib-diventa-farmaco-orfano-in-ue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/568-carenza-di-fibrinogeno-determina-aifa-garantisce-la-disponibilita-in-italia]]></loc><lastmod>2020-12-05T14:59:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/539-anemia-falciforme-il-ferrochelante-deferiprone-diventa-farmaco-orfano-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/519-sclerosi-sistemica-il-paquinimod-diviene-farmaco-orfano-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/491-deficit-fattore-xiii-autorizzato-negli-usa-lunico-farmaco-organo-disponibile]]></loc><lastmod>2015-06-08T10:21:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/407-anemia-di-fanconi-lema-approva-vettore-lentivirale-per-la-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/332-afasia-progressiva-ppa-arriva-il-primo-farmaco-orfano-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/272-farmaci-orfani-in-italia-rappresentano-solo-l15-per-cento-della-spesa-farmaceutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/254-emofilia-per-chi-ha-sviluppato-inibitori-del-fattore-ottavo-umani-arriva-un-nuovo-farmaco-orfano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/239-linfoma-follicolare-approvato-luso-di-rituximab-come-terapia-di-mantenimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/211-artrite-idiopatica-giovanile-sistemica-presto-potrebbe-arrivare-il-primo-farmaco-per-la-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/farmaci-orfani/32-cistinosi-fda-concede-status-di-priority-review-a-soluzione-oftalmica-di-sigma-tau]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22932-mobilita-scolastica-per-i-docenti-con-disabilita-o-malattie-croniche-le-novita-2026-27]]></loc><lastmod>2026-04-13T17:32:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22872-agevolazioni-auto-e-iva-al-4-per-i-veicoli-adattati-non-e-sempre-necessaria-la-legge-104]]></loc><lastmod>2026-03-25T19:26:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22864-congedo-e-malattia-figlio-2026-le-nuove-soglie-di-indennizzo-per-le-famiglie]]></loc><lastmod>2026-03-23T18:02:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22848-inps-gli-assegni-di-invalidita-contributivi-potranno-essere-aumentati-fino-al-minimo]]></loc><lastmod>2026-03-16T17:44:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22833-oblio-oncologico-e-accomodamento-ragionevole-come-si-configura-il-diritto-nella-pratica]]></loc><lastmod>2026-03-11T19:00:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22828-agevolazioni-fiscali-2026-cosa-cambia-davvero-con-la-riforma-della-disabilita]]></loc><lastmod>2026-03-09T17:42:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22782-dal-1-marzo-la-riforma-della-disabilita-si-estende-ad-altre-40-province]]></loc><lastmod>2026-02-24T17:14:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22712-laccomodamento-ragionevole-e-lempowerment-delle-persone-con-disabilita]]></loc><lastmod>2026-02-03T08:55:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22684-dal-2026-cambia-lisee-per-alcune-prestazioni-inps]]></loc><lastmod>2026-01-23T17:37:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22633-invalidita-civile-tutti-gli-importi-previsti-per-il-2026-e-relativi-limiti-di-reddito]]></loc><lastmod>2026-04-21T13:26:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22548-fisco-disponibile-online-una-guida-accessibile-alle-persone-con-disabilita-visiva]]></loc><lastmod>2025-11-25T09:42:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22515-calzature-ortopediche-escluse-dai-rimborsi-interrogazione-alla-camera-e-famiglie-in-difficolta]]></loc><lastmod>2025-11-14T15:08:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22417-permessi-104-la-cassazione-chiarisce-che-conta-lassistenza-non-lorario]]></loc><lastmod>2025-10-19T22:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22358-riforma-della-disabilita-la-sperimentazione-della-nuova-procedura-di-accertamento-si-estende-ad-altre-nove-province]]></loc><lastmod>2025-09-30T21:41:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22306-al-via-il-bonus-psicologo-2025-come-funziona]]></loc><lastmod>2025-09-15T08:55:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22243-assegno-ordinario-di-invalidita-l-integrazione-al-minimo-spetta-anche-con-il-sistema-contributivo]]></loc><lastmod>2025-08-12T07:46:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22229-scarpe-ortopediche-non-piu-rimborsate-famiglie-lasciate-sole-tra-scarica-barile-istituzionale-e-diritti-negati]]></loc><lastmod>2025-11-14T15:08:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22219-dalla-diagnosi-precoce-all-inclusione-evoluzione-dei-diritti-per-le-persone-sorde-in-italia]]></loc><lastmod>2025-07-28T16:25:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22200-tutela-lavorativa-per-i-malati-oncologici-cronici-e-con-patologie-invalidanti-la-legge-e-definitiva]]></loc><lastmod>2026-01-08T10:37:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22196-accessibilita-dal-28-giugno-e-legge-in-tutta-europa-cosa-cambia-per-i-cittadini]]></loc><lastmod>2025-07-15T18:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22175-nuovi-criteri-per-l-accertamento-della-disabilita-in-caso-di-autismo-diabete-di-tipo-2-e-sclerosi-multipla]]></loc><lastmod>2025-07-12T17:01:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22144-agevolazioni-fiscali-2025-la-guida-dell-agenzia-delle-entrate-utile-anche-per-chi-convive-con-una-malattia-rara-o-una-disabilita]]></loc><lastmod>2025-07-09T17:21:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22085-invalidita-civile-nuova-procedura-inps-per-il-passaggio-alla-maggiore-eta-se-si-agisce-sei-mesi-prima-niente-nuova-visita]]></loc><lastmod>2025-06-19T18:21:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22076-invalidita-civile-meno-visite-tempi-piu-rapidi-ecco-come-cambia-il-procedimento]]></loc><lastmod>2025-06-11T15:28:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22062-novita-fiscali-2025-detrazione-per-persone-cieche-con-cane-guida-confermata-e-aggiornata]]></loc><lastmod>2025-06-09T17:44:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22055-ddl-per-i-lavoratori-con-gravi-patologie-un-si-quasi-definitivo-ma-con-tutele-ridotte]]></loc><lastmod>2025-06-05T20:43:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22045-disabilita-e-fisco-2025-tutto-quello-che-serve-sapere-sulla-nuova-circolare-dell-agenzia-delle-entrate]]></loc><lastmod>2025-06-09T10:38:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/22027-tutela-dei-soggetti-fragili-nelle-forniture-di-energia-e-gas-tutte-le-novita-della-legge-60-2025]]></loc><lastmod>2025-05-28T09:45:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21880-assegno-di-inclusione-dopo-le-novita-sui-carichi-di-cura-ecco-le-nuove-soglie-e-integrazioni]]></loc><lastmod>2025-04-07T15:13:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21850-ape-sociale-2025-dall-inps-le-novita-per-caregiver-e-lavoratori-con-disabilita]]></loc><lastmod>2025-03-31T07:27:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21845-inserimento-lavorativo-delle-persone-con-disabilita-le-risorse-2024-arrivano-in-ritardo]]></loc><lastmod>2025-03-26T13:27:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21793-certificato-medico-introduttivo-per-l-invalidita-civile-cosa-cambia-per-i-cittadini]]></loc><lastmod>2025-03-10T19:11:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21775-assegno-di-inclusione-nuove-disposizioni-per-l-attribuzione-dei-carichi-di-cura]]></loc><lastmod>2025-03-04T19:35:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21750-nuove-agevolazioni-fiscali-per-l-assunzione-di-persone-con-disabilita]]></loc><lastmod>2025-02-25T11:38:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21720-assegno-unico-universale-2025-tutte-le-novita-per-le-famiglie-con-figli-con-disabilita]]></loc><lastmod>2025-02-14T17:03:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21687-invalidita-civile-tutti-gli-importi-previsti-per-il-2025-e-relativi-limiti-di-reddito]]></loc><lastmod>2025-02-03T18:02:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21676-semplificazione-delle-procedure-inps-per-la-disabilita-cosa-cambia-per-i-cittadini-nel-2025]]></loc><lastmod>2025-01-30T16:20:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21661-disability-card-con-l-approvazione-definitiva-assistenza-e-diritti-garantiti-in-tutta-europa]]></loc><lastmod>2025-01-24T11:18:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21650-invalidita-il-sindacato-dei-medici-italiani-chiede-all-inps-la-semplificazione-delle-nuove-procedure]]></loc><lastmod>2025-01-21T11:45:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21620-sperimentazione-del-nuovo-accertamento-di-invalidita-dall-inps-le-indicazioni-operative]]></loc><lastmod>2025-01-09T18:54:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21554-nuova-procedura-di-accertamento-dell-invalidita-dall-inps-le-prime-indicazioni]]></loc><lastmod>2024-12-04T15:05:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21429-fino-a-3-600-euro-annui-per-l-assistenza-a-domicilio-per-bimbi-con-patologie-croniche-sotto-i-tre-anni]]></loc><lastmod>2024-10-28T17:05:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21261-malattie-rare-inps-revoca-assegno-di-invalidita-ad-alcuni-pazienti-con-charcot-marie-tooth]]></loc><lastmod>2024-09-05T10:33:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21235-agevolazioni-fiscali-sanitarie-e-per-persone-con-disabilita-la-guida-completa-dell-age]]></loc><lastmod>2024-08-22T11:22:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21130-sostegno-ai-caregiver-familiari-in-toscana-rinnovato-il-contributo-di-400-euro-mensili]]></loc><lastmod>2024-07-02T08:41:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21128-integrazione-lavorativa-dall-ue-le-linee-guida-per-gli-accomodamenti-ragionevoli-per-persone-con-disabilita]]></loc><lastmod>2024-07-01T06:19:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21058-pensione-d-inabilita-per-invalidi-civili-aggiornati-gli-importi-per-il-2024]]></loc><lastmod>2024-06-07T13:34:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21047-congedo-di-assistenza-a-familiare-con-disabilita-grave-ecco-gli-importi-dell-indennita-2024]]></loc><lastmod>2024-06-04T07:47:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/21019-riforma-disabilita-nove-le-provincie-da-cui-partira-la-sperimentazione-del-progetto-di-vita]]></loc><lastmod>2024-05-29T18:20:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20983-ape-sociale-con-la-proroga-2024-arriva-anche-l-inasprimento-dei-requisiti-d-accesso]]></loc><lastmod>2024-05-16T19:07:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20906-disabilita-il-nuovo-decreto-rivede-la-terminologia-e-le-procedure-di-valutazione-per-legge-104-e-invalidita-civile]]></loc><lastmod>2024-04-24T09:41:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20869-commissione-lea-finalmente-nominata-la-nuova-commissione-nazionale]]></loc><lastmod>2024-06-06T15:44:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20867-fondo-a-sostegno-dei-caregiver-in-friuli-venezia-giulia-300-euro-al-mese-per-chi-assiste-un-familiare-con-disabilita-gravissima]]></loc><lastmod>2024-04-12T10:09:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20837-smart-working-per-i-lavoratori-fragili-non-e-piu-un-diritto-esigibile]]></loc><lastmod>2024-04-08T09:29:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20715-percentuali-di-riferimento-per-l-invalidita-civile-urgente-l-aggiornamento-delle-tabelle-per-l-inps]]></loc><lastmod>2024-03-05T13:36:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20649-assegno-unico-figli-con-disabilita-l-isee-gli-importi-e-le-maggiorazioni-2024]]></loc><lastmod>2024-02-20T10:56:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20588-bonus-sulle-bollette-di-acqua-luce-e-gas-quali-sono-i-requisiti-per-accedere-e-come-ottenerli]]></loc><lastmod>2026-03-26T14:53:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20550-agevolazioni-fiscali-e-detrazioni-sulle-spese-sanitarie-tutto-quello-che-c-e-da-sapere]]></loc><lastmod>2024-01-24T14:41:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20530-invalidita-civile-e-legge-104-senza-visita-ecco-quando-e-possibile]]></loc><lastmod>2024-01-18T09:11:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20504-assegno-di-inclusione-cos-e-chi-ne-ha-diritto-e-come-farne-richiesta]]></loc><lastmod>2024-01-16T12:39:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20499-bollette-gas-e-luce-per-gli-utenti-vulnerabili-la-possibilita-di-conservare-le-tariffe-del-mercato-tutelato]]></loc><lastmod>2024-02-02T17:28:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20496-invalidita-civile-tutti-gli-importi-previsti-per-il-2024-e-relativi-limiti-di-reddito]]></loc><lastmod>2024-01-18T12:26:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20461-disabilita-nomenclatore-tariffario-ausili-per-l-attivita-sportiva-e-prodotti-personalizzabili-le-carenze-piu-gravi]]></loc><lastmod>2023-12-19T14:40:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20394-disabilita-online-il-nuovo-portale-inps-per-seguire-l-iter-di-legge-104-e-invalidita-civile]]></loc><lastmod>2023-11-29T10:05:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20293-prestazioni-di-genetica-sigu-da-gennaio-2024-in-molte-regioni-diagnosi-genetiche-a-carico-delle-famiglie]]></loc><lastmod>2023-11-09T09:05:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20213-nuovo-nomenclatore-le-principali-novita-del-comparto-ausili-e-protesi-dal-2024]]></loc><lastmod>2023-10-09T16:19:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20212-nuovo-nomenclatore-le-principali-novita-del-comparto-specialistica-ambulatoriale-dal-2024]]></loc><lastmod>2024-03-09T20:19:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20211-decreto-tariffe-finalmente-l-ok-da-governo-e-regioni-ma-non-sara-operativo-prima-del-2024]]></loc><lastmod>2023-10-12T13:16:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/20218-lea-ed-esenzioni-malattie-rare-troppo-lenti-i-tempi-di-aggiornamento-troppi-pazienti-attendono]]></loc><lastmod>2023-10-12T08:10:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/19987-caregiver-ordinanza-della-cassazione-esonera-da-obbligo-di-lavoro-notturno]]></loc><lastmod>2023-07-10T10:48:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/19712-permessi-legge-104-niente-piu-referente-unico-dell-assistenza-da-scegliere-tra-i-caregiver-familiari]]></loc><lastmod>2023-07-10T12:19:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/19543-agevolazioni-fiscali-per-i-disabili-via-le-detrazioni-per-i-figli-a-carico-assorbite-dall-assegno-unico-e-universale]]></loc><lastmod>2024-02-20T10:53:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/19416-invalidita-civile-tutti-gli-importi-previsti-per-il-2023-e-relativi-limiti-di-reddito]]></loc><lastmod>2022-12-27T10:59:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/19329-invalidita-civile-per-i-minori-disponibile-la-procedura-semplificata-online]]></loc><lastmod>2022-11-25T11:20:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/19308-invalidita-civile-a-novembre-2022-un-bonus-di-150-euro-per-chi-ha-reddito-basso]]></loc><lastmod>2022-11-21T08:33:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/19257-agevolazioni-sport-per-tutti-arriva-la-detrazione-su-spese-per-attivita-sportiva-adattata]]></loc><lastmod>2022-11-17T09:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/19223-invalidita-civile-aumentano-del-2-pensioni-e-prestazioni-di-ottobre-novembre-e-dicembre-2022]]></loc><lastmod>2022-10-28T10:24:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/19126-assegno-unico-e-universale-per-famiglie-con-figli-disabili-arriva-l-aumento-anche-retroattivo]]></loc><lastmod>2024-02-20T10:53:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/19063-invalidita-civile-avviati-i-controlli-sui-redditi-2018-da-parte-di-inps]]></loc><lastmod>2022-09-15T17:12:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18931-infortunio-e-inabilita-lavorativa-dal-1-luglio-2022-i-nuovi-importi]]></loc><lastmod>2022-07-18T09:40:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18878-malattie-rare-intesa-omar-uniciv-per-supportare-i-pazienti-nell-ottenimento-dei-diritti]]></loc><lastmod>2022-07-04T09:35:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18856-disabilita-e-caregiver-approvato-il-decreto-che-modifichera-i-congedi-per-i-familiari]]></loc><lastmod>2022-10-21T08:38:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18853-agevolazioni-fiscali-semplificata-la-procedura-di-accesso-al-portale-dell-age-per-genitori-e-tutori]]></loc><lastmod>2022-06-29T09:16:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18563-congedi-parentali-nuove-misure-per-i-genitori-con-figli-disabili-e-per-i-caregiver-familiari]]></loc><lastmod>2022-04-20T13:23:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18545-european-disability-card-chi-ne-ha-diritto-e-come-fare-domanda]]></loc><lastmod>2022-04-14T08:55:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18542-lavoratori-fragili-niente-piu-smart-working-e-assenze-giustificate]]></loc><lastmod>2022-04-29T09:14:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18520-collocamento-mirato-pubblicate-le-nuove-linee-guida]]></loc><lastmod>2022-04-07T10:31:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18495-lavoratori-con-malattie-rare-agevolazioni-e-diritti]]></loc><lastmod>2022-07-18T11:22:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18445-telefonia-e-internet-agevolazioni-agcom-anche-per-disabili-con-gravi-limitazioni-di-deambulazione]]></loc><lastmod>2022-03-22T15:24:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18403-disabilita-via-libera-ai-permessi-per-i-familiari-acquisiti-anche-per-gli-uniti-civilmente]]></loc><lastmod>2022-03-10T19:10:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18398-revisione-dell-invalidita-civile-dall-inps-la-nuova-procedura-semplificata]]></loc><lastmod>2022-11-11T10:44:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18270-si-approvi-con-urgenza-il-decreto-tariffe-per-rendere-esigibili-i-nuovi-lea]]></loc><lastmod>2022-02-14T09:20:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18251-nuovo-nomenclatore-a-che-punto-siamo-e-cosa-manca-ancora]]></loc><lastmod>2022-02-05T19:08:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18244-agevolazioni-fiscali-per-i-disabili-nuove-detrazioni-per-le-spese-di-abbattimento-barriere]]></loc><lastmod>2022-06-06T11:34:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18162-invalidita-civile-tutti-gli-importi-previsti-per-il-2022-e-relativi-limiti-di-reddito]]></loc><lastmod>2022-10-28T10:32:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18145-dall-inps-la-rettifica-sull-inattivita-lavorativa-come-requisito-per-l-assegno-d-invalidita-accettato-un-reddito-fino-a-4-931-euro-annui]]></loc><lastmod>2021-12-30T08:40:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/18017-caregiver-in-abruzzo-arrivano-i-contributi-economici-per-i-genitori-dei-disabili-gravissimi]]></loc><lastmod>2021-12-09T15:03:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17944-invalidita-sulle-pensioni-inps-prende-in-giro-gli-inabili-totali]]></loc><lastmod>2021-12-09T15:07:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17864-covid-19-le-tutele-previste-per-i-lavoratori-fragili-fino-a-dicembre-2021]]></loc><lastmod>2022-03-14T12:34:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17858-invalidita-civile-e-legge-104-grazie-a-procedura-online-la-visita-non-serve-piu-in-alcuni-casi]]></loc><lastmod>2022-10-05T14:55:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17725-malattie-rare-presentata-una-risoluzione-su-invalidita-ed-esenzione-sanitaria]]></loc><lastmod>2021-08-26T14:23:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17705-pazienti-non-vaccinabili-saranno-esentati-dal-green-pass]]></loc><lastmod>2021-12-09T15:27:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17696-invalidita-civile-inps-non-tocca-indennita-di-accompagnamento-ancora-dubbi-su-altre-prestazioni]]></loc><lastmod>2021-12-09T15:27:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17693-nuovo-decreto-covid-prorogato-il-diritto-a-smart-working-ma-il-green-pass-non-tutela-i-fragili]]></loc><lastmod>2021-09-27T13:00:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17672-invalidita-civile-dall-inps-l-ipotesi-temuta-gli-importi-potrebbero-essere-vincolati-al-reddito]]></loc><lastmod>2021-07-22T18:21:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17657-inserimento-lavorativo-disabili-il-problema-e-davvero-la-legge-68-99]]></loc><lastmod>2021-07-18T18:22:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17543-permessi-legge-104-possono-essere-richiesti-in-regime-di-smart-working]]></loc><lastmod>2021-12-09T15:28:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17481-agevolazioni-fiscali-per-i-disabili-dall-agenzia-delle-entrate-la-versione-aggiornata-della-guida-dedicata]]></loc><lastmod>2022-01-31T17:03:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17477-agevolazioni-fiscali-per-disabili-cambia-la-procedura-per-l-iva-al-4-per-i-sussidi-informatici]]></loc><lastmod>2021-12-09T15:30:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17408-l-amministrazione-di-sostegno-a-cosa-serve-quando-si-nomina-quali-sono-i-suoi-doveri]]></loc><lastmod>2021-05-09T17:00:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17388-prelievo-a-domicilio-e-un-diritto-per-le-persone-in-condizione-di-fragilita]]></loc><lastmod>2021-05-06T13:48:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17353-lavoratori-fragili-arriva-dall-inps-la-tutela-retroattiva-giustificate-le-assenze-dei-dipendenti]]></loc><lastmod>2021-12-09T15:31:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17185-covid-smart-working-e-congedi-parentali-da-marzo-a-giugno-2021-ecco-cosa-e-previsto]]></loc><lastmod>2022-01-15T11:51:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17120-dpcm-2-marzo-caregiver-ammessi-in-ospedale-ma-nessuna-tutela-sul-fronte-lavoro-per-i-fragili-e-chi-li-assiste]]></loc><lastmod>2021-04-29T11:39:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/17089-disabilita-e-agevolazioni-fiscali-iva-al-4-settore-auto-puo-essere-richiesta-anche-dopo-acquisto]]></loc><lastmod>2021-02-28T16:01:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16991-non-autosufficienze-i-fondi-2020-superano-i-600-milioni-confermati-stanziamenti-aggiuntivi]]></loc><lastmod>2021-02-18T11:43:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16977-assegno-unico-per-i-figli-a-partire-dal-2021-la-maggiorazione-prevista-per-la-disabilita]]></loc><lastmod>2024-02-20T10:54:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16963-fondo-per-i-caregiver-tempi-e-modalita-di-accesso-ai-finanziamenti-per-le-regioni]]></loc><lastmod>2021-02-18T14:01:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16930-disabilita-e-malattie-rare-quei-fondi-per-i-caregiver-mai-assegnati-o-ancora-in-attesa]]></loc><lastmod>2021-05-24T14:15:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16908-covid-e-lavoratori-fragili-da-gennaio-2021-l-assenza-torna-a-essere-equiparata-al-ricovero-ospedaliero]]></loc><lastmod>2022-01-13T10:56:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16894-disabilita-e-benefici-in-tempo-di-covid-inps-chiarisce-sui-benefici-previsti-per-i-portatori-di-handicap-grave]]></loc><lastmod>2021-02-18T14:24:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16890-nuove-disposizioni-anticovid-2021-le-nuove-regole-per-tutti-e-i-cambiamenti-per-disabili-e-malati-rari]]></loc><lastmod>2021-03-15T09:17:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16888-congedi-parentali-covid-2021-dall-inps-dettagli-su-requisiti-durata-indennizzo-e-incompatibilita]]></loc><lastmod>2022-01-15T11:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16885-disabilita-e-prestazioni-sociali-revisionati-gli-importi-delle-pensioni-per-il-2021]]></loc><lastmod>2021-02-18T14:17:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16878-disabilita-sensoriali-tutte-le-agevolazioni-orientate-a-una-miglior-comunicazione]]></loc><lastmod>2022-03-22T12:02:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16865-legge-di-bilancio-2021-quali-misure-a-tutela-della-disabilita-e-delle-categorie-piu-fragili]]></loc><lastmod>2021-04-29T11:18:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16716-tutela-lavoratori-fragili-dal-ministero-l-impegno-a-riformulare-la-disciplina-del-lavoro-agile]]></loc><lastmod>2021-04-29T11:37:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16672-invalidita-civile-legge-104-e-diritti-dei-malati-rari-online-la-guida-gratuita-dello-sportello-legale-o-ma-r]]></loc><lastmod>2022-07-18T11:02:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16501-invalidita-civile-aumentate-le-pensioni-di-inabilita-dal-compimento-dei-18-anni]]></loc><lastmod>2021-02-18T14:26:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16396-disabilita-e-agevolazioni-fiscali-aggiornata-la-guida-dell-agenzia-delle-entrate]]></loc><lastmod>2021-02-18T14:30:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16368-coronavirus-con-il-dpcm-7-agosto-prorogate-le-misure-anti-contagio]]></loc><lastmod>2021-02-18T14:29:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16323-disabilita-cosa-cambia-con-il-decreto-rilancio-e-la-sentenza-della-corte-costituzionale]]></loc><lastmod>2020-07-29T11:17:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16254-coronavirus-e-lavoratori-a-rischio-inps-chiarisce-chi-e-come-certifica-l-assenza]]></loc><lastmod>2021-02-18T14:28:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16173-procedura-di-riconoscimento-dell-invalidita-dal-1-giugno-e-cambiata-la-modalita]]></loc><lastmod>2022-11-11T10:58:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16139-covid-19-il-trattamento-dei-dati-sanitari-tra-privacy-e-interesse-pubblico]]></loc><lastmod>2020-06-07T20:43:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16136-post-coronavirus-fondi-per-disabilita-e-non-autosufficienze-ecco-tutti-gli-stanziamenti]]></loc><lastmod>2021-03-22T10:10:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16137-lavoro-tutela-di-malati-rari-genitori-e-caregiver-dal-dl-rilancio]]></loc><lastmod>2021-04-29T11:29:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16119-coronavirus-fase-2-cosa-cambia-per-malati-rari-e-disabili]]></loc><lastmod>2021-02-18T14:36:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16070-decreto-rilancio-quali-agevolazioni-per-i-malati-rari]]></loc><lastmod>2021-06-30T12:57:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/16011-decreto-cura-italia-confermata-la-possibilita-di-assenza-dal-lavoro-fino-al-30-aprile]]></loc><lastmod>2021-04-29T11:17:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15918-legge-104-a-chi-spettano-i-giorni-aggiuntivi-per-coronavirus-e-come-fare-domanda]]></loc><lastmod>2021-02-18T14:38:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15870-invalidita-come-viene-calcolata-la-percentuale]]></loc><lastmod>2021-02-18T14:40:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15791-decreto-curaitalia-novita-e-tutele-per-i-pazienti-con-malattie-rare]]></loc><lastmod>2021-02-18T14:41:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15772-coronavirus-quali-tutele-sul-lavoro-per-i-malati-rari]]></loc><lastmod>2021-02-18T14:42:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15699-malattie-genetiche-la-lotta-all-oscurita-tra-diritto-di-non-sapere-e-dovere-di-informarsi]]></loc><lastmod>2020-02-26T22:14:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15648-malattie-genetiche-e-diritto-di-non-sapere-cruciale-un-corretto-counselling-genetico]]></loc><lastmod>2020-02-11T19:18:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15650-malattie-genetiche-il-confine-e-il-conflitto-tra-diritto-alla-privacy-e-diritto-di-non-sapere]]></loc><lastmod>2020-02-11T19:16:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15567-disabilita-l-agenzia-delle-entrate-aggiorna-la-guida-ai-benefici-fiscali]]></loc><lastmod>2026-01-16T16:13:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15525-invalidita-civile-dall-inps-l-aggiornamento-dei-trattamenti-previdenziali]]></loc><lastmod>2021-02-18T14:53:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15487-tumori-in-lazio-verra-adottata-una-procedura-piu-rapida-il-riconoscimento-d-invalidita]]></loc><lastmod>2019-12-08T20:15:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15406-malattie-rare-e-lavoro-l-inail-aumenta-l-assegno-di-incollocabilita]]></loc><lastmod>2022-03-31T13:32:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15369-malattie-rare-i-diritti-dei-pazienti-sul-posto-di-lavoro]]></loc><lastmod>2021-02-18T14:46:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15352-malattie-rare-la-normativa-sull-inserimento-lavorativo-dei-pazienti]]></loc><lastmod>2022-04-01T13:16:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15342-disabilita-inps-aumenta-assegno-per-famiglie-con-figli-inabili]]></loc><lastmod>2019-10-23T20:45:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15320-disabilita-la-normativa-italiana-sull-abbattimento-delle-barriere-architettoniche]]></loc><lastmod>2019-10-16T20:40:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15292-spese-sanitarie-tutte-le-indicazioni-utili-per-la-detrazione]]></loc><lastmod>2019-10-11T12:08:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15258-invalidita-civile-per-minori-la-procedura-di-riconoscimento-e-le-prestazioni-economiche]]></loc><lastmod>2022-12-02T10:37:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15196-tumori-rari-tutti-i-diritti-che-spettano-a-malati-e-familiari]]></loc><lastmod>2021-02-18T15:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15083-quali-diritti-per-il-caregiver-del-malato-oncologico-raro]]></loc><lastmod>2019-07-28T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15059-tumori-rari-privacy-e-tutela-degli-interessi-giuridici-dei-pazienti]]></loc><lastmod>2019-07-21T18:09:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/15032-tumori-rari-quali-agevolazioni-fiscali-per-i-malati-e-le-famiglie]]></loc><lastmod>2021-02-18T15:01:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14997-tumori-rari-quali-sono-i-diritti-del-malato-nella-vita-quotidiana]]></loc><lastmod>2021-02-18T14:58:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14979-tumori-rari-quali-esenzioni-su-visite-mediche-e-acquisto-di-farmaci]]></loc><lastmod>2021-02-18T15:56:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14957-tumori-quali-agevolazioni-e-diritti-sul-lavoro-per-i-malati-oncologici]]></loc><lastmod>2021-02-18T15:54:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14932-tumori-rari-e-invalidita-civile-quali-diritti-e-quali-prestazioni]]></loc><lastmod>2021-02-18T15:52:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14873-malati-rari-con-invalidita-sensoriali-le-agevolazioni-previste-dalla-finanziaria-2019]]></loc><lastmod>2021-02-18T15:51:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14823-isee-2019-novita-e-agevolazioni-per-malattie-rare-e-disabilita]]></loc><lastmod>2021-02-18T15:49:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14773-dichiarazione-dei-redditi-il-730-con-malattia-rara-e-o-invalidita-civile]]></loc><lastmod>2019-10-10T08:55:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14727-malattie-rare-tutte-le-esenzioni-aggiornate-al-2019-scarica-la-guida-gratuita]]></loc><lastmod>2019-07-18T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14712-distrofia-di-duchenne-e-becker-dall-inps-le-linee-guida-per-i-medici-legali-incaricati-dell-accertamento-dell-invalidita]]></loc><lastmod>2019-07-18T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14600-dopo-di-noi-cosa-prevede-oggi-la-legge]]></loc><lastmod>2021-03-22T10:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/14473-fondo-per-le-non-autosufficienze-erogati-400-milioni-di-euro-come-impattera-sulle-malattie-rare]]></loc><lastmod>2019-07-18T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13534-tumori-nel-lazio-un-protocollo-d-intesa-per-la-tutela-della-disabilita-associata]]></loc><lastmod>2019-07-18T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13415-scovare-i-falsi-ciechi-o-calunniare-paula-morandi-treu-ha-una-malattia-rara-la-lhon]]></loc><lastmod>2019-07-18T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13178-legge-104-che-cos-e-e-come-si-ottiene-l-accertamento-dell-handicap]]></loc><lastmod>2022-07-18T11:19:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13174-invalidita-civile-come-fare-ricorso]]></loc><lastmod>2020-11-16T13:28:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13173-invalidita-civile-e-prestazioni-economiche-indennita-accompagnamento-e-pensioni]]></loc><lastmod>2022-01-07T15:46:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13172-invalidita-civile-le-percentuali-e-i-benefici-correlati]]></loc><lastmod>2020-11-16T13:27:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13171-fare-domanda-di-invalidita-civile-l-iter-dettagliato]]></loc><lastmod>2022-11-11T15:36:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13170-come-ottenere-l-esenzione-per-invalidita-civile]]></loc><lastmod>2021-05-10T13:03:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13169-la-mia-malattia-rara-non-ha-codice-di-esenzione-cosa-posso-fare]]></loc><lastmod>2019-07-18T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13168-malattie-rare-come-ottenere-l-esenzione-in-base-al-reddito]]></loc><lastmod>2019-07-18T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13167-quali-diritti-ottengo-con-l-esenzione-di-malattia-rara]]></loc><lastmod>2021-01-12T14:45:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13166-come-si-ottiene-l-esenzione-per-una-malattia-rara]]></loc><lastmod>2022-11-14T14:16:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/13032-esenzioni-e-diritti-i-pazienti-in-un-labirinto-fatto-di-norme-ma-anche-di-prassi-locali]]></loc><lastmod>2019-04-17T09:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/12725-malattie-rare-quali-ausili-e-prestazioni-garantiti-dai-nuovi-lea]]></loc><lastmod>2019-07-18T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/12666-nuovi-lea-2017-ecco-la-guida-alle-esenzioni-per-le-malattie-rare]]></loc><lastmod>2022-12-01T10:45:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/12659-invalidita-civile-intesa-bambino-gesu-inps-per-semplificarne-il-riconoscimento]]></loc><lastmod>2019-04-17T09:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/12596-malattie-croniche-come-si-ottiene-l-esenzione]]></loc><lastmod>2019-07-18T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/11881-arianna-la-fibrosi-cistica-e-il-parcheggio-negato]]></loc><lastmod>2019-04-17T09:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/10790-disabilita-nuovi-sgravi-contributivi-per-chi-assume-lavoratori-disabili-a-tempo-indeterminato]]></loc><lastmod>2019-04-17T09:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/10748-disabilita-l-indennita-non-e-reddito-ora-disponibile-la-nuova-modulistica]]></loc><lastmod>2019-04-17T09:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/10680-invalidita-civile-nasce-a-roma-lo-sportello-che-aiuta-gli-invalidi-a-difendere-i-propri-diritti]]></loc><lastmod>2019-04-17T09:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/10504-disabilita-il-nomenclatore-dei-dispositivi-sara-aggiornato-insieme-ai-lea-quando-nessuna-certezza-sui-tempi]]></loc><lastmod>2019-04-17T09:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/10071-isee-la-sentenza-indennita-di-accompagnamento-non-e-reddito]]></loc><lastmod>2019-04-17T09:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/10035-nuovi-lea-previsti-per-29-febbraio-lorenzin-questione-di-giorni]]></loc><lastmod>2018-01-31T14:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/9969-assistenza-disabili-prorogato-progetto-home-care-premium-ma-solo-per-dipendenti-pubblici]]></loc><lastmod>2018-01-31T14:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/9933-disabilita-la-guida-alle-agevolazioni-fiscali-2016]]></loc><lastmod>2020-01-12T16:44:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/9888-decreto-appropriatezza-e-tagli-sanitari-cosa-cambiera-per-i-malati-rari]]></loc><lastmod>2018-01-31T14:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/8324-malattie-rare-quali-diritti-in-ambito-lavorativo]]></loc><lastmod>2019-07-18T17:42:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/7682-assistenza-domiciliare-c-e-tempo-fino-al-31-marzo-per-fare-domanda-all-inps]]></loc><lastmod>2018-01-31T14:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/7326-tumori-quali-sono-i-diritti-dei-malati-oncologici]]></loc><lastmod>2018-01-31T14:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/7250-malattie-e-legge-104-permessi-di-lavoro-e-congedo-parentale-chi-ne-ha-diritto]]></loc><lastmod>2021-06-16T10:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/7151-invalidita-civile-e-malattie-rare-che-cose-e-come-si-ottiene]]></loc><lastmod>2022-11-14T16:44:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/7101-livelli-essenziali-di-assistenza-lea-fermi-al-2001-il-report-del-ministero-della-salute-tra-luci-e-ombre]]></loc><lastmod>2018-01-31T14:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/7087-disabilita-e-malattie-rare-la-guida-ai-diritti]]></loc><lastmod>2018-01-31T11:59:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/6945-pnmr-de-filippo-vogliamo-eliminare-le-discriminazioni-e-rendere-omogenee-le-esenzioni]]></loc><lastmod>2018-01-31T08:10:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/6398-malattie-croniche-il-governo-studia-la-modifica-dei-ticket]]></loc><lastmod>2018-01-31T08:36:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/5472-tumori-la-carta-europea-dei-diritti-del-malato-di-cancro-presentata-a-strasburgo]]></loc><lastmod>2015-05-29T14:10:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/5399-malattie-reumatiche-ampliate-le-esenzioni-in-emilia-romagna]]></loc><lastmod>2017-10-20T08:20:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/3482-emilia-romagna-esenzione-ticket-medicinali-per-malattie-rare-via-libera-in-commissione]]></loc><lastmod>2018-01-31T08:36:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/1692-malattie-rare-balduzzi-sui-lea-e-lista-delle-esenzioni-stiamo-lavorando-quella-del-2008-era-superata]]></loc><lastmod>2017-10-20T08:20:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/1537-malattie-rare-si-della-camera-a-nuove-esenzioni-aiuti-per-i-farmaci-orfani-e-valutazione-di-nuovi-screening]]></loc><lastmod>2018-01-31T08:26:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/1411-sindrome-di-sjogren-in-italia-piu-di-16mila-malati-attendono-lesenzione-dal-ticket]]></loc><lastmod>2018-01-31T11:59:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/461-malattie-rare-gruppo-di-associazioni-chiedere-alle-regioni-di-allargare-elenco-delle-esenzioni]]></loc><lastmod>2018-01-31T08:26:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/invalidita-civile-esenzioni-e-diritti/3589-sara-presentato-oggi-il-qcodice-del-diritto-del-minore-alla-salute-e-ai-servizi-sanitari]]></loc><lastmod>2015-05-29T14:10:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/22950-diagnosi-genetica-preimpianto-quando-la-pgt-e-la-scelta-giusta]]></loc><lastmod>2026-04-20T16:53:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/22925-diagnosi-preimpianto-in-italia-la-guida-omar-per-le-coppie-con-malattie-rare]]></loc><lastmod>2026-04-10T14:50:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/21922-linee-guida-pma-procreazione-medicalmente-assistita-accolto-il-ricorso-al-tar]]></loc><lastmod>2025-04-18T15:26:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/21875-nipt-test-gratuiti-presentata-una-proposta-di-legge-alla-regione-lazio]]></loc><lastmod>2025-04-03T18:34:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/21150-malattie-rare-e-accesso-alla-pma-40-associazioni-chiedono-l-attivazione-della-pgt-unit-del-veneto]]></loc><lastmod>2024-07-08T08:15:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/21098-nipt-test-per-le-donne-in-gravidanza-ecco-dove-e-gratuito]]></loc><lastmod>2026-01-14T17:29:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/21120-test-del-dna-fetale-o-nipt-che-cos-e-a-cosa-serve-e-come-si-sceglie]]></loc><lastmod>2025-04-10T19:53:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/21037-la-consulenza-genetica-per-le-coppie-che-cercano-un-figlio-come-e-quando-e-necessaria]]></loc><lastmod>2024-05-31T15:48:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/20971-nuovi-lea-e-genetica-medica-sigu-cosi-si-impediscono-diagnosi-tempestive-a-danno-dei-pazienti]]></loc><lastmod>2024-05-15T10:41:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/20831-procreazione-medicalmente-assistita-una-proposta-di-revisione-della-legge-40-2004]]></loc><lastmod>2024-04-04T09:57:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/20798-diagnosi-preimpianto-per-malattie-genetiche-a-padova-pronta-la-pgt-unit-ma-manca-il-personale-specializzato]]></loc><lastmod>2024-04-22T10:17:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/20688-pma-e-tecniche-di-sostituzione-del-dna-mitocondriale-in-italia-presentata-la-prima-proposta-di-legge]]></loc><lastmod>2024-04-02T08:31:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/20597-pma-come-deve-essere-il-centro-ideale-per-eseguire-i-test-genetici-preimpianto]]></loc><lastmod>2024-04-02T08:31:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/18516-diagnosi-genetica-preimpianto-nasce-l-associazione-nido]]></loc><lastmod>2024-04-02T08:33:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/17881-centri-italiani-per-pgd-diagnosi-genetica-preimpianto-per-malattie-genetiche]]></loc><lastmod>2024-07-05T16:31:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/16035-tumori-e-malattie-rare-diventare-mamma-e-possibile-grazie-alla-pma]]></loc><lastmod>2024-04-02T08:32:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/14226-diagnosi-preimpianto-e-malattie-rare-10-cose-da-sapere]]></loc><lastmod>2024-04-02T08:34:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/13324-infertilita-ora-si-puo-combattere-con-l-acquisizione-di-gameti-e-la-diagnosi-preimpianto]]></loc><lastmod>2024-04-02T08:34:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/13239-procreazione-medica-assistita-nuovo-servizio-pubblico-di-diagnosi-genetica-preimpianto]]></loc><lastmod>2024-04-02T08:37:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/12202-procreazione-assistita-se-un-genitore-e-portatore-di-una-malattia-genetica-lo-stabilisce-il-tribunale-di-milano]]></loc><lastmod>2024-04-02T08:37:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/8231-fecondazione-assisitita-le-coppie-con-patologie-genetiche-hanno-diritto-alla-diagnosi-preimpianto]]></loc><lastmod>2024-04-02T08:37:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/7978-malattie-rare-e-diagnosi-preimpianto-diritto-o-polemica]]></loc><lastmod>2024-04-02T08:37:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/3618-legge-40-bocciato-il-ricorso-la-diagnosi-preimpianto-e-un-diritto-per-i-portatori-di-malattie-rare]]></loc><lastmod>2024-04-02T08:37:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/pma-e-diagnosi-preimpianto-malattie-rare-e-salute-riproduttiva/3169-talassemia-si-alla-fecondazione-assistita-con-diagnosi-preimpianto]]></loc><lastmod>2024-04-02T08:37:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22957-stati-generali-della-genetica-e-della-genomica-sigu-in-prima-linea-per-promuovere-sostenibilita-ed-equita]]></loc><lastmod>2026-04-22T08:11:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22921-malattie-rare-il-caregiver-non-puo-essere-escluso]]></loc><lastmod>2026-04-10T07:36:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22892-displasia-fibromuscolare-interrogazione-alla-camera-richiesti-codice-di-esenzione-e-percorsi-dedicati]]></loc><lastmod>2026-03-30T16:10:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22878-nuovi-lea-il-percorso-prosegue-ora-trasmesso-il-decreto-isorisorse]]></loc><lastmod>2026-03-26T14:32:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22870-non-autosufficienza-via-libera-al-piano-2025-2027-3-miliardi-per-i-servizi-ma-le-regioni-chiedono-subito-i-fondi]]></loc><lastmod>2026-03-25T11:27:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22841-malattie-rare-piu-accesso-ai-test-genetici-e-genomici-anche-per-la-diagnosi-della-sordita]]></loc><lastmod>2026-03-16T10:00:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22746-sindrome-del-vomito-ciclico-presentata-uninterrogazione-al-senato]]></loc><lastmod>2026-02-12T17:18:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22739-lea-la-commissione-affari-sociali-della-camera-indica-al-governo-le-osservazioni-da-valutare]]></loc><lastmod>2026-02-10T15:37:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22720-carenza-di-flebocortid-cresce-la-preoccupazione-per-le-persone-malattia-di-addison]]></loc><lastmod>2026-02-06T10:38:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22714-insufficienza-intestinale-cronica-benigna-una-patologia-rara-ancora-senza-esenzione-nei-lea]]></loc><lastmod>2026-02-03T19:30:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22675-ape-sociale-prorogata-al-2026-dallinps-la-riapertura-delle-domande-e-le-nuove-scadenze]]></loc><lastmod>2026-01-20T18:00:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22671-agevolazioni-fiscali-pubblicata-la-nuova-guida-dellagenzia-delle-entrate]]></loc><lastmod>2026-01-19T16:35:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22662-caregiver-familiari-dal-governo-il-disegno-di-legge-che-conferma-riconoscimento-e-sostegno]]></loc><lastmod>2026-01-15T07:34:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22660-disabilita-approvato-il-terzo-piano-di-azione-la-riforma-entra-nella-sua-fase-operativa]]></loc><lastmod>2026-02-13T11:05:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22661-riforma-del-ssn-il-cantiere-della-sanita-tra-ospedali-e-territorio]]></loc><lastmod>2026-01-13T19:49:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22635-dopo-di-noi-nuove-regole-di-ripartizione-dei-fondi-il-decreto-cambia-i-criteri-e-ridisegna-le-risorse]]></loc><lastmod>2026-01-02T18:35:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22632-legge-di-bilancio-maggior-sostegno-alla-diagnosi-genetica-e-alluso-dei-test-ngs]]></loc><lastmod>2025-12-30T14:26:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22618-farmaci-orfani-doppia-interrogazione-al-senato-denunciati-ritardi-su-prezzo-e-rimborso-e-accesso-regionale]]></loc><lastmod>2025-12-22T21:07:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22596-nasce-lintergruppo-parlamentare-lavoro-e-fragilita]]></loc><lastmod>2025-12-11T18:32:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22588-oltre-lascolto-il-ruolo-strategico-della-partecipazione-dei-pazienti-nei-processi-regolatori]]></loc><lastmod>2025-12-10T13:03:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22586-oltre-la-terapia-come-lesperienza-del-paziente-puo-trasformare-le-decisioni-sanitarie]]></loc><lastmod>2025-12-09T08:17:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22577-le-associazioni-di-pazienti-nei-processi-decisionali-evidenze-e-riflessioni-dal-documento-inpags]]></loc><lastmod>2025-12-04T09:01:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22578-sanita-e-inclusione-tutte-le-novita-previste-dal-disegno-di-legge-semplificazioni-bis]]></loc><lastmod>2025-12-04T09:21:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22569-livelli-essenziali-delle-prestazioni-un-disegno-di-legge-delega-il-governo-alla-loro-definizione]]></loc><lastmod>2025-12-01T17:32:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22488-associazioni-regionali-e-formazione-risorse-strategiche-per-la-partecipazione-ai-processi-regolatori]]></loc><lastmod>2025-11-11T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22483-omar-incontra-lonorevole-luciano-ciocchetti]]></loc><lastmod>2025-11-06T17:17:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22470-omar-incontra-il-sottosegretario-marcello-gemmato]]></loc><lastmod>2025-11-04T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22477-partecipazione-dei-pazienti-alle-decisioni-terapeutiche-piu-di-un-terzo-delle-associazioni-rischia-di-essere-esclusa]]></loc><lastmod>2025-11-03T19:02:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22464-formazione-e-partecipazione-il-ruolo-delle-associazioni-di-pazienti-e-le-sfide-dellaccesso-al-ruas]]></loc><lastmod>2025-11-02T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22458-scuola-piu-tutele-per-studenti-con-malattie-rare-approvato-emendamento-sullinclusione]]></loc><lastmod>2025-10-29T10:03:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22440-aggiornamento-lea-intesa-in-conferenza-stato-regioni-ma-non-e-ancora-operativo]]></loc><lastmod>2025-10-24T10:17:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22396-telemedicina-il-decreto-che-cambia-il-volto-dellassistenza-per-pazienti-rari-e-cronici]]></loc><lastmod>2025-10-13T16:56:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22387-medici-senza-strumenti-e-piccole-e-medie-imprese-a-rischio-fallimento-lappello-alla-presidente-meloni]]></loc><lastmod>2025-10-14T12:27:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22373-regione-lazio-arriva-lintesa-per-sostenere-gli-studenti-caregiver]]></loc><lastmod>2025-10-06T16:06:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22364-nasce-lintergruppo-parlamentare-genetica-e-genomica-la-sigu-al-tavolo-della-programmazione]]></loc><lastmod>2025-10-02T18:25:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22363-caregiver-anche-la-toscana-si-dota-di-una-legge-regionale]]></loc><lastmod>2025-09-30T21:42:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22330-sangue-e-plasma-il-piano-nazionale-2025-rilancia-la-raccolta-e-guarda-alle-terapie]]></loc><lastmod>2025-09-23T19:44:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22329-tar-del-lazio-annulla-il-nuovo-nomenclatore-tariffario-cosa-accade-ora]]></loc><lastmod>2025-09-22T15:36:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22302-verso-un-nuovo-modello-di-accesso-precoce-alle-terapie-per-malattie-gravi-o-rare]]></loc><lastmod>2025-09-15T17:27:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22287-dal-diritto-alla-legge-il-parlamento-affronta-il-fine-vita]]></loc><lastmod>2025-09-11T07:26:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22276-scelte-di-fine-vita-il-percorso-della-corte-costituzionale]]></loc><lastmod>2025-09-04T21:36:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22241-farmaci-per-la-disforia-di-genere-ddl-del-governo-stabilisce-nuove-regole-per-i-minori]]></loc><lastmod>2025-08-10T13:35:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22228-aggiornamento-dei-lea-ed-elenco-delle-malattie-rare-nuova-interrogazione-sollecita-tempi-piu-rapidi]]></loc><lastmod>2025-08-01T10:40:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22210-morte-cardiaca-improvvisa-nei-giovani-la-toscana-verso-una-legge-per-prevenirla]]></loc><lastmod>2025-07-25T09:50:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22198-aifa-si-apre-al-dialogo-social-e-sportello-pazienti-per-una-sanita-piu-vicina]]></loc><lastmod>2025-07-27T10:41:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22207-caregiver-on-malavasi-serve-subito-una-legge-nazionale]]></loc><lastmod>2025-07-25T13:27:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22193-suicidio-medicalmente-assistito-la-societa-italiana-di-neurologia-sollecita-una-legge-chiara-equa-e-rispettosa-della-dignita]]></loc><lastmod>2025-07-14T17:02:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22153-omar-incontra-il-senatore-guido-liris]]></loc><lastmod>2025-07-02T10:12:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22142-batterie-e-riparazioni-per-carrozzine-elettriche-il-ministro-della-salute-chiarisce-la-normativa-in-aula]]></loc><lastmod>2025-06-27T16:02:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22133-sindrome-di-scheuermann-malavasi-fondamentale-l-aggiornamento-della-tabella-per-il-riconoscimento-dell-invalidita]]></loc><lastmod>2025-06-26T13:27:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22119-omar-incontra-il-prof-vincenzo-salvatore]]></loc><lastmod>2025-06-23T16:42:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22095-distonia-alla-camera-si-chiede-il-riconoscimento-come-malattia-professionale]]></loc><lastmod>2025-06-14T16:13:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22092-batterie-per-carrozzine-elettriche-a-carico-degli-utenti-il-caso-veneto-apre-un-fronte-nazionale]]></loc><lastmod>2025-06-16T08:06:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22060-fine-vita-ancora-non-c-e-l-accordo-su-un-testo-condiviso]]></loc><lastmod>2025-06-06T13:42:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22046-nomine-css-sigu-manca-un-genetista-medico-si-rischia-di-rimanere-fuori-da-un-epoca]]></loc><lastmod>2025-06-09T15:16:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22041-consiglio-superiore-di-sanita-css-ecco-le-nuove-nomine-2025-2028]]></loc><lastmod>2025-07-09T15:30:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22039-omar-incontra-la-senatrice-elena-murelli]]></loc><lastmod>2025-05-30T18:04:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22025-78-assemblea-mondiale-della-sanita-le-malattie-rare-sono-una-priorita-di-salute-pubblica-globale]]></loc><lastmod>2025-05-26T18:20:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22015-fecondazione-l-appello-del-pd-per-una-riforma-della-legge-40]]></loc><lastmod>2025-05-23T08:33:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/22001-lep-livelli-essenziali-delle-prestazioni-approvato-disegno-di-legge-per-delega-al-governo]]></loc><lastmod>2025-05-29T09:26:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21997-dare-struttura-alla-complessita-in-lombardia-nasce-un-intergruppo-per-le-malattie-rare]]></loc><lastmod>2025-05-16T17:22:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21980-farmaceutica-le-prospettive-italiane-tra-riforma-ue-e-riordino-nazionale]]></loc><lastmod>2025-05-14T07:42:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21970-sordita-una-legge-per-diagnosi-precoce-inclusione-e-accesso-alle-cure-il-ddl-approda-in-commissione]]></loc><lastmod>2025-05-09T17:25:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21962-disabilita-ministero-annuncia-30-milioni-dedicati-ai-caregiver]]></loc><lastmod>2025-05-09T06:33:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21957-disabilita-una-mozione-per-attenzionare-la-necessita-di-sostegno-psicologico-dei-familiari]]></loc><lastmod>2025-05-07T10:34:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21939-screening-genetico-neonatale-una-proposta-di-legge-nazionale-al-senato]]></loc><lastmod>2025-04-29T10:50:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21937-lea-2024-le-altre-novita-dal-dpcm-che-cambieranno-l-assistenza-sanitaria]]></loc><lastmod>2025-04-28T07:15:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21936-malattie-croniche-esenti-fibromialgia-idrosadenite-suppurativa-e-malattia-polmonare-da-microbatteri-finalmente-nei-lea]]></loc><lastmod>2026-01-12T17:34:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21933-ausili-su-misura-e-di-serie-nei-nuovi-lea-la-protesica-si-aggiorna-secondo-i-nuovi-bisogni]]></loc><lastmod>2025-04-22T06:26:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21931-specialistica-ambulatoriale-piu-prestazioni-e-maggiore-appropriatezza-nei-nuovi-lea]]></loc><lastmod>2025-04-20T10:33:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21926-in-arrivo-l-aggiornamento-dei-lea-screening-neonatale-esteso-nipt-e-nuove-malattie-rare-e-croniche-esenti]]></loc><lastmod>2025-04-28T07:22:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21905-omar-incontra-il-senatore-orfeo-mazzella]]></loc><lastmod>2025-04-16T12:26:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21872-disabilita-e-legge-di-bilancio-2025-una-sollecitazione-per-rispondere-alle-reali-necessita]]></loc><lastmod>2025-04-02T15:54:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21835-l-unione-europea-e-i-diritti-delle-persone-con-disabilita-troppe-lacune-nel-rispetto-della-convenzione-onu]]></loc><lastmod>2025-05-29T09:30:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21828-nasce-il-tavolo-tecnico-per-il-progetto-dama-un-modello-uniforme-di-assistenza-per-le-persone-con-disabilita]]></loc><lastmod>2025-03-19T18:32:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21821-farmaci-per-malattie-rare-la-proposta-dell-on-gemmato-trasferire-la-distribuzione-dagli-ospedali-alle-farmacie-del-territorio]]></loc><lastmod>2025-03-17T18:40:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21781-riforma-della-disabilita-rimandata-al-2027-dal-decreto-milleproroghe]]></loc><lastmod>2025-03-05T09:51:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21772-verso-una-legge-nazionale-per-i-caregiver-familiari-l-audizione-della-ministra-locatelli]]></loc><lastmod>2025-03-03T13:08:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21742-il-centro-nazionale-sangue-e-a-rischio-l-appello-delle-associazioni]]></loc><lastmod>2025-02-20T19:06:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21741-lea-e-decreto-tariffe-aggiornamento-tra-opportunita-e-criticita]]></loc><lastmod>2025-02-20T10:00:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21726-european-accessibility-act-nuove-opportunita-per-persone-con-malattie-rare-e-croniche]]></loc><lastmod>2025-02-13T17:45:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21728-mozione-bipartisan-al-senato-un-impegno-concreto-per-i-malati-rari]]></loc><lastmod>2025-02-14T08:17:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21727-testo-unico-sulle-malattie-rare-gemmato-ritardi-dovuti-a-coordinamento-tra-stato-e-regioni]]></loc><lastmod>2025-02-14T08:18:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21719-suicidio-medicalmente-assistito-in-toscana-e-legge]]></loc><lastmod>2025-02-13T18:27:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21706-cure-domiciliari-per-pazienti-cronici-e-complessi-in-discussione-un-disegno-di-legge]]></loc><lastmod>2025-02-11T08:16:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21682-una-giornata-nazionale-dedicata-ai-rare-sibling]]></loc><lastmod>2025-03-07T10:46:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21696-sardegna-un-nuovo-modello-di-assistenza-per-le-malattie-rare]]></loc><lastmod>2025-02-05T10:47:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21669-nuova-bozza-del-piano-cronicita-inserite-ulteriori-patologie-tra-cui-epilessia-ed-endometriosi]]></loc><lastmod>2025-01-27T16:48:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21673-ageismo-sanitario-e-malattie-rare-malavasi-fondamentale-garantire-accesso-a-presa-in-carico-diagnostica-terapeutica-e-assistenziale-delle-persone-anziane]]></loc><lastmod>2025-01-30T08:07:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21659-omar-incontra-pierluigi-russo-direttore-tecnico-scientifico-di-aifa]]></loc><lastmod>2025-01-23T15:45:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21649-malattie-rare-l-appello-delle-associazioni-dell-inpags-network-sulla-legge-di-bilancio-2025]]></loc><lastmod>2025-01-21T10:29:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21637-cassazione-le-spese-di-assistenza-per-persone-con-disabilita-al-100-sono-sempre-deducibili]]></loc><lastmod>2025-01-16T17:05:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21644-inpagsnetwork-un-anno-di-lavoro]]></loc><lastmod>2025-01-20T16:27:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21640-riforma-della-disabilita-un-confronto-al-senato-solleva-le-prime-criticita-applicative]]></loc><lastmod>2025-01-17T12:42:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21614-legge-di-bilancio-2025-tutte-le-misure-per-il-comparto-sanita]]></loc><lastmod>2025-01-02T15:43:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21598-screening-neonatale-per-la-sma-la-regione-piemonte-fa-il-primo-passo-verso-l-attivazione]]></loc><lastmod>2024-12-20T08:12:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21592-genetica-medica-bloccato-il-fondo-per-la-diagnosi-con-tecnologia-ngs]]></loc><lastmod>2024-12-17T09:43:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21573-morti-cardiache-improvvise-il-calciatore-bove-e-stato-fortunato-ma-e-necessario-prevenire]]></loc><lastmod>2024-12-11T10:24:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21504-progetto-inpags-le-associazioni-sono-un-ponte-fra-pazienti-sistema-salute-e-industria]]></loc><lastmod>2024-11-20T17:50:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21503-progetto-inpags-oltre-cinquanta-le-associazioni-coinvolte-nel-network]]></loc><lastmod>2024-11-20T17:51:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21511-i-pazienti-protagonisti-delle-decisioni-terapeutiche]]></loc><lastmod>2024-11-20T12:54:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21499-progetto-inpags-le-associazioni-devono-poter-partecipare-ai-processi-decisionali-sui-farmaci]]></loc><lastmod>2025-11-07T09:10:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21493-una-proposta-di-legge-per-favorire-l-interlocuzione-fra-pazienti-e-istituzioni]]></loc><lastmod>2024-11-15T18:22:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21494-nuovi-lea-saranno-in-vigore-dal-30-dicembre-2024]]></loc><lastmod>2024-11-15T16:13:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21488-revisione-delle-lea-sigu-lancia-l-allarme-genetica-per-malattie-rare-completamente-trascurata]]></loc><lastmod>2024-11-14T08:26:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21475-nuovi-lea-l-entrata-in-vigore-potrebbe-essere-anticipata-al-1-dicembre-2024]]></loc><lastmod>2024-11-15T08:35:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21442-farmaci-dialogo-tra-associazioni-e-aifa-per-ipotizzare-le-regole-della-partecipazione-della-comunita-dei-pazienti-pags-al-processo-regolatorio]]></loc><lastmod>2024-11-14T17:50:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21439-ape-sociale-uno-stanziamento-di-110-milioni-di-euro-copre-la-proroga-fino-al-2028]]></loc><lastmod>2024-10-28T18:40:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21252-malattie-rare-e-test-genetici-ngs-pronto-il-decreto-per-il-fondo-dedicato]]></loc><lastmod>2024-09-04T10:10:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21242-turismo-accessibile-50-milioni-stanziati-per-progetti-di-accoglienza-e-inclusione-lavorativa]]></loc><lastmod>2024-08-27T09:54:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21185-malattie-rare-il-fondamentale-ruolo-del-genetista-clinico-nella-presa-in-carico-dei-pazienti]]></loc><lastmod>2024-07-19T13:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21182-malattie-rare-in-puglia-presentati-14-progetti-finanziati-con-1-milione-e-400mila-euro]]></loc><lastmod>2024-07-17T15:10:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21138-ddl-terzo-settore-e-politiche-sociali-soddisfazione-per-le-novita-da-fish-e-forum-terzo-settore]]></loc><lastmod>2024-07-03T10:08:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21085-smart-working-per-i-lavoratori-fragili-ancora-nessun-passo-avanti-nella-tutela]]></loc><lastmod>2024-06-14T19:28:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21051-ruolo-del-genetista-medico-presentata-in-parlamento-una-risoluzione-con-le-richieste-di-sigu]]></loc><lastmod>2024-08-05T09:22:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21032-sindrome-ctnnb1-un-interrogazione-chiede-di-finanziare-la-ricerca]]></loc><lastmod>2024-05-30T17:51:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/21024-disabilita-e-non-autosufficienza-26-associazioni-ricorrono-al-tar-contro-regione-lombardia]]></loc><lastmod>2024-05-28T08:37:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20980-cure-palliative-il-progetto-di-legge-gasparri-cancella-decenni-di-progressi-nel-campo-dei-diritti-della-persona-malata]]></loc><lastmod>2024-05-31T15:50:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20963-nuovi-lea-al-senato-un-interrogazione-che-solleva-le-criticita-dell-intero-contesto-sanitario-nazionale]]></loc><lastmod>2024-05-11T13:58:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20942-terapia-genica-per-talassemia-e-anemia-falciforme-un-interrogazione-per-conoscere-i-tempi-di-approvazione-di-aifa]]></loc><lastmod>2024-05-08T13:44:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20922-genetica-medica-un-interrogazione-parlamentare-per-incalzare-il-ministero-della-salute-a-valorizzare-questo-ambito-fondamentale]]></loc><lastmod>2024-04-30T10:00:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20921-malattie-rare-senza-esenzione-il-ministero-aggiorni-la-lista-delle-patologie]]></loc><lastmod>2024-09-05T13:51:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20919-aggiornamento-lea-dal-sen-crisanti-un-interrogazione-per-chiedere-lo-stato-di-elaborazione-del-nomenclatore]]></loc><lastmod>2024-04-29T14:09:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20896-aifa-adottato-il-nuovo-regolamento-della-commissione-scientifica-ed-economica]]></loc><lastmod>2024-04-22T14:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20878-disabilita-approvato-l-ultimo-decreto-attuativo-della-legge-delega]]></loc><lastmod>2024-04-16T12:33:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20856-screening-prenatale-e-neonatale-necessari-standard-nazionali-per-evitare-diseguaglianze-su-base-regionale]]></loc><lastmod>2024-04-10T07:56:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20855-attuazione-autonomia-differenziata-delle-regioni-osservatorio-malattie-rare-in-audizione-alla-camera]]></loc><lastmod>2024-04-09T12:10:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20832-rinviata-l-entrata-in-vigore-dei-lea-molte-le-critiche-e-le-pressioni-sul-governo]]></loc><lastmod>2024-05-03T13:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20829-disability-card-c-e-intesa-tra-gli-stati-membri-dell-ue-ma-ci-vorranno-quattro-anni-perche-sia-operativa]]></loc><lastmod>2024-04-03T15:00:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20811-lea-l-entrata-in-vigore-delle-nuove-tariffe-slitta-al-1-gennaio-2025]]></loc><lastmod>2024-04-02T18:10:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20801-centro-nazionale-di-malattie-rare-iss-a-quando-il-concorso-e-la-nomina-per-il-nuovo-direttore]]></loc><lastmod>2024-03-25T16:48:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20780-diagnosi-genetica-per-patologie-oncologiche-e-malattie-rare-un-nuovo-appello-per-accelerare-i-finanziamenti]]></loc><lastmod>2024-03-20T16:46:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20778-il-decreto-tariffe-entri-in-vigore-come-previsto-dal-1-aprile-i-diritti-dei-cittadini-non-meritano-altre-proroghe-ma-garanzia-di-esigibilita-su-tutto-il-territorio]]></loc><lastmod>2024-05-31T15:51:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20773-omar-incontra-l-onorevole-marcello-gemmato]]></loc><lastmod>2024-03-18T16:49:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20769-sindrome-di-sjogren-in-discussione-un-disegno-di-legge-per-inserirla-tra-le-malattie-rare]]></loc><lastmod>2024-03-18T15:37:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20756-sclerosi-laterale-amiotrofica-in-puglia-una-proposta-di-legge-per-la-diagnosi-genetica-precoce]]></loc><lastmod>2024-03-15T11:36:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20748-caregiver-familiare-in-toscana-una-proposta-di-legge-per-il-riconoscimento-della-figura-e-il-sostegno]]></loc><lastmod>2024-03-14T15:50:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20749-caregiver-familiare-attualmente-in-discussione-6-proposte-di-legge-per-riconoscimento-e-tutela]]></loc><lastmod>2024-03-13T14:57:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20741-test-genetici-e-malattie-rare-sempre-piu-necessari-anche-per-la-sla]]></loc><lastmod>2024-03-12T12:31:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20738-obesita-monogenica-urgente-l-inserimento-nella-lista-delle-malattie-rare]]></loc><lastmod>2024-03-11T12:35:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20739-garante-dei-diritti-delle-persone-con-disabilita-approvato-in-via-definitiva-il-decreto-ma-sara-operativo-dal-2025]]></loc><lastmod>2024-03-11T12:41:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20736-decreto-tariffe-dalla-conferenza-stato-regioni-le-nuove-regole-sulla-validita-delle-prescrizioni]]></loc><lastmod>2024-03-11T08:06:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20730-nuovi-lea-entreranno-in-vigore-ad-aprile]]></loc><lastmod>2024-03-08T10:18:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20728-gemmato-i-farmaci-nelle-farmaci-del-territorio-per-incrementare-i-livelli-di-assistenza-di-prossimita]]></loc><lastmod>2024-03-08T15:56:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20716-livelli-essenziali-di-assistenza-senza-il-rinnovo-della-commissione-nessuno-recepisce-le-istanze-di-aggiornamento]]></loc><lastmod>2024-03-05T13:40:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20694-omar-incontra-l-onorevole-valentina-grippo]]></loc><lastmod>2025-01-23T15:49:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20695-accesso-piu-agevole-alla-patente-di-guida-per-le-persone-con-disabilita-l-iter-normativo-continua]]></loc><lastmod>2024-02-29T18:26:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20699-basta-essere-pazienti-la-petizione-per-il-riconoscimento-dei-diritti-universali-delle-persone-con-malattia-rara]]></loc><lastmod>2024-03-04T09:58:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20683-testo-unico-malattie-rare-per-la-piena-operativita-mancano-ancora-i-decreti-attuativi]]></loc><lastmod>2024-02-27T08:45:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20648-test-prenatali-una-proposta-di-legge-per-garantire-il-nipt-gratuitamente-a-tutte-le-donne-in-gravidanza]]></loc><lastmod>2024-06-27T12:50:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20635-malattie-rare-invalidanti-e-malattie-oncologiche-si-discute-la-legge-per-la-tutela-del-posto-di-lavoro]]></loc><lastmod>2024-02-16T07:50:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20621-omar-incontra-l-on-marco-lacarra]]></loc><lastmod>2025-01-23T15:50:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20606-aifa-pierluigi-russo-e-il-nuovo-direttore-tecnico-scientifico]]></loc><lastmod>2024-02-08T16:25:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20598-caregiver-familiare-una-proposta-di-legge-per-tutelare-i-2-8-milioni-di-persone-in-italia-che-assistono-un-familiare-non-autosufficiente]]></loc><lastmod>2024-02-07T14:01:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20569-sindrome-delle-gambe-senza-riposo-chiesto-l-inserimento-nei-lea]]></loc><lastmod>2024-01-29T11:08:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20536-caregiver-al-via-i-lavori-del-tavolo-tecnico-e-ripartiti-i-fondi-per-progetti-regionali]]></loc><lastmod>2024-01-20T16:27:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20537-un-altro-passo-in-avanti-per-la-legge-delega-sulla-disabilita]]></loc><lastmod>2024-01-20T16:57:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20515-diritto-alla-mobilita-delle-persone-con-disabilita-da-fish-alcune-proposte-per-migliorare-il-codice-della-strada]]></loc><lastmod>2024-01-17T09:37:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20521-lombardia-erogazione-di-ausili-e-protesi-per-l-attivita-sportiva]]></loc><lastmod>2024-01-16T14:34:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20498-legge-di-bilancio-2024-tutte-le-misure-d-interesse-per-il-mondo-delle-malattie-rare-e-della-disabilita]]></loc><lastmod>2024-01-09T15:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20477-diagnosi-preimpianto-esclusa-dai-lea-sempre-piu-cittadini-costretti-a-ricorrere-al-privato]]></loc><lastmod>2023-12-26T10:45:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20473-piano-nazionale-malattie-rare-2023-2026-il-ruolo-cruciale-della-formazione]]></loc><lastmod>2023-12-21T19:11:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20488-test-ngs-approvato-il-fondo-dedicato-alla-diagnosi-genetica-per-le-malattie-rare]]></loc><lastmod>2023-12-31T09:25:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20470-piano-nazionale-malattie-rare-2023-2026-ecco-i-9-punti-fondamentali]]></loc><lastmod>2023-12-21T15:15:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20476-sequenziamento-esoma-per-malattie-rare-nella-legge-di-bilancio-2024-un-fondo-dedicato-ai-test-ngs]]></loc><lastmod>2023-12-31T09:25:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20474-smart-working-lavoratori-fragili-proroga-fino-a-marzo-2024-ma-solo-per-il-settore-privato]]></loc><lastmod>2023-12-22T13:31:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20469-fondo-unico-disabilita-la-dotazione-dovrebbe-superare-i-552-milioni-di-euro]]></loc><lastmod>2024-01-08T16:33:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20427-oblio-oncologico-approvata-al-senato-una-legge-dedicata]]></loc><lastmod>2023-12-07T17:09:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20405-omar-incontra-l-onorevole-marco-furfaro]]></loc><lastmod>2024-02-12T13:01:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20393-legge-di-bilancio-2024-tantissimi-gli-emendamenti-riguardanti-le-malattie-rare]]></loc><lastmod>2023-11-29T08:41:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20390-lavoratori-fragili-richiesta-la-proroga-per-lo-smart-working]]></loc><lastmod>2023-11-28T15:34:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20358-in-attesa-dell-operativita-dei-lea-del-2017-gia-si-parla-dell-urgenza-di-nuovi-aggiornamenti]]></loc><lastmod>2023-11-20T08:15:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20340-screening-neonatale-esteso-renzi-interroga-il-ministro-schillaci-su-attuativo-un-ritardo-che-fa-la-differenza-tra-la-vita-e-la-morte]]></loc><lastmod>2023-11-15T09:29:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20335-accertamenti-diagnostici-genetici-e-nuovo-nomenclatore-l-on-malavasi-interroga-il-ministro-schillaci]]></loc><lastmod>2023-11-13T15:26:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20302-legge-di-bilancio-all-interno-anche-un-fondo-unico-per-l-inclusione-delle-persone-con-disabilita]]></loc><lastmod>2023-12-20T19:20:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20248-malattie-dermatologiche-e-salute-della-pelle-nasce-l-intergruppo-parlamentare]]></loc><lastmod>2023-10-21T09:17:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20209-malattie-mitocondriali-avviato-il-dibattito-pubblico-su-tecnica-di-sostituzione-dna-mitocondriale]]></loc><lastmod>2023-10-09T08:08:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20177-testo-unico-malattie-rare-malavasi-si-stanno-trascurando-e-disattendendo-le-aspettative-di-milioni-di-cittadini-e-delle-loro-famiglie]]></loc><lastmod>2023-10-02T07:05:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20156-lazio-arrivano-i-buoni-servizio-a-supporto-delle-persone-non-autosufficienti]]></loc><lastmod>2023-09-28T17:47:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20172-smart-working-lavoratori-fragili-copertura-in-scadenza-ma-in-discussione-una-proposta-di-legge-per-la-stabilizzazione]]></loc><lastmod>2024-04-05T07:48:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20151-turismo-accessibile-interrogazione-parlamentare-sul-caso-del-tredicenne-lasciato-a-terra-da-lufthansa]]></loc><lastmod>2023-09-27T06:34:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20145-disabilita-e-diritto-alla-mobilita-la-proposta-di-legge-per-l-accessibilita-delle-stazioni-di-servizio-carburante-auto]]></loc><lastmod>2023-09-22T13:40:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20134-garante-nazionale-disabilita-c-e-l-ok-dal-governo-ma-sara-operativo-dal-2025]]></loc><lastmod>2024-02-01T09:24:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20139-terapia-per-il-cancro-al-seno-her2low-verso-la-rimborsabilita-per-un-anticorpo-monoclonare]]></loc><lastmod>2023-09-20T14:01:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20121-omar-incontra-il-senatore-ignazio-zullo]]></loc><lastmod>2023-12-01T12:43:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20114-regione-toscana-stanziati-51-1-milioni-di-euro-per-i-disabili-gravissimi]]></loc><lastmod>2023-09-14T12:18:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20111-deficit-dell-ormone-della-crescita-una-proposta-di-legge-per-istituire-la-giornata-nazionale]]></loc><lastmod>2023-09-13T08:35:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20042-psoriasi-pustolosa-generalizzata-e-le-altre-patologie-in-attesa-di-essere-inserite-nella-lista-delle-malattie-rare]]></loc><lastmod>2023-07-30T12:40:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20028-lanciato-a-como-il-progetto-emergenza-bambini-fragili-per-migliorare-l-accesso-al-primo-soccorso]]></loc><lastmod>2023-07-26T11:25:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19998-omar-incontra-l-onorevole-simona-loizzo]]></loc><lastmod>2023-12-01T12:44:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/20002-malattie-rare-colombo-garante-disabili-regione-campania-italia-a-due-velocita]]></loc><lastmod>2023-07-14T08:00:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19999-disabilita-ancora-troppe-difficolta-nell-accesso-alle-cure-soprattutto-ospedaliere]]></loc><lastmod>2023-07-13T13:07:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19994-morte-cardiaca-improvvisa-ogni-anno-1-000-casi-tra-gli-under-35-troppi-decessi-senza-spiegazione]]></loc><lastmod>2023-07-11T09:37:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19976-car-t-per-la-terapia-dei-tumori-rari-i-dubbi-relativi-all-accreditamento-jacie-dei-centri]]></loc><lastmod>2023-07-20T09:29:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19975-carenza-di-immunoglobulina-umana-grande-rischio-per-i-pazienti-l-interrogazione-al-ministero-della-salute]]></loc><lastmod>2023-07-10T10:30:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19966-omar-incontra-l-onorevole-ilenia-malavasi]]></loc><lastmod>2023-12-01T12:44:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19944-turismo-accessibile-al-vaglio-una-proposta-di-legge-che-mette-in-fila-le-regole-dell-accoglienza-per-tutti]]></loc><lastmod>2023-06-25T21:16:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19920-autonomia-differenziata-cosa-prevede-il-disegno-di-legge]]></loc><lastmod>2023-06-19T14:45:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19896-omar-incontra-l-onorevole-ylenja-lucaselli]]></loc><lastmod>2023-12-01T12:45:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19872-malattie-rare-la-sintesi-delle-politiche-sociosanitarie-di-maggio-2023]]></loc><lastmod>2023-06-05T08:32:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19862-disabilita-ora-anche-l-ospedale-regina-margherita-di-torino-eroga-il-certificato-specialistico-pediatrico]]></loc><lastmod>2023-06-01T15:07:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19846-omar-incontra-l-onorevole-paolo-ciani]]></loc><lastmod>2023-12-01T12:45:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19836-via-libera-delle-regioni-al-piano-nazionale-malattie-rare-2023-2026]]></loc><lastmod>2023-07-11T13:59:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19837-malattie-rare-ciancaleoni-bartoli-omar-approvazione-del-piano-e-tassello-importante-lieti-di-aver-contribuito-ora-tutti-al-lavoro]]></loc><lastmod>2023-05-24T15:59:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19814-regione-lazio-istituito-il-garante-per-la-disabilita]]></loc><lastmod>2023-05-17T14:38:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19811-decesso-di-fiano-romano-in-50-tra-associazioni-e-clinici-chiedono-la-legge-per-prevenire-la-morte-cardiaca-giovanile]]></loc><lastmod>2023-05-15T12:39:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19771-piano-nazionale-della-genomica-tra-le-priorita-anche-diagnosi-e-prevenzione-delle-malattie-rare]]></loc><lastmod>2023-05-02T18:31:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19764-malattie-rare-la-sintesi-delle-politiche-sociosanitarie-di-aprile-2023]]></loc><lastmod>2023-05-03T07:56:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19735-approvato-il-nomenclatore-tariffario-dei-nuovi-lea-congratulazioni-di-omar-al-ministro-schillaci-e-alla-conferenza-stato-regioni]]></loc><lastmod>2023-04-19T14:25:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19715-screening-neonatale-per-la-sma-e-tutela-e-lavoratori-fragili-presentate-due-interrogazioni-parlamentari]]></loc><lastmod>2023-04-13T16:30:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19676-malattie-rare-la-sintesi-delle-politiche-sociosanitarie-di-marzo-2023]]></loc><lastmod>2023-04-28T17:57:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19619-il-lungo-viaggio-delle-persone-con-malattie-rare-dall-oscurita-alla-risoluzione-onu-del-2021]]></loc><lastmod>2023-03-13T18:36:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19609-invalidita-civile-e-benefici-assistenziali-le-associazioni-chiedono-miglioramenti-concreti-al-nuovo-governo]]></loc><lastmod>2023-03-10T09:26:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19601-malattie-rare-in-sintesi-le-politiche-sociosanitarie-di-febbraio-2023]]></loc><lastmod>2023-03-14T19:25:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19590-malattie-rare-il-parlamento-approva-mozione-all-unanimita]]></loc><lastmod>2023-03-06T08:00:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19561-malattie-rare-licenziato-il-piano-nazionale-a-pochi-giorni-dalla-giornata-mondiale]]></loc><lastmod>2023-02-21T17:56:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19516-sanita-ecco-le-linee-programmatiche-del-ministro-schillaci]]></loc><lastmod>2023-02-06T08:56:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19497-malattie-rare-il-ministro-schillaci-conferisce-delega-a-gemmato]]></loc><lastmod>2023-02-14T17:20:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19484-ritardo-dei-nuovi-lea-presentata-interrogazione-parlamentare]]></loc><lastmod>2023-01-27T15:18:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19479-al-via-i-lavori-del-comitato-nazionale-malattie-rare]]></loc><lastmod>2023-01-25T10:17:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19444-fondo-per-il-caregiver-familiare-25-milioni-di-euro-destinati-alle-regioni]]></loc><lastmod>2023-01-17T22:04:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19440-puglia-al-vaglio-una-proposta-di-legge-per-la-carta-d-identita-genetica-dei-nuovi-nati]]></loc><lastmod>2023-03-15T10:44:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19414-manovra-di-bilancio-2023-gli-emendamenti-presentati-e-le-modifiche-approvate]]></loc><lastmod>2022-12-23T10:37:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19404-legge-di-bilancio-2023-proseguito-l-esame-alla-camera-dei-deputati]]></loc><lastmod>2022-12-20T10:24:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19392-malattie-croniche-e-rare-i-pazienti-dalla-politica-ci-aspettiamo-interventi-rapidi-ed-efficaci]]></loc><lastmod>2022-12-14T12:16:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19393-ministero-della-salute-istituito-il-tavolo-di-consultazione-con-le-societa-scientifiche]]></loc><lastmod>2022-12-14T16:28:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19381-sanita-schillaci-sblocchera-i-lea-l-annuncio-sul-decreto-tariffe-uniformita-e-tutela-per-i-malati-rari]]></loc><lastmod>2022-12-12T10:58:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19372-legge-di-bilancio-6-gli-emendamenti-presentanti-dal-nuovo-intergruppo-malattie-rare-dell-on-maria-elena-boschi-e-altri-2-quelli-firmati-dall-on-ubaldo-pagano-da-sempre-vicino-all-alleanza-malattie-rare]]></loc><lastmod>2022-12-12T09:45:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19371-ministro-schillaci-presentate-le-linee-programmatiche-per-il-dicastero-della-sanita]]></loc><lastmod>2022-12-07T19:59:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19362-sanita-inizia-l-esame-della-manovra-di-bilancio-2023]]></loc><lastmod>2022-12-06T08:10:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19357-disabilita-omar-e-amr-attuazione-della-legge-delega-grande-occasione-anche-per-i-malati-rari]]></loc><lastmod>2022-12-02T18:27:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19354-testo-unico-malattie-rare-presentata-interrogazione-su-decreti-attuativi]]></loc><lastmod>2023-01-13T13:30:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19345-disabilita-lombardia-approva-legge-regionale-su-vita-indipendente-e-inclusione-sociale]]></loc><lastmod>2022-12-02T18:29:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19343-sanita-avviato-intergruppo-parlamentare-malattie-rare-e-approvato-il-ddl-bilancio-2023]]></loc><lastmod>2022-11-28T13:36:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19339-ricostituito-l-intergruppo-parlamentare-malattie-rare-l-annuncio-oggi-all-evento-omar]]></loc><lastmod>2022-11-28T11:06:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19338-malattie-rare-primo-confronto-pubblico-tra-19esima-legislatura-governo-e-associazioni]]></loc><lastmod>2022-11-29T09:40:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19309-affair-caregiver-italia-condannata-da-onu-su-diritti-delle-persone-con-disabilita]]></loc><lastmod>2022-11-21T19:03:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19307-tumori-e-nato-l-intergruppo-parlamentare-oncologia-prevenzione-ricerca-e-innovazione]]></loc><lastmod>2022-12-02T18:30:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19295-caregiver-la-rivolta-delle-associazioni-lombarde-contro-un-progetto-di-legge-inadeguato]]></loc><lastmod>2022-11-23T19:14:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19289-disabilita-e-legge-delega-e-tempo-di-pensare-ai-decreti-attuativi]]></loc><lastmod>2022-11-18T09:49:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19287-caregiver-familiari-dalla-regione-lazio-il-primo-riconoscimento-della-figura-giuridica]]></loc><lastmod>2022-11-17T12:19:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19277-caregiver-tante-iniziative-regionali-ma-manca-una-legge-nazionale-che-riconosca-questo-ruolo]]></loc><lastmod>2022-11-17T12:37:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19275-sanita-eletta-la-nuova-commissione-permanente-le-nuove-proposte-di-legge-oncologia-e-finanziamenti-sanitari-e-molto-altro]]></loc><lastmod>2022-11-14T18:37:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19274-patologie-oncologiche-e-malattie-croniche-in-discussione-una-proposta-di-legge-per-la-tutela-del-lavoro]]></loc><lastmod>2023-07-27T10:16:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19254-anziani-non-autosufficienti-cosa-prevede-la-legge-delega-e-perche-i-fondi-non-bastano-per-tutti]]></loc><lastmod>2022-11-09T10:27:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19252-nuovo-governo-nomina-sottosegretari-nuove-misure-anti-covid-19-approvazione-linee-guida-telemedicina-7-giorni-sanita]]></loc><lastmod>2022-11-08T09:33:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19236-da-omar-auguri-di-buon-lavoro-al-sottosegretario-alla-salute-marcello-gemmato]]></loc><lastmod>2023-02-01T17:45:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19235-meloni-al-governo-ottenuta-la-fiducia-inizia-a-parlare-di-salute-7-giorni-sanita]]></loc><lastmod>2025-09-09T15:00:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19207-obesita-e-diabete-prosegue-il-lavoro-dell-apposito-intergruppo-parlamentare]]></loc><lastmod>2022-10-25T13:52:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19214-malattie-rare-da-omar-gli-auguri-al-ministro-della-salute]]></loc><lastmod>2022-11-02T17:19:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19209-orazio-schillaci-e-il-nuovo-ministro-della-salute-ecco-il-nuovo-governo-7-giorni-sanita]]></loc><lastmod>2022-11-08T15:34:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19152-sanita-partecipata-dal-gruppo-di-studio-gestito-dal-ministero-della-salute-le-prime-indicazioni-operative]]></loc><lastmod>2022-10-07T12:36:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19141-disabilita-solo-4-le-strutture-che-erogano-il-certificato-specialistico-pediatrico-gratuito]]></loc><lastmod>2022-10-04T15:58:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19138-test-di-next-generation-sequencing-accordo-tra-ministero-e-regioni-per-lo-stanziamento-di-5-milioni]]></loc><lastmod>2022-10-04T13:49:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19136-scuola-e-disabilita-potenziato-il-fondo-per-l-assistenza-all-autonomia-e-alla-comunicazione]]></loc><lastmod>2022-10-04T13:43:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19125-nel-nuovo-parlamento-chi-si-prendera-l-incarico-di-dare-voce-ai-22-milioni-di-malati-cronici-italiani]]></loc><lastmod>2022-10-03T13:02:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19104-7-giorni-sanita-elezioni-politiche-e-iter-di-formazione-di-governo-e-parlamento]]></loc><lastmod>2022-10-03T13:02:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19098-malattie-rare-istituito-il-comitato-nazionale-previsto-dalla-legge-175]]></loc><lastmod>2022-09-22T16:01:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19072-7-giorni-sanita-interrogazione-dell-onorevole-dall-osso-sul-tema-dei-lavoratori-fragili]]></loc><lastmod>2022-09-16T15:13:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19070-nuovi-lea-oggi-attesa-approvazione-decreto-la-paura-dell-ennesimo-rinvio]]></loc><lastmod>2025-09-09T15:01:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19029-sport-amatoriale-e-disabilita-arriva-il-finanziamento-per-ausili-e-protesi-di-ultima-generazione]]></loc><lastmod>2022-12-21T18:50:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19039-7-giorni-sanita-il-sen-barboni-presenta-un-interrogazione-sulla-fibrosi-cistica]]></loc><lastmod>2022-09-09T14:44:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/19021-le-malattie-rare-incontrano-la-politica]]></loc><lastmod>2022-09-06T11:09:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18987-7-giorni-sanita-dalle-regioni-via-libera-al-piano-per-la-non-autosufficienza-2022-2024]]></loc><lastmod>2022-09-09T14:42:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18982-non-autosufficienze-dalle-regioni-ok-al-piano-triennale-2022-2024-con-uno-stanziamento-per-quest-anno-di-882-milioni]]></loc><lastmod>2022-08-04T20:01:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18981-ipotensione-liquorale-patologia-poco-nota-troppe-le-difficolta-per-curarsi-all-estero]]></loc><lastmod>2022-08-04T19:25:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18977-malattie-rare-il-governo-ha-meno-di-due-mesi-per-fare-il-proprio-dovere]]></loc><lastmod>2022-08-02T07:57:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18976-covid-19-e-vaccini-siglato-il-protocollo-con-le-farmacie]]></loc><lastmod>2022-08-01T16:34:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18972-7-giorni-sanita-esami-in-conferenza-stato-regioni-malattie-rare-della-retina-e-nomina-aifa]]></loc><lastmod>2022-07-29T12:18:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18941-7-giorni-sanita-crisi-di-governo-sciolte-le-camere-al-voto-il-25-settembre]]></loc><lastmod>2022-07-22T15:59:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18937-esofagite-eosinofila-eoe-dalla-senatrice-binetti-la-richiesta-di-inserimento-tra-i-lea]]></loc><lastmod>2022-07-21T17:42:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18936-diritto-al-lavoro-dei-disabili-l-interrogazione-della-sen-binetti]]></loc><lastmod>2022-09-16T15:12:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18933-caregiver-in-liguria-un-contributo-di-350-euro-grazie-al-fondo-ad-hoc-per-gravi-demenze]]></loc><lastmod>2022-07-19T06:53:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18930-regione-lazio-stanza-5-5-milioni-di-euro-per-il-sostegno-alle-persone-con-disabilita]]></loc><lastmod>2022-07-18T14:29:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18918-7-giorni-sanita-via-libera-alla-quarta-dose-di-vaccino-anti-covid-per-over-60-e-fragili-over-12]]></loc><lastmod>2022-07-22T15:57:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18899-7-giorni-sanita-interrogazione-della-sen-binetti-sul-testo-unico-malattie-rare]]></loc><lastmod>2022-07-08T15:59:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18897-testo-unico-malattie-rare-una-legge-che-fatica-ad-essere-applicata]]></loc><lastmod>2022-07-07T17:45:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18892-medicina-di-precisione-dall-on-noja-un-interrogazione-che-chiede-di-adeguarsi-a-novita-diagnostiche-e-terapeutiche]]></loc><lastmod>2022-07-07T06:35:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18863-7-giorni-sanita-le-indicazioni-del-ministero-del-lavoro-su-covid-19-e-lavoratori-fragili]]></loc><lastmod>2022-07-01T14:49:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18855-in-arrivo-per-le-regioni-902-milioni-di-contributo-per-la-gestione-della-fase-intrapandemica]]></loc><lastmod>2022-06-30T13:43:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18841-testo-unico-malattie-rare-6-mesi-sono-gia-stati-persi]]></loc><lastmod>2022-06-27T09:22:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18827-7-giorni-sanita-dalla-senatrice-binetti-un-interrogazione-sui-fondi-non-erogati-per-la-fibrosi-cistica]]></loc><lastmod>2022-06-24T15:28:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18819-pubblicato-il-decreto-per-la-riforma-dell-assistenza-sanitaria-territoriale]]></loc><lastmod>2022-06-24T13:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18811-ossigenoterapia-ancora-nessuna-risposta-ai-pazienti-che-chiedono-di-ricaricare-gli-stroller-portatili]]></loc><lastmod>2022-06-23T10:50:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18791-7-giorni-sanita-la-senatrice-binetti-chiede-stabilizzazione-delle-tutele-per-i-lavoratori-fragili]]></loc><lastmod>2022-06-24T15:27:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18789-malattie-oncologiche-approvate-dalla-camera-nuove-misure-per-l-attuazione-del-piano-nazionale-dedicato]]></loc><lastmod>2022-06-17T13:38:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18779-progetti-terapeutici-riabilitativi-individualizzati-arriva-la-proposta-di-legge-per-rimettere-la-persona-al-centro]]></loc><lastmod>2022-06-17T13:42:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18781-riforma-dell-assistenza-sanitaria-territoriale-tra-le-proposte-anche-iniziative-specifiche-per-malati-rari-e-cronici]]></loc><lastmod>2022-06-17T13:30:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18774-lavoratori-fragili-dalla-senatrice-paola-binetti-una-stabilizzazione-delle-tutele]]></loc><lastmod>2022-06-15T12:19:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18775-morte-cardiaca-improvvisa-un-disegno-di-legge-per-favorire-diagnosi-e-prevenzione]]></loc><lastmod>2022-06-15T15:28:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18750-7-giorni-sanita-elezioni-e-referendum-2022-norme-anti-contagio-e-voto-assistito]]></loc><lastmod>2022-06-10T14:24:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18740-fascicolo-sanitario-elettronico-dall-europa-la-proposta-di-uno-spazio-digitale-sovranazionale]]></loc><lastmod>2022-06-06T09:40:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18726-telemedicina-novita-e-linee-guida-per-rendere-piu-efficiente-l-assistenza-domiciliare]]></loc><lastmod>2022-06-03T14:08:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18721-7-giorni-sanita-il-ministro-speranza-interrogato-sul-tema-dei-lavoratori-fragili]]></loc><lastmod>2022-06-01T16:01:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18719-puglia-e-calabria-in-prima-linea-per-rafforzare-la-sanita-territoriale]]></loc><lastmod>2022-06-01T13:36:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18715-invalidita-civile-stop-alla-revisione-per-le-persone-con-sla-sma-e-malattie-del-motoneurone]]></loc><lastmod>2022-06-06T09:49:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18698-7-giorni-sanita-pubblicato-in-gazzetta-ufficiale-il-dm-assistenza-domiciliare]]></loc><lastmod>2022-05-27T15:33:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18691-malattie-rare-in-puglia-27-000-i-pazienti-con-2-000-patologie-diverse-seguiti-dai-centri-territoriali]]></loc><lastmod>2022-05-25T15:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18671-7-giorni-sanita-via-libera-del-senato-al-dl-riaperture]]></loc><lastmod>2022-05-20T15:24:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18647-7-giorni-sanita-in-corso-alla-camera-l-esame-degli-emendamenti-al-ddl-delega-ircss]]></loc><lastmod>2022-05-20T15:10:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18617-7-giorni-sanita-interrogazione-dell-on-bologna-sul-fondo-aifa-per-il-rimborso-dei-farmaci-orfani]]></loc><lastmod>2022-05-06T15:47:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18603-fascicolo-sanitario-elettronico-ok-dalle-regioni-alla-riforma-e-alle-nuove-linee-guida]]></loc><lastmod>2022-05-05T10:57:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18590-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-26-al-29-aprile-2022]]></loc><lastmod>2022-04-29T15:16:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18567-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-19-al-22-aprile-2022]]></loc><lastmod>2022-04-29T15:11:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18549-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dall-11-al-14-aprile-2022]]></loc><lastmod>2022-04-22T15:20:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18546-erogazione-dei-test-diagnostici-ngs-presentata-interrogazione-parlamentare]]></loc><lastmod>2022-04-14T09:23:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18522-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-4-all-8-aprile-2022]]></loc><lastmod>2022-04-08T14:36:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18518-lavoratori-fragili-chiesta-al-governo-la-proroga-delle-tutele-fino-al-30-giugno]]></loc><lastmod>2022-04-05T14:06:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18500-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-28-marzo-al-1-aprile-2022]]></loc><lastmod>2022-04-01T14:42:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18494-home-therapy-le-interrogazioni-dell-onorevole-fabiola-bologna]]></loc><lastmod>2022-05-26T15:11:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18493-malattie-rare-non-diagnosticate-interrogazione-della-sen-binetti-sulle-esenzioni]]></loc><lastmod>2022-03-30T14:01:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18458-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-21-al-25-marzo-2022]]></loc><lastmod>2022-03-25T16:18:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18431-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-14-al-18-marzo-2022]]></loc><lastmod>2022-03-25T16:15:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18406-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-7-all-11-marzo-2022]]></loc><lastmod>2022-03-11T16:53:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18400-testo-unico-malattie-rare-gia-in-ritardo-sull-attuazione]]></loc><lastmod>2022-03-09T10:32:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18399-8-marzo-e-donne-con-disabilita-a-che-punto-siamo-e-quali-sono-le-prospettive]]></loc><lastmod>2022-03-09T11:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18381-sindrome-post-finasteride-un-interrogazione-al-senato-su-questa-patologia-semi-sconosciuta]]></loc><lastmod>2022-03-06T19:32:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18378-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-28-febbraio-al-4-marzo-2022]]></loc><lastmod>2022-03-04T15:40:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18379-sanita-pronto-il-documento-di-riforma-dell-assistenza-territoriale-ma-e-nuovo-stallo-da-parte-delle-regioni]]></loc><lastmod>2022-09-12T09:41:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18363-malattie-rare-urgenti-i-decreti-attuativi-per-applicare-il-testo-unico]]></loc><lastmod>2022-02-28T16:00:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18347-nuovi-lea-ministero-pronti-con-aggiornamento-e-pnmr-ma-manca-ancora-ok-a-decreto-tariffe]]></loc><lastmod>2022-03-14T10:36:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18344-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-21-al-25-febbraio-2022]]></loc><lastmod>2022-02-25T16:40:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18335-testo-unico-malattie-rare-un-interrogazione-per-sollecitare-i-tempi-di-attuazione]]></loc><lastmod>2022-03-04T11:59:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18313-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-14-al-18-febbraio]]></loc><lastmod>2022-02-18T17:11:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18286-7-giorni-sanita-i-provvedimenti-in-ambito-sanitario-dal-7-all-11-febbraio-2022]]></loc><lastmod>2022-02-11T15:48:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18285-associazioni-di-pazienti-un-interrogazione-per-coinvolgerle-presso-le-commissioni-dell-agenzia-italiana-del-farmaco]]></loc><lastmod>2022-02-21T11:28:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18280-nuovi-lea-le-associazioni-questo-ritardo-e-inaccettabile]]></loc><lastmod>2022-02-11T15:47:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18261-nuovi-lea-il-decreto-e-finalmente-pronto-ma-da-un-mese-si-attende-la-firma-delle-regioni]]></loc><lastmod>2022-02-14T09:22:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18249-la-legge-104-compie-30-anni-una-norma-straordinaria-ma-che-deve-essere-adeguata-ai-tempi]]></loc><lastmod>2022-02-04T10:47:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18209-acondroplasia-un-interrogazione-per-accelerare-l-immissione-sul-mercato-di-vosoritide]]></loc><lastmod>2022-01-23T21:40:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18208-strategia-europea-sui-prodotti-farmaceutici-il-contributo-dei-pazienti-esperti-eupati]]></loc><lastmod>2022-01-25T09:49:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18219-indennita-antitubercolari-le-indennita-spettanti-ai-malati-di-tbc]]></loc><lastmod>2024-06-10T13:43:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18196-orticaria-acquagenica-un-interrogazione-per-chiederne-l-inserimento-nei-lea]]></loc><lastmod>2022-01-20T16:25:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18128-farmaci-orfani-il-termine-per-l-inserimento-nei-prontuari-regionali-passa-da-6-a-2-mesi]]></loc><lastmod>2022-03-29T08:31:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18109-malattie-rare-le-nazioni-unite-adottano-la-prima-risoluzione-sui-diritti-dei-pazienti]]></loc><lastmod>2023-03-06T18:45:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18101-legge-di-bilancio-e-decreto-attuazione-pnrr-ecco-cosa-si-muove-per-i-malati-rari]]></loc><lastmod>2021-12-15T10:46:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18067-sequenziamento-dell-esoma-impugnata-la-legge-della-regione-puglia-dinanzi-alla-corte-costituzionale]]></loc><lastmod>2021-12-05T16:34:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18056-testo-unico-malattie-rare-ecco-i-prossimi-passi-attuativi-necessari]]></loc><lastmod>2021-11-30T15:11:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18055-il-testo-unico-malattie-rare-e-legge-ecco-la-nuova-normativa]]></loc><lastmod>2022-07-18T13:37:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/18032-malattie-rare-omar-in-audizione-all-incontro-del-gruppo-di-lavoro-per-l-analisi-delle-problematiche-connesse-alla-pandemia]]></loc><lastmod>2021-11-24T16:43:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17989-testo-unico-malattie-rare-fedemo-bene-l-approvazione-ma-nessun-passo-indietro-su-emofilia]]></loc><lastmod>2021-11-30T15:12:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17969-testo-unico-malattie-rare-tutti-plaudono-a-una-legge-giusta-e-guardano-alla-sua-applicazione]]></loc><lastmod>2022-03-29T08:35:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17968-cosa-prevede-il-testo-unico-malattie-rare-ecco-la-sintesi-della-legge-approvata]]></loc><lastmod>2021-11-30T15:12:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17966-malattie-rare-il-testo-unico-da-oggi-e-legge-le-prossime-tappe-per-l-attuazione]]></loc><lastmod>2021-11-30T15:12:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17883-testo-unico-sulle-malattie-rare-approvato-in-commissione-xii-al-senato-ora-manca-solo-approvazione-definitiva-del-decreto-legge]]></loc><lastmod>2021-11-30T15:12:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17632-testo-unico-malattie-rare-omar-testo-depotenziato-ma-ora-serve-approvarlo-poi-vigilanza-e-correttivi]]></loc><lastmod>2021-11-30T15:13:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17631-nuovi-lea-un-interrogazione-per-chiedere-l-emanazione-dei-decreti-attuativi]]></loc><lastmod>2021-07-08T17:11:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17628-sileri-dopo-l-estate-il-nuovo-piano-nazionale-malattie-rare]]></loc><lastmod>2021-07-07T15:33:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17598-ossigenoterapia-un-interrogazione-per-garantire-l-uso-dei-dispositivi-medici-anche-in-ambiente-non-domestico]]></loc><lastmod>2021-06-28T15:18:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17567-istituito-presso-il-gabinetto-del-ministero-della-salute-il-tavolo-tecnico-malattie-rare]]></loc><lastmod>2021-06-21T11:59:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17480-testo-unico-malattie-rare-approvato-alla-camera-ora-passa-all-esame-in-senato]]></loc><lastmod>2021-11-30T15:13:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17458-testo-unico-malattie-rare-lunedi-24-maggio-esame-camera]]></loc><lastmod>2021-11-30T15:13:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17455-disabilita-e-licenziamenti-si-richiede-l-intervento-della-ministra-stefani]]></loc><lastmod>2021-05-19T09:51:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17420-lombardia-approvata-la-delibera-sull-aggiornamento-della-rete-malattie-rare]]></loc><lastmod>2021-05-11T15:39:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17324-malattie-rare-positivo-incontro-tra-intergruppo-parlamentare-e-sottosegretario-sileri]]></loc><lastmod>2022-03-29T08:33:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17312-sindrome-di-sjogren-nuova-interrogazione-parlamentare-per-inserire-la-malattia-tra-le-rare]]></loc><lastmod>2021-04-18T15:36:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17243-malattie-rare-il-governo-draghi-attribuisce-la-delega-specifica-al-sottosegretario-sileri]]></loc><lastmod>2022-03-29T08:34:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17242-malattie-rare-ancora-ritardi-sull-esame-della-legge-necessaria-ora-piu-che-mai]]></loc><lastmod>2021-11-30T15:13:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17219-vaccinazioni-anti-covid-19-per-soggetti-fragili-e-loro-caregiver-noja-non-si-abbassi-la-guardia]]></loc><lastmod>2021-03-25T11:17:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17184-covid-19-per-i-malati-rari-la-vaccinazione-presso-i-centri-di-riferimento]]></loc><lastmod>2021-03-15T18:01:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17112-l-appello-a-speranza-vaccinare-le-persone-fragili-prima-di-quelle-in-salute]]></loc><lastmod>2022-03-29T08:29:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17086-sanita-il-testo-unico-sulle-malattie-rare-in-aula-29-marzo]]></loc><lastmod>2022-03-29T08:28:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17074-malattie-rare-e-disabilita-in-europa-impegno-su-assistenza-sanitaria-inclusione-e-ricerca]]></loc><lastmod>2021-02-24T15:36:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16945-vaccino-covid-19-i-pazienti-con-ipf-e-altre-malattie-interstiziali-non-possono-attendere]]></loc><lastmod>2021-01-28T14:54:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16935-sma-due-nuove-interrogazioni-sulla-terapia-genica]]></loc><lastmod>2022-03-29T08:27:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16886-sma-il-parlamento-interroga-il-ministero-su-screening-neonatale-e-terapia-genica]]></loc><lastmod>2022-03-29T08:18:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16790-screening-neonatale-e-piano-malattie-rare-l-impegno-del-viceministro-pierpaolo-sileri]]></loc><lastmod>2020-12-09T17:35:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16778-malattie-rare-il-covid-ha-aggravato-ritardi-istituzionali-e-disparita-regionali-preesistenti]]></loc><lastmod>2020-12-07T12:50:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16687-disabilita-grave-congedo-straordinario-e-bonus-baby-sitting-del-decreto-ristori-bis]]></loc><lastmod>2021-06-30T13:09:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16655-malattie-rare-on-bologna-concluso-iter-pdl-ora-si-vada-in-aula]]></loc><lastmod>2020-11-06T17:41:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16621-malattie-rare-ripartono-i-lavori-sulla-proposta-di-legge]]></loc><lastmod>2020-10-28T13:53:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16619-malattie-rare-una-priorita-anche-durante-la-pandemia]]></loc><lastmod>2020-10-27T11:22:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16602-malattie-rare-il-tam-tam-dei-pazienti-sul-web-basta-ritardi-nelle-attivita-istituzionali]]></loc><lastmod>2020-11-11T10:21:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16565-pdl-malattie-rare-riprende-oggi-alla-camera-l-esame-del-testo]]></loc><lastmod>2020-10-15T08:46:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17077-malattie-rare-il-testo-unico-deve-essere-approvato-prima-della-legge-di-bilancio]]></loc><lastmod>2021-02-25T19:19:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16536-covid-19-si-va-verso-l-obbligo-di-mascherine-anche-all-aperto]]></loc><lastmod>2020-10-06T14:54:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/17076-vii-premio-omar-sen-binetti-il-nuovo-piano-malattie-rare-e-una-priorita]]></loc><lastmod>2021-07-08T14:59:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16514-recovery-fund-ci-sara-una-scheda-sulle-malattie-rare]]></loc><lastmod>2020-10-01T08:25:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16207-decreto-rilancio-presentati-due-emendamenti-per-la-tutela-dei-pazienti-oncologici]]></loc><lastmod>2020-06-21T21:37:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16215-post-covid-prorogati-i-piani-terapeutici-e-le-ricette-mediche]]></loc><lastmod>2021-02-16T08:48:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16203-decreto-rilancio-le-associazioni-approvare-emendamenti-per-lavoratori-con-disabilita]]></loc><lastmod>2020-06-21T20:30:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16194-family-act-previsti-assegno-universale-sostegno-all-educazioni-e-congedi-parentali-flessibili]]></loc><lastmod>2020-06-17T12:26:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16175-decreto-scuola-consentita-la-didattica-a-distanza-per-gli-studenti-piu-fragili]]></loc><lastmod>2020-06-14T21:31:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16045-coronavirus-comitato-bioetica-indica-i-principi-da-seguire-per-il-triage]]></loc><lastmod>2020-05-10T21:24:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16031-coronavirus-omar-in-audizione-al-senato-per-le-proposte-a-favore-dei-malati-rari-durante-la-fase-2]]></loc><lastmod>2020-05-05T17:27:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16021-emergenza-covid-19-iniziative-regionali-a-favore-dei-malati-rari]]></loc><lastmod>2020-05-03T23:08:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/16007-malattie-autoimmuni-presentata-un-interrogazione-sulla-carenza-di-idrossiclorochina]]></loc><lastmod>2020-04-27T21:55:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15974-covid-19-decreto-cura-italia-malati-rari-dicono-no-a-sconti-su-tabacco-riscaldato]]></loc><lastmod>2020-04-20T14:50:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15937-covid-19-procedure-semplificate-per-farmaci-ad-uso-compassionevole-e-studi-clinici]]></loc><lastmod>2020-04-12T22:16:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15878-coronavirus-il-ministero-fa-chiarezza-sulle-situazioni-di-immunosoppressione]]></loc><lastmod>2020-04-01T12:26:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15816-coronavirus-lombardia-proroga-i-piani-terapeutici-per-malattie-rare]]></loc><lastmod>2020-03-23T18:58:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15822-coronavirus-aifa-proroga-la-scadenza-dei-piani-terapeutici]]></loc><lastmod>2020-03-23T23:09:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15813-coronavirus-interrogazione-alla-camera-sui-pazienti-immunodepressi]]></loc><lastmod>2020-03-23T18:35:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15766-coronavirus-asp-catania-proroga-le-scadenze-dei-certificati-di-esenzione-ticket]]></loc><lastmod>2020-03-17T19:50:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15758-coronavirus-regione-campania-proroga-i-piani-terapeutici-per-malattie-rare]]></loc><lastmod>2020-03-15T18:32:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15741-coronavirus-le-nuove-disposizioni-della-presidenza-del-consiglio]]></loc><lastmod>2020-03-10T18:29:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15725-riabilitazione-i-pazienti-si-appellano-al-ministro-speranza]]></loc><lastmod>2020-03-04T15:00:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15610-patient-advocacy-nel-lazio-arriva-il-facilitatore-dei-pazienti-e-teresa-petrangolini]]></loc><lastmod>2020-01-27T21:40:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15580-aifa-arriva-il-nuovo-direttore-e-il-farmacologo-nicola-magrini]]></loc><lastmod>2020-01-15T09:31:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15562-malattie-polmonari-presentata-un-interrogazione-sugli-apparecchi-per-la-respirazione-negli-aerei]]></loc><lastmod>2020-01-10T22:12:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15535-linfedema-mancano-i-decreti-attuativi-dei-lea-del-2017-i-pazienti-costretti-a-comprare-i-tutori]]></loc><lastmod>2019-12-22T18:32:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15483-malattie-rare-i-pazienti-scrivono-alle-istituzioni-ricordatevi-di-noi-in-bilancio]]></loc><lastmod>2019-12-14T15:09:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15447-malattie-rare-in-emilia-romagna-nasce-un-centro-di-coordinamento-regionale]]></loc><lastmod>2019-11-26T13:31:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15437-malattie-scheletriche-rare-il-policlinico-umberto-i-garantisce-la-piena-attivita-del-centro-di-riferimento]]></loc><lastmod>2019-11-23T15:39:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15410-malattie-rare-in-italia-ancora-pochi-fondi-per-la-ricerca-occorre-strategia-condivisa]]></loc><lastmod>2019-11-16T23:15:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15387-malattie-rare-le-associazioni-di-pazienti-in-audizione-alla-camera]]></loc><lastmod>2019-11-09T14:32:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15311-malattie-rare-omar-in-audizione-alla-xii-commissione-affari-sociali]]></loc><lastmod>2019-10-15T12:20:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15284-malattie-rare-da-istituzioni-pazienti-e-tecnici-5-punti-per-il-ministro-speranza]]></loc><lastmod>2019-10-08T13:54:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15160-governo-via-giulia-grillo-al-ministero-della-salute-arriva-roberto-speranza]]></loc><lastmod>2019-09-05T10:05:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15126-malattie-rare-per-combatterle-la-parola-d-ordine-e-collaborazione]]></loc><lastmod>2019-08-20T16:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15080-farmaci-orfani-in-italia-tanti-database-che-non-dialogano-fra-loro]]></loc><lastmod>2019-08-03T17:28:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15070-riconoscere-la-sordocecita-come-disabilita-specifica-arriva-la-proposta-di-legge-sostenuta-delle-associazioni-di-pazienti-e-omar]]></loc><lastmod>2019-09-10T14:24:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15047-piano-nazionale-malattie-rare-l-on-bagnasco-il-ministro-risponda-prima-della-pausa-estiva]]></loc><lastmod>2019-07-21T18:15:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14962-malattie-rare-la-sen-binetti-chiede-notizie-sul-piano-nazionale-si-attende-risposta-dal-ministero]]></loc><lastmod>2019-07-10T13:29:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/15018-sperimentazioni-cliniche-l-interrogazione-dell-on-lorenzin-al-ministro-grillo]]></loc><lastmod>2019-07-10T13:29:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14831-malattie-rare-la-regione-marche-sostiene-i-caregiver-familiari-con-1-000-euro-al-mese]]></loc><lastmod>2019-05-20T15:40:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14836-malattie-rare-pediatriche-un-disegno-di-legge-in-esame-al-senato]]></loc><lastmod>2019-05-21T11:17:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14822-malattie-rare-in-lombardia-aggiornata-la-rete-regionale]]></loc><lastmod>2019-05-18T17:28:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14764-malattia-di-meniere-nelle-marche-un-pdta-per-migliorare-la-vita-dei-pazienti]]></loc><lastmod>2019-04-29T17:37:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14752-tumori-rari-approvata-una-legge-che-istituisce-la-rete-nazionale-dei-registri-dei-tumori-rari]]></loc><lastmod>2019-04-23T16:25:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14701-malattie-respiratorie-la-riabilitazione-deve-essere-basata-sui-bisogni-reali-dei-pazienti]]></loc><lastmod>2019-04-08T12:02:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14684-malattie-rare-eurordis-invita-gli-eurodeputati-ad-aderire-alla-campagna-pledge4rd]]></loc><lastmod>2019-04-05T10:08:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14629-malattie-rare-omar-necessario-finanziare-il-nuovo-piano-nazionale]]></loc><lastmod>2019-03-27T08:29:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14562-malattie-rare-cominciato-il-percorso-legislativo-della-proposta-bologna]]></loc><lastmod>2019-03-11T12:34:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14541-nuovo-pnmr-intergruppo-parlamentare-malattie-rare-e-il-nostro-impegno-prioritario]]></loc><lastmod>2019-03-06T11:38:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14495-piano-nazionale-malattie-rare-il-ministro-grillo-convoca-il-nuovo-tavolo]]></loc><lastmod>2019-02-22T09:30:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14480-esofagite-eosinofila-i-pazienti-ancora-in-attesa-del-riconoscimento-di-malattia-rara]]></loc><lastmod>2019-02-18T19:29:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14477-sindrome-di-sjogren-grillo-non-e-malattia-rara-resta-valido-il-codice-di-esenzione-per-patologia-cronica]]></loc><lastmod>2019-02-18T17:53:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14427-consiglio-superiore-di-sanita-ecco-tutte-le-nuove-nomine]]></loc><lastmod>2019-02-06T08:37:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14419-farmaci-orfani-il-ministero-risponde-all-interrogazione-dell-on-de-filippo-ma-non-convince]]></loc><lastmod>2019-02-05T12:59:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14418-nuovi-lea-ancora-ritardi-sui-decreti-attuativi-tutto-fermo-da-due-anni]]></loc><lastmod>2019-02-05T12:53:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14415-politiche-sanitarie-al-via-la-consultazione-sulla-partecipazione-civica-in-sanita-di-cittadinanzattiva]]></loc><lastmod>2019-02-04T20:56:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14408-presentata-mozione-al-senato-per-una-migliore-presa-in-carico-e-cura-del-paziente-oncologico]]></loc><lastmod>2019-02-02T18:06:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14361-malattie-rare-necessario-provvedere-all-aggiornamento-dei-lea]]></loc><lastmod>2019-01-14T19:00:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14353-farmaci-orfani-i-pazienti-si-appellano-al-ministro-perche-riveda-norma-che-li-penalizza]]></loc><lastmod>2019-01-11T17:34:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14329-farmaci-orfani-scoppia-la-polemica-sulla-legge-di-bilancio]]></loc><lastmod>2019-01-11T10:11:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14328-farmaci-orfani-binetti-equita-non-e-trattare-in-modo-uguale-aziende-che-uguali-non-sono-ho-depositato-un-interrogazione-in-merito]]></loc><lastmod>2019-01-11T10:09:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14351-malattie-rare-in-italia-sono-ancora-una-priorita-sanitaria]]></loc><lastmod>2019-01-11T09:51:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14208-malattie-rare-e-farmaci-orfani-due-disegni-di-legge-in-esame-al-senato]]></loc><lastmod>2018-11-27T10:29:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14197-sarcoidosi-un-interrogazione-per-chiedere-la-tutela-dei-diritti-dei-malati]]></loc><lastmod>2019-03-15T10:07:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14095-tumori-nasce-la-rete-nazionale-dei-registri-e-dei-sistemi-di-sorveglianza]]></loc><lastmod>2018-10-30T11:12:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14029-lombardia-1-6-milioni-di-euro-per-le-malattie-rare]]></loc><lastmod>2018-10-11T10:45:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/14002-malattie-rare-uniamo-fimr-onlus-chiede-un-si-del-governo-alla-proposta-ue-sull-hta]]></loc><lastmod>2018-10-05T18:10:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/13996-malattie-rare-al-ministro-della-salute-si-chiedono-soluzioni-pratiche-e-notizie-del-pnm-scaduto]]></loc><lastmod>2018-10-04T14:57:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/13977-tumori-testa-collo-presentata-una-mozione-al-senato]]></loc><lastmod>2018-11-04T18:38:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/13822-uso-compassionevole-dei-farmaci-in-italia-luci-e-ombre-di-una-prassi-piu-diffusa-di-quanto-si-pensi]]></loc><lastmod>2018-08-03T16:23:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/13808-malattie-rare-lascia-un-po-perplessi-la-decisione-europea-di-non-rinnovare-il-cegrd]]></loc><lastmod>2018-07-31T17:34:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/13758-malattie-rare-l-efficienza-organizzativa-della-rete-regionale-della-lombardia]]></loc><lastmod>2018-07-16T10:08:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/13752-ausili-e-protesi-ass-coscioni-urge-l-aggiornamento-dei-lea-e-del-nomenclatore-tariffario]]></loc><lastmod>2018-07-13T16:29:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/13434-malattie-rare-in-puglia-introdotto-il-contributo-di-solidarieta-a-favore-della-ricerca]]></loc><lastmod>2018-04-13T09:31:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/13352-malattie-rare-in-lazio-ecco-dove-ottenere-le-esenzioni-per-malattia-rara]]></loc><lastmod>2018-04-13T07:15:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/13055-malattie-rare-da-eurordis-le-proposte-per-migliorare-l-accesso-ai-farmaci]]></loc><lastmod>2017-12-22T11:25:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/13010-malattie-rare-nascono-i-parliamentary-advocates-una-nuova-voce-per-i-pazienti-europei]]></loc><lastmod>2017-12-09T15:15:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12989-tumori-rari-la-rete-nazionale-nasce-per-agevolare-diagnosi-e-terapie]]></loc><lastmod>2017-12-05T10:27:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12706-nasce-la-rete-nazionale-tumori-rari-raggiunta-l-intesa-stato-regioni]]></loc><lastmod>2017-09-27T21:30:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12704-on-binetti-il-2017-anno-importante-per-le-malattie-rare]]></loc><lastmod>2017-09-26T20:06:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12473-sperimentazioni-cliniche-istituito-nuovo-comitato-etico-nazionale]]></loc><lastmod>2017-07-05T13:19:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12373-eurordis-compie-20-anni-una-storia-di-impegno-e-successo-con-un-futuro-tutto-da-costruire]]></loc><lastmod>2017-06-11T20:31:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12272-nuovi-lea-insediata-la-commissione-ministeriale-per-il-monitoraggio]]></loc><lastmod>2017-05-18T10:57:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12247-nuovi-lea-la-sindrome-mayer-rokitansky-kuster-hauser-ha-ottenuto-il-riconoscimento]]></loc><lastmod>2017-05-18T11:01:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12208-biotestamento-il-paziente-potra-rifiutare-le-terapie-primo-ok-della-camera-al-disegno-di-legge]]></loc><lastmod>2017-12-14T15:42:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12141-nuovi-lea-l-emilia-romagna-e-la-prima-regione-a-recepirli]]></loc><lastmod>2017-04-06T16:28:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12106-farmaci-innovativi-entro-fine-mese-l-aifa-indichera-i-criteri-per-la-loro-classificazione]]></loc><lastmod>2017-03-23T16:26:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12082-nuovi-lea-osservatorio-malattie-rare-non-confondere-perfezionamento-di-un-iter-con-la-soddisfazione-dei-bisogni-siamo-solo-al-momento-zero-dell-applicazione]]></loc><lastmod>2017-05-18T11:06:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/12050-biotestamento-istat-presenta-un-rapporto-sui-casi-italiani-di-suicidio-tra-malati]]></loc><lastmod>2017-12-14T15:41:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11988-simona-bellagambi-eurordis-farmaci-orfani-pediatrici-lanciata-consultazione-pubblica-europea]]></loc><lastmod>2017-02-26T15:05:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11983-tumore-al-seno-e-all-ovaio-approvata-mozione-per-estendere-in-tutta-italia-l-esenzione-ticket-per-le-donne-positive-a-brca1-e-brca2]]></loc><lastmod>2017-02-25T11:36:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11984-simona-bellagambi-eurordis-diritto-a-diagnosi-e-cura-puntare-a-non-facile-uguaglianza]]></loc><lastmod>2017-02-27T10:50:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11985-malattie-rare-mozione-bianconi-binetti-per-aggiornare-il-piano-nazionale]]></loc><lastmod>2017-02-26T11:24:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11813-nuovi-lea-osservatorio-malattie-rare-dal-ministro-lorenzin-ci-aspettiamo-massima-attenzione-anche-su-applicazione-dello-screening-metabolico-allargato]]></loc><lastmod>2017-01-17T14:49:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11800-il-premier-gentiloni-ha-firmato-i-nuovi-lea]]></loc><lastmod>2017-05-18T11:08:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11799-nuovi-lea-sempre-piu-vicina-la-pubblicazione-in-gazzetta-ufficiale]]></loc><lastmod>2017-05-15T08:41:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11757-atassie-pediatriche-un-progetto-di-rete-per-la-diagnosi-il-monitoraggio-e-la-cura-di-queste-patologie]]></loc><lastmod>2016-12-22T15:28:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11717-dolore-cronico-over-65-prosegue-in-parlamento-europeo-la-campagna-di-sensibilizzazione-siha]]></loc><lastmod>2016-12-10T17:03:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11649-malattie-rare-e-minori-pubblicato-in-abruzzo-il-bando-caregiver]]></loc><lastmod>2016-11-25T15:52:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11642-nuovi-lea-oggi-il-direttore-dell-osservatorio-malattie-rare-in-audizione-alla-camera]]></loc><lastmod>2016-11-24T15:05:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11470-malattie-rare-in-paesi-come-il-peru-non-ci-sono-sovvenzioni-ad-hoc]]></loc><lastmod>2016-10-17T09:44:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11467-malattie-rare-in-cina-le-politiche-di-rimborso-sono-orientate-alle-persone-ad-alto-reddito]]></loc><lastmod>2016-10-20T14:59:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11395-malattie-rare-ema-e-fda-lavorano-in-partnership-allo-sviluppo-di-nuove-terapie]]></loc><lastmod>2016-10-05T16:14:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11221-ema-e-fda-rafforzano-la-collaborazione-sul-coinvolgimento-del-paziente]]></loc><lastmod>2016-09-10T14:31:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11205-nuovi-lea-procede-l-iter-per-l-approvazione-ok-dalle-regioni]]></loc><lastmod>2016-09-09T07:46:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11091-pandas-presentata-alla-camera-interrogazione-sul-gruppo-di-malattie-rare-pediatriche]]></loc><lastmod>2016-08-05T10:36:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11070-nuovi-lea-e-polemica-sull-assenza-della-riabilitazione-oncologica]]></loc><lastmod>2016-08-02T13:22:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11062-nuovi-lea-procede-l-iter-per-l-approvazione-dopo-ok-ufficiale-da-ministero-economia]]></loc><lastmod>2016-08-01T14:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11021-malattie-croniche-trasmesso-alla-conferenza-stato-regioni-il-piano-nazionale-delle-cronicita]]></loc><lastmod>2016-07-25T10:44:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/11004-campania-per-de-luca-prioritaria-la-ricerca-sulle-malattie-rare-e-tumori]]></loc><lastmod>2016-07-21T07:34:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10981-lea-ok-informale-dal-ministero-economia-ecco-le-novita-per-malattie-rare-e-disabilita]]></loc><lastmod>2016-07-15T09:32:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10961-sperimentazione-clinica-dei-farmaci-entro-il-2018-dovra-essere-applicato-nuovo-regolamento-ue]]></loc><lastmod>2016-07-13T07:58:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10933-nuovi-lea-pronti-ora-manca-solo-ok-del-ministero-economia-e-finanze]]></loc><lastmod>2016-07-08T09:11:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10932-le-regioni-danno-il-via-libera-condizionato-ai-nuovi-lea-passo-importante-ma-non-decisivo]]></loc><lastmod>2016-07-07T15:19:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10929-nuovi-lea-conferenza-stato-regioni-pronta-al-via-libera-ma-impone-condizioni]]></loc><lastmod>2016-07-07T13:04:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10903-uso-compassionevole-dei-farmaci-de-filippo-ammette-modifiche-della-normativa-non-ancora-ultimate]]></loc><lastmod>2016-07-01T13:03:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10884-brexit-mettera-in-crisi-la-sanita-a-farne-le-spese-potrebbero-essere-i-malati-rari]]></loc><lastmod>2016-12-27T19:24:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10871-senato-un-disegno-di-legge-punta-a-tutelare-e-valorizzare-il-lavoro-dei-caregiver-familiari]]></loc><lastmod>2016-06-28T13:38:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10860-rene-policistico-la-presa-in-carico-dei-pazienti-migliorera-la-promessa-di-de-filippo]]></loc><lastmod>2016-06-27T07:53:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10843-nuovi-lea-lorenzin-invia-nuovo-testo-alle-regioni-ma-i-pazienti-sono-ancora-in-attesa]]></loc><lastmod>2016-06-23T15:35:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10835-puglia-necessarie-reti-pdta-e-dati-real-life-per-innovare-le-terapie-oncologiche]]></loc><lastmod>2016-06-23T07:16:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10820-dispositivi-orfani-e-necessaria-una-direttiva-ue]]></loc><lastmod>2016-06-17T12:31:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10778-livelli-essenziali-di-assistenza-e-malattie-rare-stallo-continuo-decreto-incagliato-nelle-stanze-del-mef]]></loc><lastmod>2016-06-10T13:20:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10693-nomenclatore-tariffario-ass-coscioni-si-appella-a-renzi-e-lorenzin]]></loc><lastmod>2016-05-27T12:13:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10689-approvato-dal-senato-il-disegno-di-legge-dopo-di-noi-piu-sostegni-per-la-disabilita-grave]]></loc><lastmod>2016-05-27T09:06:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10678-senato-approva-ddl-lorenzin-su-ordini-sanitari-e-sperimentazioni-cliniche]]></loc><lastmod>2016-05-25T09:09:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10662-malattie-rare-le-dieci-raccomandazioni-alla-commissione-europea-e-agli-stati-membri]]></loc><lastmod>2016-05-20T12:42:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10526-abruzzo-arrivano-i-finanziamenti-per-i-caregiver-entro-l-anno-ci-sara-un-nuovo-intervento]]></loc><lastmod>2016-05-04T07:36:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10445-sarcoidosi-la-patologia-potrebbe-rientrare-nei-nuovi-livelli-essenziali-di-assistenza]]></loc><lastmod>2016-04-26T07:11:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10365-xantomatosi-cerebro-tendinea-un-interrogazione-chiede-di-fare-chiarezza-sulle-terapie-disponibili]]></loc><lastmod>2025-06-09T12:19:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10349-il-caso-della-maratoneta-vincenza-sicari-al-centro-di-un-interrogazione-parlamentare]]></loc><lastmod>2016-04-11T09:03:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10245-disabilita-un-disegno-di-legge-di-paola-taverna-m5s-punta-a-favorire-le-assunzioni-obbligatorie]]></loc><lastmod>2016-03-22T17:00:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10207-livelli-essenziali-di-assistenza-i-deputati-m5s-attaccano-la-lorenzin-mentre-la-coscioni-la-diffida]]></loc><lastmod>2016-03-17T17:27:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10166-registro-tumori-paola-binetti-tuteleremo-privacy-malati-e-inseriremo-norme-su-tumori-rari]]></loc><lastmod>2016-03-11T07:44:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10146-registro-tumori-legge-bocciata-problematica-la-tutela-della-privacy]]></loc><lastmod>2016-03-09T09:12:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10085-ossigenoterapia-necessario-un-sistema-universale-decine-di-migliaia-i-pazienti-che-ne-hanno-bisogno]]></loc><lastmod>2016-03-02T08:33:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10055-la-siar-accesso-tempestivo-ai-farmaci-per-le-malattie-gravi]]></loc><lastmod>2016-03-02T08:04:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10083-la-politica-ai-malati-rari-fate-lobbying-sul-governo-senza-esitare]]></loc><lastmod>2016-03-01T15:20:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10069-malattie-rare-la-politica-scende-in-campo-e-chiede-maggiori-tutele-per-i-malati-servono-subito-leggi-chiare]]></loc><lastmod>2016-02-29T12:20:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/10006-al-senato-un-interrogazione-sull-idrosadenite-suppurativa-hs-malattia-dermatologica-rara]]></loc><lastmod>2016-02-22T14:35:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9987-registri-tumori-gli-oncologi-invitano-la-camera-a-fare-presto-e-bene]]></loc><lastmod>2016-02-17T18:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9979-nomenclatore-l-oms-invita-i-paesi-membri-ad-individuare-50-ausili-tecnici-fondamentali]]></loc><lastmod>2016-02-17T09:11:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9967-decreto-appropriatezza-marcia-indietro-del-ministero-della-salute-a-giorni-una-circolare-esplicativa]]></loc><lastmod>2016-02-15T08:13:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9920-abruzzo-in-arrivo-100-000-per-le-famiglie-dei-malati-rari]]></loc><lastmod>2016-02-08T11:54:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9901-dopo-di-noi-approvata-in-prima-lettura-alla-camera-la-proposta-di-legge]]></loc><lastmod>2016-02-04T17:22:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9862-sanita-in-arrivo-altri-2-miliardi-di-tagli-nel-corso-del-2016-il-veneto-non-ci-sta-e-chiede-di-riaprire-il-confronto-con-lo-stato]]></loc><lastmod>2016-01-30T08:49:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9847-registro-tumori-in-commissione-una-nuova-proposta-targata-pd]]></loc><lastmod>2016-01-29T14:56:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9779-disabilita-dal-senato-un-disegno-di-legge-per-tutelare-stomizzati-e-incontinenti]]></loc><lastmod>2016-01-20T13:47:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9770-politiche-sanitarie-la-conferenza-stato-regioni-potrebbe-sparire]]></loc><lastmod>2016-01-19T16:33:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9745-emilia-romagna-approvata-risoluzione-sulle-malattie-rare]]></loc><lastmod>2016-01-15T08:21:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9734-registro-tumori-in-commissione-affari-sociali-arrivano-nuove-proposte-di-legge]]></loc><lastmod>2016-01-13T08:02:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9707-farmaci-innovativi-aggiornata-la-lista-aifa]]></loc><lastmod>2016-01-08T09:30:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9706-malattie-rare-de-filippo-aggiorneremo-i-lea-entro-60-giorni]]></loc><lastmod>2016-01-07T15:37:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9679-salute-orale-aggiornate-dal-ministero-le-linee-guida-nazionali]]></loc><lastmod>2015-12-28T11:23:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9656-stabilita-insieme-agli-800-milioni-per-i-lea-arrivano-i-tagli]]></loc><lastmod>2015-12-22T10:50:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9636-stabilita-arrivano-6-milioni-di-euro-per-la-ricerca-sulle-malattie-rare]]></loc><lastmod>2015-12-17T13:30:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9627-farmaci-orfani-attaccarli-significa-offendere-i-malati-rari]]></loc><lastmod>2015-12-16T08:56:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9626-sen-bianconi-giu-le-mani-dai-farmaci-orfani]]></loc><lastmod>2015-12-16T09:31:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9528-al-senato-un-interrogazione-sulla-diagnosi-dell-ipercolesterolemia-familiare]]></loc><lastmod>2015-12-04T07:38:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9512-tumori-rari-alla-camera-due-mozioni-firmate-da-pd-e-movimento-5-stelle]]></loc><lastmod>2015-12-02T16:41:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9463-decreto-appropriatezza-la-conferenza-stato-regioni-inserisce-i-test-genetici]]></loc><lastmod>2015-11-26T15:07:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9423-decreto-appropriatezza-tra-le-prestazioni-previste-anche-i-test-genetici]]></loc><lastmod>2015-11-23T16:12:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9424-stabilita-una-norma-finanzia-l-acquisto-dei-farmaci-innovativi]]></loc><lastmod>2015-11-23T16:15:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9417-sardegna-la-giunta-regionale-intende-contenere-la-spesa-farmaceutica-con-una-delibera]]></loc><lastmod>2015-11-23T09:01:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9416-malattie-rare-le-nuove-raccomandazioni-della-commissione-europea]]></loc><lastmod>2015-11-23T09:00:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9377-punti-nascita-sono-123-le-strutture-sotto-lo-standard-previsto-dal-ministero]]></loc><lastmod>2015-11-18T09:12:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9365-tumori-rari-binetti-invita-il-governo-a-occuparsi-celermente-della-questione]]></loc><lastmod>2015-11-17T08:48:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9291-nuovi-lea-passo-indietro-del-governo-per-le-malattie-rare-cade-anche-la-priorita]]></loc><lastmod>2015-11-04T14:15:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9216-malattie-rare-la-nuova-rd-action-europea-e-ora-insediata]]></loc><lastmod>2015-10-23T09:56:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9205-reti-regionali-di-assistenza-pareciperanno-alle-ern-bianconi-grande-soddisfazione]]></loc><lastmod>2015-10-23T07:48:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9204-malattie-rare-dalle-regioni-via-libera-alle-reti-europee-di-eccellenza]]></loc><lastmod>2015-10-23T07:49:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9200-malattie-reumatiche-e-patologie-infiammatorie-croniche-arrivano-i-pdta-percorsi-diagnostici-terapeutici-assistenziali]]></loc><lastmod>2015-10-22T10:27:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9183-legge-stabilita-e-sanita-la-dichiarazione-di-claudio-giustozzi-associazione-giuseppe-dossetti]]></loc><lastmod>2015-10-20T12:51:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9182-nuovi-lea-potrebbero-essere-approvati-entro-la-fine-di-febbraio]]></loc><lastmod>2015-10-20T10:48:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/9025-camera-via-libera-a-una-risoluzione-di-paola-binetti-ap-sulle-malattie-rare]]></loc><lastmod>2015-10-01T15:28:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8963-il-rapporto-sulla-sanita-transfrontaliera-mette-in-evidenza-i-progressi-e-gli-sforzi-a-livello-comunitario-e-nazionale]]></loc><lastmod>2015-09-22T10:51:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8948-farmaci-orfani-dagli-usa-la-proposta-di-estendere-di-6-mesi-l-esclusivita-di-mercato]]></loc><lastmod>2015-09-18T08:28:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8951-una-risoluzione-di-paola-binetti-ap-chiede-il-potenziamenti-dei-lea-e-una-fiscalita-di-vantaggio-per-i-farmaci-orfani]]></loc><lastmod>2015-09-21T10:26:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8818-ospedali-pubblici-e-asl-del-lazio-l-8-settembre-sciopero-del-personale-cup]]></loc><lastmod>2015-08-25T10:28:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8752-la-camera-dice-si-ai-tagli-sul-fondo-sanitario-nazionale]]></loc><lastmod>2015-08-04T14:05:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8717-malattie-rare-conclusa-l-indagine-della-camera]]></loc><lastmod>2019-03-26T17:32:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8715-sanita-ecco-cosa-prevede-il-dl-enti-locali-approvato-dal-senato]]></loc><lastmod>2015-07-29T10:30:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8657-farmaci-governo-punta-a-potenziare-aifa-ma-taglia-mezzo-miliardo-sulla-spesa-farmaceutica]]></loc><lastmod>2015-07-21T10:28:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8641-camera-indagine-conoscitiva-sulle-malattie-rare-al-rush-finale]]></loc><lastmod>2015-07-17T11:19:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8581-stato-regioni-via-libera-al-taglio-da-2-35-miliardi-al-fondo-sanitario-regionale]]></loc><lastmod>2015-07-06T11:09:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8535-la-asl-di-viterbo-istituisce-il-tavolo-tematico-sulle-malattie-rare]]></loc><lastmod>2015-06-29T09:58:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8451-calabria-presentata-una-proposta-di-legge-sull-assistenza-ai-malati-rari]]></loc><lastmod>2015-06-15T14:18:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8432-fecondazione-assistita-cosa-cambia-con-l-ultima-sentenza-della-corte-costituzionale]]></loc><lastmod>2015-06-12T11:26:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8403-malattie-rare-facchin-la-lista-si-puo-aggiornare-anche-senza-passare-per-i-lea-mentre-per-lo-screening-neonatale-sarebbe-necessario]]></loc><lastmod>2015-06-09T11:31:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8289-camera-le-proposte-delle-regioni-per-la-rete-dedicata-alle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8230-malattie-rare-la-xii-camera-ha-ascoltato-liss-e-la-direzione-della-programmazione-sanitaria-del-ministero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8229-fecondazione-le-coppie-fertili-portatrici-di-malattie-genetiche-rivolgono-un-appello-alla-corte-costituzionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8181-approvata-dal-senato-una-mozione-di-paola-taverna-sulla-sperimentazione-animale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8069-malattie-rare-quale-contributo-da-parte-delle-regioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8057-2015-04-20-16-06-02]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8038-registri-e-test-genetici-i-temi-affrontati-dagli-esperti-di-malattie-rare-della-commissione-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8012-sanita-le-regioni-faranno-i-conti-con-23-milardi-di-taglio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/8011-settimana-decisiva-per-le-coppie-portatrici-di-malattie-genetiche-che-ricorrono-alla-fecondazione-assistita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7986-farmaci-emoderivati-pubblicato-il-decreto-su-centri-di-frazionamento-e-di-produzione-plasma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7939-federfarma-insostenibili-nuovi-tagli-del-governo-alla-farmaceutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7761-federanziani-no-a-riduzione-fondo-sanitario-2015]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7751-premio-malattie-rare-del-polmone-2015-il-vincitore-e-daniele-mont-d-arpizio]]></loc><lastmod>2015-06-08T11:33:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7734-malattie-rare-melazzini-arisla-lancia-appello-al-governo-qcreare-prima-possibile-una-fast-trackq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7731-camera-al-via-indagine-conoscitiva-sulle-malattie-rare-in-commissione-affari-sociali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7725-regioni-taglio-da-due-miliardi-al-fondo-sanitario-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7673-riordino-aifa-cittadinanzattiva-e-associazioni-chiedono-partecipazione-nella-politica-farmaceutica-italiana]]></loc><lastmod>2020-01-08T16:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7593-estendere-i-lea-ai-diritti-sanitari-lappello-delle-associazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7580-malattie-rare-in-francia-il-secondo-pnmr-esteso-al-2016]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7579-puglia-arriva-il-piano-triennale-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7560-nuovi-lea-ecco-lelenco-delle-malattie-rare-che-entreranno-a-farne-parte]]></loc><lastmod>2018-01-17T15:56:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7540-lorenzin-416-milioni-per-potenziare-i-livelli-essenziali-di-assistenza]]></loc><lastmod>2021-01-12T15:43:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7519-il-presidente-della-repubblica-ricorda-limportanza-del-diritto-alla-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7496-lea-paola-binetti-chiede-chiarezza-su-malattie-rare-inserite-nellelenco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7495-stato-regioni-in-arrivo-due-miliardi-di-euro-di-tagli-sulla-sanita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7486-presentati-i-nuovi-lea-screening-neonatale-per-malattie-rare-nomenclatore-tariffario-nuovi-vaccini-ed-eterologa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7485-molise-farmaci-di-fascia-c-gratuiti-per-i-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7404-cambia-il-sistema-sanitario-lombardo-piu-attenzione-per-i-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7401-sardegna-parte-distribuzione-territoriale-dei-farmaci-ospedalieri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7358-entro-il-15-gennaio-si-dovrebbe-procedere-allaggiornamento-dei-lea-livelli-essenziali-di-assistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7321-disabilita-ass-coscioni-lorenzin-e-renzi-rispetteranno-il-patto-di-aggiornamento-dei-leanomenclatore-previsto-per-il-3112]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7319-legge-di-stabilita-arrivano-altri-5-milioni-di-euro-sullo-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7299-giustozzi-ass-dossetti-qnuovo-centrodestra-apertamente-schierato-contro-i-malati-rariq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7294-malattie-rare-uniamo-denuncia-qtemiamo-gravi-passi-indietro-sullo-stato-qualitativo-oggi-raggiunto-dallassistenzaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7201-vargiu-sc-lavorare-per-la-creazione-di-una-rete-europea-per-la-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7177-jobs-act-no-allistituzione-di-un-fondo-per-i-lavoratori-autonomi-malati-di-cancro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7165-molise-iorio-denuncia-tagli-per-i-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7086-disabilita-urgentissimo-laggiornamento-del-nomenclatore-tariffario-la-denuncia-dellass-coscioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7085-riforma-sanitaria-sardegna-bocciati-due-emendamenti-sui-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7023-renzi-il-fondo-per-la-non-autosufficienza-sara-portato-a-400-milioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/7017-scende-in-piazza-la-rabbia-dei-disabili-e-dei-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6999-malattie-rare-combattere-gli-sprechi-e-le-inefficienze-organizzare-una-rete-che-funzioni-concretamente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6980-il-sottosegretario-alla-salute-de-filippo-pronti-i-risarcimenti-per-i-danni-da-emoderivati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6974-malattie-rare-le-reti-regionali-implementate-attraverso-la-teleconsulenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6970-piano-nazionale-malattie-rare-mir-onlus-qgravi-lacune-e-occasione-mancata-per-quasi-2-milioni-di-malati-rari-in-italiaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6953-tumori-e-carenza-farmaci-si-riaccende-la-polemica-sui-prezzi-esorbitanti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6951-farmaci-i-criteri-aifa-per-lautorizzazione-la-risposta-del-ministero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6914-la-commissione-europea-si-impegna-a-garantire-servizi-dedicati-alle-malattie-rare]]></loc><lastmod>2015-05-26T16:11:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6912-piano-nazionale-malattie-rare-2013-2016-ecco-il-testo-definitivo]]></loc><lastmod>2015-05-26T16:17:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6888-conferenza-stato-regioni-sancito-laccordo-sul-piano-nazionale-malattie-rare]]></loc><lastmod>2015-05-26T16:16:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6876-terapie-domiciliari-diritto-del-paziente-responsabilita-della-regione]]></loc><lastmod>2015-05-26T16:14:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6865-sardegna-polemiche-sulla-riorganizzazione-della-rete-trasfusionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6769-tumori-gravi-i-ritardi-nella-commercializzazione-dei-nuovi-farmaci-ennesima-denuncia-degli-oncologi-europei]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6750-leucemia-mieloide-cronica-i-pazienti-attendono-la-terapia-senato-interroga-il-ministero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6674-governo-entro-la-fine-dellanno-sara-aggiornato-lelenco-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6640-in-parlamento-si-lavora-per-la-salute-e-lassistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6564-lettera-alle-commissioni-parlamentari-in-merito-alla-bozza-di-decreto-sulla-definizione-degli-standard-ospedalieri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6566-filomena-gallo-il-governo-deve-garantire-leterologa-ed-aggiornare-i-lea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6560-eterologa-il-ministero-conferma-la-liceita-della-pratica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6558-rischio-caos-per-leterologa-lorenzin-annuncia-un-tavolo-per-settembre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6545-fecondazione-eterologa-il-decreto-legge-potrebbe-essere-rinviato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6542-fecondazione-eterologa-la-regolamentazione-si-discute-oggi-in-consiglio-dei-ministri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6487-sangue-infetto-gli-emofilici-chiedono-giustizia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6480-farmaci-gli-oncologi-a-lorenzin-inaccettabili-disparita-di-accesso-alle-terapie-innovative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6457-sanita-la-bocca-del-patto-per-la-salute-discrimina-i-malati-la-denincia-delle-associazioni-del-csa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6449-malattie-rare-e-medicina-personalizzata-in-toscana-un-finanziamento-da-146-milioni-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6434-illustrato-alla-camera-lo-studio-sulla-sostenibilita-del-ssn-per-garantire-i-lea-necessario-limpegno-dello-stato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6426-il-professor-emilio-clementi-nel-comitato-scientifico-di-omar]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6424-reti-regionali-per-le-malattie-rare-il-ministero-al-lavoro-sulla-valutazione-della-qualita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6423-sperimentazioni-cliniche-grazie-al-registo-europeo-libero-accesso-alle-informazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6397-farmaci-al-via-imi-2-programma-di-ricerca-ue-da-3-miliardi-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6347-malattie-rare-pubblicato-il-nuovo-regolamento-europeo-sulle-sperimentazioni-cliniche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6342-meningite-b-la-puglia-dichiara-guerra-vaccino-gratis-per-i-neonati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6320-tumori-rari-nuova-proposta-di-legge-presentata-dallassociazione-dossetti]]></loc><lastmod>2019-06-18T18:11:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6277-piano-nazionale-malattie-rare-foucs-alla-camera-tra-associazioni-e-istituzioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6056-farmaci-in-via-di-sviluppo-ema-lancia-progetto-pilota-sulladaptive-licensing]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6049-farmaci-orfani-dallema-nuovi-incentivi-per-le-pmi-per-le-attivita-di-post-autorizzazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6046-medicinali-per-terapie-avanzate-nuove-direttive-dalla-commissione-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5975-meningite-in-toscana-il-vaccino-sara-presto-gratuito]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/6022-piano-nazionale-malattie-rare-ecco-il-testo-trasmesso-dal-ministro-alla-conferenza-stato-regioni]]></loc><lastmod>2015-05-28T11:53:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5957-assistenza-sessuale-presentato-al-senato-il-ddl-su-assistenza-sessuale-per-le-persone-disabili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5935-lorenzin-lo-schema-di-piano-nazionale-malattie-rare-trasmesso-alla-conferenza-stato-regioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5900-malattie-rare-osservatorio-con-la-firma-del-piano-nazionale-e-lintroduzione-dello-screening-neonatale-allargato-lorenzin-sara-ricordata-come-il-ministro-della-svolta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5898-malattie-rare-lorenzin-firmera-entro-domani-il-piano-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5871-screening-neonatale-lorenzin-risponde-a-omar-garantendo-limpegno-per-lallargamento-alle-patologie-metaboliche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5868-malattie-rare-agli-stati-generali-losservatorio-lancia-un-allarme-i-ritardi-mettono-a-rischio-i-5-mln-destinati-allo-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5862-cure-transfrontaliere-italia-ufficialmente-parte-del-sistema-europeo-delle-cure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5781-uniamo-federazione-italiane-malattie-rare-onlus-apprezza-lapertura-dimostrata-dal-ministro-lorenzin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5765-vargiu-presidente-commussione-affari-sociali-positiva-la-presenza-dellosservatorio-malattie-rare-agli-stati-generali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5759-stati-generali-della-salute-il-ministro-invita-losservatorio-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5726-malattie-rare-approvata-dalla-camera-dei-deputati-una-mozione-unitaria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5744-il-presidente-della-commissione-sanita-del-consiglio-regionale-della-lombardia-dare-spazio-a-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5715-la-camera-chiede-allunanimita-interventi-a-favore-dei-malati-rari]]></loc><lastmod>2015-05-28T12:06:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5710-stati-generali-della-salute-le-malattie-rare-sono-le-grandi-assenti]]></loc><lastmod>2015-05-28T12:07:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5701-malattie-rare-in-discussione-oggi-la-mozione-su-farmaci-diagnosi-e-assistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5681-malattie-rare-i-pazienti-pugliesi-chiedono-maggiori-garanzie-per-il-centro-mr-del-policlinico-di-bari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5671-senato-prosegue-liter-dei-ddl-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5624-eurordis-e-uniamo-a-lorenzin-chiarezza-su-stamina-e-sulle-terapie-con-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5607-senato-prosegue-il-cammino-dei-disegni-di-legge-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5605-lorenzin-accelera-sul-patto-della-salute-e-annuncia-battaglia-contro-titolo-v]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5589-piano-nazionale-malattie-rare-i-pazienti-non-possono-piu-aspettare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5545-molise-istituito-fondo-per-la-non-autosufficienza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5558-farmindustria-da-renzi-vorremmo-stabilita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5523-sarcoidosi-anche-in-friuli-verso-linclusione-tra-le-patologie-croniche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5524-il-pd-a-renzi-la-sanita-deve-essere-volano-di-sviluppo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5511-sanita-renzi-non-ignori-le-necessita-in-ambito-lea-farmaci-e-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5493-tumori-potenziate-le-attivita-del-registro-della-campania]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5468-malattie-rare-in-norvegia-e-nata-lunita-nazionale-di-consulenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5463-il-ministro-lorenzin-ha-confermato-laggiornamento-dei-lea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5443-malattie-rare-il-ministero-annuncia-legge-per-eliminare-le-differenze-regionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5412-puglia-i-malati-rari-protestano-lassessore-regionale-presto-risposte-concrete]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5387-malattie-rare-in-lombardia-nel-2013-censite-638-patologie]]></loc><lastmod>2015-08-24T07:42:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5388-malattie-rare-in-lombardia-nel-2013-censite-638-patologie-23736572]]></loc><lastmod>2015-08-24T07:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5383-cittadinanzattiva-tribunale-per-i-diritti-del-malato-soddisfazione-per-inserimento-della-commissione-sanita-del-senato-di-proposte-in-schema-direttiva-europea-su-cure-transfrontaliere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5289-cure-transfrontaliere-le-proposte-di-modifica-di-cittadinazattiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5209-cisti-di-tarlov-i-pazienti-chiedono-il-riconoscimento-della-patologia]]></loc><lastmod>2019-07-14T20:21:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5153-legge-di-stabilita-gli-emofilici-in-allerta-per-gli-effetti-di-un-emendamento-presentato-da-calabro-e-leone-dellncd]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5119-malattie-rare-secondo-il-direttore-del-cnmr-iss-occorrono-provvedimenti-per-migliorare-la-tutela-dei-pazienti-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5082-legge-di-stabilita-gare-dacquisto-per-i-farmaci-generici-ega-esprime-la-sua-preoccupazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5092-assistenza-transfrontaliera-liberi-di-scegliere-dove-farsi-curare-attenzione-alle-regole]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5059-malattie-rare-autoimmuni-i-pazienti-chiedono-laggiornamento-dellelenco-malattie-e-la-gratuita-dei-farmaci]]></loc><lastmod>2019-06-19T08:09:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5025-emoglobinopatie-gli-esperti-chiedono-un-registro-malattia-e-nuove-politiche-sanitarie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/5040-emofilia-in-lazio-le-linee-guida-per-contenere-la-spesa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4964-screening-neonatale-ministero-favorevole-a-quello-allargato-necessario-superare-le-differenze-regionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4905-malattie-rare-presentato-al-senato-un-ordine-del-giorno-per-laggiornamento-dei-lea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4867-dolore-cronico-affligge-un-europeo-su-cinque-efic-necessaria-unazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4862-sla-dopo-la-protesta-e-morto-un-uomo-ora-i-malati-ascoltati-dal-governo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4851-sla-dopo-la-protesta-di-ieri-oggi-i-pazienti-incontrano-i-ministri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4838-legge-di-stabilita-oltre-un-miliardo-di-tagli-in-sanita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4802-legge-di-stabilita-il-ministro-lorenzin-evita-nuovi-tagli-al-comparto-sanitario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4799-sla-i-malati-tornano-a-protestare-a-roma-usala-minaccia-di-lasciarsi-morire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4771-stamina-impossibile-proseguire-la-sperimentazione-la-comunicazione-ufficiale-dal-ministero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4688-malattie-rare-la-germania-presenta-52-proposte-politiche-nel-piano-nazionale]]></loc><lastmod>2019-06-19T08:20:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4611-malattie-rare-la-commissione-sanita-riprende-lesame-dei-provvedimenti]]></loc><lastmod>2015-05-28T12:14:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4597-metodo-stamina-la-bocciatura-del-comitato-scientifico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4586-sla-il-comune-di-roma-delibera-i-fondi-per-i-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4490-malattie-rare-la-commissione-europea-istituisce-un-nuovo-gruppo-di-esperti-sul-modello-eucerd]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4483-malattie-rare-le-raccomandazioni-ue-per-le-reti-europee-di-riferimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4482-interrogazione-m5s-al-senato-caos-sui-registri-tumori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4474-malattie-rare-bianconi-accolto-odg-a-dl-fare-su-farmaci-orfani-per-2-milioni-di-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4456-cure-compassionevoli-presto-sara-avviato-losservatorio-sulle-terapie-avanzate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4455-staminali-accolto-odg-bonfrisco-su-cure-compassionevoli-qil-testo-consente-ai-tribunali-di-intervenire-sulla-gestione-dei-protocolli-terapeuticiq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4453-stamina-locatelli-psi-non-si-faccia-rientrare-dalla-finestra-quello-che-e-uscito-dalla-porta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4450-stamina-gli-scienziati-italiani-chiedono-lintervento-del-ministro-qil-protocollo-di-vannoni-sia-reso-pubblicoq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4449-staminali-associazione-coscioni-no-alla-competenza-regionale-per-le-terapie-compassionevoli-richiesto-lintervento-del-ministro-lorenzin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4447-malattie-rare-cominciato-ieri-in-senato-lesame-del-ddl]]></loc><lastmod>2015-05-28T12:21:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4439-staminali-vannoni-ha-consegnato-la-documentazione-alliss]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4424-malattie-rare-il-1-agosto-il-senato-discutera-tre-proposte-di-legge]]></loc><lastmod>2015-05-28T12:23:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4406-malattie-rare-in-europa-disponibile-online-la-relazione-annuale-eucerd]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4389-registro-delle-malattie-rare-sicilia-in-ritardo-di-dieci-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4381-farmaci-orfani-il-governo-chiede-corsia-preferenziale-nelle-procedure-di-prezzo-e-rimborso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4349-malattie-rare-finito-il-mandato-di-eucerd-la-nuova-commissione-sara-di-nuovo-al-lavoro-da-ottobre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4267-creutzfeldt-jacob-di-nuovo-allarme-per-un-caso-in-sardegna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4268-caso-stamina-quando-sara-avviata-la-sperimentazione-clinica-rigorosa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4258-registri-malattie-rare-eucerd-raccomanda-lutilizzo-di-standard-internazionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4217-farmaci-la-regione-lazio-rivoluziona-i-comitati-etici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4200-malattie-rare-al-via-un-network-europeo-per-la-diagnosi-e-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4166-malattie-rare-vargiu-sc-attenzione-al-tema-e-corsie-preferenziali-per-le-proposte-di-legge-ad-alto-impatto-sociale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4111-sanita-lorenzin-presto-un-nuovo-patto-per-la-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4107-malattie-rare-fioccano-le-proposte-di-legge-in-parlamento-attenzione-puntata-sullo-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4097-il-dl-balduzzi-e-legge-le-sperimentazioni-con-staminali-continueranno-sotto-la-supervisione-di-iss-e-aifa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4084-dl-balduzzi-diciotto-mesi-per-la-sperimentazione-sulle-staminali-il-testo-torna-al-senato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4072-caso-stamina-dal-governo-3-milioni-di-euro-per-la-sperimentazione-vannoni-se-li-risparmino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4058-caso-stamina-i-trapianti-a-base-di-staminali-saranno-classificati-come-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4030-farmaci-orfani-ema-semplifica-le-procedure-per-lautorizzazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/4003-farmaci-orfani-in-europa-e-polemica-sulle-politiche-di-rimborso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3955-staminali-ecco-il-parere-dellema-non-rispettare-gli-standard-mette-a-rischio-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3907-malattie-rare-la-francia-presenta-il-secondo-piano-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3906-farmaci-orfani-la-commissione-europea-ha-modificato-le-direttive-sulla-trasparenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3900-staminali-il-senato-approva-il-decreto-balduzzi-ora-il-passaggio-alla-camera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3899-staminali-e-metodo-vannoni-dure-le-critiche-allitalia-dalla-societa-internazionale-presieduta-da-yamanaka]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3891-sma-e-staminali-le-famiglie-chiedono-chiarezza-al-ministro-balduzzi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3864-malattie-rare-europarlamentare-matera-pdl-annuncia-interrogazione-sul-riconoscimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3844-staminali-balduzzi-permette-la-prosecuzione-delle-cure-e-polemica-internazionale]]></loc><lastmod>2015-05-28T13:02:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3812-malattie-rare-non-riconosciute-parlamento-europeo-condivide-la-gravita-del-problema]]></loc><lastmod>2015-05-28T13:03:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3794-puglia-a-bari-il-primo-centro-per-le-malattie-rare-sabba-per-ora-stiamo-lavorando-su-poche-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3761-farmaci-cittadinanzattiva-ancora-una-volta-le-associazioni-di-cittadini-e-di-pazienti-sono-le-grandi-escluse-dai-processi-decisionali-aifa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3725-malattie-rare-sifo-saranno-la-nostra-priorita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3724-malattie-rare-in-campania-si-discute-il-piano-regionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3672-protezione-dati-sensibili-dallue-potrebbero-giungere-ostacoli-alla-ricerca-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3714-malattie-rare-lunione-europea-stanzia-144-milioni-di-euro-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3707-malattie-rare-nel-lazio-tante-iniziative-nonostante-piano-di-rientro-e-incertezza-politica]]></loc><lastmod>2019-03-26T17:54:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3706-toscana-presentato-il-nuovo-sito-del-registro-e-il-numero-verde-attivo-anche-nel-week-end]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3705-registri-delle-malattie-rare-il-mancato-ruolo-delle-associazioni-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3704-registri-malattie-rare-grande-opportunita-per-usare-al-meglio-le-risorse]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3693-registro-nazionale-malattie-rare-in-italia-107837-casi-di-malattia-rara-e-504-malattie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3646-malattie-reumatiche-prima-causa-di-disabilita-necessario-un-piano-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3627-farmaci-cittadinanzattiva-ad-aifa-chiediamo-la-partecipazione-attiva-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3606-pnmr-uniamo-nessuna-misura-innovativa-e-solo-una-base-su-cui-lavorare-insieme]]></loc><lastmod>2015-05-28T13:11:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3574-umbria-arrivano-le-linee-guida-per-la-rete-regionale-per-la-terapia-del-dolore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3587-piano-nazionale-malattie-rare-e-nuovi-lea-richieste-e-perplessita-delle-associazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3573-sindrome-di-sjoegren-non-e-una-malattia-rara-ma-i-pazienti-hanno-diritto-allesenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3565-malattie-rare-e-lea-lassociazione-dossetti-si-e-trattato-dello-spot-elettorale-di-fine-anno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3552-malattie-rare-lunione-europea-annuncia-un-finanziamento-di-38-milioni-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3553-malattie-rare-approvati-in-toscana-percorsi-diagnostico-terapeutici-specializzati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3505-piano-nazionale-malattie-rare-news-lappello-della-cndmr-a-tutte-le-associazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3498-xeroderma-pigmentoso-ministri-interrogati-sullaccesso-a-terapie-e-agevolazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3492-malattie-rare-obiettivi-comuni-per-eurordis-e-lalleanza-canadese-cord]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3447-emoderivati-secondo-il-consiglio-superiore-di-sanita-i-controlli-devono-continuare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3446-malattie-rare-il-mir-al-premier-monti-approvate-lelenco-malattie-prima-delle-elezioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3411-screening-neonatale-per-le-malattie-lisosomiali-il-ruolo-cruciale-del-consenso-dei-genitori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3407-malattie-rare-balduzzi-ha-definito-i-nuovi-lea-la-parola-passa-alla-conferenza-stato-regioni]]></loc><lastmod>2018-08-20T16:34:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3406-sanita-si-dalla-stato-regioni-al-riparto-dei-fondi-balduzzi-soddisfatto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3404-malattie-rare-claudio-giustozzi-rompe-con-balduzzi-e-si-dimette-da-coordinatore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3400-piano-nazionale-delle-malattie-rare-la-delusione-della-consulta-nazionale-cndmr]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3397-malattie-rare-per-i-pazienti-del-molise-i-farmaci-saranno-ancora-gratuiti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3396-legge-di-stabilita-rifinanziamento-parziale-del-fondo-non-autosufficienza-interventi-settoriali-per-la-ricerca-e-deregolamentazione-sugli-emoderivati-centodieci-malattie-rare-entreranno-nei-lea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3389-piano-nazionale-malattie-rare-presentata-la-prima-bozza]]></loc><lastmod>2015-05-28T13:14:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3390-piano-nazionale-malattie-rare-il-ministero-delude-e-la-maggior-parte-delle-associazioni-va-fuori-tema]]></loc><lastmod>2015-05-28T13:13:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3377-emofilia-fedemo-chiede-giustizia-al-governo-monti-per-quanti-furono-contagiati-da-sangue-infetto-negli-anni-80-90]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3340-molise-da-gennaio-i-farmaci-per-le-malattie-rare-saranno-a-carico-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3312-donazione-di-farmaci-alle-onlus-arriva-il-si-di-montecitorio-ora-il-testo-passa-al-senato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3291-glutine-i-farmaci-che-lo-contengono-potrebbe-avere-un-nuovo-obbligo-di-etichettatura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3268-malattie-rare-il-18-dicembre-balduzzi-presenza-la-bozza-di-piano-nazionale-alle-associazioni]]></loc><lastmod>2015-05-28T13:18:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3260-la-risposta-artoi-allallarme-lanciato-dal-presidente-del-consiglio-monti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3251-le-malattie-reumatiche-escluse-dagli-obiettivi-sanitari-del-2012-le-reazioni-di-cittadinazattiva-e-anmar]]></loc><lastmod>2015-05-28T13:21:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3250-patologie-reumatiche-bassoli-pd-il-governo-ripristini-i-fondi-a-sostegno-dei-pazienti-e-delle-reti-reumatologiche]]></loc><lastmod>2015-05-28T13:22:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3236-sla-la-commissione-affari-sociali-da-i-numeri-al-lotto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3235-sla-usala-fiducioso-sullaumento-dei-fondi-grilli-apporteremo-le-correzioni-necessarie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3214-sla-dalla-lega-a-rifondazione-solidarieta-bipartisan-ai-pazienti-ma-ora-servono-i-soldi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3212-sla-i-malati-hanno-vinto-il-governo-raddoppiera-i-fondi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3209-sla-in-veneto-stanziati-2-milioni-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3176-sla-confermata-la-protesta-a-roma-usala-attacca-bersani-per-silenzio-e-il-sottosegretario-guerra-per-le-contraddizioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3174-diagnosi-preimpianto-nota-del-centro-di-bioetica-delluniversita-cattolica-in-merito-alla-sentenza-del-tribunale-di-cagliari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3166-sla-balduzzi-chiede-ai-malati-di-interrompere-lo-sciopero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3148-sla-lappello-di-usala-se-non-vi-basta-lo-sciopero-della-fame-avrete-i-morti-in-tv]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3146-sla-e-non-autosufficienza-nella-legge-di-stabilita-200-milioni-il-testo-alla-prova-dellaula]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3139-sangue-infetto-lon-dionisi-interroga-balduzzi-sul-mancato-risarcimento-di-una-paziente-con-talassemia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3135-cannabis-terapeutica-ieri-a-montecitorio-la-protesta-dei-pazienti-con-sla-e-sclerosi-multipla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3114-sla-altro-che-posti-letto-i-pazienti-in-sciopero-della-fame-per-restare-a-casa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3104-sla-e-disabilita-i-malati-vogliono-restare-a-casa-risparmiando-soldi-pubblici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3075-eucerd-disponibili-i-rapporti-sulle-attivita-per-le-malattie-rare-in-ogni-paese-europeo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3098-disabilita-per-farina-coscioni-e-welby-lo-sciopero-della-fame-continua]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3091-decreto-balduzzi-la-versione-definitiva-e-i-dubbi-di-cittadinanzattiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3089-sla-i-ministri-promettono-un-piano-per-la-non-autosufficienza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3083-cresce-il-welfare-cresce-litalia-gli-effetti-della-mobilitazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3081-oggi-pomeriggio-i-ministri-balduzzi-e-fornero-incontrano-i-malati-di-sla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3052-riesame-delle-percentuali-di-invalidita-i-malati-rari-fanno-appello-alla-commissione-affari-sociali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/3047-uniamo-aderisce-idealmente-alla-manifestazione-nazionale-qdiritto-alla-cura-diritto-a-curareq-in-programma-a-roma-il-27-ottobre-2012]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2992-malati-cronici-e-anziani-il-peso-grava-totalmente-sulle-spalle-delle-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2981-piano-nazionale-malattie-rare-pnmr-il-volume-alla-ricerca-dellapprodo-diventa-e-book]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2946-malattie-reumatiche-cittadinanzattiva-qil-governo-cancelli-lulteriore-riduzione-di-16-miliardi-del-fondo-sanitario-nazionaleq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2945-cittadinanzattiva-su-nuovi-tagli-alla-sanita-il-governo-ammetta-di-voler-chiudere-il-servizio-sanitario-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2925-epirare-presto-la-piattaforma-europea-per-registri-e-database-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2908-sanita-dl-balduzzi-in-due-giorni-spariti-gli-emendamenti-su-screening-e-nomenclatore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2862-malattie-rare-le-cure-costano-troppo-e-i-pazienti-devono-rinunciare-alle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2859-fibromialgia-fatica-cronica-e-sensibilita-chimica-multipla-in-friuli-venezia-giulia-una-petizione-per-il-riconoscimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2825-uniamo-fimr-onlus-presenta-un-memorandum-alla-commissione-affari-sociali-in-materia-di-tutela-della-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2816-decreto-balduzzi-cittadinanzattiva-presenta-un-pacchetto-di-emendamenti-a-favore-dei-cittadini]]></loc><lastmod>2015-05-28T14:13:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2771-fibrosi-cistica-on-coscioni-allarme-per-i-finanziamenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2752-malattie-rare-lon-reguzzoni-in-due-mesi-ha-presentato-decine-di-interrogazioni-sullo-stato-della-ricerca]]></loc><lastmod>2019-05-24T16:50:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2760-trapianti-tra-vivi-ora-e-legge-iter-veloce-e-accordo-bipartisan-litalia-puo-andarne-fiera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2715-farmaci-biosimilari-al-via-la-consultazione-pubblica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2710-nuovi-bonus-elettrici-per-malati-gravi-soddisfazione-di-cittadinanzattiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2730-sanita-approvato-il-decreto-balduzzi-i-lea-aggiornati-entro-il-31-dicembre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2698-decreto-balduzzi-scontente-aziende-farmacie-e-medici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2693-rapporto-eucerd-2012-lattivita-dellema-sempre-piu-orientata-ai-farmaci-orfani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2692-rapporto-eucerd-2012-litalia-eccellenza-in-ricerca-ma-si-attende-il-piano-nazionale-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2697-malattie-rare-in-puglia-istituito-il-sistema-informativo-verso-il-miglioramento-della-rete]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2691-aggiornamento-lea-109-nuove-malattie-non-sono-sufficienti-qualsiasi-lista-e-strumento-ad-excludendum]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2685-sanita-la-bozza-del-decreto-balduzzi-gia-in-crisi]]></loc><lastmod>2015-05-28T14:25:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2673-fibrosi-cistica-e-fecondazione-assistita-la-corte-europea-boccia-la-nostra-legge-40]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2671-sanita-pronta-la-prima-bozza-della-riforma-balduzzi]]></loc><lastmod>2015-05-28T14:25:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2601-malattie-rare-oltre-la-spending-review-il-valore-sociale-delle-associazioni-di-settore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2582-epatite-attivato-dal-ministero-della-salute-il-gruppo-di-lavoro-per-la-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2567-malattie-rare-dalloms-la-panoramica-delle-attivita-in-corso-e-la-revisione-della-classificazione-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2570-spending-review-e-farmaci-assobiotec-qbasta-con-i-tagli-allinnovazione-biofarmaceuticaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2560-spending-review-i-timori-delle-case-farmaceutiche-le-conseguenze-sui-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2497-salute-pedoto-pd-bonus-energia-per-utilizzo-apparecchiature-elettromedicali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2496-piano-nazionale-per-le-malattie-rare-il-governo-deve-intervenire-con-azioni-immediate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2474-autismo-in-umbria-il-centro-diurno-la-semente-di-spello-festeggia-il-primo-anniversario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2466-farmaci-assobiotec-ancora-una-volta-considerati-come-un-costo-e-non-un-valore]]></loc><lastmod>2016-08-08T19:23:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2419-assistenza-transfrontaliera-dove-andare-come-avere-il-rimborso-come-chiedere-lautorizzazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2420-trapianto-tra-vivi-anche-la-commissione-sanita-del-senato-ha-approvato-la-proposta-di-legge]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2359-malattie-rare-dalle-associazioni-di-pazienti-un-progetto-sulle-previsioni-di-spesa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2332-ricerca-il-credito-dimposta-solo-sulle-assunzioni-assobiotec-se-non-si-interviene-le-aziende-fuggiranno-dal-paese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2328-conferenza-stato-regioni-oggi-si-discute-il-riparto-del-fondo-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2321-malattie-reumatiche-richiesta-a-gran-voce-lapprovazione-delle-reti-reumatologiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2308-molise-grazie-alla-regione-garantiti-i-farmaci-gratuiti-ai-malati-rari-nonostante-il-piano-di-rientro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2301-la-commissione-europea-lancia-heidi-un-wiki-con-una-sezione-dedicata-alle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2275-malattie-rare-lonorevole-binetti-meno-tasse-piu-sviluppo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2249-malattie-rare-a-brescia-la-dote-finanziaria-per-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2174-trapianti-dorgano-tanti-in-lista-dattesa-ma-lo-stato-ha-tagliato-il-70-per-cento-dei-fondi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2230-trapianti-tra-vivi-il-senato-ha-adottato-il-testo-di-base-entro-domani-sera-lapprovazione-definitiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2225-trapianti-dopo-il-si-della-camera-il-senato-lavora-sulla-nuova-norma-che-amplia-la-donazione-tra-vivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2199-policlinico-santa-maria-alle-scotte-potenziata-lattivita-dellonco-ematologia-pediatrica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2165-sanita-balduzzi-propone-la-franchigia-al-posto-del-ticket]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2110-malattie-rare-prevenire-con-lacido-folico-online-il-nuovo-sito-del-cnmr]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2062-malattie-da-amianto-balduzzi-qlue-dece-costituire-una-rete-di-eccellenza-per-la-ricercaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2004-giornata-mondiale-dellemofilia-balduzzi-annuncia-la-firma-dei-decreti-regolatori-del-sistema-plasma-e-plasmaderivati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2002-sangue-ed-emoderivati-firmati-dal-ministro-i-decreti-attuativi-dellart-15-della-legge-2192005]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/2001-malattie-rare-al-via-l-interrogazione-alla-camera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1967-piano-nazionale-delle-malattie-rare-la-consultazione-e-proprogata-fino-al-20-aprile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1955-piano-nazionale-delle-malattie-rare-si-puo-contribuire-alla-consultazione-fino-al-13-aprile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1944-nasce-losservatorio-epidemiologico-delle-marche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1949-acufene-uninterrogazione-parlamentare-per-inserirlo-nellelenco-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1911-sanita-oggi-autorevoli-esperti-a-confronto-sui-temi-della-governance-in-sanita-dei-livelli-essenziali-di-assistenza-e-del-diritto-alla-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1858-farmaci-biologici-laccesso-sara-diverso-in-ogni-regione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1835-malattie-rare-invio-della-petizione-per-il-riconoscimento-delle-malattie-non-ancora-riconosciute-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1809-vaccini-pronto-il-nuovo-piano-nazionale-2012-14]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1797-piano-nazionale-per-le-malattie-rare-taruscio-qsiamo-a-buon-punto-un-gruppo-ristretto-sta-elaborando-una-prima-bozzaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1775-malattie-rare-binetti-quali-iniziative-per-garantire-equo-accesso-ai-servizio-socio-sanitari-nel-paese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1747-malattie-rare-nel-regno-unito-si-lavora-al-primo-piano-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1754-malattie-rare-12-progetti-di-ricerca-per-3-milioni-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1744-la-consulta-nazionale-delle-malattie-rare-consegna-al-ministro-balduzzi-la-proposta-unilaterale-di-piano-nazionale-per-le-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1743-malattie-rare-al-via-una-consultazione-pubblica-dal-13-marzo-ospitata-dal-portale-malatirariit]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1734-genzyme-ha-celebrato-la-giornata-internazionale-delle-malattie-rare-con-la-seconda-edizione-del-patient-advocacy-leadership-awards-pal-awards]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1733-giornata-mondiale-delle-malattie-rare-cittadinanzattivaqdalle-parole-si-passi-ai-fattiq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1732-consulta-nazionale-delle-malattie-rare-qpositivo-il-bilancio-della-quinta-giornata-mondiale-per-i-malati-rariq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1726-malattie-rare-il-decreto-di-legge-e-pronto-il-problema-sono-i-costi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1696-malattie-rare-spinelli-uniamo-si-rischia-di-vanificare-un-lungo-lavoro-gia-fatto-se-il-nuovo-organismo-riunito-presso-il-ministero-partira-da-zero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1693-malattie-rare-claudio-giustozzi-nominato-coordinatore-delle-associazioni-pazienti-presso-il-gabinetto-del-ministero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1684-malattie-rare-neurologiche-allospedale-qsan-giuseppeq-di-empoli-disponibile-un-ambulatorio-dedicato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1680-malattie-rare-aggiornati-i-dati-del-registro-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1645-staminali-cordonali-adoces-auspica-una-nuova-azione-legislativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1593-sangue-infetto-i-contagiati-contro-il-decreto-firmato-dal-ministero-della-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1575-malattie-neglette-tropicali-glaxosmithkine-sostiene-i-paesi-in-via-di-sviluppo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1545-malattie-rare-uniamo-risultato-straordinario-la-politica-con-la-p-maiuscola-va-nella-direzione-giusta]]></loc><lastmod>2015-06-03T15:04:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1535-cistinuria-il-farmaco-per-trattarla-non-e-piu-disponibile-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1532-malattie-rare-ieri-la-discussione-alla-camera-di-tre-mozioni]]></loc><lastmod>2015-06-03T15:08:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1518-malattie-rare-la-soddisfazione-delle-associazioni-per-lodg-approvato-in-senato]]></loc><lastmod>2015-06-03T15:21:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1519-malattie-rare-uniamo-fimr-ora-serve-un-grande-impegno-solidale-per-lattuazione]]></loc><lastmod>2015-06-03T15:09:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1517-malattie-rare-governo-favorevole-a-numerosi-miglioramenti-del-sistema]]></loc><lastmod>2015-06-05T15:26:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1515-fibrosi-cistica-grave-la-situazione-del-centro-regionale-veneto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1494-9gen-malattie-rare-sen-bianconi-insiste-per-lapprovazione-della-legge]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1492-malattie-rare-la-codificazione-e-un-problema-ancora-da-risolvere]]></loc><lastmod>2015-06-05T15:32:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1491-91-malattie-rare-disponibile-su-omar-il-rapporto-itisan-1120]]></loc><lastmod>2015-06-05T16:00:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1493-malattie-rare-bianconi-pdl-al-senato-si-ricominci-parlando-dei-farmaci-orfani]]></loc><lastmod>2015-06-05T15:29:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1462-malattie-rare-nuovi-lea-e-ausili-il-governo-monti-si-impegna-alla-camera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1426-malattie-rare-balduzzi-una-priorita-velocizzare-laggiornamento-dei-lea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1417-farmaci-laifa-inaugura-un-ciclo-di-incontri-con-pazienti-e-aziende]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1363-legge-40-la-lega-italiana-fibrosi-cistica-contro-le-linee-guida-presentate-dal-governo-uscente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1353-malattie-rare-bertoglio-screening-e-nuove-109-patologie-priorita-per-la-sanita-pubblica]]></loc><lastmod>2015-06-05T16:21:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1339-malattie-rare-lelenco-non-e-aggiornato-da-10-anni-e-le-associazioni-si-appellano-alleuropa]]></loc><lastmod>2015-06-05T16:22:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1330-ricerca-assobiotec-litalia-e-rimasta-al-palo-e-le-nostre-proposte-completamente-ignorate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1326-malattie-rare-il-ministero-della-salute-risponde-allinterrogazione-binetti]]></loc><lastmod>2015-06-05T16:25:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1319-ricerca-ecco-come-il-biotech-ci-migliora-la-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1266-ras-sidoli-assobiotec-adottare-subito-le-linee-guida-europee-sul-peer-review]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1251-malattie-rare-mozione-al-senato-si-vuole-l-inserimento-nelle-109-malattie-rare-tra-quelle-esenti]]></loc><lastmod>2015-06-05T16:37:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1240-sla-da-novembre-pronti-gli-assegni-per-i-malati-dellumbria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1209-oncologia-il-santandrea-di-roma-inaugura-linea-telefonica-dedicata-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1159-malattie-neurodegenerativa-dal-miur-5-milioni-alla-sissa-di-trieste]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1119-malattie-rare-il-ministero-ripartisce-i-fondi-2009-a-lazio-e-abruzzo-nemmeno-un-euro]]></loc><lastmod>2015-06-05T17:20:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/1067-malattie-rare-la-regione-lazio-attiva-un-sezione-dedicata-sul-proprio-sito]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/983-malattie-rare-approvato-progetto-per-il-portale-della-rete-del-fvg]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/987-malattie-rare-nella-provincia-di-trento-informazione-capillare-grazie-a-una-struttura-dedicata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/985-malattie-rare-focus-sullorganizzazione-della-rete-nella-provincia-di-trento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/986-malattie-rare-la-provincia-di-trento-fornisce-ai-malati-anche-farmaci-di-fascia-c-e-off-label]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/955-sla-umbria-avvia-sperimentalmente-programma-di-assistenza-indiretta-ai-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/930-sla-trovato-laccordo-in-umbria-per-lassegno-di-cura-ai-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/861-sla-in-umbria-finalmente-trovato-laccordo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/855-sla-la-giunta-dellumbria-delibera-con-la-delusione-di-sandra-monacelli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/846-malattie-rare-bertoglio-dal-governo-solo-non-risposte-e-immobilita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/839-sla-giunta-dellumbria-ha-deliberato-nuovi-servizi-di-presa-in-carico-per-i-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/838-malattie-rare-palmisano-assobiotec-da-on-roccella-risposte-vuote-i-fatti-non-ci-sono]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/818-sla-un-umbria-va-avanti-la-proposta-monacelli-per-lassistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/829-malattie-rare-difficolta-ad-ottenere-i-farmaci-di-fascia-c-i-malati-vadano-in-day-hospital]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/828-malattie-rare-lon-roccella-risponde-su-accesso-al-farmaco-fondo-nazionale-e-piano-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/819-sla-il-centro-di-padova-ancora-senza-riconoscimento-si-va-avanti-grazie-al-volontariato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/816-polmoni-si-apre-la-strada-per-il-trapianto-da-vivente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/805-biosimilari-la-guerra-scoppia-sullepo-la-normativa-manca-e-si-decide-in-tribunale]]></loc><lastmod>2015-06-05T17:55:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/789-malattie-neuromuscolari-governo-e-regioni-si-accordano-per-la-presa-in-carico-global]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/787-malattie-rare-superato-lostacolo-della-diagnosi-anche-avere-terapie-e-assistenza-e-difficile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/786-malattie-rare-rapporto-di-cittadinanzattiva-boccia-i-pediatri-e-anche-le-scuole]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/771-reumatologia-nasce-consortium-il-network-internazionale-per-le-malattie-autoimmuni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/765-sla-dalla-regione-marche-300-euro-mensili-alle-famiglie-che-assistono-i-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/757-liguria-i-primi-a-beneficiare-del-fascicolo-elettronico-saranno-proprio-i-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/752-pemfigo-orale-in-sardegna-i-pazienti-devono-andare-da-sassari-a-cagliari-per-un-esame]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/741-malattie-rare-piccinocchi-simg-medico-di-famiglia-ancora-poco-formato-e-integrato-nella-rete]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/736-malattie-rare-ora-ce-una-super-associazione-di-pazienti-si-parte-dal-ddl-52-e-ddl-bianchi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/715-screening-e-un-fondo-nazionale-le-associazioni-pazienti-al-fianco-della-proposta-assobiotec]]></loc><lastmod>2015-06-08T09:29:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/658-sicilia-comincia-la-ridefinizione-della-rete-regionale-per-le-malattie-rare]]></loc><lastmod>2025-06-26T15:59:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/610-malattie-rare-migliorano-i-tempi-della-diagnosi-i-problemi-sono-nella-presa-in-carico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/598-toscana-entro-novembre-sara-attivo-il-contact-center-per-malati-e-medici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/597-toscana-per-le-malattie-rare-la-regione-punta-su-formazione-e-informazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/578-farmaci-orfani-contro-disparita-di-accesso-alla-terapia-assobiotec-propone-fondo-unico-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/545-toscana-la-asl-11-attiva-percorso-di-diagnosi-precoce-delle-malattie-del-sistema-nervoso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/522-emoderivati-al-via-tavolo-tecnico-al-ministero-della-salute]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/465-imaging-il-ministero-della-salute-finanzia-rete-di-condivisione-di-radiologiche-cerebrali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/517-bolzano-la-provincia-entra-nellarea-vasta-del-triveneto-per-la-presa-in-carico-del-malati-rari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/482-toscana-entro-il-2011-un-contact-center-per-i-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/477-malattie-rare-sidoli-assobiotec-qrafforzare-il-sostegno-pubblico-alla-ricerca-di-eccellenzaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/462-malattie-rare-la-lettera-delle-associazioni-alle-regioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/440-riabilitazione-melazzini-aisla-soddisfatti-per-il-nuovo-piano-di-indirizzo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/438-malattie-rare-fazio-vorrebbe-piu-di-100-nuove-patologie-nei-lea-ma-serve-la-copertura-economica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/429-malattie-rare-pediatriche-al-bambino-gesu-di-roma-percorsi-multidisciplinari-appositi]]></loc><lastmod>2017-08-09T15:43:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/420-sanita-lombardia-e-pfizer-rinnovano-i-progetti-di-collaborazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/424-sardegna-telefono-o-web-e-le-informazioni-sulle-malattie-rare-sono-a-portata-di-mano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/399-fibrosi-cistica-in-umbria-non-e-a-rischio-chiusura-il-centro-di-branca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/389-reumatologia-pediatrica-oggi-umbria-il-primo-seminario-per-costruire-percorsi-diagnostici-terapeutici-uniformi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/349-sla-in-umbria-disegno-di-legge-per-bonus-alle-famiglie-che-assistono-i-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/344-sindrome-antifosfolipidi-aps-per-i-malati-nessuna-esenzione-a-livello-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/334-malattie-reumatiche-lassociazione-dei-malati-critica-il-nuovo-piano-sanitario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/330-malati-rari-in-italia-sono-piu-di-un-milione-e-mezzo-assisterli-spesso-costa-il-posto-di-lavoro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/303-policlinico-milano-compie-due-anni-lo-sportello-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/299-staminali-il-prossimo-anno-lumbria-avra-la-sua-biobanca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/292-emofilia-le-associazioni-dei-malati-chiedono-che-litalia-adotti-i-decalogo-europeo-sulla-cura]]></loc><lastmod>2015-06-08T16:42:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/291-sla-arrivano-100milioni-di-euro-laisla-ringrazia-i-malati-che-martedi-hanno-aderito-alla-protesta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/287-sla-dopo-la-protesta-dei-malati-presentato-un-emendamento-a-favore-dellassistenza-in-commissione-bilancio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/284-testamento-biologico-anche-torino-ora-ha-un-registro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/275-sla-domani-i-malati-in-protesta-davanti-al-ministero-delleconomia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/263-lea-e-nuovo-nomenclatore-lettera-aperta-dei-malati-di-sla-ai-ministeri-competentii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/241-talassemia-troppi-malati-campani-costretti-a-cure-fuori-regione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/176-toscana-la-regione-stanzia-100-mila-euro-per-riorganizzare-la-rete-delle-malattie-rare-pediatriche-al-meyer-il-ruolo-di-coordinamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/168-fondi-per-ricerca-su-malattie-rare-pd-qgoverno-chiarisca-su-stanziamenti-q]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/171-sindrome-di-sjogren-in-italia-16mila-malati-ma-la-malattia-non-e-tra-quelle-esenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/154-ostia-apre-lo-sportello-informativo-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/117-ipertensione-polmonare-in-lombardia-il-progetto-virgilio-screening-sulla-popolazione-a-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/115-puglia-si-allarga-la-rete-dei-centri-emofilia-pubblicato-in-gazzetta-il-nuovo-elenco-dei-centri-per-i-difetti-ereditari-della-coagulazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/90-talassemia-in-regione-sicilia-il-deputato-vinciullo-pdl-presenta-interrogazione-sullassistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/75-puglia-integrata-la-rete-regionale-per-lemofilia-nuovi-centri-a-monopoli-e-scorrano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/34-uniamo-conclusa-la-conferenza-europea-di-cracovia-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/politiche-socio-sanitarie/50-aspirazioni-endotracheali-approvato-il-regolamento-per-la-formazione-di-personale-non-medico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22949-quando-la-genetica-incontra-il-pesce-zebra-un-progetto-di-ricerca-per-capire-la-sindrome-col4a1-a2]]></loc><lastmod>2026-04-21T08:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22940-quando-lo-screening-non-basta-le-zone-dombra-nella-diagnosi-precoce-della-sordita-neonatale]]></loc><lastmod>2026-04-16T17:25:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22931-tumore-delle-corde-vocali-il-passaggio-dei-tessuti-a-uno-stato-fluido-rende-la-malattia-piu-aggressiva]]></loc><lastmod>2026-04-15T18:00:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22898-un-mini-stomaco-per-studiare-una-rarissima-malattia-genetica]]></loc><lastmod>2026-04-04T13:45:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22916-malattie-immunomediate-e-rischio-tumorale-pubblicata-la-prima-indagine-italiana-sul-tema]]></loc><lastmod>2026-04-08T17:20:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22913-disturbi-del-neurosviluppo-individuata-una-nuova-causa-genetica]]></loc><lastmod>2026-04-08T17:10:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22897-ricercatori-italiani-scoprono-una-nuova-malattia-genetica-rara]]></loc><lastmod>2026-04-01T14:28:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22866-sindrome-kabuki-e-di-digeorge-al-via-il-progetto-micro-care]]></loc><lastmod>2026-03-24T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22849-modulare-il-metabolismo-per-aumentare-lefficacia-delle-terapie-contro-il-cancro]]></loc><lastmod>2026-03-16T17:44:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22847-malattie-rare-il-primo-bando-aifa-per-il-finanziamento-della-ricerca]]></loc><lastmod>2026-03-16T18:22:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22844-sindrome-di-leigh-identificata-una-potenziale-terapia]]></loc><lastmod>2026-03-13T17:18:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22823-un-abbraccio-antico-e-una-malattia-rara-svelato-il-mistero-genetico-della-grotta-del-romito]]></loc><lastmod>2026-03-06T11:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22817-gangliosidosi-gm1-la-storia-di-sofia-e-le-ricerche-di-universita-di-padova-e-sr-tiget]]></loc><lastmod>2026-03-04T18:49:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22811-sicurezza-dei-farmaci-in-gravidanza-avviato-il-progetto-protect]]></loc><lastmod>2026-03-05T08:41:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22812-sordita-e-malattie-rare-come-linnovazione-sta-cambiando-laccesso-allimpianto-cocleare]]></loc><lastmod>2026-03-02T18:28:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22778-encefalopatia-epilettica-scn2a-una-terapia-sperimentale-offre-nuove-speranze]]></loc><lastmod>2026-02-24T08:29:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22758-lupus-la-realta-nascosta-dei-pazienti-italiani]]></loc><lastmod>2026-02-17T09:17:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22755-se-il-muscolo-non-e-sano-il-problema-potrebbe-risiedere-nei-perossisomi]]></loc><lastmod>2026-02-17T09:17:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22754-teleangectasia-emorragica-ereditaria-studio-genetico-ne-raddoppia-le-stime-di-prevalenza]]></loc><lastmod>2026-02-17T09:16:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22747-malattie-genetiche-rare-telethon-e-regione-lombardia-finanziano-27-progetti-di-ricerca]]></loc><lastmod>2026-02-12T18:17:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22745-ricerca-e-salute-al-via-la-xv-edizione-dei-bandi-gilead]]></loc><lastmod>2026-02-12T11:58:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22726-quanto-sappiamo-delle-malattie-rare-proposto-un-nuovo-modello-per-misurare-lo-stato-della-ricerca]]></loc><lastmod>2026-02-09T18:57:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22705-aceruloplasminemia-la-sfida-della-ricerca-tra-complessita-reti-internazionali-e-nuove-speranze-terapeutiche]]></loc><lastmod>2026-02-03T08:54:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22691-demenza-frontotemporale-per-la-malattia-di-bruce-willis-si-sperimentano-nuove-terapie]]></loc><lastmod>2026-01-26T22:58:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22678-un-vecchio-farmaco-potrebbe-essere-la-chiave-per-trattare-la-sindrome-di-bachmann-bupp]]></loc><lastmod>2026-02-12T10:55:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22666-fondazione-mauro-baschirotto-prosegue-la-ricerca-sulla-malattia-di-lafora]]></loc><lastmod>2026-01-16T15:13:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22667-malattie-rare-nuova-possibile-terapia-per-le-forme-gravi-di-alfa-sarcoglicanopatia]]></loc><lastmod>2026-01-16T15:33:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22653-bardet-biedl-la-malattia-rara-che-colpisce-vista-metabolismo-e-reni-perche-oggi-e-piu-facile-riconoscerla]]></loc><lastmod>2026-01-12T18:04:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22659-gangliosidosi-gm1-e-la-mucopolisaccaridosi-di-tipo-iv-b-nuove-speranze-su-terapia-genica-da-una-ricerca-italiana]]></loc><lastmod>2026-01-14T10:14:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22650-gregor-una-piattaforma-per-la-genomica-delle-malattie-rare]]></loc><lastmod>2026-01-12T18:04:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22636-diagnosi-precoce-delle-malattie-rare-il-potenziale-ruolo-delle-cartelle-cliniche-elettroniche]]></loc><lastmod>2026-01-02T18:35:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22627-malattie-rare-scheletriche-quando-la-diagnosi-precoce-passa-dalla-tecnologia]]></loc><lastmod>2025-12-23T11:58:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22607-staminali-e-medicina-comparata-nuove-prospettive-dalla-pratica-veterinaria]]></loc><lastmod>2025-12-15T10:59:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22591-lupus-eritematoso-sistemico-tutte-le-novita-diagnostiche-e-terapeutiche]]></loc><lastmod>2025-12-09T18:08:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22567-qual-e-il-momento-migliore-per-fare-lo-screening-uditivo-ai-neonati]]></loc><lastmod>2025-12-01T17:31:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22529-malattie-rare-animali-tanti-passi-avanti-negli-ultimi-decenni-ma-servono-piu-risorse]]></loc><lastmod>2025-11-25T09:40:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22487-lia-al-fianco-del-chimico-per-accelerare-lo-sviluppo-di-farmaci-per-malattie-rare-e-complesse]]></loc><lastmod>2025-11-10T10:24:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22475-ce-una-base-scientifica-per-la-pet-therapy-benefici-fisici-e-psicologici-a-confronto]]></loc><lastmod>2025-11-06T23:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22479-tumori-biomarcatori-genetici-per-una-migliore-risposta-allimmunoterapia]]></loc><lastmod>2025-11-05T11:31:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22455-malattie-rare-e-animali-il-difficile-passaggio-da-oggetto-di-studio-a-soggetto-da-curare]]></loc><lastmod>2025-10-28T15:24:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22434-lupus-spiegato-il-meccanismo-che-aumenta-il-rischio-di-trombosi]]></loc><lastmod>2025-10-22T14:54:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22393-chirurgia-robotica-per-limpianto-cocleare-primi-interventi-al-bambino-gesu]]></loc><lastmod>2025-10-13T17:10:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22412-ricerca-e-salute-annunciati-i-vincitori-delledizione-2025-dei-bandi-gilead]]></loc><lastmod>2025-10-15T16:04:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22395-progeria-un-gene-dei-centenari-sembra-protegge-il-cuore-dai-danni-causati-dalla-malattia]]></loc><lastmod>2025-10-13T16:55:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22391-sindrome-di-skraban-deardorff-quando-famiglie-e-ricerca-camminano-insieme-per-un-futuro-migliore]]></loc><lastmod>2025-10-10T14:36:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22383-sindrome-di-pierpont-al-via-in-italia-il-progetto-di-ricerca-drop-out]]></loc><lastmod>2025-10-08T10:54:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22370-gemelli-digitali-lultima-frontiera-nel-campo-della-medicina-personalizzata]]></loc><lastmod>2025-10-05T22:05:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22345-intelligenza-artificiale-un-nuovo-alleato-per-la-diagnosi-delle-malattie-genetiche-rare]]></loc><lastmod>2025-09-26T15:46:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22346-le-terapie-avanzate-in-italia-la-genetica-al-centro-della-rivoluzione-terapeutica]]></loc><lastmod>2025-09-29T12:59:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22344-drug-repurpousing-il-ruolo-della-genetica-medica-e-essenziale]]></loc><lastmod>2026-03-13T16:13:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22343-il-dna-come-carta-didentita-la-genetica-forense-ridisegna-le-indagini]]></loc><lastmod>2025-09-29T09:04:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22341-lintelligenza-artificiale-al-centro-della-rivoluzione-genetica-tutte-le-novita-dal-congresso-sigu-2025]]></loc><lastmod>2025-09-25T18:55:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22305-la-genetica-italiana-tra-presente-e-futuro-genomica-avanzata-terapie-innovative-ed-intelligenza-artificiale]]></loc><lastmod>2025-09-16T12:09:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22289-malattie-rare-verso-terapie-mirate-grazie-allanalisi-in-3d-dei-lisosomi]]></loc><lastmod>2025-09-10T18:30:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22259-esofago-di-barrett-nuove-evidenze-sui-meccanismi-all-origine-della-patologia]]></loc><lastmod>2025-08-28T21:13:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22255-un-paese-dell-irpinia-una-mutazione-nascosta-e-una-ricerca-basata-sulla-collaborazione-tra-scienziati-e-cittadini]]></loc><lastmod>2025-08-25T17:54:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22252-htlv-1-un-virus-poco-conosciuto-ma-in-grado-di-causare-gravi-patologie]]></loc><lastmod>2025-08-20T19:43:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22248-malattie-neurodegenerative-la-ricerca-italiana-impegnata-a-svelarne-i-segreti]]></loc><lastmod>2025-08-17T17:33:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22246-malattie-rare-aperte-le-candidature-al-premio-chiara-gemmo-dedicato-a-giovani-ricercatori]]></loc><lastmod>2025-08-12T07:47:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22235-malattie-rare-studio-italiano-getta-luce-sul-ruolo-della-proteina-ddx11]]></loc><lastmod>2025-08-06T16:46:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22231-malattie-rare-100-i-progetti-di-studio-candidati-al-bando-di-ricerca-indipendente-di-aifa]]></loc><lastmod>2025-08-01T17:08:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22194-sordita-e-malattie-rare-un-binomio-piu-comune-di-quanto-si-pensi]]></loc><lastmod>2025-07-23T18:07:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22223-andrea-lenzi-nominato-presidente-del-consiglio-nazionale-delle-ricerche]]></loc><lastmod>2025-07-29T09:11:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22190-ribonucleasi-nelle-malattie-genetiche-rare-quale-ruolo-per-questi-enzimi]]></loc><lastmod>2025-07-22T17:14:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22199-scoperta-in-un-paese-in-provincia-di-avellino-una-nuova-mutazione-genetica-associata-a-morte-improvvisa]]></loc><lastmod>2025-07-17T08:46:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22148-yougoody-istituto-italiano-tumori-la-prevenzione-e-anche-una-questione-di-stile]]></loc><lastmod>2025-07-01T21:13:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22140-invecchiamento-e-salute-a-human-technopole-un-erc-da-2-5-milioni-per-studiare-il-declino-del-sistema-immunitario]]></loc><lastmod>2025-06-27T12:59:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22111-malattie-rare-andrea-ballabio-si-aggiudica-il-beth-levine-prize]]></loc><lastmod>2025-06-20T18:23:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22099-caldo-e-cervello-il-legame-invisibile-e-la-minaccia-per-la-salute-neurologica]]></loc><lastmod>2025-06-17T15:44:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22094-malattie-mitocondriali-legate-al-gene-polg-da-padova-una-scoperta-importante]]></loc><lastmod>2025-06-13T20:17:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22065-malattie-rare-pubblicato-il-bando-di-ricerca-indipendente-2025-di-aifa]]></loc><lastmod>2025-06-06T17:08:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22051-gravidanza-e-primi-giorni-di-vita-dalla-proteomica-urinaria-segnali-per-diagnosi-precoci]]></loc><lastmod>2025-06-05T20:43:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22030-paziente-paraplegico-torna-a-camminare-dopo-un-incidente-sul-lavoro]]></loc><lastmod>2025-05-27T17:42:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22026-genetica-con-i-test-ngs-sui-campioni-di-dna-preistorici-definiti-i-flussi-migratori-degli-uomini-di-55-000-anni-fa]]></loc><lastmod>2025-05-27T09:57:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22012-genetica-medica-italia-al-centro-della-trasformazione-europea]]></loc><lastmod>2025-05-29T09:30:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/22005-disturbi-neuroevolutivi-scoperto-il-ruolo-del-gene-rnu2-2]]></loc><lastmod>2025-05-20T18:33:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21995-il-contratto-per-la-ricerca-di-telethon-un-modello-di-riferimento-per-attrarre-talenti-della-scienza-in-italia]]></loc><lastmod>2025-05-16T17:17:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21999-terapie-crispr-personalizzate-la-genetica-medica-entra-in-una-nuova-era]]></loc><lastmod>2025-05-19T09:59:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21992-malattia-di-tangier-svelati-i-fattori-genetici-e-clinici-che-aumentano-il-rischio-cardiovascolare]]></loc><lastmod>2025-05-16T17:05:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21942-sindrome-vexas-una-malattia-scoperta-e-studiata-grazie-all-editing-del-genoma]]></loc><lastmod>2025-05-05T08:38:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21912-code-diarrea-congenita-neonatale-un-passo-avanti-verso-trattamenti-di-precisione]]></loc><lastmod>2025-04-15T16:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21907-malattie-rare-il-cda-di-aifa-approva-il-bando-di-ricerca-indipendente-per-il-2025]]></loc><lastmod>2025-06-06T17:08:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21894-telethon-vimm-e-fondazione-cariparo-insieme-per-un-progetto-sulle-malattie-neuromuscolari]]></loc><lastmod>2025-04-10T17:50:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21862-malattie-cardiache-congenite-a-pavia-progressi-nel-campo-delle-terapie-avanzate]]></loc><lastmod>2025-04-01T07:38:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21837-un-braccio-robotico-controllato-con-il-pensiero-una-svolta-per-le-persone-paralizzate]]></loc><lastmod>2025-03-25T14:41:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21823-distrofia-facio-scapolo-omerale-concluso-il-progetto-epithe4fshd]]></loc><lastmod>2025-03-18T17:29:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21818-malattie-rare-accordo-triennale-tra-telethon-e-fondazione-regionale-per-la-ricerca-biomedica]]></loc><lastmod>2025-03-15T11:07:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21809-covid-e-malattie-rare-ecco-quali-patologie-hanno-comportato-un-maggior-rischio-di-mortalita]]></loc><lastmod>2025-05-16T13:29:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21785-genetica-per-la-diagnosi-neonatale-al-via-il-progetto-baby-wolf]]></loc><lastmod>2025-03-07T15:53:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21790-malattie-rare-al-via-il-progetto-gen-rare-del-gemelli]]></loc><lastmod>2025-03-07T19:35:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21752-malattie-endocrinologiche-riuniti-a-roma-i-massimi-esperti-europei-per-parlare-di-transizione]]></loc><lastmod>2025-02-27T17:25:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21748-la-neurotuta-exopulse-mollii-suit-innovazione-nella-neurostimolazione-per-le-malattie-rare]]></loc><lastmod>2025-02-24T21:12:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21743-all-academy-winter-school-della-sigu-la-genetica-e-protagonista-assoluta]]></loc><lastmod>2025-02-22T11:19:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21714-shock-cardiogeno-al-via-lo-studio-enigma]]></loc><lastmod>2025-02-10T16:53:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21712-disturbi-dello-spettro-autistico-un-nuovo-studio-mette-al-centro-il-ruolo-degli-aminoacidi-tra-le-possibili-cause]]></loc><lastmod>2025-02-10T16:52:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21692-depressione-svelato-un-possibile-legame-con-le-alterazioni-epigenetiche]]></loc><lastmod>2025-02-07T10:10:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21691-neurostimolazione-applicata-alle-malattie-rare-la-neurotuta-puo-essere-un-ausilio-valido]]></loc><lastmod>2025-02-04T18:23:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21647-la-relazione-tra-eta-e-tumore-dell-endometrio]]></loc><lastmod>2025-01-20T18:46:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21632-individuata-una-nuova-patologia-la-sindrome-tipo-noonan-con-o-senza-craniosinostosi]]></loc><lastmod>2025-01-15T12:36:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21618-sindrome-di-kleefstra-di-tipo-2-una-patologia-che-potrebbe-presto-cambiare-nome]]></loc><lastmod>2025-01-08T11:45:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21609-trapianti-la-ricerca-punta-alla-creazione-di-cuore-a-partire-da-cellule-staminali-pluripotenti]]></loc><lastmod>2024-12-27T10:49:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21610-mutazioni-nel-gene-atxn7l3-causano-ritardo-dello-sviluppo-e-ipotonia]]></loc><lastmod>2024-12-27T11:06:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21607-malattie-genetiche-rare-da-telethon-piu-di-6-milioni-di-euro-per-la-ricerca]]></loc><lastmod>2024-12-20T18:31:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21561-malattie-endocrinologiche-rare-nasce-il-registro-europeo-endo-ern-core]]></loc><lastmod>2024-12-06T18:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21558-terapia-genica-ricercatori-dell-sr-tiget-ricevono-due-erc-consolidator-grant]]></loc><lastmod>2024-12-06T11:52:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21549-dal-cordone-ombelicale-un-ancora-di-salvezza-per-i-bimbi-nati-prematuri]]></loc><lastmod>2024-12-04T19:00:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21546-farmacogenetica-quando-i-geni-determinano-la-risposta-ai-farmaci]]></loc><lastmod>2024-12-02T15:57:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21521-morte-cardiaca-improvvisa-la-ricerca-punta-all-eventuale-relazione-con-le-canalopatie-cardiache]]></loc><lastmod>2024-11-25T18:35:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21459-tumore-al-polmone-tra-ricerca-scientifica-e-nuove-opportunita-di-cura]]></loc><lastmod>2024-11-05T18:57:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21449-donare-il-proprio-corpo-alla-scienza-in-italia-e-possibile]]></loc><lastmod>2024-11-01T18:46:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21425-la-rivoluzione-del-sequenziamento-del-genoma-nel-trattamento-dei-tumori-infantili]]></loc><lastmod>2024-10-25T15:06:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21411-in-che-modo-la-genetica-interviene-nella-diagnosi-dei-tumori]]></loc><lastmod>2024-10-23T10:01:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21404-sindrome-di-lyell-la-cura-arriva-da-un-farmaco-off-label]]></loc><lastmod>2024-10-22T12:27:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21387-sindrome-di-leigh-ricercatori-italiani-all-opera-per-trovare-una-terapia]]></loc><lastmod>2024-10-15T22:05:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21346-malattie-neuromuscolari-con-il-bando-telethon-uildm-finanziati-sei-nuovi-progetti-di-studio]]></loc><lastmod>2024-10-01T17:34:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21319-tumore-alla-prostata-strumenti-sempre-piu-efficaci-per-identificare-il-rischio]]></loc><lastmod>2024-09-25T11:30:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21306-glomerulosclerosi-focale-segmentale-dal-gaslini-di-genova-un-nuovo-approccio-terapeutico]]></loc><lastmod>2024-09-19T16:02:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21290-malattie-rare-piu-frequenti-se-l-eta-del-padre-e-avanzata]]></loc><lastmod>2024-09-16T16:23:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21280-oncologia-giovane-ricercatrice-dell-universita-tor-vergata-vince-l-erc-starting-grant-2024]]></loc><lastmod>2024-09-11T18:25:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21272-malattie-rare-lo-european-research-council-finanzia-gli-studi-di-tre-giovani-ricercatori-telethon]]></loc><lastmod>2024-09-10T11:06:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21233-fenib-una-malattia-neurodegenerativa-rarissima-e-sottodiagnosticata]]></loc><lastmod>2024-08-13T15:38:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21225-sequenziamento-del-genoma-quali-usi-nella-pratica-clinica]]></loc><lastmod>2024-08-09T15:45:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21215-malattie-neuromuscolari-l-impatto-del-treat-nmd]]></loc><lastmod>2024-08-02T10:01:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21214-genomica-e-malattie-rare-e-tempo-di-riscrivere-il-ruolo-del-genetista]]></loc><lastmod>2024-08-06T13:51:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21202-test-genetici-ngs-cosa-sono-e-quando-utilizzarli]]></loc><lastmod>2024-07-29T13:18:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21197-malattie-rare-uno-studio-conferma-i-ritardi-diagnostici-in-europa]]></loc><lastmod>2024-07-25T15:04:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21187-malattie-genetiche-rare-da-telethon-quasi-4-milioni-di-euro-per-la-ricerca]]></loc><lastmod>2024-07-19T13:42:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21113-cataratta-congenita-nuovi-dati-da-uno-studio-italiano]]></loc><lastmod>2024-06-25T13:44:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21108-intelligenza-artificiale-e-calcolo-quantistico-sono-il-futuro-della-scienza-medica]]></loc><lastmod>2024-06-24T18:14:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21046-malattie-rare-e-ai-10-milioni-di-euro-per-una-piattaforma-innovativa-per-le-malattie-rare]]></loc><lastmod>2024-06-18T14:05:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21044-tumore-al-polmone-al-via-la-piattaforma-di-ricerca-di-fondazione-umberto-veronesi]]></loc><lastmod>2024-06-03T16:04:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21028-sindrome-di-jacobs-quando-un-maschio-ha-un-cromosoma-y-in-piu]]></loc><lastmod>2024-05-29T18:20:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/21014-intelligenza-artificiale-e-malattie-rare-i-modi-in-cui-puo-beneficiare-la-ricerca]]></loc><lastmod>2024-06-18T14:05:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20908-malattie-del-neurosviluppo-accordo-quadro-tra-irccs-medea-e-universita-cattolica]]></loc><lastmod>2024-04-24T11:07:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20871-terza-edizione-del-bando-telethon-cariplo-finanziati-14-progetti-ricerca]]></loc><lastmod>2024-04-15T13:42:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20848-sindrome-di-pitt-hopkins-ancora-nessuna-cura-ma-tre-sperimentazioni-in-corso]]></loc><lastmod>2024-04-08T17:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20804-malattie-rare-e-possibile-sviluppare-terapie-dagli-scarti-del-plasma]]></loc><lastmod>2024-03-25T15:10:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20792-malattia-delle-sei-dita-scoperto-il-gene-che-la-causa]]></loc><lastmod>2024-03-22T10:48:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20772-sindrome-di-lynch-la-biopsia-liquida-apre-la-strada-a-una-diagnosi-tempestiva-di-tumori-associati]]></loc><lastmod>2024-03-20T11:08:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20764-salute-del-cervello-lanciata-a-roma-la-strategia-italiana-e-il-manifesto-one-brain-one-health]]></loc><lastmod>2024-03-18T13:38:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20766-settimana-mondiale-del-cervello-psichiatria-dell-osso-e-in-atto-una-rivoluzione-silenziosa]]></loc><lastmod>2024-03-18T13:35:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20765-one-brain-one-health-arriva-il-manifesto-sulla-salute-del-cervello]]></loc><lastmod>2024-03-18T13:44:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20709-ricerca-individuata-nuova-malattia-del-neurosviluppo-correlata-al-gene-dennd5b]]></loc><lastmod>2024-03-04T19:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20706-mutazione-del-gene-ehmt2-identificato-il-primo-caso-al-mondo]]></loc><lastmod>2024-03-02T18:27:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20670-online-un-questionario-per-valutare-l-impatto-delle-malattie-neuromuscolari]]></loc><lastmod>2024-02-22T19:06:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20623-displasia-spondiloepifisaria-individuato-un-gene-responsabile]]></loc><lastmod>2024-02-12T14:50:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20603-malattie-rare-non-diagnosticate-nel-mondo-13-programmi-in-15-anni]]></loc><lastmod>2024-02-15T18:30:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20543-gene-nsrp1-le-mutazioni-causano-un-grave-disturbo-dello-sviluppo-neurologico]]></loc><lastmod>2024-02-02T12:52:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20571-nistagmo-infantile-nucci-puo-essere-solo-un-sintomo-oppure-una-patologia-vera-e-propria]]></loc><lastmod>2024-01-29T11:36:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20562-sordita-ereditaria-grazie-alla-terapia-genica-aissiam-ora-puo-sentire]]></loc><lastmod>2024-01-30T13:15:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20522-emiplegia-alternante-dell-infanzia-le-novita-della-ricerca]]></loc><lastmod>2024-01-18T08:32:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20511-malattie-rare-un-analisi-a-livello-europeo-sulle-terapie-geniche]]></loc><lastmod>2024-01-12T15:50:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20483-malattie-neuromuscolari-e-ricerca-traslazionale-i-tavoli-tecnici-per-la-valutazione-indipendente-del-treat-nmd]]></loc><lastmod>2023-12-27T12:19:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20484-malattie-neuromuscolari-il-network-internazionale-treat-nmd-per-la-ricerca]]></loc><lastmod>2023-12-27T12:19:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20386-rasopatie-pazienti-e-ricercatori-uniti-nel-progetto-di-ricerca-euras]]></loc><lastmod>2023-11-28T13:49:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20380-cardiomiopatia-aritmogena-finanziato-un-progetto-dell-universita-di-padova]]></loc><lastmod>2023-11-24T11:52:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20285-sindrome-feto-alcolica-e-la-piu-grave-e-negletta-disabilita-permanente-di-origine-non-genetica]]></loc><lastmod>2024-02-22T19:03:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20279-anemia-di-fanconi-individuata-la-firma-molecolare]]></loc><lastmod>2023-10-31T10:58:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20267-molecular-tumor-board-una-preziosa-realta-per-i-pazienti-oncologici]]></loc><lastmod>2023-10-28T19:39:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20226-generation-study-nel-regno-unito-parte-il-progetto-di-sequenziamento-del-genoma-di-100mila-bambini]]></loc><lastmod>2023-10-14T11:18:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20223-morte-cardiaca-improvvisa-la-commissione-lancet-traccia-il-percorso-da-seguire]]></loc><lastmod>2023-10-13T17:15:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20204-sindrome-di-phelan-mcdermid-aggiornate-le-linee-guida-europee]]></loc><lastmod>2023-10-08T20:48:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20208-disturbi-del-neurosviluppo-nasce-tele-neurart-la-prima-rete-pediatrica-virtuale-mai-realizzata-al-mondo]]></loc><lastmod>2023-10-09T13:57:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20183-distrofie-muscolari-dei-cingoli-grazie-al-progresso-diagnostico-oggi-esiste-una-nuova-nomenclatura]]></loc><lastmod>2023-10-04T07:43:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20181-malattie-ultra-rare-negli-usa-un-team-di-investigatori-va-a-caccia-di-diagnosi-genetiche]]></loc><lastmod>2024-03-04T19:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20153-malattie-rare-annunciati-i-vincitori-dello-spring-seed-grant-2023-di-telethon]]></loc><lastmod>2023-09-25T15:46:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20135-dolore-cronico-infiammazione-e-disturbi-del-sonno-tre-condizioni-strettamente-collegate]]></loc><lastmod>2023-09-26T08:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20125-dissecazione-aortica-il-trattamento-e-quasi-sempre-chirurgico-ma-bisogna-agire-immediatamente]]></loc><lastmod>2023-09-20T07:35:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20128-dissecazione-aortica-una-malattia-vascolare-con-una-mortalita-elevatissima]]></loc><lastmod>2023-09-18T17:48:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20081-il-conte-dracula-piangeva-lacrime-di-sangue]]></loc><lastmod>2023-09-04T16:58:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20060-tumori-l-italia-al-vertice-nel-mondo-negli-studi-sulla-biopsia-liquida]]></loc><lastmod>2023-08-25T09:16:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20063-tumori-con-la-radiomica-si-punta-a-migliorare-la-diagnosi-e-personalizzare-la-terapia]]></loc><lastmod>2023-08-17T16:10:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20052-malattie-neuromuscolari-dal-baco-da-seta-le-nuove-frontiere-nella-ricerca-tecnologica]]></loc><lastmod>2023-08-07T09:06:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19948-geni-il1rapl1-e-il1rapl2-la-loro-mutazione-altera-la-struttura-delle-sinapsi]]></loc><lastmod>2023-06-25T21:19:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19906-paralisi-spastiche-ereditarie-a-trieste-si-studia-kidins220-proteina-associata-alla-sindrome-sino]]></loc><lastmod>2023-06-16T14:59:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19869-sindrome-di-kleefstra-al-via-la-prima-ricerca-italiana]]></loc><lastmod>2023-06-04T13:11:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19863-oncologia-la-dr-ssa-giulia-mazzaschi-vince-il-premio-research-to-care]]></loc><lastmod>2023-06-02T22:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19826-disturbi-del-neurosviluppo-il-supporto-ai-genitori-modifica-l-espressione-genica-nei-bambini]]></loc><lastmod>2023-05-23T10:18:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19748-malattie-rare-da-fondazione-cariplo-e-telethon-5-milioni-di-euro-per-la-ricerca-di-base]]></loc><lastmod>2023-04-26T19:13:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19750-neuromielite-ottica-quali-sono-i-fattori-che-incidono-su-una-diagnosi-errata]]></loc><lastmod>2023-04-26T19:14:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19680-malattie-genetiche-rare-ricercatori-del-tigem-di-pozzuoli-si-aggiudicano-due-erc-grants]]></loc><lastmod>2023-04-03T15:06:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19642-ricerca-scientifica-al-via-il-progetto-terabit]]></loc><lastmod>2023-03-21T20:59:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19635-la-denuncia-di-una-giovane-studiosa-in-italia-la-ricerca-scientifica-ti-sfianca-e-eterna-battaglia-per-trovare-finanziamenti]]></loc><lastmod>2023-03-16T19:17:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19633-malattie-mitocondriali-l-associazione-mitocon-sostiene-la-ricerca-scientifica]]></loc><lastmod>2023-03-15T19:15:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19591-ricerca-indipendente-torna-il-bando-di-fondazione-roche]]></loc><lastmod>2023-03-07T14:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19574-malattie-genetiche-rare-da-telethon-piu-di-5-milioni-di-euro-alla-ricerca-di-eccellenza]]></loc><lastmod>2023-03-31T21:02:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19576-sindrome-di-beckwith-wiedemann-uno-studio-sulla-patologia-potrebbe-trovare-risposte-su-infertilita-e-poliabortivita]]></loc><lastmod>2023-03-01T20:47:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19549-ricerca-scientifica-lanciata-la-xii-edizione-dei-bandi-gilead]]></loc><lastmod>2023-02-19T17:04:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19492-covid-19-nuovo-studio-evidenzia-come-l-infezione-persista-nel-tempo]]></loc><lastmod>2023-02-03T20:53:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19488-distrofia-facio-scapolo-omerale-nuovo-test-molecolare-consente-di-individuare-i-pazienti-in-sole-72-ore]]></loc><lastmod>2023-01-28T11:56:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19486-neurite-ottica-ischemica-anteriore-contrastare-la-patologia-con-l-aiuto-della-camera-iperbarica]]></loc><lastmod>2023-01-30T09:13:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19471-paralisi-spastica-ereditaria-infantile-usare-l-intelligenza-artificiale-per-studiare-le-mutazioni-associate]]></loc><lastmod>2023-01-21T12:31:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19451-distrofia-miotonica-di-tipo-1-vertex-ed-entrada-insieme-per-una-nuova-potenziale-terapia]]></loc><lastmod>2023-01-20T15:28:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19426-neurologia-individuata-cellula-del-cervello-che-regola-le-decisioni]]></loc><lastmod>2022-12-30T17:48:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19388-identificata-nuova-malattia-ultra-rara-dello-sviluppo-correlata-al-gene-arf]]></loc><lastmod>2023-01-13T18:14:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19369-coronavirus-un-farmaco-per-la-colangite-biliare-primitiva-potrebbe-affiancare-i-vaccini-nella-prevenzione]]></loc><lastmod>2022-12-09T08:50:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19359-sindrome-di-smith-magenis-identificati-alcuni-meccanismi-implicati-nello-sviluppo-della-patologia]]></loc><lastmod>2022-12-04T19:32:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19288-malattie-mitocondriali-e-pma-la-tecnica-di-sostituzione-del-dna-mitocondriale]]></loc><lastmod>2024-02-13T12:25:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19248-malattie-neuromuscolari-afm-telethon-finanzia-due-progetti-di-ricerca-padovani]]></loc><lastmod>2022-11-05T14:51:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19204-sindrome-ring14-un-progetto-di-ricerca-del-sant-orsola-vince-il-bando-di-ring14-international]]></loc><lastmod>2022-10-26T17:20:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19186-malattie-genetiche-rare-da-fondazione-just-italia-un-finanziamento-per-accelerare-la-diagnosi]]></loc><lastmod>2022-10-20T18:33:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19178-autotrapianto-di-isole-pancreatiche-la-procedura-migliora-il-controllo-del-diabete-nei-casi-di-rimozione-del-pancreas]]></loc><lastmod>2022-10-14T18:48:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19164-trapianti-anche-i-malati-rari-possono-donare-gli-organi]]></loc><lastmod>2022-10-12T10:10:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19107-malattie-genetiche-annunciati-i-vincitori-del-bando-telethon-spring-seed-grant-2022]]></loc><lastmod>2022-09-24T19:28:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19095-malattie-dermatologiche-l-azienda-almirall-lancia-un-bando-per-la-ricerca-di-nuove-terapie]]></loc><lastmod>2022-09-21T17:27:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/19006-tumori-i-linfociti-nkt-come-potenziale-piattaforma-cellulare-di-trattamento]]></loc><lastmod>2022-08-29T16:45:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18998-tumori-in-italia-nasce-il-primo-dottorato-di-ricerca-in-adroterapia]]></loc><lastmod>2022-08-12T18:01:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18954-invecchiamento-studio-italiano-apre-nuove-prospettive-per-vivere-in-salute-la-terza-eta]]></loc><lastmod>2022-07-24T17:29:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18921-malattie-rare-in-toscana-uno-studio-sul-tasso-di-sopravvivenza-dei-pazienti]]></loc><lastmod>2022-07-16T20:48:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18869-atassie-ereditarie-aisa-odv-lancia-un-bando-di-ricerca]]></loc><lastmod>2022-07-05T16:23:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18835-tumori-al-cnao-verra-sviluppata-una-nuova-terapia-con-neutroni]]></loc><lastmod>2022-06-25T15:07:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18810-tmau-trimetilaminuria-o-sindrome-da-odore-di-pesce-al-san-paolo-di-milano-c-e-una-equipe-dedicata]]></loc><lastmod>2022-06-23T12:16:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18737-adenocarcinoma-polmonare-scoperta-una-firma-molecolare-responsabile-dello-sviluppo-del-tumore]]></loc><lastmod>2022-06-05T15:15:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18734-sindrome-di-beckwith-wiedemann-martina-zanetti-vince-il-premio-simone-casapieri]]></loc><lastmod>2022-06-05T14:25:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18703-tumori-quali-processi-metabolici-ne-influenzano-la-crescita]]></loc><lastmod>2022-05-29T22:39:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18678-ricerca-andrea-ballabio-nominato-consulente-scientifico-dell-istituto-veneto-di-medicina-molecolare]]></loc><lastmod>2022-05-22T18:53:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18675-malattie-rare-telethon-e-fondazione-cariplo-finanziano-24-progetti-di-ricerca]]></loc><lastmod>2022-05-22T17:59:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18677-ittiosi-congenite-significativo-l-impatto-sulla-qualita-di-vita-delle-famiglie]]></loc><lastmod>2022-05-22T18:37:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18659-sars-cov-2-identificato-il-meccanismo-di-replicazione-del-virus]]></loc><lastmod>2022-05-16T11:29:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18654-malattie-scheletriche-rare-cosa-si-aspettano-i-pazienti-da-un-registro-dati-europeo]]></loc><lastmod>2022-05-15T20:43:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18611-malattie-rare-dal-ministero-della-salute-oltre-520-milioni-per-il-potenziamento-della-ricerca-biomedica]]></loc><lastmod>2022-05-05T18:33:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18559-paralisi-cerebrale-infantile-uno-studio-italiano-porta-in-cina-la-ricerca-sulla-nutrizione-clinica]]></loc><lastmod>2022-04-15T22:32:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18525-ricerca-scientifica-aperto-il-bando-spring-seed-grant-di-fondazione-telethon]]></loc><lastmod>2026-04-08T17:01:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18461-malattie-del-neurosviluppo-dell-occhio-parte-il-progetto-di-ricerca-brain4sight]]></loc><lastmod>2022-03-27T21:40:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18436-ricerca-scientifica-torna-il-bando-di-gilead-per-i-migliori-progetti-italiani]]></loc><lastmod>2022-03-21T14:12:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18438-sindrome-mdpl-una-malattia-da-invecchiamento-precoce-recentemente-scoperta-in-italia]]></loc><lastmod>2022-03-21T15:01:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18423-lissencefalia-xlag-ed-encefalopatia-epilettica-dee1-identificati-i-difetti-molecolari-alla-base-delle-due-patologie]]></loc><lastmod>2022-03-15T19:00:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18392-paralisi-cerebrale-l-universita-di-pisa-guidera-una-delle-piu-grandi-ricerche-europee]]></loc><lastmod>2022-03-06T23:18:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18388-nuova-malattia-rara-scoperta-all-irccs-casa-sollievo-della-sofferenza]]></loc><lastmod>2022-03-06T22:15:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18369-telethon-ecco-il-bando-seed-grant-investire-oggi-per-raccogliere-i-frutti-domani]]></loc><lastmod>2022-03-01T15:12:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18318-sindrome-di-leigh-la-ricerca-scientifica-non-si-ferma]]></loc><lastmod>2022-02-21T15:05:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18319-disfunzioni-sessuali-correlate-a-farmaci-individuati-i-criteri-diagnostici]]></loc><lastmod>2022-02-23T09:00:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18309-disfunzione-sessuale-post-ssri-due-studi-italiani-per-scoprirne-l-eziologia]]></loc><lastmod>2022-02-22T02:01:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18295-sindromi-atassiche-all-universita-di-ferrara-il-primo-dottorato-di-ricerca-dedicato]]></loc><lastmod>2022-02-15T17:10:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18294-neurochaperonopatie-dalla-genetica-la-possibilita-di-diagnosticare-malattie-senza-nome]]></loc><lastmod>2022-02-13T14:56:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18217-atassia-spinocerebellare-di-tipo-1-fondazione-acaref-finanzia-un-nuovo-studio]]></loc><lastmod>2022-01-23T22:56:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18211-osteopetrosi-autosomica-recessiva-un-nuovo-test-e-in-grado-di-individuare-anomalie-nella-struttura-ossea]]></loc><lastmod>2022-01-23T22:05:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/18207-sindrome-di-brugada-al-bambino-gesu-il-primo-studio-nei-minori-di-12-anni]]></loc><lastmod>2022-01-23T20:24:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17976-malattie-rare-dalle-fondazioni-telethon-e-cariplo-un-bando-congiunto-per-la-ricerca]]></loc><lastmod>2021-11-07T12:15:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17932-sindrome-di-beckwith-wiedemann-la-dr-ssa-pierpaola-tannorella-vince-il-premio-simone-casapieri]]></loc><lastmod>2021-10-26T13:16:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17930-encefalopatia-epilettica-slc6a1-dallo-studio-di-un-piccolo-pesce-la-speranza-di-una-terapia]]></loc><lastmod>2021-10-26T13:11:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17928-malattie-infettive-e-oncoematologiche-premiati-i-vincitori-del-bando-gilead-sciences-2021]]></loc><lastmod>2021-10-26T13:48:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17924-malattie-rare-nasce-il-progetto-di-ricerca-europeo-screen4care]]></loc><lastmod>2021-10-23T19:09:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17846-tumori-identificato-un-recettore-che-sembra-in-grado-di-interferire-con-il-processo-metastatico]]></loc><lastmod>2021-10-03T17:08:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17842-ricerca-no-profit-aism-airc-e-telethon-chiedono-al-governo-la-rapida-attuazione-delle-misure-per-ridurre-i-costi]]></loc><lastmod>2021-10-03T16:00:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17805-adenocarcinoma-polmonare-scoperti-4-sottotipi-molecolari-che-potranno-indirizzare-verso-terapie-ad-hoc]]></loc><lastmod>2021-09-22T15:30:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17727-covid-19-l-interferone-potrebbe-avere-un-ruolo-nel-determinare-la-gravita-della-malattia]]></loc><lastmod>2021-08-27T15:02:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17688-paraparesi-spastica-ereditaria-avviato-uno-studio-preclinico-all-irccs-stella-maris]]></loc><lastmod>2021-07-25T18:31:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17652-ricerca-scientifica-approvato-emendamento-per-ridurre-gli-oneri-fiscali-per-l-acquisto-di-reagenti-e-apparecchiature]]></loc><lastmod>2021-07-18T16:35:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17638-anomalie-congenite-al-via-l-indagine-eurolinkcat]]></loc><lastmod>2021-07-11T17:42:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17634-malattie-parossistiche-rare-ricerca-italiana-getta-nuova-luce-sul-ruolo-del-gene-prrt2]]></loc><lastmod>2021-07-11T16:11:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17562-ricerca-scientifica-scoperto-il-gene-che-regola-il-rilascio-di-interferone-beta]]></loc><lastmod>2021-06-20T17:29:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17511-distrofia-muscolare-una-proteina-modificata-riduce-l-infiammazione-e-promuove-la-rigenerazione-di-tessuti]]></loc><lastmod>2021-06-06T19:21:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17470-covid-19-dalla-genomica-le-chiavi-di-comprensione-del-virus]]></loc><lastmod>2021-05-24T16:38:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17307-sindromi-da-iperaccrescimento-al-via-il-progetto-io-mi-vedo-cosi]]></loc><lastmod>2021-04-18T16:15:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17285-covid-19-nasce-il-progetto-cometa-per-misurare-l-impatto-della-pandemia-sui-pazienti-fragili]]></loc><lastmod>2024-10-09T18:18:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17231-malattie-neurodegenerative-uno-studio-identifica-i-meccanismi-coinvolti-nell-esordio]]></loc><lastmod>2021-03-28T20:36:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17182-fegato-grasso-la-mutazione-di-una-proteina-predice-la-fibrosi-epatica-in-bambini-e-adulti]]></loc><lastmod>2021-03-19T09:36:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17124-progeria-al-via-il-progetto-di-studio-tc-ner]]></loc><lastmod>2021-03-06T19:44:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17101-neoplasie-mieloproliferative-e-sindrome-di-angelman-l-impegno-di-from-nella-ricerca]]></loc><lastmod>2021-02-28T19:30:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17097-malattie-genetiche-rare-al-via-45-progetti-di-studio-in-tutta-italia]]></loc><lastmod>2021-03-04T14:41:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17088-malattie-rare-al-bambino-gesu-identificate-4-nuove-patologie-orfane-di-diagnosi]]></loc><lastmod>2021-02-28T15:49:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17078-rachitismo-ipofosfatemico-ereditario-oggi-esiste-una-speranza-di-cura]]></loc><lastmod>2021-02-26T11:57:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17050-pans-e-pandas-in-corso-un-indagine-per-scoprire-come-vivono-i-piccoli-pazienti]]></loc><lastmod>2021-02-21T15:38:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17024-tumori-del-fegato-presentato-uno-studio-sugli-effetti-negativi-del-covid-19]]></loc><lastmod>2021-02-14T21:22:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/17025-malattie-neurodegenerative-dall-ue-un-bando-da-19-milioni-di-euro-per-la-ricerca]]></loc><lastmod>2021-02-14T21:38:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16924-sindrome-di-leigh-dall-europa-2-4-milioni-di-euro-per-la-ricerca]]></loc><lastmod>2021-01-28T12:33:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16920-ricerca-scientifica-lanciata-la-decima-edizione-dei-bandi-gilead]]></loc><lastmod>2021-01-24T00:19:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16872-malattie-neuropsichiatriche-pubblicato-uno-studio-nazionale-sugli-effetti-del-lockdown]]></loc><lastmod>2021-01-12T15:54:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16825-progeria-realizzata-una-tecnologia-che-identifica-le-alterazioni-del-dna]]></loc><lastmod>2020-12-20T22:48:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16813-ricerca-raffaella-di-micco-si-aggiudica-prestigioso-finanziamento-erc]]></loc><lastmod>2020-12-15T17:03:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16781-paraparesi-spastica-ereditaria-vips-onlus-apre-il-bando-di-ricerca-2020]]></loc><lastmod>2020-12-08T20:09:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16718-malattie-rare-identificato-gene-alla-base-di-un-grave-ritardo-del-neurosviluppo]]></loc><lastmod>2020-11-22T21:56:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16719-covid-19-perche-alcune-persone-si-ammalano-piu-gravemente-di-altre]]></loc><lastmod>2020-11-22T22:42:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16660-deficit-del-trasportatore-di-riboflavina-nuova-speranza-di-cura-dalle-cellule-staminali]]></loc><lastmod>2020-11-16T13:18:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16659-metastasi-tumorali-dimostrato-il-ruolo-dell-oncosoppressore-atr]]></loc><lastmod>2020-11-09T10:45:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16657-ricerca-farmaceutica-nasce-alfathon-il-primo-hackathon-completamente-digitale]]></loc><lastmod>2020-11-07T18:09:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16637-linfomi-al-via-il-premio-brusamolino-2020]]></loc><lastmod>2020-11-01T18:51:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16632-malattia-di-hirayama-possibile-un-legame-con-il-gioco-del-basket]]></loc><lastmod>2020-10-31T17:59:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16603-paraparesi-spastica-ereditaria-di-tipo-7-individuato-un-possibile-bersaglio-terapeutico]]></loc><lastmod>2020-10-23T17:16:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16572-covid-19-da-telethon-200mila-euro-per-finanziare-4-progetti-di-ricerca]]></loc><lastmod>2020-10-18T18:24:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16433-tumore-del-polmone-scoperte-le-mutazioni-che-causano-resistenza-all-immunoterapia]]></loc><lastmod>2020-09-14T17:40:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16432-malattie-rare-350mila-euro-per-la-ricerca-da-associazioni-pazienti-e-fondazione-telethon]]></loc><lastmod>2020-09-14T10:15:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16382-malattie-del-neurosviluppo-il-gene-kdm5c-sembra-avere-un-ruolo-di-primo-piano]]></loc><lastmod>2020-09-03T15:13:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16351-ricerca-carmine-settembre-tigem-si-aggiudica-finanziamento-erc]]></loc><lastmod>2020-08-02T14:26:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16349-sequenziamento-genomico-del-neonato-dalla-lombardia-un-bando-per-uno-studio-di-fattibilita]]></loc><lastmod>2020-08-02T13:51:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16338-malattie-rare-identificata-una-nuova-sindrome-del-neurosviluppo]]></loc><lastmod>2020-07-29T11:09:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16321-covid-19-conclusa-con-successo-la-fase-di-discovery-del-progetto-mabco19]]></loc><lastmod>2020-07-26T13:23:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16310-distrofia-dall-europa-piu-di-3-milioni-di-euro-per-la-ricerca]]></loc><lastmod>2020-07-20T10:30:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16275-coronavirus-nessuna-trasmissione-con-le-punture-di-zanzara]]></loc><lastmod>2020-07-12T13:33:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16269-coronavirus-pubblicato-su-nature-lo-studio-condotto-a-vo]]></loc><lastmod>2020-07-06T11:11:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16256-tumori-renali-e-cisti-scoperto-un-meccanismo-che-ne-promuove-la-formazione]]></loc><lastmod>2020-07-06T10:05:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16231-covid-19-minor-accesso-a-terapie-intensive-e-piu-mortalita-per-i-pazienti-con-tumore-toracico]]></loc><lastmod>2020-06-29T10:08:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16213-coronavirus-dimostrato-il-potere-germicida-dei-raggi-uv]]></loc><lastmod>2020-06-21T23:30:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16205-sindrome-di-clouston-individuato-un-anticorpo-monoclonale-per-contrastarla]]></loc><lastmod>2020-06-23T10:11:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16202-sindrome-di-beckwith-wiedemann-un-premio-in-memoria-di-simone-casapieri]]></loc><lastmod>2020-06-21T20:10:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16183-ipermemoria-svelato-il-meccanismo-che-ordina-i-ricordi]]></loc><lastmod>2020-06-17T20:31:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16184-covid-19-studio-italiano-dimostra-sicurezza-ed-efficacia-della-colchicina]]></loc><lastmod>2020-06-15T13:43:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16132-coronavirus-il-tigem-avvia-un-progetto-di-ricerca-finanziato-da-regione-campania]]></loc><lastmod>2020-06-01T13:10:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16134-covid-19-inibitori-del-complemento-e-anticorpi-monoclonali-tra-i-nuovi-farmaci-in-studio]]></loc><lastmod>2020-06-05T07:45:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16102-covid-19-nessun-rischio-per-i-pazienti-in-trattamento-con-antipertensivi]]></loc><lastmod>2020-05-24T17:57:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16088-demenza-frontotemporale-nuovo-studio-getta-luce-sui-sintomi-psichiatrici-della-patologia]]></loc><lastmod>2020-05-20T11:08:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16089-malattie-neurodegenerative-l-universita-di-trento-punta-sull-rna]]></loc><lastmod>2020-05-20T13:53:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16072-progeria-studio-italiano-approfondisce-i-meccanismi-cellulari-alla-base-della-patologia]]></loc><lastmod>2020-05-17T17:42:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16047-malattie-rare-fondazione-telethon-apre-tre-bandi-di-ricerca]]></loc><lastmod>2020-05-12T08:48:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15984-covid-19-e-trapianto-l-immunosoppressione-non-sembra-accrescere-il-rischio-di-contagio-virale]]></loc><lastmod>2020-04-20T22:15:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15887-covid-19-citta-della-speranza-finanzia-uno-studio-immunologico-unico-in-veneto]]></loc><lastmod>2020-03-31T18:52:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15875-covid-19-un-progetto-di-studio-da-toscana-life-sciences-e-inmi-spallanzani]]></loc><lastmod>2020-03-30T22:18:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15810-coronavirus-il-mondo-si-mobilita-per-lo-sviluppo-di-un-vaccino]]></loc><lastmod>2020-03-24T06:46:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15771-covid-19-nuovo-studio-sull-incubazione-del-sars-cov-2]]></loc><lastmod>2020-03-18T17:53:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15724-liberta-di-ricerca-scientifica-l-italia-e-23esima-al-mondo]]></loc><lastmod>2020-03-03T17:41:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15693-malattie-rare-la-figura-dell-internista-un-punto-di-riferimento-per-i-pazienti]]></loc><lastmod>2020-02-24T21:44:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15680-bronchiectasie-un-problema-piu-diffuso-e-sottostimato-di-quanto-si-pensi]]></loc><lastmod>2025-11-21T18:19:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15666-sindrome-nefrosica-con-il-reverse-phenotyping-e-possibile-una-diagnosi-piu-accurata]]></loc><lastmod>2020-02-14T17:07:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15656-acalasia-esofagea-studio-italiano-approfondisce-le-basi-genetiche-della-patologia]]></loc><lastmod>2020-02-12T18:28:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15608-ricerca-scientifica-individuato-un-inedito-codice-tridimensionale-del-dna]]></loc><lastmod>2020-01-28T21:23:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15565-tumore-al-polmone-individuato-un-possibile-bersaglio-per-nuovi-approcci-terapeutici]]></loc><lastmod>2020-01-12T15:08:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15514-malattie-rare-la-proposta-di-telethon-un-unica-regia-per-coordinare-la-ricerca]]></loc><lastmod>2019-12-14T20:30:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15508-malattie-rare-al-via-il-progetto-pilota-seed-grant-di-fondazione-telethon]]></loc><lastmod>2019-12-14T16:19:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15493-ricerca-biomedica-da-equiter-e-telethon-un-investimento-di-16-milioni-di-euro]]></loc><lastmod>2019-12-09T11:06:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15467-sindrome-di-sjoegren-uno-studio-italiano-rivela-che-esistono-due-tipologie-di-pazienti]]></loc><lastmod>2019-12-02T10:36:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15456-progeria-testate-molecole-antisenso-per-un-potenziale-approccio-contro-l-invecchiamento-precoce]]></loc><lastmod>2019-11-26T18:11:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15438-paraparesi-spastica-ereditaria-aivips-onlus-lancia-due-bandi-di-ricerca]]></loc><lastmod>2019-11-24T17:32:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15378-displasia-immuno-ossea-di-schimke-realizzato-un-nuovo-modello-cellulare-per-la-ricerca]]></loc><lastmod>2019-11-05T18:50:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15373-malattie-rare-fondazione-telethon-avvia-il-progetto-seed-grant]]></loc><lastmod>2020-09-14T09:16:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15375-malattie-rare-con-l-intelligenza-artificiale-la-diagnosi-e-piu-rapida]]></loc><lastmod>2019-11-04T22:34:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15366-sindrome-di-leigh-aperto-il-primo-bando-del-leigh-syndrome-roadmap-project]]></loc><lastmod>2019-11-03T17:54:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15347-distrofia-miotonica-di-tipo-1-al-via-nuovo-studio-internazionale]]></loc><lastmod>2019-10-27T22:58:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15323-tumori-l-analisi-del-dna-helixafe-si-dimostra-utile-nella-prevenzione-precoce]]></loc><lastmod>2019-10-17T15:12:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15204-disabilita-intellettive-identificato-un-meccanismo-molecolare-alla-loro-origine]]></loc><lastmod>2019-09-19T12:35:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15202-tumore-al-polmone-per-i-fumatori-il-rischio-di-malattia-non-e-uguale-per-tutti]]></loc><lastmod>2019-09-18T19:54:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15195-burnside-butler-la-malattia-cambia-se-viene-dal-padre-o-dalla-madre]]></loc><lastmod>2019-09-17T13:36:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15187-malattie-rare-una-proteina-malfunzionante-alla-base-dell-invecchiamento-precoce]]></loc><lastmod>2019-09-15T15:01:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15181-leucodistrofia-adld-speranze-da-uno-studio-italiano-sulla-tecnica-rnai]]></loc><lastmod>2019-09-11T21:07:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15106-tumori-identificato-un-nuovo-bersaglio-terapeutico-nella-proteina-erap1]]></loc><lastmod>2019-08-07T21:20:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15081-adenocarcinoma-polmonare-allo-studio-nuove-cure-personalizzate]]></loc><lastmod>2021-11-02T15:43:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/15075-malattie-neuromuscolari-da-telethon-e-uildm-3-milioni-500mila-euro-per-la-ricerca]]></loc><lastmod>2019-07-30T13:46:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14967-malattie-scheletriche-rare-necessario-valutare-l-efficacia-dei-nuovi-farmaci]]></loc><lastmod>2019-07-01T21:33:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14880-sindromi-malformative-congenite-nuove-mutazioni-scoperte-grazie-al-sequenziamento-di-ultima-generazione]]></loc><lastmod>2019-06-07T11:03:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14769-carcinoma-polmonare-non-a-piccole-cellule-la-biopsia-liquida-per-un-migliore-trattamento]]></loc><lastmod>2021-11-02T15:10:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14755-tumori-individuata-una-proteina-che-protegge-i-processi-di-replicazione-del-dna]]></loc><lastmod>2019-04-23T16:43:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14756-obesita-scoperto-il-ruolo-di-due-enzimi-che-regolano-il-metabolismo-dell-organismo-in-risposta-all-ambiente]]></loc><lastmod>2019-04-23T17:03:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14683-malattie-rare-senza-nome-quattro-ospedali-del-centro-sud-insieme-per-ricerca-e-diagnosi]]></loc><lastmod>2019-04-19T13:02:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14625-cardiochirurgia-stessa-sicurezza-per-anestesia-volatile-o-intravenosa]]></loc><lastmod>2019-03-22T18:36:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14577-sindrome-di-down-nei-giovani-la-muscolatura-invecchia-piu-velocemente]]></loc><lastmod>2019-03-14T22:34:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14539-malattie-bollose-autoimmuni-nuove-speranze-grazie-al-biologico]]></loc><lastmod>2019-03-05T22:21:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14464-malattia-di-addison-il-ruolo-degli-anticorpi-nel-rischio-di-sviluppare-la-patologia]]></loc><lastmod>2019-02-18T10:56:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14435-xlpdr-x-linked-reticulate-pigmentary-disorder]]></loc><lastmod>2019-02-06T22:15:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14436-non-e-fibrosi-cistica-potrebbe-essere-xlpdr]]></loc><lastmod>2019-02-07T18:26:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14416-malattie-rare-sono-7-gli-studi-che-saranno-finanziati-da-aifa]]></loc><lastmod>2019-02-04T20:56:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14383-telethon-assegnato-al-presidente-naldini-il-premio-louis-jeantet-per-la-medicina-traslazionale]]></loc><lastmod>2019-02-18T16:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14384-innovazione-nelle-life-science-al-via-amgen-scholars-per-ispirare-gli-scienziati-di-domani]]></loc><lastmod>2019-01-25T09:29:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14366-descritta-la-sindrome-perching-ha-alcuni-sintomi-in-comune-con-altre-malattie-rare]]></loc><lastmod>2019-01-15T21:48:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14302-contrastare-il-cancro-con-la-teoria-dei-giochi]]></loc><lastmod>2018-12-19T20:44:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14272-atassia-scoperto-il-difetto-cellulare-alla-base-di-una-rara-forma-ereditaria]]></loc><lastmod>2018-12-12T21:10:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14261-sindrome-di-brugada-individuata-la-base-del-rischio-di-aritmie-gravi-e-morte-improvvisa]]></loc><lastmod>2018-12-10T18:11:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14225-crolla-un-dogma-della-genetica-umana-il-dna-mitocondriale-puo-essere-ereditato-anche-dal-padre]]></loc><lastmod>2018-11-30T17:53:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14156-editing-genomico-e-immunoterapia-la-nuova-frontiera-nella-lotta-ai-tumori]]></loc><lastmod>2018-11-14T21:54:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14034-sindrome-di-helsmoortel-van-der-aa-un-nuovo-disturbo-del-neurosviluppo]]></loc><lastmod>2018-10-14T17:04:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/14018-scoperta-una-rara-malattia-genetica-del-neurosviluppo-la-sindrome-fheig]]></loc><lastmod>2018-10-09T17:07:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13878-displasia-ectodermica-ipoidrotica-una-terapia-prenatale-per-prevenire-la-malattia]]></loc><lastmod>2018-09-04T07:47:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13794-tumore-del-polmone-uno-studio-rivela-i-due-volti-della-proteina-hmena]]></loc><lastmod>2018-07-30T16:22:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13767-ipermemoria-autobiografica-uno-studio-italiano-ne-indaga-per-la-prima-volta-i-meccanismi]]></loc><lastmod>2018-07-18T10:33:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13757-distrofia-dei-cingoli-2d-test-preclinici-su-farmaci-ideati-per-la-fibrosi-cistica]]></loc><lastmod>2018-07-16T10:23:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13703-malattia-di-chagas-il-rischio-associato-e-di-strongiloidiasi]]></loc><lastmod>2018-06-25T17:38:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13631-tmem199-cdg-nuove-informazioni-sulla-rarissima-malattia-genetica-epatica]]></loc><lastmod>2018-06-07T09:59:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13595-medicina-le-potenzialita-dell-oro-in-ambito-diagnostico-e-terapeutico]]></loc><lastmod>2018-05-26T15:38:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13547-tumore-al-fegato-il-microbiota-intestinale-predice-chi-si-ammalera-tra-le-persone-a-rischio]]></loc><lastmod>2018-05-11T15:30:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13524-ricerca-scoperta-da-un-team-italiano-una-nuova-malattia-che-provoca-una-grave-encefalopatia]]></loc><lastmod>2018-05-05T10:55:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13519-iperplasia-surrenale-congenita-le-bimbe-possono-essere-scambiate-per-maschi-nella-prima-infanzia]]></loc><lastmod>2018-05-04T15:51:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13513-malattie-rare-l-impegno-di-roche-si-rafforza-fibrosi-cistica-fibrosi-polmonare-idiopatica-emofilia-ma-non-solo]]></loc><lastmod>2018-05-05T09:31:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13505-sindrome-di-marinesco-sjoegren-da-studio-italiano-la-speranza-di-una-potenziale-terapia]]></loc><lastmod>2018-05-02T11:27:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13497-tumori-identificato-un-nuovo-ruolo-della-proteina-aurora-b-cruciale-per-la-loro-formazione]]></loc><lastmod>2018-04-28T14:30:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13460-danno-renale-acuto-uno-studio-italiano-scopre-un-nuovo-meccanismo-di-risposta]]></loc><lastmod>2018-04-19T15:32:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13473-sindrome-di-pans-pandas-uno-studio-italiano-ne-certifica-un-legame-con-i-batteri-intestinali]]></loc><lastmod>2022-08-11T17:52:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13479-malattie-rare-l-importanza-dei-farmaci-innovativi-per-amicus-therapeutics]]></loc><lastmod>2018-04-23T15:42:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13478-malattie-rare-alnylam-e-il-concetto-di-innovazione-inclusiva]]></loc><lastmod>2018-04-23T15:31:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13477-malattie-rare-e-ricerca-l-impegno-di-sanofi-genzyme]]></loc><lastmod>2018-04-23T15:14:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13399-sindrome-di-usher-dalla-terapia-genica-speranza-contro-la-sordita]]></loc><lastmod>2018-03-30T11:22:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13398-staminali-neuronali-il-recettore-tlr4-ne-induce-la-proliferazione]]></loc><lastmod>2018-03-30T11:13:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13372-malattie-rare-la-ricerca-punta-sulla-terapia-genica-ma-nel-presente]]></loc><lastmod>2019-06-12T10:16:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13342-autismo-uno-studio-sulla-pupilla-per-tentare-di-predire-il-disturbo]]></loc><lastmod>2018-03-15T11:16:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13322-sindrome-di-swyer-i-pazienti-hanno-un-cariotipo-maschile-ma-organi-genitali-femminili]]></loc><lastmod>2018-03-08T04:13:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13291-sindrome-di-gottron-identificato-gene-alla-base-della-malattia]]></loc><lastmod>2018-02-28T12:29:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13250-sindrome-di-phelan-mcdermid-in-gioco-anche-complesse-anomalie-cromosomiche]]></loc><lastmod>2018-02-19T22:21:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13215-trapianto-di-fegato-arriva-metroticket-il-primo-algoritmo-che-ne-prevede-il-risultato]]></loc><lastmod>2018-02-11T22:46:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13165-clonazione-le-due-scimmiette-copia-create-in-cina-risvegliano-dubbi-e-paure]]></loc><lastmod>2018-01-30T18:49:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13085-distrofie-e-atrofie-muscolari-la-terapia-genica-avanza-a-grandi-passi]]></loc><lastmod>2018-01-09T01:40:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13059-mutazioni-del-gene-fa2h-in-corso-tre-progetti-per-conoscerle-meglio]]></loc><lastmod>2017-12-22T12:47:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/13031-tubercolosi-da-studio-iss-un-test-per-diagnosticarla-dalle-urine]]></loc><lastmod>2017-12-16T14:41:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12988-sindrome-4h-la-ricerca-continua-oltreoceano]]></loc><lastmod>2017-12-10T21:09:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12981-cancro-molecole-antisenso-per-colpire-con-precisione-le-cellule-tumorali]]></loc><lastmod>2017-12-02T15:35:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12930-gli-esperti-del-bambino-gesu-scoprono-la-causa-di-due-malattie-rare]]></loc><lastmod>2019-04-19T13:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12848-neuropatie-autoimmuni-croniche-efficacia-simile-per-immunoglobuline-endovena-o-sottocute]]></loc><lastmod>2017-10-31T11:46:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12812-disturbi-dello-sviluppo-sessuale-bassa-qualita-di-vita-per-i-pazienti-soprattutto-per-le-femmine]]></loc><lastmod>2017-10-23T09:58:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12723-ricerca-uno-studio-italiano-sintetizza-molecole-anticancro-dal-luppolo]]></loc><lastmod>2017-10-03T10:27:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12715-biobanche-enorme-potenziale-per-la-ricerca-ma-troppo-scarsi-i-fondi]]></loc><lastmod>2017-09-29T17:57:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12687-tumore-della-prostata-per-un-paziente-su-tre-e-possibile-la-sorveglianza-attiva]]></loc><lastmod>2017-09-24T20:48:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12667-tumori-cure-personalizzate-grazie-alla-profilazione-genomica]]></loc><lastmod>2017-09-20T22:32:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12662-tumori-a-ovaio-e-mammella-svelata-la-funzione-dei-geni-brca1-e-brca2]]></loc><lastmod>2017-09-19T09:49:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12656-anoressia-nervosa-confermata-l-esistenza-di-una-predisposizione-genetica]]></loc><lastmod>2017-09-16T16:09:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12598-malattie-ematologiche-la-terapia-genica-potrebbe-essere-il-futuro]]></loc><lastmod>2018-09-12T17:44:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12588-sindrome-delle-unghie-gialle-molte-le-domande-ancora-aperte]]></loc><lastmod>2017-08-21T14:45:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12516-il-dna-in-3d-con-quali-algoritmi-studieremo-l-architettura-del-genoma]]></loc><lastmod>2017-08-21T14:14:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12511-genova-apre-il-primo-centro-clinico-per-le-malattie-senza-diagnosi]]></loc><lastmod>2019-04-19T13:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12470-abuso-di-cocaina-possibile-terapia-con-modulatori-dello-stress-ossidativo]]></loc><lastmod>2017-07-07T08:15:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12387-fegato-grasso-piu-a-rischio-chi-nasce-con-basso-peso]]></loc><lastmod>2017-06-13T08:37:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12324-sordita-genetica-la-terapia-genica-muove-i-primi-passi]]></loc><lastmod>2017-05-28T16:55:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12303-tumori-scoperto-il-modo-in-cui-la-cellula-rottama-un-recettore-chiave]]></loc><lastmod>2017-05-21T16:24:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12279-uno-studio-sull-rna-dei-sardi-per-capire-meglio-il-funzionamento-del-genoma-umano]]></loc><lastmod>2017-05-15T13:38:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12274-sindrome-di-digeorge-individuata-l-origine-genetica-della-patologia-renale-associata]]></loc><lastmod>2017-05-15T09:37:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12234-tumori-solidi-e-italiano-il-brevetto-del-primo-programma-di-monitoraggio-delle-mutazioni-somatiche-correlate]]></loc><lastmod>2017-04-30T18:01:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12195-malattie-del-motoneurone-identificato-meccanismo-di-rimozione-delle-proteine-corrotte-che-ne-sono-responsabili]]></loc><lastmod>2017-04-22T10:19:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12171-la-sindrome-dell-armadillo-la-malattia-rara-che-non-esiste-ma-che-spiega-le-patologie-surrenali]]></loc><lastmod>2017-04-12T13:58:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12094-cancro-al-seno-individuato-un-farmaco-contro-le-cellule-staminali-tumorali]]></loc><lastmod>2017-03-20T11:00:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12062-invecchiamento-cellulare-una-molecola-antisenso-per-bloccarlo]]></loc><lastmod>2019-11-25T14:20:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12044-identificati-quattordici-nuovi-disturbi-dello-sviluppo-nei-bambini]]></loc><lastmod>2019-04-19T13:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12013-trisomia-21-da-fondazione-jerome-lejeune-un-bando-di-ricerca]]></loc><lastmod>2017-03-03T09:17:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11993-atassia-unife-aisa-e-fondazione-a-c-a-re-f-insieme-per-la-ricerca]]></loc><lastmod>2017-02-26T16:30:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/12001-malattie-rare-dal-silenziamento-dell-rna-rnai-nuove-prospettive-per-amiloidosi-porfiria-ed-emofilia]]></loc><lastmod>2017-07-11T17:30:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11954-tumori-sviluppata-una-biopsia-liquida-non-invasiva-per-la-diagnosi-e-il-monitoraggio-delle-terapie-oncologiche]]></loc><lastmod>2017-02-19T19:23:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11917-malattie-rare-e-social-media-i-questionari-online-possono-essere-utili-ma-hanno-delle-limitazioni]]></loc><lastmod>2017-02-12T19:42:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11890-distrofia-dei-cingoli-lgmd-studio-italiano-ipotizza-nuovo-approccio-terapeutico]]></loc><lastmod>2017-02-04T17:00:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11886-tumori-uno-studio-italiano-svela-i-movimenti-delle-metastasi]]></loc><lastmod>2017-02-04T14:44:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11849-trapianti-il-fegato-invecchia-meno-se-posto-in-microambiente-piu-giovane]]></loc><lastmod>2017-01-28T11:29:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11832-ebola-uno-studio-osserva-la-replicazione-del-virus-nelle-vie-respiratorie]]></loc><lastmod>2017-01-23T11:32:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11827-atassia-con-aprassia-oculomotoria-tipo-xrcc1-su-nature-per-la-prima-volta-descritta-questa-nuova-malattia]]></loc><lastmod>2017-01-22T19:05:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11781-superbatteri-una-nuova-possibile-arma-arriva-dal-grafene]]></loc><lastmod>2017-01-09T15:33:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11739-paleopatografia-la-disciplina-che-studia-la-storia-delle-malattie-attraverso-le-biografie-dei-grandi]]></loc><lastmod>2016-12-17T15:18:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11732-sindrome-di-lesch-nyhan-nuove-speranze-da-una-proteina-fossile-contenuta-nel-dna-degli-ominoidi]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11681-parker-institute-for-cancer-immunotherapy-e-cancer-research-institute-lanciano-un-alleanza-sui-neoantigeni-del-cancro]]></loc><lastmod>2016-12-03T11:08:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11618-malattia-di-steinert-la-meta-dei-pazienti-non-e-consapevole-degli-effetti-della-patologia]]></loc><lastmod>2016-11-19T16:20:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11619-condividere-dati-e-campioni-biologici-i-malati-rari-dicono-si-al-progetto-genoma]]></loc><lastmod>2016-11-19T16:37:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11589-disfunzione-erettile-onde-d-urto-a-bassa-intensita-potrebbero-essere-un-alternativa-ai-farmaci]]></loc><lastmod>2016-11-08T17:07:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11548-malattie-neurologiche-presto-anche-in-italia-il-piu-completo-studio-epidemiologico-osservazionale-mondiale]]></loc><lastmod>2016-10-29T17:57:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11529-malattie-della-retina-positivo-il-primo-impianto-di-stimolatore-corticale-visivo-wireless]]></loc><lastmod>2016-10-26T14:54:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11525-miopatia-miotubolare-un-bando-per-i-progetti-di-ricerca-su-nuove-terapie]]></loc><lastmod>2016-10-25T14:39:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11520-malattie-genetiche-nasce-nuova-tecnologia-per-la-condivisione-online-di-dati-di-genomica]]></loc><lastmod>2016-10-24T14:28:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11505-ricerca-indipendente-pubblicato-il-bando-aifa-2016]]></loc><lastmod>2016-10-21T09:49:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11491-malattie-neurologiche-tutte-le-novita-terapeutiche-presentate-dalla-sin]]></loc><lastmod>2016-10-19T15:09:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11489-malattie-rare-a-firenze-si-parla-di-terapia-genica-e-cellulare]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11487-malattie-rare-la-terapia-genica-e-realta-grazie-alla-ricerca-made-in-italy]]></loc><lastmod>2019-02-18T16:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11468-il-sequenziamento-dell-esoma-favorisce-la-diagnosi-solo-in-un-caso-su-due]]></loc><lastmod>2016-10-16T22:02:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11422-una-task-force-multidisciplinare-per-i-disturbi-genetici-l-esperienza-svizzera]]></loc><lastmod>2016-10-08T10:43:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11414-sequenziamento-di-nuova-generazione-la-fda-pubblica-due-linee-guida-per-i-test]]></loc><lastmod>2016-10-08T10:41:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11415-tutto-quello-che-avreste-voluto-sapere-sul-bambino-con-tre-dna]]></loc><lastmod>2016-10-07T17:49:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11374-dall-epigenetica-nuovi-interruttori-molecolari-per-mettere-a-tacere-i-geni]]></loc><lastmod>2019-02-18T16:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11365-ittiosi-ricercatori-usa-prospettano-nuova-possibilita-di-cura]]></loc><lastmod>2016-10-02T09:04:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11350-genetica-deficit-cognitivi-e-motori-in-eta-infantile-a-causa-del-gene-gpt2]]></loc><lastmod>2016-10-01T10:41:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11345-bambino-gesu-identificate-due-nuove-sindromi-neurodegenerative]]></loc><lastmod>2016-10-01T09:25:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11341-abrahim-il-primo-bambino-con-il-dna-di-tre-genitori]]></loc><lastmod>2016-09-29T07:29:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11314-ipertensione-puo-essere-una-questione-genetica]]></loc><lastmod>2016-09-27T14:37:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11275-miosite-da-corpi-inclusi-nessuna-congferma-su-efficacia-della-terapia-con-arimoclomol]]></loc><lastmod>2016-09-24T10:56:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11271-mucopolisaccaridosi-la-terapia-enzimatica-riduce-l-ipertrofia-cardiaca]]></loc><lastmod>2016-09-17T16:17:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11277-ricerca-clinica-il-futuro-presentato-un-position-paper-sul-trend-europeo-e-italiano]]></loc><lastmod>2016-09-19T15:19:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11225-leucoencefalopatia-lcc-la-causa-della-malattia-e-nella-mutazione-del-singolo-gene-snord118]]></loc><lastmod>2016-09-10T15:23:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11220-sindrome-di-cornelia-de-lange-il-protocollo-del-san-gerardo-di-monza-per-l-anestesia-generale]]></loc><lastmod>2016-09-10T11:27:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11215-neoplasie-mieloproliferative-in-fase-fibrotica-il-trattamento-con-deferasirox-e-fattibile-ed-efficace]]></loc><lastmod>2016-09-10T10:37:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11233-un-italiano-tra-i-vincitori-del-grant-for-growth-innovation-2016-di-merck]]></loc><lastmod>2016-09-12T13:09:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11207-rene-policistico-mappate-le-mutazioni-genetiche-responsabili]]></loc><lastmod>2016-09-10T09:07:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11190-cardiomiopatie-il-vad-allunga-la-sopravvivenza-dei-piccoli-pazienti-in-attesa-di-trapianto]]></loc><lastmod>2016-09-02T14:54:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11192-disabilita-intellettiva-e-strabismo-legati-al-gene-adat3-uno-studio-saudita-delinea-il-fenotipo]]></loc><lastmod>2016-09-02T15:14:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11188-disturbi-neurologici-le-immunoglobuline-per-via-endovenosa-sono-sicure-anche-nei-pazienti-anziani]]></loc><lastmod>2016-09-02T10:11:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11183-tumore-al-seno-piu-a-rischio-chi-fa-uso-di-terapia-ormonale-sostitutiva-combinata]]></loc><lastmod>2016-09-02T15:18:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11184-sindrome-di-cockayne-il-fattore-prognostico-piu-importante-e-la-presenza-di-cataratta-precoce]]></loc><lastmod>2019-10-31T14:22:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11182-sindrome-di-shwachman-diamond-bodian-le-difficolta-nella-diagnosi-differenziale]]></loc><lastmod>2016-09-01T17:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11161-neutropenia-febbrile-nelle-neoplasie-ematologiche-nessuna-differenza-significativa-nell-efficacia-di-micafungin-e-voriconazolo]]></loc><lastmod>2016-08-30T14:21:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11149-deficit-dell-ormone-della-crescita-studio-clinico-avanzato-su-terapia-con-transcon-growth-hormone]]></loc><lastmod>2016-08-26T13:25:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11124-sindrome-arc-sistema-immunitario-dei-pazienti-forse-compromesso-da-difetto-genetico]]></loc><lastmod>2016-08-17T19:32:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11130-tumori-al-bambino-gesu-scoperto-interruttore-che-disattiva-le-cellule-killer]]></loc><lastmod>2016-08-23T08:01:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11120-usa-scoperto-fattore-genetico-correlato-a-rara-neuropatia-pediatrica]]></loc><lastmod>2016-08-22T07:32:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11100-malattia-moyamoya-la-gravita-della-patologia-e-l-impatto-sulla-qualita-di-vita]]></loc><lastmod>2016-08-05T13:38:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11097-sindrome-di-down-nei-bambini-la-rivastigmina-e-sicura-e-ben-tollerata-ma-non-migliora-gli-aspetti-cognitivi-e-del-linguaggio]]></loc><lastmod>2016-08-05T12:18:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11089-sindrome-di-eisenmenger-i-tassi-di-mortalita-a-10-anni-di-follow-up-si-avvicinano-al-60-70]]></loc><lastmod>2016-08-04T15:09:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11060-sindrome-di-hurler-la-terapia-con-staminali-non-basta-ad-arginare-i-danni-muscolo-scheletrici]]></loc><lastmod>2016-08-01T18:08:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11068-telethon-scoperti-i-meccanismi-d-insorgenza-della-sindrome-di-lowe]]></loc><lastmod>2022-05-13T16:56:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11049-atassia-telangectasia-molti-pazienti-non-rispondono-agli-approcci-terapeutici-disponibili]]></loc><lastmod>2016-07-29T10:19:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11017-polidramnios-e-sindrome-di-bartter-prenatale-a-causarli-e-una-mutazione-nel-gene-maged2]]></loc><lastmod>2016-07-22T13:30:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11000-ipercinesia-uno-studio-italiano-scopre-la-causa-comune-in-malattie-diverse]]></loc><lastmod>2016-07-19T14:54:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/11007-telethon-un-modello-di-ricerca-di-eccellenza-da-replicare]]></loc><lastmod>2019-02-18T16:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10991-emocromatosi-ereditaria-il-test-genetico-e-il-nuovo-standard-diagnostico]]></loc><lastmod>2016-07-15T13:20:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10986-l-odissea-diagnostica-nei-gravi-disturbi-dello-sviluppo-neurologico-il-sequenziamento-dell-intero-esoma-come-test-di-prima-linea]]></loc><lastmod>2016-07-15T12:41:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10984-malattie-neurologiche-la-sin-promuove-la-ricerca-con-7-premi]]></loc><lastmod>2016-07-15T12:34:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10948-infarto-del-miocardio-controllando-un-unica-proteina-si-potrebbero-ridurre-i-danni-al-cuore]]></loc><lastmod>2016-07-08T20:49:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10947-disturbo-bipolare-forse-legato-a-rare-mutazioni-genetiche]]></loc><lastmod>2016-07-08T20:39:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10946-c-e-vita-dopo-la-morte-centinaia-di-geni-sopravvivono-per-giorni]]></loc><lastmod>2016-07-14T07:50:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10891-malattie-da-accumulo-lisosomiale-lanciata-un-indagine-nazionale-sui-servizi-assistenziali]]></loc><lastmod>2016-06-30T15:01:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10816-consulenza-genetica-in-europa-troppo-spesso-fornita-da-chi-non-ha-le-competenze-necessarie]]></loc><lastmod>2016-06-17T12:09:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10797-ricerca-indipendente-roche-finanziera-8-progetti-nell-ambito-della-medicina-di-precisione]]></loc><lastmod>2016-06-16T09:47:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10782-ricerca-danese-studia-o-fondo-l-azione-terapeutica-dell-anticorpo-eculizumab]]></loc><lastmod>2016-06-12T17:35:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10611-distrofia-muscolare-facio-scapolo-omerale-nuove-speranze-dalla-risonanza-magnetica]]></loc><lastmod>2016-05-16T15:43:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10536-sindrome-da-distonia-mioclonica-testata-con-successo-la-terapia-con-zonisamide]]></loc><lastmod>2016-05-06T09:48:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10519-steatosi-epatica-non-alcolica-sviluppato-un-punteggio-per-calcolare-il-rischio-di-decesso]]></loc><lastmod>2016-05-03T12:48:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10487-steatosi-epatica-non-alcolica-la-carenza-di-vitamina-d-peggiorerebbe-la-patologia]]></loc><lastmod>2016-04-29T07:58:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10478-terapie-antivirali-il-futuro-nuovo-farmaco-efficace-contro-tutte-le-infezioni]]></loc><lastmod>2016-04-28T14:01:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10475-esofagite-eosinofila-studiosi-usa-svelano-l-origine-proteica-dei-danni-all-esofago]]></loc><lastmod>2021-11-12T17:21:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10447-merck-e-h-farm-insieme-in-un-progetto-di-open-innovation-in-ambito-healthcare]]></loc><lastmod>2016-04-26T10:31:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10453-terapia-genica-al-s-raffaele-si-lavora-per-la-nefrite-lupica]]></loc><lastmod>2016-04-26T14:21:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10448-un-nuovo-progetto-dedicato-alla-genomica-per-astrazeneca]]></loc><lastmod>2016-04-26T13:08:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10436-fondazione-regionale-per-la-ricerca-biomedica-i-vincitori-del-bando-2015]]></loc><lastmod>2016-04-22T15:36:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10361-malattie-rare-dall-universita-della-basilicata-una-borsa-di-studio-post-lauream]]></loc><lastmod>2016-04-12T13:17:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10331-scienziati-americani-individuano-la-molecola-che-attiva-gli-spermatozoi]]></loc><lastmod>2016-04-09T07:33:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10350-terapia-genica-telethon-studia-l-applicazione-per-le-leucodistrofie]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10316-telethon-al-via-un-progetto-per-dare-un-nome-alle-malattie-rare-senza-diagnosi]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10298-sindrome-xlpdr-identificato-il-gene-responsabile-della-malattia]]></loc><lastmod>2016-04-04T15:24:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10265-dalla-fda-250-000-dollari-per-studiare-la-storia-naturale-di-venti-malattie-rare]]></loc><lastmod>2016-03-25T11:53:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10266-malattie-rare-e-farmaci-orfani-una-storia-che-inizia-500-anni-fa]]></loc><lastmod>2016-03-25T12:10:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10263-interferoni-le-proteine-che-ci-proteggono-dalle-infezioni]]></loc><lastmod>2016-03-25T11:08:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10249-ricerca-scientifica-no-agli-studi-sugli-embrioni-soprannumerari]]></loc><lastmod>2016-03-23T16:08:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10223-terapia-del-dolore-nuovo-farmaco-potrebbe-nascere-dal-veleno-di-tarantola]]></loc><lastmod>2016-03-18T14:21:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10222-sindrome-di-maroteux-lamy-nuove-conferme-su-terapia-enzimatica-sostitutiva]]></loc><lastmod>2016-03-18T14:16:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10199-diagnosi-prenatale-applicata-per-la-prima-volta-la-celocentesi-per-la-sindrome-di-cockayne]]></loc><lastmod>2019-10-31T14:58:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10175-sindrome-di-vici-quando-la-cellula-attacca-se-stessa]]></loc><lastmod>2016-03-11T12:06:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10095-malattie-rare-nasce-rete-internazionale-usa-italia]]></loc><lastmod>2019-04-19T13:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10051-coinvolgere-le-organizzazioni-di-pazienti-nella-ricerca-sulle-malattie-rare-l-esempio-australiano]]></loc><lastmod>2016-02-26T13:47:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10050-sindrome-di-andersen-tawil-anomalie-bioelettriche-potrebbero-causare-le-malformazioni-facciali-associate]]></loc><lastmod>2016-02-26T13:47:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10063-malattie-rare-del-metabolismo-osseo-disponibile-online-l-atlante-medico-delle-patologie]]></loc><lastmod>2016-02-29T14:57:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10061-malattie-rare-del-metabolismo-osseo-nasce-il-primo-laboratorio-di-ricerca-italiano]]></loc><lastmod>2016-02-29T07:48:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/10070-sindrome-eec-nuova-speranza-dalla-terapia-genetica-per-la-malattia-rara]]></loc><lastmod>2016-02-29T15:51:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9994-scoperta-una-rara-mutazione-nel-gene-opa1-associata-ad-una-fatale-malattia-mitocondriale]]></loc><lastmod>2016-02-19T11:16:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9985-malattie-rare-non-diagnosticate-da-aprile-pediatri-e-famiglie-potranno-richiedere-accesso-al-programma-undiagnosed-disease]]></loc><lastmod>2019-04-19T13:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9972-sindrome-di-smith-magenis-le-strategie-di-trattamento-per-i-disturbi-comportamentali]]></loc><lastmod>2016-02-15T14:45:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9918-sindrome-di-pfeiffer-quando-le-ossa-del-cranio-si-fondono-prematuramente]]></loc><lastmod>2016-02-05T14:37:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9930-scoperto-un-raro-tipo-di-intolleranza-al-jogging]]></loc><lastmod>2016-02-10T09:52:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9928-tumori-un-test-del-sangue-universale-per-scoprirli-in-tempo]]></loc><lastmod>2016-02-09T11:24:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9924-autismo-e-disturbi-dell-umore-che-sia-colpa-della-flora-intestinale]]></loc><lastmod>2016-02-08T15:52:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9909-deficit-del-fattore-vii-nuove-speranze-da-esperimenti-preclinici-sulla-terapia-genica]]></loc><lastmod>2016-02-05T13:29:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9880-ricerca-telethon-scoperto-il-gene-custode-del-gps-cerebrale]]></loc><lastmod>2019-02-18T16:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9867-sindrome-di-alstroem-il-modello-di-assistenza-sanitaria-adottato-nel-regno-unito]]></loc><lastmod>2016-02-01T11:12:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9842-esofago-di-barret-nessun-rischio-dal-caffe-o-the]]></loc><lastmod>2016-01-29T12:19:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9835-dieta-squilibrata-troppo-zucchero-inibisce-la-riproduzione-di-cellule-staminali-nel-cervello]]></loc><lastmod>2016-01-29T08:43:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9822-malattie-rare-le-diagnosi-miracolose-dalla-banca-del-genoma-inglese-dalla-tecnologia-al-riposizionamento-dei-farmaci]]></loc><lastmod>2019-04-19T13:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9781-database-per-la-ricerca-quattro-nuove-risorse-ricevono-la-raccomandazione-irdirc]]></loc><lastmod>2016-01-20T15:12:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9780-malattie-del-sangue-uno-studio-indaga-la-correlazione-con-le-malattie-ossee]]></loc><lastmod>2016-01-20T15:03:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9758-sindrome-3mc1-la-ricerca-continua]]></loc><lastmod>2016-01-15T13:29:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9757-malattie-neuromuscolari-l-efficacia-del-sequenziamento-di-nuova-generazione]]></loc><lastmod>2016-05-06T16:47:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9756-sindrome-da-anticorpi-anti-fosfolipidi-i-risultati-del-progetto-progetto-euro-phospolipid]]></loc><lastmod>2016-01-19T08:25:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9746-sindrome-di-duncan-scoperto-un-nuovo-bersaglio-molecolare-per-il-suo-trattamento]]></loc><lastmod>2016-01-15T08:25:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9716-dalle-malattie-rare-a-quelle-comuni-la-sindrome-di-laron-e-il-legame-con-la-riduzione-di-cancro-e-diabete]]></loc><lastmod>2016-01-13T09:15:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9715-malattia-emolitica-del-feto-e-del-neonato-i-progressi-dell-era-molecolare]]></loc><lastmod>2016-01-08T12:05:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9714-la-ricerca-sulle-malattie-rare-fondamentale-anche-per-le-patologie-piu-comuni]]></loc><lastmod>2016-01-13T09:17:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9713-la-lotta-al-cancro-passa-anche-dallo-studio-delle-malattie-rare-il-caso-dell-anemia-di-fanconi]]></loc><lastmod>2016-01-08T11:51:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9687-malattia-di-leigh-il-sequenziamento-dell-esoma-per-una-corretta-terapia-di-supporto]]></loc><lastmod>2018-11-30T17:26:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9708-preeclampsia-un-test-del-sangue-puo-predirla]]></loc><lastmod>2016-01-08T10:12:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9604-carenza-di-fosfomannomutasi-l-efficacia-della-scala-icars-nella-valutazione-delle-alterazioni-del-cervelletto]]></loc><lastmod>2015-12-11T12:21:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9597-leucemie-pubblicato-uno-studio-sul-ruolo-delle-memory-stem-t-cell]]></loc><lastmod>2018-02-21T02:24:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9598-ipermetioninemia-come-valutare-l-evoluzione-della-rara-patologia]]></loc><lastmod>2015-12-11T12:00:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9488-polineuropatia-da-amilioidosi-familiare-transtiretina-correlata-novita-su-trattamento-farmacologico]]></loc><lastmod>2017-09-30T12:47:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9408-crioterapia-sistemica-la-terapia-che-venne-dal-freddo]]></loc><lastmod>2015-11-23T15:55:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9426-acondroplasia-scoperto-meccanismo-responsabile-della-crescita-delle-ossa]]></loc><lastmod>2015-11-24T14:29:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9404-sindrome-di-phelan-mcdermid-sono-circa-600-i-pazienti-nel-mondo]]></loc><lastmod>2015-11-20T11:43:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9418-sindrome-perisilviana-congenita-scoperta-la-causa-dal-team-di-neurologia-del-meyer]]></loc><lastmod>2015-11-23T09:19:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9349-malattie-rare-irdirc-pubblica-lo-stato-di-avanzamento-della-ricerca]]></loc><lastmod>2015-11-13T09:59:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9345-sindrome-ring14-finanziati-due-nuovi-importanti-progetti-di-ricerca]]></loc><lastmod>2015-11-13T08:59:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9302-malattie-rare-autoimmuni-l-azione-dell-enzima-cgas-in-lupus-e-sindrome-aicardi-goutieres]]></loc><lastmod>2015-11-10T17:48:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9185-risonanza-magnetica-con-contrasto-in-alcuni-casi-puo-causare-la-fibrosi-sistemica-nefrognica]]></loc><lastmod>2015-10-20T13:04:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9125-sindrome-di-sjogren-polimorfismo-genetico-aumenta-rischio-di-linfoma]]></loc><lastmod>2015-10-13T14:28:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9145-atassia-cerebellare-nuove-speranze-dal-riluzolo-farmaco-gia-usato-per-la-sla]]></loc><lastmod>2015-10-14T09:17:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9109-progeria-una-rivoluzionaria-scoperta-potrebbe-aprire-la-strada-a-nuovi-trattamenti]]></loc><lastmod>2019-11-25T14:21:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9041-malattie-neuromuscolari-per-la-prima-volta-in-italia-un-alleanza-per-la-ricerca]]></loc><lastmod>2019-02-18T16:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9036-fibrodisplasia-ossificante-progressiva-pubblicata-un-importante-scoperta-di-regeneron]]></loc><lastmod>2015-10-02T14:33:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9014-acalasia-idiopatica-risultati-eccellenti-con-le-cure-palliative-per-oltre-il-90-dei-pazienti]]></loc><lastmod>2015-09-29T10:17:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9011-sindrome-di-kallmann-e-possibile-individuale-in-eta-fetale-se-si-conosce-il-contesto-familiare]]></loc><lastmod>2018-03-26T14:29:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/9009-sarcoidosi-le-nuove-tecnologie-facilitano-la-diagnosi-ma-non-possono-sostituire-la-competenza-del-medico]]></loc><lastmod>2015-09-30T07:07:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8961-meningite-fulminante-conferme-positive-per-il-vaccino-trumenba]]></loc><lastmod>2015-09-22T10:45:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8937-bpco-risultati-deludenti-per-combinazione-fluticasone-furoato-vilanterolo]]></loc><lastmod>2015-09-17T17:23:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8945-neuromielite-ottica-buoni-risultati-per-lo-schema-di-trattamento-fisso-con-rituximab]]></loc><lastmod>2015-09-17T17:22:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8911-quale-qualita-di-vita-nei-pazienti-con-sindrome-locked-in]]></loc><lastmod>2015-09-14T13:21:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8903-sindrome-di-brugada-quando-il-cuore-cede-all-improvviso]]></loc><lastmod>2018-02-07T10:37:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8902-sindrome-di-brugada-nuove-strategie-terapeutiche-per-la-gestione-delle-aritmie-ventricolari]]></loc><lastmod>2015-09-11T10:18:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8867-distrofia-trombocitica-emorragica-scoperte-nuove-varianti-genetiche-della-patologia-ereditaria]]></loc><lastmod>2015-09-04T12:57:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8832-ngly1-il-national-institute-of-health-americano-cerca-pazienti-da-tutto-il-mondo]]></loc><lastmod>2015-08-27T15:37:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8793-pandas-pas-nuovi-studi-disponibili]]></loc><lastmod>2015-08-20T14:52:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8773-sindrome-di-alstroem-la-fibrosi-interstiziale-ventricolare-sinistra-e-associata-alla-disfunzione-miocardica]]></loc><lastmod>2015-08-06T21:56:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8774-sindrome-di-wolfram-didmoad-nato-il-progetto-euro-wabb-per-le-linee-guida-internazionali]]></loc><lastmod>2015-08-06T22:31:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8769-malattia-di-basedow-graves-la-ridistribuzione-della-composizione-corporea-dopo-il-trattamento-con-iodio-radioattivo]]></loc><lastmod>2015-08-06T21:08:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8759-nuove-tecnologie-farmaceutiche-jcr-si-accorda-con-eisai-per-superare-la-barriera-emato-encefalica]]></loc><lastmod>2015-08-06T16:53:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8762-sindrome-di-noonan-studio-brasiliano-identifica-due-nuovi-geni-responsabili-della-malattia]]></loc><lastmod>2015-08-06T18:03:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8746-sindrome-di-hermansky-pudlak-incoraggianti-prospettive-da-uno-studio-sulla-fibrosi-polmonare-associata-alla-patologia]]></loc><lastmod>2015-07-31T13:39:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8744-displasie-di-grebe-hunter-thompson-e-du-pan-un-indagine-genetica]]></loc><lastmod>2015-07-31T13:09:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8633-sindrome-di-usher-rilevata-un-alta-prevalenza-di-mutazioni-cdh23]]></loc><lastmod>2017-05-26T10:06:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8684-malattie-rare-uno-studio-suggerisce-cautela-nell-utilizzo-di-database-per-la-diagnosi]]></loc><lastmod>2015-07-24T08:43:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8683-ricerca-medica-apple-lanciala-piattaforma-researchkit]]></loc><lastmod>2015-07-24T08:40:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8679-regolamento-ue-sulle-sperimentazioni-cliniche-necessario-proteggere-i-partecipanti-alla-ricerca-piu-vulnerabili]]></loc><lastmod>2015-07-24T08:24:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8643-sindrome-di-seckel-uno-studio-fornisce-chiarimenti-sulle-basi-molecolari-della-malattia]]></loc><lastmod>2015-07-20T09:00:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8627-tromboastenia-di-glanzmann-sia-le-piastrine-che-il-fattore-ricombinante-viia-sono-efficaci-per-il-trattamento-delle-emorragie-non-chirurgiche]]></loc><lastmod>2015-07-16T09:56:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8603-ricerca-scientifica-e-sperimentazione-animale-l-italia-si-allinei-con-il-resto-dell-europa]]></loc><lastmod>2015-07-10T10:44:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8577-sequenziamento-del-dna-un-progetto-di-rare-genomics-per-aiutare-i-malati-rari]]></loc><lastmod>2015-07-06T09:50:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8580-malattie-genetiche-rare-un-progetto-di-crowdsourcing-per-accelerare-la-ricerca]]></loc><lastmod>2015-07-06T10:12:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8569-sindrome-da-fatica-cronica-necessario-promuovere-la-ricerca-sulla-malattia]]></loc><lastmod>2015-07-03T12:27:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8563-istituti-di-ricerca-tigem-e-tiget-di-telethon-cosa-sono]]></loc><lastmod>2019-02-18T16:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8531-sindrome-di-aicardi-identificata-una-mutazione-genetica-associata-alla-patologia]]></loc><lastmod>2015-06-29T07:37:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8459-malattie-rare-dello-scheletro-telethon-e-skeleton-insieme-per-combatterle]]></loc><lastmod>2019-02-18T16:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8447-neuromielite-ottica-uno-studio-confronta-outcome-con-azatioprina-micofenolato-mofetile-e-rituximab]]></loc><lastmod>2015-06-15T10:15:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8421-neuromielite-ottica-risultati-incoraggianti-dal-trattamento-a-lungo-termine-con-tocilizumab]]></loc><lastmod>2015-06-11T15:25:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8382-malattie-neuromuscolari-il-comitato-tact-per-lo-sviluppo-di-nuove-terapie]]></loc><lastmod>2015-06-05T09:03:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8345-sindrome-di-adams-oliver-uno-studio-genetico-getta-nuova-luce-sulle-cause-della-malattia]]></loc><lastmod>2015-05-29T09:48:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8342-sclerosi-multipla-record-di-adesioni-al-bando-di-ricerca-di-progressive-ms-alliance]]></loc><lastmod>2015-05-29T08:54:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8320-tumore-alla-prostata-prosegue-con-successo-la-fase-di-arruolamento-dello-studio-pros-it]]></loc><lastmod>2021-02-20T19:06:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8285-rabdomiolisi-anche-le-malattie-genetiche-possono-essere-la-causa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8284-microcefalia-familiare-a-provocarla-sono-le-mutazioni-nel-gene-kif11]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8267-malattia-di-hirschsprung-individuate-due-nuove-mutazioni-causa-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8266-rigetto-acuto-mediato-da-anticorpi-presentati-nuovi-dati-su-eculizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8238-sarcoidosi-dalla-francia-aggiornamenti-sulla-patologia-in-eta-pediatrica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8199-il-sequenziamento-dellesoma-essenziale-per-le-condizioni-genetiche-non-diagnosticate]]></loc><lastmod>2016-05-06T16:36:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8191-sindrome-di-boucher-neuhauser-colpisce-trenta-famiglie-nel-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8189-tumore-al-polmone-un-test-del-sangue-per-la-sua-diagnosi-precoce]]></loc><lastmod>2021-11-02T16:38:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8141-sindrome-di-smith-magenis-sms-una-malattia-ancora-sconosciuta-e-sottodiagnosticata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8145-sindrome-di-frey-non-esistono-studi-che-valutino-lefficacia-dei-trattamenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8113-herpes-zoster-il-candidato-vaccino-di-gsk-dimostra-unefficacia-globale-del-972-per-cento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8116-malaria-il-candidato-vaccino-si-e-dimostrato-efficace-nel-monitoraggio-a-3-4-anni]]></loc><lastmod>2015-06-08T11:29:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8090-malattia-di-tay-sachs-la-terapia-con-pirimetamina-sembra-avere-solo-effetto-transitorio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8086-glicogenosi-di-tipo-i-studio-indaga-gli-effetti-di-una-nuova-forma-di-amido-di-mais]]></loc><lastmod>2019-06-18T17:47:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8076-transcelerate-biopharma-lancia-due-nuovi-iniziative-globali-volte-a-migliorare-la-ricerca-clinica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8066-ricerca-clinica-10-punti-per-rilanciarla-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8030-giornata-internazionale-della-malattia-di-pompe-genzyme-partecipa-alla-campagna-globale-di-sensibilizzazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/8014-malattie-genetiche-i-supermercati-auchan-e-simply-insieme-per-dare-una-mano-alla-ricerca-scientifica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7990-sindrome-di-ayme-gripp-identificato-nuovo-gene-responsabile-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7965-paraparesi-spastiche-ereditarie-laumento-dei-riflessi-tendinei-e-il-segno-di-babinski-sono-utili-per-identificare-i-portatori-asintomatici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7971-malattie-rare-e-ricerca-prosegue-lo-sviluppo-di-rd-connect]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7959-paraparesi-spastiche-ereditarie-in-sardegna-la-prevalenza-piu-alta-mai-registrata-in-un-paese-occidentale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7931-alcaptonuria-aku-society-lancia-una-campagna-di-crowdfunding-per-testare-farmaco-promettente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7936-disabilita-intellettiva-e-autismo-identificato-il-meccanismo-che-li-provoca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7912-distrofia-dei-cingoli-tipo-2e-raccolti-900mila-dollari-per-un-progetto-di-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7911-leucoencefalopatia-uno-studio-italiano-suggerisce-limportanza-di-valutare-le-mutazioni-nfu1]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7909-sindrome-della-tripla-h-grazie-alla-ricerca-italiana-oggi-sappiamo-molto-sulla-rara-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7858-infarto-in-un-paziente-su-tre-langioplastica-non-basta-a-ridare-ossigeno-al-cuore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7842-eventi-cardiovascolari-evolocumab-li-potrebbe-ridurre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7824-ospedale-di-siena-harvard-e-agenzia-intelligence-americana-insieme-per-uno-studio-sul-potenziamento-cognitivo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7807-obesita-chirurgia-bariatrica-intervento-salvavita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7806-malattie-neurodegenerative-scoperto-interruttore-che-le-spegne]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7777-sindrome-di-kearns-sayre-studio-indaga-la-supplementazione-di-acido-folico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7770-sindrome-di-mowat-wilson-il-gene-responsabile-della-malattia-potrebbe-essere-anche-la-causa-dellasplenia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7748-sindrome-di-netherton-nuova-terapia-a-base-di-acido-ribonucleico]]></loc><lastmod>2016-09-30T09:42:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7720-sindrome-di-sneddon-una-delle-malattie-piu-rare-al-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7745-sindrome-di-rett-e-anemia-di-pearson-individuato-collegamento-biochimico-tra-le-due-malattie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7743-strumenti-operativi-per-le-ern-eurordis-si-aggiudica-il-bando-della-ce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7658-sindrome-di-lesch-nyhan-individuati-marcatori-per-la-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7657-malattia-di-hirschsprung-scoperta-la-mutazione-che-altera-la-motilita-intestinale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7688-litalia-ancora-protagonista-del-programma-gsk-discovery-partnership-with-academia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7624-bambino-gesu-nuova-procedura-mininvasiva-per-trattamento-disturbi-della-minzione]]></loc><lastmod>2025-05-03T10:13:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7607-sindrome-di-tangier-individuata-una-possibilita-terapeutica-per-ridurre-i-sintomi]]></loc><lastmod>2025-05-16T17:10:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7603-sindrome-di-sjogren-uno-studio-cinese-conferma-in-europa-e-una-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7602-sindrome-di-sjogren-in-un-area-francese-multietnica-i-dati-ne-confermano-la-rarita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7550-glomerulonefrite-membranoproliferativa-dimostrati-benefici-dalla-terapia-con-eculizuman]]></loc><lastmod>2022-03-28T13:57:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7522-2015-02-03-15-20-26]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7541-2015-02-05-09-47-43]]></loc><lastmod>2016-01-28T15:31:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7500-ricerca-scientifica-ricreati-in-laboratorio-muscoli-che-reagiscono-come-quelli-naturali]]></loc><lastmod>2019-06-18T17:48:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7465-cancro-al-colon-miglioramenti-con-aspirina-e-inibitori-della-cox-2]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7439-antibiotico-resistenza-gruppo-di-ricercatori-statunitensi-isola-un-nuovo-antibiotico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7433-ricerca-clinica-attivo-on-line-il-database-clinregs]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7435-sindrome-di-hajdu-cheney-il-responsabile-e-il-gene-notch2]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7451-atassia-teleangectasia-ecco-il-vincitore-del-bando-di-ricerca-proposto-da-aip-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7421-disordine-dello-sviluppo-sessuale-46xy-e-bambini-con-sviluppo-sessuale-atipico-lo-screening-e-lanalisi-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7389-carcinoma-endometriale-luso-di-bifosfonati-azotati-riduce-lincidenza-tumorale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7380-test-genomico-per-i-neonati-l827-dei-genitori-usa-e-interessato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7365-il-chmp-dellema-approva-la-prima-terapia-a-base-di-cellule-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7367-sindrome-di-lesch-nyhan-il-trattamento-con-baclofene-intratecale-migliora-i-sintomi-motori-e-i-comportamenti-autolesivi]]></loc><lastmod>2016-05-06T16:23:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7374-leucemie-spesso-a-complicarle-anche-infezioni-fungine-in-agguato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7373-malattie-renali-di-origine-genetica-messo-a-punto-e-brevettato-dal-meyer-un-nuovo-metodo-che-utilizza-i-progenitori-renali-ottenuti-dalle-urine-per-la-diagnosi-e-lo-studio-di-queste-patologie-78366088]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7352-sindrome-di-sturge-weber-identificata-la-mutazione-genetica-responsabile-della-malattia]]></loc><lastmod>2023-01-27T16:27:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7325-pandas-e-pans-oggi-disponibile-un-protocollo-diagnostico-condiviso-a-livello-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7317-progetto-teseo-la-medicina-generale-focalizzata-nella-lotta-al-dolore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7292-sindrome-di-usher-un-metodo-di-sequenziamento-di-nuova-generazione-per-la-diagnosi-molecolare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7257-linfomi-non-hodgkin-e-tumori-solidi-gruppo-menarini-crea-nuovo-anticorpo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7259-atassia-spino-cerebellare-un-comune-antibiotico-potrebbe-essere-trasformato-in-cura-la-scoperta-del-san-raffaele-di-milano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7246-epilessie-miocloniche-progressive-individuata-nuova-mutazione-implicata-nella-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7244-rene-policistico-nessun-beneficio-dalla-combinazione-di-ace-inibitore-arb]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7240-ospedale-pediatrico-bambino-gesu-parte-la-sperimentazione-per-il-cuore-artificiale-pediatrico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7232-artrite-giovanile-idiopatica-per-prevenire-riattivazioni-e-importante-ordine-di-sospensione-dei-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7196-malattie-reumatiche-limportanza-di-diagnosi-e-trattamento-precoci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7150-sindrome-di-simpson-golabi-behmel-la-maggior-parte-dei-pazienti-ha-unintelligenza-normale-e-non-presenta-il-caratteristico-aspetto-facciale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7140-malattia-lald-buoni-i-risultati-per-la-terapia-enzimatica-sostitutiva-con-sebelipase-alfa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7135-innovativi-progetti-in-neurologia-arti-bionici-comandati-senza-fili-dal-cervello]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7097-sindrome-di-holt-oram-uno-studio-fotografa-ventanni-di-dati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7126-studio-americano-dona-nuova-speranza-al-farmaco-zetia-di-merck]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7111-scoperto-un-piccolo-anticorpo-in-grado-di-traghettare-i-farmaci-oltre-la-barriera-ematoencefalica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7063-diagnosi-prenatale-arriva-lamniocentesi-rivoluzionaria-messa-a-punto-dalla-ricerca-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/7040-leucemia-mieloide-acuta-vosaroxin-non-ha-raggiunto-lendpoint-primario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6961-cancro-del-colon-retto-con-le-statine-aumenta-la-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6947-neuromielite-ottica-buoni-i-risultati-ottenuti-con-micofenolato-mofetil]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6916-idrosadenite-suppurativa-abbvie-annuncia-i-risultati-dello-studio-pioneer-ii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6923-leucemia-promielocitica-acuta-buoni-i-risultati-per-la-combinazione-triossido-darsenico-atra]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6907-sindrome-di-mayer-rokitansky-kuster-hauser-che-cose-e-come-si-diagnostica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6915-miopatia-ereditaria-da-corpi-inclusi-ultragenyx-annuncia-dati-positivi-per-ux001]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6828-ricerca-telethon-scoperto-un-gene-che-controlla-il-movimento-dei-muscoli]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6799-encefalite-di-bickerstaff-in-veneto-un-caso-della-rarissima-patologia-neurologica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6790-malattie-scheletriche-e-cartilaginee-studio-sulle-cellule-ips-offre-nuove-speranze-terapeutiche]]></loc><lastmod>2019-06-18T17:57:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6771-terapia-del-dolore-la-nuova-frontiera-degli-oppioidi-prodotti-a-partire-dal-lievito]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6783-tromboembolismo-arterioso-al-via-nuovi-studi-clinici-su-275000-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6751-sperimentazioni-cliniche-oncologiche-i-criteri-per-aumentare-la-partecipazione-di-adolescenti-e-giovani-adulti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6752-malattie-rare-importante-linserimento-dei-patient-reported-oucomes-negli-studi-clinici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6731-tiroide-in-provetta-lobiettivo-e-di-svilupparla-usando-cellule-di-pelle-provenienti-dal-paziente-stesso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6671-sindrome-di-stiff-man-una-possibile-soluzione-dalle-cellule-staminali]]></loc><lastmod>2022-12-20T17:45:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6660-chilomicronemia-familiare-al-via-lo-studio-di-fase-iii-per-indagare-isis-apociiirx]]></loc><lastmod>2015-11-17T14:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6648-il-microbiota-un-mondo-segreto-nel-nostro-intestino-che-aiutera-a-curare-tante-malattie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6641-tumore-al-polmone-puo-essere-diagnosticato-dalla-temperatura-del-respiro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6635-sindrome-di-lyell-medici-italiani-scoprono-una-terapia-risolutiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6631-cellule-staminali-e-microvescicole-un-nuovo-dispostivo-farmacologico-per-veicolare-chemioterapici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6623-tumore-del-seno-identificato-nuovo-meccanismo-responsabile-delle-metastasi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6605-trapianto-di-rene-alexion-avvia-trial-di-registrazione-multinazionale-di-eculizumab-per-la-prevenzione-della-delayed-graft-function-dgf]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6600-tumore-del-polmone-terapie-cucite-su-misura-per-ogni-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6590-dolore-cronico-muscolo-scheletrico-dimostrata-possibile-familiarita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6572-charge-trovato-possibile-legame-tra-p53-e-lo-sviluppo-di-questa-malattia-rara]]></loc><lastmod>2019-08-07T21:03:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6573-microangiopatia-trombotica-associata-a-sindrome-da-anticorpi-antifosfolipidi-successo-ottenuto-nel-trattamento-con-eculizumab]]></loc><lastmod>2019-06-18T18:04:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6565-xeroderma-pigmentoso-una-proteina-per-salvare-i-bambini-della-luna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6528-leucemia-linfatica-cronica-ok-ue-per-obinutuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6541-tumore-al-seno-un-nuovo-gene-per-predire-il-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6525-aiom-e-cipomo-al-ministro-lorenzin-inaccettabili-disparita-di-accesso-ai-farmaci-oncologici-innovativi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6526-carcinoma-testa-collo-docetaxel-e-cetuximab-migliorano-sopravvivenza-globale-e-sopravvivenza-libera-da-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6524-leucemia-mieloide-cronica-le-infusioni-di-linfociti-sono-efficaci-in-caso-di-ricaduta-post-trapianto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6508-rapporto-annuale-sulle-attivita-a-favore-delle-malattie-rare-in-europa-e-online-ledizione-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6500-malattia-infiammatoria-intestinale-il-trattamento-va-proseguito-anche-in-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6474-leucemia-mieloide-acuta-volasertib-promosso-in-fase-ii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6491-sardegna-sara-potenziata-la-ricerca-al-microcitemico-di-cagliari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6482-sindrome-nefrosica-dal-meyer-di-firenze-un-nuovo-test-per-diagnosticarla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6461-sindrome-di-sjogren-nessun-miglioramento-con-idrossiclorochina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6445-sindrome-di-noonan-il-lavoro-di-marco-tartaglia-alliss]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6443-terapia-genica-telethon-finanzia-gli-studi-dellicgeb-di-trieste]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6428-patologie-genetiche-telethon-finanzia-la-ricerca-italiana-per-un-totale-di-11733290-euro]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6429-telethon-oltre-11-milioni-di-euro-alla-ricerca-italiana-sulle-malattie-genetiche-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6404-malattie-rare-una-nuova-rete-di-assistenza-potra-supportare-medici-e-pazienti-nella-diagnosi]]></loc><lastmod>2019-04-19T13:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6383-rabdomiosarcoma-risultati-positivi-per-laggiunta-di-temsirolimus-alla-chemioterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6369-sindrome-di-budd-chiari-per-corretto-trattamento-necessaria-la-diagnosi-precoce]]></loc><lastmod>2019-06-18T18:09:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6260-trombosi-venosa-profonda-ed-embolia-polmonare-approvato-dabigatran-etexilato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6286-neurologia-renzo-guerrini-idel-meyer-di-frienze-in-prima-prima-pagina-sul-lancet-neurology]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6280-atassia-telangiectasia-aip-onlus-finanzia-importante-studio-sulla-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6275-staminali-grazie-alle-cellule-manipolate-possibile-il-trapianto-di-midollo-da-genitore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6215-beta-talassemia-e-sindromi-mielodisplastiche-acceleron-pharma-annuncia-dati-provvisori-dalla-sperimentazione-di-due-nuovi-farmaci-per-queste-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6200-diagnosi-prenatale-disponibili-le-nuove-linee-guida-europee]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6194-ring-14-onlus-e-universita-di-milano-bicocca-unite-nella-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6187-malattie-mitocondriali-il-besta-scopre-una-vitamina-per-contrastarle]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6170-bisturi-molecolari-correggono-i-geni-delle-cellule-staminali-del-sangue]]></loc><lastmod>2025-02-05T18:38:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6065-crisi-epilettiche-la-stimolazione-del-nervo-vago-produce-risultati-positivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6068-bayer-hemophilia-awards-2014-quattro-italiani-tra-i-premiati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/6003-psoriasi-tofacitinib-raggiunge-lend-piont-primario-negli-studi-opt]]></loc><lastmod>2018-10-11T09:14:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5996-telethon-scoperta-a-proteina-che-mantiene-giovane-il-cuore]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5947-ipercalcemia-maligna-denosumab-efficace-in-due-terzi-dei-casi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5943-neuromielite-ottica-confermata-efficacia-azatioprina-nonostante-scarsa-tollerabilita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5922-disturbo-adhd-una-regolare-assunzione-di-farmaci-diminuisce-il-rischio-di-incidenti-stradali]]></loc><lastmod>2019-06-18T18:25:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5893-tiroide-se-va-in-tilt-cambia-pure-la-grafia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5905-sindrome-di-down-si-studia-in-italia-un-nuovo-test-che-permette-di-avere-la-diagnosi-gia-al-ii-mese-di-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5878-malattia-di-hailey-hailey-la-patologia-risponde-al-trattamento-con-talidomide]]></loc><lastmod>2019-06-18T18:27:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5804-psoriasi-a-placche-significativi-miglioramenti-clinici-grazie-a-un-nuovo-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5806-displasia-ectodermica-a-milano-il-primo-centro-di-riferimento-per-la-sperimentazione-di-edi200-la-proteina-che-puo-sconfiggere-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5748-papillomavirus-umano-conferme-per-la-vaccinazione-anti-hpv]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5703-disturbi-del-sonno-e-apnee-notturne-aumentano-il-rischio-cardiovascolare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5723-epidermiolisi-bollosa-la-proteina-decorina-potrebbe-miglioarne-lapproccio-terapeutico]]></loc><lastmod>2016-06-09T07:28:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5698-tumori-del-sistema-nervoso-centrale-risultati-positivi-per-temozolomide]]></loc><lastmod>2019-05-23T17:53:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5648-insufficienza-surrenalica-e-morbo-di-addison-cosa-sono-e-come-si-curano]]></loc><lastmod>2017-03-10T10:37:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5646-insufficienza-surrenalica-arriva-in-italia-una-nuova-terapia-a-base-di-idrocortisone-a-rilascio-modificato]]></loc><lastmod>2025-05-13T16:02:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5622-cefalee-presentato-il-primo-social-manifesto-per-migliorare-accesso-e-qualita-delle-cure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5621-premio-giovane-ricercatore-2014-assegnato-a-teresa-ravizza-ricercatrice-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5620-novartis-i-dati-sui-nuovi-farmaci-approvati-sono-ora-piu-accessibili-ai-ricercatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5619-malattia-generalizzata-dei-piccoli-vasi-lomocisteina-contribuisce-allo-sviluppo-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5592-anche-in-italia-il-discovery-fast-track-challenge-2014-per-per-gli-esploratori-dei-farmaci-del-futuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5559-sindrome-di-sjogren-trattamento-con-rituximab-risulta-efficace-ma-non-a-lungo-termine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5519-giornata-mondiale-delle-malattie-rare-ring14-festeggia-con-importanti-risultati-scientifici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5503-sperimentazione-di-farmaci-innovativi-farmindustria-e-regione-liguria-hanno-firmato-un-accordo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5500-vats-lobectomy-introdotta-al-san-giovanni-bosco-la-chirurgia-polmonare-mininvasiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5442-terapia-del-dolore-la-metilcobalamina-mostra-numerosi-effetti-analgesici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5434-artrite-psoriasica-risposta-durevole-con-apremilast]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5430-leucemia-mieloide-acuta-un-nuovo-test-per-la-diagnosi-precoce-e-il-monitoraggio-della-malattia]]></loc><lastmod>2019-06-19T08:01:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5422-neurinoma-del-nervo-acustico-laspirina-ne-interrompe-la-proliferazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5423-polineuropatia-amiloide-familiare-risultati-incoraggianti-per-diflunisal]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5418-malattia-di-wilson-alla-pari-il-trattamento-con-d-penicillamina-e-quello-con-zinco-solfato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5397-epatite-autoimmune-alternativa-terapeutica-basata-sulla-combinazione-budesonide-azatioprina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5406-distrofie-muscolari-scoperto-il-meccanismo-che-puo-rendere-efficace-il-trapianto-di-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5353-leucemia-mieloide-cronica-risposta-molecolare-a-imatinib-predice-sopravvivenza-a-lungo-termine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5369-neuromielite-ottica-successo-per-il-primo-trapianto-di-staminali-ematopoietiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5320-papillomavirus-umano-lema-approva-il-nuovo-dosaggio-del-vaccino-cervarix]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5328-distrofie-retiniche-e-malformazioni-vascolari-grazie-a-magi-confermate-le-potenzialita-del-test-genetico-con-next-generation-sequencing]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5316-malattie-rare-pubblicato-il-6d-bando-congiunto-e-rare-per-progetti-di-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5317-atrofia-muscolare-spinale-sma-europe-ha-pubblicato-il-6d-bando-per-progetti-di-ricerca-sulla-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5303-sindrome-di-down-luniversita-di-bologna-sperimenta-una-terapia-a-base-di-fluoxetina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5295-sindrome-ipex-dai-ricercatori-telethon-san-raffaele-una-nuova-speranza-di-cura]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5288-clinical-trial-center-nasce-al-policlinico-gemelli-una-nuova-realta-di-ricerca-clinica-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5254-neuromielite-ottica-il-trapianto-con-staminali-ematopoietiche-allogeniche-ha-dato-ottimi-risultati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5270-tumori-limmunoterapia-oncologica-al-1d-posto-tra-le-novita-scientifiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5207-beta-talassemia-major-il-neridronato-si-e-dimostrato-efficace-nella-cura-dellosteoporosi-in-uno-studio-di-fase-2]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5237-melanoma-la-risposta-immunitaria-aiuta-a-identificare-i-pazienti-a-rischio-di-recidiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5218-qscarpinare-per-la-ricerca-in-viaggio-con-la-stargardtq-un-libro-per-sostenere-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5177-malattie-genetiche-nbia-dal-besta-due-importanti-novita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5167-neuropatie-ereditarie-al-san-raffaele-individuati-nuovi-bersagli-terapeutici-per-una-possibile-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5108-polineuropatia-cronica-infiammatoria-demielinizzante-il-trattamento-si-basa-sulluso-di-immunoglobuline-e-steroidi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5103-inaugurata-a-pozzuoli-la-nuova-sede-del-tigem-centro-allavanguardia-per-la-ricerca-sulle-malattie-genetiche]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5101-malattie-della-tiroide-nei-bambini-sottostimate-1-su-3-non-viene-diagnosticata-tempestivamente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5066-innovativi-test-molecolari-e-genetici-contro-i-malati-di-laboratorio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5029-sindrome-di-sapho-realizzate-le-linee-guida-per-la-gestione-della-malattia]]></loc><lastmod>2019-06-19T08:09:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5019-sindrome-eec-nuova-terapia-genica-messa-a-punto-per-curare-la-cecita]]></loc><lastmod>2019-06-19T08:10:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/5028-la-chirurgia-oncologica-mini-invasiva-nei-tumori-esofago-gastrici-dalla-laparoscopia-al-robot]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4997-sindrome-da-fibrosi-enfisema-polmonare-combinati-scoperta-una-possibile-base-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4986-malattie-scheletriche-lue-finanzia-lo-studio-sulle-cause-genetiche]]></loc><lastmod>2019-06-19T08:12:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4949-malattie-rare-limportanza-del-network-telethon-di-biobanche-genetiche]]></loc><lastmod>2019-06-19T08:14:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4929-malattie-genetiche-rare-un-innovativo-software-ideato-allo-scopo-di-rendere-piu-semplice-la-diagnosi]]></loc><lastmod>2019-06-19T08:15:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4926-epatite-c-gilead-annuncia-nuovi-dati-inerenti-la-risposta-virale-sostenuta-per-regimi-a-base-di-sofosbuvir-in-pazienti-affetti-dal-genotipo-3-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4909-rene-policistico-maggiore-chiarezza-nei-meccanismi-molecolari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4911-dolore-cronico-da-botulino-e-tetano-una-nuova-speranza-terapeutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4917-telethon-da-ricerca-su-rara-malattie-renale-scoperto-un-meccanismo-che-regola-lipertensione]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4794-malattia-aterosclerotica-coronarica-diffusa-cad-al-via-lo-studio-multicentrico-italiano-it-disappears]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4778-distrofie-muscolari-e-atrofie-neurogene-grazie-allanalisi-di-rete-si-esegue-unindagine-quantitativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4777-cardiomiopatia-ipertrofica-pediatrica-alto-il-rischio-di-morte-improvvisa]]></loc><lastmod>2019-06-19T08:18:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4774-anemia-falciforme-in-avvio-la-seconda-fase-di-sperimentazione-per-il-farmaco-aes-103]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4740-le-nuove-frontiere-preimpianto-e-della-diagnosi-prenatale-attraverso-tecniche-non-invasive]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4725-ictus-i-vantaggi-delle-cellule-staminali-amniotiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4738-telethon-per-la-prima-volta-i-mitocondri-giudicati-colpevoli-di-difetti-cardiaci-congeniti]]></loc><lastmod>2026-04-08T17:03:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4654-miosite-da-corpi-inclusi-bimagrumab-definito-terapia-fortemente-innovativa-negli-usa]]></loc><lastmod>2019-06-19T08:23:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4690-malattie-neurologiche-rare-pubblicata-una-guida-pratica-per-il-trattamento-di-queste-patologie]]></loc><lastmod>2019-06-19T08:20:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4687-malattie-rare-istituito-team-di-studio-per-lo-sviluppo-di-nuovi-metodi-di-valutazione-dei-trattamenti-sperimentali]]></loc><lastmod>2019-06-19T08:20:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4697-il-sistema-immunitario-ha-una-base-genetica-scoperto-in-sardegna-il-meccanismo-di-ereditariera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4685-anomalie-congenite-elaborate-disposizioni-etiche-da-un-apposito-comitato-internazionale]]></loc><lastmod>2019-06-19T08:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4691-malattie-rare-del-rene-la-sfida-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4698-malattie-rare-ricerca-universitaria-premiata-da-telethon-con-350mila-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4696-malattie-rare-delle-ossa-lunione-europea-finanzia-uno-studio-allateneo-de-laquila]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4694-atrofia-e-distrofia-muscolare-da-telethon-una-nuova-strategia-per-salvare-i-muscoli]]></loc><lastmod>2019-02-18T16:12:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4645-trapianti-renali-sperimentato-luso-del-farmaco-eculizumab-per-la-profilassi-del-rigetto-anticorpo-mediato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4644-malattie-polmonari-una-delle-principali-cause-di-morte-in-europa]]></loc><lastmod>2019-06-19T08:23:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4638-ricerca-telethon-ecco-il-gene-che-aiuta-il-metabolismo]]></loc><lastmod>2019-02-18T16:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4630-ricerca-telethon-dalla-sindrome-dellx-fragile-verso-la-comprensione-di-altre-patologie-neuronali]]></loc><lastmod>2019-06-19T08:23:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4578-scoperta-una-nuova-sindrome-da-immunodeficienza-correlata-alle-mutazioni-del-gene-vps45]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4563-encefalomiopatie-mitocondriali-ad-esordio-infantile-identificata-la-causa-frequente]]></loc><lastmod>2019-06-19T08:24:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4574-malattie-genetiche-rare-la-ricerca-italiana-apre-nuove-prospettive-terapeutiche]]></loc><lastmod>2019-02-18T16:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4557-atassia-cerebellare-studio-italiano-scopre-la-causa-piu-frequente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4526-tirosinemia-tipo-1-disponibili-le-raccomandazioni-europee-per-la-gestione-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4524-malattie-da-insufficienza-midollare-unapp-aiuta-i-pazienti-a-registrare-i-miglioramenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4556-malattie-ematologiche-eculizumab-in-grado-di-controllare-una-trasfusione-sbagliata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4523-sindrome-di-hermansky-pudlak-le-linee-guida-per-la-presa-in-carico-globale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4493-dismorfismi-rari-successo-per-il-progetto-pilota-europeo-dyscerne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4480-cavernoma-cerebrale-una-malattia-che-affligge-i-cittadini-ispanici-del-new-mexico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4479-ipoparatiroidismo-nps-pharmaceuticals-iscrive-il-primo-paziente-nel-registro-mondiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4498-malattie-da-difetti-dellimprinting-genomico-nasce-la-nuova-rete-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4446-sindrome-di-sjoegren-i-linfociti-nk-possibile-causa-della-malattia-autoimmune]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4477-sindrome-iper-ige-nuovo-studio-australiano-migliora-la-comprensione-della-malattia]]></loc><lastmod>2019-06-19T08:26:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4469-aniridia-gli-ultimi-progressi-nel-campo-di-questo-raro-disturbo-congenito]]></loc><lastmod>2019-06-19T08:27:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4452-telethon-una-nuova-scoperta-migliora-la-comprensione-delle-patologie-rare-genetiche]]></loc><lastmod>2019-02-18T16:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4418-anomalie-cromosomiche-nei-disordini-neoplastici-ora-disponibili-le-linee-guida]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4414-immunodeficienza-primaria-ricercatori-israeliani-scoprono-la-mutazione-piu-diffusa-tra-i-bimbi-arabi]]></loc><lastmod>2019-06-19T08:31:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4420-per-la-prima-volta-telethon-finanzia-un-progetto-di-ricerca-su-ring14]]></loc><lastmod>2019-02-18T16:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4411-sindrome-eec-individuata-la-proteina-che-agisce-come-modificatore-genetico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4394-colestasi-intraepatica-della-gravidanza-icp-potrebbe-causare-tendenza-allobesita-del-nascituro]]></loc><lastmod>2023-09-28T15:22:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4387-anomalie-reni-e-tratto-urinario-cakut-studio-diretto-dal-gaslini-individua-il-primo-gene-responsabile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4362-glomerulosclerosi-focale-segmentale-il-cnr-di-napoli-ne-scopre-le-cause-genetiche]]></loc><lastmod>2024-05-24T14:45:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4361-cheratoderma-palmo-plantare-non-epidermolitico-nepkk-scoperta-la-causa-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4354-sindrome-camptodattilia-artropatia-ginocchio-varo-pericardite-scoperte-5-nuove-mutazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4353-malattia-da-depositi-densi-ddd-al-via-studio-pilota-con-cdx-1135]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4326-atassie-spinocerebellari-nuove-prospettive-nel-campo-della-diagnosi-precoce]]></loc><lastmod>2019-06-19T08:33:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4324-brains-for-brain-una-fondazione-per-combattere-le-malattie-genetiche-rare-che-danneggiano-il-cervello]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4323-malattia-di-krabbe-per-rallentarla-oggi-ce-solo-il-trapianto-ma-va-fatto-precocemente-e-per-questo-serve-lo-screening-neonatale-per-il-futuro-si-lavora-ad-un-farmaco]]></loc><lastmod>2025-10-28T17:34:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4320-malattie-lisosomiali-diagnosi-precoce-con-lo-screening-neonatale-e-terapie-capaci-di-difendere-il-cervello]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4296-diagnosi-prenatale-per-le-malattie-monogeniche-si-guarda-ad-indagini-precoci-e-non-invasive]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4294-malattie-rare-scoperta-una-nuova-sindrome-che-causa-sordita-e-miopia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4269-sequenziamento-genetico-pubblicate-le-linee-guida-internazionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4274-primo-trapianto-di-microbiota-intestinale-nel-lazio-e-la-seconda-volta-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4238-malformazione-dandy-walker-uno-studio-italiano-chiarisce-alcuni-aspetti-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4248-cavernomi-cerebrali-studio-italiano-identifica-possibile-terapia-farmacologica]]></loc><lastmod>2019-09-08T15:53:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4228-sindrome-di-lowe-al-via-un-progetto-di-ricerca-collettivo-grazie-a-funds-4-research]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4204-ictus-giovanile-presentati-al-convegno-di-magi-nuovi-studi-per-identificarne-le-cause-e-prevenire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4206-malformazioni-vascolari-ancora-meta-dei-casi-senza-causa-identificata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4202-ingroma-cistico-noia-gemelli-il-68-dei-bimbi-nascerebbe-sano-oggi-vengono-abortiti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4192-sarcoidosi-con-nuove-tecnologie-si-cercano-altri-geni-associati-alla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4158-sindrome-di-cotard-guarito-paziente-convinto-di-essere-morto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4144-malattia-di-wilson-in-sardegna-e-10-volte-piu-diffusa-rispetto-al-resto-del-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4126-adhd-la-maggior-parte-dei-pediatri-americani-non-segue-le-linee-guida-cliniche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4121-malattie-genetiche-rare-identificata-una-nuova-patologia-che-colpisce-la-mielina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4134-sindrome-di-struge-weber-trovata-la-mutazione-genetica-responsabile-00]]></loc><lastmod>2023-01-27T15:41:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4114-grande-successo-per-il-13d-congresso-nazionale-della-associazione-italiana-di-miologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4113-glioblastoma-multiforme-tracciato-lidentikit-genetico-del-tessuto-alla-base-delle-recidive-del-piu-aggressivo-tumore-cerebrale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4099-x-fragile-ad-hong-kong-si-effettua-lo-screening-per-individuare-le-portatrici-sane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4092-difetti-del-ciclo-dellurea-pubblicate-le-linee-guida-europee]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4091-malattie-rare-su-orphanet-disponibili-nuovi-linee-guida-di-emergenza-in-lingua-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4065-sindrome-di-ehelers-danlos-i-ricercatori-di-brescia-scoprono-18-nuove-mutazioni]]></loc><lastmod>2018-11-23T10:07:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4068-carcinoma-della-prostata-fda-approva-il-farmaco-iniettabile-xofigor-radio-223-dicloruro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4043-distonia-focale-della-mano-risultati-incoraggianti-a-breve-termine-con-la-tms]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4037-artrite-idiopatica-giovanile-sistemica-negli-usa-approvato-il-trattamento-con-canakinumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4020-autismo-aumenta-il-rischio-se-la-madre-assume-antidepressivi-in-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/4015-distrofia-dei-cingoli-telethon-scopre-il-gene-responsabile-della-rara-patologia]]></loc><lastmod>2019-02-18T16:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3998-ricerca-il-bambino-gesu-di-roma-studiera-il-microbiota-intestinale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3975-sindrome-mccune-albright-la-diagnosi-precoce-previene-la-neuropatia-ottica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3981-distrofia-retinica-autosomica-recessiva-scoperto-il-gene-responsabile]]></loc><lastmod>2019-02-18T16:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3973-san-raffaele-telethon-scoperta-carta-didentita-delle-cellule]]></loc><lastmod>2019-02-18T16:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3931-sindrome-di-klinefelter-colpisce-gli-uomini-e-causa-infertilita-il-punto-su-diagnosi-e-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3953-ricerca-telethon-il-gene-spazzino-che-ripulisce-le-cellule-aiuta-anche-a-rimuovere-i-grassi]]></loc><lastmod>2019-02-18T16:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3927-tumori-la-doppia-faccia-della-proteina-e2f3-in-eta-fetale-fa-crescere-il-bambino-se-si-riattiva-nelladulto-aiuta-il-cancro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3897-mucopolisaccaridosi-telethon-scopre-una-proteina-inganna-cervello-per-far-passare-lenzima]]></loc><lastmod>2019-02-18T16:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3878-malattia-di-creutzfeldt-jakob-la-rapida-perdita-delludito-puo-essere-un-sintomomalattia-di-creutzfeldt-jakob-la-rapida-perdita-delludito-puo-essere-un-sintomo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3890-malattie-rare-bianconi-entro-il-2013-il-piano-nazionale-in-coerenza-con-le-linee-guida-ue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3888-elenco-categorie-test]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3879-alcaptonuria-nuove-conferme-per-il-trattamento-con-nitisinone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3860-pandas-a-roma-congresso-internazionale-carelli-confidiamo-nel-riconoscimento-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3848-cancro-la-ricerca-italiana-scopre-lazione-antitumorale-del-maltolo9]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3847-sindrome-di-down-una-proteina-potrebbe-essere-la-causa-dei-problemi-di-apprendimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3849-tumori-un-farmaco-per-farli-dimagrire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3843-sindrome-coronarica-acuta-sca-parere-positivo-allapprovazione-in-ue-di-rivaroxaban]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3841-oncologia-celgene-apre-la-strada-a-nuove-terapie-genetiche]]></loc><lastmod>2018-08-02T18:19:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3828-sindrome-di-barth-ricercatori-fiorentini-scoprono-sei-nuove-mutazioni]]></loc><lastmod>2016-09-18T10:42:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3826-sindrome-del-rene-policistico-dal-san-raffaele-una-scoperta-sui-meccanismi-patologici-e-una-nuova-prospettiva-terapeutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3822-scoperto-meccanismo-attraverso-cui-la-cocaina-danneggia-le-funzioni-cerebrali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3818-deficit-di-piruvato-idrogenasi-il-tigem-di-napoli-ha-individuato-un-possibile-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3802-telethon-nuovi-importanti-sviluppi-verso-una-retina-artificiale]]></loc><lastmod>2019-02-18T16:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3779-sindrome-da-delezione-del-cromosoma-22-dal-bambino-gesu-un-nuovo-studio-ne-chiarisce-alcuni-aspetti-genetici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3775-prova]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3680-distrofia-muscolare-dei-cingoli-disponibile-un-documento-sulla-strategia-diagnostica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3733-atassia-teleangectasia-realizzato-in-italia-un-test-diagnostico-per-individuare-i-portatori-sani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3681-sindrome-da-insensibilita-agli-androgeni-ais-pronte-le-linee-guida]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3674-sindrome-di-alstroem-da-padova-la-scoperta-il-danno-neurologico-e-piu-diffuso-di-quanto-si-creda]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3642-sindrome-di-turner-allargamento-dellaorta-e-valvola-bicuspide-indicano-un-maggior-rischio-di-dissecazione-dellaorta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3641-anemia-falciforme-servono-linee-guida-per-il-passaggio-dal-pediatra-al-medico-di-base]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3640-anemia-falciforme-la-frequente-la-carenza-di-vitamina-d-mette-a-rischio-le-ossa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3623-malattie-reumatologiche-con-interessamento-polmonare-necessario-lapproccio-multidisciplinare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3586-sindrome-di-usher-ancora-passi-avanti-verso-la-terapia-genica]]></loc><lastmod>2016-09-16T18:01:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3564-tumore-metastatico-del-colon-retto-il-trattamento-con-regorafenib-mostra-un-beneficio-di-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3557-distrofia-miotonica-tipo-1-e-2-aspetti-in-comune-e-differenze-cliniche-e-molecolari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3561-autismo-individuato-un-possibile-bersaglio-terapeutico-le-proteine-mdga]]></loc><lastmod>2019-06-19T08:35:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3531-sindrome-di-cowden-scoperte-due-nuove-mutazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3528-depressione-bipolare-tradotta-in-italiano-la-scala-di-berk-utilizzata-per-riconoscere-precocemente-i-casi-piu-gravi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3500-sindromi-miasteniche-congenite-si-possono-curare-ma-vanno-individuate-esattamente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3496-malattia-di-canavan-la-terapia-genica-potrebbe-funzionare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3494-virus-di-epstein-barr-identificato-un-nuovo-bersaglio-del-virus-responsabile-della-malattia-del-bacio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3463-cancro-intestinale-individuate-delle-mutazioni-genetiche-che-potrebbero-causarlo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3487-sindrome-di-kleine-levin-tanto-sonno-fame-e-iperattivita-sessuale-questi-possono-esserne-i-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3486-cellule-staminali-un-nuovo-metodo-di-produzione-potrebbe-aiutare-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3479-malattie-mitocondriali-una-nuova-scoperta-dalluniversita-di-bari-e-il-cnr]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3455-artrite-idiopatica-giovanile-sistemica-due-farmaci-gia-in-commercio-cambiano-il-futuro-delle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3449-leucemia-lingegneria-genetica-apre-nuove-speranze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3426-ring-14-studio-genetico-apre-nuove-speranze-per-la-rara-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3423-sindrome-di-usher-individuate-due-nuove-possibili-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3422-sindrome-di-sticker-chiarite-lassociazione-tra-mutazioni-genetiche-e-perdita-delludito]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3420-malattie-rare-per-capire-leffetto-del-farmaci-si-usano-le-cellule-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3419-leucemia-promielocitica-puo-essere-curata-senza-chemioterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3414-tecnologia-antisense-biogen-idec-e-isis-si-accordano-per-sviluppare-nuovi-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3403-sindromi-di-brown-vialetto-van-laere-e-di-fazio-londe-una-semplice-vitamina-la-riboflavina-puo-salvare-la-vita]]></loc><lastmod>2021-11-04T15:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3398-tumori-scoperta-la-proteina-che-frena-il-glioblastoma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3361-sclerosi-tuberosa-per-langiomiolipoma-il-trattamento-con-rapamicina-funziona]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3371-la-toscana-apre-una-nuova-frontiera-nella-ricerca-scientifica-alla-scoperta-dei-segreti-del-cervello-e-del-corpo-umano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3327-dolore-cronico-una-nuova-speranza-per-la-terapia-personalizzata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3315-distress-respiratorio-neonatale-forse-causato-da-una-mutazione-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3283-distrofia-muscolare-nasce-il-sito-web-che-aiuta-i-medici-a-identificarne-i-primi-sintomi-pediatrici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3308-blefarofimosi-ritardo-mentale-identificato-il-gene-responsabile-della-rara-sindrome]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3282-tecniche-di-trasferimento-genico-ecco-il-libro-sullo-stato-dellarte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3220-sindrome-antifosfolipidi-utile-la-terapia-a-base-di-statine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3241-medulloblastoma-scoperta-la-causa-dai-ricercatori-italiani-di-ibcn-e-cnr]]></loc><lastmod>2022-04-08T22:20:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3191-iperbilirubinemia-oggi-e-piu-facile-identificare-i-neonati-che-necessitano-di-fototerapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3179-distrofia-facioscapolomerale-di-tipo-2-scoperte-le-cause-genetiche-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3121-uveite-necessario-un-approccio-interdisciplinare]]></loc><lastmod>2016-05-27T17:21:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3159-sindrome-mednik-ricercatori-italiani-ne-scoprono-causa-e-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3153-scoperta-una-mutazione-genetica-che-causa-ipotiroidismo-congenito-e-macrorchidismo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3149-chirurgia-rigenerativa-orale-e-maxillo-facciale-nuovi-tessuti-dalla-banca-delle-cellule-e-del-tessuto-muscoloscheletrico-della-regione-emilia-romagna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3142-malattie-genetiche-rare-12-milioni-di-euro-dallunione-europea-per-un-progetto-internazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3120-artrite-idiopatica-giovanile-efficacia-garantita-sia-per-terapia-orale-che-parenterale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3145-sla-e-tumori-potrebbero-essere-correlati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3108-malattia-di-moyamoya-proposte-le-linee-guida-per-la-gestione-pediatrica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3119-tumori-del-nervo-acustico-a-siena-nuova-tecnica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3116-rtss-candidato-vaccino-contro-la-malaria-riduce-la-malaria-di-circa-un-terzo-nei-bambini-africani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3094-ricerca-il-network-europeo-ecrin-valuta-nuovi-progetti-anche-le-associazioni-possono-proporne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3074-sindrome-di-cowden-e-diabete-tipo-2-due-malattie-opposte-legate-al-gene-pten]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3062-laminopatie-lesperienza-vincente-dei-ricercatori-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3060-malattie-rare-mitocondriali-si-spera-di-spezzare-la-catena-della-trasmissione-con-lo-spindle-transfert]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3058-cheratoderma-palmoplantare-individuato-un-gene-che-causa-la-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/3033-discinesia-ciliare-primaria-identificato-lerrore-genetico-che-la-causa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2999-malattie-neurodegenerative-la-causa-potrebbe-essere-un-difetto-mitocondriale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2979-telangectasia-emorragica-ereditaria-e-gravidanza-uno-studio-rassicura-le-donne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2982-sindrome-di-cornelia-de-lange-sembra-possibile-la-diagnosi-prenatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2994-artrite-reumatoide-una-proteina-potrebbe-bloccare-linfiammazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2959-acondroplasia-benefici-da-controlli-e-cure-tempestive-dei-disturbi-respiratori-nel-sonno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2918-atresia-delle-coane-dal-texas-dito-puntato-sullatrazina-noto-erbicida]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2919-atresia-delle-coane-dal-texas-dito-puntato-sullatrazina-noto-erbicida-59118652]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2915-progeria-esiste-un-farmaco-sperimentale-in-grado-di-migliorare-linvecchiamento-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2875-fibrodisplasia-ossificante-progressiva-dal-giappone-lindicazione-per-una-nuova-strada-dterapeutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2874-sindorme-secisbp2-scoperta-la-causa-di-una-malattia-che-aveva-confuso-la-comunita-scientifica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2907-miotonie-non-distrofiche-un-comune-farmaco-per-il-cuore-diminuisce-la-rigidita-muscolare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2870-immunodeficienza-combinata-grave-la-terapia-genica-puo-ripristinare-il-sistema-immunitario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2873-atassia-spastica-ereditaria-scoperta-la-causa-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2922-nobel-premiati-gurdon-e-yamanaka-per-la-ricerca-sulla-riprogrammazione-delle-staminali-adulte]]></loc><lastmod>2026-01-15T13:43:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2869-malformazioni-ano-rettali-la-riproduzione-assistita-ne-aumenta-il-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2821-teleangectasia-emorragica-ereditaria-quali-sono-le-basi-genetiche-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2820-teleangectasia-emorragica-ereditaria-le-epistassi-oggi-si-trattano-con-interventi-minimamente-invasivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2861-sindrome-ring-14-al-via-importante-progetto-scientifico-per-comprendere-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2818-artrite-idiopatica-giovanile-a-esordio-sistemico-un-piano-di-trattamento-della-childhood-arthritis-and-rheumatology-research-alliance]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2838-malattia-di-creutzfeldt-jakob-un-nuovo-test-puo-facilitare-la-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2829-morte-improvvisa-da-stress-fisico-ed-emotivo-verso-una-possibile-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2716-uveite-e-spesso-associate-a-malattie-sistemiche-necessario-approccio-interdisciplinare]]></loc><lastmod>2016-05-27T17:23:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2664-sindrome-del-qt-lungo-un-nuovo-farmaco-per-il-trattamento-potrebbe-arrivare-dagli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2708-le-donne-sono-piu-felici-degli-uomini-e-colpa-di-un-gene]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2680-sindrome-di-digeorge-una-proteina-presente-nel-materiale-genetico-potrebbe-influenzare-la-gravita-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2703-emiplegia-alternante-scoperte-le-mutazioni-genetiche-che-la-determinano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2701-scoperta-una-mutazione-che-causa-la-carenza-di-vitamina-b12]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2676-malattia-di-alexander-necessario-valutare-il-rischio-di-apnea-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2665-esofago-di-barret-laspirina-potrebbe-ridurne-il-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2661-malattia-di-pelizaeus-merzbacher-puo-confondersi-con-la-paraplegia-spastica-ereditaria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2678-cancro-al-seno-dal-manto-della-vergine-la-speranza-di-un-nuovo-antitumorale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2637-malattia-di-castleman-il-trattamento-piu-corretto-e-quello-chirurgico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2656-glioblastoma-nuove-prospettive-terapeutiche-dalle-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2632-distrofia-muscolare-miotonica-scoperta-una-terapia-efficace-sul-modello-animale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2650-patologie-genetiche-mendeliane-il-sequenziamento-di-ultima-generazione]]></loc><lastmod>2016-08-01T18:24:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2629-anemia-di-fanconi-nuove-osservazioni-scientifiche-sulla-rara-malattia]]></loc><lastmod>2017-10-18T09:37:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2610-nefropatia-membranosa-idiopatica-e-sindrome-nefrosica-buoni-risultati-dal-trattamento-con-rituximab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2597-spondiloartrite-giovanile-aggiornate-le-line-guida-per-il-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2592-neuromielite-ottica-il-ruolo-della-proteina-acquaporina-4]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2583-emiplegia-alternante-individuato-il-gene-primario-che-causa-la-rara-malattia-neurologica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2533-xeroderma-pigmentoso-primi-passi-verso-la-terapia-genica-grazie-a-studio-francese-sugli-animali-il-trasferimento-dei-geni-non-ha-dato-effetti-collaterali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2536-dal-sospetto-alla-certezza-la-sindrome-mielodisplastica-smd-e-una-malattia-delle-cellule-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2532-degenerazione-retinica-cerebellare-infantile-scoperta-una-nuova-mutazione-che-la-causa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2531-sindrome-digeorge-possibile-individuarla-con-la-mappatura-genomica-del-feto-senza-esami-invasivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2527-cherubinismo-pubblicate-le-linee-guida-per-la-pratica-clinica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2515-autismo-basterebbe-leliminazione-di-un-solo-gene-per-innescarlo]]></loc><lastmod>2019-06-19T08:37:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2526-disturbi-del-ciclo-dellurea-pronte-le-linee-guida-europee-per-litalia-ha-lavorato-alberto-burlina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2486-atassia-telangiectasia-dallaustralia-un-passo-avanti-nella-ricerca-sulle-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2482-tumore-cerebrale-scoperta-una-rara-variante-genetica-associata-al-glioma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2479-tubercolosi-resistente-ai-farmaci-un-nuovo-trattamento-attende-lapprovazione-della-fda]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2467-cellule-staminali-da-liquido-amniotico-potrebbero-essere-la-soluzione-piu-vicina-alle-embrionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2432-malattia-di-tay-sachs-a-rischio-anche-gli-irlandesi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2414-malattia-di-raynaud-il-trattamento-con-vardenafil-potrebbe-migliorare-i-sintomi-clinici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2418-malattie-rare-dompe-bandisce-5-borse-di-studio-in-medical-chemistry]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2402-decifrate-le-informazioni-nascoste-del-piccolo-genoma-dimenticato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2386-obesita-a-volte-il-problema-e-nei-geni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2381-melanoma-alla-cattolica-di-roma-scoperta-proteina-che-potrebbe-fermarlo]]></loc><lastmod>2026-04-04T13:47:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2335-istruzione-e-ricerca-il-futuro-e-sulla-rete-garr-a-banda-ultralarga]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2337-congresso-internazionale-pneumologia-2012-fra-servizi-al-malato-e-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2315-deficit-di-glucocorticoidi-fgd-scoperto-il-gene-che-rende-incapaci-di-affrontare-gli-stress-fisici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2318-malattie-reumatiche-fira-indice-8-bandi-di-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2310-sindorme-di-clove-identificata-la-causa-genetica-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2304-malattie-rare-polmonari-raccomandazioni-europee-per-laccesso-alle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2314-trombosi-venosa-lefficacia-dellaspirina-come-terapia-preventiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2309-la-ricerca-su-itune-per-licgeb-di-trieste-oltre-60-mila-visite-in-9-mesi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2302-sindrome-da-anticorpi-antifosfolipidi-disponibili-le-linee-guida-di-emergenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2299-malattie-mitocondriali-tutte-le-novita-dal-convegno-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2295-melanoma-e-metastasi-cerebrali-presentati-a-chigago-i-risultati-dello-studio-italiano-coordinato-a-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2266-malattie-autoimmuni-in-sardegna-uno-studio-sulla-prevalenza-di-12-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2274-malattie-rare-al-via-uno-studio-sulle-cellule-ips-grazie-a-universita-di-harvard-e-ring14]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2221-polineuropatia-demielinizzante-infiammatoria-cronica-cidp-immunoglobuline-o-metilprednisolone]]></loc><lastmod>2016-04-12T14:12:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2258-malattie-cardiovascolari-da-icgeb-terapia-genica-e-utilizzo-di-cellule-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2240-trapianti-contro-la-gvhd-arriva-dal-canada-il-primo-farmaco-a-base-di-staminali-mesenchimali]]></loc><lastmod>2016-10-23T18:27:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2197-endocrinologia-limportanza-della-vitamina-d]]></loc><lastmod>2016-10-23T18:32:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2173-alcaptonuria-al-via-un-progetto-di-ricerca-alluniversita-di-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2204-gli-eredi-di-dulbecco-fanno-viaggiare-la-ricerca-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2170-trapianti-per-avere-risultati-migliori-meglio-sarebbe-non-attendere-il-peggioramento-del-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2168-leucemia-linfomi-e-tumori-a-bologna-terapie-personalizzate-grazie-alla-mappa-del-dna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2142-malattia-di-creutzfeldt-jacob-scoperto-un-marcatore-per-la-diagnosi]]></loc><lastmod>2017-02-19T19:39:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2108-omocistinuria-lintegrazione-con-vitamina-b6-potrebbe-ridurre-il-rischio-di-coaguli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2114-distrofia-muscolare-facio-scapolo-omerale-scoperto-un-nuovo-meccanismo-di-malattia-e-possibile-target-terapeutico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2053-otosclerosi-ludito-puo-essere-ripristinato-con-limpianto-cocleare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2065-al-san-raffaele-ottenuto-il-sequenziamento-completo-del-genoma-umano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2008-malattie-rare-orphan-europe-academy-per-la-formazione-dei-medici-specialisti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2005-malattie-croniche-con-chronic-care-model-il-paziente-responsabile-gestisce-la-sua-cronicita-tre-progetto-multiprofessionali-allavanguardia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/2000-cardiorobur-come-funziona-il-cuore-dei-calciatori-collaborazione-tra-la-cardiologia-universitaria-del-policlinico-santa-maria-alle-scotte-di-siena-e-lac-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1961-atassia-telangectasia-scoperto-un-meccanismo-correlato-alla-neurodegenerazione-nella-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1971-malattie-rare-e-rarissime-limpegno-di-magi-istituto-non-profit-di-genetica]]></loc><lastmod>2024-06-20T17:27:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1957-distrofia-facio-scapolo-omerale-uno-studio-thelethon-rimette-in-discussione-le-basi-genetiche]]></loc><lastmod>2016-07-19T17:12:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1942-trombocitopenia-con-assenza-di-radio-tar-la-determina-il-basso-livello-della-proteina-y14]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1943-trombocitopenia-con-assenza-di-radio-tar-la-determina-il-basso-livello-della-proteina-y14-5264282]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1884-malattie-neurologiche-nuova-scoperta-il-cloro-orchestra-il-dialogo-fra-i-neuroni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1901-al-via-il-progetto-europeo-sicode-italia-in-prima-linea-nella-ricerca-dedicata-alle-interfacce-cervello-macchina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1898-medicina-perinatale-a-firenze-aprira-la-scuola-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1882-malattie-mitocondriali-monogenetiche-analizzate-tutte-le-opzioni-terapeutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1878-malattie-rare-rhenovia-dichiara-il-proprio-impegno-nella-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1888-glomerulonefrite-gnmp-si-guarda-alleculizumab-di-alexion-come-possibile-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1873-malattie-rare-un-nuovo-metodo-per-lanalisi-delle-cause]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1865-fenilchetonuria-oggi-a-roma-i-massimi-esperti-a-livello-internazionale]]></loc><lastmod>2017-10-05T10:24:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1854-disabilita-intellettiva-di-origine-genetica-scoperta-una-possibile-terapia]]></loc><lastmod>2019-06-19T08:39:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1807-carcinomi-polmonari-identificato-un-nuovo-marker-dal-cnr-di-napoli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1808-farmaci-antitumorali-a-disposizione-cat-il-super-microscopio-3-d]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1798-sindrome-di-olmsted-la-mutazione-del-gene-trpv3-potrebbe-essere-la-causa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1796-ricerca-sanofi-e-center-for-genomic-regulation-insieme-per-la-lotta-alle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1788-fibrodisplasia-ossificante-progressiva-al-gaslini-di-genova-diagnosi-molecolare-ma-anche-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1765-colite-ulcerosa-pediatrica-approvato-dalla-commissione-europea-luso-di-infliximab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1738-atassia-spinocerebellare-di-tipo-3-vareniclina-migliora-i-sintomi-assiali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1746-malattie-genetiche-rare-negli-usa-parte-il-progetto-the-rare99x-clinical-exome-challenge]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1742-diagnosi-prenatale-un-test-sul-sangue-per-identificare-sindrome-di-down-e-trisomie-18-e-13]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1736-distrofia-miotonica-di-tipo-1-la-funzione-endocrina-potrebbe-essere-correlata-alla-gravita-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1716-malattie-da-accumulo-lisosomiale-nuove-prospettive-grazie-a-diagnosi-precoce-terapia-enzimatica-e-assistenza-domiciliare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1731-malattie-rare-neglette-e-viralia-leccellenza-italiana-dellicgeb]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1730-emofilia-sma-fibrosi-cistica-dalla-ricerca-dellicgeb-pallottole-molecolari-per-evitare-le-conseguenze-dellerrore-genetico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1722-malattie-rare-nasce-l-organismo-internazionale-di-ricerca-irdirc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1719-sindrome-di-perlman-scoperto-il-gene-responsabile-della-grave-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1720-ataxia-di-friedreich-finanziamenti-europei-alla-ricerca-di-roma-tor-vergata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1706-laminopatie-in-italia-ce-un-network-di-clinici-ricercatori-e-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1672-distonia-oromandibolare-la-tossina-botulinica-puo-migliorare-la-sintomatologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1674-artrite-idiopatica-giovanile-piu-alto-il-rischio-di-sviluppare-tumori-maligni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1637-malformazioni-linfatiche-il-sildenafil-potrebbe-essere-una-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1654-tumori-la-semuloparina-riduce-il-rischio-di-trombosi-venosa-durante-la-chemioterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1658-immunologia-la-ricerca-italiana-avanza-nelle-indagini-sui-linfociti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1604-sindrome-di-treacher-collins-nuove-scoperte-grazie-ai-pesci-zebra]]></loc><lastmod>2022-01-05T19:04:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1607-nefrite-lupica-il-trattamento-con-rituximab-non-migliora-la-risposta-renale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1597-incontinentia-pigmenti-scoperto-un-link-genetico-con-il-favismo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1567-neuromielite-ottica-basta-una-analisi-del-sangue-per-distinguerla-dalla-sclerosi-multipla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1559-neoplasie-mieloproloferative-microrna-decisivo-per-la-patogenesi-di-questi-tumori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1534-fibrodisplasia-ossificante-progressiva-non-esiste-un-trattamento-terapeutico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1524-malattia-di-myhre-ricercatori-italiano-scoprono-la-causa-della-rarissima-patologia]]></loc><lastmod>2018-10-09T17:08:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1512-sindrome-di-sjogren]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1503-121-atresia-biliare-per-chi-deve-essere-trapiantato-la-madre-potrebbe-essere-donatore-migliore-del-padre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1499-hdls-il-male-che-mangia-la-materia-bianca-cerebrale-potrebbe-essere-sottodiagnosticato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1511-paraplegia-spastica-ereditaria-tipo-12-trovato-un-altro-gene-coinvolto-e-il-23esimo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1489-sindrome-di-kabuki-trovato-un-nuovo-gene-alla-ricerca-ha-collaborato-il-prof-dallapiccola]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1480-sindrome-di-poland-al-convengo-dellaisp-mondo-scientifico-e-pazienti-a-confronto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1467-cherubinismo-scoperte-analogie-genetiche-con-le-leucemia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1469-anemia-di-fanconi-ripaldi-la-maggiore-speranza-oggi-e-il-trapianto-da-familiare-hla-identico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1461-sindrome-weaver-ricerca-canadese-scopre-possibile-gene-responsabili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1454-malformazioni-uro-genito-anorettali-al-via-progetto-mugar-net]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1451-eminegligenza-spaziale-da-ictus-studio-romano-mostra-benefici-della-stimolazione-transcranica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1427-piastrinopatie-dai-sardi-un-aiuto-fondamentale-per-la-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1419-sindrome-ring-14-ricerca-di-milano-bicocca-mostra-soggettivita-delle-abilita-linguistiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1406-stimolazione-cerebrale-profonda-tra-estensione-di-malattie-trattabili-e-accessibilita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1401-ricerca-litalia-forte-nella-ricerca-biologico-molecolare-si-perde-quando-si-tratta-di-trasformarla-in-brevetti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1402-malattie-rare-il-meeting-di-bioceonomy-occasione-di-incontro-tra-pubblico-e-privato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1383-sindrome-da-iper-ige-iperimmunoglobulina-e-due-fenotipi-due-diverse-cause-genetiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1368-edema-della-retina-una-microsfera-rilascia-cortisone-per-sei-mesi-con-una-sola-iniezione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1348-distrofia-corneale-di-schnyder-ricerca-americana-mostra-analogie-con-meccanismo-del-cancro-alla-vescica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1337-rna-regolatore-dellattivita-dei-geni-in-caso-di-crisi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1334-sclerosi-tuberosa-ricerca-su-staminali-neurali-fa-luce-sul-ruolo-del-mediatore-mtor]]></loc><lastmod>2018-12-16T10:55:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1329-bassa-statura-un-problema-comune-a-molte-malattie-rare-al-gemelli-un-meeting]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1327-scuola-ed-eccellenza-riprendono-gli-incontri-organizzati-alla-fondazione-sigma-tau]]></loc><lastmod>2020-11-19T17:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1313-beckwith-wiedemann-studio-cnr-universita-napoli-fa-luce-su-meccanismo-genetico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1310-sclerosi-tuberosa-studio-italiano-spiega-meglio-il-ruolo-del-mediatore-mtor]]></loc><lastmod>2018-12-16T10:58:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1297-rischio-cardiovascolare-laspirina-ad-oltre-100-anni-si-conferma-lamica-del-cuore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1298-rischio-cardiovascolare-prima-di-tutto-i-sani-stili-di-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/errore]]></loc><lastmod>2019-05-15T15:43:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1262-coreoacantocitosi-da-verona-una-scoperta-sui-meccanismi-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1246-sindrome-di-lowe-dal-tigem-di-napoli-scoperto-meccanismo-che-danneggia-i-reni]]></loc><lastmod>2025-04-04T14:58:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1208-malformazione-arnold-chiari-tipo-1-al-via-chiariamo-primo-registro-nazionale-per-la-malformazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/869-porpora-nelle-nuove-linee-guida-la-plasmaferesi-resta-il-trattamento-delezione]]></loc><lastmod>2019-08-30T15:01:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1144-stimolazione-a-onde-elettromagnetiche-nuova-frontiera-per-il-trattamento-di-lesioni-al-cervello]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1122-malattia-di-alexander-nuovi-studi-sulla-correlazione-genotipo-fenotipo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1116-sla-trovato-il-gene-responsabile-della-forma-sporadica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1113-studi-renali-in-toscana-un-laboratorio-di-eccellenza-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1112-ipoplasia-renale-trovato-il-gene-responsabile-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1097-ritardo-mentale-x-linked-negli-animali-e-legato-al-ciclo-sonno-veglia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1016-distrofia-emery-dreifuss-legata-allx-individuate-otto-nuove-mutazioni-genetiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1013-meno-calorie-piu-cervello-controllare-lalimentazione-tiene-giovane-la-mente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1014-esposizione-a-raggi-x-dal-corpo-umano-una-reazione-protettiva-naturale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1025-sindrome-piastrine-grigie-trovato-il-gene-responsabile-della-rarissima-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1036-sindrome-kbg-al-bambino-gesu-di-roma-identificato-gene-responsabile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/1001-sindrome-antifosfolipidi-nuova-terapia-con-eparina-meno-effetti-collaterali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/999-diagnostica-si-fa-strada-dep-array-tecnologia-nata-a-bologna-e-oggi-pronta-alla-quotazione-in-borsa]]></loc><lastmod>2015-10-26T11:08:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/960-sindrome-di-noonan-portatori-della-mutazione-ptpn11a-maggiori-rischio-di-tumore]]></loc><lastmod>2022-09-22T15:19:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/953-sindrome-di-proteus-si-cerca-mutazione-genetica-nello-scheletro-di-joseph-merrick]]></loc><lastmod>2018-12-07T19:33:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/940-ricerca-nasce-galileo-research-prime-sfide-in-oncologia-e-nella-malattie-del-sistema-nervoso-centrale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/935-sclerodermia-giovanile-localizzata-da-studio-italiano-dati-favorevoli-alluso-del-metotressato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/917-mielolesioni-udine-stimolazione-elettrica-per-riattivare-la-locomozione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/901-glaucoma-a-trentanni-vede-per-la-prima-volta-grazie-alla-cheratoprotesi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/896-neuropatia-post-traumatica-a-le-scotte-di-siena-paziente-curato-con-la-neuromodulazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/876-mmunodeficienza-congenita-alluniversita-di-firenze-i-diritti-commerciali-del-test-brevettato-dal-meyer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/875-immunodeficienza-congenita-messo-a-punto-al-meyer-test-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/857-mastocitosi-lauria-oltre-al-prurito-si-rischiano-anche-reazioni-allergiche-gli-antistaminici-sono-spesso-usati-in-via-preventiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/845-glioma-delle-vie-ottiche-collirio-sperimentale-contenente-ngf-migliora-la-vista-nei-bimbi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/809-risonanza-magnetica-dal-prossimo-anno-la-7-tesla-a-campo-ultra-alto-alla-fondazione-imago-7]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/799-neuromielite-ottica-anche-nei-pazienti-affetti-da-questo-male-si-trovano-lesioni-cerebrali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/792-malattia-di-gaucher-la-terapia-enzimatica-sostitutiva-compie-20-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/785-oncocercosi-per-fermare-la-cecita-basta-un-farmaco-che-si-somministra-una-volta-lanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/780-malattia-di-lafora-ridurre-la-glicogeno-sintasi-potrebbe-ridurre-neurodegenerazione-ed-epilessia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/764-disturbi-identita-di-genere-in-sardegna-un-progetto-per-fare-il-punto-si-ricerca-e-trattamenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/763-glioblastoma-dalla-california-un-vaccino-che-potrebbe-aumentare-la-sopravvivenza]]></loc><lastmod>2016-02-18T17:04:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/748-malattie-rare-la-classifica-di-orphanet-sulla-prevalenza-dalla-sindrome-di-down-alla-progeria]]></loc><lastmod>2025-01-15T12:37:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/750-malattia-rare-orphanet-mette-in-ordine-la-bibliografia-dei-casi-clinici]]></loc><lastmod>2019-06-11T14:26:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/746-ricerca-studio-italiano-mostra-come-ripulire-le-cellule]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/742-cuore-per-gli-intrapiantabili-una-speranza-dal-cuore-artificiale-vad]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/724-ricerca-a-sigma-tau-l-award-research-excellence-per-gli-studi-sulle-carnitine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/709-malattie-rare-oggi-dieta-e-farmaci-domani-sempre-piu-genetica]]></loc><lastmod>2018-08-31T14:06:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/640-immunodeficienza-grave-combinata-diagnosi-neonatale-aumenta-del-50-per-cento-la-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/635-genetica-determinato-il-profilo-completo-dei-geni-alterati-nella-sindrome-di-down]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/630-eec-alla-mangiagalli-di-milano-due-interventi-perfettamente-riusciti-in-pochi-giorni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/628-rara-malformazione-cardiaca-da-collaborazione-tra-meyer-e-fondazione-monasterio-terapia-allavanguardia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/625-prematuri-scoperto-un-gene-che-puo-causare-la-nascita-anticipata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/612-deficit-delle-proteine-del-surfattante-il-dott-somaschini-ci-spiega-queste-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/611-deficit-della-proteina-del-surfattante-leccellenza-e-italiana-e-si-trova-al-san-raffaele]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/606-neuromielite-ottica-il-rituximab-puo-essere-un-possibile-trattamento-di-seconda-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/587-malattia-di-turner-studio-inglese-mostra-i-vantaggi-di-dare-estrogeni-a-partire-dai-9-anni]]></loc><lastmod>2019-06-11T14:32:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/584-staminali-e-acido-ialuronico-cosi-a-padova-si-provano-a-rigenerare-i-muscoli-scheletrici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/553-trapianti-al-policlinico-di-milano-si-riparano-polmoni-per-renderli-disponibili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/544-gastroschisi-alle-scotte-di-siena-eccezionale-intervento-salvavita-su-neonata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/534-fenomeno-di-raynaud-il-sildenafil-potrebbe-ridurre-gli-attacchi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/528-nefrite-lupica-ricercatori-italiani-scoprono-come-le-cellule-dendritiche-entrano-nei-reni-dei-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/481-sindrome-di-wolfram-nuovo-studio-smentisce-correlazione-grado-di-sordita-e-il-sesso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/466-sclerodermia-stop-alluso-alternativo-della-lidocaina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/463-blefarospasmo-i-risultati-del-blink-test-possono-aiutare-ad-individuare-le-forme-psicogene]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/442-farmaci-quelli-di-origine-plasmatica-saranno-studiati-a-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/432-scoperto-a-torino-il-gene-nt5e]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/423-staminali-le-embrionali-e-le-pluripotenti-indotte-non-si-equivalgono-del-tutto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/416-adhd-la-dieta-puo-aiutare-ma-i-test-delle-immunoglobuline-g-non-servono]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/415-distrofia-corneale-di-fuchs-nella-progressione-potrebbero-essere-coinvolti-i-radicali-liberi]]></loc><lastmod>2015-06-08T11:11:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/395-retinite-pigmentosa-al-tigem-di-napoli-primo-passo-verso-la-terapia-genica]]></loc><lastmod>2020-06-25T09:43:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/385-test-genetici-si-studia-una-nuova-tecnica-in-grado-di-individuare-oltre-400-possibili-mutazioni]]></loc><lastmod>2016-09-27T13:59:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/380-staminali-dalle-amniotiche-possibili-passi-avanti-per-le-terapie-rigenerative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/378-sfissia-neonatale-la-bambino-gesu-di-roma-arriva-la-terapia-che-scongiura-i-danni-cerebrali]]></loc><lastmod>2018-12-13T17:38:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/371-trombocitopenia-2-al-san-matteo-di-pavia-identificato-il-gene-responsabile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/360-ards-si-potrebbero-proteggere-i-polmoni-bloccando-la-delta-chinasi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/356-nuove-terapie-respiratorie-80-mln-in-ricerca-alla-chiesi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/354-sindrome-antifosfolipidi-facciamo-il-punto-della-situazione-con-il-prof-meroni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/352-sindrome-di-treacher-collins-individuate-nuove-mutazioni-genetiche]]></loc><lastmod>2022-01-05T18:59:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/343-sindrome-antifosfolipidi-aps-la-somministrazione-di-vitamina-d-aiuta-a-prevenire-le-trombosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/335-sindrome-di-turner-arriva-un-nuove-test-precoce-e-preciso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/328-neuromielite-ottica-potrebbe-esserci-un-legame-con-episodi-di-iperckemia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/298-les-dalla-fda-prima-approvazione-per-un-nuovo-anticorpo-monoclonale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/268-malattie-rare-il-sequenziamento-dellexome-ne-fa-individuare-sempre-piu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/256-anemia-di-fanconi-piccoli-passi-avanti-verso-la-terapia-genica-ma-ad-oggi-lunica-soluzione-e-ancora-il-trapianto-possibilmente-da-donatore-consanguineo-compatibile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/232-miopatia-facio-scapolo-omerale-fshd-studio-internazionale-sulla-correlazione-genotipo-fenotipo-dimostra-che-i-quadri-clinici-delle-due-forme-note-sono-identici]]></loc><lastmod>2020-06-11T18:00:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/196-dalla-nota-sla-alla-malattia-di-tay-sachs-il-prof-vescovi-lancia-dallumbria-la-nuova-sperimentazione-con-le-staminali-benedetta-dalliss]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/189-sindrome-di-mabry-scoperta-la-mutazione-responsabile-grazie-ad-un-nuovo-processo-di-analisi-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/183-sindrome-di-van-den-ende-gupta-il-progetto-canadese-radical-scopre-il-gene-responsabile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/179-dita-unite-o-labbro-leporino-associate-a-anomalie-dei-denti-e-dei-capelli-una-ricerca-italiana-ha-definito-meccanismi-patogenetici-comuni-di-due-forme-di-displasia-ectodermica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/173-sclerosi-sistemica-il-bosentan-riduce-la-formazione-di-nuove-lo-dimostra-uno-studio-firmato-dal-prof-matucci-cerinic-delluniversita-di-firenze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/156-genetica-un-nuovo-metodi-di-analisi-per-trovare-i-geni-responsabili-delle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/144-bubble-boys-terapia-genica-e-chemioterapia-insieme-per-ripristinare-il-sistema-immunitario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/133-ittiosi-a-coriandoli-i-ricercatori-sperano-di-poter-copiare-il-processo-spontaneo-che-genera-cellule-sane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/129-retinite-pigmentosa-tre-ricerche-condotta-in-germania-israele-e-usa-individuano-nuove-mutazioni-genetiche-responsabili-tra-gli-autori-anche-un-italia-il-prof-rivolta-che-da-anni-lavora-alluniversita-di-losanna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/126-gire-con-i-campi-magnetici-su-cervello-per-guarire-pronta-al-san-raffaele-la-nuova-stimolazione-transcranica-che-arriva-in-profondita]]></loc><lastmod>2024-10-09T18:16:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/120-distrofia-corneale-di-fuchs-studio-identifica-alterazione-genetica-che-moltiplica-il-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/109-spiegato-il-mistero-genetico-degli-ebrei-askenaziti-il-popolo-che-vive-100-anni-ma-mostra-unincidenza-superiore-di-alcune-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/99-malattia-di-rufs-scoperta-la-mutazione-che-la-causa-nei-cani-ora-la-ricerca-sulluomo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/91-indrome-di-kabuki-studio-americano-scopre-il-gene-che-mutando-causa-la-malattia-individuato-gia-33-differenti-mutazioni-del-gene-responsabile-il-mll2]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/71-sindrome-di-perrault-scoperti-i-geni-che-causano-la-rarissima-malattia-alla-ricerca-americana-condotta-su-una-famiglia-di-origini-irlandesi-italiane-ha-partecipato-anche-una-ricercatrice-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/59-bubbole-boy-al-via-un-nuovo-studio-sulla-terapia-genetica-potrebbe-portare-a-guarire-la-malattia-con-un-solo-trattamento-senza-trapianto-e-senza-chemioterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/57-trapianto-di-cornea-maggiori-rischi-se-ci-sono-neovascolarizzazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/43-retina-artificiale-creata-da-cellule-staminali-embrionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/41-osteopetrosi-maligna-maya-avra-una-vita-normale-grazie-al-trapianto-di-midollo-osseo-effettuato-al-san-matteo-di-pavia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/49-fshd-presentato-a-modena-il-primo-registro-nazionale-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/20-calcinosi-universale-la-speranza-da-un-ormone-di-sintesi-ma-i-soldi-per-la-ricerca-non-ci-sono]]></loc><lastmod>2016-10-25T07:10:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/ricerca-scientifica/16-calcinosi-tumorale-familiare-scoperte-tre-mutazioni-genetiche-responsabili-dellaccumulo-di-calcio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/22647-screening-neonatale-esteso-otto-nuove-patologie-annunciate-uninterrogazione-chiede-al-ministero-di-confermare-il-nuovo-panel]]></loc><lastmod>2026-03-04T16:59:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/22643-screening-genomico-alla-nascita-in-puglia-identificata-una-rarissima-malattia-neurometabolica]]></loc><lastmod>2026-01-05T14:04:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/22609-genoma-puglia-la-sfida-della-diagnosi-precoce-universale]]></loc><lastmod>2025-12-15T15:45:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/22520-gravidanza-e-screening-neonatale-uno-studio-italiano-apre-nuove-prospettive-per-la-medicina-preventiva]]></loc><lastmod>2025-11-25T09:41:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/22517-screening-neonatale-simmesn-bene-i-nuovi-lea-ma-attenzione-ai-bisogni-delle-famiglie-mentre-si-allarga-la-criticita-dei-minori-migranti]]></loc><lastmod>2025-11-14T18:18:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/22474-nuovi-lea-aismme-bene-le-otto-nuove-malattie-nello-screening-neonatale-ma-non-basta]]></loc><lastmod>2025-11-01T18:31:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/22420-leuropa-premia-linnovazione-italiana-nello-screening-neonatale-ferrara-riconosciuta-come-key-innovator]]></loc><lastmod>2025-10-16T17:04:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/22291-screening-neonatale-per-la-sma-interrogazione-in-senato-per-accelerare-lapprovazione-nazionale]]></loc><lastmod>2025-09-11T10:58:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/22233-screening-neonatale-genomico-un-nuovo-studio-indica-come-selezionare-i-geni-da-testare]]></loc><lastmod>2025-08-04T14:42:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/22004-quali-malattie-rare-includere-nello-screening-genetico-alla-nascita-il-progetto-screen4care-pubblica-il-nuovo-treat-panel]]></loc><lastmod>2025-05-20T18:32:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21930-screening-neonatale-entrano-nel-panel-sma-e-8-altre-patologie]]></loc><lastmod>2026-03-04T16:58:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21824-screening-neonatale-genomico-la-sfida-della-standardizzazione]]></loc><lastmod>2025-03-18T17:28:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21806-screening-neonatale-in-sardegna-incrementati-i-fondi-oltre-500mila-euro-da-utilizzare]]></loc><lastmod>2025-03-12T19:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21663-avviato-il-reclutamento-italiano-per-lo-screening-genetico-neonatale-del-progetto-screen4care]]></loc><lastmod>2025-01-28T09:16:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21653-screening-genetico-neonatale-la-puglia-incrementa-le-risorse-per-ampliare-la-copertura-a-tutti-i-neonati]]></loc><lastmod>2025-01-22T17:41:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21500-screening-genetico-neonatale-nasce-un-progetto-tutto-italiano-finanziato-dal-pnrr]]></loc><lastmod>2024-11-27T12:15:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21492-screen4care-il-lavoro-dell-ospedale-bambino-gesu-nella-realizzazione-dello-screening-genetico]]></loc><lastmod>2024-11-15T18:21:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21473-screen4care-a-che-punto-e-lo-studio-dello-screening-genetico-nei-neonati]]></loc><lastmod>2024-11-07T18:59:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21438-congresso-simmesn-2024-tantissimi-temi-trattati-alla-presenza-di-giovani-clinici-attenti-e-partecipi]]></loc><lastmod>2024-10-28T16:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21340-screening-neonatale-per-la-sma-ora-attivo-anche-in-emilia-romagna]]></loc><lastmod>2024-09-30T17:34:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21289-screening-neonatale-esteso-dall-on-malavasi-un-nuovo-sollecito-all-aggiornamento]]></loc><lastmod>2024-09-16T15:54:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21236-screen4care-120-scienziati-impegnati-per-la-diagnosi-tempestiva-attraverso-screening-genetico-neonatale]]></loc><lastmod>2024-11-07T17:44:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21222-genomica-una-risorsa-in-piu-al-servizio-dello-screening-neonatale]]></loc><lastmod>2024-08-06T13:52:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21125-screening-neonatale-sma-la-puglia-e-un-esempio-di-eccellenza-italiana]]></loc><lastmod>2024-06-28T14:06:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/21020-omar-diventa-collaboratore-e-divulgatore-per-l-italia-di-screen4care-progetto-di-ricerca-europeo-sullo-screening-genetico-neonatale]]></loc><lastmod>2024-05-28T08:50:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20918-screening-neonatale-in-sardegna-la-burocrazia-frena-l-ampliamento]]></loc><lastmod>2024-04-29T08:50:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20796-screening-genomico-neonatale-annunciati-i-risultati-del-progetto-rings]]></loc><lastmod>2024-03-25T12:11:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20691-screening-neonatali-la-simmesn-il-panel-sia-aggiornato-prima-possibile]]></loc><lastmod>2024-02-28T17:44:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20581-screening-per-la-sma-la-sicilia-approva-il-provvedimento-per-sottoporre-tutti-i-nuovi-nati]]></loc><lastmod>2024-02-03T12:30:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20540-screen4care-il-progetto-europeo-riunisce-screening-neonatale-e-tecnologie-digitali]]></loc><lastmod>2024-01-22T12:12:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20494-screening-neonatale-per-la-sma-attivo-in-veneto-ma-e-extra-lea-ancora-in-attesa-troppe-regioni]]></loc><lastmod>2024-01-13T14:07:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20445-screening-neonatale-in-veneto-dal-1-gennaio-attivo-per-la-sma]]></loc><lastmod>2023-12-15T17:27:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20414-screening-neonatale-dalle-associazioni-una-lettera-al-ministro-per-l-allargamento-della-lista-di-patologie]]></loc><lastmod>2023-12-20T16:35:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20395-screening-neonatale-pronto-in-lombardia-un-piano-di-progressivo-allargamento-del-panel]]></loc><lastmod>2023-11-29T13:19:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20383-screening-neonatale-esteso-dal-ministero-la-comunicazione-a-gennaio-la-sma-nel-panel]]></loc><lastmod>2023-11-27T10:18:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20376-screening-neonatale-esteso-in-liguria-con-programma-pilota-in-due-anni-salvati-4-bambini]]></loc><lastmod>2023-11-22T14:21:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20214-screening-neonatale-malavasi-necessario-aggiornare-panel-nazionale-attualmente-troppe-disparita-regionali]]></loc><lastmod>2023-10-10T13:47:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20186-screening-neonatale-puglia-risolve-il-problema-di-mancanza-di-fondi-effettivo-lo-sne-per-61-patologie]]></loc><lastmod>2023-10-05T07:23:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/20155-screening-neonatale-al-via-in-piemonte-un-progetto-per-la-mappatura-genetica-di-oltre-500-patologie]]></loc><lastmod>2023-09-27T17:59:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19995-atrofia-muscolare-spinale-sma-anche-la-lombardia-allarga-il-panel-dello-screening-neonatale]]></loc><lastmod>2023-07-11T15:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19883-screening-genomico-neonatale-il-suo-impiego-potrebbe-diminuire-i-tassi-di-mortalita-infantile]]></loc><lastmod>2023-06-12T10:18:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19693-puglia-in-soli-4-giorni-la-diagnosi-di-una-malattia-rarissima-vita-salvata-grazie-a-indagine-genetica]]></loc><lastmod>2023-04-05T18:51:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19646-malattie-lisosomiali-lo-screening-neonatale-rappresenta-un-assoluta-priorita]]></loc><lastmod>2023-03-23T21:59:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19605-screening-neonatale-esteso-presentata-interrogazione-parlamentare]]></loc><lastmod>2023-11-14T13:33:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19557-therareside-2023-futuro-dal-primo-giorno-la-storia-di-clara]]></loc><lastmod>2023-02-28T18:36:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19532-screening-neonatale-le-patologie-immediatamente-inseribili-nel-panel-e-quelle-da-rivalutare-a-breve]]></loc><lastmod>2023-03-15T09:26:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19531-screening-neonatale-10-nuove-malattie-rare-attendono-di-essere-incluse-nella-lista-nazionale]]></loc><lastmod>2023-02-14T11:39:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19472-screening-neonatale-in-abruzzo-altre-sette-malattie-incluse-nel-panel]]></loc><lastmod>2023-01-21T20:43:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19383-legge-di-bilancio-va-avanti-l-emendamento-dell-on-boschi-sullo-screening-neonatale]]></loc><lastmod>2022-12-12T11:23:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19367-screening-neonatale-per-le-malattie-metaboliche-ereditarie-le-novita-dall-ultimo-congresso-simmesn]]></loc><lastmod>2022-12-12T09:27:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/19013-screening-neonatale-quali-malattie-metaboliche-possono-essere-aggiunte-ai-pannelli-europei]]></loc><lastmod>2022-09-06T16:12:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/18712-decreto-tariffe-lo-stallo-dovuto-alla-conferenza-delle-regioni-impedisce-anche-l-aggiornamento-dello-screening-neonatale]]></loc><lastmod>2022-06-01T11:09:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/18412-screening-neonatale-l-impegno-congiunto-di-cometa-asmme-e-ospedale-di-padova]]></loc><lastmod>2022-03-13T18:40:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/18413-le-10-raccomandazioni-di-metabern-per-lo-screening-neonatale]]></loc><lastmod>2022-03-14T19:07:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/18263-malattie-rare-25-associazioni-chiedono-l-aggiornamento-dello-screening-neonatale]]></loc><lastmod>2022-02-14T18:29:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/18222-screening-neonatale-in-5-anni-l-italia-ha-fatto-progressi-ma-si-e-arenata-sull-aggiornamento-del-panel]]></loc><lastmod>2022-02-14T18:30:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/18221-screening-neonatale-sono-7-le-patologie-da-inserire-a-livello-nazionale]]></loc><lastmod>2022-01-26T11:44:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/18124-screening-neonatale-cade-la-necessita-degli-studi-di-hta-ora-procedere-all-aggiornamento-del-panel]]></loc><lastmod>2021-12-22T12:37:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/17852-screening-neonatale-da-4-mesi-si-attende-il-decreto-del-ministro-speranza-per-l-inserimento-della-sma]]></loc><lastmod>2021-10-04T10:24:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/17603-screening-neonatale-l-on-lapia-chiede-al-ministero-se-e-quando-intenda-inserire-le-malattie-lisosomiali]]></loc><lastmod>2021-06-30T16:42:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/17391-screening-neonatale-la-valutazione-di-nuove-patologie-dovrebbe-concludersi-a-fine-maggio]]></loc><lastmod>2021-05-04T13:28:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/17176-difetti-prossimali-del-ciclo-dell-urea-lo-screening-neonatale-e-possibile]]></loc><lastmod>2021-03-15T22:16:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16952-screening-neonatale-come-ridurre-il-costo-economico-e-sociale-dei-falsi-positivi]]></loc><lastmod>2021-02-02T09:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16943-screening-neonatale-in-liguria-un-progetto-pilota-per-sma-e-scid]]></loc><lastmod>2021-01-27T19:18:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16867-deficit-di-biotinidasi-lo-screening-neonatale-ha-salvato-i-nostri-figli]]></loc><lastmod>2021-01-07T17:32:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16841-screening-neonatale-legge-di-bilancio-mette-a-rischio-il-finanziamento]]></loc><lastmod>2020-12-23T12:55:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16820-screening-neonatale-sono-almeno-7-le-patologie-da-aggiungere-alla-lista-nazionale]]></loc><lastmod>2020-12-23T11:51:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16750-lo-screening-neonatale-e-attivo-in-tutta-italia-ma-la-calabria-non-fornisce-i-dati]]></loc><lastmod>2020-12-01T08:54:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16746-screening-neonatale-omar-consegna-al-gruppo-del-ministero-il-quaderno-prospettive-di-estensione-del-panel]]></loc><lastmod>2021-02-13T19:07:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16747-screening-neonatale-al-via-i-lavori-del-gruppo-sne]]></loc><lastmod>2020-11-30T08:47:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16708-screening-neonatale-omar-patologie-da-inserire-vi-sono-note-potete-fare-in-fretta]]></loc><lastmod>2020-11-19T11:28:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16703-screening-neonatale-non-c-e-tempo-da-perdere]]></loc><lastmod>2020-11-20T10:11:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/16628-screening-neonatale-interrogazione-binetti-sull-aggiornamento-del-panel]]></loc><lastmod>2020-10-30T12:30:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15697-screening-neonatale-l-esperienza-del-centro-di-coordinamento-del-lazio]]></loc><lastmod>2020-02-26T22:12:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15695-screening-neonatale-la-regione-toscana-pronta-ad-avviare-il-progetto-sulla-sma]]></loc><lastmod>2020-02-25T20:53:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15692-screening-neonatale-aip-onlus-plaude-all-approvazione-dell-emendamento-noja]]></loc><lastmod>2020-02-24T21:22:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15688-screening-neonatale-esteso-il-position-paper-delle-associazioni-di-pazienti]]></loc><lastmod>2020-02-24T11:34:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15665-screening-neonatale-dopo-la-diagnosi-viene-un-adeguata-presa-in-carico-dei-pazienti]]></loc><lastmod>2020-02-23T23:32:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15663-screening-neonatale-approvato-l-emendamento-noja]]></loc><lastmod>2020-02-13T17:48:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15653-screening-neonatale-qual-e-l-impatto-della-terapia-genica]]></loc><lastmod>2020-02-11T22:58:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15645-screening-neonatale-l-impegno-delle-istituzioni-nell-ampliamento-del-panel]]></loc><lastmod>2020-02-10T12:09:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15643-screening-neonatale-per-le-malattie-neuromuscolari-il-sondaggio-della-ern-euro-nmd]]></loc><lastmod>2020-02-09T22:23:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15631-malattie-lisosomiali-in-veneto-il-progetto-di-screening-neonatale-piu-vasto-d-europa]]></loc><lastmod>2020-02-05T08:25:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15609-screening-neonatale-le-associazioni-di-pazienti-lanciano-appello-a-sostegno-dell-emendamento-noja]]></loc><lastmod>2020-01-28T15:17:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15564-screening-neonatale-sviluppati-nuovi-test-per-diverse-malattie-rare]]></loc><lastmod>2020-01-11T18:44:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15500-screening-neonatale-in-alcune-regioni-si-sta-gia-valutando-l-inserimento-di-nuove-patologie]]></loc><lastmod>2019-12-10T18:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15497-screening-neonatale-le-associazioni-lisosomiali-presenti-al-convegno-di-roma]]></loc><lastmod>2019-12-10T14:54:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15499-screening-neonatale-a-tre-anni-dall-avvio-si-guarda-ad-un-ampliamento-del-panel-di-malattie]]></loc><lastmod>2019-12-10T18:08:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15498-screening-neonatale-esteso-presentato-il-position-paper-di-uniamo-fimr-onlus]]></loc><lastmod>2019-12-10T17:18:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15501-screening-neonatale-il-test-per-la-sma-puo-cambiare-la-storia-naturale-della-malattia]]></loc><lastmod>2019-12-10T18:09:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15502-screening-neonatale-aip-occorre-pensare-alle-immunodeficienze-primitive]]></loc><lastmod>2019-12-10T18:11:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15496-malattie-rare-il-96-5-dei-neonati-ha-avuto-lo-screening-metabolico-nel-2012-era-il-25]]></loc><lastmod>2019-12-10T18:00:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15436-screening-neonatale-esteso-lanciata-la-campagna-informativa-sneinaction]]></loc><lastmod>2019-11-23T15:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/15010-screening-neonatale-il-modello-italiano-adottato-dall-osce]]></loc><lastmod>2019-10-01T10:44:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14854-screening-neonatale-la-battaglia-di-un-padre-per-introdurre-in-irlanda-il-modello-italiano]]></loc><lastmod>2019-05-29T11:03:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14846-screening-neonatale-per-le-omocistinurie-troppe-le-differenze-fra-gli-stati-europei]]></loc><lastmod>2019-05-27T15:11:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14782-screening-neonatale-per-la-scid-l-esperienza-californiana]]></loc><lastmod>2019-05-07T10:42:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14444-screening-neonatale-aismme-a-bruxelles-per-parlare-della-legge-167-2016]]></loc><lastmod>2019-02-10T21:23:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14401-screening-neonatale-omar-pietra-miliare-italiana-per-un-percorso-europeo]]></loc><lastmod>2019-01-30T19:10:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14400-screening-neonatale-la-sen-paola-taverna-porta-il-modello-italiano-in-ue]]></loc><lastmod>2019-01-30T12:01:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14362-screening-neonatale-per-malattie-lisosomiali-ecco-perche-e-fondamentale]]></loc><lastmod>2019-01-30T10:48:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14350-avviato-lo-screening-neonatale-esteso-al-san-carlo-di-potenza]]></loc><lastmod>2019-04-16T14:39:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14269-acidemia-metilmalonica-con-omocisitinuria-con-lo-screening-possibile-la-presa-in-carico-immediata]]></loc><lastmod>2019-01-08T12:16:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14262-malattie-metaboliche-dallo-screening-neonatale-alla-medicina-metabolica-dell-adulto]]></loc><lastmod>2018-12-17T12:18:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14255-omocistinuria-e-acidurie-organiche-l-importanza-di-screening-neonatale-e-test-secondari]]></loc><lastmod>2018-12-11T13:05:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14234-screening-neonatale-approvato-l-emendamento-volpi]]></loc><lastmod>2018-12-04T10:50:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14188-screening-neonatale-l-appello-delle-associazioni-per-l-approvazione-dell-emendamento-alla-legge-167-200]]></loc><lastmod>2018-11-23T11:08:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14165-screening-neonatale-un-emendamento-dei-5-stelle-propone-di-andare-oltre-le-malattie-metaboliche]]></loc><lastmod>2018-11-19T09:22:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/14145-screening-neonatale-ignorato-l-appello-dell-organizzazione-mondiale-della-sanita]]></loc><lastmod>2018-11-12T21:49:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13846-screening-neonatale-da-settembre-sara-ampliato-in-toscana]]></loc><lastmod>2018-10-28T18:15:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13777-screening-neonatale-la-proposta-inglese-una-revisione-sistematica-a-livello-internazionale]]></loc><lastmod>2018-07-20T16:27:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13778-screening-neonatale-una-scarsa-informazione-sui-rischi-e-i-benefici]]></loc><lastmod>2018-07-20T16:27:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13469-screening-neonatali-il-centro-di-coordinamento-ha-completato-la-mappatura-dei-centri]]></loc><lastmod>2018-04-20T11:08:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13441-screening-neonatale-il-lazio-nomina-il-centro-di-coordinamento-regionale-guidato-da-di-lallo]]></loc><lastmod>2018-04-16T12:12:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13381-screening-neonatale-in-piemonte-e-valle-d-aosta-raddoppiate-le-diagnosi-preventive]]></loc><lastmod>2018-03-27T21:08:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13305-screening-neonatale-obbligatorio-un-traguardo-raggiunto-che-per-aismme-significa-nuovi-obiettivi]]></loc><lastmod>2018-03-05T13:04:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13297-triplicati-in-un-anno-i-casi-di-una-rara-malattia-metabolica-fra-le-cause-la-dieta-vegana]]></loc><lastmod>2018-03-01T13:30:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13298-i-difetti-della-rimetilazione-sette-malattie-metaboliche-incluse-nel-pannello-di-screening]]></loc><lastmod>2018-03-01T13:28:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13135-screening-neonatale-migliorare-i-test-per-includere-le-malattie-da-accumulo-lisosomiale]]></loc><lastmod>2018-01-22T16:18:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/13067-screening-neonatale-i-dati-sulle-malattie-da-accumulo-lisosomiale-nel-nor-est-italia]]></loc><lastmod>2017-12-24T16:48:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12972-screening-neonatale-ciancaleoni-omar-la-legge-167-non-chiede-la-firma-del-consenso-informato-una-ragione-in-piu-per-fare-campagne-di-comunicazione]]></loc><lastmod>2017-12-01T11:48:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12750-screening-neonatale-esteso-primi-bilanci-dal-burlo-garofolo-di-trieste]]></loc><lastmod>2017-10-07T17:18:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12654-screening-neonatale-la-puglia-si-adegua-e-fa-rete-con-la-basilicata]]></loc><lastmod>2022-05-24T16:44:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12648-screening-neonatale-dove-manca-i-bambini-rischiano-la-vita]]></loc><lastmod>2017-09-14T16:52:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12529-screening-neonatale-sempre-piu-accurati-i-test-per-individuare-diverse-malattie-lisosomiali]]></loc><lastmod>2017-12-24T15:53:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12456-screening-neonatale-25-milioni-di-euro-a-disposizione-delle-regioni]]></loc><lastmod>2017-07-02T18:25:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12267-maternita-e-malattie-rare-l-importanza-della-prevenzione-e-dello-screening-neonatale]]></loc><lastmod>2017-05-12T09:59:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12140-emilia-romagna-addio-allo-screening-limitato-a-23-malattie]]></loc><lastmod>2017-04-06T16:32:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12098-screening-neonatale-il-31-marzo-prima-riunione-del-centro-di-coordinamento]]></loc><lastmod>2017-03-20T16:14:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12043-screening-neonatale-aip-onlus-nel-centro-di-coordinamento]]></loc><lastmod>2017-03-08T11:09:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/12029-screening-neonatale-il-meyer-punto-di-riferimento-azionale-per-la-diagnosi-precoce-delle-malattie-metaboliche-ereditarie]]></loc><lastmod>2017-03-06T14:26:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11995-screening-neonatale-esteso-un-diritto-alla-vita-per-tutti-i-bambini]]></loc><lastmod>2017-02-26T17:10:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11904-malattie-da-accumulo-lisosomiale-la-fda-approva-il-primo-sistema-di-screening-neonatale]]></loc><lastmod>2017-02-09T17:02:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11820-screening-omar-bene-la-scelta-di-giancarlo-la-marca-al-coordinamento-screening-neonatale]]></loc><lastmod>2017-03-19T18:03:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11816-screening-neonatale-allargato-da-febbraio-si-fara-anche-in-piemonte]]></loc><lastmod>2017-01-18T15:52:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11814-screening-neonatale-in-puglia-nessun-ruolo-per-la-biofordrug-del-prof-colabufo]]></loc><lastmod>2017-02-06T16:15:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11809-malattie-da-accumulo-lisosomiale-il-78-dei-pazienti-e-favorevole-allo-screening-neonatale]]></loc><lastmod>2017-01-15T16:26:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11815-screening-domani-la-stato-regioni-nomina-il-proprio-rappresentante-nel-centro-di-coordinamento]]></loc><lastmod>2017-01-19T08:00:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11808-omocistinuria-e-difetti-della-metilazione-quando-e-consigliato-lo-screening-neonatale]]></loc><lastmod>2017-01-15T16:26:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11783-puglia-al-via-lo-screening-neonatale-allargato-per-piu-di-40-malattie-metaboliche]]></loc><lastmod>2017-02-06T16:11:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11625-screening-neonatale-presto-un-ddl-per-indirne-la-giornata-nazionale]]></loc><lastmod>2016-11-21T11:53:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11624-screening-neonatale-allargato-arrivato-dm-che-salva-i-fondi-mai-utilizzati]]></loc><lastmod>2016-11-21T10:30:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11488-sindrome-dei-bambini-bolla-in-arrivo-il-test-per-la-diagnosi-neonatale-italiano]]></loc><lastmod>2016-10-19T13:12:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11174-screening-neonatale-la-legge-167-2016-e-in-gazzetta-in-vigore-dal-15-settembre]]></loc><lastmod>2016-09-02T07:05:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11166-screening-neonatale-friuli-in-soli-5-mesi-la-malattia-di-2-bimbi-e-stata-individuata-alla-nascita]]></loc><lastmod>2016-08-31T13:21:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11090-screening-neonatale-obbligatorio-per-legge-il-commento-dell-associazione-aismme]]></loc><lastmod>2016-08-05T11:46:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11082-screening-neonatale-allargato-e-legge-il-senato-ha-approvato-il-ddl-taverna-ora-l-inserimento-nei-lea]]></loc><lastmod>2016-08-31T13:24:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/11053-screening-neonatali-la-commissione-sanita-del-senato-si-accinge-a-votare-il-ddl-taverna-in-sede-deliberante]]></loc><lastmod>2016-07-29T10:55:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10807-screening-neonatale-l-associazione-aismme-l-italia-e-un-paese-all-avanguardia]]></loc><lastmod>2016-06-18T10:48:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10798-screening-neonatali-camera-approva-all-unanimita-il-disegno-di-legge]]></loc><lastmod>2016-06-16T13:07:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10783-screening-neonatali-prosegue-l-iter-del-disegno-di-legge-de-filippo-pieno-sostegno-del-governo]]></loc><lastmod>2016-06-14T07:30:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10756-screening-neonatale-ancora-ritardi-per-il-ddl-taverna]]></loc><lastmod>2016-06-08T10:49:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10496-screening-neonatali-possibile-l-approvazione-definitiva-entro-le-prossime-settimane]]></loc><lastmod>2016-04-29T10:24:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10248-screening-allargato-nel-2014-test-eseguito-sul-43-dei-neonati-italiani-ora-sia-obbligo-nazionale]]></loc><lastmod>2016-03-24T07:31:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10246-screening-neonatali-iniziato-l-esame-del-ddl-taverna-alla-camera]]></loc><lastmod>2016-03-23T13:31:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10213-lorenzin-non-vogliamo-affossare-il-ddl-sugli-screening-neonatali-mio-decreto-era-dovuto]]></loc><lastmod>2016-03-18T11:35:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10196-screening-neonatale-a-rischio-la-salute-di-480-000-neonati-all-anno-il-dibattito-si-accende]]></loc><lastmod>2016-03-23T09:55:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10195-screening-neonatale-a-rischio-sen-taverna-ci-appelliamo-anche-a-tecnici-e-a-regioni]]></loc><lastmod>2016-03-15T09:03:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10172-screening-neonatale-uniamo-fimr-onlus-il-governo-gioca-sulla-salute-dei-cittadini]]></loc><lastmod>2016-03-11T11:29:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10169-giu-le-mani-dagli-screening-neonatali-il-ministero-rischia-di-negare-diritto-alla-salute-dei-neonati-italiani]]></loc><lastmod>2016-03-11T10:16:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/10141-tirosinemia-di-tipo-1-si-puo-curare-con-screening-neonatale-e-monitoraggio-costante]]></loc><lastmod>2016-03-08T16:03:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9962-screening-neonatale-allargato-entro-aprile-prendera-il-via-l-iter-alla-camera]]></loc><lastmod>2016-02-12T15:20:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9890-malattie-rare-metaboliche-lo-screening-arriva-in-friuli-venezia-giulia]]></loc><lastmod>2016-02-03T10:26:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9654-fibrosi-cistica-anche-l-abruzzo-effettuera-lo-screening-neonatale]]></loc><lastmod>2015-12-21T16:08:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9653-lo-screening-neonatale-per-le-malattie-da-accumulo-lisosomiale-il-punto-di-vista-dei-fornitori-di-assistenza-sanitaria-genetica]]></loc><lastmod>2015-12-21T16:05:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9648-screening-neonatale-il-commento-di-aismme]]></loc><lastmod>2015-12-18T15:36:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9647-screening-neonatali-gia-previsti-i-fondi-per-farli-rientrare-nei-lea]]></loc><lastmod>2015-12-18T15:18:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9641-paola-taverna-m5s-gli-screening-neonatali-entreranno-nei-lea-felice-per-questo-risultato]]></loc><lastmod>2015-12-18T07:53:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9639-screening-neonatale-il-commento-del-presidente-di-uniamo-fimr-onlus]]></loc><lastmod>2015-12-17T15:45:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9638-screening-neonatale-ddl-taverna-approvato-questa-mattina-dal-senato]]></loc><lastmod>2015-12-17T14:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9477-inserimento-screening-neonatale-esteso-nei-lea-l-appello-di-uniamo-fimr-onlus]]></loc><lastmod>2015-11-30T08:24:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9435-malika-4-mesi-e-morta-per-la-malattia-di-pompe-lo-screening-l-avrebbe-probabilmente-salvata]]></loc><lastmod>2015-11-30T08:27:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/9321-immunodeficienze-primitive-escluse-dallo-screening-neonatale-i-pazienti-si-appellano-a-lorenzin]]></loc><lastmod>2015-11-09T11:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8983-screening-neonatale-laura-bianconi-ncd-inserire-nel-decreto-anche-la-scid]]></loc><lastmod>2015-09-24T14:16:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8478-screening-neonatale-quali-patologie-il-progetto-pilota-per-malattia-di-pompe-fabry-e-mucopolicassaridosi-tipo-i]]></loc><lastmod>2015-07-22T08:16:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8636-prosegue-in-senato-l-istruttoria-della-proposta-di-legge-presentata-da-paola-taverna-m5s]]></loc><lastmod>2015-07-16T14:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8594-screening-neonatale-esteso-ancora-attese-per-per-l-approvazione-del-disegno-di-legge]]></loc><lastmod>2015-07-09T11:06:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8576-fenilchetonuria-screening-e-presa-in-carico-nel-sud-est-europa]]></loc><lastmod>2016-03-24T15:27:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8530-screening-neonatale-promossa-la-metodica-della-spettrometria-di-tandem-massa]]></loc><lastmod>2015-06-26T11:01:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8523-un-neonato-ogni-5000-e-affetto-da-patologie-metaboliche-ereditarie]]></loc><lastmod>2018-02-15T18:08:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8519-screening-neonatale-esteso-i-pediatri-italiani-sanno-cos-e]]></loc><lastmod>2015-06-26T09:49:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8487-i-metodi-di-screening-neonatale-nel-mondo-cordone-ombelicale-o-goccia-di-sangue]]></loc><lastmod>2015-06-19T13:52:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8411-screening-neonatale-la-battaglia-della-sen-taverna-per-l-approvazione-del-ddl]]></loc><lastmod>2015-06-09T15:09:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8404-screening-neonatale-l-impegno-del-tavolo-interregionale-per-le-malattie-rare]]></loc><lastmod>2015-06-09T11:31:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8272-malattie-metaboliche-ereditarie-un-progetto-per-potenziare-il-centro-screening-di-verona]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8210-screening-neonatale-esteso-ecco-la-bozza-del-decreto-sullo-scriing-trasmesso-da-lorenzin-alle-regioni]]></loc><lastmod>2015-07-09T09:24:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8209-screening-neonatale-sen-taverna-ritardo-di-un-anno-come-sono-stati-usati-i-fondi]]></loc><lastmod>2015-05-29T14:42:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8146-screening-neonatale-per-duchenne-sma-e-malattia-di-pompe-unipotesi-vantaggiosa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8170-screening-neonatale-pronto-lelenco-delle-patologie-e-il-decreto-ministeriale]]></loc><lastmod>2015-07-09T09:21:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/8157-lo-screening-neonatale-scalda-i-motori-regioni-chiamate-a-fornire-il-proprio-parere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/7958-screening-metabolico-allargato-da-gennaio-2015-avviato-anche-nella-regione-marche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/7788-2015-03-09-14-44-48]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/7453-screening-metabolico-allargato-per-le-malattie-rare-al-tg2-lorenzin-commenta-servizio-asimme]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/7368-deficit-di-g6pd-possibile-la-diagnosi-precoce-grazie-al-test-di-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/7377-screening-neonatale-nel-regno-unito-il-via-ad-un-nuovo-programma-per-le-malattie-genetiche-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/7307-screening-neonatale-metabolico-allargato-ora-disponibile-un-vademecum-per-il-pediatra]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/7127-screening-metabolico-neonatale-allargato-prezioso-alleato-del-pediatra-risorsa-fondamentale-per-la-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/7024-losservatorio-al-senato-lo-screening-neonatale-come-straordinario-strumento-di-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6962-screening-neonatale-il-governatore-tom-corbett-firma-nuovo-disegno-di-legge]]></loc><lastmod>2019-06-18T17:54:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6905-ipotiroidismo-congenito-nei-bambini-prematuri-e-necessario-ripetere-lo-screening]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6637-immunodeficienza-combinata-grave-test-trec-rileva-la-condizione-nei-neonati]]></loc><lastmod>2019-06-18T18:02:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6459-screening-neonatale-allargato-m5s-interroga-il-ministro-sul-grave-ritardo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6417-screening-neonatale-entro-il-2015-screening-allargato-nelle-marche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6368-screening-neonatale-ampliato-il-progetto-pilota-in-gran-bretagna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6348-malattie-rare-processo-decisionale-per-migliorare-i-programmi-di-screening-neonatale-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6350-screening-neonatale-epposi-pubblica-i-risultati-di-una-revisione-dei-programmi-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6325-screening-neonatale-i-genitori-sono-favorevoli]]></loc><lastmod>2019-06-18T18:10:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6156-screening-neonatale-negli-usa-si-discute-linclusione-delle-patologie-da-accumulo-lisosomiale]]></loc><lastmod>2019-06-18T18:17:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/6037-screening-neonatale-la-ricerca-italiana-va-avanti-ma-la-politica-resta-indietro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5960-screening-neonatale-come-e-cambiato-negli-ultimi-50-anni-e-come-cambiera-in-futuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5791-iperplasia-congenita-dei-surreni-sperimentata-una-nuova-procedura-di-screening-neonatale]]></loc><lastmod>2019-06-18T18:28:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5743-oligosaccaridosi-sperimentata-una-nuova-strategia-di-screening]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5740-malattie-da-accumulo-lisosomiale-nuovo-protocollo-permette-lo-screening-neonatale-simultaneo-di-6-patologie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5756-malattie-rare-lo-screening-neonatale-sempre-piu-necessario-per-emoglobinopatie-e-patologie-lisosomiali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5757-malattie-rare-lo-screening-neonatale-sempre-piu-necessario-per-emoglobinopatie-e-patologie-lisosomiali-96835327]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5575-malattie-della-tiroide-raccomandato-lo-screening-universale-in-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5482-screening-neonatale-leredita-di-50-anni-di-test-per-la-fenilchetonuria]]></loc><lastmod>2016-03-24T15:28:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5392-deficit-macdd-patologia-piu-diffusa-di-quanto-si-pensi-necessario-lo-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5356-ipotiroidismo-congenito-lo-screening-neonatale-deve-essere-reso-universale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5323-screening-neonatale-allargato-in-puglia-stanziati-i-fondi-per-avviarlo]]></loc><lastmod>2015-12-21T12:25:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5168-screening-neonatale-a-foggia-sara-avviata-lindagine-per-40-malattie-metaboliche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5136-screening-neonatale-per-la-fibrosi-cistica-e-in-puglia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5113-acidemia-glutarica-di-tipo-i-lo-screening-neonatale-rappresenta-una-strategia-vantaggiosa-anche-economicamente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5010-screening-neonatale-il-destino-di-una-vita-in-una-goccia-di-sangue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5017-screening-neonatale-pedron-aismme-qil-destino-di-una-vita-puo-cambiare-con-un-test-ma-tutto-dipende-ancora-dalla-fortuna-non-e-accettabileq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/5016-screening-neonatale-la-marca-meyer-q]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4907-anemia-falciforme-disponibili-le-raccomandazioni-italiane-dellaieop]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4885-malattie-metaboliche-ed-encefalopatie-i-neonati-hanno-diritto-allo-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4798-screening-neonatale-allargato-entro-fine-2014-sara-avviato-anche-nelle-marche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4780-screening-neonatale-per-la-fibrosi-cistica-vorresti-essere-informato-se-tuo-figlio-risultasse-portatore-sano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4789-screening-neonatale-in-veneto-padova-pronta-a-partire-a-gennaio-ma-saranno-le-singole-asl-a-dover-aderire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4739-dal-paziente-orfano-di-terapia-alle-terapie-orfane-di-pazientilo-screening-neonatale-allargato-potrebbe-risolvere-il-problema-delle-diagnosi-tardive]]></loc><lastmod>2017-10-05T10:25:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4744-malattia-di-krabbe-una-semplice-tecnica-biochimica-potrebbe-facilitare-lo-screening]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4711-screening-neonatale-il-centro-bambino-gesu-della-basilicata-aderisce-al-programma-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4486-screening-neonatale-pubblicato-il-parere-eucerd-per-una-politica-di-condivisione-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4401-screening-neonatale-allargato-in-veneto-sara-avviato-nel-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4383-screening-neonatale-per-le-lisosomiali-leccellenza-dellumbria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4291-screening-neonatale-necessaria-la-collaborazione-a-livello-europeo-verso-politiche-piu-uniformi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4287-screening-neonatale-allargato-anche-il-m5s-chiede-una-politica-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4265-screening-neonatale-per-le-emoglobinopatie-il-modello-friulano-funziona]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4266-fibrosi-cistica-finalmente-anche-in-basilicata-lo-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4259-regione-liguria-i-pionieri-dello-screening-neonatale-ieri-e-domani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4190-malattia-di-pompe-negli-usa-si-raccomanda-lo-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4191-screening-neonatale-allargato-una-lettera-aperta-al-ministro-lorenzin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4145-malattia-di-wilson-la-sardegna-e-ideale-per-un-progetto-pilota-di-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4069-screening-neonatale-allargato-in-veneto-ancora-polemica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4061-malattie-metaboliche-ereditarie-proposta-di-legge-sullo-screening-neonatale-obbligatorio]]></loc><lastmod>2015-05-28T13:00:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/4004-screening-neonatale-negli-usa-salvati-12000-bambini-allanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3990-screening-neonatale-uno-dei-progressi-piu-importanti-del-ventesimo-secolo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3989-screening-neonatale-usa-festeggiano-i-50-anni-in-italia-su-quello-allargato-ce-ancora-molto-da-fare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3985-ipotiroidismo-congenito-25-anni-di-sorveglianza-grazie-al-registro-nazionale-inrich]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3831-malattia-di-pompe-e-distrofia-muscolare-di-duchenne-proposto-screening-per-i-neonati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3770-screening-anche-le-marche-guardano-ad-un-progetto-pilota-sulle-lisosomiali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3654-screening-neonatale-per-le-lisosomiali-ottimi-risultati-per-il-progetto-pilota-in-umbria]]></loc><lastmod>2020-10-12T09:40:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3719-screening-neonatale-fondamentali-tanto-quanto-la-ricerca-scientifica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3711-screening-neonatale-aismme-quando-e-un-semplice-test-a-fare-la-differenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3597-screening-neonatale-negli-usa-un-database-condiviso-da-quattro-stati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3596-mucopolisaccaridosi-negli-usa-sara-avviato-un-programma-di-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3578-atassia-telangiectasia-puo-essere-diagnosticata-con-lo-screening-neonatale-che-si-usa-per-la-scid]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3532-screening-neonatale-in-campania-non-si-fara-il-test-per-le-malattie-metaboliche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3512-screening-neonatale-in-italia-copre-solo-un-quarto-delle-malattie-metaboliche-individuabili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3461-immunodeficienza-primaria-uno-studio-conferma-lopportunita-di-inserirle-tra-gli-screening-neonatali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3478-screening-neonatale-leccellenza-di-firenze-sara-esportata-negli-usa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3408-screening-neonatale-per-le-lisosomiali-spunti-interessanti-da-uno-studio-americano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3409-screening-neonatale-per-le-lisosomali-rimane-lo-scoglio-dellesordio-tardivo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3412-screening-neonatali-per-le-malattie-rare-possibili-sviluppi-futuri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3410-screening-neonatale-e-malattie-lisosomiali-il-dibatto-sul-pannello-uniforme]]></loc><lastmod>2025-10-28T17:35:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3402-screening-neonatale-allargato-in-veneto-si-e-giunti-a-una-decisione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3382-screening-neonatale-in-veneto-ancora-polemiche-tra-padova-e-verona]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3374-screening-neonatale-corbetta-necessaria-una-modalita-unica-per-i-test-e-per-la-conservazione-del-materiale-biologico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3373-screening-neonatale-serve-un-network-nazionale-per-raccogliere-e-conservare-i-campioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3351-screening-neonatale-potrebbe-essere-esteso-anche-alla-distrofia-di-duchenne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3253-screening-neonatale-dalla-toscana-un-progetto-per-litalia-sul-test-per-lada-scid]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3198-screening-neonatale-allargato-in-veneto-pronte-le-apparecchiature-ma-tardano-le-decisioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3188-screening-neonatale-i-materiali-informativi-sono-utili-ma-la-consulenza-e-fondamentale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3189-screening-neonatale-i-materiali-informativi-sono-utili-ma-la-consulenza-e-fondamentale-18780517]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3156-tirosinemia-epatorenale-la-diagnosi-precoce-e-la-giusta-terapia-permettono-ai-pazienti-una-vita-normale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3029-tirosinemia-di-tipo-iii-lo-screening-neonatale-consente-ai-pazienti-una-vita-normale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3025-anemia-falciforme-lo-screening-neonatale-potrebbe-salvare-molte-vite]]></loc><lastmod>2018-10-14T17:59:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3023-screening-neonatale-in-puglia-anche-il-prof-luciano-cavallo-esprime-la-sua-soddisfazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/3009-screening-neonatale-in-puglia-papadia-in-due-anni-quello-allargato-ma-a-breve-il-test-per-la-fibrosi-cistica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2993-screening-in-puglia-pedron-aismme-apprendiamo-con-soddisfazione-la-notizia-dellallargamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2988-screening-neonatale-in-puglia-la-soddisfazione-dellassociazione-amegep]]></loc><lastmod>2019-07-10T13:34:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2973-screening-neonatale-la-puglia-verso-lallargamento-a-30-malattie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2933-screening-neonatale-in-sardegna-e-realta-diagnosticato-a-cagliari-un-caso-di-malattia-metabolica-ereditaria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2853-screening-lappello-di-aismme-per-allagamento-e-uniformita-del-test-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2855-screening-neonatale-negli-usa-si-effettua-su-4-milioni-di-neonati-lanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2876-screening-neonatali-presentato-emendamento-bipartisan-per-inserirli-nei-lea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2810-screening-pratica-in-aumento-nei-paesi-a-basso-e-medio-reddito]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2828-screening-neonatali-cittadinanzattiva-chiede-inserimento-nei-lea-indirizzi-chiari-per-le-regioni-percorsi-integrati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2580-screening-neonatale-seidita-aig-parlarne-nei-corsi-pre-parto-per-un-vero-consenso-informato]]></loc><lastmod>2015-05-28T14:47:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2557-screening-neonatale-il-consenso-informato-e-una-procedura-possibile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2340-diagnosi-prenatale-piu-precisa-se-si-usa-il-dna-dei-genitori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/2138-diagnosi-neonatale-del-difetto-di-adenosina-deminasi-disponibile-il-test-precoce-grazie-a-meyer-e-univerista-di-firenze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1991-screening-neonatale-in-gran-bretagna-progetto-pilota-per-400000-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1816-screening-neonatale-per-malattie-lisosomiali-troppo-delicato-per-essere-trattato-a-livello-regionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1682-screening-neonatale-metabolico-allargato-lappello-di-aismme-onlus-alla-conferenza-stato-regioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1599-screening-neonatale-anche-la-sardegna-verso-quello-allargato-ad-oltre-40-malattie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1600-screening-neonatale-toscana-storia-di-uneccellenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1544-anemia-falciforme-oggi-un-convegno-a-modena-con-il-prof-lucio-luzzatto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1497-101screening-studio-austriaco-su-malattie-lisosomiali-mostra-incidenza-maggiore-di-quella-attesa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1320-screening-neonatale-dallapiccola-necessario-fare-piu-informazione-e-incrementare-lofferta-nelle-regioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1318-screening-neonatale-appello-della-consulta-delle-malattie-rare-a-cernobbio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1217-screening-neonatale-dallemilia-romagna-un-depliant-informativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1197-screening-cerone-simmesn-screening-neonatale-metabolico-allargatoavere-la-strumentazione-e-solo-un-punto-di-partenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1190-screening-neonatale-pedron-aismme-italia-a-macchia-di-leopardo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1191-screening-metabolico-allargato-i-tanti-volti-ditalia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1135-malattie-metaboliche-rare-ne-sani-ne-malati-arrivano-i-patients-in-waiting]]></loc><lastmod>2015-06-05T17:14:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1136-malattia-di-krabbe-negli-usa-ce-un-programma-di-screening]]></loc><lastmod>2015-06-05T17:12:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/1087-screening-neonatale-al-santa-croce-di-fano-arrivera-la-tandem-mass]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/877-malattie-rare-dal-governo-nessuna-vera-apertura-sugli-screening-neonatali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/697-screening-neonatale-tirosinemia-e-disturbi-del-ciclo-dellurea-si-possono-scoprire-dalla-nascita-e-curare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/574-allargamento-degli-screening-e-delle-esenzioni-le-regioni-fanno-da-sole]]></loc><lastmod>2015-06-08T09:50:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/441-screening-neonatale-passano-da-3-a-30-le-malattie-rare-ricercate-in-emilia-romagna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/404-screening-neonatale-corriereit-fa-il-punto-sui-centri-allavanguardia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/screening-neonatale/229-liguria-allavanguardia-in-italia-nello-screening-neonatale-delle-malattie-metaboliche-ereditarie-sono-33-le-malattie-che-vengono-analizzate-sulla-stessa-goccia-di-sangue-presso-listituto-g-gaslinidi-genova-ndal-2005-centro-di-riferimento-regionale-per]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22854-lupus-eritematoso-sistemico-pubblicati-i-risultati-dello-studio-di-fase-iii-su-obinutuzumab]]></loc><lastmod>2026-03-18T17:03:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22836-atrofia-ottica-autosomica-dominante-avviato-il-primo-studio-clinico-al-mondo]]></loc><lastmod>2026-03-11T19:01:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22805-staminali-trattamenti-illeciti-a-domicilio-anche-in-italia-linchiesta-di-presadiretta-con-il-contributo-di-ota]]></loc><lastmod>2026-03-02T10:15:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22797-curarsi-con-le-staminali-attenzione-alle-truffe-anche-in-italia]]></loc><lastmod>2026-02-27T16:18:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22638-teleangectasia-emorragica-ereditaria-risultati-promettenti-da-nuovo-farmaco-sperimentale]]></loc><lastmod>2026-01-02T18:36:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22574-sperimentazioni-cliniche-per-la-prima-volta-parlano-i-pazienti]]></loc><lastmod>2025-12-02T12:20:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22422-oncologia-lo-studio-clinico-rome-evidenzia-il-valore-di-un-approccio-agnostico]]></loc><lastmod>2025-11-05T11:32:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22360-trial-clinici-e-malattie-rare-come-affrontare-la-sfida-del-reclutamento-dei-partecipanti]]></loc><lastmod>2025-10-08T10:55:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22242-sindrome-di-usher-importante-recupero-della-vista-per-il-primo-paziente-trattato-con-terapia-genica-a-doppio-vettore]]></loc><lastmod>2025-08-10T14:35:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22214-sordita-ereditaria-e-terapia-genica-i-primi-risultati-nei-pazienti-con-mutazioni-del-gene-otof]]></loc><lastmod>2025-07-28T17:39:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/22048-tumori-della-mammella-brca-mutati-necessario-porre-attenzione-ai-tempi-ottimali-di-somministrazione-delle-terapie]]></loc><lastmod>2025-06-09T17:35:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21972-readi-un-nuovo-progetto-europeo-per-una-ricerca-clinica-inclusiva-e-senza-barriere]]></loc><lastmod>2025-05-09T17:23:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21884-sindrome-di-lowe-al-via-uno-studio-clinico-grazie-alla-collaborazione-tra-telethon-e-can-fite]]></loc><lastmod>2025-04-08T14:14:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21882-intelligenza-artificiale-generativa-e-dati-sintetici-ecco-perche-sono-fondamentali-per-le-sperimentazioni-cliniche]]></loc><lastmod>2025-04-07T15:17:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21678-risonanza-magnetica-positivi-i-risultati-di-fase-iii-sul-nuovo-mezzo-di-contrasto-gadoquatrane]]></loc><lastmod>2025-01-30T17:17:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21572-sperimentazioni-cliniche-per-malattie-rare-cruciali-per-arrivare-a-nuove-terapie-ma-restano-ostacoli-da-superare]]></loc><lastmod>2024-12-11T20:23:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21560-trial-clinici-l-intelligenza-artificiale-migliora-l-arruolamento-dei-partecipanti]]></loc><lastmod>2024-12-06T18:30:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21458-acondroplasia-positivi-i-risultati-dello-studio-registrativo-su-navepegritide]]></loc><lastmod>2024-11-05T18:57:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21431-come-superare-gli-ostacoli-e-realizzare-uno-studio-clinico-di-successo-l-esempio-dell-alcaptonuria]]></loc><lastmod>2024-10-28T17:06:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21278-cheratocono-nuove-prospettive-terapeutiche-da-trial-clinico-tutto-italiano]]></loc><lastmod>2024-09-11T18:24:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21176-la-strada-verso-una-terapia-genica-per-la-paraplegia-spastica-ereditaria]]></loc><lastmod>2024-07-16T14:21:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21067-calcificazione-arteriosa-da-deficit-di-cd73-l-etidronato-rallenta-la-progressione-della-malattia]]></loc><lastmod>2024-06-10T16:41:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/21012-glomerulosclerosi-focale-segmentaria-al-gaslini-individuata-una-nuova-terapia-con-anticorpi-monoclonali]]></loc><lastmod>2024-05-24T15:29:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/20986-giornata-internazionale-degli-studi-clinici-da-eupati-un-video-di-sensibilizzazione]]></loc><lastmod>2024-06-28T07:21:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/20541-demenza-frontotemporale-malattia-che-ha-colpito-anche-bruce-willis-oggi-si-sta-studiando-una-terapia-genica]]></loc><lastmod>2024-01-23T18:12:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/20230-neuromielite-ottica-nuovi-dati-clinici-rafforzano-l-efficacia-di-inebilizumab]]></loc><lastmod>2023-10-14T12:04:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/20100-malattie-rare-come-stanno-cambiando-le-sperimentazioni-cliniche]]></loc><lastmod>2023-09-14T07:15:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/20015-arresto-cardiaco-pediatrico-extra-ospedaliero-studio-italiano-dimostra-efficacia-della-terapia-con-ngf-e-stimolazioni-transcraniche]]></loc><lastmod>2023-08-07T08:57:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/20027-sarcoidosi-a-padova-avviato-trial-clinico-di-fase-iii-su-un-nuovo-farmaco]]></loc><lastmod>2023-07-24T08:12:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/19984-neuromielite-ottica-inebilizumab-riduce-la-formazione-di-lesioni-subcliniche-nel-midollo-spinale]]></loc><lastmod>2023-07-07T15:29:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/19949-trattamento-delle-infezioni-nel-post-trapianto-positivi-i-dati-di-uno-studio-sul-farmaco-posoleucel]]></loc><lastmod>2023-06-25T21:20:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/19907-tumore-al-polmone-dati-clinici-promettenti-per-la-terapia-tumor-treating-fields]]></loc><lastmod>2023-06-16T19:42:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/19799-sindrome-dell-odore-di-pesce-tmau-al-san-paolo-di-milano-sara-avviata-una-sperimentazione-clinica]]></loc><lastmod>2023-05-12T15:59:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/19931-nefropatia-da-iga-il-farmaco-sparsentan-efficace-nella-riduzione-della-proteinuria]]></loc><lastmod>2023-06-22T17:41:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/19678-sindrome-post-finasteride-studio-preclinico-italiano-valuta-il-possibile-impiego-di-allopregnanolone]]></loc><lastmod>2023-03-31T11:39:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/19400-ematologia-al-congresso-ash-i-risultati-aggiornati-del-portfolio-di-farmaci-di-roche]]></loc><lastmod>2022-12-18T17:39:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/19211-terapie-a-base-di-staminali-arriva-il-vademecum-anti-truffa-di-osservatorio-terapie-avanzate]]></loc><lastmod>2022-10-25T13:23:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/19033-cheratocono-in-via-di-studio-un-innovativa-tecnica-di-cross-linking-corneale]]></loc><lastmod>2022-09-11T14:07:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/18759-alopecia-areata-gli-studi-clinici-in-corso-nel-mondo]]></loc><lastmod>2022-06-12T12:08:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/18681-nefropatia-da-iga-la-fda-concede-la-revisione-prioritaria-per-il-farmaco-sparsentan]]></loc><lastmod>2023-06-22T17:35:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/18239-displasia-ectodermica-ipoidrotica-legata-all-x-al-via-studio-clinico-su-un-innovativo-trattamento-prenatale]]></loc><lastmod>2022-01-30T23:29:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/18002-esofagite-eosinofila-buoni-risultati-di-fase-iii-per-dupilumab]]></loc><lastmod>2021-11-13T21:05:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17845-carcinoma-uroteliale-risultati-positivi-per-erdafitinib-in-combinazione-con-cetrelimab]]></loc><lastmod>2021-10-03T16:46:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17821-carcinoma-polmonare-non-a-piccole-cellule-cemiplimab-piu-chemioterapia-migliora-la-sopravvivenza-globale]]></loc><lastmod>2021-09-26T22:07:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17687-malattia-da-agglutinine-fredde-nuovi-dati-dimostrano-l-efficacia-di-sutimlimab]]></loc><lastmod>2021-07-25T18:19:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17643-sindrome-di-phelan-mcdermid-attesa-per-i-risultati-del-trial-di-fase-ii-su-amo-01]]></loc><lastmod>2021-07-13T11:10:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17622-distrofia-miotonica-congenita-iniziato-lo-studio-cardine-sul-farmaco-amo-02]]></loc><lastmod>2021-07-06T17:28:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17532-carcinoma-polmonare-non-a-piccole-cellule-con-sotorasib-sopravvivenza-globale-di-12-5-mesi]]></loc><lastmod>2021-11-02T14:45:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17407-glomerulosclerosi-focale-segmentale-positivi-i-primi-dati-di-fase-iii-su-sparsentan]]></loc><lastmod>2021-05-09T16:48:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17330-malformazione-cavernosa-cerebrale-procede-con-successo-la-sperimentazione-sul-propranololo]]></loc><lastmod>2021-04-25T15:37:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17056-carcinoma-prostatico-metastatico-apalutamide-migliora-la-sopravvivenza-complessiva]]></loc><lastmod>2021-02-21T17:42:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17053-gastrite-e-duodenite-eosinofila-nuovo-anticorpo-si-mostra-efficace-in-uno-studio-di-fase-ii]]></loc><lastmod>2021-02-21T17:23:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/17062-covid-19-iniziata-la-seconda-parte-dello-studio-clinico-su-ptc299]]></loc><lastmod>2021-02-23T10:14:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16983-carcinoma-polmonare-nsclc-avanzato-buone-risposte-da-sotorasib]]></loc><lastmod>2021-11-02T15:35:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16902-pharma-media-day-bayer-presenta-oltre-50-progetti-in-fase-di-sviluppo-clinico]]></loc><lastmod>2021-01-20T18:24:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16429-covid-19-sperimentazione-clinica-di-fase-i-ii-per-il-vaccino-di-sanofi-e-gsk]]></loc><lastmod>2020-09-12T14:41:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16395-malattie-epatiche-oltre-40-abstract-presentati-da-gilead-al-congresso-ilc]]></loc><lastmod>2020-08-30T20:11:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16367-virus-respiratorio-sinciziale-pubblicati-i-risultati-clinici-di-nirsevimab-nei-neonati]]></loc><lastmod>2020-08-09T21:59:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16324-covid-19-importanti-risposte-immunitarie-dal-vaccino-azd1222]]></loc><lastmod>2020-07-26T14:36:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16260-sperimentazioni-cliniche-nasce-in-italia-la-prima-carta-per-la-partecipazione-dei-pazienti]]></loc><lastmod>2020-07-05T18:02:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16197-coronavirus-al-via-la-sperimentazione-di-fase-ii-iii-sul-farmaco-orale-ptc299]]></loc><lastmod>2020-06-19T13:41:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16055-coronavirus-pubblicati-i-risultati-dello-studio-clinico-su-anakinra]]></loc><lastmod>2020-05-11T16:17:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16034-carcinoma-polmonare-non-a-piccole-cellule-miglioramento-della-sopravvivenza-con-cemiplimab]]></loc><lastmod>2021-11-02T14:47:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/16006-covid-19-in-sperimentazione-anche-l-impiego-di-immunoglobuline-per-via-endovenosa]]></loc><lastmod>2020-05-11T08:56:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/15815-sperimentazioni-cliniche-nuove-indicazioni-da-aifa-per-l-emergenza-coronavirus]]></loc><lastmod>2020-03-23T18:49:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/15811-coronavirus-i-principali-farmaci-in-sperimentazione]]></loc><lastmod>2020-03-22T22:22:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/15678-fibrodisplasia-ossificante-progressiva-sospesi-gli-studi-sul-palovarotene]]></loc><lastmod>2020-02-21T10:00:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/15474-sindromi-pros-e-proteus-una-sperimentazione-in-corso-in-italia]]></loc><lastmod>2019-12-08T22:29:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/15333-distrofia-dei-cingoli-2e-nuovi-risultati-positivi-per-la-terapia-genica-srp-9003]]></loc><lastmod>2019-10-21T20:09:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/15166-malformazione-cavernosa-cerebrale-da-un-vecchio-farmaco-una-possibile-terapia]]></loc><lastmod>2019-09-08T17:43:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/15131-sindrome-di-gorlin-inizia-una-sperimentazione-in-sei-centri-italiani]]></loc><lastmod>2019-08-25T20:29:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/15119-tumore-alla-vescica-uno-studio-italiano-valutera-l-impiego-della-radioterapia-adiuvante]]></loc><lastmod>2019-08-14T16:55:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/15029-sperimentazioni-cliniche-cicchetti-fase-i-e-investimento-fase-iii-e-risparmio-per-il-ssn]]></loc><lastmod>2019-07-12T18:49:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/14920-sperimentazioni-cliniche-necessario-che-i-pazienti-abbiano-piu-peso]]></loc><lastmod>2019-06-15T17:23:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/14907-malformazione-cavernosa-cerebrale-ancora-aperte-le-iscrizioni-per-lo-studio-clinico-sul-propranololo]]></loc><lastmod>2019-06-14T14:51:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/14904-sindrome-di-noonan-un-farmaco-antitumorale-migliora-la-cardiopatia]]></loc><lastmod>2019-06-11T17:07:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/14825-miopatia-miotubulare-legata-all-x-promettenti-i-risultati-di-fase-i-ii-della-terapia-genica]]></loc><lastmod>2019-05-19T16:52:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/14706-distrofia-dei-cingoli-2e-primi-risultati-clinici-favorevoli-per-la-terapia-genica]]></loc><lastmod>2019-04-09T10:28:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/14323-malattie-del-motoneurone-un-farmaco-cannabinoide-sembra-ridurre-la-spasticita]]></loc><lastmod>2019-01-02T19:09:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/14228-insonnia-familiare-fatale-in-italia-si-sperimenta-la-doxiciclina-a-scopo-preventivo]]></loc><lastmod>2018-12-04T10:17:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/14138-distrofia-miotonica-di-tipo-1-dati-clinici-positivi-per-il-farmaco-amo-02]]></loc><lastmod>2018-11-08T19:12:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/14071-carcinoma-polmonare-e-melanoma-conferme-d-efficacia-per-la-terapia-car-t]]></loc><lastmod>2021-11-02T15:45:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13880-carcinoma-polmonare-pazienti-arruolati-nello-studio-giotag]]></loc><lastmod>2021-11-02T15:46:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13875-malformazione-cavernosa-parte-in-italia-una-sperimentazione-sul-popranololo]]></loc><lastmod>2019-05-06T13:12:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13730-fibrodisplasia-ossificante-progressiva-nuovi-risultati-di-fase-ii-per-palovarotene]]></loc><lastmod>2018-07-04T17:10:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13698-sindrome-di-phelan-mcdermid-amo-pharma-inizia-la-sperimentazione-clinica-di-amo-01]]></loc><lastmod>2018-06-25T17:39:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13651-cartilagine-danneggiata-con-le-staminali-potrebbe-rigenerarsi]]></loc><lastmod>2018-06-11T12:50:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13628-tumori-test-preclinici-confermano-la-sicurezza-della-terapia-car-t-cd44v6]]></loc><lastmod>2018-06-06T15:36:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13615-tumori-avviato-studio-internazionale-per-valutare-l-efficacia-dell-adroterapia-con-ioni-carbonio]]></loc><lastmod>2018-06-02T14:47:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13510-emicrania-episodica-risultati-positivi-per-erenumab-da-uno-studio-di-fase-iiib]]></loc><lastmod>2018-05-02T15:18:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13258-carcinoma-prostatico-presentate-all-asco-di-san-francisco-le-nuove-ricerche]]></loc><lastmod>2018-02-21T19:13:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13110-il-dossier-aifa-in-italia-la-ricerca-sui-farmaci-cresce-del-3]]></loc><lastmod>2018-01-14T21:54:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13097-farmaci-tornano-a-crescere-le-sperimentazioni-cliniche-in-italia]]></loc><lastmod>2018-01-11T15:34:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13076-sperimentazioni-pediatriche-sono-cinquemila-in-europa-e-quasi-mille-in-italia]]></loc><lastmod>2018-01-09T09:59:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/13045-carcinoma-mammario-presentati-i-dati-dello-studio-monaleesa-7-su-ribociclib]]></loc><lastmod>2017-12-18T11:57:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12947-carcinoma-prostatico-confermato-il-profilo-di-sicurezza-della-targeted-alpha-therapy]]></loc><lastmod>2017-11-25T16:35:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12928-carcinoma-mammario-ulteriori-conferme-cliniche-per-ribociclib]]></loc><lastmod>2017-11-22T16:15:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12846-leucemie-e-tumori-solidi-positivi-test-preclinici-sulla-sicurezza-dell-immunoterapia-adottiva]]></loc><lastmod>2017-10-31T11:47:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12799-cheratite-da-acanthamoeba-parte-in-italia-lo-studio-clinico-odak]]></loc><lastmod>2017-10-21T09:25:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12716-trapianto-di-reni-confermata-l-efficacia-del-mantenimento-con-everolimus]]></loc><lastmod>2017-09-30T09:27:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12622-tumore-al-polmone-canakinumab-riduce-il-rischio-di-mortalita-associata]]></loc><lastmod>2017-09-05T16:04:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12602-tumori-troppo-pochi-i-pazienti-inclusi-negli-studi-clinici]]></loc><lastmod>2017-08-29T22:11:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12405-steatosi-epatica-non-alcolica-nuove-speranze-arrivano-da-oltipraz]]></loc><lastmod>2017-06-17T15:26:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12382-carcinoma-mammario-conferme-di-efficacia-e-sicurezza-per-ribociclib-piu-letrozolo]]></loc><lastmod>2017-06-12T15:46:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12372-carcinoma-polmonare-conferme-di-superiorita-per-alectinib-rispetto-a-terapia-standard]]></loc><lastmod>2021-11-02T15:51:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12296-oncologia-da-roche-dati-clinici-aggiornati-su-20-nuovi-farmaci]]></loc><lastmod>2017-05-22T13:54:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12178-cistinuria-l-acido-alfa-lipoico-funziona-nel-modello-animale]]></loc><lastmod>2019-01-17T17:43:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/12051-tumore-al-seno-buoni-risultati-da-combinazione-di-pertuzumab-trastuzumab-e-chemioterapia]]></loc><lastmod>2017-03-11T16:34:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11911-malattie-rare-neuromuscolari-al-giro-di-boa-le-ultime-novita-su-farmaci-e-trial-clinici]]></loc><lastmod>2017-10-01T20:20:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11880-cancro-alla-vescica-l-immunoterapico-pembrolizumab-prolunga-la-sopravvivenza]]></loc><lastmod>2017-02-03T18:54:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11805-disautonomia-familiare-a-tel-aviv-si-sperimenta-sui-topi-la-fosfatidilserina-un-integratore-alimentare-gia-usato-per-contrastare-la-perdita-di-memoria]]></loc><lastmod>2017-05-22T15:07:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11654-fibrodisplasia-ossificante-progressiva-dati-incoraggianti-da-studio-di-fase-ii-su-palovarotene]]></loc><lastmod>2016-11-28T16:30:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11515-uveite-non-infettiva-pubblicati-i-risultati-di-efficacia-del-farmaco-adalimumab]]></loc><lastmod>2016-10-23T20:01:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11466-nasce-spot-my-trial-il-primo-motore-di-ricerca-italiano-sulle-sperimentazioni-cliniche]]></loc><lastmod>2016-10-16T22:02:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11356-leucemia-aml-e-sindrome-mds-iniziata-sperimentazione-di-fase-ii-sulla-molecola-sy-1425]]></loc><lastmod>2016-10-01T10:43:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11308-malattia-mitocondriale-primaria-elamipretide-migliora-i-risultati-del-test-del-cammino]]></loc><lastmod>2016-09-24T10:57:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11272-glomerulosclerosi-focale-segmentale-il-farmaco-sparsentan-riduce-la-proteinuria]]></loc><lastmod>2016-09-17T16:17:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11228-broncopneumopatia-bpco-risultati-positivi-da-combinazione-fluticasone-furoato-vilanterolo]]></loc><lastmod>2016-09-11T09:38:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11185-virus-ebola-ancora-dubbi-sul-trattamento-sperimentale-con-favipiravir]]></loc><lastmod>2016-09-02T09:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11125-sindrome-epatorenale-iniziato-arruolamento-in-studio-di-fase-iii-su-farmaco-terlipressina]]></loc><lastmod>2016-08-17T19:43:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11093-sperimentazioni-cliniche-su-piccoli-gruppi-essenziale-il-punto-di-vista-dei-pazienti]]></loc><lastmod>2016-08-05T11:02:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11064-miopatia-gne-ultragenyx-pronta-con-il-trial-di-fase-iii-su-terapia-ace-er]]></loc><lastmod>2016-08-01T13:29:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11015-distrofia-facio-scapolo-omerale-promettenti-risultati-di-fase-i-per-candidato-farmaco-ace-083]]></loc><lastmod>2016-07-22T13:19:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/11012-sindrome-di-lyell-all-idi-di-roma-si-applica-con-successo-l-unico-protocollo-terapeutico-conosciuto]]></loc><lastmod>2016-07-21T14:10:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10999-paralisi-periodiche-la-diclorfenamide-riduce-gli-attacchi-e-migliora-la-qualita-di-vita]]></loc><lastmod>2016-07-19T14:32:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10989-cardiomiopatia-ipertrofica-ostruttiva-in-fase-ii-il-programma-di-sviluppo-del-farmaco-myk-461]]></loc><lastmod>2016-07-15T13:08:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10974-ebola-delusione-per-un-farmaco-sperimentale-non-migliora-la-sopravvivenza]]></loc><lastmod>2016-07-14T15:23:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10954-tumore-polmonare-non-a-piccole-cellule-buoni-risultati-da-pembrolizumab]]></loc><lastmod>2021-11-02T15:13:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10902-sindrome-di-hallervorden-spatz-positivi-i-primi-dati-clinici-su-terapia-sperimentale-re-024]]></loc><lastmod>2016-07-01T12:49:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10849-tumori-del-sangue-presentati-nuovi-dati-su-venetoclax]]></loc><lastmod>2016-06-24T12:29:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10720-miosite-da-corpi-inclusi-novita-deludenti-dallo-sviluppo-clinico-di-bimagrumab]]></loc><lastmod>2016-06-01T14:59:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10703-porpora-trombotica-trombocitopenica-risultati-positivi-dallo-sviluppo-clinico-preliminare-del-composto-bax-930]]></loc><lastmod>2016-05-27T13:26:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10701-uveite-anteriore-non-infettiva-esiti-positivi-dalla-sperimentazione-clinica-del-farmaco-ns2]]></loc><lastmod>2016-05-27T13:21:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10715-l-ema-promuove-nuove-linee-guida-sulla-sperimentazione-clinica-dei-farmaci-tecnici-gia-al-lavoro]]></loc><lastmod>2016-06-01T13:57:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10460-fibrodisplasia-ossificante-progressiva-effetti-positivi-di-palovarotene-su-modelli-murini]]></loc><lastmod>2016-04-28T07:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10314-cancro-al-polmone-continua-la-sperimentazione-clinica-di-fase-iii-su-avelumab]]></loc><lastmod>2021-11-02T15:58:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10226-miopatia-gne-novita-incoraggianti-dalla-sperimentazione-di-fase-ii-sulla-terapia-ace-er]]></loc><lastmod>2018-11-20T17:48:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/10235-cancro-alla-prostata-buoni-risultati-da-docetaxel-come-prima-terapia]]></loc><lastmod>2021-02-20T19:04:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/9830-paracetamolo-in-gravidanza-il-mhra-prenderlo-nella-dose-piu-bassa-per-il-minor-tempo-possibile]]></loc><lastmod>2016-01-28T16:21:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/9791-aifa-e-farmindustria-pronte-a-cogliere-la-sfida-rappresentata-dal-nuovo-regolamento-europeo]]></loc><lastmod>2016-01-22T09:15:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/9695-farmaci-diffusi-i-dati-sulla-sperimentazione-clinica-dei-medicinali-per-le-malattie-rare]]></loc><lastmod>2016-01-04T11:44:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/9603-malattie-rare-novartis-illustra-i-progressi-nello-sviluppo-clinico-di-proprie-terapie]]></loc><lastmod>2015-12-11T12:17:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/9492-carcinoma-prostatico-riscontri-positivi-dalla-terapia-con-temsirolimus-seguita-a-docetaxel]]></loc><lastmod>2021-02-20T19:11:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/9407-sindrome-da-deficit-di-glut-1-aggiornato-il-programma-di-sperimentazione-del-farmaco-triheptanoin-ux007]]></loc><lastmod>2015-11-20T13:21:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/9403-malattie-rare-alnylam-presentera-nuovi-dati-clinici-su-due-terapie-rnai-sperimentali]]></loc><lastmod>2015-11-20T11:39:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/9241-ipertensione-polmonare-associata-a-sarcoidosi-in-forma-grave-la-prostaciclina-si-dimostra-ok]]></loc><lastmod>2015-10-28T10:46:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/9007-carcinoma-polmonare-afatinib-dimostra-sopravvivenza-complessiva-superiore-rispetto-a-erlotinib]]></loc><lastmod>2021-11-02T16:29:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/9006-adenocarcinoma-polmonare-nintedanib-in-associazione-a-docetaxel-riduce-la-progressione-del-tumore]]></loc><lastmod>2021-11-02T16:25:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8908-caps-catastrophic-antiphospholipid-syndrome-studiato-il-potenziale-terapeutico-del-farmaco-eculizumab]]></loc><lastmod>2015-09-16T07:26:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8862-trombocitopenia-e-sindrome-di-sjogren-risultati-positivi-per-rituximab]]></loc><lastmod>2015-09-04T11:05:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8772-anemia-da-insufficienza-renale-reclutato-il-primo-paziente-nello-studio-di-fase-ii-della-terapia-sperimentale-targt-epo]]></loc><lastmod>2015-08-06T21:34:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8782-cancro-al-polmone-atezolizumab-raggiunge-end-point-primario-in-studio-di-fase-ii]]></loc><lastmod>2024-11-01T16:35:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8767-malattia-di-huntington-in-avvio-lo-studio-di-fase-i-iia-del-farmaco-sperimentale-isis-httrx]]></loc><lastmod>2015-08-06T20:19:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8631-sindrome-poems-la-lenalidomide-e-l-unica-opzione-di-trattamento-sicura-ed-efficace]]></loc><lastmod>2015-07-16T13:42:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8533-acondroplasia-positivi-i-dati-preliminari-di-uno-studio-pediatrico-del-farmaco-bmn-111-vosoritide]]></loc><lastmod>2015-06-29T09:05:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8522-osteoartrite-risultati-positivi-da-uno-studio-italiano-sulla-terapia-tramite-neridronato]]></loc><lastmod>2015-06-26T10:04:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8481-tumore-del-polmone-buoni-risultati-per-studio-di-fase-ii-sull-anti-pd-l1-di-roche]]></loc><lastmod>2021-11-02T16:34:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8085-cancro-avanzato-al-polmone-non-a-piccole-cellule-astrazeneca-presenta-gli-ultimi-dati-dello-studio-aura]]></loc><lastmod>2021-11-02T15:19:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/8064-neurite-ottica-buone-prosepttive-per-il-nuovo-farmaco-sperimentale-che-ripara-i-neuroni]]></loc><lastmod>2016-03-17T11:56:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7996-sindrome-di-sjogren-larsson-avviata-la-fase-ii-dello-studio-sul-farmaco-ns2]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7655-gangliosidosi-gm1-lysogene-al-lavoro-per-una-futura-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7581-sperimentazioni-cliniche-avviata-una-consultazione-pubblica-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7509-malattia-di-parkinson-newron-pharmaceuticals-annuncia-lavvio-dello-studio-di-fase-ii-su-snn0031]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7507-sclerosi-laterale-amiotrofica-newron-pharmaceuticals-annuncia-lavvio-dello-studio-su-snn0029]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7508-glomerulopatia-c3-a-progressione-rapida-eculizumab-migliora-le-funzioni-renali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7501-atrofia-muscolare-spinale-roche-acquisisce-trophos]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7466-calcificazione-arteriosa-generalizzata-infantile-gaci-risultati-positivi-per-lenzima-sbc-105]]></loc><lastmod>2018-09-11T18:06:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7432-trasparenza-in-campo-scientifico-negli-usa-nuova-proposta-di-regolamentazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7372-malattie-renali-di-origine-genetica-messo-a-punto-e-brevettato-dal-meyer-un-nuovo-metodo-che-utilizza-i-progenitori-renali-ottenuti-dalle-urine-per-la-diagnosi-e-lo-studio-di-queste-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7330-miosite-da-corpi-inclusi-trial-pilota-con-bimagrumab-ha-ottenuto-buoni-risultati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7281-malattie-rare-gli-studi-clinici-sono-l115-di-quelli-registrati-su-clinicaltrialsgov]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7242-cancro-alle-ovaie-risultati-interessanti-per-lanticorpo-sperimentale-cirmtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7139-astra-zeneca-inizia-un-programma-di-sviluppo-per-valutare-la-capacita-di-medi2452-in-situazioni-demergenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7095-fibrodisplasia-ossificante-progressiva-clementia-pharm-inizia-uno-studio-di-estensione-di-fase-2-sul-palovarotene]]></loc><lastmod>2018-08-03T14:03:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/7072-dermatite-al-via-lo-studio-di-fase-iii-su-dupilumab]]></loc><lastmod>2015-10-22T18:11:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/6918-rna-interference-alnylam-presenta-i-risultati-di-nuovi-studi-clinici-e-pre-clinici]]></loc><lastmod>2019-01-14T14:22:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/6821-nel-trapianto-di-microbiota-possibile-soluzione-a-tante-malattie-da-diabete-a-obesita-fino-anche-ad-autismo-e-sclerosi-multipla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/6777-carcinoma-polmonare-parte-la-sperimentazione-di-un-vaccino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/6552-ipocalcemia-autosomica-dominante-sperimentazione-in-corso-per-farmaco-npsp795]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/6153-cancro-al-polmone-deludente-limpiego-dello-psicostimolante-modafinil-per-il-trattamento-della-fatica]]></loc><lastmod>2021-11-02T16:45:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/5998-atrofia-muscolare-spinale-la-ricerca-e-per-la-prima-volta-in-una-fase-cosi-avanzata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/5861-sperimentazioni-cliniche-in-europa-saranno-rese-pubbliche-in-una-banca-dati-di-libero-accesso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/5828-carcinoma-della-prostata-avviato-studio-di-fase-ii-per-radio-223-dicloruro-in-combinazione-con-abiraterone-acetato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/5194-leucemia-linfocitica-cronica-presentati-i-risultati-sul-farmaco-gs-9973]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/5190-immunodeficienza-combinata-grave-sperimentata-una-nuova-terapia-genica-con-risultati-positivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/5118-sperimentazini-cliniche-lorenzin-annuncia-un-tavolo-di-lavoro-per-renderne-piu-veloce-laccesso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/4386-carcinoma-della-prostata-resistente-crpc-radio-223-dicloruro-aumenta-sopravvivenza-e-la-qualita-della-vita]]></loc><lastmod>2021-02-20T19:14:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/4185-sindrome-di-poems-e-italiano-il-primo-studio-prospettico-attivo-in-europa-99172973]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/4184-sindrome-di-poems-e-italiano-il-primo-studio-prospettico-attivo-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/4029-sperimentazioni-farmacologiche-in-europa-sempre-meno-pazienti-arruolati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/3728-alcaptonuria-al-via-larruolamento-pazienti-per-la-sperimentazione-con-nitisinone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/3657-difetto-di-cobalamina-c-avviata-la-sperimentazione-sullepi-743]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/3222-aziende-farmaceutiche-insieme-per-unico-database-sulle-sperimentazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/3122-ipoparatiroidismo-risultati-positivi-per-il-farmaco-natpara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/2955-staminali-a-torino-si-pensa-a-quelle-del-fegato-come-base-per-rigenerare-anche-i-reni-danneggiati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/2926-malattie-rare-ecrin-promuove-un-bando-per-lattuazione-di-6-studi-clinici-europei]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/2822-teleangectasia-emerrogacia-ereditaria-a-pavia-si-sperimenta-la-talidomide]]></loc><lastmod>2025-02-03T17:41:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/2491-tumore-al-colon-e-al-polmone-risposte-positive-per-un-nuovo-vaccino-in-sperimentazione]]></loc><lastmod>2021-11-02T16:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/2433-ipoparatiroidismo-prime-sperimentazioni-per-un-sostituto-sintetico-dellormone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/2069-sperimentazioni-farmacologiche-fuori-ue-ema-devono-rispettare-gli-standard-clinici-ed-etici-dellunione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/1952-epidermiolisi-bollosa-promettenti-risultati-dalla-terapia-genica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/1789-leishmaniosi-viscerale-fetale-si-sperimenta-il-primo-vaccino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/1506-91-acondroplasia-biomarin-avviera-un-trial-di-fase-1-entro-marzo-con-bmn-111]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/1184-malattia-di-wolman-proseguono-i-trial-sulla-prima-possibile-terapia-sostitutiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/1171-sclerosi-multiplaa-novembre-la-sperimentazione-di-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/1084-artrite-idiopatica-giovanile-sistemica-la-speranza-viene-dal-farmaco-usato-per-le-caps]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/1037-locked-in-salvatore-crisafulli-sembrerebbe-rispondere-al-metodo-della-biocorrezione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/1026-staminali-cerebrali-via-libera-del-comitato-etico-umbro-alla-sperimentazione-di-vescovi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/907-staminali-cerebrali-regione-umbria-i-ritardi-sono-da-imputare-alle-mancanza-di-alcuni-documenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/897-staminali-cerebrali-polemiche-per-il-ritardo-della-sperimentazione-condotta-dal-prof-vescovi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/843-autismo-liss-avvia-reclutamento-di-bambini-a-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/793-malattia-di-gaucher-a-udine-torino-e-firenze-nuovi-trial-per-la-terapia-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/593-linfangiomatosi-diffusa-il-propranololo-puo-essere-unalternativa-terapeutica-per-i-bambini]]></loc><lastmod>2019-06-12T17:18:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/403-malattia-di-steiner-primi-risultati-positivi-per-luso-di-mexiletina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/162-malattie-rare-per-la-gaucher-si-sperimenta-un-nuovo-farmaco-trial-clinici-a-udine-e-firenze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/sperimentazioni/160-gaucher-di-tipo-1-in-italia-si-arruolano-pazienti-italiani-per-la-sperimentazione-di-fase-tre-della-terapia-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/22862-quando-la-ricerca-scientifica-incontra-un-volto-la-storia-di-stefano-e-viola]]></loc><lastmod>2026-03-20T16:15:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/22853-ludovico-due-malattie-rare-e-il-blind-tennis-ero-solo-lo-sport-mi-ha-salvato]]></loc><lastmod>2026-03-18T17:02:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/22685-displasia-fibromuscolare-quando-la-scrittura-diventa-strumento-di-consapevolezza]]></loc><lastmod>2026-01-23T15:35:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/22162-quando-farmaci-per-la-pelle-o-per-i-capelli-compromettono-la-sessualita-il-piacere-e-l-identita]]></loc><lastmod>2025-07-07T12:59:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/22163-disfunzioni-sessuali-da-farmaci-quando-l-assenza-di-informazioni-compromette-la-vita]]></loc><lastmod>2026-02-26T09:25:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21918-malattia-di-perthes-continua-la-battaglia-di-andrea-e-mamma-simona-per-il-riconoscimento-della-patologia]]></loc><lastmod>2025-05-05T14:19:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21863-malattie-rare-ilaria-parlanti-ho-subito-25-interventi-chirurgici-ora-la-mia-storia-aiutera-altri]]></loc><lastmod>2025-04-01T07:43:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21749-marta-russo-da-influencer-della-disabilita-a-cavaliere-al-merito-della-repubblica]]></loc><lastmod>2025-02-24T21:13:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21725-alessandro-coppola-i-giovani-hanno-bisogno-di-ascoltare-storie-vere-come-la-mia]]></loc><lastmod>2025-02-13T18:25:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21718-addio-a-elena-simbolo-di-resilienza-nella-lotta-alle-malattie-rare]]></loc><lastmod>2025-02-13T09:12:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21645-sindrome-di-van-der-knapp-lo-sfogo-di-mamma-carla-siamo-stanchi-di-dover-combattere-anche-per-i-diritti-piu-basilari]]></loc><lastmod>2025-01-22T11:55:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21581-emanuele-elisa-filippo-e-gli-altri-vivere-con-una-cardiopatia-congenita-e-possibile]]></loc><lastmod>2024-12-13T15:40:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21582-cardiopatie-congenite-da-quasi-30-anni-l-associazione-piccoli-grandi-cuori-e-al-fianco-dei-pazienti]]></loc><lastmod>2024-12-13T15:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21568-deficit-congenito-del-plasminogeno-nicolo-puo-ora-curarsi-grazie-ad-una-terapia-specifica]]></loc><lastmod>2024-12-10T15:19:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21418-demenza-frontotemporale-ilaria-cucchi-mi-impegnero-con-tutta-me-stessa-sara-la-mia-seconda-battaglia]]></loc><lastmod>2024-10-23T10:06:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21348-boccia-paralimpica-uno-sport-adatto-anche-alle-disabilita-piu-gravi]]></loc><lastmod>2024-10-04T12:02:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21337-malattie-rare-dalla-diagnosi-quasi-impossibile-la-storia-di-jordan]]></loc><lastmod>2024-09-30T15:54:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21274-delezione-del-braccio-corto-del-cromosoma-2-i-genitori-di-vincenzo-cerchiamo-famiglie-come-noi]]></loc><lastmod>2024-09-10T14:12:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21231-paralimpiadi-parigi-2024-eva-ceccatelli-grazie-allo-sport-ho-affrontato-la-malattia-come-una-partita-da-giocare]]></loc><lastmod>2024-08-12T17:40:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21230-paralimpiadi-parigi-2024-l-esordio-di-valentina-petrillo-atleta-transgender-e-ipovedente]]></loc><lastmod>2024-08-12T17:27:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21229-paralimpiadi-parigi-2024-federica-sileoni-per-me-l-equitazione-non-e-uno-sport-ma-un-autentica-passione]]></loc><lastmod>2024-08-09T18:38:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21220-paralimpiadi-parigi-2024-carolina-costa-il-judo-ha-accompagnato-tutta-la-mia-vita]]></loc><lastmod>2024-08-09T15:45:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21218-parigi-2024-livia-cecagallina-ho-incontrato-il-tiro-a-segno-per-caso-ma-da-allora-non-ne-ho-piu-fatto-meno]]></loc><lastmod>2024-08-07T17:28:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21216-parigi-2024-matteo-parenzan-per-me-lo-sport-e-stato-la-medicina-che-la-scienza-non-e-riuscita-a-trovare]]></loc><lastmod>2024-08-07T13:28:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21201-paralimpiadi-parigi-2024-vincenzo-boni-atleta-al-mattino-e-consulente-informatico-al-pomeriggio]]></loc><lastmod>2024-07-26T10:08:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21190-sindrome-trico-rino-falangea-quando-un-disturbo-dell-apprendimento-e-il-campanello-d-allarme-di-una-malattia-rara]]></loc><lastmod>2024-07-22T14:40:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21069-nasce-kif1a-italia-l-associazione-che-vuole-portare-le-sperimentazioni-usa-anche-nel-nostro-paese]]></loc><lastmod>2024-06-10T17:12:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/21060-disabilita-e-ausili-per-comprare-la-carrozzina-elettrica-ho-dovuto-ricorrere-alla-solidarieta]]></loc><lastmod>2024-06-07T16:35:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20961-cistite-interstiziale-la-testimonianza-di-chiara]]></loc><lastmod>2024-05-10T12:10:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20938-miosite-la-storia-di-marco-non-mangiavo-piu-ora-sono-rinato-grazie-alle-giuste-terapie]]></loc><lastmod>2024-05-06T18:00:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20893-giornata-della-salute-della-donna-da-pavia-la-storia-di-elena-e-della-sua-lotta-contro-un-tumore-raro]]></loc><lastmod>2024-04-22T09:12:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20803-mattia-mi-ha-insegnato-il-valore-della-forza-e-della-resilienza]]></loc><lastmod>2024-03-25T15:01:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20711-quindici-anni-in-attesa-di-una-diagnosi-l-odissea-di-un-ragazzo-americano-affetto-da-acromatopsia]]></loc><lastmod>2024-03-04T19:29:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20676-atassia-telangiectasia-mamma-eleonora-racconta-il-suo-incontro-con-una-malattia-dal-nome-impronunciabile]]></loc><lastmod>2024-02-28T17:58:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20661-cardiopatie-congenite-nata-con-il-cuore-senza-un-ventricolo-diventa-mamma-di-due-gemelli]]></loc><lastmod>2024-02-20T16:51:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20592-giornata-contro-il-bullismo-ridevano-per-la-mia-malattia-rara-vi-racconto-come-sono-riuscita-a-reagire]]></loc><lastmod>2024-02-07T09:43:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20437-liste-di-attesa-per-noi-malati-rari-il-problema-e-piu-drammatico]]></loc><lastmod>2023-12-13T10:26:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20436-ci-vorrebbe-un-furgone-la-battaglia-di-minus-per-l-autonomia-e-quei-diritti-negati-alle-persone-con-disabilita]]></loc><lastmod>2023-12-13T16:24:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20402-la-racchetta-di-sinner-all-asta-per-aiutare-un-bimbo-con-una-rarissima-malattia-neurologica]]></loc><lastmod>2023-12-01T08:54:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20332-amputato-a-causa-di-una-malattia-rara-oggi-emanuele-lambertini-e-un-campione-paralimpico]]></loc><lastmod>2023-11-13T13:45:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20283-deficit-di-timidina-chinasi-2-dall-ucraina-all-italia-per-ricevere-una-terapia-sperimentale]]></loc><lastmod>2023-11-03T10:12:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/20075-ilaria-e-le-susine-pelate-un-esempio-di-coraggio-per-quanti-affrontano-una-diagnosi-di-sarcoma]]></loc><lastmod>2023-08-25T17:33:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19965-dal-senegal-all-italia-la-storia-a-lieto-fine-di-mouhamed-bimbo-nato-senza-occhi]]></loc><lastmod>2023-07-10T10:45:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19951-la-storia-di-bea-la-bambina-di-pietra-con-un-alterazione-del-dna-unica-al-mondo]]></loc><lastmod>2023-06-28T16:42:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19868-vulvodinia-il-percorso-di-asia-dopo-anni-di-dolori-la-svolta-grazie-a-una-speciale-terapia]]></loc><lastmod>2023-06-04T12:15:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19807-sindrome-nedamss-sono-solo-sei-i-pazienti-italiani]]></loc><lastmod>2023-05-17T18:35:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19813-sarcoma-a-pavia-primo-caso-al-mondo-di-gravidanza-naturale-dopo-adroterapia-alla-pelvi]]></loc><lastmod>2023-05-16T19:29:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19782-paralisi-spastica-ereditaria-infantile-quando-la-difficolta-nel-compiere-i-primi-passi-nasconde-una-malattia-rara]]></loc><lastmod>2023-05-09T13:10:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19762-sindrome-della-persona-rigida-valerio-la-mia-fortuna-aver-trovato-un-medico-che-conosce-la-patologia]]></loc><lastmod>2023-08-24T16:47:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19721-mutazione-del-gene-cert1-oltre-alla-piccola-carlotta-solo-tre-casi-accertati-nel-mondo]]></loc><lastmod>2024-05-29T21:28:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19699-mutazione-p312r-sul-gene-psmc5-yoni-e-ollie-sono-gli-unici-due-casi-al-mondo]]></loc><lastmod>2023-04-06T11:29:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19659-mutazione-del-gene-il1rapl2-la-ricerca-della-mamma-di-viola-dall-italia-alla-cina]]></loc><lastmod>2023-04-04T08:30:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19573-vincenzo-unico-caso-italiano-di-neuropatia-congenita-ipomielinizzante-dovuta-a-mutazione-del-gene-cntnap1]]></loc><lastmod>2023-02-27T21:30:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19468-la-storia-di-valeria-favorito-sorella-di-midollo-di-fabrizio-frizzi]]></loc><lastmod>2023-02-09T11:07:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19203-la-storia-di-laura-e-martina-una-malattia-rara-chiamata-gaci-ma-due-destini-molto-diversi]]></loc><lastmod>2022-10-25T13:50:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19171-deficit-del-trasportatore-della-creatina-sono-solo-130-i-casi-segnalati-nel-mondo]]></loc><lastmod>2026-01-20T14:20:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19061-la-storia-di-virginia-che-non-parla-e-non-cammina-a-causa-di-una-malattia-senza-nome]]></loc><lastmod>2022-09-15T15:39:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19032-therareside-la-storia-di-anna-e-carlo-che-pedalano-assieme-alle-loro-figlie-affette-da-malattia-rara]]></loc><lastmod>2022-09-16T08:58:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/19016-malformazione-ano-rettale-la-nuova-vita-di-un-bimbo-ucraino-grazie-al-policlinico-di-milano]]></loc><lastmod>2022-09-07T17:10:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18953-mutazione-del-gene-col4a1-la-battaglia-di-costanza-e-iniziata-nella-pancia-della-mamma]]></loc><lastmod>2022-08-01T09:15:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18868-malattie-rare-senza-nome-carol-e-quei-sintomi-misteriosi-che-nessuno-riesce-a-spiegare]]></loc><lastmod>2022-07-03T18:39:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18857-sindrome-di-charge-bambini-e-ragazzi-che-ne-sono-affetti-meritano-un-progetto-di-vita]]></loc><lastmod>2023-03-24T18:35:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18809-sindrome-dell-odore-di-pesce-la-testimonianza-di-laura-la-mia-vita-con-la-tmau]]></loc><lastmod>2022-06-29T08:16:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18798-resistenza-all-ormone-igf-1-la-storia-di-eva-la-bambina-che-non-riesce-a-crescere]]></loc><lastmod>2022-06-24T14:06:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18757-sindrome-di-beckwith-wiedemann-la-storia-di-leo-che-lotta-anche-contro-un-tumore-raro]]></loc><lastmod>2022-06-14T09:30:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18755-alopecia-areata-oggi-delle-cure-esistono-e-funzionano]]></loc><lastmod>2022-06-11T11:50:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18733-malattia-di-perthes-andrea-si-e-sottoposto-con-successo-a-un-delicato-intervento-alla-gamba]]></loc><lastmod>2025-05-05T14:15:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18657-delezione-xq28-i-genitori-del-piccolo-jacopo-cercano-qualcuno-con-cui-confrontarsi]]></loc><lastmod>2022-05-16T11:15:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18623-microtriplicazione-del-braccio-corto-del-cromosoma-1-solo-quattro-casi-al-mondo]]></loc><lastmod>2022-05-07T20:53:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18534-non-siamo-eroi-ma-facciamo-cose-eroiche-la-storia-di-mariangela-caregiver-familiare]]></loc><lastmod>2022-04-27T15:45:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18509-l-appello-di-una-mamma-alle-istituzioni-mia-figlia-ha-tre-malattie-rare-necessita-di-assistenza-qualificata]]></loc><lastmod>2022-04-03T14:20:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18435-sindrome-del-vomito-ciclico-la-storia-di-margherita-che-sognava-i-succhi-di-frutta]]></loc><lastmod>2022-03-20T22:08:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18404-il-viaggio-della-speranza-di-yuliya-da-kiev-a-napoli-grazie-a-una-rete-partita-dall-osservatorio-malattie-rare]]></loc><lastmod>2022-03-11T11:35:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18389-il-piccolo-giacomo-e-la-rarissima-sindrome-legata-al-cromosoma-6-solo-20-casi-al-mondo]]></loc><lastmod>2022-03-06T22:33:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18357-il-bambino-23-la-vicenda-di-una-famiglia-alle-prese-con-una-malattia-rarissima]]></loc><lastmod>2022-03-07T14:42:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18354-nebulose-sulla-pelle-una-storia-vera-sull-angiodisplasia-venosa]]></loc><lastmod>2022-03-01T21:39:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18320-displasia-fibromuscolare-la-storia-di-giuliana-una-vita-normale-e-possibile-nonostante-la-patologia]]></loc><lastmod>2022-02-21T16:26:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18257-neuropatia-a-piccole-fibre-la-travagliata-storia-di-daniela]]></loc><lastmod>2022-02-06T12:02:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18176-mutazione-del-gene-sptbn2-esistono-altri-casi-come-quello-del-piccolo-andrea]]></loc><lastmod>2022-01-15T16:32:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18134-delezione-2p16-3-i-genitori-di-crystal-e-giuseppe-cercano-altre-famiglie-che-convivono-con-la-patologia]]></loc><lastmod>2021-12-24T14:32:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18092-deformita-di-madelung-la-storia-di-maya-che-oggi-non-e-piu-invalida]]></loc><lastmod>2021-12-12T17:45:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18069-sindrome-di-ehlers-danlos-laura-ha-atteso-25-anni-per-una-diagnosi-ho-vissuto-in-un-labirinto]]></loc><lastmod>2021-12-05T17:11:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/18003-francesca-neri-la-mia-vita-con-la-cistite-interstiziale]]></loc><lastmod>2021-11-20T18:53:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17996-il-precipizio-dell-amore-un-libro-che-racconta-la-ricerca-della-normalita-in-condizioni-eccezionali]]></loc><lastmod>2021-11-13T20:06:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17975-sindrome-di-raynaud-claes-isabella-non-e-piu-l-unica-paziente-italiana]]></loc><lastmod>2021-11-06T23:41:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17822-la-piccola-elettra-e-la-sua-lotta-contro-una-malattia-rara-non-ancora-identificata]]></loc><lastmod>2021-09-28T13:28:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17770-quando-l-arte-diventa-un-super-potere-la-storia-di-agata-toschi-oltre-la-disabilita]]></loc><lastmod>2021-09-14T11:25:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17745-tremore-ortostatico-rende-la-vita-difficile-e-i-medici-non-conoscono-la-patologia]]></loc><lastmod>2021-09-05T12:57:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17741-paralimpiadi-tokyo-federico-mancarella-affetto-da-spina-bifida-si-aggiudica-il-bronzo-nella-canoa]]></loc><lastmod>2021-09-03T14:22:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17733-paralimpiadi-medaglia-di-bronzo-alla-judoka-carolina-costa-affetta-da-cheratocono]]></loc><lastmod>2021-09-03T14:15:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17717-malattie-rare-senza-nome-il-piccolo-diego-e-in-cerca-di-una-diagnosi]]></loc><lastmod>2021-08-16T11:34:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17689-malattia-di-perthes-la-battaglia-di-mamma-simona-per-il-riconoscimento-della-patologia]]></loc><lastmod>2022-06-01T14:14:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17682-benedetta-de-luca-l-influencer-che-si-batte-per-l-inclusione-delle-persone-con-disabilita]]></loc><lastmod>2021-07-25T17:14:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17668-disabilita-e-discriminazione-il-caso-della-carrozzina-di-anita-e-l-emblema-dell-abilismo]]></loc><lastmod>2021-07-19T09:52:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17594-martina-la-mia-vita-con-due-rare-patologie-della-pelle]]></loc><lastmod>2021-06-28T00:23:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17529-sindrome-da-microdelezione-5q14-3-mamma-nicoletta-cerca-altri-casi-come-quello-del-suo-jacopo]]></loc><lastmod>2021-06-14T13:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17482-idrosadenite-suppurativa-la-denuncia-di-valeria-e-federica-dopo-due-anni-non-ci-rinnovano-piu-l-esenzione]]></loc><lastmod>2021-05-27T11:32:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17473-delezione-2q37-mamma-antonella-cerca-ancora-casi-simili-al-suo-antonio]]></loc><lastmod>2021-05-26T09:14:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17441-malattie-neuromuscolari-quattro-mamme-si-raccontano]]></loc><lastmod>2021-05-16T14:59:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17424-sindrome-di-bainbridge-ropers-sofia-la-bambina-che-parla-con-gli-occhi]]></loc><lastmod>2021-05-11T16:22:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17375-malattia-di-kimura-la-lunga-odissea-di-lucia-che-cerca-altri-pazienti-come-lei]]></loc><lastmod>2021-05-02T17:29:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17317-irene-sta-carina-dal-diario-di-una-mamma-la-vita-di-una-bambina-disabile-nel-mondo-degli-altri]]></loc><lastmod>2021-04-26T09:05:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17314-displasia-campomelica-la-storia-di-roberta-la-bambina-che-ribalta-le-prognosi-negative]]></loc><lastmod>2021-04-21T10:58:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17282-malattie-ultra-rare-quando-le-famiglie-dei-piccoli-pazienti-si-incontrano]]></loc><lastmod>2021-04-11T20:42:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17261-anemia-emolitica-autoimmune-sintomi-e-step-diagnostici-dall-esperienza-di-un-paziente]]></loc><lastmod>2021-04-06T09:00:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17236-linfoma-epatosplenico-a-cellule-t-il-ricordo-di-edoardo-per-rimarcare-l-importanza-di-ricerca-e-donazione]]></loc><lastmod>2021-03-28T22:03:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17205-fight-the-stroke-la-fondazione-che-si-batte-per-i-bambini-con-ictus-perinatale]]></loc><lastmod>2021-03-21T21:43:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17179-una-malattia-senza-nome-e-una-passione-sconfinata-per-la-scuola-la-storia-di-chiara]]></loc><lastmod>2021-03-14T16:14:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/17130-amici-di-tommy-e-cecilia-l-associazione-per-l-inclusione-e-il-tempo-libero-dei-bambini-con-disabilita]]></loc><lastmod>2023-06-14T10:13:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16913-sindrome-eec-la-storia-di-francesca-jones-quattro-dita-per-mano-e-campionessa-di-tennis]]></loc><lastmod>2021-01-23T21:35:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16898-linfoma-di-hodgkin-la-vittoria-di-teresa-cherubini-sulla-malattia]]></loc><lastmod>2021-01-19T21:15:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16875-hanno-perso-tre-figli-a-causa-di-una-patologia-misteriosa-la-storia-di-helene-e-mikk-cederroth]]></loc><lastmod>2021-01-09T20:56:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16870-malformazione-artero-venosa-polmonare-la-storia-di-chloe-nata-due-volte]]></loc><lastmod>2021-01-09T16:49:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16853-artrite-idiopatica-giovanile-la-storia-di-martina-tra-gravidanza-e-lavoro]]></loc><lastmod>2020-12-30T18:28:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16521-sindrome-di-raynaud-claes-i-genitori-di-isabella-cercano-altre-famiglie-con-mutazione-clcn4]]></loc><lastmod>2020-10-06T08:40:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16414-tromboastenia-di-glanzmann-la-scelta-di-marco-mi-sono-tatuato-gli-stessi-lividi-di-mio-figlio]]></loc><lastmod>2020-09-07T15:52:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16381-mutazione-del-gene-ywhag-solo-venti-casi-nel-mondo]]></loc><lastmod>2020-08-27T07:54:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16291-sindrome-cdkl5-mamma-e-ricercatrice-studia-la-terapia-per-la-malattia-rara-di-sua-figlia]]></loc><lastmod>2020-07-14T17:02:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16281-collagenopatie-ereditarie-serve-piu-consapevolezza-da-parte-della-scienza]]></loc><lastmod>2020-07-12T17:56:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16127-cheratocono-grazie-al-trapianto-di-cornea-kevin-e-potuto-tornare-a-una-vita-normale]]></loc><lastmod>2020-06-11T08:02:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/16044-rare-sibling-mattia-nominato-alfiere-della-repubblica-per-l-amore-verso-il-fratello-malato]]></loc><lastmod>2020-05-10T20:55:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15736-malattie-rare-la-storia-di-diana-salvata-dalla-ricerca-e-guarita-grazie-al-trapianto]]></loc><lastmod>2020-03-08T15:02:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15596-malattie-genetiche-rare-la-patologia-di-adele-non-ha-un-nome]]></loc><lastmod>2020-01-27T10:12:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15566-mutazione-del-gene-huwe1-riccardo-e-l-unico-caso-in-italia]]></loc><lastmod>2020-01-12T15:06:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15547-sindrome-di-beckwith-wiedemann-la-storia-del-piccolo-ellis-alla-maratona-telethon]]></loc><lastmod>2019-12-31T18:24:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15548-sindrome-di-beckwith-wiedemann-ora-gabriele-ha-una-diagnosi-anche-grazie-a-telethon]]></loc><lastmod>2019-12-31T18:22:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15534-madre-vera-la-suora-di-chieti-che-adotta-i-bimbi-rari-abbandonati-dopo-il-parto]]></loc><lastmod>2019-12-23T09:21:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15396-malattia-di-addison-marco-ha-atteso-5-anni-per-arrivare-alla-diagnosi]]></loc><lastmod>2019-11-17T20:03:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15368-sindrome-di-cockayne-lucia-la-medicina-non-ha-potuto-fare-nulla-per-mia-figlia]]></loc><lastmod>2026-04-01T15:49:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15307-paraparesi-spastica-ereditaria-in-italia-un-crowdfunding-per-la-ricerca]]></loc><lastmod>2019-10-14T21:24:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15183-malformazione-ano-rettale-bimbo-di-un-giorno-salvo-grazie-a-una-tecnica-del-policlinico-di-milano]]></loc><lastmod>2019-09-12T20:59:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/15116-malattia-di-pelizaeus-merzbacher-grazie-a-un-ponte-di-solidarieta-luigi-puo-godere-del-mare]]></loc><lastmod>2019-08-13T21:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14952-anemia-di-fanconi-antonella-il-trapianto-di-midollo-mi-ha-salvato-la-vita]]></loc><lastmod>2020-03-02T11:00:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14886-lichen-sclero-atrofico-malattia-invisibile-e-invalidante-che-puo-colpire-anche-i-bambini]]></loc><lastmod>2019-06-05T19:08:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14766-mutazione-del-gene-alg13-un-appello-per-viola]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14676-acondroplasia-la-storia-di-davide-e-della-conquista-di-quei-25-centimetri-che-gli-hanno-cambiato-la-vita]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14671-monica-e-la-sua-lotta-quotidiana-contro-la-policondrite-ricorrente]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14665-mutazione-del-gene-gabrb2-nora-non-e-piu-sola-ha-trovato-francesco]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14660-fattore-k-due-amiche-la-corsa-e-un-blog-che-racconta-quando-la-vita-entra-nel-cancro]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14519-alcaptonuria-la-lotta-di-nick-per-salvare-i-suoi-figli-l-unica-terapia-era-stata-ideata-come-diserbante]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14521-quota-100-cometto-ho-dedicato-tutta-la-vita-ad-assistere-mia-figlia-a-me-non-spetta-nulla]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14500-la-battaglia-di-riccardo-e-dei-suoi-genitori-contro-una-malattia-senza-nome]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14468-mutazioni-del-gene-gabrb2-nora-e-l-unico-caso-in-italia]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14469-mutazioni-del-gene-iqsec2-tre-mamme-italiane-fondano-un-associazione]]></loc><lastmod>2022-09-09T11:51:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/14037-paraparesi-spastica-ereditaria-spg35-la-battaglia-di-un-padre-per-arginare-la-malattia]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/13612-sindrome-mpph-la-storia-di-claudia-e-davide-e-di-una-diagnosi-un-po-particolare]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/13520-david-cameron-dalla-malattia-rara-che-uccise-il-figlio-alla-ricerca-di-test-genetici-low-cost]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/13404-sindrome-tango2-nel-mondo-sono-noti-20-casi-due-sono-fratellini-italiani]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/13376-sindrome-di-kallmann-la-battaglia-di-giulia-per-avere-un-figlio]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/13331-il-sarcoma-di-ewing-le-ha-tolto-la-vita-ma-non-le-ha-impedito-di-amarla-la-storia-di-holly]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/13093-osteogenesi-imperfetta-la-lotta-di-rosanna-contro-gli-sguardi-del-paese-e-la-cecita-delle-istituzioni]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12733-una-frattura-che-non-guarisce-la-storia-di-francesco]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12607-il-sogno-realizzato-di-carlo-diventare-skipper-nonostante-la-cecita]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12594-sara-possibile-in-futuro-un-mondo-senza-malattie]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12567-ellie-e-il-miracolo-della-scienza-quando-una-storia-salva-molte-vite]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12523-diversamente-amore-quando-le-malattie-rare-non-sono-un-tabu]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12487-il-sogno-di-silvia-diventare-guardia-forestale-nonostante-la-sclerosi-multipla]]></loc><lastmod>2017-07-10T16:11:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12399-giorgia-smile-la-tredicenne-che-affronta-una-malattia-sconosciuta]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12376-amicus-la-biotech-dal-cuore-italo-americano-che-nasce-da-una-vita-straordinaria-quella-di-john-crowley]]></loc><lastmod>2017-06-14T08:55:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12354-haden-il-bimbo-autistico-che-vende-i-suoi-disegni-per-aiutare-il-fratellino-malato]]></loc><lastmod>2017-06-08T09:14:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12333-il-sogno-di-paolo-rendere-accessibile-il-cammino-di-santiago-ai-disabili]]></loc><lastmod>2017-06-01T08:42:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12301-in-italia-un-milione-di-malati-sotto-i-16-anni-non-ha-una-diagnosi]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12299-arte-e-malattie-rare-la-domestica-ritratta-dal-mantegna-non-soffriva-di-neurofibromatosi]]></loc><lastmod>2017-05-20T15:33:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12273-sarcoma-di-ewing-laura-riccioli-d-oro-ha-vinto-la-sua-battaglia]]></loc><lastmod>2017-05-15T09:05:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12257-francesca-la-bimba-aliena-che-ha-dovuto-lasciare-la-terra-per-colpa-della-sua-malattia]]></loc><lastmod>2017-05-08T18:18:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12160-la-missione-di-un-padre-sviluppare-un-farmaco-per-guarire-i-suoi-figli]]></loc><lastmod>2017-04-06T16:29:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12144-il-viaggio-della-piccola-scarlett-dalla-francia-fino-a-palermo-per-ricevere-una-diagnosi]]></loc><lastmod>2017-04-01T18:35:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12125-un-bambino-con-duchenne-e-suo-padre-insieme-in-un-impresa-sportiva-straordinaria]]></loc><lastmod>2017-03-27T16:08:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12122-canada-una-comunita-si-mobilita-per-il-trapianto-di-fegato-di-colleen]]></loc><lastmod>2017-04-06T16:33:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/12065-silvana-la-diagnosi-di-visceroptosi-l-ho-fatta-io]]></loc><lastmod>2017-03-15T14:34:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11914-epidermodisplasia-verruciforme-abul-bajandar-soprannominato-per-anni-uomo-albero-ha-riacquistato-l-uso-delle-mani]]></loc><lastmod>2017-02-12T17:37:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11863-paolo-palumbo-il-giovane-chef-affetto-da-sla-che-rida-il-sapore-ai-tracheotomizzati]]></loc><lastmod>2017-02-02T16:10:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11830-idrosadenite-suppurativa-ecco-come-si-vive-tra-dolore-cisti-ed-ulcere-spese-sanitarie-e-burocrazia]]></loc><lastmod>2019-05-18T16:25:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11828-nevo-melanocitico-congenito-gigante-la-storia-di-enza]]></loc><lastmod>2017-01-23T15:29:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11824-nevo-melanocitico-congenito-gigante-la-storia-di-anna]]></loc><lastmod>2017-01-23T15:26:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11758-a-genova-un-porto-dedicato-ai-piccoli-pazienti-per-vivere-con-serenita-la-malattia]]></loc><lastmod>2016-12-22T15:57:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11712-le-malattie-rare-in-sudafrica-l-impegno-di-mamma-kelly]]></loc><lastmod>2016-12-10T13:37:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11709-osteogenesi-imperfetta-la-danza-di-chiara-contro-la-malattia]]></loc><lastmod>2016-12-10T11:50:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11692-glicogenosi-di-tipo-1-mamma-alessandra-e-il-figlio-niccolo-raccontano-la-malattia]]></loc><lastmod>2016-12-12T09:24:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11698-la-sindrome-mal-de-debarquement-sentirsi-in-mare-anche-sulla-terraferma]]></loc><lastmod>2016-12-09T10:37:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11694-heather-etchevers-l-importanza-del-crowdfunding-per-le-malattie-rare]]></loc><lastmod>2016-12-08T10:19:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11688-alcaptonuria-nicolas-sireau-la-mia-battaglia-contro-la-malattia-delle-ossa-nere]]></loc><lastmod>2019-02-26T19:43:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11684-begonya-nafria-nella-ricerca-sulle-malattie-rare-bisogna-superare-i-confini-geografici]]></loc><lastmod>2016-12-05T10:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11599-natale-storia-di-una-diagnosi-arrivata-dopo-tredici-anni]]></loc><lastmod>2021-02-25T10:26:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11587-mixoma-e-se-fosse-stato-questo-raro-tumore-cardiaco-a-uccidere-gabriotto]]></loc><lastmod>2016-11-10T11:33:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11354-malattie-rare-l-incubo-vissuto-dai-genitori-credevamo-di-perdere-il-nostro-taylor]]></loc><lastmod>2016-10-01T10:42:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11315-fabio-pisacane-arriva-in-serie-a-dopo-la-sindrome-di-guillain-barre]]></loc><lastmod>2016-09-27T14:37:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11311-in-un-affresco-del-mantegna-i-sintomi-della-neurofibromatosi]]></loc><lastmod>2023-03-02T16:52:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/11324-atrofia-muscolare-spinale-grandi-speranze-per-il-candidato-farmaco-nusinersen]]></loc><lastmod>2016-09-26T10:18:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/10800-roberto-camelia-l-arbitro-di-boxe-con-la-protesi]]></loc><lastmod>2016-06-18T15:56:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/10543-erika-novarria-la-prima-boxer-donna-amputata-non-mollate-mai]]></loc><lastmod>2016-05-10T07:10:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/10503-alex-il-bambino-che-non-tollera-luce-e-calore]]></loc><lastmod>2016-05-20T08:20:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/10461-il-cammino-di-carlo-sulla-via-francigena-dopo-aver-sconfitto-il-melanoma-metastatico]]></loc><lastmod>2016-04-26T15:12:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/10456-cistinuria-l-appello-di-una-mamma-troppe-differenze-regionali-nel-trattamento-dei-malati-rari]]></loc><lastmod>2016-04-26T14:51:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/10275-la-piccola-lizzy-domani-incontra-il-papa-il-sogno-vederlo-prima-della-cecita]]></loc><lastmod>2016-03-29T15:49:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/10225-una-malattia-rara-in-famiglia-la-storia-di-roberta]]></loc><lastmod>2019-05-24T16:36:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9986-elisa-la-sindrome-di-williams-e-un-dono-quello-della-musica]]></loc><lastmod>2016-02-17T18:13:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9911-l-appello-di-silvia-34-anni-ho-una-malattia-rara-sconosciuta-qualcuno-puo-aiutarmi]]></loc><lastmod>2016-02-05T13:47:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9906-cosimo-papa-di-un-bimbo-affetto-da-una-malattia-rara-ignota-cerca-disperatamente-lavoro]]></loc><lastmod>2016-02-05T11:26:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9893-sindrome-di-werner-dopo-anni-di-cure-sbagliate-due-fratelli-trovano-assistenza-a-roma]]></loc><lastmod>2016-02-03T15:40:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9786-malattie-rare-romana-liuzzo-si-racconta-ho-la-lam-ed-ora-sono-pronta-a-raccontare-la-mia-storia]]></loc><lastmod>2016-01-21T09:23:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9759-porpora-trombotica-trombocitopenica-la-storia-e-la-speranza-del-piccolo-david]]></loc><lastmod>2019-08-30T14:55:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9623-giulia-e-affetta-da-tre-malattie-rare-il-padre-e-senza-lavoro-chiediamo-aiuto-per-la-famiglia]]></loc><lastmod>2015-12-15T14:59:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9532-sindrome-di-brown-vialetto-van-laere-2-piccola-paziente-diagnosticata-e-curata-negli-usa]]></loc><lastmod>2015-12-04T10:29:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9503-anna-e-la-sindrome-di-cushing-ero-arrivata-a-desiderare-di-morire-oggi-sto-bene-e-parlo-della-malattia]]></loc><lastmod>2015-12-02T14:26:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9434-sindrome-di-birt-hogg-dube-solo-80-casi-in-tutto-il-mondo-la-storia-di-giorgia]]></loc><lastmod>2023-03-31T11:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9437-martina-non-puo-avere-l-esenzione-perche-la-sua-e-una-patologia-unica-e-non-rara]]></loc><lastmod>2015-11-25T15:30:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/9287-i-progetti-di-ricerca-del-comitato-italiano-progetto-mielina-a-favore-del-san-raffaele-di-milano-e-del-meyer-di-firenze]]></loc><lastmod>2015-11-04T09:05:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8920-le-carte-che-mi-sono-state-servite]]></loc><lastmod>2016-05-06T16:44:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8745-leucodistrofia-la-storia-del-piccolo-xavier]]></loc><lastmod>2015-07-31T13:33:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8751-un-lavoro-per-il-papa-di-federico-affetto-da-una-rara-malattia-ancora-sconosciuta]]></loc><lastmod>2019-05-29T05:01:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8528-sindrome-di-sjoegren-la-testimonianza-di-anna]]></loc><lastmod>2015-06-26T10:52:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8480-gangliosidosi-gm1-la-storia-della-piccola-giulia]]></loc><lastmod>2019-08-08T15:51:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8294-sindrome-di-lesch-nyan-la-vita-con-la-malattia-e-lassociazione-italiana-pazienti]]></loc><lastmod>2016-09-29T20:33:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8293-sindrome-di-lesch-nyhan-limpegno-dellassociazione-italiana]]></loc><lastmod>2016-09-27T14:03:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8292-sindrome-di-lesch-nyan-grazie-ai-maratonabili-lo-sport-supera-le-barriere]]></loc><lastmod>2016-09-27T14:01:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8307-displasia-fibromuscolare-credevo-di-essere-sana-ma-ho-scoperto-di-essere-piu-fragile-di-quanto-pensassi]]></loc><lastmod>2015-05-24T13:33:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8196-ngky1-per-ora-le-terapie-sono-solo-di-supporto-ma-la-ricerca-va-avanti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8195-combattere-una-malattia-con-laiuto-dei-nuovi-media-il-caso-ngly1]]></loc><lastmod>2018-02-15T17:48:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8194-come-riconoscere-lngly1-una-delle-malattie-piu-rare-al-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8198-malattie-rare-cristina-racconta-mio-figlio-soffriva-di-una-malattia-ignota-alla-scienza-lngly1]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8197-la-storia-di-luisa-da-napoli-al-maryland-per-sconfiggere-lngly1]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/8142-sindrome-di-smith-magenis-sms-la-testimonianza-di-sabrina-e-il-sogno-di-unassociazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/7827-retinite-pigmentosa-la-storia-di-lara-che-vuole-vedere-il-mondo-prima-di-perdere-la-vista]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/7502-malattie-rare-chi-sono-gli-eroi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/7262-medicina-fetale-il-12-dicembre-al-gemelli-di-roma-il-convegno-aigoc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/7247-sindrome-di-sotos-dallesperienza-di-silvia-nasce-lassociazione-sindrome-di-sotos-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/7210-marika-la-mia-vita-con-tre-malattie-rare]]></loc><lastmod>2016-05-06T16:18:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/7198-tremore-ortostatico-primitivo-pot-quello-di-cui-non-si-parla-mai-sono-gli-effetti-secondari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/7197-malattia-di-pitt-hopkins-calvin-ha-ottenuto-la-diagnosi-grazie-al-test-di-exome-sequencing]]></loc><lastmod>2024-04-08T17:53:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/7090-viaggio-della-speranza-dalla-russia-a-siena-per-una-grave-patologia-dellorecchio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6986-anidrosi-lassenza-di-sudorazione-puo-essere-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6950-al-via-oggi-il-2d-workshop-internazionale-finanziato-dallassociazione-ring14-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6933-sindrome-di-de-barsy-lizzie-velasquez-e-la-donna-piu-magra-del-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6798-malattia-di-erdheim-chester-ecd-unalleanza-globale-per-supportare-i-pazienti-e-trovare-una-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6796-sindrome-di-apert-la-storia-di-samantha]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6768-kylie-simonds-la-storia-della-bimba-malata-di-cancro-che-senza-dimenticare-di-sorridere-ha-inventato-lo-zainetto-per-aiutare-i-bambini-a-vivere-meglio-la-chemioterapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6741-cacciata-dallhotel-perche-il-nipote-affetto-da-autismo-disturbava]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6712-sindrome-di-allan-herndon-dudley-da-quattro-anni-in-guerra-contro-la-burocrazia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6711-appello-disperato-del-papa-di-giulia-affetta-da-tre-malattie-rare-aiutatemi-a-trovare-un-lavoro]]></loc><lastmod>2015-12-15T14:40:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6662-emiplegia-alternante-a-varese-niente-piu-esenzione-per-il-farmaco-che-allevia-i-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6577-sclerosi-laterale-amiotrofica-susanna-la-blogger-che-scrive-con-gli-occhi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6540-una-rarissima-malattia-le-ricopre-il-piccolo-corpo-di-peli-e-la-madre-labbandona]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6539-lipodistrofia-vicky-e-quei-muscoli-che-la-mettono-a-disagio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6537-emofilia-10-ore-al-pronto-soccorso-prima-di-essere-assistito-per-una-emorragia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6527-sindrome-di-sanfilippo-lamore-tra-un-bimbo-e-un-cane-abbandonato]]></loc><lastmod>2016-05-31T15:49:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6513-delezione-cromosoma-2-lappello-di-maria-cerco-una-terapie-e-altre-famiglie-che-vivano-il-problema]]></loc><lastmod>2016-02-14T11:07:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6476-tremore-ortostatico-primitivo-accettare-la-malattia-per-vivere-ancora-la-storia-di-valerie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6469-displasia-ectodermica-la-storia-di-jose]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6442-sindrome-di-sjoegren-dal-tumore-alla-malattia-rara-senza-perdere-la-speranza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6375-sindrome-di-marinesco-sjoegren-la-difficile-diagnosi-del-piccolo-marco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6372-malattia-di-moyamoya-la-conoscenza-aumenta-la-capacita-di-gestirla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6373-sarcoma-di-ewing-impegnarsi-per-far-crescere-la-speranza-di-tanti-giovani-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6390-atresia-dellesofago-petar-dallex-jugoslavia-al-meyer-di-firenze-per-essere-salvato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6366-luke-e-il-sogno-di-volare-come-superman]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6288-sindrome-di-kallmann]]></loc><lastmod>2016-10-25T18:27:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6287-sindrome-della-fermentazione-intestinale-una-malattia-rara-con-i-sintomi-da-sbornia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6251-retinite-pigmentosa-matteo-e-campione-di-judo-nonostante-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6216-malattie-rare-un-parco-giochi-per-cristian-affetto-da-sma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6214-sindrome-di-eec-giulia-testimonial-per-i-malati-rari-e-per-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6159-malattia-di-pitt-hopkins-mia-figlia-normale-fino-a-sei-mesi-poi-linizio-del-calvario]]></loc><lastmod>2024-04-08T17:57:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6112-alcaptonuria-i-primi-segnali-dal-pannolino-del-neonato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6063-acidosi-metilmalonica-la-denuncia-della-famiglia-ripianano-i-debiti-della-sanita-facendoci-pagare-le-medicine]]></loc><lastmod>2019-06-18T18:19:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6076-giulia-ha-tre-malattie-rare-la-sua-famiglia-e-in-difficolta-lappello-del-padre-qsenza-lavoro-non-posso-assistere-mia-figliaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6044-meningioma-il-calciatore-carlo-vicedomini-segna-il-suo-goal-personale]]></loc><lastmod>2019-06-18T18:21:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5971-anita-ha-la-sma-la-mia-famiglia-ha-puntato-sui-miei-punti-di-forza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/6020-malattia-di-krabbe-si-lavora-alla-terapia-genica-ma-ci-vorra-ancora-del-tempo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5969-sma-fabio-sono-affetto-dalla-malattia-ma-continuo-a-girare-il-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5963-la-malattia-di-krabbe-sono-pronta-a-lottare-fino-alla-fine-per-aiutare-il-mio-bambino]]></loc><lastmod>2020-08-18T11:25:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5948-foxp1-la-causa-del-ritardo-cognitivo-potrebbe-essere-una-rara-mutazione-genetica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5944-polineuropatia-amiloide-familiare-fap-fabio-scopre-la-malattia-dopo-la-morte-del-padre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5904-fenilchetonuria-sara-racconta-ero-spaventatissima-ma-grazie-alla-dieta-mia-figlia-oggi-sta-beneq]]></loc><lastmod>2016-03-24T15:28:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5876-pemfigoide-cicatriziale-isabella-e-iniziato-con-un-raffreddore-oggi-combatto-una-battaglia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5873-giulia-ha-la-fibrosi-cistica-insegna-nuoto-e-vive-al-massimo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5855-fibromialgia-katie-da-dover-alla-francia-per-continuare-a-lottare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5851-il-jazzista-petrucciani-grande-nonostante-la-malattia-che-non-gli-ha-permesso-di-crescere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5800-sindrome-da-anticorpi-antifosfolipidi-catastrofica-caps-la-vita-cambia-allimprovviso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5821-grazie-a-internet-scoperta-la-malattia-di-grace-la-carenza-di-ngly1]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5750-hiv-la-storia-di-mississipi-baby-rappresenta-una-concreta-speranza-per-i-neonati-sieropositivi]]></loc><lastmod>2021-01-12T15:38:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5696-lodissea-di-giuseppina-la-puglia-non-riconosce-la-sua-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5695-retinite-pigmentosa-prima-di-perdere-la-vista-il-dodicenne-louis-va-a-scoprire-il-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5687-sindrome-di-gorlin-andrea-cerca-famiglie-che-conoscano-la-malattia]]></loc><lastmod>2019-08-26T08:43:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5639-la-storia-di-andrea-che-una-bracciata-dopo-laltra-lotta-contro-losteopseudoglioma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5633-il-piccolo-george-combatte-contro-la-malattia-di-leigh]]></loc><lastmod>2018-06-23T15:41:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5629-3650-caramelle-lanno-e-il-solo-cibo-che-puo-mangiare-un-bimbo-affetto-da-una-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5541-narcolessia-lory-mi-addormento-facendo-shopping-o-andando-a-passeggio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5530-glicogenosi-quattro-ali-per-volare-una-storia-damore-che-aiuta-i-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5532-sindrome-di-evans-mio-figlio-vuole-vivere-e-guardare-al-futuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5483-vincenzo-amava-vivere-e-scrivere-poesie-la-distrofia-muscolare-lha-portato-via]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5480-sindrome-di-sanfilippo-i-miei-figli-vivono-con-questa-malattia]]></loc><lastmod>2017-11-09T18:23:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5436-mille-chilometri-per-una-diagnosi-osteopetrosi-maligna-infantile-la-storia-di-una-famiglia-come-tante]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5425-in-bicicletta-con-la-fibrosi-polmonare-idiopatica-fino-santiago-de-compostela]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5385-estrofia-vescicale-epispadia-i-malati-sono-abbandonati-a-se-stessi-la-patologia-non-e-riconosciuta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5382-glomerulonefrite-membrano-proliferativa-di-tipo-ii-i-pazienti-si-battono-per-il-riconoscimento-della-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5380-amiloidosi-la-storia-di-mario-come-cambiata-la-mia-vita-con-una-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5307-affetta-da-malattia-reumatica-cronica-denuncia-abbandonata-dalle-istituzioni-pago-io-per-tutti-i-falsi-invalidi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5267-sindrome-di-cornelia-de-lange-martina-e-rifiutata-dagli-ospedali-problema-risolto-dal-tam-tam-della-rete]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5206-epidermoliosi-bollosa-anna-farfalla-per-un-giorno-batte-il-record-mondiale]]></loc><lastmod>2021-01-12T15:42:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5147-nonostante-la-disabilita-gravissima-scrive-lamore-per-la-vita]]></loc><lastmod>2019-06-19T08:06:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5042-fibroplasia-ossificante-progressiva-la-malattia-rara-diagnosticata-al-figlio-del-capitano-del-livorno-andrea-luci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/5008-sindrome-di-sjogren-lincontro-con-lassociazione-animass]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/4992-sindrome-di-keppen-lubinsky-la-storia-di-daniele-uno-dei-3-pazienti-al-mondo-affetti-da-questa-rarissima-patologia]]></loc><lastmod>2025-11-10T07:57:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/4820-retinite-pigmentosa-accusata-di-fingersi-cieca-ora-la-sentenza-di-assoluzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/4716-sindrome-di-alstroem-kay-parkinson-i-miei-figli-sono-rimasti-senza-una-diagnosi-per-piu-di-15-anni]]></loc><lastmod>2016-01-22T12:35:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/4525-angioma-cavernoso-cerebrale-nasce-anacc-onlus-prima-associazione-italiana-di-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/4555-sindrome-di-mcleod-per-enrico-non-ce-nessuna-cura-il-fratello-qsiamo-esasperatiq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/4527-sla-daniele-partecipera-alla-maratona-del-brenta-in-carrozzina-spinto-dalla-solidarieta]]></loc><lastmod>2019-06-19T08:25:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/4464-sindrome-di-praedr-willi-claudia-lotta-contro-la-malattia-e-linps-le-nega-il-sussidio-di-invalidita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/4467-sindrome-di-arnold-chiari-chiara-sara-operata-negli-usa]]></loc><lastmod>2019-06-19T08:27:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/4422-sindrome-xyy-grazie-a-osservatorio-malattie-rare-i-genitori-si-incontrano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/4338-sindrome-di-mowat-wilson-in-italia-e-attiva-un-associazione-che-riunisce-le-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3659-distrofia-di-duchenne-saverio-oggi-ha-18-anni-vive-grazie-al-cuore-artificiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3658-sindrome-di-gorham-stout-pina-ha-perso-suo-figlio-e-vuole-costiture-unassociazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3543-mucolipidosi-di-tipo-4-loretta-cerca-altre-famiglie-con-le-quali-confrontarsi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3522-craniostenosi-una-diagnosi-precoce-puo-evitare-danni-cerebrali-ma-ci-vuole-un-medico-esperto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3472-fibrosi-cistica-riammesso-a-scuola-il-bambino-di-montepaone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3433-fibrosi-cistica-scuola-dellinfanzia-rifiuta-lammissione-di-un-bambino-affetto-dalla-rara-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3391-aciduria-idrossiglutarica-maria-rosa-cerca-altre-famiglie-che-conoscano-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3381-sindrome-di-ehlers-danlos-nessuno-vuole-operare-la-ventiseienne-di-eraclea]]></loc><lastmod>2019-02-11T15:36:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3347-sindrome-di-potocki-lupski-claudio-cerca-altre-famiglie-che-conoscano-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3257-beta-sarcogliacanopatie-il-gruppo-dei-familiari-gfb-cerca-altri-pazienti-italiani-affetti-da-questa-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3246-sindrome-di-kleine-levin-nicole-ha-dormito-per-64-ore-di-fila]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3147-cistite-interstiziale-la-diagnosi-di-nadia-e-arrivata-dopo-25-anni-anche-grazie-al-web]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3069-adiposi-dolorosa-chiara-cerca-pazienti-affetti-da-questa-rara-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3068-sindrome-di-klippel-trenaunay-weber-anna-e-stata-abbandonata-dalle-istituzioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/3001-leucinosi-inps-restituisce-il-sussidio-alla-piccola-malata-vicentina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2954-leucinosi-a-vicenza-linps-nega-lassegno-di-accompagnamento-a-una-bambina-di-10-mesi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2899-dolore-cronico-luca-moretto-con-il-colore-sdrammatizzo-il-dolore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2904-sindrome-di-gardner-il-caso-di-claudio-la-asl-gli-nega-il-trasporto-in-ambulanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2765-ha-contratto-la-larva-migrans-una-malattia-tropicale-che-nessuno-in-europa-sa-curare]]></loc><lastmod>2020-01-08T17:06:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2742-tartarughe-in-corsia-un-libro-e-uno-spettacolo-per-i-piccoli-malati-rari-in-ospedale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2657-osteodistrofia-congenita-di-albright-elena-ottiene-la-diagnosi-dopo-18-anni-e-si-racconta-in-un-blog]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2624-atassia-di-fredreich-federico-fara-la-maratona-di-new-york-in-handbike]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2614-ipertermia-maligna-im-un-test-da-20-centesimi-potrebbe-evitare-le-peggiori-conseguenze-della-malattia-ma-non-e-obbligatorio-e-molti-ospedali-non-lo-fanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2613-ipertermia-maligna-im-valentina-ha-rischiato-di-morire-a-18-anni-per-unanestesia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2588-sindrome-eec-ecco-il-blog-di-giulia-che-racconta-se-stessa-e-la-sua-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2561-sindrome-di-sapho-luigi-ne-soffre-da-25-anni-e-disoccupato-da-12-anni-con-uninvalidita-del-67]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2562-pandas-la-storia-di-nicholas-che-ha-ottenuto-una-diagnosi-dopo-7-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2480-atrofia-muscolare-spinale-per-laura-luniversita-e-un-percorso-ad-ostacoli-tra-burocrazia-e-trasporti-inesistenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2463-sindorme-di-bannayan-zonana-la-piccola-chicca-e-nata-con-la-rara-malattia]]></loc><lastmod>2017-11-12T17:14:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2454-sindromi-phts-anna-maria-vuole-costituire-unassociazione-per-colmare-i-vuoti]]></loc><lastmod>2024-10-23T09:59:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2407-alcaptonuria-luna-ha-atteso-anni-prima-di-ottenere-una-diagnosi]]></loc><lastmod>2019-02-26T18:29:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2372-displasia-ectodermica-ipoidrotica-x-linked-negli-usa-procedura-veloce-per-un-nuovo-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2279-malformazioni-uro-ano-rettali-cosa-sono-e-come-e-possibile-conviverci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2289-fascite-necrotizzante-doppio-trapianto-di-arti-dopo-la-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2276-tromboastenia-di-glanzmann-angelica-ha-avuto-la-diagnosi-al-careggi-dopo-31-anni-di-sofferenze]]></loc><lastmod>2020-08-26T16:26:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2241-sindrome-da-fatica-cronica-giada-racconta-i-suoi-20-anni-di-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2233-malattia-rara-da-accumulo-di-glicogeno-diagnostica-con-il-test-del-dna-e-curata-con-una-bibita-allamido-di-mais]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/2147-dopo-la-varicella-una-rara-malattia-della-pelle-curata-con-successo-la-piccola-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1920-malattie-rare-in-lazio-non-sono-stanziati-i-fondi-per-lapprovvigionamento-di-immunoglobuline]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1896-anomalie-pupillari-a-udine-una-diagnosi-tempestiva-ha-salvato-la-vista-della-piccola-sofia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1831-emiplegia-alternante-su-repubblicait-nancy-brilli-racconta-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1830-malattie-rare-dalla-california-alla-neonatologia-di-monza-per-avere-la-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1550-sla-e-carcinoma-del-colon-retto-palmina-giannini-chiede-aiuto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1472-atrofia-muscolare-spinale-la-malattia-non-ferma-elena-laureata-fidanzata-e-con-tanta-voglia-di-vivere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1474-sma-sabrina-dal-2006-vive-da-sola-grazie-ad-abilitando-un-progetto-innovativo-della-lombardia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/937-albinismo-oculocutaneo-da-disagio-a-stile-di-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1175-fibrosi-idiopatica-polmonare-giovanna-ha-sconfitto-la-bestia-nera-con-il-trapianto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1138-sindrome-arnold-chiari-a-gabriella-serve-aiuto-il-comune-di-catania-le-chiede-900-euro-al-mese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1041-neurofibromatosi-1-daniela-con-la-mia-malattia-nessuno-ti-da-un-lavoro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1020-sla-prosegue-la-lotta-di-toni-ginnastica-integratori-e-un-po-di-fai-da-te]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/1007-progeria-negli-usa-due-casi-nella-stessa-zona-entreranno-nella-sperimentazione-clinica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/996-sindrome-hallervorden-spatz-domingo-e-bloccato-in-un-corpo-che-non-risponde-con-gli-sms-ha-scritto-un-libro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/988-fibrosi-cistica-due-genitori-raccontano-la-diagnosi-e-arrivata-dopo-due-mesi-non-sapevamo-nulla-dello-screening-neonatale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/989-sindrome-preder-willi-quattro-anni-e-mezzo-per-la-diagnosi-a-nostra-figlia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/968-acromatopsia-in-italia-circa-100-pazienti-e-unassociazione-che-si-occupa-di-loro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/969-sindrome-da-fatica-cronica-valentina-ha-preso-il-diploma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/959-sindrome-di-noonan-per-ottenere-una-diagnosi-corretta-possono-servire-anni-e-poi]]></loc><lastmod>2019-06-12T08:50:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/956-acromatopsia-i-medici-credevano-che-tyla-fosse-cieca-ma-non-era-cosi]]></loc><lastmod>2024-03-04T19:27:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/950-sla-il-22-luglio-scorso-e-morto-lumbro-giulio-galli-era-in-prima-fila-per-i-diritti-dei-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/886-slapiu-di-tre-mesi-per-avere-lausilio-per-la-ventilazione-notturna]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/883-enterocolite-necrotizzante-sono-serviti-6-interventi-ma-ora-il-piccolo-puo-nutrirsi-normalmente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/827-sla-franca-ci-racconta-la-malattia-del-marito-toni-allinizio-non-voleva-capire-e-sempre-stato-un-uomo-sportivo-e-atletico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/694-sindrome-kleesftra-9qstds-silvia-non-ho-mai-conosciuto-altri-con-il-male-di-mia-figlia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/648-deletion-2q37-in-italy-two-moms-found-out-their-kids-have-this-rare-disease]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/647-delezione-2q37-antonella-e-simona-lanciano-un-nuovo-appello-chi-conosce-altri-casi-ci-contatti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/642-porpora-trombocitopenica-irene-12-anni-vorrei-guarire-usando-un-farmaco-che-non-sia-il-cortisone]]></loc><lastmod>2016-02-16T18:32:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/638-charge-bimbo-di-tre-anni-potra-sentire-grazie-ad-intervento-effettuato-al-ramazzini-di-carpi]]></loc><lastmod>2019-08-07T21:08:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/629-porpora-alfonso-convive-con-la-malattia-da-30-anni-tra-lunghe-pause-e-qualche-ricaduta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/621-porpora-trombocitopenica-anna-per-i-lividi-di-ida-protestai-con-le-maestre-non-era-colpa-loro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/616-porpora-trombocitopenica-marini-ha-seguito-le-cure-e-da-6-mesi-e-libera-dal-cortisone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/613-deficit-del-surfattante-raffaele-ha-vissuto-19-mesi-la-diagnosi-e-arrivata-solo-alla-fine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/609-porpora-trombocitopenica-conchita-racconta-che-vergogna-quei-lividi-ma-ora-non-ci-sono-piu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/565-delezione-2q37-la-mamma-di-antonio-non-e-piu-sola-trovata-in-italia-bimba-con-stessa-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/546-leucodistrofia-la-forma-di-mattia-non-e-definita-senza-diagnosi-niente-studi-sperimentali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/532-malattia-di-kimura-in-soccorso-di-martina-arriva-la-ausl-di-parma-sara-esente-da-ticket-per-5-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/520-delezione-2q37-antonio-ne-e-affetto-la-sua-mamma-cerca-gli-altri-casi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/506-malattia-di-kimura-a-parma-lunica-bimba-malata-un-imprevisto-per-il-nostro-sistema-sanitario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/505-il-mistero-di-enrico-viii-il-re-potrebbe-essere-stato-affetto-dalla-malattia-di-mcleod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/370-mcs-nessun-riconoscimento-per-una-malata-di-bari-malattia-scambiata-per-problema-psicologico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/331-le-malattie-rare-cambiano-la-vita-lo-testimonianza-di-gabriella-alla-redazione-di-disabilicom]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/302-fibrosi-cistica-valeria-oggi-ha-i-polmoni-nuovi-e-una-bambina]]></loc><lastmod>2015-06-08T16:38:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/260-mngie-ragazza-guarita-grazie-a-trapiantom-di-midollo-osseo-effettuato-a-le-scotte-di-siena]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/258-anemia-di-fanconi-ecco-perche-il-test-al-deb-messo-a-punto-in-italia-non-puo-sbagliare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/210-aou-meyer-dopo-il-deposito-del-brevetto-del-nuovo-test-precoce-e-stato-scoperto-il-primo-bambino-di-tirosenemia-tipo-i-non-aveva-alcun-sintomo-dieta-e-terapia-farmacologia-il-neonato-sta-bene]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/202-anomalia-di-ebstein-salvato-a-le-scotte-di-siena-ragazzo-di-14-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/170-neuropatia-assonale-lunico-centro-a-fare-la-diagnosi-in-italia-e-listituto-medea-in-provincia-di-lecco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/141-prematuro-con-due-patologie-rare-operato-al-monasterio-di-massa-con-il-primo-intervento-contemporaneo-a-cuore-e-trachea-effettuato-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/113-peter-oxford-convivo-con-la-fibrosi-cistica-ma-nella-mia-vita-ho-fatto-tutto-quello-che-volevo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/storie/44-ha-la-malattia-di-tay-sachs-non-ce-nulla-da-fare-ma-la-terapia-con-il-miglustat-sta-rallentando-la-malattia]]></loc><lastmod>2026-03-04T18:53:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/22804-emilia-romagna-ancora-in-stallo-la-terapia-enzimatica-domiciliare-la-consigliera-ugolini-chiede-lattuazione-immediata-della-delibera-1415-2022]]></loc><lastmod>2026-03-01T23:06:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/22456-emilia-romagna-apertura-dellassessore-fabi-alla-terapia-enzimatica-domiciliare-per-malattie-lisosomiali]]></loc><lastmod>2025-10-28T17:42:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/22438-emilia-romagna-terapia-enzimatica-ancora-bloccata-il-28-ottobre-linterpellanza-arriva-in-aula]]></loc><lastmod>2025-10-23T22:05:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/22226-terapia-enzimatica-sostitutiva-domiciliare-nuovo-appello-delle-associazioni-in-emilia-romagna]]></loc><lastmod>2025-07-30T17:47:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/22123-terapia-domiciliare-per-le-malattie-rare-e-sanita-di-prossimita-un-diritto-negato-ai-pazienti-dell-emilia-romagna]]></loc><lastmod>2025-06-25T08:52:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/22009-come-il-covid-ha-cambiato-l-assistenza-alle-persone-con-malattie-da-accumulo-lisosomiale]]></loc><lastmod>2025-05-22T17:29:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/19082-assistenza-domiciliare-in-toscana-e-allarme-rosso-per-i-pazienti-anziani-e-fragili]]></loc><lastmod>2022-09-19T07:55:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/19034-malattie-lisosomiali-in-emilia-romagna-al-via-la-somministrazione-della-terapia-salvavita-a-domicilio]]></loc><lastmod>2022-09-09T12:01:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/18910-negato-il-centro-estivo-a-bambina-con-disabilita-gravissima-non-ci-sono-infermieri-per-assisterla]]></loc><lastmod>2022-09-01T17:46:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/18794-lombardia-bloccata-in-ospedale-per-la-mancanza-di-assistenza-domiciliare]]></loc><lastmod>2022-06-18T13:22:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/18701-disabilita-gravissima-e-adi-voucher-sociosanitari-in-lombardia-organizzazioni-sociali-escluse-da-accreditamento]]></loc><lastmod>2022-05-30T16:42:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/18548-terapia-enzimatica-in-lombardia-finalmente-disponibile-a-domicilio-per-tutti-i-malati-rari]]></loc><lastmod>2022-04-14T11:37:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/18307-pnrr-serve-investire-sull-assistenza-domiciliare-e-pensare-ai-malati-rari]]></loc><lastmod>2022-02-17T09:49:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/17400-assistenza-domiciliare-le-famiglie-dei-malati-rari-con-grave-disabilita-abbandonate-a-se-stesse]]></loc><lastmod>2021-05-06T10:05:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/17339-malattie-rare-l-assistenza-domiciliare-e-in-frantumi-per-via-della-pandemia]]></loc><lastmod>2021-05-03T12:51:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/16791-non-si-ignorino-i-bisogni-dei-malati-rari-da-ora-servono-percorsi-domiciliari-adi-e-telemedicina]]></loc><lastmod>2020-12-10T14:52:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/16720-assistenza-domiciliare-e-telemedicina-strumenti-per-una-migliore-gestione-delle-malattie-rare]]></loc><lastmod>2020-12-14T18:02:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/16161-neuropatie-disimmuni-i-pazienti-chiedono-il-trattamento-domiciliare]]></loc><lastmod>2020-06-10T10:42:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/16126-malattie-lisosomiali-e-covid-19-l-home-therapy-un-primo-traguardo-durante-l-emergenza]]></loc><lastmod>2020-05-31T20:45:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/15914-terapia-domiciliare-continua-l-impegno-di-csl-behring]]></loc><lastmod>2020-04-06T17:11:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/15895-coronavirus-i-malati-rari-sostengono-emendamento-binetti-per-la-terapia-a-domicilio]]></loc><lastmod>2020-04-08T14:11:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/15886-terapie-domiciliari-l-emergenza-covid-19-spinge-regione-toscana-e-aifa-nella-direzione-giusta]]></loc><lastmod>2020-04-01T12:26:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/15821-covid-19-takeda-conferma-home-therapy-per-i-malati-rari-in-tutta-italia]]></loc><lastmod>2020-03-23T22:52:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/15755-coronavirus-sanofi-genzyme-da-anni-offriamo-infusione-domiciliare-per-le-malattie-lisosomiali]]></loc><lastmod>2020-03-13T15:27:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/15749-coronavirus-i-malati-rari-chiedono-la-terapia-domiciliare]]></loc><lastmod>2020-03-11T12:55:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/15111-malattie-lisosomiali-dossier-su-terapia-domiciliare-consegnato-al-ministero-della-salute]]></loc><lastmod>2019-08-09T16:45:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/14532-home-therapy-i-pazienti-con-malattie-lisosomiali-chiedono-un-patto-d-intesa-alle-regioni]]></loc><lastmod>2019-03-03T19:03:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/14433-malattie-lisosomiali-le-associazioni-raccolgono-le-richieste-di-terapia-domiciliare]]></loc><lastmod>2019-02-07T09:59:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/14321-malattie-lisosomiali-il-100-dei-pazienti-consiglierebbe-le-infusioni-a-domicilio]]></loc><lastmod>2020-08-05T15:15:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/14274-home-therapy-per-le-malattie-lisosomiali-tutti-gli-studi-italiani-ne-confermano-i-vantaggi]]></loc><lastmod>2018-12-12T21:09:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/14110-malattie-metaboliche-come-la-home-therapy-cambia-la-vita-dei-pazienti]]></loc><lastmod>2018-11-04T17:58:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/14109-malattie-lisosomiali-quali-vantaggi-porta-la-home-therapy-ai-pazienti]]></loc><lastmod>2018-11-04T17:07:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/14107-home-therapy-per-le-malattie-lisosomiali-da-progetto-pilota-a-diritto-dei-pazienti]]></loc><lastmod>2018-10-31T18:39:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/14106-home-therapy-per-le-malattie-rare-l-esperienza-del-veneto]]></loc><lastmod>2018-10-31T18:39:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/14099-home-therapy-sen-binetti-per-i-pazienti-e-un-diritto]]></loc><lastmod>2018-10-30T18:50:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/14098-home-therapy-per-le-malattie-rare-fondamentale-la-collaborazione-tra-pubblico-e-privato]]></loc><lastmod>2018-10-30T18:57:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/12258-malattie-rare-invalidanti-la-regione-umbria-a-sostegno-di-pazienti-e-familiari-con-1200-euro-al-mese]]></loc><lastmod>2017-05-09T10:38:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/7515-assistenza-domiciliare-per-malattie-croniche-air-liquide-acquisisce-optimal-medical-therapies]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/4701-dialisi-a-domicilio-tutti-i-vantaggi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/4471-assistenza-domiciliare-i-malati-vengono-abbandonati-nei-week-end]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/4369-malattie-lisosomiali-la-terapia-domiciliare-migliora-la-vita]]></loc><lastmod>2015-05-29T14:40:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/2958-terapie-domiciliari-scade-a-fine-mese-la-consultazione-aifa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/2909-progetto-tutor-parini-permette-di-non-perdere-giornate-lavorative-o-di-scuola-e-di-evitare-trasporti-settimanali-con-perdita-di-tempo-e-denaro]]></loc><lastmod>2015-05-26T14:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/2706-assistenza-domiciliare-ecco-come-aderire-al-progetto-tutor]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/2705-terapie-domiciliari-la-forza-del-progetto-tutor-e-nella-squadra]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/2711-fibrosi-cistica-e-terapia-domiciliare-aifa-avvia-una-consultazione-pubblica]]></loc><lastmod>2015-05-26T14:46:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/2367-fibrosi-cistica-in-toscana-i-farmaci-ospedalieri-somministrati-a-domicilio]]></loc><lastmod>2015-05-26T14:44:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/2338-apnee-ostruttive-al-san-giuseppe-di-milano-il-servizio-polissonografia-a-domicilio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/1137-gaucher-adesso-la-terapia-enzimatica-si-puo-fare-a-km-zero-le-infusioni-arrivano-a-casa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/405-farmaci-a-domicilio-grazie-ad-un-accordi-tra-farmindustria-e-poste-italiane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/news/terapie-domiciliari/372-sla-a-bologna-nuovo-percorso-assistenziale-dalla-diagnosi-allassistenza-a-domicilio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema]]></loc><lastmod>2020-05-18T10:25:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/16965-soffro-di-lipedema-e-ho-allergie-quale-drenante-naturale-posso-assumere]]></loc><lastmod>2021-02-02T15:29:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/16449-mi-e-stato-diagnosticato-un-linfedema-ma-soffro-anche-di-lipedema-un-parere]]></loc><lastmod>2020-09-14T15:12:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/16448-lipedema-la-malattia-e-riconosciuta-in-italia-quali-centri-in-emilia-romagna-e-quali-cure]]></loc><lastmod>2020-09-14T15:07:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/13116-lipedema-agli-arti-inferiori-quali-trattamenti-efficaci]]></loc><lastmod>2018-01-17T12:18:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/12563-sono-affetta-da-linfedema-posso-donare-il-sangue]]></loc><lastmod>2017-08-03T14:47:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/12414-lipedema-in-italia-ci-sono-chirurghi-specializzati]]></loc><lastmod>2017-06-19T14:57:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/11136-linfedema-quali-centri-in-toscana]]></loc><lastmod>2016-11-14T11:07:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/10861-linfedema-quale-specialista-nei-pressi-di-milano]]></loc><lastmod>2016-11-14T11:07:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/10750-lipedema-necessita-di-consulto-prima-di-una-possibile-gravidanza]]></loc><lastmod>2016-11-14T11:07:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/10713-linfedema-cronico-all-arto-sinistro-puo-essere-causato-da-trattamenti-estetici]]></loc><lastmod>2016-11-14T11:07:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/9818-linfedema-agli-arti-inferiori-quale-specialista-a-caserta]]></loc><lastmod>2016-11-14T11:08:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/9817-linfedema-alla-coscia-consigliato-intervento]]></loc><lastmod>2016-11-14T11:08:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/9730-esperti-di-lipedema-vicino-a-modena]]></loc><lastmod>2016-11-14T11:08:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/9728-quali-specialisti-di-lipedema-in-sardegna]]></loc><lastmod>2016-11-14T11:08:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/9667-linfedema-dove-effettuare-una-visita-a-milano]]></loc><lastmod>2016-11-14T11:09:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/9099-lipedema-quale-abbigliamento-usare]]></loc><lastmod>2016-11-14T11:09:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/9085-linfedema-centro-specializzato-vicino-a-piacenza]]></loc><lastmod>2016-11-14T11:09:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/9084-lipedema-consulto-per-eventuale-liposuzione]]></loc><lastmod>2016-11-14T11:10:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/9083-asportazione-linfonodi-inguinali-la-microchirurgia-puo-essere-utile]]></loc><lastmod>2016-11-14T11:10:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/8694-lipedema-quali-centri-specializzati-in-veneto]]></loc><lastmod>2016-11-14T11:10:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/8672-lipedema-indicazioni-sulla-cura]]></loc><lastmod>2016-11-14T11:11:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/8671-lipedema-richiesta-di-visita]]></loc><lastmod>2016-11-14T11:11:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/8543-lipedema-liposuzione-risolutiva]]></loc><lastmod>2016-11-14T11:11:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/8121-lipedema-dove-curarsi]]></loc><lastmod>2016-11-14T11:12:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/8120-lipedema-quale-cura]]></loc><lastmod>2016-11-14T11:12:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/8119-linfedema-congenito-ai-genitali-consigli]]></loc><lastmod>2016-11-14T11:12:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/7969-lipedema-consigli-su-cura-e-farmaci]]></loc><lastmod>2016-11-14T11:13:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/7968-quali-centri-specializzati-per-lipedema-nelle-marche]]></loc><lastmod>2016-11-14T11:13:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/7891-quali-centri-specializzati-a-roma]]></loc><lastmod>2016-11-14T11:13:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/7848-specialista-lipedema-in-lombardia]]></loc><lastmod>2016-11-14T11:14:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/linfedema-e-lipedema/7838-linfedema-quali-centri-specializzati-a-milano]]></loc><lastmod>2016-11-14T11:14:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica]]></loc><lastmod>2020-11-16T18:48:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/14289-come-accedere-al-pirfenidone-in-puglia-per-anziano-di-85-anni]]></loc><lastmod>2018-12-17T11:28:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/14288-possibile-assumere-cortisone-unitamente-al-nintedanib]]></loc><lastmod>2018-12-17T11:29:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/12617-puo-il-nintedonib-provocare-vomito]]></loc><lastmod>2017-09-04T14:44:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/12616-ipf-e-possibile-reperire-il-nintedonib-a-pagamento-in-italia-o-all-estero]]></loc><lastmod>2017-09-04T19:50:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/11845-ipf-come-accedere-al-farmaco-nintedanib]]></loc><lastmod>2017-01-27T10:44:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/11066-ipf-informazioni-su-trapianto-e-prescrizione-nintedanib]]></loc><lastmod>2016-11-14T10:49:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/10481-che-terapia-somministrare-a-paziente-cardiopatico-e-diabetico-con-ipf]]></loc><lastmod>2016-11-14T10:49:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/9902-in-che-condizioni-somministrare-pirfenidone-e-ninteladib]]></loc><lastmod>2016-11-14T10:50:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/9760-informazioni-fibrosi-polmonare-associata-ad-artrite-reumatoide]]></loc><lastmod>2016-11-14T10:50:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/9500-ci-puo-essere-una-relazione-tra-ipf-anemia-e-polmonite]]></loc><lastmod>2016-11-14T10:50:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/9326-familiarita-ipf-impedisce-l-uso-di-pirfenidone]]></loc><lastmod>2016-11-14T10:50:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/9325-come-contrastare-gli-effetti-collaterali-di-ninteladib]]></loc><lastmod>2016-11-14T10:51:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/9228-figlio-di-un-paziente-con-ipf-devo-farmi-controlli]]></loc><lastmod>2016-11-14T10:51:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/9189-ipf-pirfenidone-disponibile-dopo-gli-80-anni-di-eta]]></loc><lastmod>2016-11-14T10:51:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/9188-ipf-nintenadib-gia-somministrabile-in-italia]]></loc><lastmod>2016-11-14T10:51:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-polmonare-idiopatica/9086-informazioni-sulla-fibrosi-polmonare-secondaria-ad-artrite-reumatoide]]></loc><lastmod>2016-11-14T10:52:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica]]></loc><lastmod>2020-11-16T18:47:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/12357-valore-anomalo-di-tripsina-in-neonato-c-e-la-possibilita-che-sia-affetto-da-fibrosi-cistica]]></loc><lastmod>2017-06-06T14:07:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/11944-come-considerare-il-valore-proveniente-dal-test-del-sudore]]></loc><lastmod>2017-02-17T11:54:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/11151-figlio-di-tre-mesi-affetto-da-fibrosi-cistica-in-eterozigosi-cosa-aspettarmi]]></loc><lastmod>2016-11-14T10:43:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/9729-si-puo-somministrare-orkambi-a-un-neonato-affetto-da-fibrosi-cistica]]></loc><lastmod>2016-11-14T10:43:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/8508-orkambi-utile-anche-per-chi-ha-una-mutazione-df508-t338i]]></loc><lastmod>2016-11-14T10:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/8309-orkambi-buono-anche-per-chi-ha-una-mutazione-df508-e-n1303k]]></loc><lastmod>2016-11-14T10:43:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/8201-kalydeco-accessibile-per-pazienti-con-trapianto-di-polmone]]></loc><lastmod>2016-11-14T10:44:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/7481-fibrosi-cistica-siamo-portatori-sani-di-mutazione-e-pensiamo-alla-gravidanza-cosa-fare]]></loc><lastmod>2016-11-14T10:44:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/7446-fibrosi-cistica-quali-difficolta-per-ottenere-kalydeco]]></loc><lastmod>2016-11-14T10:44:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/7216-terapia-con-ivacaftor-per-mutazione-con-proteina-residua-possibile]]></loc><lastmod>2016-11-14T10:45:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/fibrosi-cistica/7226-neonato-con-fibrosi-cistica-quali-possibilita-di-sopravvivenza]]></loc><lastmod>2016-11-14T10:45:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario]]></loc><lastmod>2023-01-30T09:03:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/15520-ricorrenti-crisi-allergiche-con-angioedema-controindicazioni-dell-antistaminico-per-lunghi-periodi]]></loc><lastmod>2020-03-16T11:09:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/13964-angioedemi-agli-occhi-e-pomfi-puo-essere-angioedema-di-natura-allergica]]></loc><lastmod>2018-09-25T10:46:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/13802-esami-nella-norma-ma-gonfiore-a-collo-labbro-e-gola-posso-escludere-l-angioedema]]></loc><lastmod>2018-07-31T11:27:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/13679-carenza-c1-inibitore-in-ragazza-di-26-anni-puo-significare-angioedema]]></loc><lastmod>2018-06-18T14:07:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/13492-angioedema-ereditario-come-avere-la-certezza-della-diagnosi]]></loc><lastmod>2018-04-27T10:48:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/13491-angioedema-idiopatico-quali-centri-lo-trattano]]></loc><lastmod>2018-04-27T10:45:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/13490-angioedema-alle-palpebre-cosa-fare]]></loc><lastmod>2018-04-27T10:42:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/12254-gonfiore-al-viso-mani-e-piedi-quali-esami-fare]]></loc><lastmod>2017-05-08T15:29:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/11943-edema-agli-occhi-al-mattino-cosa-fare]]></loc><lastmod>2017-02-17T11:50:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/11942-angioedema-e-gastrite-possono-essere-correlati]]></loc><lastmod>2017-02-17T11:45:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/11844-quali-esami-per-riconoscere-angioedema]]></loc><lastmod>2017-01-27T10:36:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/11746-angioedema-che-significato-ha-il-valore-clq]]></loc><lastmod>2016-12-19T11:26:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/11582-paziente-affetta-da-orticaria-a-chi-rivolgersi-in-sicilia]]></loc><lastmod>2016-11-11T21:42:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/11167-paziente-affetta-da-angioedema-con-attacchi-di-orticaria-puo-essere-allergia]]></loc><lastmod>2016-11-11T21:42:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/11134-sospetto-angioedema-quali-centri-in-sicilia-a-cui-rivolgersi]]></loc><lastmod>2016-11-11T21:41:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/11131-casi-di-angioedema-in-famiglia-cosa-fare]]></loc><lastmod>2016-11-11T21:41:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/11102-angioedema-chiarimenti-sulla-trasmissione-della-malattia]]></loc><lastmod>2016-11-11T21:41:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/10345-edemi-palpebrali-ricorrenti-a-chi-mi-rivolgo]]></loc><lastmod>2016-11-11T21:40:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/10104-grave-angioedema-su-ragazzo-di-20-anni]]></loc><lastmod>2016-11-11T21:39:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/9977-orticaria-da-reazione-allergica-ricomparsa-fenomeno-dopo-molti-anni]]></loc><lastmod>2016-11-11T21:38:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/9820-angioedema-quali-terapie-provare]]></loc><lastmod>2016-11-11T21:38:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/9199-sospetto-angioedema-quali-centri-specializzati-in-veneto-emilia-romagna]]></loc><lastmod>2016-11-11T21:37:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/9190-consiglio-per-gonfiore-al-viso-e-alla-lingua]]></loc><lastmod>2016-11-11T21:37:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/9068-centri-per-diagnosi-di-angioedema]]></loc><lastmod>2016-11-11T21:36:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/8899-sospetto-angioedema-in-ragazza-di-14-anni]]></loc><lastmod>2016-11-11T21:36:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/8371-sospetto-edema-di-quincke-cosa-fare]]></loc><lastmod>2016-11-11T21:36:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/8123-sospetto-angioedema-allintestino]]></loc><lastmod>2016-11-11T21:35:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/8122-labbro-gonfio-puo-essere-angioedema]]></loc><lastmod>2016-11-11T21:34:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7904-gonfiore-al-viso-e-linfonodi-ingrossati-puo-essere-angioedema]]></loc><lastmod>2016-11-11T21:34:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7881-consulenza-per-deficit-c4-inibitore-ed-episodi-di-orticaria]]></loc><lastmod>2016-11-11T21:33:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7826-dosaggio-c1-inibitore-dopo-cortisone-e-efficace]]></loc><lastmod>2016-11-11T21:33:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7808-angioedema-agli-occhi-quale-puo-essere-la-causa]]></loc><lastmod>2016-11-11T21:31:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7794-angioedema-e-orticaria-possono-essere-causati-da-una-terapia-ormonale]]></loc><lastmod>2016-11-11T21:50:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7671-c-e-correlazione-tra-deficit-di-fattore-dodicesimo-e-angioedema-ereditario-di-tipo-tre]]></loc><lastmod>2016-11-11T21:30:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7670-quali-analisi-fare-per-avere-la-certezza-che-si-tratta-di-angioedema]]></loc><lastmod>2016-11-11T21:51:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7669-angioedema-la-cura-con-antistaminico-e-tranex-da-effetti-collaterali]]></loc><lastmod>2016-11-11T21:52:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7615-presenza-di-anticorpi-ana-possono-essere-associati-ad-angioedema]]></loc><lastmod>2016-11-11T21:53:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7409-angioedema-ereditario-o-reazione-allergica]]></loc><lastmod>2016-11-11T21:25:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7313-orticaria-o-angioedema]]></loc><lastmod>2016-11-11T21:24:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7218-edema-di-quincke-che-fare]]></loc><lastmod>2016-11-11T21:23:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/7166-angioedema-al-viso-e-ai-genitali-puo-trattarsi-di-angioedema-ereditario]]></loc><lastmod>2016-11-11T21:22:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/6937-ho-problemi-da-circa-15-anni-puo-trattarsi-di-angioedema-ereditario]]></loc><lastmod>2016-11-11T21:21:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/6896-malattie-reumatiche-o-angioedema-ereditario]]></loc><lastmod>2016-11-11T21:21:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/6852-angioedema-di-origine-sconosciuta-cosa-devo-fare]]></loc><lastmod>2016-11-11T21:20:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/6432-gonfiore-a-labbra-e-bocca-devo-sospettare-angioedema-ereditario]]></loc><lastmod>2016-11-11T21:19:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/angioedema-ereditario/6387-gonfiori-ricorrenti-alla-mano-che-si-tratti-di-angioedema]]></loc><lastmod>2016-11-11T21:17:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/sindrome-di-hunter]]></loc><lastmod>2023-07-12T08:56:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/sindrome-di-hunter/6486-sperimentazioni-per-la-sindrome-di-hunter-quali-novita]]></loc><lastmod>2016-11-14T11:23:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito]]></loc><lastmod>2020-11-16T18:42:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/20036-cmv-con-amniocentesi-negativa-si-possono-escludere-danni-al-bambino]]></loc><lastmod>2026-01-12T16:53:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/20035-cmv-e-possibile-che-mi-si-riattivi-in-una-seconda-gravidanza]]></loc><lastmod>2023-07-24T14:24:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/20019-cmv-a-febbraio-2022-posso-cercare-una-nuova-gravidanza]]></loc><lastmod>2023-07-17T15:15:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/20018-cmv-alla-37-3-settimana-di-gestazione-quale-consiglio]]></loc><lastmod>2023-07-17T15:11:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/20017-cmv-a-25-settimane-come-proseguire-la-gravidanza]]></loc><lastmod>2023-07-17T15:04:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/16931-infezione-pregressa-da-cmv-e-malattie-autoimmuni-quali-ripercussioni-sul-feto]]></loc><lastmod>2022-12-27T15:40:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/16388-cmv-igg-e-igm-alte-come-nel-2008-e-possibile]]></loc><lastmod>2020-08-25T15:00:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/16345-cmv-rialzo-delle-igg-alla-ventesima-settimana-possibile-reinfezione]]></loc><lastmod>2020-07-31T13:27:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/16295-cmv-igm-al-2-0-e-igg-non-sufficienti-per-la-valutazione-della-loro-avidita-cosa-consiglia]]></loc><lastmod>2020-07-15T14:45:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/16294-cmv-in-gravidanza-alta-avidita-e-positiva-per-dna-virale-cosa-fare]]></loc><lastmod>2020-07-15T14:53:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/16153-cmv-igg-positive-e-igm-negative-in-gravidanza-devo-approfondire]]></loc><lastmod>2020-06-09T15:32:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/16152-cmv-igg-positive-in-entrambe-le-gravidanze-si-tratta-di-un-infezione-pregressa]]></loc><lastmod>2020-06-09T15:24:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15714-bimbo-nato-positivo-al-cmv-se-al-nido-si-ammala-potrebbe-attivarsi-il-virus]]></loc><lastmod>2020-03-02T14:56:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15571-cmv-alla-13esima-settimana-e-valori-discordanti-tra-due-test-come-agire]]></loc><lastmod>2020-01-13T14:01:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15570-cmv-alla-nona-settimana-possibile-sia-la-riattivazione-di-una-sospetta-infezione-incontrata-un-anno-fa]]></loc><lastmod>2020-01-13T13:54:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15569-cmv-alla-decima-settimana-posso-evitare-la-villocentesi-e-optare-per-un-amniocentesi-piu-avanti]]></loc><lastmod>2020-01-13T13:37:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15568-positiva-al-cmv-posso-riprendere-il-percorso-di-procreazione-medicalmente-assistita]]></loc><lastmod>2020-01-13T13:34:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15529-positiva-al-cmv-esiste-una-terapia-come-in-veterinaria-per-impedire-che-si-riattivi-in-gravidanza]]></loc><lastmod>2019-12-18T16:04:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15528-possibile-riattivazione-cmv-e-rischioso-progettare-una-gravidanza]]></loc><lastmod>2019-12-18T15:58:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15470-cmv-alla-14esima-settimana-l-infezione-e-avvenuta-prima-o-dopo-il-concepimento]]></loc><lastmod>2019-12-02T11:05:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15469-quali-sono-le-conseguenze-per-neonato-dopo-la-cura-per-cmv]]></loc><lastmod>2019-12-02T10:46:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15098-cmv-alla-17-4-settimana-potrei-aver-eseguito-il-prelievo-proprio-all-inizio-dell-infezione]]></loc><lastmod>2019-08-01T13:36:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15097-cmv-alla-quinta-settimana-quando-ho-contratto-il-virus-e-quali-ulteriori-accertamenti]]></loc><lastmod>2019-08-01T13:10:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15096-cmv-alla-30esima-settimana-come-procedere]]></loc><lastmod>2019-08-01T13:04:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15066-presunta-riattivazione-cmv-all-ottava-settimana-gravidanza-cosa-fare]]></loc><lastmod>2019-07-22T14:52:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15065-il-citomegalovirus-viene-rilevato-dalle-analisi-nel-periodo-d-incubazione]]></loc><lastmod>2019-07-22T14:44:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15064-riattivazione-cmv-e-ricerca-di-una-gravidanza-cosa-fare]]></loc><lastmod>2019-07-22T14:39:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15007-cmv-contratto-in-gravidanza-igm-assente-ci-sono-rischi-per-il-bambino]]></loc><lastmod>2019-07-08T15:04:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15006-cmv-contratto-nell-ultima-gravidanza-quanto-devo-aspettare-per-cercarne-un-altra]]></loc><lastmod>2019-07-08T14:07:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15005-cmv-con-i-miei-valori-e-possibile-cercare-una-gravidanza]]></loc><lastmod>2019-07-08T14:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15004-cmv-alla-17esima-settimana-come-capire-se-ho-contratto-il-virus-in-questi-4-mesi]]></loc><lastmod>2019-07-08T13:58:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/15003-riattivazione-cmv-alla-seconda-gravidanza-posso-stare-tranquilla]]></loc><lastmod>2019-07-08T13:54:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/14750-bimba-di-3-mesi-con-cmv-quali-danni]]></loc><lastmod>2019-04-18T13:07:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/14749-bimbo-di-3-mesi-positivo-a-cmv-cosa-fare]]></loc><lastmod>2019-04-18T13:03:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/14658-cmv-a-29esima-settimana-di-gravidanza-devo-ripetere-ogni-mese-gli-esami]]></loc><lastmod>2019-03-29T13:30:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/14657-cmv-a-sesta-settimana-di-gravidanza-cosa-fare]]></loc><lastmod>2019-03-29T13:27:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/14656-immune-al-cmv-gia-alla-prima-gravidanza-ora-alla-seconda-posso-stare-tranquilla]]></loc><lastmod>2019-03-29T13:23:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/14655-cmv-alle-36esima-settimana-quali-conseguenze-per-la-mia-bambina]]></loc><lastmod>2019-03-29T13:19:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/14339-cmv-in-gravidanza-alla-decima-settimana-infezione-primaria-o-riattivazione]]></loc><lastmod>2019-01-08T16:09:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/14260-gravidanza-all-ottava-settimana-possibile-riattivazione-cmv]]></loc><lastmod>2018-12-10T16:48:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/14259-bimba-di-4-anni-con-cmv-utile-terapia-antivirale-per-evitare-declino-uditivo]]></loc><lastmod>2018-12-10T16:45:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13971-risultati-cmv-discordanti-cosa-mi-consiglia-di-fare]]></loc><lastmod>2018-09-26T14:51:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13929-cmv-alla-15esima-settimana-consigliata-terapia-con-immunoglobuline]]></loc><lastmod>2018-09-17T14:59:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13928-cmv-in-gravidanza-mi-consiglia-l-amniocentesi-anche-senza-i-risultati-dell-avidity]]></loc><lastmod>2018-09-17T14:54:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13882-cmv-all-ottavo-mese-cosa-fare]]></loc><lastmod>2018-09-04T09:15:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13881-cmv-tra-la-23esima-e-la-27esima-settimana-possibile-la-cura-con-immunoglobuline]]></loc><lastmod>2018-09-04T09:09:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13859-cmv-durante-la-prima-gravidanza-alla-seconda-rischio-una-riattivazione]]></loc><lastmod>2018-08-23T10:19:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13858-una-riattivazione-del-cmv-alla-fine-della-gravidanza-e-possibile-cosa-fare]]></loc><lastmod>2018-08-23T09:59:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13857-cmv-all-ottava-settimana-cosa-mi-consiglia-di-fare]]></loc><lastmod>2018-08-23T09:54:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13663-cmv-alla-10esima-settimana-virus-contratto-gia-in-gravidanza]]></loc><lastmod>2018-06-15T09:14:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13655-cmv-alla-14esima-settimana-cosa-mi-consiglia-di-fare]]></loc><lastmod>2018-06-11T15:22:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13654-cmv-alla-settima-settimana-come-interpretare-i-risultati-degli-esami]]></loc><lastmod>2018-06-11T15:17:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13653-cmv-alla-13esima-settimana-quali-rischi-per-il-bambino]]></loc><lastmod>2018-06-11T15:12:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13605-possibile-correlazione-tra-aborti-spontanei-e-cmv]]></loc><lastmod>2018-05-28T09:40:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13604-bimbo-nato-positivo-al-cmv-con-problemi-di-vista-cosa-fare]]></loc><lastmod>2018-05-28T09:36:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13538-igg-positive-e-igm-negative-alla-14esima-settimana-cosa-significa]]></loc><lastmod>2018-05-11T10:19:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13537-cmv-positivo-alla-nona-settimana-cosa-fare]]></loc><lastmod>2018-05-11T10:15:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13403-virus-cmv-in-liquido-amniotico-cosa-fare]]></loc><lastmod>2018-04-03T15:20:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13115-cmv-alla-29-1esima-settimana-di-gravidanza-consigliata-somministrazione-di-immunoglobuline-e-parto-cesareo-anticipato]]></loc><lastmod>2018-01-17T12:07:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/13058-cmv-alla-11esima-settimana-di-gravidanza-come-comportarmi]]></loc><lastmod>2017-12-22T12:39:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12679-cmv-alla-11esima-settimana-di-gravidanza-herpes-labiale-puo-avere-alterato-i-dati]]></loc><lastmod>2017-09-22T13:24:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12678-cmv-alla-settima-settimana-di-gravidanza-quali-consigli]]></loc><lastmod>2017-09-22T13:24:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12615-alterazione-nella-risonanza-magnetica-fetale-quali-danni-potrebbe-avere-il-feto]]></loc><lastmod>2017-09-04T13:51:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12593-variazione-delle-igg-e-igm-devo-preoccuparmi]]></loc><lastmod>2017-08-22T15:25:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12592-cmv-alla-30esima-settimana-cosa-fare]]></loc><lastmod>2017-08-22T15:20:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12542-infezione-primaria-cmv-alla-nona-settimana-di-gravidanza-pericolo-per-il-feto]]></loc><lastmod>2017-07-27T13:41:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12541-sospetta-riattivazione-cmv-alla-settima-settimana-pericolo-per-il-feto]]></loc><lastmod>2017-07-27T13:23:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12291-cmv-alla-21esima-settimana-cosa-fare]]></loc><lastmod>2017-05-19T13:41:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12253-cmv-all-ottava-settimana-c-e-possibilita-di-contagio-per-il-feto]]></loc><lastmod>2017-05-08T15:23:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12239-cmv-all-ottava-settimana-cosa-e-meglio-fare]]></loc><lastmod>2017-05-02T15:06:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12227-icsi-positiva-a-febbraio-puo-esserci-stato-contagio-per-il-feto]]></loc><lastmod>2017-04-28T13:32:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12226-cmv-in-caso-di-amniocentesi-negativa-si-puo-escludere-il-contagio]]></loc><lastmod>2017-04-28T13:32:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12175-cmv-alla-27esima-settimana-dove-sottoporsi-a-immunoglobuline]]></loc><lastmod>2017-04-10T13:44:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12174-cmv-con-probabile-infezione-del-feto-cosa-fare]]></loc><lastmod>2017-04-10T13:31:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12111-richiesta-chiarimento-su-rmn-fetale]]></loc><lastmod>2017-03-24T15:07:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12110-cmv-dubbio-alla-seconda-gravidanza-ci-sono-rischi-per-il-feto]]></loc><lastmod>2017-03-24T15:00:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/12109-cmv-alla-seconda-gravidanza-quando-potrei-aver-contratto-il-virus]]></loc><lastmod>2017-03-24T14:45:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11966-cmv-alla-decima-settimana-come-procedere]]></loc><lastmod>2017-02-20T15:17:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11945-valori-cmv-contraddittori-posso-escludere-rischi]]></loc><lastmod>2017-02-17T13:31:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11941-bimba-con-cmv-e-problemi-motori-migliorera]]></loc><lastmod>2017-02-17T11:35:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11940-bimba-positiva-a-cmv-con-sintomi-gastrointestinali]]></loc><lastmod>2017-02-17T11:32:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11939-delucidazioni-su-cura-con-immunoglobuline]]></loc><lastmod>2017-02-17T11:29:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11902-probabile-riattivazione-cmv-cosa-fare]]></loc><lastmod>2017-02-07T15:28:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11901-cmv-alla-decima-settimana-devo-preoccuparmi]]></loc><lastmod>2017-02-07T15:24:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11900-riattivazione-cmv-alla-seconda-gravidanza-rischi-per-il-feto]]></loc><lastmod>2017-02-07T15:17:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11874-cmv-positivo-esami-da-ripetere]]></loc><lastmod>2017-02-01T10:50:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11847-ho-un-figlio-autistico-possibile-che-la-causa-sia-il-cmv-in-gravidanza]]></loc><lastmod>2017-01-27T10:54:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11846-cmv-risultato-dubbio-dobbiamo-preoccuparci]]></loc><lastmod>2017-01-27T10:51:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11797-bimba-nata-con-cmv-cosa-fare]]></loc><lastmod>2017-01-12T11:58:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11796-igg-e-igm-alte-e-il-caso-di-cercare-una-gravidanza]]></loc><lastmod>2017-01-12T11:47:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11773-cmv-all-unidcesima-settimana-esistono-cure]]></loc><lastmod>2017-01-02T16:12:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11764-cmv-negativo-ma-igg]]></loc><lastmod>2016-12-23T09:34:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11747-cmv-alla-10ma-settimana-di-gravidanza-come-comportarsi]]></loc><lastmod>2016-12-19T15:07:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11745-rialzo-delle-igg-alla-10ma-settimana-di-gravidanza-puo-indicare-una-riattivazione-del-virus]]></loc><lastmod>2016-12-19T11:22:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11720-cmv-contratto-alla-18esima-settimana-cosa-fare]]></loc><lastmod>2016-12-13T13:03:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11719-quanto-aspettare-prima-di-cercare-una-gravidanza-dopo-aver-contratto-il-cmv]]></loc><lastmod>2016-12-13T11:56:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11701-cmv-contratto-poco-prima-della-gravidanza-come-comportarsi]]></loc><lastmod>2016-12-07T11:10:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11637-cmv-in-gravidanza-ma-bimba-attualmente-sana-il-virus-puo-manifestarsi]]></loc><lastmod>2016-11-22T15:44:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11636-bimba-nata-con-anomalie-a-causa-del-cmv-cosa-fare]]></loc><lastmod>2016-11-22T15:37:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11635-cmv-al-settimo-mese-di-gravidanza-quali-rischi]]></loc><lastmod>2016-11-22T15:38:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11585-cmv-in-gravidanza-e-un-infezione-primaria-o-una-riattivazione]]></loc><lastmod>2016-11-14T18:10:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11293-gravidanza-dopo-precedente-aborto-per-cmv-posso-stare-tranquilla]]></loc><lastmod>2016-11-09T16:07:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11292-presunto-cmv-in-gravidanza-puo-essere-un-falso-positivo]]></loc><lastmod>2016-11-09T16:07:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11291-igg-negative-ed-igm-positive-puo-essere-un-falso-positivo]]></loc><lastmod>2016-11-09T16:07:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11289-cmv-in-gravidanza-cosa-fare-se-la-bambina-risultasse-positiva]]></loc><lastmod>2016-11-09T16:11:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11157-quanto-e-il-rischio-che-mia-figlia-all-asilo-contragga-il-cmv]]></loc><lastmod>2016-11-14T14:13:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11153-cmv-in-gravidanza-quali-rischi-corre-mia-figlia]]></loc><lastmod>2016-11-14T14:14:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11152-cmv-in-gravidanza-ma-amniocentesi-negativa-posso-stare-tranquilla]]></loc><lastmod>2016-08-29T14:34:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11128-cmv-in-gravidanza-cosa-fare-quando-il-bambino-nasce]]></loc><lastmod>2016-11-09T16:13:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11065-gemello-nato-con-cmv-consigliata-terapia-e-follow-up]]></loc><lastmod>2016-11-09T16:13:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11046-cmv-alla-quinta-settimana-di-gravidanza-cosa-fare]]></loc><lastmod>2016-11-09T16:14:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11038-coxsackie-virus-in-gravidanza-quali-rischi]]></loc><lastmod>2016-11-09T16:14:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/11037-cmv-igg-positive-alla-26esima-settimana-di-gravidanza]]></loc><lastmod>2016-11-09T16:14:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10979-analisi-positive-al-cmv-infezione-prima-o-durante-la-gravidanza]]></loc><lastmod>2016-11-14T14:10:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10934-variabile-avidita-delle-igg-in-gravidanza-a-quando-risale-l-infezione-da-cmv]]></loc><lastmod>2016-11-14T14:10:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10918-cmv-trasmesso-al-feto-immunoglobuline-o-interruzione-di-gravidanza]]></loc><lastmod>2016-11-14T14:09:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10909-cmv-nei-primi-mesi-di-gravidanza-a-chi-rivolgermi]]></loc><lastmod>2016-11-14T14:09:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10873-infezione-da-cmv-alla-nona-settimana-di-gravidanza-cosa-fare]]></loc><lastmod>2016-11-09T16:16:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10806-infezione-da-cmv-e-sospetta-gravidanza-cosa-fare]]></loc><lastmod>2016-11-09T16:16:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10804-controlli-per-neonata-che-ha-contratto-il-cmv]]></loc><lastmod>2016-11-14T14:19:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10803-cmv-contratto-ad-inizio-gravidanza]]></loc><lastmod>2016-11-14T14:20:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10751-cmv-in-gravidanza-infezione-contratta-prima-o-dopo-il-concepimento]]></loc><lastmod>2016-11-09T16:17:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10724-cmv-alla-31esima-settimana-che-fare]]></loc><lastmod>2016-11-09T16:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10676-cmv-possibile-riattivazione]]></loc><lastmod>2016-11-09T16:18:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10649-cmv-infezione-periconcezionale-cosa-fare]]></loc><lastmod>2016-11-09T16:18:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10568-infezione-da-cmv-presa-in-gravidanza-consigliata-cura-di-immunoglobuline]]></loc><lastmod>2016-11-09T16:18:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10567-gravidanza-15esima-settimana-sospetta-falsa-positivita-o-riattivazione-cmv]]></loc><lastmod>2016-11-09T16:19:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10566-lieve-aumento-igm-in-gravidanza-potrebbe-essere-un-contagio-iniziale]]></loc><lastmod>2016-11-09T16:19:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10514-cmv-positivo-quando-potrei-provare-ad-avere-una-gravidanza]]></loc><lastmod>2016-11-09T16:19:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10480-possibile-crossreattivita-cosa-fare]]></loc><lastmod>2016-11-14T14:26:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10479-danni-cerebrali-al-feto-a-causa-del-cmv-cosa-fare]]></loc><lastmod>2016-11-14T14:27:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10403-cmv-in-gravidanza-con-avidita-diminuita-possibilita-di-contagio-verticale]]></loc><lastmod>2016-11-14T14:28:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10400-sospetto-cmv-in-gravidanza]]></loc><lastmod>2016-11-14T14:28:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10348-igg-in-aumento-in-gravidanza-sospetta-riattivazione-cmv]]></loc><lastmod>2016-11-14T14:29:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10347-sospetta-riattivazione-cmv-cosa-fare-e-quali-rischi-per-il-feto]]></loc><lastmod>2016-11-14T14:30:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10346-cmv-alla-34esima-settimana-quali-rischi-per-il-feto]]></loc><lastmod>2016-11-14T14:31:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10300-neonata-affetta-da-cmv-asintomatica-opportuno-un-antivirale]]></loc><lastmod>2016-11-14T14:32:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10276-positiva-a-cmv-ad-ottava-settimana-di-gravidanza-cosa-fare]]></loc><lastmod>2016-11-14T14:32:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10269-igg-e-igm-positive-puo-essere-una-riattivazione-del-cmv]]></loc><lastmod>2016-11-14T14:33:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10240-cmv-a-inizio-gravidanza-quali-sono-i-rischi]]></loc><lastmod>2016-11-14T14:33:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10230-cmv-a-20-settimane-cosa-fare]]></loc><lastmod>2016-11-14T14:34:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10198-perche-il-ginecologo-ci-ha-fatto-ripetere-le-analisi-per-il-cmv]]></loc><lastmod>2016-11-14T14:35:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10197-cmv-a-inizio-gravidanza-e-meglio-sottopormi-a-somministrazioni-di-immunoglobuline-aspecifiche]]></loc><lastmod>2016-11-14T14:35:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10165-cmv-igg-positive-a-30-settimane]]></loc><lastmod>2016-11-14T14:35:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10164-cmv-quinto-mese-di-gravidanza-c-e-da-preoccuparsi]]></loc><lastmod>2016-11-14T14:36:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10150-bimba-di-11-mesi-igg-positiva-cosa-fare]]></loc><lastmod>2016-11-14T14:57:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10138-terza-gravidanza-possibile-riattivazione-cmv]]></loc><lastmod>2016-11-14T14:57:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10078-cmv-a-22esima-settimana-di-gravidanza-devo-preoccuparmi]]></loc><lastmod>2016-11-14T14:58:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10077-cmv-seroconversion-between-weeks-17-25]]></loc><lastmod>2016-11-14T14:58:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10046-cmv-dopo-il-quinto-mese-posso-sperare-in-un-bambino-sano]]></loc><lastmod>2016-11-14T14:59:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10023-cmv-risonanza-magnetica-ok-a-35-settimane-esclude-danni-al-feto]]></loc><lastmod>2016-11-14T14:59:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10014-amniocentesi-ok-alla-26esima-settimana-il-feto-puo-infettarsi-anche-in-seguito]]></loc><lastmod>2016-11-14T15:00:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10013-infezione-primaria-cmv-utile-una-risonanza-magnetica]]></loc><lastmod>2016-11-14T15:00:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/10012-risultati-borderline-cmv-possibile-falso-allarme]]></loc><lastmod>2016-11-14T15:01:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9983-cmv-al-sesto-mese-di-gravidanza-possibili-danni-al-bambino]]></loc><lastmod>2016-11-14T15:01:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9925-cmv-a-7-4-settimane-pericolo-di-trasmissione-al-feto]]></loc><lastmod>2016-11-14T15:01:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9868-cmv-a-11-settimane-cosa-fare]]></loc><lastmod>2016-11-14T15:02:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9866-cmv-a-7-settimane-c-e-speranza-che-il-feto-non-sia-contagiato]]></loc><lastmod>2016-11-14T15:02:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9852-l-amniocentesi-puo-contagiare-il-feto]]></loc><lastmod>2016-11-14T15:03:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9851-dopo-quanto-si-puo-intraprendere-una-gravidanza-dopo-contagio-cmv]]></loc><lastmod>2016-11-14T15:04:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9850-amniocentesi-per-cmv-a-18-settimane-e-attendibile]]></loc><lastmod>2016-11-14T15:05:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9849-cmv-in-gravidanza-puo-essere-falso-positivo]]></loc><lastmod>2016-11-14T15:05:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9848-cmv-in-gravidanza-possibile-anticipare-il-parto-per-evitare-contagio-del-feto]]></loc><lastmod>2016-11-14T15:06:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9821-cmv-anche-in-seconda-gravidanza-cosa-fare]]></loc><lastmod>2016-11-14T15:06:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9735-cmv-ad-inizio-gravidanza-e-possibile-cominciare-terapia-di-immunoglobuline]]></loc><lastmod>2016-11-14T15:06:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9705-infezione-primaria-da-cmv-ad-inizio-gravidanza-e-feto-probabilmente-infettato-che-fare]]></loc><lastmod>2016-11-14T15:07:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9691-cmv-trasmesso-al-feto-opportuno-cominciare-cura-antivirale]]></loc><lastmod>2016-11-14T15:07:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9689-cmv-nel-primo-trimestre-di-gravidanza-quale-percentuale-di-rischio-di-trasmissione-al-feto]]></loc><lastmod>2016-11-14T15:08:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9677-cmv-in-gravidanza-e-amniocentesi-alla-21esima-settimana-non-e-troppo-tardi]]></loc><lastmod>2016-11-14T15:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9666-cmv-in-gravidanza-in-quanto-tempo-si-azzerano-le-igm]]></loc><lastmod>2016-11-14T15:09:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9640-cmv-in-gravidanza-dopo-5-anni-e-una-riattivazione]]></loc><lastmod>2016-11-14T15:09:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9557-cmv-in-gravidanza-quando-fare-l-amniocentesi-per-escludere-il-contagio-al-feto]]></loc><lastmod>2016-11-14T15:10:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9537-possibile-riattivazione-cmv-a-undicesima-settimana-di-gravidanza]]></loc><lastmod>2016-11-14T15:10:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9536-risultato-dubbio-su-controllo-cmv]]></loc><lastmod>2016-11-14T15:11:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9419-riattivazione-virus-cmv-c-e-pericolo-per-il-feto]]></loc><lastmod>2016-11-14T15:11:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9387-neonato-con-cmv-sintomatico-o-asintomatico]]></loc><lastmod>2016-11-14T15:12:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9372-cmv-alla-33-1-settimana-di-gravidanza-posso-aver-contagiato-mia-figlia]]></loc><lastmod>2016-11-14T15:12:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9356-parere-su-esame-cmv-alla-15-1-settimana-di-gravidanza]]></loc><lastmod>2016-11-14T15:13:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9318-parere-su-esame-cmv-alla-12-5-settimana-di-gravidanza]]></loc><lastmod>2016-11-14T15:13:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9292-possibili-danni-al-feto-se-contagio-da-cmv-e-avvenuto-prima-della-gravidanza]]></loc><lastmod>2016-11-14T15:14:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9243-positiva-al-cmv-quando-iniziare-stimolazione-per-fecondazione-assistita]]></loc><lastmod>2016-11-14T15:14:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9242-igg-positive-in-gravidanza-si-tratta-del-citomegalovirus-congenito]]></loc><lastmod>2016-11-14T15:15:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9230-positiva-al-cmv-posso-cercare-un-figlio]]></loc><lastmod>2016-11-14T15:15:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9229-carenza-di-anticorpi-anti-cmv-come-procedere]]></loc><lastmod>2016-11-14T15:16:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9164-riattivazione-cmv-in-gravidanza]]></loc><lastmod>2016-11-14T15:16:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9141-parere-su-risultati-analisi-infezione-recente-o-pregressa]]></loc><lastmod>2016-11-14T15:17:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9140-risultati-cmv-negativi-ma-igm-alti-cosa-significa]]></loc><lastmod>2016-11-14T15:17:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9139-caso-di-cmv-all-asilo-di-mio-figlio-rischioso-per-la-mia-gravidanza]]></loc><lastmod>2016-11-14T15:17:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9138-valori-positivi-per-cmv-si-puo-dedurre-qualcosa]]></loc><lastmod>2016-11-14T15:18:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9098-cmv-e-distacco-della-placenta-cosa-consiglia]]></loc><lastmod>2016-11-14T15:19:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9097-presunta-immunita-da-cmv-posso-stare-tranquilla]]></loc><lastmod>2015-10-28T14:10:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9096-bambino-con-intestino-iperecogeno-puo-essere-infezione-da-cmv]]></loc><lastmod>2015-10-28T14:10:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9095-cmv-alla-11esima-settimana-come-muovermi]]></loc><lastmod>2015-10-28T14:10:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9094-cmv-alla-14esima-settimana-rinvio-amniocentesi]]></loc><lastmod>2016-11-14T15:20:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9093-cmv-al-sesto-mese-di-gravidanza-come-capire-se-e-riattivazione-o-infezione-primaria]]></loc><lastmod>2016-11-14T15:21:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9092-cmv-su-neonato-quali-rischi]]></loc><lastmod>2016-11-14T15:22:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9091-igg-diventate-positive-e-igm-sempre-negative-cosa-significa]]></loc><lastmod>2016-11-14T15:22:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9090-dubbio-cmv-in-gravidanza-con-tiroidite-autoimmune-puo-essere-un-falso-positivo]]></loc><lastmod>2016-11-14T15:22:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9087-posso-aver-trasmesso-cmv-al-feto-con-amnocentesi]]></loc><lastmod>2016-11-14T15:23:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9070-cmv-positivo-a-cosa-vado-incontro]]></loc><lastmod>2016-11-14T15:23:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/9069-nuova-effettuazione-esami-per-sospetto-cmv]]></loc><lastmod>2016-11-14T15:24:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8896-cmv-alla-36esima-settimana-di-gravidanza-con-placenta-spessa-il-feto-e-a-rischio-contagio]]></loc><lastmod>2016-11-14T15:24:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8895-lavorare-a-contatto-con-adolescenti-puo-alzare-il-rischio-di-contagio-da-cmv]]></loc><lastmod>2016-11-14T15:25:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8852-test-cmv-positivo-in-gravidanza-cosa-fare]]></loc><lastmod>2016-11-14T15:25:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8826-terapia-a-base-di-immunoglobuline-e-possibile-farla-solo-per-un-infezione-primaria]]></loc><lastmod>2016-11-14T15:26:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8823-cmv-contratto-tra-ottava-e-nona-settimana-di-gravidanza]]></loc><lastmod>2016-11-14T15:26:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8805-cmv-in-gravidanza-richiesta-parere-su-valori-igg]]></loc><lastmod>2016-11-14T15:27:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8781-cmv-in-gravidanza-c-e-la-possibilita-che-il-virus-sia-passato-al-feto]]></loc><lastmod>2016-11-14T15:27:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8780-cmv-alla-16esima-settimana-di-gravidanza]]></loc><lastmod>2016-11-14T15:27:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8720-si-puo-trasmettere-il-citomegalovirus-in-acqua]]></loc><lastmod>2016-11-14T15:28:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8693-mia-figlia-e-affetta-da-citomegalovirus-troppo-tardi-per-il-test-di-avidita]]></loc><lastmod>2016-11-14T15:28:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8670-cmv-alla-14esima-settimana-di-gravidanza-consiglio-su-immunoglobuline]]></loc><lastmod>2016-11-14T15:29:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8669-neonato-infetto-da-citomegalovirus]]></loc><lastmod>2016-11-14T15:29:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8668-riattivazione-cmv-in-gravidanza-e-madre-affetta-da-sclerosi-multipla]]></loc><lastmod>2016-11-14T15:30:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8667-citomegalovirus-in-gravidanza-puo-essere-una-riattivazione]]></loc><lastmod>2016-11-14T15:30:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8590-cmv-riattivazione-al-primo-trimestre-di-gravidanza]]></loc><lastmod>2016-11-14T15:31:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8552-citomegalovirus-alla-25esima-settimana-di-gravidanza]]></loc><lastmod>2016-11-14T15:31:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8497-infezione-da-cmv-contratta-tra-la-6-e-la-8-settimana-di-gestazione]]></loc><lastmod>2016-11-14T15:32:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8470-cmv-in-gravidanza-in-attesa-del-test-avidity]]></loc><lastmod>2016-11-14T15:32:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8420-citomegalovirus-in-gravidanza-quali-cure-ed-esami]]></loc><lastmod>2016-11-14T15:44:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8416-cmv-in-gravidanza-va-bene-fare-l-amniocentesi-adesso]]></loc><lastmod>2016-11-14T15:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8415-sospetto-citomegalovirus-in-gravidanza-devo-preoccuparmi]]></loc><lastmod>2016-11-14T15:45:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8373-cmv-posso-ritentare-una-gravidanza]]></loc><lastmod>2016-11-14T15:45:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8372-citomegalovirus-in-gravidanza-sospetta-riattivazione]]></loc><lastmod>2016-11-14T15:46:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8336-citomegalovirus-in-gravidanza-le-punture-di-immunoglobuline-aiutano]]></loc><lastmod>2016-11-14T15:46:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8335-cmv-in-gravidanza-quali-accertamenti]]></loc><lastmod>2015-05-28T14:25:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8334-test-citomegalovirus-dubbio-posso-provare-ad-avere-un-bambino]]></loc><lastmod>2015-05-28T14:20:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8128-cmv-in-gravidanza-cosa-fare-se-il-virus-e-passato-al-liquido]]></loc><lastmod>2016-11-14T15:48:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8127-citomegalovirus-posso-allattare-il-mio-bambino]]></loc><lastmod>2016-11-14T15:48:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8126-cmv-in-gravidanza-richiesta-valutazione-clinica]]></loc><lastmod>2016-11-14T15:49:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8125-citomegalovirus-in-gravidanza-dove-rivolgermi-in-germania]]></loc><lastmod>2016-11-14T15:52:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8124-cmv-all-ottava-settimana-di-gravidanza-feto-puo-essere-contagiato]]></loc><lastmod>2016-11-14T15:52:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/8010-parto-prematuro-e-neonato-positivo-al-citomegalovirus]]></loc><lastmod>2016-11-14T15:53:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7967-cmv-in-gravidanza-devo-preoccuparmi]]></loc><lastmod>2016-11-14T15:53:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7966-citomegalovirus-in-gravidanza-quando-iniziare-somministrazione-di-immunoglobuline]]></loc><lastmod>2016-11-14T15:54:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7903-cmv-in-gravidanza-dopo-aborto-devo-preoccuparmi]]></loc><lastmod>2016-11-14T15:54:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7890-citomegalovirus-alla-quinta-settimana-devo-interrompere-la-gravidanza]]></loc><lastmod>2016-11-14T15:55:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7860-cmv-alla-37esima-settimana-parto-naturale-o-cesareo]]></loc><lastmod>2016-11-14T15:56:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7837-cambiamento-risultati-igg-in-gravidanza]]></loc><lastmod>2016-11-14T15:57:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7836-sospetto-cmv-in-gravidanza-dobbiamo-preoccuparci-per-il-feto]]></loc><lastmod>2016-11-14T15:57:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7783-citomegalovirus-puo-essere-causa-di-sordita]]></loc><lastmod>2016-11-14T15:58:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7782-infezione-da-cmv-nellultimo-trimestre-di-gravidanza]]></loc><lastmod>2016-11-14T15:59:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7756-cmv-alla-17esima-settimana-consigli]]></loc><lastmod>2016-11-14T15:59:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7755-citomegalovirus-in-gravidanza-quali-cure-per-ridurre-conseguenze]]></loc><lastmod>2016-11-14T16:00:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7754-cmv-in-gravidanza-cosa-rischia-il-feto]]></loc><lastmod>2016-11-14T16:01:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7694-sospetto-citomegalovirus-in-gravidanza-cosa-devo-fare]]></loc><lastmod>2016-11-14T16:02:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7687-cmv-in-gravidanza-come-procedere]]></loc><lastmod>2016-11-14T16:02:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7685-riattivazione-virus-cmv-esiste-pericolo-per-il-feto]]></loc><lastmod>2016-11-14T16:03:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7668-aborto-spontaneo-per-cmv-richiesta-informazioni]]></loc><lastmod>2016-11-14T16:03:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7667-lipoacusia-puo-essere-causata-dal-citomegalovirus]]></loc><lastmod>2016-11-14T16:05:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7621-citomegalovirus-in-gravidanza-esiste-terapia-preventiva]]></loc><lastmod>2016-11-14T16:06:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7546-2015-02-05-15-49-39]]></loc><lastmod>2016-11-14T14:09:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7544-citomegalovirus-devo-aspettare-prima-di-cercare-una-gravidanza]]></loc><lastmod>2016-11-14T14:08:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7518-mio-figlio-di-4-anni-non-negativizza-il-cmv-che-fare]]></loc><lastmod>2016-11-14T16:10:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7491-citomegalovirus-a-fine-gravidanza-come-comportarsi]]></loc><lastmod>2016-11-14T16:11:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7490-decima-settimana-di-gravidanza-positiva-al-cmv-che-fare]]></loc><lastmod>2016-11-14T16:11:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7489-citomegalovirus-igm-persistenti-cosa-fare]]></loc><lastmod>2016-11-14T16:16:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7488-dubbi-sullavidity-test-per-citomegalovirus-in-gravidanza]]></loc><lastmod>2016-11-14T16:17:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7454-ho-scoperto-di-avere-il-citomegalovirus-e-sono-in-attesa-cosa-devo-fare]]></loc><lastmod>2016-11-14T16:17:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7410-che-accertamenti-fare-dopo-le-prime-analisi-per-il-citomegalovirus]]></loc><lastmod>2016-11-14T16:18:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7408-citomegalovirus-e-rischio-di-contagio-che-fare]]></loc><lastmod>2016-11-14T16:18:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7407-mia-figlia-di-18-mesi-potrebbe-aver-contratto-il-citomegalobirus]]></loc><lastmod>2016-11-14T16:19:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7392-ho-contratto-il-cmv-e-desidero-una-gravidanza-come-fare]]></loc><lastmod>2016-11-14T16:19:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7337-citomegalovirus-in-gravidanza-devo-preoccuparmi]]></loc><lastmod>2016-11-14T16:20:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7336-cmv-positivo-devo-fare-lamniocentesi-o-ci-sono-altri-esami-possibili]]></loc><lastmod>2016-11-14T16:20:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7305-citomegalovirus-in-gravidanza-posso-stare-tranquilla]]></loc><lastmod>2016-11-14T16:21:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7304-mia-figlia-e-nata-con-infezione-da-citomegalovirus-che-fare]]></loc><lastmod>2016-11-14T16:21:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7303-gli-stessi-valori-del-citomegalovirus-a-distanza-di-un-anno-cosa-fare]]></loc><lastmod>2016-11-14T16:22:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7227-citomegalovirus-in-gravidanza-come-capire-se-linfezione-e-in-atto]]></loc><lastmod>2016-11-14T16:22:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7188-citomegalovirus-infezione-contratta-prima-del-concepimento]]></loc><lastmod>2016-11-14T16:23:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7170-riattivazione-del-citomegalovirus-in-gravidanza-cosa-fare]]></loc><lastmod>2016-11-14T16:23:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7169-test-delludito-da-eseguire-di-nuovo]]></loc><lastmod>2016-11-14T16:24:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7168-quanto-attendere-per-tentare-una-seconda-gravidanza]]></loc><lastmod>2016-11-14T16:25:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7167-infezione-pericolosa-citomegalovirus-positivo-a-9-settimane-di-gravidanza]]></loc><lastmod>2016-11-14T16:25:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7136-positiva-al-citomegalovirus-in-gravidanza-che-esami-devo-effettuare]]></loc><lastmod>2016-11-14T16:26:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7050-dubbi-su-citomegalovirus]]></loc><lastmod>2016-11-14T16:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7049-mio-figlio-ha-contratto-il-citomegalovirus-nel-primo-mese-di-vita-che-fare]]></loc><lastmod>2016-11-14T16:27:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7048-diciottesima-settimana-di-gravidanza-puo-esserci-riattivazione-di-citomegalovirus]]></loc><lastmod>2016-11-14T16:28:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7047-nona-settimana-di-gravidanza-e-febbricola-puo-trattarsi-di-citomegalovirus]]></loc><lastmod>2016-11-14T16:29:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7005-ho-contratto-il-cmv-in-gravidanza-e-mi-consigliano-laborto-cosa-fare]]></loc><lastmod>2016-11-14T16:33:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7004-analisi-positive-al-citomegalovirus-in-gravidanza-come-comportarsi-nunzia]]></loc><lastmod>2016-11-14T16:34:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7003-citomegalovirus-in-gravidanza-possibile-che-ci-siano-danni-gravi]]></loc><lastmod>2016-11-14T16:35:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/7002-il-citomegalovirus-potrebbe-aver-causato-laborto]]></loc><lastmod>2016-11-14T16:36:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6935-sono-immune-al-citomegalovirus]]></loc><lastmod>2016-11-14T16:38:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6934-positiva-al-cmv-in-gravidanza-parto-naturale-e-allattamento-sono-possibii]]></loc><lastmod>2016-11-14T16:38:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6901-positiva-al-citomegalovirus-devo-sottopormi-a-terapia-con-immunoglobuline]]></loc><lastmod>2016-11-14T16:39:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6893-cosa-fare-nella-seconda-gravidanza-dopo-la-prima-in-cui-si-e-avuta-riattivazione]]></loc><lastmod>2016-11-14T16:41:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6894-ho-contratto-il-citomegalovirus-con-infezione-primaria-che-fare]]></loc><lastmod>2016-11-14T16:40:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6895-potrei-aver-contratto-il-citomegalovirsus]]></loc><lastmod>2016-11-14T16:40:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6834-falso-positivo-o-riattivazione]]></loc><lastmod>2016-11-14T16:41:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6833-citomegalovirus-errore-nelle-analisi]]></loc><lastmod>2016-11-14T16:42:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6832-falsa-positivita]]></loc><lastmod>2016-11-14T16:47:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6831-citomegalovirus-riattivatosi-in-gravidanza-come-agire]]></loc><lastmod>2016-11-14T16:47:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6830-gravidanza-gemellare-positiva-al-cmv]]></loc><lastmod>2016-11-14T16:48:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6781-citomegalovirus-potrebbe-esdsere-una-riattivazione]]></loc><lastmod>2016-11-14T16:49:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6780-analisi-cmv-positive-allottavo-mese-di-gravidanza-che-fare]]></loc><lastmod>2016-11-14T16:50:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6779-citomegalovirus-rischio-di-trasmetterlo-al-feto]]></loc><lastmod>2016-11-14T16:51:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6778-dubbi-su-citomegalovirus-alla-prima-gravidanza]]></loc><lastmod>2016-11-14T16:52:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6760-citomegalovirus-si-puo-trasmettere-in-ufficio]]></loc><lastmod>2016-11-14T16:53:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6759-mv-igg-8030-cosa-fare-per-il-citomegalovirus]]></loc><lastmod>2016-11-14T16:54:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6758-specialisti-a-napoli]]></loc><lastmod>2016-11-14T16:55:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6757-valori-dubbi-come-mi-comporto]]></loc><lastmod>2016-11-14T16:55:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6743-il-feto-e-gia-fuori-pericolo]]></loc><lastmod>2016-11-14T16:56:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6742-posso-stare-tranquilla-se-linfezione-e-antecedente-al-concepimento]]></loc><lastmod>2016-11-14T16:58:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6738-valori-cmv-igm-borderline-in-gravidanza]]></loc><lastmod>2016-11-14T16:58:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6735-possibile-riattivazione-del-citomegalovirus-necessaria-amniocentesi]]></loc><lastmod>2016-11-14T16:59:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6690-mpre-positiva-al-cmv-ad-un-anno-di-distanza]]></loc><lastmod>2016-11-14T17:01:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6689-igg-e-igm-positivi-in-gravidanza-come-mi-comporto]]></loc><lastmod>2016-11-14T17:02:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6617-positiva-al-citomegalovirus-in-gravidanza-non-so-come-comportarmi]]></loc><lastmod>2016-11-14T17:03:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6616-cmv-e-nuova-gravidanza]]></loc><lastmod>2016-11-14T17:18:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6604-devo-sottopormi-allamniocentesi-per-verificare-la-presenza-di-cmv]]></loc><lastmod>2016-11-14T17:19:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6568-infezione-di-vecchia-data-o-rischio-cmv-congenito]]></loc><lastmod>2016-11-14T17:20:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6529-citomegalovirus-in-gravidanza-meglio-un-parto-anticipato]]></loc><lastmod>2016-11-14T17:21:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6519-come-scoprire-se-il-citomegalovirus-si-e-riattivato]]></loc><lastmod>2016-11-14T17:22:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6492-vorrei-un-altro-figlio-ma-ho-il-cmv-che-fare]]></loc><lastmod>2016-11-14T17:23:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6489-ho-effettuato-il-test-di-screening-per-il-cmv-come-comprendere-i-risultati]]></loc><lastmod>2016-11-14T17:23:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6479-il-citomegalovirus-puo-aver-causato-laborto]]></loc><lastmod>2016-11-14T17:24:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6455-mia-figlia-presenta-ipocausia-da-citomegalovirus-e-utile-la-cura-a-11-mesi]]></loc><lastmod>2016-11-14T17:25:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6453-positiva-al-citomegalovirus-devo-fare-lamniocentesi]]></loc><lastmod>2016-11-14T17:25:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6452-prima-gravidanza40-anni-e-un-dubbio-sul-citomegalovirus]]></loc><lastmod>2016-11-14T17:26:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6435-ho-contratto-il-citomegalovirus-4-anni-fa-quali-rischi-per-una-gravidanza]]></loc><lastmod>2016-11-14T17:26:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6419-citomegalovirus-o-infezione-luetica]]></loc><lastmod>2016-11-14T17:27:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6379-citomegalovirus-non-sono-immune-come-capire-se-ho-contratto-il-virus]]></loc><lastmod>2016-11-14T17:28:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6378-citomegaluvirus-e-rischi-per-il-feto-come-mi-devo-comportare]]></loc><lastmod>2016-11-14T17:29:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6343-citomegalovirus-in-gravidanza-potrei-aver-infettato-unamica]]></loc><lastmod>2016-11-14T17:29:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6272-cmv-positiva-il-test-di-avidita-indica-il-55-che-significa]]></loc><lastmod>2016-11-14T17:30:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6271-sto-pianificando-una-gravidanza-e-sono-positiva-al-cmv-possibile-ricevere-le-immunoglobuline]]></loc><lastmod>2016-11-14T17:30:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6270-citomegalovirus-infeziione-primaria-o-contagio-precedente]]></loc><lastmod>2016-11-14T17:31:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6249-avidity-tests-discordanti-che-fare]]></loc><lastmod>2016-11-14T17:31:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6248-positiva-al-cmv-in-gravidanza-mia-figlia-e-risultata-negativa-posso-stare-tranquilla]]></loc><lastmod>2016-11-14T17:32:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6232-positiva-al-cmv-alla-14esima-settimana-che-fare]]></loc><lastmod>2016-11-14T17:32:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6186-il-citomegalovirus-puo-mettere-a-rischio-la-mia-gravidanza]]></loc><lastmod>2016-11-14T17:33:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6185-citomegalovirus-ed-herpes-zoster-consiglia-lamniocentesi]]></loc><lastmod>2016-11-14T17:33:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6123-fecondazione-artificiale-e-citomegalovirus-che-fare]]></loc><lastmod>2016-11-14T17:34:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6073-in-famiglia-hanno-contratto-il-cmv-come-prevenire-il-contagio]]></loc><lastmod>2016-11-14T17:34:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6072-ho-deciso-di-abortire-e-la-decisione-giusta]]></loc><lastmod>2016-11-14T17:35:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6058-il-mio-bambino-e-a-rischio-sono-positiva-al-citomegalovirus-con-forte-avidita]]></loc><lastmod>2016-11-14T17:35:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6033-analisi-effettuate-come-capire-i-rischi-sul-mio-bambino]]></loc><lastmod>2016-11-14T17:36:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/6032-29-settimana-di-gestazione-igg-350-e-igm-assenti]]></loc><lastmod>2016-11-14T17:36:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5937-seconda-gravidanza-possibile-riattivazione-del-citomegalovirus]]></loc><lastmod>2016-11-14T17:38:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5926-citomegalovirus-puo-essere-ancora-attivo-nelladulto]]></loc><lastmod>2016-11-14T17:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5908-virus-contratto-alla-13ma-settimana-necessario-ters-di-avidta]]></loc><lastmod>2016-11-14T17:39:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5899-gravidanza-gemellare-con-presenza-di-citomegalovirus-quali-indagini-effettuare]]></loc><lastmod>2016-11-14T17:40:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5836-la-prima-figlia-e-nata-con-problemi-di-udito-a-causa-del-citomegalovirus-come-evitarli-nella-seconda-garavidanza]]></loc><lastmod>2016-11-14T17:40:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5835-a-causa-del-cmv-ho-interrotto-la-prima-gravidanza-che-accertamenti-fare-ora]]></loc><lastmod>2016-11-14T17:41:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5822-ho-eseguito-il-test-cmv-al-sesto-mese-di-gravidanza-posso-tranquillizzarmi]]></loc><lastmod>2016-11-14T17:41:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5778-conversione-igg-citomegalovirus]]></loc><lastmod>2016-11-14T17:42:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5709-mi-sono-accorta-di-aver-contratto-il-virus-alla-settima-settimana-di-gravidanza-e-ora]]></loc><lastmod>2016-11-14T17:42:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5644-mia-figlia-di-11-mesi-ha-un-ritardo-nello-sviluppo-che-si-tratti-di-citomegalovirus]]></loc><lastmod>2016-11-14T17:43:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5643-mio-figlio-e-affetto-da-citomegalovirus-cosa-e-necessario-fare]]></loc><lastmod>2016-11-14T17:43:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5625-ho-contratto-il-cmv-quanto-tempo-aspettare-per-una-gravidanza]]></loc><lastmod>2016-11-14T17:45:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5600-citomegalovirus-contratto-prima-del-concepimento]]></loc><lastmod>2016-11-14T17:45:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5587-posso-aver-contratto-il-virus-alla-25esima-settimana]]></loc><lastmod>2016-11-14T17:46:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5494-quali-gli-esami-per-sapere-con-certezza-se-recidiva]]></loc><lastmod>2016-11-14T17:46:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5492-test-positivo-sto-facendo-la-terapia-corretta]]></loc><lastmod>2016-11-14T17:47:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5491-sieroconversione-cmv-in-gravidanza]]></loc><lastmod>2016-11-14T17:47:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5448-ho-fatto-il-test-per-il-citomegalovirus-posso-stare-tranquilla]]></loc><lastmod>2016-11-14T17:50:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5411-il-cmv-puo-causare-sintomi-gravi-nelladulto]]></loc><lastmod>2016-11-14T17:52:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5410-contratto-il-virus-in-gravidanza-necessaria-lamniocentesi]]></loc><lastmod>2016-11-14T17:53:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5404-non-ho-mai-contratto-il-virus-e-vorrei-progettare-una-seconda-gravidanza-quale-rischio]]></loc><lastmod>2016-11-14T17:53:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5366-citomegalovirus-in-gravidanza-gemellare-devo-ripetere-lesame]]></loc><lastmod>2016-11-14T17:54:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5365-citomegalovirus-ed-herpes-possibile-un-falso-positivo]]></loc><lastmod>2016-11-14T17:54:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5330-il-citomegalovirus-si-puo-trasmettere-in-piscina]]></loc><lastmod>2016-11-14T17:55:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5326-mia-figlia-e-nata-con-citomegalovirus-ma-e-asintomatica-posso-stare-tranquilla]]></loc><lastmod>2016-11-14T17:56:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5325-mia-moglie-ha-contratto-il-virus-in-gravidanza-che-fare]]></loc><lastmod>2016-11-14T17:56:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5324-la-sordita-di-mia-sorella-puo-essere-dovuta-al-citomegalovirus]]></loc><lastmod>2016-11-14T18:00:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5294-non-ho-eseguto-lesame-per-il-cmv-e-sono-incinta-devo-preoccuparmi]]></loc><lastmod>2016-11-14T18:01:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5268-incinta-di-due-gemelli-in-seguito-a-iui-e-positiva-al-cmv-che-fare]]></loc><lastmod>2016-11-14T18:02:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5226-ho-sia-le-igg-che-le-igm-alte-per-il-citomegalovirus-sono-alla-decima-settimana-di-gravidanza-che-fare]]></loc><lastmod>2016-11-14T18:03:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5225-sono-incinta-e-igg-gm-sono-presenti-che-fare]]></loc><lastmod>2016-11-14T18:03:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5178-quale-rischio-di-contagio-in-gravidanza]]></loc><lastmod>2016-11-14T18:03:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5135-sono-incinta-e-il-test-e-positivo-che-rischio-ce-per-il-mio-bambino]]></loc><lastmod>2016-11-14T18:04:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/5006-ho-dovuto-abortire-a-6-mesi-a-causa-di-malformazioni-del-feto-e-stata-colpa-del-cmv]]></loc><lastmod>2016-11-14T18:05:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/4751-sono-incinta-e-gli-anticorpi-anti-citomegalovirus-sono-risultati-positivi-cosa-devo-fare]]></loc><lastmod>2016-11-14T18:05:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/4750-sono-al-quarto-mese-di-gravidanza-a-cosa-devo-fare-attenzione-per-prevenire-il-cmv]]></loc><lastmod>2016-11-14T18:06:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/4749-dopo-aver-contratto-uninfezione-primaria-da-citomegalovirus-quanto-tempo-deve-passare-per-poter-progettare-una-gravidanza-senza-rischi-per-il-feto]]></loc><lastmod>2016-11-14T18:07:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/4748-ho-scoperto-alla-trentasettesima-settimana-di-essere-affetta-da-cmv-cosa-devo-fare]]></loc><lastmod>2016-11-14T18:07:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/4747-ho-il-citomegalovirus-igg-265-e-igm-presenti-cosa-significa]]></loc><lastmod>2016-11-14T18:08:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/4539-come-si-puo-prevenire-linfezione-da-citomegalovirus]]></loc><lastmod>2016-11-14T18:08:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/citomegalovirus-congenito/4536-perche-le-donne-in-gravidanza-rischiano-di-contrarre-il-citomegalovirus]]></loc><lastmod>2016-11-14T18:09:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie]]></loc><lastmod>2020-11-16T18:48:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/16447-ipercolesterolemia-e-vero-che-la-berberina-favorisce-la-trombosi]]></loc><lastmod>2020-09-14T14:59:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/16445-ipercolesterolemia-desidero-una-gravidanza-come-comportarmi]]></loc><lastmod>2020-09-14T15:08:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/16444-ipercolesterolemia-quali-esami-fare-per-avere-una-diagnosi]]></loc><lastmod>2020-09-14T15:08:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/12570-ipercolesterolemia-come-gestirla-in-gravidanza]]></loc><lastmod>2017-08-04T13:44:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/12569-colesterolo-alto-nonostante-la-dieta-cosa-fare]]></loc><lastmod>2017-08-04T13:37:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/12330-iperlp-a-lipoproteinemia-dove-rivolgermi]]></loc><lastmod>2017-06-19T13:03:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/12329-ipercolesterolemia-terapia-con-barberol-puo-avere-effetti-collaterali]]></loc><lastmod>2017-06-19T13:04:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/12292-sospetta-ipercolesterolemia-in-ragazza-di-27-anni]]></loc><lastmod>2017-05-19T14:08:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/12173-bambina-di-7-anni-con-ipercolesterolemia-consigliabile-una-cura-con-i-questran]]></loc><lastmod>2017-04-10T13:15:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/12172-consiglio-per-ipercolesterolemia-con-colesterolo-totale-alto-nonostante-la-dieta]]></loc><lastmod>2017-04-10T13:09:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/12108-abito-in-molise-a-chi-potrei-rivolgermi-per-ipercolesterolemia-genetica]]></loc><lastmod>2017-03-24T14:26:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/12107-quali-esami-fare-per-stabilire-un-eventuale-ereditarieta-nella-linea-genetica-pre-genitoriale]]></loc><lastmod>2017-03-24T14:08:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/11795-esiste-un-integratore-che-sostituisce-le-statine]]></loc><lastmod>2017-01-12T11:41:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/11772-ipercolesterolemia-come-trattarla-in-gravidanza]]></loc><lastmod>2017-01-02T15:41:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/11594-iperlipoproteinemia-quali-centri-in-friuli]]></loc><lastmod>2016-11-14T10:58:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/11133-ipercolesterolemia-dove-effettuare-gli-esami-necessari-a-roma]]></loc><lastmod>2016-11-14T10:58:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/11117-dislipidemia-quali-centri-specializzati-in-puglia]]></loc><lastmod>2016-11-14T10:59:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/11035-giovane-con-dislipidemia-servono-ulteriori-esami]]></loc><lastmod>2016-11-14T10:59:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/10962-trigliceridi-elevati-necessari-esami-approfonditi]]></loc><lastmod>2016-11-14T10:59:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/9727-fegato-in-sofferenza-possibile-un-deficit-di-lipasi-acida-lisosomiale]]></loc><lastmod>2016-11-14T10:59:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/8722-affetta-da-ipercolesterolomia-e-lipolinfedema-come-dimagrire]]></loc><lastmod>2016-11-14T11:00:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ipercolesterolemia-familiare-e-dislipidemie/8718-caso-complesso-di-ipercolesterolomia-richiesta-di-visita]]></loc><lastmod>2016-11-14T11:00:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-epatiche-autoimmuni]]></loc><lastmod>2020-11-16T18:56:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-epatiche-autoimmuni/16938-sono-affetto-da-epatite-autoimmune-posso-fare-il-vaccino-anti-covid-19]]></loc><lastmod>2021-01-27T11:40:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-epatiche-autoimmuni/15099-autoimmunita-mitocondriale-epatica-quali-criteri-consentono-altre-sperimentazioni-terapeutiche]]></loc><lastmod>2019-08-02T13:52:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-epatiche-autoimmuni/15041-colangite-sclerosante-con-epatite-autoimmune-cosa-fare]]></loc><lastmod>2019-07-19T08:47:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-epatiche-autoimmuni/15040-cirrosi-autoimmune-in-anziano-l-antibiotico-danneggia-i-reni]]></loc><lastmod>2019-07-15T15:37:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-epatiche-autoimmuni/15011-92enne-affetta-da-colangite-come-attenuare-il-prurito]]></loc><lastmod>2019-07-09T14:44:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-epatiche-autoimmuni/11295-come-funziona-il-servizio]]></loc><lastmod>2019-04-29T11:08:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/deficit-di-lipasi-acida-lisosomiale]]></loc><lastmod>2020-11-16T18:45:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/deficit-di-lipasi-acida-lisosomiale/16939-quale-test-deve-essere-prescritto-per-verificare-il-deficit-di-lipasi-acida-lisosomiale]]></loc><lastmod>2021-01-27T12:05:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/deficit-di-lipasi-acida-lisosomiale-bambini]]></loc><lastmod>2020-11-16T18:46:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/lipodistrofia]]></loc><lastmod>2020-11-16T18:50:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/lipodistrofia/16591-dove-si-puo-essere-seguiti-per-lipodistrofia-causata-da-medicinali-per-la-cura-hiv]]></loc><lastmod>2020-10-19T15:41:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/lipodistrofia/15039-sospetta-lipodistrofia-in-un-bambino-dove-rivolgersi-in-italia-per-compilazione-e112]]></loc><lastmod>2019-07-15T15:03:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/lipodistrofia/15012-lipodistrofia-dove-avere-la-diagnosi-a-bari]]></loc><lastmod>2019-07-09T14:49:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/lipodistrofia/14623-cosa-significa-pelle-lipodistrofica]]></loc><lastmod>2019-03-26T14:47:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/lipodistrofia/14622-progressiva-perdita-di-grasso-cutaneo-puo-essere-lipodistrofia]]></loc><lastmod>2019-03-22T13:23:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/lipodistrofia/14621-lipodistrofia-con-quale-meccanismo-biochimico-la-leptina-abbassa-i-livelli-di-glicemia-e-trigliceridi]]></loc><lastmod>2019-03-26T14:48:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/lipodistrofia/13935-rientranza-coscia-sinistra-puo-essere-lipodistrofia]]></loc><lastmod>2018-09-18T13:58:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/distrofia-muscolare-di-duchenne-pediatrici]]></loc><lastmod>2025-03-19T09:34:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/distrofia-muscolare-di-duchenne-pediatrici/16397-bimbo-di-3-anni-un-po-impacciato-e-scoordinato-puo-avere-la-distrofia-di-duchenne]]></loc><lastmod>2020-08-31T14:52:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/distrofia-muscolare-di-duchenne-pediatrici/14348-bimbo-di-2-anni-cammina-sulle-punte-puo-avere-la-distrofia-di-duchenne]]></loc><lastmod>2019-01-10T16:31:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/distrofia-muscolare-di-duchenne-pediatrici/13159-bimbo-di-6-anni-affetto-da-duchenne-puo-assumere-eteplirsen]]></loc><lastmod>2018-01-29T16:02:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/distrofia-muscolare-di-duchenne-giovani-e-adulti]]></loc><lastmod>2022-06-06T16:58:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/distrofia-muscolare-di-duchenne-giovani-e-adulti/13134-duchenne-informazioni-sull-assunzione-di-raxone]]></loc><lastmod>2018-07-09T19:27:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/distrofia-muscolare-di-duchenne-giovani-e-adulti/12564-duchenne-quali-ricerche-e-terapie-sono-disponibili]]></loc><lastmod>2017-08-03T14:47:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry]]></loc><lastmod>2025-02-05T11:50:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry/15017-sospetto-di-malattia-di-fabry-dove-rivolgermi-a-milano]]></loc><lastmod>2019-07-10T13:16:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry/15016-malattia-di-fabry-a-roma-quali-centri-se-ne-occupano-devo-far-fare-il-test-a-mia-figlia]]></loc><lastmod>2019-07-10T13:09:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry/15015-malattia-di-fabry-dove-effettuare-il-test-per-l-enzima-alfa-galattosidasi-in-sicilia]]></loc><lastmod>2019-07-10T13:03:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry/15014-malattia-di-fabry-dove-rivolgermi-in-puglia]]></loc><lastmod>2019-07-10T12:58:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry/14347-malattia-di-fabry-a-che-eta-sorgono-i-primi-sintomi]]></loc><lastmod>2019-01-10T16:18:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry/14337-malattia-di-fabry-c-e-un-test-da-ripetere-per-diagnosticarla]]></loc><lastmod>2019-01-08T15:32:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry/13907-malattia-di-fabry-si-puo-evitare-di-trasmetterla-ai-figli-possibile-la-diagnosi-genetica-pre-impianto]]></loc><lastmod>2018-09-10T15:05:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry/13884-madre-affetta-in-forma-lieve-da-fabry-necessarie-le-infusioni-quali-effetti-collaterali]]></loc><lastmod>2018-09-04T09:36:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry/13883-bassissimo-livello-di-alfagalattosidasi-e-possibile-avere-il-morbo-di-fabry]]></loc><lastmod>2018-09-04T10:49:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-fabry/13657-malattia-di-fabry-consigliato-che-i-familiari-si-sottopongano-al-test-genetico]]></loc><lastmod>2018-06-12T13:48:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-sud]]></loc><lastmod>2020-11-16T18:52:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-sud/16443-micobatterio-xenopi-quali-conseguenze-e-terapie]]></loc><lastmod>2020-09-14T14:38:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-sud/15044-micobatterio-tubercolare-una-volta-curata-puo-ripresentarsi-in-futuro]]></loc><lastmod>2019-07-16T14:59:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-sud/14291-quali-esami-fare-per-escludere-micobatterio-chimera]]></loc><lastmod>2019-07-16T14:53:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-sud/14290-quali-esami-fare-per-escludere-infezione-da-micobatterio-chimera]]></loc><lastmod>2019-07-16T14:53:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-nord]]></loc><lastmod>2020-11-16T18:53:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-nord/15715-ntm-rischio-di-contagio-per-un-neonato]]></loc><lastmod>2020-03-02T15:10:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-nord/15522-micobatterio-kansasii-quali-cure-e-accorgimenti-nella-vita-quotidiana]]></loc><lastmod>2019-12-16T16:34:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-nord/15521-mycobacterium-avium-e-pseudomonas-aeruginosa-quali-trattamenti]]></loc><lastmod>2019-12-16T16:27:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-nord/15043-mycobacterium-intracellulare-se-non-curato-in-che-tempi-porta-a-danni]]></loc><lastmod>2019-07-16T14:51:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-nord/15042-mycobacterium-avium-quale-esame-fare-per-avere-diagnosi]]></loc><lastmod>2019-07-16T14:48:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-nord/14748-non-serve-la-terapia-antibiotica-per-il-mycobacterium-intracellulare-e-vero]]></loc><lastmod>2019-04-18T12:54:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-polmonare-da-micobatteri-non-tubercolari-pazienti-del-centro-nord/13903-terapia-antibiotica-per-micobatteriosi-disseminata-da-m-chimerae-ma-senza-risultati-quali-altre-terapie]]></loc><lastmod>2018-09-10T11:31:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/porfiria]]></loc><lastmod>2020-11-16T18:56:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/porfiria/16941-soffro-di-porfiria-posso-vaccinarmi-contro-il-covid-19]]></loc><lastmod>2021-01-27T12:37:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/porfiria/14620-c-e-correlazione-tra-protoporfiria-fibromialgia-e-intolleranza-al-glutine]]></loc><lastmod>2019-03-22T13:07:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/porfiria/14619-porfiria-quali-vaccini-per-un-viaggio-in-africa]]></loc><lastmod>2019-03-22T13:04:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/ceroidolipofuscinosi-neuronali]]></loc><lastmod>2020-11-16T18:41:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/rachitismo-ipofosfatemico]]></loc><lastmod>2025-04-30T12:34:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/rachitismo-ipofosfatemico/15716-rachitismo-in-gravidanza-quando-fare-il-test-genetico]]></loc><lastmod>2020-03-02T15:14:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/rachitismo-ipofosfatemico/15519-quale-alimentazione-per-un-bambino-di-8-anni-affetto-da-rachitismo]]></loc><lastmod>2019-12-16T14:58:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/rachitismo-ipofosfatemico/15446-carenza-di-calcio-alle-ossa-puo-essere-xlh-o-di-qualche-altra-forma-di-rachitismo]]></loc><lastmod>2019-11-25T16:26:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus]]></loc><lastmod>2021-03-17T17:19:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16678-covid-19-quali-patologie-sono-esentate-dal-portare-la-mascherina]]></loc><lastmod>2020-11-11T15:33:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16677-verra-riproposto-il-certificato-v07-che-tutele-sono-previste-al-momento]]></loc><lastmod>2020-11-11T15:27:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16625-astensione-dal-lavoro-per-covid-19-equiparato-a-ricovero-ospedaliero-con-moglie-a-carico-mi-viene-decurtato-lo-stipendio]]></loc><lastmod>2020-10-28T16:37:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16624-covid-19-e-astensione-dal-lavoro-e-stato-ripristinato-il-codice-v07]]></loc><lastmod>2020-10-28T16:06:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16595-astensione-dal-lavoro-per-covid-19-lo-stipendio-verra-decurtato-continuero-a-percepire-l-assegno-ordinario-invalidita]]></loc><lastmod>2020-10-20T15:16:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16590-covid-19-non-sono-in-grado-di-lavorare-con-la-mascherina-posso-usufruire-dello-smart-working]]></loc><lastmod>2020-10-20T08:42:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16567-covid-19-quando-si-puo-essere-esentati-dall-obbligo-di-indossare-la-mascherina]]></loc><lastmod>2020-10-20T08:43:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16544-sono-affetto-da-sindrome-di-marfan-sono-a-maggior-rischio-complicanze-da-covid-19]]></loc><lastmod>2020-10-09T14:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16457-coronavirus-sono-una-docente-in-malattia-avro-visite-fiscali]]></loc><lastmod>2020-10-20T08:43:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16456-sono-un-docente-e-lavoratore-fragile-di-quali-tutele-posso-avvalermi-posso-essere-esonerato]]></loc><lastmod>2020-09-16T14:24:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16412-coronavirus-fino-a-quando-si-puo-richiedere-malattia-con-il-codice-v07-puo-essere-retroattivo]]></loc><lastmod>2020-09-16T14:24:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16411-i-giorni-di-malattia-con-certificato-v07-vengono-conteggiati-nei-180-giorni-corrisposti-dall-inps]]></loc><lastmod>2020-09-16T14:24:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16398-un-ragazzino-con-bicuspidia-aortica-e-piu-a-rischio-in-caso-d-infezione-da-coronavirus-si-puo-chiedere-la-didattica-a-distanza]]></loc><lastmod>2020-09-16T14:24:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16319-coronavirus-e-codice-v07-l-assenza-e-conteggiata-nel-comporto]]></loc><lastmod>2020-07-22T14:45:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16242-i-soggetti-affetti-da-rettocolite-ulcerosa-in-remissione-non-sottoposti-a-terapia-immunosoppressiva-sono-a-maggior-rischio-covid-19]]></loc><lastmod>2020-06-29T14:41:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16241-favismo-e-covid-19-quali-cure-si-possono-assumere-si-e-soggetti-a-maggior-rischio]]></loc><lastmod>2020-06-29T14:42:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16170-ho-superato-i-180-giorni-di-malattia-qual-e-il-trattamento-economico-con-certificato-v07-possono-concedermi-lo-smart-working]]></loc><lastmod>2020-06-12T13:25:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16169-ho-scoperto-solo-ora-del-certificato-v07-posso-recuperare-i-giorni-di-malattia-retroattivi-fino-ad-oggi]]></loc><lastmod>2020-06-12T13:18:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16168-la-malattia-di-fabry-puo-interferire-nella-guarigione-dal-coronavirus]]></loc><lastmod>2020-06-12T13:14:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16118-coronavirus-quale-il-trattamento-economico-spetta-a-chi-usufruisce-del-codice-v07]]></loc><lastmod>2020-05-27T10:37:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16117-coronavirus-quali-patologie-e-condizioni-portano-al-diritto-dell-astensione-dal-lavoro-v07]]></loc><lastmod>2020-05-27T10:18:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16116-con-il-codice-di-astensione-al-lavoro-v07-e-possibile-uscire-di-casa]]></loc><lastmod>2020-05-27T10:15:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16115-rinnovo-del-codice-v07-le-modalita-e-le-procedure-sono-rimaste-le-stesse]]></loc><lastmod>2020-05-27T10:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16005-e-pericoloso-il-covid-19-per-un-asintomatico-wolff-parkinson-white]]></loc><lastmod>2020-04-27T11:04:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16004-con-il-certificato-v07-sulla-paga-ci-sono-le-trattenute-per-malattia-o-siamo-esonerati-esiste-un-incentivo-inps-per-la-legge-104-si-ha-diritto-ugualmente-alla-maturazione-dei-18-giorni]]></loc><lastmod>2020-04-27T10:58:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/16003-il-certificato-di-astensione-al-lavoro-con-codice-v07-scade-il-30-aprile-verra-rinnovato]]></loc><lastmod>2020-04-27T10:53:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15991-soffro-di-asma-come-faccio-ad-indossare-la-mascherina-se-faccio-fatica-a-respirare]]></loc><lastmod>2020-04-24T15:54:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15990-sono-un-medico-affetto-da-covid-19-essendo-ancora-positivo-dopo-40-giorni-il-virus-puo-essersi-cronicizzato]]></loc><lastmod>2020-04-24T15:51:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15973-covid-19-con-il-certificato-di-astensione-dal-lavoro-l-assenza-e-computata-ai-fini-del-comporto-ci-sono-trattenute]]></loc><lastmod>2020-04-20T11:42:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15972-sono-immunodepressa-perche-la-mia-azienda-non-mi-riconosce-il-certificato-v07]]></loc><lastmod>2020-04-20T11:39:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15971-in-caso-di-soggetto-positivo-a-covid-19-il-condominio-viene-avvisato-e-da-chi]]></loc><lastmod>2020-04-20T11:27:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15970-covid-19-come-mai-sono-stati-esclusi-dal-diritto-di-restare-a-casa-i-cardiopatici]]></loc><lastmod>2020-04-20T11:23:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15955-coronavirus-posso-usufruire-di-congedo-lavorativo-per-valvulopatia-congenita-e-cardiopatia-cronica]]></loc><lastmod>2020-04-14T15:22:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15954-coronavirus-la-sindrome-di-brugada-comporta-un-maggior-rischio]]></loc><lastmod>2020-04-14T15:06:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15953-covid-19-sono-affetto-da-asma-posso-usufruire-del-codice-v07]]></loc><lastmod>2020-04-14T14:10:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15952-covid-19-la-fibrosi-da-psittacosi-comporta-un-maggior-rischio]]></loc><lastmod>2020-04-14T13:41:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15951-coronavirus-con-sindrome-di-moskowitz-e-sindrome-emolitico-uremica-si-e-considerati-immunodepressi]]></loc><lastmod>2020-04-14T13:12:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15894-la-mia-compagna-soffre-di-asma-e-opportuno-che-mi-isoli-per-non-contagiarla-in-caso-di-covid-19]]></loc><lastmod>2020-04-01T11:28:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15893-soffro-di-apnea-notturna-sono-a-rischio-in-caso-di-contagio-da-covid-19-devo-astenermi-dal-lavoro]]></loc><lastmod>2020-04-01T11:23:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15892-soffro-di-ipf-e-sono-in-cura-con-esbriet-il-coronavirus-potrebbe-essermi-fatale]]></loc><lastmod>2020-04-01T10:57:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15891-il-medico-di-famiglia-opta-per-il-certificato-medico-dell-inps-e-sono-in-cassa-integrazione-cosa-fare]]></loc><lastmod>2020-04-01T10:45:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15890-sono-affetto-da-una-malattia-rara-sottoposto-a-terapia-immunosoppressiva-l-assenza-dal-lavoro-rientra-nel-periodo-di-malattia]]></loc><lastmod>2020-04-01T10:32:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15889-ho-una-malattia-cronica-come-procedere-per-il-certificato-d-astensione-al-lavoro]]></loc><lastmod>2020-04-04T15:19:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15882-per-usufruire-del-decreto-cura-italia-e-adeguata-la-procedura-attraverso-il-medico-di-famiglia]]></loc><lastmod>2020-03-31T11:12:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15881-sono-affetta-da-sindrome-di-kartagener-posso-usufruire-del-decreto-cura-italia-a-chi-rivolgermi]]></loc><lastmod>2020-03-31T11:06:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15880-usufruisco-del-decreto-cura-italia-ma-se-l-azienda-va-in-cassa-integrazione-che-succede]]></loc><lastmod>2020-03-31T11:06:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15879-ho-una-patologia-cronica-autoimmune-posso-usufruire-del-decreto-cura-italia]]></loc><lastmod>2020-03-31T10:58:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15869-morbo-di-wilson-e-lupus-eritematoso-sono-piu-a-rischio-di-complicazioni]]></loc><lastmod>2020-03-30T16:08:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15859-che-tipo-di-medicinali-bisogna-prendere-per-curare-questa-malattia-quali-medicinali-invece-non-servono]]></loc><lastmod>2020-03-26T14:42:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15858-quali-sono-le-possibili-complicazioni-e-pericoli-di-prendere-il-coronavirus]]></loc><lastmod>2020-03-26T14:40:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15857-ho-la-neurofibromatosi-di-tipo-1-ho-un-rischio-maggiore-di-contrarre-il-coronavirus]]></loc><lastmod>2020-03-26T14:37:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15856-coronavirus-ho-sclerosi-multipla-e-lupus-posso-chiedere-congedo-lavorativo]]></loc><lastmod>2020-03-25T17:58:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15855-coronavirus-con-invalidita-per-neoplasia-cerebrale-posso-usufruire-di-smart-working]]></loc><lastmod>2020-03-25T17:37:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15854-coronavirus-e-asma-esiste-congedo-dal-lavoro]]></loc><lastmod>2020-03-25T17:18:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15853-coronavirus-con-un-malato-cronico-in-famiglia-posso-usufruire-di-lavoro-flessibile]]></loc><lastmod>2020-03-25T16:50:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15852-coronavirus-e-diabete-di-tipo-1-posso-usufruire-di-congedo-dal-lavoro]]></loc><lastmod>2020-03-25T16:39:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15851-coronavirus-e-colangite-biliare-primitiva-previsto-congedo-lavorativo]]></loc><lastmod>2020-03-25T15:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15848-sono-affetto-da-polimiosite-in-terapia-immunosoppressiva-sono-soggetto-a-rischio-coronavirus]]></loc><lastmod>2020-03-25T13:17:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15846-sono-affetta-da-piastrinopenia-idiopatica-autoimmune-sono-un-soggetto-a-rischio]]></loc><lastmod>2020-03-25T13:18:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15845-malattia-di-von-willebrand-quali-rischi-in-caso-di-contagio-covid-19]]></loc><lastmod>2020-03-25T12:17:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15844-medico-microcitemico-con-linfociti-e-globuli-bianchi-anomali-sono-piu-a-rischio-covid-19]]></loc><lastmod>2020-03-25T12:19:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15836-coronavirus-con-quali-patologie-si-puo-ottenere-congedo-lavorativo]]></loc><lastmod>2020-03-24T17:00:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15835-coronavirus-e-sjogren-ho-febbre-e-tosse-e-lavoro-in-rsa-cosa-devo-fare]]></loc><lastmod>2020-03-24T16:17:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15834-coronavirus-e-ischemia-previsto-congedo-lavorativo-per-prevenzione-contagio]]></loc><lastmod>2020-03-24T15:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15833-coronavirus-e-policitemia-vera-oltre-al-medico-curante-chi-puo-emettere-certificato-di-rischio]]></loc><lastmod>2020-03-24T15:07:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15832-coronavirus-esiste-congedo-lavorativo-per-cardiopatia]]></loc><lastmod>2020-03-24T14:49:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15831-coronavirus-e-immunodepressione-essendo-gia-in-congedo-lavorativo-mi-occorre-comunque-certificato-con-codice-v07]]></loc><lastmod>2024-10-09T18:13:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15830-coronavirus-quali-tutele-per-chi-soffre-di-malattie-croniche]]></loc><lastmod>2020-03-24T14:11:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15829-coronavirus-come-comportarsi-nei-confronti-delle-terapie-con-immunosoppressori-e-immunoglobuline]]></loc><lastmod>2020-03-25T12:21:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15828-febbre-mediterranea-familiare-la-colchicina-puo-dare-complicanze]]></loc><lastmod>2020-03-25T12:21:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15827-displasia-di-mondini-ed-eva-il-coronavirus-puo-dare-effetti-piu-gravi-sui-pazienti]]></loc><lastmod>2020-03-25T12:33:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15825-sindrome-di-klinefelter-e-celiachia-si-e-piu-a-rischio-di-contrarre-il-covid-19]]></loc><lastmod>2020-03-24T13:50:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15824-malattia-di-still-la-terapia-farmacologica-puo-esporre-maggiormente-al-coronavirus]]></loc><lastmod>2020-03-25T12:34:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15820-coronavirus-e-timoma-per-il-ricovero-fiduciario-devo-inviare-certificato-di-malattia-all-inps]]></loc><lastmod>2020-03-23T19:43:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15819-coronavirus-e-immunodepressione-chi-attesta-la-certificazione-di-rischio-di-contagio]]></loc><lastmod>2024-10-09T18:14:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15817-coronavirus-e-disabilita-usufruendo-della-legge-104-come-ottengo-permessi-aggiuntivi]]></loc><lastmod>2020-03-23T18:56:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15814-coronavirus-sono-paziente-oncologica-come-usufruisco-di-quanto-previsto-da-decreto-cura-italia]]></loc><lastmod>2020-03-23T18:34:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15808-coronavirus-ho-la-sarcoidosi-e-sono-in-terapia-con-cortisone-sono-piu-a-rischio]]></loc><lastmod>2020-03-23T18:01:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15807-soffro-di-asma-allergica-sono-soggetto-piu-a-rischio-se-prendo-il-coronavirus]]></loc><lastmod>2020-03-23T18:01:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15806-coronavirus-e-fibrosi-cistica-quali-rischi-e-meglio-evitare-una-gravidanza]]></loc><lastmod>2020-03-23T18:02:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15805-coronavirus-e-arnold-chiari-come-si-ottiene-un-periodo-di-estensione-dal-lavoro]]></loc><lastmod>2020-03-19T22:43:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15804-coronavirus-sono-malata-oncologica-chi-puo-attestare-la-mia-immunodepressione-per-congedo-lavorativo]]></loc><lastmod>2020-03-19T19:20:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15803-coronavirus-sono-invalida-e-soffro-di-problemi-immunitari-cosa-devo-fare-per-non-recarmi-al-lavoro]]></loc><lastmod>2024-10-09T18:18:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15802-coronavirus-essendo-invalida-posso-usare-i-giorni-riservati-alle-cure-per-non-andare-al-lavoro]]></loc><lastmod>2020-03-19T18:54:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15801-coronavirus-quali-possibilita-di-congedo-lavorativo-per-pazienti-con-diabete]]></loc><lastmod>2020-03-19T18:42:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15800-coronavirus-prendendo-immunosoppressori-devo-ricorrerere-alle-ferie-per-non-andare-al-lavoro]]></loc><lastmod>2020-03-19T18:29:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15799-coronavirus-di-quale-congedo-lavorativo-posso-usufruire-avendo-avuto-un-inarto]]></loc><lastmod>2020-03-19T18:13:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15798-coronavirus-esiste-congedo-lavorativo-per-paziente-con-sindrome-di-brugada]]></loc><lastmod>2020-03-19T17:59:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15797-coronavirus-quale-congedo-lavorativo-per-cardiopatico-in-attesa-di-trapianto]]></loc><lastmod>2020-03-19T17:47:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15796-coronavirus-ho-la-sindrome-crest-chi-puo-certificarmi-l-assenza-dal-lavoro]]></loc><lastmod>2020-03-19T17:22:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15795-coronavirus-vi-sono-congedi-per]]></loc><lastmod>2020-03-19T16:54:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15794-coronavirus-quali-tutele-per-i-pazienti-con-fibroelastosi-pleuroparenchimale-idiopatica]]></loc><lastmod>2020-03-19T17:00:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15793-coronavirus-reduci-da-guillain-barre-hanno-diritto-a-congedo-lavorativo]]></loc><lastmod>2020-03-19T17:00:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15792-coronavirus-superata-la-fase-d-emergenza-quando-un-paziente-a-rischio-potra-uscire-in-sicurezza]]></loc><lastmod>2020-03-19T12:07:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15790-coronavirus-come-comportarsi-se-un-condomino-e-risultato-positivo]]></loc><lastmod>2020-03-19T12:04:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15789-coronavirus-i-pazienti-affetti-da-miastenia-gravis-sono-piu-a-rischio]]></loc><lastmod>2020-03-19T12:02:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15788-coronavirus-e-sindrome-della-bocca-urente-sono-piu-a-rischio]]></loc><lastmod>2020-03-18T18:00:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15787-coronavirus-chi-e-affetto-da-epatite-autoimmune-potrebbe-essere-maggiormente-a-rischio]]></loc><lastmod>2020-03-18T17:49:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15786-coronavirus-chi-e-affetto-da-glut1-corre-rischi-maggiori]]></loc><lastmod>2020-03-18T17:38:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15785-coronavirus-da-sospendere-la-terapia-per-sclerosi-sistemica]]></loc><lastmod>2020-03-18T16:57:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15784-coronavirus-e-psoriasi-bisogna-prendere-precauzioni-in-piu]]></loc><lastmod>2020-03-18T10:49:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15783-coronavirus-e-granulamatosi-con-poliangioite-quali-rischi]]></loc><lastmod>2020-03-18T18:12:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15782-coronavirus-chi-e-portatore-di-mutazione-di-un-fattore-della-coagulazione-e-piu-a-rischio]]></loc><lastmod>2020-03-18T10:42:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15779-coronavirus-chi-e-affetto-da-malattia-di-cogan-e-piu-a-rischio]]></loc><lastmod>2020-03-17T12:07:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15778-coronavirus-ho-sono-affetta-da-pemfigoide-bolloso-cosa-fare-con-il-lavoro]]></loc><lastmod>2020-03-17T17:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15777-coronavirus-chi-e-affetto-da-sindrome-di-barre-non-e-maggiormente-a-rischio]]></loc><lastmod>2020-03-18T09:07:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15776-coronavirus-piu-a-rischio-i-pazienti-con-atresia-esofagea]]></loc><lastmod>2020-03-17T11:25:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15767-coronavirus-la-sindrome-di-sjogren-comporta-rischi-maggiori]]></loc><lastmod>2020-03-16T10:57:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15757-coronavirus-sono-invalido-civile-esiste-un-congedo]]></loc><lastmod>2020-03-16T10:53:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15756-coronavirus-e-sindrome-di-verneuil-ho-diritto-ad-astenermi-dal-lavoro]]></loc><lastmod>2020-03-13T17:45:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattie-rare-e-coronavirus/15754-coronavirus-esiste-qualche-forma-di-congedo-dal-lavoro-per-persone-con-invalidita-o-malattie-croniche]]></loc><lastmod>2020-03-12T15:46:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/emofilia]]></loc><lastmod>2022-09-05T15:35:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/emofilia/16594-emofilia-a-maggiori-rischi-con-il-covid-19-meglio-chiedere-la-didattica-a-distanza]]></loc><lastmod>2020-10-20T11:06:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/emofilia/16593-mio-figlio-e-affetto-da-emofilia-quante-volte-devo-fare-controllare-le-articolazioni]]></loc><lastmod>2020-10-20T11:02:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/malattia-di-gaucher]]></loc><lastmod>2023-05-26T17:37:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/amiloidosi]]></loc><lastmod>2023-05-26T17:49:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/amiloidosi/16940-amiloidosi-e-ipotensione-cosa-fare]]></loc><lastmod>2021-01-27T12:19:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/amiloidosi/16844-quale-farmaco-costituisce-la-scelta-migliore-per-trattare-l-amiloidosi-hattr]]></loc><lastmod>2021-01-27T12:19:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/amiloidosi/16843-amiloidosi-quali-cure-disponibili-come-ottenere-il-rimborso-dal-snn]]></loc><lastmod>2021-01-27T12:19:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/miastenia-grave]]></loc><lastmod>2026-01-12T15:55:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/miastenia-grave/16932-miastenia-e-covid-19-si-puo-fare-il-vaccino]]></loc><lastmod>2021-01-27T12:12:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/leucodistrofia-metacromatica]]></loc><lastmod>2024-03-25T11:57:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/deficit-di-piruvato-chinasi]]></loc><lastmod>2023-06-06T09:47:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/espertorisponde/deficit-di-piruvato-chinasi/19427-deficit-di-piruvato-chinasi-e-gia-possibile-accedere-al-farmaco-mitapivat]]></loc><lastmod>2022-12-28T11:44:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/20547-come-incidono-permessi-e-congedi-per-assistenza-sul-calcolo-di-tredicesima]]></loc><lastmod>2024-01-22T18:39:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/20491-congedo-straordinario-per-assistenza-e-permessi-104-sono-compatibili]]></loc><lastmod>2024-01-08T12:15:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/20261-indennita-di-accompagnamento-quando-continua-a-essere-erogata-anche-durante-un-ricovero]]></loc><lastmod>2023-10-26T17:19:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/20240-smart-working-per-il-lavoratore-fragile-fino-a-dicembre-2023]]></loc><lastmod>2023-10-18T08:49:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/19631-assegni-e-pensione-legati-all-invalidita-quali-sono-le-differenze]]></loc><lastmod>2023-03-14T16:52:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/19453-lavoratori-con-disabilita-come-funziona-il-congedo-per-cure]]></loc><lastmod>2023-02-20T15:54:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/19441-malattie-rare-e-periodo-di-comporto-quanti-sono-giorni-di-assenza-giustificata-per-malattia]]></loc><lastmod>2023-01-11T15:13:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/19410-online-la-guida-tutti-i-diritti-dei-talassemici-dedicata-a-pazienti-e-caregiver]]></loc><lastmod>2022-12-22T12:23:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18632-emergenza-ucraina-le-misure-di-accoglienza-previste-dal-friuli-venezia-giulia]]></loc><lastmod>2022-05-10T17:03:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18581-emergenza-ucraina-le-misure-di-accoglienza-previste-dalla-calabria]]></loc><lastmod>2022-04-27T12:52:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18580-emergenza-ucraina-le-misure-di-accoglienza-previste-dalla-basilicata]]></loc><lastmod>2022-04-27T10:46:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18512-emergenza-ucraina-le-misure-sanitarie-dell-accoglienza-il-dossier-di-omar]]></loc><lastmod>2022-05-10T17:05:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18487-emergenza-ucraina-le-misure-di-accoglienza-previste-dalla-puglia]]></loc><lastmod>2022-04-04T07:33:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18486-emergenza-ucraina-le-misure-di-accoglienza-previste-dal-piemonte]]></loc><lastmod>2022-04-04T07:33:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18484-emergenza-ucraina-le-misure-di-accoglienza-previste-dalla-valle-d-aosta]]></loc><lastmod>2022-04-04T07:33:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18483-emergenza-ucraina-le-misure-di-accoglienza-previste-dall-umbria]]></loc><lastmod>2022-04-04T07:33:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18482-emergenza-ucraina-le-misure-di-accoglienza-previste-dal-trentino-alto-adige]]></loc><lastmod>2022-04-04T07:33:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18480-emergenza-ucraina-le-misure-di-accoglienza-previste-dalla-liguria]]></loc><lastmod>2022-04-04T07:33:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18479-emergenza-ucraina-le-misure-di-accoglienza-previste-dall-emilia-romagna]]></loc><lastmod>2022-04-04T07:33:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18478-emergenza-ucraina-le-misure-di-accoglienza-previste-dall-abruzzo]]></loc><lastmod>2022-04-04T07:33:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18469-emergenza-ucraina-le-misure-di-accoglienza-previste-dalla-toscana]]></loc><lastmod>2022-04-04T07:33:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18468-emergenza-ucraina-le-misure-di-accoglienza-previste-dal-lazio]]></loc><lastmod>2022-04-04T07:54:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18467-emergenza-ucraina-le-misure-di-accoglienza-previste-dalla-lombardia]]></loc><lastmod>2022-04-04T07:33:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18466-emergenza-ucraina-le-misure-di-accoglienza-previste-dal-veneto]]></loc><lastmod>2022-04-04T07:34:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18301-quali-sono-le-misure-legate-al-covid-in-vigore-per-i-lavoratori-fragili]]></loc><lastmod>2022-03-14T14:14:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18281-reddito-di-cittadinanza-e-invalidita-civile-sono-compatibili]]></loc><lastmod>2022-02-10T16:21:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18023-disabilita-il-progetto-individualizzato-per-la-vita-indipendente]]></loc><lastmod>2021-11-21T21:59:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/18022-come-si-realizza-il-progetto-individualizzato-per-la-vita-indipendente-l-esperienza-di-claudia]]></loc><lastmod>2021-11-21T22:00:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/17940-inclusione-scolastica-la-denuncia-di-nicolo-voglio-andare-a-scuola-con-i-miei-compagni-sullo-scuolabus]]></loc><lastmod>2021-10-26T12:47:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/17885-lea-ancora-troppe-prestazioni-negate-ai-malati-rari-il-caso-della-crigler-najjar-e-il-mancato-accesso-al-bonus-energia]]></loc><lastmod>2021-10-15T14:53:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/17579-disabili-e-caregiver-la-scelta-della-sede-di-lavoro-e-diritto-a-non-essere-trasferiti]]></loc><lastmod>2021-06-25T12:59:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/17440-licenziata-paziente-con-fibrosi-cistica-mentre-era-in-coma-in-seguito-a-trapianto-polmonare]]></loc><lastmod>2021-05-16T11:48:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/17258-epilessia-farmacoresistente-la-denuncia-troppi-i-diritti-negati-a-causa-della-scarsa-conoscenza]]></loc><lastmod>2021-04-06T08:58:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/17249-disabilita-e-covid-congedi-e-smart-working-alternativi-ledono-il-diritto-dei-piu-fragili-e-delle-loro-famiglie]]></loc><lastmod>2021-06-16T09:48:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/17215-assegno-per-il-nucleo-familiare-come-funziona-a-chi-spetta-e-come-fare-domanda]]></loc><lastmod>2021-12-09T15:33:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/17073-lavoro-posso-chiedere-la-trasformazione-del-contratto-di-lavoro-full-time-in-contratto-di-lavoro-part-time]]></loc><lastmod>2021-12-09T16:03:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/17072-ape-sociale-cos-e-chi-puo-farne-richiesta-dell-anticipo-pensionistico-e-con-quali-modalita]]></loc><lastmod>2026-01-15T16:28:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/17031-invalidita-e-prepensionamento-cosa-prevede-la-legge]]></loc><lastmod>2022-03-31T15:22:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/16974-caregiver-familiari-lavoratori-a-tempo-pieno-invisibili-a-tutti]]></loc><lastmod>2021-02-08T21:03:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/16884-indennita-di-frequenza-per-i-minori-e-compatibile-con-l-assegno-di-mantenimento]]></loc><lastmod>2021-01-20T12:55:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/16883-pensione-di-invalidita-civile-e-assegno-di-mantenimento-sono-compatibili]]></loc><lastmod>2021-01-15T09:56:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/16504-covid-docenti-e-personale-ata-chi-ha-patologie-a-rischio-puo-essere-esonerato]]></loc><lastmod>2020-09-28T18:06:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/16164-decreto-rilancio-la-guida-gratuita-del-ministero-per-lavoratori-e-famiglie]]></loc><lastmod>2020-07-29T11:20:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/16121-o-una-malattia-rara-sono-considerato-a-rischio-covid-19-posso-assentarmi-dal-lavoro]]></loc><lastmod>2022-01-13T10:55:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/14705-assegno-ordinario-d-invalidita-che-cos-e-e-chi-puo-chiederlo]]></loc><lastmod>2020-11-16T14:25:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/14674-caregiver-familiare-l-innalzamento-di-un-fondo-che-non-puo-essere-destinato-a-nessuno]]></loc><lastmod>2019-06-25T13:25:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/14632-sindrome-di-williams-stop-alla-revisione-annuale-per-invalidita-civile-e-legge-104]]></loc><lastmod>2019-06-25T13:25:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/14520-malattie-rare-una-risoluzione-parlamentare-il-ministro-riconosca-i-diritti-dei-pazienti]]></loc><lastmod>2019-06-25T13:25:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/14494-reddito-di-cittadinanza-malattie-rare-e-disabilita-e-davvero-un-aiuto-alle-famiglie]]></loc><lastmod>2019-06-25T13:25:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/14437-malattie-rare-stop-agli-extra-lea-i-pazienti-potrebbero-subire-discriminazioni]]></loc><lastmod>2022-05-24T16:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/13979-deficit-di-cobalamina-c-per-i-piccoli-pazienti-le-iniezioni-sono-un-incubo-si-lotta-per-ridurle]]></loc><lastmod>2019-06-25T13:25:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/13271-pma-e-diagnosi-genetica-preimpianto-per-i-portatori-di-malattie-rare-genetiche-e-davvero-un-diritto]]></loc><lastmod>2019-06-25T13:25:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/13274-malattie-rare-e-trasferimento-all-estero-quali-diritti-alle-cure-e-accesso-ai-farmaci]]></loc><lastmod>2019-06-25T13:25:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/13262-sportello-legale-omar-una-rubrica-di-consulenza-legale-a-disposizione-dei-malati-rari]]></loc><lastmod>2020-10-08T12:58:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/13257-contatta-lo-sportello-legale-di-osservatorio-malattie-rare]]></loc><lastmod>2019-06-25T13:25:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/13176-ilaria-vacca-e-roberta-venturi]]></loc><lastmod>2020-10-08T12:58:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/sportello-legale-omar-dalla-parte-dei-rari/13149-altro-titolo-dell-articolo-h2]]></loc><lastmod>2019-06-25T13:25:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10627-ipf-i-centri-dell-abruzzo-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-05-18T14:53:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10631-ipf-i-centri-della-basilicata-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-07-04T16:48:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10632-ipf-i-centri-della-calabria-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-09-02T13:22:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10630-ipf-i-centri-della-campania-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-05-18T14:43:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10623-ipf-i-centri-dell-emilia-romagna-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-01-11T16:31:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10606-ipf-i-centri-del-friuli-venezia-giulia-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-01-11T16:03:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10626-ipf-i-centri-del-lazio-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-05-18T14:00:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10621-ipf-i-centri-della-liguria-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2021-10-11T17:00:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10618-ipf-i-centri-della-lombardia-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2024-05-30T08:02:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10624-ipf-i-centri-delle-marche-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-01-11T18:50:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10628-ipf-i-centri-del-molise-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-05-18T14:55:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10620-ipf-i-centri-del-piemonte-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2021-10-11T17:14:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10629-ipf-i-centri-della-puglia-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-05-18T16:27:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10634-ipf-i-centri-della-sardegna-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-07-06T14:12:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10633-ipf-i-centri-della-sicilia-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-07-04T17:25:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10622-ipf-i-centri-della-toscana-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-01-11T17:52:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10617-ipf-i-centri-del-trentino-alto-adige-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-01-11T15:51:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10625-ipf-i-centri-dell-umbria-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-01-11T19:13:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10619-ipf-i-centri-della-valle-d-aosta-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2021-10-11T17:15:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/ipf-guida-ai-centri-italiani-per-la-fibrosi-polmonare-idiopatica/10616-ipf-i-centri-del-veneto-per-la-fibrosi-polmonare-idiopatica]]></loc><lastmod>2022-01-11T15:45:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/20342-psoriasi-pustolosa-generalizzata-i-centri-dell-abruzzo]]></loc><lastmod>2025-06-24T08:31:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/20852-psoriasi-pustolosa-generalizzata-i-centri-della-basilicata]]></loc><lastmod>2025-06-24T08:33:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/20920-psoriasi-pustolosa-generalizzata-i-centri-della-calabria]]></loc><lastmod>2025-06-24T08:34:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/19458-psoriasi-pustolosa-generalizzata-i-centri-della-campania]]></loc><lastmod>2025-06-24T08:36:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/19459-psoriasi-pustolosa-generalizzata-i-centri-dell-emilia-romagna]]></loc><lastmod>2025-06-24T08:38:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/20854-psoriasi-pustolosa-generalizzata-i-centri-del-friuli-venezia-giulia]]></loc><lastmod>2025-06-24T08:41:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/19460-psoriasi-pustolosa-generalizzata-i-centri-del-lazio]]></loc><lastmod>2025-06-24T08:42:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/19461-psoriasi-pustolosa-generalizzata-i-centri-della-liguria]]></loc><lastmod>2025-06-24T08:43:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/19462-psoriasi-pustolosa-generalizzata-i-centri-della-lombardia]]></loc><lastmod>2025-06-24T08:44:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/20343-psoriasi-pustolosa-generalizzata-i-centri-delle-marche]]></loc><lastmod>2025-06-24T08:45:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/19463-psoriasi-pustolosa-generalizzata-i-centri-del-piemonte]]></loc><lastmod>2025-06-24T08:50:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/19464-psoriasi-pustolosa-generalizzata-i-centri-della-puglia]]></loc><lastmod>2025-06-24T08:54:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/20344-psoriasi-pustolosa-generalizzata-i-centri-della-sardegna]]></loc><lastmod>2025-06-24T08:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/20345-psoriasi-pustolosa-generalizzata-i-centri-della-sicilia]]></loc><lastmod>2025-06-24T09:00:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/19465-psoriasi-pustolosa-generalizzata-i-centri-della-toscana]]></loc><lastmod>2025-06-24T09:01:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/20853-psoriasi-pustolosa-generalizzata-i-centri-del-trentino-alto-adige]]></loc><lastmod>2025-06-24T09:02:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/20851-psoriasi-pustolosa-generalizzata-i-centri-dell-umbria]]></loc><lastmod>2025-09-22T18:09:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/20850-psoriasi-pustolosa-generalizzata-i-centri-della-valle-d-aosta]]></loc><lastmod>2025-06-24T09:04:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/psoriasi-pustolosa-generalizzata-guida-ai-centri-italiani/19466-psoriasi-pustolosa-generalizzata-i-centri-del-veneto]]></loc><lastmod>2025-06-24T09:07:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17012-rachitismo-ipofosfatemico-i-centri-di-riferimento-dell-abruzzo]]></loc><lastmod>2021-07-08T18:32:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17011-rachitismo-ipofosfatemico-i-centri-di-riferimento-della-calabria]]></loc><lastmod>2021-07-08T18:33:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17010-rachitismo-ipofosfatemico-i-centri-di-riferimento-della-campania]]></loc><lastmod>2021-07-19T14:08:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17009-rachitismo-ipofosfatemico-i-centri-di-riferimento-dell-emilia-romagna]]></loc><lastmod>2021-07-08T18:34:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17008-rachitismo-ipofosfatemico-i-centri-di-riferimento-del-friuli-venezia-giulia]]></loc><lastmod>2021-07-08T18:35:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17007-rachitismo-ipofosfatemico-i-centri-di-riferimento-del-lazio]]></loc><lastmod>2021-07-08T18:35:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17006-rachitismo-ipofosfatemico-i-centri-di-riferimento-della-liguria]]></loc><lastmod>2021-07-08T18:36:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17005-rachitismo-ipofosfatemico-i-centri-di-riferimento-della-lombardia]]></loc><lastmod>2021-07-08T18:36:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17004-rachitismo-ipofosfatemico-i-centri-di-riferimento-delle-marche]]></loc><lastmod>2021-07-08T18:38:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17003-rachitismo-ipofosfatemico-i-centri-di-riferimento-del-molise]]></loc><lastmod>2021-07-08T18:37:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17002-rachitismo-ipofosfatemico-i-centri-di-riferimento-di-piemonte-e-valle-d-aosta]]></loc><lastmod>2021-07-08T18:39:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17001-rachitismo-ipofosfatemico-i-centri-di-riferimento-della-puglia]]></loc><lastmod>2022-05-24T16:38:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/17000-rachitismo-ipofosfatemico-i-centri-di-riferimento-della-sardegna]]></loc><lastmod>2021-07-08T18:39:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/16999-rachitismo-ipofosfatemico-i-centri-di-riferimento-della-sicilia]]></loc><lastmod>2021-07-08T18:40:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/16998-rachitismo-ipofosfatemico-i-centri-di-riferimento-della-toscana]]></loc><lastmod>2021-07-08T18:40:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/16997-rachitismo-ipofosfatemico-i-centri-di-riferimento-del-trentino-alto-adige]]></loc><lastmod>2021-07-08T18:41:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/16996-rachitismo-ipofosfatemico-i-centri-di-riferimento-dell-umbria]]></loc><lastmod>2021-07-08T18:41:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/i-nostri-servizi/rachitismo-ipofosfatemico-guida-ai-centri-italiani/16995-rachitismo-ipofosfatemico-i-centri-di-riferimento-del-veneto]]></loc><lastmod>2021-07-08T18:41:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/22461-ipoparatiroidismo-guida-ai-diritti]]></loc><lastmod>2025-10-30T14:18:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/21873-i-bisogni-dei-pazienti-con-malattie-rare-del-complemento-casi-studio-epn-e-c3g]]></loc><lastmod>2025-04-03T08:23:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/21802-screening-per-la-sma-la-responsabilita-di-una-scelta]]></loc><lastmod>2025-03-12T14:00:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/21544-medicina-di-genere-anziano-l-esempio-dell-amiloidosi-cardiaca-il-libro-bianco]]></loc><lastmod>2024-12-02T08:37:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/21072-sclerosi-laterale-amiotrofica-sla-manifesto-sui-bisogni-clinici-insoddisfatti-dei-malati-e-delle-loro-famiglie]]></loc><lastmod>2024-06-11T17:25:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/20462-guida-ai-diritti-esigibili-dei-pazienti-con-amiloidosi-cardiaca]]></loc><lastmod>2023-12-19T14:48:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/20370-progetto-rare-sibling-storia-di-una-rete-che-continua-a-crescere]]></loc><lastmod>2023-11-21T14:50:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/20350-guida-sintetica-ai-diritti-esigibili-dei-pazienti-con-miastenia-gravis]]></loc><lastmod>2023-11-16T10:29:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/19533-quaderno-sne-prospettive-di-estensione-del-panel]]></loc><lastmod>2023-02-15T10:23:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/19407-tutti-i-diritti-dei-talassemici-la-guida-dedicata-a-pazienti-e-caregiver]]></loc><lastmod>2022-12-22T12:09:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/19321-malattie-rare-e-sibling-la-presa-in-carico-della-famiglia-e-un-gioco-di-squadra-basato-sulla-comunicazione]]></loc><lastmod>2022-11-23T15:41:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/18938-nico-e-cosi]]></loc><lastmod>2022-07-21T16:40:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/18619-la-malattia-da-ustione-patologia-rara-orfana-dei-lea]]></loc><lastmod>2022-07-21T16:21:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/18144-quaderno-amytour-pazienti-e-medici-dialogano-sull-amiloidosi]]></loc><lastmod>2021-12-29T19:00:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/18011-miastenia-una-malattia-che-non-si-vede]]></loc><lastmod>2022-06-01T09:43:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/17432-huntington-da-affare-di-famiglia-a-questione-pubblica-il-libro-bianco]]></loc><lastmod>2021-12-29T18:34:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/17366-gli-equilibristi]]></loc><lastmod>2021-12-29T18:36:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/17361-invalidita-civile-e-legge-104-tutti-i-diritti-dei-malati-rari]]></loc><lastmod>2021-04-30T12:21:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/17367-amiloidosi-cardiaca-conoscerla-per-diagnosticarla-in-tempo-e-gestirla-al-meglio]]></loc><lastmod>2021-05-12T13:30:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/17364-il-valore-della-cura-e-dell-assistenza-nell-emofilia]]></loc><lastmod>2021-12-29T18:48:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/17363-sulle-proprie-gambe-racconti-di-xln-e-rachitismo-ipofosfatemico]]></loc><lastmod>2021-12-29T18:40:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/17365-la-mia-storia-e-quella-di-mio-fratello-racconti-di-famiglie-e-di-malattie-rare]]></loc><lastmod>2021-05-07T11:14:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/17362-malattia-polmonare-da-micobatteri-non-tubercolari-una-malattia-orfana-e-rara]]></loc><lastmod>2021-12-29T18:50:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/le-nostre-pubblicazioni/17368-malattie-rare-guida-alle-nuove-esenzioni-edizione-aggiornata]]></loc><lastmod>2021-12-29T18:35:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/21246-cheratite-da-acanthamoeba-approvazione-europea-per-la-poliesanide]]></loc><lastmod>2024-08-30T10:44:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/21121-early-access-programs-eap-ossfor-strumenti-fondamentali-che-necessitano-di-un-aggiornamento]]></loc><lastmod>2024-06-26T10:03:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/20432-farmaci-orfani-italia-seconda-in-europa-con-50-terapie-disponibili-e-tempi-di-immissione-in-commercio-al-di-sopra-della-media-ue]]></loc><lastmod>2023-12-13T09:57:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/19493-farmaci-orfani-130-molecole-autorizzate-da-ema-nel-2021-122-disponibili-in-italia]]></loc><lastmod>2023-01-31T10:21:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/19382-malattie-rare-e-pnrr-opportunita-e-proposte-per-una-digitalizzazione-della-sanita-efficace-ed-equa]]></loc><lastmod>2022-12-12T10:50:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/19117-pnrr-e-malattie-rare-necessario-investire-su-sanita-digitale-e-intelligenza-artificiale]]></loc><lastmod>2022-09-27T11:16:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/18695-malattie-rare-il-6-quaderno-di-ossfor-e-sui-servizi-di-assistenza-domiciliare-integrata]]></loc><lastmod>2022-05-25T17:57:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/18098-v-rapporto-ossfor-l-impatto-della-pandemia-sui-malati-rari]]></loc><lastmod>2021-12-13T11:28:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/18097-malattie-rare-dal-v-rapporto-ossfor-le-proposte-per-l-utilizzo-del-pnrr]]></loc><lastmod>2021-12-13T14:18:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/17780-assistenza-domiciliare-partecipa-all-indagine-online-per-il-miglioramento-del-servizio-a-livello-nazionale]]></loc><lastmod>2021-09-15T10:54:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/17015-malattie-rare-ossfor-presenta-il-riconoscimento-dell-innovativita-per-i-farmaci-orfani]]></loc><lastmod>2021-02-12T10:21:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/16741-malattie-rare-e-farmaci-orfani-presentato-il-4-rapporto-ossfor]]></loc><lastmod>2020-11-27T11:10:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/15740-farmaci-orfani-un-indagine-francese-ne-ha-valutato-l-accessibilita]]></loc><lastmod>2020-03-10T18:48:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/14973-farmaci-orfani-con-la-negoziazione-il-prezzo-cala-del-25]]></loc><lastmod>2019-06-30T10:07:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/14908-farmaci-orfani-il-loro-valore-sta-anche-nella-riduzione-dei-costi-indiretti-delle-malattie-rare]]></loc><lastmod>2019-06-12T13:00:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/14867-riabilitazione-la-sen-binetti-sollecita-chiarimenti-con-un-interrogazione-orale-urgente]]></loc><lastmod>2019-05-30T18:08:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/14776-farmaci-orfani-promuovere-al-piu-presto-tavoli-tecnici-istituzionali-su-hta-dei-piccoli-numeri]]></loc><lastmod>2019-05-07T14:46:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/14771-riabilitazione-i-dubbi-delle-associazioni-dopo-l-incontro-al-ministero-della-salute]]></loc><lastmod>2019-05-30T13:13:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/14406-malattie-rare-sen-binetti-incalzeremo-il-governo-affinche-si-impegni-a-favore-dei-pazienti]]></loc><lastmod>2019-01-30T19:08:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/14379-accesso-ai-fondi-della-legge-326-ecco-le-nuove-modalita-di-accesso]]></loc><lastmod>2019-01-23T10:42:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/14173-farmaci-orfani-cresce-l-offerta-ma-aumenta-la-complessita-gestionale-sul-territorio]]></loc><lastmod>2018-11-20T14:09:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/14119-accesso-ai-farmaci-per-le-malattie-rare-l-italia-e-al-quarto-posto-in-europa]]></loc><lastmod>2018-11-05T19:14:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/14030-farmaci-orfani-settore-in-crescita-ma-le-terapie-soddisfano-solo-il-3-dei-bisogni-dei-pazienti]]></loc><lastmod>2018-11-03T16:17:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/13957-dalla-legge-648-96-al-dialogo-aifa-aziende-le-proposte-di-ossfor-per-agevolare-l-accesso-ai-farmaci-orfani]]></loc><lastmod>2018-09-24T14:15:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/13696-farmaci-orfani-necessario-distinguere-tra-terapie-per-malattie-rare-e-ultra-rare]]></loc><lastmod>2018-06-25T17:40:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/13501-farmaci-orfani-e-piu-difficile-che-siano-approvati-rispetto-ai-medicinali-comuni]]></loc><lastmod>2018-06-25T09:02:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/13413-malattie-rare-e-farmaci-orfani-servono-maggiori-investimenti-la-parola-al-presidente-aifa-stefano-vella]]></loc><lastmod>2018-06-25T09:01:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/13282-27-febbraio-2018-roma-le-malattie-rare-e-la-sfida-per-i-nuovi-modelli-di-ricerca]]></loc><lastmod>2018-02-27T00:23:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/13236-farmaci-orfani-la-proposta-siar-per-un-accesso-rapido-alle-nuove-terapie]]></loc><lastmod>2018-02-14T23:08:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12995-un-anno-di-osservatorio-farmaci-orfani-ossfor-macchia-ora-guardiamo-al-futuro]]></loc><lastmod>2018-02-14T23:10:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12994-rapporto-ossfor-tutti-i-dati-del-primo-anno-di-attivita]]></loc><lastmod>2018-02-14T23:10:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12967-i-rapporto-ossfor-le-malattie-rare-costano-al-ssn-circa-1-2-della-spesa-pubblica-e-in-italia-il-costo-annuo-dei-farmaci-e-tra-i-piu-bassi-d-europa]]></loc><lastmod>2018-02-14T23:11:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12879-malattie-rare-l-alleanza-amr-traccia-la-road-map-per-il-2018]]></loc><lastmod>2018-02-14T23:11:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12828-le-malattie-rare-esempio-della-complessita-e-sfida-per-l-innovazione]]></loc><lastmod>2018-02-14T23:12:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12819-lavorare-per-le-malattie-rare-e-l-innovazione-l-impegno-di-shire]]></loc><lastmod>2017-10-23T16:47:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12816-malattie-rare-che-cos-e-l-hta-dei-piccoli-numeri]]></loc><lastmod>2017-10-23T16:48:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12815-early-acess-programmes-perche-tutelano-i-malati-rari]]></loc><lastmod>2018-09-11T18:02:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12814-nuovi-lea-tutte-le-novita-dedicate-alle-malattie-rare]]></loc><lastmod>2017-10-23T11:15:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12712-ossfor-malattie-rare-un-modello-per-la-medicina-personalizzata]]></loc><lastmod>2018-02-14T23:13:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12705-farmaci-sperimentali-e-orfani-chi-ha-diritto-alla-terapia-spieghiamo-gli-early-access-programmes]]></loc><lastmod>2018-02-14T23:14:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12603-dott-schieppati-cosi-abbiamo-calcolato-i-costi-di-dieci-malattie-rare]]></loc><lastmod>2017-08-30T09:22:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12600-malattie-rare-la-piu-vasta-indagine-europea-sui-costi-e-sulla-qualita-di-vita]]></loc><lastmod>2017-08-24T16:17:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12467-accesso-alle-cure-in-europa-maggiori-difficolta-per-i-malati-rari]]></loc><lastmod>2017-07-06T07:04:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12439-farmaci-ad-uso-compassionevole-le-proposte-di-eurordis]]></loc><lastmod>2017-06-28T18:21:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12384-approvazioni-di-farmaci-orfani-negli-stati-uniti-e-in-europa-ecco-perche-uniformarle]]></loc><lastmod>2017-06-12T16:18:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12266-malattie-rare-e-farmaci-orfani-clinici-pazienti-e-giornalisti-alleati-contro-la-disinformazione]]></loc><lastmod>2017-05-11T14:10:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12264-sma-di-tipo-i-attesa-in-europa-l-approvazione-di-nusinersen]]></loc><lastmod>2017-05-11T07:17:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12156-costi-socio-economici-e-qualita-di-vita-un-analisi-su-dieci-malattie-rare-in-europa]]></loc><lastmod>2017-04-06T16:29:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12093-giovanni-la-via-serve-piu-impegno-per-i-farmaci-pediatrici-da-parte-dell-industria]]></loc><lastmod>2017-03-20T09:53:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12049-farmaci-orfani-macchia-ossfor-bene-scaccabarozzi-contro-falsi-miti-che-danneggiano-pazienti-con-malattie-rare]]></loc><lastmod>2018-02-14T23:15:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12046-ossfor-pubblica-il-proceeding-del-i-incontro-pubblico]]></loc><lastmod>2018-02-14T23:16:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12026-la-figlia-ha-la-sindrome-di-sanfilippo-la-mamma-decide-di-fondare-un-azienda-biotech]]></loc><lastmod>2017-03-05T19:29:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12025-uso-off-label-di-farmaci-orfani-una-risorsa-valida-ma-servono-regole-piu-precise]]></loc><lastmod>2017-03-05T18:59:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12028-prevalenza-in-aumento-per-quattro-neoplasie-ematologiche-in-europa]]></loc><lastmod>2017-03-06T12:02:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/12016-farmaci-ad-uso-pediatrico-il-parlamento-europeo-approva-una-mozione-per-cambiare-il-regolamento]]></loc><lastmod>2017-03-03T19:06:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11910-su-youtube-tutti-gli-interventi-del-i-incontro-pubblico-di-ossfor]]></loc><lastmod>2017-02-13T09:45:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11895-farmaci-orfani-l-accesso-tempestivo-e-un-imperativo-etico]]></loc><lastmod>2017-02-06T14:36:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11894-farmaci-orfani-esiste-un-rapporto-fra-le-raccomandazioni-di-hta-e-il-rimborso]]></loc><lastmod>2017-02-06T11:23:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11896-early-access-sotto-la-lente-di-ossfor-i-programmi-di-accesso-alle-terapie-sperimentali]]></loc><lastmod>2018-02-14T23:16:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11632-farmaci-orfani-perche-la-creazione-di-ossfor]]></loc><lastmod>2018-02-14T23:17:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11630-malattie-rare-e-farmaci-orfani-l-identikit-dei-pazienti-tracciato-da-ossfor]]></loc><lastmod>2018-02-14T23:18:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11631-presentato-su-salus-tg-l-osservatorio-farmaci-orfani-ossfor]]></loc><lastmod>2017-01-26T13:50:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11629-quanto-costa-un-malato-raro-all-anno-la-risposta-da-ossfor]]></loc><lastmod>2018-02-14T23:21:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11628-farmaci-orfani-aifa-disponilbile-al-confronto-con-l-osservatorio-farmaci-orfani]]></loc><lastmod>2018-02-14T23:19:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11627-nasce-ossfor-osservatorio-farmaci-orfani-ecco-di-cosa-si-tratta]]></loc><lastmod>2017-01-26T12:34:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11616-malattie-rare-donna-e-giovane-l-identikit-del-paziente-dalla-prima-ricerca-di-ossfor]]></loc><lastmod>2018-02-14T23:18:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11609-presentata-al-senato-la-prima-ricerca-di-ossfor-l-osservatorio-farmaci-orfani]]></loc><lastmod>2018-02-14T23:20:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/progetti/osservatorio-farmaci-orfani/11586-farmaci-orfani-il-nostro-paese-puo-ancora-permettersi-i-costi-delle-terapie]]></loc><lastmod>2017-01-24T15:17:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22937-mercedes-callori-e-la-nuova-presidente-del-gruppo-les-italiano-odv]]></loc><lastmod>2026-04-15T09:46:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22923-lupus-e-nefrite-lupica-al-via-la-survey-nazionale-promossa-da-apmarr]]></loc><lastmod>2026-04-10T11:04:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22910-sindrome-di-rett-le-associazioni-stanno-reinventando-la-presa-in-carico]]></loc><lastmod>2026-04-04T13:35:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22884-sindrome-di-xia-gibbs-dalla-storia-di-simone-nasce-lassociazione-italiana-dei-pazienti]]></loc><lastmod>2026-03-27T18:48:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22736-piattaforma-nazionale-cude-se-ne-discute-in-parlamento]]></loc><lastmod>2026-02-09T16:58:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22686-lassociazione-la-pluma-blanca-entra-nello-sportello-malattie-rare-di-chieti]]></loc><lastmod>2026-01-23T15:31:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22676-deficit-di-creatina-da-un-appello-solitario-a-una-rete-di-famiglie]]></loc><lastmod>2026-02-12T10:56:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22612-biwy-il-cartone-animato-per-i-piccoli-pazienti-protagonista-al-meeting-europeo-di-ern-ithaca]]></loc><lastmod>2025-12-18T09:40:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22534-piemonte-e-valle-daosta-le-associazioni-delle-malattie-rare-mancano-indicazioni-certe-per-i-pazienti]]></loc><lastmod>2025-11-20T08:54:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22427-reumatologia-al-via-progetto-di-ricerca-su-spondiloartriti-lupus-e-nefrite-lupica]]></loc><lastmod>2025-10-21T12:01:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22410-malattie-reumatologiche-i-pazienti-vanno-coinvolti-per-garantire-equo-accesso-alle-cure]]></loc><lastmod>2025-10-16T10:00:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22318-riforma-della-disabilita-dalle-associazioni-una-lettera-al-ministro-locatelli-perche-riprenda-il-processo-attuativo-della-legge-delega]]></loc><lastmod>2025-09-18T20:59:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22292-disabilita-sensoriali-linclusione-si-fa-anche-camminando-insieme]]></loc><lastmod>2025-09-11T14:45:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22251-malattie-reumatologiche-e-croniche-i-consigli-degli-esperti-per-un-estate-sicura]]></loc><lastmod>2025-08-19T17:52:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22205-sarcoma-epitelioide-da-torino-un-nuovo-progetto-di-ricerca-sostenuto-dalle-associazioni]]></loc><lastmod>2025-07-24T06:54:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22178-porpora-trombotica-trombocitopenica-anptt-gestione-sia-collettiva]]></loc><lastmod>2025-07-22T17:09:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22155-l-alleanza-malattie-rare-compie-8-anni-omar-al-fianco-dei-pazienti-con-rispetto-e-solidarieta]]></loc><lastmod>2025-07-03T17:18:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22156-sindrome-di-sjoegren-primaria-sistemica-una-malattia-invisibile-rara-e-degenerativa]]></loc><lastmod>2025-07-03T17:18:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22120-incontinenza-oltre-5-milioni-di-italiani-colpiti-ma-resta-un-tabu-la-fais-lancia-la-campagna-parliamone]]></loc><lastmod>2025-06-24T10:55:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22107-malattie-reumatologiche-apmarr-conquista-il-premio-eccellenze-in-sanita-2025]]></loc><lastmod>2025-06-18T17:32:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22102-giornata-della-distrofia-facio-scapolo-omerale-il-20-giugno-l-italia-si-illumina-di-arancione]]></loc><lastmod>2025-06-18T07:38:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22054-malattie-reumatologiche-la-presidente-di-apmarr-nominata-cavaliere-al-merito-della-repubblica]]></loc><lastmod>2025-06-05T16:26:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/22029-malattie-ematologiche-rare-dai-diritti-riconosciuti-sulla-carta-alle-difficolta-reali]]></loc><lastmod>2025-05-29T17:16:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21994-malattie-ematologiche-rare-i-pazienti-sollecitano-l-istituzione-della-distribuzione-per-conto-dei-farmaci]]></loc><lastmod>2025-05-16T16:12:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21989-progetto-inpags-una-survey-per-conoscere-le-associazioni]]></loc><lastmod>2025-06-03T13:35:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21978-giornata-mondiale-delle-mps-un-mignolo-per-sensibilizzare-sulle-mucopolisaccaridosi]]></loc><lastmod>2025-05-14T06:53:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21977-infermiere-di-famiglia-e-comunita-si-cerca-un-modello-condiviso]]></loc><lastmod>2025-05-12T16:20:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21929-stelle-ai-piedi-una-battaglia-rara-ma-non-solitaria]]></loc><lastmod>2025-05-05T08:44:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21908-foxg1-la-storia-di-un-padre-di-un-associazione-e-di-una-sindrome-rara-ancora-poco-conosciuta]]></loc><lastmod>2025-04-15T11:56:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21898-malattie-ematologiche-a-ma-r-e-onlus-lancia-il-sondaggio-aiutaci-ad-aiutarti]]></loc><lastmod>2025-05-29T09:36:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21868-sindrome-di-arnold-chiari-aisap-e-punto-di-riferimento-per-le-famiglie]]></loc><lastmod>2025-04-02T15:07:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21846-nessuna-famiglia-deve-sentirsi-sola-la-rete-di-aiuto-per-la-sindrome-di-jacobs]]></loc><lastmod>2025-03-28T08:37:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21783-malattie-reumatologiche-quasi-6-pazienti-su-10-riportano-problemi-nella-relazione-con-il-partner]]></loc><lastmod>2025-03-06T18:45:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21755-malattie-ematologiche-rare-al-via-la-partnership-tra-amare-onlus-e-federazione-united]]></loc><lastmod>2025-02-26T19:23:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21730-paraparesi-spastica-ereditaria-fahn-spg35-una-giornata-per-la-prevenzione-della-malattia]]></loc><lastmod>2025-02-18T13:50:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21717-nasce-aifa-ascolta-il-nuovo-sportello-per-le-associazioni-dei-pazienti]]></loc><lastmod>2025-02-11T13:56:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21670-sindrome-da-fatica-cronica-indetta-la-seconda-edizione-del-concorso-frammenti-di-vita-con-la-cfs-me]]></loc><lastmod>2025-01-31T11:22:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21654-un-delfino-una-farfalla-e-un-coniglietto-tre-favole-per-spiegare-la-sclerosi-sistemica-ai-piu-piccoli]]></loc><lastmod>2025-01-24T15:36:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21660-malattie-neurologiche-rare-sabato-la-prima-tappa-dell-aisap-clinic-itinerante]]></loc><lastmod>2025-01-24T10:41:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21631-sindromi-pans-pandas-la-realta-virtuale-a-supporto-della-terapia-del-dolore-nei-bambini]]></loc><lastmod>2025-01-15T12:35:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21627-audizioni-presso-la-commissione-scientifico-economica-del-farmaco-nuove-modalita-di-richiesta-rese-note-dall-aifa]]></loc><lastmod>2025-01-13T15:10:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21594-sindromi-da-iperaccrescimento-torna-la-farfallina-biwy-per-i-piccoli-pazienti]]></loc><lastmod>2024-12-20T09:26:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21557-giornata-delle-persone-con-disabilita-nicoletti-nessuno-e-escluso-odv-una-azione-concreta-tra-tante-parole-vuote]]></loc><lastmod>2024-12-04T20:22:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21538-endometriosi-sui-nuovi-lea-si-sta-facendo-troppa-disinformazione]]></loc><lastmod>2024-11-29T09:22:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21520-disabilita-e-sessualita-lanciata-la-settima-edizione-del-concorso-sensuability-comics]]></loc><lastmod>2024-12-09T09:45:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21497-vaccinazioni-istituzioni-clinici-e-cittadini-riuniti-per-garantire-la-tutela-dei-piu-fragili]]></loc><lastmod>2024-11-18T17:35:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21423-psoriasi-il-29-ottobre-ricorre-la-giornata-mondiale]]></loc><lastmod>2024-10-28T17:57:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21402-giornata-della-mastocitosi-2024-le-citta-si-illuminano-di-viola]]></loc><lastmod>2024-10-17T14:22:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21308-campania-aperte-le-iscrizioni-al-registro-delle-associazioni-dei-malati-rari]]></loc><lastmod>2024-09-20T08:37:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21309-uno-sguardo-raro-film-festival-c-e-tempo-fino-al-30-settembre-per-partecipare]]></loc><lastmod>2024-09-20T09:28:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21302-sindrome-di-usher-domani-la-nona-giornata-mondiale]]></loc><lastmod>2024-09-19T13:04:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21291-disability-pride-veneto-oltre-600-persone-tra-le-piazze-di-padova-per-celebrare-l-orgoglio-disabile]]></loc><lastmod>2024-09-17T08:40:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21192-oscar-s-angels-l-associazione-che-supporta-le-famiglie-di-bambini-ricoverati-in-ospedale]]></loc><lastmod>2024-07-22T14:58:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21165-disability-pride-month-in-veneto-si-celebra-parlando-di-sessualita-e-progetto-di-vita-live-sui-social]]></loc><lastmod>2024-07-25T08:18:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21155-sindrome-charge-l-ecografia-fetale-puo-consentire-la-diagnosi-prenatale]]></loc><lastmod>2024-07-08T09:55:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21160-all-universita-di-bologna-si-studia-un-triplice-approccio-per-contrastare-il-cancro]]></loc><lastmod>2024-07-09T11:25:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21123-incolimpiadi-nasce-il-primo-game-quiz-dedicato-all-incontinenza]]></loc><lastmod>2024-06-27T17:30:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21114-cataratta-congenita-una-malattia-fortemente-invalidante-non-riconosciuta-come-rara]]></loc><lastmod>2024-06-25T13:43:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21089-malattie-bollose-autoimmuni-il-rischio-piu-grande-e-la-solitudine]]></loc><lastmod>2024-06-18T16:05:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21091-lazio-operativa-la-scheda-malattie-rare-emergenza-smre]]></loc><lastmod>2024-06-18T15:53:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21075-sindrome-di-sjoegren-in-italia-colpisce-circa-20mila-persone]]></loc><lastmod>2024-06-12T15:38:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/21040-sindrome-da-fatica-cronica-amcfs-compie-venti-anni-di-attivita]]></loc><lastmod>2024-06-03T09:41:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20994-sindromi-di-sotos-e-di-malan-nasce-assi-tv]]></loc><lastmod>2024-05-20T11:38:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20976-ittiosi-maggio-e-il-mese-di-sensibilizzazione-sulla-patologia]]></loc><lastmod>2024-05-15T15:02:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20956-festa-della-mamma-i-nostri-bambini-non-ci-sono-piu-ma-noi-siamo-madri-lo-stesso]]></loc><lastmod>2024-05-09T12:58:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20864-sindrome-col4a1-a2-il-12-aprile-e-la-giornata-di-sensibilizzazione]]></loc><lastmod>2024-04-11T10:02:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20826-gnao1-dalle-famiglie-100mila-euro-per-la-ricerca-ma-non-solo]]></loc><lastmod>2024-04-02T14:47:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20822-insonnia-firmato-un-protocollo-d-intesa-tra-rls-italia-e-aipas]]></loc><lastmod>2024-04-01T16:30:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20768-malattia-da-deficit-di-cdkl5-online-il-podcast-raramente-viaggio-intorno-alla-disabilita]]></loc><lastmod>2024-03-21T11:57:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20713-sindromi-da-iperaccrescimento-il-cartone-animato-biwy-arriva-ai-piccoli-pazienti-di-forlimpopoli]]></loc><lastmod>2024-03-05T13:11:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20667-incontinenza-e-stomia-sempre-piu-ricca-la-campagna-di-sensibilizzazione-fais]]></loc><lastmod>2024-02-22T18:15:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20624-sindrome-di-brugada-il-rischio-di-una-morte-improvvisa-la-storia-di-lollo-per-la-giornata-mondiale-delle-cardiopatie-congenite]]></loc><lastmod>2024-02-12T17:53:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20627-morte-cardiaca-improvvisa-50-associazioni-chiedono-la-calendarizzazione-della-proposta-di-legge]]></loc><lastmod>2024-02-13T16:37:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20570-ricerca-sostegno-alle-famiglie-e-sensibilizzazione-ecco-gli-obiettivi-di-nistagmo-italia]]></loc><lastmod>2024-01-29T11:37:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20538-sindrome-di-ondine-da-dieci-anni-l-associazione-aisicc-allevia-l-ansia-dei-genitori]]></loc><lastmod>2024-01-25T08:28:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20531-paraplegia-spastica-7-al-via-un-progetto-di-ricerca-sulla-sintomatologia-oftalmologica]]></loc><lastmod>2024-01-18T19:42:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20490-regione-lombardia-taglia-i-fondi-per-le-disabilita-gravi-e-gravissime-la-preoccupazione-delle-associazioni]]></loc><lastmod>2024-01-08T10:11:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20329-fenilchetonuria-donata-all-ospedale-di-birmingham-la-prestigiosa-medaglia-john-scott]]></loc><lastmod>2023-11-13T10:07:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20324-neurofibromatosi-avviato-il-progetto-famiglie-di-rara-bellezza]]></loc><lastmod>2023-11-15T08:11:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20304-mutazione-del-gene-slc6a1-in-italia-partira-a-breve-la-prima-ricerca-sulla-patologia]]></loc><lastmod>2023-11-17T17:34:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20286-disordini-da-esposizione-fetale-ad-alcol-e-droghe-diaz-racconto-la-mia-storia-di-dolore-per-divulgare-la-prevenzione-di-questi-disturbi]]></loc><lastmod>2023-11-06T10:44:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20257-stomycraft-grande-successo-per-il-gioco-dedicato-ai-bambini-stomizzati]]></loc><lastmod>2023-10-25T08:16:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20256-acondroplasia-oggi-la-giornata-mondiale-per-sensibilizzare-in-italia-i-pazienti-sono-almeno-4mila]]></loc><lastmod>2023-10-24T17:17:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20233-mastocitosi-sistemiche-oggi-la-giornata-internazionale]]></loc><lastmod>2023-10-14T21:13:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20229-ceroidolipofuscinosi-l-associazione-a-ncl-finanzia-progetto-su-modello-preclinico-di-cln8]]></loc><lastmod>2023-10-14T11:58:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20205-sindrome-di-phelan-mcdermid-la-soddisfazione-di-uniphelan-per-le-nuove-linee-guida]]></loc><lastmod>2023-10-08T20:46:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20196-sindromi-pandas-e-pans-prof-ssa-gagliano-non-solo-streptococco-necessaria-piu-attenzione-alla-diagnosi-clinica]]></loc><lastmod>2023-10-06T15:30:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20195-giornata-mondiale-pandas-e-pans-galardini-in-italia-oltre-1-200-casi-certi-ma-e-probabile-una-sottodiagnosi]]></loc><lastmod>2023-10-06T15:33:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20159-giornata-delle-malattie-rare-della-retina-ora-necessario-implementare-la-diagnosi-genetica]]></loc><lastmod>2023-09-28T17:48:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20118-alleanza-malattie-rare-rinnova-la-collaborazione-con-osservatorio-sanita-digitale-e-osservatorio-life-science-innovation-del-politecnico-di-milano]]></loc><lastmod>2023-09-18T18:07:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20070-sclerosi-sistemica-con-ails-non-si-ferma-la-lotta-alla-malattia]]></loc><lastmod>2023-08-28T13:17:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20069-maniblu-raccontare-la-sclerosi-sistemica-con-un-fumetto]]></loc><lastmod>2023-08-22T10:25:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20065-malattie-rare-siglato-accordo-tra-associazione-as-ma-ra-e-federazione-nazionale-tsrm-e-pstrp]]></loc><lastmod>2023-08-22T10:57:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20031-malattie-respiratorie-grande-successo-per-la-cena-del-respiro-2023-di-ammp]]></loc><lastmod>2023-07-24T10:08:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20005-cardiopatie-congenite-tante-malattie-un-unica-associazione]]></loc><lastmod>2023-07-17T08:48:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/20006-disabilita-c-e-anche-se-non-la-vedi-la-campagna-di-aicca-sulle-problematiche-di-salute-invisibili-agli-occhi]]></loc><lastmod>2023-07-17T08:47:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19956-incontinenza-e-stomia-da-oltre-20-anni-la-fais-rappresenta-le-associazioni-italiane-dei-pazienti]]></loc><lastmod>2023-06-27T15:55:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19957-incontinenza-e-stomia-la-campagna-siamo-un-opera-d-arte-abbatte-i-pregiudizi]]></loc><lastmod>2023-06-28T09:12:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19922-malattie-rare-online-un-questionario-per-valutare-le-difficolta-dei-pazienti-nell-accesso-a-sport-e-attivita-fisica]]></loc><lastmod>2023-06-19T17:27:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19905-macrodattilia-e-sindromi-pros-i-pazienti-italiani-possono-contare-sull-aimp]]></loc><lastmod>2023-06-16T13:30:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19889-inclusione-scolastica-da-associazione-cimadori-alcune-proposte-per-migliorare-l-accoglienza-dei-ragazzi-con-autismo]]></loc><lastmod>2023-06-14T10:46:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19895-sla-dall-associazione-viva-la-vita-uno-spazio-virtuale-dedicato-ai-caregiver]]></loc><lastmod>2023-06-12T18:01:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19853-asal-l-associazione-per-la-sindrome-di-alport-che-guarda-soprattutto-ai-giovani]]></loc><lastmod>2023-05-31T10:36:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19854-sindrome-di-alport-dall-associazione-asal-un-supporto-psicologico-alle-famiglie]]></loc><lastmod>2023-05-31T15:12:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19816-ittiosi-uno-spot-per-far-conoscere-al-grande-pubblico-questa-rara-patologia-della-pelle]]></loc><lastmod>2023-05-18T16:43:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19781-orchestra-per-la-vita-un-associazione-al-servizio-della-ricerca-scientifica-sul-sarcoma-epitelioide]]></loc><lastmod>2023-05-09T13:09:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19772-fenilchetonuria-per-l-associazione-ape-l-inclusione-si-fa-a-tavola]]></loc><lastmod>2023-05-02T17:26:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19773-malattie-metaboliche-ereditarie-l-educazione-alimentare-inizia-a-scuola]]></loc><lastmod>2023-05-02T17:26:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19704-sindrome-di-prader-willi-in-italia-undici-associazioni-riunite-sotto-un-unica-bandiera]]></loc><lastmod>2023-04-13T11:13:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19705-sindrome-di-prader-willi-necessaria-piu-attenzione-alle-complicanze-psichiatriche]]></loc><lastmod>2023-04-13T17:17:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19714-giornata-nazionale-donazione-organi-il-91-dei-riceventi-sono-malati-rari-percentuale-che-sale-se-si-guarda-ai-soli-minori-di-16-anni]]></loc><lastmod>2024-11-03T10:48:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19675-disabilita-l-alleanza-malattie-rare-alle-istituzioni-occorre-garantire-maggiore-inclusione]]></loc><lastmod>2023-03-31T09:40:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19664-sindrome-col4a1-a2-e-italiana-l-unica-associazione-europea-dei-pazienti]]></loc><lastmod>2023-03-26T21:48:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19665-sindrome-col4a1-a2-presto-una-realta-le-prime-linee-guida-sulla-gestione-della-patologia]]></loc><lastmod>2023-03-26T21:49:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19586-dalla-ricerca-al-supporto-l-impegno-dell-associazione-conslancio-per-le-persone-affette-da-sla]]></loc><lastmod>2023-03-06T17:16:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19587-sla-dall-associazione-conslancio-un-corso-di-formazione-rivolto-a-familiari-e-caregiver]]></loc><lastmod>2023-03-06T07:56:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19496-da-caregiver-a-caregiver-la-onlus-gilo-care-si-prende-cura-di-chi-si-prende-cura]]></loc><lastmod>2023-02-03T20:56:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19495-caregiver-condividere-le-proprie-esperienze-per-vincere-la-solitudine]]></loc><lastmod>2023-02-03T20:55:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19436-sarcoma-epitelioide-a-milano-ora-esiste-l-associazione-mc4-in-corsa-per-la-vita]]></loc><lastmod>2023-01-09T21:34:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19437-sarcoma-epitelioide-le-parole-di-mariagrazia-combattero-la-malattia-per-onorare-il-mio-matteo]]></loc><lastmod>2023-01-09T21:38:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19421-sperimentazioni-cliniche-ecco-come-avere-sul-proprio-sito-un-motore-di-ricerca-in-italiano-e-gratis]]></loc><lastmod>2022-12-27T11:34:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19334-lega-italiana-sclerosi-sistemica-il-nostro-primo-obiettivo-e-promuovere-una-diagnosi-precoce]]></loc><lastmod>2022-12-01T10:14:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19335-sclerosi-sistemica-ho-scoperto-di-avere-la-malattia-grazie-al-progetto-ospedale-aperto]]></loc><lastmod>2022-12-01T10:13:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19299-sindrome-di-beckwith-wiedemann-un-cartone-animato-per-aiutare-i-bambini-ad-affrontare-visite-e-ospedalizzazioni]]></loc><lastmod>2022-11-23T22:14:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19143-sindrome-di-sjoegren-si-chiama-animass-odv-l-associazione-nazionale-dei-pazienti]]></loc><lastmod>2022-10-11T14:34:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19142-sindrome-di-sjoegren-indagine-nazionale-conferma-la-rarita-della-patologia]]></loc><lastmod>2022-10-11T14:32:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19105-sclerosi-laterale-amiotrofica-nel-lazio-viva-la-vita-onlus-supporta-pazienti-e-familiari]]></loc><lastmod>2022-09-26T07:28:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19102-sla-dagli-aperitivi-ai-concerti-viva-la-vita-onlus-si-impegna-ad-esaudire-i-desideri-dei-pazienti]]></loc><lastmod>2022-09-26T07:29:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19073-nessuno-e-escluso-l-associazione-al-servizio-delle-famiglie-che-convivono-con-gravi-disabilita]]></loc><lastmod>2022-09-16T15:10:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19071-scuola-e-disabilita-quando-la-campanella-non-suona-per-tutti]]></loc><lastmod>2022-09-16T15:10:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19037-mutazione-del-gene-iqsec2-le-iniziative-dell-associazione-italiana-per-il-benessere-dei-piccoli-pazienti]]></loc><lastmod>2022-09-09T11:51:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19002-federazione-malattie-rare-infantili-14-associazioni-unite-per-far-sentire-la-propria-voce]]></loc><lastmod>2022-09-01T09:12:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/19001-intersessualita-in-piemonte-se-ne-occupa-la-federazione-malattie-rare-infantili]]></loc><lastmod>2022-09-01T09:10:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18935-charcot-marie-tooth-riunire-supportare-e-informare-i-pazienti-e-la-missione-di-acmt-rete]]></loc><lastmod>2022-07-28T14:55:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18940-charcot-marie-tooth-i-pazienti-incontrano-seri-problemi-nel-vedersi-riconosciuta-l-invalidita]]></loc><lastmod>2022-07-25T13:19:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18886-mutazione-del-gene-nexmif-in-italia-nasce-la-prima-associazione-dei-pazienti]]></loc><lastmod>2023-04-27T13:33:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18885-la-voce-di-diva-la-vita-di-una-bambina-nexmif-nelle-pagine-di-un-libro]]></loc><lastmod>2022-07-04T15:48:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18865-l-alleanza-malattie-rare-festeggia-i-5-anni-di-attivita]]></loc><lastmod>2022-07-04T09:00:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18783-distrofia-facio-scapolo-omerale-dal-2008-l-associazione-fshd-italia-e-al-fianco-dei-pazienti]]></loc><lastmod>2022-06-17T09:39:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18776-distrofia-facio-scapolo-omerale-per-i-pazienti-il-rinnovo-della-patente-e-un-calvario-infinito]]></loc><lastmod>2022-06-17T09:39:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18780-sla-al-via-un-corso-per-caregiver-sulla-gestione-dell-impatto-emotivo-della-malattia]]></loc><lastmod>2022-06-16T16:17:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18758-alopecia-areata-lo-schiaffo-di-will-smith-e-stato-vissuto-dai-pazienti-come-una-rivalsa]]></loc><lastmod>2022-06-14T09:07:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18693-sindrome-di-sanifilippo-in-italia-attiva-l-associazione-sanfilippo-fighters]]></loc><lastmod>2024-04-08T17:33:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18694-sindrome-di-sanfilippo-la-cura-arrivera-una-canzone-per-sostenere-la-ricerca]]></loc><lastmod>2024-04-08T17:32:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18645-lichen-scleroatrofico-in-italia-lisclea-e-l-unica-associazione-che-se-ne-occupa]]></loc><lastmod>2022-05-13T16:54:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18644-storia-di-marta-con-lichen-sclero-atrofico-la-serenita-e-una-conquista]]></loc><lastmod>2022-05-13T16:54:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18583-malattie-rare-non-diagnosticate-per-i-pazienti-italiani-e-attiva-la-fondazione-hopen]]></loc><lastmod>2022-04-27T15:51:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18582-casa-hopen-la-casa-per-i-ragazzi-con-malattie-genetiche-senza-diagnosi]]></loc><lastmod>2022-04-27T15:51:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18568-sla-prendersi-cura-dei-pazienti-significa-anche-migliorare-la-loro-qualita-di-vita]]></loc><lastmod>2022-04-26T16:02:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18371-decreto-tariffe-omar-e-cittadinanzattiva-alle-regioni-aggiornate-subito-i-lea]]></loc><lastmod>2022-04-14T10:28:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18330-decreto-tariffe-il-ritardo-nell-approvazione-e-ormai-inaccettabile]]></loc><lastmod>2022-04-13T07:29:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18329-decreto-tariffe-le-associazioni-basta-attese-si-raggiunga-accordo]]></loc><lastmod>2022-04-13T07:29:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/17826-testo-unico-malattie-rare-approvare-subito-e-prepararsi-ad-alcuni-correttivi-per-il-futuro]]></loc><lastmod>2021-11-30T15:13:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/17370-alleanza-malattie-rare-il-think-net-permanente-al-quale-partecipano-oltre-430-associazioni]]></loc><lastmod>2025-03-14T16:55:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/17299-al-via-alleati-per-crescere-il-corso-di-formazione-promosso-dall-alleanza-malattie-rare-e-da-omar]]></loc><lastmod>2022-03-18T11:45:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/17369-alleanza-malattie-rare-l-elenco-delle-associazioni-aderenti]]></loc><lastmod>2026-03-18T16:27:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/17371-l-alleanza-malattie-rare-si-appella-a-speranza-vaccini-prima-ai-fragili]]></loc><lastmod>2021-05-11T08:07:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/17111-malattie-rare-bisogni-sanitari-ma-non-solo-oggi-l-incontro-con-ministre-di-famiglia-disabilita-e-politiche-giovanili]]></loc><lastmod>2021-05-04T09:49:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/17385-alleanza-malattie-rare-ecco-le-modalita-per-aderire]]></loc><lastmod>2025-01-10T11:00:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/15019-l-alleanza-malattie-rare-alla-maratona-sul-patto-per-la-salute]]></loc><lastmod>2022-03-18T11:45:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/14747-riabilitazione-la-richiesta-di-chiarimento-di-40-associazioni-dell-alleanza-malattie-rare-sui-provvedimenti-del-ministro-della-salute]]></loc><lastmod>2022-03-18T11:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/18429-i-documenti-dell-alleanza-malattie-rare]]></loc><lastmod>2022-03-21T11:41:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/13339-appello-dell-alleanza-malattie-rare-al-futuro-ministero-della-salute-accolto-dalla-senatrice-rizzotti]]></loc><lastmod>2022-03-18T11:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/13303-alleanza-malattie-rare-pubblica-una-lettera-aperta-al-prossimo-ministro-della-salute]]></loc><lastmod>2022-03-18T11:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/12874-alleanza-italiana-malattie-rare-il-primo-incontro-ufficiale]]></loc><lastmod>2022-03-18T11:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/12826-le-malattie-rare-e-la-medicina-personalizzata-alleanza-malattie-rare-per-i-pazienti]]></loc><lastmod>2022-03-18T11:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/12490-nata-l-alleanza-malattie-rare-ecco-le-modalita-per-l-adesione]]></loc><lastmod>2022-03-18T11:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/12471-sen-bianconi-alleanza-per-malattie-rare-ridurra-distanza-tra-societa-civile-e-politica]]></loc><lastmod>2022-03-18T11:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alleanza-malattie-rare/12469-nata-l-alleanza-italiana-per-le-malattie-rare]]></loc><lastmod>2022-03-18T11:44:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/20519-coordinamento-malattie-rare-piemonte-e-valle-d-aosta-un-modello-interregionale-a-beneficio-dei-pazienti]]></loc><lastmod>2024-01-17T09:29:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/19473-coordinamento-malattie-rare-della-campania-nuovi-pdta-molta-formazione-attenzione-ai-cittadini]]></loc><lastmod>2023-06-15T09:05:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/19425-lazio-per-il-coordinamento-malattie-rare-la-parola-d-ordine-e-abbattere-le-diseguaglianze]]></loc><lastmod>2023-06-15T09:05:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18964-friuli-venezia-giulia-parola-chiave-del-coordinamento-malattie-rare-e-fare-rete]]></loc><lastmod>2023-06-15T09:05:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18960-friuli-venezia-giulia-il-coordinamento-regionale-e-aperto-alla-rappresentanza-dei-pazienti]]></loc><lastmod>2022-07-28T09:36:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18959-lombardia-per-i-pazienti-una-rete-regionale-malattie-rare-con-59-presidi-che-ha-prodotto-oltre-120-pdta]]></loc><lastmod>2022-07-28T09:46:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18891-malattie-rare-i-centri-di-coordinamento-regione-per-regione]]></loc><lastmod>2026-02-23T08:30:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18883-centro-di-coordinamento-malattie-rare-umbria]]></loc><lastmod>2026-02-23T12:04:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18882-centro-di-coordinamento-malattie-rare-trento-e-bolzano]]></loc><lastmod>2024-05-08T11:30:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18881-centro-di-coordinamento-malattie-rare-delle-marche]]></loc><lastmod>2025-03-25T11:50:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18880-centro-di-coordinamento-malattie-rare-toscana]]></loc><lastmod>2024-05-08T11:26:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18879-centro-di-coordinamento-malattie-rare-lombardia]]></loc><lastmod>2023-12-11T08:50:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18877-centro-di-coordinamento-malattie-rare-friuli-venezia-giulia]]></loc><lastmod>2024-05-08T11:05:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18849-centro-di-coordinamento-malattie-rare-emilia-romagna]]></loc><lastmod>2024-05-08T12:26:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18845-centro-di-coordinamento-malattie-rare-della-campania]]></loc><lastmod>2024-06-19T07:58:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18844-centro-di-coordinamento-malattie-rare-della-calabria]]></loc><lastmod>2024-05-08T13:15:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18840-centro-di-coordinamento-malattie-rare-della-basilicata]]></loc><lastmod>2024-05-08T11:02:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18825-centro-di-coordinamento-malattie-rare-dell-abruzzo]]></loc><lastmod>2024-05-08T12:27:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18823-centro-di-coordinamento-malattie-rare-della-sicilia]]></loc><lastmod>2024-05-08T11:25:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18822-centro-di-coordinamento-malattie-rare-della-sardegna]]></loc><lastmod>2024-05-08T11:20:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18821-centro-di-coordinamento-malattie-rare-della-puglia]]></loc><lastmod>2024-05-08T11:17:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18820-centro-di-coordinamento-malattie-rare-del-molise]]></loc><lastmod>2024-05-08T11:12:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18818-centro-di-coordinamento-malattie-rare-del-piemonte-e-della-valle-d-aosta]]></loc><lastmod>2024-05-08T11:15:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18817-centro-di-coordinamento-malattie-rare-della-liguria]]></loc><lastmod>2024-05-08T11:11:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18816-centro-di-coordinamento-malattie-rare-del-lazio]]></loc><lastmod>2024-05-08T11:07:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18815-centro-di-coordinamento-malattie-rare-del-veneto]]></loc><lastmod>2024-05-08T11:34:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18692-assistenza-domiciliare-integrata-per-malati-rari-un-modello-da-declinare-su-bisogni-complessi]]></loc><lastmod>2022-07-28T09:46:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/centri-coordinamento-malattie-rare-regionali/18625-malattie-rare-prioritario-incrementare-la-formazione-in-ambito-medico-ma-non-solo]]></loc><lastmod>2022-07-28T09:36:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/video]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/redazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/22857-hiv-dati-positivi-dagli-studi-di-fase-iii-sulla-terapia-con-doravirina-islatravir]]></loc><lastmod>2026-03-19T18:16:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/22560-hiv-in-italia-e-stabile-in-numero-di-nuovi-casi]]></loc><lastmod>2025-12-19T14:42:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/22213-hiv-il-chmp-dice-si-all-uso-di-lenacapavir-in-regime-di-profilassi-per-esposizione]]></loc><lastmod>2025-07-28T17:49:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/22211-hiv-l-appello-di-anlaids-crescono-le-infezioni-necessario-fare-il-test]]></loc><lastmod>2025-07-27T10:31:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/22078-icar-2025-vivere-con-l-hiv-oggi-significa-gestire-nuove-sfide-ma-anche-nuove-possibilita]]></loc><lastmod>2025-06-12T07:29:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/21987-per-la-prima-volta-in-veneto-il-congresso-di-riferimento-su-hiv-epatiti-e-virus-emergenti]]></loc><lastmod>2025-05-14T07:48:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/21540-hiv-simit-aumentano-i-casi-ma-con-la-terapia-antiretrovirale-e-cambiata-la-storia-dell-infezione]]></loc><lastmod>2024-11-29T19:06:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/19915-hiv-la-rimborsabilita-della-prep-come-chiave-per-una-prevenzione-accessibile-in-italia]]></loc><lastmod>2023-06-19T10:48:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/19647-la-cura-inaspettata-un-libro-racconta-i-due-volti-opposti-dell-hiv]]></loc><lastmod>2023-03-19T12:45:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/19349-aids-una-nuova-procedura-per-riconoscere-se-il-virus-e-dormiente]]></loc><lastmod>2022-11-30T19:10:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/18061-hiv-le-persone-che-vivono-con-il-virus-affrontano-ancora-oggi-pregiudizi-e-discriminazioni]]></loc><lastmod>2021-12-01T13:56:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/18005-hiv-al-via-la-terza-edizione-di-a-way-together]]></loc><lastmod>2021-11-13T21:35:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/17963-hiv-e-sars-cov-2-gli-anticorpi-monoclonali-al-centro-delle-terapie-del-futuro]]></loc><lastmod>2021-11-01T19:53:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/17140-hiv-identificato-un-raro-gruppo-di-pazienti-del-congo-con-virus-controllato]]></loc><lastmod>2021-03-07T14:00:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/17029-hiv-fostemsavir-approvato-in-europa]]></loc><lastmod>2021-02-14T22:12:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/16863-hiv-approvazione-europea-per-rilpivirina-iniettiva]]></loc><lastmod>2020-12-30T22:03:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/16823-hiv-dalla-russia-segnali-incoraggianti-sullo-sviluppo-di-un-vaccino]]></loc><lastmod>2020-12-20T21:44:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/16757-hiv-in-progressivo-calo-le-nuove-diagnosi-ma-crescono-i-contagi-tra-i-giovani]]></loc><lastmod>2020-11-30T18:35:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/16587-hiv-i-pazienti-chiedono-migliore-qualita-di-vita-e-piu-tollerabilita-delle-terapie]]></loc><lastmod>2020-10-19T14:08:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/16239-hiv-disponibile-in-italia-la-terapia-con-dolutegravir-lamivudina]]></loc><lastmod>2020-07-03T12:55:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/16090-hiv-dal-bambino-gesu-un-test-istantaneo-per-controllare-la-carica-virale-nei-bambini]]></loc><lastmod>2020-05-20T11:22:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/15661-hiv-qual-e-il-ruolo-delle-cellule-nk-nella-risposta-all-infezione]]></loc><lastmod>2020-02-13T22:33:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/15495-hiv-praticamente-azzerato-il-rischio-infezioni-da-trasfusione]]></loc><lastmod>2019-12-09T12:15:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/15479-hiv-parte-il-progetto-sperm-positive-la-rivincita-dei-carica-zero]]></loc><lastmod>2019-12-05T10:38:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/15424-hiv-scoperto-un-nuovo-sottotipo-del-virus]]></loc><lastmod>2019-11-18T20:39:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/15425-hiv-i-pazienti-sieropositivi-in-terapia-antiretrovirale-non-trasmettono-il-virus]]></loc><lastmod>2019-11-18T20:58:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/15344-hiv-disponibile-in-italia-la-combinazione-dolutegravir-rilpivirina]]></loc><lastmod>2019-10-24T15:40:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/15128-hiv-positivi-i-dati-clinici-di-fostemsavir-a-96-settimane]]></loc><lastmod>2019-08-22T15:24:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/15085-hiv-gilead-annuncia-i-dati-piu-recenti-del-programma-di-ricerca-in-corso]]></loc><lastmod>2019-07-30T14:53:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/15035-hiv-approvazione-europea-per-la-combinazione-dolutegravir-lamivudina]]></loc><lastmod>2019-07-12T21:01:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/14604-hiv-1-nuovi-dati-su-bictegravir-emplicitabina-e-tenofovir-alafenamide]]></loc><lastmod>2019-03-20T14:25:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/14530-hiv-il-vaccino-tat-riduce-il-virus-latente]]></loc><lastmod>2019-02-27T22:16:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/14105-hiv-creati-in-russia-embrioni-umani-impermeabili-al-virus]]></loc><lastmod>2018-10-31T18:15:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/13818-aids-segnali-allarmanti-di-riaccensione-della-pandemia-globale]]></loc><lastmod>2018-08-02T17:48:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/13746-hiv-1-concessa-l-autorizzazione-all-immissione-in-commercio-in-europa-al-regime-a-base-di-bictegravir-emtricitabina-tenofovir-alafenamide]]></loc><lastmod>2018-07-07T16:23:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/13509-hiv-30-milioni-di-euro-per-un-nuovo-impianto-produttivo-gsk-in-italia]]></loc><lastmod>2018-05-02T15:02:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/13408-hiv-raccomandata-dal-chmp-l-immissione-in-commercio-della-combinazione-dolutegravir-rilpivirina]]></loc><lastmod>2018-04-05T15:16:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/13267-hiv-al-via-l-ottavo-studio-di-fase-iii-su-combinazione-dolutegravir-e-lamivudina]]></loc><lastmod>2018-02-22T17:20:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/13020-hiv-in-partenza-lo-studio-di-fase-iii-con-cabotegravir-nelle-donne]]></loc><lastmod>2018-02-22T17:24:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/12974-hiv-oggi-la-giornata-mondiale]]></loc><lastmod>2017-12-01T12:20:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/12904-aids-in-europa-troppe-differenze-nella-lotta-all-epidemia]]></loc><lastmod>2017-11-16T10:19:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/12853-aids-milano-entra-a-far-parte-delle-fast-track-cities]]></loc><lastmod>2017-10-31T17:20:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/12855-aids-presentata-la-nuova-versione-delle-linee-guida-europee]]></loc><lastmod>2017-10-31T18:38:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/12575-hiv-nuovi-risultati-di-fase-iii-per-bictegravir-in-combinazione]]></loc><lastmod>2017-08-09T15:11:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/12556-hiv-parere-positivo-del-chmp-per-darunavir]]></loc><lastmod>2017-08-03T07:54:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/12409-hiv-risultati-positivi-da-bictegravir-in-combinazione]]></loc><lastmod>2017-06-19T15:58:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/12386-hiv-richiesta-di-registrazione-per-dolutegravir-piu-rilpivirina]]></loc><lastmod>2017-06-19T15:58:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/12361-hiv-un-test-predice-l-efficacia-del-vaccino-antinfluenzale-nei-piccoli-pazienti]]></loc><lastmod>2017-10-31T16:58:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/12196-hiv-ed-epatiti-in-italia-trasfusioni-sicure-nessuna-infezione-da-oltre-10-anni]]></loc><lastmod>2017-06-19T15:57:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/11750-hiv-opinione-positiva-del-chmp-circa-la-riduzione-dei-limiti-di-eta-e-di-peso-corporeo-per-dolutegravir]]></loc><lastmod>2017-06-19T15:59:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/11697-hiv-la-lombardia-e-prima-in-italia-per-nuove-diagnosi]]></loc><lastmod>2016-12-03T16:36:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/11675-hiv-arriva-nelle-farmacie-italiane-il-primo-autotest]]></loc><lastmod>2016-12-01T16:43:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/11671-hiv-al-via-la-campagna-di-lila-onlus-per-la-diffusione-del-test-rapido]]></loc><lastmod>2016-11-30T15:05:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/11657-giornata-mondiale-contro-l-hiv-aids-i-dati-2015-dell-iss]]></loc><lastmod>2016-11-26T17:00:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/11638-hiv-al-via-studio-di-fase-3-per-l-associazione-cabotegravir-e-rilpivirina]]></loc><lastmod>2016-11-22T16:06:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/11496-hiv-in-italia-circa-il-15-dei-portatori-non-e-consapevole]]></loc><lastmod>2016-10-20T09:58:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/11449-hiv-dalla-ricerca-delle-forbici-molecolari-per-bloccare-la-replicazione-del-virus]]></loc><lastmod>2016-10-13T14:10:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/11344-hiv-un-report-sui-futuri-cambiamenti-delle-condizioni-di-vita-dei-pazienti]]></loc><lastmod>2016-09-29T15:40:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/11140-hiv-approvata-la-combinazione-emtricitabina-tenofovir-per-la-profilassi-pre-esposizione]]></loc><lastmod>2016-08-25T10:27:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/10837-aids-e-ist-compie-29-anni-il-telefono-verde-dell-iss]]></loc><lastmod>2016-06-23T09:59:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/10913-lipodistrofia-hiv-associata-l-efficacia-della-leptina]]></loc><lastmod>2017-04-10T17:18:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/10717-aids-dal-bambino-gesu-una-nuova-strategia-internazionale-per-sconfiggerlo]]></loc><lastmod>2016-06-01T14:25:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/10648-hiv-al-via-il-progetto-di-ricerca-traslazionale-epiical]]></loc><lastmod>2016-05-19T14:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/10583-hiv-si-allunga-l-aspettativa-di-vita-nel-2030-record-degli-over-cinquanta]]></loc><lastmod>2016-05-12T14:27:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/10127-hiv-viiv-healthcare-completa-l-acquisizione-delle-attivita-di-ricerca-di-bms]]></loc><lastmod>2019-08-22T15:13:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/9784-hiv-ed-epatite-in-italia-il-sangue-per-le-trasfusioni-e-sicuro]]></loc><lastmod>2016-01-20T16:57:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/9506-hiv-approvata-da-commissione-europea-nuovo-regime-a-singola-compressa]]></loc><lastmod>2015-12-02T14:49:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/9484-hiv-una-nuova-potenziale-terapia-potrebbe-arrivare-dal-selenio]]></loc><lastmod>2015-12-01T10:30:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/9447-hiv-la-campagna-di-sensibilizzazione-di-lila-onlus-per-far-conoscere-il-test-rapido-salivare]]></loc><lastmod>2015-11-25T17:26:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/9336-hiv-eliminando-il-virus-dell-epatite-c-dai-pazienti-coinfetti-la-terapia-antiretrovirale-funziona-meglio]]></loc><lastmod>2015-11-11T15:59:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/9236-hiv-dati-positivi-di-efficacia-e-tollerabilita-per-il-nuovo-farmaco-quattro-in-uno]]></loc><lastmod>2015-10-27T14:30:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/8970-hiv-obiettivo-primario-raggiunto-da-combinazione-emtricitabina-e-tenofovir-alafenamide]]></loc><lastmod>2015-09-22T14:49:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/8665-hiv-al-bambino-gesu-alleanza-internazionale-per-sconfiggerlo]]></loc><lastmod>2015-07-22T09:31:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/8303-hiv-grande-scoperta-sul-dna-del-virus-fondamentale-per-eradicare-infezione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/8273-hiv-cresce-la-richiesta-di-terapie-women-friendly]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/8265-hiv-avviata-una-nuova-collaborazione-tra-glaxosmithkline-e-la-north-carolina-university]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/8104-vaccino-tat-potenziata-lefficacia-della-terapia-antiretrovirale-e-stimolato-il-sistema-immunitario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/8105-hiv-nuovo-meccanismo-dazione-per-il-farmaco-abx464]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/7793-aids-e-hiv-nuove-cure-possibili-dalle-nucleoporine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/7768-hiv-uno-studio-italiano-scopre-dove-il-virus-si-nasconde-nelle-cellule]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/7498-hiv-lema-convalida-la-domanda-per-limmissione-in-commercio-di-tenofovir-alafenamide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/7363-hiv-la-sifilide-ne-accelera-la-diffusione-i-risultati-dello-studio-iss-irccs-san-gallicano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/7171-hiv-in-italia-sono-le-donne-a-rischiare-di-piu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/7119-hiv-gilead-ha-presentato-domanda-di-registrazione-per-il-trattamento-con-tenofovir-alafenamide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/7035-hiv-via-libera-dellaifa-a-dolutegravir-in-classe-h-48968505]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/6993-hivaids-cosa-chiede-il-paziente-alla-terapia-la-risposta-nella-prima-indagine-mirata-sulla-popolazione-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/6957-hiv-via-libera-dellaifa-a-dolutegravir-in-classe-h]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/6839-hiv-monopillola-da-ora-rimborsabile-anche-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/6530-hiv-nessuna-complicazione-renale-con-il-regime-a-quattro-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/6393-lotta-allaids-amedeo-di-savoia-torino-riorganizzato-per-la-centralita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/6319-hiv-viiv-healthcare-e-janssen-insieme-per-una-nuova-terapia-di-combinazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/6217-hiv-almeno-il-44-degli-infetti-presenterebbe-una-viremia-non-controllata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/6218-hiv-il-vaccino-potrebbe-essere-pronto-entro-il-2018]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/6130-hiv-4000-nuovi-casi-allanno-150mila-i-sieropositivi-prevalentemente-35-36-anni-tra-gli-omosessuali-10-15-nella-fascia-deta-16-25]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/6091-vaccino-aids-opzione-temporanea-per-non-disperdere-fondi-e-risultati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5867-hiv-viiv-healthcare-annuncia-nuove-iniziative-per-favorire-laccesso-al-farmaco-salva-vita-dolutegravir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5857-hiv-e-epatite-c-buoni-risultati-da-nuova-terapia-combinata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5749-infezione-da-virus-hiv-si-potra-prevenire-con-uniniezione-mensile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5751-innovativa-terapia-genica-apre-nuove-speranze-nella-riduzione-della-carica-virale-dellhiv]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5752-risultati-positivi-per-le-nuove-terapie-per-lhiv-le-news-dal-croi-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5742-terapia-hiv-conferme-per-il-farmaco-raltegravir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5736-coinfezione-hcv-hiv-esiti-promettenti-dalla-sperimentazione-del-farmaco-faldaprevir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5731-hiv-risultati-comparabili-alla-terapia-standard-per-la-terapia-di-mantenimento-basata-sulla-combinazione-rilpivirina-gsk744]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5724-la-ricerca-italiana-protagonista-a-boston-nuove-terapie-e-approfondimenti-su-hiv-ed-epatite]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5438-hiv-la-terapia-antiretrovirale-aumenta-notevolmente-laspettativa-di-vita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5357-hiv-il-vaccino-italiano-attualmente-in-sperimentazione-sembra-dare-risultati-positivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5331-hiv-aids-approvato-in-europa-dolutegravir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5275-hiv-regione-lazio-approva-il-nuovo-decreto-sulla-terapia-antiretrovirale-cure-piu-efficaci-per-10000-pazienti-n]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5197-hiv-aids-anche-in-italia-la-pillola-unica-che-migliora-la-qualita-di-vita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5198-hiv-aids-approvato-dalla-commissione-europea-il-farmaco-elvitegravir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5161-hiv-meno-farmaci-e-piu-qualita-di-vita-esperti-e-pazienti-a-confronto-per-limplementazione-del-modello-di-cura-del-futuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5088-hiv-appena-nata-trattata-con-antiretrovirali-sembra-guarita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/5045-al-via-due-progetti-per-ottimizzare-il-percorso-assistenziale-di-uomini-e-donne-con-hiv]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/4873-aids-hiv-preoccupante-laumento-delle-farmacoresistenze-nei-paesi-europei]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/4800-hiv-la-terapia-antiretrovirale-con-raltegravir-sembra-sicura-ed-efficace-in-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/4560-hiv-la-maggior-parte-dei-pazienti-giovani-presenta-lieve-disabilita-motoria-e-cognitiva]]></loc><lastmod>2019-06-19T08:25:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/4428-aids-in-alcuni-casi-la-terapia-potra-essere-semplificata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/4384-aids-studio-condotto-tra-italia-e-usa-punta-alla-remissione-definitiva-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/4300-aids-presentate-le-nuove-linee-guida-mondiali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3994-hiv-e-antiretrovirali-in-gravidanza-quale-il-rischio-di-effetti-teratogeni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3882-aids-scoperto-lanticorpo-che-elimina-gran-parte-dei-ceppi-virali-dellhiv]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3807-hiv-al-via-la-seconda-edizione-del-workshop-nazionale-sul-test-hiv-a-risposta-rapida]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3755-8-marzo-sieropositivoit-riparte-dalle-donne-per-promuovere-la-prevenzione-di-hiv-aids]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3726-hiv-altera-la-capacita-di-riconoscere-le-emozioni-nel-volto-altrui]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3635-voteresti-per-me-se-avessi-lhiv-la-campagna-elettorale-della-lega-italiana-per-la-lotta-contro-laids]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3493-aids-possibile-bloccare-il-virus-prima-che-attacchi-le-cellule]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3379-monti-scrive-a-osservatorio-aids-e-lila-possiamo-trovare-i-soldi-per-il-fondo-globale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3274-hiv-e-aids-preoccupanti-i-dati-del-ministero-della-salute-quattromila-nuove-infezioni-lanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3242-aids-stiamo-vincendo-laids-in-africa-non-fermiamoci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3269-giornata-mondiale-aids-i-dati-del-centro-operativo-e-i-numeri-del-telefono-verde]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3186-hiv-risultati-positivi-per-il-farmaco-tenofovir-alafenamide-fumarato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/3157-hiv-svelato-alliss-un-nuovo-meccanismo-di-ingresso-del-virus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2980-hiv-sono-le-donne-a-rischiare-di-piu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2927-progetto-simulating-adherence-senatori-e-operatori-sanitari-al-servizio-del-paziente-con-hiv]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2709-il-virus-dellhiv-potrebbe-diventare-un-alleato-nella-lotta-al-cancro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2684-hiv-approvato-in-usa-il-farmaco-quattro-in-uno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2668-aids-tubercolosi-e-malaria-italia-esclusa-dal-fondo-globale-per-la-lotta-contro-queste-malattie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2649-hiv-la-profilassi-con-isoniazide-protegge-dal-rischio-della-tbc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2630-hiv-sono-tre-i-casi-di-apparente-guarigione-grazie-al-trapianto-di-midollo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2590-aids-aggiornate-le-linee-guida-italiane-sulluso-dei-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2572-hiv-aumentano-i-casi-di-resistenza-ai-farmaci-di-prima-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2462-hiv-negli-usa-si-sperimenta-un-test-gratuito-da-fare-in-farmaci-in-soli-20-minuti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2483-hiv-una-sola-pillola-per-quattro-farmaci-superato-lo-studio-di-fase-tre]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2473-vivi-con-lhiv-niente-musica-e-niente-sport-lo-ha-deciso-lesercito]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2390-aids-ricercatori-delliss-aprono-la-strada-ad-una-terapia-a-termine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2187-la-salute-non-conosce-confini-campagna-dinformazione-e-sensibilizzazione-su-hiv-e-altre-patologie-virali-croniche-negli-istituti-penitenziari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/2130-aids-ed-epatite-c-in-italia-e-ancora-emergenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1953-aids-nuovo-vaccino-presentato-a-cuba]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1867-aids-la-marijhuana-potrebbe-bloccare-la-diffusione-del-virus-nella-malattia-in-fase-avanzata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1862-hiv-conference-hiv-in-europe-di-copenaghen-litalia-e-lunico-paese-dellunione-europea-a-disporre-delle-proprie-linee-guida]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1847-aids-telefono-verde-i-dati-di-oltre-24-anni-dattivita-del-numero-800061861]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1786-hiv-emtricitabina-e-renofovir-per-proteggere-i-partner-dei-sieropositivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1662-aids-a-trieste-si-sperimenta-un-vaccino-a-base-di-cellule-dendritiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1642-hiv-la-proteina-samhd1-e-in-grado-di-impedire-la-replicazione-del-virus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1643-hiv-necessaria-una-nuova-strategia-per-far-progredire-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1650-hiv-cancro-e-diabete-scoperti-possibili-nuovi-biosensori-in-grado-di-riconoscere-le-mutazioni-genetiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1528-hiv-nei-paesi-a-basso-reddito-si-muore-ancora-per-patologie-opportunistiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1525-hiv-anti-retrovirali-promossi-efficaci-nel-trattamento-prolungato-restano-la-terapia-delezione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1408-aids-domani-la-giornata-mondiale-il-telefono-verde-fa-orario-prolungato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1129-hiv-si-apre-domani-a-siena-il-convegno-internazionale-di-icri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/1099-hiv-ricercatori-americani-hanno-sintetizzato-il-laboratorio-le-lectine-nemiche-del-contagio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/944-hiv-arriva-she-il-primo-programma-per-le-donne-affette-dal-virus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/922-hiv-concluso-lo-ias2011-di-roma-la-scienza-ottimista-sulla-possibilita-di-una-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/923-hiv-allo-ias2011-di-roma-dettate-le-priorita-per-il-prossimo-futuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/914-hiv-presentati-allo-ias2011-i-risultati-degli-studi-di-fase-due-su-raltegravir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/915-hiv-stefano-vella-il-trattamento-puo-essere-visto-anche-come-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/916-hiv-si-continua-a-sperare-in-un-prossimo-vaccino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/912-hiv-la-parola-dordine-oggi-e-prevenire-il-contagio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/911-hiv-oggi-possiamo-parlare-di-malattia-virale-cronica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/807-aids-alliss-nuovo-trial-clinico-per-il-vaccino-su-usa-la-proteina-tat-associata-a-env]]></loc><lastmod>2025-10-14T18:47:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/650-hiv-liss-premiata-con-100mila-dollari-dalla-fondazione-di-bill-gates]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/631-aids-lauranofin-gia-usato-per-lartrite-reumatoride-stana-lhiv-nel-magazzino-dove-si-annida]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv/282-lipodistrofia-da-hiv-gli-adolescenti-americani-che-ne-sono-affetti-potranno-usare-il-tesamoreli]]></loc><lastmod>2025-10-14T18:45:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/22530-alzheimer-possibile-opportunita-terapeutica-da-due-farmaci-oncologici-gia-approvati]]></loc><lastmod>2025-11-18T18:06:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/22411-35a-conferenza-di-alzheimer-europe-scienza-e-comunita-unite-per-il-futuro-della-cura-della-demenza]]></loc><lastmod>2025-10-14T16:49:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/22366-malattia-di-alzheimer-approvazione-europea-per-dodanemab]]></loc><lastmod>2025-10-03T18:20:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/22327-giornata-mondiale-alzheimer-un-decalogo-per-la-prevenzione-della-demenza]]></loc><lastmod>2025-09-21T12:32:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/22239-alzheimer-dalla-ricerca-nuove-prospettive-per-migliorare-la-conoscenza-della-patologia]]></loc><lastmod>2025-08-10T11:57:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/22150-cure-palliative-un-bisogno-inascoltato-per-due-pazienti-con-demenza-su-tre]]></loc><lastmod>2025-07-01T21:09:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/22073-terapia-genica-per-l-alzheimer-i-risultati-preclinici-sembrano-essere-incoraggianti]]></loc><lastmod>2025-06-11T17:01:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/21657-alzheimer-gli-anticorpi-monoclonali-arrivano-anche-in-europa]]></loc><lastmod>2025-01-22T17:43:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/21516-malattia-di-alzheimer-ema-approva-lecanemab]]></loc><lastmod>2024-11-22T16:50:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/21301-alzheimer-identificato-un-nuovo-meccanismo-molecolare-coinvolto-nella-perdita-di-memoria]]></loc><lastmod>2024-09-18T14:06:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/20955-alzheimer-passi-avanti-nella-comprensione-della-genetica-della-malattia]]></loc><lastmod>2024-05-09T14:06:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/20388-legge-di-bilancio-nessun-finanziamento-per-il-piano-nazionale-demenze]]></loc><lastmod>2023-12-01T12:30:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/20103-alzheimer-settembre-e-il-mese-mondiale-dedicato-alla-malattia]]></loc><lastmod>2023-09-09T12:26:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/19971-anticorpi-monoclonali-contro-la-malattia-di-alzheimer-una-strada-piu-impervia-del-previsto]]></loc><lastmod>2023-07-04T17:37:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/19832-neuroscienze-e-alzheimer-nasce-il-nuovo-intergruppo-parlamentare]]></loc><lastmod>2023-05-25T10:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/19728-demenza-le-linee-guida-per-una-comunicazione-etica-e-inclusiva]]></loc><lastmod>2023-04-28T10:51:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/19598-malattie-neurologiche-a-monza-un-incontro-per-discutere-di-sostenibilita-delle-cure]]></loc><lastmod>2023-03-04T12:58:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/19432-alzheimer-delude-la-sperimentazione-di-fase-iii-sull-anticorpo-monoclonale-gantenerumab]]></loc><lastmod>2023-01-02T16:38:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/19251-alzheimer-dementia-friendly-italia-e-nontiscordaredivolermibene-premiati-in-europa]]></loc><lastmod>2022-11-05T15:11:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/19113-demenza-al-via-indagine-nazionale-sulle-condizioni-socio-economiche-delle-famiglie-dei-pazienti]]></loc><lastmod>2022-09-24T20:44:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/19075-malattia-di-alzheimer-il-21-settembre-e-la-giornata-mondiale]]></loc><lastmod>2022-09-17T20:06:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/19045-alzheimer-una-molecola-sperimentale-potrebbe-aprire-nuovi-scenari-nel-trattamento-della-malattia]]></loc><lastmod>2022-09-11T14:54:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/19017-alzheimer-settembre-e-il-mese-dedicato-alla-patologia]]></loc><lastmod>2022-09-02T12:49:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/18928-malattie-neurologiche-croniche-redatto-dalla-sin-il-documento-s-m-a-r-t-care]]></loc><lastmod>2022-07-16T21:11:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/18710-alzheimer-allo-studio-anticorpi-monoclonali-e-cocktail-di-farmaci]]></loc><lastmod>2022-05-30T12:11:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/18658-demenza-pubblicato-il-manuale-vivere-con-l-alzheimer-rivolto-a-familiari-e-caregiver]]></loc><lastmod>2022-05-16T11:21:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/18536-piano-nazionale-demenze-definita-la-ripartizione-dei-fondi-stanziati]]></loc><lastmod>2022-04-10T13:30:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/17878-alzheimer-al-via-in-7-centri-italiani-il-primo-progetto-pilota-di-telemedicina]]></loc><lastmod>2021-10-09T20:04:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/17811-alzheimer-identificato-il-ruolo-della-proteina-pin1-nella-degenerazione-neuronale]]></loc><lastmod>2021-09-23T11:07:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/17808-demenza-uno-studio-rivela-che-il-covid-19-puo-accelerarne-i-sintomi]]></loc><lastmod>2021-09-22T17:05:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/17799-alzheimer-oggi-e-la-giornata-mondiale]]></loc><lastmod>2021-09-21T14:21:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/17773-alzheimer-al-via-la-campagna-nontiscordaredivolermibene]]></loc><lastmod>2021-09-14T11:38:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/17704-demenza-nasce-il-sito-dedicato-alle-comunita-amiche]]></loc><lastmod>2021-08-01T15:28:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/17537-alzheimer-la-sin-accoglie-con-favore-l-approvazione-accelerata-di-aducanumab-da-parte-della-fda]]></loc><lastmod>2021-06-13T19:17:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/17320-demenza-in-italia-la-gestione-della-malattia-e-migliorata-del-10-in-tre-anni]]></loc><lastmod>2021-04-18T19:23:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/17210-demenze-federazione-alzheimer-italia-aderisce-alla-proposta-del-network-non-autosufficienza]]></loc><lastmod>2021-03-21T23:57:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/16986-demenza-i-medici-fanno-chiarezza-sul-consenso-informato-per-la-vaccinazione-anti-covid]]></loc><lastmod>2021-02-07T20:18:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/16906-alzheimer-l-assistenza-sanitaria-a-rilevanza-sociale-per-i-pazienti-deve-essere-gratuita]]></loc><lastmod>2021-01-20T00:25:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/16462-alzheimer-oggi-ricorre-la-giornata-mondiale]]></loc><lastmod>2020-09-20T16:51:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/15983-alzheimer-e-covid-19-l-impatto-dell-obbligo-di-non-uscire-su-pazienti-e-caregiver]]></loc><lastmod>2020-04-20T18:50:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/15900-coronavirus-e-alzheimer-10-consigli-per-affrontare-la-quarantena]]></loc><lastmod>2020-04-02T17:01:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/15550-alzheimer-i-consigli-di-sin-e-federazione-alzheimer-italia-per-le-festivita-natalizie]]></loc><lastmod>2020-01-01T18:59:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/15346-alzheimer-aducanumab-pronto-per-la-richiesta-di-approvazione-negli-stati-uniti]]></loc><lastmod>2019-10-25T09:47:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/15208-malattia-di-alzheimer-oggi-la-giornata-mondiale]]></loc><lastmod>2019-09-20T21:05:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/15063-demenze-la-federazione-alzheimer-italia-scrive-una-lettera-aperta-al-ministro-grillo]]></loc><lastmod>2019-07-21T18:06:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/14955-demenza-la-rete-italiana-delle-comunita-amiche-per-l-inclusione-dei-pazienti]]></loc><lastmod>2019-06-26T09:08:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/14888-cosa-pensi-della-demenza-un-sondaggio-per-aiutare-i-pazienti-di-tutto-il-mondo]]></loc><lastmod>2019-06-05T18:42:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/14742-malattia-di-alzheimer-individuate-cinque-nuovi-varianti-genetiche-associate]]></loc><lastmod>2019-04-17T16:02:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/14681-malattia-di-alzheimer-interrotto-lo-sviluppo-clinico-del-farmaco-aducanumab]]></loc><lastmod>2019-04-04T18:03:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/14575-demenza-federazione-alzheimer-italia-pubblica-la-guida-le-parole-contano]]></loc><lastmod>2019-03-14T18:37:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/14052-demenza-federazione-alzheimer-lancia-petizione-per-finanziare-il-piano-nazionale]]></loc><lastmod>2018-10-17T10:06:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/13992-malattia-di-alzheimer-presentato-il-rapporto-mondiale-2018]]></loc><lastmod>2018-10-17T10:12:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/13947-alzheimer-arriva-chat-yourself-un-app-che-aiuta-i-pazienti]]></loc><lastmod>2018-09-20T10:44:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/13768-alzheimer-partnership-tra-qbe-foundation-e-11-organizzazioni-che-si-occupano-di-ricerca-e-assistenza]]></loc><lastmod>2018-07-18T10:49:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/13715-demenza-presentato-al-parlamento-europeo-il-rapporto-sugli-ostacoli-rilevati-dai-familiari-nella-diagnosi]]></loc><lastmod>2018-07-01T14:53:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/13529-alzheimer-necessaria-la-creazione-di-reti-nazionali-e-di-nuovi-criteri-diagnostici]]></loc><lastmod>2018-05-05T15:20:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/13210-pronto-alzheimer-accolte-in-totale-oltre-150mila-richieste-di-aiuto]]></loc><lastmod>2018-02-07T18:50:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/13146-alzheimer-il-centro-dino-ferrari-la-ricerca-continua]]></loc><lastmod>2018-01-24T10:57:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/12703-alzheimer-i-vincitori-del-premio-giornalistico-informare-per-conoscere]]></loc><lastmod>2017-09-26T18:46:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/12557-alzheimer-scoperte-29-nuove-varianti-genetiche]]></loc><lastmod>2017-08-03T10:08:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/12494-demenza-in-italia-bene-la-ricerca-ma-ancora-insufficiente-l-assistenza]]></loc><lastmod>2017-07-12T13:47:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/12484-guardami-negli-occhi-parlami-sono-una-persona-speciale-ho-l-alzheimer]]></loc><lastmod>2017-07-12T12:44:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/12478-alzheimer-e-parkinson-due-malattie-innescate-dallo-stesso-enzima]]></loc><lastmod>2017-07-08T10:58:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/12307-alzheimer-entro-il-15-luglio-le-iscrizioni-al-concorso-giornalistico-informare-per-conoscere-2017]]></loc><lastmod>2017-06-19T16:19:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/12169-alzheimer-la-ricerca-italiana-ha-individuato-una-nuova-origine-della-malattia]]></loc><lastmod>2017-06-19T16:19:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/11500-alzheimer-la-testimonianza-del-missionario-padre-giancarlo]]></loc><lastmod>2017-06-19T16:19:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/11448-la-federazione-alzheimer-italia-premiata-per-il-progetto-comunita-amica-delle-persone-con-demenza]]></loc><lastmod>2017-06-19T16:20:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/11318-alzheimer-aducanumab-ottiene-designazione-fast-track-da-fda]]></loc><lastmod>2016-09-24T11:02:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/11319-alzheimer-l-uso-di-antipsicotici-e-correlato-al-rischio-di-polmonite]]></loc><lastmod>2017-06-19T16:20:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/11301-alzheimer-presentato-il-rapporto-mondiale-2016]]></loc><lastmod>2016-09-22T15:47:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/11282-alzheimer-la-societa-italiana-di-neurologia-illustra-le-nuove-strategie-preventive]]></loc><lastmod>2016-09-19T17:39:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/11194-alzheimer-le-terapie-in-corso-di-sviluppo-sono-sempre-piu-promettenti-l-obiettivo-e-cancellare-la-placche]]></loc><lastmod>2016-09-05T13:32:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/10997-alzheimer-abbiategrasso-prima-comunita-amica-dei-pazienti-con-demenza]]></loc><lastmod>2017-06-19T16:51:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/10801-la-federazione-alzheimer-italia-entra-a-far-parte-della-federazione-cure-palliative]]></loc><lastmod>2016-06-16T14:15:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/10744-alzheimer-individuato-specifico-enzima-come-potenziale-bersaglio-molecolare]]></loc><lastmod>2016-06-07T17:21:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/10684-diabete-di-tipo-2-piu-a-rischio-i-pazienti-affetti-da-alzheimer]]></loc><lastmod>2016-05-26T13:24:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/10491-alzheimer-prosegue-lo-studio-di-fase-iii-sul-farmaco-sperimentale-azd3293]]></loc><lastmod>2016-04-29T08:53:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/10490-alzheimer-a-maggio-a-milano-cure-e-assistenza-odontoiatriche-per-i-pazienti]]></loc><lastmod>2016-04-29T08:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/10209-malattia-di-alzheimer-tornano-in-evidenza-i-potenziali-benefici-del-farmaco-bexarotene]]></loc><lastmod>2016-03-18T09:11:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/10059-malattia-di-alzheimer-la-diagnosi-grazie-alla-firma-olfattiva]]></loc><lastmod>2016-02-26T14:36:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/10100-alzheimer-600mila-i-malati-in-italia-la-ricerca-censis-aima]]></loc><lastmod>2016-03-02T16:15:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/9932-alzheimer-e-altre-demenze-pubblicate-dall-ema-le-nuove-linee-guida]]></loc><lastmod>2016-02-09T16:57:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/9942-alzheimer-la-scienza-si-interroga-sull-ipotesi-che-la-malattia-sia-trasmissibile]]></loc><lastmod>2016-02-11T14:08:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/9832-pronto-alzheimer-da-sostegno-ai-familiari-dei-malati-sono-4-877-le-richieste-di-aiuto-solo-nell-ultimo-anno]]></loc><lastmod>2016-01-29T08:10:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/9610-alzheimer-studio-clinico-per-l-uso-preventivo-del-farmaco-sperimentale-crenezumab]]></loc><lastmod>2015-12-11T14:04:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/9535-alzheimer-familiare-individuata-una-disfunzione-proteica-comune-anche-ad-altri-disturbi-neurodegenerativi]]></loc><lastmod>2015-12-04T11:25:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/9296-alzheimer-forse-causato-da-infezioni-fungine-cerebrali]]></loc><lastmod>2015-11-10T18:06:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8981-alzheimer-e-demenza-al-gemelli-un-percorso-clinico-assistenziale-dedicato]]></loc><lastmod>2015-09-24T13:48:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8982-alzheimer-la-sin-sottolinea-il-ruolo-fondamentale-della-diagnosi-precoce-e-della-prevenzione]]></loc><lastmod>2015-09-24T14:08:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8932-alzheimer-gli-ultimi-dati-della-ricerca-scientifica]]></loc><lastmod>2015-09-17T09:44:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8942-alzheimer-i-livelli-ridotti-di-vitamina-d-ne-aumentano-il-rischio]]></loc><lastmod>2015-09-17T17:02:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8874-un-salto-per-l-alzheimer-crowdfunding-aperto-fino-al-30-settembre]]></loc><lastmod>2015-09-07T08:08:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8860-rapporto-mondiale-alzheimer-nel-mondo-c-e-un-caso-di-demenza-ogni-3-secondi]]></loc><lastmod>2015-09-04T06:51:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8740-alzheimer-rvt-101-migliorerebbe-le-capacita-cognitive-e-funzionali-dei-pazienti]]></loc><lastmod>2015-07-31T10:51:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8608-malattia-di-alzheimer-il-legame-con-il-diabete-e-la-proteina-neuroprotettiva]]></loc><lastmod>2015-07-13T09:42:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8609-malattia-di-alzheimer-basta-sedativi-meglio-formare-chi-si-prende-cura-dei-pazienti]]></loc><lastmod>2015-07-13T09:43:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8492-alzheimer-un-concorso-giornalistico-per-sensibilizzare-su-questa-malattia]]></loc><lastmod>2015-06-22T13:04:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8363-diabete-e-alzheimer-possibile-un-legame-tra-le-due-malattie]]></loc><lastmod>2015-06-03T15:08:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8366-alzheimer-studio-longitudinale-per-creare-banca-dati-per-la-ricerca]]></loc><lastmod>2015-06-03T16:01:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8268-alzheimer-approvato-luso-di-bryostatin-1-come-terapia-compassionevole]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8221-obesita-infantile-giovani-a-rischio-alzheimer-gia-da-adolescenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/8174-alzheimer-ora-e-possibile-leggere-e-firmare-online-la-dichiarazione-di-glasgow-anche-in-italiano]]></loc><lastmod>2015-06-08T11:28:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/7942-alzheimer-nuove-speranze-per-nuovo-anticorpo-monoclonale-aducanumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/7438-alzheimer-accordo-janssen-ac-immune-per-mettere-a-punto-il-vaccino-anti-tau]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/7394-malattia-di-alzheimer-attivo-a-milano-il-centro-pronto-alzheimer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/7077-alzheimer-i-familiari-dei-malati-potranno-ricevere-assistenza-e-consulenza-gratuite]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/6926-malattia-di-alzheimer-studio-italiano-individua-nuovo-fattore-diagnostico-e-prognostico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/6838-malattia-di-alzheimer-il-farmaco-ariceptr-raggiunge-lendpoint-primario]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/6744-xxi-giornata-mondiale-alzheimer-insieme-per-capire-e-rispondere-ai-comportamenti-del-malato-di-alzheimer]]></loc><lastmod>2017-06-19T16:22:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/6723-malattia-di-alzheimer-astinenza-dal-fumo-dieta-sana-attivita-fisica-e-intellettuale-prevenzione-e-controllo-dipertensione-e-diabete-sono-fattori-che-contribuiscono-a-ridurre-il-rischio-di-demenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/6556-alzheimer-afro-americani-piu-soggetti-alla-patologia-a-causa-di-varianti-di-un-gene]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/6498-alzheimer-risultati-contrastanti-per-la-sperimentazione-di-crenezumab]]></loc><lastmod>2015-12-07T16:53:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/6207-nasce-la-global-alzheimers-and-dementia-action-alliance-presente-la-federazione-alzheimer-italia-presente-alla-nascita-dellalleanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/6075-innovazione-ed-eccellenza-in-flebologia-le-vene-fattore-chiave-nel-parkinson-e-nel-morbo-di-alzheimer-non-solo-nella-sclerosi-multipla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5959-alzheimer-uno-studio-tutto-italiano-svela-come-si-accumulano-le-proteine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5923-alzheimer-nasce-a-napoli-il-primo-ambulatorio-pubblico-della-campania]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5892-alzheimer-si-chiama-c4d-il-test-che-previene-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5670-malattia-di-alzheimer-eisai-e-biogen-idec-hanno-avviato-una-collaborazione-per-sviluppare-e-commercializzare-trattamenti-contro-questa-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5440-malattia-di-alzheimer-la-vitamina-e-e-in-grado-di-rallentare-la-perdita-funzionale-correlata-alla-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5441-malattia-di-alzheimer-risultati-deludenti-per-gli-anticorpi-umanizzati-solanezumab-e-bapineuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5417-al-via-la-campagna-pronto-alzheimer-per-il-sostegno-ai-familiari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5297-alzheimer-sperimentato-al-besta-di-milano-un-nuovo-programma-integrato-di-assistenza-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5281-identificata-nuova-tecnica-in-grado-di-trasportare-anticorpi-oltre-la-barriera-emato-encefalica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5277-alzheimer-nuova-speranza-terapeutica-dal-farmaco-sperimentale-gantenerumab]]></loc><lastmod>2023-01-02T16:16:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5233-alzheimer-in-puglia-sara-collaudata-una-nuova-tecnologia-per-lassistenza-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5243-alzheimer-otsuka-e-lundbeck-svilupperanno-un-vaccino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5104-demenza-44-milioni-di-persone-ne-sono-affette-il-rapporto-di-alzheimers-disease-international]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5057-alzheimer-le-proteine-tossiche-che-danneggiano-i-neuroni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/5012-alzheimer-scoperto-come-le-proteine-tossiche-danneggiano-i-neuroni-agendo-al-loro-interno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/4940-alzheimer-gruppo-di-ricerca-italiano-individua-un-enzima-protettivo-dei-neuroni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/4941-alzheimer-nuovo-test-clinico-rileva-il-rischio-di-sviluppare-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/4901-parkinson-e-alzheimer-influenzate-dallo-stress-in-gravidanza-francia-e-italia-al-lavoro-con-un-nuovo-laboratorio-internazionale-per-scoprirlo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/4679-la-federazione-alzheimer-italia-ha-presentato-il-nuovo-rapporto-mondiale-alzheimer-un-viaggio-per-prendersi-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/4531-alzheimer-dopo-il-rame-ora-sotto-accusa-anche-il-ferro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/4506-alzheimer-leccesso-di-rame-potrebbe-favorirne-linsorgenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/4458-alzheimer-un-test-del-sangue-in-grado-di-individuare-i-primi-segni-di-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/4409-alzheimer-una-mutazione-genetica-potrebbe-essere-daiuto-per-lo-sviluppo-di-una-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/4162-alzheimer-delude-la-sperimentazione-su-animali-del-bexarotene]]></loc><lastmod>2016-03-14T16:14:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/4063-alzheimer-dal-mario-negri-di-milano-una-nuova-tecnica-per-studiarene-i-meccanismi-intracellularii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3859-alzheimer-fino-al-7-aprile-un-sms-per-sostenere-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3830-alzheimer-si-allolio-doliva-no-ai-drink-di-troppo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3803-alzheimer-i-disturbi-del-sonno-possono-aumentare-il-rischio-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3804-alzhiemer-dagli-usa-la-proposta-procedure-piu-semplici-per-i-farmaci-sperimentali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3595-alzheimer-potenziali-benefici-da-te-verde-e-vino-rosso]]></loc><lastmod>2016-03-17T00:47:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3520-alzheimer-verso-la-diagnosi-precoce-grazie-a-uno-studio-abruzzese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3508-alzheimer-in-lazio-approvate-le-linee-guida-per-luso-delle-risorse-destinate-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3286-alzheimer-nuovo-approccio-terapeutico-dal-modello-animale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3229-alzheimer-spiegarlo-ai-bambini-con-le-avventure-di-gino-pettirosso-smemorino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3167-alzheimer-una-diagnosi-estremamente-precoce-e-utile-o-rischiosa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3158-alzheimer-ideata-una-pinza-molecolare-per-prevenire-e-contrastare-gli-effetti-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3124-alzheimer-un-nuovo-possibile-bersaglio-molecolare-e-un-enzima-scoperto-studiando-i-topi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/3012-alzheimer-al-cemi-del-gemelli-sostegno-psicologico-per-familiari-e-caregivers-dei-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2967-alzheimer-nel-2013-saranno-testati-due-farmaci-a-livello-mondiale]]></loc><lastmod>2023-01-02T16:21:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2843-alzheimer-un-solo-trauma-cerebrale-medio-o-grave-possibile-concausa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2802-alzheimer-una-malattia-che-colpisce-anche-le-istituzioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2787-alzheimer-scoperto-un-nuovo-enzima-coinvolto-nella-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2782-alzheimer-le-raccomandazioni-statunitensi-per-la-gestione-clinica-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2720-alzheimer-test-di-eye-tracking-mostra-possibilita-di-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2658-alzheimer-dal-cacao-un-aiuto-contro-linvecchiamento-del-cervello-lo-sostiene-uno-studio-abruzzese]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2670-alzheimer-le-donne-peggiorano-piu-in-fretta-degli-uomini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2651-alzheimer-un-test-del-sangue-potrebbe-fornire-la-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2625-alzheimer-estrogeni-in-grado-di-provenire-la-demenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2611-alzheimer-cadono-le-speranze-riposte-nel-bapinezumab-attentus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2569-alzheimer-da-vancouver-i-risultati-delle-piu-recenti-sperimentazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2548-un-farmaco-per-svegliare-dallapatia-i-malati-di-alzheimer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2547-alzheimer-la-diagnosi-dallesame-della-retina-e-i-legame-con-il-diabete]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2528-prime-manifestazione-dell-alzheimer-familiare-25-anni-prima-dellesplosione-completa-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2546-alzheimer-gia-in-commercio-farmaci-utili-per-rallentarne-levoluzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2511-alzheimer-una-mutazione-protegge-dalla-malattia-presto-potenziali-farmaci-per-il-trattamento-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2490-alzheimer-disponibile-la-prima-applicazione-iphone-e-android-dedicata-a-chi-si-prende-cura-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2346-alzheimer-un-vaccino-in-grado-di-combattere-la-neurodegenerazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2283-alzheimer-la-stimolazione-cerebrale-profonda-puo-rallentare-la-progressione-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/2236-alzehimer-il-vino-rosso-potrebbe-proteggerci-dalla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1982-alzheimer-approvato-negli-stati-uniti-lagente-diagnostico-florbetapir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1904-alzheimer-un-nuovo-test-potrebbe-facilitare-la-diagnosi-e-lo-sviluppo-di-nuovi-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1903-alzheimer-una-nuova-speranza-dalla-proteina-fkbp52]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1897-alzheimer-la-resistenza-allinsulina-del-cervello-contribuisce-al-declino-cognitivo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1813-alzheimer-epotilone-d-potenzialmente-efficace-per-rallentare-la-progressione-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1678-alzheimer-scoperta-la-beta-arrestina-una-proteina-correlata-alla-memoria-a-breve-termine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1651-alzheimer-buoni-i-risultati-del-progetto-europeo-sociable]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1615-alzheimer-un-antitumorale-in-grado-di-ridurre-i-sintomi-della-patologia]]></loc><lastmod>2016-03-14T16:16:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1592-alzheimer-cnr-brevetta-vaccino-contro-gli-accumuli-di-beta-amiloide-nel-cervello]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1522-alzheimer-la-dimensione-del-cervello-puo-predirne-il-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1507-alzheimer-dalla-regione-lazio-piu-di-2-milioni-di-euro-per-assistenza-e-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1446-alzheimer-ricerca-svolta-dalliss-individua-meccanismo-dazione-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1333-alzheimer-nel-lazio-una-proposta-di-legge-per-lassistenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1210-alzheimer-cominciato-ad-orvieto-un-corso-di-formazione-per-chi-e-coinvolto-nella-gestione-del-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1167-alzheimer-il-governo-si-impegna-monitorare-la-crescita-dei-casi-e-aiutare-la-ricerca]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1094-alzheimer-oggi-la-giornata-mondiale-ecco-la-prima-candid-camera-di-federazione-alzheimer]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1073-alzheimer-in-occasione-della-giornata-mondiale-sciopero-delle-identita-su-facebook]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1018-alzheimer-troppo-sale-nel-piatto-fa-male-al-cervello]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1011-alzheimer-sintetizzato-in-laboratorio-lhuperzine-a-fino-ad-oggi-lo-si-ricavava-da-un-muschio-a-rischio-estinzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1009-alzheimer-potrebbe-essere-scoperto-precocemente-grazie-alle-tecniche-di-imaging]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/1006-alzheimer-dal-22-al-28-agosto-con-un-sms-al-45505-molto-si-puo-fare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/alzheimer/939-alzheimer-trovato-possibile-biomarcatore-per-rilevare-malattia-20-anni-prima-dellesordio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/22900-degenerazione-maculare-avanzata-un-microimpianto-retinico-wireless-per-tornare-a-vedere]]></loc><lastmod>2026-04-01T17:05:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/21326-atrofia-geografica-la-protesta-dei-pazienti-dopo-il-no-dell-ema-al-farmaco-pegcetacoplan]]></loc><lastmod>2024-09-26T18:15:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/20634-degenerazione-maculare-al-gemelli-una-ricerca-innovativa-con-cellule-staminali-cordonali]]></loc><lastmod>2024-02-15T17:22:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/20263-oftalmologia-al-via-nuovo-bando-roche-per-i-servizi]]></loc><lastmod>2023-10-27T09:37:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/20235-degenerazione-maculare-arriva-in-italia-il-primo-anticorpo-bispecifico-per-uso-oculare]]></loc><lastmod>2023-10-14T21:37:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/20188-atrofia-geografica-nessun-legame-tra-il-farmaco-pegcetacoplan-e-i-sette-casi-di-vasculite-retinica]]></loc><lastmod>2024-09-19T07:54:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/20074-uscito-il-nuovo-singolo-di-fiamma-celano-cantante-affetta-da-degenerazione-maculare]]></loc><lastmod>2023-09-05T08:38:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/19833-maculopatie-un-rischio-per-over-60-e-diabetici]]></loc><lastmod>2023-05-25T10:29:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/19469-degenerazione-maculare-legata-all-eta-presentato-il-rapporto-altems-sull-impatto-economico-della-patologia]]></loc><lastmod>2023-01-23T10:36:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/19112-degenerazione-maculare-legata-all-eta-approvazione-europea-per-faricimab]]></loc><lastmod>2022-09-24T20:33:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/18614-maculopatie-una-diretta-facebook-per-rispondere-alle-domande-dei-pazienti]]></loc><lastmod>2022-05-06T13:35:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/18601-e-online-sottosopra-il-nuovo-singolo-di-una-cantautrice-rara]]></loc><lastmod>2023-08-24T17:13:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/17981-degenerazione-maculare-legata-all-eta-fda-approva-un-trattamento-alternativo-alle-iniezioni-oculari-mensili]]></loc><lastmod>2021-11-08T12:14:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/17646-degenerazione-maculare-legata-all-eta-fondamentali-una-diagnosi-accurata-e-un-percorso-terapeutico-ad-hoc]]></loc><lastmod>2021-07-13T16:34:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/16438-maculopatia-la-campagna-salvarelavistasipuo-si-arricchisce-di-un-nuovo-video]]></loc><lastmod>2020-09-14T00:03:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/16289-maculopatie-al-via-la-campagna-salvarelavistasipuo]]></loc><lastmod>2020-07-13T11:28:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/13943-degenerazione-maculare-approvato-in-europa-il-nuovo-schema-di-trattamento-di-aflibercept]]></loc><lastmod>2018-09-19T20:49:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/13530-degenerazione-maculare-nuovi-promettenti-dati-di-fase-iii-per-brolucizumab]]></loc><lastmod>2018-05-05T16:20:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/13432-degenerazione-maculare-benefici-visivi-da-terapia-sperimentale-basata-su-staminali]]></loc><lastmod>2018-05-05T16:17:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/13321-degenerazione-maculare-nuovi-dati-su-aflibercept]]></loc><lastmod>2018-03-08T02:52:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/12870-degenerazione-maculare-molti-italiani-non-conoscono-la-patologia]]></loc><lastmod>2017-11-08T17:35:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/12491-degenerazione-maculare-senile-in-italia-troppe-differenze-nel-percorso-di-cura]]></loc><lastmod>2017-11-08T17:34:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/12428-degenerazione-maculare-senile-buoni-risultati-da-brolucizumab]]></loc><lastmod>2017-06-23T15:54:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/10533-maculopatie-in-giappone-e-stata-sperimentata-una-tecnica-innovativa-per-la-cura]]></loc><lastmod>2016-05-05T15:19:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/10043-degenerazione-maculare-legata-all-eta-efficace-il-trattamento-con-statine]]></loc><lastmod>2016-02-25T16:48:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/9631-maculopatia-il-50-per-cento-dei-malati-non-conosce-il-proprio-disturbo-visivo]]></loc><lastmod>2015-12-16T11:13:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/8673-degenerazione-maculare-al-manchester-royal-eye-hospital-il-primo-impianto-di-protesi-retinica-argus]]></loc><lastmod>2015-07-22T13:03:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/7661-maculopatia-disatteso-il-diritto-alla-cura-di-65mila-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/7566-maculopatia-disponibile-una-app-per-semplificare-la-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/6997-3-novembre-2014-qnon-perdiamoci-la-vistaq-prende-il-via-la-campagna-contro-le-maculopatie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/6877-maculopatie-per-la-terapia-con-ranibizumab-arriva-la-siringa-preriempita-hi-tech]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/6732-maculopatia-lospedale-schiara-di-trento-e-in-crisi-di-personale]]></loc><lastmod>2019-06-18T17:58:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/6340-aflibercept-ha-ricevuto-la-chmp-opinion-per-il-trattamento-del-danno-visivo-causato-da-edema-maculare-diabetico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/6245-maculopatie-luca-pani-aifa-plaude-a-fimmg-e-federanziani-per-la-proposta-di-creazione-di-un-comitato-consultivo-advisory-board-su-queste-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/6244-degenerazione-maculare-senile-novartis-acquisisce-i-diritti-di-vendita-di-fovista-al-di-fuori-degli-stati-uniti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/6114-degenerazione-maculare-senile-risultati-negativi-per-sirolimus-in-pazienti-con-atrofia-geografica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/6131-degenerazione-maculare-senile-la-preparazione-nelle-farmacie-ospedaliere-di-bevacizumab-e-garanzia-di-sicurezza-per-il-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/6036-terapie-intravitreali-dopo-tanto-clamore-ce-chi-non-riesce-ancora-a-farsi-curare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/6018-degenerazione-maculare-i-dati-novartis-presentati-al-congresso-arvo-2014-confermano-i-risultati-ottenuti-dalla-pratica-clinica-ed-evidenziano-il-profilo-di-sicurezza-di-lucentisr]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/5802-maculopatie-al-san-martino-di-genova-e-disponibile-un-laser-di-ultima-generazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/5801-degenerazione-maculare-lattivita-fisica-e-un-rimedio-anche-per-le-patologie-neurodegenerative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/5827-degenerazione-maculare-legata-alleta-da-oggi-e-rimborsato-il-farmaco-eylea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/5755-maculopatia-la-denucia-del-dramma-dei-pazienti-non-tutti-hanno-accesso-alle-cure-salva-vista]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/5722-degenerazione-maculare-dopo-il-caso-avastinlucentis-occorre-una-modifica-legislativa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/5663-degenerazione-maculare-un-nuovo-composto-chimico-sarebbe-in-grado-di-ripristinare-nei-topi-la-sensibilita-alla-luce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/5676-degenerazioni-retiniche-lo-zafferano-abruzzese-sembra-avere-effetti-antiossidanti-e-antiapoptotici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/5138-maculopatiaa-genova-concluso-il-congresso-su-diagnosi-e-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/4847-maculopatie-a-treviso-visite-gratuite-grazie-al-centro-deccellenza-cafoncello]]></loc><lastmod>2016-03-07T10:45:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/4614-15-23-settembre-2013-settimana-internazionale-della-degenerazione-maculare-senile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/4582-maculopatia-oms-determina-quale-il-farmaco-indispensabile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/4372-degenerazione-maculare-senile-colpisce-oggi-1-milione-di-italiani-fondamentale-la-diagnosi-precoce]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/4208-degenerazione-maculare-legata-alleta-sensibilizzazione-e-prevenzione-possono-evitarla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/4112-degenerazione-maculare-legata-alleta-un-nuovo-farmaco-la-mette-in-trappola]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/4090-degenerazione-maculare-senile-i-farmaci-per-abbassare-il-colesterolo-potrebbero-essere-efficaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/3935-maculopatia-pazienti-e-medici-chiedono-al-ministro-balduzzi-cure-accessibili-e-rimborsabili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/3539-degenerazione-maculare-neovascolare-laspirina-ne-aumenta-il-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/3349-edema-maculare-diabetico-dme-e-da-occlusione-venosa-retinica-rvo-ranibizumab-rimborsato-dal-ssn]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/3344-edema-maculare-bayer-presenta-vegf-trap-eye-soluzione-di-aflibercept-per-iniezione-per-lautorizzazione-marketing-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/3248-degenerazione-maculare-senile-approvato-in-europa-il-nuovo-farmaco-eylea]]></loc><lastmod>2022-04-28T17:23:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/2800-degenerazione-maculare-aflibercept-raccomandato-dal-comitato-europeo-per-i-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/1945-maculopatia-senile-scoperto-meccanismo-alla-base-dei-casi-piu-gravi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/degenerazione-maculare/1677-edema-maculare-bayer-chiedera-presto-la-registrazione-europea-per-il-farmaco-aflibercept]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/22881-endometriosi-per-ottenere-la-diagnosi-occorrono-in-media-dai-5-agli-8-anni]]></loc><lastmod>2026-03-26T16:02:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/22386-big-data-e-intelligenza-artificiale-aiutano-a-capire-meglio-lendometriosi]]></loc><lastmod>2025-10-08T10:53:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/21855-endometriosi-una-patologia-che-nel-30-dei-casi-provoca-infertilita]]></loc><lastmod>2025-03-28T12:17:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/17466-endometriosi-piccole-cose-arrabbiate-dentro-di-te]]></loc><lastmod>2021-05-26T08:13:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/17177-endometriosi-diventare-mamme-si-puo]]></loc><lastmod>2021-03-14T15:51:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/14639-endometriosi-marzo-e-il-mese-dedicato-alla-patologia]]></loc><lastmod>2019-03-25T19:30:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/14481-endometriosi-in-italia-si-stimano-circa-3-milioni-di-casi]]></loc><lastmod>2025-10-03T15:47:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/12099-endometriosi-l-importanza-del-supporto-emotivo-e-della-preservazione-della-fertilita]]></loc><lastmod>2017-06-19T16:01:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/9148-endometriosi-un-altro-passo-in-avanti-nella-ricerca]]></loc><lastmod>2017-06-19T16:02:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/7728-endometriosi-al-via-la-settimana-della-consapevolezza]]></loc><lastmod>2017-06-19T16:01:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/7504-endometriosi-in-vigore-la-legge-approvata-in-sardegna]]></loc><lastmod>2017-06-19T16:02:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/7229-sardegna-approvata-legge-sullendometriosi]]></loc><lastmod>2017-06-19T16:04:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/7036-endometriosi-al-gemelli-congresso-su-nuove-sfide-diagnostiche-chirurgiche-e-terapeutiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/6910-endometriosi-siena-e-milano-coordinano-studio-unico-in-italia-per-una-nuova-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/6395-endometriosi-ne-soffre-una-donna-su-dieci-in-eta-fertile]]></loc><lastmod>2015-05-27T08:18:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/6247-endometriosi-profonda-laparoscopia-in-3d-nel-trattamento-della-patologia]]></loc><lastmod>2015-05-28T11:47:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/5954-endometriosi-la-nuova-sfida-della-ricerca-e-di-mettere-a-punto-test-diagnostici-meno-invasivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/5929-endometriosi-presentata-interrogazione-da-m5s]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/5889-endometriosi-15-milioni-per-migliorare-il-percorso-diagnostico-assistenziale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/5860-endometriosi-e-gestione-del-dolore-ecco-le-piu-recenti-acquisizioni-scientifiche]]></loc><lastmod>2019-06-18T18:27:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/5067-endometriosi-severa-fertilita-a-rischio-dopo-la-chirurgia]]></loc><lastmod>2025-10-03T15:49:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/4915-endometriosi-aie-avanza-una-proposta-di-legge]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/4914-endometriosi-una-malattia-sociale-a-forte-impatto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/endometriosi/4108-endometriosi-adesso-si-puo-dire-basta-ai-dolori-grazie-a-un-nuovo-progestinico-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/21729-malattie-epatiche-presentato-al-ministero-della-salute-il-libro-bianco-di-aisf]]></loc><lastmod>2025-02-14T10:37:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/20912-epatite-c-8-10-anni-perche-in-italia-diventi-una-malattia-rara]]></loc><lastmod>2024-04-24T13:17:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/20911-l-obiettivo-dell-oms-eradicare-l-epatite-c-entro-il-2030]]></loc><lastmod>2024-04-24T13:18:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/20040-epatiti-oggi-ricorre-la-giornata-mondiale]]></loc><lastmod>2023-08-10T16:28:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/18951-epatite-c-lanciato-nuovo-test-diagnostico-che-rileva-antigene-e-anticorpi-del-virus-hcv]]></loc><lastmod>2022-07-24T15:41:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/16864-epatite-c-il-bilancio-aifa-2020-sull-eradicazione-del-virus]]></loc><lastmod>2020-12-30T22:13:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/16313-epatite-c-aifa-approva-nuova-rimborsabilita-per-glecaprevir-pibrentasvir]]></loc><lastmod>2020-07-20T11:20:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/15694-epatite-c-71-milioni-di-euro-stanziati-in-italia-per-screening-gratuiti]]></loc><lastmod>2020-02-25T19:03:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/15398-epatite-c-un-paziente-su-tre-arriva-al-trattamento-con-infezione-avanzata-o-cirrosi]]></loc><lastmod>2019-11-09T23:30:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/15322-epatite-c-in-italia-restano-da-trattare-dai-60-ai-120mila-pazienti]]></loc><lastmod>2019-10-17T15:14:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/15062-epatite-c-nuove-strategie-di-screening-per-far-emergere-il-sommerso]]></loc><lastmod>2019-07-21T18:06:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/14001-epatite-c-circa-300-000-i-pazienti-ancora-da-curare-in-italia]]></loc><lastmod>2018-10-05T18:04:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/13065-epatite-c-in-sardegna-sara-possibile-curare-tutti]]></loc><lastmod>2017-12-23T14:24:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/12969-epatite-c-in-italia-piu-di-100-000-i-pazienti-trattati]]></loc><lastmod>2017-11-28T11:09:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/12854-epatite-c-nuovi-dati-real-life-sull-efficacia-di-elbasvir-grazoprevir]]></loc><lastmod>2017-10-31T18:35:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/12468-epatite-c-ok-da-ema-a-sofosbuvir-velpatasvir-voxilaprevir]]></loc><lastmod>2017-07-04T09:17:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/12446-epatite-c-nel-lazio-sara-possibile-curare-tutti]]></loc><lastmod>2017-06-27T14:27:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/12240-epatite-c-confermato-il-profilo-di-efficacia-e-tollerabilita-di-elbasvir-grazoprevir]]></loc><lastmod>2017-06-19T16:06:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/11837-epatite-c-cronica-l-ema-adotta-la-procedura-accelerata-per-la-valutazione-di-sof-vel-vox]]></loc><lastmod>2017-06-19T16:06:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/11798-epatite-b-approvato-in-europa-tenofovir-alafelanide]]></loc><lastmod>2017-06-19T16:07:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/11672-epatite-nasce-la-rete-senza-la-c]]></loc><lastmod>2017-06-19T16:07:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/11036-giornata-mondiale-contro-l-epatite-test-gratuiti-al-centro-diagnostico-italiano]]></loc><lastmod>2017-06-19T16:07:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/10958-epatite-c-la-commissione-europea-autorizza-l-immissione-in-commercio-di-velpatasvir-sofosbuvir]]></loc><lastmod>2016-07-15T06:14:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/10922-epatite-c-primi-risultati-da-un-sondaggio-nazionale-sull-accesso-ai-nuovi-farmaci]]></loc><lastmod>2016-07-06T21:36:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/10882-epatite-c-in-puglia-trattati-5mila-pazienti-sara-possibile-curare-tutti]]></loc><lastmod>2016-06-29T14:20:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/10696-epatite-c-emerge-un-legame-genetico-con-un-raro-disordine-da-accumulo-di-grassi]]></loc><lastmod>2016-05-31T15:53:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/10646-i-pazienti-affetti-da-epatite-c-scrivono-a-renzi-i-malati-non-hanno-accesso-alla-terapia-salva-vita]]></loc><lastmod>2016-05-19T13:14:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/10530-san-marino-al-via-una-campagna-di-informazione-contro-l-epatite-c]]></loc><lastmod>2016-05-05T13:25:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/10467-i-generici-per-l-epatite-c-potrebbero-non-arrivare-mai-in-italia-parola-del-dg-aifa-luca-pani]]></loc><lastmod>2016-04-27T09:46:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/10418-epatite-c-nuovi-dati-su-elbasvir-grazoprevir]]></loc><lastmod>2016-04-20T14:22:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/9982-epatite-c-un-patto-per-la-gestione-integrata-del-paziente-la-strategia-terapeutica-del-futuro]]></loc><lastmod>2016-02-17T10:03:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/9783-epatite-c-avviati-sei-studi-di-fase-iii-per-nuovo-regime-orale]]></loc><lastmod>2016-01-20T16:54:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/9673-epatite-c-attenzione-all-interazione-tra-antivirali-e-altri-farmaci]]></loc><lastmod>2016-05-21T12:08:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8931-epatite-c-buoni-risultati-da-terapia-con-ombitasvir-paritaprevir-ritonavir-e-dasabuvir]]></loc><lastmod>2015-09-17T09:55:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8859-epatite-c-investire-nell-innovazione-puo-cambiarne-la-storia]]></loc><lastmod>2015-09-03T13:53:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8849-coinfezione-epatite-c-e-hiv-risultati-positivi-da-combinazione-ledipasvir-sofosbuvir]]></loc><lastmod>2015-09-01T08:03:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8698-epatite-oggi-e-domani-linea-diretta-gratuita-con-l-esperto]]></loc><lastmod>2015-07-27T12:50:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8621-epatite-c-disponibile-un-sito-e-un-servizio-telefonico-di-cittadinanzattiva-tribunale-per-i-diritti-del-malato]]></loc><lastmod>2015-07-15T08:51:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8547-la-conferenza-stato-regioni-e-pronta-a-intervenire-italia-ha-numeri-record]]></loc><lastmod>2015-07-02T08:23:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8364-epatite-c-parte-il-servizio-di-consulto-telefonico]]></loc><lastmod>2015-06-05T07:06:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8328-epatite-c-aifa-approva-trattamento-a-base-di-viekirax-e-exviera]]></loc><lastmod>2015-05-27T15:16:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8280-epatite-c-raggiunto-accordo-tra-aifa-e-giled-per-commercializzazione-farmaci-innovativi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8249-terapia-eradicante-contro-lepatite-c-la-procura-di-torino-apre-uninchiesta]]></loc><lastmod>2015-05-25T08:55:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8211-epatite-c-a-disposizione-il-numero-verde-gratuito]]></loc><lastmod>2015-05-25T08:53:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8184-hiv-ed-epatite-c-almeno-25mila-i-pazienti-coinfetti-senza-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8114-epatite-c-tipo-2-5-gilead-annuncia-i-risultati-degli-studi-sui-regimi-terapeutici-a-base-di-sofosbuvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8115-epatite-c-gliead-annuncia-i-dati-del-regime-sperimentale-composto-da-sofosbuvir-gs-5816-e-gs-9857]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8117-epatite-c-in-fase-avanzata-harvoni-e-sovaldi-mostrano-efficacia-e-sicurezza]]></loc><lastmod>2015-06-08T11:29:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8093-epatite-c-presentati-nuovi-dati-su-simeprevir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/8026-epatite-c-un-vecchio-antistaminico-potrebbe-sconfiggere-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7988-epatite-c-nuova-terapia-promettente-che-dimezza-i-tempi-di-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7809-epatite-c-al-virus-e-associato-un-maggior-rischio-di-malattia-arteriosa-periferica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7689-epatite-c-in-toscana-nessuna-limitazione-ai-trattamenti-con-farmaci-innovativi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7627-epatite-c-arriva-in-italia-lantivirale-simeprevir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7626-in-arrivo-tre-nuovi-farmaci-contro-l-epatite-c]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7548-emergenza-epatite-c-quale-programmazione-sanitaria-per-combattere-la-malattia-e-garantire-laccesso-ai-nuovi-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7445-epatite-c-abbvie-annuncia-larrivo-di-un-nuovo-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7271-epatite-c-sofosbuvir-approvato-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7267-legge-di-stabilita-in-arrivo-15-miliardi-per-eradicare-epatite-c]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7175-epatite-c-confermata-lefficacia-della-combinazione-ledipasvirsofosbuvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7176-epatite-c-presentati-i-risultati-dello-studio-ally-al-the-liver-meeting-201-di-boston]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7138-epatite-c-la-commissione-europea-rilascia-lautorizzazione-per-limmissione-in-commercio-di-harvonri]]></loc><lastmod>2016-02-24T17:48:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7079-epatite-c-cronica-gilead-annuncia-i-risultati-dello-studio-con-harvonir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/7038-epatite-c-aifa-comunica-le-categorie-destinatarie-della-terapia-interferon-free-di-abbvie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6992-epatite-caifa-ha-reso-note-le-categorie-di-pazienti-a-cui-sara-rivolto-il-trattamento-di-abbvie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6949-epatite-c-pani-aifa-entro-un-mese-verranno-pubblicati-in-gazzetta-criteri-somministrazione-sofosbuvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6795-tribunale-per-i-diritti-del-malato-cittadinanzattiva-su-nuovi-farmaci-per-epatite-c-importante-passo-in-avanti-ma-il-diritto-va-garantito-in-tempi-certi-a-tutti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6788-epatite-c-raggiunto-laccordo-per-la-rimborsabilita-di-sovaldi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6765-epatite-c-il-chmp-esprime-parere-positivo-per-ledipasvirsofosbuvir-di-giliead-per-il-trattamento-dellinfezione-cronica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6658-epatite-c-farmaci-che-salvano-la-vita-ancora-indisponibili-non-possiamo-piu-aspettare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6628-epatite-c-arriva-il-si-dellema-alla-commercializzazione-di-daclatasvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6557-epatite-c-entro-il-2036-sara-una-malattia-rara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6501-epatite-c-in-italia-394-pazienti-trattati-con-sofosbuvir-aifa-chiedera-allargamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6483-lorenzin-presto-un-piano-nazionale-di-eradicazione-dellepatite-c]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6450-epatite-c-appello-a-gilead-di-5-societa-scientifiche-e-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6412-epatite-c-parere-favorevole-per-daclatasvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6414-epatite-c-risultati-positivi-per-il-regime-combinato-ledipasvir-sofosbuvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6415-epatite-c-competizione-farmaceutica-in-corso-per-la-prima-terapia-interamente-orale-e-interferon-free]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6304-epatite-c-e-cirrosi-la-prima-rete-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6262-epatite-c-uno-studio-evidenzia-gli-effetti-benefici-di-sofosbuvir-nella-prevenzione-delle-complicanze-legate-alla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6165-epatite-c-diversi-i-temi-trattati-al-congresso-epatiti-virali-tra-presente-e-futuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6067-epatite-c-cronica-risultati-positivi-per-la-terapia-interferone-pegilato-ribavirina-nei-pazienti-in-eta-pediatrica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/6043-epatite-c-risultati-positivi-per-la-terapia-antivirale-di-abbvie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5980-epatite-c-incontro-aifa-gilead-per-rendere-disponibile-sofosbuvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5952-epatite-c-bastano-8-settimane-per-sapere-se-la-triplice-terapia-funziona]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5945-epatite-c-lassociazione-sofosbuvir-e-ledispavir-ottiene-fino-al-100-dei-risultati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5919-epatite-c-nuovi-farmaci-di-ultima-generazione-primo-passo-verso-la-rivoluzione-terapeutica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5884-epatite-c-cronica-uno-studio-italiano-si-interessa-per-la-prima-volta-delle-popolazioni-speciali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5859-epatite-c-parere-positivo-del-chmp-per-simeprevir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5753-epatite-c-risultati-incoraggianti-per-la-terapiatripla-interferon-free]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5615-infezioni-da-epatite-c-si-possono-ridurre-anche-attraverso-interventi-comportamentali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5546-epatite-c-le-novita-ci-sono-informati-adesso-lanciata-la-nuova-campagna-di-sensibilizzazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5332-epatite-c-autorizzata-la-commercializzazione-di-sofosbuvir-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5279-epatite-c-risultati-positivi-per-il-farmaco-sperimentale-faldaprevir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5116-epatite-c-risultati-positivi-per-la-combinazione-antivirali-ribavirina-sviluppata-da-abbvie-pharmaceuticals]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/5054-epatite-c-parere-positivo-dellema-per-il-trattamento-con-sofosbuvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4967-epatite-c-risultati-positivi-per-i-farmaci-boehringer-ingelheim-nel-trattamento-senza-interferone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4918-epatite-c-parere-favorevole-del-chmp-per-uso-compassionevole-di-sofosbuvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4919-epatite-c-parere-positivo-dellfda-per-il-farmaco-simeprevir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4825-epatite-c-oggi-e-possibile-la-terapia-con-due-inibitori-orali-anche-in-combinazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4824-epatite-c-jassen-sviluppera-il-farmaco-sperimentale-gsk2336805]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4703-epatite-c-approvato-eltrombopag-per-il-trattamento-della-trombocitopenia-associata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4708-contagiati-da-trasfusioni-sbagliate-i-pazienti-hanno-diritto-al-risarcimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4594-epatite-c-al-via-le-sperimentazioni-di-fase-ii-per-i-farmaci-ad-azione-antivirale-diretta-di-boehringer-ingelheim]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4460-emotrasfusioni-in-abruzzo-gli-indennizzi-arrivano-in-ritardo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4370-epatite-in-campania-sono-84-mila-i-malati-lappello-degli-specialisti-da-napoli-la-cura-esiste-ma-in-pochi-lo-sanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4301-epatite-pronto-il-piano-nazionale-si-attende-lapprovazione-del-ministro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4118-epatite-c-ema-convalida-la-domanda-di-autorizzazione-di-sofosbuvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/4034-epatite-c-con-le-statine-si-abbassa-il-rischio-di-carcinoma-epatocellulare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/3977-epatite-c-la-sperimentazione-di-sofosbuvir-in-italia-e-stata-condotta-a-san-giovanni-rotondo-foggia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/3960-epatite-c-nuovi-dati-positivi-per-il-trattamento-con-sofosbuvir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/3827-epatite-c-approvato-il-trattamento-con-pegasys-anche-per-i-pazienti-pediatrici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/3700-epatite-c-sofosbuvir-di-gilead-raggiunge-lendpoint-primario-nel-quarto-studio-cardine-di-fase-iii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/3699-epatite-i-nuovi-farmaci-ancora-inaccessibili-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/3698-epatite-c-in-veneto-laccesso-ai-farmaci-e-disponibile-solo-nei-centri-di-riferimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/3506-epatite-c-al-via-larruolamento-dei-pazienti-per-la-terapia-senza-interferone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/3227-epatite-c-in-usa-approvato-eltrombopag-per-il-trattamento-della-trombocitopenia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/3177-epatite-c-i-farmaci-senza-interferone-sembrano-essere-piu-efficaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/2902-epatite-c-allitalia-spetta-il-primato-negativo-dellue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/2743-epatite-c-un-anticorpo-monoclonale-potrebbe-prevenire-linfezione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/2615-aifa-rimborsabili-due-nuovi-farmaci-contro-epatite-c-boceprevir-e-telaprevir]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/2503-epatite-la-bulgaria-lancia-lo-sviluppo-del-piano-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/2493-epatite-laspirina-potrebbe-protegge-dal-tumore-al-fegato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/2157-epatite-c-l-alleanza-contro-lepatite-denuncia-il-ritardo-di-aifa-nellapprovazione-dei-nuovi-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/2047-epatite-c-presentati-i-risultati-su-gs-7977-nuovo-farmaco-per-i-pazienti-con-infezione-da-genotipo-1]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/2038-epatite-c-bloccato-lo-sviluppo-di-alisporivir-il-farmaco-avrebbe-causato-un-decesso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/2025-epatite-c-la-terapia-migliore-il-italia-non-e-ancora-disponibile-i-pazienti-si-fanno-sentire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/1849-epatite-c-avviata-in-puglia-la-sperimentazione-di-un-nuovo-farmaco]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/1393-epatite-nasce-lalleanza-tra-medici-e-pazienti-per-combattere-la-malattia]]></loc><lastmod>2015-06-05T16:13:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/epatite-c/1280-epatite-c-ricercatore-sissa-indaga-lrna-per-capire-come-interrompere-la-replicazione-del-virus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/22725-dpcm-lea-verso-lapprovazione-cfu-italia-chiede-modifiche-alla-voce-dedicata-alla-fibromialgia]]></loc><lastmod>2026-02-09T18:56:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/22253-fibromialgia-cfu-italia-lancia-indagine-nazionale-rivolta-ai-pazienti]]></loc><lastmod>2025-08-21T08:49:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/21969-12-maggio-2025-si-accende-una-luce-viola-per-la-fibromialgia]]></loc><lastmod>2025-05-15T08:47:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/21464-fibromialgia-i-pazienti-italiani-chiedono-il-riconoscimento-della-patologia]]></loc><lastmod>2024-11-07T11:04:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/20988-fibromialgia-uno-studio-cerca-i-fattori-in-comune-con-l-emicrania]]></loc><lastmod>2024-05-20T06:58:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/19972-fibromialgia-a-barbara-suzzi-cfu-italia-odv-il-riconoscimento-di-ufficiale-della-repubblica]]></loc><lastmod>2023-07-07T14:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/19831-fibromialgia-indagine-nazionale-rivela-poca-trasparenza-e-troppe-differenze-regionali]]></loc><lastmod>2023-05-25T10:28:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/19353-fibromialgia-in-sardegna-approvata-l-indennita-regionale-di-800-euro-annui]]></loc><lastmod>2022-12-02T12:59:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/18355-fibromialgia-un-indagine-rivela-i-bisogni-dei-pazienti-per-vivere-meglio]]></loc><lastmod>2022-03-02T11:48:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17907-fibromialgia-tutte-le-opportunita-terapeutiche-disponibili-l-approccio-non-farmacologico]]></loc><lastmod>2021-10-20T15:08:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17912-fibromialgia-questa-illustre-sconosciuta]]></loc><lastmod>2021-10-22T07:32:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17911-fibromialgia-i-criteri-diagnostici-adottati-dalla-comunita-scientifica-internazionale]]></loc><lastmod>2021-10-21T07:26:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17910-fibromialgia-identificati-i-criteri-per-definire-la-severita-di-malattia]]></loc><lastmod>2021-10-21T07:14:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17909-fibromialgia-un-disegno-di-legge-per-riconoscerla-come-cronica-e-invalidante]]></loc><lastmod>2021-10-20T15:09:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17906-fibromialgia-un-pdta-italiano-esiste-ma-ancora-non-viene-applicato-a-livello-nazionale]]></loc><lastmod>2021-10-20T15:07:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17908-fibromialgia-le-opportunita-terapeutiche-disponibili-l-approccio-farmacologico]]></loc><lastmod>2021-10-20T15:08:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17890-fibromialgia-uno-studio-italiano-svela-i-legami-con-il-covid-19]]></loc><lastmod>2021-10-16T21:25:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17429-fibromialgia-cinque-giovani-illustratrici-danno-un-volto-alla-malattia]]></loc><lastmod>2021-05-12T14:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17383-fibromialgia-un-indagine-fa-luce-su-una-patologia-ancora-poco-compresa]]></loc><lastmod>2021-05-02T21:43:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/17318-fibromialgia-il-nostro-dolore-e-un-invisibile]]></loc><lastmod>2021-04-18T18:36:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/16673-fibromialgia-dalla-cannabis-una-possibile-opzione-terapeutica]]></loc><lastmod>2020-11-11T11:31:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/16357-fibromialgia-studio-genomico-evidenzia-una-componente-autoimmune]]></loc><lastmod>2020-08-02T16:27:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/15002-fibromialgia-e-disagio-lavorativo-al-via-uno-studio-sugli-accomodamenti-ragionevoli]]></loc><lastmod>2020-02-27T15:07:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/14927-fibromialgia-a-siena-uno-studio-per-valutare-i-livelli-di-gravita-della-malattia]]></loc><lastmod>2020-02-27T15:08:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/14915-fibromialgia-una-proposta-di-legge-per-riconoscerne-la-natura-cronica-e-invalidante]]></loc><lastmod>2020-02-27T15:08:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/14405-fibromialgia-tutte-le-iniziative-del-parlamento-e-delle-regioni]]></loc><lastmod>2020-02-27T15:08:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/14376-fibromialgia-in-sardegna-approvata-un-legge-per-la-tutela-dei-pazienti]]></loc><lastmod>2020-02-27T15:08:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/14233-fibromialgia-il-parlamento-al-lavoro-riconoscerne-la-condizione-invalidante]]></loc><lastmod>2020-02-27T15:09:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/14205-fibromialgia-un-interrogazione-per-riconoscerne-la-condizione-invalidante]]></loc><lastmod>2020-02-27T15:09:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/11557-fibromialgia-la-puglia-approva-mozione-per-il-riconoscimento-nazionale-di-malattia-rara]]></loc><lastmod>2020-02-27T15:12:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/11013-fibromialgia-emilia-romagna-prima-regione-a-fare-luce-sulla-malattia-invisibile]]></loc><lastmod>2020-02-27T15:14:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/9410-il-dr-giovanni-lombardi-la-crioterapia-sistemica-e-efficace-ma-dev-essere-sempre-associata-alla-terapia-convenzionale]]></loc><lastmod>2020-02-27T15:17:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/8506-fibromialgia-i-lattobacilli-dello-yogurt-migliorerebbero-la-patologia]]></loc><lastmod>2020-02-27T15:17:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/6960-fibromialgia-il-farmaco-memantina-riduce-il-dolore]]></loc><lastmod>2020-02-27T15:18:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/6306-fibromialgia-da-uno-studio-spagnolo-conferme-sullutilita-dellapproccio-terapeutico-multidisciplinare]]></loc><lastmod>2020-02-27T15:19:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/6197-fibromialgia-se-ne-e-parlato-allincontro-geff]]></loc><lastmod>2020-02-27T15:24:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/6168-fibromialgia-limportanza-della-terapia-multidisciplinare]]></loc><lastmod>2020-02-27T15:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/5920-fibromialgia-stimolazione-magnetica-transcranica-migliora-la-qualita-di-vita]]></loc><lastmod>2020-02-27T15:25:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/5728-fibromialgia-per-trattare-il-dolore-una-nuova-metodica-multidisciplinare]]></loc><lastmod>2020-02-27T15:27:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/5603-fibromialgia-delude-lo-spry-nasale-a-base-di-ossitocina]]></loc><lastmod>2020-02-27T15:27:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/5544-fibromialgia-lallenamento-sportivo-riduce-il-dolore]]></loc><lastmod>2020-02-27T15:30:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/5560-fibromialgia-ecco-i-nuovi-criteri-classificativi-per-la-diagnosi]]></loc><lastmod>2020-02-27T15:30:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/5393-fibromialgia-evelina-chiede-aiuto-alle-istituzioni-la-mia-malattia-ancora-non-riconosciuta]]></loc><lastmod>2020-02-27T15:32:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/5376-fibromialgia-la-vitamina-d-puo-migliorare-il-dolore]]></loc><lastmod>2020-02-27T15:33:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/5159-fibromialgia-nasce-a-verona-il-primo-centro-di-riferimento-nazionale-anfisc]]></loc><lastmod>2020-02-27T15:34:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/4904-fibromialgia-risultati-positivi-per-la-sperimentazione-con-il-farmaco-pregabalin]]></loc><lastmod>2020-02-27T15:35:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/4814-fibromialgia-dopo-anni-di-rifiuti-la-als-concede-il-riconoscimento-dellinvalidita]]></loc><lastmod>2020-02-27T15:37:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/4637-fibromialgia-il-farmaco-milnacipran-sembra-combattere-efficacemente-i-dolori-causati-dalla-malattia]]></loc><lastmod>2020-02-27T15:37:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/3914-fibromialgia-confermata-lefficacia-della-creatina]]></loc><lastmod>2020-02-27T15:39:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/3471-fibromialgia-in-friuli-venezia-giulia-verso-il-riconoscimento-della-malattia]]></loc><lastmod>2020-02-27T15:42:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/3168-fibromialgia-il-dolore-potrebbe-derivare-da-una-risposta-errata-dei-recettori-oppioidi]]></loc><lastmod>2020-02-27T15:42:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/3024-fibromialgia-in-veneto-si-chiede-il-riconoscimento-della-patologia]]></loc><lastmod>2020-02-27T15:44:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/2783-fibromialgia-luniversita-di-modena-e-reggio-emilia-cerca-volontari-per-studio-sulle-cause]]></loc><lastmod>2020-02-27T15:45:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/2565-fibromialgia-molti-pazienti-usano-la-marijuana-per-ottenere-sollievo-e-illegale-ma-non-ci-sono-studi-a-sufficienza-per-escludere-che-funzioni]]></loc><lastmod>2020-02-27T15:47:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/2416-fibromialgia-il-trattamento-con-sodio-ossibato-sembra-ridurre-il-dolore]]></loc><lastmod>2020-02-27T15:49:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/2405-fibromialgia-la-terapia-con-gh-allevia-il-dolore-migliorando-la-vita-dei-pazienti]]></loc><lastmod>2020-02-27T15:51:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/1735-fibromialgia-naltrexone-a-dosi-ridotte-potrebbe-ridurre-il-dolore]]></loc><lastmod>2020-02-27T16:08:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/1630-fibromialgia-lesercizio-fisico-allevia-il-dolore-cronico-e-migliora-la-memoria]]></loc><lastmod>2020-02-27T16:10:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibromialgia/10106-fibromialgia-per-ora-niente-esenzione-permanente-come-malattia-cronica]]></loc><lastmod>2020-02-27T15:15:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/22400-malattia-di-la-peyronie-disponibile-una-nuova-terapia-con-acido-ialuronico]]></loc><lastmod>2025-10-13T16:57:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/13554-malattia-di-la-peyronie-sempre-piu-raro-il-ricorso-alla-chirurgia-tradizionale]]></loc><lastmod>2018-05-11T18:21:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/13496-malattia-di-la-peyronie-oggi-c-e-una-terapia-efficace-per-il-pene-curvo]]></loc><lastmod>2018-04-28T12:53:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/12970-malattia-di-la-peyronie-con-collagenasi-miglioramenti-oggettivi-nel-96-dei-pazienti-trattati]]></loc><lastmod>2019-08-18T17:20:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/12761-malattia-di-la-peyronie-i-dati-real-life-confermano-l-efficacia-del-trattamento-con-collagenasi]]></loc><lastmod>2017-10-11T09:25:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/12316-malattia-di-la-peyronie-presentati-i-primi-dati-real-life-di-pazienti-trattati-con-collagenasi-in-italia]]></loc><lastmod>2017-10-11T09:28:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/12197-malattia-di-la-peyronie-eseguiti-in-italia-i-primi-interventi-terapeutici-con-collagenasi]]></loc><lastmod>2017-06-19T16:10:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/12198-malattia-di-la-peyronie-disponibile-in-italia-il-nuovo-trattamento-farmacologico-con-collagenasi]]></loc><lastmod>2017-06-19T16:09:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/8056-malattia-di-la-peyronie-ue-approva-nuovo-medicinale-a-base-di-collagenasi]]></loc><lastmod>2017-06-19T16:10:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/7386-malattia-di-peyroniechmp-approva-luso-di-xiapex]]></loc><lastmod>2017-04-18T16:23:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/6329-malattia-di-peyronie-dalla-ricerca-nuove-speranze-sul-trattamento-farmacologico]]></loc><lastmod>2019-06-18T18:10:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-la-peyronie/5983-malattia-di-peyronie-presentati-i-dati-circa-luso-di-xiaflex-xiapex]]></loc><lastmod>2017-04-18T16:30:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/22917-parkinson-i-segnali-da-non-ignorare-e-i-comportamenti-utili-per-la-salute-del-cervello]]></loc><lastmod>2026-04-08T17:33:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/22922-parkinson-arriva-in-italia-la-nuova-terapia-con-levodopa-carbidopa-ed-entacapone]]></loc><lastmod>2026-04-10T08:09:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/22875-parkinson-allasst-gaetano-pini-cto-disponibile-una-nuova-terapia]]></loc><lastmod>2026-04-09T17:14:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/22858-parkinson-esperti-italiani-invitano-alla-cautela-sulla-terapia-con-staminali-approvata-in-giappone]]></loc><lastmod>2026-03-19T18:49:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/22555-dialoghi-con-mr-parkinson-al-cinema-il-documentario-che-racconta-la-convivenza-con-la-patologia]]></loc><lastmod>2025-11-27T09:47:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/22444-parkinson-disponibile-in-italia-la-prima-apomorfina-sublinguale]]></loc><lastmod>2025-10-26T10:59:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/22185-malattia-di-parkinson-avviato-il-progetto-vampire-per-la-diagnosi-precoce]]></loc><lastmod>2025-07-14T09:26:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/22154-parkinson-e-cellule-staminali-l-allarme-degli-esperti-contro-false-terapie-e-disinformazione]]></loc><lastmod>2025-07-03T17:18:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/21651-parkinson-risultati-positivi-dallo-studio-post-autorizzativo-sulla-citicolina]]></loc><lastmod>2025-01-22T09:14:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/21612-terapie-cellulari-per-il-parkinson-una-storia-lunga-50-anni-e-l-europa-e-in-prima-linea]]></loc><lastmod>2024-12-27T13:29:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/21541-parkinson-oltre-il-tremore-una-malattia-che-e-cento-malattie]]></loc><lastmod>2024-11-29T16:21:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/21535-giornata-nazionale-parkinson-porte-aperte-ai-pazienti-in-piu-di-100-centri-specializzati-in-tutta-italia]]></loc><lastmod>2024-11-28T16:56:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/21368-parkinson-creato-un-modello-sperimentale-di-malattia-giovanile-per-studiarne-lo-sviluppo]]></loc><lastmod>2024-10-09T18:10:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/21194-parkinson-lo-stretto-di-messina-a-nuoto-per-sensibilizzare-il-pubblico-sulla-malattia]]></loc><lastmod>2024-07-22T15:30:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/20857-parkinson-si-avvia-alla-conclusione-lo-studio-clinico-sulla-citicolina]]></loc><lastmod>2024-04-10T08:36:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/20863-malattia-di-parkinson-l-11-aprile-e-la-giornata-mondiale]]></loc><lastmod>2024-04-10T18:21:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/20820-malattia-di-parkinson-rimborsabile-in-italia-la-terapia-con-foslevodopa-foscarbidopa]]></loc><lastmod>2024-03-29T09:41:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/20732-parkinson-al-mondino-di-pavia-prime-somministrazioni-di-una-nuova-terapia]]></loc><lastmod>2024-03-08T11:55:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/20192-parkinson-300mila-gli-italiani-colpiti-dalla-patologia]]></loc><lastmod>2023-10-03T17:05:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/19741-parkinson-e-alzheimer-nella-laguna-di-venezia-il-segreto-per-sconfiggere-le-due-patologie]]></loc><lastmod>2023-04-21T19:41:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/19711-parkinson-l-esposizione-ad-ambienti-naturali-puo-ridurre-il-rischio-di-ospedalizzazioni]]></loc><lastmod>2023-04-11T14:43:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/18769-parkinson-il-consumo-moderato-di-caffe-potrebbe-essere-un-fattore-protettivo]]></loc><lastmod>2022-06-13T15:46:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/18526-malattia-di-parkinson-oggi-e-la-giornata-mondiale]]></loc><lastmod>2022-04-09T20:12:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/18475-parkinson-al-via-indagine-record-sulle-mutazioni-del-gene-gba]]></loc><lastmod>2022-03-28T20:45:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/18040-malattia-di-parkinson-il-27-novembre-si-celebre-la-giornata-nazionale]]></loc><lastmod>2021-11-27T09:57:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/17982-malattia-di-parkinson-nuove-speranze-terapeutiche-dall-alfa-sinucleina]]></loc><lastmod>2021-11-08T12:28:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/17691-malattia-di-parkinson-effettuato-a-siena-un-innovativo-intervento-di-neuromodulazione]]></loc><lastmod>2021-07-25T19:01:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/17341-parkinson-scoperto-un-nuovo-meccanismo-alla-base-della-malattia]]></loc><lastmod>2021-04-25T23:46:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/17319-parkinson-nasce-a-milano-un-laboratorio-per-la-valutazione-della-disautonomia]]></loc><lastmod>2021-04-18T19:04:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/16290-malattia-di-parkinson-dimostrati-gli-effetti-di-lunga-durata-della-terapia-con-levodopa]]></loc><lastmod>2020-07-13T12:04:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/16268-parkinson-3-200-interventi-in-teleassistenza-durante-l-emergenza-covid-19]]></loc><lastmod>2020-07-05T20:47:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/16192-malattia-di-parkinson-la-patologia-non-aumenta-il-rischio-di-covid-19]]></loc><lastmod>2020-06-16T17:15:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/15898-covid-19-una-help-line-per-i-pazienti-con-parkinson-o-altri-disordini-del-movimento]]></loc><lastmod>2020-04-02T15:33:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/14838-parkinson-aifa-rassicura-sulla-disponibilita-del-farmaco-sinemet]]></loc><lastmod>2019-05-21T14:30:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/14141-parkinson-il-legame-con-la-gaucher-e-la-speranza-di-una-diagnosi-precoce]]></loc><lastmod>2018-11-09T15:47:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/13949-parkinson-in-giappone-il-primo-trial-clinico-con-staminali-pluripotenti-indotte]]></loc><lastmod>2018-09-22T10:04:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/13638-parkinson-arriva-una-app-per-i-pazienti-e-per-chi-li-assiste]]></loc><lastmod>2018-06-07T15:22:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/13578-malattia-di-parkinson-la-caffeina-potra-semplificare-la-diagnosi]]></loc><lastmod>2018-05-21T09:47:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/12935-parkinson-al-via-studio-italiano-per-scoprire-come-prevenire-la-malattia]]></loc><lastmod>2017-11-21T19:26:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/12697-malattia-di-parkinson-un-nuovo-metodo-per-la-riabilitazione-cognitiva-del-movimento]]></loc><lastmod>2017-09-26T10:09:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/12576-malattia-di-parkinson-come-conviverci-in-estate]]></loc><lastmod>2017-08-09T15:11:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/12038-malattia-di-parkinson-una-storia-lunga-due-secoli]]></loc><lastmod>2017-06-19T16:17:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/11644-giornata-della-malattia-di-parkinson-la-sin-ribadisce-l-importanza-della-diagnosi-precoce]]></loc><lastmod>2018-06-07T15:24:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/11645-parkinson-un-legume-puo-migliorare-le-condizioni-dei-pazienti]]></loc><lastmod>2017-06-19T16:15:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/10964-malattia-di-parkinson-il-farmaco-xadago-safinamide-arriva-anche-in-olanda]]></loc><lastmod>2018-06-07T15:25:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/10831-parkinson-necessaria-cautela-nei-confronti-degli-studi-clinici-sulle-cellule-staminali]]></loc><lastmod>2017-06-19T16:17:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/10743-malattia-di-parkinson-zambon-lancia-il-farmaco-xadago-safinamide-nel-regno-unito]]></loc><lastmod>2018-06-07T15:25:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/10721-parkinson-il-farmaco-xadago-safinamide-disponibile-anche-in-danimarca-e-svezia]]></loc><lastmod>2018-06-07T15:26:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/10334-morbo-di-parkinson-oggi-la-giornata-mondiale]]></loc><lastmod>2018-06-07T15:26:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/10277-malattia-di-parkinson-primi-test-su-nuova-tecnologia-3d-per-il-trapianto-di-cellule-nervose]]></loc><lastmod>2018-06-07T15:27:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/10099-malattia-di-parkinson-safinamide-ora-disponibile-anche-in-italia]]></loc><lastmod>2018-06-07T15:27:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/10003-malattia-di-parkinson-eltoprazina-dichiarata-farmaco-orfano-dalla-fda]]></loc><lastmod>2018-06-07T15:28:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9944-parkinson-testato-un-nuovo-metodo-per-la-diagnosi-precoce-della-patologia]]></loc><lastmod>2018-06-07T15:28:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9943-malattia-di-parkinson-necessaria-fisioterapia-piu-mirata]]></loc><lastmod>2018-06-07T15:28:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9844-parkinson-rivastigmina-puo-migliorare-la-stabilita-dell-andatura]]></loc><lastmod>2018-06-07T15:29:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9840-parkinson-tecnica-del-gel-intestinale-di-levodopa-carbidopa-sicura-e-tollerata]]></loc><lastmod>2018-06-07T15:30:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9808-parkinson-sperimentazione-clinica-sul-farmaco-per-il-colesterolo-alto-simvastatina]]></loc><lastmod>2018-06-07T15:30:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9765-malattia-di-parkinson-dipraglurant-diventa-farmaco-orfano-negli-usa]]></loc><lastmod>2018-06-07T15:31:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9710-parkinson-usa-abilitano-amarantus-al-brevetto-di-eltoprazina-per-la-terapia-della-discinesia-da-levodopa]]></loc><lastmod>2016-01-08T11:38:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9692-parkinson-esiti-neuroprotettivi-dalla-sperimentazione-animale-del-farmaco-lbt-3627]]></loc><lastmod>2018-06-07T15:32:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9682-parkinson-l-impiego-notturno-di-rotigotina-allevia-i-disturbi-del-sonno-associati-alla-patologia]]></loc><lastmod>2018-06-07T15:32:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9609-parkinson-al-via-la-campagna-di-sensibilizzazione-di-parkinson-italia-onlus]]></loc><lastmod>2018-06-07T15:33:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9482-parkinson-arriva-la-stimolazione-automatica-meccanica-periferica]]></loc><lastmod>2015-11-30T15:39:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9448-parkinson-a-bologna-nasce-il-primo-percorso-diagnostico-terapeutico-assistenziale]]></loc><lastmod>2018-06-07T15:34:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9453-parkinson-piccola-sperimentazione-del-farmaco-antileucemico-nilotinib-registra-risultati-incoraggianti]]></loc><lastmod>2018-06-07T15:34:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9446-giornata-nazionale-parkinson-ecco-le-regioni-in-cui-ci-si-ammala-di-piu]]></loc><lastmod>2015-11-27T10:30:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9393-parkinson-250mila-casi-in-italia-ma-poche-regioni-hanno-uno-specifico-pdta]]></loc><lastmod>2015-11-20T09:24:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9335-parkinson-il-28-novembre-la-giornata-nazionale]]></loc><lastmod>2015-11-11T15:48:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/9021-malattia-di-parkinson-e-disordini-del-movimento-dal-i-congresso-dell-accademia-limpe-dismov-nuove-frontiere-terapeutiche]]></loc><lastmod>2015-10-01T11:05:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/8741-malattia-di-parkinson-in-avvio-lo-studio-di-fase-iii-del-farmaco-sperimentale-tozadenant]]></loc><lastmod>2015-07-31T10:59:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/8652-parkinson-il-cto-asl-roma-c-diventa-centro-di-riferimento-specialistico-regionale-per-la-neurochirurgia]]></loc><lastmod>2015-07-21T08:26:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/8400-malattia-di-parkinson-accordo-tra-biotie-e-fda-su-un-protocollo-speciale-di-valutazione-per-tozadenant]]></loc><lastmod>2015-06-05T15:03:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/8276-parkinson-la-denuncia-delle-associazioni-in-lombardia-farmaci-piu-costosi-e-difficili-da-reperire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/8252-malattia-di-parkinson-zambon-lancia-xadago-in-germania]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/8102-malattia-di-parkinson-presentato-il-dossier-registrativo-per-safinamide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/8027-morbo-di-parkinson-studio-dimostra-una-diminuzione-dei-batteri-intestinali-nei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/7852-parkinson-fda-approva-immissione-in-commercio-di-safinamide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/7765-parkinson-maggiori-difficolta-per-le-donne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/7614-parkinson-nuova-promettente-terapia-a-base-di-opicapone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/7572-parkinson-pazienti-europei-in-rete-con-il-progetto-pd-manager-dellirccs-san-camillo]]></loc><lastmod>2018-02-15T17:52:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/7476-malattia-di-parkinson-lfda-approva-la-combinazione-carbidopalevodopa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/7194-giornata-nazionale-della-malattia-di-parkinson-rivoluzione-nel-trattamento-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/7193-il-gemelli-per-la-giornata-nazionale-parkinson]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/7039-malattia-di-parkinson-scoperta-la-causa-della-forma-giovanile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/6614-malattia-di-parkinson-trattata-con-un-farmaco-che-provoca-orgasmi-multipli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/6493-malattia-di-parkinson-scoperti-sei-nuovi-fattori-genetici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/6506-parkinson-nuove-prospettive-grazie-alla-ricerca-italiana]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/6460-malattia-di-parkinson-studio-fase-2b-mostra-tollerabilita-ed-efficacia-del-tozadenant]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/6331-malattia-di-parkinson-le-donne-sottoposte-a-terapia-sono-meno-inclini-degli-uomini-a-sviluppare-sintomi-non-motori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/6309-morbo-di-parkinson-da-uno-studio-italiano-risultati-positivi-per-linibitore-rasagilina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/6312-malattia-di-parkinson-gli-istituti-clinici-di-perfezionamento-di-milano-icp-hanno-inaugurato-i-nuovi-ambulatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/6221-malattia-di-parkinson-numeri-in-crescita-nel-nostro-paese-e-cure-spesso-inadeguate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/6169-parkinsonstudio-cnr-identifica-un-nuovo-processo-neurodegenerativo-specifico-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/5953-parkinson-i-dieci-segnali-che-possono-precedere-linsorgenza-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/5942-parkinson-un-cerotto-per-tenere-sotto-controllo-i-parametri-e-somministrare-i-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/5824-parkinson-lab-360d-al-via-primo-laboratorio-multidisciplinare-dedicato-alle-persone-con-malattia-di-parkinson]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/5773-morbo-di-parkinson-un-gruppo-di-ricercatori-italiani-fotografano-la-regione-profonda-del-cervello-colpita-dalla-malattia-grazie-alla-risonanza-magnetica-a-campo-ultra-alto-della-fondazione-imago-7]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/5617-parkinson-il-pramipexolo-er-pare-essere-efficace-e-sicuro-a-lungo-termine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/5285-parkinson-roche-si-accorda-con-prothena-per-lo-sviluppo-di-un-nuovo-farmaco-sperimentale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/5274-parkinson-da-uno-studio-internazionale-nuovi-dati-sul-trattamento-con-levadopa-e-safinamide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/5051-parkinson-linea-diretta-con-il-neurologo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/4989-parkinson-il-30-novembre-la-giornata-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/4990-nasce-losservatorio-nazionale-parkinson-la-presentazione-il-19-novembre-a-milano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/4874-malattia-di-parkinson-risultati-positivi-per-la-sperimentazione-di-ipx066]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/4505-morbo-di-parkinson-studio-innovativo-suggerisce-luso-della-chinetina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/4371-parkinson-idrocarburi-solventi-e-pesticidi-sono-fattori-di-rischio-per-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/4124-parkinson-aggiornate-le-linee-guida-dellistituto-superiore-di-sanita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/3947-parkinson-dal-mannitolo-una-potenziale-terapia-per-ora-testata-sul-modello-animale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/3737-parkinson-la-neurostimolazione-subtalamica-precoce-puo-essere-unarma-contro-le-complicanze-motorie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/3490-parkinson-possibile-diagnosticarlo-con-un-test-delle-ghiandole-salivari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/3452-parkinson-a-milano-si-sperimenta-una-terapia-a-base-di-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2969-parkinson-nuove-conferme-per-il-ruolo-dellalfa-sinucleina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2714-parkinson-la-stimolazione-cerebrale-profonda-per-aiutare-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2726-parkinson-proseguono-gli-studi-sul-farmaco-a-base-di-piombo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2699-parkinson-il-fumo-di-sigaretta-impedisce-la-progressione-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2620-parkinson-il-caffe-puo-attenuarne-i-sintomi-motori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2435-parkinson-la-diagnosi-potrebbe-arrivare-dalla-voce-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2374-parkinson-kevin-vive-con-la-malattia-da-20-anni-e-si-racconta-in-un-libro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2347-malattia-di-parkinson-in-austria-primi-studi-per-un-vaccino]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2272-malattia-di-parkinson-a-milano-un-progetto-per-la-gestione-domiciliare-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2033-malattia-di-parkinson-linfusione-intestinale-di-levodopa-e-carbidopa-promette-risultati-migliori-di-quella-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/2010-malattia-di-parkinson-gli-antidepressivi-sono-potenzialmente-efficaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1981-malattia-di-parkinson-accordo-tra-newron-e-zambon-farmaceutici-per-il-safinamide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1745-morbo-di-parkinson-scoperta-alle-scotte-una-nuova-forma-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1713-parkinson-la-sopravvivenza-dipende-da-fattori-demografici-e-clinici-meno-a-rischio-le-donne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1683-parkinson-e-hiv-calano-i-costi-degli-integratori-alla-papaya-fermentata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1430-parkinson-dormire-fa-bene-ma-il-sonno-puo-essere-un-problema]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1405-parkinson-durante-la-terapia-con-levadopa-utile-evitare-proteine-di-giorno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1400-parkinson-le-cadute-sono-un-problema-grave-ecco-come-prevenirle]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1399-arkinson-corrette-informazioni-allenamento-motorio-e-supporto-psicologico-sono-il-primo-passo-per-convivere-con-la-ma]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1394-parkinson-oggi-la-giornata-nazionale-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1267-parkinson-chi-si-ammala-oggi-ha-solo-il-40-per-cento-delle-possibilita-di-avere-le-migliori-cure]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1078-parkinson-completato-arruolamento-per-lo-studio-di-fase-tre-con-safinamide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/1012-parkinson-dalle-cellule-della-pelle-di-un-paziente-riprodotti-i-neuroni-malati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/949-parkinson-completato-larruolamento-di-pazienti-per-lo-studio-di-fase-tre-motion]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson/932-parkinson-studio-sulla-popolazione-sarda-ha-permesso-di-trovare-nuovo-gene-responsabile]]></loc><lastmod>2018-12-27T19:06:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/22789-sclerosi-multipla-6-9-milioni-di-euro-per-3-progetti-di-studio-sulle-forme-progressive]]></loc><lastmod>2026-02-24T08:31:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/22698-sclerosi-multipla-due-nuovi-tasselli-sul-ruolo-del-virus-di-epstein-barr]]></loc><lastmod>2026-01-27T23:30:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/22528-sclerosi-multipla-pediatrica-e-mononucleosi-la-correlazione-potrebbe-essere-diretta]]></loc><lastmod>2025-11-18T18:06:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/22036-la-sclerosi-multipla-cambia-volto-grazie-ai-big-data]]></loc><lastmod>2026-02-28T15:21:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/21434-sclerosi-multipla-al-via-il-progetto-agenda-della-sclerosi-multipla-e-patologie-correlate-2025]]></loc><lastmod>2024-10-28T17:11:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/21275-sclerosi-multipla-tolebrutinib-raggiunge-l-endpoint-primario-nello-studio-di-fase-iii-hercules]]></loc><lastmod>2024-09-10T16:32:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/21023-sclerosi-multipla-oggi-la-giornata-mondiale]]></loc><lastmod>2024-05-28T10:02:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/21010-sclerosi-multipla-disponibile-in-italia-il-primo-biosimilare-a-base-di-natalizumab]]></loc><lastmod>2024-05-24T14:36:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/20928-sclerosi-multipla-recidivante-nuovi-dati-clinici-confermano-l-efficacia-sostenuta-di-frexalimab]]></loc><lastmod>2024-05-03T10:40:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/20693-sclerosi-multipla-recidivante-positivi-i-dati-clinici-di-fase-ii-su-frexalimab]]></loc><lastmod>2024-02-28T17:46:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/20443-sclerosi-multipla-e-neuromielite-ottica-da-aism-le-nuove-comunicazioni-tecnico-scientifiche-per-l-accertamento-dell-invalidita]]></loc><lastmod>2024-02-28T17:46:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/20255-sclerosi-multipla-presentati-nuovi-dati-sull-efficacia-a-lungo-termine-di-ocrelizumab]]></loc><lastmod>2023-10-26T18:39:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/20187-malattie-neurologiche-disimmuni-grazie-a-marcatori-sierologici-passi-avanti-nella-diagnosi]]></loc><lastmod>2023-10-02T17:24:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/20012-sclerosi-multipla-positivi-risultati-di-fase-iii-per-ocrelizumab-in-formulazione-sottocutanea]]></loc><lastmod>2023-07-20T10:31:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/19708-sclerosi-multipla-mettere-a-dieta-il-sistema-immunitario-per-combattere-la-malattia]]></loc><lastmod>2023-04-13T17:16:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/19625-sclerosi-multipla-aperto-il-nuovo-bando-fism-per-la-ricerca]]></loc><lastmod>2023-03-12T10:37:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/19477-sclerosi-multipla-ad-aism-e-fism-il-premio-icpermed-best-practice-in-personalised-medicine-recognition-2022]]></loc><lastmod>2023-01-21T21:42:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/19443-sclerosi-multipla-pubblicati-i-risultati-del-primo-studio-al-mondo-con-cellule-staminali-neurali]]></loc><lastmod>2023-01-12T13:01:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/19232-sclerosi-multipla-nuovi-dati-confermano-efficacia-e-sicurezza-di-ocrelizumab]]></loc><lastmod>2022-10-30T12:44:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/19233-sclerosi-multipla-al-via-la-campagna-diamo-uno-strappo-alla-sm]]></loc><lastmod>2022-10-30T12:45:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/19185-sclerosi-multipla-ponesimod-rimborsabile-in-italia]]></loc><lastmod>2022-10-19T14:01:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/19079-sclerosi-multipla-l-appello-di-aism-alle-forze-politiche]]></loc><lastmod>2022-09-17T20:59:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/18994-sclerosi-multipla-dalla-sin-le-prime-linee-guida-italiane-dedicate-alla-patologia]]></loc><lastmod>2022-08-12T10:00:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/18799-sclerosi-multipla-nasce-un-app-per-l-autovalutazione-delle-funzioni-cognitive]]></loc><lastmod>2022-06-18T14:35:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/18626-sclerosi-multipla-nasce-l-app-esprimiti]]></loc><lastmod>2022-05-07T21:23:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/18360-sclerosi-multipla-dall-analisi-delle-proteine-del-sangue-nuove-prospettive-di-ricerca]]></loc><lastmod>2022-02-27T20:29:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/18266-sclerosi-multipla-al-via-la-campagna-di-aism-l-apparenza-inganna]]></loc><lastmod>2022-02-07T15:31:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/18161-sclerosi-multipla-al-via-la-campagna-aism-il-futuro-sei-tu]]></loc><lastmod>2022-01-07T12:47:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/18075-sclerosi-multipla-due-video-per-far-conoscere-la-spasticita-associata]]></loc><lastmod>2021-12-05T22:22:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17937-sclerosi-multipla-presentati-nuovi-dati-clinici-a-lungo-termine-su-tolebrutinib]]></loc><lastmod>2021-10-28T22:10:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17837-sclerosi-multipla-alla-milano-fashion-week-le-scarpe-di-chi-non-si-ferma]]></loc><lastmod>2021-09-30T14:39:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17825-sclerosi-multipla-e-gravidanza-compito-del-ginecologo-e-anche-quello-di-trasmettere-serenita-alla-paziente]]></loc><lastmod>2021-09-30T14:40:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17775-sclerosi-multipla-progressiva-identificata-proteina-chiave-nel-processo-neurodegenerativo]]></loc><lastmod>2021-09-14T11:40:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17762-sclerosi-multipla-e-gravidanza-l-aspetto-psicologico-non-va-sottovalutato]]></loc><lastmod>2021-09-10T17:22:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17732-sclerosi-multipla-alle-pazienti-va-fornito-un-counseling-sulla-maternita-fin-dalla-diagnosi]]></loc><lastmod>2021-08-29T18:32:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17690-sclerosi-multipla-aggiornate-le-condizioni-per-la-prescrizione-di-cladribina-compresse]]></loc><lastmod>2021-07-25T18:54:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17626-sclerosi-multipla-scoperto-nuovo-meccanismo-di-demielinizzazione]]></loc><lastmod>2021-07-06T17:49:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17597-sclerosi-multipla-ce-approva-l-uso-di-teriflunomide-in-bambini-e-adolescenti]]></loc><lastmod>2021-06-28T00:48:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17564-sclerosi-multipla-realizzato-un-white-paper-su-nuove-tecnologie-per-il-patient-journey]]></loc><lastmod>2021-06-20T17:57:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17565-sclerosi-multipla-dalle-lipossine-un-possibile-strumento-per-combattere-la-malattia]]></loc><lastmod>2021-06-20T18:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17519-sclerosi-multipla-un-indagine-fa-luce-sulla-percezione-della-malattia-da-parte-degli-italiani]]></loc><lastmod>2021-06-06T21:39:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17499-sclerosi-multipla-approvazione-europea-per-ponesimod]]></loc><lastmod>2021-05-31T18:43:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17489-giornata-mondiale-della-sclerosi-multipla-2021-uno-studio-sul-covid-19]]></loc><lastmod>2021-05-30T16:32:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17484-diventare-mamma-quando-si-ha-la-sclerosi-multipla-falsi-miti-pianificazione-e-gestione-della-gravidanza-con-il-supporto-delle-equipe-multidisciplinari]]></loc><lastmod>2021-05-28T11:22:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17426-sclerosi-multipla-la-malattia-di-per-se-non-comporta-una-gravidanza-a-rischio]]></loc><lastmod>2021-05-18T09:47:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17331-sclerosi-multipla-nelle-donne-in-gravidanza-il-rischio-di-depressione-e-piu-alto]]></loc><lastmod>2021-04-25T16:06:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17183-sclerosi-multipla-nasce-la-rete-red-di-aism]]></loc><lastmod>2021-03-14T19:13:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/17100-sclerosi-multipla-i-pazienti-trattati-con-cladribina-sviluppano-una-risposta-ai-vaccini-comuni]]></loc><lastmod>2022-04-21T12:48:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16929-sclerosi-multipla-le-staminali-ematopoietiche-sembrano-bloccare-la-progressione-di-malattia]]></loc><lastmod>2021-01-24T21:32:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16905-sclerosi-multipla-al-via-il-programma-virtual-nurse]]></loc><lastmod>2021-01-20T00:11:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16831-sclerosi-multipla-con-un-adeguata-pianificazione-la-gravidanza-e-assolutamente-possibile]]></loc><lastmod>2020-12-21T20:37:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16818-sclerosi-multipla-le-cellule-che-producono-mielina-sono-sane-e-funzionanti]]></loc><lastmod>2020-12-16T14:49:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16617-sclerosi-multipla-al-via-la-campagna-sm-e-gravidanza-semplicemente-mamma]]></loc><lastmod>2020-10-26T14:17:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16478-sclerosi-multipla-presentato-uno-studio-sui-livelli-di-fatigue-dei-pazienti]]></loc><lastmod>2020-09-24T14:11:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16390-sclerosi-multipla-il-mancato-controllo-del-virus-di-epstein-barr-e-concausa-della-malattia]]></loc><lastmod>2020-08-27T23:41:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16333-sclerosi-multipla-fino-al-19-ottobre-si-puo-partecipare-al-premio-innovazione-digitale]]></loc><lastmod>2020-07-26T18:51:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16266-sclerosi-multipla-da-fism-un-finanziamento-di-5-milioni-di-euro-per-la-ricerca]]></loc><lastmod>2020-07-05T20:10:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16267-sclerosi-multipla-il-futuro-della-gestione-del-paziente-tra-continuita-e-innovazione]]></loc><lastmod>2020-07-05T20:31:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16191-sclerosi-multipla-verificata-l-efficacia-del-questionario-per-la-diagnosi-di-disfagia]]></loc><lastmod>2020-06-16T17:00:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16162-sclerosi-multipla-nuovi-dati-a-lungo-termine-su-efficacia-e-sicurezza-di-evobrutinib]]></loc><lastmod>2020-06-10T10:48:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16122-sclerosi-multipla-il-30-maggio-un-evento-per-connettere-i-pazienti-di-tutto-il-mondo]]></loc><lastmod>2020-05-29T09:58:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16114-sclerosi-multipla-nasce-il-progetto-formativo-sm]]></loc><lastmod>2020-05-26T22:35:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16066-sclerosi-multipla-e-covid-19-pubblicati-i-risultati-del-primo-studio-al-mondo]]></loc><lastmod>2020-05-13T21:30:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/16036-sclerosi-multipla-risultati-clinici-incoraggianti-da-nuovo-inibitore-della-proteina-btk]]></loc><lastmod>2020-05-05T17:35:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15949-sclerosi-multipla-e-covid-19-nasce-piattaforma-globale-per-la-raccolta-dati]]></loc><lastmod>2020-04-14T11:22:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15899-covid-19-e-sclerosi-multipla-arriva-l-assistente-virtuale-amica-mya]]></loc><lastmod>2020-04-02T15:55:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15850-sclerosi-multipla-raccomandazioni-globali-su-covid-19]]></loc><lastmod>2020-03-25T14:32:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15684-sclerosi-multipla-e-malattie-rare-abbinate-in-nuovo-modello-di-ricerca]]></loc><lastmod>2020-02-20T22:07:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15640-sclerosi-multipla-sul-palco-di-sanremo-la-danza-di-ivan-cottini-contro-la-malattia]]></loc><lastmod>2020-02-07T08:44:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15558-sclerosi-multipla-piu-bisogni-insoddisfatti-e-meno-qualita-di-vita]]></loc><lastmod>2020-01-07T18:06:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15384-sclerosi-multipla-un-algoritmo-per-predirne-l-evoluzione]]></loc><lastmod>2019-11-07T17:52:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15298-sclerosi-multipla-identificata-una-mappa-genetica-dettagliata-della-patologia]]></loc><lastmod>2019-10-10T21:19:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15224-sclerosi-multipla-presentata-all-ectrims-l-iniziativa-globale-proms]]></loc><lastmod>2019-09-22T00:12:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15225-sclerosi-multipla-nuovi-dati-su-ocrelizumab-mostrano-una-ridotta-progressione-della-disabilita]]></loc><lastmod>2019-09-22T00:21:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15205-sclerosi-multipla-gli-interferoni-beta-non-hanno-effetto-sugli-esiti-delle-gravidanze]]></loc><lastmod>2019-09-19T12:38:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15184-sclerosi-multipla-merck-avvia-programma-di-fase-iii-con-evobrutinib]]></loc><lastmod>2019-09-13T14:06:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15084-sclerosi-multipla-i-consigli-per-gestire-il-caldo]]></loc><lastmod>2019-07-30T14:42:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/15036-sclerosi-multipla-al-via-la-iv-edizione-del-premio-merck-in-neurologia]]></loc><lastmod>2019-10-16T14:40:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14871-sclerosi-multipla-la-ricerca-dell-iss-per-contrastare-la-patologia]]></loc><lastmod>2019-06-02T17:56:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14866-sclerosi-multipla-oggi-ricorre-la-giornata-mondiale]]></loc><lastmod>2019-10-16T14:41:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14812-sclerosi-multipla-nuovi-dati-confermano-l-efficacia-di-dimetil-fumarato-e-natalizumab]]></loc><lastmod>2019-05-15T16:03:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14813-sclerosi-multipla-identificata-nei-linfociti-b-e-nei-monociti-l-espressione-alterata-di-nuovi-geni-associati-alla-malattia]]></loc><lastmod>2019-05-15T16:22:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14760-sclerosi-multipla-cladribina-compresse-ora-e-rimborsabile-anche-in-italia]]></loc><lastmod>2019-04-25T18:02:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14680-sclerosi-multipla-approvato-negli-usa-il-farmaco-orale-siponimod]]></loc><lastmod>2019-04-04T17:46:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14610-sclerosi-multipla-dal-governo-possibile-marcia-indietro-sulla-riabilitazione]]></loc><lastmod>2019-05-03T16:52:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14489-sclerosi-multipla-riparte-l-iniziativa-di-merck-sul-tema-genitorialita]]></loc><lastmod>2019-10-16T14:41:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14315-sclerosi-multipla-nuovi-dati-sulla-sicurezza-dell-interferone-beta-1b-in-gravidanza]]></loc><lastmod>2018-12-27T18:47:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14277-sclerosi-multipla-fingolimod-approvato-in-europa-per-bambini-e-adolescenti]]></loc><lastmod>2018-12-13T16:08:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14077-sclerosi-multipla-all-ectrims-nuovi-dati-su-teriflunomide-e-alemtuzumab]]></loc><lastmod>2018-10-24T21:57:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14070-sclerosi-multipla-presentati-all-ectrims-gli-studi-condotti-da-novartis]]></loc><lastmod>2018-10-22T16:53:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14065-sclerosi-multipla-un-indagine-mondiale-rivolta-ai-caregivers]]></loc><lastmod>2018-10-21T18:01:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14050-sclerosi-multipla-ocrelizumab-riduce-la-progressione-della-disabilita]]></loc><lastmod>2018-10-16T17:54:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14051-sclerosi-multipla-fda-ed-ema-accettano-domanda-di-registrazione-per-siponimod]]></loc><lastmod>2018-10-16T17:54:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/14026-sclerosi-multipla-ocrelizumab-approvato-in-italia]]></loc><lastmod>2018-10-11T09:37:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13954-sclerosi-multipla-ok-del-chmp-per-l-uso-di-fingolimod-a-partire-dai-10-anni-d-eta]]></loc><lastmod>2018-09-21T13:53:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13918-sclerosi-multipla-ancora-pochi-giorni-per-partecipare-al-premio-merck-in-neurologia]]></loc><lastmod>2018-09-13T15:34:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13855-sclerosi-multipla-lo-sport-all-aria-aperta-fa-bene]]></loc><lastmod>2018-08-22T08:46:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13745-sclerosi-multipla-nuovi-dati-confermano-l-efficacia-di-cladribina-compresse]]></loc><lastmod>2019-04-25T17:23:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13728-sclerosi-multipla-la-sfida-vinta-da-cristina-e-massimiliano-a-nuoto]]></loc><lastmod>2018-07-04T11:03:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13678-sclerosi-multipla-nuovi-dati-positivi-su-sicurezza-ed-efficacia-di-ocrelizumab]]></loc><lastmod>2018-06-17T18:00:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13660-sclerosi-multipla-al-via-la-iii-edizione-del-premio-merck-in-neurologia]]></loc><lastmod>2018-06-13T14:45:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13634-sclerosi-multipla-interferone-beta-sicuro-e-tollerato-anche-in-gravidanza]]></loc><lastmod>2018-06-07T11:39:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13601-sclerosi-multipla-novartis-con-aism-per-celebrare-50-anni-di-lotta-contro-la-patologia]]></loc><lastmod>2018-05-26T21:36:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13576-sclerosi-multipla-recidivante-pediatrica-fingolimod-approvato-dalla-fda]]></loc><lastmod>2018-05-20T19:36:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13553-sclerosi-multipla-grande-successo-per-la-seconda-edizione-di-afiancodelcoraggio]]></loc><lastmod>2018-05-11T18:09:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13511-sclerosi-multipla-recidivante-nuovi-dati-positivi-per-ocrelizumab]]></loc><lastmod>2018-05-02T15:41:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13406-sclerosi-multipla-siponimod-ritarderebbe-significativamente-la-progressione-della-disabilita]]></loc><lastmod>2018-04-04T15:50:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13405-sclerosi-multipla-da-aism-un-bando-di-5-milioni-per-la-ricerca]]></loc><lastmod>2018-04-04T15:30:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13325-sclerosi-multipla-il-trapianto-di-cellule-staminali-neurali-riduce-l-infiammazione-cronica-del-sistema-nervoso-centrale]]></loc><lastmod>2018-03-09T04:08:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13266-sclerosi-multipla-pazienti-poco-informate-sui-temi-legati-gravidanza]]></loc><lastmod>2018-02-22T23:28:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/13184-sclerosi-multipla-ocrelizumab-approvato-nell-unione-europea]]></loc><lastmod>2018-02-01T12:19:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12876-sclerosi-multipla-con-fingolimod-meno-ricadute-nei-pazienti-pediatrici]]></loc><lastmod>2017-11-09T10:55:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12877-sclerosi-multipla-conferme-di-efficacia-per-cladribina-compresse]]></loc><lastmod>2019-04-25T17:27:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12753-sclerosi-multipla-e-squilibrio-del-microbiota-possibile-una-relazione]]></loc><lastmod>2017-10-08T14:36:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12738-sclerosi-multipla-scoperta-proteina-farmaco-rilasciata-dalle-cellule-staminali]]></loc><lastmod>2017-10-04T13:35:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12651-sclerosi-multipla-settembre-e-il-mese-per-diventare-volontario-aism]]></loc><lastmod>2017-09-13T16:12:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12653-sclerosi-multipla-fingolimod-riduce-le-ricadute-in-bambini-e-adolescenti]]></loc><lastmod>2017-09-13T18:42:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12629-sclerosi-multipla-la-commissione-europea-approva-cladribina-compresse]]></loc><lastmod>2019-04-25T17:30:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12584-sclerosi-multipla-recidivante-daclizumab-ora-rimborsabile-in-italia]]></loc><lastmod>2017-08-17T16:12:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12534-sclerosi-multipla-nuove-strategie-per-promuovere-la-riparazione]]></loc><lastmod>2017-07-28T09:50:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12531-sclerosi-multipla-e-lupus-erimatoso-scoperta-la-variante-di-un-gene-associata-alle-due-malattie]]></loc><lastmod>2017-07-25T10:39:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12497-sclerosi-multipla-nuovi-dati-a-sostegno-di-cladribina-compresse]]></loc><lastmod>2017-07-12T18:21:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12408-sclerosi-multipla-ema-richiede-revisione-sulla-sicurezza-di-daclizumab]]></loc><lastmod>2017-06-18T17:41:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12410-sclerosi-multipla-i-benefici-di-cure-palliative-mirate]]></loc><lastmod>2017-06-21T15:37:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12362-sclerosi-multipla-merck-avvia-la-piu-ampia-indagine-rivolta-ai-caregiver]]></loc><lastmod>2017-06-08T17:38:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12363-sclerosi-multipla-ad-oggi-114-000-gli-italiani-colpiti]]></loc><lastmod>2017-06-08T17:38:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12341-sclerosi-multipla-prof-comi-le-staminali-neurali-non-sono-del-paziente-serve-l-immunosoppressione]]></loc><lastmod>2017-06-05T08:41:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12336-sclerosi-multipla-al-san-raffaele-primo-studio-clinico-sul-trapianto-di-staminali-neurali]]></loc><lastmod>2017-06-04T14:24:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12337-staminali-neurali-per-la-sclerosi-multipla-un-progetto-partito-piu-di-15-anni-fa]]></loc><lastmod>2017-10-04T13:06:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12283-sclerosi-multipla-diventare-mamma-e-possibile]]></loc><lastmod>2017-05-15T16:23:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12263-sclerosi-multipla-buoni-risultati-da-cladribina-compresse]]></loc><lastmod>2017-05-09T16:03:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12215-sclerosi-multipla-nasce-a-genova-un-nuovo-centro-di-eccellenza]]></loc><lastmod>2017-04-23T14:06:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/12181-sclerosi-multipla-nuovo-screening-identifica-possibili-farmaci-rimielinizzanti]]></loc><lastmod>2017-04-13T10:30:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11973-sclerosi-multipla-cladribina-compresse-riduce-significativamente-l-atrofia-cerebrale]]></loc><lastmod>2019-04-25T17:34:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11864-sclerosi-multipla-non-provata-la-correlazione-tra-alte-dosi-di-natalizumab-e-lo-sviluppo-di-leucoencefalopatia]]></loc><lastmod>2017-01-29T18:57:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11835-sclerosi-multipla-al-via-la-settimana-nazionale-aism-dei-lasciti]]></loc><lastmod>2017-01-24T15:13:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11817-sclerosi-multipla-a-palermo-un-nuovo-servizio-di-assistenza-dedicato-alle-donne]]></loc><lastmod>2017-01-18T16:00:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11754-sclerosi-multipla-pubblicati-sul-nejm-i-risultati-positivi-degli-studi-di-fase-iii-su-ocrelizumab]]></loc><lastmod>2018-02-01T12:40:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11749-sclerosi-multipla-i-racconti-dei-pazienti-raccolti-in-un-libro]]></loc><lastmod>2016-12-24T17:52:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11716-sclerosi-multipla-due-playlist-per-stimolare-le-capacita-cognitive-dei-giovani-pazienti]]></loc><lastmod>2016-12-10T16:40:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11592-sclerosi-multipla-i-neurologi-italiani-diventare-genitori-si-puo]]></loc><lastmod>2016-11-09T11:20:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11566-sclerosi-multipla-grande-successo-per-la-tappa-sarda-della-nordic-tales]]></loc><lastmod>2016-11-04T07:52:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11533-sclerosi-multipla-presentati-i-dati-su-sicurezza-ed-efficacia-di-cladribina-compresse]]></loc><lastmod>2019-04-25T17:38:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11474-sclerosi-multipla-scoperto-il-funzionamento-della-terapia-orale-piu-diffusa]]></loc><lastmod>2016-10-17T10:27:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11446-sclerosi-multipla-proteine-neuronali-possibili-biomarcatori-della-malattia]]></loc><lastmod>2016-10-13T14:01:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11325-sclerosi-multipla-a-genova-il-primo-bootcamp-techcare-dalla-cura-al-prendersi-cura]]></loc><lastmod>2016-09-26T10:28:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11305-sclerosi-multipla-sanofi-genzyme-presente-all-ectrims-con-oltre-35-presentazioni-di-nuovi-dati-degli-studi-clinici]]></loc><lastmod>2016-09-23T10:59:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11304-sclerosi-multipla-annunciati-i-vincitori-del-grant-for-multiple-sclerosis-innovation-2016]]></loc><lastmod>2016-09-23T10:51:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11302-sclerosi-multipla-dall-ectrims-ulteriori-conferme-su-farmaco-ocrelizumab]]></loc><lastmod>2016-09-23T10:26:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11300-sclerosi-multipla-12-6-milioni-di-euro-assegnati-a-3-progetti-di-ricerca]]></loc><lastmod>2016-09-22T15:37:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11191-sclerosi-multipla-buoni-risultati-da-siponimod]]></loc><lastmod>2016-09-05T09:24:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/11076-sclerosi-multipla-al-binaghi-di-cagliari-si-sperimenta-la-medicina-narrativa]]></loc><lastmod>2016-08-03T13:26:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10993-sclerosi-multipla-l-ema-approva-l-immissione-in-commercio-di-cladribina-compresse]]></loc><lastmod>2019-04-25T17:42:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10959-sclerosi-multipla-sette-pazienti-correranno-alla-maratona-di-new-york]]></loc><lastmod>2016-07-12T14:41:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10957-sclerosi-multipla-angioplastica-delle-giugulari-colpite-da-ccsvi-ne-migliora-sintomi]]></loc><lastmod>2019-04-29T15:28:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10885-sclerosi-multipla-fda-ed-ema-concordano-su-ocrelizumab]]></loc><lastmod>2016-06-30T10:12:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10823-sclerosi-multipla-diventare-genitore-e-possibile-anche-per-chi-e-affetto-dalla-malattia]]></loc><lastmod>2016-06-18T16:37:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10767-sclerosi-multipla-individuato-il-gene-che-potrebbe-causare-la-malattia]]></loc><lastmod>2016-06-09T14:37:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10714-sclerosi-multipla-premiata-da-aism-la-giovane-ricercatrice-alice-laroni]]></loc><lastmod>2016-05-31T15:33:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10690-sclerosi-multipla-il-prof-vescovi-revert-onlus-presto-avviata-sperimentazione-su-terapia-cellulare]]></loc><lastmod>2016-05-27T07:23:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10674-sclerosi-multipla-dalla-sin-le-ultime-novita-terapeutiche]]></loc><lastmod>2016-05-24T13:31:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10582-sclerosi-multipla-parere-positive-del-chmp-per-daclizumab]]></loc><lastmod>2016-05-13T10:26:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10581-sclerosi-multipla-al-via-la-prima-fase-del-concorso-the-world-vs-ms]]></loc><lastmod>2016-05-12T14:12:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10558-sclerosi-multipla-aumenta-il-numero-degli-italiani-colpiti]]></loc><lastmod>2016-05-09T09:38:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10531-sclerosi-multipla-nuovo-record-di-1985-abstract-per-il-congresso-ectrims-di-londra]]></loc><lastmod>2016-05-05T13:35:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10489-sclerosi-multipla-e-ccsvi-dal-primo-maggio-parte-la-settimana-della-consapevolezza]]></loc><lastmod>2016-04-29T08:26:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10420-sclerosi-multipla-nuovi-dati-positivi-da-alemtuzumab]]></loc><lastmod>2016-04-20T14:49:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10398-sclerosi-multipla-nuovi-risultati-di-efficacia-per-il-farmaco-ocrelizumab]]></loc><lastmod>2016-04-18T10:54:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10326-sclerosi-multipla-in-commercio-un-nuovo-strumento-per-migliorare-l-aderenza-alle-terapie]]></loc><lastmod>2016-04-08T09:55:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10319-sclerosi-multipla-meno-ricadute-con-natalizumab]]></loc><lastmod>2016-04-07T14:50:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10268-sclerosi-multipla-scoperto-il-meccanismo-che-blocca-la-riparazione-del-danno-della-mielina]]></loc><lastmod>2016-03-29T16:07:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10256-sclerosi-multipla-riparte-la-campagna-io-non-sclero]]></loc><lastmod>2016-03-25T09:21:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10254-sclerosi-multipla-buoni-risultati-da-trattamento-con-glatiramer-acetato]]></loc><lastmod>2016-03-24T16:31:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10206-sclerosi-multipla-nuove-speranze-da-trapianto-di-cellule-staminali]]></loc><lastmod>2016-03-15T16:19:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10202-sclerosi-multipla-daclizumab-migliorerebbe-la-qualita-della-vita-nei-pazienti]]></loc><lastmod>2016-03-15T16:02:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10101-sclerosi-multipla-apre-il-bando-fism-2016-per-la-ricerca]]></loc><lastmod>2016-03-02T16:22:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10039-sclerosi-multipla-svelato-il-ruolo-del-metabolismo-nel-funzionamento-dei-linfociti-t-umani]]></loc><lastmod>2016-02-25T15:53:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10042-sclerosi-multipla-disponibile-in-italia-nuova-formulazione-di-glatiramer-acetato]]></loc><lastmod>2016-02-25T16:38:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10041-sclerosi-multipla-novartis-e-microsoft-insieme-per-valutare-lo-stato-del-movimento-nei-pazienti]]></loc><lastmod>2016-02-25T16:35:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/10032-sclerosi-multipla-anche-in-toscana-il-pdta-ora-e-realta]]></loc><lastmod>2016-02-24T16:34:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9975-sclerosi-multipla-meno-recidive-con-sospensione-graduale-di-natalizumab]]></loc><lastmod>2016-02-15T15:57:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9974-sclerosi-multipla-nuove-prospettive-dal-trattamento-con-fenitoina-della-neurite]]></loc><lastmod>2016-02-15T15:46:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9981-sclerosi-multipla-nuove-raccomandazioni-dall-ema-per-ridurre-il-rischio-di-pml-correlato-alla-terapia-con-natalizumab]]></loc><lastmod>2016-02-17T09:36:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9980-sclerosi-multipla-diagnosi-piu-semplice-e-veloce-con-la-rm-3tesla]]></loc><lastmod>2016-02-17T09:25:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9886-sclerosi-multipla-negli-usa-terapia-pediatrica-con-interferone-diversa-dal-resto-del-mondo]]></loc><lastmod>2016-02-02T11:49:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9898-sclerosi-laterale-amiotrofica-aisla-premia-tre-giovani-infermiere-neolaureate]]></loc><lastmod>2016-02-04T12:04:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9839-sclerosi-multipla-nessun-rischio-in-gravidanza-per-dimetilfumarato]]></loc><lastmod>2016-01-29T12:00:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9836-sclerosi-multipla-a-brescia-un-progetto-per-la-continuita-delle-cure]]></loc><lastmod>2016-01-29T08:22:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9809-sclerosi-multipla-latitudine-e-intensita-del-sole-tra-i-fattori-di-rischio]]></loc><lastmod>2016-01-22T14:47:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9834-insufficienza-venosa-cronica-cerebrospinale-ccsvi-la-patologia-esiste-correlata-o-meno-alla-sclerosi-multipla]]></loc><lastmod>2016-01-28T16:46:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9785-sclerosi-multipla-il-trapianto-autologo-di-cellule-staminali-potrebbe-ridurre-la-disabilita]]></loc><lastmod>2016-01-20T17:09:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9743-sclerosi-multipla-dall-ema-nuove-raccomandazioni-su-effetti-di-fingolimod]]></loc><lastmod>2016-01-13T11:26:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9674-sclerosi-multipla-spasticita-dolore-disturbi-urinari-l-esperienza-italiana-con-tetraidrocannabinolo-spray]]></loc><lastmod>2015-12-23T13:09:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9534-sclerosi-multipla-diventare-genitori-e-possibile]]></loc><lastmod>2015-12-04T11:21:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9508-sclerosi-multipla-da-pam-panorama-una-raccolta-fondi-a-sostegno-di-aism]]></loc><lastmod>2015-12-02T15:02:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9364-sclerosi-multipla-la-prof-ssa-marrosu-cagliari-in-sardegna-la-piu-alta-incidenza-al-mondo]]></loc><lastmod>2015-11-20T07:41:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9383-sclerosi-multipla-scoperta-una-ridotta-ossigenazione-microvascolare]]></loc><lastmod>2015-11-18T15:20:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9363-sclerosi-multipla-la-prof-ssa-marrosu-cagliari-finalmente-avremo-una-possibilita-terapeutica-per-la-forma-progressiva-primaria]]></loc><lastmod>2015-11-20T07:40:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9307-sclerosi-multipla-un-e-book-per-parlare-degli-aspetti-psicologici]]></loc><lastmod>2015-11-06T11:59:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9233-sclerosi-multipla-la-cladribina-non-aumenta-il-rischio-di-tumore]]></loc><lastmod>2015-10-27T13:57:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9180-sclerosi-multipla-incoraggianti-i-nuovi-dati-su-teriflunomide-e-alemtuzumab]]></loc><lastmod>2015-10-20T09:43:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9165-ocrelizumab-per-la-sclerosi-multipla-i-commenti-dell-azienda-del-mondo-scientifico-e-delle-associazioni]]></loc><lastmod>2015-10-19T09:25:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9151-sclerosi-multipla-pubblicato-il-piu-grande-studio-di-genetica-finora-condotto-in-italia]]></loc><lastmod>2015-10-14T13:23:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9144-sclerosi-multipla-la-soddisfazione-dell-aism-per-il-nuovo-trattamento-con-ocrelizumab-per-la-forma-prograssiva]]></loc><lastmod>2016-01-26T16:28:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9153-sclerosi-multipla-la-riabilitazione-cambia-la-storia-quotidiana-dei-pazienti]]></loc><lastmod>2015-10-14T13:22:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9162-sclerosi-multipla-nuova-terapia-con-ocrelizumab-comi-un-giorno-che-restera-nella-storia]]></loc><lastmod>2015-10-15T08:26:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9123-sclerosi-multipla-primariamente-progressiva-la-prima-terapia-efficace-potrebbe-essere-disponibile-fra-un-anno]]></loc><lastmod>2015-10-15T08:51:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9122-sclerosi-multipla-per-le-forme-recidivanti-e-in-arrivo-un-farmaco-piu-efficace-dell-interferone]]></loc><lastmod>2015-10-15T08:52:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9058-sclerosi-multipla-arriva-in-italia-nuova-terapia-sottocutanea-a-base-di-peginterferone-beta-1a]]></loc><lastmod>2015-10-07T14:59:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9057-sclerosi-multipla-effetto-antinfiammatorio-dell-ifn-beta-aumentato-da-contraccettivi-orali-ad-alto-dosaggio-di-estrogeni]]></loc><lastmod>2015-10-07T14:56:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9060-sclerosi-multipla-progressiva-assegnato-il-bando-collaborative-network-planning-awards]]></loc><lastmod>2015-10-07T15:10:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/9059-hiv-parere-positivo-del-chmp-per-nuovo-regime-a-singola-compressa]]></loc><lastmod>2015-10-07T15:05:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8974-sclerosi-multipla-anche-l-emilia-romagna-adotta-il-pdta]]></loc><lastmod>2015-09-23T14:02:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8875-sclerosi-multipla-a-settembre-riparte-la-campagna-di-reclutamento-volontari-aism]]></loc><lastmod>2015-09-07T08:12:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8848-sclerosi-multipla-accordo-novartis-e-glaxosmithkline-per-impiego-di-ofatumumab]]></loc><lastmod>2015-09-01T07:59:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8851-sclerosi-multipla-il-deficit-di-vitamina-d-aumenterebbe-il-rischio]]></loc><lastmod>2015-09-01T09:23:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8820-sclerosi-multipla-fda-aggiunge-il-rischio-di-infezione-cerebrale-all-etichetta-del-farmaco-gilenya-fingolimod]]></loc><lastmod>2015-08-25T14:01:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8723-sclerosi-multipla-quali-i-problemi-e-i-punti-di-forza-nel-mantenere-il-posto-di-lavoro]]></loc><lastmod>2015-07-31T08:08:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8653-sclerosi-multipla-al-via-il-progetto-girocamper]]></loc><lastmod>2015-07-21T08:59:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8654-sclerosi-multipla-e-artrite-reumatoide-arrivano-in-campania-i-percorsi-diagnostico-terapeutici]]></loc><lastmod>2015-07-21T09:06:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8656-sclerosi-multipla-uno-studio-riproduce-la-plasticita-corticale-osservata-nei-pazienti]]></loc><lastmod>2015-07-21T10:01:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8558-sclerosi-multipla-il-prof-comi-spiega-l-efficacia-del-farmaco-ocrelizumab]]></loc><lastmod>2015-07-03T09:57:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8557-sclerosi-multipla-dati-positivi-per-ocrelizumab-da-due-studi-di-fase-iii]]></loc><lastmod>2018-02-01T12:38:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8349-giornata-mondiale-della-sclerosi-multipla-gli-eventi-di-genzyme]]></loc><lastmod>2015-06-01T08:22:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8330-sclerosi-multipla-a-indianapolis-presentati-i-dati-su-teriflunomide-e-alemtuzumab]]></loc><lastmod>2015-05-28T10:29:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8279-giornata-mondiale-della-sclerosi-multipla-le-richieste-dellagenda-di-aism]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8275-sclerosi-multipla-le-10-tesi-dellmsmlab-per-migliorare-le-risposte-ai-problemi-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8255-sclerosi-multipla-scoperto-un-nuovo-gene-implicato-nella-risposta-al-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8215-settimana-della-consapevolezza-sulla-ccsvi-bilancio-positivo-per-ccsvi-sm-onlus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8180-sclerosi-multipla-un-percorso-riabilitativo-alle-terme-romane-di-monfalcone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8161-sclerosi-mutipla-al-via-uno-studio-di-fase-iii-su-ponesimod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8162-sm-recidivante-remittente-il-trattamento-con-inf-beta-non-e-correlato-all-insorgenza-di-sm-secondariamente-progressiva]]></loc><lastmod>2015-06-08T11:28:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8163-sclerosi-multipla-recidivante-remittente-approvato-il-farmaco-generico-del-glatiramer-acetato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8144-sclerosi-multipla-il-trattamento-con-natalizumab-potrebbe-essere-correlato-ad-una-riattivazione-del-virus-varicella-zoster]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8139-sclerosi-multipla-studio-italiano-individua-nel-punteggio-mrs-il-miglior-fattore-predittivo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8103-sclerosi-multipla-disponibile-anche-in-italia-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8083-sclerosi-multipla-il-pdta-del-san-luigi-di-orbassano-premiato-dal-market-access-award]]></loc><lastmod>2017-06-19T17:17:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/8073-sclerosi-multipla-nuovi-dati-di-efficacia-per-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7945-sclerosi-multipla-fingolimod-intrappola-i-linfociti-e-agisce-sullimmunotolleranza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7946-sclerosi-multipla-zamboni-riceve-riconoscimento-internazionale-nel-campo-delle-malattie-vascolari]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7935-sclerosi-multipla-la-presa-in-carico-del-paziente-al-centro-della-msmlabweek]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7879-sclerosi-multipla-la-fiction-io-non-sclero-diventa-realta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7850-sclerosi-multipla-quale-dieta-ne-favorisce-lo-sviluppo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7795-sclerosi-multipla-scoperta-proteina-che-potrebbe-rallentarne-il-decorso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7726-sclerosi-multipla-ridotta-risposta-alle-pratiche-vaccinali-nei-pazienti-trattati-con-fingolimod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7666-sclerosi-multipla-vince-il-charcot-award-2015-il-neurologo-italiano-giancarlo-comi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7636-sclerosi-multipla-al-via-lo-studio-zamboni-l-associazione-pazienti-chiede-attenzione-al-ministero]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7562-google-e-biogen-insieme-per-trovare-la-causa-della-sclerosi-multipla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7535-sclerosi-multipla-riconosciuto-rimborsabile-il-farmaco-tecfidera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7382-sclerosi-multipla-pubblicato-il-libro-scritto-dalla-miss-leila-cattalini-affetta-dalla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7383-vaccinazioni-correlate-allo-sviluppo-di-malattie-a-carico-del-sistema-nervoso]]></loc><lastmod>2019-06-18T17:51:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7393-sclerosi-multipla-primi-successi-accertati-per-trapianto-di-staminali-ematopoietiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7371-sclerosi-multipla-e-ccsvi-al-via-la-valutazione-del-metodo-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7370-sclerosi-multipla-e-ccsvi-lancet-ignora-zamboni-e-i-malati-protestano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7316-sclerosi-multipla-documento-di-consenso-per-ridurre-il-rischio-di-infezione-da-varicella-zoster]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7256-sclerosi-multipla-possibile-affrontare-la-gravidanza-in-sicurezza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7263-sclerosi-multipla-lazio-pubblica-decreto-istitutivo-del-pdta-specifico-e-il-primo-in-italia]]></loc><lastmod>2015-05-26T15:37:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7228-sclerosi-multipla-lattore-rodolfo-lagana-si-racconta-per-la-prima-volta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7230-sclerosi-multipla-trattamento-con-natalizumab-rallenta-latrofia-cerebrale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7120-sclerosi-multipla-miglioramenti-nella-qualita-di-vita-grazie-alluso-di-un-analogo-della-vitamina-d]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7108-sclerosi-multipla-negli-usa-approvato-trattamento-con-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7102-sclerosi-multipla-in-lazio-il-piano-diagnostico-terapeutico-assistenziale-lintervista-al-dott-gasperini]]></loc><lastmod>2019-03-26T17:42:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7099-sclerosi-multipla-la-regione-lazio-determina-uno-specifico-pdta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7078-sclerosi-multipla-arruolati-i-primi-pazienti-nello-studio-empire]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7081-sclerosi-multipla-nel-lazio-un-nuovo-modello-assistenziale-per-garantire-la-presa-in-carico-globale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7059-sclerosi-multipla-la-regione-sardegna-intende-riformare-la-rete-assistenziale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/7034-sclerosi-multipla-possibile-correlazione-tra-il-farmaco-tecfidera-e-linsorgenza-di-leucoencefalopatia-multifocale-progressiva]]></loc><lastmod>2016-10-17T10:29:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6965-sclerosi-multipla-lutilizzo-delloligonucleotide-antisenso-atl1102-riduce-lattivita-associata-alla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6927-sclerosi-multipla-il-trattamento-con-glatiramer-acetato-ripristina-la-normale-funzione-delle-cellule-b]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6869-sclerosi-multipla-alla-dottssa-silvia-rossi-il-premio-per-la-migliore-pubblicazione-scientifica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6722-sclerosi-multipla-bluetooth-connessione-usa-e-desing-semplificano-la-terapia-con-betaferon]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6673-sclerosi-multipla-il-futuro-e-staminale-buoni-i-primi-risultati-del-progetto-mesems]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6705-sclerosi-multipla-genzyme-al-congresso-ectrims-2014]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6675-sclerosi-multipla-la-terapia-con-alemtuzumab-dimostra-risultati-a-lungo-termine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6639-sclerosi-multipla-nuove-conferme-per-fingolimod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6654-sclerosi-multipla-costa-38000-euro-allanno-per-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6610-sclerosi-multipla-disponibile-dal-1d-settembre-in-italia-teriflunomide-terapia-orale-in-monosomministrazione-giornaliera-per-pazienti-con-decorso-di-malattia-recidivante-remittente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6584-sclerosi-multipla-i-tagli-allassistenza-domiciliare-mettono-in-difficolta-cento-famiglie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6571-sclerosi-multipla-ue-approva-peginterferone-beta-1a-di-biogen-idec]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6543-sclerosi-multipla-possibile-utilita-dei-farmaci-antiretrovirali-oggi-usati-per-lhiv]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6496-sclerosi-multipla-lunione-europea-approva-peginterferone-beta-1-a]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6413-sclerosi-multipla-fingolimod-ottiene-nuova-approvazione-della-commissione-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6332-sclerosi-multipla-conferme-per-dalfampridina-a-rilascio-prolungato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6300-sclerosi-multipla-presenti-al-neuromed-i-migliori-esperti-nazionali-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6263-sclerosi-multipla-merck-serono-mettera-a-disposizione-dei-pazienti-un-nuovo-software-e-un-dispositivo-per-iniezioni-aggiornato]]></loc><lastmod>2019-06-18T18:13:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6148-sclerosi-multipla-30-maggio-primo-h-open-day-onda-italiano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6151-sclerosi-multipla-recidivante-remittente-peginterferone-beta-1a-ha-ottenuto-il-parere-positivo-del-chmp-per-il-trattamento-della-patologia-nellunione-europea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6113-sclerosi-multipla-lemtrada-sembra-rallentare-latrofia-muscolare-e-ridurre-le-lesioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6144-sclerosi-multipla-parere-positivo-dellue-alliso-di-peginterferone-beta-1-a]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6149-sclerosi-multipla-genzyme-celebra-la-sesta-giornata-mondiale-dedicata-alla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6145-sclerosi-multipla-in-sardegna-prevalenza-altissima-la-parola-alla-prof-marrosu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6143-sclerosi-multipla-oggi-la-giornata-mondiale-molti-i-passi-avanti-per-la-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6086-sclerosi-multipla-presentata-oggi-la-carta-dei-diritti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6027-sclerosi-multipla-risultati-positivi-per-natalizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6042-sclerosi-multipla-laggiunta-di-estriolo-alla-terapia-riduce-il-tasso-di-recidiva-nelle-donne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/6007-sclerosi-multipla-biogen-idec-presenta-i-nuovi-dati-sul-peginterferone-beta-1a]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5984-sclerosi-multipla-genzyme-presenta-il-supplemento-della-biologics-license-application-per-lemtrada]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5985-sclerosi-multipla-lemtrada-approvato-in-brasile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5997-sclerosi-multiplarallentamento-dellatrofia-cerebrale-e-riduzione-del-numero-di-nuove-lesioni-prolungati-a-tre-anni-nei-pazienti-trattati-con-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5949-sm-secondaria-progressiva-simvastatina-ad-alte-dosi-rallenta-latrofia-cerebrale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5950-sclerosi-multipla-recidivante-remittente-confermata-efficacia-di-fingolimod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5882-sclerosi-multipla-una-sospensione-nella-terapia-con-natalizumab-puo-causare-recidiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5883-sclerosi-multipla-recidivante-remittente-conferme-per-il-farmaco-fingolimod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5858-sclerosi-multipla-secondaria-progressiva-nuovi-risultati-positivi-per-simvastatina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5805-sclerosi-multipla-il-polo-del-san-giuseppe-di-empoli-diventa-maggiorenne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5747-sclerosi-multipla-a-breve-linizio-della-sperimentazione-sulluomo-basata-sullutilizzo-di-cellule-staminali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5738-sclerosi-multipla-la-vitamina-d-gioca-un-ruolo-di-primo-piano-nella-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5727-sclerosi-mutipla-importante-correlazione-con-latrofia-cerebrale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5719-ccsvi-insufficienza-venosa-cronica-cerebrospinale-secondo-la-comunita-scientifica-esiste-puo-essere-presente-anche-nella-sclerosi-multipla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5641-sclerosi-multipla-lapnea-ostruttiva-notturna-possibile-causa-di-affaticamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5394-sclerosi-multipla-diverso-effetto-tra-farmaci-equivalenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5413-sclerosi-multipla-il-dimetil-fumarato-approvato-nellunione-europea-come-trattamento-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5379-sclerosi-multipla-tra-le-cause-ci-sarebbe-un-batterio-di-origine-alimentare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5370-sclerosi-multipla-fda-approva-il-glatiramer-acetato-in-somministrazione-trisettimanale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5367-sclerosi-multipla-lema-non-raccomanda-il-farmaco-orale-laquindimod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5327-sclerosi-multipla-al-via-il-progetto-qmanagement-labq-per-ottimizzare-risorse-e-migliorare-gli-standard]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5309-sclerosi-multipla-il-farmaco-sperimentale-fingolimod-ottiene-nuovi-risultati-positivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5290-sclerosi-multipla-in-sicilia-nasce-lqassociazione-sclerosi-multipla-sacro-cuoreq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5278-sclerosi-multipla-recidivante-al-via-lo-studio-di-fase-iiiii-sullimmunoglobulina-octagam]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5276-sclerosi-multipla-il-farmaco-lemtrada-respinto-dallfda]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5162-sclerosi-multipla-il-ruolo-delle-alterazioni-metaboliche-alla-base-della-disfunzione-immunitaria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5152-sclerosi-multipla-la-vitamina-d-puo-essere-daiuto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5134-sclerosi-multipla-in-sardegna-una-mozione-trasversale-per-potenziare-i-centri-per-diagnosi-e-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5114-sclerosi-multipla-la-terapia-a-base-di-teriflunomide-e-una-valida-alternativa-al-trattamento-con-interferone-beta-1a]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5115-sclerosi-multipla-primi-risultati-positivi-per-il-farmaco-duloxetina-utilizzato-nella-terapia-del-dolore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5086-sclerosi-multipla-le-cellule-staminali-ematopoietiche-utili-nel-trattamento-delle-forme-severe-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5087-sclerosi-multipla-recidivante-remittente-il-farmaco-daclizumab-hyp-sembra-efficace-nel-bloccare-lattivita-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5089-sclerosi-multipla-dati-positivi-per-il-farmaco-fingolimod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5055-sclerosi-multipla-assegnati-i-riconoscimenti-per-la-prima-edizione-del-grant-for-multiple-sclerosis-innovation]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5044-sclerosi-multipla-chmp-ha-concesso-nellunione-europea-la-designazione-di-nuova-sostanza-attiva-al-dimetilfumarato-contenuto-in-tecfidera]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5014-sclerosi-multipla-il-legame-tra-ccsvi-e-patologia-sempre-piu-in-discussione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/5015-sclerosi-multipla-1-milione-e-125-mila-euro-stanziati-per-la-ricerca-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4963-sclerosi-multipla-la-denuncia-costretto-a-uscire-di-casa-su-un-montacarichi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4927-sclerosi-multipla-nuovi-dati-positivi-per-il-trattamento-con-fampridina-a-rilascio-prolungato]]></loc><lastmod>2019-06-19T08:15:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4900-sclerosi-multipla-una-possibile-speranza-terapeutica-dalle-cellule-staminali-adulte-riprogrammate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4868-sclerosi-multipla-fino-al-70-dei-pazienti-soffre-di-disturbi-cognitivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4875-sclerosi-multipla-avviato-a-torino-il-primo-percorso-diagnostico-terapeutico-assistenziale-pdta]]></loc><lastmod>2019-03-26T17:48:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4843-sclerosi-multipla-premiato-allectrims-il-medico-italiano-luca-prosperini-per-una-strategia-riabilitativa-domiciliare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4826-sclerosi-multipla-il-congresso-ectrims-non-ha-affrontato-correttamente-il-tema-ccsvi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4755-sclerosi-multipla-nuovi-dati-sul-dimetilfumarato-ne-confermano-efficacia-e-sicurezza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4770-sclerosi-multipla-oggi-nel-mondo-23-milioni-di-pazienti-600-mila-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4714-sclerosi-multipla-dallectrims-nuovi-dati-positivi-sulluso-di-teriflunomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4699-sclerosi-multipla-scoperte-48-nuove-varanti-genetiche-associate-alla-grave-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4636-sclerosi-multipla-la-commissone-europea-approva-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4600-sclerosi-multipla-e-ccsvi-lo-studio-dimostra-lassenza-di-correlazione-tra-le-due-patologie-le-polemiche-continuano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4589-sclerosi-multipla-teriflunomide-approvato-in-ue-prof-comi-dobbiamo-giocare-danticipo-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4587-sclerosi-multipla-la-commissione-europea-ha-approvato-teriflunomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4572-sclerosi-multipla-oggi-a-milano-un-incontro-per-far-chiarezza-sul-metodo-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4500-sclerosi-multipla-secondo-un-nuovo-studio-nessuna-evidenza-per-metodo-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4462-sclerosi-multipla-nuove-polemiche-in-sardegna-sul-metodo-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4430-sclerosi-multipla-il-pd-della-sardegna-deposita-interpellanza-sui-trattamenti-alternativi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4398-sclerosi-multipla-al-giglio-di-cefalu-ambulatorio-interamente-dedicato-alle-donne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4352-sclerosi-multipla-ora-sul-mercato-lo-spry-a-base-di-cannabis-contro-la-spasticita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4289-sclerosi-multipla-parere-positivo-del-chmp-per-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4246-sclerosi-multipla-una-nuova-tecnica-di-risonanza-magnetica-fornisce-diagnosi-piu-precise]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4236-sclerosi-multipla-nuove-prospettive-allapproccio-terapeutico-riabilitativo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4143-sclerosi-multipla-la-giornata-mondiale-da-voce-ai-giovani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4125-sclerosi-multipla-le-donne-afroamericane-sono-piu-a-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4142-sclerosi-multipla-ieri-la-giornata-mondiale-genzyme-rinnova-limpegno-sul-fronte-delle-terapie-innovative]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4060-sclerosi-multipla-fondamentale-la-collaborazione-tra-medico-e-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4051-sclerosi-multipla-i-centri-italiani-partecipano-al-programma-bollini-rosa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4038-sclerosi-multila-approvato-in-italia-luso-della-cannabis-contro-la-spasticita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4007-sclerosi-multipla-i-diritti-sul-lavoro-e-le-agevolazioni-assistenziali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/4010-sclerosi-multipla-al-via-la-seconda-edizione-del-premio-per-i-giovani-ricercatori-italiani-promosso-da-sin-e-sostenuto-da-merck-serono]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3993-sclerosi-multipla-il-trattamento-con-natalizumab-e-i-rischi-di-leucoencefalopatia-multifocale-progressiva-lmp]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3986-sclerosi-multipla-teriflunomide-terapia-orale-per-singola-somministrazione-giornaliera-ritarda-linsorgenza-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3941-centri-per-la-sclerosi-multipla-nel-lazio-orientati-verso-i-bisogni-dei-cittadini-che-restano-pero-ancora-poco-coinvolti-nelle-scelte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3921-sclerosi-multipla-il-teriflunomide-approvato-anche-in-america-latina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3908-sclerosi-multipla-piu-di-63-mila-pazienti-trattati-con-fingolimod]]></loc><lastmod>2015-12-03T18:55:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3912-sclerosi-multipla-il-virus-di-epstein-barr-aggrava-la-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3887-sclerosi-multipla-la-statunitense-fda-approva-il-trattamento-con-dimetil-fumarato-in-capsule]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3861-sclerosi-multipla-il-farmaco-laquinimod-agisce-garantisce-risultati-migliori-se-somministrato-precocemente]]></loc><lastmod>2017-05-15T16:33:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3836-sclerosi-multipla-possibile-ridurre-le-iniezioni-di-glatiramer-acetato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3839-sclerosi-multipla-lormone-adrenocorticotropo-puo-rendere-la-terapia-piu-efficace]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3825-sclerosi-multipla-parere-positivo-dellue-per-luso-di-tecfidera-dimetil-fumarato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3821-sclerosi-multipla-confermata-lefficacia-di-alemtuzumab-genzyme]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3819-sclerosi-multipla-presentati-i-risultati-positivi-sulla-sperimentazione-di-peginterferone-beta-1-a]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3805-sclerosi-multipla-presto-sara-sviluppato-un-trattamento-a-base-di-linfociti-t]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3787-sclerosi-multipla-genzyme-presenta-i-dati-relativi-ai-programmi-di-sviluppo-clinico-di-teriflunomide-e-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3782-sclerosi-multipla-un-farmaco-oncologico-sembra-ridurne-i-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3664-sclerosi-multipla-nessuna-relazione-con-linsufficienza-venosa-cerebrospinale-cronica-ccsvi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3636-slcerosi-multipla-richiesto-luso-di-natalizumab-come-trattamento-di-prima-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3600-sclerosi-multipla-scoperto-alluniversita-di-siena-anticorpo-naturale-con-potenti-proprieta-immunosoppressive]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3580-sclerosi-multipla-la-dieta-puo-influire-sulla-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3563-sclerosi-multipla-il-trattamento-con-alemtuzumab-sara-valutato-dall-fda-statunitense]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3555-sclerosi-multipla-risultati-positivi-per-il-trattamento-con-peginterferone-beta-1a]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3524-sclerosi-multipla-la-riabilitazione-computerizzata-potrebbe-essere-il-futuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3488-sclerosi-multipla-al-via-lo-studio-brave-dreams-parte-in-4-centri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3466-sclerosi-multipla-in-sardegna-lincidenza-e-triplicata-rispetto-alla-media-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3437-sclerosi-multipla-e-cannabis-terapeutica-mancano-ancora-conferme-sui-reali-benefici-di-sativex]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3445-sclerosi-multipla-scoperte-le-cause-della-perdita-della-vista]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3287-sclerosi-multipla-scoperta-una-nanoparticella-che-potrebbe-bloccare-la-distruzione-di-mielina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3095-sclerosi-multipla-merck-serono-lancia-il-grant-for-multiple-sclerosis-innovation]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/3086-clerosi-multipla-pubblicati-i-risultati-di-due-studi-comparativi-di-tra-alemtuzumab-e-rebif]]></loc><lastmod>2017-03-31T10:52:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2978-sclerosi-multipla-confermati-gli-effetti-positivi-a-lungo-termine-di-natalizumab-sulle-forme-recidivanti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2966-sclerosi-multipla-bassi-livelli-di-vitamina-d-aggravano-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2962-sclerosi-multipla-parte-larruolamento-dei-pazienti-per-lo-studio-sulle-staminali-mesenchimali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2920-sclerosi-multipla-proposta-nuova-classificazione-in-due-diverse-forme-di-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2952-sclerosi-multipla-presentato-il-secondo-studio-di-fase-iii-su-teriflunomide-in-monosomministrazione-giornaliera-per-via-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2949-sclerosi-multipla-nuove-conferme-per-il-trattamento-con-dimetil-fumarato-per-via-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2901-sclerosi-multipla-merck-serono-sostiene-la-ricerca-con-un-award-e-un-simposio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2807-sclerosi-multipla-il-ginko-biloba-non-migliora-i-sintomi-cognitivi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2804-la-mia-vita-contro-la-sclerosi-multipla-la-prima-facebook-fan-page-curata-da-un-panel-di-specialisti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2768-sclerosi-multipla-la-fda-approva-il-teriflunomide-niente-iniezioni-ma-una-sola-compressa-al-giorno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2695-sclerosi-multipla-da-usa-e-polonia-ancora-conferme-per-la-ricerca-del-prof-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2663-sclerosi-multipla-presto-disponibile-il-trattamento-con-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2600-sclerosi-multipla-e-ccsvi-al-via-oggi-la-sperimentazione-sul-metodo-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2537-sclerosi-multipla-aism-firma-un-protocollo-dintesa-col-sindacato-ugl]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2494-sclerosi-multipla-la-provocazione-sostenere-che-la-ccsvi-non-esiste-equivale-a-sostenere-che-la-terra-e-piatta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2430-sclerosi-multipla-le-alte-temperature-esterne-aggravano-la-condizione-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2387-sclerosi-multipla-basta-aghi-adesso-ce-la-penna-pre-riempita-con-linterferone-beta-1-a]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2362-sclerosi-multipla-depositata-la-domanda-di-registrazione-per-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2376-sclerosi-multipla-a-monterotondo-rm-un-convegno-il-15-giugno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2375-sclerosi-multipla-richiesta-lautorizzazione-per-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2294-sclerosi-multipla-merck-serono-presenta-il-prototipo-vincitore-del-concorso-mondiale-di-design]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2298-sclerosi-multipla-al-via-uno-studio-con-le-staminali-mesenchimali-adulte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2214-sclerosi-multipla-limportanza-di-valutare-la-qualita-della-vita-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2254-sclerosi-multipla-dal-26-maggio-al-3-giugno-la-settimana-nazionale-dedicata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2196-sclerosi-multipla-teriflunomide-e-alemtuzumab-le-nuove-strategie-vincenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2222-sm-e-metodo-zamboni-la-fondazione-hilarescere-qultile-il-documento-fdaq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2215-sclerosi-multipla-unapp-per-tablet-debutta-al-san-raffaele]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2195-sclerosi-multipla-negli-usa-11-milioni-di-dollari-lanno-spesi-per-diagnosi-errate]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2190-sclerosi-multipla-sul-new-england-journal-nuova-analisi-di-rischio-pml-per-la-somministrazione-di-tysabri]]></loc><lastmod>2016-02-16T14:21:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2134-sclerosi-multipla-natalizumab-in-grado-di-contrastare-la-spossatezza-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2132-sclerosi-multipla-il-glatiramer-acetato-riduce-la-spasticita-e-migliora-la-deambulazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2163-sclerosi-multipla-e-metodo-zamboni-la-risposta-dellassociazione-ccsvi-nella-sm-onlus-al-comunicato-della-fda-sulla-sicurezza-del-trattamento-per-la-ccsvi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2162-sclerosi-multipla-e-metodo-zamboni-dagli-usa-allerta-per-ictus-e-decessi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2120-sclerosi-multipla-arriva-il-social-network-dedicato-ai-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2121-sclerosi-multipla-un-nuovo-potenziale-trattamento-dalle-foglie-dulivo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2037-sclerosi-multipla-un-farmaco-sperimentale-riduce-le-lesioni-cerebrali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2066-sclerosi-multipla-studio-di-fase-3-conferma-i-risultati-positivi-del-farmaco-orale-bg-12]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2074-sclerosi-multipla-alemtuzumab-migliora-significativamente-lindice-di-disabilita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2049-sclerosi-multipla-paola-perego-e-gianluca-zambrotta-lanciano-campagna-5x1000]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2045-sclerosi-multipla-le-raccomandazioni-dellema-per-lutilizzo-di-fingolimod-senza-rischi-cardiaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/2034-sclerosi-multipla-genzyme-mostra-allamerican-academy-of-neurology-il-forte-impegno-e-presenta-i-risultati-degli-studi-di-fase-iii]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1988-sclerosi-multipla-il-trattamento-con-betaferon-comporta-un-vantaggio-in-termini-di-sopravvivenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1951-sclerosi-multipla-e-gravidanza-domande-e-risposte]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1950-sclerosi-multipla-e-donne-a-milano-ne-hanno-discusso-i-maggiori-esperti-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1927-sclerosi-multipla-il-mercato-dei-farmaci-raggiungera-i-502-milioni-di-euro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1891-sclerosi-multipla-lintervento-per-la-ccsvi-migliora-i-sintomi-nel-75-per-cento-dei-casi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1868-sclerosi-multipla-non-piu-garantita-lattivazione-del-polo-diagnostico-di-cona-ferrara]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1846-sclerosi-multipla-una-nuova-classe-di-farmaci-per-lartrite-reumatoide-sara-un-futuro-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1834-sclerosi-multipla-recidivante-remittente-laquinimod-puo-ridurre-lattivita-infiammatoria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1842-sclerosi-multipla-3-milioni-di-euro-messi-a-disposizione-dalla-fism]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1794-sclerosi-multipla-un-nuovo-processo-patologico-derivante-dagli-astrociti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1779-sclerosi-multipla-la-giornata-della-donna-si-festeggia-impegnandosi-contro-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1727-sclerosi-multipla-aism-in-piazza-con-liniziativa-qgardenia-dellaismq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1689-sclerosi-multipla-lagenzia-europea-del-farmaco-ha-autorizzato-il-teriflunomide-per-la-terapia-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1652-sclerosi-multipla-conclusa-la-campagna-sms-solidale-dellassociazione-ccsvi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1631-sclerosi-multipla-la-regione-emilia-romagna-finanzia-lo-studio-brave-dreams-per-il-metodo-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1584-sclerosi-multipla-mozione-in-regione-per-avviare-studio-del-prof-galassi-con-il-metodo-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1581-sclerosi-multipla-fingolimod-usato-solo-come-farmaco-di-seconda-linea-in-via-precauzionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1578-sclerosi-multipla-fino-al-15-febbraio-basta-un-sms-al-45597-per-sostenere-il-trial-brave-dreams-guidato-da-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1557-sclerosi-multipla-al-via-audit-civico-nel-lazio-partecipano-sei-diversi-ospedali-romani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1555-sclerosi-multipla-per-chi-usa-tysabri-ce-un-nuovo-modo-di-calcolare-il-rischio-di-leucoencefalopatia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1549-sclerosi-multipla-serve-monitoraggio-cardiovascolare-dopo-la-prima-dose-di-gilenya]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1523-sclerosi-multipla-aism-non-finanzia-la-sperimentazione-zamboni-e-va-avanti-con-lo-studio-cosmo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1477-sclerosi-multipla-individuati-dei-marcatori-di-malattia-presenti-nel-sangue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1414-sclerosi-multipla-approvata-la-somministrazione-di-rebifr-alla-comparsa-dei-primi-sintomi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1376-sclerosi-multipla-ecco-come-la-risonanza-magnetica-fotografa-il-sistema-nervoso-centrale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1377-sclerosi-multipla-ecco-i-nuovi-criteri-per-la-diagnosi-attraverso-la-risonanza-magnetica]]></loc><lastmod>2015-06-05T16:16:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1340-sclerosi-multipla-pozzilli-il-vero-problema-oggi-e-laderenza-alla-terapia]]></loc><lastmod>2024-10-09T18:17:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1341-sclerosi-multipla-dalla-diagnosi-alla-terapia-fino-al-dibattito-sulla-ccsvi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1277-sclerosi-multipla-laffaticamento-cronico-come-elemento-nella-diagnosi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1258-sclerosi-multipla-luso-precoce-di-betaferon-previene-necessita-di-terapie-di-seconda-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1259-sclerosi-multipla-maggiore-sopravvivenza-se-si-comincia-precocemente-trattamento-con-betaferon]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1260-sclerosi-multipla-per-chi-e-in-terapia-con-interferone-beta-ce-il-programma-betaplus]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1243-sclerosi-multipla-sara-litaliana-maria-trojano-a-guidare-lectrims-dal-2012]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1242-sclerosi-multipla-dalla-sapienza-di-roma-lallarme-in-italia-malati-sempre-piu-giovani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1235-sclerosi-multipla-nuovi-dati-sul-fingolimod-presentati-allectrims-di-amsterdam]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1237-sclerosi-multipla-le-richieste-dei-sostenitori-del-metodo-zamboni-allectrims]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1207-sclerosi-multipla-accordo-tra-merk-serono-e-ono-pharmaceutical-per-sviluppo-farmaco-orale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1205-sclerosi-multipla-il-teriflunomide-efficace-contro-le-recidive-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1176-sclerosi-multipla-confermate-capacita-del-natalizumab-di-ridurre-le-recidive]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1173-sclerosi-multipla-secondo-studio-usa-il-60-dei-nuovi-pazienti-non-comincia-una-terapia-farmacologica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1145-sclerosi-multipla-la-stimolazione-transcranica-per-i-casi-refrattari-ai-trattamenti-standard]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1146-sclerosi-multipla-concluso-il-primo-studio-di-magics-per-la-stimolazione-transcranica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1140-sclerosi-multipla-dalle-staminali-mesenchimiali-una-possibile-speranza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1109-sclerosi-multipla-merk-kgaa-acquisisce-i-diritti-mondiali-del-programma-pi-2301]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1103-sclerosi-multipla-da-praga-una-conferma-per-il-metodo-zamboni]]></loc><lastmod>2015-06-05T17:25:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1077-sclerosi-multipla-e-ccsvi-ancora-un-acceso-dibattito-tra-i-ricercatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1056-sclerosi-multipla-studio-serbo-sostiene-la-correzione-con-ccsvi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1035-sclerosi-multipla-studio-padovano-smentisce-associazione-con-ccsvi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1047-sclerosi-multipla-si-tenta-anche-la-strada-delle-staminali-ematopoietiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1050-sclerosi-multipla-sul-ruolo-della-ccsvi-continua-il-dibattito-a-colpi-di-studi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1019-sclerosi-multipla-secondo-studio-canadese-troppe-complicazioni-nel-trattamento-con-angioplasica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1017-sclerosi-multipla-nascera-vicino-a-laquila-il-centro-di-eccellenza-di-aism]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/994-sclerosi-multipla-a-pisa-da-oggi-larruolamento-per-il-metodo-zamboni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/992-sclerosi-multipla-studio-condotto-anche-in-italia-conferma-natura-autoimmmune-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/966-sclerosi-multipla-ricercatori-umbri-chiariscono-il-ruolo-dellenzima-ido-nel-controllo-della-reazione-autoimmune]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/943-sclerosi-multipla-il-fampyre-autorizzato-in-ue-potra-essere-usato-nei-pazienti-con-problemi-della-deambulazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/936-sclerosi-multipla-positivi-i-primi-risultati-dei-trial-con-alemtuzumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/895-sclerosi-multipla-e-ccsvi-la-sardegna-finanzia-studio-sul-metodo-zamboni]]></loc><lastmod>2018-12-27T19:11:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/891-sclerosi-multipla-merk-serono-chiede-allema-di-poter-usare-il-rebif-per-la-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/618-sclerosi-multipla-la-causa-scatenante-potrebbe-essere-una-batterio]]></loc><lastmod>2018-01-16T11:30:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/228-sclerosi-multipla-da-una-farmaco-contro-la-leucemia-linfoide-la-speranza-di-rallentare-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sclerosi-multipla/1985-sclerosi-multipla-caso-leucoencefalopatia-multifocale-progressiva-in-paziente-trattato-con-fingolimod]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22955-malattia-renale-cronica-in-italia-milioni-di-pazienti-senza-diagnosi]]></loc><lastmod>2026-04-20T18:05:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22947-insonnia-cronica-presentato-un-policy-paper-per-riconoscere-la-patologia-come-prioritaria]]></loc><lastmod>2026-04-20T16:53:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22905-autismo-limportanza-di-diagnosi-e-interventi-basati-su-evidenze-scientifiche]]></loc><lastmod>2026-04-02T08:29:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22798-diabete-di-tipo-1-possibile-ritardare-la-malattia-grazie-a-nuove-terapie-immunomodulanti]]></loc><lastmod>2026-02-27T10:16:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22786-sindrome-di-tourette-gli-insulti-ai-bafta-accendono-lo-scontro-tra-clinica-e-sensibilita]]></loc><lastmod>2026-02-23T15:48:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22760-bronchiectasie-una-malattia-respiratoria-cronica-ancora-troppo-sottovalutata]]></loc><lastmod>2026-02-17T09:18:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22759-bronchiectasie-il-peso-invisibile-di-una-malattia-che-toglie-respiro-e-vita-sociale]]></loc><lastmod>2026-02-17T09:18:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22733-broncopneumopatia-cronica-ostruttiva-dupilumab-rimborsabile-in-italia]]></loc><lastmod>2026-02-10T15:41:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22711-bronchiectasie-la-malattia-cronica-delle-vie-aree-piu-comune-dopo-asma-e-bpco]]></loc><lastmod>2026-02-03T08:55:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22608-malattia-di-crohn-lintelligenza-artificiale-svela-un-mistero-genetico-e-apre-a-nuovi-approcci-terapeutici]]></loc><lastmod>2025-12-15T11:16:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22540-bronchiectasie-approvazione-europea-per-brensocatib]]></loc><lastmod>2025-11-21T18:15:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22500-celiachia-la-dieta-senza-glutine-tra-nuove-ricerche-e-falsi-miti]]></loc><lastmod>2025-11-08T11:50:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22406-malattie-infiammatorie-croniche-intestinali-quando-la-cura-dipende-dalla-relazione-medico-paziente]]></loc><lastmod>2025-10-13T17:06:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22407-malattie-infiammatorie-croniche-intestinali-una-guida-pratica-per-migliorare-laderenza-terapeutica]]></loc><lastmod>2025-10-13T17:06:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22365-occlusione-venosa-retinica-faricimab-rimborsabile-in-italia]]></loc><lastmod>2025-10-02T08:29:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22321-colite-ulcerosa-via-libera-alla-rimborsabilita-di-etrasimod]]></loc><lastmod>2025-09-19T09:06:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22166-diagnosi-precoce-per-diabete-e-celiachia-lo-screening-funziona-al-via-la-fase-nazionale-nel-2025]]></loc><lastmod>2025-07-07T20:29:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22164-idrosadenite-suppurativa-urge-il-riconoscimento-come-malattia-cronica]]></loc><lastmod>2025-07-07T13:38:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22129-disturbi-respiratori-ostruttivi-asma-grave-e-bpco-ancora-legati-ad-alti-tassi-di-morbilita-e-mortalita]]></loc><lastmod>2025-06-25T14:38:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22088-malattia-renale-associata-a-diabete-di-tipo-2-risultati-positivi-dalla-combinazione-di-finerenone-ed-empagliflozin]]></loc><lastmod>2025-06-13T11:44:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22043-ictus-cerebrale-perche-nei-giovani-e-in-aumento]]></loc><lastmod>2025-06-03T14:51:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/22021-malattie-infiammatorie-croniche-intestinali-a-cagliari-il-confronto-tra-clinica-e-ricerca]]></loc><lastmod>2025-05-23T18:43:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21968-salute-respiratoria-al-via-le-campagne-di-sensibilizzazione-della-consulta-della-pneumologia]]></loc><lastmod>2025-05-09T11:15:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21948-spondiloartrite-assiale-meno-di-un-paziente-su-4-ottiene-un-controllo-completo-dei-sintomi-con-i-fans]]></loc><lastmod>2025-04-30T15:37:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21921-gotta-una-malattia-antica-ma-ancora-attuale]]></loc><lastmod>2025-04-19T11:02:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21736-diabete-di-tipo-1-uno-studio-retrospettivo-conferma-l-efficacia-del-trapianto-di-isole-pancreatiche]]></loc><lastmod>2025-02-17T16:16:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21662-ictus-cerebrale-da-alice-italia-un-progetto-per-migliorare-la-gestione-della-disfagia]]></loc><lastmod>2025-01-24T12:17:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21595-malattia-renale-cronica-il-menu-di-natale-della-sin]]></loc><lastmod>2024-12-18T10:26:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21590-diabete-autoimmune-di-tipo-1-al-via-la-campagna-un-passo-avanti]]></loc><lastmod>2024-12-18T11:46:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21514-al-via-la-vitiligine-week-una-settimana-completamente-rivolta-ai-pazienti-e-ai-loro-bisogni]]></loc><lastmod>2024-11-22T13:18:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21486-colite-ulcerosa-al-via-la-campagna-voci-di-pancia]]></loc><lastmod>2024-11-13T12:15:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21489-malattie-mediate-da-infiammazione-di-tipo-2-dupilumab-rimborsabile-in-italia-in-4-nuove-indicazioni]]></loc><lastmod>2024-11-13T15:54:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21483-malattia-renale-cronica-una-corretta-alimentazione-aiuta-a-preservare-la-funzionalita-dei-reni]]></loc><lastmod>2024-11-12T18:01:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21457-presentato-a-roma-il-manifesto-futurista-delle-malattie-reumatologiche]]></loc><lastmod>2024-11-05T18:58:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21437-ictus-cerebrale-il-29-ottobre-la-giornata-mondiale]]></loc><lastmod>2024-10-28T17:10:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21398-malattia-renale-cronica-verso-una-cura-ottimale]]></loc><lastmod>2024-10-16T09:17:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21389-malattie-cardiache-arriva-il-primo-pacemaker-bicamerale-senza-fili-al-mondo]]></loc><lastmod>2024-10-15T08:30:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21390-i-pacemaker-senza-fili-una-rivoluzione-tecnologica-in-cardiologia]]></loc><lastmod>2024-10-15T08:30:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21392-malattie-del-cuore-se-si-facesse-prevenzione-il-50-delle-morti-sarebbe-evitabile]]></loc><lastmod>2024-10-14T16:53:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21250-artrite-reumatoide-la-biopsia-dei-tessuti-infiammati-per-cure-piu-efficaci-e-personalizzate]]></loc><lastmod>2024-09-02T08:53:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21203-salute-verso-un-programma-di-screening-per-diabete-e-celiachia]]></loc><lastmod>2024-07-29T13:18:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21177-broncopneumopatia-cronica-ostruttiva-approvazione-europea-per-dupilumab]]></loc><lastmod>2024-07-17T13:29:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21053-broncopneumopatia-cronica-ostruttiva-ok-del-chmp-per-dupilumab]]></loc><lastmod>2024-06-06T16:42:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21034-vitiligine-ruxolitinib-rimborsabile-in-italia]]></loc><lastmod>2024-05-31T09:33:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21025-bronco-pneumopatia-cronica-ostruttiva-presentati-i-risultati-di-fase-iii-di-dupilumab]]></loc><lastmod>2024-05-28T08:54:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/21021-malattia-di-crohn-upadacitinib-ottiene-la-rimborsabilita-da-aifa]]></loc><lastmod>2024-05-27T12:25:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20975-malattie-respiratorie-gruppo-chiesi-e-karolinska-institutet-insieme-per-lo-sviluppo-di-nuove-terapie]]></loc><lastmod>2024-05-15T16:05:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20949-diabete-1-e-celiachia-parte-da-napoli-lo-screening-nazionale-per-la-loro-individuazione-precoce]]></loc><lastmod>2024-05-09T09:14:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20927-ictus-cerebrale-platinette-e-il-nuovo-testimonial-di-alice-italia-odv]]></loc><lastmod>2024-05-03T10:37:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20925-sindrome-di-tourette-alessandro-borghi-racconta-la-sua-esperienza-con-la-malattia]]></loc><lastmod>2024-05-03T11:19:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20913-asma-eosinofilico-grave-nuovo-studio-approfondisce-il-meccanismo-d-azione-di-mepolizumab]]></loc><lastmod>2024-04-24T13:23:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20910-psoriasi-a-placche-presentati-i-dati-a-4-anni-su-bimekizumab]]></loc><lastmod>2024-04-24T12:56:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20891-poliposi-nasale-un-profumo-speciale-creato-per-supportare-i-pazienti]]></loc><lastmod>2024-04-19T18:25:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20886-torna-asma-zero-week-consulenze-mediche-gratuite-in-40-centri-specializzati]]></loc><lastmod>2024-04-18T10:55:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20849-stenosi-aortica-severa-a-padova-interventi-con-valvola-di-nuova-generazione-con-consente-di-ridurre-la-mortalita-all-1]]></loc><lastmod>2024-04-08T09:48:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20818-disturbi-dello-spettro-autistico-in-italia-ne-e-affetto-1-bambino-su-77]]></loc><lastmod>2024-03-29T09:45:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20821-infiammazione-di-tipo-2-una-causa-piu-patologie]]></loc><lastmod>2024-03-29T10:04:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20731-fegato-grasso-al-via-un-progetto-europeo-per-la-diagnosi-precoce]]></loc><lastmod>2024-03-08T11:40:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20705-giornata-mondiale-dell-obesita-il-4-marzo-consulti-gratuiti-all-irccs-multimedica]]></loc><lastmod>2024-02-29T18:53:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20666-dolore-cronico-disponibile-in-italia-un-nuovo-neurostimolatore-impiantabile]]></loc><lastmod>2024-02-22T18:15:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20662-vitiligine-un-manifesto-in-cinque-punti-per-rispondere-ai-bisogni-insoddisfatti-dei-pazienti]]></loc><lastmod>2024-02-20T17:09:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20636-malattie-infiammatorie-croniche-intestinali-in-italia-sono-250mila-i-pazienti]]></loc><lastmod>2024-02-15T17:31:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20601-occlusione-venosa-retinica-nuovi-dati-positivi-a-lungo-termine-su-faricimab]]></loc><lastmod>2024-02-07T16:08:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20549-epatite-b-al-san-raffaele-sperimentata-per-la-prima-volta-al-mondo-una-molecola-immunoterapica]]></loc><lastmod>2024-01-23T12:31:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20481-ictus-presentato-il-manuale-di-valutazione-della-comunicazione-del-percorso-assistenziale-del-paziente]]></loc><lastmod>2023-12-22T19:04:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20442-asma-una-survey-nazionale-conferma-la-necessita-di-un-ottimizzazione-terapeutica]]></loc><lastmod>2023-12-14T12:29:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20374-dermatite-atopica-approvazione-europea-per-lebrikizumab]]></loc><lastmod>2023-11-21T18:27:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20330-epatite-delta-diasorin-e-gilead-sciences-insieme-per-lo-sviluppo-di-un-test-diagnostico]]></loc><lastmod>2025-12-17T09:10:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20331-malattia-renale-cronica-al-via-l-iniziativa-weekidney]]></loc><lastmod>2023-11-13T10:39:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20303-anemia-da-malattia-renale-cronica-arriva-il-primo-libro-bianco]]></loc><lastmod>2023-11-09T17:04:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20266-ictus-ogni-anno-colpisce-nel-mondo-12-milioni-di-persone]]></loc><lastmod>2023-10-28T19:16:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20237-epatite-delta-nel-mondo-colpisce-circa-10-milioni-di-persone]]></loc><lastmod>2023-10-14T22:03:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20221-malattie-reumatiche-anmar-tutte-le-regioni-attivino-tavoli-e-gruppi-di-lavoro]]></loc><lastmod>2023-10-12T13:49:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20158-dermatite-atopica-parere-positivo-del-chmp-per-lebrikizumab]]></loc><lastmod>2023-09-28T17:47:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20066-dolore-cronico-ne-soffrono-13-milioni-di-italiani-e-150-milioni-di-europei]]></loc><lastmod>2023-08-23T17:00:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20013-vitiligine-approvata-in-europa-la-prima-terapia-specifica-per-la-patologia]]></loc><lastmod>2023-08-14T18:00:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20050-psoriasi-al-via-la-nuova-campagna-awarness-respectpsorias-di-apiafco]]></loc><lastmod>2023-08-07T08:52:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/20034-colite-ulcerosa-upadacitinib-ottiene-la-rimborsabilita-in-italia]]></loc><lastmod>2023-07-27T20:36:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19867-vulvodinia-un-nuovo-approccio-terapeutico-a-base-di-cortisonici-analgesici-e-cannabis]]></loc><lastmod>2023-06-08T07:53:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19808-anemia-sintomatica-associata-a-malattia-renale-cronica-roxadustat-disponibile-in-italia]]></loc><lastmod>2023-05-18T18:56:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19751-malattia-di-crohn-la-commissione-europea-approva-upadacitinib]]></loc><lastmod>2023-04-27T21:41:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19706-dermatite-atopica-abrocitinib-disponibile-in-italia-per-pazienti-over-18]]></loc><lastmod>2023-04-13T18:18:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19687-ictus-al-via-il-progetto-fast-heroes]]></loc><lastmod>2023-04-05T18:55:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19528-malattie-infiammatorie-croniche-intestinali-al-via-master-universitario-della-cattolica]]></loc><lastmod>2023-02-12T18:56:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19515-nefrite-lupica-belimumab-indicato-per-il-trattamento-della-patologia]]></loc><lastmod>2023-02-04T12:19:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19504-malattie-reumatologiche-fira-nuove-evidenze-scientifiche-raccomandano-il-vaccino-anti-covid]]></loc><lastmod>2023-02-02T20:23:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19476-malattie-infiammatorie-croniche-intestinali-al-via-ibd-cooking-channel]]></loc><lastmod>2023-01-23T10:33:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19452-malattia-renale-cronica-nasce-la-piattaforma-renal-care]]></loc><lastmod>2023-01-14T15:40:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19422-malattie-reumatologiche-i-consigli-a-tavola-per-le-feste]]></loc><lastmod>2022-12-27T11:45:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19403-vitiligine-dagli-usa-un-nuovo-farmaco-inibitore-della-janus-chinasi]]></loc><lastmod>2022-12-20T17:59:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19374-osteoporosi-virginia-visconti-vince-borsa-di-studio-per-giovani-ricercatori]]></loc><lastmod>2022-12-12T16:37:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19361-malattie-reumatologiche-cure-sempre-piu-digitali-e-integrate]]></loc><lastmod>2022-12-04T19:56:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19336-malattia-di-crohn-approvazione-europea-per-risankizumab]]></loc><lastmod>2022-11-27T12:10:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19305-malattie-infiammatorie-croniche-intestinali-l-importanza-dell-alimentazione]]></loc><lastmod>2022-11-20T11:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19221-ictus-il-29-ottobre-e-la-giornata-mondiale]]></loc><lastmod>2022-10-28T08:37:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19208-vitiligine-una-malattia-dall-origine-complessa]]></loc><lastmod>2022-10-25T13:50:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19167-patologie-gastrointestinali-croniche-online-il-portale-gi-point-it]]></loc><lastmod>2022-10-13T17:04:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19111-malattia-di-crohn-il-chmp-raccomanda-l-approvazione-di-risankizumab]]></loc><lastmod>2022-09-24T20:20:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19044-colite-ulcerosa-la-battaglia-di-martina-santagiuliana-al-festival-di-venezia]]></loc><lastmod>2022-09-11T14:37:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/19042-dermatite-atopica-oggi-la-giornata-mondiale]]></loc><lastmod>2022-09-11T14:18:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18989-nefrite-lupica-aifa-approva-belimumab]]></loc><lastmod>2022-08-05T12:27:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18874-psoriasi-un-cortometraggio-per-superare-le-paure-e-liberare-le-proprie-emozioni]]></loc><lastmod>2022-07-03T19:51:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18875-steatosi-epatica-non-alcolica-presentate-le-nuove-linee-guida]]></loc><lastmod>2022-07-08T09:43:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18896-aneurisma-dell-aorta-addominale-un-killer-silenzioso-che-uccide-6000-italiani-all-anno]]></loc><lastmod>2022-07-07T14:42:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18837-malattie-reumatologiche-confermata-la-validita-dei-farmaci-biobetter]]></loc><lastmod>2022-06-25T16:50:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18838-ictus-la-fase-della-neuroriabilitazione-e-fondamentale]]></loc><lastmod>2022-06-25T16:44:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18768-depressione-disponibile-in-italia-il-primo-farmaco-spray-nasale]]></loc><lastmod>2022-06-13T15:34:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18736-malattia-renale-cronica-lanciata-la-campagna-anemia-non-aspettare-agisci]]></loc><lastmod>2022-06-05T15:02:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18709-colite-ulcerosa-il-chmp-raccomanda-l-approvazione-di-upadacitinib]]></loc><lastmod>2022-05-30T12:02:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18684-insufficienza-cardiaca-nanophoria-raccoglie-fondi-per-lo-sviluppo-di-una-terapia-sperimentale]]></loc><lastmod>2022-05-22T21:06:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18685-artrite-psoriasica-upadacitinib-ottiene-la-rimborsabilita-da-aifa]]></loc><lastmod>2022-05-22T21:15:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18634-malattie-reumatologiche-il-crei-lancia-un-concorso-fotografico-aperto-ai-pazienti]]></loc><lastmod>2022-05-11T11:39:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18613-dermatite-atopica-al-via-la-campagna-rimettiti-in-gioco]]></loc><lastmod>2022-05-06T09:45:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18535-malattie-reumatiche-approvata-alla-camera-una-mozione-per-la-tutela-dei-pazienti]]></loc><lastmod>2022-04-10T13:18:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18474-osteoporosi-pubblicato-il-rapporto-scope-21]]></loc><lastmod>2022-03-28T20:37:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18443-colite-ulcerosa-ustekinumab-disponibile-in-italia]]></loc><lastmod>2022-03-21T17:02:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18418-malattie-respiratorie-astrazeneca-e-honeywell-insieme-per-sviluppo-di-nuovi-inalatori]]></loc><lastmod>2022-03-15T19:06:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18393-malattie-autoimmuni-croniche-al-via-wonder-progetto-pilota-per-l-integrazione-scolastica]]></loc><lastmod>2022-03-06T23:36:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18358-lupus-eritematoso-sistemico-anifrolumab-approvato-in-europa]]></loc><lastmod>2022-02-27T20:08:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18265-asma-grave-il-chmp-raccomanda-l-approvazione-di-dupilumab-nei-bambini]]></loc><lastmod>2022-02-07T15:17:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18258-ictus-cerebrale-attenzione-alla-depressione-postuma]]></loc><lastmod>2022-02-07T00:11:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18241-prurigo-nodularis-secondo-studio-di-fase-iii-conferma-i-benefici-di-dupilumab]]></loc><lastmod>2022-01-31T10:24:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18242-poliposi-nasale-la-storia-di-rossana-un-incubo-durato-dodici-anni]]></loc><lastmod>2022-01-31T10:41:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18235-bronco-pneumopatia-cronica-ostruttiva-nasce-un-sistema-per-il-telemonitoraggio-dei-pazienti]]></loc><lastmod>2022-01-30T21:26:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18236-malattie-croniche-e-pandemia-le-associazioni-chiedono-al-governo-di-salvaguardare-il-diritto-alla-salute-dei-pazienti]]></loc><lastmod>2022-01-30T23:31:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18216-covid-19-l-appello-di-fand-onlus-non-chiudete-le-diabetologie]]></loc><lastmod>2022-01-23T22:46:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18179-scompenso-cardiaco-cronico-dapagliflozin-rimborsabile-in-italia]]></loc><lastmod>2022-01-15T17:43:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18160-malattie-reumatiche-il-dolore-cronico-colpisce-un-paziente-su-quattro]]></loc><lastmod>2022-01-07T17:05:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18154-asma-grave-dupilumab-si-dimostra-efficace-nei-bambini-che-non-rispondono-alle-terapie]]></loc><lastmod>2022-01-02T15:45:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18140-patologie-neurologiche-croniche-le-raccomandazioni-della-sin-per-vivere-serenamente-le-festivita]]></loc><lastmod>2021-12-27T15:15:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18120-dermatite-atopica-la-ce-approva-abrocitinib]]></loc><lastmod>2021-12-20T19:30:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18094-malattie-reumatologiche-apmarr-chiede-la-cancellazione-dell-art-5-del-decreto-fiscale]]></loc><lastmod>2021-12-12T18:10:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18095-insufficienza-intestinale-cronica-benigna-e-sindrome-dell-intestino-corto-al-via-un-progetto-per-migliorare-il-percorso-assistenziale]]></loc><lastmod>2021-12-12T18:23:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18074-malattia-di-crohn-e-colite-ulcerosa-aumentano-i-casi-in-italia]]></loc><lastmod>2021-12-05T22:13:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18052-artrite-psoriasica-la-commissione-europea-approva-risankizumab]]></loc><lastmod>2021-11-28T00:13:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18004-autismo-nasce-il-progetto-farm4autism]]></loc><lastmod>2021-11-13T21:24:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/18018-poliposi-nasale-una-patologia-da-conoscere-e-riconoscere]]></loc><lastmod>2021-11-19T17:53:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17962-prurigo-nodularis-dupilumab-riduce-significativamente-il-prurito-e-le-lesioni-cutanee]]></loc><lastmod>2021-10-31T23:38:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17960-osteoporosi-dall-universita-di-trieste-una-nuova-tecnologia-per-lo-studio-dell-osso]]></loc><lastmod>2021-10-31T23:01:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17935-artrite-psoriasica-parere-positivo-del-chmp-per-risankizumab]]></loc><lastmod>2021-10-28T22:09:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17936-dermatite-atopica-presentata-la-serie-animata-dado-e-adele-due-amici-per-la-pelle]]></loc><lastmod>2021-10-23T22:50:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17942-psoriasi-il-29-ottobre-e-la-giornata-mondiale]]></loc><lastmod>2021-10-26T14:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17901-malattie-autoimmuni-e-infiammatorie-scoperte-quattro-nuove-sindromi]]></loc><lastmod>2021-10-17T21:27:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17902-psoriasi-e-dermatite-atopica-stop-a-lesioni-e-prurito-con-le-nuove-terapie]]></loc><lastmod>2021-10-17T21:43:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17914-malattie-infiammatorie-autoimmuni-e-covid-19-societa-italiana-di-gastroenterologia-fondamentale-vaccinarsi]]></loc><lastmod>2021-10-19T18:30:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17877-malattie-autoimmuni-reumatologiche-e-dermatologiche-il-genere-fa-la-differenza]]></loc><lastmod>2021-10-09T19:59:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17850-malattia-renale-cronica-approvazione-europea-per-dapagliflozin]]></loc><lastmod>2021-10-03T18:06:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17851-asma-e-bpco-urge-una-maggiore-aderenza-terapeutica-da-parte-dei-pazienti]]></loc><lastmod>2021-10-03T18:17:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17810-iperpotassiemia-approvato-in-italia-il-trattamento-con-ciclosilicato-di-sodio-e-zirconio]]></loc><lastmod>2021-09-23T11:10:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17777-dermatite-atopica-il-14-settembre-e-la-giornata-mondiale]]></loc><lastmod>2021-09-14T14:34:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17760-malattie-infiammatorie-intestinali-aifa-approva-vedolizumab-in-formulazione-sottocutanea]]></loc><lastmod>2021-09-10T16:31:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17749-dermatite-atopica-lo-studio-registrativo-su-dupilumab-soddisfa-tutti-gli-endpoint]]></loc><lastmod>2021-09-05T14:02:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17750-artrite-reumatoide-la-causa-scatenante-potrebbe-risiedere-in-un-batterio-delle-gengive]]></loc><lastmod>2021-09-05T14:14:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17746-psoriasi-a-placche-approvazione-europea-per-bimekizumab]]></loc><lastmod>2021-09-07T15:27:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17711-malattie-reumatologiche-infantili-a-bari-nasce-il-progetto-per-non-perdere-la-bussola]]></loc><lastmod>2021-08-06T20:05:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17692-malattie-croniche-autoimmuni-l-appello-di-apmarr-green-pass-obbligatorio-anche-negli-hotel-e-sulle-spiagge]]></loc><lastmod>2021-07-27T06:47:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17665-colite-ulcerosa-nuovi-dati-positivi-per-ustekinumab]]></loc><lastmod>2021-07-18T22:03:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17625-dermatite-atopica-parere-positivo-del-chmp-per-upadacitinib]]></loc><lastmod>2021-07-06T17:55:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17596-diabete-hack-to-the-future-premia-il-progetto-olimpiadi-della-salute-2-0]]></loc><lastmod>2021-06-28T00:42:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17536-lupus-eritematoso-sistemico-dimostrati-i-benefici-di-anifrolumab-a-livello-cutaneo-e-articolare]]></loc><lastmod>2021-06-13T19:07:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17518-asma-da-moderata-grave-presentati-i-dati-di-fase-iii-su-dupilumab-nei-bambini-tra-i-6-e-gli-11-anni]]></loc><lastmod>2021-06-06T21:29:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17500-malattie-reumatiche-presentata-una-web-listening-sulle-problematiche-dei-pazienti]]></loc><lastmod>2021-05-31T18:55:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17471-asma-dal-7-all-11-giugno-torna-la-settimana-di-sensibilizzazione]]></loc><lastmod>2021-05-23T20:43:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17448-nefrite-lupica-la-commissione-europea-approva-belimumab]]></loc><lastmod>2021-05-19T19:40:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17449-patologie-autoimmuni-gli-esperti-nessuna-controindicazione-per-vaccino-anti-covid]]></loc><lastmod>2021-05-19T19:39:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17445-psoriasi-al-via-la-campagna-buongiorno-pelle]]></loc><lastmod>2021-05-16T16:18:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17453-malattie-infiammatorie-croniche-dell-intestino-oggi-la-giornata-mondiale]]></loc><lastmod>2021-05-18T22:47:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17425-asma-al-via-l-iniziativa-nextbreathchallenge]]></loc><lastmod>2021-05-11T17:12:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17416-lupus-il-10-maggio-e-la-giornata-mondiale-dedicata-alla-patologia]]></loc><lastmod>2021-05-10T17:20:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17382-bpco-approvazione-europea-per-beclometasone-formoterolo-glicopirronio-in-inalatore-a-polvere-secca]]></loc><lastmod>2021-05-03T08:09:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17340-asma-grave-per-l-87-dei-pazienti-la-patologia-limita-significativamente-le-scelte-di-vita]]></loc><lastmod>2021-04-25T23:26:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17287-malattie-infiammatorie-croniche-e-sport-lanciata-la-campagna-passione-accesa]]></loc><lastmod>2021-04-11T22:01:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17262-asma-grave-eosinofilico-arriva-in-italia-il-primo-trattamento-per-bambini]]></loc><lastmod>2021-04-03T15:35:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17237-artrite-reumatoide-aifa-approva-infliximab-in-formulazione-sottocutanea]]></loc><lastmod>2021-03-28T22:14:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17238-spondiloartrite-sieronegativa-la-nuova-vita-di-camilla-grazie-ai-farmaci-biologici]]></loc><lastmod>2021-03-28T22:25:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17138-coronaropatia-e-arteriopatia-periferica-aifa-ammette-rivaroxaban-al-rimborso]]></loc><lastmod>2021-03-12T12:19:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17099-malattie-epatiche-croniche-nuovo-trattamento-orale-evita-il-ricorso-a-trasfusioni-piastriniche]]></loc><lastmod>2021-02-28T18:23:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17027-ictus-ischemico-il-covid-19-ne-aumenta-il-rischio-e-il-ritardo-diagnostico]]></loc><lastmod>2021-02-14T21:57:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/17028-colite-ulcerosa-tofacitinib-disponibile-in-italia]]></loc><lastmod>2021-02-14T22:07:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16985-diabete-di-tipo-2-una-webserie-per-aiutare-i-pazienti-a-semplificarne-la-gestione]]></loc><lastmod>2021-02-07T20:09:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16958-artrite-psoriasica-e-spondilite-anchilosante-la-ce-approva-upadacitinib]]></loc><lastmod>2021-01-31T14:40:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16959-diabete-i-nuovi-farmaci-hanno-anche-un-effetto-cardioprotettivo]]></loc><lastmod>2021-01-31T14:55:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16928-malattie-reumatologiche-e-rare-al-via-reumart-la-creativita-come-risorsa]]></loc><lastmod>2021-01-24T21:17:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16817-glaucoma-necessari-degli-screening-mirati]]></loc><lastmod>2020-12-16T14:21:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16788-artrite-reumatoide-e-diabete-di-tipo-2-anakinra-efficace-in-entrambe-le-patologie]]></loc><lastmod>2020-12-09T12:32:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16745-malattie-reumatiche-al-via-il-progetto-di-telemedicina-iarplus]]></loc><lastmod>2020-11-29T21:13:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16699-scompenso-cardiaco-dapagliflozin-approvato-in-europa]]></loc><lastmod>2020-11-16T15:21:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16674-eczema-cronico-risultati-positivi-per-delgocitinib-in-crema]]></loc><lastmod>2020-11-12T18:44:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16675-asma-grave-benralizumab-puo-eliminare-la-necessita-di-corticosteroidi-orali]]></loc><lastmod>2020-11-12T18:44:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16676-dermatite-atopica-lo-stress-che-ne-deriva-coinvolge-tutta-la-famiglia]]></loc><lastmod>2020-11-12T18:44:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16645-lupus-conoscerlo-e-il-primo-passo-per-non-temerlo]]></loc><lastmod>2020-11-04T18:32:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16647-autismo-uno-studio-evidenza-i-potenziali-effetti-positivi-dei-probiotici]]></loc><lastmod>2020-11-06T08:15:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16644-dermatite-atopica-l-appello-andea-maggiori-supporti-economici-e-sociali-ai-pazienti]]></loc><lastmod>2020-11-04T18:45:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16618-malattie-infiammatorie-intestinali-a-volte-colpiscono-piu-di-un-bersaglio]]></loc><lastmod>2020-10-26T14:19:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16620-ictus-cerebrale-il-29-ottobre-e-la-giornata-mondiale]]></loc><lastmod>2020-10-27T12:26:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16609-malattie-reumatiche-no-alla-sospensione-dei-ricoveri-programmati-in-campania]]></loc><lastmod>2020-10-24T17:46:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16585-malattia-di-crohn-nuovi-risultati-di-fase-iii-su-ustekinumab]]></loc><lastmod>2020-10-19T12:01:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16586-artrite-reumatoide-approvazione-europea-per-filgotinib]]></loc><lastmod>2020-10-19T12:14:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16582-autismo-in-basilicata-un-centro-per-il-trattamento-precoce-dei-piccoli-pazienti]]></loc><lastmod>2020-10-19T09:53:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16584-dermatite-atopica-e-covid-19-la-normativa-a-tutela-dei-pazienti]]></loc><lastmod>2020-10-19T10:41:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16578-dermatite-atopica-l-impatto-psicologico-del-bullismo]]></loc><lastmod>2020-10-18T21:30:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16573-malattie-reumatiche-crollo-del-40-di-nuove-diagnosi-durante-la-pandemia]]></loc><lastmod>2020-10-18T20:03:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16570-ipertensione-dal-17-al-24-ottobre-screening-gratuito-in-farmacia]]></loc><lastmod>2020-10-16T09:33:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16559-covid-19-ancora-trascurata-la-cura-delle-malattie-croniche]]></loc><lastmod>2020-10-12T11:05:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16568-il-percorso-di-gravidanza-della-donna-con-lupus-eritematoso-sistemico-e-sindrome-da-anticorpi-antifosfolipidi]]></loc><lastmod>2020-10-16T09:33:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16551-dermatite-atopica-come-affrontare-le-difficolta-dovute-alla-pandemia]]></loc><lastmod>2020-10-13T10:07:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16522-dermatite-atopica-garantire-la-continuita-terapeutica-nella-fase-ii-della-pandemia]]></loc><lastmod>2020-10-13T10:06:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16476-psoriasi-nasce-il-nuovo-canale-virtuale-psopoint]]></loc><lastmod>2020-09-24T14:06:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16497-dermatite-atopica-e-covid-19-le-difficolta-dei-pazienti]]></loc><lastmod>2020-10-13T10:07:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16475-asma-moderata-grave-buoni-risultati-di-fase-iii-per-dupilumab]]></loc><lastmod>2020-09-24T14:04:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16472-asma-grave-eosinofilico-disponibile-in-italia-la-penna-per-l-autosomministrazione-di-benralizumab]]></loc><lastmod>2020-09-23T18:07:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16439-dermatite-atopica-arriva-l-assistente-personale-ida]]></loc><lastmod>2020-09-14T09:53:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16442-dermatite-atopica-e-covid-19-i-rischi-per-i-pazienti-e-le-necessita-di-cure]]></loc><lastmod>2020-09-14T14:42:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16417-arteriopatia-periferica-nuovi-dati-confermano-l-efficacia-di-rivaroxaban]]></loc><lastmod>2020-09-07T16:47:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16418-malattia-renale-cronica-presentati-i-risultati-di-fase-iii-di-dapagliflozin]]></loc><lastmod>2020-09-07T17:02:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16356-broncopneumopatia-bpco-al-via-il-progetto-narrarsi-ai-tempi-del-covid-19]]></loc><lastmod>2020-08-02T16:09:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16331-osteoporosi-al-via-la-campagna-multimediale-fai-vincere-le-tue-ossa]]></loc><lastmod>2020-07-26T18:24:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16332-ictus-cerebrale-i-consigli-di-alice-italia-per-l-estate]]></loc><lastmod>2020-07-26T18:41:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16312-malattie-croniche-intestinali-ibdpoint-di-takeda-vince-il-premio-informazione-scientifica-multicanale]]></loc><lastmod>2020-07-20T11:04:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16237-psoriasi-novartis-lancia-una-campagna-nazionale-di-sensibilizzazione]]></loc><lastmod>2020-06-29T12:44:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16238-bpco-buoni-risultati-dalla-combinazione-budesonide-glicopirronio-formoterolo]]></loc><lastmod>2020-06-29T12:58:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16211-diabete-di-tipo-2-canagliflozin-riduce-del-30-40-il-rischio-di-malattia-renale]]></loc><lastmod>2020-06-21T23:08:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16212-emicrania-nuovo-studio-rivela-i-meccanismi-dell-allodinia-cutanea-associata]]></loc><lastmod>2020-06-21T23:17:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16190-asma-grave-si-stima-colpisca-dal-3-5-al-10-dei-pazienti]]></loc><lastmod>2020-06-16T16:50:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16158-diabete-via-libera-dell-ema-a-nuove-indicazioni-per-canagliflozin]]></loc><lastmod>2020-06-10T09:39:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16160-diabete-occorre-migliorare-la-cura-delle-complicanze-renali-e-cardiovascolari]]></loc><lastmod>2020-06-10T09:54:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16065-malattie-croniche-prosegue-il-progetto-di-telemedicina-vicini-di-salute]]></loc><lastmod>2020-05-13T20:56:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/16015-covid-19-non-provato-che-il-contagio-si-manifesti-inizialmente-con-crisi-epilettiche]]></loc><lastmod>2020-05-03T17:18:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15982-malattie-croniche-terapie-a-domicilio-grazie-a-sanofi4you]]></loc><lastmod>2020-04-20T18:37:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15950-diabete-e-obesita-la-dieta-chetogenica-sembra-dare-benefici]]></loc><lastmod>2020-04-14T11:35:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15928-malattia-renale-cronica-conclamata-efficacia-di-dapaglifozin]]></loc><lastmod>2020-04-08T19:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15929-lupus-eritematoso-sistemico-con-le-nuove-terapie-migliora-la-qualita-della-vita]]></loc><lastmod>2020-04-08T19:47:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15931-coronavirus-i-consigli-di-a-l-i-ce-italia-per-l-attivita-fisica-in-casa]]></loc><lastmod>2020-04-08T20:22:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15897-lupus-eritematoso-sistemico-preoccupazione-circa-l-eventuale-carenza-d-idrossiclorochina]]></loc><lastmod>2020-04-02T15:10:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15843-coronavirus-i-pazienti-con-diabete-chiedono-semplificazione-del-ritiro-dei-farmaci-in-dpc]]></loc><lastmod>2020-03-25T15:44:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15746-colite-ulcerosa-e-malattia-di-crohn-parere-positivo-del-chmp-per-vedolizumab]]></loc><lastmod>2020-03-10T20:30:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15747-malattia-renale-cronica-confermato-il-ruolo-positivo-del-consumo-di-caffe]]></loc><lastmod>2020-03-10T20:47:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15748-psoriasi-risankizumab-ottiene-la-rimborsabilita-da-aifa]]></loc><lastmod>2020-03-10T21:00:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15723-diabete-da-abbott-e-insulet-un-sistema-integrato-di-misurazione-del-glucosio]]></loc><lastmod>2020-03-03T15:01:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15700-malattie-reumatologiche-presentata-un-interpellanza-parlamentare]]></loc><lastmod>2020-02-27T17:30:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15701-disabilita-e-condizioni-di-lavoro-lanciata-indagine-nazionale]]></loc><lastmod>2020-02-27T17:28:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15698-malattie-croniche-ancora-troppa-la-distanza-tra-medico-e-paziente]]></loc><lastmod>2020-02-27T10:30:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15683-diabete-di-tipo-2-dati-clinici-confermano-la-sicurezza-di-linagliptin]]></loc><lastmod>2020-02-20T21:31:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15685-malattie-reumatiche-autoimmuni-i-vaccini-appaiono-sicuri-ma-servono-piu-studi]]></loc><lastmod>2020-02-20T22:28:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15657-diabete-e-dipendenza-da-nicotina-uno-studio-ne-dimostra-la-relazione]]></loc><lastmod>2020-02-13T22:34:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15639-dermatite-atopica-fda-valuta-dupilumab-anche-per-pazienti-pediatrici]]></loc><lastmod>2020-02-07T08:44:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15597-psoriasi-studio-di-fase-iii-dimostra-la-superiorita-di-bimekizumab-su-adalimumab]]></loc><lastmod>2020-01-21T17:11:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15577-psoriasi-bimekizumab-ottiene-risultati-positivi-nello-studio-di-fase-iii-be-ready]]></loc><lastmod>2020-01-14T18:20:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15578-osteoporosi-severa-approvazione-europea-per-romosozumab]]></loc><lastmod>2020-01-14T18:31:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15557-artrite-reumatoide-la-commissione-europea-approva-upadacitinib]]></loc><lastmod>2020-01-07T17:41:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15494-ictus-cerebrale-al-via-gli-incontri-di-supporto-consapevole-per-pazienti-e-familiari]]></loc><lastmod>2019-12-09T11:47:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15399-asma-grave-su-71-pronto-soccorso-solo-il-48-ha-un-protocollo-dedicato]]></loc><lastmod>2019-11-09T23:49:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15364-artrite-reumatoide-parere-positivo-del-chmp-europeo-per-upadacitinib]]></loc><lastmod>2019-10-31T15:45:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15365-osteoporosi-severa-il-chmp-raccomanda-romosozumab]]></loc><lastmod>2019-10-31T16:00:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15351-ictus-cerebrale-oggi-la-giornata-mondiale-2]]></loc><lastmod>2019-10-28T18:57:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15321-spondiloartrite-assiale-raggiunto-l-endpoint-primario-nello-studio-di-fase-iii-su-secukinumab]]></loc><lastmod>2019-10-17T15:14:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15296-steatoepatite-non-alcolica-l-acido-obeticolico-migliora-la-fibrosi]]></loc><lastmod>2019-10-11T11:03:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15297-diabete-il-dispositivo-freestyle-libre-vince-il-prix-galien-italia-2019]]></loc><lastmod>2019-10-10T21:19:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15299-epatite-b-cronica-una-molecola-riattiva-il-sistema-immunitario-contro-il-virus]]></loc><lastmod>2019-10-10T21:19:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15252-epatite-b-cronica-disponibile-in-italia-un-nuovo-trattamento-dopo-oltre-un-decennio-di-latenza-terapeutica]]></loc><lastmod>2019-10-02T09:37:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15254-psoriasi-a-placche-una-nuova-pubblicazione-dimostra-come-secukinumab-sia-in-grado-di-migliorare-l-infiammazione]]></loc><lastmod>2019-10-02T09:42:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15256-rinosinusite-cronica-con-poliposi-nasale-il-chmp-raccomanda-l-approvazione-di-dupilumab]]></loc><lastmod>2019-10-02T09:37:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15257-lupus-eritematoso-sistemico-3-persone-su-4-non-ne-hanno-mai-sentito-parlare]]></loc><lastmod>2019-10-01T16:02:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15206-disturbi-dello-spettro-autistico-analisi-statistica-conferma-l-efficacia-di-amo-02]]></loc><lastmod>2019-09-19T12:37:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15182-diabete-di-tipo-2-e-malattia-coronarica-ticagrelor-riduce-il-rischio-di-eventi-cardiovascolari]]></loc><lastmod>2019-09-13T15:47:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15161-diabete-il-rischio-e-doppio-nei-bambini-se-il-fegato-e-grasso]]></loc><lastmod>2019-09-05T15:59:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15162-dermatite-atopica-grave-risultati-positivi-per-dupilumab-nei-bambini]]></loc><lastmod>2019-09-05T15:58:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15155-malattie-cardiovascolari-trovata-una-porta-molecolare-che-diminuisce-i-danni-al-cuore]]></loc><lastmod>2019-09-04T20:14:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15141-vulvodinia-una-lettera-dai-pazienti-per-accendere-i-riflettori-sulla-patologia]]></loc><lastmod>2023-05-23T10:15:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15142-vulvodinia-la-denuncia-di-cecilia-manca-una-figura-medica-di-riferimento]]></loc><lastmod>2023-05-23T10:14:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15060-insufficienza-cardiaca-cronica-in-italia-merck-e-nuovamente-titolare-del-bisoprololo-fumarato]]></loc><lastmod>2019-07-21T18:09:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15061-spondiloartrite-assiale-tre-quarti-dei-pazienti-faticano-a-trovare-un-lavoro]]></loc><lastmod>2019-07-21T18:07:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15034-fibrillazione-atriale-pubblicate-le-previsioni-per-l-anno-2060]]></loc><lastmod>2019-07-12T20:47:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15030-diabete-autoimmune-latente-negli-adulti-allo-studio-le-prime-linee-guida-internazionali]]></loc><lastmod>2019-07-12T19:59:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15027-disabilita-avviati-i-percorsi-di-formazione-relativi-al-progetto-plus]]></loc><lastmod>2019-07-12T18:13:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/15001-asma-eosinofilico-in-europa-via-libera-all-auto-somministrazione-di-benralizumab]]></loc><lastmod>2019-07-08T17:01:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14980-ictus-gli-esperti-segnalano-un-aumento-dei-casi-durante-la-gestazione]]></loc><lastmod>2019-07-04T17:09:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14939-ictus-cerebrale-la-nuotata-di-alberto-sassoli-sensibilizzare-alla-prevenzione]]></loc><lastmod>2019-06-21T13:52:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14912-ictus-cerebrale-si-allunga-fino-a-9-ore-la-finestra-temporale-per-la-terapia-trombolitica]]></loc><lastmod>2019-06-12T15:23:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14887-spondilite-anchilosante-i-dati-preoccupanti-del-sondaggio-emas]]></loc><lastmod>2020-02-27T13:48:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14870-asma-al-via-asmazeroweek-con-visite-gratuite-di-controllo-in-tutta-italia]]></loc><lastmod>2019-06-02T16:21:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14859-malattie-infiammatorie-croniche-intestinali-online-la-campagna-di-sensibilizzazione-semicimetto]]></loc><lastmod>2019-05-28T18:48:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14811-poliartriti-croniche-nuovi-approcci-di-cura-e-counselling-mirato-aiutano-le-donne-a-realizzare-il-desiderio-di-maternita]]></loc><lastmod>2020-02-27T13:49:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14786-autismo-l-arte-come-forma-di-riabilitazione]]></loc><lastmod>2019-05-07T16:13:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14741-malattie-reumatiche-anmar-lancia-indagine-sull-impatto-delle-patologie-in-italia]]></loc><lastmod>2019-04-17T15:53:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14612-rene-policistico-il-ruolo-centrale-della-terapia-nutrizionale]]></loc><lastmod>2019-03-21T19:23:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14603-ictus-cerebrale-in-aumento-tra-i-giovani-l-allarme-di-a-l-i-ce-italia-onlus]]></loc><lastmod>2019-03-20T14:09:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14576-psoriasi-a-placche-parere-positivo-del-chmp-per-risankizumab]]></loc><lastmod>2019-03-14T22:26:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14529-ictus-fondamentale-la-tempestivita-della-presa-in-carico]]></loc><lastmod>2019-02-27T22:07:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14488-ictus-cerebrale-al-via-una-campagna-indovina-l-ictus-osserva-riconosci-intervieni]]></loc><lastmod>2019-02-19T22:50:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14380-ictus-cerebrale-si-alla-settimana-bianca-ma-solo-seguendo-regole-precise]]></loc><lastmod>2019-10-16T14:42:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14365-steatoepatite-non-alcolica-accordo-tra-gilead-e-scholar-rock-per-potenziali-terapie]]></loc><lastmod>2019-01-15T18:37:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14326-epatopatia-cronica-dal-chmp-parere-positivo-per-lusutrombopag]]></loc><lastmod>2019-01-03T18:08:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14303-bronchiectasia-fda-concede-la-designazione-qipd-al-colistimetato-sodico-in-polvere]]></loc><lastmod>2018-12-20T12:28:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14305-autismo-iniziata-la-fase-di-consultazione-sulle-nuove-linee-guida-italiane]]></loc><lastmod>2018-12-20T12:24:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14222-disturbi-dello-spettro-autistico-miglioramenti-con-il-farmaco-sperimentale-amo-02]]></loc><lastmod>2018-11-29T22:36:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14184-dermatite-atopica-fda-valuta-l-approvazione-di-dupilumab-negli-adolescenti]]></loc><lastmod>2018-11-21T17:54:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14157-dermatite-atopica-oggi-i-pazienti-italiani-possono-contare-su-dupilumab]]></loc><lastmod>2018-11-15T16:39:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14104-caroline-wozniacki-la-tennista-che-vince-contro-l-artrite-reumatoide]]></loc><lastmod>2020-02-27T14:20:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14085-ictus-cerebrale-oggi-la-giornata-mondiale]]></loc><lastmod>2018-10-28T10:51:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14083-rinosinusite-cronica-con-poliposi-nasale-positivi-i-dati-clinici-di-fase-iii-su-dupilumab]]></loc><lastmod>2018-10-25T16:44:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14084-malattie-reumatiche-apmar-lancia-la-campagna-reumache]]></loc><lastmod>2020-02-27T12:36:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14024-malattia-di-crohn-darvadstrocel-vince-il-prix-galien-italia-2018]]></loc><lastmod>2018-10-11T08:50:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14025-artrite-reumatoide-tofacitinib-disponibile-anche-in-italia]]></loc><lastmod>2018-10-11T09:16:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/14028-colite-ulcerosa-simone-sabbioni-io-ce-l-ho-fatta-e-partecipero-ai-mondiali-di-nuoto]]></loc><lastmod>2018-10-11T11:41:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13995-insufficienza-renale-59-congresso-sin-innovazione-in-dialisi-e-gestione-del-paziente-cronico]]></loc><lastmod>2018-10-04T15:37:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13975-dermatite-atopica-risultati-clinici-positivi-per-dupilumab-negli-adolescenti]]></loc><lastmod>2018-09-28T10:19:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13919-dermatite-atopica-il-farmaco-dupilumab-autorizzato-anche-in-italia]]></loc><lastmod>2018-09-13T15:34:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13896-lupus-eritematoso-sistemico-possibile-il-coinvolgimento-di-batteri-intestinali]]></loc><lastmod>2018-09-06T17:55:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13865-dermatite-atopica-e-psoriasi-nuovo-ambulatorio-al-bambino-gesu]]></loc><lastmod>2019-10-16T14:43:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13844-autismo-individuati-due-geni-responsabili-della-patologia]]></loc><lastmod>2018-08-16T13:42:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13831-psoriasi-identificati-i-fattori-genetici-che-ne-determinano-lo-sviluppo]]></loc><lastmod>2018-08-09T08:40:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13787-malattia-di-crohn-e-colite-ulcerosa-costi-sociali-per-oltre-21-milioni-di-euro-l-anno]]></loc><lastmod>2018-07-30T17:21:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13770-artrite-reumatoide-sarilumab-disponibile-anche-in-italia]]></loc><lastmod>2018-07-19T11:27:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13726-diabete-al-via-la-campagna-accendi-la-testa-e-fai-girare-la-voce]]></loc><lastmod>2019-10-16T14:44:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13727-autismo-al-via-il-piu-grande-finanziamento-mondiale-per-la-ricerca-sulla-patologia]]></loc><lastmod>2018-07-04T11:03:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13702-spondilite-anchilosante-parte-la-campagna-sai-se-hai-la-sa-scegli-il-tuo-futuro]]></loc><lastmod>2020-02-27T14:21:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13677-colite-ulcerosa-e-malattia-di-crohn-profilo-di-sicurezza-migliore-per-vedolizumab-rispetto-alla-terapia-con-antagonisti-del-tnf-alfa]]></loc><lastmod>2018-06-17T17:39:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13662-malattie-reumatiche-l-appello-della-presidente-apmar-al-ministro-grillo]]></loc><lastmod>2020-02-27T12:37:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13633-obesita-liraglutide-3-mg-si-conferma-efficace-nel-ridurre-il-peso-corporeo-anche-nella-vita-reale]]></loc><lastmod>2018-06-07T11:10:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13600-fibrillazione-atriale-al-via-la-terza-edizione-di-riprenditi-la-vita]]></loc><lastmod>2018-05-26T21:16:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13610-malattie-reumatiche-il-position-paper-di-anmar-sui-farmaci]]></loc><lastmod>2019-10-16T14:43:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13577-tumori-le-malattie-reumatiche-autoimmuni-e-infiammatorie-ne-aumenterebbero-il-rischio]]></loc><lastmod>2018-05-21T09:06:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13552-malattie-reumatiche-trascurare-ritmi-circadiani-scelte-alimentari-e-microbiota-intestinale-fa-aumentare-il-rischio-di-ammalarsi]]></loc><lastmod>2018-05-11T17:54:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13487-apnee-ostruttive-nel-sonno-la-diagnosi-precoce-arriva-dal-dentista]]></loc><lastmod>2019-10-16T14:44:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13431-dermatite-atopica-l-associazione-andea-compie-un-anno]]></loc><lastmod>2019-10-16T14:45:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13430-insufficienza-renale-cronica-da-baxter-un-circuito-di-eventi-per-formare-e-informare-correttamente]]></loc><lastmod>2018-04-12T13:16:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13429-psoriasi-al-via-la-nuova-edizione-della-campagna-chiedi-al-tuo-dermatologo]]></loc><lastmod>2018-04-12T13:13:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13386-nefropatia-diabetica-complicanza-per-oltre-1-milione-di-diabetici-italiani]]></loc><lastmod>2018-03-29T16:36:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13395-autismo-troppi-paesi-senza-diagnosi-e-trattamenti]]></loc><lastmod>2018-03-29T17:54:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13365-steatoepatite-non-alcolica-nash-alnylam-e-regeneron-insieme-per-scoprire-nuovi-trattamenti]]></loc><lastmod>2018-03-22T19:33:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13366-colite-ulcerosa-e-malattia-di-crohn-dati-real-world-favorevoli-per-vedolizumab]]></loc><lastmod>2018-03-22T20:58:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13343-obesita-materna-prole-a-maggior-rischio-di-malattie-croniche]]></loc><lastmod>2018-03-15T13:00:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13299-psoriasi-a-placche-nuovi-risultati-positivi-da-secukinumab]]></loc><lastmod>2018-03-01T16:28:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13265-malattie-infiammatorie-intestinali-25-000-persone-piu-informate-grazie-ai-supereroi]]></loc><lastmod>2018-02-22T23:32:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13237-malattie-infiammatorie-croniche-il-workshop-di-economia-e-farmaci]]></loc><lastmod>2020-02-27T14:27:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13238-diabete-di-tipo-1-studio-dimostra-relazione-con-l-autoimmunita]]></loc><lastmod>2018-02-14T21:52:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13209-fibrillazione-atriale-dagli-usa-conferme-su-sicurezza-ed-efficacia-di-rivaroxaban]]></loc><lastmod>2018-02-07T18:09:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13182-malattie-infiammatorie-croniche-certolizumab-pegol-utilizzabile-anche-in-gravidanza-e-allattamento]]></loc><lastmod>2018-02-01T11:57:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13152-allergie-come-cambia-la-vita-di-chi-ne-e-afflitto]]></loc><lastmod>2018-01-27T14:00:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13144-psoriasi-conferme-di-superiorita-per-secukinumab-rispetto-a-ustekinumab]]></loc><lastmod>2018-01-24T09:42:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13124-malattie-reumatiche-la-sir-scende-in-piazza-con-la-campagna-reumadays]]></loc><lastmod>2020-02-27T14:28:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13100-malattia-di-crohn-si-studia-una-terapia-orale-che-non-preveda-immunosoppressione]]></loc><lastmod>2018-01-16T11:03:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13077-coronaropatia-e-arteriopatia-periferica-domanda-di-approvazione-usa-per-rivaroxaban]]></loc><lastmod>2017-12-30T19:31:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13078-malattia-di-crohn-opinione-positiva-del-chmp-per-darvadstrocel]]></loc><lastmod>2017-12-30T19:24:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13018-asma-grave-a-milano-il-primo-workshop-del-registro-nazionale]]></loc><lastmod>2017-12-11T17:09:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13019-obesita-grave-la-chirurgia-bariatrica-ha-effetti-positivi-anche-sul-fegato]]></loc><lastmod>2017-12-11T17:27:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13021-fibrillazione-atriale-in-italia-ne-soffre-un-anziano-su-12]]></loc><lastmod>2017-12-11T19:01:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/13001-psoriasi-ungueale-e-palmo-plantare-efficacia-a-lungo-termine-per-secukinumab]]></loc><lastmod>2017-12-07T16:24:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12965-malattie-reumatiche-un-paziente-su-tre-deve-lasciare-il-lavoro]]></loc><lastmod>2020-02-27T14:30:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12966-psoriasi-il-primo-report-globale-sull-indice-di-felicita-dei-pazienti]]></loc><lastmod>2017-11-27T23:02:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12968-malattia-di-crohn-una-diagnosi-su-5-riguarda-gli-under-18]]></loc><lastmod>2019-10-16T14:45:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12973-artrite-reumatoide-a-breve-in-italia-nuovo-farmaco-orale-per-le-forme-resistenti]]></loc><lastmod>2019-08-18T17:21:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12934-coronaropatia-e-arteriopatia-periferica-richiesta-di-approvazione-europea-per-rivaroxaban]]></loc><lastmod>2017-11-21T17:57:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12937-dermatite-atopica-da-inversa-onlus-un-sondaggio-rivolto-ai-pazienti]]></loc><lastmod>2017-11-22T16:30:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12905-spondilite-anchilosante-assenza-di-progressione-radiologica-con-secukinumab]]></loc><lastmod>2017-11-16T11:32:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12907-malattie-reumatiche-il-rapporto-we-care-mette-in-luce-le-criticita-in-italia]]></loc><lastmod>2017-11-16T16:09:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12850-autismo-la-musicoterapia-puo-aiutare-la-regolazione-emotiva-del-bambino]]></loc><lastmod>2017-10-31T15:58:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12843-rene-policistico-inserito-nei-nuovi-lea-come-malattia-cronica-e-invalidante]]></loc><lastmod>2017-10-31T11:56:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12794-psoriasi-a-raccontare-la-malattia-il-progetto-sulla-mia-pelle]]></loc><lastmod>2017-10-18T17:01:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12795-malattie-reumatiche-un-emergenza-per-oltre-5-milioni-di-italiani]]></loc><lastmod>2020-02-27T14:32:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12790-artrite-scoperto-meccanismo-che-causa-infiammazione-cronica]]></loc><lastmod>2017-10-17T18:27:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12769-malattie-infiammatorie-croniche-intestinali-al-via-in-italia-la-campagna-ibdunmasked]]></loc><lastmod>2017-10-15T10:48:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12770-artrite-reumatoide-nasce-il-progetto-di-teatroterapia-ripartiamo]]></loc><lastmod>2020-02-27T14:33:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12751-fibrillazione-atriale-parte-la-seconda-edizione-di-riprenditi-la-vita]]></loc><lastmod>2017-10-08T10:22:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12735-ictus-in-aumento-tra-i-giovani-per-l-abuso-di-alcool-e-stupefacenti]]></loc><lastmod>2019-10-16T14:47:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12737-artrite-reumatoide-nel-40-dei-pazienti-e-in-forma-precoce-e-aggressiva]]></loc><lastmod>2020-02-27T14:34:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12702-fibrillazione-atriale-rivaroxaban-approvato-in-europa-per-pazienti-con-stent]]></loc><lastmod>2017-09-26T17:50:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12658-malattia-dell-occhio-secco-shire-deposita-la-domanda-di-approvazione-europea-per-lifitegrast]]></loc><lastmod>2017-09-19T11:19:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12627-malattie-cardiovascolari-rivaroxaban-riduce-il-rischio-di-ictus-e-morte]]></loc><lastmod>2017-09-07T09:34:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12628-malattie-reumatologiche-scoperta-l-origine-di-una-grave-infiammazione-associata]]></loc><lastmod>2017-09-07T09:20:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12583-gvhd-cronica-il-farmaco-ibrutinib-approvato-negli-usa]]></loc><lastmod>2019-01-17T17:27:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12555-ictus-cerebrale-la-disfagia-si-verifica-in-circa-il-50-dei-pazienti]]></loc><lastmod>2017-08-01T15:05:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12514-artrite-reumatoide-scoperto-un-nuovo-interruttore-chiave-della-malattia]]></loc><lastmod>2017-07-16T14:54:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12496-psoriasi-aggiornate-le-indicazioni-europee-di-secukinumab]]></loc><lastmod>2017-07-12T16:50:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12474-spondilite-anchilosante-il-video-della-campagna-sai-che-la-sa]]></loc><lastmod>2020-02-27T14:38:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12450-osteoporosi-nuove-linee-guida-per-diagnosi-e-prescrizioni-corrette]]></loc><lastmod>2017-06-29T13:43:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12451-osteoporosi-in-italia-circa-4-milioni-e-mezzo-di-pazienti]]></loc><lastmod>2017-06-29T13:27:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12415-artrite-reumatoide-baricitinib-capace-di-agire-in-maniera-selettiva-su-dolore-e-fatica]]></loc><lastmod>2017-06-19T15:09:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12385-insufficienza-renale-le-ultime-innovazioni-nelle-tecniche-di-dialisi]]></loc><lastmod>2017-06-12T17:49:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12334-bpco-tutte-le-novita-dal-respiration-day]]></loc><lastmod>2017-06-01T10:19:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12309-artrite-reumatoide-fda-approva-l-anticorpo-sarilumab]]></loc><lastmod>2019-01-17T17:40:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12290-spondilite-anchilosante-non-confondiamola-con-il-mal-di-schiena]]></loc><lastmod>2020-02-27T14:41:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12281-artrite-idiopatica-dal-congresso-di-reumatologia-pediatrica-tutte-le-novita]]></loc><lastmod>2020-02-27T14:42:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12262-scompenso-cardiaco-anche-in-italia-via-libera-a-rimborsabilita-per-sacubitril-valsartan]]></loc><lastmod>2017-05-09T15:33:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12237-malattie-reumatiche-una-vita-senza-dolore-cronico-e-possibile]]></loc><lastmod>2020-02-27T14:43:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12241-malattie-reumatiche-nasce-fimr-la-federazione-italiana-che-unisce-medici-e-pazienti]]></loc><lastmod>2020-02-27T14:44:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12224-lupus-eritematoso-sistemico-in-arrivo-una-terapia-promettente-capace-di-fermarne-la-progressione]]></loc><lastmod>2017-04-27T14:39:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12216-autismo-nuova-ricerca-apre-alla-possibilita-di-prevedere-la-malattia-prima-che-si-manifesti]]></loc><lastmod>2017-04-23T14:04:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12183-psoriasi-prosegue-la-campagna-chiedi-al-tuo-dermatologo]]></loc><lastmod>2017-04-13T10:36:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12148-autismo-e-cammino-sulle-punte-dei-piedi-una-ricerca-che-aiuta-a-comprendere-e-correggere-questo-stigma-sociale]]></loc><lastmod>2017-04-07T09:13:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12158-dermatite-atopica-nasce-l-associazione-nazionale-dedicata-ai-pazienti]]></loc><lastmod>2017-04-06T07:24:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12145-autismo-ieri-la-giornata-mondiale-l-appello-congiunto-delle-associazioni-dei-pazienti]]></loc><lastmod>2017-04-03T07:47:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12137-dermatite-atopica-moderata-grave-la-fda-approva-dupilumab]]></loc><lastmod>2017-03-30T15:49:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12129-psoriasi-nuovi-dati-clinici-confermano-l-efficacia-di-secukinumab]]></loc><lastmod>2017-04-01T16:14:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12105-artrite-psoriasica-celgene-lancia-il-social-contest-light-on-psoriatic-arthritis]]></loc><lastmod>2020-02-27T14:52:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12067-psoriasi-novartis-lancia-la-campagna-chiedi-al-tuo-dermatologo]]></loc><lastmod>2017-03-14T10:44:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12075-malattia-di-crohn-e-colite-ulcerosa-due-patologie-in-aumento-soprattutto-tra-bambini-e-adolescenti]]></loc><lastmod>2017-03-16T10:10:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/12041-malattie-infiammatorie-croniche-dell-intestino-conferme-sulla-sicurezza-ed-efficacia-del-biosimilare-di-infliximab]]></loc><lastmod>2017-03-09T19:09:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11964-ipotiroidismo-levotiroxina-approvata-anche-negli-stati-uniti]]></loc><lastmod>2017-02-20T15:04:40+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11922-infezioni-intestinali-un-pool-di-esperti-europei-consiglia-il-trapianto-di-flora]]></loc><lastmod>2017-02-13T15:39:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11923-diabete-almeno-una-persona-colpita-in-ogni-famiglia]]></loc><lastmod>2017-02-13T16:08:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11927-artrite-reumatoide-e-artrite-psoriasica-quando-il-paziente-puo-sospendere-i-farmaci]]></loc><lastmod>2017-02-13T16:40:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11898-cistite-interstiziale-assegnato-a-lucia-deganutti-il-bakken-award-2016]]></loc><lastmod>2017-02-07T10:36:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11892-malattie-autoimmuni-uno-studio-conferma-la-tendenza-a-colpire-lo-stesso-soggetto-con-patologie-diverse]]></loc><lastmod>2022-10-23T13:12:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11765-tromboembolia-venosa-edoxaban-efficace-e-sicuro-anche-per-i-pazienti-a-piu-alto-rischio]]></loc><lastmod>2016-12-23T10:11:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11744-malattie-infiammatorie-autoimmuni-in-aumento-i-casi-pediatrici]]></loc><lastmod>2016-12-17T16:06:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11663-malattia-di-crohn-approvato-dalla-commissione-europea-ustekinumab]]></loc><lastmod>2016-11-27T21:35:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11639-emicrania-episodica-buoni-risultati-da-erenumab]]></loc><lastmod>2016-11-22T16:17:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11593-diabete-una-settimana-di-screening-gratuiti-ed-eventi-in-occasione-della-giornata-mondiale]]></loc><lastmod>2016-11-09T11:41:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11564-celiachia-italia-protagonista-di-uno-studio-internazionale-su-cause-e-diagnosi]]></loc><lastmod>2016-11-03T18:17:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11536-diabete-in-un-paper-la-strategia-integrata-per-il-trattamento-della-malattia]]></loc><lastmod>2016-10-28T08:15:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11499-bpco-aipo-chiede-l-eliminazione-del-piano-terapeutico-per-le-associazioni-laba-lama]]></loc><lastmod>2016-10-20T14:53:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11450-dolore-pelvico-cronico-femminile-dal-24-al-28-ottobre-open-week-all-azienda-ospedaliera-universitaria-senese]]></loc><lastmod>2016-10-13T14:16:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11447-steatoepatite-non-alcolica-buoni-risultati-per-solitromicina]]></loc><lastmod>2016-10-13T14:04:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11398-psoriasi-oltre-la-meta-dei-pazienti-non-raggiunge-l-obiettivo-terapeutico-di-una-pelle-libera-da-lesioni]]></loc><lastmod>2016-10-06T08:00:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11397-psoriasi-nuovi-dati-positivi-per-secukinumab]]></loc><lastmod>2016-10-06T07:51:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11392-cardiopatie-maria-cecilia-hospital-primo-centro-in-italia-per-numero-d-impianti-di-cardiocapsula]]></loc><lastmod>2016-10-05T15:21:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11359-insufficienza-cardiaca-partita-sperimentazione-di-fase-iii-su-vericiguat]]></loc><lastmod>2016-10-01T11:03:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11343-psoriasi-dalla-collaborazione-tra-novartis-e-ied-nasce-clearskin-lovers]]></loc><lastmod>2016-09-29T15:34:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11342-orticaria-domani-la-terza-giornata-mondiale]]></loc><lastmod>2016-09-29T15:02:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11306-bpco-terapia-di-combinazione-migliora-significativamente-la-capacita-di-esercizio]]></loc><lastmod>2016-09-23T11:07:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11165-fibrillazione-atriale-rischio-di-ictus-piu-alto-per-i-pazienti-diabetici-trattati-con-insulina]]></loc><lastmod>2016-08-30T14:38:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11164-malattie-cardiovascolari-nuova-guida-all-uso-degli-ipocolesterolemizzanti-in-add-on-alle-statine]]></loc><lastmod>2016-08-30T14:35:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11163-malattia-del-trapianto-contro-l-ospite-un-valido-aiuto-dall-infusione-di-staminali]]></loc><lastmod>2016-08-30T14:33:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11158-fibrillazione-atriale-nuove-conferme-per-rivaroxaban]]></loc><lastmod>2016-08-30T13:46:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11118-artrite-reumatoide-ema-valuta-approvazione-del-candidato-farmaco-sarilumab]]></loc><lastmod>2017-05-23T18:42:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11122-baker-la-nuotatrice-usa-medaglia-d-argento-ha-il-morbo-di-crohn]]></loc><lastmod>2016-08-12T07:04:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11112-disturbi-respiratori-nel-sonno-i-risultati-del-censimento-aipo-2015]]></loc><lastmod>2016-08-09T13:11:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11075-malattie-croniche-nasce-galvani-bioelectronics-dedicata-allo-sviluppo-di-farmaci-bioelettronici]]></loc><lastmod>2017-06-19T17:18:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11058-artrite-idiopatica-giovanile-il-costo-medio-annuale-per-paziente-varia-da-18-913-euro-in-francia-a-36-396-euro-in-svezia]]></loc><lastmod>2016-07-29T12:30:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11048-ittiosi-congenta-degli-usa-un-alleanza-per-lo-sviluppo-di-un-trattamento-efficace-per-i-pazienti]]></loc><lastmod>2016-07-29T08:52:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11034-osteoporosi-piu-politiche-di-prevenzione-colmano-il-deficit-di-vitamina-d]]></loc><lastmod>2016-07-26T13:48:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/11045-diabete-mellito-di-tipo-2-prosegue-con-successo-lo-studio-esinodop]]></loc><lastmod>2016-07-28T14:05:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10998-gravidanza-l-uso-di-lamotrigina-non-e-associato-a-un-rischio-di-schisi-oro-facciale-e-piede-torto]]></loc><lastmod>2016-07-19T14:21:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10960-sindrome-da-intestino-corto-europa-approva-il-farmaco-revestive-teduglutide-per-pazienti-pediatrici]]></loc><lastmod>2024-02-08T15:11:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10899-malattie-reumatiche-l-impatto-del-dolore-sulla-vita-sessuale-dei-pazienti]]></loc><lastmod>2016-07-01T09:51:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10925-psoriasi-i-pazienti-sono-discriminati-a-causa-delle-lesioni-alla-pelle]]></loc><lastmod>2016-07-06T21:49:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10881-edema-maculare-diabetico-al-via-il-primo-percorso-dedicato-ai-pazienti-toscani]]></loc><lastmod>2016-06-29T14:17:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10879-asma-grave-nell-adulto-e-nel-bambino-ora-disponibile-il-registro-nazionale]]></loc><lastmod>2016-06-29T14:06:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10841-dolore-cronico-alcune-cellule-del-sistema-nervoso-ne-possiedono-memoria-permanente]]></loc><lastmod>2016-06-23T10:11:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10840-trombosi-disponibile-il-primo-sistema-di-automisurazione-del-pt-inr-con-tecnologia-bluetooth-integrata]]></loc><lastmod>2016-06-23T10:09:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10838-steatosi-epatica-non-alcolica-bmi-normale-e-allattamento-al-seno-ne-riducono-il-rischio]]></loc><lastmod>2016-06-23T10:02:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10731-cura-del-dolore-da-bruxelles-le-raccomandazioni-degli-esperti-europei]]></loc><lastmod>2018-01-17T22:59:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10718-bcpo-completati-due-studi-su-terapia-di-tripla-associazione]]></loc><lastmod>2016-06-01T14:36:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10704-malattie-reumatiche-rare-la-bsr-inglese-evidenzia-il-bisogno-di-un-approccio-diagnostico-e-terapeutico-piu-efficiente]]></loc><lastmod>2016-05-27T13:28:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10685-lupus-uno-studio-identifica-i-fattori-di-rischio]]></loc><lastmod>2016-05-26T13:48:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10683-scompenso-cardiaco-novartis-crea-il-programma-clinico-fortihfy]]></loc><lastmod>2016-05-26T13:02:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10642-bpco-l-associazione-ics-laba-per-inalazione-extrafine-riduce-le-esacerbazioni]]></loc><lastmod>2016-05-18T15:26:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10641-osteoporosi-dopo-la-prima-frattura-solo-il-26-dei-soggetti-riceve-valutazioni-e-trattamenti]]></loc><lastmod>2016-05-18T15:16:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10638-l-endometriosi-deve-essere-considerata-una-malattia-invalidante]]></loc><lastmod>2016-05-18T08:12:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10562-osteoartrite-primi-dati-dalla-sperimentazione-avanzata-del-farmaco-fasinumab]]></loc><lastmod>2016-05-09T14:58:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10569-al-san-francesco-di-nuoro-organico-insufficiente-per-curare-i-bambini-autistici]]></loc><lastmod>2016-05-10T13:14:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10524-diabete-di-tipo-2-potenzialita-terapeutiche-dalla-scoperta-di-un-nuovo-ormone]]></loc><lastmod>2016-05-03T13:26:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10523-psoriasi-la-malattia-potrebbe-aumentare-il-rischio-di-aneurisma-dell-aorta]]></loc><lastmod>2016-05-03T13:22:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10529-autismo-al-via-la-seconda-fase-d-indagine-dell-osservatorio-nazionale]]></loc><lastmod>2016-05-05T13:20:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10492-malattie-coronariche-l-endometriosi-ne-aumenta-il-rischio-fino-al-200]]></loc><lastmod>2016-04-29T09:01:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10474-adhd-nuova-formulazione-del-farmaco-vyvanse-in-via-di-approvazione-negli-usa]]></loc><lastmod>2016-04-27T14:33:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10451-fibrillazione-atriale-nuovi-dati-positivi-per-rivaroxaban]]></loc><lastmod>2016-08-29T13:35:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10417-nefrite-lupica-polimorfismi-marker-predittivi-di-risposta-alla-ciclofosfamide]]></loc><lastmod>2016-04-20T13:56:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10421-diabete-giovanile-i-20-anni-dell-associazione-agd-italia]]></loc><lastmod>2016-04-20T15:02:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10315-dermatite-atopica-nuovi-dati-dalla-sperimentazione-di-fase-iii-sul-farmaco-dupilumab]]></loc><lastmod>2016-04-27T18:21:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10299-malattie-del-futuro-ai-primi-posti-obesita-malattie-metaboliche-e-del-fegato]]></loc><lastmod>2016-04-01T10:42:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10295-autismo-nasce-il-primo-pronto-soccorso-online-disponibile-24-ore-su-24]]></loc><lastmod>2016-04-01T09:11:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10288-ictus-cerebrale-i-consigli-degli-esperti-per-il-mese-della-prevenzione]]></loc><lastmod>2016-03-31T15:53:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10279-autismo-al-via-la-campagna-di-sensibilizzazione-per-l-inclusione-sociale]]></loc><lastmod>2016-03-30T13:26:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10289-colite-ulcerosa-e-morbo-di-chron-nuovi-dati-positivi-sull-efficacia-di-vedolizumab]]></loc><lastmod>2016-10-23T18:01:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10253-diabete-di-tipo-1-i-progressi-nel-campo-della-terapia-con-cellule-pancreatiche]]></loc><lastmod>2016-03-24T16:19:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10252-congiuntiviti-allergiche-nei-bambini-attenzione-alla-vernal]]></loc><lastmod>2016-03-24T16:15:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10242-bpco-e-malattie-respiratorie-croniche-esteso-il-piano-terapeutico-alle-associazioni-di-farmaci]]></loc><lastmod>2016-03-22T16:10:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10208-artrite-reumatoide-un-composto-estratto-dal-te-verde-potrebbe-diminuire-l-infiammazione-articolare]]></loc><lastmod>2017-02-13T16:14:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10205-psoriasi-secukinumab-superiore-a-ustekinumab-nel-mantenere-una-cute-esente-da-lesioni]]></loc><lastmod>2016-03-15T16:16:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10204-ipotiroidismo-assumere-la-levotiroxina-in-formula-liquida-insieme-alla-colazione-e-possibile]]></loc><lastmod>2016-03-15T16:12:34+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10203-emorragia-digestiva-la-mortalita-raddoppia-al-sud]]></loc><lastmod>2016-03-15T16:06:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10163-diabete-la-soluzione-di-fand-per-i-dispositivi-medici-in-lombardia]]></loc><lastmod>2016-03-10T16:14:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10128-artrite-reumatoide-possibile-relazione-tra-la-malattia-e-l-esposizione-alle-polveri-tessili]]></loc><lastmod>2016-03-04T15:07:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10102-artrite-reumatoide-approvata-da-fda-nuova-formulazione-di-tofacitinib]]></loc><lastmod>2018-10-11T09:16:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/10040-celiachia-l-eta-di-introduzione-del-glutine-non-riduce-il-rischio-di-sviluppare-la-malattia]]></loc><lastmod>2016-02-25T16:33:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9973-lupus-alcuni-fattori-dietetici-ridurrebbero-dosi-di-glucocorticoidi]]></loc><lastmod>2016-02-15T15:40:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9945-artrite-reumatoide-ultrasuoni-marker-responsivi-ad-abatacept]]></loc><lastmod>2016-02-11T14:26:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9896-diabete-nuove-linee-guida-aace-per-la-sua-gestione-del-diabete]]></loc><lastmod>2016-02-05T10:36:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9900-diabete-da-oggi-i-bambini-europei-hanno-accesso-ad-una-nuova-tecnologia-di-misurazione]]></loc><lastmod>2016-02-04T16:23:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9843-malattia-coronarica-in-europa-ancora-uso-inadeguato-delle-statine]]></loc><lastmod>2016-01-29T12:21:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9845-sindrome-dell-occhio-secco-shire-rideposita-la-domanda-di-registrazione-per-lifitegrast]]></loc><lastmod>2017-09-18T20:29:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9833-malattie-respiratorie-solo-il-13-dei-pazienti-aderisce-alla-terapia-costi-in-aumento-e-terapie-sbagliate]]></loc><lastmod>2016-01-28T16:47:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9841-sindrome-dell-intestino-irritabile-un-antistaminico-puo-alleviare-sintomi-e-dolore]]></loc><lastmod>2016-01-29T12:15:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9788-ictus-cerebrale-parkinson-e-alzheimer-al-centro-del-convegno-sin-sicilia]]></loc><lastmod>2016-01-21T14:44:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9744-spondilite-anchilosante-risultati-positivi-per-secukinumab]]></loc><lastmod>2016-01-13T11:33:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9742-lupus-risultati-positivi-per-anifrolumab]]></loc><lastmod>2016-01-13T11:23:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9741-malattia-di-chron-risultati-negativi-per-il-trapianto-di-cellule-staminali]]></loc><lastmod>2016-10-23T17:50:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9678-diabete-di-tipo-2-e-malattie-legate-all-obesita-da-harvard-una-terapia-rivoluzionaria]]></loc><lastmod>2015-12-28T11:21:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9672-malattie-infiammatorie-intestinale-la-guarigione-della-mucosa-e-il-nuovo-obiettivo]]></loc><lastmod>2016-10-23T17:50:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9671-artrite-reumatoide-nuovo-marker-per-il-rischio-precoce]]></loc><lastmod>2015-12-23T12:10:20+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9662-diabete-in-individui-naturalmente-protetti-dalla-malattia-si-cerca-il-segreto-per-sconfiggerlo]]></loc><lastmod>2015-12-22T11:55:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9661-diabete-in-partenza-il-progetto-di-telemedicina-dell-associazione-medici-diabetologi]]></loc><lastmod>2015-12-22T11:52:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9629-artrite-reumatoide-scoperte-tre-nuove-classi-di-molecole-efficaci-contro-i-casi-piu-critici]]></loc><lastmod>2015-12-16T10:25:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9634-malattie-infiammatorie-croniche-intestinali-i-pazienti-italiani-si-raccontano-in-un-cortometraggio]]></loc><lastmod>2015-12-17T09:11:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9628-malattia-renale-cronica-in-italia-al-primo-posto-per-rilevanza-epidemiologica-gravita-invalidita-peso-assistenziale-ed-economico]]></loc><lastmod>2015-12-16T10:10:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9533-ipotiroidismo-le-raccomandazioni-dei-medici-di-medicina-generale]]></loc><lastmod>2015-12-04T11:18:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9558-trombosi-venosa-profonda-nuove-conferme-positive-per-rivaroxaban-di-bayer]]></loc><lastmod>2015-12-11T08:53:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9520-osteoartrosi-obesita-e-sovrappeso-ne-aumentano-il-rischio]]></loc><lastmod>2015-12-03T15:09:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9507-dolore-cronico-in-arrivo-un-kit-per-misurarlo-presso-i-medici-di-base]]></loc><lastmod>2015-12-02T14:53:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9510-diabete-i-pazienti-chiedono-coerenza-al-mondo-politico]]></loc><lastmod>2015-12-02T15:48:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9509-insufficienza-renale-cronica-dal-10-forum-risk-management-in-sanita-emerge-la-necessita-di-un-pdta-a-livello-nazionale]]></loc><lastmod>2015-12-04T08:55:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9487-spondilite-anchilosante-e-artrite-psoriasica-approvato-secukinumab-in-due-nuove-indicazioni]]></loc><lastmod>2015-12-01T11:23:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9445-malattie-neurodegenerative-sviluppato-metodo-che-traccia-i-flussi-di-rifiuti-cellulari-che-le-causano]]></loc><lastmod>2015-11-25T17:15:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9441-ipertrigliceridemia-l-isobutate-sarebbe-una-terapia-efficace]]></loc><lastmod>2015-11-25T16:06:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9409-malattie-articolari-il-dr-bonomi-con-crioterapia-sistemica-possibile-remissione-dei-dolori-fino-a-un-anno]]></loc><lastmod>2022-03-28T14:16:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9422-crioterapia-sistemica-con-la-terapia-del-freddo-i-farmaci-non-sono-piu-necessari]]></loc><lastmod>2015-11-23T15:49:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9406-artrite-reumatoide-presentati-i-risultati-di-successo-dello-studio-di-fase-iii-su-sarilumab]]></loc><lastmod>2015-11-20T12:25:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9382-diabete-di-tipo-1-il-documentario-del-meyer-firmato-dal-regista-chiarini]]></loc><lastmod>2015-11-20T07:46:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9329-malattie-infettive-al-xiv-congresso-simit-presentato-il-libro-bianco]]></loc><lastmod>2015-11-10T15:49:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9297-diabete-150-minuti-di-sport-a-settimana-ne-diminuiscono-il-rischio]]></loc><lastmod>2015-11-05T11:39:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9268-artrite-reumatoide-pronta-negli-usa-la-forma-generica-del-farmaco-arava-leflunomide-di-sanofi]]></loc><lastmod>2015-10-30T10:41:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9295-bpco-roflumilast-avrebbe-maggiore-efficacia-nella-riduzione-delle-riacutizzazioni-dei-pazienti-piu-gravi]]></loc><lastmod>2015-11-05T11:18:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9260-un-farmaco-antiasmatico-potrebbe-combattere-l-invecchiamento-cerebrale]]></loc><lastmod>2015-10-30T09:36:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9232-malattia-dell-occhio-secco-battuta-d-arresto-per-l-approvazione-di-lifitegrast-negli-usa]]></loc><lastmod>2015-10-27T13:55:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9238-colite-ulcerosa-buoni-i-dati-a-lungo-termine-per-il-trattamento-con-ozanimod]]></loc><lastmod>2015-10-27T14:42:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9235-psoriasi-disponibile-la-app-psoriasis-360-per-monitorare-la-malattia]]></loc><lastmod>2015-10-27T14:25:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9234-diabete-avviato-il-progetto-internazionale-cities-changing-diabetes]]></loc><lastmod>2015-10-27T14:17:37+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9239-lipodistrofia-risultati-positivi-dal-trattamento-con-crema-a-base-di-elastargene-3c]]></loc><lastmod>2017-04-10T17:32:05+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9208-dermatite-atopica-pubblicati-i-dati-della-sperimentazione-di-fase-iib-del-farmaco-dupilumab]]></loc><lastmod>2015-10-23T08:42:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9194-diabete-di-tipo-1-nuove-speranze-per-elastargene-3c-in-bambini-e-adolescenti-con-lipodistrofia]]></loc><lastmod>2015-10-21T13:52:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9193-sensibilita-al-glutine-sempre-piu-italiani-lo-eliminano-senza-essere-intolleranti-ne-allergici]]></loc><lastmod>2015-10-21T13:43:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9191-colite-ulcerosa-e-chron-cosa-vuol-dire-ammalarsi-per-una-donna]]></loc><lastmod>2016-10-23T17:53:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9195-diabete-nuove-conferme-dal-farmaco-antidiabetico-liraglutide]]></loc><lastmod>2015-10-21T14:02:59+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9184-ipotiroidismo-presentata-al-congresso-dell-american-thyroid-association-una-ricerca-tutta-italiana]]></loc><lastmod>2015-10-20T12:55:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9181-malformazioni-vascolari-al-tg1-medicina-un-approfondimento-con-il-prof-mattassi]]></loc><lastmod>2015-10-20T10:45:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9129-infarto-nuovo-test-per-identificarlo-in-maniera-piu-rapida]]></loc><lastmod>2015-10-14T13:26:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9150-meno-infarti-ma-piu-letali-nelle-donne-ogni-anno-15mila-decessi-per-infarto]]></loc><lastmod>2015-10-14T10:11:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9149-influenza-torna-il-virus-ah1n1-del-2009-vaccinazione-fondamentale-per-le-categorie-a-rischio]]></loc><lastmod>2015-10-14T10:05:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9166-vaccini-avviata-la-campagna-vacci-a-vaccinarti-dedicata-agli-over-65]]></loc><lastmod>2015-10-16T13:37:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9130-ictus-al-congresso-sin-il-punto-sulla-nuova-frontiera-terapeutica]]></loc><lastmod>2015-10-13T15:57:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9154-vaccini-in-calo-aifa-lancia-l-allarme-l-italia-rischia-grosso]]></loc><lastmod>2015-10-14T13:21:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9146-psoriasi-la-nuova-app-che-misura-il-peso-della-malattia]]></loc><lastmod>2015-10-14T09:19:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9142-psoriasi-nuovi-dati-positivi-per-la-terapia-con-secukinumab]]></loc><lastmod>2015-10-14T09:07:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9081-broncopneumopatia-cronica-ostruttiva-bpco-nel-2030-sara-la-terza-causa-di-morte]]></loc><lastmod>2015-10-09T10:21:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9080-diabete-neonatale-l-analisi-del-genoma-rivoluziona-la-diagnosi-e-la-terapia-dei-pazienti]]></loc><lastmod>2015-10-09T10:04:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9079-asma-severo-un-paziente-su-due-continua-a-manifestare-sintomi-nonostante-le-terapie-a-base-di-broncodilatatori-e-corticosteroidi]]></loc><lastmod>2015-10-09T09:55:32+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/9023-diabete-di-tipo-2-risultati-positivi-per-empagliflozin]]></loc><lastmod>2015-10-01T15:07:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8969-artrite-reumatoide-peggiore-il-danno-articolare-se-la-malattia-si-sviluppa-in-eta-avanzata]]></loc><lastmod>2015-09-22T14:47:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8934-osteoporosi-in-aumento-i-casi-maschili]]></loc><lastmod>2015-09-18T06:51:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8933-osteoporosi-piu-colpiti-i-diabetici-di-tipo-1-e-2]]></loc><lastmod>2015-09-17T09:51:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8930-autismo-al-via-lo-screening-nei-nidi-e-nelle-scuole]]></loc><lastmod>2015-09-16T13:32:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8913-reumatologia-la-metabolomica-nuovo-possibile-approccio-di-ricerca]]></loc><lastmod>2015-09-14T14:08:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8877-diabete-di-tipo-2-chirurgia-metabolica-piu-efficace-della-terapia-medica-convenzionale]]></loc><lastmod>2015-09-07T08:30:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8894-talidomide-una-possibilita-terapeutica-per-colite-ulcerosa-uc-e-morbo-di-chron]]></loc><lastmod>2020-01-20T15:14:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8893-salute-dell-apparato-muscolo-scheletrico-il-centro-diagnostico-italiano-a-disposizione-per-consulti]]></loc><lastmod>2015-09-10T14:00:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8861-sindrome-dell-occhio-secco-nuove-prospettive-per-i-bisogni-non-soddisfatti-dei-pazienti]]></loc><lastmod>2015-09-04T10:59:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8850-diabete-novo-avvia-la-fase-iii-di-semaglutide]]></loc><lastmod>2015-09-01T08:11:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8837-lupus-erimatoso-sistemico-uno-studio-italiano-chiarisce-molti-aspetti-della-malattia]]></loc><lastmod>2015-08-28T08:33:23+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8819-malattie-neuropsichiatriche-nuova-collaborazione-tra-irccs-mario-negri-e-villa-santa-maria]]></loc><lastmod>2015-08-25T13:45:50+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8813-endometriosi-da-settembre-a-treviglio-un-ambulatorio-specifico]]></loc><lastmod>2015-08-24T14:38:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8825-colite-ulcerosa-pediatrica-risultati-promettenti-dalla-talidomide]]></loc><lastmod>2015-08-27T13:28:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8788-sensibilita-al-glutine-non-celiaca-tracciate-nuove-linee-guida-per-la-diagnosi]]></loc><lastmod>2015-08-20T12:59:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8787-artrosi-neridronato-efficace-nel-trattamento-del-dolore-acuto-al-ginocchio]]></loc><lastmod>2015-08-20T12:56:26+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8786-artrite-reumatoide-risultati-positivi-per-abatacept]]></loc><lastmod>2015-08-20T12:54:11+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8790-osteoporosi-e-artrite-reumatoide-identificati-i-fattori-d-insuccesso-terapeutico]]></loc><lastmod>2015-08-20T13:14:03+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8747-pemfigo-il-rischio-di-mortalita-aumenta-solo-dopo-i-65-anni]]></loc><lastmod>2015-07-31T13:43:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8732-lupus-epratuzumab-non-raggiunge-gli-end-point-di-efficacia-in-due-studio-di-fase-iii]]></loc><lastmod>2015-07-31T09:45:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8712-psoriasi-si-chiude-la-seconda-edizione-di-sulla-mia-pelle]]></loc><lastmod>2015-07-28T08:18:15+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8692-ricerca-traslazionale-in-reumatologia-nasce-il-primo-master-universitario-in-italia]]></loc><lastmod>2015-07-24T10:02:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8660-autismo-un-alleanza-pubblico-privato-per-la-ricerca]]></loc><lastmod>2015-07-21T10:48:47+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8651-autismo-selettivita-alimentare-non-incide-sulla-gravita-della-malattia]]></loc><lastmod>2015-07-21T08:20:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8626-osteoporosi-uricemia-influenzerebbe-il-metabolismo-osseo]]></loc><lastmod>2015-07-16T09:49:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8620-diabete-unit4-scelta-da-canadian-diabetes-association-per-supportare-l-organizzazione]]></loc><lastmod>2015-07-14T13:27:43+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8589-malattie-cardiovascolari-al-policlinico-casilino-intervento-alle-coronarie-all-avanguardia]]></loc><lastmod>2015-07-07T13:38:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8592-neuroimmunologia-due-studi-dimostrerebbero-relazione-tra-sistema-nervoso-centrale-e-quello-immunitario]]></loc><lastmod>2015-07-09T09:04:31+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8586-brainzone-una-campagna-digitale-d-informazione-per-la-salute-del-cervello]]></loc><lastmod>2015-07-07T08:30:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8544-malattie-reumatiche-al-rizzoli-medici-e-pazienti-a-confronto]]></loc><lastmod>2015-07-02T14:17:22+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8542-artrite-psoriasica-da-oggi-disponibile-un-app-per-la-gestione-della-malattia]]></loc><lastmod>2015-06-30T13:44:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8539-morbo-di-crohn-studio-cergas-indaga-il-trend-delle-ospedalizzazioni-e-degli-interventi]]></loc><lastmod>2015-06-29T13:41:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8505-gastroenterologia-e-reumatologia-a-roma-un-ambulatorio-integrato-per-le-diagnosi-difficili]]></loc><lastmod>2015-06-25T08:50:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8491-lupus-una-survey-indaga-le-problematiche-di-chi-ne-e-affetto]]></loc><lastmod>2015-06-22T10:53:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8496-tromboembolismo-venoso-bayer-estende-i-propri-studi-clinici-su-rivaroxaban]]></loc><lastmod>2015-06-22T14:52:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8507-osteoporosi-piu-a-rischio-i-pazienti-con-malattie-infiammatorie]]></loc><lastmod>2015-06-24T10:09:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8471-diabete-ecco-l-identikit-di-chi-ne-soffre]]></loc><lastmod>2015-06-19T10:28:06+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8441-diabete-di-tipo-2-perdita-di-peso-mantenuta-per-4-anni-con-dapagliflozin]]></loc><lastmod>2015-06-12T14:35:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8440-malattie-reumatiche-una-mostra-itinerante-sulla-quotidianita-di-chi-ne-soffre]]></loc><lastmod>2015-06-12T14:28:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8460-malattie-croniche-il-70-delle-famiglie-non-accede-a-programmi-di-supporto]]></loc><lastmod>2015-06-17T08:15:24+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8431-vulvodinia-un-associazione-e-una-petizione-per-farla-conoscere]]></loc><lastmod>2023-05-23T10:13:45+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8399-artrite-reumatoide-risultati-positivi-provenienti-dalla-sperimentazione-clinica-di-sarilumab]]></loc><lastmod>2015-06-05T15:00:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8414-malattia-di-crohn-uno-studio-su-un-nuovo-farmaco-apre-prospettive-di-remissione]]></loc><lastmod>2015-06-10T08:38:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8413-diabete-l-impatto-economico-nei-sistemi-sanitari-mondiali]]></loc><lastmod>2015-06-10T08:26:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8375-diabete-astrazeneca-e-altems-ucsc-insieme-per-un-progetto-di-formazione]]></loc><lastmod>2015-06-04T13:47:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8365-psoriasi-scoperti-legami-con-obesita]]></loc><lastmod>2015-06-03T15:53:00+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8367-diabete-e-insufficienza-renale-ecco-le-linee-guida-intenazionali]]></loc><lastmod>2015-06-05T07:07:17+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8362-trombosi-venosa-ed-embolia-polmonare-apixaban-rimborsato-dal-ssn]]></loc><lastmod>2015-06-03T15:03:58+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8333-psoriasi-l-importanza-di-un-trattamento-adeguato]]></loc><lastmod>2015-05-28T13:28:28+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8343-colesterolo-ldl-nuove-terapie-al-46-congresso-nazionale-anmco]]></loc><lastmod>2015-05-29T09:11:38+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8332-rene-policistico-approvato-in-europa-tolvaptan]]></loc><lastmod>2015-05-29T08:09:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8299-malattia-di-crohn-per-bambini-e-adolescenti-una-speranza-dai-farmaci-biologici]]></loc><lastmod>2016-10-23T18:15:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8306-ipertensione-polmonare-tromboembolica-cronica-ecco-la-vincitrice-del-concorso-breathless-moments]]></loc><lastmod>2015-05-28T08:41:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8283-medicina-personalizzata-astra-zeneca-amplia-le-aree-di-interesse]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8281-diabete-mellito-tipo-2-gli-usa-finanziano-innovativo-studio-che-sara-condotto-a-terni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8262-hpv-vaccinare-adolescenti-maschi-previene-i-tumori-dellorofaringe]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8264-lupus-pfizer-e-23andme-lanciano-uno-studio-per-identificare-le-basi-genetiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8217-diabete-di-tipo-2-farmaci-di-terza-linea-combinati-con-metformina-non-tutti-di-pari-efficacia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8216-diabete-di-tipo-2-dapagliflozin-meglio-di-glipizide-come-terapia-aggiuntiva-a-metformina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8219-lupus-risposta-individuale-a-rituximab-molto-variabile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8218-dolore-cronico-in-italia-pochissimi-pazienti-ricevono-una-terapia-continuativa-con-oppioidi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8225-revisione-dei-lea-la-denuncia-dei-diabetologi-mette-a-rischio-la-salute-dei-diabetici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8224-ipertensione-arteriosa-in-occasione-della-giornata-mondiale-sankyo-presenta-la-serie-web-ivan-iperteso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8175-malattie-reumatiche-riabilitazione-determinante-per-qualita-di-vita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8143-malattia-di-crohn-buoni-risultati-per-talidomide]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8165-malattie-reumatiche-presentate-le-linee-guida-per-il-corretto-uso-dei-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8097-abbattere-il-glucosio-in-eccesso-attraverso-il-rene-da-astrazeneca-la-nuova-terapia-contro-il-diabete]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8106-dolore-neuropatico-le-nuove-terapie-interventistiche-sostituiscono-quelle-farmacologiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8107-malattia-di-crohn-pubblicate-le-linee-guida-per-la-gestione-delle-fistole-perianali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8095-artrite-psoriasica-ottenuti-buoni-i-risultati-per-ixekizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8091-artrite-reumatoide-risultati-positivi-per-il-trattamento-certolizumab-dmards-non-biologici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8077-malattia-dellocchio-secco-negli-adulti-fda-accetta-la-new-drug-application-per-lifitegrast]]></loc><lastmod>2017-09-18T20:32:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8053-psoriasi-adipso-finanzia-studio-dei-geni-implicati-nel-metabolismo-osseo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8070-24-aprile-2015-giornata-mondiale-contro-la-meningite-i-vaccini-unico-strumento-di-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8023-diabete-presentato-alla-camera-il-manifesto-dei-diritti-e-dei-doveri-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8034-colon-irritabile-un-paziente-su-dieci-e-depresso]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/8028-osteoporosi-qual-e-il-ruolo-dellitalia-nella-sua-cura]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7982-malattie-reumatiche-ancora-limitate-le-sperimentazioni-sugli-interventi-di-aderenza-al-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7985-emicrania-cronica-tossina-botulinica-a-efficace-come-trattamento-nel-lungo-periodo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7984-obesita-ue-approva-liraglutide-come-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7983-lupus-dosi-elevate-di-corticosteroidi-cs-sarebbe-da-annoverare-tra-le-cause-principali-del-danno-dorgano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7952-colon-irritabile-glutine-colpevole-una-volta-su-quattro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7943-artrite-reumatoide-studio-di-fase-ii-per-il-primo-nano-anticorpo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7934-sindrome-coronarica-acuta-la-combinazione-ezetimibesimvastatina-riduce-il-rischio-cariovascolare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7900-psoriasi-online-i-cortometraggi-del-concorso-sulla-mia-pelle-promosso-da-janssen]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7894-psoriasi-secukinumab-superiore-a-ustekinumab-nella-risoluzione-delle-manifestazioni-cutanee]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7851-psoriasi-cronica-a-placche-parere-positivo-ue-per-adalimumab]]></loc><lastmod>2020-01-20T15:11:08+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7843-diabete-di-tipo-1-adiponectina-urinaria-potrebbe-predire-una-progressione-della-nefropatia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7810-diabete-di-tipo-1-promettente-nuova-insulina-il-cui-effetto-durerebbe-14-ore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7800-malattie-renali-croniche-lappello-sin-improrogabile-la-definizione-di-un-nuovo-modello-di-rete-nefrologica-nazionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7763-psoriasi-cronica-a-placche-nei-bambini-parere-positivo-del-chmp-per-adalimumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7762-fibrillazione-atriale-aggiornamento-della-scheda-tecnica-per-rivaroxaban]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7760-artrite-idiopatica-i-bambini-possono-recuperare-laltezza-perduta]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7744-sindrome-dellocchio-secco-shire-chiede-nda-per-lifitegrast]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7706-il-percorso-del-paziente-in-terapia-anticoagulante-orale-limportanza-del-rapporto-ospedale-e-territorio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7691-encefalopatia-epatica-approvata-rifaximina-550-mg]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7690-autismo-un-progetto-europeo-per-lo-sviluppo-di-politiche-assistenziali-unitarie-e-condivise]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7635-bpco-nuovi-dati-dimostrano-efficacia-di-roflumilast]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7609-artrite-psoriasica-identificate-le-varianti-genetiche-che-aumentano-il-rischio-di-sviluppare-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7623-malattie-autoimmuni-disponibile-in-italia-il-primo-anticorpo-monoclonale-biosimilare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7574-prevenzione-cardiovascolare-lanmco-lancia-la-banca-del-cuore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7577-carcinoma-timico-risultati-positivi-per-studio-di-fase-ii-di-sunitinib]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7549-fibrillazione-atriale-non-valvolare-nuovi-dati-di-sicurezza-per-rivaroxaban]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7537-2015-02-04-16-12-43]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7538-2015-02-04-16-51-55]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7474-artrite-psoriasica-conferme-per-apremilast]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7475-artrite-reumatoide-risultati-incoraggianti-per-il-farmaco-sperimentale-pf-04171327]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7477-malattia-di-crohn-buoni-i-tassi-di-recidiva-dopo-linterruzione-del-trattamento-con-anti-tnf]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7478-artrite-psoriasica-il-trattamento-precoce-con-etanercept-migliora-gli-outcome]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7437-dolore-cronico-neuropatico-biogen-chiude-accodo-con-convergence-pharmaceuticals]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7444-psoriasi-secukinumab-primo-farmaco-biologico-approvato-da-ema-come-trattamento-di-prima-linea]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7388-malattia-di-crohn-risultati-positivi-per-la-profilassi-con-farmaci-anti-tnf]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7342-artrite-reumatoide-in-gravidanza-aumenta-il-rischio-di-nascite-premature]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7220-qmalattie-cronichesempre-piu-alti-i-costi-a-carico-dei-pazientiq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7174-diabete-di-tipo-2-presentato-a-milano-il-nuovo-farmaco-alogliptin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7154-broncopneumopatia-cronica-ostruttiva-buoni-i-risultati-ottenuti-con-il-sistema-di-ventilazione-niov]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7153-psoriasi-a-placche-risultati-positivi-per-brodalumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7161-melanoma-a-rischio-anche-dinverno-le-raccomandazioni-degli-specialisti-e-un-nuovo-farmaco-qintelligenteq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7118-celiachia-individuate-reazioni-anche-nei-confronti-delle-proteine-non-glutine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7121-diabete-di-tipo-i-risultati-positivi-per-luso-di-ormd-0801]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7100-oggi-la-giornata-mondiale-del-diabete-attenzione-ai-casi-pediatrici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7076-artrite-reumatoide-xencor-rinegozia-laccordo-xmab5871-con-amgen]]></loc><lastmod>2016-05-06T16:00:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7061-diabete-di-tipo-ii-si-da-parte-dellagenzia-americana-del-farmaco-a-saxagliptin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7082-artrite-reumatoide-il-trattamento-con-abatacept-metotressato-manda-in-remissione-la-malattia-per-altri-6-mesi-dopo-la-sospensione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7083-artrite-reumatoide-il-trattamento-con-etanercept-metotressato-va-continuato-dopo-la-remissione-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7057-colite-ulcerosa-pubblicati-risultati-positivi-per-il-farmaco-rpc1063]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/7060-dolore-neuropatico-associato-a-diabete-buoni-risultati-dal-trattamento-con-mirogabalin]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6972-diabete-abbott-presenta-freestyler-libre-il-rivoluzionario-sistema-di-monitoraggio-flash-del-glucosio-da-ora-disponibile-anche-in-italia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6930-10d-giornata-mondiale-della-psoriasi-la-malattia-riconosciuta-tra-le-priorita-delloms]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6920-colon-irritabile-il-glutine-vero-colpevole-in-un-caso-su-quattro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6928-diabete-di-tipo-1-migliore-luso-di-analoghi-dellinsulina-in-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6929-diabete-di-tipo-1-novo-nordisk-alle-prese-con-la-realizzazione-dellinsulina-a-durata-dazione-super-lunga]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6938-ccsvi-ora-disponibili-le-linee-guida-internazionali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6867-artrite-psoriasica-lintervista-a-ignazio-olivieri]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6868-artrite-psoriasica-lintervista-a-mariagrazia-pisu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6879-pemfigo-volgare-al-via-lo-studio-di-fase-iii-su-atumumab-di-stiefel]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6883-artrite-psoriasica-divulgato-documento-di-approfondimento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6822-artrite-psoriasica-ustekinumab-ottiene-lapprovazione-per-lartrite-psoriasica-attiva]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6782-prevenzione-personalizzata-delle-malattie-croniche-al-via-alluniversita-cattolica-progetto-internazionale-precedi-finanziato-da-ue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6772-malattia-di-crohn-emesso-consenso-internazionale-su-classificazione-diagnosi-e-trattamento-di-fistole-perianali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6787-orticaria-oggi-la-prima-giornata-mondiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6770-psoriasi-a-placche-buoni-risultati-per-ponesimod-ma-actelion-pharmaceuticals-non-intende-proseguire-gli-studi-per-questa-indicazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6764-epilessie-infantili-le-mutazioni-che-causano-caos-nel-cervello]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6672-malattia-di-crohn-responsabili-le-epimutazioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6627-insufficienza-renale-cronica-approvata-la-commercializzazione-di-velphoro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6583-prevenire-le-malattie-croniche-lobiettivo-della-ricerca-biomedica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6562-edema-maculare-diabetico-approvato-in-europa-il-farmaco-eylea]]></loc><lastmod>2015-11-11T17:14:39+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6532-epatite-b-accesso-facilitato-al-tenofovir-alafenamide-nei-paesi-in-via-di-sviluppo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6533-celiachia-patologia-in-rapido-aumento-anche-in-asia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6456-insufficienza-renale-cronica-in-lazio-avviato-un-programma-di-assistenza-domiciliare-grazie-a-baxter]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6365-ipotiroidismo-la-terapia-non-va-sospesa-in-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6330-malattia-di-crohn-chi-assume-un-farmaco-anti-tnf-deve-continuare-la-terapia-con-gli-immunomodulatori]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6357-neovascolarizzazione-coroideale-secondaria-a-miopia-patologica-mcnv-ranibizumab-e-ora-rimborsato-dal-sistema-sanitario-nazionale-per-il-trattamento-della-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6341-ipertensione-arteriosa-un-test-genetico-rileva-il-rischio-di-sviluppare-questa-condizione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6303-malattie-gastrointestinali-e-reumatologiche-confermate-cause-comuni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6261-obesita-e-dolore-cronico-unaccoppiata-spesso-sottovalutata]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6137-lautocontrollo-nel-diabete-primo-studio-italiano-in-real-world-analizza-i-dati-di-circa-4000-pazienti-presso-un-campione-di-asl-italiane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6142-colite-ulcerosa-e-morbo-di-chron-approvato-in-europa-il-trattamento-con-vedolizumab]]></loc><lastmod>2016-10-23T18:30:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6064-lupus-erimatoso-sistemico-le-rare-manifestazioni-neonatali-e-la-correlazione-con-la-sindrome-di-sjogren]]></loc><lastmod>2019-06-18T18:19:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6066-dolore-cronico-una-nuova-possibilita-per-chi-ne-soffre-viene-dalla-stimolazione-midollare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6077-sport-e-disabilita-la-pratica-della-vela-nella-paraparesi-spastica-ereditaria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6039-ipertensione-arteriosa-10d-giornata-mondiale-contro-la-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6041-sindrome-da-secchezza-oculare-nuovi-risultati-positivi-per-il-trattamento-con-lifitegrast]]></loc><lastmod>2019-06-18T18:21:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6028-acondroplasia-firmato-protocollo-tra-acondroplasia-insieme-per-crescere-e-istituto-g-pini-di-milano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/6010-malattia-di-chron-operazione-da-25-miliardi-di-dollari-per-il-farmaco-ged-0301]]></loc><lastmod>2016-10-23T17:55:02+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5951-merck-e-pfizer-stringono-accordo-contro-lupus-e-nefrite-lupica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5938-sindrome-metabolica-in-corso-di-artrite-reumatoide-lidrossiclorochina-sembra-prevenirne-linsorgenza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5880-diabete-di-tipo-2-simvastatina-e-bezafibrato-potenziano-lattivita-hdl]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5881-artrite-reumatoide-risultati-positivi-per-olokizumab-vengono-da-uno-studio-americano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5832-la-dieta-mediterranea-riduce-linfiammazione-cronica-silente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5803-malattia-di-crohn-e-colite-ulcerosa-il-trattamento-prolungato-con-vedolizumab-porta-alla-remissione-clinica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5820-qautismo-vaccini-allarme-infondatoqlassociazione-culturale-pediatri-si-esprime]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5817-2-aprile-giornata-mondiale-dellautismo-al-bambin-gesu]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5782-vaccini-e-autismo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5774-artrosi-e-malattie-reumatiche-attivo-da-aprile-presso-laou-senese-il-centro-di-diagnosi-e-trattamento-dellartrosi-della-mano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5772-vaccini-e-autismo-nessuna-correlazione-lo-comunica-liss]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5768-malattia-di-crohn-e-colite-ulcerosa-parere-positivo-del-chmp-in-europa-per-il-trattamento-con-entyvior-vedolizumab]]></loc><lastmod>2016-10-23T18:22:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5720-vivere-con-il-diabete-controllo-e-liberta-per-affrontare-la-malattia-serenamente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5717-cannabinoidi-approvato-anche-in-italia-luso-terapeutico-via-libera-alle-prescrizioni]]></loc><lastmod>2017-10-19T18:08:29+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5714-a-caccia-dei-sensori-molecolari-antiobesita-alla-cattolica-di-roma-avviato-un-progetto-contro-lobesita-patologica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5673-morbo-di-crohn-e-rettocolite-ulcerosa-attivo-nuovo-servizio-di-diagnosi-precoce-della-asl-roma-a]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5618-artrite-reumatoide-eular-aggiorna-su-efficacia-e-sicurezza-dei-trattamenti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5616-artrite-reumatoide-studio-ricerca-fattori-predittivi-di-risposta-alle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5610-dolore-neuropatico-periferico-stimolazione-del-nervo-risulta-efficace]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5486-linee-guida-anticolesterolo-europa-e-usa-divergono]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5485-diabete-di-tipo-2-astrazeneca-ha-rilevato-i-prodotti-della-bristol-myers-squibb]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5439-diabete-e-malattie-croniche-il-ssn-risparmia-grazie-a-un-kit-di-dispositivi-medici-certificati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5396-morbo-di-crohn-dagli-stati-uniti-nuove-linee-guida]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5371-cure-palliative-in-italia-230-strutture-per-oltre-2500-posti-letto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5334-asma-broncopneumopatia-enfisema-polmonare-piu-vicini-a-terapie-personalizzate-ed-efficaci]]></loc><lastmod>2017-06-19T17:15:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5319-autismo-possibili-benefici-dallimpiego-di-ossitocina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5321-malattie-croniche-intestinali-dalleccellenza-forlivese-la-creazione-di-un-registro-regionale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5280-malattia-renale-cronica-nel-nostro-paese-sono-due-milioni-e-200000-le-persone-a-soffrirne]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5230-malattie-reumatiche-lobesita-impedisce-il-successo-delle-terapie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5199-diabete-di-tipo-ii-farmaci-insulino-sensibilizzanti-riducono-il-rischio-cancro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5185-artrite-reumatoide-esiti-promettenti-dallutilizzo-congiunto-di-adalimumab-e-metotressato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5186-colite-ulcerosa-e-malattia-di-crohn-esperti-dellfda-esprimono-parere-positivo-in-merito-a-vedolizumab]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5164-malattie-croniche-i-pazienti-italiani-costretti-a-pagare-1600-euro-lanno-per-cure-e-farmaci]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5179-insufficienza-renale-cronica-la-dialisi-peritoneale-rimane-la-terapia-migliore-per-preparare-i-pazienti-al-trapianto-e-per-garantire-una-qualita-di-vita-migliore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5129-diabete-i-pazienti-italiani-sono-tra-i-piu-depressi-e-discriminati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/5013-diabete-di-tipo-2-il-primo-studio-per-un-target-glicemico-ad-hoc-per-i-pazienti-anziani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4968-malattia-di-crohn-adalimumab-mantiene-la-malattia-in-remissione-fino-a-4-anni]]></loc><lastmod>2016-10-23T17:57:10+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4971-diabete-cellule-trans-fanno-da-scudo-contro-la-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4920-diabete-di-tipo-2-al-via-uno-studio-sullimportanza-della-vitamina-d-nella-prevenzione-della-malattia]]></loc><lastmod>2019-06-19T08:16:01+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4939-malattie-neurodegenerative-congresso-sin-a-milano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4894-palermo-in-prima-fila-nella-lotta-al-diabete-con-uniniziativa-di-sensibilizzazione-della-cittadinanza-sulla-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4892-celiachiail-regolamento-europeo-potrebbe-danneggiare-i-pazienti-la-camera-discute-cinque-mozioni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4889-malattie-infettive-al-san-raffaele-di-milano-800-specialisti-nel-ricordo-di-carlo-urbani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4887-diabete-giovanile-nuove-prospettive-terapeutiche-grazie-al-supporto-del-mayer-di-firenze]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4866-diabete-dallumbria-una-proposta-di-legge-ad-hoc]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4801-malattie-infiammatorie-croniche-intestinali-al-via-il-progetto-db-mici-in-liguria]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4754-malattie-reumatiche-da-apmar-associazione-persone-con-malattie-reumatiche-una-campagna-di-sensibilizzazione-per-i-pazienti-piu-piccoli]]></loc><lastmod>2020-02-27T12:44:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4734-insufficienza-renale-cronica-presentato-un-nuovo-sito-dedicato-alla-malattia]]></loc><lastmod>2019-06-19T08:18:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4710-obesita-infantile-la-misurazione-della-circonferenza-addominale-e-un-indicatore-utile-anche-nei-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4689-edema-maculare-diabetico-nuovi-dati-positivi-per-il-trattamento-con-vegf-trap-eye-aflibercept]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4670-carcinoma-della-prostata-lue-ha-raccomandato-per-lapprovazione-il-radio-223-dicloruro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4640-colite-ulcerosa-e-malattia-di-crohn-esiti-positivi-dalla-sperimentazione-del-farmaco-vedolizumab]]></loc><lastmod>2019-06-19T08:23:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4547-edema-maculare-secondario-bayer-riceve-lapprovazione-per-la-nuova-indicazione-di-eylea-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4473-autismo-la-regione-lombardia-chiede-il-riconoscimento-inps]]></loc><lastmod>2019-06-19T08:27:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4459-cure-palliative-a-genova-piu-sostegno-ai-pazienti-grazie-alla-convezione-ghirotti-regione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4468-diabete-da-shire-il-progetto-healtoghether-per-prevenire-le-ulcere-da-piede-diabetico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4434-edema-maculare-presto-aflibercept-disponibile-in-europa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4437-anziani-e-farmaci-studio-aifa-analizza-la-correttezza-delle-cure-nella-popolazione-over-65]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4423-diabete-di-tipo-2-al-via-al-primo-studio-clinico-per-azp-531]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4341-neovascolarizzazione-coroidealie-miopica-ranibizumab-approvato-in-ue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4319-malattie-croniche-concessa-autorizzazione-a-due-farmaci-biosimilari-per-le-malattie-autoimmuni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4305-malattie-reumatiche-croniche-oltre-100-mila-pazienti-non-hanno-accesso-ai-farmaci-biologicimalattie-reumatiche-croniche-oltre-100-mila-pazienti-non-hanno-accesso-ai-farmaci-biologici]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4310-malattie-croniche-accordo-tra-gemelli-e-bambino-gesu-per-tutelare-i-pazienti-che-diventano-adult]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4247-diabete-la-nanotecnologia-in-futuro-aiutera-i-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4216-psoriasi-disponibili-le-linee-guida-dellistituto-superiore-di-sanita]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4175-immunologia-studio-inglese-cerca-di-individuare-varianti-geniche-che-predispongono-al-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4180-neovascolarizzazione-coroidea-miopica-positivi-risultati-del-trial-con-vegf-trap-eye]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4133-autismo-dal-20-maggio-al-1-giugno-la-campagna-nazionale-per-la-ricerca]]></loc><lastmod>2019-06-19T08:34:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4094-diabete-al-via-la-campagna-diabete-insieme]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4093-artrite-reumatoide-no-dellema-a-xelianz-per-le-forme-moderate-o-gravi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/4075-celiachia-uno-studio-italiano-permette-la-diagnosi-precoce-con-un-nuovo-test]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3926-diabete-ricordi-serve-piu-in-prevenzione-e-ricerca-sulle-terapie-avanzate-ma-la-complessita-regolamentare-e-i-tempi-di-sviluppo-rendono-i-costi-sempre-e-piu-insostenibili]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3884-artrite-pediatrica-colpiti-10-mila-bambini-necessaria-diagnosi-precoce-e-percorsi-terapeutici-adeguati]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3701-celiachia-dalla-svezia-unipotesi-si-puo-prevenire-aggiungendo-glutine-nella-prima-nutrizione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3648-malattie-infiammatorie-croniche-intestinali-in-italia-almeno-200000-pazienti]]></loc><lastmod>2016-10-23T18:24:14+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3667-malattie-croniche-in-lombardia-avviato-il-telemonitoraggio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3625-malattie-croniche-la-medicina-rigenerativa-apre-nuove-prospettive]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3626-diabete-il-piano-nazionale-e-diventato-legge-dopo-26-anni]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3542-artrite-idiopatica-infantile-il-farmaco-canakinumab-di-novartis-allevia-i-sintomi-dei-pazienti-gravi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3523-artrite-reumatoide-risultati-positivi-per-la-terapia-con-rituximab-e-metotressato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3507-epatite-b-dal-regno-unito-le-linee-guida-per-la-pratica-clinica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3489-diabete-mellito-in-umbria-una-proposta-di-legge-per-la-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3415-morbo-di-chron-approvato-in-europa-il-trattamento-con-adalimumab-per-i-pazienti-pediatrici]]></loc><lastmod>2016-10-23T17:48:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3297-diabete-di-tipo-2-un-paziente-su-tre-e-over-65]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3276-embolia-polmonare-e-trombosi-venosa-profonda-rivaroxaban-raccomandato-in-europa]]></loc><lastmod>2016-08-29T13:37:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3228-diabete-tipo-2-approvata-in-europa-una-nuova-molecola]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3213-sindrome-del-colon-irritabile-il-male-non-e-tutto-nella-testa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3187-sindrome-metabolica-a-rischio-le-donne-che-si-sottopongono-a-terapia-ormonale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3163-artrite-reumatoide-nuove-conferme-per-luso-di-metotrexato]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3161-morbo-di-crohn-e-colite-ulcerosa-scoperti-71-nuovi-geni-associati-alle-patologie]]></loc><lastmod>2016-10-23T17:59:13+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3128-lupus-eritematoso-sistemico-e-aumento-del-rischio-di-preeclampsia-in-gravidanza]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3056-diabete-di-tipo-2-attenzione-alle-fluttuazioni-glicemiche]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3034-lupus-eritematoso-sistemico-il-ruolo-potenziale-della-vitamina-d]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3049-morbo-di-crohn-individuata-una-nuova-potenziale-terapia-farmacologica]]></loc><lastmod>2019-06-19T08:36:18+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3031-demenze-isolato-un-nuovo-gene-da-un-team-tutto-italiano]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3021-malattia-di-pelizaeus-merzbacher-fatto-il-primo-passo-verso-il-trapianto-di-staminali-neurali-nei-bambini]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/3000-diabete-malattie-cardiovascolari-e-cancro-al-seno-sono-legate-ad-uno-stesso-ormone-62857055]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2986-diabete-malattie-cardiovascolari-e-cancro-al-seno-sono-legate-ad-uno-stesso-ormone]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2983-emicrania-cronica-arriva-il-neurostimolatore-piu-piccolo-del-mondo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2914-diabete-di-tipo-2-i-batteri-intestinali-rivelano-la-presenza-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2897-neurologia-fino-al-9-ottobre-il-congresso-della-sin-a-rimini-preside-giancarlo-comi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2893-prevenzione-ictus-trombosi-venosa-profonda-ed-embolia-polmonare-in-italia-si-aspetta-ancora-lapprovazione-dellaifa-per-il-rivaroxaban]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2882-malattie-croniche-la-diagnosi-prenatale-e-possibile]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2866-diabete-individuato-il-gene-che-causa-la-sensibilita-allinsulina]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2803-prevenire-il-diabete-si-puo-guarda-che-cosa-mangi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2811-malattia-coronarica-pronto-il-primo-dispositivo-bioriassorbibile]]></loc><lastmod>2015-05-28T14:15:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2767-retina-il-ranibizumab-mostra-benefici-per-tre-diverse-patologie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2681-diabete-di-tipo-2-piu-a-rischio-messicani-e-americani-discendenti-da-tribu-amerindie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2679-diabete-vicina-la-possibilita-di-controllare-il-glucosio-da-saliva-e-lacrime]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2635-diabete-e-ipertensione-assumere-uova-in-gravidanza-puo-aiutare-la-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2652-taranto-tumori-tirelli-da-studio-cro-nessun-incremento-cancro-al-polmone-rispetto-a-media-sud]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2609-celiachia-un-milione-e-mezzo-di-americani-non-sa-di-esserne-affetto]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2584-epatite-b-un-percorso-web-per-aiutare-pazienti-e-medici-nella-gestione-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2460-distonia-focale-la-tossina-botulinica-rappresenta-un-trattamento-efficace]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2470-disabili-e-malati-cronici-bolletta-energetica-da-oltre-1150-allanno]]></loc><lastmod>2019-06-19T08:37:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2451-malattie-croniche-intestinali-a-forli-linfermiere-diventa-case-manager]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2452-malattie-croniche-intestinali-a-forli-linfermiere-diventa-case-manager-63845825]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2450-malattie-croniche-presto-i-pazienti-saranno-monitorati-grazie-a-una-speciale-t-shirt]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2431-osteoporosi-in-europa-costa-gia-36-miliardi-lanno-ma-la-situazione-peggiorera-con-linvecchiamento-della-popolazione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2409-epatite-d-negli-usa-linterferone-si-inietta-con-un-device-a-rilascio-automatico]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2373-artrite-reumatoide-potrebbe-essere-innescata-dai-batteri-intestinali]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2327-cancro-al-seno-diagnosticabile-con-un-esame-del-sangue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2296-epatite-b-test-gratuiti-a-milano-bergamo-e-brescia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2259-ictus-da-fibrillazione-al-via-liniziativa1-missioni-1-million-per-finanziare-ricerca-e-prevenzione]]></loc><lastmod>2017-06-27T14:46:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2231-lupus-giovanile-dagli-usa-piani-terapeutici-ad-hoc-per-la-nefrite]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2244-cresce-la-rete-per-la-giornata-del-sollievo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2238-malattie-renali-croniche-ne-sono-affetti-42-mila-italiani]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2228-dolore-cronico-il-27-maggio-la-giornata-nazionale-del-sollievo-104-ospedali-con-il-bollino-rosa]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2201-malattie-reumatiche-croniche-costano-piu-di-4-milardi-di-euro-lanno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2171-diabete-e-insufficienza-renale-disponibile-la-terapia-no-limits]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2191-epatite-b-fino-al-15-giugno-il-test-gratis-in-15-citta-italiane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2167-broncopneumopatia-cronica-ostruttiva-bpco-i-fumatori-piu-soggetti-alla-patologia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2183-tiroide-al-via-la-settimana-dedicata-al-gemellinvisite-gratis-per-donne-gravide-onche-cercano-un-figlio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2140-nevralgia-del-trigemino-lacosamide-puo-ridurre-il-dolore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2125-malattie-croniche-complesse-colpiscono-1-bambino-su-200]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2042-artrite-reumatoride-le-raccomandazioni-per-la-gestione-del-dolore]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2084-nube-verde-su-mosca-incidente-chimico-no-e-solo-colpa-delle-betulle-il-rischio-sono-le-allergie]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2054-pemfigo-volgare-scoperto-il-gene-che-la-controlla]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2050-artrosi-alle-mani-il-2-maggio-visite-gratis-in-5-citta-italiane]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1980-sindrome-di-tourette-i-tic-oculari-sono-un-sintomo-della-malattia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2006-sullhimalaya-con-il-diabete-di-tipo-1-segui-il-viaggio-di-4-alpinisti-sul-blog-ottomilaventisette]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/2020-patologie-cardiache-ora-a-disposizione-la-carta-globale-del-paziente]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1962-lupus-erimatoso-a-disposizione-dei-test-per-valutare-la-condizione-neurologica-globale-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1959-linfoma-di-hodkin-ridurre-la-dose-di-chemioterapia-puo-essere-efficace-oltre-che-sicuro]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1935-embolia-polmonare-la-terapia-con-rivaroxaban-per-via-orale-puo-semplificare-il-trattamento]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1946-malattie-della-tiroide-in-7-giorni-la-diagnosi-visite-gratis-nella-settimana-della-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1934-il-cancro-si-potra-trattare-come-una-malattia-cronica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1954-malattie-reumatiche-croniche-cittadinanzattiva-devono-essere-prioritarie-per-la-sanita-pubblica]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1916-diabete-di-tipo-1-approvata-la-sperimentazione-clinica-di-pancreas-artificiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1923-autismo-al-via-una-ricerca-internazionale-che-coinvolgera-litalia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1885-diabete-tipo-2-si-puo-combattete-con-la-chirurgia-anti-obesita-lo-dice-studio-condotto-al-gemelli]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1837-broncopneumopatia-cronica-ostruttiva-un-nuovo-modello-per-la-gestione-dei-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1814-malattie-croniche-nasce-litalian-wellness-alliance-per-promuovere-la-cura-della-prevenzione]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1803-mal-di-schiena-scoperta-molecola-responsabile-dellinvecchiamento-della-colonna-vertebrale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1790-celiachia-denunciato-il-businnes-del-senza-glutine-che-svuota-il-portafogli-dei-presunti-pazienti]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1773-lotta-al-diabete-verso-la-partnership-tra-italia-e-qatar]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1657-morbo-di-crohn-e-coliti-le-cure-alternative-possono-vanificare-i-trattamenti-farmacologici]]></loc><lastmod>2016-10-23T18:34:52+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1614-artrite-reumatoide-risultati-deludenti-per-il-trattamento-con-apilimod]]></loc><lastmod>2017-05-17T13:55:33+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1529-enhancer-hs-12-interruttore-genetico-che-rende-il-lupus-qferoceq]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1478-trombosi-xarelto-ottiene-due-nuove-indicazioni-terapeutiche-in-ue]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1460-malattie-croniche-a-roma-uno-sportello-dedicato-promosso-da-sipmed]]></loc><lastmod>2019-01-03T18:17:25+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1346-tumore-al-collo-dellutero-dal-lancet-oncology-conferme-per-il-vaccino-cevarix]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1309-diabete-1-una-giornata-normale-grazie-al-pancreas-artificiale]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1059-celiachia-nuova-normativa-ue-sulle-etichette-potrebbe-essere-un-rischio]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/1002-celiachia-nelle-donne-potrebbe-provocare-infertilita-che-passa-con-una-dieta-senza-glutine]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/900-malattie-croniche-italia-a-macchia-di-leopardo-sulla-medicina-di-genere]]></loc><lastmod>2018-10-31T18:16:54+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/873-speciale-spoletoscienza-hanson-malattie-non-trasmissibili-come-diabete-e-cardiovascolari-sono-destinate-a-crescere]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/783-tumori-cerebrali-pediatrici-valutazione-dello-sviluppo-neurocognitivo-primo-passo-della-terapia]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/739-tumore-del-rene-anche-in-italia-il-pazopanib-rallenta-la-progressione-di-quasi-un-anno]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/529-lupus-approvato-negli-usa-un-nuovo-farmaco-prodotto-da-hgs-e-glaxo]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/499-diabete-mellito-tipo-2-italiani-scoprono-possibile-gene-coinvolto-grazie-allo-studio-sulle-malattie-rare]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/altre-malattie-croniche/417-lupus-individuato-il-difetto-di-regolazione-degli-anticorpi]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibrosi-polmonare-idiopatica-che-cose]]></loc><lastmod>2023-04-11T18:02:19+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-alzheimer-che-cose]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-creutzfeldt-jakob-che-cose]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/hiv-e-aids-cosa-sono]]></loc><lastmod>2018-01-16T11:33:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/ipertensione-polmonare-tromboembolica-cronica-cteph-che-cose]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/discinesia-tardiva-che-cose]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sensibilita-chimica-multipla-che-cose]]></loc><lastmod>2016-03-10T15:33:51+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sla-che-cose]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/ipertensione-arteriosa-polmonare-cose]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/distress-respiratorio-neonatale-che-cose]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sindrome-di-hunter-mucopolisaccaridosi-tipo-ii-che-cose]]></loc><lastmod>2018-11-15T11:17:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/farmaci-orfani-cosa-sono]]></loc><lastmod>2017-11-27T21:55:04+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/tumori-della-testa-e-del-collo-cosa-sono]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sindromi-del-cromosoma-14-che-cosa-sono]]></loc><lastmod>2015-05-23T09:28:27+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sindrome-da-stanchezza-cronica-che-cose]]></loc><lastmod>2016-05-06T15:19:49+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sla-che-cose-19067]]></loc><lastmod>2016-05-06T15:19:09+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/talassemia-che-cose]]></loc><lastmod>2018-12-19T18:57:46+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sindrome-di-rett-che-cose]]></loc><lastmod>2016-03-10T13:52:07+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-pompe-che-cose]]></loc><lastmod>2018-03-09T10:48:36+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-parkinson-che-cose]]></loc><lastmod>2018-10-01T08:46:21+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/sindorme-dellx-fragile-che-cose]]></loc><lastmod>2016-03-09T16:50:35+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/algodistrofia-che-cose]]></loc><lastmod>2015-06-05T16:31:48+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/fibrosi-cistica-che-cose]]></loc><lastmod>2016-03-10T14:11:16+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-fabry-che-cose]]></loc><lastmod>2016-03-10T14:17:41+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-gaucher-che-cose]]></loc><lastmod>2018-03-09T10:48:55+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/malattia-di-huntington-che-cose]]></loc><lastmod>2017-04-23T18:16:57+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/cosa-sono-le-malattie-rare]]></loc><lastmod>2017-05-15T10:56:44+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/cosa-sono-i-tumori-rari]]></loc><lastmod>2017-08-10T10:33:30+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/il-progetto]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/il-progetto/17-chi-siamo]]></loc><lastmod>2025-12-16T08:50:56+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/comitato-scientifico]]></loc><lastmod>2026-03-30T15:33:53+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/contatti]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/contatti/136-contatti]]></loc><lastmod>2025-02-05T08:44:12+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/documenti]]></loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.osservatoriomalattierare.it/translate-in-your-language]]></loc><lastmod>2023-06-28T10:57:42+00:00</lastmod><changefreq>weekly</changefreq><priority>0.5</priority></url></urlset>